EU Local Number	Report Type	EV Gateway Receipt Date	Primary Source Qualification	Primary Source Country for Regulatory Purposes	Literature Reference	Patient Age Group	Patient Age Group (as per reporter)	Parent Child Report	Patient Sex	Reaction List PT (Duration - Outcome - Seriousness Criteria)	Suspect/interacting Drug List (Drug Char - Indication PT - Action taken - [Duration - Dose - Route])	Concomitant/Not Administered Drug List (Drug Char - Indication PT - Action taken - [Duration - Dose - Route])	ICSR Form	Vaccine	Downloaddate
EU-EC-10014735204	Spontaneous	2023-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	ADJUPANRIX [A/VIETNAM/1194/2004 (H5N1) LIKE STRAIN USED (NIBRG-14), POLYSORBATE 80, SQUALENE, SPLIT INFLUENZA VIRUS (INACTIVATED) OF STRAIN A/VIETNAM/1194/2004 (H5N1) LIKE STRAIN USED (NIBRG-14), DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Unknown - [n/a - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014735204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10010843645	Spontaneous	2021-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Heart rate increased (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypertension (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	ADJUPANRIX [A/VIETNAM/1194/2004 (H5N1) LIKE STRAIN USED (NIBRG-14), POLYSORBATE 80, SQUALENE, SPLIT INFLUENZA VIRUS (INACTIVATED) OF STRAIN A/VIETNAM/1194/2004 (H5N1) LIKE STRAIN USED (NIBRG-14), DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010843645&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001386103	Spontaneous	2018-05-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dizziness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sinus node dysfunction (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	AFLUNOV [A/VIETNAM/1194/2004 (H5N1) LIKE STRAIN USED (NIBRG-14), SORBITAN TRIOLEATE, POLYSORBATE 80, SQUALENE, A/TURKEY/TURKEY/1/05 (H5N1)-LIKE STRAIN (NIBRG-23)] (S - Immunisation - Unknown - [n/a - .5mL - Intramuscular])|AFLUNOV [A/VIETNAM/1194/2004 (H5N1) LIKE STRAIN USED (NIBRG-14), SORBITAN TRIOLEATE, POLYSORBATE 80, SQUALENE, A/TURKEY/TURKEY/1/05 (H5N1)-LIKE STRAIN (NIBRG-23)] (S - n/a - Unknown - [n/a - .5mL - Intramuscular])|LYRICA [PREGABALIN] (S - Product used for unknown indication - Dose reduced - [n/a - n/a - Oral])|LYRICA [PREGABALIN] (S - n/a - Dose reduced - [n/a - 150mg - n/a])|[SOTALOL, SOTALOL HYDROCHLORIDE] (S - Hypertension - Drug withdrawn - [24d - 40mg - Unknown])	[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[MICRONISED SPIRONOLACTONE, POTASSIUM CANRENOATE, SPIRONOLACTONE, SPIRONOLACTONE BP] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[MOXONIDINE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001386103&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11971145	Spontaneous	2017-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Intervertebral disc protrusion (134d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Intestinal haemorrhage (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Renal failure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	AFLUNOV [A/VIETNAM/1194/2004 (H5N1) LIKE STRAIN USED (NIBRG-14), SORBITAN TRIOLEATE, POLYSORBATE 80, SQUALENE, A/TURKEY/TURKEY/1/05 (H5N1)-LIKE STRAIN (NIBRG-23)] (S - Immunisation - Unknown - [n/a - n/a - Intramuscular])|CELLCEPT [MYCOPHENOLATE MOFETIL] (S - Graft versus host disease - Dose not changed - [n/a - 500mg - n/a])|NOXAFIL [POSACONAZOLE] (S - Prophylaxis - Dose not changed - [n/a - 100mg - Unknown])|PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (S - Prophylaxis - Dose not changed - [n/a - 40mg - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/FLORIDA/4/2006), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), ANTIGENS OF THE INFLUENZA VIRUS A/CALIFORNIA/7/2009 (H1N1)-LIKE VIRUS PDM09, ANTIGENS OF THE INFLUENZA VIRUS A/VICTORIA/361/2011 (H3N2)-LIKE VIRUS, ANTIGENS OF THE INFLUENZA VIRUS B/WISCONSIN/1/2010-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/WISCONSIN/67/2005 REASS. NYMCX-161-B), A/SOLOMON ISLANDS/3/2006 (H1N1) - LIKE STRAIN (A/SOLOMON ISLANDS/3/2006 REASS. IVR-145), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE STRAIN (A/CALIFORNIA/7/2009, X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), SQUALENE, SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/BRISBANE/9/2014 (WILD TYPE), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/BRISBANE/9/2014 (WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), SQUALENE, SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/MASSACHUSETTS/2/2012-LIKE STRAIN USED B/MASSACHUSETTS/2/2012 WILD TYPE, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)] (S - Immunisation - Unknown - [n/a - n/a - Intramuscular])|[AMPHOTERICIN B, AMPHOTERICINE B, LIPOSOME] (S - Prophylaxis - Dose not changed - [n/a - 10mg - n/a])|[COLISTIMETHATE SODIUM] (S - Prophylaxis - Dose not changed - [n/a - 1{DF} - Unknown])|[EVEROLIMUS] (S - Product used for unknown indication - Dose not changed - [n/a - .1mg - Unknown])|[FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE] (S - Product used for unknown indication - Dose not changed - [n/a - 12ug - Unknown])|[PRAVASTATIN, PRAVASTATIN SODIUM] (S - Hypercholesterolaemia - Dose not changed - [n/a - 20mg - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11971145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003057320	Spontaneous	2019-02-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003057320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8199234	Spontaneous	2014-07-29 00:00:00	Healthcare Professional	Non European Economic Area	Van Ussel I et al, Encephalitis related to a H1N1 vaccination: case report and review of the literature, Clinical Neurology and Neurosurgery, 124 2014 8-15 Lapphra et al. Adverse  neurologic reactions after both doses of Pandemic H1N1influenza vaccine with optic and demyelination. Pediatric infectious disease journal Jan2010;30 (1):1-2 J-P Stübgen, A literature review on optic neuritis following vaccination against virus infections, Autoimmun Rev (2013), dx.doi.org/10.1016/j.autrev.2013.03.012 Data migrated from the EudraVigilance E2B(R2) Literature repository	2 Months - 2 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eye disorder (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fall (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myopia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Optic disc haemorrhage (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Optic neuritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Papilloedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual acuity reduced (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8199234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8188361	Spontaneous	2014-07-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea exertional (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin plaque (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somatic symptom disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vertigo positional (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vestibular disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Parenteral])	[ALPHA-TOCOPHEROL] (C - n/a - Unknown - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[MEDROXYPROGESTERONE ACETATE] (C - n/a - Unknown - [n/a - n/a - Intramuscular])|[NAPROXEN] (C - n/a - Unknown - [n/a - n/a - n/a])|[TOPIRAMATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[VITAMIN B12] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8188361&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8174096	Spontaneous	2014-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Atrial fibrillation (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Chest discomfort (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Irritable bowel syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Loss of consciousness (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Night sweats (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Orthostatic hypotension (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Seizure (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Throat tightness (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8174096&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Life Threatening	Hospitalisation
EU-EC-8163604	Spontaneous	2014-07-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Hypertension (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8163604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8163605	Spontaneous	2014-07-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Abdominal distension (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Aphasia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypokinesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	DRY EYE THERAPY [EYE MEDICATION] (C - n/a - Unknown - [n/a - n/a - Unknown])|[BUDESONIDE, FORMOTEROL, BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE, FORMOTEROL FUMARATE HYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[CLOBETASOL PROPIONATE] (C - n/a - Unknown - [n/a - n/a - Ophthalmic])|[FLUTICASONE PROPIONATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[GLICLAZIDE] (C - n/a - Unknown - [n/a - n/a - Oral])|[NYSTATIN] (C - n/a - Unknown - [n/a - n/a - Oral])|[RABEPRAZOLE, RABEPRAZOLE SODIUM] (C - n/a - Unknown - [n/a - n/a - Oral])|[RISEDRONATE MONOSODIUM, RISEDRONATE SODIUM] (C - n/a - Unknown - [n/a - n/a - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - Unknown - [n/a - n/a - Oral])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8163605&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8163606	Spontaneous	2014-07-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Heart rate increased (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8163606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8163607	Spontaneous	2014-07-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8163607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8144848	Spontaneous	2014-07-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Immune thrombocytopenia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8144848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8144849	Spontaneous	2014-07-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Decreased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[SIMVASTATIN] (S - n/a - Unknown - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8144849&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8094618	Spontaneous	2014-06-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Mental impairment (n/a - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Parenteral])|[MONTELUKAST, MONTELUKAST SODIUM] (S - n/a - Unknown - [n/a - n/a - Oral])	[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8094618&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8066243	Spontaneous	2014-06-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abnormal behaviour (n/a - Fatal - Results in Death);Anxiety (n/a - Fatal - Results in Death);Blood lactic acid increased (n/a - Fatal - Results in Death);Confusional state (n/a - Fatal - Results in Death);Hypoxic-ischaemic encephalopathy (n/a - Fatal - Results in Death);Myocardial ischaemia (n/a - Fatal - Results in Death);Pulmonary congestion (n/a - Fatal - Results in Death);Pulmonary oedema (n/a - Fatal - Results in Death)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (S - n/a - Unknown - [n/a - n/a - Unknown])|[CELECOXIB] (S - n/a - Unknown - [n/a - n/a - Unknown])|[CLOZAPINE] (S - n/a - Unknown - [n/a - n/a - Unknown])|[LORAZEPAM] (S - n/a - Unknown - [n/a - n/a - Unknown])|[MIRTAZAPINE] (S - n/a - Unknown - [n/a - n/a - Unknown])|[TEMAZEPAM] (S - n/a - Unknown - [n/a - n/a - Unknown])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (S - n/a - Unknown - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8066243&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7959983	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Stridor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Wheezing (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959983&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7960653	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Encephalitis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Extrapyramidal disorder (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Paresis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960653&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7955182	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (0d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (0d - Recovered/Resolved - Other Medically Important Condition);Flushing (0d - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (0d - Recovered/Resolved - Other Medically Important Condition);Urticaria (0d - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955182&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7955186	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (3h - Recovered/Resolved - Other Medically Important Condition);Bronchospasm (n/a - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (3h - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (3h - Recovered/Resolved - Other Medically Important Condition);Vision blurred (n/a - Recovered/Resolved - Other Medically Important Condition);Wheezing (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - n/a - Not applicable - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - n/a - Unknown - [n/a - n/a - n/a])|[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[DILTIAZEM] (C - n/a - Unknown - [n/a - n/a - n/a])|[ESTROGENS CONJUGATED, ESTRONE SODIUM SULFATE, EQUILIN SULFATE SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[QUININE SULPHATE BP] (C - n/a - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7748479	Spontaneous	2014-03-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Accidental overdose (n/a - Unknown - Other Medically Important Condition);Product administered to patient of inappropriate age (n/a - Unknown - Other Medically Important Condition);Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - .25mL - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7748479&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7389708	Spontaneous	2013-12-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Disabling);Hypotonia (n/a - Recovering/Resolving - Disabling);Muscular weakness (n/a - Recovering/Resolving - Disabling);Narcolepsy (n/a - Recovering/Resolving - Disabling);Somnolence (n/a - Recovering/Resolving - Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7389708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7303395	Spontaneous	2013-11-12 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7303395&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7248558	Spontaneous	2013-10-25 00:00:00	Healthcare Professional	Non European Economic Area	I. Rouleau et al, Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine, dx.doi.org/10.1016/j.vaccine.2013.10.033 Data migrated from the EudraVigilance E2B(R2) Literature repository	65-85 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Bronchospasm (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Laryngeal oedema (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Oedema mouth (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pharyngeal oedema (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia aspiration (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Product complaint (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Pulmonary oedema (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Renal failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory disorder (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory distress (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Vomiting (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Wheezing (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	UNKNOWN MEDICATION [UNKNOWN] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - n/a - Not applicable - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[BETHANECHOL CHLORIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[FERROUS SULFATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[FINASTERIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[ISOSORBIDE 5 MONONITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE MONONITRATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (C - n/a - Not applicable - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[TAMSULOSIN HYDROCHLORIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7248558&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7042784	Spontaneous	2013-08-23 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7042784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6633704	Spontaneous	2013-04-26 00:00:00	Healthcare Professional	Non European Economic Area	Kumamoto et al. Case report; Drug induced lung injury caused by 2009 pandemic H1N1 vaccine. Nihon Naika Gakkai Zasshi. 2011 Oct 10;100(10):3034-7. Watanabe S., et al. Influenza vaccine-induced interstitial lung disease. European Respiratory Journal 41: 474-477, No. 2, Feb 2013. Data migrated from the EudraVigilance E2B(R2) Literature repository	18-64 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Interstitial lung disease (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6633704&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6582789	Spontaneous	2013-04-11 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Alcohol intolerance (n/a - Unknown - Other Medically Important Condition);Amnesia (n/a - Unknown - Other Medically Important Condition);Arthralgia (n/a - Unknown - Other Medically Important Condition);Back pain (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Encephalomyelitis (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Irritable bowel syndrome (n/a - Unknown - Other Medically Important Condition);Multiple allergies (n/a - Unknown - Other Medically Important Condition);Night sweats (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Peripheral coldness (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6582789&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6485924	Spontaneous	2013-03-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Acute respiratory failure (1d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Asphyxia (1d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Febrile convulsion (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sudden infant death syndrome (1d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6485924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6397065	Spontaneous	2013-02-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Endocrine disorder (n/a - Not Recovered/Not Resolved - Disabling);Expired product administered (n/a - Unknown - Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6397065&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6264303	Spontaneous	2013-01-09 00:00:00	Healthcare Professional	Non European Economic Area	T.Fairhead et al, Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients, Transplant Infectious Disease 2012:14 : 575-583	18-64 Years	Not Specified	No	Female	Albuminuria (n/a - Unknown - Other Medically Important Condition);Antibody test positive (n/a - Unknown - Other Medically Important Condition);Blood creatinine increased (n/a - Unknown - Other Medically Important Condition);Kidney transplant rejection (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6264303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6204481	Spontaneous	2012-12-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Weight increased (n/a - Unknown - Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6204481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5977599	Spontaneous	2012-10-10 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Unknown - Disabling);Bedridden (3wk - Recovered/Resolved - Disabling);Dyspnoea (n/a - Unknown - Disabling);Gait inability (n/a - Unknown - Disabling);Gallbladder disorder (n/a - Unknown - Disabling);Gastrooesophageal reflux disease (n/a - Unknown - Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5977599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5213348	Spontaneous	2012-02-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Product complaint (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5213348&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5213349	Spontaneous	2012-02-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Product complaint (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5213349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5198126	Spontaneous	2012-02-06 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Mendes MFSG et al. Narcolepsy after A/H1N1 vaccination, Clinics 2012, 67(1): 77-78	12-17 Years	Not Specified	No	Female	Abnormal dreams (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Dysarthria (n/a - Unknown - Other Medically Important Condition);Dysphonia (n/a - Unknown - Other Medically Important Condition);Head discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Sleep apnoea syndrome (n/a - Unknown - Other Medically Important Condition);Sleep attacks (n/a - Recovered/Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5198126&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5087790	Spontaneous	2011-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site rash (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Paresis (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5087790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5087791	Spontaneous	2011-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paresis (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5087791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5036227	Spontaneous	2011-12-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia (n/a - Unknown - Other Medically Important Condition);Paresis (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5036227&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5036228	Spontaneous	2011-12-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypotension (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5036228&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5036229	Spontaneous	2011-12-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5036229&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5036230	Spontaneous	2011-12-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paresis (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5036230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5036231	Spontaneous	2011-12-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Other Medically Important Condition);Paresis (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5036231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5036232	Spontaneous	2011-12-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Other Medically Important Condition);Paresis (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5036232&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5027667	Spontaneous	2011-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypotension (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5027667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5027668	Spontaneous	2011-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Sensory loss (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5027668&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5027669	Spontaneous	2011-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Injection site erythema (n/a - Unknown - Other Medically Important Condition);Injection site induration (n/a - Unknown - Other Medically Important Condition);Injection site nodule (n/a - Unknown - Other Medically Important Condition);Injection site pain (n/a - Unknown - Other Medically Important Condition);Injection site warmth (n/a - Unknown - Other Medically Important Condition);Paresis (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5027669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4991756	Spontaneous	2011-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Paresis (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4991756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4991771	Spontaneous	2011-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site atrophy (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4991771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4947946	Spontaneous	2011-10-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cyanosis (n/a - Unknown - Other Medically Important Condition);Hypotension (n/a - Unknown - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4947946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4947947	Spontaneous	2011-10-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anal haemorrhage (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4947947&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4947948	Spontaneous	2011-10-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Syncope (n/a - Recovering/Resolving - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4947948&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4941802	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Rash (n/a - Unknown - Other Medically Important Condition);Thrombocytopenic purpura (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4941802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4941809	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest discomfort (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Eye pruritus (n/a - Unknown - Other Medically Important Condition);Hypotension (n/a - Unknown - Other Medically Important Condition);Injection site oedema (n/a - Unknown - Other Medically Important Condition);Injection site pain (n/a - Unknown - Other Medically Important Condition);Injection site pruritus (n/a - Unknown - Other Medically Important Condition);Injection site reaction (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Sneezing (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4941809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4941830	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4941830&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4917472	Spontaneous	2011-10-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysstasia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4917472&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4917473	Spontaneous	2011-10-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Allodynia (n/a - Recovered/Resolved - Other Medically Important Condition);Decreased vibratory sense (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Electric shock sensation (n/a - Recovered/Resolved - Other Medically Important Condition);Feeling of body temperature change (n/a - Recovered/Resolved - Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Muscle spasms (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Vision blurred (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4917473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4917474	Spontaneous	2011-10-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Limb discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ocular hyperaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4917474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4881637	Spontaneous	2011-09-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (n/a - Unknown - Other Medically Important Condition);Injection site atrophy (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4881637&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4881638	Spontaneous	2011-09-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4881638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4851445	Spontaneous	2011-09-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Feeling hot (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Swelling face (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4851445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4851458	Spontaneous	2011-09-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Apnoea (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4851458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4851459	Spontaneous	2011-09-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Loss of consciousness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4851459&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4815965	Spontaneous	2011-09-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4815965&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4812662	Spontaneous	2011-09-05 00:00:00	Healthcare Professional	Non European Economic Area	Dauvilliers et al. Post H1N1 narcolepsy-cataplexy. Sleep 2010 33: (11); 1-3	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Disabling);Narcolepsy (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling);Weight increased (n/a - Unknown - Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4812662&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4793957	Spontaneous	2011-08-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Injection site erythema (n/a - Unknown - Other Medically Important Condition);Injection site pain (n/a - Unknown - Other Medically Important Condition);Injection site warmth (n/a - Unknown - Other Medically Important Condition);Paresis (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4793957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4793959	Spontaneous	2011-08-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Paresis (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4793959&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4787868	Spontaneous	2011-08-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Decreased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])|[SIMVASTATIN] (S - n/a - n/a - [7y - 20mg - Oral])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Unknown])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4787868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4782010	Spontaneous	2011-08-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Injection site erythema (n/a - Unknown - Other Medically Important Condition);Injection site pain (n/a - Unknown - Other Medically Important Condition);Injection site warmth (n/a - Unknown - Other Medically Important Condition);Paresis (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4782010&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4778435	Spontaneous	2011-08-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Injection site induration (n/a - Recovered/Resolved - Other Medically Important Condition);Paralysis (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4778435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4766647	Spontaneous	2011-08-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Altered state of consciousness (n/a - Unknown - Other Medically Important Condition);Crying (n/a - Unknown - Other Medically Important Condition);Hyperaesthesia (n/a - Unknown - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Injection site induration (n/a - Unknown - Other Medically Important Condition);Injection site oedema (n/a - Unknown - Other Medically Important Condition);Injection site pain (n/a - Unknown - Other Medically Important Condition);Lethargy (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Slow response to stimuli (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4766647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4759439	Spontaneous	2011-08-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cyanosis (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4759439&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4746897	Spontaneous	2011-08-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adolescent	No	Not Specified	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4746897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4736844	Spontaneous	2011-08-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4736844&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4736872	Spontaneous	2011-08-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Presyncope (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4736872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4736873	Spontaneous	2011-08-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Headache (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4736873&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4690235	Spontaneous	2011-07-14 00:00:00	Healthcare Professional	Non European Economic Area	Peixoto L et al.Relapse of myelitis and optic neuritis following H1N1 vaccination. 26th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis October 2010. Abstr. 718	12-17 Years	Adolescent	No	Female	Eye pain (n/a - Unknown - Other Medically Important Condition);Neuromyelitis optica spectrum disorder (n/a - Unknown - Other Medically Important Condition);Vision blurred (n/a - Unknown - Other Medically Important Condition);Visual acuity reduced (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4690235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4690249	Spontaneous	2011-07-14 00:00:00	Healthcare Professional	Non European Economic Area	Peixoto L et al.Relapse of myelitis and optic neuritis following H1N1 vaccination. 26th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis October 2010. Abstr. 718	18-64 Years	Adult	No	Female	Dysaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Neuromyelitis optica spectrum disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Paraparesis (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4690249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4676551	Spontaneous	2011-07-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Pruritus (n/a - Recovered/Resolved - );Rash (n/a - Recovered/Resolved - )	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4676551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4676552	Spontaneous	2011-07-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (2d - Recovered/Resolved - );Pruritus (3d - Recovered/Resolved - )	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4676552&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4676566	Spontaneous	2011-07-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Feeling hot (n/a - Unknown - Other Medically Important Condition);Hyperaemia (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Paresis (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4676566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4676570	Spontaneous	2011-07-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia (n/a - Unknown - Other Medically Important Condition);Paresis (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4676570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4600104	Spontaneous	2011-06-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Unknown - Other Medically Important Condition);Face oedema (n/a - Unknown - Other Medically Important Condition);Hyperaemia (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Oedema (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4600104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4564199	Spontaneous	2011-05-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Asthenia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Cardio-respiratory arrest (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Cardiomegaly (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Coronary artery disease (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Depressed level of consciousness (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Feeling cold (1d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Left ventricular hypertrophy (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pulmonary congestion (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pulmonary oedema (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory acidosis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[CYANOCOBALAMIN] (S - Prophylaxis - Unknown - [1d - n/a - Unknown])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PUFFERS [UNKNOWN] (C - Lung disorder - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4564199&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4552354	Spontaneous	2011-05-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4552354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4440159	Spontaneous	2011-04-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Induration (n/a - Recovered/Resolved - Other Medically Important Condition);Local reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4440159&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4404028	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4404029	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cyanosis (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Hypotonia (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Hypotonic-hyporesponsive episode (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404029&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4404030	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Inappropriate schedule of product administration (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/H1N1 INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404030&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4404031	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (2h - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hypersensitivity (2h - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404031&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4404033	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Petechiae (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404033&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4404034	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Face oedema (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Oedema peripheral (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4404035	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash pruritic (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404035&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4404036	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cardiogenic shock (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myocarditis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404036&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4404037	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404037&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4404038	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404038&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4404039	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diplopia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Facial paralysis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404039&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4404040	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Febrile convulsion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404040&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4404041	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404041&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4404042	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Laryngeal oedema (n/a - Unknown - Life Threatening, Other Medically Important Condition);Seizure (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4404043	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Bacterial infection (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Loss of consciousness (1h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Syncope (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404043&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4404044	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	SYNFLORIX [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4404045	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[POLIOMYELITIS VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4404047	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Immune thrombocytopenia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4404048	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cardio-respiratory arrest (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ventricular fibrillation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404048&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4404049	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blister (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysphagia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Stevens-Johnson syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CLONAZEPAM] (C - n/a - Unknown - [n/a - n/a - n/a])|[LAMOTRIGINE] (C - n/a - Unknown - [n/a - n/a - n/a])|[VALPROATE SEMISODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404049&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4404050	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404050&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4400821	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rhinorrhoea (n/a - Unknown - Other Medically Important Condition);Skin lesion (n/a - Unknown - Other Medically Important Condition);Stevens-Johnson syndrome (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400821&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4400822	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypotension (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4400823	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neuropathy peripheral (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Painful respiration (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4400824	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400824&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4400829	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Asthenia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Coma (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Confusional state (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysphagia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Encephalitis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Haemolysis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myocarditis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Polyneuropathy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pulmonary congestion (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Quadriparesis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Thrombocytopenia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Viral infection (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400829&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4400830	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Burning sensation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Peripheral sensory neuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Scoliosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Spinal cord disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400830&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4400831	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4400832	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4400834	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Headache (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lethargy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of consciousness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Skin atrophy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4400835	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cerebral atrophy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Encephalitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Herpes virus infection (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia aspiration (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400835&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4400836	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400836&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4400837	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Male	Polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400837&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4400838	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Constipation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Demyelination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperreflexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myelitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paraparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paresis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Quadriparesis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Urinary retention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400838&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4400840	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Seizure (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400840&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4400842	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (n/a - Unknown - Life Threatening, Other Medically Important Condition);Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400842&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4400843	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Seizure (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DIPHTHERIA AND TETANUS VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400843&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4400844	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Diarrhoea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400844&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4400845	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paresis (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4400846	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Seizure (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4400847	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400847&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4400848	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Dizziness (n/a - Unknown - Disabling, Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Disabling, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Disabling, Other Medically Important Condition);Gait inability (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Disabling, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4400849	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypotonic-hyporesponsive episode (15min - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400849&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4400850	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4397405	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397406	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Extra dose administered (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|VACCINE (UNSPECIFIED) [VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397407	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397407&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397408	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397408&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397409	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])|[PNEUMOCOCCAL VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397409&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397410	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397410&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397411	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397411&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397412	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397413	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397414	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397414&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397415	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Apnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397416	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397416&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397417	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397418	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397418&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397419	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation);Peripheral coldness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397420	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Cyanosis (n/a - Unknown - Life Threatening, Other Medically Important Condition);Cyanosis central (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Respiratory disorder (n/a - Unknown - Life Threatening, Other Medically Important Condition);Vomiting (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397421	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Local reaction (n/a - Unknown - Other Medically Important Condition);Oedema (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4397422	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397423	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Erythema (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397423&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4397424	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397425	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397425&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397426	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397427	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397428	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397429	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Local reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397430	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Deafness (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397430&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397432	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397432&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397433	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397434	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Local reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397434&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397435	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Local reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397436	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Induration (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397437	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Local reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397438	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Chills (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397438&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397439	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397439&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397440	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397440&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397441	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Conjunctival hyperaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysphonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Neck pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397442	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Injection site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site warmth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Local reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397442&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397443	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397443&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397444	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hyperaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397445	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397446	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Syncope (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397447	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397447&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397448	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397449	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397451	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Intermittent claudication (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lymph node palpable (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ocular hyperaemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Radiculopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[N. MENINGITIDIS GROUP C POLYSACCHARIDE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397452	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cardio-respiratory arrest (n/a - Fatal - Results in Death);Cyanosis (n/a - Fatal - Results in Death);Grunting (n/a - Fatal - Results in Death);Pallor (n/a - Fatal - Results in Death);Slow response to stimuli (n/a - Fatal - Results in Death);Sudden death (n/a - Fatal - Results in Death)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CAPTOPRIL] (C - n/a - Unknown - [n/a - n/a - Unknown])|[CARVEDILOL] (C - n/a - Unknown - [n/a - n/a - Unknown])|[DIGOXIN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FUROSEMIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397452&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4397454	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hypotension (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Local reaction (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Malaise (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Myalgia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sudden death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4397455	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Arthralgia (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397456	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397456&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4397457	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Dyslalia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Encephalitis viral (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eye movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Quadriparesis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Speech disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DIPHTHERIA, TETANUS AND PERTUSSIS VACCINE (ADSORBED)] (C - n/a - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - n/a - Not applicable - [n/a - n/a - Unknown])|[POLIOMYELITIS VACCINE (ORAL)] (C - n/a - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397458	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypertension (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	CONTRACEPTIVE PILL [ORAL CONTRACEPTIVE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[GINKGO BILOBA] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4397459	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chest discomfort (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397459&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4397460	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Headache (n/a - Unknown - Life Threatening, Other Medically Important Condition);Skin disorder (n/a - Unknown - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Unknown - Life Threatening, Other Medically Important Condition);Vomiting (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397460&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397461	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397461&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4397462	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397463	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Lip swelling (n/a - Unknown - Life Threatening, Other Medically Important Condition);Oropharyngeal discomfort (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397463&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397464	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Face oedema (n/a - Unknown - Life Threatening, Other Medically Important Condition);Oedema peripheral (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397464&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397465	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397466	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hyperaemia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397467	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397468	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Nausea (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition);Vomiting (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397469	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397470	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4397471	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397471&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4397472	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397472&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4397473	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4397474	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chest pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pericarditis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397475	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397476	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Urticaria (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397477	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Viral infection (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4397478	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397479	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Diarrhoea (3d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (3d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotension (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Syncope (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397479&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4397480	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397480&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397482	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397483	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4397484	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4397485	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397485&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397486	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Flushing (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site warmth (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397486&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397487	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Muscular weakness (n/a - Unknown - Disabling);Paraparesis (n/a - Unknown - Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397487&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4397489	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Laryngeal oedema (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neck pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397489&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4397490	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Tachycardia (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397490&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397491	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Generalised oedema (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397491&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397492	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397493	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Headache (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397495	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397495&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397496	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Crying (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cyanosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);General physical health deterioration (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Locked-in syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Meningitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle rigidity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nuchal rigidity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rales (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Speech disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397497	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Ataxia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Extensor plantar response (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyporeflexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397498	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Prurigo (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397499	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Prurigo (n/a - Unknown - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397500	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Confusional state (10h - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Speech disorder (10h - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])|[CALCIUM CARBONATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - Unknown - [n/a - n/a - n/a])|[VITAMINS NOS] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397502	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397503	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injected limb mobility decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4397504	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (5d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (5d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - n/a - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397506	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397507	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Eyelid oedema (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Prurigo (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4397508	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening);Face oedema (n/a - Recovering/Resolving - Life Threatening);Pruritus (n/a - Recovering/Resolving - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397510	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397510&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4397511	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397511&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397513	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397514	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	Yes	Female	Abortion spontaneous (n/a - Unknown - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Foetal heart rate abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393557	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393557&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393559	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypokinesia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393559&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393560	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Application site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393560&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393561	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393561&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393562	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393562&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393563	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393563&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393564	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393564&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393566	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening);Bladder disorder (n/a - Unknown - Life Threatening);Face oedema (n/a - Unknown - Life Threatening);Oedema peripheral (n/a - Unknown - Life Threatening);Oral discomfort (n/a - Unknown - Life Threatening);Oropharyngeal discomfort (n/a - Unknown - Life Threatening);Speech disorder (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393567	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393567&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393568	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening);Headache (n/a - Recovering/Resolving - Life Threatening);Rash pruritic (n/a - Recovering/Resolving - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393568&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393569	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393570	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Myelitis (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393571	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Injection site erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site warmth (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393571&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393572	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Flushing (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site induration (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site warmth (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393572&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393573	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393573&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393574	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Flushing (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site warmth (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393574&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393575	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Injection site erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site oedema (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393575&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393576	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393577	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393578	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393578&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393579	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393579&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393580	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393581	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Crying (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393581&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393582	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393582&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393583	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393583&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393584	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393585	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393586	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Unknown - Life Threatening, Other Medically Important Condition);Dizziness (n/a - Unknown - Life Threatening, Other Medically Important Condition);Erythema (n/a - Unknown - Life Threatening, Other Medically Important Condition);Fatigue (n/a - Unknown - Life Threatening, Other Medically Important Condition);Feeling hot (n/a - Unknown - Life Threatening, Other Medically Important Condition);Headache (n/a - Unknown - Life Threatening, Other Medically Important Condition);Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition);Local reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Myalgia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pain (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pallor (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Somnolence (n/a - Unknown - Life Threatening, Other Medically Important Condition);Vomiting (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393587	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393587&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393588	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyelonephritis acute (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393588&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393589	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393589&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393590	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393591	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393592	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393592&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393593	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Angioedema (n/a - Unknown - Other Medically Important Condition);Face oedema (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393593&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4393594	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Crying (n/a - Unknown - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393594&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393595	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393596	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393597	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393597&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393598	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393599	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393600	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393600&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393601	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Adverse event (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393602	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Seizure (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393603	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Seizure (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393604	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393605	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Seizure (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393605&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393606	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Unknown - Life Threatening);Seizure (n/a - Unknown - Life Threatening);Urticaria (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393607	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pain (n/a - Unknown - Life Threatening);Seizure (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393608	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Nausea (n/a - Unknown - Life Threatening);Pain (n/a - Unknown - Life Threatening);Pallor (n/a - Unknown - Life Threatening);Pyrexia (n/a - Unknown - Life Threatening);Seizure (n/a - Unknown - Life Threatening);Vomiting (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393609	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hyperaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Induration (n/a - Unknown - Caused/Prolonged Hospitalisation);Oedema (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393609&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393610	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393610&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393611	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393612	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393612&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393613	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393613&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393614	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393615	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393615&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393616	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening);Rash pruritic (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393617	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393617&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393618	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Loss of consciousness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Seizure (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393618&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393619	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393619&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393620	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393620&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393621	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DIPHTHERIA AND TETANUS VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])|[HEPATITIS B VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393621&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4393622	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393622&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393623	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Thrombocytopenic purpura (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393624	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Acute kidney injury (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Confusional state (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Erythema multiforme (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Oliguria (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Sepsis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393624&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393625	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393626	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393627	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393627&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393628	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site bruising (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site induration (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site warmth (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393628&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393629	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening);Urticaria (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393629&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393630	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393630&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393631	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393631&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393632	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Agitation (n/a - Unknown - Caused/Prolonged Hospitalisation);Crying (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site movement impairment (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393632&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393633	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening);Eyelid oedema (n/a - Unknown - Life Threatening);Lip oedema (n/a - Unknown - Life Threatening);Pyrexia (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DIPHTHERIA, TETANUS AND PERTUSSIS (ACELLULAR, COMPONENT) VACCINE (ADSORBED)] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])|[POLIOMYELITIS VACCINE (INACTIVATED)] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393633&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393634	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393634&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4393635	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393635&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393636	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393636&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393637	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening);Angioedema (n/a - Unknown - Life Threatening);Neurological symptom (n/a - Unknown - Life Threatening);Oedema (n/a - Unknown - Life Threatening);Pain (n/a - Unknown - Life Threatening);Urticaria (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393637&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393638	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393639	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening);Rash (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393640	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393640&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393641	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393641&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393642	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393642&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393643	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393643&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393644	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393644&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393645	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Local reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393645&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393646	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site warmth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Local reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393647	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393648	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393648&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393649	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393649&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393650	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393650&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393651	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Induration (n/a - Unknown - Caused/Prolonged Hospitalisation);Oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393652	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393652&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393653	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393653&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393654	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393655	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393655&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393656	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393656&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393657	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393657&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393658	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Seizure (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393658&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393659	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Life Threatening, Other Medically Important Condition);Seizure (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393659&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393693	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393694	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393695	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393696	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia viral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393697	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393699	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Poor quality sleep (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393699&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393700	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Angioedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Eyelid oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393700&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393701	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Face oedema (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393702	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393702&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393703	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Back pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Multiple sclerosis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Myelitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Neoplasm (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393703&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393704	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393704&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393705	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Paraparesis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393706	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Feeling hot (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Induration (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393706&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393707	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Localised oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393707&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393708	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neurocysticercosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Strabismus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393709	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Swelling (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393709&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393710	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Pyrexia (n/a - Recovered/Resolved - Life Threatening);Seizure (n/a - Recovered/Resolved - Life Threatening);Vomiting (n/a - Recovered/Resolved - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393710&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393712	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Face oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Skin exfoliation (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393712&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393713	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393714	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393714&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393717	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Hypothermia (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393717&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4393718	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (1d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Angioedema (1d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Cough (1d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Dyspnoea (1d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Speech disorder (1d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393718&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393719	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393719&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393720	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia oral (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paralysis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393722	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393722&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393723	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chest pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Coma (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depressed level of consciousness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysarthria (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperglycaemia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ischaemic stroke (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393723&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393724	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cyanosis (n/a - Unknown - Life Threatening, Other Medically Important Condition);Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition);Nausea (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pallor (n/a - Unknown - Life Threatening, Other Medically Important Condition);Slow response to stimuli (n/a - Unknown - Life Threatening, Other Medically Important Condition);Somnolence (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DIPHTHERIA, TETANUS AND PERTUSSIS (ACELLULAR, COMPONENT) VACCINE (ADSORBED)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[POLIOMYELITIS VACCINE (ORAL)] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393725	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393725&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393726	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paresis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393727	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pneumonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393727&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4393728	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypersensitivity (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ALUMINIUM PHOSPHATE, CORYNEBACTERIUM DIPHTHERIAE CRM197 CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE, ALUMINIUM PHOSPHATE, CORYNEBACTERIUM DIPHTHERIAE, NEISSERIA MENINGITIDIS, ALUMINIUM PHOSPHATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393728&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393729	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Local reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393729&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393730	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Agitation (n/a - Unknown - Life Threatening, Other Medically Important Condition);Headache (n/a - Unknown - Life Threatening, Other Medically Important Condition);Nervousness (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Tremor (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393730&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393731	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Rash pruritic (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393731&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393766	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Meningoencephalitis herpetic (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393767	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4387292	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Productive cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387292&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4387293	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Induration (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4387294	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387294&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4387295	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4387296	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387296&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4387297	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ear pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Syncope (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4387298	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4387299	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387299&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4387300	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Seizure (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387300&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4387301	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Seizure (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4387302	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Seizure (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4387303	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening);Dyspnoea (n/a - Unknown - Life Threatening);Hyperhidrosis (n/a - Unknown - Life Threatening);Muscle spasms (n/a - Unknown - Life Threatening);Pallor (n/a - Unknown - Life Threatening);Peripheral coldness (n/a - Unknown - Life Threatening);Presyncope (n/a - Unknown - Life Threatening);Retching (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4387304	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4387305	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Cyanosis (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Petechiae (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4387306	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Induration (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387306&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4387307	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site induration (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site warmth (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387307&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4387308	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Asthenia (0d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hypotonic-hyporesponsive episode (0d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pallor (0d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Tremor (0d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Vomiting (0d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4387309	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypertonia (1d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hypotonic-hyporesponsive episode (1d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4387310	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387310&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4387311	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4387314	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Arthralgia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Blister (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Erythema (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Skin disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4387316	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cough (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urticaria (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387316&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4376102	Spontaneous	2011-03-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4376102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4282484	Spontaneous	2011-02-10 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Samad I., Su Hong Binti Abdul Azim Lim S. Erythema multiforme secondary to H1N1 vaccine. Southern Medical Journal, 2011;104: 73-74	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema multiforme (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lip oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Papule (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Periorbital oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash maculo-papular (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Skin hypopigmentation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Skin lesion (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[BECLOMETASONE DIPROPIONATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[DOMPERIDONE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FLUNARIZINE, FLUNARIZINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[OMEPRAZOLE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[ORPHENADRINE CITRATE, PARACETAMOL] (C - n/a - Unknown - [n/a - n/a - Unknown])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4282484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4208945	Spontaneous	2011-01-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Back pain (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4208945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4208946	Spontaneous	2011-01-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Ecchymosis (n/a - Recovered/Resolved - Other Medically Important Condition);Immune thrombocytopenia (n/a - Recovered/Resolved - Other Medically Important Condition);Petechiae (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4208946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4204852	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Bacterial sepsis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chest pain (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Metabolic acidosis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Renal failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory disorder (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Septic shock (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4204853	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Cough (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dizziness (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Headache (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4204855	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dermatitis bullous (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema multiforme (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperaemia (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204855&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4204860	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Recovered/Resolved - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	VACCINE (UNSPECIFIED) [VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204860&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4204861	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Irritability (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204861&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4204862	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Monoplegia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204862&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4204863	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Injection site pain (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Injection site paraesthesia (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Laryngeal oedema (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Nodule (n/a - Unknown - Life Threatening, Other Medically Important Condition);Tachycardia (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204863&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4204865	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4204867	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Seizure (3min - Recovered/Resolved - Life Threatening);Somnolence (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4204869	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nerve compression (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Quadriparesis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204869&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4204870	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Angioedema (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urticaria (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DIPHTHERIA AND TETANUS VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])|[HEPATITIS B VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[YELLOW FEVER VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204870&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4204872	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Syncope (n/a - Unknown - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4204874	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Interstitial lung disease (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Severe acute respiratory syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Viral infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204874&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4204875	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site abscess (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Injection site swelling (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Lipoma (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4204876	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Meningism (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Meningitis pneumococcal (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Productive cough (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204876&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4204877	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PHENYTOIN] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4205303	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4205304	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4205305	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Cough (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sudden death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4205307	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Seizure (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DIPHTHERIA, TETANUS, PERTUSSIS AND HAEMOPHILUS B VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[POLIOMYELITIS VACCINE (INACTIVATED)] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205307&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4205309	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Seizure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4205311	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Face oedema (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Tachycardia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4205312	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Laryngeal oedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4205325	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Encephalitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4205328	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Chronic obstructive pulmonary disease (n/a - Unknown - Caused/Prolonged Hospitalisation);Contusion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205328&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4205331	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cerebrovascular accident (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Coma (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Confusional state (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ear pain (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperglycaemia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mydriasis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205331&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4205336	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4205339	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4205340	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205340&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4205345	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205345&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4205347	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205347&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4205350	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Blood creatine phosphokinase increased (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Gastrointestinal ulcer (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Myocardial infarction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Renal failure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Upper gastrointestinal haemorrhage (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[SIMVASTATIN] (S - n/a - Unknown - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4205351	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic shock (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cyanosis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotension (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Purpura (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Skin lesion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachycardia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205351&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4205353	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4205355	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	SYNFLORIX [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4205357	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition);Seizure (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4205364	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - n/a - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205364&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4197801	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Abortion spontaneous (n/a - Unknown - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaginal haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197801&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4197802	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Arthralgia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Cardio-respiratory arrest (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Chest pain (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Eye pain (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Myalgia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Shock (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sudden death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[YELLOW FEVER VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4197803	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Agitation (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Cardio-respiratory arrest (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Diarrhoea (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Epistaxis (6d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Fatigue (4d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Influenza (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Oedema peripheral (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pulmonary fibrosis (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (5d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory failure (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sudden death (1d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Vomiting (6d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197803&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4197806	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Apathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Balance disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysstasia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypophagia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyporeflexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonic-hyporesponsive episode (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197806&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4197807	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4197808	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197808&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4197809	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4197810	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Memory impairment (19d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Meningoencephalitis herpetic (19d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Nasal obstruction (30d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (30d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Rhinorrhoea (30d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BENZATHINE BENZYLPENICILLIN, BENZYLPENICILLIN PROCAINE, BENZATHINE BENZYLPENICILLIN, BENZYLPENICILLIN POTASSIUM] (C - Infection - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4197811	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening);Laryngeal oedema (n/a - Recovering/Resolving - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4197812	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Recovered/Resolved - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4197815	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4197816	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hyperthermia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4197817	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Headache (n/a - Unknown - Life Threatening, Other Medically Important Condition);Muscle rigidity (3min - Unknown - Life Threatening, Other Medically Important Condition);Mydriasis (3min - Unknown - Life Threatening, Other Medically Important Condition);Pallor (n/a - Unknown - Life Threatening, Other Medically Important Condition);Seizure (n/a - Unknown - Life Threatening, Other Medically Important Condition);Vomiting (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4197823	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hepatomegaly (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Immunodeficiency (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Lymphadenitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Lymphoma (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory syncytial virus infection (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4197824	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Seizure (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197824&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4197825	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4197826	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Respiratory tract infection (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Septic shock (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197826&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4197827	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Seizure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4197829	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Areflexia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Back pain (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Cardio-respiratory arrest (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Demyelination (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197829&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4197842	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Productive cough (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory disorder (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197842&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4191756	Spontaneous	2010-12-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diplegia (n/a - Recovered/Resolved - Other Medically Important Condition);Haemarthrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Movement disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema peripheral (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[MENINGOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Subcutaneous])	ANTIBIOTICS [ANTIBIOTICS] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FACTOR VIII] (C - n/a - Unknown - [n/a - n/a - Unknown])|[PARACETAMOL] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4191756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4184671	Spontaneous	2010-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Contusion (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Meningitis meningococcal (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sudden death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Vomiting (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4184671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4184682	Spontaneous	2010-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperthermia (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory distress (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4184682&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4184687	Spontaneous	2010-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Diarrhoea (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DIPHTHERIA AND TETANUS VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4184687&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4184710	Spontaneous	2010-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4184710&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4184747	Spontaneous	2010-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4184747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4172457	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Contusion (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (4d - Recovered/Resolved - Other Medically Important Condition);Petechiae (n/a - Recovered/Resolved - Other Medically Important Condition);Purpura (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (1d - Recovered/Resolved - Other Medically Important Condition);Thrombocytopenia (n/a - Recovering/Resolving - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4172457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4172462	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Contusion (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Heavy menstrual bleeding (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4172462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4168961	Spontaneous	2010-12-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Arthralgia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Bone pain (n/a - Unknown - Life Threatening, Other Medically Important Condition);Dizziness (n/a - Unknown - Life Threatening, Other Medically Important Condition);Headache (n/a - Unknown - Life Threatening, Other Medically Important Condition);Malaise (n/a - Unknown - Life Threatening, Other Medically Important Condition);Nodule (n/a - Unknown - Life Threatening, Other Medically Important Condition);Oedema (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pain (n/a - Unknown - Life Threatening, Other Medically Important Condition);Retching (n/a - Unknown - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4168961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4168972	Spontaneous	2010-12-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Asthma (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4168972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4168973	Spontaneous	2010-12-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cellulitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lethargy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 500{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4168973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4168977	Spontaneous	2010-12-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cellulitis (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 500{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4168977&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4156278	Spontaneous	2010-12-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4156278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4156280	Spontaneous	2010-12-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Rash (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4156280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4156281	Spontaneous	2010-12-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4156281&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4156284	Spontaneous	2010-12-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4156284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4156308	Spontaneous	2010-12-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4156308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4133971	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Crying (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Irritability (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4133971&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4133977	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Skin plaque (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4133977&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4133980	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4133980&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4133981	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Arthralgia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Erythema (n/a - Unknown - Life Threatening, Other Medically Important Condition);Eye pain (n/a - Unknown - Life Threatening, Other Medically Important Condition);Headache (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4133981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4133982	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Injection site pain (n/a - Unknown - Life Threatening, Other Medically Important Condition);Malaise (n/a - Unknown - Life Threatening, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4133982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4133984	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Prurigo (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4133984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4133985	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4133985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4133986	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4133986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4133987	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4133987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4133990	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Erythema (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Skin disorder (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4133990&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4133991	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4133991&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4129172	Spontaneous	2010-11-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4129172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4129183	Spontaneous	2010-11-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DIPHTHERIA AND TETANUS VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4129183&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4129185	Spontaneous	2010-11-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (4d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Conjunctivitis (4d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Lip oedema (4d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Prurigo (4d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4129185&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4129189	Spontaneous	2010-11-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash macular (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4129189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4129190	Spontaneous	2010-11-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4129190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4129193	Spontaneous	2010-11-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Prurigo (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4129193&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4115149	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Anaphylactic reaction (1wk - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash maculo-papular (1wk - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115150	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Febrile convulsion (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115152	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115152&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115153	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Diarrhoea (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Feeling hot (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115154	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site nodule (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115155	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Lymphadenopathy (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115155&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115156	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site urticaria (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115158	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Blister (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115158&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115159	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115159&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115160	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115160&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115162	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Eyelid oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Skin disorder (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Throat irritation (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115165	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115165&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115167	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal distension (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115167&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4115169	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115169&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115170	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site induration (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115171	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site inflammation (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115171&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115172	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Eyelid oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115173	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Febrile convulsion (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115174	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115174&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115176	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hyperaemia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Lacrimation increased (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Sneezing (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115177	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hyperaemia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115177&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4115178	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Diarrhoea (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Speech disorder (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115178&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4111295	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cardio-respiratory arrest (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Chest pain (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Headache (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Heart rate increased (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Hypotension (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Myopericarditis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Oxygen saturation decreased (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sudden death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Tachycardia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Tachypnoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4111295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4111296	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Bronchiolitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Irritability (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachypnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4111296&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4111301	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cyanosis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Irritability (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory tract infection (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sudden death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Vomiting (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4111301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4111304	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition);Vomiting (6d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4111304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4111309	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4111309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4111314	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Prurigo (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Skin lesion (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4111314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4111530	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Herpes virus infection (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4111530&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4111536	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Hand deformity (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia oral (n/a - Unknown - Caused/Prolonged Hospitalisation);Syncope (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4111536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4100042	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4100043	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[MENINGOCOCCAL GROUP C CONJUGATE VACCINE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100043&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4100050	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Facial paralysis (n/a - Recovering/Resolving - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100050&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4100060	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cyanosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4100061	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100061&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4100062	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100062&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4100063	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100063&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4100068	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4100070	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4100072	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100072&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4100075	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Eyelid oedema (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Meningism (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Viral infection (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4100077	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chest pain (n/a - Recovered/Resolved - Other Medically Important Condition);Hypertensive crisis (n/a - Recovered/Resolved - Other Medically Important Condition);Palpitations (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4079478	Spontaneous	2010-11-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Blood pressure increased (n/a - Unknown - Other Medically Important Condition);Caesarean section (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Live birth (n/a - Unknown - Other Medically Important Condition);Vaginal haemorrhage (n/a - Unknown - Other Medically Important Condition);Wrong product administered (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	IRON [IRON] (C - Blood iron decreased - Unknown - [n/a - 300mg - Oral])|[DOCUSATE SODIUM] (C - Constipation - Unknown - [n/a - n/a - Unknown])|[PROPYLTHIOURACIL] (C - Hyperthyroidism - Unknown - [n/a - n/a - Oral])|[THIAMAZOLE] (C - Hyperthyroidism - Unknown - [n/a - 5mg - Oral])|[VITAMINS NOS] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4079478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4079501	Spontaneous	2010-11-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Fatigue (1d - Recovered/Resolved - Other Medically Important Condition);Headache (2d - Recovered/Resolved - Other Medically Important Condition);Hypertension (n/a - Unknown - Other Medically Important Condition);Live birth (n/a - Unknown - Other Medically Important Condition);Myalgia (1d - Recovered/Resolved - Other Medically Important Condition);Placental insufficiency (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4079501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4057476	Spontaneous	2010-10-27 00:00:00	Healthcare Professional	Non European Economic Area	IMPACT newsletter, Fall 2010 Issue # 30	12-17 Years	Not Specified	No	Not Specified	CSF protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);CSF white blood cell count increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Encephalomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lethargy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Magnetic resonance imaging head abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Spinal cord disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4057476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4057478	Spontaneous	2010-10-27 00:00:00	Healthcare Professional	Non European Economic Area	IMPACT newsletter, Fall 2010 Issue # 30	3-11 Years	Not Specified	No	Not Specified	Cognitive disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pleocytosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Stupor (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4057478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4054766	Spontaneous	2010-10-26 00:00:00	Healthcare Professional	European Economic Area	Dauvilliers et al. Post H1N1 narcolepsy-cataplexy. Sleep 2010 33: (11); 1-3	18-64 Years	Not Specified	No	Not Specified	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4054766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4054787	Spontaneous	2010-10-26 00:00:00	Healthcare Professional	European Economic Area	Dauvilliers et al. Post H1N1 narcolepsy-cataplexy. Sleep 2010 33: (11); 1-3	12-17 Years	Not Specified	No	Not Specified	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4054787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4054812	Spontaneous	2010-10-26 00:00:00	Healthcare Professional	European Economic Area	Dauvilliers et al. Post H1N1 narcolepsy-cataplexy. Sleep 2010 33: (11); 1-3	3-11 Years	Not Specified	No	Not Specified	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4054812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4054857	Spontaneous	2010-10-26 00:00:00	Healthcare Professional	European Economic Area	Dauvilliers et al. Post H1N1 narcolepsy-cataplexy. Sleep 2010 33: (11); 1-3	18-64 Years	Not Specified	No	Not Specified	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4054857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4001807	Spontaneous	2010-10-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Maternal exposure before pregnancy (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4001807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4001819	Spontaneous	2010-10-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Contusion (4d - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Heavy menstrual bleeding (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4001819&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3972423	Spontaneous	2010-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Gagnon R et al. Safety vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine. J Allergy Clin Imunol 210;126(2): 317-323	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3972423&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3972424	Spontaneous	2010-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Gagnon R et al. Safety vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine. J Allergy Clin Imunol 210;126(2): 317-323	3-11 Years	Not Specified	No	Male	Crying (30min - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Wheezing (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3972424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3944853	Spontaneous	2010-09-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Jaundice neonatal (n/a - Unknown - Other Medically Important Condition);Maternal exposure timing unspecified (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - n/a])	IRON [IRON] (C - Blood iron decreased - Unknown - [n/a - 300mg - n/a])|[DOCUSATE SODIUM] (C - Constipation - Unknown - [n/a - n/a - n/a])|[PROPYLTHIOURACIL] (C - Product used for unknown indication - Unknown - [n/a - 100mg - n/a])|[THIAMAZOLE] (C - Hyperthyroidism - Unknown - [n/a - n/a - n/a])|[VITAMINS NOS] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3944853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3926625	Spontaneous	2010-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hyperaemia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Localised oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3926625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3926646	Spontaneous	2010-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site haematoma (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site inflammation (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3926646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3926650	Spontaneous	2010-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Eyelid oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3926650&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3926651	Spontaneous	2010-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Urticaria (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3926651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-3926653	Spontaneous	2010-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Headache (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Unknown - Life Threatening, Other Medically Important Condition);Vomiting (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3926653&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3926657	Spontaneous	2010-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3926657&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3926662	Spontaneous	2010-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3926662&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3926666	Spontaneous	2010-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Erythema (n/a - Unknown - Life Threatening, Other Medically Important Condition);Headache (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3926666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3926670	Spontaneous	2010-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Erythema (n/a - Unknown - Life Threatening, Other Medically Important Condition);Oedema peripheral (n/a - Unknown - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3926670&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3926675	Spontaneous	2010-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Gait disturbance (5d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3926675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-3926692	Spontaneous	2010-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Arthralgia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3926692&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3926721	Spontaneous	2010-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3926721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3913550	Spontaneous	2010-08-20 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Tremblay M et al. Guillain-Barre Syndrome following H1N1 immunization in a pediatric patient. The annals of pharmacotherapy 2010; 44:1330-1333	3-11 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cranial nerve paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Ear infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hyperreflexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Movement disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Neck pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Neuropathy peripheral (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tongue movement disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3913550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3891028	Spontaneous	2010-08-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hepatic enzyme increased (n/a - Unknown - Other Medically Important Condition);Liver injury (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3891028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3855053	Spontaneous	2010-07-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Parosmia (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3855053&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851269	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (1h - Recovered/Resolved - Other Medically Important Condition);Bronchospasm (1h - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Heart rate irregular (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Ill-defined disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Product complaint (n/a - Unknown - Other Medically Important Condition);Respiratory disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (1h - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851270	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema mucosal (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Product complaint (n/a - Unknown - Other Medically Important Condition);Throat irritation (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition);Wheezing (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851270&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851271	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Anaphylactic shock (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Heart rate irregular (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Sense of oppression (n/a - Recovered/Resolved - Other Medically Important Condition);Suffocation feeling (n/a - Recovered/Resolved - Other Medically Important Condition);Throat irritation (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition);Use of accessory respiratory muscles (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851272	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Cyanosis (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Livedo reticularis (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition);Respiratory disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851272&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851273	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851273&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851274	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (1h - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal swelling (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	NO CONCURRENT MEDICATION [NO CONCURRENT MEDICATION] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851274&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851276	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Back pain (n/a - Unknown - Other Medically Important Condition);Dizziness (3d - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Eye swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Swelling (3d - Recovered/Resolved - Other Medically Important Condition);Swelling face (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[GLUCOSAMINE, GLUCOSAMINE SULFATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[INFLUENZA VIRUS VACCINE POLYVALENT] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[RISEDRONATE MONOSODIUM, RISEDRONATE SODIUM] (C - Osteoporosis - Unknown - [n/a - 35mg - Unknown])|[VITAMIN D] (C - n/a - Unknown - [n/a - 1000[iU] - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851276&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851278	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Feeling hot (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Paraesthesia oral (n/a - Unknown - Other Medically Important Condition);Rash erythematous (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851279	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depressed level of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Flushing (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Migraine (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ophthalmoplegia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Throat tightness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851279&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3851280	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851281	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dry mouth (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Unknown - Other Medically Important Condition);Eye irritation (n/a - Unknown - Other Medically Important Condition);Eye pruritus (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Throat irritation (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851281&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851282	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Dysgeusia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Laryngeal oedema (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Oedema mouth (n/a - Unknown - Other Medically Important Condition);Paraesthesia oral (n/a - Unknown - Other Medically Important Condition);Pharyngeal swelling (n/a - Unknown - Other Medically Important Condition);Pharyngolaryngeal abscess (n/a - Unknown - Other Medically Important Condition);Retching (n/a - Unknown - Other Medically Important Condition);Swollen tongue (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Tachypnoea (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851283	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cyanosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pallor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tachycardia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tachypnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Throat tightness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Wheezing (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851284	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Lacrimation increased (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851286	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Cyanosis (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site induration (3d - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Tachypnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DIAZEPAM] (C - n/a - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851286&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851287	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaphylactic reaction (19h - Recovered/Resolved - Other Medically Important Condition);Chest discomfort (19h - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (19h - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (19h - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851287&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851288	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (30min - Unknown - Other Medically Important Condition);Cough (30min - Unknown - Other Medically Important Condition);Dysphagia (30min - Unknown - Other Medically Important Condition);Flushing (30min - Unknown - Other Medically Important Condition);Nausea (30min - Unknown - Other Medically Important Condition);Paraesthesia (30min - Unknown - Other Medically Important Condition);Skin warm (30min - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851289	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphonia (n/a - Recovered/Resolved - Other Medically Important Condition);Laryngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Wheezing (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851290	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Choking (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Dysphonia (n/a - Unknown - Other Medically Important Condition);Grunting (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Throat irritation (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851290&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851291	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Depressed level of consciousness (n/a - Unknown - Other Medically Important Condition);Hypopnoea (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Stridor (n/a - Unknown - Other Medically Important Condition);Wheezing (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851292	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Hypotension (n/a - Unknown - Other Medically Important Condition);Panic reaction (n/a - Unknown - Other Medically Important Condition);Paraesthesia oral (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851292&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851293	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (4h - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Tachypnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition);Tongue disorder (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851294	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site urticaria (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Throat irritation (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851294&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851295	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Adverse event (2h - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (2h - Recovered/Resolved - Other Medically Important Condition);Dysphonia (2h - Recovered/Resolved - Other Medically Important Condition);Oedema mouth (2h - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (2h - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (2h - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851296	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (30min - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (30min - Recovered/Resolved - Other Medically Important Condition);Throat tightness (30min - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851296&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851297	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Agitation (n/a - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Anxiety (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (3d - Recovered/Resolved - Other Medically Important Condition);Feeling abnormal (3d - Recovered/Resolved - Other Medically Important Condition);Pharyngeal swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Rash erythematous (3d - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851298	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (5h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (5h - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3851299	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (10min - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (10min - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (2d - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (2d - Not Recovered/Not Resolved - Other Medically Important Condition);Heart rate increased (10min - Not Recovered/Not Resolved - Other Medically Important Condition);Pallor (10min - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (10min - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia oral (10min - Not Recovered/Not Resolved - Other Medically Important Condition);Tongue disorder (10min - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851299&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851300	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal discomfort (4h - Recovered/Resolved - Other Medically Important Condition);Agitation (4h - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (4h - Recovered/Resolved - Other Medically Important Condition);Dizziness (4h - Recovered/Resolved - Other Medically Important Condition);Flushing (4h - Recovered/Resolved - Other Medically Important Condition);Gait disturbance (4h - Recovered/Resolved - Other Medically Important Condition);Nausea (4h - Recovered/Resolved - Other Medically Important Condition);Pharyngeal swelling (4h - Recovered/Resolved - Other Medically Important Condition);Tremor (4h - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851300&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851301	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Face oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lip oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tongue oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3851302	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851303	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H1N1), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H3N2), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN B] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851304	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chest pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle tightness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pharyngeal swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Urticaria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851305	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (2h - Recovered/Resolved - Other Medically Important Condition);Cough (2h - Recovered/Resolved - Other Medically Important Condition);Lip oedema (2h - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (2h - Recovered/Resolved - Other Medically Important Condition);Urticaria (2h - Recovered/Resolved - Other Medically Important Condition);Wheezing (2h - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851306	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling cold (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (1min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851306&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3851307	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Anxiety (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851307&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851308	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851309	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Oral pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Rash macular (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851310	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Lacrimation increased (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Swollen tongue (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851310&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851311	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Dry mouth (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphonia (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851312	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Throat irritation (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851313	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Hypocalcaemia (n/a - Unknown - Other Medically Important Condition);Shock (n/a - Unknown - Other Medically Important Condition);Stridor (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851314	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Apnoea (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Lip swelling (n/a - Unknown - Other Medically Important Condition);Periorbital oedema (n/a - Unknown - Other Medically Important Condition);Use of accessory respiratory muscles (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851315	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Other Medically Important Condition);Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Back pain (n/a - Unknown - Other Medically Important Condition);Chills (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Paraesthesia oral (n/a - Unknown - Other Medically Important Condition);Skin tightness (n/a - Unknown - Other Medically Important Condition);Swelling face (n/a - Unknown - Other Medically Important Condition);Throat irritation (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851316	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Altered state of consciousness (n/a - Unknown - Other Medically Important Condition);Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chills (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Injection site pruritus (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition);Tongue disorder (n/a - Unknown - Other Medically Important Condition);Wheezing (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851316&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851352	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Flushing (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851352&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851353	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest pain (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851354	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Blood potassium decreased (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851355	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Flushing (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851356	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Respiratory tract congestion (n/a - Unknown - Other Medically Important Condition);Wheezing (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851356&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851357	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Dysphonia (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851358	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Flushing (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Throat irritation (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851359	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Blood pressure increased (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Rash maculo-papular (n/a - Unknown - Other Medically Important Condition);Wheezing (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851360	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Chills (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851361	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Sensation of foreign body (n/a - Unknown - Other Medically Important Condition);Swollen tongue (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851361&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851362	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Eye pruritus (n/a - Unknown - Other Medically Important Condition);Lacrimation increased (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Throat irritation (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851362&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851363	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851363&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851364	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Blood potassium decreased (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851364&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851365	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Anxiety (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Feeling hot (n/a - Unknown - Other Medically Important Condition);Flushing (n/a - Unknown - Other Medically Important Condition);Ocular hyperaemia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851366	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Unknown - Other Medically Important Condition);Periorbital oedema (n/a - Unknown - Other Medically Important Condition);Skin burning sensation (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851367	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Unknown - Other Medically Important Condition);Feeling cold (n/a - Unknown - Other Medically Important Condition);Heart rate increased (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Muscle tightness (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851368	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Anxiety (n/a - Unknown - Other Medically Important Condition);Dizziness (5min - Unknown - Other Medically Important Condition);Dysphagia (n/a - Unknown - Other Medically Important Condition);Dysphonia (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851370	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Injection site pain (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Swollen tongue (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851371	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Eyelid oedema (n/a - Unknown - Other Medically Important Condition);Lip swelling (n/a - Unknown - Other Medically Important Condition);Oral mucosal erythema (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ACRIVASTINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851371&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851372	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia oral (n/a - Unknown - Other Medically Important Condition);Paraesthesia oral (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851373	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Anxiety (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia oral (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Paraesthesia mucosal (n/a - Unknown - Other Medically Important Condition);Respiratory rate increased (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851374	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Angioedema (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851375	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Heart rate irregular (n/a - Unknown - Other Medically Important Condition);Ocular hyperaemia (n/a - Unknown - Other Medically Important Condition);Oedema peripheral (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Renal pain (n/a - Unknown - Other Medically Important Condition);Respiratory distress (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition);Tongue disorder (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851376	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851377	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Swelling face (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H1N1), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H3N2), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN B] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851377&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851378	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (2h - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851379	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Cyanosis (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851379&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851380	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site abscess (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema mouth (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851380&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851381	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (1h - Recovered/Resolved - Other Medically Important Condition);Cough (1h - Recovered/Resolved - Other Medically Important Condition);Dizziness (1h - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (1h - Recovered/Resolved - Other Medically Important Condition);Erythema (1h - Recovered/Resolved - Other Medically Important Condition);Urticaria (1h - Recovered/Resolved - Other Medically Important Condition);Wheezing (1h - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851381&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851383	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Loss of consciousness (3min - Unknown - Other Medically Important Condition);Tonic convulsion (3min - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851383&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851384	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Adverse reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Crying (n/a - Recovered/Resolved - Other Medically Important Condition);Cyanosis (11min - Recovered/Resolved - Other Medically Important Condition);Depressed level of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphonia (n/a - Recovered/Resolved - Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved - Other Medically Important Condition);Lethargy (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition);Stridor (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851385	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain upper (1d - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (1d - Recovered/Resolved - Other Medically Important Condition);Dysphonia (1d - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (1d - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (1d - Recovered/Resolved - Other Medically Important Condition);Wheezing (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])|[TRIVALENT INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851386	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Chest discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphonia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Eyelid oedema (5min - Recovered/Resolved - Other Medically Important Condition);Gingival swelling (5min - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition);Tongue oedema (5min - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[HYDROCHLOROTHIAZIDE, LOSARTAN, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851386&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851387	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Adverse event (n/a - Recovered/Resolved - Other Medically Important Condition);Chest pain (n/a - Recovered/Resolved - Other Medically Important Condition);Circumoral oedema (2h - Recovered/Resolved - Other Medically Important Condition);Dysarthria (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphonia (2h - Recovered/Resolved - Other Medically Important Condition);Eyelid oedema (2h - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Stridor (2h - Recovered/Resolved - Other Medically Important Condition);Swollen tongue (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	EVISTA [RALOXIFENE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[MORPHINE, MORPHINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851388	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Chest discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Ear pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Rash pruritic (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[FLUTICASONE PROPIONATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851389	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain (1d - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (1d - Recovered/Resolved - Other Medically Important Condition);Dysphonia (1d - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (1d - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (1d - Recovered/Resolved - Other Medically Important Condition);Rhonchi (1h - Recovered/Resolved - Other Medically Important Condition);Urticaria (1d - Recovered/Resolved - Other Medically Important Condition);Wheezing (1d - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])|[TRIVALENT INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851391	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Adverse event (n/a - Unknown - Other Medically Important Condition);Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Blood pressure increased (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Unknown - Other Medically Important Condition);Dysphonia (n/a - Unknown - Other Medically Important Condition);Eye pruritus (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Ocular hyperaemia (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Paraesthesia oral (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition);Tongue oedema (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851393	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Chest discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Dry throat (n/a - Recovered/Resolved - Other Medically Important Condition);Feeling hot (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851393&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851395	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Ocular hyperaemia (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Sneezing (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851395&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851396	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851396&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851397	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Depressed level of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851397&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851398	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaphylactic reaction (15min - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (15min - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (15min - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851399	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cyanosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Flushing (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851400	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (2h - Recovered/Resolved - Other Medically Important Condition);Cold sweat (2h - Recovered/Resolved - Other Medically Important Condition);Dysgeusia (2h - Recovered/Resolved - Other Medically Important Condition);Dysphagia (2h - Recovered/Resolved - Other Medically Important Condition);Feeling of body temperature change (2h - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (2h - Recovered/Resolved - Other Medically Important Condition);Palpitations (2h - Recovered/Resolved - Other Medically Important Condition);Tongue disorder (2h - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H1N1), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H3N2), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN B] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851401	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851402	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Heart rate increased (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Presyncope (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851403	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Unknown - Other Medically Important Condition);Feeling hot (n/a - Unknown - Other Medically Important Condition);Flushing (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851404	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851404&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851405	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Oral discomfort (n/a - Unknown - Other Medically Important Condition);Throat irritation (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - n/a - Unknown])	[VALPROIC ACID] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851407	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Pharyngeal swelling (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851407&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851408	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Blood pressure increased (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851408&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851409	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851409&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851498	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blood pressure increased (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Flushing (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Lacrimation increased (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851499	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest pain (n/a - Unknown - Other Medically Important Condition);Dysphonia (n/a - Unknown - Other Medically Important Condition);Flushing (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851500	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Flushing (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851501	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Flushing (n/a - Unknown - Other Medically Important Condition);Hypotension (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Tachypnoea (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851502	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Circulatory collapse (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Throat irritation (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851504	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (30min - Unknown - Other Medically Important Condition);Cough (30min - Unknown - Other Medically Important Condition);Flushing (30min - Unknown - Other Medically Important Condition);Nausea (30min - Unknown - Other Medically Important Condition);Throat tightness (30min - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851505	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Chills (n/a - Unknown - Other Medically Important Condition);Confusional state (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851505&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851506	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851507	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Choking (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depressed level of consciousness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Throat tightness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Urticaria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851508	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Bronchial oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphonia (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal swelling (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3851509	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Nervousness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851509&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851510	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (15min - Recovered/Resolved - Other Medically Important Condition);Nausea (2min - Recovered/Resolved - Other Medically Important Condition);Throat tightness (2min - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851510&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851512	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Adverse event (6min - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (6min - Recovered/Resolved - Other Medically Important Condition);Cough (6min - Recovered/Resolved - Other Medically Important Condition);Rash macular (6min - Recovered/Resolved - Other Medically Important Condition);Use of accessory respiratory muscles (6min - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851513	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Agitation (10min - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (10min - Recovered/Resolved - Other Medically Important Condition);Erythema (10min - Recovered/Resolved - Other Medically Important Condition);Irritability (10min - Recovered/Resolved - Other Medically Important Condition);Lip swelling (10min - Recovered/Resolved - Other Medically Important Condition);Rash macular (10min - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851514	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Aggression (n/a - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (30min - Recovered/Resolved - Other Medically Important Condition);Cold sweat (n/a - Recovered/Resolved - Other Medically Important Condition);Depressed level of consciousness (30min - Recovered/Resolved - Other Medically Important Condition);Face oedema (30min - Recovered/Resolved - Other Medically Important Condition);Livedo reticularis (n/a - Recovered/Resolved - Other Medically Important Condition);Nasopharyngitis (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (30min - Recovered/Resolved - Other Medically Important Condition);Throat tightness (30min - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3851515	Spontaneous	2010-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3851515&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839222	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (2d - Recovered/Resolved - Other Medically Important Condition);Chest pain (2d - Recovered/Resolved - Other Medically Important Condition);Dysgeusia (2d - Recovered/Resolved - Other Medically Important Condition);Erythema (2d - Recovered/Resolved - Other Medically Important Condition);Face oedema (2d - Recovered/Resolved - Other Medically Important Condition);Tachycardia (2d - Recovered/Resolved - Other Medically Important Condition);Throat tightness (2d - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839222&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839224	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (1h - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (1h - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (1h - Recovered/Resolved - Other Medically Important Condition);Hypertension (1h - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (1h - Recovered/Resolved - Other Medically Important Condition);Nausea (1h - Recovered/Resolved - Other Medically Important Condition);Pallor (1h - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);Tachypnoea (1h - Recovered/Resolved - Other Medically Important Condition);Tongue disorder (1h - Recovered/Resolved - Other Medically Important Condition);Tongue oedema (1h - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H1N1), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H3N2), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN B] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839224&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839225	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Flushing (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839226	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dry throat (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphagia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839227	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chest discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tachypnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Wheezing (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839227&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839228	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition);Tachypnoea (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839228&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839229	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Adverse event (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash macular (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash pruritic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Throat irritation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Throat tightness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839229&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839230	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Other Medically Important Condition);Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839231	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839232	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cyanosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Laryngeal oedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pharyngeal oedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tachycardia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Throat tightness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tongue oedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839232&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839233	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Hypotension (n/a - Unknown - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Tachypnoea (n/a - Unknown - Other Medically Important Condition);Use of accessory respiratory muscles (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839233&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839234	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia oral (n/a - Unknown - Other Medically Important Condition);Tongue oedema (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839235	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Chest pain (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Lip swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Swollen tongue (n/a - Recovered/Resolved - Other Medically Important Condition);Tachypnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition);Wheezing (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[DICLOFENAC SODIUM, MISOPROSTOL] (C - n/a - Unknown - [n/a - n/a - Unknown])|[IRBESARTAN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - Unknown - [n/a - n/a - Unknown])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839236	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Adverse event (n/a - Recovered/Resolved - Other Medically Important Condition);Altered state of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Lip oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[FLUTICASONE PROPIONATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839236&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839237	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Other Medically Important Condition);Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Anxiety (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Unknown - Other Medically Important Condition);Lip oedema (n/a - Unknown - Other Medically Important Condition);Pharyngeal oedema (n/a - Unknown - Other Medically Important Condition);Swelling face (n/a - Unknown - Other Medically Important Condition);Swollen tongue (n/a - Unknown - Other Medically Important Condition);Tachypnoea (n/a - Unknown - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839238	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Cough (3h - Unknown - Other Medically Important Condition);Dysphonia (3h - Unknown - Other Medically Important Condition);Hypertension (3h - Unknown - Other Medically Important Condition);Laryngeal oedema (3h - Unknown - Other Medically Important Condition);Lip oedema (3h - Unknown - Other Medically Important Condition);Pharyngeal oedema (3h - Unknown - Other Medically Important Condition);Throat tightness (3h - Unknown - Other Medically Important Condition);Tongue oedema (3h - Unknown - Other Medically Important Condition);Urticaria (2h - Unknown - Other Medically Important Condition);Wheezing (3h - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839239	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Anxiety (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Paraesthesia oral (n/a - Unknown - Other Medically Important Condition);Tachypnoea (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839239&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839240	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Adverse event (n/a - Unknown - Other Medically Important Condition);Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839240&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839241	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Lip oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Tongue oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839241&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839242	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal discomfort (2h - Recovered/Resolved - Other Medically Important Condition);Adverse event (2h - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (2h - Recovered/Resolved - Other Medically Important Condition);Erythema (2h - Recovered/Resolved - Other Medically Important Condition);Flushing (2h - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (2h - Recovered/Resolved - Other Medically Important Condition);Stridor (2h - Recovered/Resolved - Other Medically Important Condition);Throat tightness (2h - Recovered/Resolved - Other Medically Important Condition);Tongue disorder (2h - Recovered/Resolved - Other Medically Important Condition);Wheezing (2h - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839242&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839243	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (4h - Recovered/Resolved - Other Medically Important Condition);Throat tightness (4h - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839243&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839244	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site warmth (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839244&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839245	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Throat irritation (15min - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839246	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839247	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dry throat (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition);Tongue dry (n/a - Unknown - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839248	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest discomfort (50min - Unknown - Other Medically Important Condition);Dysarthria (n/a - Unknown - Other Medically Important Condition);Dyspnoea (50min - Unknown - Other Medically Important Condition);Hypertension (50min - Unknown - Other Medically Important Condition);Nausea (50min - Unknown - Other Medically Important Condition);Pallor (50min - Unknown - Other Medically Important Condition);Throat tightness (50min - Unknown - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839249	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Dysarthria (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Paraesthesia oral (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Tachypnoea (n/a - Unknown - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839250	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Chest discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site induration (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site rash (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site urticaria (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[EPINEPHRINE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839250&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839251	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (7d - Recovered/Resolved - Other Medically Important Condition);Burning sensation (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphonia (n/a - Recovered/Resolved - Other Medically Important Condition);Eyelid oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Head discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Hypertension (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[NAPROXEN] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839252	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaphylactic reaction (2h - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphonia (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema mouth (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[ATENOLOL, ATENOLOL BP] (C - n/a - Unknown - [n/a - n/a - Unknown])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[IRBESARTAN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839252&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839253	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphoria (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Tongue disorder (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839253&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839254	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (5min - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (5min - Recovered/Resolved - Other Medically Important Condition);Tachypnoea (5min - Recovered/Resolved - Other Medically Important Condition);Throat tightness (5min - Recovered/Resolved - Other Medically Important Condition);Tongue oedema (5min - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839254&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839255	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839255&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839256	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839257	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Paraesthesia mucosal (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839258	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839259	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylaxis prophylaxis (n/a - Unknown - Other Medically Important Condition);Depressed level of consciousness (1min - Unknown - Other Medically Important Condition);Hypotonic-hyporesponsive episode (1min - Unknown - Other Medically Important Condition);Protrusion tongue (1min - Unknown - Other Medically Important Condition);Swollen tongue (1min - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3839260	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Pharyngeal swelling (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Tachypnoea (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3839261	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Agitation (3h - Unknown - Other Medically Important Condition);Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Pallor (3h - Unknown - Other Medically Important Condition);Restlessness (3h - Unknown - Other Medically Important Condition);Throat tightness (3h - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3839261&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3824251	Spontaneous	2010-07-09 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	65-85 Years	Not Specified	No	Male	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3824251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3824252	Spontaneous	2010-07-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Sensory loss (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3824252&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3824254	Spontaneous	2010-07-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Areflexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Back pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (45d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Insomnia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - Unknown - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - n/a - Unknown - [n/a - n/a - n/a])|[LABETALOL HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3824254&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3812248	Spontaneous	2010-07-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Application site infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sepsis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[MENINGOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3812248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3791427	Spontaneous	2010-06-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Not Specified	Asthma (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Exposure via breast milk (n/a - Unknown - Other Medically Important Condition);Nasopharyngitis (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3791427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3760291	Spontaneous	2010-06-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Blood glucose increased (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Necrotising fasciitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sepsis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[MENINGOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3760291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3744322	Spontaneous	2010-06-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Abnormal behaviour (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Aggression (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Biopsy bone marrow (n/a - Unknown - Life Threatening, Other Medically Important Condition);Blood test abnormal (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Fatigue (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pancytopenia (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Weight decreased (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	UNSPECIFIED MEDICATION [UNKNOWN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (C - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3744322&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3744350	Spontaneous	2010-06-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blister (27d - Recovered/Resolved - Other Medically Important Condition);Diabetes mellitus inadequate control (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (29d - Recovered/Resolved - Other Medically Important Condition);Erythema multiforme (27d - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (29d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Skin exfoliation (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	GALVUS [VILDAGLIPTIN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[CANDESARTAN CILEXETIL] (C - n/a - Unknown - [n/a - n/a - Unknown])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[VERAPAMIL] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3744350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-3731913	Spontaneous	2010-05-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Arthralgia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Haematuria (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Purpura (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3731913&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-3717045	Spontaneous	2010-05-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Induration (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3717045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3698025	Spontaneous	2010-05-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Decreased appetite (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Foetal hypokinesia (1wk - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Stillbirth (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3698025&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3665733	Spontaneous	2010-04-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Feeling drunk (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Swollen tongue (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3665733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3647922	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Recovering/Resolving - Other Medically Important Condition);Diarrhoea (3d - Recovered/Resolved - Other Medically Important Condition);Eczema (28d - Recovered/Resolved - Other Medically Important Condition);Fatigue (3d - Recovered/Resolved - Other Medically Important Condition);Nausea (3d - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-3647931	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic shock (1h - Recovered/Resolved - Other Medically Important Condition);Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PREDNISOLONE] (C - Nephrotic syndrome - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3647932	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3647935	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647935&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3647936	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3647942	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647942&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3647943	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647943&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3647944	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Adverse event (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3647945	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3647946	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3647947	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647947&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3647948	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647948&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3647949	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647949&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3647950	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647950&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3647951	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647951&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3647952	Spontaneous	2010-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3647952&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3637702	Spontaneous	2010-04-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3637702&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3632239	Spontaneous	2010-04-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Aspiration (n/a - Fatal - Results in Death);Cardio-respiratory arrest (n/a - Fatal - Results in Death);Hypoxia (n/a - Fatal - Results in Death);Vomiting (n/a - Fatal - Results in Death)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3632239&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-3608118	Spontaneous	2010-03-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Male	Adverse event (1d - Recovered/Resolved With Sequelae - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3608118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3580359	Spontaneous	2010-03-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Dyskinesia (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Fall (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Memory impairment (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[BUPROPION, BUPROPION HYDROCHLORIDE] (S - Product used for unknown indication - Unknown - [8d - 150mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3580359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3580371	Spontaneous	2010-03-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Aphasia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Arteriosclerosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Ischaemic stroke (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Left ventricular hypertrophy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3580371&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3569993	Spontaneous	2010-03-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ill-defined disorder (n/a - Unknown - Other Medically Important Condition);Illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lethargy (n/a - Unknown - Other Medically Important Condition);Lymphocyte count increased (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Migraine (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neck pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Skin discolouration (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Systemic lupus erythematosus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);White blood cell count increased (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[HEPATITIS B SURFACE ANTIGEN, HEPATITIS A VACCINE (INACTIVATED)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[INFLUENZA VIRUS VACCINE POLYVALENT] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3569993&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3551117	Spontaneous	2010-03-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Back pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Intervertebral disc disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neck pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuritis (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3551117&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3536848	Spontaneous	2010-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	18-64 Years	Not Specified	No	Female	Cranial nerve paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperglycaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle rigidity (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[INSULIN, INSULIN HUMAN] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3536848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3536849	Spontaneous	2010-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cranial nerve paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3536849&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3536850	Spontaneous	2010-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cranial nerve paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotension (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Paresis (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3536850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3536851	Spontaneous	2010-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	65-85 Years	Not Specified	No	Male	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Peripheral sensorimotor neuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Sensory loss (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	UNKNOWN MEDICATION [UNKNOWN] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3536851&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3536852	Spontaneous	2010-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Cranial nerve paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Endotracheal intubation (n/a - Unknown - Caused/Prolonged Hospitalisation);Epigastric discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastrointestinal disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Osteoporosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3536852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3536853	Spontaneous	2010-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cranial nerve paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysstasia (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia oral (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3536853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3536855	Spontaneous	2010-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3536855&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3536856	Spontaneous	2010-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	18-64 Years	Not Specified	No	Male	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cranial nerve paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paresis (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3536856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3536857	Spontaneous	2010-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cranial nerve paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	ANTIHYPERTENSIVE [ANTIHYPERTENSIVE] (C - n/a - Unknown - [n/a - n/a - n/a])|DIABETES MEDICATION [DIABETES MEDICATION] (C - n/a - Unknown - [n/a - n/a - n/a])|UNKNOWN MEDICATION [UNKNOWN] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3536857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3536858	Spontaneous	2010-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3536858&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3536859	Spontaneous	2010-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3536859&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3536860	Spontaneous	2010-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cranial nerve paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	ANTIHYPERTENSIVE [ANTIHYPERTENSIVE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3536860&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3536861	Spontaneous	2010-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (37d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyporeflexia (37d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (37d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (37d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia oral (37d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Radiculopathy (37d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CELECOXIB] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3536861&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3531055	Spontaneous	2010-02-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Neuralgia (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (2d - Recovered/Resolved - Disabling);Transmission of an infectious agent via product (n/a - Unknown - Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	NO CONCURRENT MEDICATIONS [NO CONCURRENT MEDICATION] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3531055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-3531056	Spontaneous	2010-02-24 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	65-85 Years	Not Specified	No	Male	Cranial nerve paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysstasia (n/a - Unknown - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[WARFARIN SODIUM] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3531056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3531057	Spontaneous	2010-02-24 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Confusional state (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Cranial nerve paralysis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Endotracheal intubation (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia aspiration (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Respiratory paralysis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3531057&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-3531058	Spontaneous	2010-02-24 00:00:00	Healthcare Professional	Non European Economic Area	Michele Mandel &quot;One small needle, a world of trouble; Rare condition caused by H1N1 shot?&quot;, The Toronto Sun, Sun 31 Jan 2010, Page 5, News	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3531058&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-3522142	Spontaneous	2010-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Contusion (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Eye pruritus (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Local reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Productive cough (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	CELLCEPT [MYCOPHENOLATE MOFETIL] (C - Heart transplant - Unknown - [n/a - 250mg - Oral])|PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - Stent placement - Unknown - [n/a - 75mg - Oral])|[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - 80mg - Oral])|[ASCORBIC ACID, MAGNESIUM OXIDE, HEAVY, MAGNESIUM] (C - Hypomagnesaemia - Unknown - [n/a - 15mL - Oral])|[EZETIMIBE] (C - Dyslipidaemia - Unknown - [n/a - 10mg - Oral])|[FLUVASTATIN, FLUVASTATIN SODIUM] (C - Dyslipidaemia - Unknown - [n/a - 80mg - Oral])|[MYCOPHENOLATE SODIUM, MYCOPHENOLIC ACID] (C - Heart transplant - Unknown - [n/a - 360mg - Oral])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - Hypertension - Unknown - [n/a - 2mg - Oral])|[PREDNISONE] (C - Heart transplant - Unknown - [n/a - 5mg - Oral])|[TACROLIMUS, TACROLIMUS MONOHYDRATE] (C - Heart transplant - Unknown - [n/a - 2mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3522142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-3522143	Spontaneous	2010-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Flushing (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Product complaint (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3522143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3522144	Spontaneous	2010-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Loss of consciousness (n/a - Unknown - Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Product complaint (n/a - Unknown - Other Medically Important Condition);Sensation of foreign body (n/a - Unknown - Other Medically Important Condition);Tachypnoea (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	UNSPECIFIED INHALER [INHALER] (C - Asthma - Unknown - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3522144&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3522145	Spontaneous	2010-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Angioedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cyanosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Product complaint (n/a - Unknown - Other Medically Important Condition);Retching (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3522145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3522146	Spontaneous	2010-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Depressed level of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Dysgeusia (n/a - Recovered/Resolved - Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Product complaint (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition);Tongue oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H1N1), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H3N2), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN B] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3522146&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3522147	Spontaneous	2010-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Circulatory collapse (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling abnormal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling cold (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Product complaint (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory arrest (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swelling face (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3522147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3522148	Spontaneous	2010-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Angioedema (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Dysphonia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Unknown - Other Medically Important Condition);Product complaint (n/a - Unknown - Other Medically Important Condition);Stridor (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Tachypnoea (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition);Wheezing (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	INHALERS [INHALER] (C - Asthma - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3522148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3522149	Spontaneous	2010-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Product complaint (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H1N1), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H3N2), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN B] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3522149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3522150	Spontaneous	2010-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Not Specified	Cough (n/a - Fatal - Results in Death, Other Medically Important Condition);Cyanosis (n/a - Fatal - Results in Death, Other Medically Important Condition);Product complaint (n/a - Unknown - Results in Death, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3522150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-3507380	Spontaneous	2010-02-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic shock (1d - Recovered/Resolved - Life Threatening);Fatigue (2d - Recovered/Resolved - Life Threatening);Hypersensitivity (1d - Recovered/Resolved - Life Threatening);Pruritus (1d - Recovered/Resolved - Life Threatening);Swelling face (1d - Recovered/Resolved - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - Antiphospholipid syndrome - Unknown - [n/a - n/a - Unknown])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Anxiety disorder - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3507380&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3507392	Spontaneous	2010-02-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Cell death (n/a - Unknown - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Foetal distress syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Foetal heart rate abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Placental insufficiency (n/a - Unknown - Caused/Prolonged Hospitalisation);Skin maceration (n/a - Unknown - Caused/Prolonged Hospitalisation);Stillbirth (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3507392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3487598	Spontaneous	2010-02-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Muscle tightness (n/a - Not Recovered/Not Resolved - Disabling);Neuritis (n/a - Unknown - Disabling);Pain in extremity (n/a - Unknown - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Ulnar neuritis (n/a - Unknown - Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3487598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-3457470	Spontaneous	2010-01-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Brain fog (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Unknown - Disabling);Decreased activity (n/a - Recovering/Resolving - Disabling);Decreased appetite (n/a - Unknown - Disabling);Disability (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Unknown - Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Impaired driving ability (n/a - Not Recovered/Not Resolved - Disabling);Liver function test increased (n/a - Unknown - Disabling);Loss of personal independence in daily activities (n/a - Not Recovered/Not Resolved - Disabling);Lymphocyte morphology abnormal (n/a - Unknown - Disabling);Mental impairment (n/a - Not Recovered/Not Resolved - Disabling);Movement disorder (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Oral mucosal blistering (n/a - Not Recovered/Not Resolved - Disabling);Oropharyngeal pain (n/a - Recovered/Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Panic attack (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Red blood cell sedimentation rate increased (n/a - Recovered/Resolved - Disabling);Respiratory disorder (n/a - Recovered/Resolved - Disabling);Thinking abnormal (n/a - Not Recovered/Not Resolved - Disabling);Tonsillar disorder (n/a - Not Recovered/Not Resolved - Disabling);Weight decreased (n/a - Unknown - Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H1N1), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H3N2), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN B] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3457470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-3447942	Spontaneous	2010-01-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic shock (n/a - Recovering/Resolving - Life Threatening);Apnoea (n/a - Recovering/Resolving - Life Threatening);Cough (n/a - Recovered/Resolved - Life Threatening);Cyanosis (n/a - Recovered/Resolved - Life Threatening);Disturbance in attention (n/a - Unknown - Life Threatening);Dyspnoea (n/a - Recovered/Resolved - Life Threatening);Mental impairment (n/a - Unknown - Life Threatening);Sinus disorder (n/a - Recovering/Resolving - Life Threatening);Skin discolouration (n/a - Recovered/Resolved - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3447942&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3428944	Spontaneous	2010-01-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Not Specified	Conjunctivitis (n/a - Unknown - Other Medically Important Condition);Pulmonary congestion (n/a - Unknown - Other Medically Important Condition);Purulent discharge (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3428944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3428946	Spontaneous	2010-01-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Angioedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3428946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3428961	Spontaneous	2010-01-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hemiparesis (n/a - Recovering/Resolving - Other Medically Important Condition);Monoparesis (n/a - Recovering/Resolving - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3428961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3384727	Spontaneous	2009-12-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Coxsackie viral infection (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Immune system disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Lip swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Lyme disease (n/a - Unknown - Other Medically Important Condition);Oral pain (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Skin discolouration (n/a - Recovered/Resolved - Other Medically Important Condition);Skin disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Stevens-Johnson syndrome (n/a - Recovered/Resolved - Other Medically Important Condition);Stomatitis (n/a - Recovered/Resolved - Other Medically Important Condition);Streptococcal infection (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3384727&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3383778	Spontaneous	2009-12-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abnormal behaviour (n/a - Recovered/Resolved - Other Medically Important Condition);Confusional state (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Recovered/Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3383778&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3369869	Spontaneous	2009-12-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (9d - Recovered/Resolved - Other Medically Important Condition);Hot flush (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Nausea (9d - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Palpitations (9d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[BROMAZEPAM] (C - Sleep disorder - Unknown - [n/a - n/a - Unknown])|[LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE OXIDE] (C - Irritable bowel syndrome - Unknown - [n/a - n/a - Unknown])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - Rhinitis - Unknown - [n/a - n/a - Unknown])|[NAPROXEN, NAPROXEN SODIUM] (C - Pain - Unknown - [n/a - n/a - Unknown])|[TRIFOLIUM PRATENSE L.] (C - Hot flush - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3369869&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3362445	Spontaneous	2009-12-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Bell's palsy (n/a - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Live birth (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[ASCORBIC ACID, FOLIC ACID, IRON] (C - Vitamin supplementation - Unknown - [n/a - 1{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3362445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3362446	Spontaneous	2009-12-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Deafness (n/a - Not Recovered/Not Resolved - Disabling);Deafness neurosensory (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Injection site pain (n/a - Not Recovered/Not Resolved - Disabling);Vertigo (n/a - Not Recovered/Not Resolved - Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3362446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-3362447	Spontaneous	2009-12-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3362447&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3362448	Spontaneous	2009-12-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3362448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3362449	Spontaneous	2009-12-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Diarrhoea (n/a - Unknown - Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3362449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3351856	Spontaneous	2009-12-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthma (n/a - Not Recovered/Not Resolved - Disabling);Blood glucose increased (n/a - Not Recovered/Not Resolved - Disabling);Cough (n/a - Not Recovered/Not Resolved - Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Recovering/Resolving - Disabling);Suspected transmission of an infectious agent via product (n/a - Unknown - Disabling);Upper respiratory tract infection (n/a - Not Recovered/Not Resolved - Disabling)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3351856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-3351857	Spontaneous	2009-12-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Asthma (n/a - Recovered/Resolved - Other Medically Important Condition);Ill-defined disorder (14d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition);Suspected transmission of an infectious agent via product (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	[FLUTICASONE PROPIONATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3351857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3344198	Spontaneous	2009-12-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (0d - Recovered/Resolved - Other Medically Important Condition);Depressed level of consciousness (0d - Recovered/Resolved - Other Medically Important Condition);Dizziness (0d - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (0d - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (0d - Recovered/Resolved - Other Medically Important Condition);Localised oedema (0d - Recovered/Resolved - Other Medically Important Condition);Nausea (0d - Recovered/Resolved - Other Medically Important Condition);Oedema mouth (0d - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (0d - Recovered/Resolved - Other Medically Important Condition);Product complaint (0d - Unknown - Other Medically Important Condition);Wheezing (0d - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3344198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3344199	Spontaneous	2009-12-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Bronchospasm (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Generalised oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Product complaint (n/a - Unknown - Other Medically Important Condition);Respiratory disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3344199&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3344200	Spontaneous	2009-12-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (2d - Recovered/Resolved - Other Medically Important Condition);Chest discomfort (2d - Recovered/Resolved - Other Medically Important Condition);Dysgeusia (2d - Recovered/Resolved - Other Medically Important Condition);Erythema (2d - Recovered/Resolved - Other Medically Important Condition);Face oedema (2d - Recovered/Resolved - Other Medically Important Condition);Generalised oedema (2d - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (2d - Recovered/Resolved - Other Medically Important Condition);Lip oedema (2d - Recovered/Resolved - Other Medically Important Condition);Product complaint (2d - Unknown - Other Medically Important Condition);Tachycardia (2d - Recovered/Resolved - Other Medically Important Condition);Throat tightness (2d - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3344200&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3344201	Spontaneous	2009-12-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (70min - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (70min - Recovered/Resolved - Other Medically Important Condition);Oedema mouth (70min - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (70min - Recovered/Resolved - Other Medically Important Condition);Product complaint (70min - Unknown - Other Medically Important Condition);Pruritus (70min - Recovered/Resolved - Other Medically Important Condition);Respiratory disorder (70min - Recovered/Resolved - Other Medically Important Condition);Urticaria (70min - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3344201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3331504	Spontaneous	2009-12-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest discomfort (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chest pain (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);H1N1 influenza (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3331504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-3331507	Spontaneous	2009-12-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3331507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3331511	Spontaneous	2009-12-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute kidney injury (n/a - Unknown - Other Medically Important Condition);Anaemia (n/a - Unknown - Other Medically Important Condition);Blood creatinine increased (n/a - Unknown - Other Medically Important Condition);Immune system disorder (n/a - Unknown - Other Medically Important Condition);Neutropenia (n/a - Unknown - Other Medically Important Condition);Pancytopenia (n/a - Unknown - Other Medically Important Condition);Thrombocytopenia (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3331511&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3331512	Spontaneous	2009-12-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Recovering/Resolving - Other Medically Important Condition);Chills (n/a - Recovering/Resolving - Other Medically Important Condition);Cough (n/a - Recovering/Resolving - Other Medically Important Condition);Insomnia (n/a - Recovering/Resolving - Other Medically Important Condition);Oropharyngeal pain (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3331512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3331514	Spontaneous	2009-12-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Consciousness fluctuating (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Fall (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Fear (n/a - Recovered/Resolved - Other Medically Important Condition);Feeling abnormal (n/a - Recovered/Resolved - Other Medically Important Condition);Feeling cold (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Mobility decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition);Swollen tongue (n/a - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3331514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3323416	Spontaneous	2009-12-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cellulitis (8d - Recovered/Resolved - Other Medically Important Condition);Infection (8d - Recovered/Resolved - Other Medically Important Condition);Injection site inflammation (8d - Recovered/Resolved - Other Medically Important Condition);Injection site pain (8d - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (8d - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3323416&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3323419	Spontaneous	2009-12-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema nodosum (n/a - Recovering/Resolving - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovering/Resolving - Other Medically Important Condition);Nodule (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Other Medically Important Condition);Swelling (n/a - Recovering/Resolving - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CLONIDINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 2{DF} - n/a])|[ESTRADIOL] (C - n/a - Unknown - [n/a - 1mg - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - .125mg - n/a])|[NIFEDIPINE] (C - n/a - Unknown - [n/a - n/a - n/a])|[PROGESTERONE, PROGESTERONE, MICRONISED] (C - n/a - Unknown - [n/a - 200mg - n/a])|[ZOPICLONE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3323419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3323420	Spontaneous	2009-12-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Blood glucose abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3323420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3323422	Spontaneous	2009-12-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic shock (0d - Recovered/Resolved - Life Threatening);Dyspnoea (0d - Recovered/Resolved - Life Threatening);Flushing (0d - Recovered/Resolved - Life Threatening);Pharyngeal swelling (0d - Recovered/Resolved - Life Threatening);Pyrexia (0d - Recovered/Resolved - Life Threatening);Rash (0d - Recovered/Resolved - Life Threatening);Swelling face (0d - Recovered/Resolved - Life Threatening)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - .25mL - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3323422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3323423	Spontaneous	2009-12-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Syncope (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3323423&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3323424	Spontaneous	2009-12-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3323424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3308503	Spontaneous	2009-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (30min - Recovered/Resolved - Other Medically Important Condition);Angioedema (30min - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (30min - Recovered/Resolved - Other Medically Important Condition);Swollen tongue (30min - Recovered/Resolved - Other Medically Important Condition);Throat tightness (30min - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3308503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3305335	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rash pruritic (n/a - Unknown - Other Medically Important Condition);Rash vesicular (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	AVANDIA [ROSIGLITAZONE MALEATE] (C - n/a - Unknown - [n/a - 4mg - Unknown])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - Unknown - [n/a - 10mg - Unknown])|[IRBESARTAN] (C - n/a - Unknown - [n/a - 150mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305335&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3305345	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Chest discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dry throat (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia oral (n/a - Unknown - Caused/Prolonged Hospitalisation);Retching (n/a - Unknown - Caused/Prolonged Hospitalisation);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation);Stridor (n/a - Unknown - Caused/Prolonged Hospitalisation);Syncope (n/a - Unknown - Caused/Prolonged Hospitalisation);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305345&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3305346	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Angioedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia oral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pulse volume decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Throat irritation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3305347	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Angioedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chest discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sensation of foreign body (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Throat tightness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[EPINEPHRINE] (S - n/a - Unknown - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305347&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3305348	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition);Tachypnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305348&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3305349	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Anaphylactic reaction (1d - Recovered/Resolved - Other Medically Important Condition);Flushing (1d - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (1d - Recovered/Resolved - Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (1d - Recovered/Resolved - Other Medically Important Condition);Pallor (1d - Recovered/Resolved - Other Medically Important Condition);Sensory disturbance (1d - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (1d - Recovered/Resolved - Other Medically Important Condition);Vomiting (1d - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3305351	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (2min - Recovered/Resolved - Other Medically Important Condition);Cyanosis (0d - Unknown - Other Medically Important Condition);Dyspnoea (0d - Unknown - Other Medically Important Condition);Nausea (0d - Unknown - Other Medically Important Condition);Tachypnoea (0d - Unknown - Other Medically Important Condition);Throat tightness (0d - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	NO CONCURRENT MEDICATION [NO CONCURRENT MEDICATION] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305351&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3305352	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Angioedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia oral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pharyngeal hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pharyngeal swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Swollen tongue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Throat tightness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tongue disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305352&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3305353	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (n/a - Unknown - Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition);Tardive dyskinesia (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H1N1), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H3N2), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN B] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3305354	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Allergy to vaccine (1h - Recovered/Resolved - Other Medically Important Condition);Angioedema (1h - Recovered/Resolved - Other Medically Important Condition);Anxiety (1h - Recovered/Resolved - Other Medically Important Condition);Chest discomfort (1h - Recovered/Resolved - Other Medically Important Condition);Erythema (1h - Recovered/Resolved - Other Medically Important Condition);Flushing (1h - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (1h - Recovered/Resolved - Other Medically Important Condition);Pruritus (1h - Recovered/Resolved - Other Medically Important Condition);Rash papular (1h - Recovered/Resolved - Other Medically Important Condition);Throat irritation (1h - Recovered/Resolved - Other Medically Important Condition);Throat tightness (1h - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[LANSOPRAZOLE] (C - n/a - Unknown - [n/a - 30mg - Oral])|[LEVONORGESTREL] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3305355	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Oral pruritus (n/a - Unknown - Other Medically Important Condition);Paraesthesia (1d - Recovered/Resolved - Other Medically Important Condition);Pruritus (1d - Recovered/Resolved - Other Medically Important Condition);Rash (1d - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3305356	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (4d - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Eye pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (1d - Recovered/Resolved - Other Medically Important Condition);Injection site urticaria (n/a - Recovered/Resolved - Other Medically Important Condition);Lacrimation increased (n/a - Recovered/Resolved - Other Medically Important Condition);Lip swelling (4d - Recovered/Resolved - Other Medically Important Condition);Ocular hyperaemia (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (4d - Recovered/Resolved - Other Medically Important Condition);Pruritus (5d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition);Rash macular (5d - Recovered/Resolved - Other Medically Important Condition);Skin discolouration (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305356&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3305357	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (5h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Angioedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood potassium decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Loss of personal independence in daily activities (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory distress (n/a - Unknown - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation);Throat tightness (n/a - Unknown - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[THIAMINE HYDROCHLORIDE, RETINOL] (C - n/a - Unknown - [n/a - n/a - n/a])|[VENLAFAXINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3305358	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ill-defined disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[NICOTINE, NICOTINE BITARTRATE DIHYDRATE] (C - Ex-tobacco user - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3305360	Spontaneous	2009-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Atrial fibrillation (2d - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3291020	Spontaneous	2009-11-24 00:00:00	Healthcare Professional	Non European Economic Area	The Canadian Press, Nov 19, 2009, Winnipeg	18-64 Years	Not Specified	No	Female	Bacterial infection (n/a - Fatal - Results in Death);Ill-defined disorder (3d - Fatal - Results in Death);Illness (4d - Fatal - Results in Death);Sepsis (n/a - Fatal - Results in Death)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|TAMIFLU [OSELTAMIVIR, OSELTAMIVIR PHOSPHATE] (S - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3291020&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-3291024	Spontaneous	2009-11-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Diarrhoea (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hypersensitivity (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Nausea (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Urticaria (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3291024&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3291029	Spontaneous	2009-11-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthmatic crisis (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3291029&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3291030	Spontaneous	2009-11-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Dizziness (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Ill-defined disorder (n/a - Unknown - Other Medically Important Condition);Injection site discomfort (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3291030&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3278643	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Feeling cold (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling hot (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hot flush (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Hypertension (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Swelling face (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	ANTI-ANXIETY MED- NAME UNKNOWN [ANXIOLYTIC] (C - Anxiety - Unknown - [n/a - n/a - Unknown])|[HYDROXYZINE HYDROCHLORIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3278643&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3278644	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Eye pain (2d - Recovered/Resolved - );Headache (2d - Recovered/Resolved - );Hyperacusis (2d - Recovered/Resolved - );Paraesthesia (2d - Recovered/Resolved - );Photosensitivity reaction (2d - Recovered/Resolved - )	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3278644&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3278657	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (29min - Recovered/Resolved - Other Medically Important Condition);Cough (29min - Recovered/Resolved - Other Medically Important Condition);Cyanosis (29min - Recovered/Resolved - Other Medically Important Condition);Depressed level of consciousness (29min - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (29min - Recovered/Resolved - Other Medically Important Condition);Erythema (29min - Recovered/Resolved - Other Medically Important Condition);Face oedema (29min - Recovered/Resolved - Other Medically Important Condition);Generalised oedema (29min - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (29min - Recovered/Resolved - Other Medically Important Condition);Hypotension (29min - Recovered/Resolved - Other Medically Important Condition);Hypotonia (29min - Recovered/Resolved - Other Medically Important Condition);Pallor (29min - Recovered/Resolved - Other Medically Important Condition);Slow response to stimuli (29min - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3278657&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3278660	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Bell's palsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5{DF} - Unknown])|[INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H1N1), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H3N2), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN B] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3278660&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3258087	Spontaneous	2009-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza - Unknown - [n/a - n/a - Intramuscular])|TAMIFLU [OSELTAMIVIR, OSELTAMIVIR PHOSPHATE] (S - Antiviral prophylaxis - Unknown - [n/a - 75mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3258087&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3239259	Spontaneous	2009-11-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash pruritic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Suspected transmission of an infectious agent via product (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3239259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3225765	Spontaneous	2009-11-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3225765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3225766	Spontaneous	2009-11-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3225766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3225767	Spontaneous	2009-11-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3225767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3225768	Spontaneous	2009-11-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3225768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3225770	Spontaneous	2009-11-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3225770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3225771	Spontaneous	2009-11-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3225771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3225772	Spontaneous	2009-11-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3225772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3225773	Spontaneous	2009-11-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Not Specified	Febrile convulsion (n/a - Unknown - Other Medically Important Condition)	AREPANRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3225773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10011862121	Spontaneous	2022-03-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Disabling);Sjogren's syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMIC INFLUENZA VACCINE (H5N1) (LIVE ATTENUATED, NASAL) ASTRAZENECA NASAL SPRAY, SUSPENSION [A/VIETNAM/1203/2004 (H5N1) STRAIN (A/VIETNAM/1203/2004, MEDI 0141000136)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011862121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10011113746	Spontaneous	2021-12-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (2d - Recovered/Resolved - );Fatigue (2d - Recovered/Resolved - );Malaise (1d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - );Tremor (1d - Recovered/Resolved - );Vaccination site pain (2d - Recovered/Resolved - )	PANDEMIC INFLUENZA VACCINE (H5N1) (LIVE ATTENUATED, NASAL) ASTRAZENECA [A/VIETNAM/1203/2004 (H5N1) STRAIN (A/VIETNAM/1203/2004, MEDI 0141000136)] (S - Influenza immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011113746&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10016749470	Spontaneous	2024-02-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Diarrhoea (n/a - Unknown - );Exposure during pregnancy (n/a - Unknown - );Vomiting (n/a - Unknown - )	PANDEMIC INFLUENZA VACCINE H5N1 BAXTER [A/VIETNAM/1203/2004 (H5N1)] (S - Influenza immunisation - Drug withdrawn - [1d - n/a - Intramuscular use])	[COLECALCIFEROL] (C - Pregnancy - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, FOLIC ACID, POTASSIUM IODIDE, FOLIC ACID, POTASSIUM IODIDE, VITAMIN B12] (C - Pregnancy - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016749470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016575913	Spontaneous	2024-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Male	Skin reaction (n/a - Unknown - )	PANDEMIC INFLUENZA VACCINE H5N1 BAXTER [A/VIETNAM/1203/2004 (H5N1)] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016575913&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10015160512	Spontaneous	2023-05-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chest discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chills (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hot flush (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMIC INFLUENZA VACCINE H5N1 BAXTER [A/VIETNAM/1203/2004 (H5N1)] (S - Influenza immunisation - Drug withdrawn - [1d - .5mL - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015160512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10015033639	Spontaneous	2023-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Lymphadenopathy (n/a - Not Recovered/Not Resolved - )	PANDEMIC INFLUENZA VACCINE H5N1 BAXTER [A/VIETNAM/1203/2004 (H5N1)] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015033639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014268551	Spontaneous	2022-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site pain (3d - Recovered/Resolved - )	PANDEMIC INFLUENZA VACCINE H5N1 BAXTER [A/VIETNAM/1203/2004 (H5N1)] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014268551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10011914324	Spontaneous	2022-03-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - );Dysmenorrhoea (n/a - Not Recovered/Not Resolved - );Facial paralysis (7d - Recovered/Resolved - Other Medically Important Condition);Menstruation irregular (n/a - Not Recovered/Not Resolved - );Mood altered (n/a - Not Recovered/Not Resolved - )	PANDEMIC INFLUENZA VACCINE H5N1 BAXTER [A/VIETNAM/1203/2004 (H5N1)] (S - Influenza immunisation - Drug withdrawn - [29d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011914324&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10011161886	Spontaneous	2022-01-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Not Specified	Encephalitis (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly)	PANDEMIC INFLUENZA VACCINE H5N1 BAXTER [A/VIETNAM/1203/2004 (H5N1)] (S - Influenza immunisation - Drug withdrawn - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011161886&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10016862927	Spontaneous	2024-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Immunisation reaction (n/a - Recovered/Resolved - )	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular use])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016862927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016778652	Spontaneous	2024-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Somnolence (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - .5mL - Subcutaneous use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016778652&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016733827	Spontaneous	2024-02-01 00:00:00	Healthcare Professional	European Economic Area	Mayet A, Haus-Cheymol R, Bouaiti EA, Decam C, Simon F, Merens A et al.. Adverse events following vaccination in the French armed forces: An overview of surveillance conducted from 2002 to 2010.. Euro Surveill.. 2012;17(24):unk	18-64 Years	Not Specified	No	Male	Headache (96h - Recovered/Resolved - Other Medically Important Condition);Presyncope (96h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (96h - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016733827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10016729373	Spontaneous	2024-01-31 00:00:00	Healthcare Professional	European Economic Area	Mayet A, Haus-Cheymol R, Bouaiti EA, Decam C, Simon F, Merens A, et al.. Adverse events following vaccination in the French armed forces: An overview of surveillance conducted from 2002 to 2010.. Euro Surveillance. 2012;17(24):20193	18-64 Years	Not Specified	No	Male	Presyncope (2295min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular use])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS TYPE 1 (INACTIVATED), POLIOVIRUS TYPE 2 (INACTIVATED), POLIOVIRUS TYPE 3 (INACTIVATED), PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular use])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016729373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10016729374	Spontaneous	2024-01-31 00:00:00	Healthcare Professional	European Economic Area	Mayet A.. Surveillance of adverse events following vaccination in the French armed forces, 2011-2012.. Public Health. 2015;unk:unk Mayet A, Haus-Cheymol R, Bouaiti EA, Decam C, Simon F, Merens A, et al.. Adverse events following vaccination in the French armed forces: An overview of surveillance conducted from 2002 to 2010.. Euro Surveillance.. 2012;17(24):20193	18-64 Years	Not Specified	No	Female	Facial paralysis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Miller Fisher syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016729374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10016729933	Spontaneous	2024-01-31 00:00:00	Healthcare Professional	European Economic Area	Mayet A, Haus-Cheymol R, Bouaiti E et al.. Adverse events following vaccination in the French armed forces: An overview of surveillance conducted from 2002 to 2010.. Euro Surveill.. 2012;17(24):unk	18-64 Years	Not Specified	No	Male	Gingival bleeding (20d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mouth haemorrhage (20d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Petechiae (20d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Thrombocytopenia (20d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Thrombocytopenic purpura (20d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular use])|[MENINGOCOCCAL GROUP A, C, W135 AND Y CONJUGATE VACCINE] (S - Immunisation - Not applicable - [1d - 1{DF} - Subcutaneous use])	[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016729933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10016730897	Spontaneous	2024-01-31 00:00:00	Healthcare Professional	European Economic Area	Mayet A, Haus-Cheymol R, Bouaiti EA, Decam C, Simon F, Merens A, et al.. Adverse events following vaccination in the French armed forces: An overview of surveillance conducted from 2002 to 2010.. Euro Surveillance. 2012;17(24):20193 Mayet A. et al.. Increase in reported adverse events following seasonal influenza vaccination among the French armed forces, 2008-2009: Possible role of stimulated reporting and background cases of influenza-like infection. Public Health. 2012;126:70-6	18-64 Years	Not Specified	No	Male	Chest pain (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myopericarditis (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular use])|[MENINGOCOCCAL GROUP A, C, W135 AND Y CONJUGATE VACCINE] (S - Immunisation - Not applicable - [1d - n/a - Subcutaneous use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016730897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10016730932	Spontaneous	2024-01-31 00:00:00	Healthcare Professional	European Economic Area	Mayet A, Nivoix P, Haus-Cheymol R et al.. Increase in reported adverse events following seasonal influenza vaccination among the French armed forces, 2008-2009: possible role of stimulated reporting and background cases of influenza-like infection. Public Health 2012;126:70-76., Mayet A, Haus-Cheymol R, Bouaiti E et al. Adverse events following vaccination in the french armed forces: an overview of surveillance conducted from 2002 to 2010.. Euro Surveill.. 2012;17(24):unk	18-64 Years	Not Specified	No	Male	Ataxia (5mo - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cognitive disorder (5mo - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Emotional disorder (5mo - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (5mo - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Insomnia (5mo - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Leukoencephalomyelitis (5mo - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensorimotor disorder (5mo - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep disorder (5mo - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016730932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10016485839	Spontaneous	2023-12-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (1d - Recovered/Resolved - );Pruritus (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016485839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016477916	Spontaneous	2023-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Administration site erythema (n/a - Recovering/Resolving - );Administration site induration (n/a - Recovering/Resolving - );Administration site pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous use])	[ACETYLSALICYLIC ACID] (C - Prophylaxis - n/a - [n/a - 75mg - Oral use])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016477916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016437972	Spontaneous	2023-12-11 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash macular (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash papular (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016437972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10016371996	Spontaneous	2023-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Vaccination site swelling (n/a - Unknown - )	BEXSERO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Meningococcal immunisation - Not applicable - [1d - n/a - Intramuscular use])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016371996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016362680	Spontaneous	2023-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016362680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016353804	Spontaneous	2023-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Epilepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016353804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10016343152	Spontaneous	2023-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Administration site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous use])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016343152&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016315599	Spontaneous	2023-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Condition aggravated (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016315599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10016296978	Spontaneous	2023-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Hypothyroidism (n/a - Unknown - Other Medically Important Condition);Peripheral sensory neuropathy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016296978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10016280799	Spontaneous	2023-11-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016280799&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10016272204	Spontaneous	2023-11-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza like illness (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [1d - 1{DF} - Intramuscular use])	PRALUENT [ALIROCUMAB] (C - n/a - n/a - [n/a - n/a - n/a])|TOCILIZUMAB [TOCILIZUMAB] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016272204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016272206	Spontaneous	2023-11-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza like illness (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [1d - 1{DF} - Intramuscular use])	[CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESOMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016272206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016272899	Spontaneous	2023-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthritis (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Joint swelling (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Type IIa hyperlipidaemia - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016272899&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016227384	Spontaneous	2023-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal discomfort (n/a - Recovered/Resolved - );Abdominal pain upper (n/a - Recovered/Resolved - );Apathy (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - );Feeding intolerance (n/a - Recovered/Resolved - );Flatulence (n/a - Recovered/Resolved - );Gastrointestinal pain (n/a - Recovered/Resolved - );Infection susceptibility increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Sinusitis (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016227384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10016222770	Spontaneous	2023-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (n/a - Recovered/Resolved - );Hypersensitivity (n/a - Not Recovered/Not Resolved - );Muscular weakness (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - );Pruritus (n/a - Not Recovered/Not Resolved - );Somnolence (n/a - Recovered/Resolved - );Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016222770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016212728	Spontaneous	2023-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adult	No	Female	Fall (n/a - Recovered/Resolved - );Loss of consciousness (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - );Tremor (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016212728&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10016198807	Spontaneous	2023-11-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Neuropathy peripheral (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016198807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10016169437	Spontaneous	2023-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Aortic aneurysm (n/a - Unknown - );C-reactive protein increased (5mo - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersensitivity vasculitis (n/a - Unknown - Other Medically Important Condition);Performance status decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition);Red blood cell sedimentation rate increased (5mo - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vasculitis (5mo - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016169437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10016033994	Spontaneous	2023-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash pruritic (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016033994&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10015891091	Spontaneous	2023-09-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination site cellulitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination site erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination site induration (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination site swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular use])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015891091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10015725946	Spontaneous	2023-08-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysphagia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypertension (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mobility decreased (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Syncope (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - n/a - [n/a - 50mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015725946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10015716793	Spontaneous	2023-08-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Drug reaction with eosinophilia and systemic symptoms (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PROLIA SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE [DENOSUMAB] (S - Product used for unknown indication - Not applicable - [1d - 60mg - Subcutaneous use])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Product used for unknown indication - Unknown - [1d - 1{DF} - n/a])...	[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[BORIC ACID, BORAX, BORIC ACID, SODIUM BORATE, SODIUM TETRABORATE CRYST., SODIUM TETRABORATE CRYST., BORIC ACID] (C - n/a - Unknown - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, TELMISARTAN] (C - n/a - Unknown - [n/a - n/a - n/a])|[NEBIVOLOL] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015716793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10015687680	Spontaneous	2023-08-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Dyspnoea (n/a - Recovered/Resolved - );Exposure during pregnancy (n/a - Unknown - );Productive cough (n/a - Recovered/Resolved - );Secretion discharge (n/a - Unknown - );Wheezing (n/a - Unknown - )	RELVAR ELLIPTA [FLUTICASONE FUROATE, VILANTEROL] (S - Asthma - Dose not changed - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE, FLUTICASONE, SALMETEROL] (S - Asthma, Dyspnoea - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015687680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10015678134	Spontaneous	2023-08-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypersensitivity (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015678134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10015573141	Spontaneous	2023-07-18 00:00:00	Healthcare Professional	European Economic Area	Fernandez-Flores A, Nieto Rodriguez D, Fernandez-Parrado M, Alzoghby-Abi Chaker J, Sendagorta Cudós E, Sobral Costas TG, et al.. Post-Transplant Lymphoproliferative Disorder, Monomorphic Type, in a Kidney Transplant Patient After Administration of Anti-Influenza Vaccine.. Am J Dermatopathol.. 2023;00:1-6	18-64 Years	Not Specified	No	Female	Apoptosis (n/a - Unknown - Other Medically Important Condition);Night sweats (n/a - Unknown - Other Medically Important Condition);Nodule (n/a - Unknown - Other Medically Important Condition);Post transplant lymphoproliferative disorder (n/a - Unknown - Other Medically Important Condition);Pyrexia (3d - Unknown - Other Medically Important Condition);Skin lesion (2wk - Unknown - Other Medically Important Condition);Skin mass (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015573141&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10015563217	Spontaneous	2023-07-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Not Specified	Facial paralysis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015563217&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10015441581	Spontaneous	2023-06-26 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - );Asthenia (n/a - Recovered/Resolved - );Burning sensation (n/a - Recovered/Resolved - );Dizziness (n/a - Recovered/Resolved - );Muscle spasms (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Neck pain (n/a - Recovered/Resolved - );Seizure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	[LAMOTRIGINE] (C - Seizure - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015441581&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10015319695	Spontaneous	2023-06-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cerebral infarction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Impaired work ability (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015319695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10015301059	Spontaneous	2023-06-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Unknown - Disabling);Decreased appetite (n/a - Unknown - Disabling);Erythema (n/a - Unknown - Disabling);Extravasation (n/a - Unknown - Disabling);Hypersensitivity (n/a - Unknown - Disabling);Muscular weakness (n/a - Unknown - Disabling);Pyrexia (3d - Recovered/Resolved - Disabling);Rash (n/a - Unknown - Disabling)	INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015301059&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10015252156	Spontaneous	2023-05-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abscess (n/a - Not Recovered/Not Resolved - );Cellulitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Erythema (n/a - Not Recovered/Not Resolved - );Inappropriate schedule of product administration (n/a - Unknown - );Injection site erythema (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - );Pain (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015252156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10015213198	Spontaneous	2023-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Vaccination complication (n/a - Unknown - Other Medically Important Condition)	TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23, TICK-BORNE ENCEPHALITIS VIRUS, STRAIN K23, ADSORBED ON HYDROGENATED ALUMINUM HYDROXIDE, INACTIVATED, ALGELDRATE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[CORYNEBACTERIUM DIPHTHERIAE, NEISSERIA MENINGITIDIS, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, ALUMINIUM HYDROXIDE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015213198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10015111732	Spontaneous	2023-05-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (1d - Recovered/Resolved - );Syncope (1d - Recovered/Resolved - Other Medically Important Condition);Vomiting (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015111732&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10015104003	Spontaneous	2023-05-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute abdomen (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Not Recovered/Not Resolved - Disabling);Diverticulum intestinal (n/a - Not Recovered/Not Resolved - Disabling);Small intestinal resection (n/a - Not Recovered/Not Resolved - Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling);Vertigo (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular use])	[ATORVASTATIN] (C - Type V hyperlipidaemia - n/a - [n/a - n/a - Oral use])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015104003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10015104469	Spontaneous	2023-05-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dementia Alzheimer's type (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular use])	EBIXA [MEMANTINE HYDROCHLORIDE] (C - Dementia Alzheimer's type - n/a - [n/a - n/a - Oral use])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015104469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10014999185	Spontaneous	2023-04-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Live birth (n/a - Unknown - );Maternal exposure during pregnancy (n/a - Unknown - );Oligohydramnios (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Umbilical cord around neck (n/a - Recovered/Resolved - Life Threatening)	DENGUE VACCINE [DENGUE FEVER VACCINES] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[DIPHTHERIA AND TETANUS VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014999185&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10014969388	Spontaneous	2023-04-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014969388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10014929317	Spontaneous	2023-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Angioedema (n/a - Recovering/Resolving - Other Medically Important Condition);Hypersensitivity (n/a - Recovering/Resolving - );Lip oedema (n/a - Recovered/Resolved - );Oedema mouth (n/a - Recovered/Resolved - );Rash (10d - Recovered/Resolved - )	JULUCA [RILPIVIRINE, DOLUTEGRAVIR] (S - HIV infection - Unknown - [n/a - 1{DF} - Oral use])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Unknown - [n/a - 1{DF} - Subcutaneous use])|[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (S - Facial paralysis - Drug withdrawn - [3d - 1{DF} - Oral use])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014929317&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10014883358	Spontaneous	2023-03-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - );Myalgia (n/a - Recovering/Resolving - );Neck pain (n/a - Unknown - );Pain (n/a - Unknown - );Pain in extremity (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014883358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014827936	Spontaneous	2023-03-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Eating disorder (n/a - Recovering/Resolving - );Expired product administered (n/a - Unknown - );Infection (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Restlessness (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014827936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014818982	Spontaneous	2023-03-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Contusion (n/a - Recovered/Resolved - );Immune thrombocytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Petechiae (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014818982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10014822947	Spontaneous	2023-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Aphonia (n/a - Recovering/Resolving - );Cough (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Temperature regulation disorder (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014822947&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014813508	Spontaneous	2023-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014813508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014742355	Spontaneous	2023-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Vaccination complication (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALGELDRATE, ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS NEUDOERFL STRAIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED PRODUCED IN CHICK EMBRYO CELLS, TICK-BORNE ENCEPHALITIS VIRUS, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS NEUDOERFL STRAIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED PRODUCED IN CHICK EMBRYO CELLS, TICK-BORNE ENCEPHALITIS VIRUS NEUDOERFL STRAIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED PRODUCED IN CHICK EMBRYO CELLS, ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS, ALGELDRATE] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014742355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10014706168	Spontaneous	2023-02-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Exposure during pregnancy (n/a - Unknown - );Gestational diabetes (66d - Recovered/Resolved - Other Medically Important Condition);Hyperphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Live birth (n/a - Unknown - );Polydipsia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular use])|[DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS (DTAP) VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular use])|[TRIVALENT INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014706168&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-10014625037	Spontaneous	2023-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Erythema (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014625037&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014526350	Spontaneous	2023-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Rash (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014526350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014504251	Spontaneous	2023-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Purpura (n/a - Recovering/Resolving - );Pyrexia (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [1d - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014504251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014479242	Spontaneous	2023-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Deep vein thrombosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular use])	XARELTO [RIVAROXABAN] (C - Deep vein thrombosis - Not applicable - [n/a - n/a - Oral use])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014479242&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10014480743	Spontaneous	2023-01-24 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014480743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10014384128	Spontaneous	2023-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Vaccination complication (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS TYPE 1 (INACTIVATED), POLIOVIRUS TYPE 2 (INACTIVATED), POLIOVIRUS TYPE 3 (INACTIVATED), PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014384128&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10014304711	Spontaneous	2022-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pemphigoid (33d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash pruritic (33d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Subcutaneous use])|[CEFPODOXIME PROXETIL] (S - Skin infection - Drug withdrawn - [6d - 200mg - Oral use])	ESOMEPRAZOLE [ESOMEPRAZOLE] (C - n/a - Not applicable - [n/a - 40mg - Oral use])|KETOCONAZOLE [KETOCONAZOLE] (C - n/a - Not applicable - [n/a - 1{DF} - Oral use])|[BILASTINE] (C - n/a - Not applicable - [n/a - 20mg - Oral use])|[BISOPROLOL FUMARATE] (C - n/a - Not applicable - [n/a - 2.5mg - Oral use])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - Not applicable - [n/a - 2{DF} - Nasal use])|[PARACETAMOL, OPIUM, PREPARED] (C - n/a - Not applicable - [n/a - 3{DF} - Oral use])|[PRAVASTATIN SODIUM] (C - n/a - Not applicable - [n/a - 20mg - Oral use])|[RAMIPRIL] (C - n/a - Not applicable - [n/a - 1{DF} - Oral use])|[SALBUTAMOL SULFATE] (C - n/a - Not applicable - [n/a - 3{DF} - Inhalation use])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014304711&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10014304986	Spontaneous	2022-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain upper (1d - Recovered/Resolved - );Diarrhoea (1d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014304986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014264664	Spontaneous	2022-12-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pruritus (n/a - Not Recovered/Not Resolved - );Vaccination complication (n/a - Not Recovered/Not Resolved - );Vaccination site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [1d - 1{DF} - Intramuscular use])	[LEVOTHYROXINE SODIUM] (C - n/a - Not applicable - [n/a - n/a - n/a])|[SIMVASTATIN, EZETIMIBE] (C - n/a - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014264664&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014255050	Spontaneous	2022-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Influenza like illness (n/a - Unknown - );Injection site induration (n/a - Unknown - );Injection site reaction (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014255050&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014243599	Spontaneous	2022-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adult	No	Female	Conjunctivitis (0d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014243599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014227430	Spontaneous	2022-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular use])	[BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014227430&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014191502	Spontaneous	2022-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site erythema (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014191502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014150201	Spontaneous	2022-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Rash (n/a - Recovered/Resolved - );Tongue oedema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014150201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014140415	Spontaneous	2022-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Otitis media (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014140415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014134422	Spontaneous	2022-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Vaccination site inflammation (n/a - Unknown - );Vaccination site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014134422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014119455	Spontaneous	2022-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Vaccination complication (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014119455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10014099365	Spontaneous	2022-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	General physical health deterioration (n/a - Recovering/Resolving - );Pain (n/a - Recovering/Resolving - );Paraesthesia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Rash pruritic (n/a - Recovering/Resolving - );Restlessness (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014099365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014077594	Spontaneous	2022-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Vaccination complication (n/a - Unknown - Other Medically Important Condition)	OPTAFLU [A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), B/PHUKET/3073/2013 – LIKE STRAIN (B/UTAH/9/2014, WILD TYPE), A/CALIFORNIA/7/2009 PDM09 (H1N1) - LIKE STRAIN USED A/BRISBANE/10/2010 WILD TYPE, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 PDM09 (H1N1) - LIKE STRAIN USED A/BRISBANE/10/2010 WILD TYPE] (S - n/a - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/FLORIDA/4/2006), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), ANTIGENS OF THE INFLUENZA VIRUS A/CALIFORNIA/7/2009 (H1N1)-LIKE VIRUS PDM09, ANTIGENS OF THE INFLUENZA VIRUS A/VICTORIA/361/2011 (H3N2)-LIKE VIRUS, ANTIGENS OF THE INFLUENZA VIRUS B/WISCONSIN/1/2010-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/WISCONSIN/67/2005 REASS. NYMC X-161-B), A/SOLOMON ISLANDS/3/2006 (H1N1) - LIKE STRAIN (A/SOLOMON ISLANDS/3/2006 REASS. IVR-145), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019-LIKE VIRUS (B/VICTORIA/705/2018 BVR-11), A/GUANDONG-MAONAN/SWL1536/2019 (H1N1)PDM09-LIKE VIRUS (A/VICTORIA/2454/2019 IVR-207), SQUALENE, CITRIC ACID, SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), SQUALENE, CITRIC ACID, SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019-LIKE VIRUS (B/VICTORIA/705/2018 BVR-11), A/GUANDONG-MAONAN/SWL1536/2019 (H1N1)PDM09-LIKE VIRUS (A/VICTORIA/2454/2019 IVR-207), SQUALENE, SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/BRISBANE/9/2014 (WILD TYPE), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), SQUALENE, SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/MASSACHUSETTS/2/2012-LIKE STRAIN USED B/MASSACHUSETTS/2/2012 WILD TYPE, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)] (S - n/a - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014077594&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10014019432	Spontaneous	2022-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Vaccination complication (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS (INACTIVATED) ADSORBED] (S - Immunisation - n/a - [n/a - n/a - n/a])|[DIPHTHERIA TOXOID ADSORBED, TETANUS TOXOID ADSORBED, ALGELDRATE, DIPHTHERIA TOXOID ADSORBED, TETANUS TOXOID ADSORBED, ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID, TETANUS TOXOID, DIPHTHERIA TOXOID, TETANUS TOXOID, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM HYDROXIDE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[POLIOMYELITIS VACCINE (ORAL)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014019432&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10013993857	Spontaneous	2022-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Not Specified	Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013993857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10013948925	Spontaneous	2022-11-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Cough (n/a - Recovered/Resolved - );Crying (8d - Recovered/Resolved - );Nasopharyngitis (n/a - Recovered/Resolved - );Pyrexia (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013948925&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10013781563	Spontaneous	2022-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Immunisation reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[BCG (BACILLUS CALMETTE-GUÉRIN) BACTERIA] (S - Immunisation - n/a - [n/a - n/a - n/a])|[DIPHTHERIA TOXOID ADSORBED, TETANUS TOXOID ADSORBED, ALGELDRATE, DIPHTHERIA TOXOID ADSORBED, TETANUS TOXOID ADSORBED, ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID, TETANUS TOXOID, DIPHTHERIA TOXOID, TETANUS TOXOID, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM HYDROXIDE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[DIPHTHERIA, TETANUS, PERTUSSIS AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[MEASLES VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[POLIOMYELITIS VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[RUBELLA VACCINE (LIVE)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[SMALLPOX VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])	[NORFLOXACIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013781563&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10013718606	Spontaneous	2022-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Immunisation reaction (n/a - Unknown - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS ANTIGEN, STRAIN HM175, INACTIVATED, ADSORBED ON ALUMINIUM HYDROXIDE, ALUMINIUM HYDROXIDE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[BACILLUS CALMETTE-GUERIN VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[DIPHTHERIA TOXOID ADSORBED, TETANUS TOXOID ADSORBED] (S - Immunisation - n/a - [n/a - n/a - n/a])|[HEPATITIS B VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[MEASLES VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[POLIOMYELITIS VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[RUBELLA VACCINE (LIVE)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013718606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10013719645	Spontaneous	2022-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Immunisation reaction (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS TYPE 1 (INACTIVATED), POLIOVIRUS TYPE 2 (INACTIVATED), POLIOVIRUS TYPE 3 (INACTIVATED), PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013719645&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10013712278	Spontaneous	2022-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Immunisation reaction (n/a - Unknown - )	HBVAXPRO [ALUMINIUM, HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], HEPATITIS B SURFACE ANTIGEN (RDNA), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013712278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10013675123	Spontaneous	2022-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Immunisation reaction (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS NEUDOERFL STRAIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED PRODUCED IN CHICK EMBRYO CELLS, ALGELDRATE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE VIRUS, B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), INFLUENZA VIRUS B/AUSTRIA/1359417/2021-LIKE STRAIN (B/AUSTRIA/1359417/2021, BVR-26), A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227)] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013675123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10013666382	Spontaneous	2022-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Immunisation reaction (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS TYPE 1 (INACTIVATED), POLIOVIRUS TYPE 2 (INACTIVATED), POLIOVIRUS TYPE 3 (INACTIVATED), PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013666382&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10013582561	Spontaneous	2022-09-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Nausea (1d - Recovered/Resolved - );Vaccination site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013582561&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10013547164	Spontaneous	2022-09-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Injected limb mobility decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013547164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10013550548	Spontaneous	2022-09-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	0-1 Month	Not Specified	Yes	Male	Foetal exposure during pregnancy (n/a - Unknown - );Hypoglycaemia neonatal (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	DENGUE VACCINE [DENGUE FEVER VACCINES] (S - Prophylaxis - Not applicable - [n/a - n/a - Transplacental])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[DIPHTHERIA AND TETANUS VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - Transplacental])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013550548&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10013540473	Spontaneous	2022-09-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic shock (5d - Recovered/Resolved - Life Threatening);Blood pressure decreased (5d - Recovered/Resolved - Life Threatening);Vertigo (13d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013540473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Life Threatening	Hospitalisation
EU-EC-10013481127	Spontaneous	2022-09-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Bronchitis (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013481127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10013385005	Spontaneous	2022-08-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	ASIA syndrome (n/a - Unknown - Other Medically Important Condition);Autoimmune thyroiditis (n/a - Unknown - Other Medically Important Condition);Endocrine disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling of despair (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypothyroidism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013385005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10013340807	Spontaneous	2022-08-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Bell's palsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Crying (n/a - Unknown - );Facial asymmetry (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Neuritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013340807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10013083092	Spontaneous	2022-07-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Ankle fracture (n/a - Unknown - Disabling);Anxiety (n/a - Unknown - Disabling);Arthralgia (n/a - Unknown - Disabling);Aspiration (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - );Ataxia (n/a - Unknown - );Balance disorder (n/a - Not Recovered/Not Resolved - );Blister (n/a - Unknown - Disabling);Congenital musculoskeletal disorder of limbs (n/a - Unknown - Other Medically Important Condition);Conjunctivitis (n/a - Not Recovered/Not Resolved - Disabling);Constipation (n/a - Unknown - );Cough (n/a - Unknown - );Decreased vibratory sense (n/a - Unknown - );Demyelination (n/a - Unknown - Other Medically Important Condition);Depression (n/a - Unknown - );Diplopia (n/a - Unknown - );Drooling (n/a - Unknown - );Dysarthria (n/a - Unknown - );Dysphagia (n/a - Not Recovered/Not Resolved - );Dysphonia (n/a - Unknown - );Extra dose administered (n/a - Unknown - );Fall (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - );Gait disturbance (n/a - Unknown - );Headache (n/a - Unknown - );Hemiplegia (n/a - Unknown - Other Medically Important Condition);Hyperventilation (n/a - Unknown - Disabling);Hypoaesthesia (n/a - Unknown - );Impaired work ability (n/a - Unknown - );Inflammation (n/a - Unknown - );Influenza like illness (n/a - Unknown - );Intervertebral disc degeneration (n/a - Unknown - Disabling);Laryngitis (n/a - Unknown - );Leukocytosis (n/a - Unknown - );Ligament pain (n/a - Unknown - Disabling);Limb deformity (n/a - Not Recovered/Not Resolved - );Limb immobilisation (n/a - Unknown - Disabling);Loss of personal independence in daily activities (n/a - Unknown - Disabling);Malaise (n/a - Unknown - );Mastication disorder (n/a - Unknown - );Memory impairment (n/a - Unknown - );Middle insomnia (n/a - Unknown - );Mobility decreased (n/a - Unknown - Disabling);Mood altered (n/a - Unknown - );Motor dysfunction (n/a - Unknown - );Muscle contractions involuntary (n/a - Unknown - );Muscle spasticity (n/a - Unknown - );Muscular weakness (n/a - Recovered/Resolved - );Musculoskeletal stiffness (n/a - Unknown - );Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ocular discomfort (n/a - Unknown - );Optic neuritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Optic neuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - );Paraesthesia (n/a - Unknown - Disabling);Paraparesis (n/a - Unknown - Disabling, Other Medically Important Condition);Paraplegia (n/a - Unknown - Other Medically Important Condition);Pollakiuria (n/a - Unknown - );Poor quality sleep (n/a - Unknown - );Post-traumatic pain (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Relapsing multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Rhinitis (n/a - Recovering/Resolving - Disabling);Salivary hypersecretion (n/a - Unknown - );Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sensory disturbance (n/a - Not Recovered/Not Resolved - );Sensory loss (n/a - Unknown - );Sexual dysfunction (n/a - Unknown - );Spinal pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	[ACETYLCYSTEINE, ACETYLCYSTEINE, TUAMINOHEPTANE, TUAMINOHEPTANE SULFATE, ACETYLCYSTEINE] (C - Product used for unknown indication - Unknown - [n/a - 10mL - n/a])|[ANHYDROUS FUSIDIC ACID, FUSIDIC ACID, SODIUM FUSIDATE] (C - Product used for unknown indication - Unknown - [n/a - 15mg - n/a])|[BENFLUOREX HYDROCHLORIDE] (C - Product used for unknown indication - Unknown - [n/a - 450mg - n/a])|[BETAMETHASONE, BETAMETHASONE SODIUM PHOSPHATE] (C - Product used for unknown indication - Unknown - [n/a - 2mg - n/a])|[DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS TYPE 1 (INACTIVATED), POLIOVIRUS TYPE 2 (INACTIVATED), POLIOVIRUS TYPE 3 (INACTIVATED), DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS TYPE 1 (INACTIVATED), POLIOVIRUS TYPE 2 (INACTIVATED), POLIOVIRUS TYPE 3 (INACTIVATED), ALUMINIUM HYDROXIDE, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE] (C - Prophylaxis - Unknown - [n/a - n/a - n/a])|[ECONAZOLE NITRATE] (C - Product used for unknown indication - Unknown - [n/a - 300mg - n/a])|[FOSFOMYCIN, FOSFOMYCIN TROMETAMOL] (C - Product used for unknown indication - Unknown - [n/a - 3g - n/a])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a])|[IBUPROFEN, NAPROXEN, NAPROXEN SODIUM] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a])|[IBUPROFEN] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a])|[LEVOCETIRIZINE, LEVOCETIRIZINE DIHYDROCHLORIDE] (C - Product used for unknown indication - Unknown - [n/a - 5mg - n/a])|[LOPERAMIDE, LOPERAMIDE HYDROCHLORIDE] (C - Product used for unknown indication - Unknown - [n/a - 2mg - n/a])|[METOCLOPRAMIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a])|[MICONAZOLE, MICONAZOLE NITRATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a])|[MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE] (C - Product used for unknown indication - Unknown - [n/a - 400mg - n/a])|[NEOMYCIN SULFATE, NYSTATIN, POLYMYXIN B SULFATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a])|[PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - Product used for unknown indication - Unknown - [n/a - 2000mg - n/a])...	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013083092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10012719367	Spontaneous	2022-06-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Immunisation reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [1d - 1{DF} - Intramuscular])	APROVEL [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - Influenza immunisation - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012719367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10012667071	Spontaneous	2022-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pyrexia (23d - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012667071&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-10012655427	Spontaneous	2022-06-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Unknown - );Ear disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - );Hyperacusis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Loose tooth (n/a - Unknown - );Photophobia (n/a - Recovering/Resolving - );Tinnitus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tooth disorder (n/a - Unknown - );Tooth extraction (n/a - Unknown - );Vertigo (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[ZOPICLONE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012655427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10012338225	Spontaneous	2022-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Asthenia (n/a - Fatal - Results in Death);Cardiac failure (n/a - Fatal - Results in Death);Dyspnoea (n/a - Fatal - Results in Death);Fall (n/a - Fatal - Results in Death);Oedema peripheral (n/a - Fatal - Results in Death);Pulmonary congestion (n/a - Fatal - Results in Death);Right ventricular failure (n/a - Fatal - Results in Death);Weight bearing difficulty (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012338225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10012346538	Spontaneous	2022-04-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cyanosis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Tinnitus (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012346538&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10012315904	Spontaneous	2022-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Seronegative arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Unknown])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPRANOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012315904&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10012219764	Spontaneous	2022-04-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Condition aggravated (n/a - Recovering/Resolving - );Cough (n/a - Recovering/Resolving - );Dizziness (n/a - Recovering/Resolving - );Dysuria (n/a - Recovering/Resolving - );Encephalitis (n/a - Recovering/Resolving - Other Medically Important Condition);Fasciitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovering/Resolving - );Gait disturbance (n/a - Recovering/Resolving - );Musculoskeletal pain (n/a - Recovering/Resolving - );Myelitis (n/a - Recovering/Resolving - Other Medically Important Condition);Neck pain (n/a - Recovering/Resolving - );Nervous system disorder (n/a - Recovered/Resolved - );Neuromyelitis optica spectrum disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Sneezing (n/a - Recovering/Resolving - );Spinal osteoarthritis (n/a - Recovering/Resolving - );Urinary retention (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urinary tract infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012219764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10012106454	Spontaneous	2022-04-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (n/a - Recovered/Resolved - );Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Subcutaneous])	[EZETIMIBE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUINDIONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012106454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10012085912	Spontaneous	2022-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Aggression (n/a - Unknown - Caused/Prolonged Hospitalisation);Anxiety (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Breathing-related sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Bronchial disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dry mouth (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);HLA marker study positive (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Impaired driving ability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Liver disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mental disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nocturia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Presyncope (n/a - Unknown - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Sexual dysfunction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Snoring (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Social problem (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Swelling face (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tinnitus (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Unevaluable event (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	XYREM [SODIUM OXYBATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACEBUTOLOL, ACEBUTOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CLOMIPRAMINE, CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - 75mg - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MODAFINIL] (C - n/a - n/a - [n/a - n/a - Unknown])|[MODAFINIL] (C - n/a - n/a - [n/a - n/a - n/a])|[ROPINIROLE] (C - n/a - n/a - [n/a - n/a - Unknown])|[VENLAFAXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012085912&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10012071219	Spontaneous	2022-03-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Somnolence (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012071219&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10012047161	Spontaneous	2022-03-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Aphasia (n/a - Unknown - );Arrhythmia (n/a - Unknown - );Chronic fatigue syndrome (n/a - Unknown - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012047161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10012031626	Spontaneous	2022-03-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Meniere's disease (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012031626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10011959245	Spontaneous	2022-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Giant cell arteritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Ischaemic stroke (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	DABIGATRAN ETEXILATE [DABIGATRAN ETEXILATE] (C - n/a - n/a - [n/a - n/a - n/a])|PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|TRAVOPROST [TRAVOPROST] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE, LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[EZETIMIBE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011959245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10011918299	Spontaneous	2022-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Vaccination complication (n/a - Unknown - Other Medically Important Condition)	DUKORAL [VIBRIO CHOLERAE O1 INABA, CLASSICAL BIOTYPE (HEAT INACTIVATED), VIBRIO CHOLERAE O1 INABA, EL TOR BIOTYPE (FORMALIN INACTIVATED), VIBRIO CHOLERAE O1 OGAWA, CLASSICAL BIOTYPE (HEAT INACTIVATED), VIBRIO CHOLERAE O1OGAWA, CLASSICAL BIOTYPE (FORMALIN INACTIVATED), CHOLERA TOXIN B SUBUNIT RECOMBINANT (RCTB), VIBRIO CHOLERAE O1 INABA, CLASSICAL BIOTYPE (HEAT INACTIVATED), VIBRIO CHOLERAE O1 INABA, EL TOR BIOTYPE (FORMALIN INACTIVATED), VIBRIO CHOLERAE O1 OGAWA, CLASSICAL BIOTYPE (HEAT INACTIVATED), VIBRIO CHOLERAE O1OGAWA, CLASSICAL BIOTYPE (FORMALIN INACTIVATED), CHOLERA TOXIN B SUBUNIT RECOMBINANT(RCTB) (PRODUCED IN V. CHOLERAE O1 INABA, CLASSICAL BIOTYPE STRAIN 213)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALUMINIUM HYDROXIDE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[DIPHTHERIA, TETANUS, PERTUSSIS AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[TETANUS TOXOID] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011918299&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10011888800	Spontaneous	2022-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Intermenstrual bleeding (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011888800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10011868776	Spontaneous	2022-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pruritus (0d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (0d - Recovered/Resolved - Other Medically Important Condition);Throat tightness (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Asthma - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011868776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10011852225	Spontaneous	2022-03-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Haematoma (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Intermenstrual bleeding (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011852225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10011721309	Spontaneous	2022-02-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaemia (n/a - Unknown - );Hyperaemia (n/a - Unknown - );Incision site pain (n/a - Unknown - );Injection site erythema (n/a - Unknown - );Injection site swelling (n/a - Unknown - );Pharyngitis (n/a - Unknown - );Pruritus (n/a - Unknown - );Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Scratch (n/a - Unknown - );Soft tissue infection (n/a - Unknown - );Tonsillar hypertrophy (n/a - Unknown - );Upper respiratory tract congestion (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011721309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10011605230	Spontaneous	2022-02-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Laryngeal oedema (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011605230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10011583308	Spontaneous	2022-02-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza like illness (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011583308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10011497248	Spontaneous	2022-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Interstitial lung disease (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Other])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (S - Atrial fibrillation - Not applicable - [n/a - 200mg - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (S - Atrial fibrillation - Not applicable - [n/a - 40mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011497248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10011477111	Spontaneous	2022-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Acute polyneuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011477111&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10011450394	Spontaneous	2022-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Infusion site joint erythema (3d - Recovered/Resolved - Other Medically Important Condition);Injection site oedema (3d - Recovered/Resolved - Other Medically Important Condition);Injection site pruritus (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011450394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10011387067	Spontaneous	2022-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angina pectoris (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cardiac failure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pneumonitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	COMIRNATY [TOZINAMERAN] (C - COVID-19 immunisation - n/a - [n/a - 1{DF} - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011387067&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10011238977	Spontaneous	2022-01-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Heavy menstrual bleeding (3d - Unknown - );Postmenopausal haemorrhage (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011238977&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10011158347	Spontaneous	2022-01-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cerebrovascular accident (1wk - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - )|[AMLODIPINE BESILATE, ATORVASTATIN CALCIUM, AMLODIPINE, ATORVASTATIN, AMLODIPINE, ATORVASTATIN CALCIUM] (C - n/a - n/a - )|[BETAXOLOL HYDROCHLORIDE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011158347&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10011028607	Spontaneous	2021-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011028607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10011031419	Spontaneous	2021-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Dyspnoea (n/a - Not Recovered/Not Resolved - );Expired product administered (n/a - Unknown - );Nasal crusting (n/a - Not Recovered/Not Resolved - );Night sweats (n/a - Recovering/Resolving - );Productive cough (n/a - Recovering/Resolving - );Rhinalgia (n/a - Not Recovered/Not Resolved - );Rhinitis (n/a - Not Recovered/Not Resolved - );Vaccination site erythema (n/a - Recovering/Resolving - );Vaccination site infection (n/a - Recovering/Resolving - );Vaccination site inflammation (n/a - Recovering/Resolving - );Vaccination site pain (n/a - Recovering/Resolving - );Vaccination site swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011031419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10011013122	Spontaneous	2021-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pericarditis (2wk - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [731d - 1{DF} - Intramuscular])	PREGABALIN [PREGABALIN] (C - n/a - n/a - [n/a - n/a - n/a])|[ALENDRONIC ACID, COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[CLONAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[LAMOTRIGINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011013122&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10010992386	Spontaneous	2021-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Dizziness (n/a - Recovered/Resolved - );Ear infection (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Photophobia (n/a - Recovered/Resolved - );Presyncope (n/a - Recovered/Resolved - );Viral infection (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010992386&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010952944	Spontaneous	2021-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010952944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010929269	Spontaneous	2021-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood pressure decreased (0d - Recovered/Resolved - );Feeling hot (0d - Recovered/Resolved - );Paraesthesia oral (0d - Recovered/Resolved - );Vertigo (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010929269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010912852	Spontaneous	2021-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epistaxis (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Cutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010912852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010916094	Spontaneous	2021-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pruritus allergic (16d - Recovered/Resolved - Other Medically Important Condition);Rash erythematous (16d - Not Recovered/Not Resolved - Other Medically Important Condition);Swelling face (16d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010916094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10010873627	Spontaneous	2021-12-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Injection site pain (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Somnolence (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010873627&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010826662	Spontaneous	2021-12-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Angioedema (n/a - Unknown - Other Medically Important Condition);Feeling hot (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - );Pain in extremity (n/a - Unknown - Other Medically Important Condition);Rash macular (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010826662&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10010826714	Spontaneous	2021-12-02 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Adverse event (n/a - Unknown - );Brain injury (n/a - Unknown - Other Medically Important Condition);Encephalitis viral (n/a - Unknown - Other Medically Important Condition);Extra dose administered (n/a - Unknown - );Immune system disorder (n/a - Unknown - Other Medically Important Condition);Product administered to patient of inappropriate age (n/a - Unknown - );Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[INFLUENZA VIRUS] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010826714&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10010817232	Spontaneous	2021-12-01 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Concomitant disease aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation);Extra dose administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010817232&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10010809156	Spontaneous	2021-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Peripheral sensory neuropathy (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010809156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10010782117	Spontaneous	2021-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Unknown - );Rash erythematous (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010782117&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010739466	Spontaneous	2021-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypertension (n/a - Recovered/Resolved With Sequelae - );Vertigo (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010739466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10010746105	Spontaneous	2021-11-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vertigo (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010746105&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010716008	Spontaneous	2021-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	0-1 Month	Neonate (Preterm and Term newborns)	No	Male	Astigmatism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Congenital anomaly (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspepsia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypermetropia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Motor developmental delay (n/a - Not Recovered/Not Resolved - );Paralysis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010716008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10010719079	Spontaneous	2021-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010719079&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010689784	Spontaneous	2021-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Vaccination site lymphadenopathy (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010689784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010675590	Spontaneous	2021-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Ischaemic stroke (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010675590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10010677807	Spontaneous	2021-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ear pruritus (n/a - Recovering/Resolving - );Nasal congestion (n/a - Recovering/Resolving - );Odynophagia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - COVID-19 immunisation - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010677807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010638124	Spontaneous	2021-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010638124&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010625530	Spontaneous	2021-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Axillary pain (n/a - Not Recovered/Not Resolved - );Injection site erythema (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010625530&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010637127	Spontaneous	2021-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Recovering/Resolving - );Ear pain (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - );Nasal congestion (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010637127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010637129	Spontaneous	2021-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010637129&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010624105	Spontaneous	2021-11-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Lymphadenopathy (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010624105&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010624215	Spontaneous	2021-11-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010624215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010585001	Spontaneous	2021-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Malaise (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010585001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010585004	Spontaneous	2021-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Diarrhoea (0d - Recovered/Resolved - );Headache (0d - Recovered/Resolved - );Pyrexia (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010585004&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010482466	Spontaneous	2021-10-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010482466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010408922	Spontaneous	2021-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010408922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010396373	Spontaneous	2021-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lip oedema (0d - Recovered/Resolved - );Pruritus (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010396373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010405378	Spontaneous	2021-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adolescent	No	Male	Erythema (3d - Recovered/Resolved - );Inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation);Peripheral swelling (3d - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site reaction (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...	[FLUCLOXACILLIN, FLUCLOXACILLIN SODIUM] (C - Pyrexia - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010405378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10010268897	Spontaneous	2021-10-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - );Body temperature (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Lymphadenopathy (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010268897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010178661	Spontaneous	2021-09-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Lipoma (n/a - Recovered/Resolved With Sequelae - );Vaccination site discomfort (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010178661&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10010007295	Spontaneous	2021-09-15 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Postictal paralysis (n/a - Unknown - Other Medically Important Condition)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010007295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10009842165	Spontaneous	2021-08-31 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Bone marrow oedema (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009842165&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10009743883	Spontaneous	2021-08-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Arthritis (n/a - Unknown - );Joint swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009743883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10009603119	Spontaneous	2021-08-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Injected limb mobility decreased (n/a - Recovered/Resolved - );Vaccination site joint pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009603119&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10009506081	Spontaneous	2021-07-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - );Injection site pruritus (n/a - Not Recovered/Not Resolved - );Injection site swelling (n/a - Not Recovered/Not Resolved - );Injection site warmth (n/a - Not Recovered/Not Resolved - );Paraesthesia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])...	MULTIVITAMINEN [NOT AVAILABLE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|NOT AVAILABLE (C - n/a - n/a - [n/a - 1{DF} - n/a])|[CALCIUM CARBONATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[CICLESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MAGNESIUM CARBONATE HYDROXIDE] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009506081&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10009506085	Spontaneous	2021-07-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Body temperature increased (4d - Recovered/Resolved - );Fatigue (4d - Recovered/Resolved - );Injection site erythema (4d - Recovered/Resolved - );Injection site inflammation (4d - Recovered/Resolved - );Injection site pain (4d - Recovered/Resolved - );Injection site swelling (4d - Recovered/Resolved - );Malaise (4d - Recovered/Resolved - );Nausea (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	NOT AVAILABLE (C - n/a - n/a - [n/a - 1{DF} - n/a])|VOEDINGSSUPPLEMENT [NOT AVAILABLE] (C - n/a - n/a - [n/a - 4{DF} - n/a])|[MAGNESIUM CITRATE] (C - n/a - n/a - [n/a - 2{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009506085&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10009507142	Spontaneous	2021-07-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - );Injection site swelling (n/a - Not Recovered/Not Resolved - );Injection site warmth (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])...	NOT AVAILABLE (C - n/a - n/a - [n/a - 1{DF} - n/a])|[CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, ZINC SULPHATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009507142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10009426691	Spontaneous	2021-07-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Swollen tongue (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009426691&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10009271000	Spontaneous	2021-07-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Excessive cerumen production (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fluid intake reduced (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nasal congestion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pharyngeal erythema (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rhinorrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urine output decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Varicella post vaccine (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Varicella virus test negative (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [1d - n/a - n/a])...	IRON [IRON] (C - n/a - n/a - [n/a - n/a - n/a])|[CYPROHEPTADINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009271000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10009169460	Spontaneous	2021-06-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Not Recovered/Not Resolved - Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[VALSARTAN, AMLODIPINE BESILATE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009169460&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10009122284	Spontaneous	2021-06-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (42d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009122284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Duration
EU-EC-10008895832	Spontaneous	2021-06-04 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008895832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10008898654	Spontaneous	2021-06-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Coordination abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Ear infection (n/a - Unknown - );Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hepatic steatosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hormone level abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - );Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Impulsive behaviour (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Learning disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - );Obesity (n/a - Unknown - Caused/Prolonged Hospitalisation);Obstructive airways disorder (n/a - Unknown - );Obstructive sleep apnoea syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep talking (n/a - Unknown - );Snoring (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Speech sound disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Tonsillar hypertrophy (n/a - Unknown - );Vitamin D deficiency (n/a - Unknown - Caused/Prolonged Hospitalisation);Waxy flexibility (n/a - Not Recovered/Not Resolved - );Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Wheezing (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5{DF} - Unknown])|[SODIUM VALPROATE, VALPROIC ACID] (S - n/a - Unknown - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008898654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10008794852	Spontaneous	2021-05-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Anxiety (n/a - Unknown - Other Medically Important Condition);Arrhythmia (n/a - Unknown - Other Medically Important Condition);Atrial fibrillation (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Irritability (n/a - Unknown - Other Medically Important Condition);Palpitations (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - )|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - )|[ASCORBIC ACID, MAGNESIUM OXIDE, HEAVY, MAGNESIUM] (C - n/a - n/a - )|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - )|[BISOPROLOL FUMARATE] (C - n/a - n/a - )|[ISOSORBIDE 5 MONONITRATE, ISOSORBIDE MONONITRATE] (C - n/a - n/a - )|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - )|[POTASSIUM, POTASSIUM CHLORIDE, POTASSIUM GLYCEROPHOSPHATE, POTASSIUM HYDROGEN CARBONATE, POTASSIUM HYDROGEN TARTRATE] (C - n/a - n/a - )|[RAMIPRIL] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008794852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10008719748	Spontaneous	2021-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Pruritus (n/a - Unknown - );Rash follicular (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	DESLORATADINE [DESLORATADINE] (C - Hypersensitivity - n/a - [n/a - n/a - n/a])|[CANDESARTAN CILEXETIL] (C - Hypertension - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL] (C - Vitamin supplementation - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - n/a - n/a])|[RILMENIDINE] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008719748&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008626066	Spontaneous	2021-05-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Thrombocytopenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008626066&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10008590735	Spontaneous	2021-05-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Hepatitis (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Thyroiditis (6mo - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008590735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10008557068	Spontaneous	2021-05-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Rheumatic disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008557068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10008530118	Spontaneous	2021-05-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Crying (n/a - Unknown - );Hypertrichosis (n/a - Unknown - );Interchange of vaccine products (n/a - Unknown - );Migraine (n/a - Unknown - );Nausea (n/a - Unknown - );Product administered to patient of inappropriate age (n/a - Unknown - );Vomiting (n/a - Unknown - );Wrong product administered (n/a - Unknown - )	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008530118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008517288	Spontaneous	2021-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Recovered/Resolved - );Rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008517288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008477153	Spontaneous	2021-04-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - );Inappropriate schedule of product administration (n/a - Unknown - );Influenza (n/a - Unknown - );Pain (n/a - Unknown - );Pyrexia (n/a - Unknown - )	COSENTYX [SECUKINUMAB] (S - Ankylosing spondylitis - Unknown - [n/a - 150mg - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008477153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008439401	Spontaneous	2021-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injected limb mobility decreased (4d - Recovered/Resolved - );Pain (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [1d - 1{DF} - Intramuscular])	[CIMETIDINE] (C - n/a - n/a - )|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - )|[OMEPRAZOLE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008439401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008359478	Spontaneous	2021-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Pruritus (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	[ALUMINIUM PHOSPHATE, CORYNEBACTERIUM DIPHTHERIAE CRM197 CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE, ALUMINIUM PHOSPHATE, CORYNEBACTERIUM DIPHTHERIAE, NEISSERIA MENINGITIDIS, ALUMINIUM PHOSPHATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197] (C - Immunisation - n/a - [n/a - n/a - Unknown])|[HEPATITIS B VIRUS SURFACE ANTIGEN [PRODUCED IN S. CEREVISIAE CELLS BY RDNA] ADSORBED ON ALUMINUM HYDROXIDE, HYDRATED, ALGELDRATE] (C - Immunisation - n/a - [n/a - n/a - Unknown - More in ICSR])|[MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS (LIVE, ATTENUATED), RUBELLA VIRUS (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED)] (C - Immunisation - n/a - [n/a - .5mL - Unknown])...	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008359478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008365256	Spontaneous	2021-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H1N1), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H3N2), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008365256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10008318173	Spontaneous	2021-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	[ALENDRONATE SODIUM, ALENDRONIC ACID] (C - n/a - n/a - )|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - )|[BROMAZEPAM] (C - n/a - n/a - )|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - n/a - n/a - )|[OMEPRAZOLE] (C - n/a - n/a - )|[PARACETAMOL] (C - n/a - n/a - )|[POTASSIUM CHLORIDE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008318173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10008255353	Spontaneous	2021-04-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site movement impairment (n/a - Not Recovered/Not Resolved - );Vaccination site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008255353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008142554	Spontaneous	2021-03-30 00:00:00	Healthcare Professional	Non European Economic Area	Lahouel M., Soua Y., Korbi M, Bel Hadjali H., Youssef M., Zili J.. Pityriasis rosea-like eruption following influenza (H1N1) vaccination: About a case report. Embase. 2020;12:2:1-4	18-64 Years	Not Specified	No	Male	Acanthosis (n/a - Recovered/Resolved - Other Medically Important Condition);Drug eruption (n/a - Recovered/Resolved - Other Medically Important Condition);Eczema (n/a - Recovered/Resolved - Other Medically Important Condition);Eosinophilia (n/a - Unknown - Other Medically Important Condition);Epidermal necrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Lymphocytic infiltration (n/a - Recovered/Resolved - Other Medically Important Condition);Papilloedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pityriasis rosea (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (3wk - Recovered/Resolved - Other Medically Important Condition);Rash erythematous (n/a - Recovered/Resolved - Other Medically Important Condition);Skin exfoliation (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008142554&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10008088993	Spontaneous	2021-03-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Female	Migraine (n/a - Unknown - );Nausea (n/a - Unknown - );Precocious puberty (n/a - Unknown - );Vomiting (n/a - Unknown - )	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008088993&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008066423	Spontaneous	2021-03-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Nephrotic syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008066423&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10007914898	Spontaneous	2021-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Influenza like illness (n/a - Unknown - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007914898&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007887615	Spontaneous	2021-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Loss of consciousness (0d - Recovered/Resolved - );Vomiting (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007887615&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10007785372	Spontaneous	2021-03-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007785372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007787615	Spontaneous	2021-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007787615&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10007773433	Spontaneous	2021-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Delusional disorder, unspecified type (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Psychotic disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LETROZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007773433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007758154	Spontaneous	2021-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007758154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007733482	Spontaneous	2021-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pericarditis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007733482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007683219	Spontaneous	2021-02-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007683219&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007660183	Spontaneous	2021-02-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H1N1), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN A (H3N2), INFLUENZA INACTIVATED SPLIT VIRUS STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007660183&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007614822	Spontaneous	2021-02-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Abdominal discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Blood pressure fluctuation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Body temperature fluctuation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[CYANOCOBALAMIN] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, HYDRATE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007614822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10007611754	Spontaneous	2021-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Flushing (n/a - Unknown - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	DUOPLAVIN [ACETYLSALICYLIC ACID, CLOPIDOGREL] (C - n/a - n/a - [n/a - n/a - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 40mg - Oral])|[PANTOPRAZOLE] (C - n/a - n/a - [n/a - 20mg - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007611754&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007611927	Spontaneous	2021-02-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Allergy to vaccine (n/a - Unknown - );Rash (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007611927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007607662	Spontaneous	2021-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Face oedema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007607662&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007602972	Spontaneous	2021-02-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Elderly	No	Female	Hypersensitivity (n/a - Unknown - );Lipoma (n/a - Unknown - );Swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007602972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007590199	Spontaneous	2021-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Urticaria (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007590199&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007552956	Spontaneous	2021-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Arthralgia (3d - Recovered/Resolved - );Headache (3d - Recovered/Resolved - );Pyrexia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007552956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007520457	Spontaneous	2021-02-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007520457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007505767	Spontaneous	2021-02-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Unknown - );Pruritus (n/a - Unknown - );Rash (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007505767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007499869	Spontaneous	2021-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved - );Vaccination site erythema (n/a - Recovered/Resolved - );Vaccination site induration (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007499869&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007455933	Spontaneous	2021-01-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - );Asthenia (n/a - Recovered/Resolved - );Cough (n/a - Not Recovered/Not Resolved - );Hypoacusis (n/a - Not Recovered/Not Resolved - );Influenza (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Odynophagia (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Rhinorrhoea (n/a - Recovered/Resolved - );Tinnitus (n/a - Not Recovered/Not Resolved - );Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007455933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007436674	Spontaneous	2021-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (2880min - Recovered/Resolved - );Headache (2880min - Recovered/Resolved - );Vaccination site pain (86400s - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007436674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007422218	Spontaneous	2021-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Abscess (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007422218&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007418627	Spontaneous	2021-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007418627&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007409682	Spontaneous	2021-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Pyrexia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007409682&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007311042	Spontaneous	2021-01-07 00:00:00	Healthcare Professional	European Economic Area	Liozon E.; Parreau S.; Filloux M.; Dumonteil S.; Gondran G.; Bezanahary H et.al.. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review. Autoimmunity Reviews. 2020;unk:1-7. doi:https://doi.org/10.1016/j.autrev.2020.102732	18-64 Years	Not Specified	No	Male	Aortitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Giant cell arteritis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007311042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007311101	Spontaneous	2021-01-07 00:00:00	Healthcare Professional	European Economic Area	Eric Liozon, Simon Parreau, Matthieu Filloux, Stephanie Dumonteil et.al. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review. Autoimmunity Reviews. 2020;unknown:unknown. doi:doi.org/10.1016/j.autrev.2020.102732	65-85 Years	Not Specified	No	Male	Arthritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cholestasis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Giant cell arteritis (5a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Polymyalgia rheumatica (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007311101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007311111	Spontaneous	2021-01-07 00:00:00	Healthcare Professional	European Economic Area	Eric Liozon, Simon Parreau, Matthieu Filloux, St´ephanie Dumonteil, Guillaume Gondran, Holy Bezanahary,et. al.. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review. Autoimmunity Reviews, Elsevier. 2020;102732:1-7. doi:https://doi.org/10.1016/j.autrev.2020.102732	65-85 Years	Not Specified	No	Female	Cholestasis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Giant cell arteritis (5a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ischaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain of skin (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Polymyalgia rheumatica (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Swelling face (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Trismus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007311111&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007312005	Spontaneous	2021-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Poor quality sleep (1d - Recovered/Resolved - );Vomiting (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])|[PYRVINIUM EMBONATE] (S - Enterobiasis - Not applicable - [1d - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007312005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007304541	Spontaneous	2021-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Eye pain (4320min - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Incorrect route of product administration (n/a - Unknown - );Injection site erythema (n/a - Not Recovered/Not Resolved - );Injection site oedema (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - );Rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])|[VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007304541&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007306551	Spontaneous	2021-01-06 00:00:00	Healthcare Professional	European Economic Area	Eric Liozon, Simon Parreau, Matthieu Filloux, St´ephanie Dumonteil, Guillaume Gondran, Holy Bezanahary,et. al.. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review. Autoimmunity Reviews, Elsevier. 2020;102732:1-7. doi:https://doi.org/10.1016/j.autrev.2020.102732	65-85 Years	Not Specified	No	Male	Aortitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Central nervous system vasculitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Encephalopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Extrapyramidal disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Giant cell arteritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Ischaemia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 75mg - n/a])|[ALFUZOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 20mg - n/a])|[CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - 4mg - n/a])|[EBASTINE] (C - n/a - n/a - [n/a - 10mg - n/a])|[FINASTERIDE] (C - n/a - n/a - [n/a - 5mg - n/a])|[GLIMEPIRIDE] (C - n/a - n/a - [n/a - 1mg - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 850mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007306551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007308113	Spontaneous	2021-01-06 00:00:00	Healthcare Professional	European Economic Area	Eric Liozon a, Simon Parreau a, Matthieu Filloux b, St ephanie Dumonteil, Guillaume Gondran a, Holy Bezanahary, K.H. Ly a, Anne Laure Fauchais. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: A study of 12 patients and a literature review. Autoimmunity Reviews. 2020;Unknown:unknown. doi:https://doi.org/10.1016/j.autrev.2020.102732	65-85 Years	Not Specified	No	Male	Blindness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Giant cell arteritis (5a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ischaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain of skin (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Polymyalgia rheumatica (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007308113&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007291514	Spontaneous	2021-01-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007291514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10007274366	Spontaneous	2020-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Aphthous ulcer (11d - Recovered/Resolved - );Pyrexia (11d - Recovered/Resolved - );Urticaria (11d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007274366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007266025	Spontaneous	2020-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovering/Resolving - );Arthralgia (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007266025&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007271126	Spontaneous	2020-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amnesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood sodium decreased (n/a - Unknown - );Electrolyte depletion (n/a - Unknown - );Fatigue (n/a - Unknown - );Hyperhidrosis (n/a - Unknown - );Muscle fatigue (n/a - Unknown - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - n/a])...	[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - Blood pressure abnormal - n/a - [n/a - n/a - n/a])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - Depression - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007271126&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007271455	Spontaneous	2020-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007271455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10007254591	Spontaneous	2020-12-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Headache (0d - Recovered/Resolved - );Muscular weakness (0d - Recovered/Resolved - );Nausea (0d - Recovered/Resolved - );Pallor (0d - Recovered/Resolved - );Presyncope (0d - Recovered/Resolved - );Tinnitus (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007254591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007238114	Spontaneous	2020-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Laryngospasm (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007238114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10007228174	Spontaneous	2020-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Urticaria (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007228174&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007220475	Spontaneous	2020-12-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Back pain (n/a - Recovering/Resolving - );Muscle contracture (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007220475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007211198	Spontaneous	2020-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - );Rash macular (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007211198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007189425	Spontaneous	2020-12-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Fatal - Results in Death, Other Medically Important Condition);Asthenia (n/a - Fatal - Results in Death, Other Medically Important Condition);Cough (n/a - Fatal - Results in Death, Other Medically Important Condition);Dehydration (n/a - Fatal - Results in Death, Other Medically Important Condition);Hyperglycaemia (n/a - Unknown - );Hypoxia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Fatal - Results in Death, Other Medically Important Condition);Malaise (n/a - Fatal - Results in Death, Other Medically Important Condition);Myalgia (n/a - Fatal - Results in Death, Other Medically Important Condition);Odynophagia (n/a - Unknown - );Pain (n/a - Fatal - Results in Death, Other Medically Important Condition);Pneumonia haemophilus (n/a - Fatal - Results in Death, Other Medically Important Condition);Pyrexia (n/a - Fatal - Results in Death, Other Medically Important Condition);Rales (n/a - Fatal - Results in Death, Other Medically Important Condition);Rhinorrhoea (n/a - Fatal - Results in Death, Other Medically Important Condition);Vaccination failure (n/a - Fatal - Results in Death, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	GALVUS [VILDAGLIPTIN] (C - Diabetes mellitus - n/a - [n/a - 50mg - n/a])|TELMISARTAN [TELMISARTAN] (C - Hypertension - n/a - [n/a - 50mg - n/a])|[LOSARTAN POTASSIUM, AMLODIPINE BESILATE] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007189425&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10007182489	Spontaneous	2020-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pain (n/a - Unknown - );Swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007182489&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007186567	Spontaneous	2020-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Rash (15d - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007186567&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007179601	Spontaneous	2020-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Inflammation (n/a - Recovering/Resolving - );Pain (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007179601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007124908	Spontaneous	2020-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovering/Resolving - );Erythema (n/a - Recovering/Resolving - );Hypotension (n/a - Recovering/Resolving - );Skin warm (n/a - Recovering/Resolving - );Tinnitus (n/a - Recovering/Resolving - );Vision blurred (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007124908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007117600	Spontaneous	2020-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Lymphadenopathy (n/a - Recovering/Resolving - );Swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007117600&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007118021	Spontaneous	2020-12-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Vaccination site erythema (n/a - Unknown - );Vaccination site mass (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007118021&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007113692	Spontaneous	2020-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Hypersensitivity (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007113692&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007116676	Spontaneous	2020-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Administration site oedema (3d - Recovered/Resolved - );Application site discolouration (3d - Recovered/Resolved - );Immunisation reaction (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007116676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007104544	Spontaneous	2020-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Vaccination site pain (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007104544&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007104579	Spontaneous	2020-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Back pain (n/a - Recovering/Resolving - );Chills (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - );Feeling hot (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Hyperaesthesia (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - );Pain in extremity (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007104579&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007101943	Spontaneous	2020-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007101943&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007095161	Spontaneous	2020-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Injection site haemorrhage (n/a - Recovered/Resolved - );Injection site hypersensitivity (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - );Injection site papule (n/a - Recovered/Resolved - );Injection site rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])...	[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007095161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10007101001	Spontaneous	2020-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Brain oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Encephalitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[DICLOFENAC DIETHYLAMINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM, LIDOCAINE, DICLOFENAC SODIUM, LIDOCAINE HYDROCHLORIDE] (C - Rheumatoid arthritis - n/a - [n/a - 100mg - Unknown])|[SULFASALAZINE, SULFASALAZINE PH. EUR.] (C - Rheumatoid arthritis - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007101001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007084121	Spontaneous	2020-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007084121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007016892	Spontaneous	2020-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vaccination site joint pain (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	CYMBALTA [DULOXETINE, DULOXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|DESLORATADINE [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR., ASPIRIN BP] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DEXAMFETAMINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MOMETASONE FUROATE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007016892&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10007008797	Spontaneous	2020-11-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Not Recovered/Not Resolved - );Oedema (n/a - Not Recovered/Not Resolved - );Pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007008797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007015084	Spontaneous	2020-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cough (1d - Recovered/Resolved - );Rash (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007015084&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007005584	Spontaneous	2020-11-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site oedema (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007005584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006988028	Spontaneous	2020-11-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Ankylosing spondylitis (n/a - Not Recovered/Not Resolved - );Arthralgia (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006988028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006992987	Spontaneous	2020-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Urticaria (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006992987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006984787	Spontaneous	2020-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Pyrexia (2d - Recovered/Resolved - );Vaccination site oedema (2d - Recovered/Resolved - );Vaccination site pain (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006984787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006971249	Spontaneous	2020-11-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Chills (3d - Recovered/Resolved - );Headache (3d - Recovered/Resolved - );Hyperhidrosis (3d - Recovered/Resolved - );Nausea (3d - Recovered/Resolved - );Pain in extremity (3d - Recovered/Resolved - );Retching (3d - Recovered/Resolved - );Vertigo (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006971249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006976354	Spontaneous	2020-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Immunisation reaction (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - );Vaccination site erythema (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006976354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006964648	Spontaneous	2020-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Urticaria (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006964648&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006954579	Spontaneous	2020-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Encephalitis brain stem (n/a - Unknown - Other Medically Important Condition);Facial pain (n/a - Unknown - );Nervous system disorder (n/a - Not Recovered/Not Resolved - );Pain of skin (n/a - Unknown - );Paraesthesia (n/a - Not Recovered/Not Resolved - )	SHINGRIX [RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E, STIMULON, MONOPHOSPHORYL LIPID A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	SHINGRIX [RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E, STIMULON, MONOPHOSPHORYL LIPID A] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006954579&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10006946943	Spontaneous	2020-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hyperglycaemia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Hypotension (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Hypoxia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting projectile (1d - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Dose not changed - [2d - 1{DF} - Intramuscular])	OLANZAPINE [OLANZAPINE] (C - n/a - Dose not changed - [n/a - 5mg - n/a])|[FERRIPROTINATE, IRON PROTEIN SUCCINYLATE] (C - n/a - Dose not changed - [n/a - 1{DF} - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - Dose not changed - )|[LORAZEPAM] (C - n/a - Dose not changed - [n/a - 2.5mg - n/a])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - Dose not changed - [n/a - 1{DF} - n/a])|[QUETIAPINE] (C - n/a - Dose not changed - [n/a - 200mg - Oral])|[VALPROIC ACID, SODIUM VALPROATE] (C - n/a - Dose not changed - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006946943&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10006946951	Spontaneous	2020-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Diarrhoea (3d - Recovered/Resolved - );Malaise (3d - Recovered/Resolved - );Pyrexia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006946951&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006946956	Spontaneous	2020-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Paraesthesia (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - n/a - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006946956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006946963	Spontaneous	2020-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Diarrhoea (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006946963&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006918605	Spontaneous	2020-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	Yes	Male	Cutaneous vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006918605&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006918923	Spontaneous	2020-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Arthralgia (3d - Not Recovered/Not Resolved - );Pyrexia (3d - Not Recovered/Not Resolved - );Vaccination site pain (3d - Not Recovered/Not Resolved - );Vomiting (3d - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006918923&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006924761	Spontaneous	2020-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Vaccination site vesicles (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza immunisation - Drug withdrawn - [1d - n/a - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE VACCINE] (S - n/a - Drug withdrawn - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006924761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006912458	Spontaneous	2020-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza - Not applicable - [n/a - 15ug - n/a])|[BENDROFLUMETHIAZIDE] (S - Hypertension - n/a - [n/a - 2.5mg - n/a])|[BIOFLAVONOIDS, DIOSMIN, BIOFLAVONOIDS, DIOSMIN, HESPERIDIN, FLAVONOIDS EXTRACTED FROM RUTACAE (AURANTIAE), MICRONISED PURIFIED FLAVONOIC FRACTION] (S - Varicose vein - Unknown - [n/a - 1g - n/a])	[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - Myocardial ischaemia - n/a - [n/a - 75mg - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - n/a - [n/a - 500mg - n/a])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - Hypertension - Unknown - [n/a - 8mg - n/a])|[SIMVASTATIN] (C - Dyslipidaemia - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006912458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006882282	Spontaneous	2020-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Joint stiffness (n/a - Not Recovered/Not Resolved - );Local reaction (n/a - Not Recovered/Not Resolved - );Lymphadenopathy (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006882282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006831554	Spontaneous	2020-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006831554&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006823232	Spontaneous	2020-10-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angina pectoris (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Brain fog (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cardiac disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyskinesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling cold (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperacusis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Metabolic disorder (n/a - Unknown - Other Medically Important Condition);Migraine (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Orthostatic hypotension (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pharyngitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Photophobia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Presyncope (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006823232&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10006823515	Spontaneous	2020-10-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Haematochezia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Inflammatory bowel disease (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (51h - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006823515&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006825715	Spontaneous	2020-10-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myopericarditis (n/a - Recovered/Resolved - Other Medically Important Condition);Troponin increased (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[DIPHTHERIA TOXOID, TETANUS TOXOID] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006825715&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006799508	Spontaneous	2020-10-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Local reaction (n/a - Unknown - );Pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006799508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006777747	Spontaneous	2020-09-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Blood disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006777747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006716867	Spontaneous	2020-09-21 00:00:00	Healthcare Professional	European Economic Area	Westerberg C.. Aciclovir or valaciclovir - Acute generalised exanthematous pustulosis. WHO pharmaceuticals newsletter. 2020;4:11-17	65-85 Years	Not Specified	No	Male	Acute generalised exanthematous pustulosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Unknown])|[SULFAMETHOXAZOLE, TRIMETHOPRIM] (S - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[VALACICLOVIR] (S - Product used for unknown indication - Dose not changed - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006716867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006629553	Spontaneous	2020-09-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - );Hallucination (n/a - Not Recovered/Not Resolved - );Hypertension (n/a - Not Recovered/Not Resolved - );Sleep disorder (n/a - Not Recovered/Not Resolved - );Weight increased (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006629553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006635170	Spontaneous	2020-09-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - );Injection site discomfort (n/a - Recovered/Resolved - );Injection site inflammation (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - );Injection site swelling (n/a - Recovered/Resolved - );Injection site warmth (n/a - Recovered/Resolved - );Musculoskeletal discomfort (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	MULTIVITAMINEN [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|NON SPECIFIED DRUG [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|NOT AVAILABLE (C - n/a - n/a - [n/a - n/a - n/a])|[CICLESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SALMETEROL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006635170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006636285	Spontaneous	2020-09-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - );Injection site pruritus (n/a - Not Recovered/Not Resolved - );Injection site swelling (n/a - Not Recovered/Not Resolved - );Injection site warmth (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	MULTIVITAMINEN [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|NON SPECIFIED DRUG [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID, MAGNESIUM OXIDE, HEAVY, MAGNESIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006636285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006624401	Spontaneous	2020-09-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cyanosis (73h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (73h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Wheezing (73h - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006624401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006580266	Spontaneous	2020-08-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Diplegia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Monoplegia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neck pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pharyngeal hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - .5mL - Unknown])	[AMLODIPINE MALEATE] (C - n/a - Unknown - [n/a - 15mg - Oral])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - Unknown - [n/a - 5mg - Oral])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - Unknown - [n/a - 5mg - n/a])|[DALTEPARIN SODIUM] (C - n/a - Unknown - [n/a - 5000[iU] - Unknown])|[HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - 12.5mg - Oral])|[MELPERONE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 3{DF} - Oral])|[MELPERONE] (C - n/a - Unknown - [n/a - 3{DF} - n/a])|[PROMETHAZINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 2{DF} - Oral])|[RAMIPRIL] (C - n/a - Unknown - [n/a - 3{DF} - Oral])|[SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006580266&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006562245	Spontaneous	2020-08-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (2wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Dose not changed - [n/a - 1{DF} - n/a])|[B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327)] (S - Prophylaxis - Dose not changed - [n/a - 1{DF} - n/a])	NOT AVAILABLE (C - n/a - n/a - [n/a - n/a - n/a])|[DRY EXTRACT FROM GINSENG ROOT (3-5:1): ETHANOL 36 % (V/V), GINSENG] (C - n/a - n/a - [n/a - n/a - n/a])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[NIFEDIPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PHYTOMENADIONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006562245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006516114	Spontaneous	2020-08-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vaccination site abscess (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vaccination site erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vaccination site pruritus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006516114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006508945	Spontaneous	2020-08-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - );Crying (n/a - Unknown - );Decreased appetite (n/a - Recovered/Resolved - );Delirium (n/a - Recovered/Resolved - Other Medically Important Condition);Food refusal (n/a - Recovered/Resolved - );Lethargy (n/a - Recovered/Resolved - );Psychomotor hyperactivity (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006508945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006491683	Spontaneous	2020-08-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Neurodermatitis (n/a - Unknown - );Rash (n/a - Unknown - );Skin reaction (n/a - Unknown - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALUMINIUM HYDROXIDE] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[DIPHTHERIA AND TETANUS VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM HYDROXIDE [PRODUCED IN S. CEREVISIAE (STRAIN 2150-2-3) BY RDNA], ALGELDRATE] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[HEPATITIS B VACCINE] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006491683&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006439053	Spontaneous	2020-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood pressure increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Conjunctival hyperaemia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Diabetes mellitus (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Heart rate increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Limb discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pain of skin (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Skin burning sensation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Urticaria chronic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vertigo (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006439053&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10006320903	Spontaneous	2020-07-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epiglottitis (22d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006320903&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006284007	Spontaneous	2020-07-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Facial paralysis (24h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006284007&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10006185292	Spontaneous	2020-06-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - );Insomnia (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Nervousness (n/a - Not Recovered/Not Resolved - );Pruritus (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	CANNABIDIOL [CANNABIDIOL] (C - n/a - n/a - [n/a - n/a - n/a])|IRBESARTAN 150 MG [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|NOT AVAILABLE (C - n/a - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID, MAGNESIUM OXIDE, HEAVY, MAGNESIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE] (C - n/a - n/a - [n/a - n/a - n/a])|[NICOTINAMIDE, UBIDECARENONE, ZINC, COPPER, MANGANESE, SELENIUM, ALPHA-TOCOPHEROL, UBIDECARENONE] (C - n/a - n/a - [n/a - n/a - n/a])|[TURMERIC] (C - n/a - n/a - [n/a - n/a - n/a])|[ZINC SULPHATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006185292&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006158952	Spontaneous	2020-06-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Seizure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006158952&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10006133772	Spontaneous	2020-06-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash pruritic (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006133772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006117618	Spontaneous	2020-06-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006117618&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006098359	Spontaneous	2020-06-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006098359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006098397	Spontaneous	2020-06-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006098397&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006074794	Spontaneous	2020-05-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chills (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diplopia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysstasia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eye pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Facial paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);IIIrd nerve disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Impaired driving ability (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Limb discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Multiple sclerosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nervous system disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ocular discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Optic neuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vertigo (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vitreous floaters (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	AVONEX [INTERFERON BETA-1A] (S - Multiple sclerosis - Unknown - [n/a - 30mg - n/a])|AVONEX [INTERFERON BETA-1A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006074794&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005980114	Spontaneous	2020-05-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Syncope (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005980114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005933315	Spontaneous	2020-05-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Presyncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005933315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005841555	Spontaneous	2020-04-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Induration (n/a - Not Recovered/Not Resolved - );Local reaction (n/a - Not Recovered/Not Resolved - );Nausea (n/a - Not Recovered/Not Resolved - );Vaccination site abscess (n/a - Not Recovered/Not Resolved - );Vomiting (n/a - Not Recovered/Not Resolved - )	M-M-RVAXPRO [MEASLES VIRUS ENDERS' EDMONSTON STRAIN (LIVE, ATTENUATED), MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005841555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005821070	Spontaneous	2020-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005821070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005761159	Spontaneous	2020-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Herpes zoster (6d - Recovered/Resolved - );Hyperaesthesia (n/a - Recovered/Resolved - );Rash (n/a - Recovered/Resolved - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|SHINGRIX [RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E, RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E, STIMULON, MONOPHOSPHORYL LIPID A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Dyspepsia - Unknown - [n/a - 20mg - n/a])|[CLINDAMYCIN, CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN PHOSPHATE] (C - Dental care - Unknown - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - 75mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005761159&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10005739046	Spontaneous	2020-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Neuritis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005739046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10005689118	Spontaneous	2020-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - Hypertension - n/a - [n/a - 32mg - Oral])|[LANSOPRAZOLE] (C - Hiatus hernia - n/a - [n/a - 15mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005689118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005678905	Spontaneous	2020-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Flushing (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - );Swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005678905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005625054	Spontaneous	2020-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site joint erythema (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005625054&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005625140	Spontaneous	2020-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site joint erythema (3d - Recovered/Resolved - );Vaccination site papule (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005625140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005625223	Spontaneous	2020-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Vaccination site joint erythema (2d - Recovered/Resolved - );Vaccination site papule (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005625223&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005625328	Spontaneous	2020-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site joint erythema (5d - Recovered/Resolved - );Vaccination site papule (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005625328&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005625606	Spontaneous	2020-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site oedema (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005625606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005625795	Spontaneous	2020-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site joint erythema (3d - Recovered/Resolved - );Vaccination site oedema (3d - Recovered/Resolved - );Vaccination site papule (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005625795&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005629569	Spontaneous	2020-03-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Oral herpes (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	NOT AVAILABLE (C - n/a - n/a - [n/a - 120mg - n/a])|[ASCORBIC ACID] (C - n/a - n/a - [n/a - 1500mg - n/a])|[GLUCOSAMINE, CHONDROITIN] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[SILICON] (C - n/a - n/a - [n/a - 8[drp] - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005629569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005569871	Spontaneous	2020-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Initial insomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Irritability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Mood swings (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Quality of life decreased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005569871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10005555680	Spontaneous	2020-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mood altered (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Quality of life decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005555680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005545252	Spontaneous	2020-02-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Infection (n/a - Unknown - );Oropharyngeal pain (4d - Recovered/Resolved - );Pyrexia (8d - Recovered/Resolved - );Rheumatic disorder (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (C - Immunisation - n/a - [n/a - n/a - Intramuscular])...	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005545252&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005425901	Spontaneous	2020-02-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005425901&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005425904	Spontaneous	2020-02-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005425904&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005431589	Spontaneous	2020-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dermatitis bullous (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005431589&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005411226	Spontaneous	2020-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Headache (2d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - n/a - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005411226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005379060	Spontaneous	2020-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - Hypotension - n/a - [n/a - 8mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005379060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005367212	Spontaneous	2020-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...	[DROSPIRENONE, ETHINYLESTRADIOL, LACTOSE] (C - n/a - n/a - )|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005367212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005341591	Spontaneous	2020-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Angioedema (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005341591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005343172	Spontaneous	2020-01-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthma (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Conjunctivitis allergic (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dermatitis atopic (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Lichen sclerosus (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Myocarditis (1a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pericarditis (1a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Urticaria (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005343172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10005348376	Spontaneous	2020-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - );Back pain (n/a - Unknown - );Balance disorder (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Unknown - );Fatigue (n/a - Unknown - );Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[METHENAMINE HIPPURATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005348376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10005289925	Spontaneous	2020-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - n/a])	RANEXA 375 MG PROLONGED-RELEASE TABLETS [RANOLAZINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATENOLOL] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005289925&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005267288	Spontaneous	2020-01-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Administration site erythema (n/a - Not Recovered/Not Resolved - );Administration site inflammation (n/a - Not Recovered/Not Resolved - );Administration site pain (n/a - Not Recovered/Not Resolved - );Pain in extremity (3h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005267288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005251415	Spontaneous	2020-01-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Diabetes mellitus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hepatic cirrhosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hepatorenal syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperosmolar state (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypertension (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005251415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005226815	Spontaneous	2020-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Migraine (n/a - Not Recovered/Not Resolved - Disabling)	POLIO [POLIO] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINUM HYDROXIDE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, ALGELDRATE, NEISSERIA MENINGITIDIS GROUP C, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, TETANUS TOXOID, ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, ALUMINIUM, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, N. MENINGITIDIS GROUP C POLYSACCHARIDE, ALGELDRATE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS NEUDOERFL STRAIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED PRODUCED IN CHICK EMBRYO CELLS, ALGELDRATE] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005226815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10005206943	Spontaneous	2020-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Erythema (2880min - Recovered/Resolved - );Pyrexia (2880min - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005206943&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005208807	Spontaneous	2020-01-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Brain oedema (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Encephalitis viral (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Hypotension (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Hypothermia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Leukocytosis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Meningitis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Metabolic acidosis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Neurological infection (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neutrophilia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005208807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10005208824	Spontaneous	2020-01-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - );Pain in extremity (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005208824&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005208827	Spontaneous	2020-01-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Influenza (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005208827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005197085	Spontaneous	2020-01-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Hyperpyrexia (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Palpitations (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[DIPHTHERIA TOXOID ADSORBED, TETANUS TOXOID ADSORBED, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005197085&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10005180339	Spontaneous	2020-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Discomfort (n/a - Unknown - );Hypoaesthesia (n/a - Unknown - );Paraesthesia (n/a - Unknown - );Vaccination site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	[TRANEXAMIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005180339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005174978	Spontaneous	2020-01-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Influenza A virus test positive (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005174978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005175037	Spontaneous	2020-01-09 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Meningitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005175037&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005176049	Spontaneous	2020-01-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Headache (n/a - Recovering/Resolving - );Musculoskeletal pain (n/a - Not Recovered/Not Resolved - );Polymyalgia rheumatica (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	NOT AVAILABLE (C - n/a - n/a - [n/a - 1{DF} - n/a])|[PANCREAS POWDER, PANCREATIN] (C - n/a - n/a - [n/a - 800mg - n/a])|[SOTALOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005176049&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005160443	Spontaneous	2020-01-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Meniere's disease (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005160443&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10005165189	Spontaneous	2020-01-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Influenza (n/a - Recovering/Resolving - Other Medically Important Condition);Pharyngeal erythema (n/a - Recovering/Resolving - Other Medically Important Condition);Productive cough (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	[JAPANESE ENCEPHALITIS VACCINE] (C - Immunisation - Not applicable - [n/a - .5mL - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005165189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005157254	Spontaneous	2020-01-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cough (2d - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (2d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])|[JAPANESE ENCEPHALITIS VACCINE] (S - Immunisation - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005157254&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005146680	Spontaneous	2020-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Erythema (n/a - Recovered/Resolved - );Gingivitis (n/a - Recovered/Resolved - );Hypersensitivity (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005146680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005149883	Spontaneous	2020-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain in extremity (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005149883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005144028	Spontaneous	2020-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	ELIQUIS [APIXABAN] (C - Atrial fibrillation - n/a - [n/a - 5mg - n/a])|[BISOPROLOL FUMARATE] (C - Atrial fibrillation - n/a - [n/a - 3.75mg - Oral])|[CALCIUM FOLINATE, CYANOCOBALAMIN] (C - Anaemia - n/a - [n/a - 10k[iU] - Oral])|[FUROSEMIDE] (C - Atrial fibrillation - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005144028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005123916	Spontaneous	2019-12-31 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Other Medically Important Condition);Myelitis (n/a - Unknown - Other Medically Important Condition);Odynophagia (n/a - Unknown - );Paraesthesia (n/a - Unknown - Other Medically Important Condition);Rhinorrhoea (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005123916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10005119613	Spontaneous	2019-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Herpes zoster (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	SHINGRIX [RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E, RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E, STIMULON, MONOPHOSPHORYL LIPID A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005119613&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10005106554	Spontaneous	2019-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Herpes zoster (n/a - Unknown - );Oedema (n/a - Unknown - );Rash (n/a - Unknown - )	SHINGRIX [RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E, RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E, STIMULON, MONOPHOSPHORYL LIPID A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005106554&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10005088198	Spontaneous	2019-12-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{total} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005088198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005090303	Spontaneous	2019-12-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Bronchitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005090303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005053469	Spontaneous	2019-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Deafness (20d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005053469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10005054275	Spontaneous	2019-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Optic neuritis (10d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	[CHLORDIAZEPOXIDE HYDROCHLORIDE, CLIDINIUM BROMIDE, CHLORDIAZEPOXIDE, CLIDINIUM, CHLORDIAZEPOXIDE, CLIDINIUM BROMIDE] (C - Colitis, Gastritis - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Colitis, Gastritis - n/a - [n/a - n/a - n/a])|[TRIMEBUTINE, TRIMEBUTINE MALEATE] (C - Colitis, Gastritis - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005054275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10005042107	Spontaneous	2019-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Infection susceptibility increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pustule (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Skin infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Urinary tract infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[MONTELUKAST, MONTELUKAST SODIUM] (C - Asthma - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005042107&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005042841	Spontaneous	2019-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005042841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005028742	Spontaneous	2019-12-17 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Not Specified	Diarrhoea (50d - Not Recovered/Not Resolved - );Epiglottitis (n/a - Recovering/Resolving - Other Medically Important Condition);Inappropriate schedule of product administration (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005028742&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-10005028817	Spontaneous	2019-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Sickle cell anaemia with crisis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005028817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005028989	Spontaneous	2019-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Morphoea (n/a - Not Recovered/Not Resolved - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005028989&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005006234	Spontaneous	2019-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Ventricular fibrillation (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005006234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10005008891	Spontaneous	2019-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paralysis (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{total} - Intramuscular])	EXFORGE [VALSARTAN, AMLODIPINE, VALSARTAN, AMLODIPINE BESILATE] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005008891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004983813	Spontaneous	2019-12-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Myalgia (5d - Recovered/Resolved - );Pain in extremity (6d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004983813&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004987790	Spontaneous	2019-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Motor dysfunction (35d - Not Recovered/Not Resolved - );Vaccination site joint pain (35d - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004987790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Duration
EU-EC-10004990813	Spontaneous	2019-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Vaccination site erythema (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Childhood asthma - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004990813&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004980399	Spontaneous	2019-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Dry skin (n/a - Recovering/Resolving - );Pruritus (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004980399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004980419	Spontaneous	2019-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Herpes zoster (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004980419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10004980439	Spontaneous	2019-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza like illness (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004980439&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004963882	Spontaneous	2019-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[DIGOXIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004963882&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004952239	Spontaneous	2019-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Diarrhoea (2d - Recovered/Resolved - );Malaise (2d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - );Vomiting (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004952239&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004953743	Spontaneous	2019-12-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Myositis (n/a - Recovered/Resolved - Disabling);Neuropathy peripheral (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	SYNFLORIX [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (C - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004953743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10004956931	Spontaneous	2019-12-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest discomfort (n/a - Not Recovered/Not Resolved - );Hypoaesthesia (2d - Recovered/Resolved With Sequelae - );Peripheral swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004956931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10004940106	Spontaneous	2019-12-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Allergy to plants (17a - Recovering/Resolving - );Arthralgia (17a - Recovering/Resolving - );Fatigue (17a - Recovering/Resolving - );Myalgia (17a - Recovering/Resolving - );Osteitis (17a - Recovering/Resolving - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004940106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004923390	Spontaneous	2019-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Infant	No	Female	Blister (n/a - Unknown - Other Medically Important Condition);Dermatitis (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Wound (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004923390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004914583	Spontaneous	2019-12-02 00:00:00	Healthcare Professional	European Economic Area	Reigota, C.; Santos, J.; Vilao, F.; Santos L.; Carvalho A.. VACCINE AS A TRIGGER FOR INFLAMMATORY MYOPATHY. Autoimmune and rheumatic diseases - E-Poster Congress ID: P034 –Abstract ID:1355. unk;unk:unk	65-85 Years	Not Specified	No	Male	Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myositis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004914583&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004904494	Spontaneous	2019-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Overdose (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004904494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004892064	Spontaneous	2019-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Arthralgia (2d - Recovered/Resolved - );Bone pain (2d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - );Nasopharyngitis (3d - Recovered/Resolved - );Vaccination site pain (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004892064&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004887582	Spontaneous	2019-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Catarrh (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004887582&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004888469	Spontaneous	2019-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Oedema peripheral (4320min - Recovered/Resolved - );Urticaria (4320min - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004888469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004867612	Spontaneous	2019-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - );Decreased appetite (n/a - Unknown - );Diabetes mellitus (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004867612&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004874274	Spontaneous	2019-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Thrombocytopenia (n/a - Unknown - Other Medically Important Condition)	COSENTYX [SECUKINUMAB] (S - Psoriasis - Unknown - [n/a - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004874274&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004856541	Spontaneous	2019-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Acute respiratory failure (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Radiculopathy (n/a - Unknown - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004856541&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004841635	Spontaneous	2019-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (4d - Recovering/Resolving - );Muscle discomfort (4d - Recovering/Resolving - );Myalgia (4d - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004841635&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004842014	Spontaneous	2019-11-21 00:00:00	Healthcare Professional	European Economic Area	Mintoff D., Betts A., Boffa M.J. Influenza vaccine-associated cutaneous lupus erythematosus. Orcid. Unk;Unk:Unk. doi:10.1111/CED.14130	18-64 Years	Not Specified	No	Female	Dermatitis (n/a - Recovering/Resolving - Other Medically Important Condition);Rash papular (n/a - Recovering/Resolving - Other Medically Important Condition);Rash pruritic (n/a - Recovering/Resolving - Other Medically Important Condition);Skin lesion (n/a - Recovering/Resolving - Other Medically Important Condition);Systemic lupus erythematosus (4wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004842014&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004818917	Spontaneous	2019-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Not Specified	Exposure during pregnancy (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Spina bifida (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004818917&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-10004822586	Spontaneous	2019-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Erythema (n/a - Recovered/Resolved - );Vaccination site warmth (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004822586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004812892	Spontaneous	2019-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Flushing (n/a - Unknown - );Injection site oedema (n/a - Unknown - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])...	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, ALUMINIUM HYDROXIDE GEL, MAGNESIUM HYDROXIDE, ACETYLSALICYLIC ACID, MAGNESIUM HYDROXIDE, ALGELDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - Oral])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004812892&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004815325	Spontaneous	2019-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Diarrhoea (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004815325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004798688	Spontaneous	2019-11-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Malaise (n/a - Unknown - Life Threatening);Peripheral nerve lesion (n/a - Unknown - Life Threatening);Skin haemorrhage (n/a - Unknown - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004798688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10004744700	Spontaneous	2019-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Urticaria (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004744700&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004716320	Spontaneous	2019-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Bone pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Disability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Epistaxis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Haematoma (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Immune thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Petechiae (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004716320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004701736	Spontaneous	2019-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - );Cough (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	PREVENAR 13 SUSPENSION FOR INJECTION IN SINGLE DOSE VIAL [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197] (S - n/a - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004701736&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004630281	Spontaneous	2019-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site induration (n/a - Recovered/Resolved - );Injection site pruritus (n/a - Recovered/Resolved - );Injection site reaction (1mo - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004630281&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004622482	Spontaneous	2019-10-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Foetus	Yes	Male	Foetal exposure during pregnancy (n/a - Recovered/Resolved - Congenital Anomaly, Other Medically Important Condition);Foetal growth restriction (n/a - Recovered/Resolved - Congenital Anomaly, Other Medically Important Condition);Renal aplasia (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS (INACTIVATED) ADSORBED] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])|[CLOTRIMAZOLE] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Transplacental])|[DEQUALINIUM CHLORIDE] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Transplacental])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Transplacental])|[FERRIC CARBOXYMALTOSE, IRON] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Transplacental])...	[ASCORBIC ACID, BIOTIN, COLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, THIAMINE, ZINC, CALCIUM, COPPER, IODINE, IRON, MAGNESIUM, MANGANESE, PANTOTHENIC ACID, PYRIDOXINE HYDROCHLORIDE, SELENIUM, RETINOL, ALPHA-TOCOPHEROL, VITAMIN B12, ASCORBIC ACID, BIOTIN, COLECALCIFEROL, FOLIC ACID, NICOTINIC ACID, RIBOFLAVIN, THIAMINE, CALCIUM HYDROGEN PHOSPHATE (ANHYDROUS), COPPER SULPHATE, ANHYDROUS, MAGNESIUM OXIDE, LIGHT, MANGANESE SULPHATE MONOHYDRATE, FERROUS FUMARATE, PANTOTHENIC ACID, PYRIDOXINE HYDROCHLORIDE, RETINOL, ALPHA-TOCOPHEROL, ZINC SULPHATE MONOHYDRATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, VITAMIN B12, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, CYANOCOBALAMIN, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, CALCIUM HYDROGEN PHOSPHATE (ANHYDROUS), COPPER SULPHATE, ANHYDROUS, MAGNESIUM OXIDE, LIGHT, MANGANESE SULPHATE MONOHYDRATE, FERROUS FUMARATE, PYRIDOXINE HYDROCHLORIDE, RETINOL, ZINC SULPHATE MONOHYDRATE, DL-ALPHA TOCOPHEROL ACETATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, THIAMINE HYDROCHLORIDE, ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, CALCIUM HYDROGEN PHOSPHATE (ANHYDROUS), COPPER SULPHATE, ANHYDROUS, MAGNESIUM OXIDE, LIGHT, MANGANESE SULPHATE MONOHYDRATE, FERROUS FUMARATE, PYRIDOXINE HYDROCHLORIDE, RETINOL, ALPHA-TOCOPHEROL, ZINC SULPHATE MONOHYDRATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, VITAMIN B12, THIAMINE HYDROCHLORIDE, ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, CALCIUM HYDROGEN PHOSPHATE (ANHYDROUS), COPPER SULPHATE, ANHYDROUS, MAGNESIUM OXIDE, LIGHT, MANGANESE SULPHATE MONOHYDRATE, VITAMIN B6, FERROUS FUMARATE, RETINOL, ZINC SULPHATE MONOHYDRATE, DL-ALPHA TOCOPHEROL ACETATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, VITAMIN B12, THIAMINE HYDROCHLORIDE, ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, ZINC, CALCIUM, COPPER, IRON, MAGNESIUM, MANGANESE, PHOSPHORUS, PYRIDOXINE HYDROCHLORIDE, RETINOL, DL-ALPHA TOCOPHEROL ACETATE, VITAMIN B12] (C - Product used for unknown indication - Not applicable - [n/a - n/a - Transplacental])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004622482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Severe reaction
EU-EC-10004588608	Spontaneous	2019-10-16 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Allergic bronchitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Condition aggravated (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - Oral])|[MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004588608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004449533	Spontaneous	2019-09-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Coordination abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fine motor skill dysfunction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (20d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia oral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Paresis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Pneumococcal immunisation - Unknown - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004449533&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004389585	Spontaneous	2019-09-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - );Headache (4d - Recovered/Resolved - );Malaise (4d - Recovered/Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Pain in extremity (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	BIO-KULT [NOT AVAILABLE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|NOT AVAILABLE (C - n/a - n/a - [n/a - 5mg - n/a])|NOT AVAILABLE (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004389585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004377149	Spontaneous	2019-09-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004377149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004344313	Spontaneous	2019-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004344313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004310997	Spontaneous	2019-09-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - );Injection site discomfort (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	[ASCORBIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[RUPATADINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004310997&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004311001	Spontaneous	2019-09-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	[MERCAPTOPURINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004311001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004311048	Spontaneous	2019-09-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004311048&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004306073	Spontaneous	2019-09-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site cyst (n/a - Not Recovered/Not Resolved - );Vaccination site induration (n/a - Not Recovered/Not Resolved - );Vaccination site pruritus (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004306073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004263415	Spontaneous	2019-08-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Erysipelas (n/a - Recovered/Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Neuropathy peripheral (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004263415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004237797	Spontaneous	2019-08-26 00:00:00	Healthcare Professional	European Economic Area	Mayet A. Surveillance of adverse events following vaccination in the French armed forces, 2011-2012. Public Health 2015;.	18-64 Years	Adult	No	Female	Facial paralysis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Miller Fisher syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004237797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004232375	Spontaneous	2019-08-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cyanosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004232375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004219006	Spontaneous	2019-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Micturition urgency (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Sphincter of Oddi dysfunction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004219006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004212416	Spontaneous	2019-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Vaccination failure (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004212416&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004215683	Spontaneous	2019-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Vaccination failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004215683&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004185987	Spontaneous	2019-08-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Palpitations (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	MYCOPHENOLATE MOFETIL [MYCOPHENOLATE MOFETIL] (C - n/a - n/a - [n/a - n/a - n/a])|PROTOPIC [TACROLIMUS, TACROLIMUS MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ALFACALCIDOL] (C - n/a - n/a - [n/a - n/a - n/a])|[CALCIUM, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DIMETICONE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ISPAGHULA HUSK] (C - n/a - n/a - [n/a - n/a - n/a])|[IVERMECTIN] (C - n/a - n/a - [n/a - n/a - n/a])|[MAGNESIUM, MAGNESIUM HYDROXIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])|[TACROLIMUS, TACROLIMUS MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004185987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10004137871	Spontaneous	2019-08-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site discolouration (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004137871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004127140	Spontaneous	2019-08-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cellulitis (n/a - Recovered/Resolved - Other Medically Important Condition);Induration (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site inflammation (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	[PNEUMOCOCCAL VACCINE] (C - Immunisation - Not applicable - [1d - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004127140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004108657	Spontaneous	2019-08-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Not Specified	Anaphylactic shock (0d - Recovered/Resolved - Life Threatening);Cyanosis (0d - Recovered/Resolved - Life Threatening);Loss of consciousness (0d - Recovered/Resolved - Life Threatening);Peripheral coldness (0d - Recovered/Resolved - Life Threatening);Vomiting (0d - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004108657&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10004060784	Spontaneous	2019-07-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anal abscess (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004060784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004013814	Spontaneous	2019-07-19 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Lymphadenitis (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004013814&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003969883	Spontaneous	2019-07-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003969883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003972403	Spontaneous	2019-07-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza (n/a - Recovered/Resolved - Life Threatening);Influenza A virus test positive (n/a - Recovered/Resolved - Life Threatening);Malaise (n/a - Recovered/Resolved - Life Threatening);Vaccination failure (n/a - Unknown - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[GEMFIBROZIL, INOSITOL, CYANOCOBALAMIN, FOLIC ACID, METHIONINE, TAURINE, BERBERIS VULGARIS, CHOLINE BITARTRATE, PYRIDOXINE HYDROCHLORIDE, TARAXACUM OFFICINALE, BUPLEURUM FALCATUM WHOLE] (C - Hyperlipidaemia - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003972403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10003972583	Spontaneous	2019-07-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Influenza A virus test positive (n/a - Recovered/Resolved - Life Threatening);Malaise (n/a - Recovered/Resolved - Life Threatening);Vaccination failure (n/a - Unknown - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID, PARACETAMOL] (C - Antiplatelet therapy - Unknown - [n/a - 100mg - Oral])|[AMLODIPINE] (C - Hypertension - Unknown - [n/a - 5mg - Oral])|[GEMFIBROZIL, INOSITOL, CYANOCOBALAMIN, FOLIC ACID, METHIONINE, TAURINE, BERBERIS VULGARIS, CHOLINE BITARTRATE, PYRIDOXINE HYDROCHLORIDE, TARAXACUM OFFICINALE, BUPLEURUM FALCATUM WHOLE] (C - Hyperlipidaemia - Unknown - [n/a - 20mg - Oral])|[OMEPRAZOLE SODIUM] (C - Gastrooesophageal reflux disease - Unknown - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003972583&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10003961125	Spontaneous	2019-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dry mouth (0d - Recovered/Resolved - );Pruritus (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003961125&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003955501	Spontaneous	2019-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cardiovascular disorder (9d - Recovered/Resolved - );Vertigo (9d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003955501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003933108	Spontaneous	2019-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Toxic epidermal necrolysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])|[FLURBIPROFEN] (S - Pain - Drug withdrawn - [n/a - n/a - Oral])|[OMEPRAZOLE] (S - Regurgitation - Drug withdrawn - [n/a - n/a - Oral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003933108&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003875203	Spontaneous	2019-06-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Gait inability (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Joint stiffness (n/a - Unknown - Disabling);Pain in extremity (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003875203&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10003844356	Spontaneous	2019-06-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypokinesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[VALSARTAN] (C - Hypertension - Dose not changed - [n/a - 180mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003844356&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003835433	Spontaneous	2019-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003835433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003823216	Spontaneous	2019-06-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003823216&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003828047	Spontaneous	2019-06-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Polymyalgia rheumatica (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003828047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003792315	Spontaneous	2019-06-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Neck pain (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003792315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003775748	Spontaneous	2019-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypersensitivity (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003775748&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003755412	Spontaneous	2019-06-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Paralysis (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003755412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003758674	Spontaneous	2019-06-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Micturition urgency (n/a - Recovered/Resolved - Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Sneezing (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003758674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003752281	Spontaneous	2019-06-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic obstructive pulmonary disease (n/a - Unknown - Life Threatening);Cough (n/a - Unknown - Life Threatening);Dyspnoea at rest (n/a - Unknown - Life Threatening);Face oedema (n/a - Unknown - Life Threatening);Hypersensitivity (n/a - Unknown - Life Threatening);Malaise (n/a - Unknown - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003752281&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10003728823	Spontaneous	2019-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Abdominal pain upper (n/a - Recovered/Resolved - Other Medically Important Condition);Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Chest pain (n/a - Recovered/Resolved - Other Medically Important Condition);Feeling abnormal (n/a - Recovered/Resolved - Other Medically Important Condition);Palpitations (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003728823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003717131	Spontaneous	2019-05-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	H1N1 influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003717131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003717472	Spontaneous	2019-05-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (7d - Recovered/Resolved - );Injection site erythema (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - );Injection site swelling (n/a - Recovered/Resolved - );Myalgia (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003717472&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003682662	Spontaneous	2019-05-26 00:00:00	Healthcare Professional	Non European Economic Area	B. Khishigsuren, E. Demir, S.U. Akgul, S. Temurhan, A.R. Ucar, A.B. Dirim, et al. Panel Reactive Antibody Responses Against Influenza Vaccination in Kidney Transplant Recipients. Transplantation Proceedings. 2019;51:1115-1117. doi:https://doi.org/10.1016/j.transproceed.2019.02.009	Not Specified	Adult	No	Not Specified	Panel-reactive antibody increased (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003682662&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003652549	Spontaneous	2019-05-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003652549&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003646271	Spontaneous	2019-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - );Nasopharyngitis (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003646271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003649750	Spontaneous	2019-05-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Abortion (n/a - Unknown - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003649750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003639022	Spontaneous	2019-05-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dermatitis bullous (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Eosinophilia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash maculo-papular (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003639022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003615408	Spontaneous	2019-05-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Crying (n/a - Unknown - Other Medically Important Condition);Illness (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rash morbilliform (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003615408&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003581137	Spontaneous	2019-05-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Rash (n/a - Unknown - );Wheezing (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003581137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003531386	Spontaneous	2019-05-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Irritability (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003531386&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003443220	Spontaneous	2019-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Neuritis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003443220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10003449307	Spontaneous	2019-04-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003449307&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003418673	Spontaneous	2019-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Rash (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	HYDROXYCARBAMIDE [HYDROXYCARBAMIDE] (C - Essential thrombocythaemia - Dose not changed - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - Autoimmune thyroiditis - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003418673&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003387644	Spontaneous	2019-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	General physical health deterioration (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site cellulitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003387644&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003361871	Spontaneous	2019-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Dyspnoea (n/a - Unknown - );Fatigue (n/a - Unknown - );Food aversion (n/a - Unknown - );Influenza like illness (n/a - Unknown - );Muscular weakness (n/a - Unknown - );Musculoskeletal stiffness (n/a - Unknown - );Myalgia (n/a - Not Recovered/Not Resolved - );Pain (n/a - Unknown - );Paraesthesia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003361871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10003333337	Spontaneous	2019-04-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Pain in extremity (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Somnolence (n/a - Recovering/Resolving - )	[A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008] (S - Prophylaxis - Not applicable - [n/a - 0mL - n/a])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 0mL - n/a])	[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003333337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003283434	Spontaneous	2019-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Female	Adjustment disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Anger (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Arthropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Behaviour disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Bone development abnormal (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Brain injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cervicobrachial syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Crying (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Daydreaming (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Decreased appetite (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Developmental delay (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Dysphagia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Dysstasia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Epilepsy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Eyelid ptosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Foetal exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Gaze palsy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);General physical health deterioration (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Generalised tonic-clonic seizure (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypertelorism (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypertrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypotension (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Insomnia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Irritability (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Lip dry (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Macrocephaly (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Macrosomia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Mood altered (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Motor developmental delay (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Muscle disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Pallor (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Partial seizures (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Poor sucking reflex (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [1d - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003283434&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10003231465	Spontaneous	2019-03-18 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Feeling abnormal (n/a - Not Recovered/Not Resolved - );Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraplegia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003231465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003209941	Spontaneous	2019-03-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003209941&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003210529	Spontaneous	2019-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Adverse event (n/a - Unknown - );Dyspnoea (n/a - Unknown - );Erythema (n/a - Recovered/Resolved - );Feeling hot (n/a - Recovered/Resolved - );Inflammation (n/a - Recovered/Resolved - );Injection site discomfort (n/a - Unknown - );Oedema peripheral (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Swelling (n/a - Unknown - );Vaccination site pain (n/a - Unknown - )	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - n/a - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003210529&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10003212199	Spontaneous	2019-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Facial paralysis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003212199&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003199059	Spontaneous	2019-03-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pruritus (n/a - Recovered/Resolved - );Rash erythematous (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003199059&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003199796	Spontaneous	2019-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hyperhidrosis (1d - Recovered/Resolved - );Hypotension (1d - Recovered/Resolved - );Myalgia (1d - Recovered/Resolved - );Pyrexia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003199796&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003201754	Spontaneous	2019-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Condition aggravated (n/a - Fatal - Results in Death);Lung disorder (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003201754&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10003202734	Spontaneous	2019-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003202734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003204515	Spontaneous	2019-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Injected limb mobility decreased (n/a - Unknown - Disabling);Vaccination site pain (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [0d - .5mL - Intramuscular])	[OMEPRAZOLE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[OTILONIUM BROMIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003204515&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10003190898	Spontaneous	2019-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	EDOXABAN [EDOXABAN] (C - n/a - n/a - [n/a - 1{DF} - n/a])|FLUTICASONE FUROATE [FLUTICASONE FUROATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|LEVETIRACETAM [LEVETIRACETAM] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[EZETIMIBE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[NIFEDIPINE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[TIOTROPIUM BROMIDE, OLODATEROL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 2{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003190898&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10003170114	Spontaneous	2019-03-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Breath sounds (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);H1N1 influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Nasopharyngitis (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngitis (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003170114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003152229	Spontaneous	2019-03-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Arthralgia (n/a - Unknown - );Disturbance in attention (n/a - Unknown - );Dyspnoea (n/a - Unknown - );Headache (n/a - Unknown - );Illusion (n/a - Unknown - );Immune system disorder (n/a - Unknown - );Itching scar (n/a - Unknown - );Memory impairment (n/a - Unknown - );Myalgia (n/a - Unknown - );Poor quality sleep (n/a - Unknown - );Spinal pain (n/a - Unknown - );Throat irritation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - n/a])|[HEPATITIS B SURFACE ANTIGEN, HEPATITIS A VACCINE (INACTIVATED)] (S - Hepatitis immunisation - Not applicable - [n/a - 1mL - n/a])	[TETANUS TOXOID] (C - n/a - n/a - [n/a - .5mL - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003152229&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10003155275	Spontaneous	2019-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (5d - Recovered/Resolved - Other Medically Important Condition);Influenza A virus test positive (0d - Unknown - Other Medically Important Condition);Vaccination failure (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [0d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003155275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003155692	Spontaneous	2019-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza A virus test positive (0d - Unknown - Other Medically Important Condition);Vaccination failure (7d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [0d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003155692&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003136527	Spontaneous	2019-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Vaccination failure (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [0d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003136527&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003137144	Spontaneous	2019-03-04 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003137144&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003126750	Spontaneous	2019-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hyperhidrosis (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003126750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003126763	Spontaneous	2019-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site inflammation (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - );Injection site swelling (n/a - Not Recovered/Not Resolved - );Nasopharyngitis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003126763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003126773	Spontaneous	2019-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Extensive swelling of vaccinated limb (n/a - Recovering/Resolving - );Injection site erythema (n/a - Recovering/Resolving - );Injection site pain (n/a - Recovering/Resolving - );Injection site pruritus (n/a - Recovering/Resolving - );Injection site swelling (n/a - Recovering/Resolving - );Injection site warmth (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	AVAMYS [FLUTICASONE FUROATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE DIHYDRATE PH.EUR., BECLOMETHASONE DIPROPIONATE PH. EUR., FORMOTEROL FUMARATE DIHYDRATE, BECLOMETASONE DIPROPIONATE ANHYDROUS] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003126773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003126784	Spontaneous	2019-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site erythema (4d - Recovered/Resolved - );Injection site inflammation (4d - Recovered/Resolved - );Injection site pain (4d - Recovered/Resolved - );Injection site swelling (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003126784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003127209	Spontaneous	2019-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dizziness (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003127209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003128624	Spontaneous	2019-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site bruising (n/a - Recovering/Resolving - );Injection site discomfort (n/a - Recovering/Resolving - );Injection site erythema (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - );Injection site pain (n/a - Recovering/Resolving - );Injection site pruritus (n/a - Recovering/Resolving - );Injection site swelling (n/a - Recovering/Resolving - );Injection site warmth (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003128624&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003129235	Spontaneous	2019-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Injection site erythema (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Not Recovered/Not Resolved - );Injection site pruritus (n/a - Not Recovered/Not Resolved - );Injection site swelling (n/a - Not Recovered/Not Resolved - );Injection site warmth (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003129235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003129611	Spontaneous	2019-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - );Body temperature increased (n/a - Recovering/Resolving - );Cough (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Pneumonia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003129611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10003129613	Spontaneous	2019-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dizziness (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003129613&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003116000	Spontaneous	2019-02-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain (3d - Recovered/Resolved - );Chills (3d - Recovered/Resolved - );Myalgia (3d - Recovered/Resolved - );Vomiting (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003116000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003116773	Spontaneous	2019-02-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (3d - Recovered/Resolved - );Diarrhoea (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003116773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003116805	Spontaneous	2019-02-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (3d - Recovered/Resolved - );Back pain (3d - Recovered/Resolved - );Chills (3d - Recovered/Resolved - );Myalgia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003116805&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003120515	Spontaneous	2019-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Vaccination site reaction (6d - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003120515&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10003101670	Spontaneous	2019-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Foetus	Yes	Female	Abdominal pain (n/a - Recovered/Resolved - );Exposure via breast milk (n/a - Unknown - );Foetal exposure during pregnancy (n/a - Unknown - );Jaundice neonatal (n/a - Recovered/Resolved - );Lip disorder (n/a - Recovered/Resolved - );Low birth weight baby (n/a - Unknown - );Microcephaly (n/a - Unknown - Other Medically Important Condition);Motor developmental delay (n/a - Recovered/Resolved - );Umbilical cord short (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003101670&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003094703	Spontaneous	2019-02-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (39d - Recovered/Resolved - );Arthritis (39d - Recovered/Resolved - );Erythema nodosum (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003094703&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Duration
EU-EC-10003085659	Spontaneous	2019-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Flushing (7d - Recovered/Resolved - );Haematoma (7d - Recovered/Resolved - );Injection site warmth (7d - Recovered/Resolved - );Pain (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003085659&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10003084255	Spontaneous	2019-02-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Body temperature decreased (n/a - Recovered/Resolved - );Cold sweat (n/a - Recovered/Resolved - );Dizziness (n/a - Recovered/Resolved - );Herpes zoster (n/a - Recovering/Resolving - );Influenza (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003084255&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10003051089	Spontaneous	2019-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (14d - Recovered/Resolved - );Influenza like illness (14d - Recovered/Resolved - );Pain (14d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - );Rhinorrhoea (14d - Recovered/Resolved - );Vaccination site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[ENALAPRIL MALEATE] (C - Hypertension - n/a - [n/a - 20mg - Oral])|[TAMOXIFEN, TAMOXIFEN CITRATE] (C - Breast cancer - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003051089&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003044406	Spontaneous	2019-02-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Meningitis (25d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [1d - n/a - n/a])...	JANUVIA [SITAGLIPTIN, SITAGLIPTIN PHOSPHATE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003044406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003031481	Spontaneous	2019-02-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Injection site pain (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003031481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003020374	Spontaneous	2019-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (1wk - Unknown - );Injection site erythema (1d - Unknown - );Injection site pain (1d - Unknown - );Injection site swelling (1d - Unknown - );Irritability (1wk - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[VALSARTAN] (C - n/a - n/a - [n/a - 80mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003020374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003021480	Spontaneous	2019-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (4d - Recovered/Resolved - Other Medically Important Condition);Fatigue (4d - Recovered/Resolved - Other Medically Important Condition);Influenza (4d - Recovered/Resolved - Other Medically Important Condition);Myalgia (4d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (4d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003021480&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003025696	Spontaneous	2019-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Joint swelling (n/a - Unknown - )	MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (S - n/a - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003025696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003017309	Spontaneous	2019-02-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Liver injury (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Viral infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	ESOMEPRAZOLE [ESOMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DOXAZOSIN MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[EBASTINE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERENOA REPENS, SERENOA REPENS (BARTRAM) SMALL.] (C - n/a - n/a - [n/a - n/a - n/a])|[TRIAMCINOLONE ACETONIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003017309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003008348	Spontaneous	2019-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Drug reaction with eosinophilia and systemic symptoms (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|[CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE] (S - Urinary tract infection - n/a - [n/a - n/a - Oral])	DESLORATADINE [DESLORATADINE] (C - Asthma - n/a - [n/a - n/a - Oral])|[OMEPRAZOLE] (C - Product used for unknown indication - n/a - [n/a - 20mg - Oral])|[PARACETAMOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003008348&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002991262	Spontaneous	2019-02-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Arthralgia (5wk - Recovered/Resolved - );Fatigue (5wk - Recovered/Resolved - );Neck pain (5wk - Recovered/Resolved - );Pyrexia (5wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, HYDRATE] (C - Hypothyroidism - Dose not changed - [n/a - 50ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002991262&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002980437	Spontaneous	2019-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Recovering/Resolving - );Hypoaesthesia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002980437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002980667	Spontaneous	2019-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002980667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002987822	Spontaneous	2019-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	No adverse event (n/a - Recovered/Resolved - );Product administration error (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002987822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002987841	Spontaneous	2019-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute vestibular syndrome (n/a - Recovered/Resolved - Other Medically Important Condition);Deafness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002987841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002964404	Spontaneous	2019-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Herpes zoster (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002964404&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002954527	Spontaneous	2019-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Urticaria (n/a - Not Recovered/Not Resolved - );Vaccination site erythema (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	[LEVOTHYROXINE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002954527&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002954584	Spontaneous	2019-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002954584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002954699	Spontaneous	2019-02-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Male	Back pain (n/a - Recovering/Resolving - Other Medically Important Condition);Bronchitis (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza (n/a - Recovering/Resolving - Other Medically Important Condition);Lacrimation increased (n/a - Recovering/Resolving - Other Medically Important Condition);Lethargy (n/a - Recovering/Resolving - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002954699&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002954701	Spontaneous	2019-02-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Back pain (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza (n/a - Recovering/Resolving - Other Medically Important Condition);Lacrimation increased (n/a - Recovering/Resolving - Other Medically Important Condition);Lethargy (n/a - Recovering/Resolving - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002954701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002954703	Spontaneous	2019-02-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Back pain (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza (n/a - Recovering/Resolving - Other Medically Important Condition);Lacrimation increased (n/a - Recovering/Resolving - Other Medically Important Condition);Lethargy (n/a - Recovering/Resolving - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002954703&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002954840	Spontaneous	2019-02-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Back pain (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza (n/a - Recovering/Resolving - Other Medically Important Condition);Lacrimation increased (n/a - Recovering/Resolving - Other Medically Important Condition);Lethargy (n/a - Recovering/Resolving - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002954840&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002954853	Spontaneous	2019-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Haemolysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [0d - n/a - Intramuscular])	LEVETIRACETAM [LEVETIRACETAM] (C - Dementia Alzheimer's type - Dose not changed - [n/a - n/a - n/a])|PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[FERROUS SULFATE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[LACTULOSE] (C - n/a - Dose not changed - [n/a - n/a - n/a])|[LORAZEPAM] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[MEMANTINE] (C - Dementia Alzheimer's type - Dose not changed - [n/a - n/a - Oral])|[MICRONISED PURIFIED FLAVONOIC FRACTION, CONSISTING OF 90% DIOSMIN AND 10% FLAVONOIDS EXPRESSED AS HESPERIDIN] (C - Dementia Alzheimer's type - Dose not changed - [n/a - n/a - Oral])|[QUETIAPINE, QUETIAPINE FUMARATE] (C - Dementia Alzheimer's type - Dose not changed - [n/a - n/a - Oral])|[TRAZODONE, TRAZODONE HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002954853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002955138	Spontaneous	2019-02-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Meningitis (25d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	JANUVIA [SITAGLIPTIN, SITAGLIPTIN PHOSPHATE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE, PIOGLITAZONE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002955138&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002959129	Spontaneous	2019-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Meningoradiculitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002959129&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002948043	Spontaneous	2019-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Vaccination failure (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002948043&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002937575	Spontaneous	2019-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Fatigue (7d - Recovered/Resolved - );Injection site erythema (10d - Recovered/Resolved - );Injection site pain (10d - Recovered/Resolved - );Injection site swelling (10d - Recovered/Resolved - );Irritability (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 10mg - n/a])|[CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - 35[drp] - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002937575&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002931102	Spontaneous	2019-01-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Body temperature increased (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002931102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002931117	Spontaneous	2019-01-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Contusion (n/a - Unknown - Caused/Prolonged Hospitalisation);Nasal congestion (n/a - Unknown - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Platelet count decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Purpura (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002931117&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002926278	Spontaneous	2019-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pruritus (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[CICLOPIROX OLAMINE] (C - n/a - Dose not changed - )|[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Dose not changed - [n/a - 100ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002926278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002914625	Spontaneous	2019-01-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Extensive swelling of vaccinated limb (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injected limb mobility decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002914625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002914665	Spontaneous	2019-01-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Circulatory collapse (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002914665&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002914886	Spontaneous	2019-01-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthritis (n/a - Recovering/Resolving - Other Medically Important Condition);Eczema (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Rash erythematous (n/a - Recovering/Resolving - Other Medically Important Condition);Serum sickness (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002914886&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002915528	Spontaneous	2019-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Erythema (n/a - Not Recovered/Not Resolved - );Rash pruritic (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002915528&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002919526	Spontaneous	2019-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Rash maculo-papular (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - .5{DF} - Subcutaneous])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, HYDRATE] (S - Blood thyroid stimulating hormone abnormal - Drug withdrawn - [n/a - n/a - Oral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002919526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002912074	Spontaneous	2019-01-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypophagia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza A virus test positive (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory tract congestion (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Underdose (n/a - Unknown - );Vaccination failure (3d - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002912074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002904006	Spontaneous	2019-01-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cough (n/a - Unknown - );Nasopharyngitis (n/a - Recovering/Resolving - );Respiratory disorder (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[FLECAINIDE ACETATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002904006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002905374	Spontaneous	2019-01-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Concomitant disease aggravated (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gout (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nail discolouration (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002905374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002905455	Spontaneous	2019-01-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Pallor (0d - Recovered/Resolved - );Syncope (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002905455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002905525	Spontaneous	2019-01-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Febrile convulsion (23h - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (23h - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002905525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002895940	Spontaneous	2019-01-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Disorientation (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Erythema (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Gingival bleeding (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Gingival swelling (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Rash erythematous (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Scleral oedema (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Swelling face (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vaccination site inflammation (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002895940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10002896004	Spontaneous	2019-01-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Facial paralysis (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - );Musculoskeletal stiffness (n/a - Unknown - );Oropharyngeal pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002896004&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002897344	Spontaneous	2019-01-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute pulmonary oedema (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Acute respiratory distress syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Cardio-respiratory arrest (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Haemoptysis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Multiple organ dysfunction syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - Unknown])|[METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE HEMISUCCINATE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002897344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10002887619	Spontaneous	2019-01-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Fear (n/a - Unknown - );Loss of consciousness (5min - Recovered/Resolved - Other Medically Important Condition);Psychopathic personality (5min - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002887619&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002876464	Spontaneous	2019-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Erythema (4d - Recovered/Resolved - );Oedema (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002876464&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002876535	Spontaneous	2019-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Not Specified	Back pain (n/a - Recovering/Resolving - );Decreased appetite (n/a - Recovering/Resolving - );Diarrhoea (n/a - Recovering/Resolving - );Gastrooesophageal reflux disease (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	GANFORT [TIMOLOL MALEATE, BIMATOPROST] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, LISINOPRIL, LISINOPRIL DIHYDRATE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEGA-3-ACID ETHYL ESTERS 90 WITH A SPECIFIC COMPOSITION FOR EPA AND DHA NOT LOWER THAN 85%.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002876535&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002876623	Spontaneous	2019-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Flushing (2d - Recovered/Resolved - );Oedema (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002876623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002876961	Spontaneous	2019-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Erythema (34d - Recovered/Resolved - );Oedema (34d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002876961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Duration
EU-EC-10002876977	Spontaneous	2019-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Erythema (4d - Recovered/Resolved - );Oedema (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Dose not changed - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002876977&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002877000	Spontaneous	2019-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Erythema (4d - Recovered/Resolved - );Oedema (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Dose not changed - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002877000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002877174	Spontaneous	2019-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Dose not changed - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002877174&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002880298	Spontaneous	2019-01-22 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	H1N1 influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Obstructive airways disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002880298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002871169	Spontaneous	2019-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Deafness (n/a - Unknown - Other Medically Important Condition);Immune system disorder (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002871169&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002872246	Spontaneous	2019-01-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Bronchospasm (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002872246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002872385	Spontaneous	2019-01-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002872385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002872494	Spontaneous	2019-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Rash (n/a - Unknown - );Rash pruritic (n/a - Unknown - );Scab (n/a - Unknown - );Skin wound (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002872494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002876215	Spontaneous	2019-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Erythema (n/a - Not Recovered/Not Resolved - );Injection site induration (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002876215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002860698	Spontaneous	2019-01-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraplegia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002860698&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002860800	Spontaneous	2019-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - );Pain in extremity (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002860800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002866500	Spontaneous	2019-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Administration site induration (2mo - Recovered/Resolved - );Administration site pain (2mo - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002866500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002851920	Spontaneous	2019-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Decreased appetite (2d - Recovered/Resolved - );Headache (4d - Recovered/Resolved - );Myalgia (1d - Recovered/Resolved - );Nausea (2d - Recovered/Resolved - );Presyncope (1d - Recovered/Resolved - );Pyrexia (4d - Recovered/Resolved - );Vaccination site reaction (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [1d - n/a - Intramuscular])...	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - Product used for unknown indication - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002851920&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002853924	Spontaneous	2019-01-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (9d - Recovered/Resolved - );Injection site pruritus (9d - Recovered/Resolved - );Injection site swelling (9d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Dose not changed - [n/a - n/a - Intramuscular])	HUMALOG [INSULIN LISPRO] (C - n/a - n/a - )|[COLECALCIFEROL] (C - n/a - n/a - [n/a - 2000[iU] - Oral])|[FERRITIN] (C - n/a - n/a - [n/a - 100mg - n/a])|[METHYLPHENIDATE HYDROCHLORIDE] (C - Attention deficit hyperactivity disorder - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002853924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002842210	Spontaneous	2019-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Anaemia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002842210&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002844054	Spontaneous	2019-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (14d - Recovered/Resolved - );Pruritus (14d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002844054&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002838101	Spontaneous	2019-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Injection site erythema (n/a - Not Recovered/Not Resolved - );Injection site swelling (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Nausea (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN] (S - Tick-borne encephalitis immunisation - Not applicable - [n/a - n/a - Intramuscular])...	DUKORAL [VIBRIO CHOLERAE O1 INABA, CLASSICAL BIOTYPE (HEAT INACTIVATED), VIBRIO CHOLERAE O1 INABA, EL TOR BIOTYPE (FORMALIN INACTIVATED), VIBRIO CHOLERAE O1 OGAWA, CLASSICAL BIOTYPE (HEAT INACTIVATED), VIBRIO CHOLERAE O1OGAWA, CLASSICAL BIOTYPE (FORMALIN INACTIVATED), CHOLERA TOXIN B SUBUNIT RECOMBINANT (RCTB), VIBRIO CHOLERAE O1 INABA, CLASSICAL BIOTYPE (HEAT INACTIVATED), VIBRIO CHOLERAE O1 INABA, EL TOR BIOTYPE (FORMALIN INACTIVATED), VIBRIO CHOLERAE O1 OGAWA, CLASSICAL BIOTYPE (HEAT INACTIVATED), VIBRIO CHOLERAE O1OGAWA, CLASSICAL BIOTYPE (FORMALIN INACTIVATED), CHOLERA TOXIN B SUBUNIT RECOMBINANT(RCTB) (PRODUCED IN V. CHOLERAE O1 INABA, CLASSICAL BIOTYPE STRAIN 213)] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002838101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002833916	Spontaneous	2019-01-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Enuresis (n/a - Recovering/Resolving - );Erythema (1wk - Recovered/Resolved - );Muscle spasms (n/a - Unknown - );Vasculitis (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002833916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002833950	Spontaneous	2019-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (11d - Recovered/Resolved - );Headache (10d - Recovered/Resolved - );Myalgia (11d - Recovered/Resolved - );Nausea (10d - Recovered/Resolved - );Pyrexia (10d - Recovered/Resolved - );Urticaria (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002833950&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002833970	Spontaneous	2019-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pruritus (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002833970&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002826535	Spontaneous	2019-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hyperpyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Unknown - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002826535&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002819360	Spontaneous	2019-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - );Lichen planus (n/a - Recovering/Resolving - );Tongue disorder (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002819360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002824552	Spontaneous	2019-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002824552&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002824553	Spontaneous	2019-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - );Paraesthesia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002824553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002809212	Spontaneous	2019-01-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Nasopharyngitis (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ATORVASTATIN] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[VITAMINS NOS] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002809212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002809235	Spontaneous	2019-01-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Cough (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Nasopharyngitis (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002809235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002813057	Spontaneous	2019-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - );Feeling hot (n/a - Not Recovered/Not Resolved - );Pruritus (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - );Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	[AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE] (C - Rhinorrhoea - n/a - [n/a - 1{DF} - Nasal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002813057&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002813071	Spontaneous	2019-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Conjunctival irritation (n/a - Not Recovered/Not Resolved - );Eye irritation (n/a - Not Recovered/Not Resolved - );Ocular hyperaemia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002813071&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002802149	Spontaneous	2019-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Cutaneous vasculitis (14d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002802149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002802384	Spontaneous	2019-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002802384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002802386	Spontaneous	2019-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002802386&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002795815	Spontaneous	2019-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Ear swelling (1d - Recovered/Resolved - );Urticaria (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002795815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002787934	Spontaneous	2019-01-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nephrotic syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Proteinuria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])...	CELLCEPT [MYCOPHENOLATE MOFETIL] (C - Nephrotic syndrome - n/a - [n/a - 240mg - Oral])|[AMOXICILLIN, AMOXICILLIN SODIUM, AMOXICILLIN TRIHYDRATE] (C - Rhinitis - n/a - [n/a - n/a - Oral])|[CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - Oral])|[ENZYMES NOS] (C - Nephrotic syndrome - n/a - [n/a - n/a - Oral])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (C - n/a - n/a - [n/a - 10mg - Oral])|[POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ETHYLCELLULOSE MICROENCAPSULATED 80-90%] (C - n/a - n/a - [n/a - n/a - Oral])|[PREDNISONE] (C - Nephrotic syndrome - n/a - [n/a - 10mg - Oral])|[PREDNISONE] (C - Nephrotic syndrome - n/a - [n/a - 5mg - Oral])|[PREDNISONE] (C - Nephrotic syndrome - n/a - [n/a - 7.5mg - Oral])|[TACROLIMUS, TACROLIMUS MONOHYDRATE] (C - Nephrotic syndrome - n/a - [n/a - 1.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002787934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002784841	Spontaneous	2019-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dermatochalasis (n/a - Not Recovered/Not Resolved - Disabling);Diplopia (n/a - Not Recovered/Not Resolved - Disabling);Myasthenia gravis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002784841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10002769122	Spontaneous	2019-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vaccination site inflammation (1mo - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002769122&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002769400	Spontaneous	2019-01-02 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Allergy to vaccine (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Obstructive airways disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002769400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002769659	Spontaneous	2019-01-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002769659&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002766757	Spontaneous	2019-01-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthma (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Asthmatic crisis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Chronic obstructive pulmonary disease (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Lung disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Vaccination site reaction (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	IRBESARTAN HYDROCHLOROTHIAZIDE ZENTIVA [HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - Blood pressure measurement - Unknown - [n/a - n/a - Oral])|IRBESARTAN [IRBESARTAN] (C - Blood pressure measurement - Unknown - [n/a - n/a - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a])|[FLUVASTATIN SODIUM] (C - Product used for unknown indication - Unknown - [n/a - n/a - Oral])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002766757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002760181	Spontaneous	2018-12-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Foetal death (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Freezing phenomenon (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Urinary incontinence (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - n/a - Intramuscular])	[ASCORBIC ACID, SUCCINIC ACID, IRON, FERROUS (II) GLYCINE SULFATE COMPLEX, FERROUS ION, FERROUS (II) GLYCINE SULFATE COMPLEX, POLYSACCHARIDE IRON COMPLEX] (C - n/a - n/a - [17d - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002760181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002761176	Spontaneous	2018-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002761176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002758964	Spontaneous	2018-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Oedema (12d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002758964&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002758996	Spontaneous	2018-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Injection site erythema (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002758996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002759068	Spontaneous	2018-12-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Recovering/Resolving - );Injection site induration (n/a - Recovering/Resolving - );Injection site pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002759068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002756241	Spontaneous	2018-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Vaccination site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002756241&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002744517	Spontaneous	2018-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Arthralgia (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002744517&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002746082	Spontaneous	2018-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Breast feeding (n/a - Unknown - );Dizziness (n/a - Unknown - );Dyspnoea (n/a - Recovering/Resolving - );Fatigue (n/a - Unknown - );Headache (n/a - Unknown - );Hypoaesthesia (n/a - Unknown - );Injection site pain (n/a - Recovered/Resolved - );Injection site warmth (n/a - Recovered/Resolved - );Limb discomfort (n/a - Unknown - );Nausea (n/a - Unknown - );Oropharyngeal pain (n/a - Recovered/Resolved - );Pain in extremity (15min - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002746082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002731607	Spontaneous	2018-12-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Tremor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002731607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002728878	Spontaneous	2018-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pain (n/a - Not Recovered/Not Resolved - );Swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002728878&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002722058	Spontaneous	2018-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Deafness (n/a - Not Recovered/Not Resolved - Disabling);Hypoacusis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	ELIQUIS [APIXABAN] (C - Product used for unknown indication - Not applicable - [n/a - n/a - Unknown])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - Unknown])|[METOPROLOL, METOPROLOL TARTRATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - Unknown])|[OMEPRAZOLE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - Unknown])|[RAMIPRIL] (C - Product used for unknown indication - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002722058&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10002713513	Spontaneous	2018-12-20 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cerebral infarction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Viral myocarditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002713513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002714310	Spontaneous	2018-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Thrombocytopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002714310&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002700856	Spontaneous	2018-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Glossitis (1d - Recovered/Resolved - );Hypersensitivity (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002700856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002701010	Spontaneous	2018-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dermatitis (0d - Recovered/Resolved - );Pruritus (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - 50ug - n/a])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002701010&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002703523	Spontaneous	2018-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Maternal exposure during breast feeding (n/a - Unknown - );Pain in extremity (2d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[LEVOTHYROXINE] (C - Hypothyroidism - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002703523&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002707376	Spontaneous	2018-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Injection site erythema (10d - Recovered/Resolved - );Injection site paraesthesia (10d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Dose not changed - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002707376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002707377	Spontaneous	2018-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Injection site erythema (10d - Recovered/Resolved - );Injection site paraesthesia (10d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Dose not changed - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002707377&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002692943	Spontaneous	2018-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002692943&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002694343	Spontaneous	2018-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Vaccination site pruritus (n/a - Unknown - );Vaccination site rash (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])	BETMIGA [MIRABEGRON] (C - Incontinence - n/a - [n/a - 50mg - Oral])|BRINZOLAMIDE [BRINZOLAMIDE] (C - Glaucoma - n/a - [n/a - 1{DF} - Other])|[AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE] (C - Rhinitis allergic - n/a - [n/a - 1{DF} - Nasal])|[ESTRADIOL, ESTRADIOL HEMIHYDRATE] (C - Hormone therapy - n/a - [n/a - 10ug - Vaginal])|[LATANOPROST] (C - Glaucoma - n/a - [n/a - 1{DF} - Other])|[LOSARTAN POTASSIUM] (C - Cardiac disorder - n/a - [n/a - 12.5mg - Oral])|[METOPROLOL TARTRATE] (C - Arrhythmia - n/a - [n/a - 25mg - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 20mg - Oral])|[TIMOLOL, TIMOLOL MALEATE] (C - Glaucoma - n/a - [n/a - 1{DF} - Subconjunctival])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - Anticoagulant therapy - n/a - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002694343&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002694520	Spontaneous	2018-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovering/Resolving - );Eye pain (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002694520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002696963	Spontaneous	2018-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002696963&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002687021	Spontaneous	2018-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - );Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Sneezing (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002687021&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002681915	Spontaneous	2018-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Pain (2d - Recovered/Resolved - );Peripheral swelling (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002681915&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002674097	Spontaneous	2018-12-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Face oedema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypertension (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nephrotic syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oedema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Proteinuria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Subcutaneous - More in ICSR])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002674097&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002674595	Spontaneous	2018-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Papilloedema (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002674595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002675337	Spontaneous	2018-12-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Myositis (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002675337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002671939	Spontaneous	2018-12-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site cellulitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Localised oedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002671939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002672700	Spontaneous	2018-12-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Unknown - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (15d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002672700&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002672710	Spontaneous	2018-12-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Dysphemia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Facial paralysis (n/a - Recovering/Resolving - Other Medically Important Condition);Speech sound disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Viral infection (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002672710&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002673662	Spontaneous	2018-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pharyngeal paraesthesia (1d - Recovered/Resolved - );Throat tightness (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002673662&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002657077	Spontaneous	2018-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Agranulocytosis (18d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002657077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10002662280	Spontaneous	2018-12-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002662280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002646925	Spontaneous	2018-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Underdose (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002646925&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002646955	Spontaneous	2018-12-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Blood urine present (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Illness (n/a - Recovered/Resolved - );Influenza like illness (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Urinary tract infection (n/a - Recovered/Resolved - );Vaccination site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[MECILLINAM, PIVMECILLINAM, PIVMECILLINAM HYDROCHLORIDE] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002646955&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002655613	Spontaneous	2018-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Purpura (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002655613&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002638756	Spontaneous	2018-12-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Injected limb mobility decreased (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002638756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002643644	Spontaneous	2018-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002643644&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002644825	Spontaneous	2018-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Application site pruritus (8d - Recovered/Resolved - );Erythema (8d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002644825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002627985	Spontaneous	2018-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - );Pruritus (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - n/a - n/a - [1d - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002627985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002628704	Spontaneous	2018-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vitreous detachment (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002628704&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002630193	Spontaneous	2018-12-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002630193&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002636744	Spontaneous	2018-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Dizziness (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [0d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002636744&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002620334	Spontaneous	2018-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Nervous system disorder (4wk - Recovered/Resolved - );Paraesthesia (4wk - Recovered/Resolved - );Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002620334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002623646	Spontaneous	2018-12-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ear pain (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Neck pain (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002623646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002599846	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Acute respiratory failure (n/a - Unknown - );Bone loss (12mo - Fatal - Results in Death);Breast pain (12mo - Fatal - Results in Death);Bronchitis (12mo - Fatal - Results in Death);Chest pain (n/a - Fatal - Results in Death);Colitis (n/a - Unknown - );Concussion (n/a - Fatal - Results in Death);Confusional state (12mo - Fatal - Results in Death);Diarrhoea (12mo - Fatal - Results in Death);Dysphagia (12mo - Fatal - Results in Death);Dyspnoea (12mo - Fatal - Results in Death);Ear pain (12mo - Fatal - Results in Death);Face injury (n/a - Fatal - Results in Death);Fall (12mo - Fatal - Results in Death);Fungal infection (12mo - Fatal - Results in Death);Gastrointestinal inflammation (n/a - Unknown - );Haemarthrosis (n/a - Fatal - Results in Death);Incorrect route of product administration (n/a - Unknown - );Joint swelling (n/a - Fatal - Results in Death);Mucous stools (12mo - Fatal - Results in Death);Nausea (n/a - Unknown - );Non-cardiac chest pain (12mo - Fatal - Results in Death);Oesophageal discomfort (12mo - Fatal - Results in Death);Oesophagitis (12mo - Fatal - Results in Death);Osteonecrosis of jaw (12mo - Fatal - Results in Death);Pneumonia bacterial (n/a - Fatal - Results in Death);Renal cyst (12mo - Fatal - Results in Death);Respiratory distress (12mo - Fatal - Results in Death);Urinary hesitation (n/a - Unknown - );Vomiting (n/a - Fatal - Results in Death);Wound (n/a - Fatal - Results in Death)	FOSAVANCE [ALENDRONIC ACID, COLECALCIFEROL, COLECALCIFEROL, ALENDRONATE SODIUM TRIHYDRATE] (S - n/a - Unknown - [n/a - n/a - Oral])|IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (S - n/a - Unknown - [n/a - n/a - Oral])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Oral])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - 1{DF} - Oral])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])|[ALENDRONATE SODIUM, ALENDRONATE SODIUM TRIHYDRATE, ALENDRONIC ACID] (S - n/a - Unknown - [n/a - n/a - Oral])|[ANHYDROUS DISODIUM CLODRONATE, CLODRONATE DISODIUM] (S - Osteoporosis - Unknown - [5y - n/a - Oral])|[TETANUS TOXOID, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED, ALGELDRATE, TETANUS TOXOID, ALUMINIUM HYDROXIDE] (S - Immunisation - n/a - [n/a - 1{DF} - Oral])|[TETANUS TOXOID] (S - Immunisation - n/a - [n/a - 1{DF} - Oral])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - n/a - Unknown - [n/a - n/a - Oral])|[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL] (C - n/a - Unknown - [n/a - n/a - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - n/a - Oral])|[LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002599846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10002602559	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002602559&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002602631	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002602631&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002590170	Spontaneous	2018-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain in extremity (12d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002590170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002591374	Spontaneous	2018-12-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Back pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002591374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002591726	Spontaneous	2018-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Arthralgia (2d - Recovered/Resolved - );Chills (2d - Recovered/Resolved - );Fatigue (1d - Recovered/Resolved - );Feeling of body temperature change (2d - Recovered/Resolved - );Headache (n/a - Unknown - );Myalgia (2d - Recovered/Resolved - );Pain (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002591726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002595772	Spontaneous	2018-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (7d - Recovered/Resolved - );Dysphonia (4d - Recovered/Resolved - );Myalgia (7d - Recovered/Resolved - );Oropharyngeal pain (4d - Recovered/Resolved - );Vaccination site pain (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ENALAPRIL MALEATE] (C - Hypertension - Unknown - [n/a - 5mg - Oral])|[SIMVASTATIN] (C - Blood cholesterol increased - Unknown - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002595772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002595785	Spontaneous	2018-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Synovial cyst (n/a - Unknown - );Vaccination site inflammation (n/a - Unknown - );Vaccination site mass (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002595785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002595802	Spontaneous	2018-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (3d - Recovered/Resolved - );Headache (0d - Recovered/Resolved - );Vaccination site inflammation (3d - Recovered/Resolved - );Vaccination site pruritus (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002595802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002586473	Spontaneous	2018-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Hypertension (n/a - Recovering/Resolving - );Injection site pain (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [0d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002586473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002574980	Spontaneous	2018-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 0mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002574980&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002575396	Spontaneous	2018-11-29 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blood pressure measurement (n/a - Unknown - Other Medically Important Condition);Chills (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002575396&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002575468	Spontaneous	2018-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (n/a - Unknown - );Lymph node pain (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1mg - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002575468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002575590	Spontaneous	2018-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Nasopharyngitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002575590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002575743	Spontaneous	2018-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia oral (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002575743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002564537	Spontaneous	2018-11-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002564537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002565032	Spontaneous	2018-11-28 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Tinnitus (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Unknown])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - Unknown])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002565032&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10002554166	Spontaneous	2018-11-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Dose not changed - [1d - 0mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002554166&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002560055	Spontaneous	2018-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Bell's palsy (n/a - Unknown - Other Medically Important Condition);Eyelid function disorder (n/a - Unknown - );Facial paresis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002560055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002544994	Spontaneous	2018-11-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza like illness (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])	FLUTICASONE PROPIONATE, SALMETEROL [FLUTICASONE PROPIONATE, SALMETEROL] (C - Chronic obstructive pulmonary disease - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[METFORMIN HYDROCHLORIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002544994&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002550501	Spontaneous	2018-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Vaccination site erythema (n/a - Recovered/Resolved - );Vaccination site induration (n/a - Recovered/Resolved - );Vaccination site oedema (n/a - Recovered/Resolved - );Vaccination site pain (n/a - Recovered/Resolved - );Vaccination site warmth (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002550501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002537529	Spontaneous	2018-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Respiratory tract infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza - n/a - [n/a - 1{DF} - Intramuscular])	BRIMICA GENUAIR [FORMOTEROL FUMARATE DIHYDRATE, ACLIDINIUM BROMIDE] (C - Bronchitis chronic - n/a - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002537529&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002538716	Spontaneous	2018-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Lymphadenopathy (n/a - Not Recovered/Not Resolved - );Vaccination site lymphadenopathy (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002538716&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002540469	Spontaneous	2018-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002540469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002540716	Spontaneous	2018-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Injection site erythema (5d - Recovered/Resolved - );Injection site induration (5d - Recovered/Resolved - );Injection site oedema (5d - Recovered/Resolved - );Injection site pain (5d - Recovered/Resolved - );Injection site warmth (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002540716&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002542807	Spontaneous	2018-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Hypotonia (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002542807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002528170	Spontaneous	2018-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Rash maculo-papular (n/a - Recovering/Resolving - );Rash pruritic (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002528170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002528720	Spontaneous	2018-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site necrosis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002528720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002528845	Spontaneous	2018-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyporeflexia (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002528845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002528868	Spontaneous	2018-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site necrosis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002528868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002528901	Spontaneous	2018-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Alopecia (n/a - Unknown - Other Medically Important Condition);Autoimmune disorder (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002528901&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002529359	Spontaneous	2018-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Pityriasis rosea (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002529359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002533202	Spontaneous	2018-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site pain (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002533202&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002519760	Spontaneous	2018-11-21 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Chest pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002519760&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002525018	Spontaneous	2018-11-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Hypersensitivity (n/a - Not Recovered/Not Resolved - );Pruritus (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002525018&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002510202	Spontaneous	2018-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain (5d - Recovered/Resolved - );Diarrhoea (n/a - Recovered/Resolved - );Headache (5d - Recovered/Resolved - );Pyrexia (5d - Recovered/Resolved - );Vaccination site reaction (5d - Recovered/Resolved - )	CERVARIX [3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, ALGELDRATE, ALUMINIUM, 3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002510202&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002512828	Spontaneous	2018-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Blood pressure increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dry mouth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Heart rate abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Infection susceptibility increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Palpitations (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachycardia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002512828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002514784	Spontaneous	2018-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Muscular weakness (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002514784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002517919	Spontaneous	2018-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Erythema (1d - Recovered/Resolved - );Urticaria (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002517919&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002500062	Spontaneous	2018-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Inflammation (2d - Recovered/Resolved - );Vaccination site reaction (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002500062&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002504073	Spontaneous	2018-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Chest discomfort (3d - Not Recovered/Not Resolved - );Cough (3d - Not Recovered/Not Resolved - );Disturbance in attention (3d - Not Recovered/Not Resolved - );Fatigue (3d - Not Recovered/Not Resolved - );Lymphadenopathy (3d - Not Recovered/Not Resolved - );Pain (3d - Not Recovered/Not Resolved - );Palpitations (3d - Not Recovered/Not Resolved - );Vaccination site erythema (3d - Not Recovered/Not Resolved - );Vaccination site swelling (3d - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Subcutaneous])	XARELTO [RIVAROXABAN] (C - n/a - n/a - [n/a - n/a - n/a])|[FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OLMESARTAN, OLMESARTAN MEDOXOMIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002504073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002508625	Spontaneous	2018-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Administration site joint erythema (n/a - Recovering/Resolving - );Puncture site induration (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002508625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002496790	Spontaneous	2018-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002496790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002472020	Spontaneous	2018-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - );Dyspnoea (n/a - Recovered/Resolved - );Palpitations (n/a - Recovering/Resolving - );Pharyngeal swelling (n/a - Recovering/Resolving - );Rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002472020&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002473760	Spontaneous	2018-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Acute respiratory failure (n/a - Unknown - Other Medically Important Condition);Bone loss (386d - Fatal - Results in Death);Breast pain (386d - Fatal - Results in Death);Bronchitis (387d - Fatal - Results in Death);Chest pain (n/a - Fatal - Results in Death);Colitis (n/a - Unknown - Other Medically Important Condition);Concussion (n/a - Fatal - Results in Death);Confusional state (387d - Fatal - Results in Death);Diarrhoea (387d - Fatal - Results in Death);Dysphagia (387d - Fatal - Results in Death);Dyspnoea (387d - Fatal - Results in Death);Ear pain (387d - Fatal - Results in Death);Face injury (n/a - Fatal - Results in Death);Fall (n/a - Fatal - Results in Death);Fungal infection (387d - Fatal - Results in Death);Gastrointestinal inflammation (n/a - Unknown - Other Medically Important Condition);Haemarthrosis (n/a - Fatal - Results in Death);Incorrect route of product administration (n/a - Unknown - );Joint swelling (n/a - Fatal - Results in Death);Mucous stools (387d - Fatal - Results in Death);Nausea (n/a - Unknown - Other Medically Important Condition);Non-cardiac chest pain (387d - Fatal - Results in Death);Oesophageal discomfort (386d - Fatal - Results in Death);Oesophagitis (387d - Fatal - Results in Death);Osteonecrosis of jaw (387d - Fatal - Results in Death);Pneumonia bacterial (n/a - Fatal - Results in Death);Renal cyst (387d - Fatal - Results in Death);Respiratory distress (386d - Fatal - Results in Death);Urinary hesitation (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Fatal - Results in Death);Wound (n/a - Fatal - Results in Death)	FOSAVANCE [ALENDRONIC ACID, COLECALCIFEROL, COLECALCIFEROL, ALENDRONATE SODIUM TRIHYDRATE] (S - Product used for unknown indication - Unknown - [n/a - n/a - Oral])|IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (S - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Oral])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Oral - More in ICSR])|[ALENDRONATE SODIUM, ALENDRONATE SODIUM TRIHYDRATE, ALENDRONIC ACID] (S - Product used for unknown indication - Unknown - [n/a - n/a - Oral])|[ALENDRONATE SODIUM] (S - n/a - Unknown - [n/a - n/a - Oral])|[ANHYDROUS DISODIUM CLODRONATE, CLODRONATE DISODIUM] (S - Osteoporosis - Not applicable - [2032d - 1{DF} - Oral])|[TETANUS TOXOID, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED, ALGELDRATE, TETANUS TOXOID, ALUMINIUM HYDROXIDE] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Oral])|[TETANUS TOXOID] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002473760&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10002473935	Spontaneous	2018-11-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - );Increased bronchial secretion (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002473935&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002478546	Spontaneous	2018-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chills (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002478546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002464770	Spontaneous	2018-11-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Drug hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002464770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002464774	Spontaneous	2018-11-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Recovering/Resolving - Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Other Medically Important Condition);Urticaria (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site erythema (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site pain (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site swelling (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002464774&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002464777	Spontaneous	2018-11-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cellulitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002464777&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002464816	Spontaneous	2018-11-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Chills (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovering/Resolving - );Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Increased viscosity of bronchial secretion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - );Pyrexia (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002464816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002465448	Spontaneous	2018-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Hypersensitivity (n/a - Unknown - );Peripheral swelling (n/a - Unknown - );Reaction to preservatives (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002465448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002466073	Spontaneous	2018-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Insomnia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002466073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002461128	Spontaneous	2018-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acne (n/a - Unknown - );Pruritus (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002461128&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002461416	Spontaneous	2018-11-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vaccination site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002461416&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002463106	Spontaneous	2018-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Influenza (21d - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 40mg - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - 10mg - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - 10mg - n/a])|[METHYLPREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 10mg - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 50mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002463106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10002446072	Spontaneous	2018-11-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (4d - Recovering/Resolving - );Injection site pain (4d - Recovering/Resolving - );Tenderness (4d - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Dose not changed - [1d - 0mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002446072&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002446085	Spontaneous	2018-11-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 15ug - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002446085&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002449473	Spontaneous	2018-11-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002449473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002441324	Spontaneous	2018-11-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - );Dizziness (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002441324&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002442490	Spontaneous	2018-11-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Abdominal discomfort (n/a - Unknown - );Expired product administered (n/a - Unknown - );Wrong product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002442490&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002444625	Spontaneous	2018-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Flushing (n/a - Recovering/Resolving - );Injection site oedema (n/a - Recovering/Resolving - );Injection site pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002444625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002434465	Spontaneous	2018-11-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (8d - Recovered/Resolved - );Hot flush (1d - Recovered/Resolved - );Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	CLOPIDOGREL BESILATE [CLOPIDOGREL BESILATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[ATORVASTATIN] (C - Hypercholesterolaemia - Unknown - [n/a - n/a - Unknown])|[ENALAPRIL, ENALAPRIL MALEATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002434465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002436734	Spontaneous	2018-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Transient global amnesia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002436734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002417866	Spontaneous	2018-11-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysphonia (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002417866&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002417869	Spontaneous	2018-11-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002417869&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002420412	Spontaneous	2018-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Syncope (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002420412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002410308	Spontaneous	2018-11-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Cyanosis central (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002410308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002411057	Spontaneous	2018-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Wrong product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002411057&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002411072	Spontaneous	2018-11-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Expired product administered (n/a - Unknown - );Vaccination site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002411072&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002412619	Spontaneous	2018-11-02 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation);Cold sweat (n/a - Unknown - Caused/Prolonged Hospitalisation);Splenomegaly (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002412619&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002412629	Spontaneous	2018-11-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Other Medically Important Condition);Hypoaesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002412629&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002394917	Spontaneous	2018-10-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[VALACICLOVIR, VALACICLOVIR HYDROCHLORIDE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002394917&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002397205	Spontaneous	2018-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - );Diarrhoea (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002397205&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002399412	Spontaneous	2018-10-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - );Nasopharyngitis (14d - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[BENDROFLUMETHIAZIDE] (C - Hypertension - Unknown - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[BUDESONIDE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[GLUCOSAMINE, GLUCOSAMINE SULFATE] (C - Arthritis - Unknown - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - Unknown - [n/a - n/a - n/a])|[MAGNESIUM OXIDE] (C - Gastrointestinal motility disorder - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002399412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002401351	Spontaneous	2018-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (4d - Recovered/Resolved - );Fatigue (7d - Recovered/Resolved - );Headache (1d - Recovered/Resolved - );Hyperhidrosis (2d - Recovered/Resolved - );Malaise (1d - Recovered/Resolved - );Myalgia (7d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	REMICADE 100 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION [INFLIXIMAB] (S - Ankylosing spondylitis - Not applicable - [n/a - n/a - Intravenous drip])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	ESOMEPRAZOLE [ESOMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|METHOTREXATE [METHOTREXATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL, CODEINE PHOSPHATE, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002401351&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002387148	Spontaneous	2018-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia oral (n/a - Recovered/Resolved - );Throat tightness (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002387148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002391664	Spontaneous	2018-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Deafness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002391664&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002391693	Spontaneous	2018-10-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Bronchial irritation (n/a - Not Recovered/Not Resolved - );Contusion (n/a - Recovered/Resolved - );Cough (n/a - Not Recovered/Not Resolved - );Head discomfort (n/a - Not Recovered/Not Resolved - );Nasal obstruction (n/a - Not Recovered/Not Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - );Secretion discharge (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002391693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002377556	Spontaneous	2018-10-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Hemiparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Mental status changes (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002377556&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002379388	Spontaneous	2018-10-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - );Dizziness (n/a - Recovered/Resolved - );Headache (n/a - Recovering/Resolving - );Hyperhidrosis (n/a - Recovered/Resolved - );Influenza like illness (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Rhinorrhoea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002379388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002375475	Spontaneous	2018-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Headache (n/a - Unknown - );Injection site swelling (n/a - Unknown - );Pain (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	[LETROZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002375475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002367773	Spontaneous	2018-10-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	H1N1 influenza (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002367773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10002367800	Spontaneous	2018-10-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Back pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002367800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002349626	Spontaneous	2018-10-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Not Specified	Pneumonia influenzal (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002349626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002353280	Spontaneous	2018-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Unknown - );Rash papular (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002353280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002354420	Spontaneous	2018-10-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Rash pruritic (n/a - Unknown - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002354420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002335434	Spontaneous	2018-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bell's palsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[AMOXICILLIN] (C - Bronchitis - n/a - [7d - 1g - Oral])|[DEXTROMETHORPHAN HYDROBROMIDE] (C - Cough - n/a - [n/a - n/a - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002335434&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002335645	Spontaneous	2018-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Localised oedema (n/a - Recovered/Resolved - );Swelling (n/a - Recovered/Resolved - );Temperature difference of extremities (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002335645&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002337066	Spontaneous	2018-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Paresis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza - n/a - [n/a - 1{DF} - Subcutaneous])	JANUVIA 100 MG [SITAGLIPTIN] (C - Diabetes mellitus - n/a - [n/a - 1{DF} - Oral])|[ATORVASTATIN] (C - Dyslipidaemia - n/a - [n/a - 1{DF} - Oral])|[HYDROCHLOROTHIAZIDE, RAMIPRIL] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002337066&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002332647	Spontaneous	2018-10-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Not Specified	Influenza A virus test positive (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002332647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10002316236	Spontaneous	2018-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myalgia (n/a - Recovered/Resolved - );Paraesthesia (n/a - Recovered/Resolved - );Paraesthesia oral (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002316236&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002307829	Spontaneous	2018-10-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002307829&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002310953	Spontaneous	2018-10-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myalgia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002310953&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002292325	Spontaneous	2018-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - );Nasopharyngitis (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002292325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002267060	Spontaneous	2018-10-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002267060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002270173	Spontaneous	2018-10-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Vaccination site pain (8h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002270173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002272469	Spontaneous	2018-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myopericarditis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOLMITRIPTAN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002272469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002235036	Spontaneous	2018-10-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vaccination site erythema (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002235036&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002222349	Spontaneous	2018-10-02 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	H1N1 influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002222349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002208576	Spontaneous	2018-09-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Psoriasis (191d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	HUMIRA 40 MG [ADALIMUMAB] (C - Psoriasis - Dose increased - [n/a - n/a - Subcutaneous])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002208576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Duration
EU-EC-10002188066	Spontaneous	2018-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lymphadenopathy (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002188066&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002169654	Spontaneous	2018-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Arthralgia (8wk - Recovered/Resolved - );Arthritis (8wk - Recovered/Resolved - );Feeding disorder (8wk - Recovered/Resolved - );Gait disturbance (8wk - Recovered/Resolved - );Movement disorder (8wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002169654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002171385	Spontaneous	2018-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Skin reaction (n/a - Not Recovered/Not Resolved - );Vaccination site reaction (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002171385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002160838	Spontaneous	2018-09-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Injection site erythema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002160838&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002162025	Spontaneous	2018-09-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002162025&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002147924	Spontaneous	2018-09-19 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Crying (n/a - Unknown - );Pruritus (n/a - Unknown - );Rash (n/a - Unknown - );Vomiting (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002147924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002116773	Spontaneous	2018-09-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site hypoaesthesia (n/a - Recovering/Resolving - );Sensory loss (n/a - Recovering/Resolving - );Vaccination site discomfort (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002116773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002108357	Spontaneous	2018-09-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dyspnoea (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002108357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002084573	Spontaneous	2018-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002084573&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002085257	Spontaneous	2018-09-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cough (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Rhinorrhoea (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002085257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002085286	Spontaneous	2018-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002085286&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002069921	Spontaneous	2018-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Diplopia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002069921&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002069954	Spontaneous	2018-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - );Swelling face (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	LANTUS [INSULIN GLARGINE] (C - n/a - n/a - [n/a - n/a - n/a])|NOVORAPID [INSULIN ASPART] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[DIPYRIDAMOLE, ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[DRIED FERROUS SULFATE, FERROUS SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM VALPROATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TRIMETHOPRIM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002069954&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001974532	Spontaneous	2018-08-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001974532&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001942271	Spontaneous	2018-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Adverse event (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Near death experience (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Scar (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Seizure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Swelling (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001942271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10001910297	Spontaneous	2018-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dermatitis bullous (n/a - Recovered/Resolved - );Oedema peripheral (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001910297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001906314	Spontaneous	2018-08-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Immunisation reaction (n/a - Recovered/Resolved - );Influenza like illness (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001906314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001885228	Spontaneous	2018-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001885228&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001885231	Spontaneous	2018-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Balance disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Cerebellar syndrome (n/a - Recovered/Resolved - Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved - Other Medically Important Condition);Immunisation reaction (n/a - Unknown - Other Medically Important Condition);Vertigo (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001885231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001867955	Spontaneous	2018-08-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - );Chills (n/a - Unknown - );Cough (n/a - Not Recovered/Not Resolved - );Dyspnoea (n/a - Unknown - );Hyperhidrosis (n/a - Not Recovered/Not Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - );Paraesthesia (n/a - Not Recovered/Not Resolved - );Productive cough (1mo - Recovered/Resolved - );Rhinorrhoea (n/a - Unknown - );Saliva altered (1mo - Recovered/Resolved - );Stomatitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])|[CEFPODOXIME PROXETIL] (S - n/a - n/a - [10d - n/a - Oral])|[CEFPODOXIME PROXETIL] (S - n/a - n/a - [n/a - n/a - Oral])	[ALOES DRY EXTRACT, STANDARDISED, EXTRACTUM SICCUM COMPOSITUM (4- 9 : 1) EX BAPTISIAE TINCTORIAE L. RADIX 4,92 P., ECHINACEAE PURPUREAE (L.) MOENCH RADIX 1,85 P., ECHINACEAE PALLIDAE NUTT. RADIX 1,85 P., THUJAE OCCIDENTALIS L. HERBA 1 P., ETHANOL 30 % (V/V), NATIVE DRY EXTRACT FROM RADIX BAPTISIAE TINCTORIAE, RADIX ECHINACEAE PALLIDAE, RADIX ECHINACEAE PURPUREAE, HERBA THUJAE OCCIDENTALIS] (C - n/a - n/a - [n/a - n/a - n/a])|[AMBROXOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE, BISOPROLOL FUMARATE PH. EUR., BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - )|[BROMHEXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DISTILLATE OF A MIXTURE OF RECTIFIED EUCALYPTUS OIL, RECTIFIED SWEET ORANGE OIL, RECTIFIED MYRTLE OIL AND RECTIFIED LEMON OIL IN A RATIO OF 66:32:1:1, MYRTOL] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[OLMESARTAN, OLMESARTAN MEDOXOMIL] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001867955&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10001858121	Spontaneous	2018-08-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Female	Erythema (7d - Recovered/Resolved - );Nephrotic syndrome (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001858121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001858988	Spontaneous	2018-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	HYDROXOCOBALAMIN [HYDROXOCOBALAMIN] (C - n/a - n/a - )|[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - Epilepsy - n/a - )|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001858988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10001863026	Spontaneous	2018-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001863026&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001849072	Spontaneous	2018-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001849072&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001853622	Spontaneous	2018-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Insomnia (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001853622&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001853891	Spontaneous	2018-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myalgia (n/a - Recovering/Resolving - );Neck pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001853891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001810303	Spontaneous	2018-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Fatal - Results in Death);Hypoaesthesia (n/a - Fatal - Results in Death);Lung neoplasm malignant (n/a - Fatal - Results in Death);Pain (n/a - Fatal - Results in Death);Papillitis (n/a - Fatal - Results in Death);Polyneuropathy (n/a - Fatal - Results in Death);Visual impairment (n/a - Fatal - Results in Death);Vitritis (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001810303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10001709801	Spontaneous	2018-07-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001709801&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001689940	Spontaneous	2018-07-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001689940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001690833	Spontaneous	2018-07-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Erythema (6mo - Recovered/Resolved - );Gingival bleeding (6mo - Recovered/Resolved - );Haematoma (6mo - Recovered/Resolved - );Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001690833&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001608897	Spontaneous	2018-06-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypoaesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Petechiae (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Thrombocytopenia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001608897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10001580475	Spontaneous	2018-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Feeling abnormal (n/a - Unknown - Other Medically Important Condition);Gait disturbance (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Neuropathy peripheral (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001580475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001588166	Spontaneous	2018-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site cellulitis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001588166&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001570399	Spontaneous	2018-06-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001570399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10001542265	Spontaneous	2018-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Facial asymmetry (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Loss of control of legs (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle atrophy (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Nystagmus (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Relapsing-remitting multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Urinary incontinence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[ALGELDRATE, HEPATITIS B SURFACE ANTIGENS RECOMBINANT (S, PRE-S2), HEPATITIS B SURFACE ANTIGEN (RDNA), HEPATITIS B SURFACE ANTIGENS RECOMBINANT (S, PRE-S2)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[ALUMINIUM, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN), INACTIVATED HEPATITIS A VIRUS (GBM STRAIN), HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN), ALGELDRATE, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN), ALGELDRATE, INACTIVATED HEPATITIS A VIRUS (GBM STRAIN)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[DIPHTHERIA, TETANUS AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED, REDUCED ANTIGEN(S) CONTENT)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[HEPATITIS B SURFACE ANTIGEN (RDNA), HEPATITIS B SURFACE ANTIGEN (RDNA), ALUMINIUM HYDROXIDE, HEPATITIS B SURFACE ANTIGEN, ALGELDRATE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[HEPATITIS B SURFACE ANTIGEN, HEPATITIS A VACCINE (INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[MENINGOCOCCAL GROUP A, C, W135 AND Y CONJUGATE VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[YELLOW FEVER VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001542265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001549084	Spontaneous	2018-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001549084&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001490703	Spontaneous	2018-06-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthmatic crisis (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001490703&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001494065	Spontaneous	2018-06-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Amyotrophy (n/a - Unknown - Disabling);Grip strength decreased (n/a - Not Recovered/Not Resolved - Disabling);Major depression (n/a - Unknown - Disabling);Muscle atrophy (n/a - Not Recovered/Not Resolved - Disabling);Muscle contractions involuntary (n/a - Unknown - Disabling);Muscle spasms (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Recovered/Resolved - Disabling);Post-traumatic stress disorder (n/a - Unknown - Disabling);Radiculitis brachial (n/a - Not Recovered/Not Resolved - Disabling);Resting tremor (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	[ALUMINIUM, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM HYDROXIDE [PRODUCED IN S. CEREVISIAE (STRAIN 2150-2-3) BY RDNA], HEPATITIS B SURFACE ANTIGEN (RDNA), HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM HYDROXIDE [PRODUCED IN S. CEREVISIAE (STRAIN 2150-2-3) BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN, ALGELDRATE, HEPATITIS B VIRUS SURFACE ANTIGEN [PRODUCED IN S. CEREVISIAE CELLS BY RDNA] ADSORBED ON ALUMINUM HYDROXIDE, HYDRATED, ALGELDRATE] (C - Prophylaxis - n/a - [n/a - 1{DF} - Unknown])|[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - .1mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001494065&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10001482097	Spontaneous	2018-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Asthmatic crisis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001482097&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001482098	Spontaneous	2018-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthmatic crisis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001482098&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001455241	Spontaneous	2018-06-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Seizure (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001455241&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10001425936	Spontaneous	2018-05-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Haematuria (3d - Recovered/Resolved - );Pollakiuria (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001425936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001415199	Spontaneous	2018-05-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Chills (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dehydration (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Increased bronchial secretion (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paresis (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[BROMAZEPAM] (C - Product used for unknown indication - Unknown - [n/a - n/a - Oral])|[QUETIAPINE, QUETIAPINE FUMARATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001415199&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001405728	Spontaneous	2018-05-29 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001405728&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001390705	Spontaneous	2018-05-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Not Specified	Booster dose missed (n/a - Unknown - Other Medically Important Condition);Extra dose administered (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition);Therapeutic response decreased (n/a - Unknown - Other Medically Important Condition)	HEPATITIS VACCINES [HEPATITIS VACCINES] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])|ROTARIX ORAL SUSPENSION [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [n/a - n/a - Oral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001390705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001371121	Spontaneous	2018-05-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Body temperature increased (3d - Recovered/Resolved - );Injection site erythema (n/a - Recovered/Resolved - );Injection site swelling (2wk - Recovered/Resolved - );Nausea (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001371121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001268969	Spontaneous	2018-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Recovering/Resolving - );Arthritis (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001268969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001248793	Spontaneous	2018-05-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza like illness (12d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001248793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001250151	Spontaneous	2018-05-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Therapeutic response unexpected (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	LEFLUNOMIDE [LEFLUNOMIDE] (C - Rheumatoid arthritis - n/a - [n/a - n/a - n/a])|PREGABALIN [PREGABALIN] (C - Neuropathy peripheral - n/a - [n/a - n/a - n/a])|[HYDROXYCHLOROQUINE] (C - Rheumatoid arthritis - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001250151&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001250210	Spontaneous	2018-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Product dose omission issue (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001250210&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001244095	Spontaneous	2018-05-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001244095&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001217016	Spontaneous	2018-05-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Psoriasis (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001217016&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001135492	Spontaneous	2018-04-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Abdominal discomfort (n/a - Unknown - );Abdominal pain (n/a - Unknown - );Back pain (n/a - Unknown - );Chills (n/a - Unknown - );Cold sweat (n/a - Unknown - );Cough (n/a - Unknown - );Decreased appetite (n/a - Unknown - );Eye irritation (n/a - Unknown - );Fatigue (n/a - Unknown - );Feeling hot (n/a - Unknown - );Headache (n/a - Not Recovered/Not Resolved - );Influenza (n/a - Unknown - );Musculoskeletal stiffness (n/a - Unknown - );Nasal discomfort (n/a - Unknown - );Nasopharyngitis (n/a - Unknown - );Pyrexia (n/a - Not Recovered/Not Resolved - );Sinusitis (n/a - Unknown - );Tension headache (n/a - Unknown - );Vision blurred (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001135492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001119572	Spontaneous	2018-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	DUOPLAVIN 75 MG/75 MG FILM-COATED TABLETS [ACETYLSALICYLIC ACID, CLOPIDOGREL] (C - Pacemaker syndrome - n/a - [n/a - 1{DF} - Oral])|[ATORVASTATIN] (C - Acute coronary syndrome - n/a - [n/a - 10mg - Oral])|[BISOPROLOL FUMARATE] (C - Acute coronary syndrome - n/a - [n/a - 1.25mg - Oral])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001119572&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10001125882	Spontaneous	2018-04-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Injected limb mobility decreased (n/a - Not Recovered/Not Resolved - Disabling);Nerve injury (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Tendonitis (n/a - Unknown - Disabling);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001125882&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10001128346	Spontaneous	2018-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myositis (n/a - Not Recovered/Not Resolved - Life Threatening);Rhabdomyolysis (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[OXYCODONE HYDROCHLORIDE] (S - Procedural pain - Drug withdrawn - [n/a - n/a - Oral])...	[ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE, SODIUM CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE, SODIUM CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE GEL, DRIED, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE GEL, DRIED USP, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALUMINIUM HYDROXIDE GEL, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, SODIUM ALGINATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ANETHOLE TRITHIONE] (C - n/a - n/a - [n/a - n/a - n/a])|[CARBOMER 980] (C - n/a - n/a - [n/a - n/a - n/a])|[INDAPAMIDE, PERINDOPRIL, INDAPAMIDE, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMINE, INDAPAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL, CODEINE PHOSPHATE, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001128346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10001114815	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001114815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001115113	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001115113&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001115115	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001115115&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001116278	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001116278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001116280	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001116280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001116281	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001116281&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001116282	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001116282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001116285	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001116285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001116287	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001116287&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001116288	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001116288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001116289	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001116289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001116290	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001116290&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001116291	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001116291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001116295	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001116295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001116329	Spontaneous	2018-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001116329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001107173	Spontaneous	2018-04-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Bronchopneumopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Pleurisy (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001107173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001107183	Spontaneous	2018-04-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Adult	No	Male	Contraindication to vaccination (n/a - Unknown - );Product use issue (n/a - Unknown - );Vaccination site erythema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001107183&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001092044	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - );Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001092044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001092046	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - );Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001092046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001092052	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - );Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001092052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001092054	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - );Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001092054&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001092055	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - );Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001092055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001092056	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - );Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001092056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001092546	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Extra dose administered (n/a - Unknown - );Wrong product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001092546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001093227	Spontaneous	2018-04-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001093227&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001093688	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Influenza like illness (22d - Recovered/Resolved - );Musculoskeletal stiffness (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001093688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Duration
EU-EC-10001093766	Spontaneous	2018-04-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Angina pectoris (n/a - Recovering/Resolving - Other Medically Important Condition);Arrhythmia (n/a - Recovering/Resolving - Other Medically Important Condition);Burning sensation (n/a - Recovered/Resolved - Other Medically Important Condition);Chest discomfort (n/a - Recovering/Resolving - Other Medically Important Condition);Heart rate irregular (n/a - Recovering/Resolving - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Nervousness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ACETYLSALICYLIC ACID] (C - Cardiac disorder - n/a - [n/a - 75mg - Unknown])|[AMLODIPINE, AMLODIPINE BESILATE] (C - Cardiac disorder - n/a - [n/a - 5mg - Unknown])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - Cardiac disorder - n/a - [n/a - 40mg - Unknown])|[BISOPROLOL FUMARATE] (C - Cardiac disorder - n/a - [n/a - 5mg - Unknown])|[ISOSORBIDE 5 MONONITRATE, ISOSORBIDE MONONITRATE] (C - Cardiac disorder - n/a - [n/a - 100mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001093766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001093874	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001093874&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001093879	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001093879&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001093880	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001093880&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001093882	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001093882&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001093884	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001093884&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001093908	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001093908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001093909	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001093909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001095477	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Expired product administered (n/a - Unknown - );Product dispensing error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001095477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001095527	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[BROMAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001095527&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001095539	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injected limb mobility decreased (n/a - Unknown - );Pain in extremity (n/a - Not Recovered/Not Resolved - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001095539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001085055	Spontaneous	2018-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	XARELTO [RIVAROXABAN] (C - n/a - n/a - [n/a - n/a - n/a])|[SOTALOL, SOTALOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001085055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001085190	Spontaneous	2018-04-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Urticaria (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001085190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001085328	Spontaneous	2018-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Not Specified	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001085328&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001076297	Spontaneous	2018-04-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Crying (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	[HEPATITIS A VACCINE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001076297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001076392	Spontaneous	2018-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Extra dose administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001076392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001076748	Spontaneous	2018-04-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Not Specified	Underdose (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .2mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001076748&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001076750	Spontaneous	2018-04-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Infant	No	Not Specified	Crying (n/a - Unknown - );Malaise (n/a - Unknown - );Pyrexia (n/a - Unknown - );Restlessness (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001076750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001077284	Spontaneous	2018-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dizziness (1d - Recovered/Resolved - );Hyperglycaemia (1d - Recovered/Resolved - );Neck pain (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001077284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001061954	Spontaneous	2018-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Erythema (n/a - Unknown - );Pruritus (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001061954&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001061956	Spontaneous	2018-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Vaccination site inflammation (n/a - Unknown - );Vaccination site pruritus (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001061956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001062171	Spontaneous	2018-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Underdose (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001062171&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001062198	Spontaneous	2018-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product dispensing error (n/a - Unknown - );Product prescribing error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001062198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001064254	Spontaneous	2018-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001064254&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001064255	Spontaneous	2018-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001064255&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001064949	Spontaneous	2018-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Recovering/Resolving - Other Medically Important Condition);Dry throat (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling cold (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Sneezing (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Upper respiratory tract congestion (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001064949&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001052650	Spontaneous	2018-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Product storage error (n/a - Unknown - );Vaccination site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001052650&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001052732	Spontaneous	2018-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cough (n/a - Recovering/Resolving - );Dyspnoea (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[DEXCHLORPHENIRAMINE MALEATE, BETAMETHASONE] (C - n/a - n/a - [n/a - n/a - n/a])|[GUAIFENESIN, OXOMEMAZINE, GUAIFENESIN, OXOMEMAZINE, PARACETAMOL, SODIUM BENZOATE, OXOMEMAZINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001052732&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10001052735	Spontaneous	2018-04-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[INDAPAMIDE, PERINDOPRIL, INDAPAMIDE, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMINE, INDAPAMIDE] (C - Hypertension - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001052735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001052954	Spontaneous	2018-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Inflammation (n/a - Unknown - );Pain in extremity (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001052954&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001053079	Spontaneous	2018-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001053079&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001056905	Spontaneous	2018-04-09 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Amnesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Depressed level of consciousness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hydrocephalus (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001056905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001039860	Spontaneous	2018-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Drug eruption (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001039860&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001040671	Spontaneous	2018-04-06 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001040671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10001040730	Spontaneous	2018-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Pruritus (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001040730&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001041328	Spontaneous	2018-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001041328&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001041329	Spontaneous	2018-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001041329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001041331	Spontaneous	2018-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001041331&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001041333	Spontaneous	2018-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001041333&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001041402	Spontaneous	2018-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Injection site pain (n/a - Unknown - );Product storage error (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001041402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001041891	Spontaneous	2018-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Underdose (n/a - Unknown - );Wrong technique in product usage process (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001041891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001042108	Spontaneous	2018-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001042108&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001026947	Spontaneous	2018-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Not Specified	Extra dose administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001026947&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001007838	Spontaneous	2018-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Haemolytic anaemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	ZOSTAVAX [VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (S - Varicella immunisation - n/a - [n/a - .65mL - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001007838&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001011989	Spontaneous	2018-04-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza like illness (n/a - Unknown - );Pain (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001011989&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001015496	Spontaneous	2018-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - );Palmar-plantar erythrodysaesthesia syndrome (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001015496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000993343	Spontaneous	2018-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000993343&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000993397	Spontaneous	2018-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Injury (n/a - Unknown - );Syringe issue (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000993397&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000993553	Spontaneous	2018-03-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000993553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000993558	Spontaneous	2018-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000993558&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000993560	Spontaneous	2018-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000993560&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000993561	Spontaneous	2018-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000993561&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000993562	Spontaneous	2018-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000993562&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000993564	Spontaneous	2018-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000993564&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000993567	Spontaneous	2018-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Vaccination site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000993567&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000993623	Spontaneous	2018-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Herpes zoster (n/a - Recovering/Resolving - Other Medically Important Condition);Post herpetic neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000993623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000987597	Spontaneous	2018-03-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Influenza like illness (4d - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000987597&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000971600	Spontaneous	2018-03-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Insomnia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Mental disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000971600&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000939626	Spontaneous	2018-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Condition aggravated (n/a - Unknown - Other Medically Important Condition);Injection site haemorrhage (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lipoatrophy (n/a - Unknown - Other Medically Important Condition);Product administered at inappropriate site (n/a - Unknown - Other Medically Important Condition);Scar pain (n/a - Unknown - Other Medically Important Condition);Vaccination site discharge (n/a - Unknown - Other Medically Important Condition);Vaccination site induration (n/a - Unknown - Other Medically Important Condition);Vaccination site necrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site scar (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000939626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000945795	Spontaneous	2018-03-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000945795&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000928360	Spontaneous	2018-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Dermatitis acneiform (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000928360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000929721	Spontaneous	2018-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Type 1 diabetes mellitus (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000929721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000930042	Spontaneous	2018-03-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Eczema (n/a - Unknown - );Myalgia (n/a - Not Recovered/Not Resolved - );Neck pain (n/a - Recovering/Resolving - );Tendonitis (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000930042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000924768	Spontaneous	2018-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Eye swelling (3d - Recovering/Resolving - );Pruritus (n/a - Not Recovered/Not Resolved - );Urticaria (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000924768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000902871	Spontaneous	2018-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000902871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000903645	Spontaneous	2018-03-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Pruritus (n/a - Not Recovered/Not Resolved - );Rash papular (n/a - Not Recovered/Not Resolved - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000903645&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000882426	Spontaneous	2018-03-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved - );Disease recurrence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition);Tonsillar erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Tonsillitis bacterial (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [1d - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000882426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000875557	Spontaneous	2018-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Urticaria (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])...	CLOPIDOGREL [CLOPIDOGREL, CLOPIDOGREL BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - Oral])|[ISOSORBIDE 5 MONONITRATE, ISOSORBIDE MONONITRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000875557&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000848789	Spontaneous	2018-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Syringe issue (n/a - Unknown - );Wound (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000848789&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000848790	Spontaneous	2018-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000848790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000853839	Spontaneous	2018-03-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin burning sensation (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000853839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000838198	Spontaneous	2018-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000838198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000818092	Spontaneous	2018-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Overdose (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000818092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000813686	Spontaneous	2018-03-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000813686&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000800205	Spontaneous	2018-03-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Musculoskeletal stiffness (n/a - Recovered/Resolved With Sequelae - );Vertigo (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000800205&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10000792889	Spontaneous	2018-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Bursitis (n/a - Not Recovered/Not Resolved - );Hypoaesthesia (n/a - Not Recovered/Not Resolved - );Pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[CARBOMER 974P, CARBOMERS] (C - Dry eye - n/a - [n/a - n/a - Other])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000792889&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000785994	Spontaneous	2018-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Hyperhidrosis (n/a - Recovered/Resolved - );Injection site inflammation (3d - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Vertigo (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000785994&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000777257	Spontaneous	2018-02-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (1d - Recovered/Resolved - );Inflammation (4d - Recovered/Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Nausea (1d - Recovered/Resolved - );Sacral pain (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000777257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000768448	Spontaneous	2018-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	SPINRAZA [NUSINERSEN] (S - Spinal muscular atrophy - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000768448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000756090	Spontaneous	2018-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Pain in extremity (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])...	[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000756090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000758299	Spontaneous	2018-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Diarrhoea (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000758299&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000758346	Spontaneous	2018-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Diarrhoea (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000758346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000758358	Spontaneous	2018-02-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Breast inflammation (n/a - Recovered/Resolved - Other Medically Important Condition);Chest pain (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000758358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000739417	Spontaneous	2018-02-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000739417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000729321	Spontaneous	2018-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pruritus (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000729321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000719944	Spontaneous	2018-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Lung disorder (2wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000719944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000707061	Spontaneous	2018-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition);Productive cough (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000707061&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000707410	Spontaneous	2018-02-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (2.5mo - Recovered/Resolved - );Arthritis (n/a - Recovered/Resolved - );Myalgia (2.5mo - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000707410&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000707416	Spontaneous	2018-02-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Abdominal pain (n/a - Recovered/Resolved - );Cough (n/a - Recovered/Resolved - );Ear pain (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Feeling cold (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Influenza like illness (5d - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Oropharyngeal discomfort (n/a - Recovered/Resolved - );Pharyngeal oedema (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Sneezing (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000707416&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000698452	Spontaneous	2018-02-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bronchitis (12d - Not Recovered/Not Resolved - );Chills (1wk - Not Recovered/Not Resolved - );Cough (3mo - Not Recovered/Not Resolved - );Myalgia (1wk - Not Recovered/Not Resolved - );Pyrexia (1wk - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000698452&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000691467	Spontaneous	2018-02-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000691467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000696001	Spontaneous	2018-02-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Drug ineffective (n/a - Recovering/Resolving - );Drug interaction (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (I - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])|[METHADONE] (I - Pain - Drug withdrawn - [n/a - 5mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000696001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000681991	Spontaneous	2018-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000681991&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000685401	Spontaneous	2018-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Muscular weakness (8d - Recovered/Resolved - );Pyrexia (8d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000685401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000686154	Spontaneous	2018-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - );Hypoaesthesia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000686154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000672446	Spontaneous	2018-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Injected limb mobility decreased (n/a - Recovering/Resolving - );Pain in extremity (1wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000672446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000672447	Spontaneous	2018-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Neck pain (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - );Torticollis (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000672447&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000672905	Spontaneous	2018-02-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000672905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000663858	Spontaneous	2018-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Expired product administered (n/a - Unknown - );Wrong product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 160mg - Oral])|[FENOFIBRATE, FENOFIBRATE MICRONISED] (C - n/a - n/a - [n/a - 300mg - Oral])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 20mg - Oral])|[VALSARTAN] (C - n/a - n/a - [n/a - 160mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000663858&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000665039	Spontaneous	2018-02-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000665039&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000657616	Spontaneous	2018-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000657616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000657617	Spontaneous	2018-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000657617&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000640680	Spontaneous	2018-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Lymphadenopathy (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000640680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000640978	Spontaneous	2018-02-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (1d - Not Recovered/Not Resolved - );Injection site pain (1d - Not Recovered/Not Resolved - );Injection site swelling (1d - Not Recovered/Not Resolved - );Muscle spasms (1d - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [1d - .5 - n/a - More in ICSR - More in ICSR])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000640978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000641669	Spontaneous	2018-02-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Body temperature increased (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Hyperhidrosis (n/a - Recovering/Resolving - );Injection site bruising (n/a - Recovering/Resolving - );Injection site induration (1wk - Recovered/Resolved - );Injection site pain (1wk - Recovered/Resolved - );Malaise (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Tremor (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000641669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000643259	Spontaneous	2018-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Product prescribing error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000643259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000646091	Spontaneous	2018-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000646091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000648368	Spontaneous	2018-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza like illness (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[ENALAPRIL MALEATE] (C - n/a - n/a - )|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000648368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000632819	Spontaneous	2018-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Amnesia (n/a - Recovering/Resolving - Other Medically Important Condition);Aphasia (n/a - Recovering/Resolving - Other Medically Important Condition);Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Depression (n/a - Recovering/Resolving - Other Medically Important Condition);Disturbance in attention (n/a - Recovering/Resolving - Other Medically Important Condition);Encephalitis (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);General physical health deterioration (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Hyperacusis (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza like illness (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Photophobia (n/a - Recovering/Resolving - Other Medically Important Condition);Speech disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Vertigo (n/a - Recovering/Resolving - Other Medically Important Condition);Vertigo positional (n/a - Recovering/Resolving - Other Medically Important Condition);Viral infection (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000632819&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000633961	Spontaneous	2018-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cough (n/a - Not Recovered/Not Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000633961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000638315	Spontaneous	2018-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Thrombocytopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vaccination site pain (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	BOSULIF 100 MG FILM-COATED TABLETS [BOSUTINIB] (C - Chronic myeloid leukaemia - Drug withdrawn - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000638315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000630172	Spontaneous	2018-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - );Xerosis (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000630172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000611610	Spontaneous	2018-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Rash morbilliform (4d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000611610&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000616376	Spontaneous	2018-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000616376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000616985	Spontaneous	2018-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - );Ear disorder (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000616985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000617085	Spontaneous	2018-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Not Specified	Influenza like illness (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000617085&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000617086	Spontaneous	2018-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Not Specified	Influenza like illness (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000617086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000618241	Spontaneous	2018-02-06 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000618241&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000618259	Spontaneous	2018-02-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Abdominal distension (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Abdominal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Glomerulonephritis proliferative (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nephrotic syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000618259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000620596	Spontaneous	2018-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Drug ineffective (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Influenza (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000620596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000609501	Spontaneous	2018-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Underdose (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000609501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000597274	Spontaneous	2018-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	ELIQUIS [APIXABAN] (C - Anticoagulant therapy - n/a - [n/a - 2.5mg - Unknown])|[ATORVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 10mg - Unknown])|[LORAZEPAM] (C - Sleep disorder - n/a - [n/a - 2.5mg - Unknown])|[LORAZEPAM] (C - Stress - n/a - [n/a - 2.5mg - Unknown])|[NEBIVOLOL] (C - Hypertension - n/a - [n/a - .5{DF} - Unknown])|[RAMIPRIL] (C - Hypertension - n/a - [n/a - 1.25mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000597274&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000597275	Spontaneous	2018-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[BENSERAZIDE HYDROCHLORIDE, LEVODOPA, BENSERAZIDE, LEVODOPA] (C - Parkinson's disease - n/a - [n/a - 3{DF} - Unknown])|[FLUINDIONE] (C - Anticoagulant therapy - n/a - [n/a - n/a - Unknown])|[FUROSEMIDE] (C - Diuretic therapy - n/a - [n/a - 1{DF} - Unknown])|[LIPIDOSTEROLIC EXTRACT OF SERENOA REPENS, SERENOA REPENS, SERENOA REPENS (BARTRAM) SMALL.] (C - Prostatic disorder - n/a - [n/a - 2{DF} - Unknown])|[NEBIVOLOL] (C - Hypertension - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000597275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000597426	Spontaneous	2018-02-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Not Specified	Inappropriate schedule of product administration (n/a - Unknown - );Underdose (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000597426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000597444	Spontaneous	2018-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Alopecia areata (n/a - Unknown - );Blood mercury abnormal (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000597444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000598329	Spontaneous	2018-02-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000598329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000584703	Spontaneous	2018-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Vaccination site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000584703&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000578767	Spontaneous	2018-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Skin reaction (4d - Recovered/Resolved - );Vaccination site inflammation (4d - Recovered/Resolved - );Vaccination site pruritus (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000578767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000578822	Spontaneous	2018-01-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Injected limb mobility decreased (n/a - Unknown - );Vaccination site inflammation (n/a - Unknown - );Vaccination site mass (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000578822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000568325	Spontaneous	2018-01-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Contusion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Immune thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Platelet count decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000568325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000575449	Spontaneous	2018-01-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (n/a - Not Recovered/Not Resolved - );Insomnia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000575449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000564864	Spontaneous	2018-01-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site inflammation (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000564864&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000555598	Spontaneous	2018-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Influenza like illness (1mo - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000555598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000550868	Spontaneous	2018-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Antibody test negative (n/a - Unknown - Other Medically Important Condition);Autoimmune thyroiditis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000550868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000553773	Spontaneous	2018-01-26 00:00:00	Healthcare Professional	Non European Economic Area	Pillsbury A , Quinn H , Cashman P, Leeb A , Macartney K. Active SMS-based influenza vaccine safety surveillance in Australian children, Vaccine, 2017, https://doi.org/10.1016/j.2017.10.091	3-11 Years	Child	No	Not Specified	Seizure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000553773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000535690	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Extra dose administered (n/a - Unknown - );Wrong product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000535690&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000538308	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Axillary pain (n/a - Recovering/Resolving - );Neck pain (n/a - Recovering/Resolving - );Vaccination site pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000538308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000538372	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hyperhidrosis (11h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lip swelling (11h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (11h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia oral (11h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Presyncope (13h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (11h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiration abnormal (11h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swollen tongue (11h - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	REMICADE [INFLIXIMAB] (C - n/a - n/a - )|[MESALAZINE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000538372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000539085	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Herpes zoster (n/a - Not Recovered/Not Resolved - );Pain (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000539085&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000539908	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Migraine (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000539908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000539921	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Injection site oedema (3d - Recovered/Resolved - );Injection site pain (3d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000539921&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000539924	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Myalgia (1h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000539924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000539928	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Injection site pain (24h - Recovered/Resolved - );Myalgia (24h - Recovered/Resolved - );Oral herpes (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000539928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000539939	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (1d - Recovered/Resolved - );Fatigue (1d - Recovered/Resolved - );Hyperhidrosis (1d - Recovered/Resolved - );Injection site pain (3d - Recovered/Resolved - );Myalgia (1d - Recovered/Resolved - );Pyrexia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000539939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000539945	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Injection site erythema (n/a - Recovered/Resolved - );Injection site induration (n/a - Recovered/Resolved - );Injection site pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000539945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000539946	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Headache (3h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000539946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000527344	Spontaneous	2018-01-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Carpal tunnel syndrome (n/a - Recovering/Resolving - );Hypoaesthesia (n/a - Recovering/Resolving - );Paraesthesia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000527344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000503070	Spontaneous	2018-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000503070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000503110	Spontaneous	2018-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Hypoaesthesia (n/a - Not Recovered/Not Resolved - );Influenza like illness (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000503110&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000509565	Spontaneous	2018-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - );Asthenia (n/a - Recovering/Resolving - );Cough (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000509565&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000511860	Spontaneous	2018-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - )|[FUROSEMIDE] (C - n/a - n/a - )|[GLYCERYL TRINITRATE] (C - n/a - n/a - )|[POTASSIUM CHLORIDE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000511860&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000511914	Spontaneous	2018-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain (n/a - Recovering/Resolving - );Vaccination site rash (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000511914&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000498872	Spontaneous	2018-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Expired product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Parenteral])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - )|[ATORVASTATIN] (C - n/a - n/a - )|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - )|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000498872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000499433	Spontaneous	2018-01-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Blister (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Congenital Anomaly, Other Medically Important Condition);Urticaria (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Congenital Anomaly, Other Medically Important Condition);Venous thrombosis (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Congenital Anomaly, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000499433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Life Threatening	Hospitalisation
EU-EC-10000499470	Spontaneous	2018-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Sudden hearing loss (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000499470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10000486065	Spontaneous	2018-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Face oedema (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - );Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Myocardial ischaemia - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000486065&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000487303	Spontaneous	2018-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swollen tongue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000487303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000494217	Spontaneous	2018-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Agranulocytosis (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	RITUXIMAB [RITUXIMAB] (S - Chronic lymphocytic leukaemia - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])|[CYCLOPHOSPHAMIDE MONOHYDRATE] (S - Chronic lymphocytic leukaemia - n/a - [n/a - n/a - n/a])|[FLUDARABINE PHOSPHATE] (S - Chronic lymphocytic leukaemia - n/a - [n/a - n/a - n/a])|[VALACICLOVIR] (S - n/a - Drug withdrawn - [n/a - 500mg - Oral])	[FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [14d - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000494217&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000475671	Spontaneous	2018-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Influenza like illness (n/a - Not Recovered/Not Resolved - );Pharyngitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000475671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000470531	Spontaneous	2018-01-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myelopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	EXFORGE [VALSARTAN, AMLODIPINE, VALSARTAN, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - 1{DF} - Unknown])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - 1{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000470531&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000473652	Spontaneous	2018-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Areflexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraparesis (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Urinary retention (3d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000473652&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000458453	Spontaneous	2018-01-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000458453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000459186	Spontaneous	2018-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000459186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000459195	Spontaneous	2018-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site inflammation (72h - Recovered/Resolved - );Pruritus (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000459195&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000459197	Spontaneous	2018-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Chills (2d - Recovered/Resolved - );Cough (4d - Recovered/Resolved - );Headache (1wk - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - );Rhinitis (1wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000459197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000459198	Spontaneous	2018-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site inflammation (6d - Recovered/Resolved - );Pruritus (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000459198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000459200	Spontaneous	2018-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site inflammation (6d - Recovered/Resolved - );Injection site pain (8d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000459200&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000459210	Spontaneous	2018-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (3d - Recovered/Resolved - );Pruritus (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000459210&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000459406	Spontaneous	2018-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000459406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000460190	Spontaneous	2018-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza like illness (n/a - Not Recovered/Not Resolved - );Pharyngitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000460190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000451549	Spontaneous	2018-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Autoinflammatory disease (n/a - Unknown - Other Medically Important Condition);Inappropriate schedule of product administration (n/a - Unknown - Other Medically Important Condition);Joint swelling (n/a - Unknown - Other Medically Important Condition);Polyarthritis (n/a - Unknown - Other Medically Important Condition)	TWINRIX ADULT SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/FLORIDA/4/2006), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), ANTIGENS OF THE INFLUENZA VIRUS A/CALIFORNIA/7/2009 (H1N1)-LIKE VIRUS PDM09, ANTIGENS OF THE INFLUENZA VIRUS A/VICTORIA/361/2011 (H3N2)-LIKE VIRUS, ANTIGENS OF THE INFLUENZA VIRUS B/WISCONSIN/1/2010-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/WISCONSIN/67/2005 REASS. NYMCX-161-B), A/SOLOMON ISLANDS/3/2006 (H1N1) - LIKE STRAIN (A/SOLOMON ISLANDS/3/2006 REASS. IVR-145), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE STRAIN (A/CALIFORNIA/7/2009, X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), SQUALENE, SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/BRISBANE/9/2014 (WILD TYPE), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/BRISBANE/9/2014 (WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), SQUALENE, SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/MASSACHUSETTS/2/2012-LIKE STRAIN USED B/MASSACHUSETTS/2/2012 WILD TYPE, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000451549&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000451642	Spontaneous	2018-01-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Fall (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotonia (3wk - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (3wk - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000451642&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000452613	Spontaneous	2018-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cerebral palsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/FLORIDA/4/2006), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), ANTIGENS OF THE INFLUENZA VIRUS A/CALIFORNIA/7/2009 (H1N1)-LIKE VIRUS PDM09, ANTIGENS OF THE INFLUENZA VIRUS A/VICTORIA/361/2011 (H3N2)-LIKE VIRUS, ANTIGENS OF THE INFLUENZA VIRUS B/WISCONSIN/1/2010-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/WISCONSIN/67/2005 REASS. NYMCX-161-B), A/SOLOMON ISLANDS/3/2006 (H1N1) - LIKE STRAIN (A/SOLOMON ISLANDS/3/2006 REASS. IVR-145), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), SQUALENE, CITRIC ACID, SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE STRAIN (A/CALIFORNIA/7/2009, X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), SQUALENE, SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/BRISBANE/9/2014 (WILD TYPE), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/BRISBANE/9/2014 (WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), SQUALENE, SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/MASSACHUSETTS/2/2012-LIKE STRAIN USED B/MASSACHUSETTS/2/2012 WILD TYPE, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/BRISBANE/60/2008-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000452613&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000441553	Spontaneous	2018-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Rash papular (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000441553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000426391	Spontaneous	2018-01-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Ear disorder (86400s - Recovered/Resolved - );Headache (86400s - Recovered/Resolved - );Product use issue (n/a - Unknown - )	GARDASIL 9 [HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|GARDASIL 9 [HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE] (S - n/a - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000426391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000422701	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000422701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000423061	Spontaneous	2018-01-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Overdose (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000423061&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000423096	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Pruritus (n/a - Unknown - );Rash (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000423096&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000378580	Spontaneous	2018-01-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Bell's palsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000378580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000341883	Spontaneous	2017-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000341883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000342018	Spontaneous	2017-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000342018&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000335043	Spontaneous	2017-12-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Acute leukaemia (n/a - Fatal - Results in Death);Blood urine present (n/a - Fatal - Results in Death);Fatigue (n/a - Fatal - Results in Death);Platelet count decreased (n/a - Fatal - Results in Death);Pyrexia (n/a - Fatal - Results in Death);White blood cell count decreased (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000335043&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10000337906	Spontaneous	2017-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000337906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000311722	Spontaneous	2017-12-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	Yes	Female	Arthralgia (n/a - Recovering/Resolving - );Asthenia (n/a - Recovering/Resolving - );Bronchitis (n/a - Recovering/Resolving - Other Medically Important Condition);Chest pain (n/a - Recovering/Resolving - Other Medically Important Condition);Cough (n/a - Recovering/Resolving - );Dyspnoea (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Hyperhidrosis (n/a - Recovering/Resolving - );Localised oedema (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - );Pulmonary embolism (n/a - Unknown - Other Medically Important Condition);Swelling face (n/a - Recovering/Resolving - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - n/a - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000311722&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000313471	Spontaneous	2017-12-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	Yes	Male	Arthralgia (n/a - Recovering/Resolving - );Asthenia (n/a - Recovering/Resolving - );Bronchitis (n/a - Recovering/Resolving - Other Medically Important Condition);Chest pain (n/a - Recovering/Resolving - Other Medically Important Condition);Cough (n/a - Recovering/Resolving - );Dyspnoea (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Hyperhidrosis (n/a - Recovering/Resolving - );Localised oedema (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - );Swelling face (n/a - Recovering/Resolving - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - n/a - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000313471&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000318358	Spontaneous	2017-12-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adolescent	No	Male	Vomiting (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000318358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000318525	Spontaneous	2017-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000318525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000320545	Spontaneous	2017-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site inflammation (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000320545&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000320846	Spontaneous	2017-12-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Breast pain (n/a - Recovered/Resolved - );Induration (n/a - Recovered/Resolved - );Injection site erythema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000320846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000321458	Spontaneous	2017-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site inflammation (3d - Recovered/Resolved - );Pruritus (5d - Recovered/Resolved - );Rash (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000321458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000321737	Spontaneous	2017-12-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Muscular weakness (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000321737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000305567	Spontaneous	2017-12-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000305567&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000288785	Spontaneous	2017-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cyanosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	PRITOR [TELMISARTAN] (C - Hypertension - Dose not changed - [n/a - n/a - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Gastritis - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000288785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000289137	Spontaneous	2017-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (3mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Obstructive airways disorder (4mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000289137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000278483	Spontaneous	2017-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Eosinophilia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000278483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000278494	Spontaneous	2017-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthmatic crisis (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site haematoma (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000278494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000286897	Spontaneous	2017-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Vaccination site pain (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000286897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000287616	Spontaneous	2017-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaemia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bronchopulmonary disease (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pulmonary alveolar haemorrhage (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000287616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000266640	Spontaneous	2017-12-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000266640&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000267042	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Unknown - );Injection site pain (n/a - Unknown - );Injection site warmth (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	AVASTIN [BEVACIZUMAB] (C - Ovarian cancer - n/a - [n/a - n/a - Intravenous drip])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000267042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000276012	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000276012&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000276013	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (7d - Recovered/Resolved - );Cough (7d - Recovered/Resolved - );Fatigue (7d - Recovered/Resolved - );Headache (7d - Recovered/Resolved - );Injection site erythema (n/a - Recovered/Resolved - );Myalgia (7d - Recovered/Resolved - );Pyrexia (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000276013&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000276033	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (2d - Recovered/Resolved - );Fatigue (3d - Recovered/Resolved - );Headache (2d - Recovered/Resolved - );Injection site inflammation (3d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - );Pruritus (3d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - );Rash (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000276033&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000277102	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (4h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000277102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000277114	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (4d - Recovered/Resolved - );Chills (2d - Recovered/Resolved - );Cough (4d - Recovered/Resolved - );Fatigue (4d - Recovered/Resolved - );Hyperhidrosis (4d - Recovered/Resolved - );Injection site pain (4d - Recovered/Resolved - );Myalgia (4d - Recovered/Resolved - );Nausea (4d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - );Rhinitis (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000277114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000277116	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000277116&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000277118	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (24h - Recovered/Resolved - );Headache (24h - Recovered/Resolved - );Injection site inflammation (48h - Recovered/Resolved - );Myalgia (24h - Recovered/Resolved - );Rhinitis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000277118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000255272	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000255272&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000263736	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pain in extremity (n/a - Not Recovered/Not Resolved - );Peripheral swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000263736&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000264764	Spontaneous	2017-12-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Allergy to vaccine (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Respiratory disorder (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000264764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000264932	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (2d - Recovered/Resolved - );Injection site inflammation (4d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000264932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000264939	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (4d - Recovered/Resolved - );Fatigue (6d - Recovered/Resolved - );Injection site inflammation (4d - Recovered/Resolved - );Injection site pain (4d - Recovered/Resolved - );Myalgia (3d - Recovered/Resolved - );Pruritus (3d - Recovered/Resolved - );Pyrexia (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - )|[LATANOPROST] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000264939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000264944	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hyperhidrosis (1d - Recovered/Resolved - );Injection site inflammation (4d - Recovered/Resolved - );Pruritus (2d - Unknown - );Rhinitis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000264944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000264946	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site inflammation (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000264946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000264948	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (4d - Recovered/Resolved - );Fatigue (4d - Recovered/Resolved - );Headache (4d - Recovered/Resolved - );Nausea (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000264948&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000264951	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (1d - Recovered/Resolved - );Chills (1d - Recovered/Resolved - );Cough (1d - Recovered/Resolved - );Myalgia (1d - Recovered/Resolved - );Pyrexia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000264951&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000265104	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (3d - Recovered/Resolved - );Chills (3d - Recovered/Resolved - );Fatigue (3d - Recovered/Resolved - );Hyperhidrosis (3d - Recovered/Resolved - );Injection site inflammation (4d - Recovered/Resolved - );Injection site pain (3d - Recovered/Resolved - );Myalgia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000265104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000265112	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site inflammation (4d - Recovered/Resolved - );Pruritus (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000265112&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000265115	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (6d - Recovered/Resolved - );Chills (4d - Recovered/Resolved - );Injection site inflammation (4d - Recovered/Resolved - );Injection site pain (2d - Recovered/Resolved - );Pyrexia (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000265115&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000265116	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (9d - Recovered/Resolved - );Paraesthesia (9d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000265116&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000265118	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (7d - Recovered/Resolved - );Injection site inflammation (3d - Recovered/Resolved - );Injection site pain (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ANASTROZOLE] (C - n/a - n/a - )|[CALCIUM CARBONATE, CHOLECALCIFEROL CONCENTRATE (POWDER FORM), COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - )|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - )|[PAROXETINE, PAROXETINE MESILATE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000265118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000265123	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (2d - Recovered/Resolved - );Fatigue (2d - Recovered/Resolved - );Headache (2d - Recovered/Resolved - );Hyperhidrosis (2d - Recovered/Resolved - );Lacrimation increased (2d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - );Nausea (2d - Recovered/Resolved - );Ocular hyperaemia (2d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000265123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000265125	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (3d - Recovered/Resolved - );Injection site pain (3d - Recovered/Resolved - );Myalgia (8d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000265125&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000245256	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000245256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000245534	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000245534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000253377	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (4d - Recovered/Resolved - );Asthenia (9d - Recovered/Resolved - );Headache (4d - Recovered/Resolved - );Rhinitis (8d - Recovered/Resolved - );Tonsillitis (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ESTRADIOL] (C - n/a - n/a - )|[PARACETAMOL, CODEINE PHOSPHATE, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - )|[PROGESTERONE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000253377&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000253389	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (2d - Recovered/Resolved - );Injection site pain (3d - Recovered/Resolved - );Myalgia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000253389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000253406	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (1d - Recovered/Resolved - );Injection site pain (4d - Recovered/Resolved - );Myalgia (3d - Recovered/Resolved - );Nausea (1d - Recovered/Resolved - );Pyrexia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000253406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000235321	Spontaneous	2017-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[METHADONE HYDROCHLORIDE] (C - Drug abuse - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000235321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000240811	Spontaneous	2017-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - );Chills (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])...	[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000240811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000243058	Spontaneous	2017-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Unknown - );Hiccups (n/a - Unknown - );Insomnia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])|[TRIAMCINOLONE ACETONIDE] (S - Osteoarthritis - n/a - [n/a - 1{DF} - Intra-articular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000243058&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000243710	Spontaneous	2017-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site oedema (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000243710&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000233776	Spontaneous	2017-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza like illness (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000233776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000233791	Spontaneous	2017-12-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypoaesthesia (0d - Recovered/Resolved - );Injection site erythema (n/a - Not Recovered/Not Resolved - );Injection site swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Dose not changed - [1d - n/a - n/a - More in ICSR - More in ICSR])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000233791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000233792	Spontaneous	2017-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (150min - Recovering/Resolving - );Diarrhoea (150min - Recovering/Resolving - );Nausea (150min - Recovering/Resolving - );Vaccination site pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000233792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000233807	Spontaneous	2017-12-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (6d - Recovered/Resolved - );Injection site pain (6d - Recovered/Resolved - );Injection site pruritus (6d - Recovered/Resolved - );Injection site swelling (6d - Recovered/Resolved - );Injection site warmth (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Dose not changed - [1d - .5 - n/a - More in ICSR - More in ICSR])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - Contraception - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000233807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000233823	Spontaneous	2017-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Recovering/Resolving - );Listless (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000233823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000233830	Spontaneous	2017-12-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza like illness (2d - Recovered/Resolved - );Insomnia (2d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Dose not changed - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000233830&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000233839	Spontaneous	2017-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Discomfort (11d - Recovered/Resolved - );Erythema (12d - Recovered/Resolved - );Injection site erythema (12d - Recovered/Resolved - );Injection site pruritus (11d - Recovered/Resolved - );Pruritus (12d - Recovered/Resolved - );Pyrexia (21h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000233839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000220175	Spontaneous	2017-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute respiratory distress syndrome (n/a - Recovering/Resolving - Life Threatening);Haemoptysis (n/a - Recovering/Resolving - Life Threatening);Interstitial lung disease (n/a - Recovering/Resolving - Life Threatening)	VIDAZA POWDER FOR SUSPENSION FOR INJECTION [AZACITIDINE] (S - Chronic myelomonocytic leukaemia - Not applicable - [n/a - 150mg - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000220175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10000231554	Spontaneous	2017-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000231554&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000232439	Spontaneous	2017-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Nausea (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000232439&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000207089	Spontaneous	2017-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site reaction (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	[PARACETAMOL] (C - Pain - n/a - [n/a - 1330mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000207089&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000207124	Spontaneous	2017-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Muscular weakness (n/a - Not Recovered/Not Resolved - );Neuropathy peripheral (n/a - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000207124&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000207955	Spontaneous	2017-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000207955&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000208210	Spontaneous	2017-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - );Vaccination site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000208210&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000193346	Spontaneous	2017-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000193346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000195646	Spontaneous	2017-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - Prophylaxis - n/a - [n/a - 75mg - Oral])|[ATORVASTATIN] (C - Blood cholesterol - n/a - [n/a - 40mg - Oral])|[MIANSERIN, MIANSERIN HYDROCHLORIDE] (C - Depression - n/a - [n/a - 60mg - Oral])|[RAMIPRIL] (C - Hypertension - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000195646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000195751	Spontaneous	2017-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Extra dose administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000195751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000195913	Spontaneous	2017-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Tension (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000195913&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000197759	Spontaneous	2017-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Erythema nodosum (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])...	JANUVIA [SITAGLIPTIN, SITAGLIPTIN PHOSPHATE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (C - Diabetes mellitus - n/a - [n/a - 100mg - Oral])|[BENDROFLUMETHIAZIDE, POTASSIUM CHLORIDE] (C - Oedema - n/a - [n/a - 1{DF} - Oral])|[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - 1000mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000197759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000184267	Spontaneous	2017-12-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000184267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000171419	Spontaneous	2017-12-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Shock (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000171419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000164647	Spontaneous	2017-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Product storage error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000164647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000164708	Spontaneous	2017-12-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adult	No	Female	Headache (n/a - Unknown - );Hot flush (10min - Recovered/Resolved - );Nausea (n/a - Unknown - );Oropharyngeal discomfort (n/a - Unknown - );Paraesthesia (10min - Recovered/Resolved - );Vomiting (n/a - Unknown - );Weight decreased (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ALPHATOCOPHEROL ACETATE] (C - n/a - n/a - [n/a - 1{DF} - Unknown])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - 100mg - Unknown])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000164708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000143836	Spontaneous	2017-12-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Nasopharyngitis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000143836&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000144163	Spontaneous	2017-12-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Nasopharyngitis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000144163&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000139683	Spontaneous	2017-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthritis (n/a - Unknown - );Joint swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000139683&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000139714	Spontaneous	2017-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pyrexia (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000139714&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000129782	Spontaneous	2017-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000129782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000129802	Spontaneous	2017-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Generalised oedema (7d - Recovered/Resolved - );Proteinuria (7d - Recovered/Resolved - );Urine abnormality (7d - Recovered/Resolved - );Urine albumin/creatinine ratio increased (n/a - Recovering/Resolving - );Weight increased (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000129802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000121608	Spontaneous	2017-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Epistaxis (10min - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000121608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000121618	Spontaneous	2017-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - );Neuralgia (n/a - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - );Paraesthesia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000121618&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000121622	Spontaneous	2017-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Recovering/Resolving - );Dizziness (n/a - Not Recovered/Not Resolved - );Feeling hot (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000121622&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000108026	Spontaneous	2017-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Premature labour (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000108026&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000113935	Spontaneous	2017-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Blood iron increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastrointestinal disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastrointestinal inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Vitamin B12 increased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000113935&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000114641	Spontaneous	2017-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site erythema (n/a - Unknown - );Vaccination site papule (n/a - Recovering/Resolving - );Vaccination site pruritus (n/a - Recovering/Resolving - );Vaccination site rash (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000114641&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000102219	Spontaneous	2017-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Epilepsy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000102219&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000104349	Spontaneous	2017-11-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Cerebral cyst (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Meningitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000104349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000092072	Spontaneous	2017-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Erythema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Presyncope (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Swelling face (0d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - n/a])	[BISOPROLOL FUMARATE] (C - Hypertension - Dose not changed - [n/a - 5mg - Oral])|[PERINDOPRIL ARGININE] (C - Hypertension - Dose not changed - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000092072&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10000095662	Spontaneous	2017-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved With Sequelae - );Cough (n/a - Recovered/Resolved With Sequelae - );Pyrexia (n/a - Recovered/Resolved With Sequelae - );Tracheitis (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000095662&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10000086143	Spontaneous	2017-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal distension (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[BUPROPION, BUPROPION HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1000mg - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - )|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - 1000mg - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 10mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000086143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000075314	Spontaneous	2017-11-24 00:00:00	Healthcare Professional	Non European Economic Area	Gonullu E, Hamarat H, Yorulmaz G, Ekim A. Rhabdomyolysis probably induced by influenza vaccine and fibrate therapy. European journal of rheumatology. 2015;169-169.	65-85 Years	Not Specified	No	Male	Rhabdomyolysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Unknown])|[FENOFIBRATE, FENOFIBRATE MICRONISED] (S - Product used for unknown indication - Drug withdrawn - [5mo - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000075314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000077198	Spontaneous	2017-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Inappropriate schedule of product administration (n/a - Unknown - );Off label use (n/a - Unknown - );Underdose (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000077198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000060212	Spontaneous	2017-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site inflammation (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	[ATENOLOL, ATENOLOL BP] (C - Hypertension - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000060212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000060215	Spontaneous	2017-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (4h - Recovered/Resolved - );Lethargy (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	[BECLOMETASONE DIPROPIONATE, BECLOMETASONE DIPROPIONATE ANHYDROUS] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000060215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000060231	Spontaneous	2017-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site bruising (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000060231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000060254	Spontaneous	2017-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Extensive swelling of vaccinated limb (n/a - Recovered/Resolved - );Skin plaque (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000060254&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000062952	Spontaneous	2017-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest pain (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000062952&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000062953	Spontaneous	2017-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Tonsillitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000062953&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000069856	Spontaneous	2017-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Erythema (n/a - Not Recovered/Not Resolved - );Herpes zoster (n/a - Not Recovered/Not Resolved - );Pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000069856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000069882	Spontaneous	2017-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Influenza (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	BUDESONIDE [BUDESONIDE] (C - Seasonal allergy - n/a - [n/a - n/a - Nasal])|PICATO [INGENOL MEBUTATE] (C - Actinic keratosis - n/a - [n/a - n/a - Cutaneous])|[BENDROFLUMETHIAZIDE, POTASSIUM CHLORIDE] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[ESTRADIOL, ESTRADIOL HEMIHYDRATE] (C - Oestrogen therapy - n/a - [n/a - n/a - Vaginal])|[LANSOPRAZOLE] (C - Gastrooesophageal reflux disease - n/a - [n/a - 30mg - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Hypercholesterolaemia - n/a - [n/a - 20mg - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Bronchospasm - n/a - [n/a - n/a - Respiratory (inhalation)])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - Pain - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000069882&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000072937	Spontaneous	2017-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Petechiae (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Platelet count decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Purpura (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000072937&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000072946	Spontaneous	2017-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Bradyphrenia (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Urine output decreased (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000072946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000006514	Spontaneous	2017-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Ocular hyperaemia (0d - Recovered/Resolved - );Pruritus (0d - Recovered/Resolved - );Rash erythematous (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000006514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000006525	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Malaise (n/a - Recovered/Resolved - );Pyrexia (7d - Recovered/Resolved - );Vaccination site pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000006525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000008152	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Decreased appetite (n/a - Recovered/Resolved - );Diarrhoea (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	[ACETYLSALICYLIC ACID] (C - n/a - n/a - )|[ALLOPURINOL] (C - n/a - n/a - )|[FLUVASTATIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - 850mg - n/a])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 25mg - n/a])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000008152&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000021827	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Injection site erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site movement impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[DICLOFENAC DIETHYLAMINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[EZETIMIBE] (C - n/a - n/a - [n/a - n/a - n/a])|[FINASTERIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000021827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000023809	Spontaneous	2017-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Myalgia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000023809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000031067	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Muscular weakness (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Poliomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000031067&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000031068	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000031068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000031069	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pyrexia (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swelling of eyelid (n/a - Unknown - Caused/Prolonged Hospitalisation);Urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000031069&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000036325	Spontaneous	2017-11-22 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Bronchitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling abnormal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000036325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000042419	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation);Swelling (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000042419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12966202	Spontaneous	2017-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12966202&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12963643	Spontaneous	2017-11-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (11d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12963643&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12964449	Spontaneous	2017-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abortion late (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Foetal death (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Maternal exposure during pregnancy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12964449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12958008	Spontaneous	2017-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Blood pressure decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Laryngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12958008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12958468	Spontaneous	2017-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Recovered/Resolved - );Injection site reaction (n/a - Recovered/Resolved - );Injection site swelling (n/a - Recovered/Resolved - );Local reaction (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12958468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12956436	Spontaneous	2017-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angioedema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12956436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12928311	Spontaneous	2017-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Asthma (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[BILASTINE] (C - n/a - n/a - [n/a - 1{DF} - Unknown])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 1{DF} - Unknown])|[OXAZEPAM] (C - n/a - n/a - [n/a - 1{DF} - Unknown])|[PAROXETINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE HYDROCHLORIDE, ANHYDROUS] (C - n/a - n/a - [n/a - 1{DF} - Unknown])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - 1{DF} - Unknown])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 1{DF} - Unknown])|[ZOPICLONE] (C - n/a - n/a - [n/a - 1{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12928311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12928313	Spontaneous	2017-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Male	Acne (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Peripheral swelling (n/a - Unknown - Other Medically Important Condition);Skin exfoliation (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12928313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12924325	Spontaneous	2017-10-28 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Contusion (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12924325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12919856	Spontaneous	2017-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Condition aggravated (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gait inability (21d - Recovered/Resolved - Other Medically Important Condition);Walking disability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	PREGABALIN [PREGABALIN] (C - n/a - n/a - [n/a - 100mg - Oral])|PREGABALIN [PREGABALIN] (C - n/a - n/a - [n/a - 150mg - Oral])|[ALFUZOSIN] (C - n/a - n/a - [n/a - 10mg - Oral])|[ALPRAZOLAM] (C - n/a - n/a - [n/a - .25mg - Oral])|[BACLOFEN] (C - n/a - n/a - [n/a - 10mg - Oral])|[DANTROLENE SODIUM] (C - n/a - n/a - [n/a - 25mg - Oral])|[DOMPERIDONE] (C - n/a - n/a - [n/a - 10mg - Oral])|[PAROXETINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE HYDROCHLORIDE, ANHYDROUS] (C - n/a - n/a - [n/a - 20mg - Oral])|[RABEPRAZOLE, RABEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - 20mg - Oral])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - 1mg - Oral])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - 5mg - Oral])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12919856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-12911522	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Dyspnoea (n/a - Not Recovered/Not Resolved - Results in Death);Malaise (n/a - Not Recovered/Not Resolved - Results in Death);Myocardial infarction (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[BENSERAZIDE HYDROCHLORIDE, LEVODOPA, BENSERAZIDE, LEVODOPA] (C - Parkinson's disease - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12911522&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12913099	Spontaneous	2017-10-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Peripheral coldness (n/a - Unknown - Other Medically Important Condition);Visual impairment (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[INDAPAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12913099&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12913639	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Feeding disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Hiatus hernia (n/a - Recovering/Resolving - Other Medically Important Condition);Pneumonia (n/a - Recovering/Resolving - Other Medically Important Condition);Respiratory disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Vomiting (n/a - Recovering/Resolving - Other Medically Important Condition);Weight decreased (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12913639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12915259	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Acne (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Peripheral swelling (n/a - Unknown - Other Medically Important Condition);Skin discolouration (n/a - Unknown - Other Medically Important Condition);Skin exfoliation (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12915259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12873326	Spontaneous	2017-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Adverse reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Other Medically Important Condition);Visual impairment (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12873326&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12873701	Spontaneous	2017-10-18 00:00:00	Healthcare Professional	European Economic Area	MAYET A, DURON S, MEYNARD J, KOECK J, DEPARIS X, MGLIANI R. Surveillance of adverse events following vaccination in the French armed forces, 2011-2012. Public Health 2015 Mar 06;0033-3506:1-6.	18-64 Years	Adult	No	Male	Diplopia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Eyelid ptosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Optic neuritis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12873701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12874196	Spontaneous	2017-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arrhythmia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12874196&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12875106	Spontaneous	2017-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Adult	No	Female	Asthenia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[DILTIAZEM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE, SALMETEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM CROMOGLICATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12875106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-12861279	Spontaneous	2017-10-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Chills (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12861279&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12832973	Spontaneous	2017-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Graves' disease (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lupus-like syndrome (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12832973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12833753	Spontaneous	2017-10-10 00:00:00	Healthcare Professional	European Economic Area	Blanche P, Decrette C, Sicard D. Development of Uveitis Following Vaccination for Influenza. Clinical Infectious Diseases 1994;19:979. Blanche P., Decrette C., Sicard D. Development of Uveitis Following Vaccination for Influenza, Clin Infect Dis. 1994;19 (5): 979 Cordero-Coma M, Salazar Mendez R, Garzo-Garcia I, Yilmaz T. Drug induced uveitis. Expert Opin Drug Saf. 2015 Jan;14(1):111-126.	65-85 Years	Not Specified	No	Female	Pyrexia (n/a - Unknown - Other Medically Important Condition);Uveitis (n/a - Recovered/Resolved - Other Medically Important Condition);Visual acuity reduced (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12833753&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12827055	Spontaneous	2017-10-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Choking (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Pharyngeal oedema (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12827055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12824643	Spontaneous	2017-10-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Deafness (n/a - Unknown - Disabling);Infection (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12824643&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12816855	Spontaneous	2017-10-06 00:00:00	Healthcare Professional	Non European Economic Area	Gonzalez B, Fica A. Recurrent encephalitis following annual influenza vaccine. Revista Chilena De Infectologia 2016; 33 (2): 226-228.	65-85 Years	Elderly	No	Male	Encephalitis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Meningoencephalitis herpetic (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pleocytosis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12816855&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-12817665	Spontaneous	2017-10-06 00:00:00	Healthcare Professional	Non European Economic Area	Solak B, Dikicier BS, Kara RO, Erdem T. DRESS syndrome potentially induced by allopurinol and triggered by influenza vaccine.BMJ Case Reports. 2016: Article Number A473	18-64 Years	Not Specified	No	Female	Drug reaction with eosinophilia and systemic symptoms (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hepatic function abnormal (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Renal injury (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALLOPURINOL] (S - Hyperuricaemia - n/a - [n/a - n/a - n/a])	[BUPROPION, BUPROPION HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [6y - n/a - n/a])|[INSULIN, INSULIN HUMAN] (C - Diabetes mellitus - n/a - [5y - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - n/a - [6y - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12817665&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-12818421	Spontaneous	2017-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cardiac arrest (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Renal failure (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[AMOXICILLIN SODIUM, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (C - n/a - n/a - [n/a - n/a - Unknown])|[EPINEPHRINE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12818421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-12803096	Spontaneous	2017-10-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Aplastic anaemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Bone marrow failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Haematoma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Leukopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Petechiae (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Respiratory tract infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12803096&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12798292	Spontaneous	2017-10-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12798292&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12801804	Spontaneous	2017-10-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Injection site mass (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12801804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12785526	Spontaneous	2017-09-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Febrile convulsion (0d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12785526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12754902	Spontaneous	2017-09-22 00:00:00	Healthcare Professional	Non European Economic Area	Yanai-Berar N, Ben-Itzhak O, Green J, Nakhoul F.. Influenza vaccination induced leukocytoclasticInfluenza vaccination induced leukocytoclastic vasculitis and pauci-immune crescentic glomerulonephritis.. Clinical Nephrology. 2002; 58(3):220-223. Sun D, Cao S.. Leucocytoclastic vasculitis following influenza vaccination.. BMJ Case Rep 2017; CAO.	18-64 Years	Not Specified	No	Male	Cutaneous vasculitis (6wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12754902&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12755492	Spontaneous	2017-09-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Anaphylactic shock (5min - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12755492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-12755869	Spontaneous	2017-09-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Aphasia (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysphagia (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Eating disorder (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Motor neurone disease (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nervous system disorder (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Posture abnormal (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Product administered at inappropriate site (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Parenteral])	[CARBOCISTEINE, L-CARBOCISTEINE] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM HYDROGEN CARBONATE, SODIUM ALGINATE] (C - n/a - n/a - [n/a - n/a - n/a])|[QUININE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12755869&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12732224	Spontaneous	2017-09-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Epistaxis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Immune thrombocytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Oral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12732224&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12705453	Spontaneous	2017-09-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Erythema (n/a - Unknown - Other Medically Important Condition);Inflammation (10d - Unknown - Other Medically Important Condition);Pain in extremity (10d - Not Recovered/Not Resolved - Other Medically Important Condition);Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12705453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12697820	Spontaneous	2017-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Rash (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12697820&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12698010	Spontaneous	2017-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Caesarean section (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Macule (15d - Recovered/Resolved - Other Medically Important Condition);Normal newborn (n/a - Unknown - Other Medically Important Condition);Pruritus (15d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12698010&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12700051	Spontaneous	2017-09-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Lymphadenopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12700051&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12691626	Spontaneous	2017-09-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Chills (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site inflammation (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12691626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12693036	Spontaneous	2017-09-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Acute kidney injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Haemophagocytic lymphohistiocytosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])...	METHOTREXATE [METHOTREXATE] (C - n/a - n/a - [n/a - 25mg - Intramuscular])|[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - Oral])|[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - n/a - n/a - [n/a - 650mg - Oral])|[CYANOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - Oral])|[FOLIC ACID] (C - n/a - n/a - [n/a - 5mg - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 25mg - Oral])|[OXYCODONE HYDROCHLORIDE, PARACETAMOL] (C - n/a - n/a - [n/a - n/a - Oral])|[OXYCODONE, OXYCODONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - Oral])|[PREDNISONE] (C - n/a - n/a - [n/a - 10mg - Oral])|[RISEDRONATE SODIUM] (C - n/a - n/a - [n/a - 25mg - Oral])|[TRANDOLAPRIL] (C - n/a - n/a - [n/a - 2mg - Oral])|[VITAMIN D] (C - n/a - n/a - [n/a - n/a - Oral])|[ZINC SULPHATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12693036&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12693397	Spontaneous	2017-09-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Ear infection (7d - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Influenza like illness (7d - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Tonsillitis (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12693397&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12684305	Spontaneous	2017-09-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Purpura (1wk - Recovered/Resolved - Other Medically Important Condition);Vasculitis (1wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12684305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12684962	Spontaneous	2017-09-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dry mouth (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Erythema multiforme (17d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Eye symptom (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sjogren's syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - Migraine - Dose not changed - [n/a - 400mg - Oral])|[ZOLMITRIPTAN] (C - Migraine - Dose not changed - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12684962&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12677825	Spontaneous	2017-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cellulitis (n/a - Recovered/Resolved - Disabling);Eye disorder (n/a - Recovered/Resolved - Disabling);Eye inflammation (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - Unknown])|[POTASSIUM, POTASSIUM CHLORIDE, POTASSIUM GLYCEROPHOSPHATE, POTASSIUM HYDROGEN CARBONATE, POTASSIUM HYDROGEN TARTRATE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12677825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12680430	Spontaneous	2017-09-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Alopecia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Inflammation (n/a - Unknown - Other Medically Important Condition);Mobility decreased (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	KALETRA [LOPINAVIR, RITONAVIR] (C - HIV infection - n/a - [n/a - 2{DF} - Oral])|TRUVADA [EMTRICITABINE, TENOFOVIR DISOPROXIL, EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE] (C - HIV infection - n/a - [n/a - n/a - Oral])|[LEVOCETIRIZINE, LEVOCETIRIZINE DIHYDROCHLORIDE] (C - Hypersensitivity - n/a - [n/a - 5mg - Oral])|[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - 150mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12680430&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12681810	Spontaneous	2017-09-07 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Influenza A virus test positive (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12681810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12672827	Spontaneous	2017-09-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Blindness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Optic neuritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Purulent discharge (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site nodule (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site warmth (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[RABIES VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[RABIES VIRUS (INACTIVATED) STRAIN WISTAR (PM/WI 38-1503-3M)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12672827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12646394	Spontaneous	2017-08-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Formication (n/a - Recovered/Resolved - Disabling);Induration (11d - Recovered/Resolved - Disabling);Movement disorder (16d - Recovered/Resolved - Disabling);Paraesthesia (n/a - Recovered/Resolved - Disabling);Polyneuropathy (1a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	CYMBALTA [DULOXETINE, DULOXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Unknown])|[BROMAZEPAM] (C - n/a - n/a - [n/a - n/a - Unknown])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Unknown])|[MORPHINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - Unknown])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12646394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12592822	Spontaneous	2017-08-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cervicobrachial syndrome (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (3d - Recovered/Resolved - Other Medically Important Condition);Neck pain (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12592822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12593639	Spontaneous	2017-08-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12593639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12594189	Spontaneous	2017-08-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[NEBIVOLOL] (C - n/a - Unknown - [n/a - n/a - Oral])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - Unknown - [n/a - n/a - Oral])|[PROPRANOLOL, PROPRANOLOL HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12594189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12581852	Spontaneous	2017-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Arrhythmia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Incorrect route of product administration (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Respiratory distress (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Tachycardia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Vaccination error (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	[FLUINDIONE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FUROSEMIDE] (C - n/a - Unknown - [n/a - 20mg - n/a])|[OMEPRAZOLE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12581852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12564311	Spontaneous	2017-08-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Bursitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12564311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12558311	Spontaneous	2017-08-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Local reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12558311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12556771	Spontaneous	2017-08-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12556771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12536495	Spontaneous	2017-08-10 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Syncope (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Parenteral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12536495&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12529928	Spontaneous	2017-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Discomfort (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Joint stiffness (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscle twitching (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Speech disorder (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12529928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12530286	Spontaneous	2017-08-09 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Migraine (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pulmonary congestion (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12530286&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12530287	Spontaneous	2017-08-09 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Migraine (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pulmonary congestion (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12530287&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12530341	Spontaneous	2017-08-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Gait inability (1wk - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12530341&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12531334	Spontaneous	2017-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Encephalitis viral (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12531334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12532741	Spontaneous	2017-08-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Anaphylactic shock (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Heart rate increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral coldness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12532741&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12532789	Spontaneous	2017-08-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Gait inability (1wk - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12532789&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12510137	Spontaneous	2017-08-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angioedema (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[BETAMETHASONE, BETAMETHASONE SODIUM PHOSPHATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[EPINEPHRINE] (C - n/a - Unknown - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12510137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12497704	Spontaneous	2017-08-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Lichen planus (n/a - Recovering/Resolving - Other Medically Important Condition);Oral herpes (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rash papular (n/a - Recovering/Resolving - Other Medically Important Condition);Toxic skin eruption (n/a - Recovering/Resolving - Other Medically Important Condition);Urticaria chronic (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	MICARDIS [TELMISARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - Oral])|[LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[MICRONISED SPIRONOLACTONE, POTASSIUM CANRENOATE, SPIRONOLACTONE, SPIRONOLACTONE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12497704&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12497864	Spontaneous	2017-08-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anaemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Bronchospasm (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12497864&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12501820	Spontaneous	2017-08-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Unknown - Disabling);Asthenia (n/a - Unknown - Disabling);Bone pain (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Loss of personal independence in daily activities (n/a - Unknown - Disabling);Mobility decreased (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Pain (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12501820&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12493614	Spontaneous	2017-08-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Influenza like illness (n/a - Recovered/Resolved - );Vertigo (n/a - Recovering/Resolving - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12493614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12486290	Spontaneous	2017-07-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12486290&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12480155	Spontaneous	2017-07-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bradyphrenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Contusion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Personality change (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Petechiae (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - n/a])|[PREDNISOLONE] (S - Thrombocytopenia - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12480155&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12475354	Spontaneous	2017-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (3d - Not Recovered/Not Resolved - Other Medically Important Condition);Lip swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Palatal oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12475354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12438587	Spontaneous	2017-07-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Blastocystis infection (n/a - Recovered/Resolved - Other Medically Important Condition);Eye swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12438587&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12376308	Spontaneous	2017-07-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Dyskinesia (n/a - Unknown - Other Medically Important Condition);Eye disorder (n/a - Unknown - Other Medically Important Condition);Facial paralysis (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia oral (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12376308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12361349	Spontaneous	2017-06-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Thrombocytopenic purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12361349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12354340	Spontaneous	2017-06-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dengue fever (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gastritis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Leukopenia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory alkalosis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Thrombocytopenia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Viral myocarditis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12354340&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12332100	Spontaneous	2017-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Fatal - Results in Death);Cyanosis (n/a - Fatal - Results in Death);Decreased appetite (n/a - Fatal - Results in Death);Dyspnoea (n/a - Fatal - Results in Death);Tachypnoea (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	LEVEMIR [INSULIN DETEMIR] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - n/a])|NOVORAPID [INSULIN ASPART] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - 20mg - n/a])|[CARVEDILOL] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12332100&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12332101	Spontaneous	2017-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cardiac arrest (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	[ISOSORBIDE DINITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPRANOLOL, PROPRANOLOL HYDROCHLORIDE] (C - Angina pectoris - n/a - [n/a - n/a - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12332101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12332104	Spontaneous	2017-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Cardiac failure (n/a - Fatal - Results in Death);Cystitis escherichia (n/a - Fatal - Results in Death);Dyspnoea (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	APIDRA [INSULIN GLULISINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[CARVEDILOL] (C - n/a - n/a - [n/a - 6.25mg - n/a])|[DIGOXIN, DIGOXIN PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[QUETIAPINE, QUETIAPINE FUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12332104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12332106	Spontaneous	2017-06-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dyspnoea (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	MICARDISPLUS [HYDROCHLOROTHIAZIDE, TELMISARTAN] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])|[ALLOPURINOL] (C - n/a - n/a - [n/a - 300mg - Oral])|[ALPRAZOLAM] (C - Anxiety - n/a - [n/a - .5mg - Oral])|[BARNIDIPINE HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12332106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12332108	Spontaneous	2017-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Septic shock (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[INDOBUFEN] (C - n/a - n/a - [n/a - n/a - n/a])|[NIFEDIPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12332108&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12332109	Spontaneous	2017-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Diarrhoea (n/a - Fatal - Results in Death);Pyrexia (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12332109&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12332113	Spontaneous	2017-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Multiple organ dysfunction syndrome (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	[CARVEDILOL] (C - n/a - n/a - [n/a - n/a - n/a])|[DOXAZOSIN, DOXAZOSIN MESILATE] (C - n/a - n/a - [n/a - n/a - Oral])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[URSODEOXYCHOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12332113&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12332116	Spontaneous	2017-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cardiopulmonary failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Renal failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Septic shock (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Urinary incontinence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mg - Intramuscular])	OLANZAPINE [OLANZAPINE] (C - Senile psychosis - n/a - [n/a - 2.5mg - Oral])|[OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12332116&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12333695	Spontaneous	2017-06-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Abnormal faeces (n/a - Fatal - Results in Death);Diarrhoea (n/a - Fatal - Results in Death);Faeces discoloured (n/a - Fatal - Results in Death);Hyperhidrosis (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	LYRICA [PREGABALIN] (C - Back pain - n/a - [n/a - 75mg - Oral])|[ALPRAZOLAM] (C - Depression - n/a - [n/a - .25mg - Oral])|[CLOMIPRAMINE, CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE BP] (C - Depression - n/a - [n/a - 20mg - Oral])|[HYDROCHLOROTHIAZIDE, RAMIPRIL] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE OXIDE] (C - Diarrhoea - n/a - [n/a - n/a - n/a])|[TICLOPIDINE, TICLOPIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 250mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12333695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12333701	Spontaneous	2017-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Cerebral haemorrhage (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12333701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12296766	Spontaneous	2017-06-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Fall (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12296766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12268739	Spontaneous	2017-06-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (1a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Cough (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Fatigue (1a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12268739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-12270093	Spontaneous	2017-06-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12270093&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-12270590	Spontaneous	2017-06-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Giant cell arteritis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12270590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12264975	Spontaneous	2017-06-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Hypersensitivity vasculitis (n/a - Recovering/Resolving - Other Medically Important Condition);Rash macular (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12264975&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12246131	Spontaneous	2017-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (1d - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12246131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-12214521	Spontaneous	2017-05-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Monoparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (0d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pain in extremity (2d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Vomiting (0d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12214521&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12214529	Spontaneous	2017-05-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Anaphylactic shock (1d - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Seizure (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12214529&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-12200570	Spontaneous	2017-05-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Giant cell arteritis (5a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12200570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12194351	Spontaneous	2017-05-23 00:00:00	Healthcare Professional	Non European Economic Area	Jeon H, Jeong S, Dhong E, Han S. Pilomatricoma Arising at an Influenza Vaccination Site. archives of Plastic Surgery 2014 Nov;41(6):775-777. Jeon H., Jeong S.-H., Dhong E.-S., Han S.-K.Pilomatricoma arising at an influenza vaccination site. Archives of Plastic Surgery. 2014; 41: 6 (775-777)	3-11 Years	Child	No	Female	Biopsy skin abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Bloody discharge (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Foreign body reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Hair follicle tumour benign (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Nodule (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Secretion discharge (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Skin lesion (n/a - Unknown - Caused/Prolonged Hospitalisation);Ultrasound scan abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site inflammation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site ulcer (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site warmth (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12194351&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12194608	Spontaneous	2017-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Immune thrombocytopenia (112d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12194608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12194623	Spontaneous	2017-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Giant cell arteritis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12194623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12194647	Spontaneous	2017-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Giant cell arteritis (4a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12194647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12194672	Spontaneous	2017-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Giant cell arteritis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12194672&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12194694	Spontaneous	2017-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Giant cell arteritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12194694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12194726	Spontaneous	2017-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Polymyalgia rheumatica (4a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12194726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12194734	Spontaneous	2017-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Giant cell arteritis (5a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12194734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12177642	Spontaneous	2017-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Drug ineffective (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Influenza (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12177642&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12177734	Spontaneous	2017-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12177734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12177834	Spontaneous	2017-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fibromyalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])	[LEVONORGESTREL] (C - n/a - Dose not changed - [n/a - n/a - Intra-uterine])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12177834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12158001	Spontaneous	2017-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Nephrotic syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Subcutaneous])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12158001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12152424	Spontaneous	2017-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (2.5wk - Recovered/Resolved - Other Medically Important Condition);Erysipelas (2.5wk - Recovered/Resolved - Other Medically Important Condition);Erythema (2.5wk - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (2.5wk - Recovered/Resolved - Other Medically Important Condition);Pyrexia (2.5wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12152424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12142135	Spontaneous	2017-05-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Central nervous system vasculitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Encephalopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Giant cell arteritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	[ALFUZOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - n/a - n/a])|[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[EBASTINE] (C - n/a - n/a - [n/a - n/a - n/a])|[FINASTERIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLIMEPIRIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12142135&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12106225	Spontaneous	2017-05-02 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Chills (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	RANEXA [RANOLAZINE] (C - n/a - Unknown - [n/a - 375mg - Oral])|[DILTIAZEM, DILTIAZEM HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 120mg - Oral])|[GLYCERYL TRINITRATE] (C - n/a - Unknown - [n/a - 5mg - Transdermal])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 20mg - Oral])|[VALSARTAN] (C - n/a - Unknown - [n/a - 320mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12106225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12106792	Spontaneous	2017-05-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Albuminuria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dry mouth (n/a - Unknown - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Glomerulonephritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Listless (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Renal failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12106792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12095526	Spontaneous	2017-04-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Cerebrovascular accident (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Hemiplegia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Medication error (n/a - Unknown - Other Medically Important Condition);Product storage error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - Unknown - [n/a - 75mg - Oral])|[ATENOLOL, ATENOLOL BP] (C - n/a - Unknown - [n/a - 50mg - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - 25mg - Oral])|[OMEPRAZOLE] (C - n/a - Unknown - [n/a - 10mg - Oral])|[PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - Unknown - [n/a - 1g - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - Unknown - [n/a - 5mg - Oral])|[TRAMADOL] (C - n/a - Unknown - [n/a - 150mg - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - 160mg - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - 25mg - Oral])|[VALSARTAN] (C - n/a - Unknown - [n/a - 160mg - Oral])|[VERAPAMIL] (C - n/a - Unknown - [n/a - 120mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12095526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-12095830	Spontaneous	2017-04-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angioedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12095830&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12090695	Spontaneous	2017-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Hyperthermia (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (0d - Recovered/Resolved - Other Medically Important Condition);Overdose (n/a - Unknown - Other Medically Important Condition);Vaccination error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12090695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12084461	Spontaneous	2017-04-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12084461&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12069766	Spontaneous	2017-04-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12069766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12071955	Spontaneous	2017-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abscess (6mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Impaired healing (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Skin infection (6mo - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12071955&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12055750	Spontaneous	2017-04-20 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia (3d - Recovered/Resolved - );Tremor (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mg - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12055750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-12055762	Spontaneous	2017-04-20 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - );Chills (n/a - Not Recovered/Not Resolved - );Night sweats (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mg - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12055762&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12055966	Spontaneous	2017-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Haemolytic anaemia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12055966&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12056420	Spontaneous	2017-04-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Not Specified	Vaccination site urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12056420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12057329	Spontaneous	2017-04-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	H1N1 influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Illness (n/a - Recovered/Resolved - Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12057329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12058174	Spontaneous	2017-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Asthma (n/a - Recovered/Resolved - Other Medically Important Condition);Choking sensation (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12058174&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12058227	Spontaneous	2017-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Axillary mass (n/a - Unknown - Caused/Prolonged Hospitalisation);Dry skin (n/a - Unknown - Caused/Prolonged Hospitalisation);Haematoma (n/a - Unknown - Caused/Prolonged Hospitalisation);Lymphadenitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Renal failure (n/a - Unknown - Caused/Prolonged Hospitalisation);Skin fissures (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12058227&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12043104	Spontaneous	2017-04-18 00:00:00	Healthcare Professional	Non European Economic Area	Allen R.J, Koutsakos M, Hurt A.C, Kedzierska K, Uncomplicated Cystitis in an Adult Male Following Influenza B Virus Infection, Am J Case Rep, 2017; 18: 190-193, DOI: 10.12659/AJCR.902172, ISSN 1941-5923.	18-64 Years	Adult	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Back pain (n/a - Recovered/Resolved - Other Medically Important Condition);Blood urine present (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Cystitis escherichia (n/a - Recovered/Resolved - Other Medically Important Condition);Dysuria (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Haematuria (n/a - Recovered/Resolved - Other Medically Important Condition);Haemoptysis (n/a - Recovered/Resolved - Other Medically Important Condition);Haemorrhage urinary tract (n/a - Recovered/Resolved - Other Medically Important Condition);Increased viscosity of bronchial secretion (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Monocytosis (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pollakiuria (n/a - Recovered/Resolved - Other Medically Important Condition);Productive cough (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12043104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12035731	Spontaneous	2017-04-14 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (n/a - Recovered/Resolved - );Cough (n/a - Recovered/Resolved - );Influenza (4wk - Recovered/Resolved - );Nasopharyngitis (n/a - Recovered/Resolved - );Rhinorrhoea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12035731&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12036073	Spontaneous	2017-04-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest discomfort (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12036073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12036081	Spontaneous	2017-04-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Abdominal distension (9d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Abdominal pain upper (9d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Chills (9d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Chromaturia (9d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Diarrhoea (9d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Peritonitis (9d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (9d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Vomiting (9d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[HEPATITIS B VACCINE] (S - Immunisation - Not applicable - [1d - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12036081&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12036317	Spontaneous	2017-04-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Blood glucose increased (n/a - Unknown - Other Medically Important Condition);Facial paralysis (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12036317&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12030156	Spontaneous	2017-04-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Dysaesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Hypoaesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Hyporeflexia (n/a - Recovering/Resolving - Other Medically Important Condition);Limb discomfort (n/a - Recovering/Resolving - Other Medically Important Condition);Monoparesis (n/a - Recovering/Resolving - Other Medically Important Condition);Motor dysfunction (n/a - Recovering/Resolving - Other Medically Important Condition);Neuralgic amyotrophy (n/a - Recovering/Resolving - Other Medically Important Condition);Oedema peripheral (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition)	HUMIRA [ADALIMUMAB] (S - Spondylitis - Unknown - [n/a - 40mg - Subcutaneous])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylactic chemotherapy - Not applicable - [n/a - .5mg - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12030156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11980151	Spontaneous	2017-04-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Induration (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Type I hypersensitivity (9d - Recovered/Resolved - Other Medically Important Condition);Vaccination site inflammation (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11980151&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11970794	Spontaneous	2017-03-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Irritability (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11970794&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11972974	Spontaneous	2017-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Face oedema (n/a - Recovered/Resolved - Disabling);Hypoaesthesia (n/a - Recovered/Resolved - Disabling);Injected limb mobility decreased (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11972974&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11965582	Spontaneous	2017-03-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Foetal death (n/a - Unknown - Caused/Prolonged Hospitalisation);Haemorrhage in pregnancy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Premature separation of placenta (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11965582&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11965618	Spontaneous	2017-03-30 00:00:00	Healthcare Professional	Non European Economic Area	MADHI S, CUTLAND C, KUWANDA L, WEINBERG A, HUGO A, JONES S. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sep 04;371(10):918-931.	Not Specified	Neonate (Preterm and Term newborns)	Yes	Male	Anal atresia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly);Foetal distress syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly);Maternal exposure timing unspecified (n/a - Unknown - Caused/Prolonged Hospitalisation, Congenital Anomaly);Premature baby (n/a - Unknown - Caused/Prolonged Hospitalisation, Congenital Anomaly)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11965618&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11965626	Spontaneous	2017-03-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Foetal death (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11965626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11965643	Spontaneous	2017-03-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	0-1 Month	Neonate (Preterm and Term newborns)	Yes	Female	Lower respiratory tract infection (n/a - Fatal - Results in Death);Maternal exposure timing unspecified (n/a - Unknown - Results in Death);Sepsis neonatal (n/a - Fatal - Results in Death);Upper respiratory tract infection (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11965643&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-11966861	Spontaneous	2017-03-30 00:00:00	Healthcare Professional	Non European Economic Area	Madhi S A., Cutland CL., Kuwanda L., Weinberg A., Hugo A., Jones S., et al; Maternal Flu Trial (Matflu) Team. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sep 4; 371 (10):918-31.	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Premature labour (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Premature separation of placenta (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Twin pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11966861&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11966872	Spontaneous	2017-03-30 00:00:00	Healthcare Professional	Non European Economic Area	Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, Adrian PV, van Niekerk N, Treurnicht F, Ortiz JR, Venter M, Violari A, Neuzil KM, Simões EA, Klugman KP, Nunes MC; Maternal Flu Trial (Matflu) Team. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sep 4;371(10):918-31	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Foetal death (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11966872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11967003	Spontaneous	2017-03-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cardiac tamponade (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 15ug - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11967003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11967365	Spontaneous	2017-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Chest pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	[BENDROFLUAZIDE, BENDROFLUMETHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LACTULOSE] (C - n/a - n/a - [n/a - n/a - n/a])|[TERBUTALINE SULFATE, TERBUTALINE SULFATE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11967365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11962218	Spontaneous	2017-03-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11962218&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11937401	Spontaneous	2017-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Atrioventricular block second degree (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Upper respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11937401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11937859	Spontaneous	2017-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Weiler S, Taegtmeyer AB, Mïller S, Rollason V, Livio F, Ceschi A et al.. Sélection de cas issus des centres régionaux de pharmacovigilance (Berne: vaccin contre la grippe). Swiss Medical Forum. 2016;37:757-764	18-64 Years	Adult	No	Female	Neuralgic amyotrophy (92d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - n/a - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11937859&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-11922736	Spontaneous	2017-03-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Back pain (n/a - Recovered/Resolved - Other Medically Important Condition);Dyskinesia (n/a - Recovered/Resolved - Other Medically Important Condition);Epilepsy (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Mobility decreased (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11922736&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11911309	Spontaneous	2017-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Coma (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Encephalitis autoimmune (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - n/a])	[ACETYLCYSTEINE] (C - Bronchitis - Drug withdrawn - [n/a - n/a - Oral])|[AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID] (C - Bronchitis - Drug withdrawn - [n/a - 1g - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Dyspepsia - Dose not changed - [n/a - 40mg - n/a])|[PERINDOPRIL TERT-BUTYLAMINE, AMLODIPINE, INDAPAMIDE] (C - Hypertension - Dose not changed - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11911309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-11911551	Spontaneous	2017-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	CSF protein abnormal (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myelitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - 50ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11911551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11903502	Spontaneous	2017-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11903502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11891731	Spontaneous	2017-03-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Areflexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Autonomic nervous system imbalance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cranial nerve disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diplegia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Motor dysfunction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11891731&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11883601	Spontaneous	2017-03-14 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Hair disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Hirsutism (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypersensitivity (30d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypertrichosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Irritability (30d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Papule (30d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (30d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11883601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11876818	Spontaneous	2017-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Neuritis (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11876818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-11870877	Spontaneous	2017-03-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Illness (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (3d - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[OMEPRAZOLE] (C - Gastritis - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11870877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11856060	Spontaneous	2017-03-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11856060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11848674	Spontaneous	2017-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza A virus test positive (4d - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11848674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11848675	Spontaneous	2017-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11848675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11849998	Spontaneous	2017-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Drug ineffective (n/a - Fatal - Results in Death);Influenza (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11849998&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-11841189	Spontaneous	2017-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Drug withdrawn - [n/a - .5mL - Unknown])	HUMIRA 40 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE [ADALIMUMAB] (C - n/a - Dose not changed - [n/a - n/a - Unknown])|METHOTREXATE [METHOTREXATE] (C - n/a - Dose not changed - [n/a - n/a - n/a])|[SULFASALAZINE] (C - n/a - Dose not changed - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11841189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11825535	Spontaneous	2017-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - );Hyperhidrosis (n/a - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11825535&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11818134	Spontaneous	2017-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Drug ineffective (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11818134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11818284	Spontaneous	2017-03-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Facial asymmetry (n/a - Unknown - Other Medically Important Condition);Facial paralysis (n/a - Unknown - Other Medically Important Condition);Paralytic lagophthalmos (n/a - Unknown - Other Medically Important Condition);Tongue paralysis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11818284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11820417	Spontaneous	2017-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Ankylosing spondylitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Gastrooesophageal reflux disease - Not applicable - [n/a - 1{DF} - Oral])|[FLURBIPROFEN] (C - Osteoarthritis - n/a - [n/a - n/a - Oral])|[RAMIPRIL] (C - Hypertension - Not applicable - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11820417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11795957	Spontaneous	2017-02-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Gait disturbance (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Quadriplegia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11795957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11786563	Spontaneous	2017-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Dehydration (n/a - Unknown - Life Threatening);Drug ineffective (n/a - Recovering/Resolving - Life Threatening);Influenza (n/a - Recovering/Resolving - Life Threatening);Oedema peripheral (n/a - Unknown - Life Threatening);Productive cough (n/a - Unknown - Life Threatening);Pyrexia (10d - Recovered/Resolved - Life Threatening);Rales (n/a - Recovering/Resolving - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[MIANSERIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[OXAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])|[RISPERIDONE] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11786563&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-11788580	Spontaneous	2017-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blindness (5d - Unknown - Other Medically Important Condition);Chorioretinopathy (n/a - Unknown - Other Medically Important Condition);Pupillary reflex impaired (n/a - Unknown - Other Medically Important Condition);Retinal detachment (n/a - Unknown - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11788580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11790546	Spontaneous	2017-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Apathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nystagmus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Strabismus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tonsillar hypertrophy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11790546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11780267	Spontaneous	2017-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Acute kidney injury (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Anaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bicytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dehydration (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hepatic cytolysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperthermia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Multiple organ dysfunction syndrome (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	SYNAGIS [PALIVIZUMAB] (C - n/a - n/a - [n/a - 100mg - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11780267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11781449	Spontaneous	2017-02-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Small intestinal obstruction (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11781449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11772369	Spontaneous	2017-02-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Leptospirosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neutropenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (4wk - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Still's disease (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	ANTIPSYCHOTICS [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11772369&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11774040	Spontaneous	2017-02-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyporeflexia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nosocomial infection (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory disturbance (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urinary retention (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11774040&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-11769259	Spontaneous	2017-02-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11769259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11756359	Spontaneous	2017-02-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Facial paresis (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait inability (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Motor dysfunction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11756359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11750600	Spontaneous	2017-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (10d - Recovered/Resolved - );Vaccination failure (10d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11750600&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11745827	Spontaneous	2017-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Drug ineffective (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	ROACTEMRA 20 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION [TOCILIZUMAB] (I - Polymyalgia rheumatica - Dose not changed - [n/a - n/a - Intravenous (not otherwise specified)])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (I - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[PREDNISONE] (I - Polymyalgia rheumatica - Dose not changed - [n/a - 5mg - Oral])	IRBESARTAN [IRBESARTAN] (C - n/a - Dose not changed - [n/a - 150mg - Oral])|PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - Dose not changed - [n/a - 20mg - Oral])|[FLUINDIONE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[FUROSEMIDE] (C - n/a - Dose not changed - [n/a - 60mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 850mg - Oral])|[SOTALOL HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 80mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11745827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11746627	Spontaneous	2017-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11746627&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11734540	Spontaneous	2017-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Facial paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [1d - 1mL - Intramuscular])|[HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM HYDROXIDE [PRODUCED IN S. CEREVISIAE (STRAIN 2150-2-3) BY RDNA], ALGELDRATE] (S - Immunisation - Not applicable - [1d - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11734540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11735870	Spontaneous	2017-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypertransaminasaemia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Retching (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11735870&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11736733	Spontaneous	2017-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACICLOVIR] (C - Herpes zoster - Dose not changed - [5d - 2{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11736733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11739970	Spontaneous	2017-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])	[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11739970&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11726812	Spontaneous	2017-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vaccination site oedema (n/a - Recovering/Resolving - );Vaccination site pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11726812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11709149	Spontaneous	2017-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Body temperature increased (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11709149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11697569	Spontaneous	2017-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Ecchymosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Erythema multiforme (n/a - Unknown - Caused/Prolonged Hospitalisation);Lip swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Mouth haemorrhage (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Oral mucosal blistering (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Petechiae (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash maculo-papular (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11697569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11688092	Spontaneous	2017-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11688092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11691154	Spontaneous	2017-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11691154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11684748	Spontaneous	2017-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Injection site haematoma (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11684748&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11679853	Spontaneous	2017-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Drug ineffective (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11679853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11680657	Spontaneous	2017-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Tremor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11680657&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11671648	Spontaneous	2017-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11671648&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11665602	Spontaneous	2017-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Polyneuropathy (n/a - Recovering/Resolving - Disabling)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11665602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11667584	Spontaneous	2017-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Increased bronchial secretion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11667584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11658045	Spontaneous	2017-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovered/Resolved - );Diarrhoea (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11658045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11658062	Spontaneous	2017-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - );Muscular weakness (n/a - Recovered/Resolved - );Paraesthesia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11658062&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11625140	Spontaneous	2017-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Status epilepticus (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])|[BLEOMYCIN] (S - Hodgkin's disease stage IV - Not applicable - [n/a - n/a - Intravenous drip])|[DACARBAZINE] (S - Non-Hodgkin's lymphoma stage IV - Not applicable - [n/a - n/a - Intravenous drip])|[DOXORUBICIN HYDROCHLORIDE] (S - Hodgkin's disease stage IV - Not applicable - [n/a - n/a - Intravenous drip])|[VINBLASTINE, VINBLASTINE SULFATE] (S - Hodgkin's disease stage IV - Not applicable - [n/a - n/a - Intravenous drip])	EMEND [APREPITANT, FOSAPREPITANT DIMEGLUMINE] (C - n/a - n/a - [n/a - n/a - n/a])|EXFORGE [VALSARTAN, AMLODIPINE, VALSARTAN, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE HEMISUCCINATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ONDANSETRON] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11625140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-11611680	Spontaneous	2017-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Balance disorder (n/a - Not Recovered/Not Resolved - );Dizziness (n/a - Not Recovered/Not Resolved - );Gait disturbance (n/a - Not Recovered/Not Resolved - );Photosensitivity reaction (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11611680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-11604581	Spontaneous	2017-01-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11604581&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11604709	Spontaneous	2017-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Purpura (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])|[IBUPROFEN] (S - Headache - Unknown - [n/a - n/a - Oral])|[PARACETAMOL] (S - Headache - Unknown - [n/a - 1g - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11604709&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11595248	Spontaneous	2017-01-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11595248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11597030	Spontaneous	2017-01-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Diplopia (n/a - Unknown - Other Medically Important Condition);Miller Fisher syndrome (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11597030&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11597031	Spontaneous	2017-01-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11597031&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11597032	Spontaneous	2017-01-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Elderly	No	Male	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition);West Nile viral infection (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11597032&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11597033	Spontaneous	2017-01-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11597033&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11589031	Spontaneous	2017-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Influenza (12d - Recovered/Resolved - );Vaccination failure (12d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11589031&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11583737	Spontaneous	2017-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	General physical health deterioration (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperthermia (n/a - Recovered/Resolved - Other Medically Important Condition);Infection (n/a - Recovered/Resolved - Other Medically Important Condition);Platelet count decreased (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11583737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11585124	Spontaneous	2017-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Bronchitis (n/a - Unknown - Other Medically Important Condition);Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11585124&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11587054	Spontaneous	2017-01-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Chronic obstructive pulmonary disease (n/a - Unknown - Other Medically Important Condition);Diplopia (n/a - Unknown - Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11587054&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11587055	Spontaneous	2017-01-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Elderly	No	Male	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11587055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11580240	Spontaneous	2017-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Parenteral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11580240&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11580382	Spontaneous	2017-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11580382&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11573344	Spontaneous	2017-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Encephalopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11573344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11574444	Spontaneous	2017-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Ear swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Lip oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11574444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11572420	Spontaneous	2017-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Polyarthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11572420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11556996	Spontaneous	2017-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diplopia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);VIth nerve paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPRANOLOL, PROPRANOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11556996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11556326	Spontaneous	2017-01-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11556326&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11552338	Spontaneous	2016-12-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Nasal congestion (2d - Recovered/Resolved - Other Medically Important Condition);Parosmia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11552338&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11543457	Spontaneous	2016-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hepatic cytolysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11543457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11545620	Spontaneous	2016-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Dermatitis allergic (732d - Recovered/Resolved - Other Medically Important Condition);Rash pruritic (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	[AMILORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DORNASE ALFA] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOCETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PANCREALIPASE, PANCREAS POWDER, PANCREAS POWDER FROM PORCINE, PANCREATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11545620&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-11538078	Spontaneous	2016-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Encephalitis (20d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11538078&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11530643	Spontaneous	2016-12-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Body temperature increased (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11530643&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11525309	Spontaneous	2016-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11525309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11518959	Spontaneous	2016-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hepatitis toxic (13d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Antiviral prophylaxis - Not applicable - [12d - 5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11518959&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11520249	Spontaneous	2016-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthma (n/a - Not Recovered/Not Resolved - Life Threatening);Chills (n/a - Not Recovered/Not Resolved - Life Threatening);Fatigue (n/a - Not Recovered/Not Resolved - Life Threatening);Vaccination site joint pain (n/a - Not Recovered/Not Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	ELIQUIS [APIXABAN] (C - n/a - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[THIAMINE, PYRIDOXINE HYDROCHLORIDE, VITAMIN B] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11520249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-11520288	Spontaneous	2016-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Erythema multiforme (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash pruritic (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11520288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11520415	Spontaneous	2016-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pruritus (n/a - Unknown - Other Medically Important Condition);Rash papular (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Unknown - [n/a - n/a - Unknown])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[BIOFLAVONOIDS, DIOSMIN, HESPERIDIN, MICRONISED PURIFIED FLAVONOIC FRACTION] (C - n/a - Unknown - [n/a - n/a - Unknown])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FUROSEMIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LANSOPRAZOLE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[METFORMIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[TELMISARTAN] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11520415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11521693	Spontaneous	2016-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (1wk - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11521693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11506575	Spontaneous	2016-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Blood pressure increased (19d - Recovered/Resolved - );Haematoma (8d - Recovered/Resolved - );Headache (15d - Recovered/Resolved - );Urticaria (28d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[LEVONORGESTREL] (C - Contraception - Not applicable - [n/a - n/a - Vaginal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11506575&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-11507368	Spontaneous	2016-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Abdominal pain (2d - Recovered/Resolved - Other Medically Important Condition);Arthralgia (2d - Recovered/Resolved - Other Medically Important Condition);Decreased appetite (4d - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (4d - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition);Upper respiratory tract infection (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - Hypertension - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11507368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11507476	Spontaneous	2016-12-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site erythema (3d - Recovered/Resolved - );Vaccination site oedema (3d - Recovered/Resolved - );Vaccination site pain (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11507476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11507609	Spontaneous	2016-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site erythema (3d - Recovered/Resolved - );Vaccination site oedema (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11507609&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11507863	Spontaneous	2016-12-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (2d - Recovered/Resolved - );Malaise (2d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - );Vaccination site erythema (3d - Recovered/Resolved - );Vaccination site induration (3d - Recovered/Resolved - );Vaccination site pain (3d - Recovered/Resolved - );Vaccination site pruritus (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11507863&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11510048	Spontaneous	2016-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Fine motor skill dysfunction (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11510048&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11500430	Spontaneous	2016-12-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Male	Catarrh (15d - Recovered/Resolved - );Chest pain (15d - Recovered/Resolved - );Cough (15d - Recovered/Resolved - );Dyspnoea (15d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11500430&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-11503029	Spontaneous	2016-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Diarrhoea (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypokalaemia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyponatraemia (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Inflammation (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash morbilliform (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	DULOXETINE HYDROCHLORIDE [DULOXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ALPRAZOLAM] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DILTIAZEM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[INDAPAMIDE, INDAPAMIDE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11503029&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11495042	Spontaneous	2016-12-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest pain (n/a - Unknown - Life Threatening, Other Medically Important Condition);Myocarditis (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pleurisy (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pulmonary embolism (n/a - Unknown - Life Threatening, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID] (C - Ligament sprain - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11495042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-11496160	Spontaneous	2016-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Monoplegia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11496160&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11480629	Spontaneous	2016-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Expired product administered (n/a - Unknown - Other Medically Important Condition);Medication error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11480629&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11480995	Spontaneous	2016-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Expired product administered (n/a - Unknown - Other Medically Important Condition);Medication error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11480995&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11481003	Spontaneous	2016-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Expired product administered (n/a - Unknown - Other Medically Important Condition);Medication error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11481003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11479140	Spontaneous	2016-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11479140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11472855	Spontaneous	2016-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chills (n/a - Unknown - Other Medically Important Condition);Ear discomfort (n/a - Unknown - Other Medically Important Condition);Ear pain (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypoacusis (n/a - Unknown - Other Medically Important Condition);Limb mass (n/a - Unknown - Other Medically Important Condition);Oedema peripheral (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	SIMBRINZA 10 MG/ML + 2 MG/ML [BRINZOLAMIDE, BRIMONIDINE TARTRATE] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - n/a])|[AESCIN, ESCIN, HEPARIN, DIETHYLAMINE SALICYLATE, AESCIN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[BETAMETHASONE DIPROPIONATE, SALICYLIC ACID, BETAMETHASONE, SALICYLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11472855&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11469443	Spontaneous	2016-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11469443&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11469492	Spontaneous	2016-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11469492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11469525	Spontaneous	2016-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11469525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11461347	Spontaneous	2016-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (3d - Recovered/Resolved - Other Medically Important Condition);Bone pain (3d - Recovered/Resolved - Other Medically Important Condition);Headache (3d - Recovered/Resolved - Other Medically Important Condition);Myalgia (3d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11461347&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11461522	Spontaneous	2016-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Expired product administered (n/a - Unknown - Other Medically Important Condition);Medication error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11461522&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11461523	Spontaneous	2016-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Expired product administered (n/a - Unknown - Other Medically Important Condition);Medication error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11461523&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11461539	Spontaneous	2016-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Expired product administered (n/a - Unknown - Other Medically Important Condition);Medication error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11461539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11461543	Spontaneous	2016-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Expired product administered (n/a - Unknown - Other Medically Important Condition);Medication error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11461543&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11461554	Spontaneous	2016-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Expired product administered (n/a - Unknown - Other Medically Important Condition);Medication error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11461554&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11461555	Spontaneous	2016-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Expired product administered (n/a - Unknown - Other Medically Important Condition);Medication error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11461555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11461576	Spontaneous	2016-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Expired product administered (n/a - Unknown - Other Medically Important Condition);Medication error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11461576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11461586	Spontaneous	2016-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Expired product administered (n/a - Unknown - Other Medically Important Condition);Medication error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11461586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11452452	Spontaneous	2016-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11452452&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11452612	Spontaneous	2016-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site inflammation (n/a - Recovered/Resolved - Other Medically Important Condition);Presyncope (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (2d - Recovered/Resolved - Other Medically Important Condition);Swelling face (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (6d - Recovered/Resolved - Other Medically Important Condition);Wheezing (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - Unknown - [n/a - 1{DF} - Unknown])|[MOMETASONE FUROATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11452612&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11454299	Spontaneous	2016-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);General physical health deterioration (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - Nasal])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11454299&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11456018	Spontaneous	2016-12-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Body temperature increased (2d - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Heart rate increased (n/a - Unknown - Other Medically Important Condition);Sinus pain (n/a - Unknown - Other Medically Important Condition);Vocal cord dysfunction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11456018&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11446632	Spontaneous	2016-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Face oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11446632&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11452279	Spontaneous	2016-12-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11452279&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11452288	Spontaneous	2016-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Balance disorder (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Cerebral infarction (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Syncope (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[BENDROFLUMETHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[DIGOXIN] (C - n/a - n/a - [n/a - n/a - n/a])|[DOXAZOSIN MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11452288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-11445831	Spontaneous	2016-12-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Drug interaction (n/a - Unknown - Other Medically Important Condition);Inappropriate schedule of product administration (n/a - Unknown - Other Medically Important Condition);Iritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);New daily persistent headache (9d - Recovered/Resolved - Other Medically Important Condition)	SIMPONI [GOLIMUMAB] (I - Rheumatoid arthritis - Unknown - [n/a - 50mg - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (I - Immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11445831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11414624	Spontaneous	2016-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Not Specified	Facial paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11414624&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11415257	Spontaneous	2016-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Balance disorder (24h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Camptocormia (24h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (24h - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])|[CYAMEMAZINE] (S - Neuropsychological symptoms - Drug withdrawn - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11415257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11408397	Spontaneous	2016-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vascular purpura (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11408397&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11397666	Spontaneous	2016-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Gastrointestinal lymphoma (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Hemiplegia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Hypergammaglobulinaemia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Mesenteric lymphadenitis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Staphylococcal infection (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11397666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-11398703	Spontaneous	2016-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Meningoradiculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ALFUZOSIN HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - 10mg - Oral])|[ALLOPURINOL] (C - n/a - Not applicable - [n/a - 200mg - Oral])|[FUROSEMIDE] (C - n/a - Not applicable - [n/a - 20mg - Oral])|[NEBIVOLOL] (C - n/a - Not applicable - [n/a - 5mg - Oral])|[OMEPRAZOLE] (C - n/a - Not applicable - [n/a - 20mg - Oral])|[PARACETAMOL] (C - n/a - Not applicable - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - Not applicable - [n/a - 2.5mg - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - Not applicable - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11398703&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11395207	Spontaneous	2016-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (7d - Recovering/Resolving - Other Medically Important Condition);Headache (7d - Recovered/Resolved - Other Medically Important Condition);Myalgia (7d - Recovered/Resolved - Other Medically Important Condition);Pruritus (7d - Recovered/Resolved - Other Medically Important Condition);Vaccination site irritation (7d - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11395207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11389143	Spontaneous	2016-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Extra dose administered (n/a - Recovered/Resolved - );No adverse event (n/a - Recovered/Resolved - );Vaccination error (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11389143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11368274	Spontaneous	2016-11-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11368274&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11373832	Spontaneous	2016-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Cranial nerve paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eyelid ptosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ischaemic stroke (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11373832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11373858	Spontaneous	2016-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Allergy to vaccine (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Skin warm (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11373858&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11373878	Spontaneous	2016-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Chills (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Influenza (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11373878&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11363813	Spontaneous	2016-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Paraesthesia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11363813&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11359070	Spontaneous	2016-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Pyrexia (n/a - Fatal - Results in Death)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11359070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-11345506	Spontaneous	2016-11-09 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Cellulitis (n/a - Unknown - Other Medically Important Condition);Inflammation (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11345506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11329171	Spontaneous	2016-11-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Confusional state (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Feeling abnormal (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Oxygen saturation decreased (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Somnolence (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Tachycardia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Tachypnoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Vomiting (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11329171&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-11313002	Spontaneous	2016-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Eyelid oedema (n/a - Recovering/Resolving - );Injection site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11313002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11314791	Spontaneous	2016-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Oedema peripheral (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[WARFARINUM NATRICUM CLATHRATUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11314791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11317560	Spontaneous	2016-11-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (n/a - Unknown - Results in Death);Feeling abnormal (n/a - Unknown - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11317560&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-11317576	Spontaneous	2016-11-02 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Bronchospasm (n/a - Unknown - Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation);Urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11317576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11302618	Spontaneous	2016-10-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Erythema multiforme (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11302618&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11286236	Spontaneous	2016-10-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Nasopharyngitis (n/a - Unknown - );Pain (n/a - Unknown - );Renal pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11286236&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-11279409	Spontaneous	2016-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pyrexia (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Dose not changed - [n/a - 1{DF} - Parenteral])	[FENOFIBRATE] (C - Dyslipidaemia - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11279409&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11273036	Spontaneous	2016-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Bone pain (n/a - Unknown - Other Medically Important Condition);Decreased immune responsiveness (n/a - Unknown - Other Medically Important Condition);Infection (n/a - Unknown - Other Medically Important Condition);Lymphoma (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Viral infection (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11273036&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11266146	Spontaneous	2016-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hypoacusis (n/a - Not Recovered/Not Resolved - Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11266146&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11267010	Spontaneous	2016-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Incorrect dose administered (n/a - Unknown - );Vaccination error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11267010&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11260380	Spontaneous	2016-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Disabling, Other Medically Important Condition);Myalgia (n/a - Unknown - Disabling, Other Medically Important Condition);Polyarthritis (n/a - Unknown - Disabling, Other Medically Important Condition);Rheumatoid arthritis (n/a - Unknown - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	HYDROCORTISONE [HYDROCORTISONE, HYDROCORTISONE SODIUM SUCCINATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[FLUDROCORTISONE ACETATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[PREDNISONE] (C - n/a - Unknown - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - Unknown - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11260380&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11244770	Spontaneous	2016-10-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Diarrhoea (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11244770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11207332	Spontaneous	2016-10-05 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chest pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11207332&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11201283	Spontaneous	2016-10-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Immune thrombocytopenia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11201283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11206985	Spontaneous	2016-10-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Platelet count decreased (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11206985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-11187664	Spontaneous	2016-09-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Mononeuropathy (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Skin discolouration (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11187664&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11173232	Spontaneous	2016-09-26 00:00:00	Healthcare Professional	European Economic Area	MAYET A, NIVOIX P, HAUS-CHEYMOL R, DE LAVAL F, VERRET C, DURON S, et al. Increase in reported adverse events following seasonal influenza vaccination among the French armed forces, 2008-2009: possible role of stimulated reporting and background cases of influenza-like infection. Public Health 2012;126:70-76. Mayet A, Haus-Cheymol R, Bouaiti E, Decam C, Simon F, Mérens A, et al. Adverse events following vaccination in the French armed forces: An overview of surveillance conducted from 2002 to 2010. Euro Surveillance 2012 Jun 14;17(24):.	18-64 Years	Not Specified	No	Male	Myopericarditis (48h - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[MENINGOCOCCAL GROUP A, C, W135 AND Y CONJUGATE VACCINE] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11173232&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11141232	Spontaneous	2016-09-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	LUCENTIS [RANIBIZUMAB] (S - Age-related macular degeneration - Dose not changed - [n/a - n/a - Intraocular])|LUCENTIS [RANIBIZUMAB] (S - n/a - Dose not changed - [n/a - n/a - Intraocular])|LUCENTIS [RANIBIZUMAB] (S - n/a - Not applicable - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (C - Product used for unknown indication - Unknown - [1d - n/a - Unknown])|[ACEBUTOLOL, ACEBUTOLOL HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - n/a - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (C - n/a - Not applicable - [n/a - n/a - n/a])|[FLUINDIONE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[FLUINDIONE] (C - n/a - Not applicable - [n/a - n/a - n/a])...	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11141232&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11112726	Spontaneous	2016-09-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Soft tissue infection (n/a - Recovered/Resolved - Other Medically Important Condition);Upper respiratory tract infection (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11112726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11086053	Spontaneous	2016-09-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Febrile infection (n/a - Not Recovered/Not Resolved - );Gastroenteritis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11086053&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11078720	Spontaneous	2016-08-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Gait inability (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11078720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11078745	Spontaneous	2016-08-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Facial paresis (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait inability (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11078745&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11072848	Spontaneous	2016-08-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	B-cell lymphoma (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11072848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11035675	Spontaneous	2016-08-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Pyrexia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Rash (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Vasculitis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])...	[CARVEDILOL] (C - n/a - n/a - [n/a - n/a - Unknown])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - Unknown])|[POTASSIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - Unknown])|[PRAVASTATIN, PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - n/a - Unknown])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - Unknown])|[WARFARIN, WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11035675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-11031568	Spontaneous	2016-08-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Flushing (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11031568&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11015037	Spontaneous	2016-08-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myocarditis (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11015037&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11003090	Spontaneous	2016-08-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Cold sweat (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoacusis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Presyncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11003090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10935109	Spontaneous	2016-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cardiac failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10935109&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10904517	Spontaneous	2016-07-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion missed (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cough (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10904517&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10899085	Spontaneous	2016-07-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10899085&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10892703	Spontaneous	2016-07-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neck pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10892703&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10877374	Spontaneous	2016-07-08 00:00:00	Healthcare Professional	Non European Economic Area	Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, Adrian PV, van Niekerk N, Treurnicht F, Ortiz JR, Venter M, Violari A, Neuzil KM, Simões EA, Klugman KP, Nunes MC; Maternal Flu Trial (Matflu) Team. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sep 4;371(10):918-31	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyelonephritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10877374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10877387	Spontaneous	2016-07-08 00:00:00	Healthcare Professional	Non European Economic Area	Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, Adrian PV, van Niekerk N, Treurnicht F, Ortiz JR, Venter M, Violari A, Neuzil KM, Simões EA, Klugman KP, Nunes MC; Maternal Flu Trial (Matflu) Team. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sep 4;371(10):918-31	18-64 Years	Adult	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Twin pregnancy (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10877387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10877522	Spontaneous	2016-07-08 00:00:00	Healthcare Professional	Non European Economic Area	Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, Adrian PV, van Niekerk N, Treurnicht F, Ortiz JR, Venter M, Violari A, Neuzil KM, Simões EA, Klugman KP, Nunes MC; Maternal Flu Trial (Matflu) Team. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sep 4;371(10):918-31	2 Months - 2 Years	Neonate (Preterm and Term newborns)	Yes	Female	Congenital absence of bile ducts (n/a - Recovered/Resolved - Results in Death, Other Medically Important Condition);Low birth weight baby (n/a - Unknown - Results in Death, Other Medically Important Condition);Maternal exposure timing unspecified (n/a - Unknown - Results in Death, Other Medically Important Condition);Nosocomial infection (n/a - Recovered/Resolved - Results in Death, Other Medically Important Condition);Portoenterostomy (n/a - Recovered/Resolved - Results in Death, Other Medically Important Condition);Premature baby (n/a - Unknown - Results in Death, Other Medically Important Condition);Small intestinal obstruction (n/a - Recovered/Resolved - Results in Death, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10877522&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10877548	Spontaneous	2016-07-08 00:00:00	Healthcare Professional	Non European Economic Area	Madhi S A., Cutland CL., Kuwanda L., Weinberg A., Hugo A., Jones S., et al; Maternal Flu Trial (Matflu) Team. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sep 4; 371 (10):918-31	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Foetal hypokinesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Stillbirth (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10877548&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10877674	Spontaneous	2016-07-08 00:00:00	Healthcare Professional	Non European Economic Area	Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, Adrian PV, van Niekerk N, Treurnicht F, Ortiz JR, Venter M, Violari A, Neuzil KM, Simões EA, Klugman KP, Nunes MC; Maternal Flu Trial (Matflu) Team. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sep 4;371(10):918-31	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Foetal death (n/a - Unknown - Caused/Prolonged Hospitalisation);Haemorrhage in pregnancy (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oligohydramnios (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Premature separation of placenta (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	[FENOTEROL HYDROBROMIDE] (C - n/a - n/a - [n/a - n/a - Unknown])|[SALBUTAMOL] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10877674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10801507	Spontaneous	2016-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dyspnoea (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Therapeutic product ineffective (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10801507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10751214	Spontaneous	2016-06-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Neuromyelitis optica spectrum disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Nuchal rigidity (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10751214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10738904	Spontaneous	2016-06-03 00:00:00	Healthcare Professional	European Economic Area	Mayet A, Duron S, Meynard JB, Koeck JL, Deparis X, Migliani R. Surveillance of adverse events following vaccination in the French armed forces, 2011-2012. Public Health. 2015;129 (6):763-768	18-64 Years	Not Specified	No	Female	Headache (2d - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Other Medically Important Condition);Myalgia (2d - Recovered/Resolved - Other Medically Important Condition);Nausea (2d - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (2d - Recovered/Resolved - Other Medically Important Condition);Vomiting (2d - Recovered/Resolved - Other Medically Important Condition)	MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10738904&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10738916	Spontaneous	2016-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dizziness (24h - Recovered/Resolved - Other Medically Important Condition);Headache (24h - Recovered/Resolved - Other Medically Important Condition);Pain (24h - Recovered/Resolved - Other Medically Important Condition);Pyrexia (24h - Recovered/Resolved - Other Medically Important Condition)	MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (S - Immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10738916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10734913	Spontaneous	2016-06-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Dizziness (n/a - Unknown - Other Medically Important Condition);Gait disturbance (n/a - Unknown - Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10734913&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10736255	Spontaneous	2016-06-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthmatic crisis (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10736255&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10709466	Spontaneous	2016-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	APROVEL [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10709466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10710127	Spontaneous	2016-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Facial paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10710127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10710418	Spontaneous	2016-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10710418&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10645869	Spontaneous	2016-05-11 00:00:00	Healthcare Professional	Non European Economic Area	Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, Adrian PV, van Niekerk N, Treurnicht F, Ortiz JR, Venter M, Violari A, Neuzil KM, Simões EA, Klugman KP, Nunes MC; Maternal Flu Trial (Matflu) Team. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014 Sep 4;371(10):918-31	18-64 Years	Adult	Yes	Female	Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Foetal death (n/a - Unknown - Other Medically Important Condition);Oligohydramnios (n/a - Recovered/Resolved - Other Medically Important Condition);Umbilical cord around neck (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10645869&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10640134	Spontaneous	2016-05-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10640134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10607598	Spontaneous	2016-05-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Burning sensation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10607598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10592601	Spontaneous	2016-04-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Muscle contractions involuntary (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/BRISBANE/60/2008-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/VICTORIA/ 361/2011 (H3N2), HÄMAGGLUTININ A/CALIFORNIA/7/2009 (H1N1), INFLUENZA SURFACE ANTIGENE] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10592601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10588909	Spontaneous	2016-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Pain in extremity (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10588909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10554909	Spontaneous	2016-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Rash papular (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	[DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALUMINIUM HYDROXIDE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALUMINIUM HYDROXIDE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, ALUMINIUM HYDROXIDE] (C - n/a - n/a - [n/a - .5mL - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10554909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10550989	Spontaneous	2016-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10550989&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10542652	Spontaneous	2016-04-14 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	[ALFUZOSIN] (C - n/a - n/a - [n/a - n/a - n/a])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LORAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[RABEPRAZOLE, RABEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10542652&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10537436	Spontaneous	2016-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Rash papular (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Skin exfoliation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	LEVETIRACETAM [LEVETIRACETAM] (C - n/a - n/a - [n/a - n/a - n/a])|[ALPRAZOLAM] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CANRENONE, POTASSIUM CANRENOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DOXAZOSIN, DOXAZOSIN MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[VALSARTAN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10537436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10537455	Spontaneous	2016-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID] (C - Angiopathy - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10537455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10533219	Spontaneous	2016-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypoaesthesia (7d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Oedema (7d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Oedema peripheral (7d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Pain in extremity (7d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Pruritus (7d - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1mg - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10533219&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10517648	Spontaneous	2016-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute polyneuropathy (n/a - Not Recovered/Not Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - Not applicable - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - Not applicable - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - n/a - Oral])|[PIOGLITAZONE] (C - n/a - Not applicable - [n/a - n/a - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10517648&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10513006	Spontaneous	2016-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Generalised tonic-clonic seizure (3min - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Shock symptom (3min - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	M-M-RVAXPRO [MEASLES VIRUS ENDERS' EDMONSTON STRAIN (LIVE, ATTENUATED), MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS] (S - Prophylaxis - n/a - [n/a - n/a - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10513006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10509336	Spontaneous	2016-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10509336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10509378	Spontaneous	2016-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Hypogeusia (n/a - Not Recovered/Not Resolved - );Hyposmia (n/a - Not Recovered/Not Resolved - );Nausea (n/a - Unknown - );Pain in extremity (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10509378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10495666	Spontaneous	2016-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Neuroborreliosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10495666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10496340	Spontaneous	2016-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Herpes zoster (39d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10496340&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10489610	Spontaneous	2016-03-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Bronchitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Conversion disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Demyelination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Depressed mood (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Ear pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Eye pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fall (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Monoplegia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Motor dysfunction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nervous system disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Optic neuritis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Photophobia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pithiatism (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Vertigo (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Walking disability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Wheelchair user (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[LANSOPRAZOLE] (S - n/a - Not applicable - [n/a - 15mg - n/a])	[CEFPODOXIME, CEFPODOXIME PROXETIL] (C - n/a - n/a - [10d - 100mg - Oral])|[PREDNISOLONE, PREDNISOLONE METASULFOBENZOATE SODIUM] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10489610&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10479871	Spontaneous	2016-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10479871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10480127	Spontaneous	2016-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10480127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10456273	Spontaneous	2016-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cough (n/a - Not Recovered/Not Resolved - );Influenza like illness (n/a - Not Recovered/Not Resolved - );Pyrexia (2d - Recovered/Resolved - );Rhinorrhoea (n/a - Not Recovered/Not Resolved - );Secretion discharge (n/a - Not Recovered/Not Resolved - );Vaccination site erythema (3d - Recovered/Resolved - );Vaccination site induration (3d - Recovered/Resolved - );Vaccination site irritation (3d - Recovered/Resolved - );Vaccination site warmth (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10456273&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10416341	Spontaneous	2016-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Throat irritation (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10416341&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10416437	Spontaneous	2016-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Systemic inflammatory response syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10416437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10417625	Spontaneous	2016-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site movement impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10417625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10404573	Spontaneous	2016-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Purpura (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	[AMOXICILLIN SODIUM, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (C - Bronchitis - Not applicable - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10404573&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10405031	Spontaneous	2016-03-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Burning sensation (n/a - Not Recovered/Not Resolved - );Hypoaesthesia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10405031&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10405678	Spontaneous	2016-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Listless (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Tubulointerstitial nephritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10405678&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10392998	Spontaneous	2016-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10392998&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10394781	Spontaneous	2016-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Not Specified	Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10394781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10365243	Spontaneous	2016-02-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epilepsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10365243&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10363674	Spontaneous	2016-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chest pain (n/a - Recovering/Resolving - );Hyperaemia (n/a - Recovering/Resolving - );Pain (n/a - Recovering/Resolving - );Swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10363674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10358164	Spontaneous	2016-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Flushing (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - );Skin reaction (n/a - Recovered/Resolved - );Swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intradermal])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10358164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10358910	Spontaneous	2016-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10358910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10345846	Spontaneous	2016-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vascular purpura (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10345846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10337023	Spontaneous	2016-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10337023&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10327838	Spontaneous	2016-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Epistaxis (3d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Mouth haemorrhage (3d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Petechiae (3d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Thrombocytopenic purpura (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Asthma - n/a - [n/a - n/a - Intramuscular])	BUDESONIDE [BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10327838&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10323190	Spontaneous	2016-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10323190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10309966	Spontaneous	2016-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10309966&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10311382	Spontaneous	2016-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling cold (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypopnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10311382&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10281962	Spontaneous	2016-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Cough (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rheumatoid arthritis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10281962&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10281964	Spontaneous	2016-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10281964&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10281965	Spontaneous	2016-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Cough (n/a - Unknown - );Nausea (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10281965&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10282755	Spontaneous	2016-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Headache (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10282755&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10282760	Spontaneous	2016-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Cough (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10282760&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10282780	Spontaneous	2016-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cough (7d - Unknown - Other Medically Important Condition);Headache (7d - Unknown - Other Medically Important Condition);Influenza A virus test positive (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (7d - Unknown - Other Medically Important Condition);Pyrexia (7d - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10282780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10280652	Spontaneous	2016-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Recovered/Resolved With Sequelae - );Rash (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10280652&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10276479	Spontaneous	2016-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Arthritis (10d - Recovered/Resolved - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Dose not changed - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10276479&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10269077	Spontaneous	2016-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Bronchospasm (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10269077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10269226	Spontaneous	2016-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Injection site oedema (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10269226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10267435	Spontaneous	2016-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Blood pressure decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Hyporesponsive to stimuli (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotonia (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition);Skin warm (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10267435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10257703	Spontaneous	2016-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthmatic crisis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lung disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10257703&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10257906	Spontaneous	2016-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Back pain (n/a - Recovering/Resolving - );Chills (n/a - Recovering/Resolving - );Muscle spasms (n/a - Recovering/Resolving - );Peripheral swelling (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])|[DIPHTHERIA TOXOID ADSORBED, TETANUS TOXOID ADSORBED, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM HYDROXIDE] (S - Diphtheria immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10257906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10258738	Spontaneous	2016-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Pain in extremity (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10258738&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10261427	Spontaneous	2016-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cough (25d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (19d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	MABTHERA [RITUXIMAB] (S - Rheumatoid arthritis - Dose not changed - [n/a - 1000mg - Intravenous (not otherwise specified)])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Unknown - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10261427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10244991	Spontaneous	2016-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10244991&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10245972	Spontaneous	2016-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10245972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10237116	Spontaneous	2016-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Encephalitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10237116&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10230450	Spontaneous	2016-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Erysipelas (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site warmth (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10230450&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10223303	Spontaneous	2016-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Optic neuritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10223303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10223562	Spontaneous	2016-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - );Laryngeal pain (n/a - Recovered/Resolved - );Oedema mouth (n/a - Recovered/Resolved - );Productive cough (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[PARACETAMOL] (C - n/a - n/a - [n/a - 500mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10223562&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10224437	Spontaneous	2016-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10224437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10226001	Spontaneous	2016-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Wrong technique in product usage process (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10226001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10217865	Spontaneous	2016-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10217865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10212697	Spontaneous	2016-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Rash (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10212697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10206045	Spontaneous	2016-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Acute myocardial infarction (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	APROVEL [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|COAPROVEL [HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TICLOPIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[URSODEOXYCHOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10206045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10206828	Spontaneous	2016-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Seizure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	[COLECALCIFEROL] (C - n/a - Unknown - [n/a - 800[iU] - Endotracheal])|[GLICLAZIDE] (C - n/a - Unknown - [n/a - 90mg - Oral])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10206828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10201392	Spontaneous	2016-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hyperthermia (2d - Recovered/Resolved - Other Medically Important Condition);Malaise (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10201392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10190757	Spontaneous	2016-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hyperhidrosis (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10190757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10190822	Spontaneous	2016-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Inflammation (n/a - Recovered/Resolved - );Injection site erythema (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - );Vaccination site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10190822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10188094	Spontaneous	2016-01-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Nasopharyngitis (n/a - Unknown - );Neuralgia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10188094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10189433	Spontaneous	2016-01-14 00:00:00	Healthcare Professional	European Economic Area	Geerse D.A.. Systemic capillary leak syndrome after influenza vaccination in a peritoneal dialysis patient. Peritoneal Dialysis International. 2015;35:7:772-773	65-85 Years	Not Specified	No	Female	Capillary leak syndrome (n/a - Recovered/Resolved - Life Threatening);Myalgia (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	MICARDIS [TELMISARTAN] (C - n/a - Unknown - [n/a - n/a - Oral])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10189433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10181591	Spontaneous	2016-01-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Balance disorder (n/a - Unknown - );Hypoaesthesia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[TERBINAFINHYDROCHLORID] (S - Onychomycosis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10181591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10184007	Spontaneous	2016-01-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Neck pain (n/a - Recovering/Resolving - Other Medically Important Condition);Neuralgic amyotrophy (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Swelling (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site induration (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site pain (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[HYDROXYCHLOROQUINE SULFATE] (C - Chronic cutaneous lupus erythematosus - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10184007&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10174345	Spontaneous	2016-01-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Dizziness (7d - Recovered/Resolved - );Local reaction (7d - Recovered/Resolved - );Migraine (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10174345&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10174797	Spontaneous	2016-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic shock (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Blood pressure fluctuation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Heart rate increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10174797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10170889	Spontaneous	2016-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Flushing (n/a - Recovered/Resolved - );Swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10170889&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10170476	Spontaneous	2016-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Recovering/Resolving - );Induration (n/a - Recovering/Resolving - );Injection site urticaria (n/a - Recovering/Resolving - );Local reaction (n/a - Recovering/Resolving - );Pain (n/a - Recovering/Resolving - );Vaccination site swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10170476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10168354	Spontaneous	2016-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Myelitis transverse (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10168354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10161955	Spontaneous	2016-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10161955&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10163035	Spontaneous	2016-01-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10163035&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10163476	Spontaneous	2016-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Rhinitis (2mo - Recovered/Resolved - );Stomatitis (2mo - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[DEXIBUPROFEN] (C - n/a - Dose not changed - [n/a - 400mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10163476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10157598	Spontaneous	2016-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cholestasis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Eosinophilia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pericarditis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10157598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10153187	Spontaneous	2016-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Recovered/Resolved - );Vaccination site pain (n/a - Recovered/Resolved - );Vaccination site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10153187&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10151390	Spontaneous	2016-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Eye pain (n/a - Unknown - Other Medically Important Condition);Lacrimation increased (14d - Unknown - Other Medically Important Condition);Ocular vasculitis (20d - Recovering/Resolving - Other Medically Important Condition);Uveitis (20d - Recovering/Resolving - Other Medically Important Condition);Visual impairment (14d - Recovered/Resolved - Other Medically Important Condition);Vitreous opacities (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10151390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10140244	Spontaneous	2015-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Injection site erythema (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10140244&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10140245	Spontaneous	2015-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dry mouth (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10140245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10134662	Spontaneous	2015-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10134662&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10128496	Spontaneous	2015-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Aphonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngeal oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10128496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10128536	Spontaneous	2015-12-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cerebral infarction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Quadriplegia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10128536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10114531	Spontaneous	2015-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Fixed eruption (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Parenteral])|[CODEINE, CODEINE, ERYSIMUM CHEIRANTHOIDES (LIQUID EXTRACT)] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])|[IBUPROFEN] (S - n/a - Drug withdrawn - [n/a - 400mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10114531&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10115518	Spontaneous	2015-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthma (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10115518&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10115599	Spontaneous	2015-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dehydration (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10115599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10115620	Spontaneous	2015-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Dysgeusia (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Lip oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Rash pruritic (n/a - Recovered/Resolved - Other Medically Important Condition);Wheezing (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10115620&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10116711	Spontaneous	2015-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dyspnoea (1d - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10116711&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10108226	Spontaneous	2015-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Life Threatening);Polyneuropathy (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10108226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10110035	Spontaneous	2015-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Inappropriate schedule of product administration (n/a - Unknown - );Medication error (n/a - Unknown - );No adverse event (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10110035&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10103518	Spontaneous	2015-12-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (11d - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (27d - Recovered/Resolved - Other Medically Important Condition);Headache (6d - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (11d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinitis (10d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10103518&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-10102090	Spontaneous	2015-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10102090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10096194	Spontaneous	2015-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10096194&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10096300	Spontaneous	2015-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10096300&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10096701	Spontaneous	2015-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Blindness transient (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10096701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10096758	Spontaneous	2015-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Hypotonia (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10096758&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10096810	Spontaneous	2015-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactoid reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Face oedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10096810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10090984	Spontaneous	2015-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Influenza like illness (n/a - Recovering/Resolving - Other Medically Important Condition);Pneumonia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[AMITRIPTYLINE] (C - n/a - Unknown - [n/a - 25mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10090984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10085891	Spontaneous	2015-12-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Myocardial infarction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10085891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10087625	Spontaneous	2015-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Tubulointerstitial nephritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ETHYLCELLULOSE MICROENCAPSULATED 80-90%] (S - n/a - Drug withdrawn - [n/a - 2{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10087625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10080161	Spontaneous	2015-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myocardial infarction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10080161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10080775	Spontaneous	2015-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Pyrexia (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ALLOPURINOL] (C - n/a - n/a - [n/a - 100mg - n/a])|[CARVEDILOL] (C - n/a - n/a - [n/a - 12.5mg - Oral])|[DIGOXIN] (C - n/a - n/a - [n/a - 125mg - Oral])|[FLUVASTATIN SODIUM] (C - n/a - n/a - [n/a - 80mg - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - 40mg - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE] (C - n/a - n/a - [n/a - 5mg - n/a])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - 25mg - n/a])|[WARFARIN, WARFARIN SODIUM] (C - n/a - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10080775&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10081404	Spontaneous	2015-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pruritus (36h - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10081404&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10075273	Spontaneous	2015-12-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthma (2mo - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10075273&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10073412	Spontaneous	2015-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10073412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10073426	Spontaneous	2015-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10073426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10064211	Spontaneous	2015-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site warmth (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Subcutaneous])	[BETAMETHASONE, BETAMETHASONE VALERATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LACTULOSE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[LIQUID PARAFFIN] (C - n/a - n/a - [n/a - n/a - n/a])|[OXAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[POLYVINYL ALCOHOL] (C - n/a - n/a - [n/a - n/a - n/a])|[UREA] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10064211&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10065183	Spontaneous	2015-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dry mouth (0d - Unknown - Other Medically Important Condition);Dysgeusia (0d - Unknown - Other Medically Important Condition);Lip oedema (0d - Unknown - Other Medically Important Condition);Paraesthesia oral (0d - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10065183&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10056826	Spontaneous	2015-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10056826&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10052429	Spontaneous	2015-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Eczema (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10052429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10048098	Spontaneous	2015-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (14d - Recovered/Resolved - Other Medically Important Condition);Cough (14d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (14d - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (14d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Dose not changed - [n/a - .5mL - Parenteral])	TELMISARTAN [TELMISARTAN] (C - n/a - Unknown - [n/a - 80mg - n/a])|[AMLODIPINE] (C - n/a - Unknown - [n/a - 2.5mg - n/a])|[ATORVASTATIN] (C - n/a - Unknown - [n/a - 20mg - n/a])|[BROMAZEPAM] (C - n/a - Unknown - [n/a - 1.5mg - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - 75ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10048098&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10048926	Spontaneous	2015-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erysipelas (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10048926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10041310	Spontaneous	2015-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Peripheral vascular disorder (1min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (20s - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (1min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10041310&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10029858	Spontaneous	2015-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10029858&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10030526	Spontaneous	2015-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Male	Erythema (3d - Recovered/Resolved - );Local reaction (3d - Recovered/Resolved - );Vaccination site swelling (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10030526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10031097	Spontaneous	2015-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Peripheral swelling (2d - Recovered/Resolved - );Rash (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10031097&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10031736	Spontaneous	2015-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Local reaction (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10031736&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10028348	Spontaneous	2015-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site pruritus (n/a - Unknown - );Injection site rash (n/a - Unknown - );Injection site warmth (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10028348&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10023691	Spontaneous	2015-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Diplopia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Respiratory therapy (7d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MESILATE MONOHYDRATE] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10023691&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10019118	Spontaneous	2015-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Altered state of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Feeling abnormal (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Unknown - [1d - n/a - n/a])|[DIACEREIN] (S - Product used for unknown indication - Drug withdrawn - [2d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10019118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10012561	Spontaneous	2015-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012561&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005003	Spontaneous	2015-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Night sweats (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[ASCORBIC ACID, MAGNESIUM OXIDE, HEAVY, MAGNESIUM] (C - Arrhythmia - n/a - [n/a - 250mg - Oral])|[BUDESONIDE] (C - Asthma - n/a - [n/a - n/a - Respiratory (inhalation)])|[IODINE, POTASSIUM IODIDE] (C - Radioactive iodine therapy - n/a - [n/a - .1mg - Oral])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[SIMVASTATIN] (C - Arterial stenosis - n/a - [n/a - 10mg - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9993106	Spontaneous	2015-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Recovered/Resolved - Disabling);Malaise (n/a - Recovered/Resolved - Disabling);Nausea (0d - Recovered/Resolved - Disabling);Pneumonia (n/a - Recovered/Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Seizure (30min - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9993106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9993441	Spontaneous	2015-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ear swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Salivary hypersecretion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE, LERCANIDIPINE HYDROCHLORIDE, LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TRIMETAZIDINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9993441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9995518	Spontaneous	2015-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (6d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9995518&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9995661	Spontaneous	2015-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Glossodynia (0d - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (0d - Recovered/Resolved - Other Medically Important Condition);Pain of skin (0d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (0d - Recovered/Resolved - Other Medically Important Condition);Pruritus (0d - Recovered/Resolved - Other Medically Important Condition);Throat irritation (0d - Recovered/Resolved - Other Medically Important Condition);Tongue pruritus (0d - Recovered/Resolved - Other Medically Important Condition);Urticaria (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CYAMEMAZINE, CYAMEMAZINE TARTRATE] (C - Product used for unknown indication - n/a - [n/a - 35[drp] - Oral])|[DIAZEPAM] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - Oral])|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9995661&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9987924	Spontaneous	2015-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pruritus (4d - Recovered/Resolved - );Rash (n/a - Recovered/Resolved - );Skin lesion (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9987924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9982297	Spontaneous	2015-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (16d - Recovered/Resolved - );Erythema (16d - Recovered/Resolved - );Feeling hot (16d - Recovered/Resolved - );Peripheral swelling (16d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9982297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9983076	Spontaneous	2015-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Chest discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Irritability (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9983076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9983630	Spontaneous	2015-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Extensive swelling of vaccinated limb (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9983630&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9986138	Spontaneous	2015-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Feeling hot (4wk - Recovered/Resolved - );Injection site inflammation (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[VERAPAMIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 180mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9986138&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9977590	Spontaneous	2015-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9977590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9970769	Spontaneous	2015-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Headache (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	[HYDROXYCARBAMIDE] (C - Polycythaemia - n/a - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9970769&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9972743	Spontaneous	2015-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Eczema (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9972743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9968767	Spontaneous	2015-11-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Bursitis (14d - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9968767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9968800	Spontaneous	2015-11-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Blood pressure increased (3d - Recovered/Resolved - );Dizziness (3d - Recovered/Resolved - );Vomiting (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9968800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9958942	Spontaneous	2015-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cardiac output decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9958942&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9961021	Spontaneous	2015-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[ZOLEDRONIC ACID MONOHYDRATE] (C - Product used for unknown indication - Dose not changed - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9961021&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9961847	Spontaneous	2015-11-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site induration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9961847&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9955176	Spontaneous	2015-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Male	Injection site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9955176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9951188	Spontaneous	2015-11-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);VIIIth nerve injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9951188&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9942974	Spontaneous	2015-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site erythema (n/a - Not Recovered/Not Resolved - );Vaccination site pain (n/a - Not Recovered/Not Resolved - );Vaccination site warmth (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9942974&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9946544	Spontaneous	2015-11-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Concomitant disease aggravated (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9946544&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9946641	Spontaneous	2015-11-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9946641&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9946823	Spontaneous	2015-11-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE (POLYRIBOSYLRIBITOL PHOSPHATE), TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9946823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9938198	Spontaneous	2015-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Liver injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9938198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9923261	Spontaneous	2015-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Myelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9923261&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9916204	Spontaneous	2015-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Urticaria (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9916204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9912801	Spontaneous	2015-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pruritus (4d - Recovered/Resolved - );Rash (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9912801&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9914501	Spontaneous	2015-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Dermatitis allergic (n/a - Recovering/Resolving - Other Medically Important Condition);Dysphagia (n/a - Recovering/Resolving - Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Other Medically Important Condition);Urticaria (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9914501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9907432	Spontaneous	2015-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Allergy to vaccine (0d - Recovered/Resolved - Disabling);Anaesthesia oral (4h - Recovered/Resolved - Disabling);Chills (0d - Recovered/Resolved - Disabling);Dry mouth (0d - Recovered/Resolved - Disabling);Dysgeusia (0d - Recovered/Resolved - Disabling);Hypertension (0d - Recovered/Resolved - Disabling);Limb discomfort (3h - Recovered/Resolved - Disabling);Sensory disturbance (0d - Recovered/Resolved - Disabling);Tachycardia (0d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9907432&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9903836	Spontaneous	2015-10-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (n/a - Unknown - Other Medically Important Condition);Flatulence (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Micturition urgency (n/a - Unknown - Other Medically Important Condition);Peroneal nerve palsy (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9903836&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9890934	Spontaneous	2015-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dysphagia (60min - Recovered/Resolved - Life Threatening);Hyperhidrosis (60min - Recovered/Resolved - Life Threatening);Hypersensitivity (60min - Recovered/Resolved - Life Threatening);Paraesthesia (60min - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9890934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-9891630	Spontaneous	2015-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Skin reaction (n/a - Not Recovered/Not Resolved - );Swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9891630&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9892166	Spontaneous	2015-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Rash (n/a - Unknown - );Tremor (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9892166&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-9892240	Spontaneous	2015-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Blood glucose increased (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9892240&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9885781	Spontaneous	2015-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Body temperature increased (4d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Myalgia (4d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	AZOPT 10 MG/ML [BRINZOLAMIDE] (C - n/a - Not applicable - [n/a - 5mL - Ophthalmic])|[ACETYLSALICYLIC ACID] (C - n/a - Not applicable - [n/a - 100mg - Oral])|[ALLOPURINOL] (C - n/a - Not applicable - [n/a - 100mg - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - Not applicable - [n/a - 10mg - Oral])|[BECLOMETASONE DIPROPIONATE, FORMOTEROL, BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - Not applicable - [n/a - n/a - Respiratory (inhalation)])|[BIOFLAVONOIDS, DIOSMIN, HESPERIDIN, MICRONISED PURIFIED FLAVONOIC FRACTION] (C - n/a - Not applicable - [n/a - 500mg - Oral])|[FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - Not applicable - [n/a - n/a - Respiratory (inhalation)])|[FUROSEMIDE] (C - n/a - Not applicable - [n/a - 125mg - Oral])|[GABAPENTIN] (C - n/a - Not applicable - [n/a - 300mg - Oral])|[INDOMETACIN] (C - n/a - Not applicable - [n/a - 100mg - Rectal])|[ISOSORBIDE DINITRATE] (C - n/a - Not applicable - [n/a - 1.25mg - Respiratory (inhalation)])|[ISOSORBIDE MONONITRATE] (C - n/a - Not applicable - [n/a - 50mg - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - Not applicable - [n/a - 25mg - Oral])|[MAGNESIUM CARBONATE, LIGHT, MAGNESIUM OXIDE, LIGHT, MAGNESIUM CARBONATE, MAGNESIUM OXIDE] (C - n/a - Not applicable - [n/a - 365mg - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - 850mg - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - Not applicable - [n/a - 40mg - Oral])|[PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - Not applicable - [n/a - 10mg - Oral])|[SULODEXIDE] (C - n/a - Not applicable - [n/a - n/a - Oral])|[URAPIDIL] (C - n/a - Not applicable - [n/a - 60mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9885781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-9880280	Spontaneous	2015-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Allergy to vaccine (30min - Recovered/Resolved - Disabling);Anaesthesia (30min - Recovered/Resolved - Disabling);Asthenia (n/a - Recovered/Resolved - Disabling);Chills (30min - Recovered/Resolved - Disabling);Dizziness (n/a - Recovered/Resolved - Disabling);Dry mouth (30min - Recovered/Resolved - Disabling);Dysgeusia (30min - Recovered/Resolved - Disabling);Formication (6h - Recovered/Resolved - Disabling);Hypotension (n/a - Recovered/Resolved - Disabling);Limb discomfort (n/a - Recovered/Resolved - Disabling);Muscular weakness (30min - Recovered/Resolved - Disabling);Tachycardia (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9880280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9883147	Spontaneous	2015-10-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site induration (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9883147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9875263	Spontaneous	2015-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Hyperthyroidism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9875263&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9875448	Spontaneous	2015-10-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Micturition frequency decreased (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash maculo-papular (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	AZOPT [BRINZOLAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 200mg - Oral])|[AMOXICILLIN SODIUM, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID, BETACAROTENE, ALPHATOCOPHEROL ACETATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BETAHISTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 8mg - n/a])|[CALCIUM CARBONATE, CHOLECALCIFEROL CONCENTRATE (POWDER FORM), COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CLONAZEPAM] (C - n/a - n/a - [n/a - .5mg - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ETHYLENEDIAMINE, THEOPHYLLINE, THEOPHYLLINE] (C - n/a - n/a - [n/a - 100mg - n/a])|[LEVOTHYROXINE] (C - n/a - n/a - [n/a - n/a - n/a])|[NAFTIDROFURYL] (C - n/a - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 40mg - n/a])|[PARACETAMOL, TRAMADOL, TRAMADOL HYDROCHLORIDE, PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL ARGININE] (C - n/a - n/a - [n/a - 5mg - n/a])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - 25mg - n/a])|[VITAMIN B12] (C - n/a - n/a - [n/a - 1000mg - n/a])|[WARFARIN SODIUM CLATHRATE] (C - n/a - n/a - [n/a - 3mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9875448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9859183	Spontaneous	2015-10-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pneumonia (5d - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9859183&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-9851425	Spontaneous	2015-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dry mouth (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	[ALIMEMAZINE, ALIMEMAZINE TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[OXAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM FLUORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9851425&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9854416	Spontaneous	2015-10-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9854416&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9845905	Spontaneous	2015-10-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Not Recovered/Not Resolved - );Productive cough (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9845905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9839694	Spontaneous	2015-10-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pneumonia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CARBASALATE CALCIUM] (C - n/a - n/a - [n/a - {DF} - Oral])|[CLONAZEPAM] (C - n/a - n/a - [n/a - {DF} - Oral])|[DIPYRIDAMOLE] (C - n/a - n/a - [n/a - {DF} - Oral])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - {DF} - Oral])|[SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - {DF} - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - {DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9839694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-9826114	Spontaneous	2015-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9826114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9826388	Spontaneous	2015-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (6h - Recovered/Resolved - );Pain in extremity (n/a - Recovered/Resolved - );Pyrexia (6h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	EXFORGE 5 MG/160 MG FILM-COATED TABLETS [VALSARTAN, AMLODIPINE] (C - n/a - Dose not changed - [n/a - 5mg - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - Dose not changed - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9826388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9814166	Spontaneous	2015-10-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Thrombosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site joint erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site swelling (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9814166&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9809668	Spontaneous	2015-10-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Bronchospasm (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9809668&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-9791138	Spontaneous	2015-09-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Amyotrophic lateral sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dry mouth (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dysphonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pseudobulbar palsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Speech disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Tachycardia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS (DTAP) VACCINE] (C - Immunisation - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9791138&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9776057	Spontaneous	2015-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Hypoaesthesia (1h - Recovered/Resolved - );Musculoskeletal stiffness (6d - Recovered/Resolved - );Myalgia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9776057&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9770454	Spontaneous	2015-09-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	[NIFEDIPINE] (C - n/a - n/a - [n/a - n/a - Oral])|[PAROXETINE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9770454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9772455	Spontaneous	2015-09-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Laryngeal discomfort (12h - Recovered/Resolved - );Pyrexia (12h - Recovered/Resolved - );Salivary hypersecretion (12h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9772455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9760817	Spontaneous	2015-09-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Conjunctival hyperaemia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9760817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9755817	Spontaneous	2015-09-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pericarditis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9755817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9757373	Spontaneous	2015-09-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Lymphoedema (24h - Recovered/Resolved - );Myalgia (24h - Recovered/Resolved - );Pain in extremity (24h - Recovered/Resolved - );Swelling (24h - Recovered/Resolved - );Tachycardia (24h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9757373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-9738187	Spontaneous	2015-09-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Constipation (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Gastric ulcer (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9738187&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9714246	Spontaneous	2015-09-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Herpes zoster (n/a - Recovered/Resolved - Other Medically Important Condition)	ZOSTAVAX [VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9714246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9696814	Spontaneous	2015-09-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9696814&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9691323	Spontaneous	2015-09-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Local reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9691323&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9576796	Spontaneous	2015-07-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Bradycardia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Irritability (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory distress (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Stridor (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9576796&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9567798	Spontaneous	2015-07-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cold sweat (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9567798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9553608	Spontaneous	2015-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9553608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9548768	Spontaneous	2015-07-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9548768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9548781	Spontaneous	2015-07-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Bronchitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sensory loss (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9548781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9543771	Spontaneous	2015-07-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Immune thrombocytopenia (n/a - Recovered/Resolved - Other Medically Important Condition);Platelet count decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Upper respiratory tract infection (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9543771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9543841	Spontaneous	2015-07-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9543841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9539088	Spontaneous	2015-07-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Fatigue (3mo - Recovered/Resolved - Other Medically Important Condition);Myalgia (3mo - Recovered/Resolved - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[ATORVASTATIN, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - 20mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9539088&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9525388	Spontaneous	2015-07-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Bronchitis (n/a - Recovered/Resolved - Other Medically Important Condition);Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Impaired healing (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (3wk - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (0d - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site erythema (15d - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site swelling (15d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9525388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9525446	Spontaneous	2015-07-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Ageusia (n/a - Not Recovered/Not Resolved - Disabling);Anosmia (n/a - Not Recovered/Not Resolved - Disabling);Chills (n/a - Recovered/Resolved - Disabling);Cough (3wk - Recovered/Resolved - Disabling);Headache (n/a - Recovered/Resolved - Disabling);Nasal congestion (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9525446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9495681	Spontaneous	2015-07-08 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hyporesponsive to stimuli (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9495681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9491283	Spontaneous	2015-07-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vestibular neuronitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9491283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9485302	Spontaneous	2015-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cerebral ischaemia (n/a - Not Recovered/Not Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	EBIXA [MEMANTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|LANTUS [INSULIN GLARGINE] (C - n/a - n/a - [n/a - n/a - Subcutaneous])|NOVORAPID [INSULIN ASPART] (C - n/a - n/a - [n/a - n/a - Subcutaneous])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - Oral])|[RISEDRONATE MONOSODIUM, RISEDRONATE SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[TRAZODONE, TRAZODONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9485302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-9485396	Spontaneous	2015-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sopor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - n/a - Transdermal])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9485396&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9474858	Spontaneous	2015-07-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site extravasation (5mo - Recovered/Resolved - Disabling);Pain in extremity (5mo - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9474858&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9463833	Spontaneous	2015-06-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Periarthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site nodule (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	EUCREAS [METFORMIN HYDROCHLORIDE, VILDAGLIPTIN] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - Oral])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MESILATE MONOHYDRATE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[BENDROFLUMETHIAZIDE, POTASSIUM CHLORIDE] (C - Diuretic therapy - n/a - [n/a - n/a - Oral])|[METFORMIN HYDROCHLORIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - Oral])|[RAMIPRIL] (C - Hypertension - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9463833&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9442176	Spontaneous	2015-06-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Deafness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ear pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[BROMAZEPAM] (C - n/a - n/a - [n/a - n/a - Oral])|[LISINOPRIL, LISINOPRIL ANHYDROUS, LISINOPRIL DIHYDRATE] (C - Hypertension - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9442176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9437305	Spontaneous	2015-06-23 00:00:00	Healthcare Professional	Non European Economic Area	Jöhr N, Tschopp M, Hollbach N, Halter J, Klenk L, Goldblum D. Optic neuritis after influenzae vaccination in a patient after stem cell transplantation. Klinische Monatsblatter fur Augenheilkunde 232:4:484-486.	18-64 Years	Adult	No	Female	Blindness (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Optic neuritis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Papilloedema (n/a - Unknown - Other Medically Important Condition);Pupillary reflex impaired (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	TACROLIMUS [TACROLIMUS, TACROLIMUS MONOHYDRATE] (C - Immunosuppression - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9437305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-9436225	Spontaneous	2015-06-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Back pain (n/a - Unknown - Other Medically Important Condition);Burning mouth syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dry eye (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysgeusia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Food intolerance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Idiopathic environmental intolerance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle spasms (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ocular hyperaemia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pericarditis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Urticaria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight decreased (n/a - Unknown - Other Medically Important Condition)	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (S - Alveolar osteitis - Unknown - [14d - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9436225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9391192	Spontaneous	2015-06-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Ageusia (n/a - Not Recovered/Not Resolved - Disabling);Anosmia (n/a - Not Recovered/Not Resolved - Disabling);Dry mouth (n/a - Not Recovered/Not Resolved - Disabling);Dysgeusia (n/a - Not Recovered/Not Resolved - Disabling);Oral discomfort (n/a - Not Recovered/Not Resolved - Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9391192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9385427	Spontaneous	2015-06-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Not Specified	Angioedema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9385427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9385508	Spontaneous	2015-06-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9385508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9385523	Spontaneous	2015-06-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysentery (n/a - Unknown - );Vaccination site reaction (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[PREDNISONE] (C - n/a - n/a - [n/a - 25mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9385523&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9389909	Spontaneous	2015-06-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Anal pruritus (n/a - Recovering/Resolving - );Oral mucosal blistering (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9389909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9378496	Spontaneous	2015-06-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Clumsiness (2wk - Recovered/Resolved - );Confusional state (2wk - Recovered/Resolved - );Malaise (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9378496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9370207	Spontaneous	2015-06-04 00:00:00	Healthcare Professional	European Economic Area	MAYET A, DURON S, MEYNARD J, KOECK J, DEPARIS X, MIGLIANI R. Surveillance of adverse events following vaccination in the French armed forces, 2011-2012. Publich Health 2015 Mar 06;0033-3506:1-6.	18-64 Years	Adult	No	Male	Asthma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9370207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9370210	Spontaneous	2015-06-04 00:00:00	Healthcare Professional	European Economic Area	MAYET A, DURON S, MEYNARD J, KOECK J, DEPARIS X, MIGLIANI R. Surveillance of adverse events following vaccination in the French armed forces, 2011-2012. Public Health 2015 Mar 06;0033-3506:1-6.	18-64 Years	Adult	No	Female	Facial paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Miller Fisher syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9370210&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9373790	Spontaneous	2015-06-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Extensive swelling of vaccinated limb (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1000mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9373790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9373791	Spontaneous	2015-06-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CARBIDOPA, LEVODOPA] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9373791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9373792	Spontaneous	2015-06-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9373792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9373793	Spontaneous	2015-06-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Recovering/Resolving - );Myalgia (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Vomiting (5h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[CARBASALATE CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[NITROFURANTOIN] (C - n/a - n/a - [n/a - 100mg - Oral])|[PREDNISOLON] (C - n/a - n/a - [n/a - 5mg - Oral])|[TRAMADOL HYDROCHLORIDE, PARACETAMOL] (C - n/a - n/a - [n/a - 2{DF} - Oral])|[VALSARTAN] (C - n/a - n/a - [n/a - 80mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9373793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9361200	Spontaneous	2015-06-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (7d - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (7d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition);Rhinitis (7d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9361200&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9356453	Spontaneous	2015-06-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eye irritation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neck pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Photophobia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash vesicular (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9356453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9357948	Spontaneous	2015-06-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Herpes zoster (6wk - Recovered/Resolved - );Injection site inflammation (4mo - Recovered/Resolved - );Pain in extremity (4mo - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	COAPROVEL 150 MG/12.5 MG FILM-COATED TABLETS [HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9357948&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-9337186	Spontaneous	2015-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Back pain (5mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (5mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Hot flush (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperhidrosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Influenza (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Insomnia (5mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (5mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (5mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain of skin (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Sacral pain (5mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Weight decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9337186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9331527	Spontaneous	2015-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hyperpyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Nausea (n/a - Recovering/Resolving - Other Medically Important Condition);Vomiting (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[LORAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9331527&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9331539	Spontaneous	2015-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Dehydration (n/a - Recovering/Resolving - Life Threatening);Diarrhoea (n/a - Recovering/Resolving - Life Threatening);Nausea (n/a - Recovering/Resolving - Life Threatening);Vomiting (n/a - Recovering/Resolving - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9331539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-9331564	Spontaneous	2015-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Obstructive airways disorder (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[ACENOCOUMAROL] (C - Anticoagulant therapy - n/a - [n/a - 1{DF} - Oral])|[DIGOXIN, DIGOXIN PH. EUR.] (C - Atrial fibrillation - n/a - [n/a - 1{DF} - Oral])|[ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE, ENALAPRIL, HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE, FLUTICASONE, SALMETEROL] (C - Bronchitis chronic - n/a - [n/a - 2{DF} - Respiratory (inhalation)])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - Cardiac failure - n/a - [n/a - 2{DF} - Oral])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - Atrial fibrillation - n/a - [n/a - 3{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9331564&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9331624	Spontaneous	2015-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Obstructive airways disorder (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Prophylaxis - n/a - [n/a - 100mg - Oral])|[DONEPEZIL HYDROCHLORIDE] (C - Dementia - n/a - [n/a - 5mg - Oral])|[FLUTICASONE PROPIONATE] (C - Bronchitis chronic - n/a - [n/a - 500ug - Oropharingeal])|[LACIDIPINE] (C - Hypertension - n/a - [n/a - 4mg - Oral])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - Bronchitis chronic - n/a - [n/a - 18ug - Oropharingeal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9331624&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9331630	Spontaneous	2015-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Aphasia (n/a - Fatal - Results in Death);Bronchitis (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9331630&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-9328370	Spontaneous	2015-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9328370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9328378	Spontaneous	2015-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - n/a - Drug withdrawn - [n/a - 1GBq - Intramuscular])|[YELLOW FEVER VACCINE (LIVE), YELLOW FEVER VIRUS STRAIN 17D-204 (LIVE, ATTENUATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9328378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9328478	Spontaneous	2015-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Tonsillitis (n/a - Unknown - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9328478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9312764	Spontaneous	2015-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Lymphadenitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9312764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9312772	Spontaneous	2015-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9312772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9312787	Spontaneous	2015-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9312787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9307636	Spontaneous	2015-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Acute respiratory failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9307636&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9304149	Spontaneous	2015-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Eye pruritus (n/a - Unknown - Other Medically Important Condition);Eye swelling (n/a - Unknown - Other Medically Important Condition);Jaw disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Joint swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site induration (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vision blurred (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9304149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9304180	Spontaneous	2015-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Bronchitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cardiac failure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Confusional state (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Escherichia infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fungal infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypothermia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Lung disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Malnutrition (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Normocytic anaemia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Productive cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Psychomotor skills impaired (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sinusitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Superficial vein thrombosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Viral pericarditis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 160mg - n/a])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DORZOLAMIDE, DORZOLAMIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DRIED FERROUS SULFATE, FERROUS SULFATE, FERROUS SULFATE HYDRATE, FERROUS SULPHATE SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 40mg - n/a])|[VALSARTAN] (C - n/a - n/a - [n/a - 40mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9304180&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9301747	Spontaneous	2015-05-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - );Hypotension (n/a - Recovered/Resolved - );Tachyarrhythmia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9301747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-9286665	Spontaneous	2015-05-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neuropathy peripheral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	NOVONORM [REPAGLINIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUINDIONE] (C - n/a - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 25ug - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[PROMEGESTONE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[SOTALOL, SOTALOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9286665&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9286672	Spontaneous	2015-05-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Injected limb mobility decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Limb discomfort (7d - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal stiffness (7d - Recovered/Resolved - Other Medically Important Condition);Myalgia (7d - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (7d - Recovered/Resolved - Other Medically Important Condition);Sleep disorder (7d - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9286672&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9282907	Spontaneous	2015-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9282907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9268606	Spontaneous	2015-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Quadriplegia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	XELODA [CAPECITABINE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9268606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-9272024	Spontaneous	2015-05-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - );Paresis (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	LEVEMIR 100U/ML SOLUTION FOR INJECTION [INSULIN DETEMIR] (C - n/a - n/a - [n/a - 12[iU] - Subcutaneous])|[INSULIN ASPART] (C - n/a - n/a - [n/a - 1{DF} - Subcutaneous])|[METHYLPHENIDATE HYDROCHLORIDE] (C - n/a - n/a - [n/a - {DF} - Oral])|[QUETIAPINE FUMARATE] (C - n/a - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9272024&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-9258866	Spontaneous	2015-05-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Male	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Extra dose administered (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Vaccination error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9258866&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9258882	Spontaneous	2015-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Metatarsalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Polyneuropathy (20d - Recovered/Resolved - Other Medically Important Condition);Radiculopathy (n/a - Recovered/Resolved - Other Medically Important Condition);Sciatica (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9258882&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9258887	Spontaneous	2015-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Condition aggravated (n/a - Recovering/Resolving - Other Medically Important Condition);Gait inability (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9258887&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9239337	Spontaneous	2015-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - );Groin pain (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	[PARACETAMOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9239337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9243005	Spontaneous	2015-04-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticarial vasculitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9243005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9233357	Spontaneous	2015-04-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Local reaction (n/a - Recovered/Resolved - );Pain (n/a - Not Recovered/Not Resolved - );Peripheral swelling (n/a - Not Recovered/Not Resolved - );Sensory disturbance (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9233357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9227186	Spontaneous	2015-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dermatitis bullous (n/a - Recovering/Resolving - );Skin reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 100ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9227186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9217911	Spontaneous	2015-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Condition aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9217911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9217927	Spontaneous	2015-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Intercostal neuralgia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	JANUMET [METFORMIN HYDROCHLORIDE, SITAGLIPTIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9217927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9221284	Spontaneous	2015-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cerebellar ataxia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 15ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9221284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9225136	Spontaneous	2015-04-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Eczema (n/a - Recovering/Resolving - );Extensive swelling of vaccinated limb (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9225136&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9203084	Spontaneous	2015-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Asthmatic crisis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9203084&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9203086	Spontaneous	2015-04-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9203086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9212985	Spontaneous	2015-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - );Influenza like illness (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9212985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9213393	Spontaneous	2015-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pain (n/a - Not Recovered/Not Resolved - );Sensory level abnormal (n/a - Not Recovered/Not Resolved - );Swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9213393&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9203030	Spontaneous	2015-04-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9203030&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9209881	Spontaneous	2015-04-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Injection site inflammation (n/a - Recovering/Resolving - );Pyrexia (18h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	COMBIVIR FILM-COATED TABLETS [ZIDOVUDINE, LAMIVUDINE] (C - n/a - n/a - [n/a - {DF} - Oral])|KALETRA ORAL SOLUTION [LOPINAVIR, RITONAVIR] (C - n/a - n/a - [n/a - {DF} - Oral])|[ACENOCOUMAROL] (C - n/a - n/a - [n/a - {DF} - Oral])|[INSULIN, INSULIN HUMAN] (C - n/a - n/a - [n/a - {DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9209881&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9202933	Spontaneous	2015-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation);Bronchiolitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ear infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Inappropriate schedule of product administration (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tonsillitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination error (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9202933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9192872	Spontaneous	2015-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Discomfort (n/a - Recovering/Resolving - Disabling);Hypoaesthesia (n/a - Recovering/Resolving - Disabling);Pain in extremity (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9192872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9184175	Spontaneous	2015-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site inflammation (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9184175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9184244	Spontaneous	2015-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9184244&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9184505	Spontaneous	2015-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Encephalitis (3mo - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9184505&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9186513	Spontaneous	2015-04-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pericardial effusion (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pleurisy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 80mg - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Hypercholesterolaemia - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9186513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9168555	Spontaneous	2015-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9168555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9169391	Spontaneous	2015-04-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Decreased appetite (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pallor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Prostate cancer (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Tenderness (n/a - Unknown - Other Medically Important Condition);Weight decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9169391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9166275	Spontaneous	2015-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Bronchial obstruction (n/a - Recovered/Resolved - );Bronchitis viral (n/a - Recovered/Resolved - );Condition aggravated (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9166275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9157792	Spontaneous	2015-04-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dysaesthesia (n/a - Fatal - Results in Death);Language disorder (n/a - Fatal - Results in Death);Paraesthesia (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - 50mg - n/a])|[CLONAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[NIFEDIPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEGA-3 FATTY ACIDS, OMEGA-3-ACID ETHYL ESTERS 90] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9157792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-9156917	Spontaneous	2015-04-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza like illness (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9156917&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9144068	Spontaneous	2015-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Odynophagia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9144068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9144095	Spontaneous	2015-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Odynophagia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9144095&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9144154	Spontaneous	2015-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lymphadenopathy (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])|[ALUMINIUM OXIDE, HYDRATED, DIPHTHERIA TOXOID, TETANUS TOXOID, DIPHTHERIA TOXOID, TETANUS TOXOID, DIPHTHERIA TOXOID, TETANUS TOXOID, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM HYDROXIDE] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9144154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9138311	Spontaneous	2015-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])|[AZATHIOPRINE] (S - Rheumatoid arthritis - Unknown - [n/a - n/a - n/a])	[BILASTINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESTRADIOL, ESTRADIOL HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROXOCOBALAMIN] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a])|[NITRAZEPAM, NITRAZEPAM BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9138311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9128707	Spontaneous	2015-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - );Dysphonia (n/a - Recovered/Resolved - );Influenza like illness (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9128707&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9128733	Spontaneous	2015-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9128733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9128760	Spontaneous	2015-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9128760&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9130350	Spontaneous	2015-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Influenza like illness (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site reaction (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9130350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9113488	Spontaneous	2015-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	C-reactive protein increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);White blood cell count increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9113488&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9122045	Spontaneous	2015-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hypotension (n/a - Recovered/Resolved - Life Threatening);Injury (n/a - Unknown - Life Threatening);Loss of consciousness (n/a - Recovered/Resolved - Life Threatening);Traumatic shock (n/a - Unknown - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9122045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-9122073	Spontaneous	2015-03-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9122073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9122075	Spontaneous	2015-03-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cough (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza (n/a - Recovering/Resolving - Other Medically Important Condition);Nasopharyngitis (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Rhinorrhoea (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[DUTASTERIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9122075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9101324	Spontaneous	2015-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Eye disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling hot (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovering/Resolving - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition);Vision blurred (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9101324&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9110380	Spontaneous	2015-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9110380&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9097824	Spontaneous	2015-03-24 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Agitation (n/a - Not Recovered/Not Resolved - );Confusional state (n/a - Not Recovered/Not Resolved - );Dysarthria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	KEPPRA [LEVETIRACETAM] (C - Epilepsy - n/a - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9097824&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-9093016	Spontaneous	2015-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - );Chromaturia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9093016&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9086609	Spontaneous	2015-03-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9086609&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9080752	Spontaneous	2015-03-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9080752&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9061931	Spontaneous	2015-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Abdominal distension (n/a - Fatal - Results in Death);Liver disorder (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9061931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-9062028	Spontaneous	2015-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Aphasia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Confusional state (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nuchal rigidity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 5mL - Intramuscular])	[ACETYL L-CARNITINE, ACETYLCARNITINE HYDROCHLORIDE, CARNITINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[CINNARIZINE, DIMENHYDRINATE] (C - n/a - n/a - [n/a - 2{DF} - n/a])|[CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - 4[drp] - n/a])|[DEANOL HEMISUCCINATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9062028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9062131	Spontaneous	2015-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9062131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9062296	Spontaneous	2015-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9062296&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9056735	Spontaneous	2015-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Colitis (4mo - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[FOLIC ACID] (C - Prophylaxis - n/a - [n/a - .4mg - Oral])|[MESALAZINE] (C - Colitis - Drug withdrawn - [n/a - 1g - Rectal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9056735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9056871	Spontaneous	2015-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9056871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9056937	Spontaneous	2015-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - );Asthenia (n/a - Recovering/Resolving - );Oral herpes (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9056937&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9056973	Spontaneous	2015-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza like illness (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9056973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9040576	Spontaneous	2015-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Neutrophil count decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation);White blood cell count decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9040576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9040623	Spontaneous	2015-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema peripheral (n/a - Recovered/Resolved - Other Medically Important Condition)	MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9040623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9033034	Spontaneous	2015-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Instillation site reaction (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9033034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9028656	Spontaneous	2015-03-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Nasopharyngitis (n/a - Unknown - );Platelet count normal (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|VELMETIA [METFORMIN HYDROCHLORIDE, SITAGLIPTIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [5y - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9028656&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9029857	Spontaneous	2015-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9029857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9026222	Spontaneous	2015-03-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Pneumococcal infection (n/a - Unknown - );Pneumonia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [787d - 1{DF} - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9026222&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-9012329	Spontaneous	2015-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Conjunctivitis (n/a - Recovering/Resolving - );Facial paralysis (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - );Oral herpes (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9012329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-9013472	Spontaneous	2015-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9013472&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9011344	Spontaneous	2015-03-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site inflammation (5d - Recovered/Resolved - );Myalgia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	NON SPECIFIED O.A.C. [UNKNOWN] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9011344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8999404	Spontaneous	2015-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Drug ineffective (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8999404&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8999407	Spontaneous	2015-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Drug ineffective (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8999407&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8999450	Spontaneous	2015-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Drug ineffective (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8999450&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8999458	Spontaneous	2015-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Drug ineffective (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8999458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8999460	Spontaneous	2015-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Drug ineffective (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8999460&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8999462	Spontaneous	2015-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Drug ineffective (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8999462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8999482	Spontaneous	2015-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Drug ineffective (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8999482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8999857	Spontaneous	2015-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Extensive swelling of vaccinated limb (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - );Streptococcal infection (n/a - Recovered/Resolved - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8999857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9001054	Spontaneous	2015-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Condition aggravated (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Meningeal disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Movement disorder (10min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rheumatic disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	METHOTREXATE [METHOTREXATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9001054&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8994522	Spontaneous	2015-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Pericarditis (37d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8994522&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8988307	Spontaneous	2015-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8988307&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8983090	Spontaneous	2015-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - Dose not changed - [n/a - 20mg - Oral])|[BECLOMETASONE DIPROPIONATE] (C - n/a - Dose not changed - [n/a - 400ug - Oral])|[FORMOTEROL FUMARATE] (C - n/a - Dose not changed - [n/a - 12ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8983090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8978231	Spontaneous	2015-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8978231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8969738	Spontaneous	2015-02-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Acute disseminated encephalomyelitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gastrointestinal motility disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Urinary retention (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	[DIPLOCOCCUS PNEUMONIAE TYPE I, HAEMOPHILUS INFLUENZAE, KLEBSIELLA OZAENAE, KLEBSIELLA PNEUMONIAE, NEISSERIA CATARRHALIS, STAPHYLOCOCCUS AUREUS, STREPTOCOCCUS PYOGENES, STREPTOCOCCUS VIRIDANS] (C - n/a - n/a - [n/a - n/a - n/a])|[VALSARTAN] (C - n/a - n/a - [n/a - 80mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8969738&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8971318	Spontaneous	2015-02-25 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8971318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8964798	Spontaneous	2015-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8964798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8965504	Spontaneous	2015-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8965504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8965505	Spontaneous	2015-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8965505&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8959756	Spontaneous	2015-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cellulitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8959756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8963003	Spontaneous	2015-02-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site inflammation (n/a - Recovered/Resolved - );Rash erythematous (10d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 100ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8963003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8952390	Spontaneous	2015-02-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8952390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8941943	Spontaneous	2015-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8941943&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8934487	Spontaneous	2015-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Circumoral oedema (n/a - Recovering/Resolving - );Lip oedema (n/a - Recovering/Resolving - );Pruritus (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8934487&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8934528	Spontaneous	2015-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8934528&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8934598	Spontaneous	2015-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8934598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8934613	Spontaneous	2015-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Nasopharyngitis (n/a - Recovered/Resolved - );Oropharyngeal pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8934613&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8936028	Spontaneous	2015-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8936028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8930774	Spontaneous	2015-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Not Recovered/Not Resolved - );Vaccination failure (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8930774&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8929203	Spontaneous	2015-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8929203&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8929238	Spontaneous	2015-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Hyperpyrexia (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8929238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8929303	Spontaneous	2015-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8929303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8929351	Spontaneous	2015-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - );Oral pain (n/a - Recovered/Resolved - );Swelling face (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8929351&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8923087	Spontaneous	2015-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Face oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	REVLIMID 25 MG HARD CAPSULES [LENALIDOMIDE] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8923087&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8923227	Spontaneous	2015-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovering/Resolving - );Eye swelling (n/a - Recovering/Resolving - );Flushing (n/a - Recovering/Resolving - );Nasal obstruction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8923227&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8923273	Spontaneous	2015-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Urticaria (n/a - Recovered/Resolved - );Vaccination site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	[AMLODIPINE, AMLODIPINE BESILATE] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[CAPTOPRIL, HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE, ENALAPRIL, HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8923273&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8923953	Spontaneous	2015-02-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Other Medically Important Condition);Cough (n/a - Recovering/Resolving - Other Medically Important Condition);Decreased appetite (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8923953&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8924636	Spontaneous	2015-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cellulitis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Septic shock (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	[BACITRACIN ZINC, NEOMYCIN, BACITRACIN ZINC, NEOMYCIN SULFATE, BACITRACIN, NEOMYCIN] (C - n/a - n/a - [n/a - n/a - n/a])|[DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - n/a])|[TELMISARTAN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8924636&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8925051	Spontaneous	2015-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Aphonia (n/a - Unknown - Other Medically Important Condition);Bronchitis (n/a - Unknown - Other Medically Important Condition);Laryngitis (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Sinusitis (n/a - Unknown - Other Medically Important Condition);Upper respiratory tract infection (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8925051&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8925086	Spontaneous	2015-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Demyelinating polyneuropathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Respiratory tract infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8925086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8925101	Spontaneous	2015-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Henoch-Schonlein purpura (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8925101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8925115	Spontaneous	2015-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8925115&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8925133	Spontaneous	2015-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Blood pressure increased (n/a - Recovering/Resolving - Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Other Medically Important Condition);Erythema (n/a - Recovering/Resolving - Other Medically Important Condition);Nasal congestion (n/a - Recovering/Resolving - Other Medically Important Condition);Tachycardia (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site reaction (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8925133&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8905542	Spontaneous	2015-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8905542&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8909442	Spontaneous	2015-02-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8909442&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8901245	Spontaneous	2015-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8901245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8901645	Spontaneous	2015-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8901645&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8899310	Spontaneous	2015-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypotonia (n/a - Recovered/Resolved - );Loss of consciousness (n/a - Recovered/Resolved - );Pallor (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8899310&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8899317	Spontaneous	2015-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hypotension (n/a - Recovered/Resolved - );Syncope (n/a - Recovered/Resolved - );Tachycardia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 500uL - Subcutaneous])	CLOPIDOGREL [CLOPIDOGREL, CLOPIDOGREL BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8899317&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8899318	Spontaneous	2015-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cough (n/a - Not Recovered/Not Resolved - );Influenza like illness (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8899318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8899355	Spontaneous	2015-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - );Cough (n/a - Recovered/Resolved - );Influenza (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Rhinorrhoea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8899355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8899423	Spontaneous	2015-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - );Influenza (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Rhinorrhoea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8899423&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8899449	Spontaneous	2015-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyshidrotic eczema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8899449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8899466	Spontaneous	2015-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysphagia (n/a - Recovered/Resolved - );Presyncope (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8899466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8898331	Spontaneous	2015-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - );Erythema (n/a - Recovering/Resolving - );Face oedema (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8898331&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8893029	Spontaneous	2015-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute respiratory failure (n/a - Recovered/Resolved With Sequelae - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	HIROBRIZ BREEZHALER [INDACATEROL] (C - Chronic obstructive pulmonary disease - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|RILUTEK [RILUZOLE] (C - Amyotrophic lateral sclerosis - n/a - [n/a - 1{DF} - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - Dyslipidaemia - n/a - [n/a - 1{DF} - Oral])|[LANSOPRAZOLE] (C - Chronic gastritis - n/a - [n/a - 30mg - Oral])|[LEVOTHYROXINE SODIUM] (C - Central hypothyroidism - n/a - [n/a - 1{DF} - Oral])|[METFORMIN HYDROCHLORIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - 850mg - Oral])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 2{DF} - Oral])|[WARFARIN SODIUM] (C - Atrial fibrillation - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8893029&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-8893453	Spontaneous	2015-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Escherichia pyelonephritis (n/a - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8893453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8895381	Spontaneous	2015-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8895381&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8896075	Spontaneous	2015-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	H1N1 influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8896075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8888189	Spontaneous	2015-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Neuritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8888189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8888249	Spontaneous	2015-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash erythematous (n/a - Recovered/Resolved - Other Medically Important Condition);Rash vesicular (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8888249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8888954	Spontaneous	2015-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Not Specified	Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8888954&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8889372	Spontaneous	2015-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8889372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8890076	Spontaneous	2015-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Influenza (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8890076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8890082	Spontaneous	2015-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Influenza (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8890082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8890126	Spontaneous	2015-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8890126&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8890416	Spontaneous	2015-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8890416&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8882957	Spontaneous	2015-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (n/a - Recovered/Resolved - );Injection site warmth (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[LORAZEPAM] (C - n/a - n/a - [n/a - 1mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8882957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8877905	Spontaneous	2015-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperpyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8877905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8878484	Spontaneous	2015-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cyanosis (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 10[drp] - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8878484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8878502	Spontaneous	2015-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site pain (n/a - Recovering/Resolving - );Vaccination site swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8878502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8872978	Spontaneous	2015-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8872978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8873000	Spontaneous	2015-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Ear discomfort (n/a - Recovering/Resolving - );Hypoacusis (n/a - Recovering/Resolving - );Hypoaesthesia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8873000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8873044	Spontaneous	2015-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8873044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8871972	Spontaneous	2015-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Lymphadenopathy (n/a - Recovered/Resolved - );Vaccination site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - n/a - n/a - [n/a - 2{DF} - n/a])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 2{DF} - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[TICLOPIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8871972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8872018	Spontaneous	2015-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Purpura (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 75mg - Oral])|[PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8872018&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8871341	Spontaneous	2015-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8871341&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8871349	Spontaneous	2015-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Presyncope (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8871349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-8871355	Spontaneous	2015-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Gait disturbance (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8871355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8871408	Spontaneous	2015-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8871408&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8865330	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Pyrexia (n/a - Recovering/Resolving - );Vaccination site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8865330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8865350	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Condition aggravated (n/a - Recovered/Resolved - );Confusional state (n/a - Recovered/Resolved - );Herpes simplex (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8865350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8865363	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hepatic enzyme increased (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	[HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - Hypotension - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Dyslipidaemia - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8865363&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8865408	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8865408&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8865412	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypotension (n/a - Recovered/Resolved - );Pallor (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8865412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8865414	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hyperpyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8865414&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8865435	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Malaise (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Oropharyngeal pain (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8865435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8865459	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Rash (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8865459&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8865469	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - );Vaccination site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8865469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8865496	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8865496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8865501	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypotension (n/a - Recovered/Resolved - );Muscle rigidity (n/a - Recovered/Resolved - );Pallor (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8865501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8869050	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Thrombocytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8869050&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8856294	Spontaneous	2015-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Unknown - );Dyspnoea exertional (n/a - Unknown - );Feeling cold (n/a - Unknown - );Hypotension (n/a - Unknown - );Myalgia (n/a - Unknown - );Nausea (n/a - Unknown - );Pyrexia (n/a - Unknown - );Sleep disorder (n/a - Unknown - );Somnolence (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8856294&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8858951	Spontaneous	2015-01-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Extensive swelling of vaccinated limb (4d - Recovered/Resolved - );Pyrexia (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[SODIUM VALPROATE] (C - n/a - n/a - [n/a - 4mL - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8858951&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8848815	Spontaneous	2015-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Facial paralysis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8848815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8848950	Spontaneous	2015-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest pain (n/a - Recovering/Resolving - );Hyperthermia (n/a - Recovering/Resolving - );Paraesthesia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8848950&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8849013	Spontaneous	2015-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Oedema (n/a - Unknown - );Paraesthesia oral (n/a - Unknown - );Urticaria (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8849013&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8850604	Spontaneous	2015-01-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8850604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8850606	Spontaneous	2015-01-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Cough (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8850606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8850767	Spontaneous	2015-01-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cough (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8850767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8850770	Spontaneous	2015-01-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8850770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8852534	Spontaneous	2015-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Pruritus (n/a - Not Recovered/Not Resolved - );Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[EZETIMIBE] (C - n/a - n/a - [n/a - 10mg - Oral])|[UNKNOWN] (C - n/a - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8852534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8841257	Spontaneous	2015-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8841257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8841311	Spontaneous	2015-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, ALUMINIUM HYDROXIDE GEL, MAGNESIUM HYDROXIDE, ACETYLSALICYLIC ACID, MAGNESIUM HYDROXIDE, ALGELDRATE] (C - n/a - n/a - [n/a - 150mg - Oral])|[FOLIC ACID] (C - n/a - n/a - [n/a - 5mg - Oral])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - 25mg - Oral])|[LORAZEPAM] (C - n/a - n/a - [n/a - 1mg - Oral])|[METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 100mg - Oral])|[PANTOPRAZOLE] (C - n/a - n/a - [n/a - 40mg - Oral])|[RAMIPRIL] (C - n/a - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8841311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8841346	Spontaneous	2015-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Asthma (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperpyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8841346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8842005	Spontaneous	2015-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypertension (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	GLIBENCLAMIDE [GLIBENCLAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8842005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8842121	Spontaneous	2015-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8842121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8848116	Spontaneous	2015-01-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Fatigue (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Myalgia (6wk - Recovered/Resolved With Sequelae - );Pyrexia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8848116&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-8840170	Spontaneous	2015-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site erythema (n/a - Recovering/Resolving - );Vaccination site pain (n/a - Recovering/Resolving - );Vaccination site pruritus (n/a - Recovering/Resolving - );Vaccination site swelling (n/a - Recovering/Resolving - );Vaccination site warmth (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8840170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8840227	Spontaneous	2015-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovering/Resolving - );Pain (n/a - Recovering/Resolving - );Swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8840227&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8836749	Spontaneous	2015-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8836749&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8834066	Spontaneous	2015-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myelitis transverse (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8834066&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-8825726	Spontaneous	2015-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epilepsy (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - Petit mal epilepsy - n/a - [n/a - 1200mg - Oral])|[PHENOBARBITAL] (C - Petit mal epilepsy - n/a - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8825726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8829717	Spontaneous	2015-01-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8829717&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8820670	Spontaneous	2015-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Facial paresis (n/a - Not Recovered/Not Resolved - Disabling);Hypoacusis (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESOMEPRAZOLE MAGNESIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[TRIPTORELIN, TRIPTORELIN ACETATE, TRIPTORELIN PAMOATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8820670&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8820979	Spontaneous	2015-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8820979&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8821926	Spontaneous	2015-01-20 00:00:00	Healthcare Professional	Non European Economic Area	Vermeiren P, Aubert V, Sugamele R, Aubert J, Venetz J, Meylan P, et al. Influenza vaccination and humoral alloimmunity in solid organ transplant recipients. Transplant International 2014;1-6.	18-64 Years	Adult	No	Male	Transplant rejection (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8821926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8821927	Spontaneous	2015-01-20 00:00:00	Healthcare Professional	Non European Economic Area	Vermeiren P, Aubert V, Sugamele R, Aubert J, Venetz J, Meylan P, et al. Influenza vaccination and humoral alloimmunity in solid organ transplant recipients. Transplant International 2014;1-6.	18-64 Years	Adult	No	Male	Transplant rejection (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8821927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8821928	Spontaneous	2015-01-20 00:00:00	Healthcare Professional	Non European Economic Area	Vermeiren P, Aubert V, Sugamele R, Aubert J, Venetz J, Meylan P, et al. Influenza vaccination and humoral alloimmunity in solid organ transplant recipients. Transplant International 2014;1-6.	18-64 Years	Adult	No	Male	Transplant rejection (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8821928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8821929	Spontaneous	2015-01-20 00:00:00	Healthcare Professional	Non European Economic Area	Vermeiren P, Aubert V, Sugamele R, Aubert J, Venetz J, Meylan P, et al. Influenza vaccination and humoral alloimmunity in solid organ transplant recipients. Transplant International 2014;1-6.	18-64 Years	Adult	No	Male	Antibody test positive (n/a - Unknown - Other Medically Important Condition);Transplant rejection (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8821929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8821931	Spontaneous	2015-01-20 00:00:00	Healthcare Professional	Non European Economic Area	Vermeiren P, Aubert V, Sugamele R, Aubert J, Venetz J, Meylan P, et al. Influenza vaccination and humoral alloimmunity in solid organ transplant recipients. Transplant International 2014;1-6.	18-64 Years	Adult	No	Female	Transplant rejection (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8821931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8816823	Spontaneous	2015-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ecchymosis (n/a - Recovered/Resolved - );Vaccination site erythema (n/a - Recovered/Resolved - );Vaccination site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8816823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8816377	Spontaneous	2015-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8816377&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8816380	Spontaneous	2015-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8816380&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8811168	Spontaneous	2015-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Rash (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[CAPTOPRIL, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 2{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8811168&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8814596	Spontaneous	2015-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Not Recovered/Not Resolved - );Palpitations (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - 20mg - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8814596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8814597	Spontaneous	2015-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[SIMVASTATIN] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8814597&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8814600	Spontaneous	2015-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (1d - Recovered/Resolved - );Injection site inflammation (n/a - Recovering/Resolving - );Myalgia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[DICLOFENAC NATRIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8814600&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8814602	Spontaneous	2015-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (7d - Recovered/Resolved With Sequelae - );Pyrexia (7d - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8814602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-8814604	Spontaneous	2015-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Diarrhoea (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8814604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8814607	Spontaneous	2015-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Chills (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8814607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8814609	Spontaneous	2015-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Injection site inflammation (5d - Recovered/Resolved - );Pyrexia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 25mg - Oral])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 50mg - Oral])|[UNKNOWN] (C - n/a - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8814609&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8814610	Spontaneous	2015-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Headache (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Palpitations (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[ENALAPRIL WATERSTOFMALEAAT] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8814610&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8814611	Spontaneous	2015-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Cough (n/a - Not Recovered/Not Resolved - );Headache (7d - Recovered/Resolved - );Myalgia (n/a - Recovering/Resolving - );Pyrexia (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACENOCOUMAROL] (C - n/a - n/a - [n/a - 2{DF} - Oral])|[FLECAINIDE ACETATE] (C - n/a - n/a - [n/a - 50mg - n/a])|[VERAPAMIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8814611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8809867	Spontaneous	2015-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Hypothalamo-pituitary disorder (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8809867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8797292	Spontaneous	2015-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Not Specified	Hyperpyrexia (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8797292&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8792737	Spontaneous	2015-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Recovered/Resolved - );Confusional state (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8792737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8792743	Spontaneous	2015-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8792743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8791882	Spontaneous	2015-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - );Chills (n/a - Unknown - );Somnolence (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8791882&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8790977	Spontaneous	2015-01-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Headache (n/a - Recovering/Resolving - );Myalgia (n/a - Unknown - );Nasopharyngitis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8790977&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8786903	Spontaneous	2015-01-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Injected limb mobility decreased (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8786903&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8786914	Spontaneous	2015-01-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8786914&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8779679	Spontaneous	2015-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysphonia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[DICLOFENAC EPOLAMINE, DICLOFENAC SODIUM] (S - Pain in extremity - Not applicable - [n/a - n/a - Cutaneous])|[NAPROXEN SODIUM ANHYDROUS] (S - Pain in extremity - Not applicable - [n/a - 1{DF} - Oral])|[OMEPRAZOLE] (S - n/a - Not applicable - [n/a - 1{DF} - Oral])	JANUMET [METFORMIN HYDROCHLORIDE, SITAGLIPTIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[INDAPAMIDE, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMINE, INDAPAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8779679&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8780717	Spontaneous	2015-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8780717&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8778191	Spontaneous	2015-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Not Specified	Meningoradiculitis (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8778191&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-8775570	Spontaneous	2015-01-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Atrial fibrillation (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	[METOPROLOL SUCCINATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8775570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8775576	Spontaneous	2015-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Balance disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling abnormal (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypertension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Perioral dermatitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8775576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8768558	Spontaneous	2015-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Angioedema (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	ENBREL [ETANERCEPT] (C - n/a - n/a - [n/a - 1{DF} - Subcutaneous])|LEFLUNOMIDE [LEFLUNOMIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8768558&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8768635	Spontaneous	2015-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arthralgia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Blindness (2mo - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Bronchitis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Bursitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Diplopia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dysarthria (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dysphagia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dysphonia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Eyelid ptosis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Facial paralysis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Gingival recession (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hemiparesis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Miller Fisher syndrome (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Morganella infection (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Oral discharge (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pneumonia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pruritus (1mo - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Staphylococcal infection (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Temporomandibular joint syndrome (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Tremor (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Weight decreased (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - Myocardial ischaemia - n/a - [n/a - n/a - Oral])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENZYMES NOS] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEGA-3-ACID ETHYL ESTERS, OMEGA-3-ACID ETHYL ESTERS 90] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[PROPAFENONE HYDROCHLORIDE] (C - Arrhythmia - n/a - [n/a - n/a - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8768635&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8769847	Spontaneous	2015-01-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Condition aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Eye pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Formication (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypotension (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Oral herpes (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8769847&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8758548	Spontaneous	2014-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Acute kidney injury (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myositis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8758548&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8752022	Spontaneous	2014-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8752022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8754217	Spontaneous	2014-12-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Extensive swelling of vaccinated limb (11d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8754217&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8733285	Spontaneous	2014-12-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Polyneuropathy (n/a - Recovering/Resolving - Other Medically Important Condition);Vasculitis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8733285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8736637	Spontaneous	2014-12-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Herpes zoster (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[HYDROCHLOORTHIAZIDE] (C - n/a - n/a - [n/a - 12.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8736637&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8730200	Spontaneous	2014-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vasculitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	ANTIDEPRESSANTS [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8730200&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8732315	Spontaneous	2014-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dysgeusia (4wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8732315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8732318	Spontaneous	2014-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Arthralgia (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[SIMVASTATIN] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8732318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8732322	Spontaneous	2014-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Cough (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[METFORMINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8732322&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8732335	Spontaneous	2014-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	LYRICA 75 MG HARD CAPSULES [PREGABALIN] (C - n/a - n/a - [n/a - 75mg - Oral])|[MAGNESIUMHYDROXIDE] (C - n/a - n/a - [n/a - 1448mg - Oral])|[MEBEVERINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 200mg - Oral])|[METFORMINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - Oral])|[PANTOPRAZOL NATRIUM-1.5-WATER] (C - n/a - n/a - [n/a - 40mg - Oral])|[ZOPICLON] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8732335&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8732368	Spontaneous	2014-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	[CITALOPRAM HYDROBROMIDE] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8732368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8724654	Spontaneous	2014-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Erysipelas (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8724654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8727502	Spontaneous	2014-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Chronic obstructive pulmonary disease (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8727502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8727550	Spontaneous	2014-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Thrombotic thrombocytopenic purpura (157d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8727550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8719285	Spontaneous	2014-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Neurological examination abnormal (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8719285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8719302	Spontaneous	2014-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperpyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8719302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8719307	Spontaneous	2014-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Throat irritation (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8719307&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8721213	Spontaneous	2014-12-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8721213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8721249	Spontaneous	2014-12-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8721249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8721283	Spontaneous	2014-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Hypoacusis (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8721283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8713259	Spontaneous	2014-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Respiratory disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Drug withdrawn - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8713259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8714457	Spontaneous	2014-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute generalised exanthematous pustulosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])|[SULFAMETHOXAZOLE, TRIMETHOPRIM] (S - n/a - Dose not changed - [n/a - 1{DF} - n/a])|[VALACICLOVIR HYDROCHLORIDE] (S - n/a - Dose not changed - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8714457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8714800	Spontaneous	2014-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8714800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8716096	Spontaneous	2014-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Chest pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8716096&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8716121	Spontaneous	2014-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8716121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8716171	Spontaneous	2014-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Arthralgia (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[DEXAMETHASONE, TOBRAMYCIN] (C - n/a - n/a - [n/a - {DF} - Ophthalmic])|[DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - {DF} - Ophthalmic])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - {DF} - Oral])|[LATANOPROST] (C - n/a - n/a - [n/a - {DF} - Ophthalmic])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - {DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8716171&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8707076	Spontaneous	2014-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Condition aggravated (n/a - Recovered/Resolved - Other Medically Important Condition);Epilepsy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8707076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8709650	Spontaneous	2014-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pericarditis (10mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pleural effusion (10mo - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ALLOPURINOL] (C - Hyperuricaemia - Dose not changed - [n/a - 1{DF} - Oral])|[LORATADINE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[LOSARTAN POTASSIUM] (C - Hypertension - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8709650&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8710175	Spontaneous	2014-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Body temperature increased (n/a - Recovered/Resolved - );Chills (n/a - Recovered/Resolved - );Feeling cold (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	AERIUS [DESLORATADINE] (C - Bronchial hyperreactivity - Dose not changed - [n/a - 5mg - Oral])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Bronchial hyperreactivity - Dose not changed - [n/a - 2{DF} - Respiratory (inhalation)])|[FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE] (C - Bronchial hyperreactivity - Dose not changed - [n/a - 2{DF} - Respiratory (inhalation)])|[RANITIDINE] (C - Gastrooesophageal reflux disease - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8710175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8710202	Spontaneous	2014-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Male	Erythema multiforme (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8710202&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8702727	Spontaneous	2014-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8702727&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8704107	Spontaneous	2014-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Tongue discomfort (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8704107&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8706152	Spontaneous	2014-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cardiac failure (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Parenteral])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CITALOPRAM HYDROBROMIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[CLOPIDOGREL] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8706152&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8700366	Spontaneous	2014-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Unknown - );Local reaction (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8700366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8701824	Spontaneous	2014-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Fatigue (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Paraesthesia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8701824&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8701832	Spontaneous	2014-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Body temperature increased (1mo - Not Recovered/Not Resolved - );Nasopharyngitis (2mo - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8701832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8701856	Spontaneous	2014-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Upper respiratory tract infection (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8701856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8693101	Spontaneous	2014-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pleural effusion (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sepsis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8693101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8693152	Spontaneous	2014-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Ataxia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dry mouth (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia oral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - Transient ischaemic attack - n/a - [n/a - 75mg - Oral])|[ENALAPRIL MALEATE] (C - Hypertension - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8693152&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8693163	Spontaneous	2014-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dermo-hypodermitis (n/a - Recovering/Resolving - Other Medically Important Condition);Urticaria (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site dermatitis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8693163&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8696389	Spontaneous	2014-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	C-reactive protein increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperpyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Leukocytosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8696389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8696424	Spontaneous	2014-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lip oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sensation of foreign body (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8696424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8688358	Spontaneous	2014-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cervicobrachial syndrome (n/a - Recovering/Resolving - Other Medically Important Condition);Facial paralysis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8688358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8690407	Spontaneous	2014-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Vaccination site abscess (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (C - Immunisation - n/a - [n/a - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8690407&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8691140	Spontaneous	2014-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Heart transplant rejection (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8691140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8692127	Spontaneous	2014-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Aphasia (30min - Recovered/Resolved - );Dyskinesia (30min - Recovered/Resolved - );Injection site pain (30min - Recovered/Resolved - );Paraesthesia oral (30min - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CARMELLOSE SODIUM] (C - n/a - n/a - [n/a - 1[drp] - Ophthalmic])|[DIAZEPAM] (C - n/a - n/a - [n/a - 2mg - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 25mg - Oral])|[HYPROMELLOSE] (C - n/a - n/a - [n/a - 1[drp] - Ophthalmic])|[MAGNESIUMHYDROXIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - {DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8692127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8692176	Spontaneous	2014-12-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	INSULIN LISPRO 100 U/ML - SOLUTION FOR INJECTION  (C - n/a - n/a - [n/a - 1{DF} - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8692176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8692183	Spontaneous	2014-12-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza (n/a - Recovering/Resolving - );Myalgia (3wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8692183&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8683878	Spontaneous	2014-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Face oedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8683878&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8683927	Spontaneous	2014-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Acute kidney injury (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - 75mg - Oral])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - Oral])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - 5mg - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 80mg - Oral])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - Oral])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - 25mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - Oral])|[MIRTAZAPINE] (C - n/a - n/a - [n/a - 30mg - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8683927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8686256	Spontaneous	2014-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Sudden hearing loss (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ISOSORBIDE 5 MONONITRATE, ISOSORBIDE MONONITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8686256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8687776	Spontaneous	2014-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[PANTOPRAZOL NATRIUM-1.5-WATER] (C - n/a - n/a - [n/a - n/a - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - 1000mg - Oral])|[PREDNISOLON] (C - n/a - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8687776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8687793	Spontaneous	2014-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Rash (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[LEVOCETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8687793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8680038	Spontaneous	2014-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Asthenia (13d - Recovered/Resolved - );Body temperature increased (13d - Recovered/Resolved - );Myalgia (13d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8680038&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8680736	Spontaneous	2014-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Dermatitis allergic (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8680736&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8681520	Spontaneous	2014-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Myositis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8681520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8682344	Spontaneous	2014-12-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Night sweats (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Peripheral coldness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 40mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8682344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8674697	Spontaneous	2014-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Acute respiratory failure (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperpyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8674697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8677770	Spontaneous	2014-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Myelitis transverse (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8677770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8678481	Spontaneous	2014-12-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Asthma (3h - Recovered/Resolved - );Cough (3wk - Recovered/Resolved - );Injection site inflammation (3wk - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[BUDESONIDE] (C - n/a - n/a - [n/a - 2{DF} - Oral])|[DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - 75mg - Oral])|[FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[RABEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8678481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-8673853	Spontaneous	2014-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Eyelid oedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[CLONAZEPAM] (C - n/a - n/a - [n/a - n/a - Oral])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[HAEMOPHILUS INFLUENZAE, KLEBSIELLA PNEUMONIAE, STREPTOCOCCUS PNEUMONIAE, STREPTOCOCCUS PYOGENES, RIBOSOMAL FRACTIONS] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 50ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8673853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8668913	Spontaneous	2014-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8668913&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8669496	Spontaneous	2014-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Respiratory tract infection (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8669496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8670474	Spontaneous	2014-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (3d - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8670474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8670613	Spontaneous	2014-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Malaise (0d - Recovered/Resolved - );Musculoskeletal stiffness (3d - Recovered/Resolved - );Nausea (0d - Recovered/Resolved - );Peripheral swelling (3d - Recovered/Resolved - );Syncope (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[DROSPIRENONE, ETHINYLESTRADIOL] (C - Contraception - Dose not changed - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8670613&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8670684	Spontaneous	2014-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Inflammation (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8670684&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8671401	Spontaneous	2014-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Needle issue (n/a - Unknown - );Vaccination site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8671401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8673156	Spontaneous	2014-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	Yes	Male	Ecchymosis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ATENOLOL] (C - n/a - n/a - [n/a - 25mg - Oral])|[CARBASALATE CALCIUM] (C - n/a - n/a - [n/a - 100mg - Oral])|[FUROSEMIDE] (C - n/a - n/a - [n/a - 20mg - Oral])|[METFORMINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8673156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8673166	Spontaneous	2014-12-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Cough (2wk - Recovered/Resolved - );Influenza like illness (2wk - Recovered/Resolved With Sequelae - );Pyrexia (2wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[EZETIMIBE] (C - n/a - n/a - [n/a - n/a - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[NEBIVOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 5mg - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8673166&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-8673171	Spontaneous	2014-12-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Influenza like illness (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Unknown - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8673171&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8673175	Spontaneous	2014-12-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Chills (65h - Recovered/Resolved - );Malaise (1d - Recovered/Resolved - );Myalgia (65h - Recovered/Resolved - );Night sweats (65h - Recovered/Resolved - );Pyrexia (75h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8673175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8673206	Spontaneous	2014-12-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8673206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8666095	Spontaneous	2014-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Rash papular (n/a - Unknown - )	TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8666095&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8667906	Spontaneous	2014-12-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8667906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8667910	Spontaneous	2014-12-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8667910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8659149	Spontaneous	2014-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Blood pressure increased (3d - Recovered/Resolved - );Palpitations (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - Hypertension - n/a - [n/a - 5mg - Oral])|[HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - 12.5mg - Oral])|[OLMESARTAN, OLMESARTAN MEDOXOMIL] (C - Hypertension - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8659149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8662765	Spontaneous	2014-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Neck pain (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[UNKNOWN] (C - n/a - n/a - [n/a - {DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8662765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8657739	Spontaneous	2014-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	NON SPECIFIED DRUG [UNKNOWN] (C - n/a - n/a - [n/a - 2{DF} - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8657739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8657743	Spontaneous	2014-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Oral])	VIDAZA POWDER FOR SUSPENSION FOR INJECTION [AZACITIDINE] (C - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])|[COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 150ug - Oral])|[MAGNESIUMHYDROXIDE] (C - n/a - n/a - [n/a - 724mg - Oral])|[METOCLOPRAMIDE HYDROCHLORIDE-1-WATER] (C - n/a - n/a - [n/a - 10mg - Oral])|[NITROFURANTOINE] (C - n/a - n/a - [n/a - 100mg - Oral])|[ONDANSETRON HYDROCHLORIDE-2-WATER] (C - n/a - n/a - [n/a - 8mg - Oral])|[PANTOPRAZOL NATRIUM-1.5-WATER] (C - n/a - n/a - [n/a - 40mg - Intramuscular])|[PARACETAMOL] (C - n/a - n/a - [n/a - 500mg - Oral])|[PREDNISOLON] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8657743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8657744	Spontaneous	2014-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Abdominal pain (2h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLZUUR] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[ATORVASTATINE CALCIUM-3-WATER] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[ENALAPRIL WATERSTOFMALEAAT] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[METOPROLOL TARTRAAT] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8657744&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8650204	Spontaneous	2014-12-01 00:00:00	Healthcare Professional	Non European Economic Area	Annette K Regan, Christopher C Blyth and Paul V Effler, Med J Aust 2013; 199 (11): 744-746, Using SMS technology to verify the safety of seasonal trivalent influenza vaccine for pregnant women in real time. Munoz FM, Greisinger AJ, Whemanen OA, et al. Safety of Influenza Vaccine in Pregnancy. Am J Obstet gynecol 2005; 192: 1098-1106 Regan A.K.et al.Using SMS technology to verify the safety of seasonal trivalent influenza vaccine for pregnant women in real time. Med. J. Aust. 2013 199:11 (744+746)	Not Specified	Adult	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Foetal heart rate abnormal (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8650204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8650701	Spontaneous	2014-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Erythema (n/a - Recovering/Resolving - );Pruritus (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8650701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8650713	Spontaneous	2014-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Erythema (n/a - Recovering/Resolving - );Pruritus (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8650713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8650714	Spontaneous	2014-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Not Specified	Vaccination site erythema (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8650714&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8650734	Spontaneous	2014-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Vaccination site erythema (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8650734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8650740	Spontaneous	2014-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza like illness (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8650740&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8653023	Spontaneous	2014-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[PANTOPRAZOL NATRIUM-1.5-WATER] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8653023&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8653038	Spontaneous	2014-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	IRBESARTAN 150 MG - TABLET  (C - n/a - n/a - [n/a - 150mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8653038&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8653043	Spontaneous	2014-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8653043&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8653051	Spontaneous	2014-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (4d - Recovered/Resolved With Sequelae - );Urticaria (4d - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8653051&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-8653063	Spontaneous	2014-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Extensive swelling of vaccinated limb (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	AVAMYS 27.5 MICROGRAMS/SPRAY [FLUTICASONE FUROATE] (C - n/a - n/a - [n/a - 1{DF} - Nasal])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM] (C - n/a - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8653063&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8644375	Spontaneous	2014-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Arthralgia (13d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lip exfoliation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash macular (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tongue erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	ADENURIC [FEBUXOSTAT] (S - n/a - n/a - [n/a - 1{DF} - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8644375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8647763	Spontaneous	2014-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	NON SPECIFIED DRUG [UNKNOWN] (C - n/a - n/a - [n/a - 3{DF} - Unknown])|[INHALATIEALLERGEEN] (C - n/a - n/a - [n/a - {DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8647763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8647782	Spontaneous	2014-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (2wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8647782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8643980	Spontaneous	2014-11-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - 200ug - Respiratory (inhalation)])|[CYANOCOBALAMINE] (C - n/a - n/a - [n/a - 1{DF} - Unknown])|[SALBUTAMOL] (C - n/a - n/a - [n/a - 200ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8643980&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8643981	Spontaneous	2014-11-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - );Lymphadenopathy (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8643981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8643986	Spontaneous	2014-11-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8643986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8644002	Spontaneous	2014-11-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Cough (n/a - Recovering/Resolving - );Listless (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8644002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8644005	Spontaneous	2014-11-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dyspnoea (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - 2{DF} - Respiratory (inhalation)])|[OMEPRAZOL] (C - n/a - n/a - [n/a - 20mg - Oral])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8644005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8644009	Spontaneous	2014-11-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Urticaria (12h - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL] (C - n/a - n/a - [n/a - 2{DF} - Respiratory (inhalation)])|[IPRATROPIUM BROMIDE] (C - n/a - n/a - [n/a - 2{DF} - Respiratory (inhalation)])|[LORATADINE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - {DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8644009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-8638859	Spontaneous	2014-11-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Epilepsy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[PAROXETINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8638859&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8638881	Spontaneous	2014-11-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Dizziness (12h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[AMLODIPINE BESILAAT] (C - n/a - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8638881&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8638884	Spontaneous	2014-11-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - n/a - n/a - [n/a - 1{DF} - Unknown])|[ESOMEPRAZOLE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8638884&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8638893	Spontaneous	2014-11-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Abnormal dreams (10h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	NON SPECIFIED DRUG [UNKNOWN] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8638893&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8638925	Spontaneous	2014-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Hypersensitivity (13d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (13d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swelling face (13d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[CLEMIZOLE PENICILLIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8638925&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8630441	Spontaneous	2014-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Epilepsy (n/a - Unknown - Other Medically Important Condition);Generalised tonic-clonic seizure (n/a - Unknown - Other Medically Important Condition);Partial seizures (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8630441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8630582	Spontaneous	2014-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (0d - Recovered/Resolved - );Pruritus (1d - Recovered/Resolved - );Rash (1d - Recovered/Resolved - );Tenderness (1d - Recovered/Resolved - );Urticaria (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	GLIBENCLAMIDE [GLIBENCLAMIDE] (C - Histamine intolerance - n/a - [n/a - n/a - n/a])|GLIBENCLAMIDE [GLIBENCLAMIDE] (C - Lactose intolerance - n/a - [n/a - n/a - n/a])|[LACTOSE] (C - Histamine intolerance - n/a - [n/a - n/a - n/a])|[LACTOSE] (C - Lactose intolerance - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8630582&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8633662	Spontaneous	2014-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	AERIUS 5 MG ORODISPERSIBLE TABLETS [DESLORATADINE] (C - n/a - n/a - [n/a - 5mg - Oral])|NON SPECIFIED O.A.C. [UNKNOWN] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[ZOLPIDEM TARTRAAT] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8633662&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8633680	Spontaneous	2014-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[ACENOCOUMAROL] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 25mg - Oral])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - 2{DF} - Oral])|[HUMAN NORMAL IMMUNOGLOBULIN, HUMAN NORMAL IMMUNOGLOBULIN (IV)] (C - n/a - n/a - [n/a - 35g - Intravenous (not otherwise specified)])|[HYDROXYCHLOROQUINE SULFATE] (C - n/a - n/a - [n/a - 200mg - Oral])|[PANTOPRAZOLE] (C - n/a - n/a - [n/a - 40mg - Oral])|[PREDNISONE] (C - n/a - n/a - [n/a - 7.5mg - Oral])|[RISEDRONAAT NATRIUM] (C - n/a - n/a - [n/a - 35mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8633680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8633687	Spontaneous	2014-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Unknown - );Malaise (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8633687&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8633697	Spontaneous	2014-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Pyrexia (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	[LOSARTAN KALIUM] (C - n/a - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8633697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-8633712	Spontaneous	2014-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Erythema (n/a - Recovered/Resolved - );Injection site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8633712&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8633716	Spontaneous	2014-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Myalgia (5d - Recovered/Resolved - );Nasopharyngitis (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8633716&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8628197	Spontaneous	2014-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Atrial fibrillation (10min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (1min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8628197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8628201	Spontaneous	2014-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myelopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	[ACETYLSALICYLZUUR] (C - n/a - n/a - [n/a - 80mg - Oral])|[CITALOPRAM HYDROBROMIDE] (C - n/a - n/a - [n/a - 20mg - Oral])|[LOSARTAN KALIUM] (C - n/a - n/a - [n/a - 100mg - Oral])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - 20mg - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8628201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8628207	Spontaneous	2014-11-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dizziness (n/a - Unknown - );Dyspnoea (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[AZATHIOPRINE] (C - n/a - n/a - [n/a - 150mg - Oral])|[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[FORMOTEROL FUMARATE DIHYDRATE, BECLOMETASONE DIPROPIONATE ANHYDROUS] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[INFLIXIMAB] (C - n/a - n/a - [n/a - 1{DF} - Intravenous (not otherwise specified)])|[MOMETASONE FUROATE] (C - n/a - n/a - [n/a - 1{DF} - Nasal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8628207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8628221	Spontaneous	2014-11-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Arthralgia (n/a - Recovering/Resolving - );Injection site inflammation (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8628221&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8628234	Spontaneous	2014-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (1d - Recovered/Resolved - );Dizziness (1d - Recovered/Resolved - );Vomiting (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8628234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8619264	Spontaneous	2014-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Rash (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8619264&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8620499	Spontaneous	2014-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactoid reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - .5mL - Subcutaneous])	JANUMET 50 MG/1000 MG [METFORMIN HYDROCHLORIDE, SITAGLIPTIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CIPROFLOXACIN] (C - n/a - n/a - [n/a - 500mg - n/a])|[FLUVASTATIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOLPIDEM, ZOLPIDEM TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8620499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8622406	Spontaneous	2014-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Myasthenia gravis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[PYRIDOSTIGMINE BROMIDE] (C - n/a - n/a - [n/a - 30mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8622406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8622422	Spontaneous	2014-11-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Asthenia (18h - Recovered/Resolved - );Chills (18h - Recovered/Resolved - );Diarrhoea (24h - Recovered/Resolved - );Headache (12h - Recovered/Resolved - );Myalgia (12h - Recovered/Resolved - );Oropharyngeal pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	LEFLUNOMIDE 20 MG - FILM-COATED TABLET  (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8622422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8622449	Spontaneous	2014-11-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (2wk - Recovered/Resolved With Sequelae - );Myalgia (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[QUINAPRIL] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8622449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-8622458	Spontaneous	2014-11-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	Yes	Male	Fatigue (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[ATOMOXETINE] (C - n/a - n/a - [n/a - 40mg - Oral])|[MELATONIN] (C - n/a - n/a - [n/a - 3mg - Oral])|[METHYLPHENIDATE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 27mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8622458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8614477	Spontaneous	2014-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Altered state of consciousness (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Blood disorder (n/a - Unknown - Other Medically Important Condition);Cachexia (n/a - Unknown - Other Medically Important Condition);Decreased appetite (n/a - Unknown - Other Medically Important Condition);Decubitus ulcer (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Unknown - Other Medically Important Condition);Gastritis (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Immune system disorder (n/a - Unknown - Other Medically Important Condition);Impaired healing (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Petechiae (n/a - Unknown - Other Medically Important Condition);Productive cough (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Speech disorder (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])|[ACETYLCYSTEINE, AMBROXOL HYDROCHLORIDE, BROMHEXINE HYDROCHLORIDE] (S - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE] (S - n/a - n/a - [n/a - n/a - n/a])|[CHLORTALIDONE, CHLORTALIDONE PH. EUR., CHLORTALIDONE, RESERPINE] (S - n/a - n/a - [n/a - n/a - n/a])...	[ASCORBIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [66d - n/a - n/a])|[POTASSIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8614477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8616288	Spontaneous	2014-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dysphagia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Vaccination site reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8616288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8617360	Spontaneous	2014-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - );Myalgia (1d - Recovered/Resolved - );Pyrexia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8617360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8617369	Spontaneous	2014-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8617369&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8617373	Spontaneous	2014-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Injection site inflammation (1wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - 250ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8617373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612673	Spontaneous	2014-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	AVAMYS 27.5 MICROGRAMS/SPRAY [FLUTICASONE FUROATE] (C - n/a - n/a - [n/a - 1{DF} - Nasal])|[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 30mg - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612673&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612681	Spontaneous	2014-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Neuralgia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8606220	Spontaneous	2014-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Application site erythema (7d - Recovered/Resolved - Other Medically Important Condition);Oedema peripheral (7d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Parenteral])	[HYDROXYCHLOROQUINE SULFATE] (C - Rheumatoid arthritis - n/a - [n/a - 200mg - Oral])|[MELOXICAM] (C - Rheumatoid arthritis - n/a - [n/a - 15mg - Oral])|[VERAPAMIL HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8606220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8607914	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Chills (12h - Recovered/Resolved - );Erysipelas (n/a - Unknown - );Headache (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607914&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8607920	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Faeces pale (n/a - Not Recovered/Not Resolved - );Injection site inflammation (3d - Recovered/Resolved - );Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACENOCOUMAROL] (C - n/a - n/a - [n/a - 2mg - Oral])|[CAPTOPRIL] (C - n/a - n/a - [n/a - 50mg - Oral])|[PARACETAMOL, TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607920&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8607924	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - );Myalgia (n/a - Unknown - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[LEVOCETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[METOPROLOL TARTRAAT] (C - n/a - n/a - [n/a - 25mg - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8607926	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[METFORMINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8607927	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8607929	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Dizziness (2d - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-8607930	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ETHINYLESTRADIOL, GESTODEEN] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - 250ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8607931	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	[LEVOCETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 5mg - Oral])|[SERTRALINE] (C - n/a - n/a - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8607932	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8607935	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Syncope (1h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	HUMIRA 40 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN [ADALIMUMAB] (C - n/a - n/a - [n/a - n/a - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607935&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8607943	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (n/a - Recovering/Resolving - );Pain in extremity (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FEXOFENADINE] (C - n/a - n/a - [n/a - 2{DF} - Oral])|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 2{DF} - Oral])|[FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607943&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8607949	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[LITHIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607949&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8607981	Spontaneous	2014-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Chest discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chest pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyskinesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Feeling abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8602844	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602844&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8602845	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Nasopharyngitis (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	IRBESARTAN 300 MG - TABLET  (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8602848	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Abdominal discomfort (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[BECLOMETASON DIPROPIONAAT] (C - n/a - n/a - [n/a - 200ug - Respiratory (inhalation)])|[ENALAPRIL WATERSTOFMALEAAT] (C - n/a - n/a - [n/a - 10mg - Oral])|[GLICLAZIDE] (C - n/a - n/a - [n/a - 80mg - Oral])|[HYDROCHLOORTHIAZIDE] (C - n/a - n/a - [n/a - 12.5mg - Oral])|[IPRATROPIUM BROMIDE] (C - n/a - n/a - [n/a - 40ug - Respiratory (inhalation)])|[METFORMINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1000mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8602850	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	Yes	Male	Vertigo (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8602855	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602855&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8602856	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Chills (n/a - Unknown - );Fatigue (n/a - Unknown - );Headache (n/a - Unknown - );Injection site inflammation (n/a - Unknown - );Myalgia (n/a - Unknown - );Oropharyngeal pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8602864	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Body temperature increased (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Recovering/Resolving - );Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602864&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8602867	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Headache (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	DESLORATADINE .5 MG/ML  (C - n/a - n/a - [n/a - 2.5mL - Oral])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8602868	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Fatigue (3d - Recovered/Resolved With Sequelae - );Headache (3d - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[BUPROPION HYDROCHLORIDE] (C - n/a - n/a - [n/a - 300mg - Oral])|[PAROXETINE] (C - n/a - n/a - [n/a - 60mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-8602870	Spontaneous	2014-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602870&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8602871	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dizziness (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	LEVEMIR 100U/ML SOLUTION FOR INJECTION [INSULIN DETEMIR] (C - n/a - n/a - [n/a - 40[iU] - Subcutaneous])|[GLIMEPIRIDE] (C - n/a - n/a - [n/a - 4mg - Oral])|[METFORMINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 40mg - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8593925	Spontaneous	2014-11-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Encephalopathy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Seizure (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])|[TUBERCULIN PURIFIED PROTEIN DERIVATIVE] (S - Tuberculin test - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8593925&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8596718	Spontaneous	2014-11-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - );Musculoskeletal stiffness (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8596718&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8596719	Spontaneous	2014-11-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Erythema (4h - Recovered/Resolved - );Headache (4h - Recovered/Resolved - );Injection site induration (4h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8596719&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8596720	Spontaneous	2014-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - );Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8596720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8596722	Spontaneous	2014-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8596722&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8596730	Spontaneous	2014-11-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Listless (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	GLIVEC 400 MG FILM-COATED TABLETS [IMATINIB, IMATINIB MESILATE] (C - n/a - n/a - [n/a - 400mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8596730&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8596737	Spontaneous	2014-11-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Hypoaesthesia (2d - Recovered/Resolved - );Injection site inflammation (2wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[BISOPROLOL FUMARAAT] (C - n/a - n/a - [n/a - {DF} - Oral])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - 800[iU] - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8596737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8596738	Spontaneous	2014-11-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Fatigue (n/a - Unknown - );Headache (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Unknown - );Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[DESOGESTREL] (C - n/a - n/a - [n/a - .075mg - Oral])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - 125ug - Respiratory (inhalation)])|[MOMETASONE] (C - n/a - n/a - [n/a - 50ug - Nasal])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - 100ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8596738&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8587564	Spontaneous	2014-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Dermatomyositis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8587564&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8590887	Spontaneous	2014-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (2d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - );Rash (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8590887&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8590889	Spontaneous	2014-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	GREPID 75 MG FILM-COATED TABLETS [CLOPIDOGREL, CLOPIDOGREL BESILATE] (C - n/a - n/a - [n/a - 75mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8590889&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8590891	Spontaneous	2014-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Extensive swelling of vaccinated limb (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8590891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8590892	Spontaneous	2014-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Arthralgia (72h - Recovered/Resolved - );Testicular pain (72h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[METFORMIN] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8590892&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8590894	Spontaneous	2014-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8590894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8590895	Spontaneous	2014-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Fatigue (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8590895&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8590897	Spontaneous	2014-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (1wk - Recovered/Resolved - );Pain (1wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[MORFINE SULFAAT-5-WATER] (C - Back pain - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8590897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8590903	Spontaneous	2014-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Extensive swelling of vaccinated limb (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - 200ug - Respiratory (inhalation)])|[SALBUTAMOL] (C - n/a - n/a - [n/a - {DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8590903&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8590921	Spontaneous	2014-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	XOLAIR 150 MG SOLUTION FOR INJECTION [OMALIZUMAB] (C - n/a - n/a - [n/a - 1{DF} - Intramuscular])|[DESLORATADINE] (C - n/a - n/a - [n/a - 5mg - Oral])|[FORMOTEROL FUMARATE DIHYDRATE, BECLOMETASONE DIPROPIONATE ANHYDROUS] (C - n/a - n/a - [n/a - 2{DF} - Respiratory (inhalation)])|[IPRATROPIUM BROMIDE] (C - n/a - n/a - [n/a - 2{DF} - Intramuscular])|[MOMETASONE] (C - n/a - n/a - [n/a - 1{DF} - Nasal])|[MONTELUKAST NATRIUM] (C - n/a - n/a - [n/a - 10mg - Oral])|[THEOPHYLLINE] (C - n/a - n/a - [n/a - 250mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8590921&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8583034	Spontaneous	2014-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site erythema (n/a - Unknown - Other Medically Important Condition);Injection site oedema (n/a - Unknown - Other Medically Important Condition);Injection site warmth (n/a - Unknown - Other Medically Important Condition);Skin reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	METHOTREXATE [METHOTREXATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8583034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8585526	Spontaneous	2014-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Anaphylactic reaction (1h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Bronchial obstruction (1h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dysphagia (1h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Erythema (1h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8585526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8586421	Spontaneous	2014-11-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[FLUTICASON PROPIONAAT] (C - n/a - n/a - [n/a - 50ug - Nasal])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - 250ug - Respiratory (inhalation)])|[LEVOCETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 5mg - Oral])|[SALBUTAMOL] (C - n/a - n/a - [n/a - 200ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8586421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8586427	Spontaneous	2014-11-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Headache (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8586427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8586435	Spontaneous	2014-11-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Swelling of eyelid (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8586435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8586447	Spontaneous	2014-11-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	NON SPECIFIED ANTIHISTAMINICUM [UNKNOWN] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[BECLOMETASONE] (C - n/a - n/a - [n/a - 100ug - Respiratory (inhalation)])|[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - 100ug - Respiratory (inhalation)])|[SALMETEROL XINAFOAAT] (C - n/a - n/a - [n/a - 50ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8586447&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8586448	Spontaneous	2014-11-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (12h - Recovered/Resolved - );Malaise (12h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8586448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8586449	Spontaneous	2014-11-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Musculoskeletal stiffness (3d - Recovered/Resolved - );Nausea (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[METOPROLOL TARTRAAT] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8586449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8586451	Spontaneous	2014-11-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	Yes	Male	Dizziness (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8586451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8586452	Spontaneous	2014-11-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8586452&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8579001	Spontaneous	2014-11-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Injection site pain (n/a - Recovered/Resolved - );Needle issue (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8579001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8579004	Spontaneous	2014-11-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Needle issue (n/a - Unknown - );Vaccination site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8579004&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8579007	Spontaneous	2014-11-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Needle issue (n/a - Unknown - );Vaccination site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8579007&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8581863	Spontaneous	2014-11-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anosmia (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Confusional state (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Encephalitis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Status epilepticus (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8581863&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8581887	Spontaneous	2014-11-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Fatigue (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[PANTOPRAZOLE] (C - n/a - n/a - [n/a - 40mg - Oral])|[PHENPROCOUMON] (C - n/a - n/a - [n/a - {DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8581887&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8581889	Spontaneous	2014-11-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Headache (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[ESOMEPRAZOLE] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8581889&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8581890	Spontaneous	2014-11-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (n/a - Unknown - );Headache (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8581890&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8581900	Spontaneous	2014-11-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[DROSPIRENONE, ETHINYLESTRADIOL] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[MEBEVERINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 200mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8581900&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8581901	Spontaneous	2014-11-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	PANTOPRAZOLE 20 MG - GASTRO-RESISTANT TABLET  (C - n/a - n/a - [n/a - 20mg - Oral])|[DOMPERIDONE] (C - n/a - n/a - [n/a - 10mg - Oral])|[LYNESTRENOL] (C - n/a - n/a - [n/a - 5mg - Oral])|[MIZOLASTINE] (C - n/a - n/a - [n/a - 10mg - Oral])|[MORFINE SULFAAT-5-WATER] (C - n/a - n/a - [n/a - 10mg - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - 1000mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8581901&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8576926	Spontaneous	2014-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Elderly	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Injection site joint movement impairment (n/a - Not Recovered/Not Resolved - Disabling);Periarthritis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8576926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8576982	Spontaneous	2014-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Migraine (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8576982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8576983	Spontaneous	2014-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8576983&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8576984	Spontaneous	2014-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Not Recovered/Not Resolved - );Injection site pain (5min - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8576984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8576985	Spontaneous	2014-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Rash macular (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8576985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8576998	Spontaneous	2014-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8576998&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8576999	Spontaneous	2014-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8576999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8569080	Spontaneous	2014-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (30min - Unknown - Other Medically Important Condition);Nausea (30min - Unknown - Other Medically Important Condition);Peripheral vascular disorder (30min - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8569080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8570000	Spontaneous	2014-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8570000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8570380	Spontaneous	2014-11-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	LANTUS 100 IU/ML SOLUTION FOR INJECTION IN A CARTRIDGE [INSULIN GLARGINE] (C - Type 1 diabetes mellitus - Unknown - [n/a - 1{DF} - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8570380&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8570409	Spontaneous	2014-11-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Herpes simplex (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - {DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8570409&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8563076	Spontaneous	2014-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Headache (n/a - Unknown - );Nausea (n/a - Unknown - );Neck pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8563076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8563578	Spontaneous	2014-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Acute kidney injury (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Areflexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Axillary pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Exercise tolerance decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Laryngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Leukaemoid reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Lymphadenitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Musculoskeletal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myositis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Paraparesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Peripheral swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Sensory level abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sepsis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8563578&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8564181	Spontaneous	2014-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8564181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566068	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - );Lymphadenopathy (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566070	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Dizziness (n/a - Recovering/Resolving - );Injection site erythema (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[CARBASALATE CALCIUM] (C - n/a - n/a - [n/a - 100mg - Oral])|[NEBIVOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 2.5mg - Oral])|[RABEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - 20mg - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 5mg - Oral])|[TAMSULOSIN HYDROCHLORIDE, DUTASTERIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566079	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[HYDROCHLOORTHIAZIDE] (C - n/a - n/a - [n/a - 12.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566079&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566080	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (9d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566081	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - );Lymphadenopathy (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[BECLOMETASON DIPROPIONAAT] (C - n/a - n/a - [n/a - 200ug - Respiratory (inhalation)])|[PAROXETINE HYDROCHLORIDE-0-WATER] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566081&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566082	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])...	[PERINDOPRIL ARGININE] (C - n/a - n/a - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566083	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 150ug - Oral])|[URSODEOXYCHOLIC ACID] (C - n/a - n/a - [n/a - 2.5{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566083&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566084	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566084&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566085	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566085&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566090	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[FERROUS FUMARATE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[MONTELUKAST NATRIUM] (C - n/a - n/a - [n/a - 10mg - Oral])|[TERBUTALINE SULFATE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566104	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Headache (24h - Recovered/Resolved - );Injection site reaction (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566105	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (n/a - Recovering/Resolving - );Headache (1d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - );Pyrexia (3d - Recovered/Resolved - );Vomiting (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566105&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566106	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Influenza like illness (n/a - Recovered/Resolved - );Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[SIMVASTATIN] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566107	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (24h - Recovered/Resolved - );Injection site inflammation (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566107&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8561280	Spontaneous	2014-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	PANTOPRAZOLE 20 MG - GASTRO-RESISTANT TABLET  (C - n/a - n/a - [n/a - 20mg - Oral])|[ALENDRONAAT NATRIUM-0-WATER] (C - n/a - n/a - [n/a - 70mg - Oral])|[FOLIC ACID] (C - n/a - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8561280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8561296	Spontaneous	2014-11-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8561296&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8554843	Spontaneous	2014-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8554843&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8556488	Spontaneous	2014-11-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8556488&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8556492	Spontaneous	2014-11-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 100mg - Oral])|[SUMATRIPTAN] (C - n/a - n/a - [n/a - 1{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8556492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8556495	Spontaneous	2014-11-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8556495&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8556497	Spontaneous	2014-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8556497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8549762	Spontaneous	2014-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Asthenia (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8549762&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8546694	Spontaneous	2014-10-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Body temperature increased (4d - Recovered/Resolved - );Chest pain (4d - Recovered/Resolved - );Decreased appetite (4d - Recovered/Resolved - );Dizziness (4d - Recovered/Resolved - );Myalgia (4d - Recovered/Resolved - );Productive cough (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[DIAZEPAM] (C - n/a - n/a - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8546694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8546696	Spontaneous	2014-10-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Adolescent	Yes	Female	Nausea (1d - Recovered/Resolved - );Pyrexia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8546696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8546700	Spontaneous	2014-10-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	AERIUS 5 MG ORODISPERSIBLE TABLETS [DESLORATADINE] (C - n/a - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8546700&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8546723	Spontaneous	2014-10-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8546723&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8546734	Spontaneous	2014-10-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8546734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8529713	Spontaneous	2014-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysuria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8529713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8535747	Spontaneous	2014-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Dose not changed - [n/a - 75ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8535747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8541815	Spontaneous	2014-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Malaise (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8541815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8541838	Spontaneous	2014-10-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Angina pectoris (7h - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8541838&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8541845	Spontaneous	2014-10-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Headache (3d - Recovered/Resolved - );Influenza like illness (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8541845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8541849	Spontaneous	2014-10-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - );Malaise (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[METFORMINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8541849&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8541851	Spontaneous	2014-10-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Dizziness (6d - Recovered/Resolved - );Fatigue (6d - Recovered/Resolved - );Headache (6d - Recovered/Resolved - );Injection site pruritus (6d - Recovered/Resolved - );Myalgia (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[ACENOCOUMAROL] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[FINASTERIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[PERINDOPRIL] (C - n/a - n/a - [n/a - 4mg - Oral])|[TRIAMTEREEN] (C - n/a - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8541851&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8541852	Spontaneous	2014-10-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[ENALAPRIL WATERSTOFMALEAAT, HYDROCHLOORTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8541852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8541856	Spontaneous	2014-10-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[SIMVASTATIN] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8541856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8541857	Spontaneous	2014-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Gait disturbance (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8541857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8541875	Spontaneous	2014-10-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - );Injection site rash (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8541875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8542330	Spontaneous	2014-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8542330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8520224	Spontaneous	2014-10-29 00:00:00	Healthcare Professional	European Economic Area	Balveren L et al. Reported adverse events Following influenza vaccination. Dutch Journal of Medicine 2014; 158: A6841: 376-380.	18-64 Years	Adult	No	Female	Anaphylactoid reaction (n/a - Unknown - Life Threatening);Angioedema (n/a - Recovering/Resolving - Life Threatening);Contraindication to vaccination (n/a - Unknown - Life Threatening);Presyncope (n/a - Recovering/Resolving - Life Threatening);Urticaria (n/a - Recovering/Resolving - Life Threatening);Vaccination error (n/a - Unknown - Life Threatening)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Dose not changed - [n/a - 1{DF} - Intramuscular])	HUMIRA 40 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN [ADALIMUMAB] (C - n/a - Dose not changed - [n/a - n/a - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8520224&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-8520228	Spontaneous	2014-10-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cyanosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gaze palsy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8520228&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8520287	Spontaneous	2014-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Death (n/a - Fatal - Results in Death)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8520287&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8520288	Spontaneous	2014-10-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Generalised tonic-clonic seizure (5min - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8520288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8520290	Spontaneous	2014-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Alopecia universalis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Autoimmune hepatitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Conjunctivitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Drug reaction with eosinophilia and systemic symptoms (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eosinophilia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hepatotoxicity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Liver disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myasthenia gravis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Transaminases increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Type III immune complex mediated reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ESCHERICHIA COLI, ESCHERICHIA COLI STRAIN NISSLE 1917] (C - n/a - n/a - [n/a - n/a - n/a])|[METRONIDAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[SULFASALAZINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8520290&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8521112	Spontaneous	2014-10-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8521112&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8531094	Spontaneous	2014-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (0d - Recovered/Resolved - Other Medically Important Condition);Dry mouth (0d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (0d - Recovered/Resolved - Other Medically Important Condition);Feeling hot (2d - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (0d - Recovered/Resolved - Other Medically Important Condition);Rash (2d - Recovered/Resolved - Other Medically Important Condition);Swollen tongue (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8531094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8531557	Spontaneous	2014-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Concussion (n/a - Recovering/Resolving - Other Medically Important Condition);Enteritis (n/a - Recovering/Resolving - Other Medically Important Condition);Fall (n/a - Recovering/Resolving - Other Medically Important Condition);Hyperhidrosis (n/a - Recovering/Resolving - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8531557&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8534212	Spontaneous	2014-10-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - {DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8534212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8515981	Spontaneous	2014-10-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Malaise (6d - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (6d - Recovered/Resolved - Other Medically Important Condition);Rash (6d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8515981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8516091	Spontaneous	2014-10-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Elderly	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8516091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8516258	Spontaneous	2014-10-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Headache (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory distress (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sneezing (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8516258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8516268	Spontaneous	2014-10-28 00:00:00	Healthcare Professional	Non European Economic Area	Pornsuriyasak P., Suwatanapongched T., Klaewsongkram  J., Buranapraditkun S.,  Rotjanapan P., International Journal of Infectious Diseases 26 (2014) 14-16. Acute respiratory failure secondary to eosinophilic pneumonia following influenza vaccination in an elderly man with chronic obstructive pulmonary disease.	More than 85 Years	Elderly	No	Male	Acute respiratory failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eosinophilic pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - Atrial fibrillation - n/a - [n/a - n/a - n/a])|[AZITHROMYCIN, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN HYDRATE] (C - n/a - n/a - [n/a - n/a - Unknown])|[FLUTICASONE, SALMETEROL] (C - n/a - n/a - [n/a - n/a - Unknown])|[IPRATROPIUM BROMIDE] (C - n/a - n/a - [n/a - n/a - Unknown])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - Unknown])|[VALSARTAN] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8516268&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8527135	Spontaneous	2014-10-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Liver function test increased (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8527135&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8529175	Spontaneous	2014-10-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Headache (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8529175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8523381	Spontaneous	2014-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8523381&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8514125	Spontaneous	2014-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Decreased appetite (n/a - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Other Medically Important Condition);Vertigo (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8514125&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8512352	Spontaneous	2014-10-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Hypoaesthesia (n/a - Unknown - );Malaise (n/a - Unknown - );Myalgia (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[DROSPIRENONE, ETHINYLESTRADIOL] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8512352&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8500027	Spontaneous	2014-10-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8500027&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8500035	Spontaneous	2014-10-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ISOTRETINOIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8500035&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8500047	Spontaneous	2014-10-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ETORICOXIB] (C - n/a - n/a - [n/a - n/a - n/a])|[METAMIZOLE SODIUM MONOHYDRATE, THIAMINE HYDROCHLORIDE, CHLORDIAZEPOXIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8500047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8500057	Spontaneous	2014-10-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8500057&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8500063	Spontaneous	2014-10-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8500063&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8500073	Spontaneous	2014-10-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8500073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8505591	Spontaneous	2014-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic shock (8h - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8505591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-8506854	Spontaneous	2014-10-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Pityriasis rosea (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8506854&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8507630	Spontaneous	2014-10-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Influenza like illness (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8507630&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8507647	Spontaneous	2014-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8507647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8507659	Spontaneous	2014-10-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Crying (2d - Recovered/Resolved - );Extensive swelling of vaccinated limb (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])...	KOELZALF [ARACHIDE-OLIE, GLYCERYLMONO-OLEAAT, WAS, WIT] (C - n/a - n/a - [n/a - 1{DF} - Cutaneous])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[LEVOCETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 5mg - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8507659&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8490297	Spontaneous	2014-10-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8490297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8490651	Spontaneous	2014-10-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Abdominal pain (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8490651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8492308	Spontaneous	2014-10-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dizziness (n/a - Unknown - );Headache (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[SULFASALAZINE] (C - n/a - n/a - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8492308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8487867	Spontaneous	2014-10-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Crying (10h - Recovered/Resolved - );Eye irritation (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - 100ug - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - 200ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8487867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8481005	Spontaneous	2014-10-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Cyanosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Exophthalmos (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Febrile convulsion (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Heart rate increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory rate decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8481005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8473754	Spontaneous	2014-10-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Not Specified	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8473754&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8470818	Spontaneous	2014-10-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash morbilliform (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rubella in pregnancy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8470818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8470939	Spontaneous	2014-10-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Eye disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Measles (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ocular hyperaemia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination failure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[MEASLES VACCINE, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8470939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8470940	Spontaneous	2014-10-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Bell's palsy (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8470940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8472069	Spontaneous	2014-10-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Injection site cellulitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])|[MENINGOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8472069&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8463842	Spontaneous	2014-10-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	[MODAFINIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8463842&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8450718	Spontaneous	2014-10-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Vaccination site erythema (n/a - Unknown - Other Medically Important Condition);Vaccination site pain (n/a - Unknown - Other Medically Important Condition);Vaccination site swelling (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])|[HEPATITIS B SURFACE ANTIGEN, HEPATITIS A VACCINE (INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8450718&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8446724	Spontaneous	2014-10-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling);Fine motor skill dysfunction (n/a - Not Recovered/Not Resolved - Disabling);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Motion sickness (n/a - Unknown - Disabling);Movement disorder (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8446724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8446741	Spontaneous	2014-10-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Atrial fibrillation (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Cardiac murmur (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Cerebral haemorrhage (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dysarthria (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Haemolytic anaemia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Hypotonia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Monoclonal gammopathy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Purpura (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Skin discolouration (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Speech disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Subdural haematoma (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mg - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - .5mg - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Unknown])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - 10mg - Unknown])|[DICLOFENAC SODIUM, MISOPROSTOL] (C - n/a - n/a - [n/a - 175mg - Unknown])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - Unknown])|[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - 20mg - Unknown])|[ENOXAPARIN] (C - n/a - n/a - [n/a - n/a - Unknown])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - 40mg - Unknown])|[KETOCONAZOLE] (C - n/a - n/a - [n/a - 2% - Unknown])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 75mg - Unknown])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - 20mg - Unknown])|[WARFARIN, WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8446741&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8446781	Spontaneous	2014-10-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Eye movement disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperpyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting projectile (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8446781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8446822	Spontaneous	2014-10-06 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8446822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8446886	Spontaneous	2014-10-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Angioedema (1d - Recovered/Resolved - Other Medically Important Condition);Dysphagia (1d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (1d - Recovered/Resolved - Other Medically Important Condition);Feeling hot (1d - Recovered/Resolved - Other Medically Important Condition);Flushing (1d - Recovered/Resolved - Other Medically Important Condition);Swelling (1d - Recovered/Resolved - Other Medically Important Condition);Tachycardia (15min - Recovered/Resolved - Other Medically Important Condition);Throat tightness (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8446886&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8441497	Spontaneous	2014-10-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cough (3wk - Recovered/Resolved - Other Medically Important Condition);Influenza (3wk - Recovered/Resolved - Other Medically Important Condition);Malaise (3wk - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (3wk - Recovered/Resolved - Other Medically Important Condition);Pain (3wk - Recovered/Resolved - Other Medically Important Condition);Pertussis (n/a - Recovered/Resolved - Other Medically Important Condition);Pneumonia (3wk - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - n/a - Unknown - [n/a - 100mg - n/a])|[HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - Unknown - [n/a - 50mg - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - 100mg - n/a])|[OMEPRAZOLE] (C - n/a - Unknown - [n/a - 20mg - n/a])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8441497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8441538	Spontaneous	2014-10-03 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8441538&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8441713	Spontaneous	2014-10-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cough (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Lacrimation increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ATENOLOL, ATENOLOL BP] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8441713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8438441	Spontaneous	2014-10-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site pain (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Needle issue (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8438441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8433773	Spontaneous	2014-10-01 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Balance disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Deafness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Eustachian tube obstruction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Labyrinthitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8433773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8433883	Spontaneous	2014-10-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8433883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8427909	Spontaneous	2014-09-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthma (2d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (2d - Recovered/Resolved - Other Medically Important Condition);Expired product administered (n/a - Unknown - Other Medically Important Condition);Hyperpyrexia (2d - Recovered/Resolved - Other Medically Important Condition);Medication error (n/a - Unknown - Other Medically Important Condition);Myalgia (2d - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal discomfort (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])...	AERIUS [DESLORATADINE] (C - Asthma - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8427909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8428013	Spontaneous	2014-09-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angioedema (3h - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8428013&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8429428	Spontaneous	2014-09-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Cellulitis (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])|[MENINGOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8429428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8429556	Spontaneous	2014-09-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8429556&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8423937	Spontaneous	2014-09-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Asthenia (53d - Fatal - Results in Death, Other Medically Important Condition);Cough (53d - Fatal - Results in Death, Other Medically Important Condition);Dyspnoea at rest (53d - Fatal - Results in Death, Other Medically Important Condition);Mediastinal disorder (0d - Fatal - Results in Death, Other Medically Important Condition);Orthopnoea (53d - Fatal - Results in Death, Other Medically Important Condition);Pyrexia (53d - Fatal - Results in Death, Other Medically Important Condition);Respiratory failure (0d - Fatal - Results in Death, Other Medically Important Condition);Wheezing (53d - Fatal - Results in Death, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (C - Osteoarthritis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8423937&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8423958	Spontaneous	2014-09-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Seizure (1d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8423958&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-8424279	Spontaneous	2014-09-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cutaneous vasculitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vascular purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8424279&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8409131	Spontaneous	2014-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Not Specified	Gait disturbance (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8409131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8409142	Spontaneous	2014-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Peripheral vascular disorder (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8409142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8374311	Spontaneous	2014-09-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Arrhythmia (n/a - Unknown - Caused/Prolonged Hospitalisation);Atrial fibrillation (n/a - Unknown - Caused/Prolonged Hospitalisation);Pericarditis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8374311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8374477	Spontaneous	2014-09-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Gastrointestinal disorder (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8374477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8368344	Spontaneous	2014-09-12 00:00:00	Non Healthcare Professional	European Economic Area	Menniti-Ippolito F, et al. Vaccine effectiveness against severe laboratory-confirmed influenza in children: Results of two consecutive seasons in Italy.  Vaccine (2014)	Not Specified	Not Specified	No	Female	Influenza A virus test positive (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8368344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8368367	Spontaneous	2014-09-12 00:00:00	Non Healthcare Professional	European Economic Area	Menniti-Ippolito F, et al. Vaccine effectiveness against severe laboratory-confirmed influenza in children: Results of two consecutive seasons in Italy.  Vaccine (2014)	Not Specified	Not Specified	No	Male	Influenza B virus test positive (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8368367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8347903	Spontaneous	2014-09-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cellulitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8347903&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8330531	Spontaneous	2014-09-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erysipelas (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Heart rate increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8330531&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8330538	Spontaneous	2014-09-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	C-reactive protein increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erysipelas (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Heart rate increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8330538&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8334451	Spontaneous	2014-09-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cellulitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Wound necrosis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8334451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8321492	Spontaneous	2014-09-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Hypertension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Staphylococcal bacteraemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	CELLCEPT [MYCOPHENOLATE MOFETIL] (C - n/a - n/a - [n/a - 500mg - Unknown])|NOVORAPID [INSULIN ASPART] (C - Blood insulin - Not applicable - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - Unknown])|[ALFUZOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Unknown])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - Unknown])|[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - Unknown])|[CICLOSPORIN] (C - n/a - n/a - [n/a - 55mg - Unknown])|[PREDNISONE] (C - n/a - n/a - [n/a - 7mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8321492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8321497	Spontaneous	2014-09-02 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Febrile convulsion (72h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation);Viral infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8321497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8321597	Spontaneous	2014-09-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cutaneous vasculitis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Diarrhoea haemorrhagic (8d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Gastritis erosive (15d - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Gastrointestinal haemorrhage (8d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Glomerulonephritis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Haematemesis (7d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Haemoglobin decreased (3mo - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Nausea (8d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Nephrotic syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vascular purpura (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (8d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	HYDROCORTISONE [HYDROCORTISONE, HYDROCORTISONE SODIUM SUCCINATE] (S - Addison's disease - Dose increased - [n/a - 20mg - Oral])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])|[FLUDROCORTISONE ACETATE] (S - Addison's disease - Dose not changed - [n/a - .1mg - Oral])	[COLECALCIFEROL] (C - Osteoporosis - n/a - [n/a - 15[drp] - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8321597&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8321608	Spontaneous	2014-09-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Areflexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injected limb mobility decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Monoplegia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nerve injury (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Radiculitis brachial (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site erythema (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8321608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-8321647	Spontaneous	2014-09-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Facial paralysis (87d - Recovered/Resolved - Disabling, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8321647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8321653	Spontaneous	2014-09-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Type I hypersensitivity (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8321653&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8321735	Spontaneous	2014-09-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Vertigo (14d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (S - Immunisation - Dose not changed - [n/a - n/a - Oral])	ACLASTA [ZOLEDRONIC ACID, ZOLEDRONIC ACID MONOHYDRATE] (C - n/a - n/a - [n/a - 5mg - Intravenous (not otherwise specified)])|[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8321735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8321807	Spontaneous	2014-09-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arteriosclerosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Blepharitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cataract (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Diplopia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Encephalitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Eye disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Eyelid ptosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);IIIrd nerve paresis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Mononeuritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Musculoskeletal stiffness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tongue paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Vertigo (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8321807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8322050	Spontaneous	2014-09-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Condition aggravated (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Lymphoedema (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8322050&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-8323950	Spontaneous	2014-09-02 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Bronchial obstruction (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8323950&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8296115	Spontaneous	2014-08-26 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Back pain (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Constipation (n/a - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Haemoperitoneum (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Hepatic haematoma (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Hypovolaemic shock (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Metastases to bone (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Metastases to liver (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Metastases to lung (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Osteoarthritis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Urinary retention (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[COLECALCIFEROL] (C - Hypovitaminosis - n/a - [n/a - 100000[iU] - Oral])|[FUROSEMIDE] (C - Hypertension - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8296115&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8259304	Spontaneous	2014-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Arthritis reactive (n/a - Recovering/Resolving - Other Medically Important Condition);Haematoma (n/a - Recovering/Resolving - Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site reaction (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8259304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8245296	Spontaneous	2014-08-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute disseminated encephalomyelitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8245296&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8247437	Spontaneous	2014-08-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic shock (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8247437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8235568	Spontaneous	2014-08-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Joint stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oedema peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tendon pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8235568&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8235602	Spontaneous	2014-08-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8235602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8235635	Spontaneous	2014-08-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Vaccination site nodule (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8235635&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8235720	Spontaneous	2014-08-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8235720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8152389	Spontaneous	2014-07-16 00:00:00	Non Healthcare Professional	European Economic Area	R. NOVATI, P.E. NEBIOLO, C. GALOTTO, M. MASTAGLIA, M. MANES Acute renal failure  after influenza vaccination: a case report, J PREV MED HYG 2014; 55: 31-32	18-64 Years	Not Specified	No	Male	Acute kidney injury (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID, ASCORBIC ACID, ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8152389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8154672	Spontaneous	2014-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myocarditis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [1d - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8154672&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8155595	Spontaneous	2014-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8155595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8143301	Spontaneous	2014-07-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epilepsy (n/a - Recovered/Resolved - );Injection site oedema (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	KEPPRA [LEVETIRACETAM] (C - n/a - n/a - [n/a - n/a - n/a])|[BACLOFEN, BACLOFEN PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8143301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8123481	Spontaneous	2014-07-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8123481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8081930	Spontaneous	2014-06-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8081930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8044269	Spontaneous	2014-06-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Liver disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])|[PARACETAMOL] (S - Pyrexia - n/a - [n/a - 500mg - Oral])	[ALFUZOSIN HYDROCHLORIDE] (C - Benign prostatic hyperplasia - n/a - [n/a - 10mg - Oral])|[ALLOPURINOL] (C - Gout - n/a - [n/a - 150mg - Oral])|[COLCHICINE] (C - Gout - n/a - [n/a - 1mg - Oral])|[DUTASTERIDE] (C - Benign prostatic hyperplasia - n/a - [n/a - .5mg - Oral])|[ESOMEPRAZOLE] (C - n/a - n/a - [n/a - 20mg - Oral])|[IBUPROFEN, IBUPROFEN BP, IBUPROFEN, CODEINE PHOSPHATE HEMIHYDRATE] (C - Analgesic therapy - n/a - [n/a - n/a - Oral])|[KETOPROFEN LYSINE] (C - Analgesic therapy - n/a - [n/a - n/a - Oral])|[OLMESARTAN MEDOXOMIL] (C - Hypertension - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8044269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8032285	Spontaneous	2014-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8032285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8018864	Spontaneous	2014-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Pruritus (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8018864&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8017653	Spontaneous	2014-06-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Radiculopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8017653&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7985148	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Clodoveo Ferri, Michele Colaci, Carlo UmbertoManzini, Marco Sebastiani, Dilia Giuggioli and Lucio Brugioni &quot;Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines&quot;. Hindawi Publishing Corporation, Case Reports in Rheumatology, Volume 2012, Article ID 836930, 3 pages, doi:10.1155/2012/836930	18-64 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovering/Resolving - Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Other Medically Important Condition);Organising pneumonia (n/a - Recovering/Resolving - Other Medically Important Condition);Polymyositis (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7985148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7985151	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - );Diarrhoea (n/a - Not Specified - );Rhinitis (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[TICLOPIDINE] (C - n/a - n/a - [n/a - n/a - n/a])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7985151&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7985177	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7985177&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7985189	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Influenza (7d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (7d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7985189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7985192	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (7d - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination failure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7985192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7985235	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7985235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7985240	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	General physical health deterioration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7985240&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7985248	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (8wk - Recovered/Resolved - Other Medically Important Condition);Dizziness (8wk - Recovered/Resolved - Other Medically Important Condition);General physical health deterioration (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (8wk - Recovered/Resolved - Other Medically Important Condition);Leukocytosis (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (8wk - Recovered/Resolved - Other Medically Important Condition);Peripheral vascular disorder (8wk - Recovered/Resolved - Other Medically Important Condition);Photosensitivity reaction (8wk - Recovered/Resolved - Other Medically Important Condition);Pyrexia (8wk - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [1d - 1{DF} - Intramuscular])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3] (S - n/a - Not applicable - [1d - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7985248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7985261	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Demyelination (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dystonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Febrile convulsion (n/a - Not Specified - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperreflexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sensory loss (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7985261&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7985729	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation);Contusion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Effusion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Eyelid oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Haematochezia (4wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Haematuria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Unknown - Caused/Prolonged Hospitalisation);Joint swelling (4wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ketonuria (n/a - Unknown - Caused/Prolonged Hospitalisation);Oedema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Petechiae (4wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Proteinuria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation);White blood cells urine positive (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7985729&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7971086	Spontaneous	2014-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dermatitis allergic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Purpura (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash pruritic (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	ARAVA [LEFLUNOMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - Dose not changed - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7971086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7964767	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Mechanical ventilation (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory muscle weakness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7964769	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964769&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7964826	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperpyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);IIIrd nerve paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Mononeuritis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	PRITOR [TELMISARTAN] (C - Hypertension - n/a - [n/a - 80mg - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - Hypertension - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964826&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7964876	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Thrombotic thrombocytopenic purpura (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964876&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7964959	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Dysarthria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eyelid ptosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lip swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myasthenia gravis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensation of foreign body (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swelling face (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swollen tongue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urinary incontinence (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	[ALENDRONATE SODIUM, ALENDRONATE SODIUM TRIHYDRATE, ALENDRONIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[VITAMIN D, CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964959&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7965227	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Abnormal faeces (n/a - Unknown - Other Medically Important Condition);Cholelithiasis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Constipation (n/a - Unknown - Other Medically Important Condition);Faeces discoloured (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[ACENOCOUMAROL] (S - n/a - Unknown - [n/a - 2mg - n/a])	[ACENOCOUMAROL] (C - Arrhythmia - Unknown - [n/a - 1mg - Unknown])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - Arrhythmia - Unknown - [n/a - 1{DF} - n/a])|[CIPROFIBRATE] (C - Hypercholesterolaemia - Unknown - [n/a - 100mg - n/a])|[ENALAPRIL MALEATE] (C - Hypertension - Unknown - [n/a - .5{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965227&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7968911	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pericarditis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7968911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7959764	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Acute disseminated encephalomyelitis (12d - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Feeling cold (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Quadriparesis (12d - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Urinary retention (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7959834	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eye oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Immunisation reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oral herpes (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7959900	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Gingival bleeding (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Immune thrombocytopenia (9d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Mucosal disorder (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Skin haemorrhage (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])...	[DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN] (C - Nasopharyngitis - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959900&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7959950	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Chromaturia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Haemolytic anaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hepatic cytolysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Jaundice (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Ocular icterus (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Major depression - n/a - [n/a - 5mg - n/a])|[METFORMIN EMBONATE] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959950&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7959985	Spontaneous	2014-05-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Cervical incompetence (n/a - Recovered/Resolved - Other Medically Important Condition);Cervix disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Haemorrhage (n/a - Recovered/Resolved - Other Medically Important Condition);Uterine atony (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[BETAMETHASONE] (C - n/a - n/a - [n/a - 12mg - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7960012	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Bacteriuria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Bedridden (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypertonic bladder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Lumbar spinal stenosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Prostatic obstruction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Wheelchair user (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ALLOPURINOL] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[AVOCADO OIL UNSAPONIFIABLES, SOYBEAN OIL UNSAPONIFIABLES, SOYA OIL, AVOCADO OIL] (C - n/a - n/a - [n/a - 300mg - n/a])|[COLCHICINE, DICYCLOVERINE HYDROCHLORIDE, COLCHICINE, OPIUM, STANDARDIZED POWDERED, TIEMONIUM METHYLSULPHATE, COLCHICINE, OPIUM, TIEMONIUM METHYLSULPHATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[PREDNISOLONE, PREDNISOLONE METASULFOBENZOATE SODIUM] (C - n/a - n/a - [n/a - 20mg - n/a])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 100mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960012&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960023	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Polymyalgia rheumatica (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Parenteral])	[ALPRAZOLAM] (C - n/a - n/a - [n/a - n/a - Oral])|[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[LOPRAZOLAM, LOPRAZOLAM MESILATE] (C - n/a - n/a - [n/a - n/a - Oral])|[ROPINIROLE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960023&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960120	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Acute respiratory distress syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Altered state of consciousness (27d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (27d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (27d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Hyperkalaemia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Hypotension (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Hypothermia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Hypotonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Lung disorder (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Renal failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory acidosis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sepsis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - Ischaemic heart disease prophylaxis - Dose not changed - [n/a - 1{DF} - Oral])|[CANDESARTAN CILEXETIL] (C - Hypertension - Dose not changed - [n/a - 1{DF} - Oral])|[LANSOPRAZOLE] (C - Gastrooesophageal reflux disease - Dose not changed - [n/a - 1{DF} - Oral])|[OXAZEPAM] (C - Anxiety - Dose not changed - [n/a - 1{DF} - Oral])|[PARACETAMOL, BELLADONNA DRY EXTRACT, CAFFEINE, OPIUM, PARACETAMOL, CAFFEINE, OPIUM, PARACETAMOL, CAFFEINE, OPIUM EXTRACTS, PARACETAMOL, CAFFEINE, OPIUM, PREPARED] (C - Pain - Dose not changed - [n/a - n/a - Rectal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960120&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7960143	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Ataxia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Encephalitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Nystagmus (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Opsoclonus myoclonus (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Tremor (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .25mL - Unknown])	[COLECALCIFEROL, SODIUM FLUORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SOTALOL, SOTALOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7960682	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Female	Epilepsy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Incorrect dose administered (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Seizure (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960682&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7960683	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Infection (6d - Unknown - );Influenza (6d - Recovered/Resolved - );Pyrexia (6d - Recovered/Resolved - );Vaccination failure (6d - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960683&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7960688	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960696	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Hypoacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Local reaction (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual impairment (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954448	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	Non European Economic Area	TISHER MOSHE, OFER LERY, MIRIT AMIT-VAZINA. IMMUNE THROMBOCYTOPENIC PURPURA FOLLOWIN VACCINTAION. ISRAEL VACCINE RESEARCH INITITATIVE;:322-323.	65-85 Years	Elderly	No	Male	Gastritis erosive (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gastrointestinal haemorrhage (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Melaena (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Platelet count decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Purpura (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Thrombocytopenic purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954521	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dermatitis (10d - Recovered/Resolved - Other Medically Important Condition);Skin discolouration (10d - Recovered/Resolved - Other Medically Important Condition);Vasculitis (11d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - n/a - n/a - [n/a - 400mg - n/a])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - 20mg - n/a])|[MEPREDNISONE] (C - n/a - n/a - [n/a - 4mg - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 850mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954521&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954561	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Contusion (n/a - Unknown - Other Medically Important Condition);Dehydration (n/a - Unknown - Other Medically Important Condition);Immune thrombocytopenia (n/a - Recovered/Resolved - Other Medically Important Condition)	INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954561&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954649	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Insomnia (n/a - Recovering/Resolving - Disabling);Mobility decreased (n/a - Recovering/Resolving - Disabling);Myalgia (n/a - Recovered/Resolved With Sequelae - Disabling);Sensory disturbance (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])	[FELODIPINE, FELODIPINE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954649&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-7954898	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Choking (n/a - Recovering/Resolving - Other Medically Important Condition);Erythema (n/a - Recovering/Resolving - Other Medically Important Condition);Lip oedema (n/a - Recovering/Resolving - Other Medically Important Condition);Pruritus (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site erythema (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site swelling (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954898&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7955379	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Paolo Pellegrino, Carla Carnovale, Cecilia Borsadoli, Tiziana Danini, Alessia Speziali, Valentina Perrone, Stefania Antoniazzi, Marco Pozzi, Emilio Clementi, Sonia Radice &apos;Two cases of hallucination in elderly patients due to a probable interaction between flu immunization and tramadol&apos;. Eur J Clin Pharmacol (2013) 69:1615-1616 DOI 10.1007/s00228-013-1517-5	More than 85 Years	Not Specified	No	Female	Amnestic disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Confusional state (n/a - Recovered/Resolved - Other Medically Important Condition);Drug interaction (n/a - Recovered/Resolved - Other Medically Important Condition);Hallucination (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])|[TRAMADOL HYDROCHLORIDE] (S - Arthralgia - n/a - [n/a - 20[drp] - Oral])	MICARDIS [TELMISARTAN] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[ALLOPURINOL] (C - n/a - n/a - [n/a - 150mg - n/a])|[BARNIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[CARVEDILOL] (C - n/a - n/a - [n/a - 2{DF} - n/a])|[CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10[drp] - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - 2{DF} - n/a])|[INSULIN HUMAN] (C - n/a - n/a - [n/a - n/a - n/a])|[RANITIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 150mg - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955379&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7955924	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (2d - Recovered/Resolved - );Injection site induration (n/a - Recovered/Resolved - );Injection site inflammation (n/a - Recovered/Resolved - );Injection site pain (2d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7955944	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Influenza like illness (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7950526	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Mayet A, Haus-Cheymol R, Bouaiti E, Decam C, Simon F, Mérens A, et al. Adverse events following vaccination in the French armed forces: An overview of surveillance conducted from 2002 to 2010. Euro Surveillance 2012 Jun 14;17(24):.	18-64 Years	Not Specified	No	Male	Mouth haemorrhage (480h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (480h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenic purpura (480h - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[MENINGOCOCCAL GROUP A, C, W135 AND Y CONJUGATE VACCINE] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7950526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7951220	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7951220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7951263	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovered/Resolved - Life Threatening);Laryngeal oedema (n/a - Recovered/Resolved - Life Threatening);Suffocation feeling (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7951263&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-7951335	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7951335&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7951360	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7951360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7953513	Spontaneous	2014-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Headache (1mo - Recovered/Resolved - );Injection site inflammation (1wk - Recovered/Resolved With Sequelae - );Polymyalgia rheumatica (1a - Recovered/Resolved With Sequelae - );Pyrexia (1wk - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7953513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-7945959	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Condition aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation);Diplopia (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Ophthalmoplegia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paresis (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7945959&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7945968	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bronchitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysstasia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somatic symptom disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vertigo (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	HBVAXPRO 10 MICROGRAMS/ML [HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7945968&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946005	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved - Other Medically Important Condition);Hepatic cytolysis (1wk - Recovered/Resolved - Other Medically Important Condition);Hepatic enzyme increased (1wk - Recovered/Resolved - Other Medically Important Condition);Joint swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Muscle spasms (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (24h - Recovered/Resolved - Other Medically Important Condition);Myositis (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7946006	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946022	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pneumonia escherichia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	[DILTIAZEM, DILTIAZEM HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 60mg - Oral])|[FLUTICASONE PROPIONATE] (C - n/a - Unknown - [n/a - 500mg - Respiratory (inhalation)])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - Unknown - [n/a - 100mg - Oral])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - 50mg - Oral])|[PHENPROCOUMON] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946106	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Breath sounds abnormal (n/a - Not Specified - Caused/Prolonged Hospitalisation);Nasal congestion (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Tonsillar inflammation (n/a - Not Specified - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946126	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Diplopia (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoacusis (n/a - Unknown - Caused/Prolonged Hospitalisation);Microangiopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Paresis (n/a - Unknown - Caused/Prolonged Hospitalisation);VIth nerve paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946126&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946140	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Injected limb mobility decreased (n/a - Unknown - Disabling);Peripheral swelling (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7946143	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Nephrotic syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946145	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Injection site inflammation (n/a - Recovered/Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Recovered/Resolved - Other Medically Important Condition);Productive cough (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Upper respiratory tract infection (10d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946146	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	CSF test abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946146&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946151	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Bronchitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Choking sensation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Conjunctival oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Intussusception (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tonsillitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946151&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946158	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946158&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946197	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Erythema (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngitis (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash scarlatiniform (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946198	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (157d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[ROXITHROMYCIN] (C - n/a - n/a - [n/a - 300{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946376	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cough (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946379	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946379&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946381	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946381&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946388	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Loss of consciousness (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946393	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Constipation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myelitis transverse (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory level (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urinary retention (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946393&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946398	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Henoch-Schonlein purpura (19d - Recovered/Resolved - );Pain in extremity (16d - Recovered/Resolved - );Pyrexia (19d - Recovered/Resolved - );Rash (19d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7946411	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Faeces discoloured (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gastroenteritis viral (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Generalised oedema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site inflammation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nephrotic syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pharyngeal oedema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Urine output decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946411&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946417	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946418	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946418&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946423	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute disseminated encephalomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Auditory nerve disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Hospitalisation (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Magnetic resonance imaging abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])|[RABIES VACCINE, RABIES VIRUS (INACTIVATED) STRAIN FLURY LEP] (S - Immunisation - n/a - [n/a - n/a - Unknown])|[RABIES VACCINE, RABIES VIRUS (INACTIVATED) STRAIN FLURY LEP] (S - Immunisation - n/a - [n/a - n/a - n/a])	[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN] (C - Immunisation - n/a - [n/a - 1{DF} - Unknown])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN] (C - Immunisation - n/a - [n/a - n/a - Unknown])|[MENINGOCOCCAL GROUP A, C, W135 AND Y CONJUGATE VACCINE, N. MENINGITIDIS GROUP C POLYSACCHARIDE, N. MENINGITIDIS GROUP Y POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE, N. MENINGITIDIS GROUP C POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP Y, N. MENINGITIDIS GROUP C POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE] (C - Immunisation - n/a - [n/a - n/a - Unknown])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (C - Immunisation - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946423&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946672	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Vital capacity decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])|[TETANUS TOXOID, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED, ALGELDRATE, TETANUS TOXOID, ALUMINIUM HYDROXIDE] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946672&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940911	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940982	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Aphasia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperaesthesia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site inflammation (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940984	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Angioedema (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - 2.5mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7940987	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941012	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Facial paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (10d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Herpes zoster (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (10d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash vesicular (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[TETANUS TOXOID, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, TETANUS TOXOID, ALGELDRATE, TETANUS TOXOID, ALUMINIUM, TETANUS TOXOID, ALUMINIUM HYDROXIDE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941012&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941032	Spontaneous	2014-05-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Choking (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941032&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941035	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hypersensitivity vasculitis (15d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941035&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7941073	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza A virus test positive (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941085	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Cough (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Rhinorrhoea (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941085&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941243	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941243&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941246	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941263	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chills (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Cold sweat (30min - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Dysphagia (30min - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hypersensitivity (30min - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hypotension (30min - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Nausea (30min - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pallor (30min - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941263&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-7941288	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Asthenia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Cardiac failure acute (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Gait disturbance (9d - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Gastritis erosive (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Myalgia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Myoglobin blood increased (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Myositis-like syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	NEORECORMON [EPOETIN BETA] (C - n/a - n/a - [n/a - n/a - n/a])|[ALUMINIUM CHLORHYDROXIDE-COMPLEX] (C - n/a - n/a - [n/a - n/a - n/a])|[BIOTIN, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN] (C - n/a - n/a - [n/a - n/a - n/a])|[CALCIUM ACETATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CLONIDINE, CLONIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[HEPARIN, HEPARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[IRON, IRON(III) ION, IRON, ION (FE3+), SODIUM FERRIC GLUCONATE COMPLEX] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE, METOPROLOL TARTRATE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[TORASEMIDE, TORASEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[VALSARTAN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7941301	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Van der Sande MA, van Asten L, Straus SM, Schim van der Loeff MF, Wallinga J, Conyn-van Spaendonck MA. Sudden deaths following influenza vaccination: can this be expected?. Vaccine JAN-2008:26(3):379-382.	65-85 Years	Elderly	No	Female	Sudden death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Not applicable - [n/a - 25mg - Oral])|NOT AVAILABLE (C - n/a - Not applicable - [n/a - 5mg - Oral])|[OMEPRAZOLE] (C - n/a - Not applicable - [n/a - 40mg - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAVASTATIN SODIUM] (C - n/a - Not applicable - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7941305	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hyperhidrosis (45min - Recovered/Resolved - Other Medically Important Condition);Hypotension (45min - Recovered/Resolved - Other Medically Important Condition);Seizure (45min - Recovered/Resolved - Other Medically Important Condition);Throat irritation (45min - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7941357	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941521	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Circulatory collapse (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	ENOXAPARIN SODIUM [ENOXAPARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ALENDRONATE SODIUM] (C - n/a - n/a - [n/a - 70mg - n/a])|[MACROGOL, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPYLENE GLYCOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941521&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7941619	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Male	Crying (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cyanosis (20s - Recovered/Resolved - Caused/Prolonged Hospitalisation);Inappropriate schedule of product administration (n/a - Unknown - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (20s - Recovered/Resolved - Caused/Prolonged Hospitalisation);Mydriasis (20s - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory arrest (20s - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (20s - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941619&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941819	Spontaneous	2014-05-16 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Dermatitis (n/a - Not Recovered/Not Resolved - Disabling);Henoch-Schonlein purpura (n/a - Not Recovered/Not Resolved - Disabling);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Disabling);Petechiae (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941819&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7942204	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site inflammation (1wk - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7942204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7942220	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Injection site papule (n/a - Not Specified - Other Medically Important Condition);Injection site ulcer (n/a - Not Specified - Other Medically Important Condition);Type III immune complex mediated reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7942220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7942226	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Choking sensation (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dermatitis allergic (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Swelling (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7942226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7942227	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Breath sounds abnormal (n/a - Not Specified - Caused/Prolonged Hospitalisation);Cough (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Throat tightness (n/a - Not Specified - Caused/Prolonged Hospitalisation);Tonsillar disorder (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7942227&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7936172	Spontaneous	2014-05-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Abnormal dreams (n/a - Unknown - Disabling, Other Medically Important Condition);Cataplexy (n/a - Unknown - Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Intentional self-injury (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Disabling, Other Medically Important Condition);Paralysis (n/a - Unknown - Disabling, Other Medically Important Condition);Quality of life decreased (n/a - Unknown - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	ACLASTA [ZOLEDRONIC ACID, ZOLEDRONIC ACID MONOHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[BICALUTAMIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7936172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7937262	Spontaneous	2014-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Erysipelas (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7937262&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7922363	Spontaneous	2014-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Vomiting (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7922363&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7887484	Spontaneous	2014-04-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Injection site inflammation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Soft tissue infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7887484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7886327	Spontaneous	2014-04-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (8d - Recovered/Resolved - Disabling);Fatigue (8d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7886327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7874258	Spontaneous	2014-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Blood pressure decreased (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7874258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7863322	Spontaneous	2014-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cutaneous vasculitis (47d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	AZOPT [BRINZOLAMIDE] (S - n/a - n/a - [n/a - n/a - Topical])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [1min - 1{DF} - Intramuscular])|[GRAPES (DRY SEED) STANDARDIZED PROCYANIDOLIC OLIGOMERS, PROCYANIDOL OLIGOMER] (S - n/a - n/a - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7863322&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7867369	Spontaneous	2014-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Dyspnoea (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoxia (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lung disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7867369&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7867451	Spontaneous	2014-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Bronchopneumopathy (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Hypoxia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Productive cough (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7867451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7859255	Spontaneous	2014-04-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Tinnitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7859255&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7853077	Spontaneous	2014-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7853077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7804331	Spontaneous	2014-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Lip oedema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7804331&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7790480	Spontaneous	2014-04-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Abdominal pain (n/a - Recovered/Resolved - Life Threatening);Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening);Cyanosis (n/a - Recovered/Resolved - Life Threatening);Dyspnoea (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7790480&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-7781421	Spontaneous	2014-03-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Abscess oral (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Adverse reaction (10d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cyanosis (9d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dysphoria (9d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Eyelid oedema (9d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Febrile convulsion (9d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypersensitivity (10d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Iron deficiency anaemia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Irregular breathing (9d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Oedema mouth (9d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Oliguria (9d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Peripheral coldness (9d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (9d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pupil fixed (9d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (10d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory arrest (9d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Swelling face (10d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7781421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7784850	Spontaneous	2014-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7784850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7765964	Spontaneous	2014-03-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Arthralgia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7765964&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7760062	Spontaneous	2014-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - );Lip oedema (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7760062&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7753716	Spontaneous	2014-03-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - );Lymphadenopathy (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	[LEVOTHYROXINE SODIUM] (C - Post procedural hypothyroidism - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7753716&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7750911	Spontaneous	2014-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Herpes simplex (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7750911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7746807	Spontaneous	2014-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Ecchymosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gingival bleeding (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Haemolytic anaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7746807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7732816	Spontaneous	2014-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Limb discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7732816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7716942	Spontaneous	2014-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Eyelid oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Lip oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7716942&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7717001	Spontaneous	2014-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Depressed level of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotonia (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Petit mal epilepsy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7717001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7717008	Spontaneous	2014-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Daydreaming (n/a - Recovered/Resolved - Other Medically Important Condition);Epilepsy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7717008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7720601	Spontaneous	2014-03-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Extensive swelling of vaccinated limb (5mo - Recovered/Resolved With Sequelae - );Headache (5wk - Recovered/Resolved With Sequelae - );Myalgia (4wk - Recovered/Resolved With Sequelae - );Pyrexia (2wk - Recovered/Resolved - );Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7720601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-7720914	Spontaneous	2014-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cerebellar syndrome (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7720914&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7695980	Spontaneous	2014-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pericarditis (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Dose not changed - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7695980&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7682508	Spontaneous	2014-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Chest discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Monoparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Urinary tract disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7682508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7689375	Spontaneous	2014-03-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Atypical pneumonia (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (35d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7689375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7689839	Spontaneous	2014-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Acute kidney injury (n/a - Unknown - Caused/Prolonged Hospitalisation);Blister (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation);Scab (n/a - Unknown - Caused/Prolonged Hospitalisation)	FIRMAGON [DEGARELIX, DEGARELIX ACETATE] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])|XGEVA 120 MG SOLUTION FOR INJECTION [DENOSUMAB] (S - n/a - n/a - [n/a - n/a - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Parenteral])|[BICALUTAMIDE] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])|[LEUPRORELIN, LEUPRORELIN ACETATE] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7689839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7685276	Spontaneous	2014-03-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Gingival recession (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Joint dislocation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Recovered/Resolved - Other Medically Important Condition);Spinal deformity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CARBASALATE CALCIUM] (C - n/a - Unknown - [n/a - 100mg - Oral])|[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - Dose not changed - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7685276&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7669666	Spontaneous	2014-02-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Limb discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Lip injury (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7669666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7669748	Spontaneous	2014-02-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Not Specified - Other Medically Important Condition);Face oedema (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7669748&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7667019	Spontaneous	2014-02-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Acute kidney injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Anuria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Atrial fibrillation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Blood pressure decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Cardiac failure (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cardiomyopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chronic kidney disease (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dialysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Disseminated intravascular coagulation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dry mouth (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Encephalomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hepatic failure (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hyperhidrosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Metabolic acidosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Monoplegia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Myelitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myelitis transverse (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myositis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Neurogenic bladder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Neurogenic bowel (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Oedema (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Oliguria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Paraplegia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pathogen resistance (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pneumococcal sepsis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pneumonia streptococcal (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Presyncope (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Rhabdomyolysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Rhinorrhoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Septic shock (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sinus tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Skin warm (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Spinal cord injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	NALOXONE [NALOXONE, NALOXONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[NALOXONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, NALOXONE, OXYCODONE, OXYCODONE HYDROCHLORIDE, NALOXONE, OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7667019&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7668846	Spontaneous	2014-02-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Lymphadenopathy (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[PRE/PANDEMIC INFLUENZA VACCINE (H5N1)] (C - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7668846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7661008	Spontaneous	2014-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Purpura (n/a - Not Specified - Caused/Prolonged Hospitalisation);Rash (n/a - Not Specified - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7661008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7656396	Spontaneous	2014-02-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Erythema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pharyngeal erythema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tonsillar hypertrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7656396&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7656946	Spontaneous	2014-02-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7656946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7650411	Spontaneous	2014-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Pain (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - );Rash erythematous (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7650411&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7647308	Spontaneous	2014-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Vascular purpura (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (S - Product used for unknown indication - Dose not changed - [n/a - n/a - Oral])|[BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (S - Product used for unknown indication - Dose not changed - [n/a - n/a - Oral])|[FLUVASTATIN, FLUVASTATIN SODIUM] (S - Product used for unknown indication - Dose not changed - [n/a - n/a - Oral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7647308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7641428	Spontaneous	2014-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Pharyngeal swelling (n/a - Unknown - Other Medically Important Condition);Swollen tongue (n/a - Unknown - Other Medically Important Condition);Throat irritation (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7641428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7627190	Spontaneous	2014-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Herpes zoster (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7627190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7627283	Spontaneous	2014-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - );Asthenia (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7627283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7629685	Spontaneous	2014-02-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Recovering/Resolving - );Nasopharyngitis (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7629685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7626245	Spontaneous	2014-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hot flush (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7626245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7621988	Spontaneous	2014-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash maculo-papular (24d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])|[NAPROXEN SODIUM, NAPROXEN SODIUM ANHYDROUS] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[RABEPRAZOLE SODIUM] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[THIOCOLCHICOSIDE] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7621988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7622469	Spontaneous	2014-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Arthralgia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7622469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7616758	Spontaneous	2014-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash erythematous (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])|[BETAMETHASONE, BETAMETHASONE VALERATE] (S - n/a - Drug withdrawn - [n/a - n/a - Cutaneous])|[TRAMADOL HYDROCHLORIDE] (S - n/a - Dose not changed - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7616758&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7616921	Spontaneous	2014-02-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Breath sounds abnormal (9d - Not Specified - Caused/Prolonged Hospitalisation);Choking sensation (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dermatitis allergic (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (8d - Not Specified - Caused/Prolonged Hospitalisation);Pruritus (11d - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (10d - Not Specified - Caused/Prolonged Hospitalisation);Rash (11d - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7616921&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7618309	Spontaneous	2014-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7618309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7609496	Spontaneous	2014-02-12 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Chest pain (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Cyanosis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7609496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7614859	Spontaneous	2014-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Heart rate increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7614859&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7599401	Spontaneous	2014-02-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Pyrexia (3d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Rash (4d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Thrombocytopenic purpura (0d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7599401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7599733	Spontaneous	2014-02-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (4h - Recovered/Resolved - Other Medically Important Condition);Sensation of foreign body (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7599733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7607334	Spontaneous	2014-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cutaneous vasculitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7607334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7603294	Spontaneous	2014-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Decreased appetite (n/a - Unknown - );Malaise (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7603294&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7602752	Spontaneous	2014-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site swelling (n/a - Recovered/Resolved - );Injection site warmth (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7602752&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7602929	Spontaneous	2014-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - );Asthenia (n/a - Recovered/Resolved - );Gastrointestinal pain (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7602929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7597086	Spontaneous	2014-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dermatitis exfoliative generalised (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Face oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Unknown - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])|[IBUPROFEN] (S - Influenza like illness - Drug withdrawn - [n/a - n/a - Oral])|[PARACETAMOL] (S - Influenza like illness - Drug withdrawn - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7597086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7592321	Spontaneous	2014-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Proteinuria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vascular purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])	APROVEL [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[MIANSERIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7592321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7588714	Spontaneous	2014-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Trigeminal neuralgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7588714&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7588758	Spontaneous	2014-02-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Adverse reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Autoimmune disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Disability (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Epicondylitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Exostosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Limb discomfort (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Muscle spasms (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Neuralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Radiculopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Sensory loss (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Tenderness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Tendonitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Viral infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7588758&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7586167	Spontaneous	2014-02-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysphonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Eating disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Eye disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Joint stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Peroneal nerve palsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Skin hypertrophy (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7586167&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7576676	Spontaneous	2014-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Peripheral swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[HYDROCHLOROTHIAZIDE, NEBIVOLOL] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7576676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7576728	Spontaneous	2014-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Pyrexia (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7576728&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7576743	Spontaneous	2014-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	International normalised ratio increased (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])|[WARFARIN SODIUM] (S - Atrial fibrillation - n/a - [n/a - 17.5mg - Oral])	KARVEA [IRBESARTAN] (C - n/a - n/a - [n/a - 150mg - Oral])|[RISEDRONATE MONOSODIUM, RISEDRONATE SODIUM] (C - n/a - n/a - [n/a - 35mg - Oral])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 240mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7576743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7575101	Spontaneous	2014-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Agitation (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Crying (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7575101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7575675	Spontaneous	2014-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Erythema (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Skin induration (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	[NEBIVOLOL] (C - n/a - n/a - [n/a - n/a - n/a])|[OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7575675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7573355	Spontaneous	2014-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pyrexia (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Parenteral])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[INDAPAMIDE, PERINDOPRIL ARGININE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7573355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7569263	Spontaneous	2014-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lip oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Presyncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7569263&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7561165	Spontaneous	2014-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7561165&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7556688	Spontaneous	2014-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7556688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7560041	Spontaneous	2014-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	EXFORGE [VALSARTAN, AMLODIPINE, VALSARTAN, AMLODIPINE BESILATE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|GALVUS [VILDAGLIPTIN] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[ACARBOSE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[GLICLAZIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[PRAVASTATIN SODIUM, ACETYLSALICYLIC ACID] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7560041&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7549408	Spontaneous	2014-01-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Balance disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Laryngitis (n/a - Recovered/Resolved - Other Medically Important Condition);Monoplegia (n/a - Recovered/Resolved - Other Medically Important Condition);Multiple sclerosis (2d - Recovered/Resolved - Other Medically Important Condition);Paraplegia (2d - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	REBIF [INTERFERON BETA-1A] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7549408&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7553205	Spontaneous	2014-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erysipelas (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site warmth (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7553205&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7545839	Spontaneous	2014-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Crying (n/a - Recovered/Resolved - );Tremor (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7545839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7542430	Spontaneous	2014-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Dyskinesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7542430&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7535717	Spontaneous	2014-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypoacusis (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7535717&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7535832	Spontaneous	2014-01-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ear discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoacusis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7535832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7525339	Spontaneous	2014-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7525339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7520409	Spontaneous	2014-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Body temperature increased (1d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (26d - Recovered/Resolved - Other Medically Important Condition);Fatigue (28d - Recovered/Resolved - Other Medically Important Condition);Respiratory tract infection (26d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7520409&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7500370	Spontaneous	2014-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia oral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Psychomotor skills impaired (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7500370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7494669	Spontaneous	2014-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	C-reactive protein increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sepsis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [1d - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7494669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7494792	Spontaneous	2014-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Radiculopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7494792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7483189	Spontaneous	2014-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Inflammation (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Vaccination site inflammation (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Vertigo (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7483189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7480849	Spontaneous	2014-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Hyperhidrosis (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7480849&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7480226	Spontaneous	2014-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Local reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7480226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7480227	Spontaneous	2014-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Facial pain (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7480227&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7472153	Spontaneous	2014-01-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (n/a - Unknown - Disabling);Cough (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Hyperhidrosis (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Oropharyngeal pain (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7472153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7470825	Spontaneous	2013-12-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	CSF neutrophil count increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Meningitis (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7470825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7470839	Spontaneous	2013-12-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7470839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7457499	Spontaneous	2013-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Generalised tonic-clonic seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Unresponsive to stimuli (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7457499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7459312	Spontaneous	2013-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Dizziness (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - );Hypoaesthesia (n/a - Recovering/Resolving - );Listless (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7459312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7459360	Spontaneous	2013-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pruritus (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7459360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7459376	Spontaneous	2013-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain (0d - Recovered/Resolved - );Vomiting (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7459376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7445052	Spontaneous	2013-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Injection site erythema (n/a - Unknown - );Injection site pruritus (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7445052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7448120	Spontaneous	2013-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Aggression (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Confusional state (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])|[AMOXICILLIN] (S - n/a - Drug withdrawn - [n/a - 3g - Intravenous drip])|[NEFOPAM HYDROCHLORIDE] (S - n/a - Drug withdrawn - [n/a - n/a - Intravenous (not otherwise specified)])|[RIFAMPICIN] (S - n/a - Drug withdrawn - [n/a - 300mg - Intravenous drip])	[BUPRENORPHINE] (C - n/a - n/a - [n/a - 4.8mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7448120&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7436809	Spontaneous	2013-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Peripheral sensory neuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	BRENTUXIMAB VEDOTIN [BRENTUXIMAB VEDOTIN] (S - Hodgkin's disease recurrent - n/a - [n/a - 133mg - Intravenous (not otherwise specified)])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	[GLYCINE, HAEMOPHILUS INFLUENZAE TYPE B (HIB), KLEBSIELLA OZAENAE, KLEBSIELLA PNEUMONIAE, NEISSERIA CATARRHALIS, STAPHYLOCOCCUS AUREUS, STREPTOCOCCUS PYOGENES, STREPTOCOCCUS VIRIDANS, DIPLOCOCCUS PNEUMONIAE, HAEMOPHILUS INFLUENZAE, KLEBSIELLA OZAENAE, KLEBSIELLA PNEUMONIAE, NEISSERIA CATARRHALIS, STAPHYLOCOCCUS AUREUS, STREPTOCOCCUS PNEUMONIAE, STREPTOCOCCUS PYOGENES, STREPTOCOCCUS VIRIDANS, LYOPHILIZED BACTERIAL LYSATES] (C - Immunodeficiency - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7436809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7435919	Spontaneous	2013-12-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Adult	No	Male	Henoch-Schonlein purpura (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	HYDROCORTISONE [HYDROCORTISONE, HYDROCORTISONE SODIUM SUCCINATE] (S - Adrenal insufficiency - Dose increased - [n/a - 20meq - Oral])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Adrenal insufficiency - Not applicable - [n/a - .5mL - Intramuscular])|[FLUDROCORTISONE ACETATE] (S - Adrenal insufficiency - Dose not changed - [n/a - .1mg - Oral])	[COLECALCIFEROL] (C - Osteoporosis - n/a - [n/a - 100[iU] - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7435919&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7427217	Spontaneous	2013-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Respiratory disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Cystic fibrosis - n/a - [n/a - 1{DF} - Intramuscular])	[COLISTIMETHATE SODIUM, COLISTIN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PIPERACILLIN SODIUM, TAZOBACTAM SODIUM, PIPERACILLIN, TAZOBACTAM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7427217&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7431500	Spontaneous	2013-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hepatic cytolysis (n/a - Fatal - Results in Death);Pyrexia (n/a - Fatal - Results in Death);Rhabdomyolysis (n/a - Fatal - Results in Death)	SYNAGIS [PALIVIZUMAB] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7431500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7426602	Spontaneous	2013-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Motor dysfunction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])|[NITROFURANTOIN] (S - Urinary tract infection - Drug withdrawn - [n/a - 2{DF} - Oral])|[TIANEPTINE, TIANEPTINE SODIUM] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7426602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7413474	Spontaneous	2013-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Erysipelas (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7413474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7406572	Spontaneous	2013-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - Oral])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - Oral])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[VALSARTAN] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7406572&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7400510	Spontaneous	2013-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Eczema (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7400510&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7401385	Spontaneous	2013-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7401385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7394666	Spontaneous	2013-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Epistaxis (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (4d - Recovered/Resolved - Other Medically Important Condition);Muscle spasms (0d - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (3d - Unknown - Other Medically Important Condition);Somnolence (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7394666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7387877	Spontaneous	2013-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Encephalopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Tic (n/a - Unknown - Caused/Prolonged Hospitalisation);Tourette's disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7387877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7389928	Spontaneous	2013-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Paraesthesia (4d - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (4d - Recovered/Resolved - Other Medically Important Condition);Rash (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Parenteral])	[LEVOTHYROXINE SODIUM] (C - Hypothyroidic goitre - Dose not changed - [n/a - 50ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7389928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7383884	Spontaneous	2013-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arthritis reactive (n/a - Unknown - Other Medically Important Condition);Contusion (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Infection susceptibility increased (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Joint swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pleurisy (n/a - Unknown - Other Medically Important Condition);Post-traumatic stress disorder (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[TICK-BORNE ENCEPHALITIS VIRUS] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7383884&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7386821	Spontaneous	2013-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Diplopia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])|[SIMVASTATIN] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7386821&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7377999	Spontaneous	2013-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dyspnoea (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	LANTUS [INSULIN GLARGINE] (C - n/a - n/a - [n/a - n/a - n/a])|NOVONORM [REPAGLINIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CARVEDILOL] (C - n/a - n/a - [n/a - n/a - n/a])|[EPROSARTAN MESILATE, HYDROCHLOROTHIAZIDE, EPROSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[INDOBUFEN] (C - n/a - n/a - [n/a - n/a - n/a])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[NEBIVOLOL] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7377999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7378226	Spontaneous	2013-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Feeling hot (n/a - Recovered/Resolved - Other Medically Important Condition);Injected limb mobility decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Limb discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Osteoarthritis (n/a - Recovered/Resolved - Other Medically Important Condition);Osteomyelitis (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Periostitis (n/a - Recovered/Resolved - Other Medically Important Condition);Rotator cuff syndrome (n/a - Recovered/Resolved - Other Medically Important Condition);Tendon disorder (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7378226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7378370	Spontaneous	2013-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Arthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Constipation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Joint swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Joint warmth (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7378370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7378551	Spontaneous	2013-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Burning sensation (n/a - Unknown - Other Medically Important Condition);Diplopia (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Unknown - Other Medically Important Condition);Eyelid ptosis (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Gait disturbance (n/a - Unknown - Other Medically Important Condition);Gastrointestinal disorder (n/a - Unknown - Other Medically Important Condition);General physical health deterioration (n/a - Unknown - Other Medically Important Condition);Insomnia (n/a - Unknown - Other Medically Important Condition);Migraine (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myofascitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Speech disorder (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7378551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7380373	Spontaneous	2013-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7380373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7370431	Spontaneous	2013-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7370431&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7371267	Spontaneous	2013-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7371267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7364287	Spontaneous	2013-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dysphonia (n/a - Not Recovered/Not Resolved - );Respiratory tract infection (n/a - Not Recovered/Not Resolved - )	[A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7364287&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7354468	Spontaneous	2013-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bronchitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Costochondritis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dermal cyst (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dry skin (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Herpes zoster (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Oral candidiasis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Skin fissures (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tenderness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Varicella (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[DIAZEPAM] (C - n/a - n/a - [n/a - 1mg - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - Hiatus hernia - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7354468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7357997	Spontaneous	2013-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Seizure (30min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])|[TETANUS TOXOID] (S - Immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7357997&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7345108	Spontaneous	2013-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Synovitis (9d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	[CICLESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN, EZETIMIBE] (C - n/a - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7345108&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7332164	Spontaneous	2013-11-20 00:00:00	Healthcare Professional	European Economic Area	Mayet A, Haus-Cheymol R, Bouaiti E, Decam C, Simon F, Mérens A, et al. Adverse events following vaccination in the french armed forces: an overview of surveillance conducted from 2002 to 2010. Eurosurveillance 2012 Jun 14;17(24):. Mayet A, Nivoix P, Haus-Cheymol R, De Laval F, Verret C, Duron S, et al. Increase in reported adverse events following seasonal influenza vaccination among the French armed forces, 2008-2009: possible role of stimulated reporting and background cases of influenza-like infection. Public Health 2012;126:70-76.	18-64 Years	Not Specified	No	Male	Ataxia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Cognitive disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Emotional disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Insomnia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Leukoencephalomyelitis (5mo - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sensorimotor disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7332164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7333034	Spontaneous	2013-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site pain (4d - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7333034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7334229	Spontaneous	2013-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Not Specified	Application site oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema multiforme (n/a - Recovered/Resolved - Other Medically Important Condition);Hypokinesia (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Lymph node pain (n/a - Recovered/Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7334229&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7321936	Spontaneous	2013-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7321936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7322042	Spontaneous	2013-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Haemorrhagic diathesis (n/a - Unknown - Other Medically Important Condition);Immune thrombocytopenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Thrombocytopenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	BRILIQUE [TICAGRELOR] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[OXAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7322042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7315653	Spontaneous	2013-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urinary tract inflammation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	COAPROVEL [HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - 8.75mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7315653&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7316350	Spontaneous	2013-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hyperhidrosis (6d - Recovered/Resolved - );Muscular weakness (6d - Recovered/Resolved - );Myalgia (6d - Recovered/Resolved - );Nausea (6d - Recovered/Resolved - );Somnolence (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7316350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7319308	Spontaneous	2013-11-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Extensive swelling of vaccinated limb (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovered/Resolved - )	[A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7319308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7311466	Spontaneous	2013-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Application site dermatitis (4d - Recovered/Resolved - Other Medically Important Condition);Pruritus (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7311466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7315540	Spontaneous	2013-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Balance disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7315540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7308702	Spontaneous	2013-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Diarrhoea (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7308702&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7306028	Spontaneous	2013-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Keratitis (n/a - Recovered/Resolved - Other Medically Important Condition);Raynaud's phenomenon (n/a - Unknown - Other Medically Important Condition);Sjogren's syndrome (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7306028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7291990	Spontaneous	2013-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7291990&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7285311	Spontaneous	2013-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Erythema (n/a - Recovering/Resolving - );Injection site induration (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - );Injection site warmth (n/a - Recovering/Resolving - );Pustule (n/a - Recovering/Resolving - );Swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7285311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7283077	Spontaneous	2013-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Chills (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[OMEPRAZOLE] (C - Gastrooesophageal reflux prophylaxis - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7283077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7272281	Spontaneous	2013-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cold sweat (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Diplopia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Discomfort (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Listless (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscle twitching (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (1min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7272281&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7273308	Spontaneous	2013-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Blood pressure decreased (n/a - Unknown - Other Medically Important Condition);Cold sweat (15min - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Dizziness (15min - Recovered/Resolved - Other Medically Important Condition);Lip swelling (9d - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (9d - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Unknown - Other Medically Important Condition);Urticaria (9d - Recovered/Resolved - Other Medically Important Condition)	ONBREZ BREEZHALER 150 MICROGRAM [INDACATEROL, INDACATEROL MALEATE] (S - Chronic obstructive pulmonary disease - Drug withdrawn - [n/a - 150ug - Respiratory (inhalation)])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Parenteral])	[ACETYLCYSTEINE] (C - n/a - n/a - [n/a - n/a - n/a])|[DEXTROMETHORPHAN HYDROBROMIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE, PARACETAMOL, DEXTROMETHORPHAN HYDROBROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7273308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7256182	Spontaneous	2013-10-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site reaction (n/a - Not Recovered/Not Resolved - )	[A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7256182&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7251008	Spontaneous	2013-10-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Arthralgia (n/a - Recovering/Resolving - )	[A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7251008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7236707	Spontaneous	2013-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Blood bilirubin increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Enteritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[PHENPROCOUMON] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7236707&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7238877	Spontaneous	2013-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Application site erythema (3d - Unknown - Other Medically Important Condition);Application site pain (3d - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Vaccination site induration (3d - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7238877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7234853	Spontaneous	2013-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Disabling);Asthenia (n/a - Recovered/Resolved - Disabling);Headache (n/a - Recovered/Resolved - Disabling);Nausea (n/a - Recovered/Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7234853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7227384	Spontaneous	2013-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Eosinophilic fasciitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7227384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7228873	Spontaneous	2013-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Crying (n/a - Unknown - );Injection site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7228873&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7205205	Spontaneous	2013-10-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Febrile convulsion (1min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Foaming at mouth (1min - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle rigidity (1min - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Staring (1min - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Upper respiratory tract infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7205205&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7208149	Spontaneous	2013-10-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (2mo - Recovered/Resolved With Sequelae - );Myalgia (2mo - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7208149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-7203391	Spontaneous	2013-10-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Rash pustular (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 25mg - Oral])|[METOPROLOL SUCCINAAT] (C - n/a - n/a - [n/a - 200mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7203391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7194439	Spontaneous	2013-10-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Neuralgia (n/a - Recovered/Resolved - Disabling);Neuralgic amyotrophy (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Dose not changed - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7194439&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7153545	Spontaneous	2013-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[FLUDROCORTISONE ACETATE] (C - Addison's disease - n/a - [n/a - .05mg - Oral])|[HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE PH. EUR.] (C - Addison's disease - n/a - [n/a - 12.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7153545&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7148398	Spontaneous	2013-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7148398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7149318	Spontaneous	2013-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Phlebitis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia (18d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory disorder (18d - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[BENAZEPRIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CLOMIPRAMINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[DOMPERIDONE] (C - n/a - n/a - [n/a - n/a - n/a])|[ERGOCALCIFEROL] (C - n/a - n/a - [n/a - 20[drp] - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[OXAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])|[VENLAFAXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 75mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7149318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7149327	Spontaneous	2013-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Erythema (2mo - Recovered/Resolved - Other Medically Important Condition);Fungal infection (n/a - Unknown - Other Medically Important Condition);Gait disturbance (4mo - Recovered/Resolved - Other Medically Important Condition);Haematoma (2mo - Recovered/Resolved - Other Medically Important Condition);Joint swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal stiffness (5mo - Recovered/Resolved - Other Medically Important Condition);Oedema peripheral (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	HUMALOG [INSULIN LISPRO] (C - n/a - n/a - [n/a - n/a - n/a])|LANTUS [INSULIN GLARGINE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[BENAZEPRIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[BROMAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUINDIONE] (C - n/a - n/a - [n/a - n/a - n/a])|[LACTULOSE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7149327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7150206	Spontaneous	2013-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Injection site erythema (2d - Recovered/Resolved - Other Medically Important Condition);Injection site pain (2d - Recovered/Resolved - Other Medically Important Condition);Injection site urticaria (1d - Recovered/Resolved - Other Medically Important Condition);Lip swelling (2d - Recovered/Resolved - Other Medically Important Condition);Urticaria (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[EBASTINE] (C - Urticaria chronic - n/a - [n/a - 1{DF} - Oral])|[ETHINYLESTRADIOL, GESTODENE, GESTODENE MICROFIN, ETHINYLESTRADIOL MICRONIZED] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7150206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7151873	Spontaneous	2013-09-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Hyperacusis (n/a - Recovering/Resolving - Other Medically Important Condition);Tinnitus (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7151873&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7144389	Spontaneous	2013-09-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amyotrophy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Decreased vibratory sense (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Foot fracture (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Meningitis aseptic (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Motor dysfunction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle contractions involuntary (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pelvic pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7144389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7145744	Spontaneous	2013-09-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Presyncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7145744&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7145904	Spontaneous	2013-09-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Bronchial obstruction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Demyelination (n/a - Unknown - Caused/Prolonged Hospitalisation);Disorientation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ear infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hallucination (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hearing disability (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoacusis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyponatraemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Mental disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Monoparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Motor dysfunction (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle contracture (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraplegia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyuria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Status epilepticus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 75mg - n/a])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - 400ug - n/a])|[CANDESARTAN, CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - 8mg - n/a])|[PIROXICAM] (C - n/a - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7145904&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7142687	Spontaneous	2013-09-24 00:00:00	Healthcare Professional	Non European Economic Area	Plotkin E, Bernheim J, Ben-Chetrit S, Mor A, Korzets Z. Influenza vaccine  - a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate. Nephrol Dial Transplant 2000;15:740-741.	65-85 Years	Not Specified	No	Male	Acute kidney injury (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[BEZAFIBRATE] (S - n/a - Not applicable - [n/a - 200mg - n/a])|[CERIVASTATIN] (S - n/a - Not applicable - [n/a - .9mg - n/a])	[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - n/a - n/a - [n/a - n/a - n/a])|[ISOSORBIDE MONONITRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7142687&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7126896	Spontaneous	2013-09-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anxiety (n/a - Unknown - Disabling);Chills (n/a - Unknown - Disabling);Discomfort (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Dysaesthesia (n/a - Unknown - Disabling);Dyspnoea (n/a - Unknown - Disabling);Fine motor delay (n/a - Unknown - Disabling);Hallucination (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Heart rate increased (n/a - Unknown - Disabling);Hyperhidrosis (n/a - Unknown - Disabling);Hypersensitivity (n/a - Not Recovered/Not Resolved - Disabling);Lethargy (n/a - Unknown - Disabling);Limb discomfort (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Memory impairment (n/a - Unknown - Disabling);Palpitations (n/a - Unknown - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Pruritus (n/a - Unknown - Disabling);Rash (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Tinnitus (n/a - Unknown - Disabling);Tremor (n/a - Unknown - Disabling);Urticaria (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7126896&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7109378	Spontaneous	2013-09-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Blood pressure increased (n/a - Recovered/Resolved With Sequelae - );Nephropathy (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[HYDROCHLOROTHIAZIDE, RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7109378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-7104473	Spontaneous	2013-09-12 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Malaise (n/a - Recovered/Resolved - Disabling);Pain (n/a - Recovered/Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7104473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7099925	Spontaneous	2013-09-11 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7099925&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7099935	Spontaneous	2013-09-11 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Headache (n/a - Recovering/Resolving - Disabling);Pain (n/a - Recovering/Resolving - Disabling);Pyrexia (n/a - Recovering/Resolving - Disabling);Tonsillitis (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7099935&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7082000	Spontaneous	2013-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (15d - Fatal - Results in Death);Diarrhoea (15d - Fatal - Results in Death);Malaise (15d - Fatal - Results in Death);Vomiting (15d - Fatal - Results in Death)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7082000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7069443	Spontaneous	2013-09-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute respiratory failure (n/a - Fatal - Results in Death);Cardiac failure (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[COLECALCIFEROL] (C - Vitamin D deficiency - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7069443&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7056154	Spontaneous	2013-08-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	H1N1 influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7056154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7046625	Spontaneous	2013-08-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Allodynia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Carpal tunnel syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Cubital tunnel syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7046625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7046641	Spontaneous	2013-08-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Death (1d - Fatal - Results in Death)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])|[HEPATITIS A VIRUS ANTIGEN (INACTIVATED)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7046641&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7038453	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	VIth nerve paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Prophylaxis - Not applicable - [1d - 1mL - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[POLIOMYELITIS VACCINE (INACTIVATED), POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN)] (S - Prophylaxis - Not applicable - [1d - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7038453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7039236	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arrhythmia (n/a - Unknown - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Circadian rhythm sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Unknown - Caused/Prolonged Hospitalisation);Hair growth abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypokinesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasal obstruction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation);Obstructive sleep apnoea syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Reduced facial expression (n/a - Unknown - Caused/Prolonged Hospitalisation);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep apnoea syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Slow speech (n/a - Unknown - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation);Tremor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[FLECAINIDE, FLECAINIDE ACETATE] (C - Atrial fibrillation - Drug withdrawn - [n/a - 200mg - Oral])|[LAMOTRIGINE] (C - Epilepsy - Not applicable - [n/a - 175mg - Oral])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - Atrial fibrillation - Drug withdrawn - [n/a - 40mg - Oral])|[SODIUM VALPROATE] (C - Epilepsy - Not applicable - [n/a - 1800mg - Oral])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - Cardiac fibrillation - Not applicable - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7039236&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7024873	Spontaneous	2013-08-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Facial pain (n/a - Unknown - );Trigeminal neuralgia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 20[drp] - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7024873&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7021047	Spontaneous	2013-08-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation);Myoclonic epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [30d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7021047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7011525	Spontaneous	2013-08-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Accommodation disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Encephalitis lethargica (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nervous system disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nystagmus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Speech disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Vertigo (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7011525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6995753	Spontaneous	2013-08-08 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Bell's palsy (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6995753&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6997956	Spontaneous	2013-08-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dysphagia (n/a - Fatal - Results in Death);Erythema (n/a - Fatal - Results in Death);Muscular weakness (n/a - Fatal - Results in Death);Rash (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6997956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6997961	Spontaneous	2013-08-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Lung infiltration (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6997961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6984874	Spontaneous	2013-08-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6984874&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6985412	Spontaneous	2013-08-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Transient global amnesia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6985412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6977591	Spontaneous	2013-08-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Erectile dysfunction (n/a - Recovered/Resolved - Other Medically Important Condition);Inflammation (n/a - Recovered/Resolved - Other Medically Important Condition);Lethargy (n/a - Recovered/Resolved - Other Medically Important Condition);Movement disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site inflammation (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6977591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6973187	Spontaneous	2013-08-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	BUDESONIDE [BUDESONIDE] (C - n/a - n/a - [n/a - 2{DF} - Nasal])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - Oral])|[MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - 5mg - Oral])|[PROMETHAZINE, PROMETHAZINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6973187&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6973188	Spontaneous	2013-08-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6973188&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6966695	Spontaneous	2013-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (3d - Recovered/Resolved - Other Medically Important Condition);Nausea (3d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition)	MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (S - n/a - Drug withdrawn - [4d - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6966695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6967320	Spontaneous	2013-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diplegia (n/a - Unknown - Caused/Prolonged Hospitalisation);Motor dysfunction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscle disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (3mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myositis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6967320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6961812	Spontaneous	2013-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovering/Resolving - );Vaccination site paraesthesia (n/a - Recovering/Resolving - );Vaccination site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6961812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6965034	Spontaneous	2013-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site erythema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6965034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6965436	Spontaneous	2013-07-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Oral herpes (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6965436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6952013	Spontaneous	2013-07-26 00:00:00	Healthcare Professional	European Economic Area	Mayet A, Haus-Cheymol R, Bouaiti E, Decam C, Simon F, Mérens A, et al. Adverse events following vaccination in the French armed forces: An overview of surveillance conducted from 2002 to 2010. Euro Surveillance 2012 Jun 14;17(24):.	18-64 Years	Not Specified	No	Male	Presyncope (48h - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[MENINGOCOCCAL GROUP A, C, W135 AND Y CONJUGATE VACCINE, N. MENINGITIDIS GROUP C POLYSACCHARIDE, N. MENINGITIDIS GROUP Y POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE, N. MENINGITIDIS GROUP C POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP Y, N. MENINGITIDIS GROUP C POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6952013&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6953312	Spontaneous	2013-07-26 00:00:00	Healthcare Professional	Non European Economic Area	Pemphigus vulgaris: case report. REACTIONS 2013 Mar;1445:. GILES J. Pemphigus vulgaris induced by seasonal anti-influenza vaccine. Dermatologia Revista Mexicana 2012 Oct;56:323-326.	18-64 Years	Not Specified	Yes	Female	Blister (41d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Multiple organ dysfunction syndrome (41d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pemphigus (41d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (41d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Vomiting (41d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6953312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6938488	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6938488&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6938592	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza like illness (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6938592&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6925751	Spontaneous	2013-07-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Angioedema (2mo - Recovered/Resolved - Other Medically Important Condition);Drug eruption (2mo - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Mucosal disorder (2mo - Recovered/Resolved - Other Medically Important Condition);Rash maculo-papular (2mo - Recovered/Resolved - Other Medically Important Condition);Toxic skin eruption (2mo - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[TERBINAFINE, TERBINAFINE HYDROCHLORIDE] (C - n/a - Drug withdrawn - [n/a - 250mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6925751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6920203	Spontaneous	2013-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Balance disorder (n/a - Unknown - Other Medically Important Condition);Chills (1h - Unknown - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Head discomfort (1h - Unknown - Other Medically Important Condition);Malaise (1h - Unknown - Other Medically Important Condition);Nausea (1d - Recovered/Resolved - Other Medically Important Condition);Tachycardia (1d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6920203&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6920259	Spontaneous	2013-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Ear pain (n/a - Unknown - Disabling);Hypoacusis (n/a - Unknown - Disabling);Otitis media chronic (n/a - Recovered/Resolved - Disabling);Tinnitus (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6920259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-6911835	Spontaneous	2013-07-15 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	Yes	Male	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cutaneous vasculitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Proteinuria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Renal failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vascular purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[BENSERAZIDE HYDROCHLORIDE, LEVODOPA, BENSERAZIDE, LEVODOPA] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[DEXAMETHASONE] (C - n/a - n/a - [n/a - 1 - Topical])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[INDOMETACIN] (C - n/a - n/a - [n/a - 1 - Topical])|[NICARDIPINE, NICARDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6911835&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6909166	Spontaneous	2013-07-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cellulitis (4d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Myositis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pain (4d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Swelling (4d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6909166&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6904300	Spontaneous	2013-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [1d - 1{DF} - Subcutaneous])	HUMALOG [INSULIN LISPRO] (C - n/a - n/a - [n/a - n/a - n/a])|INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - n/a - n/a - [n/a - n/a - n/a])|[FERROUS FUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6904300&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6906627	Spontaneous	2013-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chills (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6906627&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6900698	Spontaneous	2013-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dermatitis exfoliative generalised (n/a - Unknown - Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash erythematous (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash macular (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])|[BICALUTAMIDE] (S - Prostate cancer - Dose not changed - [n/a - 1{DF} - Oral])|[LEUPRORELIN, LEUPRORELIN ACETATE] (S - Prostate cancer - Dose not changed - [n/a - 3.75mg - Subcutaneous])|[METHYCLOTHIAZIDE, TRIAMTERENE] (S - Essential hypertension - Drug withdrawn - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6900698&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6887435	Spontaneous	2013-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dermatitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6887435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6887604	Spontaneous	2013-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovered/Resolved - );Decreased appetite (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Hypotension (n/a - Recovered/Resolved - );Presyncope (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6887604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6884321	Spontaneous	2013-07-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dehydration (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Influenza (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Leukopenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6884321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6870553	Spontaneous	2013-07-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Autonomic nervous system imbalance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Demyelinating polyneuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Liver function test abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pneumonia pneumococcal (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Respiratory disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6870553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6854817	Spontaneous	2013-06-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoacusis (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6854817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-6849521	Spontaneous	2013-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (5d - Recovered/Resolved - Other Medically Important Condition);Headache (5d - Recovered/Resolved - Other Medically Important Condition);Myalgia (5d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6849521&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6849567	Spontaneous	2013-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza like illness (n/a - Unknown - Other Medically Important Condition);Injection site reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6849567&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6849575	Spontaneous	2013-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza like illness (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6849575&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6849576	Spontaneous	2013-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (3d - Recovered/Resolved - Other Medically Important Condition);Injection site pain (3d - Recovered/Resolved - Other Medically Important Condition);Myalgia (3d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition)	MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6849576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6849593	Spontaneous	2013-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Unknown - Other Medically Important Condition);Injection site pain (n/a - Unknown - Other Medically Important Condition)	MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6849593&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6849599	Spontaneous	2013-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (8d - Recovered/Resolved - Other Medically Important Condition);Instillation site reaction (8d - Recovered/Resolved - Other Medically Important Condition)	MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6849599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6849602	Spontaneous	2013-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (4d - Recovered/Resolved - Other Medically Important Condition);Headache (4d - Recovered/Resolved - Other Medically Important Condition);Myalgia (4d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6849602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6839839	Spontaneous	2013-06-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Application site induration (n/a - Unknown - );Pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6839839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6835309	Spontaneous	2013-06-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Ataxia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);CSF protein increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysaesthesia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6835309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6835423	Spontaneous	2013-06-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Blood creatine phosphokinase increased (n/a - Recovered/Resolved - Other Medically Important Condition);Bronchitis (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Joint swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6835423&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6835449	Spontaneous	2013-06-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Depression (n/a - Unknown - Other Medically Important Condition);Diarrhoea (2mo - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Food intolerance (2mo - Recovered/Resolved - Other Medically Important Condition);Infection susceptibility increased (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (2mo - Recovered/Resolved - Other Medically Important Condition);Rash (2mo - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6835449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6810202	Spontaneous	2013-06-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Vaccination site cellulitis (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6810202&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6812159	Spontaneous	2013-06-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Back pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea exertional (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myocardial ischaemia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myocarditis (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (35d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6812159&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6799444	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Bedridden (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6799444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6799939	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6799939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6800121	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Dark circles under eyes (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);General physical health deterioration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypoglycaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Lip dry (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Mucosal dryness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Paronychia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pollakiuria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Polydipsia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Skin turgor decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Type 1 diabetes mellitus (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Weight decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6800121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6800651	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cholelithiasis (n/a - Unknown - Caused/Prolonged Hospitalisation);Colitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea haemorrhagic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gastric ulcer (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastritis erosive (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hepatic steatosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hepatomegaly (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Intestinal polyp (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DOXEPIN, DOXEPIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUVASTATIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE, METOPROLOL SUCCINATE (PH. EUR.)] (C - n/a - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[THEOPHYLLINE] (C - n/a - n/a - [n/a - n/a - n/a])|[VALSARTAN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6800651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6801074	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chest pain (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pulmonary embolism (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6801074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6801272	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Adverse event following immunisation (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6801272&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6801754	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Infant	No	Male	Allergy to animal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Asthma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Clostridium test positive (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Eye infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Febrile convulsion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gastroenteritis adenovirus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Milk allergy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasal congestion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Otitis media (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Seasonal allergy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	ROTATEQ [ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)] (S - Immunisation - n/a - [98d - n/a - n/a])...	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[IBUPROFEN, IBUPROFEN SODIUM DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[NAPROXEN, NAPROXEN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL, PARACETAMOL PH. EUR., PARACETAMOL, CODEINE PHOSPHATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6801754&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6801884	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Back pain (n/a - Unknown - Disabling, Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Posture abnormal (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Swelling (4d - Recovered/Resolved - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[DRY EXTRACT OF GINKGO BILOBA LEAVES (35-67:1), EXTRACTION SOLVENT: ACETONE 60% ( M / M), GINKGO BILOBA EXTRACT, GINKGO BILOBA L., FOLIUM (DRY EXTRACT), GINKGO BILOBAE EXTRACTUM SICCUM NORMATUM, GINKGO LEAF DRY EXTRACT, REFINED AND QUANTIFIED, REFINED AND QUANTIFIED GINKGO DRY EXTRACT (35-67:1), CORRESPONDING TO 8.80-10.80 MG OF FLAVONOIDS EXPRESSED AS FLAVONE GLYCOSIDES, 1.12-1.36 MG OF GINKGOLIDES A, B AND C, 1.04-1.28 MG OF BILOBALIDE, EXTRACTION SOLVENT: ACETONE 60% M/M, STANDARDISED GINKGO BILOBA EXTRACT] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6801884&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6802594	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Influenza (10d - Recovered/Resolved - Other Medically Important Condition);Otitis media (n/a - Recovered/Resolved - Other Medically Important Condition);Product dose omission issue (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6802594&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6803411	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Colorectal adenoma (n/a - Unknown - Caused/Prolonged Hospitalisation);Musculoskeletal chest pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pulmonary embolism (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6803411&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6805381	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (85d - Recovered/Resolved - Other Medically Important Condition);Bursitis (85d - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal discomfort (85d - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovered/Resolved - Other Medically Important Condition);Tenderness (85d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE [NOT AVAILABLE] (C - Contraception - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6805381&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-6807252	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Hepatic cytolysis (n/a - Recovered/Resolved - Other Medically Important Condition);Middle insomnia (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6807252&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6807502	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bronchitis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Bronchitis bacterial (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Cardiac arrest (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Mitral valve disease (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Myocardial fibrosis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Myocarditis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6807502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6809617	Spontaneous	2013-06-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Eczema (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Neurodermatitis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Psoriasis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6809617&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6810267	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cellulitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6810267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6810385	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cervicobrachial syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6810385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6810873	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Polymyalgia rheumatica (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6810873&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6810885	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Axillary pain (n/a - Recovered/Resolved - Other Medically Important Condition);Glossopharyngeal neuralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Hemiparesis (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoglossal nerve paresis (n/a - Recovered/Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Recovered/Resolved - Other Medically Important Condition);Muscle spasms (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Taste disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6810885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6811454	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Blood creatine phosphokinase increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Blood lactate dehydrogenase increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Hepatitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Immune thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Leukopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Transaminases increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6811454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6813943	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Thrombocytopenia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6813943&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6817066	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Cyanosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Joint hyperextension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6817066&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6817332	Spontaneous	2013-06-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Disabling);Condition aggravated (n/a - Unknown - Disabling);Osteoarthritis (n/a - Unknown - Disabling);Polymyalgia rheumatica (n/a - Recovering/Resolving - Disabling);Rheumatic disorder (n/a - Unknown - Disabling);Tachycardia (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[FLUINDIONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6817332&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6818144	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6818144&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6820773	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hallucination, auditory (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ACEBUTOLOL, ACEBUTOLOL HYDROCHLORIDE] (C - Cardiac disorder - n/a - [n/a - n/a - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - Affective disorder - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6820773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6821040	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Anaphylactic reaction (3h - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Angioedema (3h - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Asthmatic crisis (3h - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Lip oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Urticaria (3h - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Gastrooesophageal reflux disease - n/a - [n/a - 40mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6821040&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6821192	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6821192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6822724	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arthralgia (n/a - Unknown - Results in Death);Influenza like illness (n/a - Unknown - Results in Death);Malaise (n/a - Unknown - Results in Death);Myocardial infarction (n/a - Fatal - Results in Death);Paraesthesia (n/a - Unknown - Results in Death);Toothache (n/a - Unknown - Results in Death)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6822724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6822729	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Deafness unilateral (n/a - Unknown - Other Medically Important Condition);Ear pain (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6822729&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6822894	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Mononeuropathy (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Radiculitis brachial (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6822894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6822936	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaemia (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Lymphoproliferative disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Thrombocytopenia (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6822936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6788580	Spontaneous	2013-06-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Ophthalmic herpes zoster (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	[BRIMONIDINE TARTRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 20mg - Oral])|[TIOTROPIUM] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6788580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6782309	Spontaneous	2013-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Ear infection (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Oral herpes (n/a - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Productive cough (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (5d - Recovered/Resolved - Other Medically Important Condition);Rhinitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6782309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6777520	Spontaneous	2013-06-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Asthenia (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Vaccination site cellulitis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6777520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6779161	Spontaneous	2013-06-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diarrhoea (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tick-borne fever (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6779161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6776302	Spontaneous	2013-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site pain (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[AZATHIOPRINE] (C - n/a - n/a - [n/a - 150mg - Oral])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6776302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-6755502	Spontaneous	2013-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hypoventilation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sepsis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6755502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6756402	Spontaneous	2013-06-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoacusis (n/a - Recovered/Resolved - Other Medically Important Condition);Tinnitus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6756402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6752802	Spontaneous	2013-06-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Herpes zoster (n/a - Recovered/Resolved - );Pain in extremity (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6752802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-6752932	Spontaneous	2013-06-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Meningoradiculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6752932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6744334	Spontaneous	2013-05-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Loss of consciousness (10s - Recovered/Resolved - Other Medically Important Condition);Nausea (30min - Recovered/Resolved - Other Medically Important Condition);Syncope (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6744334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6744903	Spontaneous	2013-05-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bursitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6744903&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6735248	Spontaneous	2013-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myalgia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, ALUMINIUM HYDROXIDE GEL, MAGNESIUM HYDROXIDE, ACETYLSALICYLIC ACID, MAGNESIUM HYDROXIDE, ALGELDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - 50mg - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6735248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6735272	Spontaneous	2013-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Tracheitis (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOFENOPRIL CALCIUM, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6735272&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6735353	Spontaneous	2013-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	APROVEL [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|VICTOZA [LIRAGLUTIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[CLONIDINE, CLONIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6735353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6737384	Spontaneous	2013-05-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Bell's palsy (n/a - Recovered/Resolved - Other Medically Important Condition);Facial paralysis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6737384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6739621	Spontaneous	2013-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hyperpyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6739621&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6731681	Spontaneous	2013-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6731681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6731891	Spontaneous	2013-05-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	NOT AVAILABLE (C - n/a - n/a - [n/a - n/a - n/a])|[DIAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE] (C - n/a - n/a - [n/a - n/a - n/a])|[LORAZEPAM] (C - Seizure - n/a - [n/a - n/a - n/a])|[MAGNESIUM HYDROXIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[NAPROXEN, NAPROXEN SODIUM] (C - Dysmenorrhoea - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (C - Immunisation - n/a - [n/a - n/a - Intramuscular])|[PROPYLENE GLYCOL, SODIUM CHLORIDE, MACROGOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SENNOSIDE A+B] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6731891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6731904	Spontaneous	2013-05-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - Dysmenorrhoea - n/a - [n/a - n/a - n/a])|LEVETIRACETAM [LEVETIRACETAM] (C - n/a - n/a - [n/a - n/a - n/a])|NOT AVAILABLE (C - Constipation - n/a - [n/a - n/a - n/a])|[DOCUSATE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[DOMPERIDONE] (C - n/a - n/a - [n/a - n/a - n/a])|[ERGOCALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCORTISONE, HYDROCORTISONE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[IPRATROPIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[LORAZEPAM] (C - Seizure - n/a - [n/a - n/a - n/a])|[MAGNESIUM HYDROXIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (C - n/a - n/a - [n/a - n/a - Intramuscular])|[PROPYLENE GLYCOL, SODIUM CHLORIDE, MACROGOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TOPIRAMATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6731904&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6734727	Spontaneous	2013-05-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Mental status changes (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6734727&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6731372	Spontaneous	2013-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6731372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-6722359	Spontaneous	2013-05-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Dizziness (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Meningitis (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6722359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6723173	Spontaneous	2013-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Erysipelas (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Injected limb mobility decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site reaction (n/a - Unknown - Caused/Prolonged Hospitalisation)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6723173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6718307	Spontaneous	2013-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Extensive swelling of vaccinated limb (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6718307&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6706208	Spontaneous	2013-05-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myelitis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6706208&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6687881	Spontaneous	2013-05-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	H1N1 influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	[ASCORBIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[CHLORPROTHIXENE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DL-SERINE, FERROUS SULFATE HEPTAHYDRATE, DRIED FERROUS SULFATE, DL-SERINE, FERROUS SULFATE, FERROUS SULFATE HEPTAHYDRATE, FERROUS SULFATE HYDRATE, DL-SERINE, FERROUS SULFATE, DL-SERINE, SERINE, FERROUS SULFATE HEPTAHYDRATE, SERINE, FERROUS SULFATE HYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOMEPROMAZINE, LEVOMEPROMAZINE MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[QUETIAPINE, QUETIAPINE FUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM PICOSULFATE, SODIUM PICOSULFATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TIAPRIDE, TIAPRIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6687881&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6688907	Spontaneous	2013-05-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	[PREDNISONE] (C - Chronic obstructive pulmonary disease - Unknown - [n/a - 30mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6688907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6683999	Spontaneous	2013-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - );Hypotonia (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[SODIUM VALPROATE, VALPROIC ACID, SODIUM VALPROATE] (C - n/a - n/a - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6683999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6670918	Spontaneous	2013-05-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[SALBUTAMOL] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6670918&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6666359	Spontaneous	2013-05-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Palpitations (3wk - Recovered/Resolved - )	[A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[SOTALOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6666359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-6663327	Spontaneous	2013-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Cerebral haemorrhage (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[ISRADIPINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6663327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6652966	Spontaneous	2013-05-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - );Hyperpyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6652966&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6656756	Spontaneous	2013-05-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[BROMAZEPAM] (C - n/a - n/a - [n/a - 3mg - Oral])|[ZOPICLON] (C - n/a - n/a - [n/a - 7.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6656756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6638189	Spontaneous	2013-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6638189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6638206	Spontaneous	2013-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6638206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6638225	Spontaneous	2013-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6638225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-6638239	Spontaneous	2013-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Angioedema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6638239&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6638246	Spontaneous	2013-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - );Increased bronchial secretion (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6638246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6637546	Spontaneous	2013-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Injection site erythema (n/a - Unknown - );Vaccination site oedema (n/a - Unknown - );Vaccination site warmth (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6637546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6633044	Spontaneous	2013-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation);Polymyalgia rheumatica (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[IBUPROFEN, IBUPROFEN LYSINE, IBUPROFEN, HEPARINOID] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6633044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6633416	Spontaneous	2013-04-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (3mo - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - Dose not changed - [n/a - 1{DF} - Other])|[FOLIC ACID] (C - Product used for unknown indication - Dose not changed - [n/a - 5mg - Oral])|[LAMOTRIGINE] (C - Epilepsy - Dose not changed - [n/a - 125mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6633416&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6628533	Spontaneous	2013-04-25 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (1d - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (1d - Recovered/Resolved - Other Medically Important Condition);Muscle spasms (1d - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6628533&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6629045	Spontaneous	2013-04-25 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Eyelid oedema (9d - Recovered/Resolved - Other Medically Important Condition);Swelling face (9d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6629045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6624097	Spontaneous	2013-04-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6624097&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6624128	Spontaneous	2013-04-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza like illness (n/a - Unknown - Life Threatening, Disabling);Polydipsia (n/a - Unknown - Life Threatening, Disabling);Polyuria (n/a - Unknown - Life Threatening, Disabling);Type 1 diabetes mellitus (n/a - Unknown - Life Threatening, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6624128&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Life Threatening	Hospitalisation
EU-EC-6627103	Spontaneous	2013-04-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site induration (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site infection (n/a - Unknown - Other Medically Important Condition);Vaccination site inflammation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6627103&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6621454	Spontaneous	2013-04-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Biliary obstruction (n/a - Unknown - Caused/Prolonged Hospitalisation);Jaundice (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[AZATHIOPRINE, AZATHIOPRINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6621454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6621626	Spontaneous	2013-04-23 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bronchitis (n/a - Recovering/Resolving - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphonia (n/a - Recovering/Resolving - Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Other Medically Important Condition);Increased bronchial secretion (n/a - Recovering/Resolving - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6621626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6623115	Spontaneous	2013-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Vascular purpura (4mo - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6623115&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6613726	Spontaneous	2013-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6613726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6618883	Spontaneous	2013-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Torticollis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6618883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6613682	Spontaneous	2013-04-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Injection site abscess (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[DUTASTERIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[RAMIPRIL] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[SOTALOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 120mg - Oral])|[TAMSULOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6613682&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6612974	Spontaneous	2013-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 125ug - n/a])|[LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - 100mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6612974&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6607931	Spontaneous	2013-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	[LANSOPRAZOLE] (C - n/a - n/a - [n/a - 15mg - Oral])|[LEUPRORELIN, LEUPRORELIN ACETATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TAMOXIFEN, TAMOXIFEN CITRATE, TAMOXIFEN CITRATE PH. EUR.] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6607931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6607969	Spontaneous	2013-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[DROSPIRENONE, ESTRADIOL, DROSPIRENONE, ESTRADIOL HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - 15mg - n/a])|[PRAVASTATIN, PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - 40mg - n/a])|[PROMESTRIENE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6607969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6607999	Spontaneous	2013-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 50mg - n/a])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6607999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6608029	Spontaneous	2013-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza like illness (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[BECLOMETASONE DIPROPIONATE, BECLOMETASONE DIPROPIONATE ANHYDROUS] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[IPRATROPIUM BROMIDE, SALBUTAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[NIMODIPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[TERAZOSIN HYDROCHLORIDE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6608029&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6608047	Spontaneous	2013-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6608047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6608577	Spontaneous	2013-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dysarthria (n/a - Recovering/Resolving - Disabling);Dysphagia (n/a - Recovering/Resolving - Disabling);Hemiparesis (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	APROVEL [IRBESARTAN] (C - n/a - n/a - [n/a - 150mg - Oral])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - 20mg - Oral])|[QUETIAPINE, QUETIAPINE FUMARATE] (C - n/a - n/a - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6608577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6604695	Spontaneous	2013-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Seizure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6604695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6599772	Spontaneous	2013-04-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cyanosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling cold (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vasculitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	MEDICATION FOR BLOOD PRESSURE [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|MEDICATION FOR CHOLESTEROL [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6599772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6595512	Spontaneous	2013-04-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hallucination, auditory (n/a - Unknown - Other Medically Important Condition);Visual impairment (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6595512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6596831	Spontaneous	2013-04-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anuria (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Bradycardia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Central nervous system lesion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Cerebellar ataxia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Coma (3wk - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hepatic failure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Influenza (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Mitochondrial cytopathy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Overdose (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pleural effusion (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Renal failure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Renal tubular disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Status epilepticus (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Vaccination failure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Vision blurred (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Vomiting (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (S - n/a - Not applicable - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6596831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6589551	Spontaneous	2013-04-14 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Decreased appetite (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6589551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6589375	Spontaneous	2013-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6589375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6588935	Spontaneous	2013-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Miller Fisher syndrome (646d - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[D,L-LYSINE ACETYLSALICYLATE] (C - Myocardial ischaemia - Drug withdrawn - [n/a - 1{DF} - Oral])|[PRAVASTATIN SODIUM] (C - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[PROPAFENONE HYDROCHLORIDE] (C - Arrhythmia - Drug withdrawn - [n/a - 1{DF} - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - Hypertension - Drug withdrawn - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6588935&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6581536	Spontaneous	2013-04-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Cough (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysphonia (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Laryngitis (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasal obstruction (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhinorrhoea (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6581536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6581672	Spontaneous	2013-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Polymyositis (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhabdomyolysis (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - n/a - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - n/a - Not applicable - [n/a - n/a - Unknown])	[ACENOCOUMAROL] (C - Aortic stent insertion - Unknown - [n/a - n/a - n/a])|[DIAZEPAM] (C - n/a - Unknown - [n/a - n/a - Oral])|[VALSARTAN] (C - Hypertension - Unknown - [n/a - 80mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6581672&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6581694	Spontaneous	2013-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ACENOCOUMAROL] (C - n/a - Unknown - [n/a - n/a - n/a])|[DIAZEPAM] (C - n/a - Unknown - [n/a - n/a - Oral])|[VALSARTAN] (C - n/a - Unknown - [n/a - 80mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6581694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6581815	Spontaneous	2013-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cognitive disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Coordination abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myelitis transverse (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraplegia (n/a - Unknown - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Vertigo (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[ALUMINIUM HYDROXYPHOSPHATE SULFATE, HEPATITIS A VIRUS (STRAIN CR 326F) (INACTIVATED) PRODUCED ON HUMAN DIPLOID (MRC–5) FIBROBLAST CELLS ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, ALUMINIUM, HEPATITIS A VIRUS (STRAIN CR 326F) (INACTIVATED) PRODUCED ON HUMAN DIPLOID (MRC–5) FIBROBLAST CELLS ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HEPATITIS A VACCINE (INACTIVATED, ADSORBED), HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS ANTIGEN (INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])|[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALUMINIUM HYDROXIDE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])|[DIPHTHERIA TOXOID ADSORBED, TETANUS TOXOID ADSORBED, ALGELDRATE, DIPHTHERIA TOXOID ADSORBED, TETANUS TOXOID ADSORBED, ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID, TETANUS TOXOID, DIPHTHERIA TOXOID, TETANUS TOXOID, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM HYDROXIDE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])|[POLIOMYELITIS VACCINE (INACTIVATED), POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])|[YELLOW FEVER VACCINE (LIVE), YELLOW FEVER VIRUS STRAIN 17D-204 (LIVE, ATTENUATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6581815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6573804	Spontaneous	2013-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Deep vein thrombosis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6573804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6567523	Spontaneous	2013-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Bronchopneumopathy (n/a - Recovered/Resolved - );Dyspnoea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6567523&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-6569672	Spontaneous	2013-04-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza A virus test positive (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination failure (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6569672&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6569770	Spontaneous	2013-04-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Angioedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Dermatitis allergic (n/a - Unknown - Caused/Prolonged Hospitalisation);Petechiae (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash pruritic (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6569770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6562437	Spontaneous	2013-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dermatitis psoriasiform (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6562437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6566367	Spontaneous	2013-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Nervous system disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6566367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6558231	Spontaneous	2013-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myopericarditis (n/a - Unknown - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - n/a - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6558231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6548806	Spontaneous	2013-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Erythema (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6548806&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6548909	Spontaneous	2013-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Bronchitis (n/a - Recovered/Resolved - );Hyperpyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6548909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6548926	Spontaneous	2013-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Rash papular (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[HYDROXYCHLOROQUINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6548926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6548946	Spontaneous	2013-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Tremor (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6548946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-6548961	Spontaneous	2013-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - );Gastrointestinal disorder (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6548961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6548975	Spontaneous	2013-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dermatitis (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6548975&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6549002	Spontaneous	2013-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Immunisation reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6549002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-6544821	Spontaneous	2013-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Rhabdomyolysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6544821&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6544834	Spontaneous	2013-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute disseminated encephalomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Paresis anal sphincter (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	LYRICA [PREGABALIN] (C - n/a - n/a - [n/a - 1{DF} - Oral])|MICARDISPLUS [HYDROCHLOROTHIAZIDE, TELMISARTAN] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[ACETYL L-CARNITINE, ACETYLCARNITINE HYDROCHLORIDE, CARNITINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Intramuscular])|[CYANOCOBALAMIN, PHOSPHOLIPIDS] (C - n/a - n/a - [n/a - 1{DF} - Intramuscular])|[DOXAZOSIN, DOXAZOSIN MESILATE] (C - n/a - n/a - [n/a - 2mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6544834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6540704	Spontaneous	2013-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation);Diplopia (30d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysstasia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (30d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Miller Fisher syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Nystagmus (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	HAART [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[INSULIN, INSULIN HUMAN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6540704&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6540788	Spontaneous	2013-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Micturition disorder (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6540788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6540820	Spontaneous	2013-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Nasal])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6540820&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6541184	Spontaneous	2013-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait inability (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory distress (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6541184&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6541645	Spontaneous	2013-03-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dyskinesia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Dysstasia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Paraesthesia oral (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ACEBUTOLOL, ACEBUTOLOL HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[PERINDOPRIL ARGININE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[PHENYTOIN SODIUM] (C - Epilepsy - n/a - [n/a - n/a - n/a])|[SODIUM VALPROATE, VALPROIC ACID, SODIUM VALPROATE] (C - Epilepsy - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6541645&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6535975	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - Pain in extremity - n/a - [n/a - 75mg - Intramuscular])|[PARACETAMOL] (C - Pain in extremity - n/a - [n/a - 2g - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6535975&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6535985	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Myelopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[PERINDOPRIL ARGININE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6535985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6535989	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation);Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Myopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[ANHYDROUS CILAZAPRIL, CILAZAPRIL, CILAZAPRIL MONOHYDRATE] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6535989&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6535997	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Subcutaneous])	[ALPRAZOLAM] (C - Depression - n/a - [n/a - .5mg - Oral])|[ATENOLOL] (C - Arrhythmia - n/a - [n/a - 100mg - Oral])|[HYDROCHLOROTHIAZIDE, RAMIPRIL] (C - Hypertension - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6535997&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536008	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Dermatitis (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536023	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Amnesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	APROVEL [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LORAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536023&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536025	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Guillain-Barre syndrome (34d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperpyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	NITRATE PATCH [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CANRENONE, POTASSIUM CANRENOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CARVEDILOL] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536025&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536026	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperpyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Oxygen saturation decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	DIACOMIT [STIRIPENTOL] (C - n/a - n/a - [n/a - 75mg - n/a])|INOVELON [RUFINAMIDE] (C - n/a - n/a - [n/a - 125mg - Oral])|[AMOXICILLIN SODIUM, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (C - n/a - n/a - [n/a - 3.5mL - Oral])|[CLOBAZAM] (C - n/a - n/a - [n/a - 4mg - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - 7.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536026&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536043	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536043&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536044	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperpyrexia (48h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536051	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cardiac failure (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[FENOFIBRATE, FENOFIBRATE MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536051&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536052	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Acute disseminated encephalomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Anaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling cold (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperreflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Incontinence (n/a - Unknown - Caused/Prolonged Hospitalisation);Magnetic resonance imaging head abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Meningioma (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Myelitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraplegia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536053	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypertensive crisis (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory failure (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])...	[TIMOLOL, TIMOLOL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536053&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536132	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dermatitis (n/a - Recovered/Resolved - Life Threatening);Erythema (n/a - Recovered/Resolved - Life Threatening);Face oedema (4d - Recovered/Resolved - Life Threatening);Injection site erythema (3d - Recovered/Resolved - Life Threatening);Injection site pain (3d - Recovered/Resolved - Life Threatening);Leukocytosis (n/a - Recovered/Resolved - Life Threatening);Oedema peripheral (4d - Recovered/Resolved - Life Threatening);Protein C increased (n/a - Recovered/Resolved - Life Threatening);Pruritus (4d - Recovered/Resolved - Life Threatening);Suffocation feeling (n/a - Not Specified - Life Threatening);Swelling (n/a - Recovered/Resolved - Life Threatening);Temporomandibular joint syndrome (n/a - Unknown - Life Threatening);Tracheal obstruction (4d - Recovered/Resolved - Life Threatening);Urticaria (4d - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536132&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6536141	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Haematoma (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[CLARITHROMYCIN] (C - n/a - n/a - [n/a - 8mg - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - 250mg - Rectal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536141&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536187	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (0d - Recovered/Resolved - Other Medically Important Condition);Circulatory collapse (0d - Recovered/Resolved - Other Medically Important Condition);Hot flush (0d - Recovered/Resolved - Other Medically Important Condition);Hypotension (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536187&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6536251	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536267	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Female	Balance disorder (5h - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Specified - Caused/Prolonged Hospitalisation);Dysstasia (5h - Unknown - Caused/Prolonged Hospitalisation);Gait inability (5h - Unknown - Caused/Prolonged Hospitalisation);Hyperhidrosis (5h - Unknown - Caused/Prolonged Hospitalisation);Pallor (5h - Unknown - Caused/Prolonged Hospitalisation);Vertigo positional (5h - Unknown - Caused/Prolonged Hospitalisation);Vomiting (5h - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536272	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myelitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraplegia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Urinary retention (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, AMILORIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE DIHYDRATE, HYDROCHLOROTHIAZIDE, ANHYDROUS AMILORIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CLONIDINE, CLONIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLIMEPIRIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LISINOPRIL, LISINOPRIL ANHYDROUS, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LYOPHILISED, STANDARDISED BACTERIAL EXTRACT, LYOPHILIZED BACTERIAL LYSATES, LYOPHILIZED BACTERIAL LYSATES OF: HAEMOPHILUS INFLUENZAE STREPTOCOCCUS (DIPLOCOCCUS) PNEUMONIAE KLEBSIELLA PNEUMONIAE AND OZAENAE STAPHYLOCOCCUS AUREUS STREPTOCOCCUS PYOGENES AND VIRIDANS MORAXELLA (BRANHAMELLA / NEISSERIA) CATARRHALIS, LYSATUM BACTERIALE MIXTUM] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536272&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536295	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	Yes	Female	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle atrophy (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Specified - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Peripheral sensorimotor neuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Spinal compression fracture (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[GLICLAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - n/a - n/a])|[LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536827	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotension (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 5mg - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6536970	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Myalgia (5d - Fatal - Results in Death);Pyrexia (5d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536970&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6536975	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Confusional state (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6536975&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6537446	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Confusional state (15d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Influenza (15d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Myalgia (15d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Pyrexia (15d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6537446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-6537447	Spontaneous	2013-03-28 00:00:00	Non Healthcare Professional	European Economic Area	Ruysschaert T. Griepvaccinatie vraagt brede strategie. Artsenkrant 2013 Feb 12;2298:.	18-64 Years	Not Specified	No	Female	Cough (11d - Recovered/Resolved - Other Medically Important Condition);Influenza (11d - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (11d - Recovered/Resolved - Other Medically Important Condition);Productive cough (11d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (11d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6537447&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6537516	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Areflexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Ataxia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Diplegia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Dysstasia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Facial paresis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Goitre (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6537516&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6532606	Spontaneous	2013-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Confusional state (7d - Fatal - Results in Death);Myalgia (7d - Fatal - Results in Death);Pyrexia (7d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6532606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6532607	Spontaneous	2013-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Confusional state (3d - Fatal - Results in Death);Myalgia (3d - Fatal - Results in Death);Pyrexia (3d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6532607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6532611	Spontaneous	2013-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myalgia (2d - Fatal - Results in Death);Pyrexia (2d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6532611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6532612	Spontaneous	2013-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myalgia (20d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (20d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6532612&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6532634	Spontaneous	2013-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dyspnoea (29d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (29d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6532634&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6532692	Spontaneous	2013-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Confusional state (48d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (48d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (48d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (48d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6532692&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6532693	Spontaneous	2013-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Confusional state (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6532693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6532694	Spontaneous	2013-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Confusional state (36d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (36d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (36d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (36d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6532694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6532695	Spontaneous	2013-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Confusional state (22d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (22d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (22d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (22d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6532695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6534679	Spontaneous	2013-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Limb discomfort (n/a - Recovering/Resolving - );Pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6534679&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6528576	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Nasopharyngitis (2d - Unknown - Other Medically Important Condition);Pyrexia (2d - Unknown - Other Medically Important Condition);Seizure (1min - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6528576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6528616	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6528616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6531536	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Muscle rigidity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myositis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6531536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6521756	Spontaneous	2013-03-25 00:00:00	Non Healthcare Professional	European Economic Area	Ruysschaert T. Griepvaccinatie vraagt brede strategie. Artsenkrant 2013 Feb 12;2298:.	More than 85 Years	Not Specified	No	Female	Asthenia (16d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Cough (16d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Influenza like illness (16d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Myalgia (16d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pyrexia (16d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6521756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6524087	Spontaneous	2013-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Confusional state (29d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (29d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (29d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (29d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6524087&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6524092	Spontaneous	2013-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Confusional state (10d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Influenza like illness (10d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Myalgia (10d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pyrexia (10d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6524092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6516365	Spontaneous	2013-03-22 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Seizure (45s - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6516365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6512103	Spontaneous	2013-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blister (n/a - Not Recovered/Not Resolved - );Erythema (n/a - Not Recovered/Not Resolved - );Pruritus (n/a - Not Recovered/Not Resolved - );Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[CORTISONE ACETATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DESMOPRESSIN, DESMOPRESSIN ACETATE] (C - Hypopituitarism - n/a - [n/a - 3{DF} - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[TESTOSTERONE UNDECANOATE] (C - n/a - n/a - [n/a - 1{DF} - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6512103&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6512188	Spontaneous	2013-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovering/Resolving - );Arthralgia (n/a - Recovering/Resolving - );Migraine (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6512188&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6512205	Spontaneous	2013-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Peripheral swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6512205&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6512214	Spontaneous	2013-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Recovering/Resolving - );Vaccination site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6512214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6512321	Spontaneous	2013-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Erythema (n/a - Recovered/Resolved - );Injection site urticaria (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE, FLUTICASONE, SALMETEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6512321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6512335	Spontaneous	2013-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - );Dizziness (n/a - Recovered/Resolved - );Feeling hot (n/a - Recovered/Resolved - );Slow speech (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[LANSOPRAZOLE] (C - n/a - n/a - [n/a - 30mg - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 75ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6512335&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-6507306	Spontaneous	2013-03-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia oral (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sensation of foreign body (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6507306&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6501001	Spontaneous	2013-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Muscle contracture (n/a - Recovering/Resolving - );Vertigo positional (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - n/a])	[NEBIVOLOL] (C - Essential hypertension - n/a - [n/a - 5mg - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - Depression - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6501001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6501692	Spontaneous	2013-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hyperpyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6501692&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6501777	Spontaneous	2013-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6501777&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6501804	Spontaneous	2013-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Myalgia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6501804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6502052	Spontaneous	2013-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[COLECALCIFEROL] (C - n/a - n/a - [n/a - 25[drp] - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6502052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6502182	Spontaneous	2013-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6502182&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6502411	Spontaneous	2013-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cough (n/a - Unknown - Results in Death);Influenza (n/a - Unknown - Results in Death);Pneumonia bacterial (n/a - Fatal - Results in Death);Pyrexia (n/a - Unknown - Results in Death);Vaccination failure (n/a - Unknown - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6502411&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6503059	Spontaneous	2013-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Tenosynovitis (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6503059&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6503076	Spontaneous	2013-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6503076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6503586	Spontaneous	2013-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Injection site erythema (4d - Recovered/Resolved - );Injection site swelling (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6503586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6504573	Spontaneous	2013-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (6d - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6504573&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6506128	Spontaneous	2013-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Purpura (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6506128&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6494465	Spontaneous	2013-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Swelling (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6494465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6494944	Spontaneous	2013-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Injection site oedema (n/a - Recovering/Resolving - );Injection site pain (n/a - Unknown - );Muscle rigidity (n/a - Not Specified - );Pyrexia (3d - Recovered/Resolved - )	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6494944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6495754	Spontaneous	2013-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Somnolence (n/a - Recovered/Resolved - );Stupor (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6495754&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6495976	Spontaneous	2013-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Pruritus (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6495976&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6485602	Spontaneous	2013-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Alanine aminotransferase increased (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Anuria (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Aspartate aminotransferase increased (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Atrial fibrillation (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Blood bilirubin increased (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Blood creatinine increased (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Circulatory collapse (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cough (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Erythema (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gallbladder oedema (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Haemorrhoids (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hepatomegaly (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotension (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Infection (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lactic acidosis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mitral valve incompetence (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Multiple organ dysfunction syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pericardial effusion (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Psoriasis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Septic shock (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Shock (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Splenomegaly (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachycardia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachypnoea (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	ENBREL [ETANERCEPT] (S - Ankylosing spondylitis - Not applicable - [549d - 50mg - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC SODIUM] (S - Haemorrhoids - Unknown - [n/a - 50mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6485602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6481523	Spontaneous	2013-03-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Pyrexia (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tonsillar hypertrophy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6481523&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6477967	Spontaneous	2013-03-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cardiomyopathy (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest pain (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6477967&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6478014	Spontaneous	2013-03-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Chills (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6478014&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6479390	Spontaneous	2013-03-12 00:00:00	Non Healthcare Professional	European Economic Area	Clodoveo Ferri, Michele Colaci, Carlo UmbertoManzini, Marco Sebastiani, Dilia Giuggioli and Lucio Brugioni &quot;Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines&quot;. Hindawi Publishing Corporation, Case Reports in Rheumatology, Volume 2012, Article ID 836930, 3 pages, doi:10.1155/2012/836930	65-85 Years	Not Specified	No	Female	Dermatitis bullous (n/a - Fatal - Results in Death);Dermatomyositis (n/a - Fatal - Results in Death);Dysphagia (n/a - Fatal - Results in Death);Epstein-Barr virus infection (n/a - Fatal - Results in Death);Erythema (n/a - Fatal - Results in Death);Muscular weakness (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Immunisation - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6479390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6479405	Spontaneous	2013-03-12 00:00:00	Non Healthcare Professional	European Economic Area	Clodoveo Ferri, Michele Colaci, Carlo UmbertoManzini, Marco Sebastiani, Dilia Giuggioli and Lucio Brugioni &quot;Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines&quot;. Hindawi Publishing Corporation, Case Reports in Rheumatology, Volume 2012, Article ID 836930, 3 pages, doi:10.1155/2012/836930	18-64 Years	Not Specified	No	Female	Cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hyperpyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Organising pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Polymyositis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6479405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6462429	Spontaneous	2013-03-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Arthritis (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6462429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6467052	Spontaneous	2013-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Cutaneous vasculitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6467052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6455475	Spontaneous	2013-03-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza like illness (5d - Recovered/Resolved - Other Medically Important Condition);Myalgia (5d - Recovered/Resolved - Other Medically Important Condition);Papule (3d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (5d - Recovered/Resolved - Other Medically Important Condition);Rash (3d - Recovered/Resolved - Other Medically Important Condition);Vasculitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6455475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6455494	Spontaneous	2013-03-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site oedema (5d - Recovered/Resolved - );Injection site reaction (5d - Recovered/Resolved - );Injection site warmth (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6455494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6457031	Spontaneous	2013-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hepatic failure (54d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6457031&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6459509	Spontaneous	2013-03-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Mycoplasma infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngeal oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tonsillar hypertrophy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tonsillitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6459509&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6450470	Spontaneous	2013-03-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypotension (n/a - Fatal - Results in Death);Pyrexia (n/a - Not Recovered/Not Resolved - Results in Death);Sepsis (n/a - Not Recovered/Not Resolved - Results in Death);Shock (n/a - Fatal - Results in Death)	ENBREL [ETANERCEPT] (S - n/a - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC SODIUM] (S - Haemorrhoids - n/a - [n/a - 50mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6450470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6435195	Spontaneous	2013-03-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Axonal neuropathy (n/a - Unknown - Other Medically Important Condition);Cold sweat (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysgeusia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oedema peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6435195&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6436734	Spontaneous	2013-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (8d - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Sneezing (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6436734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6438327	Spontaneous	2013-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Blood pressure increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vertigo (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[DOXEPIN, DOXEPIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[IBUPROFEN, IBUPROFEN SODIUM DIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[PARACETAMOL, PARACETAMOL PH. EUR., PARACETAMOL, CODEINE PHOSPHATE] (C - Pain - n/a - [n/a - n/a - Oral])|[PITOFENONE HYDROCHLORIDE, METAMIZOLE SODIUM] (C - Pain - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6438327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6432876	Spontaneous	2013-02-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Dermatitis allergic (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tonsillar hypertrophy (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract congestion (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site inflammation (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6432876&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6424810	Spontaneous	2013-02-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Not Specified - Other Medically Important Condition);Dyspnoea (n/a - Not Specified - Other Medically Important Condition);Oedema (n/a - Not Specified - Other Medically Important Condition);Oropharyngeal discomfort (n/a - Not Specified - Other Medically Important Condition);Urticaria (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	WEIGHT LOSS FORMULA [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[MICRONISED SPIRONOLACTONE, POTASSIUM CANRENOATE, SPIRONOLACTONE, SPIRONOLACTONE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[PROMETHAZINE, PROMETHAZINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6424810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6424872	Spontaneous	2013-02-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Angioedema (8d - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (8d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6424872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6425675	Spontaneous	2013-02-27 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Bronchitis (2mo - Recovered/Resolved - Other Medically Important Condition);Cough (2mo - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (2mo - Recovered/Resolved - Other Medically Important Condition);Pneumonia (2mo - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6425675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6425933	Spontaneous	2013-02-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6425933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6429811	Spontaneous	2013-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	ZYPREXA [OLANZAPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[AMILORIDE HYDROCHLORIDE, CHLORTALIDONE, CHLORTALIDONE, AMILORIDE HYDROCHLORIDE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CHLORPROTHIXENE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CITALOPRAM HYDROBROMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DEXTROMETHORPHAN HYDROBROMIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, PARACETAMOL, PARACETAMOL, PARACETAMOL, ACETYLSALICYLIC ACID, CAFFEINE, PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CAFFEINE] (C - n/a - n/a - [n/a - n/a - n/a])|[LACTULOSE, LACTULOSE, LIQUID] (C - n/a - n/a - [n/a - n/a - n/a])|[LITHIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[OLANZAPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[RISPERIDONE] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM VALPROATE, VALPROIC ACID, SODIUM VALPROATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6429811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6430841	Spontaneous	2013-02-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Arthralgia (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasal congestion (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Petechiae (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thalassaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6430841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6430846	Spontaneous	2013-02-27 00:00:00	Healthcare Professional	Non European Economic Area	Rubinov A, Beiran I, Krasnitz I, Miller B. Bilateral optic neuritis after inactivated influenza vaccination. Case Communication 2012 May;705-707. Data migrated from the EudraVigilance E2B(R2) Literature repository	18-64 Years	Not Specified	No	Male	Eye pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Optic neuritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Papilloedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual acuity reduced (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6430846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6420060	Spontaneous	2013-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dysphemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lyme disease (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6420060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6420734	Spontaneous	2013-02-26 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Feeling hot (n/a - Not Specified - Other Medically Important Condition);Headache (n/a - Not Specified - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Not Specified - Other Medically Important Condition);Pyrexia (n/a - Not Specified - Other Medically Important Condition);Rhinitis (n/a - Not Specified - Other Medically Important Condition);Vaccination failure (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6420734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6426121	Spontaneous	2013-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Petechiae (n/a - Recovered/Resolved - Other Medically Important Condition);Subcutaneous haematoma (n/a - Recovered/Resolved - Other Medically Important Condition);Thrombocytopenia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mg - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6426121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6423172	Spontaneous	2013-02-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Anaemia (n/a - Recovered/Resolved - Life Threatening);Thrombocytopenia (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - n/a])|[CIPROFLOXACIN, CIPROFLOXACIN HYDRATED, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, HYDROCORTISONE] (S - Pyrexia - n/a - [n/a - 1000mg - Oral])	[FERROUS SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[NITROFURANTOIN, NITROFURANTOIN, MACROCRYSTALLINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6423172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6415656	Spontaneous	2013-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6415656&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6410706	Spontaneous	2013-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Rhinorrhoea (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination failure (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6410706&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6410733	Spontaneous	2013-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (3d - Recovered/Resolved - Other Medically Important Condition);Extensive swelling of vaccinated limb (3d - Recovered/Resolved - Other Medically Important Condition);Feeling hot (3d - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6410733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6411488	Spontaneous	2013-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6411488&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6406251	Spontaneous	2013-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Body temperature increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6406251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6406252	Spontaneous	2013-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (5d - Recovered/Resolved - Other Medically Important Condition);Swelling (5d - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6406252&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6406255	Spontaneous	2013-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site erythema (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site pain (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6406255&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6406258	Spontaneous	2013-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovering/Resolving - Other Medically Important Condition);Swelling (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site reaction (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6406258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6409023	Spontaneous	2013-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vascular purpura (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOCETIRIZINE, LEVOCETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOXAPINE, LOXAPINE SUCCINATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MACROGOL 3350, POTASSIUM CHLORIDE, SODIUM CARBONATE, SODIUM CHLORIDE, SODIUM SULFATE ANHYDROUS, MACROGOL 3350, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350, SODIUM SULPHATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM SULFATE ANHYDROUS, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL, CODEINE PHOSPHATE, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6409023&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6401877	Spontaneous	2013-02-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Male	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Monoparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Radiculitis brachial (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory loss (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6401877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6392983	Spontaneous	2013-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Deafness (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6392983&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6393036	Spontaneous	2013-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic shock (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngeal swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6393036&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6393132	Spontaneous	2013-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Balance disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tongue oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 75ug - Oral])|[TAMOXIFEN, TAMOXIFEN CITRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6393132&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6397242	Spontaneous	2013-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Ophthalmic herpes zoster (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6397242&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6398201	Spontaneous	2013-02-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Dermatitis (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6398201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6389558	Spontaneous	2013-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Influenza like illness (n/a - Fatal - Results in Death);Respiratory disorder (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 75mg - n/a])|[ACICLOVIR, ACICLOVIR BP] (C - n/a - n/a - [n/a - n/a - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - 1mg - n/a])|[DIPYRIDAMOLE, ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - n/a - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6389558&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6389559	Spontaneous	2013-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza like illness (n/a - Fatal - Results in Death);Pneumonia (n/a - Fatal - Results in Death);Somnolence (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	EBIXA [MEMANTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[CLOMETHIAZOLE, CLOMETHIAZOLE EDISILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DIHYDROERGOTAMINE MESILATE] (C - n/a - n/a - [n/a - 5mg - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - n/a])|[GALANTAMINE, GALANTAMINE HYDROBROMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ISPAGHULA HUSK] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MIRTAZAPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[OXAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - 500mg - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6389559&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6389564	Spontaneous	2013-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Lip swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Rash pruritic (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6389564&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6394073	Spontaneous	2013-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Hepatic cytolysis (n/a - Recovered/Resolved - Other Medically Important Condition);Hepatic function abnormal (n/a - Recovered/Resolved - Other Medically Important Condition);Hepatitis E (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6394073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6395124	Spontaneous	2013-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Aphasia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Demyelination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	M-M-RVAXPRO [MEASLES VIRUS ENDERS' EDMONSTON STRAIN (LIVE, ATTENUATED), MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS] (S - n/a - Not applicable - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6395124&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6395231	Spontaneous	2013-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Tetany (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[YELLOW FEVER VACCINE (LIVE), YELLOW FEVER VIRUS STRAIN 17D-204 (LIVE, ATTENUATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6395231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6391312	Spontaneous	2013-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Ataxia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6391312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6382563	Spontaneous	2013-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Erythema (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6382563&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6382569	Spontaneous	2013-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [1d - n/a - Unknown])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 75ug - Oral])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6382569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6382718	Spontaneous	2013-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Injection site infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [1d - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6382718&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6382746	Spontaneous	2013-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Application site reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erysipelas (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site inflammation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Localised oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neck pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [1d - 1{DF} - Unknown])...	[ATENOLOL] (C - n/a - n/a - [n/a - 25mg - Oral])|[BENDROFLUMETHIAZIDE] (C - n/a - n/a - [n/a - 2.5mg - Oral])|[BUPRENORPHINE] (C - n/a - n/a - [n/a - n/a - Oral])|[CHLORCYCLIZINE HYDROCHLORIDE, ERGOTAMINE TARTRATE, CAFFEINE] (C - n/a - n/a - [n/a - n/a - Oral])|[CYANOCOBALAMIN, THIAMINE, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESCITALOPRAM] (C - n/a - n/a - [n/a - 10mg - Oral])|[IBUPROFEN] (C - n/a - n/a - [n/a - 800mg - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - 1g - Oral])|[PROPIOMAZINE, PROPIOMAZINE MALEATE] (C - n/a - n/a - [n/a - 25mg - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - .2mg - n/a])|[SODIUM CROMOGLICATE] (C - n/a - n/a - [n/a - 20mg - n/a])|[VALSARTAN] (C - n/a - n/a - [n/a - n/a - Oral])|[ZOLMITRIPTAN] (C - n/a - n/a - [n/a - 2.5mg - Nasal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6382746&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6382768	Spontaneous	2013-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Facial paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - 1{DF} - n/a])|[ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23] (S - Immunisation - n/a - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6382768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6382805	Spontaneous	2013-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Salmonella sepsis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [1d - .5mL - Unknown])	INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FELODIPINE, FELODIPINE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPRANOLOL, PROPRANOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6382805&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6382813	Spontaneous	2013-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Bladder disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Demyelinating polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Extensor plantar response (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Immune system disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Meningitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Myelitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vibration test abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6382813&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6382827	Spontaneous	2013-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nephrotic syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	CELLCEPT [MYCOPHENOLATE MOFETIL] (C - n/a - n/a - [n/a - n/a - n/a])|[CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - n/a - n/a])|[CICLOSPORIN] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6382827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6378406	Spontaneous	2013-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoacusis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLYCERYL TRINITRATE, GLYCERYL TRINITRATE SOLUTION] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6378406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6380922	Spontaneous	2013-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema induratum (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ETHINYLESTRADIOL, ETONOGESTREL] (C - Contraception - Dose not changed - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6380922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6381798	Spontaneous	2013-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6381798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6381824	Spontaneous	2013-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Immunisation reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Road traffic accident (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6381824&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6381899	Spontaneous	2013-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (3d - Recovered/Resolved - Other Medically Important Condition);Headache (3d - Recovered/Resolved - Other Medically Important Condition);Myalgia (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6381899&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6381908	Spontaneous	2013-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Headache (2d - Recovered/Resolved - Other Medically Important Condition);Myalgia (2d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6381908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6381960	Spontaneous	2013-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (4d - Recovered/Resolved - Other Medically Important Condition);Headache (4d - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6381960&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6374339	Spontaneous	2013-02-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Epstein-Barr virus infection reactivation (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hemiparesis (n/a - Unknown - Other Medically Important Condition);Herpes virus infection (n/a - Unknown - Other Medically Important Condition);Herpes zoster oticus (n/a - Unknown - Other Medically Important Condition);Lacrimation disorder (n/a - Unknown - Other Medically Important Condition);Neuropathy peripheral (n/a - Unknown - Other Medically Important Condition);Rash maculo-papular (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6374339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6372885	Spontaneous	2013-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cerebellar ataxia (7d - Recovered/Resolved - Other Medically Important Condition);Encephalitis (7d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6372885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6356737	Spontaneous	2013-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Erythema (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[DOCONEXENT, ICOSAPENT, DOCONEXENT, VITAMIN D, ICOSAPENT, RETINOL, FISH OIL] (C - n/a - n/a - [n/a - n/a - n/a])|[DUTASTERIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ERDOSTEINE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[IBUPROFEN, IBUPROFEN BP, IBUPROFEN, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - 100mg - n/a])|[SULFAMETHOXAZOLE, TRIMETHOPRIM] (C - n/a - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6356737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6360308	Spontaneous	2013-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sensory disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Taste disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - n/a])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[ISPAGHULA HUSK, PSYLLIUM HUSK] (C - n/a - n/a - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[TERBUTALINE SULFATE, TERBUTALINE SULFATE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6360308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6357353	Spontaneous	2013-02-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Body temperature increased (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6357353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6359702	Spontaneous	2013-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myocarditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6359702&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6360130	Spontaneous	2013-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epilepsy (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	VIMPAT [LACOSAMIDE] (C - Partial seizures - n/a - [n/a - 300mg - Oral])|ZONEGRAN [ZONISAMIDE] (C - Partial seizures - n/a - [n/a - 250mg - Oral])|[SODIUM VALPROATE, VALPROIC ACID, SODIUM VALPROATE] (C - Partial seizures - n/a - [n/a - 1000mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6360130&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6352005	Spontaneous	2013-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angioedema (3mo - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (3mo - Recovered/Resolved - Other Medically Important Condition);Oedema (3mo - Recovered/Resolved - Other Medically Important Condition);Rash erythematous (3mo - Recovered/Resolved - Other Medically Important Condition);Urticaria (3mo - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])...	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6352005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6354017	Spontaneous	2013-02-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6354017&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6355434	Spontaneous	2013-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pericarditis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6355434&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6355447	Spontaneous	2013-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Febrile convulsion (30min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6355447&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6356200	Spontaneous	2013-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[HYDROCHLOROTHIAZIDE, RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOLPIDEM, ZOLPIDEM TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6356200&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6346626	Spontaneous	2013-02-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Aphasia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site inflammation (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Meningitis aseptic (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pleocytosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[AMOXICILLIN SODIUM, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (S - Inflammation - Drug withdrawn - [5d - n/a - Oral])|[AMOXICILLIN, AMOXICILLIN SODIUM, AMOXICILLIN TRIHYDRATE] (S - Meningitis - Drug withdrawn - [3d - 2g - Intravenous (not otherwise specified)])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - Essential hypertension - Dose not changed - [n/a - 16mg - Oral])|[L-METHIONINE, METHIONINE] (C - Prophylaxis - Dose not changed - [n/a - 500mg - Oral])|[MOXONIDINE] (C - Hypertension - Dose not changed - [n/a - .3mg - Oral])|[OXYBUTYNIN HYDROCHLORIDE] (C - Urinary incontinence - Dose not changed - [n/a - 5mg - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM] (C - Dyspepsia - Dose not changed - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6346626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6346649	Spontaneous	2013-02-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6346649&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6346724	Spontaneous	2013-02-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Angioedema (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysphonia (36d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (36d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia oral (36d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Laryngitis (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lip swelling (36d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 75mg - Oral])|[ATORVASTATIN] (C - n/a - n/a - [n/a - 10mg - Oral])|[CAPTOPRIL] (C - n/a - n/a - [n/a - 25mg - Oral])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - Oral])|[ISOSORBIDE DINITRATE] (C - n/a - n/a - [n/a - 5mg - Oral])|[NIFEDIPINE] (C - n/a - n/a - [n/a - 60mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6346724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6348457	Spontaneous	2013-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hypersensitivity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6348457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6345873	Spontaneous	2013-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6345873&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6337049	Spontaneous	2013-01-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Depressed level of consciousness (1h - Recovered/Resolved - Other Medically Important Condition);Eye movement disorder (1h - Recovered/Resolved - Other Medically Important Condition);Febrile convulsion (1h - Recovered/Resolved - Other Medically Important Condition);Seizure (1h - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6337049&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6337142	Spontaneous	2013-01-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Haematoma (n/a - Recovering/Resolving - Life Threatening, Disabling);Headache (n/a - Recovering/Resolving - Life Threatening, Disabling);Hypertension (n/a - Recovering/Resolving - Life Threatening, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6337142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Life Threatening	Hospitalisation
EU-EC-6337234	Spontaneous	2013-01-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Crying (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Generalised tonic-clonic seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Irritability (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6337234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6337771	Spontaneous	2013-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Facial paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vertigo (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vestibular neuronitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6337771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6338088	Spontaneous	2013-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Rash (10d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6338088&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6332257	Spontaneous	2013-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site abscess (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6332257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6332650	Spontaneous	2013-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Seizure (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6332650&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6316145	Spontaneous	2013-01-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Confusional state (2d - Recovered/Resolved - Other Medically Important Condition);Dermatitis exfoliative generalised (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyelonephritis (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Somnolence (2d - Recovered/Resolved - Other Medically Important Condition);Urinary tract infection (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Unknown - [n/a - 1{DF} - Intramuscular])|[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (S - n/a - Drug withdrawn - [16d - 200mg - Oral])|[GABAPENTIN] (S - Herpes zoster - Drug withdrawn - [n/a - n/a - Oral])	LYRICA [PREGABALIN] (C - Herpes zoster - n/a - [12d - n/a - n/a])|LYRICA [PREGABALIN] (C - n/a - n/a - [n/a - 150mg - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - Dose not changed - [n/a - 100mg - Oral])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 100mg - Oral])|[PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - Dose not changed - [n/a - 500mg - Oral])|[TORASEMIDE] (C - n/a - Dose not changed - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6316145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6318436	Spontaneous	2013-01-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Vertigo (n/a - Recovered/Resolved - Other Medically Important Condition);Visual impairment (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6318436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6313273	Spontaneous	2013-01-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sciatica (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6313273&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6313472	Spontaneous	2013-01-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dysaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Nervous system disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	DUKORAL [VIBRIO CHOLERAE O1 INABA, CLASSICAL BIOTYPE (HEAT INACTIVATED), VIBRIO CHOLERAE O1 INABA, EL TOR BIOTYPE (FORMALIN INACTIVATED), VIBRIO CHOLERAE O1 OGAWA, CLASSICAL BIOTYPE (HEAT INACTIVATED), VIBRIO CHOLERAE O1OGAWA, CLASSICAL BIOTYPE (FORMALIN INACTIVATED), CHOLERA TOXIN B SUBUNIT RECOMBINANT (RCTB), VIBRIO CHOLERAE O1 INABA, CLASSICAL BIOTYPE (HEAT INACTIVATED), VIBRIO CHOLERAE O1 INABA, EL TOR BIOTYPE (FORMALIN INACTIVATED), VIBRIO CHOLERAE O1 OGAWA, CLASSICAL BIOTYPE (HEAT INACTIVATED), VIBRIO CHOLERAE O1OGAWA, CLASSICAL BIOTYPE (FORMALIN INACTIVATED), CHOLERA TOXIN B SUBUNIT RECOMBINANT(RCTB) (PRODUCED IN V. CHOLERAE O1 INABA, CLASSICAL BIOTYPE STRAIN 213)] (S - Immunisation - Not applicable - [n/a - n/a - Oral])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6313472&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6316003	Spontaneous	2013-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Amyotrophic lateral sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])|[ATENOLOL] (S - n/a - Dose not changed - [n/a - .5{DF} - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (S - n/a - Not applicable - [n/a - 1{DF} - Oral])|[LISINOPRIL, LISINOPRIL ANHYDROUS] (S - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[METFORMIN HYDROCHLORIDE] (S - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[PARACETAMOL] (S - n/a - n/a - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6316003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6311343	Spontaneous	2013-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Facial paresis (32d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - n/a - Intramuscular])	[CALCIUM, CHOLECALCIFEROL CONCENTRATE, COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LETROZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[MAGNESIUM OXIDE, MAGNESIUM OXIDE, LIGHT] (C - n/a - n/a - [n/a - n/a - n/a])|[MIRTAZAPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6311343&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6311765	Spontaneous	2013-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Livedo reticularis (n/a - Not Recovered/Not Resolved - Life Threatening);Purpura (n/a - Not Recovered/Not Resolved - Life Threatening);Skin necrosis (n/a - Not Recovered/Not Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6311765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6312242	Spontaneous	2013-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Acute kidney injury (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])|[KETOROLAC TROMETAMOL] (S - Back pain - n/a - [n/a - 10[drp] - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6312242&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6307223	Spontaneous	2013-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[SODIUM VALPROATE, VALPROIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6307223&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6296583	Spontaneous	2013-01-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cough (n/a - Unknown - Disabling);Oropharyngeal pain (n/a - Unknown - Disabling);Pneumonia (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6296583&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6296584	Spontaneous	2013-01-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Oxygen saturation decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Sepsis (n/a - Unknown - Caused/Prolonged Hospitalisation);Syncope (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6296584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6296591	Spontaneous	2013-01-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6296591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6297589	Spontaneous	2013-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Sudden death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6297589&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6299663	Spontaneous	2013-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Brain neoplasm (n/a - Unknown - Other Medically Important Condition);Brain oedema (n/a - Unknown - Other Medically Important Condition);Deafness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Multiple sclerosis (n/a - Unknown - Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6299663&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6286577	Spontaneous	2013-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Thrombocytopenic purpura (7d - Fatal - Results in Death)	KEPPRA 500 MG FILM-COATED TABLETS [LEVETIRACETAM] (S - n/a - n/a - [n/a - 750mg - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6286577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6280008	Spontaneous	2013-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Neuritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - Hypertension - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6280008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6269112	Spontaneous	2013-01-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paresis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6269112&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6269976	Spontaneous	2013-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hepatitis acute (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - 5mg - Oral])|[ATORVASTATIN] (C - n/a - n/a - [n/a - 10mg - Oral])|[ERGOCALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[FENOFIBRATE] (C - n/a - n/a - [n/a - 145mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6269976&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6267823	Spontaneous	2013-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Extensive swelling of vaccinated limb (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6267823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6263654	Spontaneous	2013-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vascular purpura (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6263654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6246787	Spontaneous	2013-01-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Epstein-Barr virus infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Inflammation (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site reaction (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6246787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6249173	Spontaneous	2013-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pericarditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6249173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6249406	Spontaneous	2013-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Subcutaneous])	[ACETYLSALICYLIC ACID] (C - Thrombosis prophylaxis - n/a - [n/a - 100mg - Oral])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - 80mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6249406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6220326	Spontaneous	2012-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Ear infection (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6220326&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6230177	Spontaneous	2012-12-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dyspnoea (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6230177&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6230328	Spontaneous	2012-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Confusional state (n/a - Unknown - Caused/Prolonged Hospitalisation);Disorientation (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Viral infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Immunisation - Drug withdrawn - [n/a - n/a - Unknown])	[LEVOTHYROXINE SODIUM] (C - Hyperthyroidism - Unknown - [n/a - 50mg - Unknown])|[RISEDRONATE SODIUM] (C - Osteoarthritis - Unknown - [n/a - 35mg - Unknown])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6230328&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6233044	Spontaneous	2012-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Influenza (13d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (13d - Not Recovered/Not Resolved - Other Medically Important Condition);Viral infection (13d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6233044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6228772	Spontaneous	2012-12-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6228772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6215261	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Child	Yes	Male	Seizure (16d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6215261&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6215735	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Gastroenteritis rotavirus (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	ROTARIX [HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED), HUMAN ROTAVIRUS RIX4414 STRAIN (LIVE ATTENUATED) PRODUCED ON VERO CELLS] (S - Prophylaxis - Not applicable - [1d - 1mL - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6215735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6215848	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (2h - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (2h - Recovered/Resolved - Other Medically Important Condition);Malaise (0d - Recovered/Resolved - Other Medically Important Condition);Pharyngeal swelling (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6215848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6214544	Spontaneous	2012-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Tinnitus (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6214544&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6214967	Spontaneous	2012-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Flank pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6214967&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6205341	Spontaneous	2012-12-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Altered state of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Mania (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Meningoencephalitis herpetic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6205341&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6205387	Spontaneous	2012-12-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Cardiac hypertrophy (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Cardiogenic shock (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Heat cramps (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Somnolence (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Tachypnoea (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6205387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6207060	Spontaneous	2012-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Aphonia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6207060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6209322	Spontaneous	2012-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Deafness unilateral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Hypertension (n/a - Recovering/Resolving - Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6209322&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6200187	Spontaneous	2012-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Chest discomfort (5d - Recovered/Resolved - Other Medically Important Condition);Chills (5d - Recovered/Resolved - Other Medically Important Condition);Headache (5d - Recovered/Resolved - Other Medically Important Condition);Lymphadenopathy (5d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (5d - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Asthma - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6200187&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6201368	Spontaneous	2012-12-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Chest pain (0d - Fatal - Results in Death);Myocardial infarction (0d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	BETA-BLOCKERS [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|DIURETICS [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|PLATELET ANTIAGGREGATORY [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6201368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6202724	Spontaneous	2012-12-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cerebral infarction (n/a - Unknown - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6202724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6204130	Spontaneous	2012-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Anaphylactic shock (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[D,L-LYSINE ACETYLSALICYLATE] (C - Myocardial ischaemia - n/a - [n/a - 160mg - Oral])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - 25mg - Oral])|[LISINOPRIL, LISINOPRIL ANHYDROUS, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - 5mg - Oral])|[PANTOPRAZOLE] (C - Gastrooesophageal reflux disease - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6204130&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6204134	Spontaneous	2012-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Anaphylactic shock (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[BISOPROLOL FUMARATE] (C - Myocardial ischaemia - n/a - [n/a - 2.5mg - Oral])|[ESOMEPRAZOLE] (C - Gastrooesophageal reflux disease - n/a - [n/a - 20mg - Oral])|[MAGALDRATE, MAGALDRATE ANHYDROUS] (C - Gastrooesophageal reflux disease - n/a - [n/a - 160mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6204134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6193476	Spontaneous	2012-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Coma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[MENINGOCOCCAL GROUP A, C, W135 AND Y CONJUGATE VACCINE] (C - Immunisation - n/a - [n/a - n/a - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6193476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6193511	Spontaneous	2012-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Chest discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6193511&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6193686	Spontaneous	2012-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Rhabdomyolysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (S - n/a - n/a - [6y - n/a - n/a])|[EZETIMIBE] (S - n/a - n/a - [n/a - n/a - n/a])	[ALIMEMAZINE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TORASEMIDE, TORASEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6193686&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6193702	Spontaneous	2012-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cerebral infarction (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6193702&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6195092	Spontaneous	2012-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dyspnoea (10d - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (10d - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (10d - Recovered/Resolved - Other Medically Important Condition)	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6195092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6197738	Spontaneous	2012-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6197738&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6198449	Spontaneous	2012-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hyperhidrosis (48h - Recovered/Resolved - Other Medically Important Condition);Oral herpes (48h - Recovered/Resolved - Other Medically Important Condition);Palpitations (48h - Recovered/Resolved - Other Medically Important Condition);Pyrexia (48h - Recovered/Resolved - Other Medically Important Condition);Tachycardia (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6198449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6199332	Spontaneous	2012-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Facial paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	FOSAVANCE [ALENDRONIC ACID, COLECALCIFEROL, COLECALCIFEROL, ALENDRONATE SODIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6199332&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6188927	Spontaneous	2012-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6188927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6192015	Spontaneous	2012-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6192015&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6192145	Spontaneous	2012-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Disorientation (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6192145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6174253	Spontaneous	2012-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hallucination, visual (n/a - Recovered/Resolved - Disabling);Labyrinthitis (n/a - Recovering/Resolving - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Unknown - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Unknown - Disabling);Tremor (n/a - Unknown - Disabling);Vertigo positional (n/a - Recovering/Resolving - Disabling);Vision blurred (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6174253&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6178136	Spontaneous	2012-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6178136&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6178153	Spontaneous	2012-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6178153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6178477	Spontaneous	2012-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Urticaria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6178477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6171468	Spontaneous	2012-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bell's palsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cerumen impaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ear pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Facial paresis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6171468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6172354	Spontaneous	2012-12-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Condition aggravated (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gastric dilatation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hepatic failure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Renal disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Viral infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[YELLOW FEVER VACCINE (LIVE), YELLOW FEVER VIRUS STRAIN 17D-204 (LIVE, ATTENUATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6172354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6172549	Spontaneous	2012-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Application site erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Application site pain (n/a - Recovering/Resolving - Other Medically Important Condition);Cervical radiculopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6172549&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6168161	Spontaneous	2012-12-07 00:00:00	Healthcare Professional	European Economic Area	Mayet A, Haus-Cheymol R, Bouaiti E, Decam C, Simon F, Mérens A, et al. Adverse events following vaccination in the French armed forces: An overview of surveillance conducted from 2002 to 2010. Euro Surveillance 2012 Jun 14;17(24):.	18-64 Years	Not Specified	No	Male	Headache (96h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Presyncope (96h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (96h - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6168161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6165923	Spontaneous	2012-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myocarditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pericarditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6165923&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6148186	Spontaneous	2012-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cyanosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Immunisation - Drug withdrawn - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6148186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6149086	Spontaneous	2012-12-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Extensive swelling of vaccinated limb (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination site inflammation (n/a - Unknown - Other Medically Important Condition);Vaccination site scab (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6149086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6150697	Spontaneous	2012-12-03 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chest pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ASCORBIC ACID] (C - Hypovitaminosis - n/a - [n/a - n/a - n/a])|[VITAMIN B12] (C - Hypovitaminosis - n/a - [n/a - n/a - n/a])|[VITAMIN D] (C - Hypovitaminosis - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6150697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6151201	Spontaneous	2012-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Acute kidney injury (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash macular (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])|[SULFAMETHOXAZOLE, TRIMETHOPRIM] (S - Urinary tract infection - Not applicable - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6151201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6143694	Spontaneous	2012-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6143694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6146433	Spontaneous	2012-11-30 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Peripheral coldness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6146433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6146895	Spontaneous	2012-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Anxiety (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (48h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (48h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (48h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site erythema (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site induration (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[DIPOTASSIUM CLORAZEPATE] (C - n/a - n/a - [n/a - .5mg - n/a])|[DYDROGESTERONE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESTRADIOL] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6146895&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6146968	Spontaneous	2012-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Abdominal pain upper (8d - Recovered/Resolved - Other Medically Important Condition);Decreased appetite (8d - Recovered/Resolved - Other Medically Important Condition);Hepatic cytolysis (n/a - Recovered/Resolved - Other Medically Important Condition);Jaundice cholestatic (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (8d - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6146968&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6139632	Spontaneous	2012-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Burning sensation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eczema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Functional gastrointestinal disorder (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Inflammation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (14d - Recovered/Resolved - Other Medically Important Condition);Rash erythematous (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash papular (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Renal pain (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[LORMETAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[MINOCYCLINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PAROXETINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6139632&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6142417	Spontaneous	2012-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6142417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6137803	Spontaneous	2012-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[CHLORZOXAZONE] (C - Pain - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6137803&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6133843	Spontaneous	2012-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Faeces soft (n/a - Recovered/Resolved - Other Medically Important Condition);Glossodynia (1wk - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Infection (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Swollen tongue (1wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[ALENDRONATE SODIUM, ALENDRONIC ACID] (C - Osteoporosis - n/a - [n/a - n/a - Oral])|[COLECALCIFEROL, CALCIUM PHOSPHATE] (C - n/a - n/a - [n/a - n/a - Oral])|[COLECALCIFEROL] (C - Vitamin D deficiency - n/a - [n/a - n/a - Oral])|[PAROXETINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE HYDROCHLORIDE, ANHYDROUS] (C - Depression - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6133843&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6127050	Spontaneous	2012-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Depressed level of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoglycaemia (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (3d - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Unknown])	[BISACODYL] (C - Megacolon - Drug withdrawn - [662d - 2{DF} - Unknown])|[CALCIUM DOBESILATE] (C - n/a - Drug withdrawn - [662d - 1{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6127050&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6127052	Spontaneous	2012-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dyspnoea (1wk - Recovered/Resolved - Other Medically Important Condition);Laryngeal oedema (1wk - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Unknown])	[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6127052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6129872	Spontaneous	2012-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dyspnoea (n/a - Fatal - Results in Death);Infarction (n/a - Fatal - Results in Death);Respiratory failure (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ANETHOLE TRITHIONE] (C - n/a - n/a - [n/a - n/a - n/a])|[FENOFIBRATE, FENOFIBRATE MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6129872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6125683	Spontaneous	2012-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovering/Resolving - Other Medically Important Condition);Pneumonia (n/a - Recovering/Resolving - Other Medically Important Condition);Respiratory failure (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, AMILORIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE DIHYDRATE, HYDROCHLOROTHIAZIDE, ANHYDROUS AMILORIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CLONIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LORAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[PAROXETINE, PAROXETINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6125683&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6125705	Spontaneous	2012-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Extensive swelling of vaccinated limb (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6125705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6118940	Spontaneous	2012-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Anaphylactic reaction (0d - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6118940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6118978	Spontaneous	2012-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cardiac arrest (0d - Fatal - Results in Death);Chest pain (0d - Fatal - Results in Death);Dyspnoea (0d - Fatal - Results in Death);Hyperhidrosis (0d - Fatal - Results in Death);Hypertension (0d - Fatal - Results in Death)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	[TAMSULOSIN, TAMSULOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6118978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6121616	Spontaneous	2012-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Back pain (n/a - Unknown - Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Muscle spasms (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6121616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6121650	Spontaneous	2012-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (5d - Unknown - Other Medically Important Condition);Dizziness (5d - Unknown - Other Medically Important Condition);Fatigue (5d - Unknown - Other Medically Important Condition);Headache (5d - Unknown - Other Medically Important Condition);Myalgia (5d - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6121650&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6113745	Spontaneous	2012-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rheumatoid arthritis (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6113745&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6113759	Spontaneous	2012-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myocardial infarction (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6113759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6113761	Spontaneous	2012-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Amnesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Encephalopathy (48h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Insomnia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6113761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6113909	Spontaneous	2012-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Circulatory collapse (n/a - Fatal - Results in Death);Syncope (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6113909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6113910	Spontaneous	2012-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6113910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6104944	Spontaneous	2012-11-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Aphasia (n/a - Unknown - Other Medically Important Condition);Hypertension (n/a - Unknown - Other Medically Important Condition);Speech disorder (n/a - Unknown - Other Medically Important Condition);Vasodilatation (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6104944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6100708	Spontaneous	2012-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6100708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6100713	Spontaneous	2012-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Sudden death (3d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6100713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6100763	Spontaneous	2012-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Condition aggravated (6d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6100763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6094207	Spontaneous	2012-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Radiculitis brachial (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6094207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6092840	Spontaneous	2012-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Bronchitis (4d - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ANHYDROUS AZITHROMYCIN, AZITHROMYCIN, AZITHROMYCIN DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6092840&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6092964	Spontaneous	2012-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Respiratory disorder (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6092964&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6082312	Spontaneous	2012-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Not Specified	Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (48h - Recovered/Resolved - Other Medically Important Condition);Urinary tract infection (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6082312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6083236	Spontaneous	2012-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6083236&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6075829	Spontaneous	2012-11-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Limb discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Muscle tightness (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Other Medically Important Condition);Neuralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (4d - Recovered/Resolved - Other Medically Important Condition);Sensory loss (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6075829&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6070856	Spontaneous	2012-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Rash pruritic (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6070856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6067988	Spontaneous	2012-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (5d - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (5d - Recovered/Resolved - Other Medically Important Condition);Lymph node pain (5d - Recovered/Resolved - Other Medically Important Condition);Lymphadenopathy (5d - Recovered/Resolved - Other Medically Important Condition);Monoplegia (5d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition);Rash pruritic (5d - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	[ZOLPIDEM, ZOLPIDEM HEMITARTRATE, ZOLPIDEM TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6067988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6070146	Spontaneous	2012-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Breath sounds abnormal (1d - Unknown - Results in Death);Feeling cold (n/a - Unknown - Results in Death);Snoring (1d - Unknown - Results in Death)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6070146&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6070445	Spontaneous	2012-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6070445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6064269	Spontaneous	2012-11-05 00:00:00	Healthcare Professional	Non European Economic Area	Orcurto A, Pascual M, Hoschler K, Aubert V, Meylan P, Manuel O. Impact of anti-T-cell therapy in the immunogenicity of seasonal influenza vaccine in kidney transplant recipients. Transplantation 2012 Sep 27;94(6):630-636.	Not Specified	Adult	No	Not Specified	H1N1 influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	[ANTI-T LYMPHOCYTE IMMUNOGLOBULIN FOR HUMAN USE, RABBIT, ANTITHYMOCYTE IMMUNOGLOBULIN, RABBIT ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN] (C - Immunosuppressant drug therapy - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6064269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6058019	Spontaneous	2012-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Application site erythema (n/a - Recovering/Resolving - Other Medically Important Condition);Application site pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6058019&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6058626	Spontaneous	2012-11-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site induration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza - Not applicable - [n/a - n/a - Intramuscular])...	[HEPATITIS B SURFACE ANTIGEN, HEPATITIS A VACCINE (INACTIVATED)] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6058626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6049114	Spontaneous	2012-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Hypoaesthesia (5d - Unknown - Other Medically Important Condition);Injection site joint erythema (5d - Unknown - Other Medically Important Condition);Oedema peripheral (5d - Unknown - Other Medically Important Condition);Paraesthesia (5d - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6049114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6052099	Spontaneous	2012-10-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Pneumonia (3wk - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (14d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[ACETAZOLAMIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[FLUTICASONE PROPIONATE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[IPRATROPIUM BROMIDE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[PREDNISOLON] (C - Chronic obstructive pulmonary disease - n/a - [n/a - 10mg - Oral])|[THEOPHYLLINE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - 250mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6052099&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6034805	Spontaneous	2012-10-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Influenza (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6034805&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6004433	Spontaneous	2012-10-18 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Bursitis (n/a - Not Recovered/Not Resolved - Disabling);Mobility decreased (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Tendonitis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Anxiety - n/a - [n/a - 10mg - Unknown])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TRAZODONE, TRAZODONE HYDROCHLORIDE] (C - Insomnia - n/a - [n/a - 50mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6004433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6006594	Spontaneous	2012-10-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6006594&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5994153	Spontaneous	2012-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Arthralgia (8mo - Recovered/Resolved With Sequelae - );Injection site pain (10min - Recovered/Resolved With Sequelae - );Myalgia (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLZUUR] (C - n/a - n/a - [n/a - 80mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5994153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-5989769	Spontaneous	2012-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Not Specified	Hyperthermia (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5989769&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5984424	Spontaneous	2012-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Urticaria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[FLUOCORTOLONE PIVALATE PH. EUR., ANHYDROUS LIDOCAINE HYDROCHLORIDE, FLUOCORTOLONE PIVALATE PH. EUR., LIDOCAINE HYDROCHLORIDE, FLUOCORTOLONE PIVALATE, ANHYDROUS LIDOCAINE HYDROCHLORIDE, FLUOCORTOLONE PIVALATE, LIDOCAINE HYDROCHLORIDE] (C - Haemorrhoids - n/a - [5d - n/a - n/a])|[MEBENDAZOLE] (C - Enterobiasis - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5984424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5985680	Spontaneous	2012-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Abnormal dreams (n/a - Unknown - Disabling, Other Medically Important Condition);Cataplexy (n/a - Unknown - Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Intentional self-injury (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Disabling, Other Medically Important Condition);Paralysis (n/a - Unknown - Disabling, Other Medically Important Condition);Quality of life decreased (n/a - Unknown - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	ACLASTA [ZOLEDRONIC ACID, ZOLEDRONIC ACID MONOHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[BICALUTAMIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5985680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5969896	Spontaneous	2012-10-08 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	REBIF [INTERFERON BETA-1A] (S - Multiple sclerosis - Dose not changed - [n/a - 44ug - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - n/a - Subcutaneous])|[METHYLPREDNISOLONE] (S - Product used for unknown indication - Dose not changed - [n/a - 1000mg - Intravenous (not otherwise specified)])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5969896&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5973387	Spontaneous	2012-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cervicobrachial syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Formication (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[CLOMIPRAMINE, CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[LORAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[NEBIVOLOL] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5973387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5967106	Spontaneous	2012-10-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Neck pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[BETAMETHASONE] (C - n/a - n/a - [n/a - .5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5967106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5963765	Spontaneous	2012-10-04 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cold agglutinins positive (n/a - Unknown - Caused/Prolonged Hospitalisation);Haemolytic anaemia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	CLOPIDOGREL [CLOPIDOGREL, CLOPIDOGREL BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PYRIDOSTIGMINE, PYRIDOSTIGMINE BROMIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5963765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5945779	Spontaneous	2012-09-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Extensive swelling of vaccinated limb (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PIZOTIFEN, PIZOTIFEN MALATE, PIZOTIFEN MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5945779&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5946541	Spontaneous	2012-09-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Recovered/Resolved - Disabling);Peripheral swelling (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5946541&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5933576	Spontaneous	2012-09-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dyspnoea exertional (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Face oedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);General physical health deterioration (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5933576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5918930	Spontaneous	2012-09-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Blood pressure increased (n/a - Recovered/Resolved - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Chest pain (n/a - Unknown - Other Medically Important Condition);Gastritis (n/a - Unknown - Other Medically Important Condition);Gastroenteritis (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Pericardial effusion (n/a - Unknown - Other Medically Important Condition);Pericarditis (n/a - Recovered/Resolved - Other Medically Important Condition);Serum sickness-like reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5918930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5895304	Spontaneous	2012-09-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cervicobrachial syndrome (n/a - Recovered/Resolved - Other Medically Important Condition);Neck pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[HYDROCHLOROTHIAZIDE, LISINOPRIL, HYDROCHLOROTHIAZIDE, LISINOPRIL ANHYDROUS, LISINOPRIL ANHYDROUS, HYDROCHLOROTHIAZIDE EP, LISINOPRIL DIHYDRATE, HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5895304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5888376	Spontaneous	2012-09-12 00:00:00	Healthcare Professional	Non European Economic Area	Anyoti M, Law B. reported Case of Facial Paralysis Following Immunization in Canada. The Canadian Journal of Infectious Diseases &amp; Medical Microbiology NOV-2006:V17 #6:349.	Not Specified	Not Specified	No	Not Specified	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Bell's palsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Lethargy (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle twitching (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [9y - n/a - Unknown])|[DIPHTHERIA TOXOID ADSORBED, TETANUS TOXOID ADSORBED] (S - Immunisation - n/a - [9y - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5888376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5888518	Spontaneous	2012-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Epistaxis (n/a - Unknown - Other Medically Important Condition);Gastric haemorrhage (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5888518&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5888659	Spontaneous	2012-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Radiculopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5888659&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5889109	Spontaneous	2012-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Anaphylactic shock (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eye pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiration abnormal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Bronchopulmonary dysplasia - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5889109&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5889217	Spontaneous	2012-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Alopecia totalis (n/a - Recovered/Resolved - Other Medically Important Condition);Diffuse alopecia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5889217&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5890671	Spontaneous	2012-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Extensive swelling of vaccinated limb (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5890671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5880249	Spontaneous	2012-09-11 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenopia (n/a - Recovered/Resolved - Other Medically Important Condition);Diplopia (n/a - Recovered/Resolved - Other Medically Important Condition);Ophthalmoplegia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5880249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5882801	Spontaneous	2012-09-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])|[HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM HYDROXIDE [PRODUCED IN S. CEREVISIAE (STRAIN 2150-2-3) BY RDNA], ALGELDRATE] (S - Prophylaxis - Not applicable - [1d - 1mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5882801&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5883777	Spontaneous	2012-09-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Disabling);Dyspnoea (n/a - Recovered/Resolved - Disabling);Joint ankylosis (n/a - Recovered/Resolved - Disabling);Musculoskeletal pain (n/a - Recovered/Resolved - Disabling);Osteoarthritis (n/a - Unknown - Disabling);Pain in extremity (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5883777&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5866985	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Psoriasis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])|[FLUCLOXACILLIN] (S - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])|[METOPROLOL TARTRATE] (S - Hypertension - Unknown - [n/a - 100mg - Oral])	NOT AVAILABLE (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[CARBASALATE CALCIUM] (C - n/a - Dose not changed - [n/a - 100mg - Oral])|[FLUTICASONE PROPIONATE] (C - n/a - Dose not changed - [n/a - 1{DF} - Nasal])|[OMEPRAZOLE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5866985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5858931	Spontaneous	2012-09-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5858931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5852330	Spontaneous	2012-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Multiple organ dysfunction syndrome (n/a - Fatal - Results in Death, Life Threatening);Necrotising fasciitis (n/a - Fatal - Results in Death, Life Threatening);Septic shock (n/a - Fatal - Results in Death, Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[CHLORPHENAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN] (S - n/a - Not applicable - [n/a - n/a - n/a])|[PARACETAMOL] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5852330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5845334	Spontaneous	2012-09-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pericardial effusion (1mo - Recovered/Resolved - Other Medically Important Condition);Pericarditis (1mo - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5845334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5820856	Spontaneous	2012-08-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Hypersensitivity (1mo - Recovered/Resolved - Other Medically Important Condition);Urticaria (1mo - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5820856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5820908	Spontaneous	2012-08-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Lymphocytosis (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Renal failure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Transaminases increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[AMOXICILLIN, AMOXICILLIN SODIUM, AMOXICILLIN TRIHYDRATE] (C - Arthritis infective - n/a - [n/a - n/a - Oral])|[GENTAMICIN] (C - n/a - n/a - [n/a - n/a - n/a])|[PRISTINAMYCIN] (C - Arthritis infective - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5820908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5823344	Spontaneous	2012-08-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myocarditis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	[HUMAN NORMAL IMMUNOGLOBULIN, IMMUNOGLOBULIN G] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5823344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5796301	Spontaneous	2012-08-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injected limb mobility decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Limb discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - 6mg - n/a])|[CLONAZEPAM] (C - n/a - n/a - [n/a - .5mg - Oral])|[VALSARTAN] (C - n/a - n/a - [n/a - 80mg - n/a])|[VENLAFAXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5796301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5773253	Spontaneous	2012-08-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	IRON [IRON] (C - n/a - n/a - [n/a - n/a - n/a])|[DOCONEXENT, ICOSAPENT, FISH OIL, ICOSAPENT ETHYL, DOCOSAHEXAENOIC ACID ETHYL ESTER, OMEGA-3-ACID ETHYL ESTERS 90, OMEGA-3-ACID ETHYL ESTERS 90, DOCOSAHEXAENOIC ACID ETHYL ESTER] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - Insomnia - n/a - [n/a - n/a - n/a])|[THIAMINE HYDROCHLORIDE, RETINOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5773253&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5770008	Spontaneous	2012-08-16 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cough (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza like illness (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Total lung capacity decreased (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination failure (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	AMOXICILLIN/CLAVULANIC ACID [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL SULFATE, IPRATROPIUM BROMIDE] (C - n/a - n/a - [n/a - n/a - Nasal])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5770008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5760469	Spontaneous	2012-08-13 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Behaviour disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Confusional state (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hallucination, visual (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5760469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5756075	Spontaneous	2012-08-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Anuria (n/a - Unknown - Caused/Prolonged Hospitalisation);Colitis ischaemic (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastric ulcer (n/a - Unknown - Caused/Prolonged Hospitalisation);Haematemesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hepatic function abnormal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Large intestinal obstruction (n/a - Unknown - Caused/Prolonged Hospitalisation);Rectal haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation);Renal impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	[LITHIUM] (C - Depression - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5756276	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Haematuria (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756276&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756283	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756285	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Arthritis (n/a - Unknown - Other Medically Important Condition);Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Calcinosis (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Myositis (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756289	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756304	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Keratitis (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756306	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Arthralgia (n/a - Unknown - Other Medically Important Condition);Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756306&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756317	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	Kostianovsky A, Charles P, Alves J, Goulet M, Pagnoux C, Le Guern V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. Clinical and Experimental Rheumatology 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Septic shock (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756317&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5756323	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Arthralgia (n/a - Unknown - Other Medically Important Condition);Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756323&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756354	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Migraine (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756363	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Sinusitis (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756363&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756387	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Ulcer (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756390	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Arthritis (n/a - Unknown - Other Medically Important Condition);Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756394	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Arthralgia (n/a - Unknown - Other Medically Important Condition);Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756410	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756410&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5746195	Spontaneous	2012-08-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arrhythmia (n/a - Not Recovered/Not Resolved - Life Threatening);Extrasystoles (n/a - Not Recovered/Not Resolved - Life Threatening);Palpitations (n/a - Not Recovered/Not Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5746195&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-5725721	Spontaneous	2012-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vascular purpura (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5725721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5692076	Spontaneous	2012-07-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	H1N1 influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5692076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5686757	Spontaneous	2012-07-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	H1N1 influenza (6d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5686757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5670329	Spontaneous	2012-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Facial paralysis (n/a - Recovering/Resolving - Disabling);Herpes zoster (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5670329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5648438	Spontaneous	2012-07-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abscess (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5648438&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5648816	Spontaneous	2012-07-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cough (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza like illness (n/a - Recovering/Resolving - Other Medically Important Condition);Lower respiratory tract infection (n/a - Recovering/Resolving - Other Medically Important Condition);Lung disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition);Upper respiratory tract infection (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5648816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5634663	Spontaneous	2012-07-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Radiculopathy (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5634663&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5633648	Spontaneous	2012-07-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vascular purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5633648&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5622393	Spontaneous	2012-06-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injected limb mobility decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5622393&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5622398	Spontaneous	2012-06-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Lower respiratory tract infection (n/a - Recovered/Resolved - Other Medically Important Condition);Lung disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Upper respiratory tract infection (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5622398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5622399	Spontaneous	2012-06-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Lower respiratory tract infection (n/a - Recovered/Resolved - Other Medically Important Condition);Lung disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Upper respiratory tract infection (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5622399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5610907	Spontaneous	2012-06-27 00:00:00	Healthcare Professional	European Economic Area	Soethout E. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains. Vaccine 2012 Jun 09;1-8. Data migrated from the EudraVigilance E2B(R2) Literature repository	Not Specified	Not Specified	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5610907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5610911	Spontaneous	2012-06-27 00:00:00	Healthcare Professional	European Economic Area	Soethout E. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains. Vaccine 2012 Jun 09;1-8. Data migrated from the EudraVigilance E2B(R2) Literature repository	Not Specified	Not Specified	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5610911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5610912	Spontaneous	2012-06-27 00:00:00	Healthcare Professional	European Economic Area	Soethout E. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains. Vaccine 2012 Jun 09;1-8. Data migrated from the EudraVigilance E2B(R2) Literature repository	Not Specified	Not Specified	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5610912&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5610915	Spontaneous	2012-06-27 00:00:00	Healthcare Professional	European Economic Area	Soethout E. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains. Vaccine 2012 Jun 09;1-8. Data migrated from the EudraVigilance E2B(R2) Literature repository	Not Specified	Not Specified	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5610915&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5610920	Spontaneous	2012-06-27 00:00:00	Healthcare Professional	European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Soethout E. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains. Vaccine 2012 Jun 09;1-8.	Not Specified	Not Specified	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5610920&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5610235	Spontaneous	2012-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5610235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5597691	Spontaneous	2012-06-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Monoplegia (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Peroneal nerve palsy (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5597691&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5596850	Spontaneous	2012-06-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Atrial flutter (15h - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	[METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5596850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5596851	Spontaneous	2012-06-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Agitation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Angioedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypersensitivity (6d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5596851&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5585055	Spontaneous	2012-06-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthritis reactive (10d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Joint stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, MAGNESIUM OXIDE] (C - Cerebrovascular accident - n/a - [n/a - n/a - n/a])|[DIPYRIDAMOLE] (C - Cerebrovascular accident - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Cerebrovascular accident - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5585055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5576916	Spontaneous	2012-06-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Dyspnoea (48h - Recovered/Resolved - Other Medically Important Condition);Pneumonia (9d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (48h - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5576916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5581030	Spontaneous	2012-06-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Amyotrophy (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation);Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Decreased vibratory sense (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation);Formication (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Paresis (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation);Walking aid user (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5581030&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5567932	Spontaneous	2012-06-12 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Leukoencephalopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5567932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5542771	Spontaneous	2012-06-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5542771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5533334	Spontaneous	2012-05-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Abdominal discomfort (n/a - Unknown - Other Medically Important Condition);Bronchospasm (1wk - Recovered/Resolved - Other Medically Important Condition);Dysphonia (1wk - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (1wk - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (1wk - Recovered/Resolved - Other Medically Important Condition);Vaccination site pruritus (n/a - Unknown - Other Medically Important Condition);Wheezing (1wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5533334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5525945	Spontaneous	2012-05-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5525945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5500584	Spontaneous	2012-05-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Purpura (18d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenic purpura (18d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5500584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5490831	Spontaneous	2012-05-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Encephalitis (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5490831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-5485317	Spontaneous	2012-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Abdominal distension (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Abdominal pain (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Areflexia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Babinski reflex test (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hyporeflexia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypotonia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Kernig's sign (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Tonsillitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Upper respiratory tract infection (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Urinary retention (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Vomiting (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5485317&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5482908	Spontaneous	2012-05-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Application site hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Breast pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Gynaecomastia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vertigo (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5482908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5477034	Spontaneous	2012-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Protozoal corneal ulcer (n/a - Unknown - Other Medically Important Condition);Visual acuity reduced (n/a - Unknown - Other Medically Important Condition);Visual impairment (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5477034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5477125	Spontaneous	2012-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pericardial effusion (n/a - Recovering/Resolving - Other Medically Important Condition);Pericarditis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5477125&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5450187	Spontaneous	2012-05-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Colitis ulcerative (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site irritation (n/a - Unknown - Other Medically Important Condition);Injection site pruritus (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5450187&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5445440	Spontaneous	2012-04-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5445440&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5433982	Spontaneous	2012-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Necrotising fasciitis (n/a - Fatal - Results in Death, Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[CHLORPHENAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])|[PARACETAMOL] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5433982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5428070	Spontaneous	2012-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5428070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5416491	Spontaneous	2012-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Abdominal discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Abdominal pain (21d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chronic gastritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Duodenitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (21d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sense of oppression (21d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tic (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5416491&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5416493	Spontaneous	2012-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5416493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5419324	Spontaneous	2012-04-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - );Injection site pruritus (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[MOMETASONE FUROATE] (C - n/a - Dose not changed - [n/a - 2{DF} - Nasal])|[SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5419324&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5401194	Spontaneous	2012-04-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (12h - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5401194&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5404378	Spontaneous	2012-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	JANUMET [METFORMIN HYDROCHLORIDE, SITAGLIPTIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	[ENALAPRIL MALEATE, LERCANIDIPINE HYDROCHLORIDE, LERCANIDIPINE HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5404378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5398672	Spontaneous	2012-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Arrhythmia (n/a - Unknown - Other Medically Important Condition);C-reactive protein increased (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Chest pain (n/a - Recovering/Resolving - Other Medically Important Condition);Palpitations (n/a - Recovering/Resolving - Other Medically Important Condition);Viral infection (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[DICLOFENAC SODIUM, MISOPROSTOL] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[VENLAFAXINE] (C - n/a - Dose not changed - [n/a - 75mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5398672&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5392344	Spontaneous	2012-04-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myoclonus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5392344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5394181	Spontaneous	2012-04-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Vaccination site bruising (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5394181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5391614	Spontaneous	2012-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Agitation (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Atrial fibrillation (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Bedridden (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Bronchopneumopathy (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Cardiac failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Chest pain (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Communication disorder (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Cyanosis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Disorientation (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Ischaemic limb pain (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Leukocytosis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Neutrophilia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Peripheral coldness (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Renal failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Renal impairment (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Soft tissue necrosis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Ventricular extrasystoles (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Vitamin D deficiency (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	EBIXA [MEMANTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 20mg - n/a])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 200mg - n/a])|[BROMAZEPAM] (C - n/a - n/a - [n/a - 6mg - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - 20mg - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 50ug - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - 5mg - n/a])|[POTASSIUM CHLORIDE] (C - n/a - n/a - [n/a - 1000mg - n/a])|[ZOLPIDEM, ZOLPIDEM TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5391614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5385422	Spontaneous	2012-04-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	Yes	Male	Fatigue (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[INSULIN ASPART] (C - Type 1 diabetes mellitus - n/a - [n/a - n/a - Other])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5385422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5375137	Spontaneous	2012-04-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (68d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intradermal])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5375137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5370407	Spontaneous	2012-04-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Angioedema (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bronchitis (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Immunisation reaction (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swelling (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tenderness (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5370407&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5370410	Spontaneous	2012-04-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Angioedema (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperplasia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Throat tightness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site inflammation (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5370410&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5372780	Spontaneous	2012-04-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Dry mouth (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hiccups (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hyperglycaemia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pollakiuria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])...	[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - 80mg - Oral])|[ATENOLOL] (C - n/a - Unknown - [n/a - 100mg - Oral])|[DIGOXIN, DIGOXIN PH. EUR.] (C - n/a - Unknown - [n/a - .25mg - Unknown])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 40mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5372780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5365655	Spontaneous	2012-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Acute respiratory failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Affective disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Anaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Apathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Apnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Atelectasis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bacteriuria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bronchostenosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Endotracheal intubation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hepatomegaly (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Laryngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Liver disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Mechanical ventilation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Metabolic disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Mitochondrial enzyme deficiency (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neutropenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oliguria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5365655&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5366487	Spontaneous	2012-04-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Arthralgia (4d - Recovered/Resolved - Other Medically Important Condition);Malaise (4d - Recovered/Resolved - Other Medically Important Condition);Myalgia (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5366487&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5368589	Spontaneous	2012-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Hyperthyroidism (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5368589&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-5369497	Spontaneous	2012-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (8d - Recovered/Resolved - Other Medically Important Condition);Cough (8d - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (8d - Recovered/Resolved - Other Medically Important Condition);Myalgia (8d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (6d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5369497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5361011	Spontaneous	2012-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Swelling face (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5361011&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5356957	Spontaneous	2012-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Limb discomfort (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5356957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5359984	Spontaneous	2012-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cerebellar syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypoaesthesia oral (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5359984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5355747	Spontaneous	2012-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Encephalopathy (9d - Recovered/Resolved - Results in Death);Hepatitis fulminant (26d - Fatal - Results in Death)	HOMEOPATHIE [NOT AVAILABLE] (S - n/a - Unknown - [n/a - n/a - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])|[BUDESONIDE] (S - Asthma - Dose not changed - [n/a - 2{DF} - Respiratory (inhalation)])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5355747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5342073	Spontaneous	2012-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaesthesia oral (n/a - Unknown - Other Medically Important Condition);Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Facial paralysis (n/a - Recovering/Resolving - Other Medically Important Condition);Neck pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5342073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5335868	Spontaneous	2012-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5335868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5336302	Spontaneous	2012-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bell's palsy (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5336302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5331036	Spontaneous	2012-03-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (5d - Recovered/Resolved - Other Medically Important Condition);Gastrointestinal disorder (1wk - Recovered/Resolved - Other Medically Important Condition);Headache (3d - Recovered/Resolved - Other Medically Important Condition);Influenza (1wk - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[NIFEDIPINE] (C - Hypertension - n/a - [11d - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5331036&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5331374	Spontaneous	2012-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Autoimmune haemolytic anaemia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5331374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5323586	Spontaneous	2012-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5323586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5323772	Spontaneous	2012-03-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5323772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5319535	Spontaneous	2012-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5319535&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5310910	Spontaneous	2012-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Thrombocytopenia (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5310910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5310991	Spontaneous	2012-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Petit mal epilepsy (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5310991&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5311004	Spontaneous	2012-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5311004&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5311049	Spontaneous	2012-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5311049&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5301502	Spontaneous	2012-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Periarthritis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	INSULIN HUMAN (RDNA) [INSULIN HUMAN (RDNA)] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5301502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5297926	Spontaneous	2012-03-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Chills (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Decreased appetite (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dysstasia (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition);Superinfection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5297926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5294350	Spontaneous	2012-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Male	Blister (n/a - Recovered/Resolved - Other Medically Important Condition);C-reactive protein increased (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Skin exfoliation (n/a - Recovered/Resolved - Other Medically Important Condition);Tenderness (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5294350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5289868	Spontaneous	2012-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Hyperpyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5289868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5288332	Spontaneous	2012-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Blood bilirubin increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling of body temperature change (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Haemophagocytic lymphohistiocytosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hepatic steatosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Leukopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Transaminases increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	NEUROLEPTIC [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[BACLOFEN, BACLOFEN PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5288332&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5270450	Spontaneous	2012-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cerebellar syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5270450&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5264801	Spontaneous	2012-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5264801&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5261743	Spontaneous	2012-02-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Malaise (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5261743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5256911	Spontaneous	2012-02-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Influenza like illness (4d - Recovered/Resolved - Other Medically Important Condition);Parotitis (3wk - Recovered/Resolved - Other Medically Important Condition);Rhinitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5256911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5256917	Spontaneous	2012-02-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Dyspnoea (14d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Gait disturbance (15d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (15d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Hypoaesthesia (15d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (15d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (5d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Speech disorder (15d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5256917&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5259861	Spontaneous	2012-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	Yes	Male	Apathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neonatal hypoxia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Night sweats (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5259861&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5260221	Spontaneous	2012-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Induration (4d - Recovered/Resolved - Other Medically Important Condition);Injection site abscess (4d - Recovered/Resolved - Other Medically Important Condition);Pain (4d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5260221&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5251678	Spontaneous	2012-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Acute febrile neutrophilic dermatosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5251678&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5251720	Spontaneous	2012-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Polyneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5251720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5232930	Spontaneous	2012-02-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Drug-induced liver injury (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastrointestinal disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5232930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5236697	Spontaneous	2012-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5236697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5228738	Spontaneous	2012-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Cutaneous vasculitis (18d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vascular purpura (18d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[AMOXICILLIN, AMOXICILLIN SODIUM, AMOXICILLIN TRIHYDRATE] (S - n/a - Unknown - [n/a - n/a - Oral])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5228738&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5228764	Spontaneous	2012-02-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Plasma cell myeloma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Spinal compression fracture (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Spinal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5228764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5228084	Spontaneous	2012-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Unknown - [n/a - n/a - n/a])	[IBUPROFEN, IBUPROFEN SODIUM DIHYDRATE] (C - n/a - n/a - [n/a - 400mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5228084&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5228619	Spontaneous	2012-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5228619&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5219188	Spontaneous	2012-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Crying (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Wheezing (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5219188&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5219327	Spontaneous	2012-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Back pain (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5219327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5213673	Spontaneous	2012-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5213673&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5216273	Spontaneous	2012-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Vascular purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	INCIVO 375 MG FILM-COATED TABLETS [TELAPREVIR] (S - n/a - Drug withdrawn - [n/a - 2{DF} - n/a])|PEGASYS [PEGINTERFERON ALFA-2A] (S - n/a - Drug withdrawn - [n/a - 180ug - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])|[RIBAVIRIN] (S - n/a - Drug withdrawn - [n/a - 1200mg - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5216273&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5206373	Spontaneous	2012-02-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Blister (n/a - Recovered/Resolved - Other Medically Important Condition);Haematoma (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity vasculitis (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Rash papular (n/a - Recovered/Resolved - Other Medically Important Condition);Skin hyperpigmentation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[ACETYLSALICYLIC ACID] (C - Cardiovascular disorder - Drug withdrawn - [n/a - n/a - n/a])|[LORAZEPAM] (C - Anxiety - n/a - [n/a - n/a - n/a])|[PENTOXIFYLLINE] (C - Cardiovascular disorder - n/a - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM] (C - Cardiovascular disorder - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5206373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5208266	Spontaneous	2012-02-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Pain in extremity (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5208266&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5208267	Spontaneous	2012-02-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5208267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5204608	Spontaneous	2012-02-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5204608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5204612	Spontaneous	2012-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Extensive swelling of vaccinated limb (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])|[SALBUTAMOL SULFAAT] (C - n/a - Unknown - [n/a - 200ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5204612&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5198217	Spontaneous	2012-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5198217&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5201056	Spontaneous	2012-02-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Nasopharyngitis (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5201056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5201060	Spontaneous	2012-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Inflammation (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - .5mL - Subcutaneous])	[METHYSERGIDE] (C - Prophylaxis - Unknown - [n/a - 1mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5201060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5196728	Spontaneous	2012-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Extensive swelling of vaccinated limb (2d - Recovered/Resolved - Other Medically Important Condition);Respiration abnormal (n/a - Recovering/Resolving - Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition);Swelling face (n/a - Recovering/Resolving - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[LEVOCETIRIZINE DIHYDROCHLORIDE] (C - n/a - Unknown - [n/a - 2.5mL - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5196728&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5192867	Spontaneous	2012-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Inflammation (n/a - Recovered/Resolved - );Lymphadenopathy (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - );Pharyngitis (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5192867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5188846	Spontaneous	2012-02-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	[FLUTICASONE PROPIONATE] (C - n/a - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5188846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5183457	Spontaneous	2012-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Thrombocytopenia (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5183457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5185289	Spontaneous	2012-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site extravasation (n/a - Recovered/Resolved With Sequelae - );Injection site pain (n/a - Recovered/Resolved With Sequelae - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5185289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-5185322	Spontaneous	2012-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Malaise (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5185322&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5179298	Spontaneous	2012-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Atrial fibrillation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bronchitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Confusional state (n/a - Unknown - Caused/Prolonged Hospitalisation);Disorientation (n/a - Unknown - Caused/Prolonged Hospitalisation);Erysipelas (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Staphylococcal sepsis (n/a - Unknown - Caused/Prolonged Hospitalisation);Ventricular tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CAPTOPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[INSULIN, INSULIN HUMAN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5179298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5180809	Spontaneous	2012-01-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Polymyalgia rheumatica (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5180809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5174942	Spontaneous	2012-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Vasculitis (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5174942&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5176975	Spontaneous	2012-01-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site reaction (n/a - Recovering/Resolving - );Lymphadenitis (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5176975&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5174524	Spontaneous	2012-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - Oral])|[ALLOPURINOL] (C - n/a - n/a - [n/a - 150mg - Oral])|[ATENOLOL PH. EUR., CHLORTALIDONE PH. EUR., ATENOLOL, CHLORTALIDONE] (C - n/a - n/a - [n/a - .25{DF} - Oral])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - 20mg - Oral])|[PANTOPRAZOLE] (C - n/a - n/a - [n/a - 20mg - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5174524&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5167667	Spontaneous	2012-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Radiculopathy (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5167667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5171030	Spontaneous	2012-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Feeling cold (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	FLUTICASONE FUROATE [FLUTICASONE FUROATE] (C - n/a - n/a - [n/a - n/a - n/a])|PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 20mg - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - 20mg - n/a])|[SILVER PROTEIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5171030&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5165842	Spontaneous	2012-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Extrasystoles (1a - Recovered/Resolved - Other Medically Important Condition);Sinus bradycardia (1a - Recovered/Resolved - Other Medically Important Condition);Ventricular extrasystoles (1a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5165842&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5166676	Spontaneous	2012-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Urticaria (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	[LOSARTAN KALIUM] (C - n/a - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5166676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5157106	Spontaneous	2012-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Amyotrophic lateral sclerosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[METOPROLOL SUCCINATE, FELODIPINE, METOPROLOL TARTRATE, FELODIPINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5157106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5159034	Spontaneous	2012-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Anal incontinence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation);Localised infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sepsis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[CALCIUM CARBONATE, MAGNESIUM CARBONATE, MAGNESIUM CARBONATE HEAVY, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, BISOPROLOL] (C - n/a - n/a - [n/a - 2.5mg - n/a])|[LORAZEPAM] (C - n/a - n/a - [n/a - 1mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5159034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5159261	Spontaneous	2012-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dermatitis allergic (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (S - n/a - Dose not changed - [n/a - 10mg - Oral])|[BENZALKONIUM CHLORIDE, TUAMINOHEPTANE SULFATE, ACETYLCYSTEINE] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])|[CLOPIDOGREL] (S - n/a - Dose not changed - [n/a - 75mg - Oral])|[METOPROLOL] (S - n/a - Dose not changed - [n/a - 100mg - Oral])|[NICORANDIL] (S - n/a - Dose not changed - [n/a - 20mg - Oral])|[RAMIPRIL] (S - n/a - Dose not changed - [n/a - 5mg - Oral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5159261&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5153156	Spontaneous	2012-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood pressure increased (n/a - Recovered/Resolved - );Erythema (2wk - Not Recovered/Not Resolved - );Hyperhidrosis (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - );Needle issue (n/a - Unknown - );Paraesthesia (n/a - Recovered/Resolved - );Peripheral swelling (2wk - Recovered/Resolved - );Syringe issue (n/a - Unknown - );Vaccination site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5153156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5153157	Spontaneous	2012-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Injection site haemorrhage (n/a - Unknown - );Needle issue (n/a - Unknown - );Skin hypertrophy (4d - Recovered/Resolved - );Syringe issue (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - );Vaccination site induration (n/a - Unknown - );Vaccination site reaction (n/a - Unknown - );Vaccination site swelling (4d - Recovered/Resolved - );Vaccination site warmth (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5153157&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-5148149	Spontaneous	2012-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Breast discomfort (n/a - Unknown - Other Medically Important Condition);Lymph node pain (2wk - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5148149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5148155	Spontaneous	2012-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Rash pruritic (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5148155&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5148160	Spontaneous	2012-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Eye irritation (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Ocular hyperaemia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5148160&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5148752	Spontaneous	2012-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5148752&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5144833	Spontaneous	2012-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Coordination abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Encephalitis post immunisation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (15d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperacusis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Photosensitivity reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (15d - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])...	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[TERBUTALINE SULFATE, TERBUTALINE SULFATE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5144833&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5145123	Spontaneous	2012-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cold sweat (n/a - Recovered/Resolved - Disabling);Diarrhoea (n/a - Recovered/Resolved - Disabling);Hyperpyrexia (2d - Recovered/Resolved - Disabling);Inflammation (n/a - Recovered/Resolved - Disabling);Injected limb mobility decreased (n/a - Recovered/Resolved - Disabling);Injection site inflammation (5d - Recovered/Resolved - Disabling);Myalgia (5d - Recovered/Resolved - Disabling);Vomiting (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [1d - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5145123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5145238	Spontaneous	2012-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	Yes	Male	Sudden death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - 800ug - Unknown])|[BUDESONIDE] (C - n/a - n/a - [n/a - 200ug - Nasal])|[CYPROTERONE ACETATE] (C - n/a - n/a - [n/a - 50mg - Oral])|[GOSERELIN, GOSERELIN ACETATE] (C - n/a - n/a - [n/a - 10.8mg - Subcutaneous])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - Unknown])|[SALMETEROL, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - 50ug - Respiratory (inhalation)])|[TAMSULOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - .4mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5145238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5145924	Spontaneous	2012-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Body temperature increased (0d - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[FELODIPINE, FELODIPINE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5145924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5143928	Spontaneous	2012-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza (n/a - Recovered/Resolved With Sequelae - );Injection site inflammation (5d - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5143928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-5137817	Spontaneous	2012-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Back pain (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Cushingoid (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Deep vein thrombosis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Diabetes mellitus (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Haematoma (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Osteoporosis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Petechiae (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Pulmonary embolism (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Spinal fracture (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Thrombocytopenia (2a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Tongue haemorrhage (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5137817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5138293	Spontaneous	2012-01-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (4d - Recovered/Resolved - Other Medically Important Condition);Rash maculo-papular (4d - Recovered/Resolved - Other Medically Important Condition);Swelling face (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5138293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5140817	Spontaneous	2012-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cervicobrachial syndrome (n/a - Not Recovered/Not Resolved - Disabling);Papillophlebitis (n/a - Not Recovered/Not Resolved - Disabling);Visual acuity reduced (n/a - Not Recovered/Not Resolved - Disabling);Vitritis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5140817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5134350	Spontaneous	2012-01-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (8d - Recovered/Resolved - Other Medically Important Condition);Back pain (8d - Recovered/Resolved - Other Medically Important Condition);Breath sounds abnormal (7d - Not Specified - Other Medically Important Condition);Decreased appetite (8d - Recovered/Resolved - Other Medically Important Condition);Headache (8d - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (8d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (8d - Not Specified - Other Medically Important Condition);Upper respiratory tract infection (8d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5134350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5134353	Spontaneous	2012-01-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Henoch-Schonlein purpura (13d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (13d - Not Specified - Caused/Prolonged Hospitalisation);Petechiae (6d - Not Specified - Caused/Prolonged Hospitalisation);Rash (13d - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5134353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5134453	Spontaneous	2012-01-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Abdominal pain (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Breath sounds abnormal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyskinesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Unknown - Caused/Prolonged Hospitalisation);Nephropathy (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia mycoplasmal (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tonsillar hypertrophy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5134453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5135263	Spontaneous	2012-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Recovered/Resolved - Disabling);Body temperature increased (n/a - Recovered/Resolved - Disabling);Condition aggravated (n/a - Recovering/Resolving - Disabling);Headache (n/a - Recovered/Resolved - Disabling);Injection site erythema (2d - Recovered/Resolved - Disabling);Injection site inflammation (n/a - Recovered/Resolved - Disabling);Injection site oedema (2d - Not Specified - Disabling);Injection site pain (2d - Recovered/Resolved - Disabling);Myalgia (n/a - Recovered/Resolved - Disabling);Pancreatitis relapsing (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])...	[AZITHROMYCIN, AZITHROMYCIN DIHYDRATE] (C - n/a - n/a - [3d - 500mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5135263&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5137099	Spontaneous	2012-01-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site reaction (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5137099&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5134164	Spontaneous	2012-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5134164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5127568	Spontaneous	2012-01-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Erythema (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Skin erosion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5127568&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5127588	Spontaneous	2012-01-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Bronchitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Condition aggravated (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Productive cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rales (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5127588&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5128084	Spontaneous	2012-01-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Headache (4d - Recovered/Resolved - );Pyrexia (4d - Recovered/Resolved - );Upper respiratory tract infection (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5128084&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5128139	Spontaneous	2012-01-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest discomfort (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5128139&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5130008	Spontaneous	2012-01-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Facial paralysis (1.5mo - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[BOPINDOLOL] (C - n/a - n/a - [n/a - n/a - n/a])|[CHLORTALIDONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5130008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5124537	Spontaneous	2012-01-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Diplegia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neurological symptom (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5124537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5124677	Spontaneous	2012-01-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Eczema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site erythema (n/a - Not Specified - Other Medically Important Condition);Injection site inflammation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site swelling (n/a - Not Specified - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [5min - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5124677&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5124742	Spontaneous	2012-01-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Hypersensitivity (7d - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (n/a - Not Specified - Other Medically Important Condition);Injection site nodule (n/a - Not Specified - Other Medically Important Condition);Injection site pain (n/a - Not Specified - Other Medically Important Condition);Injection site pruritus (n/a - Not Specified - Other Medically Important Condition);Injection site reaction (7d - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (n/a - Not Specified - Other Medically Important Condition);Pyrexia (7d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5124742&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5124778	Spontaneous	2012-01-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Coma (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Depressed level of consciousness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dysphoria (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Haematemesis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Muscle twitching (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5124778&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5125162	Spontaneous	2012-01-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Abdominal discomfort (2d - Recovered/Resolved - Other Medically Important Condition);Blood pressure decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (1min - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5125162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5128009	Spontaneous	2012-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Neck pain (23d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5128009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-5121466	Spontaneous	2012-01-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Arrhythmia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperkalaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5121466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5121507	Spontaneous	2012-01-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Heart rate irregular (7h - Recovered/Resolved - Other Medically Important Condition);Malaise (7h - Recovered/Resolved - Other Medically Important Condition);Palpitations (7h - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5121507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5121569	Spontaneous	2012-01-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Kawasaki's disease (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lip erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ocular hyperaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5121569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5122014	Spontaneous	2012-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pseudoradicular syndrome (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5122014&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5122125	Spontaneous	2012-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Adenoidal disorder (n/a - Recovered/Resolved - );Asthenia (n/a - Recovered/Resolved - );Limb discomfort (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5122125&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5124009	Spontaneous	2012-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Neutropenia (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Skin necrosis (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Staphylococcal sepsis (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - n/a - Subcutaneous])|[PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (S - Influenza like illness - Drug withdrawn - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5124009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5116743	Spontaneous	2012-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5116743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5116748	Spontaneous	2012-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Dysphonia (10d - Recovered/Resolved - Other Medically Important Condition);Headache (10d - Recovered/Resolved - Other Medically Important Condition);Influenza (10d - Recovered/Resolved - Other Medically Important Condition);Myalgia (10d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5116748&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5116750	Spontaneous	2012-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Asthenia (14d - Recovered/Resolved - Other Medically Important Condition);Headache (14d - Recovered/Resolved - Other Medically Important Condition);Influenza (14d - Recovered/Resolved - Other Medically Important Condition);Malaise (14d - Recovered/Resolved - Other Medically Important Condition);Myalgia (14d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (14d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intradermal])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5116750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5117761	Spontaneous	2012-01-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Injection site reaction (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	[FLUTICASONE PROPIONATE] (C - n/a - Unknown - [n/a - 50ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5117761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5117841	Spontaneous	2012-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5117841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-5118443	Spontaneous	2012-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5118443&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5120130	Spontaneous	2012-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (n/a - Unknown - );Rash (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5120130&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5120142	Spontaneous	2012-01-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Fatigue (n/a - Recovering/Resolving - );Feeling hot (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5120142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5120932	Spontaneous	2012-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Epiglottic oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5120932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5110073	Spontaneous	2012-01-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastrointestinal disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuropathy peripheral (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Sensory loss (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5110073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5110074	Spontaneous	2012-01-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic shock (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Blood pressure decreased (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypertension (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Myocardial necrosis marker increased (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pulse abnormal (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5110074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5110205	Spontaneous	2012-01-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Pneumonia aspiration (0d - Fatal - Results in Death);Pyrexia (0d - Fatal - Results in Death);Tachypnoea (0d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])|[CARBOCISTEINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5110205&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5110208	Spontaneous	2012-01-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Asthenia (0d - Fatal - Results in Death);Bradycardia (0d - Fatal - Results in Death);Chest pain (0d - Fatal - Results in Death);Hyperkalaemia (0d - Fatal - Results in Death);Sinus node dysfunction (0d - Fatal - Results in Death);Vomiting (0d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	DIBENZOTHIAZEPINE [NOT AVAILABLE] (C - Dementia - n/a - [n/a - n/a - n/a])|[AMILORIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[BISACODYL] (C - n/a - n/a - [n/a - n/a - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DORZOLAMIDE, DORZOLAMIDE HYDROCHLORIDE] (C - Glaucoma - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[TIMOLOL, TIMOLOL MALEATE] (C - Glaucoma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5110208&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5110461	Spontaneous	2012-01-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cardiac arrest (0d - Fatal - Results in Death);Circulatory collapse (0d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	CLOPIDOGREL [CLOPIDOGREL, CLOPIDOGREL BESILATE] (C - Myocardial infarction - n/a - [n/a - n/a - n/a])|GLIBENCLAMIDE [GLIBENCLAMIDE] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - Myocardial infarction - n/a - [n/a - n/a - n/a])|[CAPTOPRIL] (C - Myocardial infarction - n/a - [n/a - n/a - n/a])|[CARVEDILOL] (C - Myocardial infarction - n/a - [n/a - n/a - n/a])|[FAMOTIDINE] (C - n/a - n/a - [n/a - n/a - n/a])|[LORAZEPAM] (C - Schizophrenia - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - n/a - n/a])|[SODIUM VALPROATE] (C - Schizophrenia - n/a - [n/a - n/a - n/a])|[ZIPRASIDONE] (C - Schizophrenia - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5110461&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5115256	Spontaneous	2012-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling abnormal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5115256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5101943	Spontaneous	2012-01-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Eye swelling (n/a - Unknown - Other Medically Important Condition);Injection site cellulitis (n/a - Unknown - Other Medically Important Condition);Injection site inflammation (n/a - Unknown - Other Medically Important Condition);Oedema peripheral (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Swelling face (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5101943&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5102203	Spontaneous	2012-01-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Drooling (n/a - Unknown - Other Medically Important Condition);Eyelid disorder (n/a - Unknown - Other Medically Important Condition);Facial paralysis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5102203&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5102550	Spontaneous	2012-01-03 00:00:00	Healthcare Professional	European Economic Area	Medicine and Science; Marianne Bergsaker; 21; 2006; Vaccination against influenza, why, for whom and with which vaccine? Bergsaker Marianne, Hungnes Olav, Iversen Bjorn. Vaccination against influenza--why, for whom and with which vaccine?. Tidsskr Nor Laegeforen 02-NOV-2006:2814-2817.	65-85 Years	Elderly	No	Female	Blood pressure abnormal (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Cardiac arrest (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5102550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5113181	Spontaneous	2012-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Drug reaction with eosinophilia and systemic symptoms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hepatitis cholestatic (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[AMOXICILLIN SODIUM, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5113181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5113462	Spontaneous	2012-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Encephalitis post immunisation (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	[TOLTERODINE L-TARTRATE, TOLTERODINE TARTRATE] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5113462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5106514	Spontaneous	2011-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Bursitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cervicobrachial syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Epicondylitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5106514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5106568	Spontaneous	2011-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Urticaria (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5106568&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5095983	Spontaneous	2011-12-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Lethargy (3wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Skin exfoliation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[FEXOFENADINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5095983&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5103373	Spontaneous	2011-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	LANTUS [INSULIN GLARGINE] (C - Diabetes mellitus - Dose not changed - [n/a - 22[iU] - Subcutaneous])|[FLUINDIONE] (C - Ischaemic cardiomyopathy - Dose not changed - [n/a - .5{DF} - Oral])|[FUROSEMIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Dose not changed - [n/a - 1{DF} - Oral])|[LOXAPINE SUCCINATE] (C - Mental disorder - Dose not changed - [n/a - 1{DF} - Oral])|[POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ETHYLCELLULOSE MICROENCAPSULATED 80-90%] (C - Hypokalaemia - Dose not changed - [n/a - 600mg - Oral])|[TIANEPTINE, TIANEPTINE SODIUM] (C - Depression - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5103373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5092451	Spontaneous	2011-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Infant	No	Male	Erysipelas (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Not Specified - Other Medically Important Condition);Induration (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5092451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5094736	Spontaneous	2011-12-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hyperaemia (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Mycoplasma infection (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tonsillar hypertrophy (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tonsillitis (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5094736&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5094745	Spontaneous	2011-12-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Nasal congestion (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngeal erythema (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tonsillar disorder (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5094745&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5095484	Spontaneous	2011-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Limb discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Muscle contracture (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5095484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5091212	Spontaneous	2011-12-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5091212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5091223	Spontaneous	2011-12-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cough (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5091223&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5091414	Spontaneous	2011-12-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Cyanosis (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5091414&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5091426	Spontaneous	2011-12-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Diplopia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Motor neurone disease (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Quadriplegia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5091426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5087121	Spontaneous	2011-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Angioedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Face oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5087121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5088102	Spontaneous	2011-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Purpura (229d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (229d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5088102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5090042	Spontaneous	2011-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5090042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5082402	Spontaneous	2011-12-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Generalised tonic-clonic seizure (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5082402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5082413	Spontaneous	2011-12-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperaemia (4d - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (4d - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[ENALAPRIL, ENALAPRIL MALEATE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[ISOSORBIDE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[METOPROLOL, METOPROLOL TARTRATE] (C - Ischaemic cardiomyopathy - n/a - [n/a - n/a - Unknown])|[PENTOXIFYLLINE] (C - Ischaemic cardiomyopathy - n/a - [n/a - n/a - Unknown])|[PRAVASTATIN, PRAVASTATIN SODIUM] (C - Hypertension - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5082413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5082426	Spontaneous	2011-12-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Muscular weakness (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5082426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5082696	Spontaneous	2011-12-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Electrocardiogram abnormal (2wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myopericarditis (2wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Troponin T increased (2wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5082696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5085454	Spontaneous	2011-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Muscle tightness (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - n/a])	[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5085454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5085995	Spontaneous	2011-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Coma (n/a - Fatal - Results in Death)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	COAPROVEL 150 MG/12.5 MG FILM-COATED TABLETS [HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - n/a - Unknown - [n/a - n/a - Oral])|HUMALOG 100 U/ML SOLUTION FOR INJECTION IN CARTRIDGE [INSULIN LISPRO] (C - n/a - Unknown - [n/a - n/a - Subcutaneous])|RASILEZ 150 MG FILM-COATED TABLETS [ALISKIREN] (C - n/a - Unknown - [n/a - n/a - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Oral])|[METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - n/a - Oral])|[NIFEDIPINE] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5085995&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5086018	Spontaneous	2011-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Arthralgia (n/a - Recovering/Resolving - );Eczema (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5086018&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5086020	Spontaneous	2011-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Prurigo (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5086020&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5086022	Spontaneous	2011-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Cystitis (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5086022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5086830	Spontaneous	2011-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cutaneous vasculitis (24d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5086830&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5078892	Spontaneous	2011-12-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Increased tendency to bruise (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Menometrorrhagia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Petechiae (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	ORAL ANTICONCEPTIVES [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5078892&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5079038	Spontaneous	2011-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5079038&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5079047	Spontaneous	2011-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Dysgeusia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Not Specified - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Specified - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, ACETYLSALICYLIC ACID, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - Unknown])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - Unknown])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - Unknown])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5079047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5081519	Spontaneous	2011-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	[FLUTICASONE PROPIONATE] (C - Asthma - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5081519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5081569	Spontaneous	2011-12-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dizziness (n/a - Recovered/Resolved - );Muscular weakness (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5081569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5082337	Spontaneous	2011-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Acute hepatic failure (n/a - Recovering/Resolving - Life Threatening);Acute kidney injury (n/a - Recovering/Resolving - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	LEVOFLOXACIN [LEVOFLOXACIN] (C - n/a - n/a - [n/a - 500mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5082337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-5077383	Spontaneous	2011-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypersensitivity vasculitis (n/a - Recovering/Resolving - Other Medically Important Condition);Purpura (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	MICARDIS [TELMISARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[ETHYL LOFLAZEPATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPRANOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5077383&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5070154	Spontaneous	2011-12-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site erythema (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5070154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5070167	Spontaneous	2011-12-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Loss of consciousness (5s - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[DIPHTHERIA TOXOID, TETANUS TOXOID] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5070167&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5070534	Spontaneous	2011-12-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Quadriplegia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5070534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5073461	Spontaneous	2011-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amnestic disorder (21h - Recovered/Resolved - Other Medically Important Condition);Disorientation (18h - Recovered/Resolved - Other Medically Important Condition);Transient global amnesia (21h - Recovered/Resolved - Other Medically Important Condition);Transient ischaemic attack (n/a - Unknown - Other Medically Important Condition);Victim of abuse (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 40mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5073461&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5068244	Spontaneous	2011-12-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cutaneous vasculitis (9d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nephropathy (2wk - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyelonephritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ACENOCOUMAROL] (C - n/a - n/a - [n/a - 1mg - Oral])|[ALLOPURINOL] (C - n/a - n/a - [n/a - 100mg - Oral])|[DILTIAZEM, DILTIAZEM HYDROCHLORIDE] (C - n/a - n/a - [n/a - 90mg - Oral])|[LISINOPRIL, LISINOPRIL ANHYDROUS, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - 10mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 850mg - Oral])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - 20mg - Oral])|[TORASEMIDE, TORASEMIDE SODIUM] (C - n/a - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5068244&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5068567	Spontaneous	2011-12-16 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository BAO H, LI L, WU W. Literature Review on Adverse Events Following Immunization for Influenza Virus Vaccine. China Academie Journal Electronic Publishing House 2010;547-553.	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5068567&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5068570	Spontaneous	2011-12-16 00:00:00	Healthcare Professional	Non European Economic Area	BAO H, LI L, WU W. Literature Review on Adverse Events Following Immunization for Influenza Virus Vaccine. China Academie Journal Electronic Publishing House 2010;547-553.	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5068570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5068812	Spontaneous	2011-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Pericarditis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[METFORMIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 850mg - Oral])|[SIMVASTATIN, EZETIMIBE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5068812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5062855	Spontaneous	2011-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Herpes zoster (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5062855&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-5062862	Spontaneous	2011-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Upper respiratory tract infection (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5062862&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5062910	Spontaneous	2011-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Migraine (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5062910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5062925	Spontaneous	2011-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Eczema (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Unknown - [n/a - 1{DF} - Intramuscular])	[FUROSEMIDE] (C - n/a - Unknown - [n/a - 20mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 850mg - Oral])|[METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - 200mg - Oral])|[NIFEDIPINE] (C - n/a - Unknown - [n/a - 30mg - Oral])|[QUINAPRIL] (C - n/a - Unknown - [n/a - 20mg - Oral])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5062925&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5065295	Spontaneous	2011-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Cough (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5065295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5065316	Spontaneous	2011-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Lymphadenopathy (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5065316&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5065890	Spontaneous	2011-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Bronchial disorder (n/a - Unknown - Other Medically Important Condition);Cough (21d - Recovered/Resolved - Other Medically Important Condition);Fatigue (21d - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (21d - Recovered/Resolved - Other Medically Important Condition);Lymphopenia (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (21d - Recovered/Resolved - Other Medically Important Condition);Pain (21d - Recovered/Resolved - Other Medically Important Condition);Pharyngeal disorder (21d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Sleep disorder (21d - Recovered/Resolved - Other Medically Important Condition);Viral infection (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5065890&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-5066311	Spontaneous	2011-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Haemolytic anaemia (n/a - Unknown - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[FUROSEMIDE, SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL TARTRATE, METOPROLOL TARTRATE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5066311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-5058586	Spontaneous	2011-12-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Angioedema (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Breath sounds abnormal (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Dysphagia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Undersensing (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Vertigo (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Wheezing (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5058586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5058588	Spontaneous	2011-12-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Angioedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation);Face oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Laryngeal oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Swelling of eyelid (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	LANTUS [INSULIN GLARGINE] (C - n/a - n/a - [n/a - n/a - n/a])|LYRICA [PREGABALIN] (C - n/a - n/a - [n/a - n/a - n/a])|[BROTIZOLAM] (C - n/a - n/a - [n/a - n/a - n/a])|[CALCIUM CITRATE, FERROUS CITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[INSULIN, INSULIN HUMAN] (C - n/a - n/a - [n/a - n/a - n/a])|[LACTULOSE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5058588&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5058589	Spontaneous	2011-12-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypertension (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sinus tachycardia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[SODIUM CHLORIDE] (C - n/a - n/a - [n/a - 500mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5058589&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5050166	Spontaneous	2011-12-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blood pressure increased (1d - Recovered/Resolved - Disabling);Cerebral disorder (1d - Recovered/Resolved - Disabling);Fatigue (1d - Recovered/Resolved - Disabling);Hypertonia (1d - Recovered/Resolved - Disabling);Hypoaesthesia (1d - Recovered/Resolved - Disabling);Monoplegia (1d - Recovered/Resolved - Disabling);Paraesthesia (1d - Recovered/Resolved - Disabling);Speech disorder (1d - Recovered/Resolved - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5050166&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5052228	Spontaneous	2011-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5052228&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5052229	Spontaneous	2011-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[BECLOMETASONE DIPROPIONATE] (C - n/a - Unknown - [n/a - 100ug - Respiratory (inhalation)])|[SALBUTAMOL] (C - n/a - Unknown - [n/a - 100ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5052229&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5052230	Spontaneous	2011-12-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Respiratory tract infection (n/a - Recovered/Resolved With Sequelae - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[HYDROCHLOORTHIAZIDE] (C - Prophylaxis - Unknown - [n/a - 12.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5052230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-5048903	Spontaneous	2011-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Pneumonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5048903&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5044911	Spontaneous	2011-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Malaise (n/a - Recovered/Resolved - );Musculoskeletal stiffness (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5044911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5044916	Spontaneous	2011-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Injection site erythema (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Unknown - [n/a - n/a - Intramuscular])	LUMIGAN 0.3 MG/ML EYE DROPS SOLUTION [BIMATOPROST] (C - n/a - Unknown - [n/a - 1[drp] - Ophthalmic])|NOVOMIX 30 PENFILL 100 U/ML SUSPENSION FOR INJECTION IN A CARTRIDGE [INSULIN ASPART, INSULIN ASPART PROTAMINE] (C - Diabetes mellitus - Unknown - [n/a - n/a - Subcutaneous])|[ALLOPURINOL] (C - n/a - Unknown - [n/a - 300mg - Oral])|[AMLODIPINE BESILAAT] (C - n/a - Unknown - [n/a - 5mg - Oral])|[ATORVASTATIN] (C - Cardiovascular disorder - Unknown - [n/a - 10mg - Oral])|[HYDROCHLOORTHIAZIDE, TRIAMTEREEN] (C - Cardiovascular disorder - Unknown - [n/a - 1{DF} - Oral])|[METOPROLOL TARTRATE] (C - Cardiovascular disorder - Unknown - [n/a - 100mg - Oral])|[VALSARTAN] (C - n/a - Unknown - [n/a - 80mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5044916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5045639	Spontaneous	2011-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Neuropathy peripheral (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5045639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5041610	Spontaneous	2011-12-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Influenza like illness (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5041610&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5041878	Spontaneous	2011-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5041878&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5041883	Spontaneous	2011-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5041883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5037665	Spontaneous	2011-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site warmth (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5037665&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5038402	Spontaneous	2011-12-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Pharyngitis (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5038402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5038421	Spontaneous	2011-12-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Influenza like illness (n/a - Recovered/Resolved With Sequelae - );Injection site pain (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5038421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-5038424	Spontaneous	2011-12-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (3wk - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5038424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5036077	Spontaneous	2011-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5036077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5035693	Spontaneous	2011-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Intracranial pressure increased (n/a - Recovered/Resolved - Disabling);Papilloedema (n/a - Recovered/Resolved - Disabling);Visual acuity reduced (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5035693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5035752	Spontaneous	2011-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza like illness (21d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5035752&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-5032520	Spontaneous	2011-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Lymphadenopathy (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[CLARITROMYCINE] (C - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5032520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5032521	Spontaneous	2011-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (1wk - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5032521&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5032522	Spontaneous	2011-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovering/Resolving - );Injection site pain (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5032522&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5032524	Spontaneous	2011-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Pain (12d - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5032524&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5032525	Spontaneous	2011-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Diarrhoea (3d - Recovered/Resolved - );Headache (3d - Recovered/Resolved - );Musculoskeletal stiffness (3d - Recovered/Resolved - );Pyrexia (3d - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	APROVEL 150 MG FILM-COATED TABLETS [IRBESARTAN] (C - Hypertension - Unknown - [n/a - 150mg - Oral])|[ATORVASTATIN] (C - n/a - Unknown - [n/a - 40mg - Oral])|[HYDROCHLOORTHIAZIDE] (C - Hypertension - Unknown - [n/a - 12.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5032525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5032538	Spontaneous	2011-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Nasopharyngitis (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5032538&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5029561	Spontaneous	2011-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Headache (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5029561&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5029578	Spontaneous	2011-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Respiratory tract infection (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5029578&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5029583	Spontaneous	2011-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Headache (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5029583&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5029584	Spontaneous	2011-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5029584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5029589	Spontaneous	2011-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Injection site pain (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5029589&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5022997	Spontaneous	2011-11-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myocardial infarction (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5022997&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5024924	Spontaneous	2011-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Injection site inflammation (48h - Recovered/Resolved - );Malaise (48h - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5024924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5024931	Spontaneous	2011-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site discolouration (n/a - Recovered/Resolved With Sequelae - );Injection site inflammation (n/a - Recovered/Resolved With Sequelae - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5024931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-5024943	Spontaneous	2011-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5024943&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5024944	Spontaneous	2011-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Adolescent	Yes	Male	Malaise (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5024944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5025294	Spontaneous	2011-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Pneumonia (n/a - Fatal - Results in Death);Pyrexia (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5025294&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5025414	Spontaneous	2011-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Shock (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5025414&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5019230	Spontaneous	2011-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Bone pain (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Sensory disturbance (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5019230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5020459	Spontaneous	2011-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Feeling cold (24h - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5020459&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5020460	Spontaneous	2011-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Haematoma (7d - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5020460&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-5020463	Spontaneous	2011-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Injection site inflammation (1wk - Recovered/Resolved - )	INTANZA 15 MICROGRAM/STRAIN [A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Prophylaxis - n/a - [n/a - 15ug - Intradermal])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5020463&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5020464	Spontaneous	2011-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (1wk - Recovered/Resolved - )	INTANZA 15 MICROGRAM/STRAIN [A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Prophylaxis - Not applicable - [n/a - 15ug - Intradermal])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5020464&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5020466	Spontaneous	2011-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Bursitis (n/a - Recovering/Resolving - );Periarthritis (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - Unknown - [n/a - 20mg - Oral])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - Unknown - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5020466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5020468	Spontaneous	2011-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5020468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5020472	Spontaneous	2011-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - );Presyncope (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5020472&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5020473	Spontaneous	2011-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Malaise (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5020473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5020482	Spontaneous	2011-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5020482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5017458	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dizziness (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - );Syncope (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[TEMAZEPAM] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-5017466	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Malaise (n/a - Not Recovered/Not Resolved - );Muscular weakness (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ANHYDROUS LEVOTHYROXINE SODIUM, LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - n/a - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5017467	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5017468	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Neuralgia (n/a - Recovered/Resolved With Sequelae - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-5017470	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (4d - Recovered/Resolved - );Malaise (1d - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5017471	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017471&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5017473	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Fatigue (n/a - Unknown - );Myalgia (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5017474	Spontaneous	2011-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dehydration (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved With Sequelae - );Vomiting (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	[LITHIUM CARBONATE] (C - n/a - Unknown - [n/a - 800mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-5017476	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Pruritus (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5017477	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5017478	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Rhinorrhoea (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[ALLOPURINOL] (C - Gout - Unknown - [n/a - 400mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5017479	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Arthralgia (n/a - Not Recovered/Not Resolved - );Dysgeusia (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017479&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-5017482	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	MICARDIS 80 MG TABLETS [TELMISARTAN] (C - Hypertension - Unknown - [n/a - 80mg - Oral])|[HYDROCHLOORTHIAZIDE] (C - Hypertension - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5017483	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5017484	Spontaneous	2011-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Abdominal discomfort (n/a - Recovering/Resolving - );Haematochezia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])|[METHYLPHENIDATE] (C - n/a - Unknown - [n/a - 30mg - Oral])|[MIRTAZAPINE] (C - n/a - Unknown - [n/a - 60mg - Oral])|[OMEPRAZOLE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[QUETIAPINE FUMARATE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5014755	Spontaneous	2011-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Hepatitis toxic (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	COAPROVEL 300 MG/12.5 MG FILM-COATED TABLETS [HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|FOSAVANCE 70 MG/2800 IU TABLETS [ALENDRONIC ACID, COLECALCIFEROL, COLECALCIFEROL, ALENDRONATE SODIUM TRIHYDRATE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - Unknown - [n/a - 20mg - Oral])|[CARBASALATE CALCIUM] (C - n/a - Unknown - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5014755&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5014757	Spontaneous	2011-11-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Influenza like illness (1wk - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	[MIZOLASTINE] (C - Hypersensitivity - Unknown - [n/a - 1{DF} - Oral])|[OMEPRAZOLE] (C - Gastrooesophageal reflux disease - Unknown - [n/a - 1{DF} - Oral])|[UNKNOWN] (C - Blood pressure increased - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5014757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5014759	Spontaneous	2011-11-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site reaction (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5014759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5014761	Spontaneous	2011-11-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site reaction (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5014761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5014762	Spontaneous	2011-11-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5014762&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5015142	Spontaneous	2011-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Febrile bone marrow aplasia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5015142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5015147	Spontaneous	2011-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Drug-induced liver injury (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[DEXTROPROPOXYPHENE HYDROCHLORIDE, PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5015147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5011074	Spontaneous	2011-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Oral])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Oral])	CYMBALTA 30 MG HARD GASTRO-RESISTANT CAPSULES [DULOXETINE, DULOXETINE HYDROCHLORIDE] (C - Musculoskeletal pain - Dose not changed - [n/a - 30mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5011074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5011075	Spontaneous	2011-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Injection site inflammation (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE] (C - Asthma - Unknown - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5011075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5006746	Spontaneous	2011-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Rash pruritic (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5006746&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5006751	Spontaneous	2011-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Rhinitis (3mo - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[UNKNOWN] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5006751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5006757	Spontaneous	2011-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Dizziness (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5006757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5006758	Spontaneous	2011-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Urticaria (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5006758&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5006759	Spontaneous	2011-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5006759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5006764	Spontaneous	2011-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Abdominal pain (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5006764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5003237	Spontaneous	2011-11-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Blood glucose increased (n/a - Recovered/Resolved - );Influenza like illness (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5003237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5003257	Spontaneous	2011-11-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Neuralgia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5003257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5003258	Spontaneous	2011-11-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Ear pain (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Pharyngitis (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5003258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5003270	Spontaneous	2011-11-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Chills (n/a - Recovered/Resolved - );Injection site reaction (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5003270&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5003597	Spontaneous	2011-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5003597&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4999824	Spontaneous	2011-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site reaction (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4999824&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4994148	Spontaneous	2011-11-17 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Allergy to vaccine (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest discomfort (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4994148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4994181	Spontaneous	2011-11-17 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Allergy to vaccine (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperventilation (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thyroid disorder (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ATENOLOL, ATENOLOL BP] (C - Tachycardia - n/a - [n/a - n/a - Oral])|[THIAMAZOLE] (C - Hyperthyroidism - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4994181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4996577	Spontaneous	2011-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Pyrexia (18h - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	[ACENOCOUMAROL] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[ALLOPURINOL] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[BUMETANIDE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])|[POTASSIUM CHLORIDE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[SPIRONOLACTON] (C - n/a - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4996577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4996578	Spontaneous	2011-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Listless (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4996578&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4996579	Spontaneous	2011-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Nasopharyngitis (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4996579&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4996580	Spontaneous	2011-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4996580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4990565	Spontaneous	2011-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hemiparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4990565&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4993206	Spontaneous	2011-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Myalgia (9d - Recovered/Resolved - );Rash (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4993206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4993207	Spontaneous	2011-11-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	[AZATHIOPRINE] (C - Crohn's disease - Unknown - [n/a - 150mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4993207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4993209	Spontaneous	2011-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site reaction (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4993209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4990137	Spontaneous	2011-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Loss of consciousness (2wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (2wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sepsis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[AMLODIPINE BESILATE, PERINDOPRIL ARGININE, AMLODIPINE, PERINDOPRIL] (C - Hypertension - n/a - [n/a - 5mg - n/a])|[METFORMIN EMBONATE] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[PRAVASTATIN SODIUM] (C - Blood cholesterol - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4990137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4984248	Spontaneous	2011-11-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Sudden death (0d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	CLOPIDOGREL [CLOPIDOGREL, CLOPIDOGREL BESILATE] (C - Coronary angioplasty - n/a - [n/a - n/a - n/a])|LANTUS [INSULIN GLARGINE] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - Coronary angioplasty - n/a - [n/a - 100mg - n/a])|[ATENOLOL, ATENOLOL BP] (C - Hypertension - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[PRAVASTATIN, PRAVASTATIN SODIUM] (C - Hyperlipidaemia - n/a - [n/a - 20mg - n/a])|[STERCULIA, STERCULIA GUM, STERCULIA URENS ROXB. GUM] (C - n/a - n/a - [n/a - 50mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4984248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4984254	Spontaneous	2011-11-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Chest pain (0d - Fatal - Results in Death);Fall (0d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	VIAGRA [SILDENAFIL, SILDENAFIL CITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4984254&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4984276	Spontaneous	2011-11-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arrhythmia (n/a - Fatal - Results in Death);Fall (n/a - Fatal - Results in Death);Haemorrhage intracranial (n/a - Fatal - Results in Death);Head injury (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	BENZODIAZEPINE [NOT AVAILABLE] (C - Sleep disorder - n/a - [n/a - n/a - n/a])|PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - Myocardial ischaemia - n/a - [n/a - 75mg - Oral])|[ACARBOSE] (C - Diabetes mellitus - n/a - [n/a - 100mg - Oral])|[ACETYLSALICYLIC ACID] (C - Myocardial ischaemia - n/a - [n/a - n/a - n/a])|[CLORAZEPATE POTASSIUM] (C - Trigeminal neuralgia - n/a - [n/a - 5mg - n/a])|[ENALAPRIL, ENALAPRIL MALEATE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4984276&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4985620	Spontaneous	2011-11-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Rash pruritic (2d - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	ENBREL 25 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE [ETANERCEPT] (C - Rheumatoid arthritis - Unknown - [n/a - n/a - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4985620&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4985631	Spontaneous	2011-11-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Body temperature increased (2d - Recovered/Resolved - );Injection site inflammation (2d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - );Pain (2d - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4985631&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4977260	Spontaneous	2011-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[DEXTROMETHORPHAN HYDROBROMIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, PARACETAMOL, PARACETAMOL, PARACETAMOL, ACETYLSALICYLIC ACID, CAFFEINE, PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CAFFEINE] (C - n/a - n/a - [n/a - n/a - n/a])|[DRY EXTRACT OF GINKGO BILOBA LEAVES (35-67:1), EXTRACTION SOLVENT: ACETONE 60% ( M / M), GINKGO BILOBA] (C - n/a - n/a - [n/a - n/a - n/a])|[IBUPROFEN, IBUPROFEN LYSINE, IBUPROFEN, HEPARINOID] (C - n/a - n/a - [n/a - n/a - n/a])|[TAMOXIFEN, TAMOXIFEN CITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4977260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4979430	Spontaneous	2011-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CARBASALATE CALCIUM] (C - n/a - Unknown - [n/a - 100mg - Oral])|[METOPROLOL SUCCINATE] (C - n/a - Unknown - [n/a - n/a - Oral])|[MIRTAZAPINE] (C - n/a - Unknown - [n/a - n/a - Oral])|[PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - Unknown - [n/a - n/a - Oral])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4979430&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4979439	Spontaneous	2011-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (4d - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4979439&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4979456	Spontaneous	2011-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4979456&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4979463	Spontaneous	2011-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site reaction (n/a - Recovered/Resolved - );Supraventricular tachycardia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4979463&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4979475	Spontaneous	2011-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Pyrexia (n/a - Recovered/Resolved - );Skin discolouration (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4979475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4979476	Spontaneous	2011-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Fatigue (n/a - Not Recovered/Not Resolved - );Injection site reaction (n/a - Recovering/Resolving - );Myalgia (n/a - Not Recovered/Not Resolved - );Pyrexia (3d - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4979476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4979477	Spontaneous	2011-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4979477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4974373	Spontaneous	2011-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypersensitivity (6d - Recovered/Resolved - Other Medically Important Condition);Pruritus (6d - Recovered/Resolved - Other Medically Important Condition);Swelling face (4d - Recovered/Resolved - Other Medically Important Condition);Urticaria (6d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4974373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4976083	Spontaneous	2011-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pain of skin (n/a - Recovered/Resolved - Other Medically Important Condition);Periorbital swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Skin burning sensation (n/a - Recovered/Resolved - Other Medically Important Condition);Swelling face (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 45ug - n/a])	[INDAPAMIDE, PERINDOPRIL ARGININE] (C - n/a - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4976083&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4976221	Spontaneous	2011-11-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Somnolence (n/a - Not Recovered/Not Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4976221&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4976249	Spontaneous	2011-11-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - );Oedema peripheral (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	[FLUTICASONE PROPIONATE, SALMETEROL] (C - n/a - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4976249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4976327	Spontaneous	2011-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4976327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4972283	Spontaneous	2011-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Stillbirth (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4972283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4970614	Spontaneous	2011-11-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Cardiac failure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4970614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4970640	Spontaneous	2011-11-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved With Sequelae - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4970640&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-4970647	Spontaneous	2011-11-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dizziness (n/a - Recovered/Resolved With Sequelae - );Illness (n/a - Recovered/Resolved With Sequelae - );Pyrexia (n/a - Recovered/Resolved With Sequelae - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4970647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-4970651	Spontaneous	2011-11-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovering/Resolving - );Musculoskeletal stiffness (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4970651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4970652	Spontaneous	2011-11-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site erythema (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4970652&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4970654	Spontaneous	2011-11-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4970654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4967957	Spontaneous	2011-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4967957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4967598	Spontaneous	2011-11-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Injection site swelling (n/a - Recovering/Resolving - );Insomnia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE] (C - n/a - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4967598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4967599	Spontaneous	2011-11-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Insomnia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[BECLOMETASONE DIPROPIONATE] (C - n/a - Unknown - [n/a - 2{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4967599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4967600	Spontaneous	2011-11-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Bronchitis chronic (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4967600&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4961678	Spontaneous	2011-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Lymph node pain (n/a - Recovered/Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site erythema (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4961678&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4964666	Spontaneous	2011-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Pain in extremity (12h - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4964666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4964676	Spontaneous	2011-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site reaction (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4964676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4964679	Spontaneous	2011-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovered/Resolved - );Tachycardia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4964679&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4964681	Spontaneous	2011-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Myalgia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4964681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4960758	Spontaneous	2011-11-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Lymphadenopathy (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[HYDROCHLOORTHIAZIDE] (C - n/a - Dose not changed - [n/a - 12.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4960758&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4960809	Spontaneous	2011-11-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4960809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4960810	Spontaneous	2011-11-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Body temperature increased (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4960810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4960812	Spontaneous	2011-11-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Varicella (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4960812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4960813	Spontaneous	2011-11-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Nasopharyngitis (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4960813&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4954346	Spontaneous	2011-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoglycaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Unresponsive to stimuli (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4954346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4954413	Spontaneous	2011-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4954413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4957234	Spontaneous	2011-11-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4957234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4950705	Spontaneous	2011-10-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Angioedema (3d - Recovered/Resolved - );Dermatitis allergic (3d - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4950705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4946862	Spontaneous	2011-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site reaction (n/a - Recovered/Resolved - );Urticaria (3wk - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4946862&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4946865	Spontaneous	2011-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site reaction (n/a - Recovering/Resolving - );Palpitations (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4946865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4947015	Spontaneous	2011-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest discomfort (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest pain (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Unknown - [n/a - n/a - n/a])	[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4947015&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4947224	Spontaneous	2011-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fasciitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site inflammation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myositis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4947224&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4944358	Spontaneous	2011-10-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dizziness (n/a - Not Recovered/Not Resolved - );Nausea (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4944358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4944364	Spontaneous	2011-10-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4944364&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4937907	Spontaneous	2011-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Diabetes mellitus inadequate control (2mo - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[GLICLAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLIMEPIRIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4937907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4933916	Spontaneous	2011-10-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4933916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4929645	Spontaneous	2011-10-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (30min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Defaecation urgency (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (30min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (30min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site pain (12h - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[METOPROLOL, METOPROLOL TARTRATE] (C - Supraventricular tachycardia - n/a - [n/a - 25mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4929645&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4930220	Spontaneous	2011-10-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Elderly	Yes	Male	Bradycardia (2min - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4930220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4930225	Spontaneous	2011-10-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Hypoaesthesia (5min - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4930225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4926429	Spontaneous	2011-10-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site reaction (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[LISINOPRIL, LISINOPRIL ANHYDROUS, LISINOPRIL DIHYDRATE] (C - n/a - Unknown - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4926429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4920596	Spontaneous	2011-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Behcet's syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Crush syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myelitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4920596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4921011	Spontaneous	2011-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Palpitations (0d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (0d - Recovered/Resolved - Other Medically Important Condition);Rash (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[MENINGOCOCCAL GROUP A, C, W135 AND Y CONJUGATE VACCINE] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4921011&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4921083	Spontaneous	2011-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Injection site cellulitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4921083&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4913463	Spontaneous	2011-10-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bronchospasm (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Wheezing (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4913463&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4913562	Spontaneous	2011-10-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Extrapyramidal disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Parkinsonism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tremor (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4913562&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4911649	Spontaneous	2011-10-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Hepatic enzyme increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Lung infiltration (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4911649&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4908981	Spontaneous	2011-10-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Malaise (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4908981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4905639	Spontaneous	2011-10-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Fontanelle bulging (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Irritability (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Meningitis (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[RETINOL ACETATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4905639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4905667	Spontaneous	2011-10-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (1wk - Recovered/Resolved - Other Medically Important Condition);Influenza (1wk - Recovered/Resolved - Other Medically Important Condition);Pyrexia (1wk - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (1wk - Recovered/Resolved - Other Medically Important Condition);Sneezing (1wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4905667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4906150	Spontaneous	2011-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Inflammation (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - );Paraesthesia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4906150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4892831	Spontaneous	2011-10-06 00:00:00	Healthcare Professional	Non European Economic Area	HSIAO JENG-YUEH. Subacute thyroiditis following influenza vaccine (vaxigrip(r)) in a young female. Kaohsiung journal of medical sciences JUN-2006:22(6):297-300.	18-64 Years	Adult	No	Female	Neck mass (n/a - Not Specified - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Swelling (n/a - Not Specified - Other Medically Important Condition);Thyroiditis subacute (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4892831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4892890	Spontaneous	2011-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Toxic epidermal necrolysis (90d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	XELODA [CAPECITABINE] (S - Breast cancer - Drug withdrawn - [2mo - n/a - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Unknown])|[ALLOPURINOL] (S - Hyperuricaemia - Drug withdrawn - [n/a - n/a - Oral])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|BONDRONAT [IBANDRONIC ACID, IBANDRONIC ACID MONOSODIUM SALT, MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|FASLODEX [FULVESTRANT] (C - n/a - n/a - [n/a - n/a - n/a])|LANTUS [INSULIN GLARGINE] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[BIPERIDEN, BIPERIDEN HYDROCHLORIDE, BIPERIDEN LACTATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DIGOXIN] (C - n/a - n/a - [n/a - n/a - n/a])|[ENOXAPARIN SODIUM] (C - Decubitus ulcer - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[NETILMICIN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PENFLURIDOL] (C - n/a - n/a - [n/a - n/a - n/a])|[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4892890&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4894493	Spontaneous	2011-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Meniere's disease (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neuritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sudden hearing loss (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tinnitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vestibular disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4894493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4892651	Spontaneous	2011-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abnormal faeces (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Ataxia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dysstasia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Electromyogram abnormal (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Micturition urgency (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Phlebitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Polyneuropathy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pulmonary embolism (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4892651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4889122	Spontaneous	2011-10-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Ageusia (n/a - Not Recovered/Not Resolved - );Anosmia (n/a - Not Recovered/Not Resolved - );Tinnitus (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4889122&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4889134	Spontaneous	2011-10-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Bursitis (6mo - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4889134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4883525	Spontaneous	2011-10-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Injection site inflammation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (24h - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4883525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4884073	Spontaneous	2011-10-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Cellulitis (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dehydration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site inflammation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Systemic inflammatory response syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4884073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4884099	Spontaneous	2011-10-03 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Monoplegia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pallor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Quadriplegia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[AMOXICILLIN, AMOXICILLIN TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4884099&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4884211	Spontaneous	2011-10-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Dizziness (10min - Recovered/Resolved - );Illness (10min - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4884211&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4880624	Spontaneous	2011-09-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Burning sensation (2d - Recovered/Resolved - Other Medically Important Condition);Insomnia (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nervousness (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (1mo - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4880624&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4880625	Spontaneous	2011-09-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Burning sensation (2d - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Somnolence (10d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4880625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4880933	Spontaneous	2011-09-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (4d - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Asthenia (7d - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Haematuria (7d - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Injection site pain (2d - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Microangiopathic haemolytic anaemia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[CYPROTERONE ACETATE, ETHINYLESTRADIOL] (C - Contraception - n/a - [4y - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4880933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4880938	Spontaneous	2011-09-30 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Female	Adenovirus infection (n/a - Not Specified - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Herpes simplex (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4880938&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4877201	Spontaneous	2011-09-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Haemorrhagic stroke (0d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE MONOHYDRATE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - Hypertension - n/a - [n/a - 5mg - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - 18ug - n/a])|[WARFARIN, WARFARIN SODIUM] (C - Cardiac valve prosthesis user - n/a - [n/a - 3mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4877201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4878357	Spontaneous	2011-09-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chest pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site pain (8d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4878357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4874060	Spontaneous	2011-09-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Meningitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4874060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4869285	Spontaneous	2011-09-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Fatigue (n/a - Recovered/Resolved - );Pain in extremity (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4869285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4826081	Spontaneous	2011-09-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Contraindication to vaccination (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasal congestion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Viral infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4826081&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4824334	Spontaneous	2011-09-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eosinophilia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	[LORAZEPAM] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[PERINDOPRIL TERT-BUTYLAMINE, INDAPAMIDE] (C - Hypertension - Dose not changed - [n/a - 1{DF} - Oral])|[PRAVASTATIN SODIUM] (C - Dyslipidaemia - Dose not changed - [n/a - 20mg - Oral])|[RABEPRAZOLE SODIUM] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[SOTALOL, SOTALOL HYDROCHLORIDE] (C - Hypertension - Dose not changed - [n/a - 1{DF} - Oral])|[ZOLPIDEM TARTRATE] (C - Insomnia - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4824334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4810575	Spontaneous	2011-09-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Blindness (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (3d - Recovered/Resolved - Disabling);Retinal oedema (n/a - Not Recovered/Not Resolved - Disabling);Strabismus (1d - Recovered/Resolved - Disabling);Vision blurred (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4810575&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4803963	Spontaneous	2011-08-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4803963&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4791506	Spontaneous	2011-08-25 00:00:00	Non Healthcare Professional	Non European Economic Area	Whalen Courtney. Man blames illnesson *flu* shot. The Orillia Packet and Times (ON):A3.	Not Specified	Not Specified	No	Male	Gait inability (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Impaired work ability (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Parenteral nutrition (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4791506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4791817	Spontaneous	2011-08-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Pruritus (10d - Recovered/Resolved - Other Medically Important Condition);Swelling (10d - Recovered/Resolved - Other Medically Important Condition);Urticaria (10d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4791817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4792816	Spontaneous	2011-08-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Pruritus (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4792816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4787037	Spontaneous	2011-08-23 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Male	Inflammation (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4787037&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4777391	Spontaneous	2011-08-18 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Female	Inflammation (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4777391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4763125	Spontaneous	2011-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Deafness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Tinnitus (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4763125&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4763220	Spontaneous	2011-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chest pain (11d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (11d - Recovered/Resolved - Other Medically Important Condition);Pleurisy (11d - Recovered/Resolved - Other Medically Important Condition);Pneumonia (11d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4763220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4763222	Spontaneous	2011-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Muscle spasms (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4763222&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4763333	Spontaneous	2011-08-12 00:00:00	Healthcare Professional	European Economic Area	DE MEESTER A, LUWAERT R, CHAUDRON J. Symptomatic Pericarditis after Influenza vaccination - Report of 2 cases.. CHEST 2000 Jun 06;117:1803-1805.	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pericardial effusion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pericarditis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4763333&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4763340	Spontaneous	2011-08-12 00:00:00	Healthcare Professional	European Economic Area	DE MEESTER A, LUWAERT R, CHAUDRON J. Symptomatic Pericarditis after Influenza vaccination - Report of 2 cases.. CHEST 2000 Jun 06;117:1803-1805.	Not Specified	Adult	No	Male	Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pericarditis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4763340&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4763370	Spontaneous	2011-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4763370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4763384	Spontaneous	2011-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic shock (45min - Recovered/Resolved - Life Threatening);Dyspnoea (45min - Recovered/Resolved - Life Threatening);Face oedema (45min - Recovered/Resolved - Life Threatening);Injection site reaction (n/a - Recovered/Resolved - Life Threatening);Rash (45min - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[NIFEDIPINE] (C - Essential hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4763384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4763421	Spontaneous	2011-08-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Asthma (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Chest pain (3d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cough (4d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cyanosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (2d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (2d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4763421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4763869	Spontaneous	2011-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hyperhidrosis (n/a - Unknown - Disabling);Trigeminal neuralgia (n/a - Unknown - Disabling)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4763869&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4763877	Spontaneous	2011-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Back pain (n/a - Recovered/Resolved - Disabling);Hypoaesthesia (n/a - Recovered/Resolved - Disabling);Induration (n/a - Recovered/Resolved - Disabling);Muscle spasms (n/a - Recovered/Resolved - Disabling);Muscular weakness (n/a - Recovered/Resolved - Disabling);Neuralgia (n/a - Recovered/Resolved - Disabling);Pain (n/a - Recovered/Resolved - Disabling)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4763877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4759364	Spontaneous	2011-08-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Haemorrhage intracranial (n/a - Fatal - Results in Death);Malaise (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	[DIPHTHERIA AND TETANUS TOXOIDS] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4759364&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4759419	Spontaneous	2011-08-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ear discomfort (n/a - Unknown - Disabling);Hypoacusis (n/a - Unknown - Disabling);Tinnitus (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4759419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4759470	Spontaneous	2011-08-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Monoplegia (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Neuritis (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Sensory loss (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4759470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4759473	Spontaneous	2011-08-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lichenification (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seborrhoeic dermatitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	NOVOMIX 30 [INSULIN ASPART, INSULIN ASPART, INSULIN ASPART PROTAMINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 160mg - Oral])|[ALPROSTADIL] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - 1mg - n/a])|[GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - 20mg - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 2.5mg - n/a])|[TERBUTALINE SULFATE] (C - n/a - n/a - [n/a - .25mg - n/a])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 40mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4759473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4759958	Spontaneous	2011-08-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Parosmia (n/a - Not Recovered/Not Resolved - Disabling);Pneumonia (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Sinusitis (n/a - Not Recovered/Not Resolved - Disabling);Taste disorder (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4759958&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4760021	Spontaneous	2011-08-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4760021&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4760057	Spontaneous	2011-08-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic shock (n/a - Recovered/Resolved - Other Medically Important Condition);Brain hypoxia (n/a - Recovered/Resolved - Other Medically Important Condition);Cardio-respiratory arrest (n/a - Recovered/Resolved - Other Medically Important Condition);Cyanosis (n/a - Recovered/Resolved - Other Medically Important Condition);Depressed level of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Dyskinesia (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Feeling cold (n/a - Recovered/Resolved - Other Medically Important Condition);Gaze palsy (n/a - Recovered/Resolved - Other Medically Important Condition);Generalised tonic-clonic seizure (4min - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotonia (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition);Salivary hypersecretion (n/a - Recovered/Resolved - Other Medically Important Condition);Screaming (n/a - Recovered/Resolved - Other Medically Important Condition);Unresponsive to stimuli (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4760057&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4760079	Spontaneous	2011-08-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[PHENYLPROPANOLAMINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4760079&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4758501	Spontaneous	2011-08-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Inflammation (n/a - Recovered/Resolved - );Night sweats (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4758501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4758502	Spontaneous	2011-08-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Paraesthesia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1000{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4758502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4758503	Spontaneous	2011-08-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Blood pressure decreased (n/a - Recovered/Resolved - );Dizziness (n/a - Recovered/Resolved - );Dyspnoea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4758503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4754850	Spontaneous	2011-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Paralysis (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - n/a])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - n/a - n/a - [n/a - 2{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4754850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4746070	Spontaneous	2011-08-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Inflammation (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4746070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4746071	Spontaneous	2011-08-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Abdominal pain (n/a - Recovered/Resolved - );Crying (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4746071&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4726814	Spontaneous	2011-07-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aphasia (n/a - Unknown - Caused/Prolonged Hospitalisation);Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation);Confusional state (n/a - Unknown - Caused/Prolonged Hospitalisation);Disorientation (n/a - Unknown - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Meningism (n/a - Unknown - Caused/Prolonged Hospitalisation);Motion sickness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[URSODEOXYCHOLIC ACID] (C - n/a - n/a - [n/a - 300mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4726814&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4725807	Spontaneous	2011-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (3d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4725807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4725936	Spontaneous	2011-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Coombs positive haemolytic anaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	EBIXA 10 MG FILM-COATED TABLETS [MEMANTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - Oral])|EXELON 9.5 MG/24 H TRANSDERMAL PATCH [RIVASTIGMINE] (C - n/a - n/a - [n/a - 1{DF} - Transdermal])|EXFORGE 5 MG/160 MG FILM-COATED TABLETS [VALSARTAN, AMLODIPINE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|PLAVIX 75 MG FILM-COATED TABLETS [CLOPIDOGREL] (C - n/a - n/a - [n/a - 75mg - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 40mg - Oral])|[CELIPROLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 200mg - Oral])|[CITALOPRAM HYDROBROMIDE] (C - n/a - n/a - [n/a - 20mg - Oral])|[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 75mg - Oral])|[MEPROBAMATE] (C - n/a - n/a - [n/a - 1400mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4725936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4720823	Spontaneous	2011-07-26 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Vaginal haemorrhage (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4720823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4704717	Spontaneous	2011-07-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4704717&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4684112	Spontaneous	2011-07-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (7mo - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4684112&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4681750	Spontaneous	2011-07-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Erythema multiforme (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4681750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4677051	Spontaneous	2011-07-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Dermatitis allergic (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4677051&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4675634	Spontaneous	2011-07-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4675634&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4670024	Spontaneous	2011-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4670024&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4671763	Spontaneous	2011-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Application site scar (n/a - Recovered/Resolved - );Erysipelas (n/a - Recovered/Resolved - );Inflammation (n/a - Recovered/Resolved - );Injected limb mobility decreased (n/a - Recovered/Resolved - );Injection site vesicles (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Swelling (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4671763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4668789	Spontaneous	2011-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Unknown - Other Medically Important Condition);Formication (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4668789&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4668895	Spontaneous	2011-07-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Listless (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - Myocardial infarction - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Hypertension - n/a - [n/a - 5mg - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Type 2 diabetes mellitus - n/a - [n/a - 850mg - n/a])|[PRAVASTATIN SODIUM] (C - Hypercholesterolaemia - n/a - [n/a - 40mg - n/a])|[RAMIPRIL] (C - Hypertension - n/a - [n/a - 10mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4668895&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4662850	Spontaneous	2011-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);C-reactive protein increased (n/a - Recovered/Resolved - Other Medically Important Condition);Leukocytosis (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Sinusitis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4662850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4659309	Spontaneous	2011-06-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Giant cell arteritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	APROVEL [IRBESARTAN] (C - n/a - n/a - [n/a - 75mg - n/a])|[FLUVASTATIN, FLUVASTATIN SODIUM] (C - n/a - n/a - [n/a - 80mg - n/a])|[PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - 1g - n/a])|[PIROXICAM] (C - n/a - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4659309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4659346	Spontaneous	2011-06-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angina pectoris (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cardiac failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4659346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4659349	Spontaneous	2011-06-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypoacusis (n/a - Recovered/Resolved With Sequelae - Disabling);Tinnitus (n/a - Unknown - Disabling);Vestibular neuronitis (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4659349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-4653727	Spontaneous	2011-06-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Stillbirth (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4653727&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4650747	Spontaneous	2011-06-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Condition aggravated (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lymphadenopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Meningism (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nerve compression (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rhinorrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sinusitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Toothache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4650747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4650810	Spontaneous	2011-06-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Cellulitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Induration (n/a - Unknown - Caused/Prolonged Hospitalisation);Oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4650810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4650846	Spontaneous	2011-06-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Decreased appetite (n/a - Recovering/Resolving - Other Medically Important Condition);Dehydration (n/a - Recovering/Resolving - Other Medically Important Condition);Lethargy (n/a - Recovering/Resolving - Other Medically Important Condition);Listless (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4650846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4639994	Spontaneous	2011-06-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypoaesthesia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4639994&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4629249	Spontaneous	2011-06-23 00:00:00	Healthcare Professional	Non European Economic Area	Chou Cheng-Hsiu, Liou Wen-Ping, Hu Kun-I, Loh Ching-Hui, Chou Chih-Chieh, Chen Yeong-Hwang. Bell&apos;s palsy associated with influenza vaccination: two case reports. Vaccine 2007:ELSEVIER:2839-2841.	18-64 Years	Adult	No	Male	Bell's palsy (n/a - Unknown - Other Medically Important Condition);Facial nerve disorder (n/a - Unknown - Other Medically Important Condition);Facial paralysis (n/a - Unknown - Other Medically Important Condition);Facial paresis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4629249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4633068	Spontaneous	2011-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Local reaction (n/a - Not Recovered/Not Resolved - Disabling);Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4633068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4625799	Spontaneous	2011-06-22 00:00:00	Healthcare Professional	Non European Economic Area	LIU CY, KAO CD, CHEN JT, YEH YS, WU ZA, LIAO KK. HYDROCEPHALUS ASSOCIATED WITH GUILLAIN-BARRE SYNDROME. JOURNAL OF CLINICAL NEUROSCIENCE 2006;13:866-869. Chih-Yang Liu, Chuen-Der Kao, Jen-Tse Chen, Yu-Shu Yeh, Zin-An Wu, Kwong-Kum Liao. Hydrocephalus associated with Guillain-Barre syndrome. Journal of Clinical Neuroscience 2006:13:866-869.	65-85 Years	Elderly	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hydrocephalus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4625799&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4621183	Spontaneous	2011-06-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	H1N1 influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4621183&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4609894	Spontaneous	2011-06-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dyspnoea (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Rash erythematous (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Vasculitis (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	JANUMET [METFORMIN HYDROCHLORIDE, SITAGLIPTIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[FENOFIBRATE, FENOFIBRATE MICRONISED] (C - Hypertension - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, TELMISARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - Asthma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4609894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4608640	Spontaneous	2011-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	Yes	Female	Sarcoidosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4608640&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4608936	Spontaneous	2011-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Haemophagocytic lymphohistiocytosis (n/a - Not Recovered/Not Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4608936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4609028	Spontaneous	2011-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Eye pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Papilloedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual acuity reduced (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4609028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4604012	Spontaneous	2011-06-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - Oral])|[DOXAZOSIN, DOXAZOSIN MESILATE] (C - n/a - n/a - [n/a - n/a - Oral])|[HYDROCHLOROTHIAZIDE, RAMIPRIL] (C - n/a - n/a - [n/a - n/a - Oral])|[METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4604012&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4604075	Spontaneous	2011-06-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4604075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4594241	Spontaneous	2011-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])|[RIFAXIMIN] (S - Diverticulitis - n/a - [n/a - 200mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4594241&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4594291	Spontaneous	2011-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4594291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4594453	Spontaneous	2011-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dermatitis contact (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4594453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4584580	Spontaneous	2011-06-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Infant	No	Male	Influenza (5d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4584580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4570899	Spontaneous	2011-05-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hepatitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - n/a])	[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4570899&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4567160	Spontaneous	2011-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Immune system disorder (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4567160&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4568553	Spontaneous	2011-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[ACETYLSALICYLZUUR] (C - n/a - Dose not changed - [n/a - 80mg - Oral])|[DIPYRIDAMOLE] (C - n/a - Dose not changed - [n/a - 150mg - Oral])|[ENALAPRIL WATERSTOFMALEAAT] (C - n/a - Dose not changed - [n/a - 20mg - Oral])|[HYDROCHLOORTHIAZIDE] (C - n/a - Dose not changed - [n/a - 12.5mg - Oral])|[HYDROXOCOBALAMINE HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 1mg - Intramuscular])|[SIMVASTATIN] (C - n/a - Dose not changed - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4568553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4559940	Spontaneous	2011-05-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4559940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4562221	Spontaneous	2011-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cerebral haemorrhage (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hemiparesis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza - Unknown - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4562221&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4555965	Spontaneous	2011-05-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Cyanosis (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eye movement disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Generalised tonic-clonic seizure (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Staring (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4555965&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4551271	Spontaneous	2011-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Facial paralysis (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4551271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4548214	Spontaneous	2011-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Choking sensation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4548214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4544364	Spontaneous	2011-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dysarthria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[HEPATITIS B SURFACE ANTIGEN, HEPATITIS A VACCINE (INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[MENINGOCOCCAL GROUP A, C, W135 AND Y CONJUGATE VACCINE, N. MENINGITIDIS GROUP C POLYSACCHARIDE, N. MENINGITIDIS GROUP Y POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE, N. MENINGITIDIS GROUP C POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP Y, N. MENINGITIDIS GROUP C POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4544364&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4541159	Spontaneous	2011-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	ZYPREXA 10 MG COATED TABLET [OLANZAPINE] (C - n/a - n/a - [n/a - n/a - Oral])|[AMISULPRIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - Oral])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[NEBIVOLOL] (C - n/a - n/a - [n/a - n/a - Oral])|[PRAZEPAM] (C - n/a - n/a - [n/a - n/a - Oral])|[SODIUM VALPROATE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4541159&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4525175	Spontaneous	2011-05-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Ecchymosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Petechiae (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tonsillitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4525175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4525189	Spontaneous	2011-05-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bronchitis (26d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (18d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gastroenteritis rotavirus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (32d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Purulent discharge (32d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (26d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site abscess (32d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site induration (32d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4525189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4525192	Spontaneous	2011-05-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest discomfort (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4525192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4525728	Spontaneous	2011-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pulmonary haemorrhage (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4525728&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4514787	Spontaneous	2011-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Bursitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Limb discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Localised oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vaccination site infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4514787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4515276	Spontaneous	2011-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Vestibular neuronitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4515276&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4515704	Spontaneous	2011-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pyrexia (14d - Recovered/Resolved - Other Medically Important Condition);Vaccination site induration (14d - Recovered/Resolved - Other Medically Important Condition);Vomiting (14d - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4515704&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4515849	Spontaneous	2011-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling abnormal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperpyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4515849&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4516398	Spontaneous	2011-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Larynx irritation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory distress (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4516398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4511479	Spontaneous	2011-05-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cardiac arrest (n/a - Fatal - Results in Death);Cardiac death (n/a - Fatal - Results in Death);Malaise (n/a - Unknown - Results in Death);Myalgia (n/a - Unknown - Results in Death);Nausea (n/a - Unknown - Results in Death);Pyrexia (n/a - Unknown - Results in Death);Wound complication (n/a - Unknown - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Dose not changed - [n/a - 1{DF} - Intramuscular])	RADIOTHERAPY [NOT AVAILABLE] (C - Breast cancer - n/a - [n/a - n/a - n/a])|[ATENOLOL, ATENOLOL BP] (C - Hypertension - Dose not changed - [n/a - 100mg - Oral])|[HYDROCHLOROTHIAZIDE] (C - Hypertension - Dose not changed - [n/a - 25mg - Oral])|[OXAZEPAM] (C - n/a - Dose not changed - [n/a - 10mg - Oral])|[PAROXETINE] (C - Depression - Dose not changed - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4511479&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4511939	Spontaneous	2011-05-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Headache (n/a - Recovering/Resolving - Disabling);Visual impairment (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[GLUCOSAMINE, GLUCOSAMINE SULFATE] (C - n/a - n/a - [n/a - 1200mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4511939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4507394	Spontaneous	2011-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4507394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4508913	Spontaneous	2011-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Arthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Joint stiffness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Joint swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Synovitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[VARICELLA VACCINE (LIVE)] (C - Immunisation - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4508913&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4506768	Spontaneous	2011-05-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4506768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4506798	Spontaneous	2011-05-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4506798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4506837	Spontaneous	2011-05-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4506837&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4498459	Spontaneous	2011-05-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vasculitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ENALAPRIL MALEATE] (C - Hypertension - n/a - [n/a - 5mg - n/a])|[SIMVASTATIN] (C - Hyperlipidaemia - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4498459&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4497134	Spontaneous	2011-05-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Renal failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	CICLOSPORIN [CICLOSPORIN] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[AZATHIOPRINE] (C - n/a - n/a - [n/a - n/a - n/a])|[CARVEDILOL] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[NICARDIPINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4497134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4494868	Spontaneous	2011-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (46d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Drug reaction with eosinophilia and systemic symptoms (49d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eosinophilia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (49d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (49d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Skin exfoliation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Skin ulcer (46d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4494868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4495696	Spontaneous	2011-04-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Influenza A virus test positive (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4495696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4495700	Spontaneous	2011-04-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4495700&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4496829	Spontaneous	2011-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4496829&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4488701	Spontaneous	2011-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Carotid arteriosclerosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Cerebral infarction (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4488701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4484314	Spontaneous	2011-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Not Specified	Abortion induced (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[AMOXICILLIN, AMOXICILLIN SODIUM, AMOXICILLIN TRIHYDRATE] (C - Sinusitis - n/a - [n/a - n/a - Oral])|[DISTILLATE OF A MIXTURE OF RECTIFIED EUCALYPTUS OIL, RECTIFIED SWEET ORANGE OIL, RECTIFIED MYRTLE OIL AND RECTIFIED LEMON OIL IN A RATIO OF 66:32:1:1, MYRTOL] (C - Sinusitis - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4484314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4484424	Spontaneous	2011-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4484424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4481080	Spontaneous	2011-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pain (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4481080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4481282	Spontaneous	2011-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Atrial fibrillation (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[PHENPROCOUMON] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[SOTALOL, SOTALOL HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[VALSARTAN] (C - n/a - Dose not changed - [n/a - 80mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4481282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4478888	Spontaneous	2011-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Bell's palsy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - Prophylaxis - Not applicable - [n/a - {DF} - Oral])|[ALENDRONATE SODIUM, ALENDRONATE SODIUM TRIHYDRATE, ALENDRONIC ACID] (C - Prophylaxis - Not applicable - [n/a - 10mg - Oral])|[CARBASALATE CALCIUM] (C - Prophylaxis - Not applicable - [n/a - 100mg - Oral])|[DIPYRIDAMOLE] (C - Prophylaxis - Not applicable - [n/a - 150mg - Oral])|[HYDROCHLOROTHIAZIDE] (C - Prophylaxis - Not applicable - [n/a - 25mg - Oral])|[OMEPRAZOLE] (C - Prophylaxis - Not applicable - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4478888&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4479134	Spontaneous	2011-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Presyncope (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	MICARDIS [TELMISARTAN] (C - n/a - n/a - [n/a - 80mg - Oral])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 50{DF} - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 40mg - Oral])|[ZOPICLONE] (C - Sleep disorder - n/a - [n/a - 7.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4479134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4468695	Spontaneous	2011-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bronchitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pleurisy (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Subcutaneous])	[CARBAMAZEPINE] (C - n/a - Dose not changed - [n/a - 200mg - Oral])|[SODIUM VALPROATE] (C - n/a - Dose not changed - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4468695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4468867	Spontaneous	2011-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[BUMETANIDE] (C - n/a - Not applicable - [n/a - 2mg - Oral])|[HALOPERIDOL, HALOPERIDOL DECANOATE] (C - n/a - Not applicable - [n/a - 50mg - Intramuscular])|[SOTALOL HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - 80mg - Oral])|[VALSARTAN] (C - n/a - Not applicable - [n/a - 160mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4468867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4467162	Spontaneous	2011-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Anaemia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Epistaxis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Gingival bleeding (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Purpura (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Thrombocytopenia (10d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])	[AMIODARONE HYDROCHLORIDE] (C - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[FLUINDIONE] (C - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Dose not changed - [n/a - 2{DF} - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Dose not changed - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4467162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4457993	Spontaneous	2011-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Ophthalmic herpes zoster (15d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4457993&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4459200	Spontaneous	2011-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Gout (n/a - Unknown - Caused/Prolonged Hospitalisation);Joint swelling (n/a - Unknown - Caused/Prolonged Hospitalisation);Swelling (n/a - Unknown - Caused/Prolonged Hospitalisation);Tenderness (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, MAGNESIUM OXIDE] (C - n/a - n/a - [n/a - 75mg - Oral])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - 40mg - Oral])|[GLYCERYL TRINITRATE] (C - Pain - n/a - [n/a - .5mg - Sublingual])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 100mg - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 80{DF} - Oral])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - 50mg - Oral])|[TRANDOLAPRIL] (C - n/a - n/a - [n/a - 2mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4459200&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4456531	Spontaneous	2011-04-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Gastroenteritis (n/a - Fatal - Results in Death);Malaise (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4456531&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4452696	Spontaneous	2011-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	MIRAPEXIN [PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE] (C - n/a - n/a - [n/a - 3{DF} - Oral])|[GABAPENTIN] (C - n/a - n/a - [n/a - 900mg - Oral])|[MIRTAZAPINE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[TRAZODONE, TRAZODONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4452696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4453048	Spontaneous	2011-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Eye infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myocardial infarction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	LANTUS [INSULIN GLARGINE] (C - n/a - Dose not changed - [n/a - 3mL - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4453048&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4453273	Spontaneous	2011-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Body temperature (n/a - Recovering/Resolving - Other Medically Important Condition);Movement disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Neck pain (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 45ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4453273&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4446427	Spontaneous	2011-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - .5mL - Subcutaneous])...	[INSULIN, INSULIN HUMAN] (C - Type 1 diabetes mellitus - n/a - [n/a - n/a - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4446427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4439520	Spontaneous	2011-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (2d - Not Recovered/Not Resolved - Other Medically Important Condition);Multiple sclerosis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4439520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4442024	Spontaneous	2011-04-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypoaesthesia (30min - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (30min - Recovered/Resolved - Other Medically Important Condition);Pharyngeal hypoaesthesia (30min - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4442024&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4442912	Spontaneous	2011-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Herpes zoster (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4442912&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4443831	Spontaneous	2011-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Polyneuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4443831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4444096	Spontaneous	2011-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovered/Resolved - Life Threatening);Lip oedema (n/a - Recovered/Resolved - Life Threatening);Palatal oedema (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	KARVEA [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[BETAHISTINE DIHYDROCHLORIDE, BETAHISTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DELORAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE, GLIBENCLAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4444096&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4435878	Spontaneous	2011-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	Yes	Male	Pruritus (3d - Recovered/Resolved - Other Medically Important Condition);Rash erythematous (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (3d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - Dose not changed - [n/a - 300mg - Oral])|[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE] (C - n/a - Dose not changed - [n/a - 50mg - Oral])|[FLECAINIDE, FLECAINIDE ACETATE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[FLUTICASONE] (C - n/a - Dose not changed - [n/a - n/a - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - Dose not changed - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4435878&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4436900	Spontaneous	2011-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Haematoma (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Immune thrombocytopenia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Petechiae (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4436900&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4430247	Spontaneous	2011-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Epstein-Barr virus infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation);Myelitis transverse (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Product storage error (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	[FLUTICASONE PROPIONATE] (C - n/a - Dose not changed - [n/a - n/a - Cutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4430247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4430481	Spontaneous	2011-04-05 00:00:00	Healthcare Professional	Non European Economic Area	Yanling M, Zhaoqi N. Case report of acute disseminated encephalomyelitis associated with vaccination of influenza virus decomposition vaccine...	12-17 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Amnesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation);Craniocerebral injury (n/a - Unknown - Caused/Prolonged Hospitalisation);Diplopia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (3d - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4430481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4431478	Spontaneous	2011-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Adverse drug reaction (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4431478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4422479	Spontaneous	2011-04-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cyanosis (0d - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (0d - Recovered/Resolved - Other Medically Important Condition);Pallor (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4422479&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4423930	Spontaneous	2011-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Asthenia (32d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (32d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoxia (32d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Interstitial lung disease (32d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (32d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[PIPOBROMAN] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])	INSULIN ASPART [INSULIN ASPART] (C - n/a - n/a - [n/a - n/a - n/a])|[ANHYDROUS CALCIFEDIOL, CALCIFEDIOL] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUINDIONE] (C - n/a - n/a - [n/a - n/a - n/a])|[LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM POLYSTYRENE SULPHONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TIANEPTINE, TIANEPTINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4423930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4412656	Spontaneous	2011-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Blood pressure increased (n/a - Recovered/Resolved - Other Medically Important Condition);Fall (n/a - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4412656&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4412685	Spontaneous	2011-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (6h - Recovered/Resolved - Other Medically Important Condition);Haematoma (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Limb discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Lip swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (6h - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLIMEPIRIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN EMBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MIDODRINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4412685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4407858	Spontaneous	2011-03-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain upper (17d - Recovered/Resolved - Other Medically Important Condition);Colitis (17d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4407858&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4408168	Spontaneous	2011-03-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4408168&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4392239	Spontaneous	2011-03-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Delirium (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disorientation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysuria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Erectile dysfunction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4392239&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4392266	Spontaneous	2011-03-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeding disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Kawasaki's disease (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lip dry (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lip erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ocular hyperaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urine output (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4392266&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4388681	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ataxia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Excessive eye blinking (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4388681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4385069	Spontaneous	2011-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Laryngeal oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palatal oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peritonsillar abscess (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4385069&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4385092	Spontaneous	2011-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epilepsy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[LAMOTRIGINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PHENOBARBITAL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4385092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4385117	Spontaneous	2011-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4385117&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4385120	Spontaneous	2011-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood ketone body (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperglycaemia (n/a - Recovered/Resolved - Other Medically Important Condition);Immunisation reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	HUMALOG [INSULIN LISPRO] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4385120&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4384767	Spontaneous	2011-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Hypothermia (2d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4384767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4360912	Spontaneous	2011-03-15 00:00:00	Healthcare Professional	European Economic Area	JOVER-SAENZ A, MIQUEL FERNANDEZ E, GARRIDO-CALVO S. Arteritits temporal posvacunal. Med Clin (Barc) 2008:130:638-639. MED CLIN (BARC) 2008; 130(16): 638-9	65-85 Years	Elderly	No	Male	Giant cell arteritis (1a - Recovered/Resolved - Other Medically Important Condition);Osteoarthritis (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Immunisation - Drug withdrawn - [n/a - .5mL - Intramuscular])	[ATENOLOL, ATENOLOL BP] (C - Hypertension - Unknown - [n/a - n/a - Oral])|[ENALAPRIL, ENALAPRIL MALEATE] (C - Hypertension - Unknown - [n/a - n/a - Oral])|[HYDROCHLOROTHIAZIDE] (C - Hypertension - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4360912&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4362570	Spontaneous	2011-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Iris adhesions (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Uveitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vitreous opacities (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4362570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4364733	Spontaneous	2011-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myositis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Somatic symptom disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4364733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4357871	Spontaneous	2011-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Bronchospasm (30min - Unknown - Other Medically Important Condition);Circulatory collapse (30min - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - 10mg - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - 40mg - n/a])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - 10mg - n/a])|[RISPERIDONE] (C - n/a - n/a - [n/a - 1mg - n/a])|[URAPIDIL] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4357871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4353073	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cough (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Lower respiratory tract infection (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4353073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4353766	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Acute polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);CSF protein increased (n/a - Not Specified - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Demyelination (n/a - Not Specified - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysphagia (1d - Not Specified - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paraesthesia (n/a - Not Specified - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paraparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - 5mg - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 20mg - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4353766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4351658	Spontaneous	2011-03-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngeal erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4351658&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4351671	Spontaneous	2011-03-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cellulitis (6d - Recovered/Resolved - Other Medically Important Condition);Pharyngeal erythema (6d - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (6d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (6d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4351671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4351746	Spontaneous	2011-03-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Otitis media (n/a - Recovered/Resolved - Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4351746&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4352147	Spontaneous	2011-03-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain (59d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Paraesthesia (59d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Unevaluable event (59d - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intravenous (not otherwise specified)])|[DROSPIRENONE, ETHINYLESTRADIOL] (S - Endometriosis - Drug withdrawn - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4352147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-4352691	Spontaneous	2011-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	APROVEL [IRBESARTAN] (C - n/a - n/a - [n/a - 300mg - n/a])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 75mg - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 20mg - n/a])|[CYPROTERONE ACETATE] (C - n/a - n/a - [n/a - 100mg - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[TRIMETAZIDINE, TRIMETAZIDINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4352691&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4342809	Spontaneous	2011-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastric haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Polyarthritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rectal haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation);Ulcer (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[KETOPROFEN] (S - n/a - n/a - [n/a - 100mg - n/a])|[PIROXICAM, PIROXICAM BETADEX] (S - n/a - n/a - [n/a - n/a - n/a])	[AVOCADO OIL UNSAPONIFIABLES, SOYBEAN OIL UNSAPONIFIABLES, SOYA OIL, AVOCADO OIL] (C - Osteoarthritis - n/a - [n/a - 300mg - n/a])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - 10mg - n/a])|[ZOFENOPRIL CALCIUM, HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4342809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4339303	Spontaneous	2011-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Febrile convulsion (5min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperpyrexia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4339303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4339951	Spontaneous	2011-03-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (8d - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (8d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	TYSABRI [NATALIZUMAB] (C - Multiple sclerosis - n/a - [n/a - n/a - n/a])|[ETHINYLESTRADIOL, NORETHISTERONE] (C - Contraception - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Thyroid disorder - n/a - [n/a - 100mg - n/a])|[RISPERIDONE] (C - Bipolar disorder - n/a - [n/a - 1mg - n/a])|[VALPROATE SEMISODIUM] (C - Bipolar disorder - n/a - [n/a - 1500mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4339951&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4340043	Spontaneous	2011-03-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Abnormal behaviour (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Agitation (7d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (7d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4340043&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4336555	Spontaneous	2011-03-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Decreased activity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Immune thrombocytopenia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash papular (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4336555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4332918	Spontaneous	2011-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Brachial plexopathy (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4332918&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4330149	Spontaneous	2011-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersensitivity (0d - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4330149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4325481	Spontaneous	2011-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cough (n/a - Unknown - Other Medically Important Condition);Influenza A virus test positive (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4325481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4323852	Spontaneous	2011-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Asthenia (n/a - Fatal - Results in Death);Cyanosis (1d - Fatal - Results in Death);Decreased appetite (n/a - Fatal - Results in Death);Hypoxia (1d - Fatal - Results in Death);Weight decreased (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	LANTUS 100 IU/ML SOLUTION FOR INJECTION IN A CARTRIDGE [INSULIN GLARGINE] (C - n/a - Dose not changed - [n/a - 8[iU] - Subcutaneous])|NOVORAPID FLEXPEN 100 U/ML SOLUTION FOR INJECTION IN A PRE-FILLED PEN [INSULIN ASPART] (C - n/a - Dose not changed - [n/a - 6[iU] - Subcutaneous])|[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[FUROSEMIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[GLYCERYL TRINITRATE, GLYCERYL TRINITRATE SOLUTION] (C - n/a - Dose not changed - [n/a - n/a - Buccal])|[MACROGOL 3350] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[PARACETAMOL] (C - n/a - Dose not changed - [n/a - 1g - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4323852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4324569	Spontaneous	2011-02-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Influenza like illness (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4324569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4324726	Spontaneous	2011-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Condition aggravated (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuroborreliosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	OESTRO-PROGESTOGEN [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESTROGEN NOS] (C - n/a - n/a - [n/a - n/a - n/a])|[GABAPENTIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4324726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4314574	Spontaneous	2011-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Loss of consciousness (n/a - Recovered/Resolved - Life Threatening);Malaise (n/a - Recovered/Resolved - Life Threatening);Respiratory arrest (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4314574&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4309337	Spontaneous	2011-02-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Cardiomyopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Central hypothyroidism (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Eyelid oedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nephrotic syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Supraventricular extrasystoles (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4309337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4311442	Spontaneous	2011-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4311442&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4311611	Spontaneous	2011-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4311611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4311828	Spontaneous	2011-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Facial paralysis (3wk - Recovered/Resolved - Other Medically Important Condition);Herpes simplex (3wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4311828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4312121	Spontaneous	2011-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (3wk - Recovered/Resolved - Other Medically Important Condition);Urticaria (1wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	ANTIHISTAMINES [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACEBUTOLOL, ACEBUTOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ALFUZOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CLONAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[DEXTROPROPOXYPHENE HYDROCHLORIDE, PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[DUTASTERIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[MACROGOL 4000] (C - n/a - n/a - [n/a - n/a - n/a])|[NICORANDIL] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN BENZATHINE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[VERAPAMIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4312121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4312124	Spontaneous	2011-02-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arrhythmia (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Demyelination (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling hot (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Heart rate increased (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation);Motor dysfunction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nerve root injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Walking aid user (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4312124&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4312142	Spontaneous	2011-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Polyneuropathy (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4312142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4312161	Spontaneous	2011-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Demyelination (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4312161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4328879	Spontaneous	2011-02-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Arrhythmia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4328879&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4306764	Spontaneous	2011-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Benign rolandic epilepsy (20min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (20min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4306764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4328501	Spontaneous	2011-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arrhythmia (12d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hepatic enzyme increased (12d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Malaise (12d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Nausea (12d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - Oral])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - Oral])|[POTASSIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4328501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4298358	Spontaneous	2011-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Intramuscular])	[ESTRADIOL, ESTRADIOL HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4298358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4327985	Spontaneous	2011-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Immunisation - Drug withdrawn - [n/a - .5mL - Intramuscular])|[FOSFOMYCIN, FOSFOMYCIN TROMETAMOL] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Unknown])|[MEPIPHYLLINE, MEPYRAMINE] (S - Catarrh - Drug withdrawn - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4327985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4328375	Spontaneous	2011-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (2d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (2d - Recovered/Resolved - Other Medically Important Condition);Fatigue (2d - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (2d - Recovered/Resolved - Other Medically Important Condition);Rales (2d - Recovered/Resolved - Other Medically Important Condition);Respiratory distress (2d - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - n/a - Not applicable - [n/a - 1{DF} - Unknown])	APROVEL 150 MG TABLETS [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4328375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4328387	Spontaneous	2011-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arthralgia (n/a - Unknown - Other Medically Important Condition);Immune system disorder (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Sarcoidosis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Unknown - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4328387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4287763	Spontaneous	2011-02-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4287763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4327475	Spontaneous	2011-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Circulatory collapse (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[ACETYLCYSTEINE] (C - n/a - Not applicable - [n/a - 600mg - Oral])|[CHLORTALIDONE] (C - n/a - Not applicable - [n/a - 25mg - Oral])|[ENALAPRIL MALEATE] (C - n/a - Not applicable - [n/a - 20mg - Oral])|[GLIMEPIRIDE] (C - n/a - Not applicable - [n/a - 6mg - Oral])|[IPRATROPIUM BROMIDE] (C - n/a - Not applicable - [n/a - n/a - Respiratory (inhalation)])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - 1850mg - Oral])|[NICARDIPINE, NICARDIPINE HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - 45mg - Oral])|[SIMVASTATIN] (C - n/a - Not applicable - [n/a - 20mg - Oral])|[THEOPHYLLINE] (C - n/a - Not applicable - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4327475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4327214	Spontaneous	2011-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (1.5a - Recovered/Resolved - Other Medically Important Condition);Demyelinating polyneuropathy (1.5a - Recovered/Resolved - Other Medically Important Condition);Facial paresis (1.5a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (1.5a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (1.5a - Recovered/Resolved - Other Medically Important Condition);Radiculopathy (1.5a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4327214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4281070	Spontaneous	2011-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Infant	No	Male	Influenza like illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Klebsiella infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pneumonia influenzal (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tachypnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4281070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4277443	Spontaneous	2011-02-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Joint swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4277443&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4279424	Spontaneous	2011-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pulmonary embolism (n/a - Not Recovered/Not Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[ALPROSTADIL] (S - n/a - Drug withdrawn - [n/a - 10ug - Intra corpus cavernosum])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4279424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4276121	Spontaneous	2011-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Chest pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4276121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4276373	Spontaneous	2011-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Epilepsy (30min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Underdose (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[BACLOFEN, BACLOFEN PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE, HYDROCHLOROTHIAZIDE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM VALPROATE, VALPROIC ACID, SODIUM, VALPROIC ACID, SODIUM VALPROATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4276373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4276403	Spontaneous	2011-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Lung disorder (5d - Recovered/Resolved - Life Threatening);Respiratory distress (5d - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4276403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4273935	Spontaneous	2011-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4273935&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4271054	Spontaneous	2011-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Henoch-Schonlein purpura (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	KARVEA [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESOMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM HYDROGEN CARBONATE, SODIUM ALGINATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4271054&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4268020	Spontaneous	2011-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Motor neurone disease (n/a - Not Specified - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4268020&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4262568	Spontaneous	2011-02-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (19d - Recovered/Resolved - Other Medically Important Condition);H1N1 influenza (19d - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (19d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition);Wheezing (17d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4262568&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4262576	Spontaneous	2011-02-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Loss of consciousness (2min - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4262576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4260312	Spontaneous	2011-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (3d - Not Specified - );Feeling hot (3d - Not Specified - );Localised oedema (3d - Not Specified - );Pain (3d - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4260312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4261366	Spontaneous	2011-02-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Hypoaesthesia (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4261366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4261367	Spontaneous	2011-02-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Hypoaesthesia (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4261367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4256198	Spontaneous	2011-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Acute polyneuropathy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Facial paresis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Walking disability (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[CARVEDILOL] (C - n/a - n/a - [n/a - .5{DF} - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - .5{DF} - n/a])|[QUINAPRIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - .5{DF} - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - .5{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4256198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4256576	Spontaneous	2011-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Feeling cold (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (2d - Recovered/Resolved - Other Medically Important Condition);Hypertension (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Palpitations (n/a - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition);Vertigo (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4256576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4257027	Spontaneous	2011-01-31 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspepsia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Motor dysfunction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oedema peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4257027&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4258867	Spontaneous	2011-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4258867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4258926	Spontaneous	2011-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Electromyogram abnormal (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Polyneuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4258926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4252427	Spontaneous	2011-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (2wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[HYDROCHLOROTHIAZIDE, LOSARTAN, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - .1mg - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [1mo - 1{DF} - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[TRIMETAZIDINE, TRIMETAZIDINE DIHYDROCHLORIDE] (C - n/a - n/a - [1wk - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4252427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4252428	Spontaneous	2011-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Immune thrombocytopenia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4252428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4255301	Spontaneous	2011-01-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Body temperature increased (n/a - Not Recovered/Not Resolved - );Conjunctivitis (n/a - Not Recovered/Not Resolved - );Dyspnoea (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1000{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4255301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4255729	Spontaneous	2011-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Papilloedema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4255729&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4251835	Spontaneous	2011-01-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bronchopneumopathy (n/a - Fatal - Results in Death);Hyperthermia (16d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4251835&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4248645	Spontaneous	2011-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4248645&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4248647	Spontaneous	2011-01-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dysgeusia (n/a - Unknown - );Rash pruritic (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4248647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4248648	Spontaneous	2011-01-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Inflammation (n/a - Recovered/Resolved - );Injection site induration (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4248648&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4243921	Spontaneous	2011-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Productive cough (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4243921&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4245815	Spontaneous	2011-01-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Peripheral swelling (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4245815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4241686	Spontaneous	2011-01-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Axillary pain (n/a - Recovered/Resolved - Other Medically Important Condition);Dermatitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4241686&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4243525	Spontaneous	2011-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cardiac failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	BETA BLOCKING AGENTS [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CANDESARTAN, CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4243525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4243528	Spontaneous	2011-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Thrombocytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4243528&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4240256	Spontaneous	2011-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4240256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4234016	Spontaneous	2011-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Arterial thrombosis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4234016&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4229394	Spontaneous	2011-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Facial paralysis (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4229394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4230435	Spontaneous	2011-01-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paresis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Seizure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4230435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4226594	Spontaneous	2011-01-17 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Vertigo (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4226594&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4228415	Spontaneous	2011-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - );Pyrexia (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4228415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4228426	Spontaneous	2011-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (3d - Recovered/Resolved - );Myalgia (3d - Recovered/Resolved - );Pyrexia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4228426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4228517	Spontaneous	2011-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Balance disorder (n/a - Unknown - Other Medically Important Condition);Inner ear disorder (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Romberg test positive (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Tinnitus (n/a - Unknown - Other Medically Important Condition);Vertigo (8d - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	CONTRACEPTIVE PILL [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4228517&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4228530	Spontaneous	2011-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Generalised oedema (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory disorder (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Weight increased (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	ANTIDEPRESSANTS [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPRANOLOL, PROPRANOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4228530&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4218971	Spontaneous	2011-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4218971&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4219646	Spontaneous	2011-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pericarditis (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4219646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4208989	Spontaneous	2011-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Atrial fibrillation (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Intramuscular])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLUCOSAMINE, GLUCOSAMINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[IBUPROFEN, IBUPROFEN BP, IBUPROFEN, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4208989&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-4207380	Spontaneous	2011-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypertension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperventilation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Restlessness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4207380&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4204226	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Primary familial brain calcification (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Status epilepticus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4201721	Spontaneous	2011-01-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Face oedema (2d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition);Tachypnoea (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4201721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4202801	Spontaneous	2011-01-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Rash (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4202801&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4203460	Spontaneous	2011-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bradycardia (1d - Recovered/Resolved - );Hypotension (1d - Recovered/Resolved - );Malaise (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4203460&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4199465	Spontaneous	2011-01-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[HYDROCHLOROTHIAZIDE, QUINAPRIL, QUINAPRIL HYDROCHLORIDE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4199465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4197533	Spontaneous	2010-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Abdominal pain (n/a - Recovered/Resolved - );Chills (n/a - Recovered/Resolved - );Diarrhoea (n/a - Recovered/Resolved - );Dyshidrotic eczema (n/a - Recovered/Resolved - );Eyelid sensory disorder (n/a - Recovered/Resolved - );Loss of consciousness (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Oropharyngeal pain (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197533&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4193735	Spontaneous	2010-12-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Malaise (4d - Recovered/Resolved - Other Medically Important Condition);Oral herpes (n/a - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (8d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4193735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4194657	Spontaneous	2010-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Iridocyclitis (15d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4194657&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4194775	Spontaneous	2010-12-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Chest discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4194775&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4194837	Spontaneous	2010-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dysphagia (24h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (48h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Face oedema (24h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Local reaction (48h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal discomfort (24h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	HORMONAL CONTRACEPTIVES [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 100ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4194837&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4194879	Spontaneous	2010-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4194879&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4194911	Spontaneous	2010-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Generalised oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	MICARDIS [TELMISARTAN] (C - n/a - n/a - [n/a - 40mg - n/a])|[COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - 1000mg - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 25ug - n/a])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4194911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4192089	Spontaneous	2010-12-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Myelitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4192089&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4192725	Spontaneous	2010-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angioedema (n/a - Not Specified - Caused/Prolonged Hospitalisation);Macroglossia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Specified - Caused/Prolonged Hospitalisation);Urticaria (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4192725&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4190875	Spontaneous	2010-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Gingival bleeding (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Immune thrombocytopenia (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])|[DEXTROPROPOXYPHENE, PARACETAMOL, CAFFEINE] (S - n/a - Drug withdrawn - [n/a - 2{DF} - Oral])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (S - n/a - Drug withdrawn - [n/a - 40mg - Oral])|[PARACETAMOL, BELLADONNA DRY EXTRACT, CAFFEINE, OPIUM, PARACETAMOL, CAFFEINE, OPIUM, PREPARED] (S - n/a - Drug withdrawn - [n/a - 2{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4190875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4189247	Spontaneous	2010-12-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Cystitis (n/a - Recovered/Resolved - );Syncope (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	[OMEPRAZOLE] (C - Dyspepsia - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4189247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4189459	Spontaneous	2010-12-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash maculo-papular (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4189459&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4184591	Spontaneous	2010-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site erythema (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site induration (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4184591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4184615	Spontaneous	2010-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dermatitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4184615&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4185742	Spontaneous	2010-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Drug withdrawn - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4185742&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4185743	Spontaneous	2010-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Arthritis (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Dose not changed - [n/a - 1{DF} - Subcutaneous])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Dose not changed - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4185743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4185744	Spontaneous	2010-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	Yes	Female	Headache (2d - Recovered/Resolved - );Influenza like illness (2d - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4185744&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4181988	Spontaneous	2010-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Lactation insufficiency (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4181988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4182257	Spontaneous	2010-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4182257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4178518	Spontaneous	2010-12-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Cough (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysphoria (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Febrile convulsion (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngitis (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4178518&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4175891	Spontaneous	2010-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Haematoma (n/a - Recovering/Resolving - );Lymphangitis (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4175891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4175894	Spontaneous	2010-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4175894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4175896	Spontaneous	2010-12-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Recovering/Resolving - );Pruritus (n/a - Recovered/Resolved With Sequelae - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Dose not changed - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Dose not changed - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Dose not changed - [n/a - 5mg - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4175896&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-4175898	Spontaneous	2010-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Diarrhoea (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FERROUS GLUCONATE, FERROUS ION] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4175898&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4175907	Spontaneous	2010-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Injection site inflammation (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4175907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4171493	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Clonic convulsion (0d - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4171493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4173114	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Lip swelling (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4173114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4173115	Spontaneous	2010-12-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4173115&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4173123	Spontaneous	2010-12-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Influenza like illness (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	SIFROL 0.088 MG TABLETS [PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[SIMVASTATIN] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4173123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4166442	Spontaneous	2010-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Asthma (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Unknown - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4166442&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4166443	Spontaneous	2010-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4166443&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4166445	Spontaneous	2010-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Diarrhoea (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4166445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4166446	Spontaneous	2010-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - );Nasopharyngitis (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4166446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4166447	Spontaneous	2010-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4166447&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4166448	Spontaneous	2010-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Erythema (n/a - Recovering/Resolving - );Skin exfoliation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4166448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4166676	Spontaneous	2010-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Confusional state (9d - Not Specified - Caused/Prolonged Hospitalisation);Hyperammonaemia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Hyponatraemia (7d - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])|[SODIUM VALPROATE, VALPROIC ACID] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[VALACICLOVIR HYDROCHLORIDE] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4166676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4163755	Spontaneous	2010-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Pyrexia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4163755&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4163758	Spontaneous	2010-12-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovered/Resolved - );Injection site inflammation (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4163758&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4161038	Spontaneous	2010-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Lymphadenopathy (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161038&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4161040	Spontaneous	2010-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Blister (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	NOT AVAILABLE (C - n/a - Dose not changed - [n/a - 500mg - Oral])|[PRAVASTATIN SODIUM] (C - n/a - Dose not changed - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161040&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4161041	Spontaneous	2010-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161041&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4161043	Spontaneous	2010-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161043&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4161045	Spontaneous	2010-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Headache (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Respiratory tract infection (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Dose not changed - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Dose not changed - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4161046	Spontaneous	2010-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Myalgia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4161047	Spontaneous	2010-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (n/a - Recovered/Resolved - );Injection site inflammation (3wk - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4161048	Spontaneous	2010-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - );Pruritus (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161048&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4161049	Spontaneous	2010-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adult	Yes	Male	Feeling hot (n/a - Recovered/Resolved - );Palpitations (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161049&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4161266	Spontaneous	2010-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Colitis microscopic (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161266&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4157902	Spontaneous	2010-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovered/Resolved - );Syncope (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Dose not changed - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Dose not changed - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4157902&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4157905	Spontaneous	2010-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4157905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4157906	Spontaneous	2010-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Asthma - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Asthma - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4157906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4157907	Spontaneous	2010-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Pyrexia (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4157907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4157908	Spontaneous	2010-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4157908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4157910	Spontaneous	2010-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Fatigue (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - );Pharyngitis (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4157910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4157911	Spontaneous	2010-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Male	Pyrexia (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4157911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4153828	Spontaneous	2010-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4153828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4154747	Spontaneous	2010-12-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4154747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4154928	Spontaneous	2010-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Blood pressure decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);International normalised ratio increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DOXAZOSIN MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUINDIONE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4154928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4151746	Spontaneous	2010-12-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Multiple sclerosis (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Dose not changed - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4151746&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4151751	Spontaneous	2010-12-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Blister (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Dose not changed - [n/a - 1{DF} - Intramuscular])|[DICLOFENAC SODIUM, MISOPROSTOL] (S - Inflammation - Dose not changed - [n/a - 75mg - Intramuscular])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (S - Asthma - Dose not changed - [n/a - 1{DF} - Respiratory (inhalation)])	[SERTRALINE] (C - n/a - Dose not changed - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4151751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4151753	Spontaneous	2010-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4151753&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4151756	Spontaneous	2010-12-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Chills (n/a - Recovered/Resolved - );Dizziness (n/a - Recovered/Resolved - );Injection site inflammation (n/a - Recovered/Resolved With Sequelae - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[CARBASALATE CALCIUM] (C - n/a - Dose not changed - [n/a - 100mg - Oral])|[SODIUM VALPROATE] (C - n/a - Dose not changed - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4151756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-4152033	Spontaneous	2010-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pleuropericarditis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4152033&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4148122	Spontaneous	2010-12-07 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Dyspnoea (2wk - Recovered/Resolved - Other Medically Important Condition);Pruritus (2wk - Recovered/Resolved - Other Medically Important Condition);Rash (2wk - Recovered/Resolved - Other Medically Important Condition);Vaccination site swelling (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4148122&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4149429	Spontaneous	2010-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vascular purpura (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - n/a])	[DIPOTASSIUM CLORAZEPATE] (C - n/a - Drug withdrawn - [n/a - 5mg - Oral])|[PHLOROGLUCINOL DIHYDRATE, PHLOROGLUCINOL, TRIMETHYLPHLOROGLUCINOL, TRIMETHYLPHLOROGLUCINOL, PHLOROGLUCINOL DIHYDRATE] (C - n/a - Dose not changed - [n/a - 4{DF} - Oral])|[TRAMADOL HYDROCHLORIDE] (C - n/a - Drug withdrawn - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4149429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4144811	Spontaneous	2010-12-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Wheezing (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4144811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4144813	Spontaneous	2010-12-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Bladder sphincter atony (0d - Recovered/Resolved - Other Medically Important Condition);Seizure (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4144813&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4144821	Spontaneous	2010-12-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Oropharyngeal pain (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Soft tissue infection (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tonsillitis (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site inflammation (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4144821&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4146446	Spontaneous	2010-12-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Urticaria (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE] (C - n/a - Dose not changed - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4146446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4146586	Spontaneous	2010-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain upper (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	LANTUS [INSULIN GLARGINE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4146586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4146595	Spontaneous	2010-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vascular purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4146595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4143027	Spontaneous	2010-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Leukoencephalopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Personality disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Psychomotor retardation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143027&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4143278	Spontaneous	2010-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Thrombocytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CARBASALATE CALCIUM] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[RABEPRAZOLE SODIUM] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4143283	Spontaneous	2010-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143284	Spontaneous	2010-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Feeling hot (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Dose not changed - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143285	Spontaneous	2010-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[MOMETASONE FUROATE] (C - n/a - Dose not changed - [n/a - 1{DF} - Nasal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143287	Spontaneous	2010-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143287&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143289	Spontaneous	2010-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Abdominal discomfort (n/a - Recovering/Resolving - );Dizziness (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143291	Spontaneous	2010-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143292	Spontaneous	2010-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Diarrhoea (n/a - Recovered/Resolved - );Syncope (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143292&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4143293	Spontaneous	2010-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dizziness (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Dose not changed - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143294	Spontaneous	2010-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Headache (n/a - Not Recovered/Not Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143294&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143295	Spontaneous	2010-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Arthralgia (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	LANTUS 100 IU/ML SOLUTION FOR INJECTION IN A CARTRIDGE [INSULIN GLARGINE] (C - n/a - Dose not changed - [n/a - n/a - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143296	Spontaneous	2010-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143296&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143297	Spontaneous	2010-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Myalgia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143305	Spontaneous	2010-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Eye irritation (n/a - Unknown - );Nausea (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143315	Spontaneous	2010-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Male	Injection site inflammation (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143316	Spontaneous	2010-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143316&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4143492	Spontaneous	2010-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Autoimmune haemolytic anaemia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	RIBAVIRIN [RIBAVIRIN] (C - Hepatitis C - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4140494	Spontaneous	2010-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dizziness (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4140494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4140499	Spontaneous	2010-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Eye pain (n/a - Recovering/Resolving - );Glossitis (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4140499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4140500	Spontaneous	2010-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4140500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4140501	Spontaneous	2010-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Lymphadenopathy (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4140501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4140507	Spontaneous	2010-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dizziness (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Dose not changed - [n/a - 200mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4140507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4137705	Spontaneous	2010-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Abnormal faeces (n/a - Recovered/Resolved With Sequelae - );Malaise (n/a - Recovered/Resolved With Sequelae - );Migraine (n/a - Recovered/Resolved With Sequelae - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4137705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-4137720	Spontaneous	2010-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Cutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4137720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4137721	Spontaneous	2010-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovered/Resolved - );Injection site inflammation (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4137721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4137722	Spontaneous	2010-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Lymphadenopathy (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4137722&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4137723	Spontaneous	2010-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site pain (n/a - Recovering/Resolving - );Lymphadenopathy (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4137723&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4137724	Spontaneous	2010-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Malaise (n/a - Recovered/Resolved - );Muscle twitching (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Neck pain (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4137724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4137725	Spontaneous	2010-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Application site erythema (n/a - Recovered/Resolved - );Application site pruritus (n/a - Recovered/Resolved - );Paraesthesia (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4137725&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4137728	Spontaneous	2010-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site reaction (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4137728&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4134997	Spontaneous	2010-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Transient ischaemic attack (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4134997&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4135008	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Face oedema (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[ETORICOXIB] (S - Psoriatic arthropathy - Drug withdrawn - [n/a - 90mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4135008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4135009	Spontaneous	2010-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Swollen tongue (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[CICLESONIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Respiratory (inhalation)])|[LEVOCETIRIZINE DIHYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4135009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4135012	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Swelling face (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4135012&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4135014	Spontaneous	2010-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Arthralgia (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE] (C - n/a - Dose not changed - [n/a - 2{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4135014&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4135015	Spontaneous	2010-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	PLAVIX 75 MG FILM-COATED TABLETS [CLOPIDOGREL] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[BARNIDIPINE HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[BECLOMETASONE DIPROPIONATE] (C - n/a - Dose not changed - [n/a - n/a - Unknown])|[CARBASALATE CALCIUM] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[CITALOPRAM] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[RABEPRAZOLE SODIUM] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[SIMVASTATIN, EZETIMIBE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4135015&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4135019	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Blood pressure increased (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4135019&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4135021	Spontaneous	2010-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Injection site reaction (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4135021&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4135024	Spontaneous	2010-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Pharyngitis (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4135024&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4135027	Spontaneous	2010-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4135027&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4135028	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Dose not changed - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4135028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4135186	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Local reaction (n/a - Recovered/Resolved - );Vaccination site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4135186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4131337	Spontaneous	2010-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Unknown - Other Medically Important Condition);Feeling hot (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Type I hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4131337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4132261	Spontaneous	2010-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Arthralgia (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4132261&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4132262	Spontaneous	2010-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Pain (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4132262&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4132263	Spontaneous	2010-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Abdominal discomfort (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4132263&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4132265	Spontaneous	2010-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4132265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4132266	Spontaneous	2010-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Fatigue (n/a - Recovering/Resolving - );Headache (n/a - Unknown - );Injection site pain (n/a - Recovered/Resolved - );Neck pain (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4132266&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4132267	Spontaneous	2010-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4132267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4132291	Spontaneous	2010-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Application site reaction (n/a - Recovered/Resolved With Sequelae - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4132291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-4132292	Spontaneous	2010-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - );Pruritus (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	[ATORVASTATIN] (C - n/a - Dose not changed - [n/a - 10mg - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - Dose not changed - [n/a - 150mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4132292&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4132293	Spontaneous	2010-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovered/Resolved With Sequelae - );Injection site reaction (n/a - Recovered/Resolved With Sequelae - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4132293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-4129362	Spontaneous	2010-11-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Unknown - Other Medically Important Condition);Dysphonia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition);Wheezing (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4129362&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4122448	Spontaneous	2010-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Bradyphrenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Foot deformity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4122448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4124665	Spontaneous	2010-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Erysipelas (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4124665&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4124968	Spontaneous	2010-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Muscular weakness (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4124968&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-4121401	Spontaneous	2010-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Disturbance in attention (n/a - Recovered/Resolved - );Feeling abnormal (n/a - Recovered/Resolved - );Injection site inflammation (n/a - Recovering/Resolving - );Limb discomfort (n/a - Recovered/Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - .5mg - Intramuscular])	INSULATARD PENFILL 100 IU/ML SUSPENSION FOR INJECTION IN A CARTRIDGE [INSULIN HUMAN ISOPHANE (RDNA)] (C - n/a - Not applicable - [n/a - 10[iU] - Intramuscular])|[FLUVASTATIN SODIUM] (C - n/a - Dose not changed - [n/a - 20mg - Oral])|[GLICLAZIDE] (C - n/a - Dose not changed - [n/a - 30mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4121401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4114605	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);H1N1 influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Oropharyngeal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Productive cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination failure (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4114605&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4114619	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	H1N1 influenza (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nasopharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination failure (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4114619&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4116318	Spontaneous	2010-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Not Recovered/Not Resolved - );Injection site induration (n/a - Not Recovered/Not Resolved - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4116318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4116319	Spontaneous	2010-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Influenza like illness (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4116319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4116320	Spontaneous	2010-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Arthralgia (n/a - Unknown - );Myalgia (n/a - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4116320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4116537	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Encephalitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4116537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4110208	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vertigo (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4110208&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4101987	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Myocardial infarction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4101987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4089611	Spontaneous	2010-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Burning sensation (3mo - Recovered/Resolved - Other Medically Important Condition);Middle insomnia (6wk - Recovered/Resolved - Other Medically Important Condition);Neurological symptom (6wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 160mg - Oral])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[ALPRAZOLAM] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - 5mg - Oral])|[INDAPAMIDE, PERINDOPRIL, INDAPAMIDE, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMINE, INDAPAMIDE] (C - n/a - n/a - [n/a - 2mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - 850mg - Oral])|[MOLSIDOMINE] (C - n/a - n/a - [n/a - 2mg - Oral])|[NICORANDIL] (C - n/a - n/a - [n/a - 10mg - Oral])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4089611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4084628	Spontaneous	2010-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Arrhythmia (n/a - Recovering/Resolving - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4084628&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4081288	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arrhythmia (n/a - Unknown - Caused/Prolonged Hospitalisation);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Bronchial disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4081288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4082607	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Myoclonus (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4082607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4082610	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Diarrhoea (n/a - Unknown - Other Medically Important Condition);Hyperpyrexia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4082610&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4083856	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Visual acuity reduced transiently (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4083856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4083872	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Eosinophilia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Erythema multiforme (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	[IBUPROFEN, NAPROXEN, NAPROXEN SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4083872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4081074	Spontaneous	2010-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Altered state of consciousness (n/a - Not Specified - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Not Specified - Caused/Prolonged Hospitalisation);Hypotension (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pulse abnormal (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4081074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4075878	Spontaneous	2010-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Circulatory collapse (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Condition aggravated (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])...	[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALMETEROL, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4075878&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4071315	Spontaneous	2010-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuropathy peripheral (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Parenteral])|TRIZIVIR 300 MG/150 MG/300 MG FILM-COATED TABLETS [ZIDOVUDINE, ABACAVIR SULFATE, LAMIVUDINE, ZIDOVUDINE, ABACAVIR, LAMIVUDINE] (S - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Parenteral])|[ALGELDRATE, HEPATITIS B SURFACE ANTIGENS RECOMBINANT (S, PRE-S2), HEPATITIS B SURFACE ANTIGEN (RDNA), HEPATITIS B SURFACE ANTIGENS RECOMBINANT (S, PRE-S2)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4071315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4064312	Spontaneous	2010-10-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4064312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4056241	Spontaneous	2010-10-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Diplegia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4056241&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4058069	Spontaneous	2010-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diarrhoea (10d - Recovered/Resolved - );Fatigue (10d - Recovered/Resolved - );Headache (10d - Recovered/Resolved - );Rhinorrhoea (10d - Recovered/Resolved - );Throat irritation (10d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 45ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4058069&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4058169	Spontaneous	2010-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CARBAMAZEPINE] (C - n/a - Dose not changed - [n/a - 7mL - Oral])|[TOPIRAMATE] (C - n/a - Dose not changed - [n/a - 75mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4058169&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4054878	Spontaneous	2010-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Eye pain (n/a - Recovered/Resolved - Other Medically Important Condition);Optic neuritis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4054878&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4050534	Spontaneous	2010-10-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	NOVOMIX 30 PENFILL [INSULIN ASPART, INSULIN ASPART, INSULIN ASPART PROTAMINE] (C - Diabetes mellitus - n/a - [n/a - n/a - Subdermal])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - n/a])|[CARBAMAZEPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[FELODIPINE] (C - n/a - n/a - [n/a - 10mg - n/a])|[FLUVASTATIN] (C - n/a - n/a - [n/a - 20mg - n/a])|[GLIMEPIRIDE] (C - Diabetes mellitus - n/a - [n/a - 3mg - Oral])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 200mg - n/a])|[MOXONIDINE] (C - n/a - n/a - [n/a - .4mg - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 10mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4050534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4050924	Spontaneous	2010-10-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4050924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4041176	Spontaneous	2010-10-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza A virus test positive (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rhinorrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4041176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4039372	Spontaneous	2010-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Erythema (2d - Recovered/Resolved - Other Medically Important Condition);Extensive swelling of vaccinated limb (2d - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4039372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4040059	Spontaneous	2010-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dysgraphia (n/a - Unknown - Other Medically Important Condition);Haematoma (n/a - Unknown - Other Medically Important Condition);Injection site reaction (n/a - Unknown - Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Peripheral swelling (n/a - Unknown - Other Medically Important Condition);Rheumatoid arthritis (n/a - Unknown - Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[INFLUENZINUM] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	AERIUS [DESLORATADINE] (C - Hypersensitivity - n/a - [n/a - 5mg - n/a])|[BEZAFIBRATE] (C - Blood triglycerides - n/a - [n/a - 400mg - n/a])|[LEVOTHYROXINE SODIUM] (C - Hyperthyroidism - n/a - [n/a - 37.5ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4040059&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4033808	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination failure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4033808&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4034204	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Catarrh (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Lacrimation increased (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4034204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4030199	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4030199&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4024104	Spontaneous	2010-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cough (n/a - Not Recovered/Not Resolved - Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling);Sarcoidosis (n/a - Unknown - Disabling);Weight decreased (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4024104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4021009	Spontaneous	2010-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Congenital Anomaly)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4021009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4021262	Spontaneous	2010-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Ophthalmic herpes zoster (n/a - Unknown - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Immunisation - Drug withdrawn - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4021262&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4008510	Spontaneous	2010-10-06 00:00:00	Healthcare Professional	Non European Economic Area	Ametov A. Differential diagnosis of thyrotoxicosis in subjects with post-immunization reaction.. Klinicheskaia Meditsina 2010;88 N°1:73-78. Data migrated from the EudraVigilance E2B(R2) Literature repository	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Catarrh (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Endocrine ophthalmopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Goitre (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Graves' disease (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperthyroidism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pallor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Petechiae (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tongue disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tonsillitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Urticaria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4008510&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4002022	Spontaneous	2010-10-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4002022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3998791	Spontaneous	2010-09-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Blister (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Erythema (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Generalised oedema (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Leukocytosis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Mouth ulceration (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pruritus (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Purulent discharge (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Skin necrosis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Stevens-Johnson syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3998791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-3976438	Spontaneous	2010-09-20 00:00:00	Healthcare Professional	Non European Economic Area	Garcia-Robledo M, Hierro-Orozco S, Achell-Nava L, Jaimes-Hernandez V. Leukocytioclastic vasculitis post-vaccination against influenza : a report of a case and bibliographical review. Dermatologia Revista Mexicana 2010 Mar;VOL 54:80-83.	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Cutaneous vasculitis (23d - Recovered/Resolved - Other Medically Important Condition);Dysaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Nodule (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Raynaud's phenomenon (n/a - Recovered/Resolved - Other Medically Important Condition);Temperature intolerance (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3976438&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-3964918	Spontaneous	2010-09-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	0-1 Month	Not Specified	No	Male	Cardiac failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Cerebral haemorrhage (n/a - Not Specified - Results in Death, Caused/Prolonged Hospitalisation);Coma (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Immune thrombocytopenia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Petechiae (n/a - Not Specified - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3964918&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-3964977	Spontaneous	2010-09-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Breath sounds abnormal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Coma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Shock (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[SODIUM VALPROATE] (C - Epilepsy - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3964977&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3959930	Spontaneous	2010-09-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cellulitis (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Tenderness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3959930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3959938	Spontaneous	2010-09-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Periorbital oedema (12.5h - Recovered/Resolved - Other Medically Important Condition);Pruritus (12.5h - Recovered/Resolved - Other Medically Important Condition);Vaccination site induration (12.5h - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3959938&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3953730	Spontaneous	2010-09-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Neurological symptom (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3953730&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3953732	Spontaneous	2010-09-09 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Schumacher Z, Bourquin C, Heininger U. Surveillance for adverse events following immunisation (AEFI) in Switzerland -1991-2001. Vaccine (2010),doi:10.1016/j.vaccine.2010.04.002.	65-85 Years	Not Specified	No	Male	Multiple organ dysfunction syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Nausea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[DOMPERIDONE, DOMPERIDONE MALEATE] (C - Nausea - n/a - [n/a - n/a - n/a])|[SULFOGAIACOL, SODIUM BENZOATE, CODEINE] (C - Pyrexia - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3953732&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-3950167	Spontaneous	2010-09-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Influenza A virus test positive (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3950167&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3950169	Spontaneous	2010-09-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Rhinorrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Syncope (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Tremor (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3950169&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3944420	Spontaneous	2010-09-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bladder disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Micturition urgency (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation);Myelitis transverse (n/a - Unknown - Caused/Prolonged Hospitalisation);Nervous system disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Urinary retention (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3944420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934761	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Influenza A virus test positive (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934763	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Influenza A virus test positive (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934765	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cough (5d - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza A virus test positive (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (1d - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rhinorrhoea (5d - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934766	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza A virus test positive (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934767	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza A virus test positive (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rhinorrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934786	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Influenza A virus test positive (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934786&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934787	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Influenza A virus test positive (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3934788	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Influenza A virus test positive (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934814	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Influenza A virus test positive (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934814&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934815	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Influenza A virus test positive (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3934818	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Influenza B virus test positive (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934819	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Influenza B virus test positive (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934819&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934820	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Influenza A virus test positive (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934820&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934821	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Influenza A virus test positive (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934821&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934823	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Influenza A virus test positive (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934840	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Influenza A virus test positive (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934840&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934841	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Influenza A virus test positive (n/a - Not Specified - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3934843	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Influenza A virus test positive (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934843&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3934845	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Influenza A virus test positive (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3934857	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Influenza A virus test positive (n/a - Not Specified - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3934862	Spontaneous	2010-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Influenza B virus test positive (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3934862&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3932682	Spontaneous	2010-08-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Arthralgia (n/a - Not Specified - Other Medically Important Condition);Fatigue (n/a - Not Specified - Other Medically Important Condition);Gait disturbance (n/a - Not Specified - Other Medically Important Condition);Hypoaesthesia (n/a - Not Specified - Other Medically Important Condition);Malaise (n/a - Not Specified - Other Medically Important Condition);Myalgia (n/a - Not Specified - Other Medically Important Condition);Myositis (7d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3932682&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3932701	Spontaneous	2010-08-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Decreased activity (0d - Recovered/Resolved - );Irritability (0d - Recovered/Resolved - );Pyrexia (0d - Recovered/Resolved - );Rash (0d - Recovered/Resolved - );Vomiting (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[VARICELLA VACCINE (LIVE)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3932701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3924111	Spontaneous	2010-08-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dermatitis (n/a - Not Specified - Disabling);Eyelid ptosis (n/a - Not Specified - Disabling);Neuritis cranial (n/a - Not Specified - Disabling);Oedema (n/a - Not Specified - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3924111&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-3924173	Spontaneous	2010-08-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (2wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[HYDROCHLOROTHIAZIDE, LOSARTAN, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - .1mg - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [1mo - 1{DF} - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[TRIMETAZIDINE, TRIMETAZIDINE DIHYDROCHLORIDE] (C - n/a - n/a - [1wk - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3924173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3924399	Spontaneous	2010-08-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Immune thrombocytopenia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3924399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3919362	Spontaneous	2010-08-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Febrile convulsion (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaria (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3919362&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3919368	Spontaneous	2010-08-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rhinorrhoea (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3919368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3919407	Spontaneous	2010-08-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rhinorrhoea (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3919407&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3915299	Spontaneous	2010-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Allodynia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Amyotrophy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Decreased vibratory sense (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Diplegia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dysphagia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Dysphonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);IIIrd nerve paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Paresis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Urinary incontinence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOCETIRIZINE, LEVOCETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3915299&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3907742	Spontaneous	2010-08-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (2d - Recovered/Resolved - );Headache (2d - Recovered/Resolved - );Malaise (2d - Recovered/Resolved - );Pain (2d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3907742&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3907793	Spontaneous	2010-08-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (2d - Recovered/Resolved - );Feeling hot (2d - Recovered/Resolved - );Localised oedema (2d - Recovered/Resolved - );Malaise (2d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - );Pain (2d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3907793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3907828	Spontaneous	2010-08-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (1d - Recovered/Resolved - );Feeling hot (1d - Recovered/Resolved - );Localised oedema (1d - Recovered/Resolved - );Pain (1d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3907828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3907840	Spontaneous	2010-08-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (7d - Recovered/Resolved - );Chills (7d - Recovered/Resolved - );Cough (7d - Recovered/Resolved - );Malaise (7d - Recovered/Resolved - );Myalgia (7d - Recovered/Resolved - );Pyrexia (7d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3907840&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3907882	Spontaneous	2010-08-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3907882&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3907887	Spontaneous	2010-08-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Pyrexia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3907887&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3907889	Spontaneous	2010-08-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3907889&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3907891	Spontaneous	2010-08-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [1mo - n/a - Unknown])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - n/a - [1mo - n/a - Unknown])|[OXYMETAZOLINE] (C - n/a - n/a - [1mo - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3907891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3907924	Spontaneous	2010-08-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3907924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3902172	Spontaneous	2010-08-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Influenza (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3902172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3893234	Spontaneous	2010-08-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Influenza (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3893234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3888694	Spontaneous	2010-08-09 00:00:00	Healthcare Professional	Non European Economic Area	Kit Yuen S, Lin Wong M, Kay Chan Y, Kai Chow C, Wah Tse M. SIADH After Influenza Vaccination. Hong Kong J Nephrol 2010 Apr;39-40.	65-85 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Inappropriate antidiuretic hormone secretion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - n/a - n/a - [n/a - n/a - Oral])|[FAMOTIDINE] (C - n/a - n/a - [n/a - 20mg - Oral])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3888694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3866962	Spontaneous	2010-07-29 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3866962&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3861888	Spontaneous	2010-07-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Anuria (n/a - Not Specified - Caused/Prolonged Hospitalisation);Bladder dilatation (n/a - Not Specified - Caused/Prolonged Hospitalisation);Demyelination (n/a - Unknown - Caused/Prolonged Hospitalisation);Diplopia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Headache (n/a - Not Specified - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Skin lesion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - n/a - [n/a - n/a - n/a])|[LORMETAZEPAM] (C - Rhinitis allergic - n/a - [n/a - n/a - Nasal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3861888&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3858735	Spontaneous	2010-07-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Acute generalised exanthematous pustulosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])|[PNEUMOCOCCAL CONJUGATE VACCINE, PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (7-VALENT, ADSORBED)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3858735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3854815	Spontaneous	2010-07-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (3d - Not Specified - Caused/Prolonged Hospitalisation);Influenza (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (3d - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (3d - Not Specified - Caused/Prolonged Hospitalisation);Rhinorrhoea (3d - Not Specified - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - n/a - [n/a - n/a - Nasal])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Nasal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3854815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3854820	Spontaneous	2010-07-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3854820&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3838676	Spontaneous	2010-07-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Constipation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Peripheral sensory neuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pollakiuria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sciatica (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Urinary tract disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Urinary tract infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[AVOCADO OIL UNSAPONIFIABLES, SOYBEAN OIL UNSAPONIFIABLES, SOYA OIL, AVOCADO OIL] (C - n/a - n/a - [n/a - 300mg - n/a])|[DRY EXTRACT OF GINKGO BILOBA LEAVES (35-67:1), EXTRACTION SOLVENT: ACETONE 60% ( M / M), GINKGO BILOBA EXTRACT, GINKGO BILOBA L., FOLIUM (DRY EXTRACT), GINKGO BILOBAE EXTRACTUM SICCUM NORMATUM, GINKGO LEAF DRY EXTRACT, REFINED AND QUANTIFIED, REFINED AND QUANTIFIED GINKGO DRY EXTRACT (35-67:1), CORRESPONDING TO 8.80-10.80 MG OF FLAVONOIDS EXPRESSED AS FLAVONE GLYCOSIDES, 1.12-1.36 MG OF GINKGOLIDES A, B AND C, 1.04-1.28 MG OF BILOBALIDE, EXTRACTION SOLVENT: ACETONE 60% M/M, STANDARDISED GINKGO BILOBA EXTRACT] (C - n/a - n/a - [n/a - 40mg - n/a])|[GRAPES (DRY SEED) STANDARDIZED PROCYANIDOLIC OLIGOMERS, PROCYANIDOL OLIGOMER] (C - n/a - n/a - [n/a - 150mg - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 75ug - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - 1g - n/a])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3838676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3840009	Spontaneous	2010-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Kavadas F, Bitnun A, MacGregor D. Acute Neurological Events Associated with Influenza Vaccination: Are the WHO Criteria for Assessing Causality Adequate?. Scandinavian Journal of Infectious Diseases 2008;565-570.	3-11 Years	Not Specified	Yes	Female	Agitation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Altered state of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Ataxia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Athetosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Choreoathetosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysarthria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Encephalitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscle twitching (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myoclonus (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Speech disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vasculitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3840009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3831867	Spontaneous	2010-07-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Insomnia (n/a - Unknown - Other Medically Important Condition);Mental disorder (n/a - Unknown - Other Medically Important Condition);Tinnitus (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3831867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3823577	Spontaneous	2010-07-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Sarcoidosis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[GLICLAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3823577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-3808553	Spontaneous	2010-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Neuritis (n/a - Not Specified - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3808553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3788251	Spontaneous	2010-06-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Brain injury (40d - Not Specified - Caused/Prolonged Hospitalisation);Ecchymosis (n/a - Not Specified - Caused/Prolonged Hospitalisation);Epididymitis (n/a - Not Specified - Caused/Prolonged Hospitalisation);Hydrocele (n/a - Not Specified - Caused/Prolonged Hospitalisation);Nephritis (40d - Not Specified - Caused/Prolonged Hospitalisation);Petechiae (n/a - Not Specified - Caused/Prolonged Hospitalisation);Seizure (n/a - Not Specified - Caused/Prolonged Hospitalisation);Vascular purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3788251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3788301	Spontaneous	2010-06-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Lymphadenopathy (n/a - Not Specified - Caused/Prolonged Hospitalisation);Lymphangioma (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3788301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3776127	Spontaneous	2010-06-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (3d - Recovered/Resolved - );Injection site pain (3d - Recovered/Resolved - );Pyrexia (3d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[HEPATITIS B SURFACE ANTIGEN, HEPATITIS A VACCINE (INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[MENINGOCOCCAL GROUP A, C, W135 AND Y CONJUGATE VACCINE, N. MENINGITIDIS GROUP C POLYSACCHARIDE, N. MENINGITIDIS GROUP Y POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE, N. MENINGITIDIS GROUP C POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP Y, N. MENINGITIDIS GROUP C POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3776127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3761769	Spontaneous	2010-06-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Immune thrombocytopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3761769&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3730504	Spontaneous	2010-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myelitis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3730504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3724147	Spontaneous	2010-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Blood pressure decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Hot flush (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Laryngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Rash papular (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3724147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3722355	Spontaneous	2010-05-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Haemorrhage subcutaneous (122d - Not Specified - Other Medically Important Condition);Purpura (122d - Not Specified - Other Medically Important Condition);Thrombocytopenic purpura (123d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3722355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3722356	Spontaneous	2010-05-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Haemorrhage subcutaneous (n/a - Not Specified - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (199d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3722356&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3722357	Spontaneous	2010-05-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Chills (n/a - Not Specified - Caused/Prolonged Hospitalisation);Cyanosis (n/a - Not Specified - Caused/Prolonged Hospitalisation);Encephalitis viral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eye movement disorder (n/a - Not Specified - Caused/Prolonged Hospitalisation);Febrile convulsion (5min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (4d - Not Specified - Caused/Prolonged Hospitalisation);Trismus (n/a - Not Specified - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3722357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3722703	Spontaneous	2010-05-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nodal arrhythmia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3722703&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3719474	Spontaneous	2010-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Agranulocytosis (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[ALPRAZOLAM] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[FENOFIBRATE, FENOFIBRATE MICRONISED] (S - n/a - Drug withdrawn - [n/a - 200mg - n/a])|[LERCANIDIPINE HYDROCHLORIDE] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[RILMENIDINE, RILMENIDINE DIHYDROGEN PHOSPHATE] (S - n/a - Drug withdrawn - [n/a - 1{DF} - n/a])|[VALSARTAN] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[ZOPICLONE] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3719474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3714546	Spontaneous	2010-05-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Chest discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Conversion disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Disorientation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperventilation (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Presyncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3714546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3714547	Spontaneous	2010-05-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Chest discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Conversion disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Disorientation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Presyncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3714547&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3714548	Spontaneous	2010-05-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chest discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Conversion disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Disorientation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Presyncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3714548&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3714549	Spontaneous	2010-05-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chest discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Conversion disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Disorientation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Presyncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3714549&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3715129	Spontaneous	2010-05-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Chest discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Conversion disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Disorientation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperventilation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Presyncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3715129&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3711101	Spontaneous	2010-05-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Arthralgia (26d - Not Specified - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Joint range of motion decreased (26d - Not Specified - Caused/Prolonged Hospitalisation);Pharyngeal erythema (n/a - Not Specified - Caused/Prolonged Hospitalisation);Tonsillar hypertrophy (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3711101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3709213	Spontaneous	2010-05-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Lip oedema (24h - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3709213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3703046	Spontaneous	2010-05-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Facial paralysis (26d - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3703046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3703913	Spontaneous	2010-05-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (12mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (2mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Food intolerance (2mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (12mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (2mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash (2mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3703913&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3701992	Spontaneous	2010-05-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site erythema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[PANTOPRAZOLE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[TRAMADOL HYDROCHLORIDE, PARACETAMOL] (C - n/a - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3701992&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3702141	Spontaneous	2010-05-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site erythema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[PANTOPRAZOLE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[TRAMADOL HYDROCHLORIDE, PARACETAMOL] (C - n/a - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3702141&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3689504	Spontaneous	2010-05-07 00:00:00	Healthcare Professional	European Economic Area	Lisotti A. Reactivation of Crohn&apos;s disease after pandemic AH1N1 and seasonal flu vaccinations. Digestive and Liver Disease 2010;. Data migrated from the EudraVigilance E2B(R2) Literature repository	18-64 Years	Not Specified	No	Female	Abdominal abscess (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Abdominal mass (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Crohn's disease (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[AZATHIOPRINE] (C - n/a - n/a - [n/a - n/a - n/a])|[MESALAZINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3689504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3686587	Spontaneous	2010-05-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Choroiditis (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Nasal])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3686587&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3681024	Spontaneous	2010-05-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Acquired haemophilia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Haematoma (43d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	[AMLODIPINE BESILATE] (C - Hypertension - Dose not changed - [n/a - n/a - Oral])|[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - Epilepsy - Dose not changed - [n/a - n/a - Oral])|[LEVOTHYROXINE SODIUM] (C - Autoimmune thyroiditis - Dose not changed - [n/a - n/a - Oral])|[PAROXETINE] (C - Depression - Dose not changed - [n/a - n/a - Oral])|[SIMVASTATIN] (C - Dyslipidaemia - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3681024&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3681309	Spontaneous	2010-05-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Erythema multiforme (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (2d - Not Specified - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3681309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3681322	Spontaneous	2010-05-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Specified - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Not Specified - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3681322&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3674907	Spontaneous	2010-04-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Encephalitis viral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3674907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3675160	Spontaneous	2010-04-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Immune thrombocytopenia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3675160&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3672346	Spontaneous	2010-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (2wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[HYDROCHLOROTHIAZIDE, LOSARTAN, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - .1mg - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[TRIMETAZIDINE, TRIMETAZIDINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3672346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3672405	Spontaneous	2010-04-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Erythema (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Haemorrhage subcutaneous (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Henoch-Schonlein purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site papule (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Papule (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Petechiae (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pharyngitis (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tonsillar hypertrophy (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3672405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3672410	Spontaneous	2010-04-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Not Specified - Other Medically Important Condition);Facial paralysis (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Lethargy (n/a - Recovered/Resolved - Other Medically Important Condition);Oculofacial paralysis (n/a - Not Specified - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3672410&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3672411	Spontaneous	2010-04-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Cerebral infarction (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Specified - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Not Specified - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Subcutaneous])	[HEPATITIS B VACCINE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3672411&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3662473	Spontaneous	2010-04-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Drooling (n/a - Not Specified - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Lacrimation increased (n/a - Unknown - Other Medically Important Condition);Loss of consciousness (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (3d - Unknown - Other Medically Important Condition);Pain (3d - Unknown - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition);Rash (2d - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Unknown - Other Medically Important Condition);Sensory loss (n/a - Unknown - Other Medically Important Condition);Tonsillitis (n/a - Unknown - Other Medically Important Condition);Vaccination site inflammation (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Nasopharyngitis - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3662473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3659542	Spontaneous	2010-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Abdominal pain (n/a - Recovered/Resolved - );Eczema (n/a - Recovered/Resolved - );Hyperhidrosis (n/a - Recovered/Resolved - );Pallor (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3659542&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3655474	Spontaneous	2010-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - );Lymphadenitis (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3655474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3652997	Spontaneous	2010-04-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Psoriasis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	REMICADE [INFLIXIMAB] (C - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3652997&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3651203	Spontaneous	2010-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Thrombocytopenic purpura (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - n/a - [n/a - .5mg - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3651203&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3643344	Spontaneous	2010-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depressed level of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vertigo (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3643344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3638537	Spontaneous	2010-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dermatitis exfoliative generalised (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Skin exfoliation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3638537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3638585	Spontaneous	2010-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute polyneuropathy (111d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3638585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3630706	Spontaneous	2010-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3630706&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3632225	Spontaneous	2010-04-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Bursitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Condition aggravated (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Joint swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DICLOFENAC, DICLOFENAC SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3632225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3627855	Spontaneous	2010-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Fatal - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3627855&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-3617347	Spontaneous	2010-04-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Polymyalgia rheumatica (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3617347&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3612547	Spontaneous	2010-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Romberg test positive (n/a - Unknown - Disabling, Other Medically Important Condition);Vestibular neuronitis (n/a - Unknown - Disabling, Other Medically Important Condition);Vestibular nystagmus (n/a - Unknown - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3612547&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-3609545	Spontaneous	2010-03-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Epistaxis (2d - Not Specified - Caused/Prolonged Hospitalisation);Glomerulonephritis acute (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Mouth haemorrhage (2d - Not Specified - Caused/Prolonged Hospitalisation);Petechiae (n/a - Not Specified - Caused/Prolonged Hospitalisation);Purpura (10d - Not Specified - Caused/Prolonged Hospitalisation);Thrombocytopenic purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3609545&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3600205	Spontaneous	2010-03-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (1d - Recovered/Resolved - Other Medically Important Condition);Muscle twitching (2min - Not Specified - Other Medically Important Condition);Pharyngeal erythema (n/a - Not Specified - Other Medically Important Condition);Pyrexia (2d - Not Specified - Other Medically Important Condition);Upper respiratory tract infection (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3600205&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3600209	Spontaneous	2010-03-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal discomfort (n/a - Not Specified - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gastritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (1wk - Not Specified - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3600209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3600406	Spontaneous	2010-03-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Gastroenteritis rotavirus (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pharyngeal erythema (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Tonsillitis (n/a - Not Specified - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3600406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3601166	Spontaneous	2010-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Herpes simplex encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3601166&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3599340	Spontaneous	2010-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Aphonia (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (2mo - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Pharyngitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pneumococcal infection (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Respiratory disorder (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3599340&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3592379	Spontaneous	2010-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Sudden hearing loss (n/a - Recovered/Resolved - Disabling);Trigeminal neuralgia (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3592379&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-3592392	Spontaneous	2010-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	[HEPATITIS B VACCINE] (C - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3592392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3593346	Spontaneous	2010-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Dyspnoea (5d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Gingival oedema (5d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Palatal oedema (5d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Tongue oedema (5d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Tinnitus - n/a - [n/a - 100mg - n/a])|[BROMAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[CALCIUM DOBESILATE, CALCIUM DOBESILATE MONOHYDRATE] (C - Tinnitus - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL, MANGANESE SULPHATE MONOHYDRATE, ZINC OXIDE, CALCIUM CARBONATE, CUPRIC OXIDE, MAGNESIUM OXIDE, BORAX, COLECALCIFEROL, SODIUM TETRABORATE CRYST., ZINC OXIDE, CALCIUM CARBONATE, CUPRIC OXIDE, MAGNESIUM OXIDE, MANGANESE SULFATE, COLECALCIFEROL, ZINC OXIDE, CALCIUM CARBONATE, CUPRIC OXIDE, MAGNESIUM OXIDE, MANGANESE SULFATE, BORAX] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3593346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3589419	Spontaneous	2010-03-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Periarthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3589419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3589782	Spontaneous	2010-03-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Acute polyneuropathy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Facial paresis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Walking disability (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[CARVEDILOL] (C - n/a - n/a - [n/a - .5{DF} - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - .5{DF} - n/a])|[QUINAPRIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - .5{DF} - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - .5{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3589782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-3586754	Spontaneous	2010-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (7d - Recovered/Resolved - );Headache (7d - Recovered/Resolved - );Lymphadenitis (7d - Recovered/Resolved - );Pyrexia (7d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED, ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALGELDRATE, HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALUMINIUM HYDROXIDE] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[YELLOW FEVER VACCINE (LIVE), YELLOW FEVER VIRUS STRAIN 17D-204 (LIVE, ATTENUATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3586754&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3584472	Spontaneous	2010-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Facial pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Otitis media acute (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tympanic membrane disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tympanic membrane hyperaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site pain (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3584472&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3583493	Spontaneous	2010-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Eczema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3583493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3580122	Spontaneous	2010-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute generalised exanthematous pustulosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])|[IBUPROFEN] (S - Headache - Drug withdrawn - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3580122&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3580129	Spontaneous	2010-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Meningitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Trigeminal neuralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3580129&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3569075	Spontaneous	2010-03-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3569075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3569367	Spontaneous	2010-03-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Flushing (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Musculoskeletal pain (n/a - Not Recovered/Not Resolved - );Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Red blood cell sedimentation rate increased (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3569367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3565967	Spontaneous	2010-03-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Asthma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3565967&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3564706	Spontaneous	2010-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Polymyalgia rheumatica (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Dose not changed - [n/a - 100ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3564706&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3560685	Spontaneous	2010-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ataxia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);CSF test abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3560685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3554301	Spontaneous	2010-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Psoriasis (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[GLICLAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3554301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3550113	Spontaneous	2010-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Optic neuritis (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3550113&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-3550620	Spontaneous	2010-03-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cough (n/a - Not Specified - Other Medically Important Condition);Headache (n/a - Not Specified - Other Medically Important Condition);Lethargy (n/a - Not Specified - Other Medically Important Condition);Pain (n/a - Not Specified - Other Medically Important Condition);Pyrexia (n/a - Not Specified - Other Medically Important Condition);Rhinorrhoea (n/a - Not Specified - Other Medically Important Condition);Sputum discoloured (n/a - Not Specified - Other Medically Important Condition);Upper respiratory tract infection (1wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3550620&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3550750	Spontaneous	2010-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Facial paresis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Walking disability (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[CARVEDILOL] (C - n/a - n/a - [n/a - .5{DF} - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - .5{DF} - n/a])|[QUINAPRIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - .5{DF} - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - .5{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3550750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-3552545	Spontaneous	2010-03-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Agitation (15d - Recovered/Resolved - Other Medically Important Condition);Palpitations (15d - Recovered/Resolved - Other Medically Important Condition);Tachycardia (15d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 5mg - Oral])|[TRIMIPRAMINE, TRIMIPRAMINE MALEATE, TRIMIPRAMINE MESILATE] (C - n/a - n/a - [n/a - 25mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3552545&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3547811	Spontaneous	2010-03-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Pyrexia (0d - Recovered/Resolved - Other Medically Important Condition);Seizure (5min - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3547811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3539536	Spontaneous	2010-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Polymyositis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[MONTELUKAST, MONTELUKAST SODIUM] (C - Asthma - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3539536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3528054	Spontaneous	2010-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood pressure increased (4d - Recovered/Resolved - Other Medically Important Condition);Choking (4d - Recovered/Resolved - Other Medically Important Condition);Erythema (4d - Recovered/Resolved - Other Medically Important Condition);Headache (4d - Recovered/Resolved - Other Medically Important Condition);Visual impairment (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3528054&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3525164	Spontaneous	2010-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Cutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3525164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3525259	Spontaneous	2010-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Bronchospasm (0d - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3525259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3521351	Spontaneous	2010-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoventilation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neuritis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paresis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia aspiration (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory loss (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3521351&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3521787	Spontaneous	2010-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Dizziness (n/a - Not Specified - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Neuritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3521787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3521807	Spontaneous	2010-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Foetal death (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3521807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3517448	Spontaneous	2010-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Miller Fisher syndrome (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3517448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-3517481	Spontaneous	2010-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthma (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3517481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3517503	Spontaneous	2010-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Uveitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3517503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3517534	Spontaneous	2010-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Optic neuropathy (104d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[BEZAFIBRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[EPLERENONE] (C - n/a - n/a - [n/a - n/a - n/a])|[LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[NEBIVOLOL] (C - n/a - n/a - [n/a - n/a - n/a])|[OLMESARTAN, OLMESARTAN MEDOXOMIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3517534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Duration
EU-EC-3514637	Spontaneous	2010-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3514637&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3512940	Spontaneous	2010-02-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Encephalopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3512940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3513349	Spontaneous	2010-02-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Chills (3d - Not Specified - Caused/Prolonged Hospitalisation);Injection site cellulitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Soft tissue inflammation (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site hypersensitivity (3d - Not Specified - Caused/Prolonged Hospitalisation);Vaccination site inflammation (3d - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3513349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3506896	Spontaneous	2010-02-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cough (6d - Recovered/Resolved - Other Medically Important Condition);Eyelid oedema (5d - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (6d - Recovered/Resolved - Other Medically Important Condition);Inflammation (6d - Recovered/Resolved - Other Medically Important Condition);Nasal congestion (6d - Recovered/Resolved - Other Medically Important Condition);Pruritus (5d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (6d - Recovered/Resolved - Other Medically Important Condition);Rash erythematous (5d - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (6d - Recovered/Resolved - Other Medically Important Condition);Vaccination site inflammation (6d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3506896&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3506902	Spontaneous	2010-02-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dermatitis allergic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Inflammation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site inflammation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngeal erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tonsillitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3506902&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3501154	Spontaneous	2010-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Areflexia (n/a - Unknown - Other Medically Important Condition);Balance disorder (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Paraesthesia (8d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3501154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3501175	Spontaneous	2010-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Blood alkaline phosphatase increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Transaminases increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3501175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3498912	Spontaneous	2010-02-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Angioedema (4d - Recovered/Resolved - Other Medically Important Condition);Blister (2d - Not Specified - Other Medically Important Condition);Injection site reaction (3d - Recovering/Resolving - Other Medically Important Condition);Joint swelling (2d - Not Specified - Other Medically Important Condition);Peripheral swelling (2d - Not Specified - Other Medically Important Condition);Pyrexia (4d - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3498912&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3496387	Spontaneous	2010-02-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (6d - Recovered/Resolved - Other Medically Important Condition);Breath sounds abnormal (n/a - Not Specified - Other Medically Important Condition);Diarrhoea (5d - Not Specified - Other Medically Important Condition);Injection site inflammation (5d - Recovered/Resolved - Other Medically Important Condition);Injection site pruritus (5d - Not Specified - Other Medically Important Condition);Pharyngeal erythema (n/a - Not Specified - Other Medically Important Condition);Pyrexia (3d - Not Specified - Other Medically Important Condition);Rash (n/a - Not Specified - Other Medically Important Condition);Vomiting (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3496387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3491172	Spontaneous	2010-02-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition);Seizure (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3491172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3494172	Spontaneous	2010-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Vascular purpura (25d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	[CALCIUM CARBONATE, CHOLECALCIFEROL CONCENTRATE (POWDER FORM), CALCIUM, CHOLECALCIFEROL CONCENTRATE, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - Oral])|[DORZOLAMIDE HYDROCHLORIDE, TIMOLOL, DORZOLAMIDE HYDROCHLORIDE, TIMOLOL MALEATE, DORZOLAMIDE, TIMOLOL] (C - n/a - n/a - [n/a - n/a - Ophthalmic])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - Oral])|[ZOLPIDEM, ZOLPIDEM TARTRATE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3494172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3488028	Spontaneous	2010-02-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Dyspnoea (8d - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (4d - Not Specified - Caused/Prolonged Hospitalisation);Throat tightness (8d - Not Specified - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3488028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3488049	Spontaneous	2010-02-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscle twitching (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory tract infection (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3488049&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3488052	Spontaneous	2010-02-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Diplopia (n/a - Not Recovered/Not Resolved - Disabling);Strabismus (n/a - Not Recovered/Not Resolved - Disabling);VIth nerve paralysis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[GLIMEPIRIDE] (C - Diabetes mellitus - n/a - [n/a - 2mg - n/a])|[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - 500mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3488052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-3488515	Spontaneous	2010-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Asthmatic crisis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3488515&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3484534	Spontaneous	2010-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Quadriplegia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3484534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3475962	Spontaneous	2010-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Neuritis cranial (11d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3475962&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3466133	Spontaneous	2010-01-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .25mL - Unknown])|[MENINGOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3466133&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3466137	Spontaneous	2010-01-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Dizziness (5d - Not Specified - Caused/Prolonged Hospitalisation);Headache (5d - Not Specified - Caused/Prolonged Hospitalisation);Pain (5d - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (5d - Not Specified - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3466137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3450297	Spontaneous	2010-01-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute polyneuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3450297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3433836	Spontaneous	2010-01-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Bone disorder (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3433836&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3431076	Spontaneous	2010-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Inflammation (n/a - Recovered/Resolved - Disabling);Injected limb mobility decreased (n/a - Recovering/Resolving - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3431076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-3431101	Spontaneous	2010-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dizziness (1mo - Recovered/Resolved - Disabling);Sudden hearing loss (n/a - Recovering/Resolving - Disabling);Tinnitus (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3431101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-3420433	Spontaneous	2010-01-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Rash (n/a - Not Specified - Caused/Prolonged Hospitalisation);Stevens-Johnson syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - 10mg - n/a])|[GLICLAZIDE] (C - n/a - n/a - [n/a - 90mg - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - 1g - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3420433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3420447	Spontaneous	2010-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyskinesia (n/a - Unknown - Other Medically Important Condition);Eye movement disorder (n/a - Unknown - Other Medically Important Condition);Facial paralysis (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ANAS BARBARIAE HEPATIS ET CORDIS EXTRACTUM, ANAS BARBARIAE HEPATIS ET CORDIS EXTRACTUM K200] (C - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3420447&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3421775	Spontaneous	2010-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Face oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tongue oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3421775&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3416767	Spontaneous	2010-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysaesthesia (10d - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Limb discomfort (10d - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3416767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3415046	Spontaneous	2010-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Abdominal pain lower (5d - Recovered/Resolved - Other Medically Important Condition);Arthralgia (41d - Recovered/Resolved - Other Medically Important Condition);Asthenia (3wk - Recovered/Resolved - Other Medically Important Condition);Back pain (n/a - Recovered/Resolved - Other Medically Important Condition);Chest pain (4d - Recovered/Resolved - Other Medically Important Condition);Cough (41d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Joint swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Muscle spasms (1wk - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (14d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (41d - Recovered/Resolved - Other Medically Important Condition);Tinnitus (41d - Recovered/Resolved - Other Medically Important Condition);Vision blurred (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3415046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3409931	Spontaneous	2010-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	General physical health deterioration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Inflammation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3409931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3406799	Spontaneous	2010-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza like illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myasthenia gravis crisis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3406799&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3403050	Spontaneous	2010-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3403050&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3400295	Spontaneous	2010-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Vascular purpura (1mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ALPRAZOLAM] (C - n/a - n/a - [n/a - n/a - n/a])|[DIHYDROERGOTAMINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUVOXAMINE, FLUVOXAMINE MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3400295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3395193	Spontaneous	2009-12-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3395193&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3393960	Spontaneous	2009-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Erythema (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[ACEBUTOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3393960&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3384577	Spontaneous	2009-12-25 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Anaemia (n/a - Unknown - Other Medically Important Condition);Folate deficiency (n/a - Unknown - Other Medically Important Condition);Macrocytosis (n/a - Unknown - Other Medically Important Condition);Thrombocytopenia (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3384577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3384606	Spontaneous	2009-12-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dehydration (n/a - Unknown - Caused/Prolonged Hospitalisation);Hepatic cytolysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoxia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lung disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash maculo-papular (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 75mg - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - 5mg - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3384606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3384735	Spontaneous	2009-12-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bronchospasm (5min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (5min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Type III immune complex mediated reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3384735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-3379602	Spontaneous	2009-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Haemoptysis (28d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pulmonary embolism (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3379602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3380519	Spontaneous	2009-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Bronchospasm (4d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3380519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3380555	Spontaneous	2009-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Breath sounds abnormal (n/a - Not Specified - Other Medically Important Condition);Cough (n/a - Not Specified - Other Medically Important Condition);Eczema (n/a - Recovered/Resolved - Other Medically Important Condition);Ocular hyperaemia (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3380555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3380558	Spontaneous	2009-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cellulitis (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site inflammation (5d - Not Specified - Caused/Prolonged Hospitalisation);Peripheral swelling (5d - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (5d - Not Specified - Caused/Prolonged Hospitalisation);Tonsillitis (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3380558&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3380936	Spontaneous	2009-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Injection site inflammation (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3380936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3380939	Spontaneous	2009-12-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Breath sounds abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Pharyngeal erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Skin infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Tonsillitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3380939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3376145	Spontaneous	2009-12-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Gait disturbance (8d - Not Specified - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Osteoarthritis (8d - Not Specified - Caused/Prolonged Hospitalisation);Purpura (8d - Not Specified - Caused/Prolonged Hospitalisation);Throat tightness (7d - Not Specified - Caused/Prolonged Hospitalisation);Tonsillar hypertrophy (7d - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3376145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3371289	Spontaneous	2009-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypotonia (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (6h - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3371289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3371536	Spontaneous	2009-12-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Petit mal epilepsy (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3371536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3372781	Spontaneous	2009-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Vasculitis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3372781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3365252	Spontaneous	2009-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Ataxia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);CSF immunoglobulin increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);CSF white blood cell count increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Decreased vibratory sense (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Encephalomyelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sensory disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])|[ALUMINIUM, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM HYDROXIDE [PRODUCED IN S. CEREVISIAE (STRAIN 2150-2-3) BY RDNA], HEPATITIS B SURFACE ANTIGEN (RDNA), HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM HYDROXIDE [PRODUCED IN S. CEREVISIAE (STRAIN 2150-2-3) BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN, ALGELDRATE, HEPATITIS B VIRUS SURFACE ANTIGEN [PRODUCED IN S. CEREVISIAE CELLS BY RDNA] ADSORBED ON ALUMINUM HYDROXIDE, HYDRATED, ALGELDRATE] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3365252&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3361494	Spontaneous	2009-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cardiac arrest (1d - Fatal - Results in Death)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[ALLOPURINOL] (S - n/a - Dose not changed - [n/a - n/a - Oral])	[CHONDROITIN SULFATE SODIUM] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3361494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-3357816	Spontaneous	2009-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza (7d - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Parenteral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3357816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3358240	Spontaneous	2009-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (6d - Recovered/Resolved - Other Medically Important Condition);Back pain (11d - Recovered/Resolved - Other Medically Important Condition);Bradycardia (n/a - Recovered/Resolved - Other Medically Important Condition);Chest pain (11d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (6d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3358240&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3358584	Spontaneous	2009-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Circumoral oedema (1d - Recovered/Resolved - Other Medically Important Condition);Cough (1d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (1d - Recovered/Resolved - Other Medically Important Condition);Throat tightness (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - n/a - n/a - [n/a - n/a - n/a])|[DELORAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3358584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3353686	Spontaneous	2009-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthma (7d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - n/a - [n/a - n/a - Nasal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3353686&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3353753	Spontaneous	2009-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3353753&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3353759	Spontaneous	2009-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Blister (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Unknown - Other Medically Important Condition);Oedema (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Skin reaction (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])|[CLOBETASOL PROPIONATE] (S - n/a - n/a - [n/a - n/a - n/a])|[LEVOCETIRIZINE, LEVOCETIRIZINE DIHYDROCHLORIDE] (S - n/a - n/a - [n/a - n/a - n/a])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMIODARONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3353759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3353816	Spontaneous	2009-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3353816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3353821	Spontaneous	2009-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Drug reaction with eosinophilia and systemic symptoms (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3353821&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3352318	Spontaneous	2009-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eye pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypertonia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Meningeal disorder (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vertigo (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3352318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3352493	Spontaneous	2009-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Erythema (3d - Recovered/Resolved - );Peripheral swelling (3d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3352493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3349791	Spontaneous	2009-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Sensory disturbance (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3349791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3349841	Spontaneous	2009-12-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest pain (17d - Recovered/Resolved - );Dyspnoea (17d - Recovered/Resolved - );Palpitations (17d - Recovered/Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	LANTUS 100 IU/ML SOLUTION FOR INJECTION IN A CARTRIDGE [INSULIN GLARGINE] (C - Diabetes mellitus - Unknown - [n/a - 1{DF} - Subcutaneous])|[CHLORTALIDONE] (C - n/a - Unknown - [n/a - 25mg - Oral])|[DICLOFENAC SODIUM, MISOPROSTOL] (C - n/a - Unknown - [n/a - 50mg - Oral])|[GABAPENTIN] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[GLICLAZIDE] (C - n/a - Unknown - [n/a - 120mg - Oral])|[LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[PARACETAMOL] (C - n/a - Unknown - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3349841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-3346091	Spontaneous	2009-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Decreased vibratory sense (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - n/a - [n/a - n/a - n/a])|[ALUMINIUM, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM HYDROXIDE [PRODUCED IN S. CEREVISIAE (STRAIN 2150-2-3) BY RDNA], HEPATITIS B SURFACE ANTIGEN (RDNA), HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM HYDROXIDE [PRODUCED IN S. CEREVISIAE (STRAIN 2150-2-3) BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN, ALGELDRATE, HEPATITIS B VIRUS SURFACE ANTIGEN [PRODUCED IN S. CEREVISIAE CELLS BY RDNA] ADSORBED ON ALUMINUM HYDROXIDE, HYDRATED, ALGELDRATE] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3346091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3346150	Spontaneous	2009-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Rheumatoid factor (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3346150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3338006	Spontaneous	2009-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Dermatitis allergic (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Dose not changed - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3338006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3338114	Spontaneous	2009-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Herpes zoster (n/a - Recovered/Resolved - );Pruritus (n/a - Recovering/Resolving - );Somnolence (n/a - Recovered/Resolved - );Vision blurred (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Dose not changed - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Dose not changed - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3338114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-3338334	Spontaneous	2009-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3338334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3338347	Spontaneous	2009-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site erythema (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - );Injection site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3338347&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3338393	Spontaneous	2009-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Palpitations (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[VERAPAMIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3338393&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-3339291	Spontaneous	2009-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Tremor (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3339291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-3340022	Spontaneous	2009-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Thrombosis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3340022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-3340023	Spontaneous	2009-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Fixed eruption (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3340023&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-3340028	Spontaneous	2009-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Malaise (n/a - Recovered/Resolved - );Night sweats (n/a - Recovered/Resolved - );Ocular hyperaemia (n/a - Recovered/Resolved - );Oropharyngeal pain (n/a - Recovered/Resolved - );Pallor (n/a - Recovered/Resolved - );Productive cough (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3340028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3340136	Spontaneous	2009-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site erythema (n/a - Recovering/Resolving - );Injection site pain (n/a - Recovering/Resolving - );Injection site swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3340136&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3340165	Spontaneous	2009-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site induration (n/a - Recovered/Resolved - );Injection site pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3340165&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3329516	Spontaneous	2009-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthmatic crisis (2d - Recovered/Resolved - Other Medically Important Condition);Laryngospasm (2d - Recovered/Resolved - Other Medically Important Condition);Urticaria (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3329516&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3329559	Spontaneous	2009-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bronchospasm (n/a - Unknown - Other Medically Important Condition);Chest pain (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Hyperthermia (n/a - Unknown - Other Medically Important Condition);Increased bronchial secretion (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	LYRICA [PREGABALIN] (C - n/a - n/a - [n/a - 300mg - n/a])|[BACLOFEN, BACLOFEN PH. EUR.] (C - n/a - n/a - [n/a - 25mg - n/a])|[ENOXAPARIN SODIUM] (C - n/a - n/a - [n/a - .4mL - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - 25mg - n/a])|[TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 150mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3329559&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3329586	Spontaneous	2009-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Deafness neurosensory (3d - Recovered/Resolved - );Eye pain (1d - Recovered/Resolved - );Tinnitus (3d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (S - Prophylaxis - Dose not changed - [n/a - 1{DF} - Oral])|[PROPRANOLOL HYDROCHLORIDE] (S - Essential tremor - Dose not changed - [n/a - 1{DF} - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (S - Dyslipidaemia - Dose not changed - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3329586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-3329634	Spontaneous	2009-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Muscle contractions involuntary (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3329634&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-3329651	Spontaneous	2009-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Dose not changed - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3329651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-3331122	Spontaneous	2009-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Bronchospasm (0d - Recovered/Resolved - Other Medically Important Condition);Contraindication to vaccination (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[SALMETEROL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3331122&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3327277	Spontaneous	2009-12-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Skin reaction (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Unknown - [n/a - n/a - n/a])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3327277&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3321259	Spontaneous	2009-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - Other Medically Important Condition);Body temperature increased (n/a - Not Specified - Other Medically Important Condition);Hyperhidrosis (n/a - Not Specified - Other Medically Important Condition);Injection site oedema (n/a - Not Specified - Other Medically Important Condition);Myalgia (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[KETOTIFEN, KETOTIFEN HYDROGEN FUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3321259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3321283	Spontaneous	2009-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Not Specified - Other Medically Important Condition);Hyperhidrosis (n/a - Not Specified - Other Medically Important Condition);Myalgia (n/a - Not Specified - Other Medically Important Condition);Nausea (n/a - Not Specified - Other Medically Important Condition);Pyrexia (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ISOSORBIDE MONONITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3321283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3315333	Spontaneous	2009-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Haemolysis (n/a - Unknown - Other Medically Important Condition);Hyperpyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[FOLIC ACID] (C - n/a - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3315333&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3307402	Spontaneous	2009-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cellulitis (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site inflammation (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3307402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3307403	Spontaneous	2009-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Injection site cellulitis (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site inflammation (7d - Not Specified - Caused/Prolonged Hospitalisation);Pharyngeal erythema (6d - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (7d - Not Specified - Caused/Prolonged Hospitalisation);Tonsillitis (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3307403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3305496	Spontaneous	2009-11-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (30d - Recovered/Resolved - Other Medically Important Condition);Dizziness (30d - Recovered/Resolved - Other Medically Important Condition);Fatigue (30d - Recovered/Resolved - Other Medically Important Condition);Guillain-Barre syndrome (30d - Recovered/Resolved - Other Medically Important Condition);Presyncope (30d - Recovered/Resolved - Other Medically Important Condition);Vertigo (30d - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3305496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3301554	Spontaneous	2009-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Hypersensitivity (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3301554&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3301566	Spontaneous	2009-11-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	Yes	Female	Confusional state (n/a - Recovering/Resolving - );Dehydration (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	NON SPECIFIED DRUG [NOT AVAILABLE] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3301566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3301572	Spontaneous	2009-11-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Insomnia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3301572&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3301853	Spontaneous	2009-11-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site erythema (3wk - Recovered/Resolved - );Injection site pain (3wk - Recovered/Resolved - );Injection site pruritus (3wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3301853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3301854	Spontaneous	2009-11-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Feeling cold (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3301854&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3297796	Spontaneous	2009-11-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (0d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site reaction (0d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Muscular weakness (0d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	BETA BLOCKING AGENTS [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3297796&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-3291550	Spontaneous	2009-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3291550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3291605	Spontaneous	2009-11-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3291605&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3291607	Spontaneous	2009-11-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Arthralgia (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Injection site induration (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3291607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3279014	Spontaneous	2009-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3279014&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3279530	Spontaneous	2009-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dyspnoea (0d - Recovered/Resolved - Other Medically Important Condition);Syncope (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3279530&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3274880	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Chills (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3274880&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3274930	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site erythema (n/a - Recovered/Resolved - );Injection site pruritus (n/a - Recovered/Resolved - );Injection site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - Unknown - [n/a - 25mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3274930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3274932	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site induration (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	[ENALAPRIL MALEATE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3274932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3274981	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	Yes	Female	Erythema (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3274981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275061	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site induration (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	AVAMYS 27.5 MICROGRAMS/SPRAY [FLUTICASONE FUROATE] (C - n/a - Dose not changed - [n/a - 2{DF} - Nasal])|[FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275061&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275084	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Flushing (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Lacrimation increased (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275084&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275085	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275085&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275087	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site erythema (n/a - Recovering/Resolving - );Injection site induration (n/a - Recovering/Resolving - );Injection site swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275087&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275091	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275092	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275093	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275093&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275094	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275097	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275097&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275106	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Eye pruritus (n/a - Recovered/Resolved - );Eyelid oedema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Dose not changed - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275107	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275107&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275108	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Chills (n/a - Recovered/Resolved - );Dizziness (n/a - Recovered/Resolved - );Dyspnoea (n/a - Recovered/Resolved - );Injection site induration (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	AERIUS 5 MG FILM-COATED TABLET [DESLORATADINE] (C - n/a - n/a - [n/a - 5mg - Oral])|[FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Dose not changed - [n/a - 2{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275108&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-3275109	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Body temperature increased (n/a - Recovered/Resolved - );Muscle rigidity (n/a - Recovered/Resolved - );Muscle twitching (n/a - Recovered/Resolved With Sequelae - );Paraesthesia (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275109&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-3275111	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Injection site induration (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275111&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275186	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Fatigue (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275188	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Diarrhoea (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	[RABEPRAZOLE SODIUM] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275188&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275193	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Peripheral swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[ENALAPRIL MALEATE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275193&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275219	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[CAPTOPRIL] (C - n/a - Unknown - [n/a - 25mg - Oral])|[FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275219&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3275298	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3275298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3277156	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Injection site erythema (n/a - Unknown - );Injection site pruritus (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	MICARDIS 40 MG TABLETS [TELMISARTAN] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[CIPROFLOXACIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[ESOMEPRAZOLE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[ETORICOXIB] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3277156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3277162	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Lymphadenopathy (n/a - Unknown - );Myalgia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3277162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3277170	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site induration (n/a - Recovered/Resolved - );Injection site pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3277170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3277172	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3277172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3277173	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Nasopharyngitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3277173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3277176	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Dose not changed - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3277176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3277177	Spontaneous	2009-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3277177&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3277289	Spontaneous	2009-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Anxiety (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Depressed mood (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Disorientation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3277289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3266640	Spontaneous	2009-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Encephalitis (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3266640&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3263900	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Lymphadenopathy (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Dose not changed - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Dose not changed - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263900&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263902	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Nausea (n/a - Recovering/Resolving - );Nightmare (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263902&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263903	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Abdominal pain (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263903&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263927	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Blood pressure increased (n/a - Not Recovered/Not Resolved - );Cough (n/a - Not Recovered/Not Resolved - );Ear infection (n/a - Not Recovered/Not Resolved - );Headache (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ETORICOXIB] (C - n/a - Dose not changed - [n/a - 90mg - Oral])|[HYDROXYCHLOROQUINE SULFATE] (C - n/a - Dose not changed - [n/a - 200mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263928	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dizziness (n/a - Recovered/Resolved With Sequelae - );Dyspnoea (n/a - Recovered/Resolved With Sequelae - );Injection site erythema (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - );Injection site swelling (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[DOXYCYCLINE HYCLATE] (C - Lyme disease - Dose not changed - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-3263931	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263932	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Diarrhoea (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - );Limb discomfort (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263933	Spontaneous	2009-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Lymphadenopathy (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263937	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263937&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263938	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Musculoskeletal pain (n/a - Unknown - );Paraesthesia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263938&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263939	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Cough (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263940	Spontaneous	2009-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Oedema peripheral (n/a - Recovered/Resolved - );Periorbital oedema (n/a - Recovered/Resolved - );Rash pruritic (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[METFORMIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263941	Spontaneous	2009-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Cough (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263941&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263942	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Body temperature increased (n/a - Recovering/Resolving - );Injection site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	APIDRA 100 U/ML SOLUTION FOR INJECTION IN VIAL [INSULIN GLULISINE] (C - n/a - Dose not changed - [n/a - 4[iU] - Subcutaneous])|LANTUS 100 IU/ML SOLUTION FOR INJECTION IN A CARTRIDGE [INSULIN GLARGINE] (C - n/a - Dose not changed - [n/a - 28[iU] - Subcutaneous])|[SIMVASTATIN] (C - n/a - Dose not changed - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263942&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263943	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Fatigue (n/a - Recovering/Resolving - );Hypoaesthesia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	[SALBUTAMOL] (C - n/a - Dose not changed - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263943&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263944	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Dose not changed - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Dose not changed - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263945	Spontaneous	2009-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site erythema (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3263946	Spontaneous	2009-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	Yes	Male	Abdominal pain (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Dose not changed - [n/a - 1{DF} - Nasal])|[CALCIUM] (C - n/a - Dose not changed - [n/a - 500mg - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Dose not changed - [n/a - 1{DF} - Respiratory (inhalation)])|[LACTITOL MONOHYDRATE] (C - n/a - Dose not changed - [n/a - 10mg - Oral])|[MONTELUKAST SODIUM] (C - n/a - Dose not changed - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3263946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3264030	Spontaneous	2009-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Hypersensitivity (n/a - Recovered/Resolved - );Ocular hyperaemia (n/a - Recovered/Resolved - );Rhinitis (n/a - Recovered/Resolved - );Swelling face (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	[METOPROLOL TARTRATE] (C - n/a - Dose not changed - [n/a - 100mg - Oral])|[SIMVASTATIN] (C - n/a - Dose not changed - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3264030&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3264144	Spontaneous	2009-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Dose not changed - [n/a - .5mL - Subcutaneous])	[ENALAPRIL MALEATE] (C - n/a - Dose not changed - [n/a - 20mg - Oral])|[HYDROCHLOROTHIAZIDE, TRIAMTERENE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3264144&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3264145	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Body temperature increased (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3264145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3264147	Spontaneous	2009-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Arthralgia (n/a - Recovering/Resolving - );Fatigue (n/a - Recovering/Resolving - );Hot flush (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3264147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3264149	Spontaneous	2009-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Palpitations (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ATENOLOL] (C - n/a - Dose not changed - [n/a - 50mg - Oral])|[ATORVASTATIN] (C - n/a - Dose not changed - [n/a - 10mg - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Dose not changed - [n/a - 13.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3264149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-3264184	Spontaneous	2009-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Influenza like illness (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	[ATENOLOL] (C - n/a - Dose not changed - [n/a - 100mg - Oral])|[ENALAPRIL MALEATE] (C - n/a - Dose not changed - [n/a - 20mg - Oral])|[OMEPRAZOLE] (C - n/a - Dose not changed - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3264184&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3264904	Spontaneous	2009-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dermatitis allergic (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[ACEPROMETAZINE MALEATE, DIPOTASSIUM CLORAZEPATE, ACEPROMAZINE MALEATE] (C - n/a - n/a - [n/a - .5{DF} - n/a])|[ALFUZOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - n/a])|[CLOMIPRAMINE, CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - 25mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3264904&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3256971	Spontaneous	2009-11-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3256971&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3240361	Spontaneous	2009-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Not Specified	Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3240361&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3235320	Spontaneous	2009-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])	ADROVANCE [ALENDRONIC ACID, COLECALCIFEROL, COLECALCIFEROL, ALENDRONATE SODIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BROMAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[FOSINOPRIL, FOSINOPRIL SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL, PARACETAMOL, CAFFEINE] (C - n/a - n/a - [n/a - n/a - n/a])|[SOTALOL, SOTALOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3235320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3235459	Spontaneous	2009-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Epistaxis (4d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[MENINGOCOCCAL GROUP A, C, W135 AND Y CONJUGATE VACCINE, N. MENINGITIDIS GROUP C POLYSACCHARIDE, N. MENINGITIDIS GROUP Y POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE, N. MENINGITIDIS GROUP C POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP Y, N. MENINGITIDIS GROUP C POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE, NEISSERIA MENINGITIDIS GROUP W135 POLYSACCHARIDE] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3235459&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3223852	Spontaneous	2009-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3223852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3219539	Spontaneous	2009-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - );Dysaesthesia (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3219539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3217138	Spontaneous	2009-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Purpura (5d - Recovered/Resolved - Other Medically Important Condition);Vascular purpura (5d - Recovered/Resolved - Other Medically Important Condition);Vasculitis (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3217138&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3217225	Spontaneous	2009-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3217225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3217256	Spontaneous	2009-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arrhythmia (7d - Recovered/Resolved - Other Medically Important Condition);Nausea (7d - Recovered/Resolved - Other Medically Important Condition);Vertigo (7d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[ALFACALCIDOL] (C - n/a - n/a - [n/a - .25ug - n/a])|[ALLOPURINOL] (C - n/a - n/a - [n/a - 100mg - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - 5mg - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - 40mg - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 5mg - n/a])|[RILMENIDINE, RILMENIDINE DIHYDROGEN PHOSPHATE] (C - n/a - n/a - [n/a - 1mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3217256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3206015	Spontaneous	2009-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pericarditis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3206015&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3200110	Spontaneous	2009-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Atrial fibrillation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3200110&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-3200130	Spontaneous	2009-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovering/Resolving - );Injection site erythema (n/a - Unknown - );Injection site swelling (n/a - Unknown - );Limb discomfort (n/a - Recovering/Resolving - );Malaise (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3200130&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-3200143	Spontaneous	2009-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	Yes	Female	Syncope (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CARBASALATE CALCIUM] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[INDAPAMIDE, PERINDOPRIL ARGININE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[ISOSORBIDE MONONITRATE] (C - n/a - Dose not changed - [n/a - 60mg - Oral])|[PREDNISOLONE] (C - n/a - Dose not changed - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3200143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-3200149	Spontaneous	2009-11-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Body temperature increased (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - );Injection site swelling (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3200149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3200185	Spontaneous	2009-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	NOT AVAILABLE (C - n/a - Not applicable - [n/a - 25mg - Oral])|[ACENOCOUMAROL] (C - n/a - Not applicable - [n/a - n/a - Oral])|[FUROSEMIDE] (C - n/a - Not applicable - [n/a - 60mg - Oral])|[PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - Not applicable - [n/a - 4mg - Oral])|[VERAPAMIL HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - 80mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3200185&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-3201416	Spontaneous	2009-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Medication error (n/a - Recovered/Resolved - );No adverse event (n/a - Not Specified - );Vaccination error (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3201416&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3183071	Spontaneous	2009-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (4d - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3183071&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3183090	Spontaneous	2009-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (2d - Recovered/Resolved - );Vertigo (2d - Recovered/Resolved - );Vomiting (2d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3183090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3183106	Spontaneous	2009-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Speech disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Stereotypy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3183106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3186094	Spontaneous	2009-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Formication (n/a - Not Specified - Other Medically Important Condition);Muscular weakness (n/a - Not Specified - Other Medically Important Condition);Pain in extremity (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[AESCIN, ESCIN, HEPARIN, DIETHYLAMINE SALICYLATE, AESCIN] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[ALFUZOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - .5{DF} - n/a])|[MESALAZINE] (C - n/a - n/a - [n/a - n/a - n/a])|[NAFTIDROFURYL OXALATE] (C - n/a - n/a - [n/a - 100mg - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - 20mg - n/a])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - 4mg - n/a])|[PIRACETAM] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3186094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3180957	Spontaneous	2009-10-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Gout (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])|[A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003)] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3180957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3176929	Spontaneous	2009-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (4d - Recovered/Resolved - Other Medically Important Condition);Erythema multiforme (2wk - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Intercostal neuralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Meningeal disorder (2d - Recovered/Resolved - Other Medically Important Condition);Neck pain (n/a - Recovered/Resolved - Other Medically Important Condition);Rash maculo-papular (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3176929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3171595	Spontaneous	2009-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3171595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3173433	Spontaneous	2009-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Allergy to vaccine (1d - Recovered/Resolved - Other Medically Important Condition);Respiratory failure (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3173433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3174434	Spontaneous	2009-10-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Chills (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Influenza like illness (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Dose not changed - [n/a - 2{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3174434&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3169844	Spontaneous	2009-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3169844&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-3170194	Spontaneous	2009-10-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site vesicles (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3170194&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3155237	Spontaneous	2009-10-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Mood altered (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3155237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3139360	Spontaneous	2009-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site erythema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Dose not changed - [n/a - n/a - Respiratory (inhalation)])|[METFORMIN] (C - n/a - Dose not changed - [n/a - 850mg - Oral])|[SALBUTAMOL] (C - n/a - Dose not changed - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3139360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3106964	Spontaneous	2009-09-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Chills (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3106964&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-3091801	Spontaneous	2009-09-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cerebral thrombosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chlamydial infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myelopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Peripheral sensory neuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3091801&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3088429	Spontaneous	2009-09-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3088429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3088977	Spontaneous	2009-09-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Coma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neuropathy peripheral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Quadriplegia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Status epilepticus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3088977&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3087076	Spontaneous	2009-09-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Polymyalgia rheumatica (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3087076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-3078433	Spontaneous	2009-09-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Sudden hearing loss (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3078433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3078517	Spontaneous	2009-09-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria chronic (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3078517&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3056005	Spontaneous	2009-09-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	C-reactive protein increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chest pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Leukocytosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3056005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3026750	Spontaneous	2009-08-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Productive cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhinitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[GEMFIBROZIL] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3026750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-3026751	Spontaneous	2009-08-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthma (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Staphylococcal infection (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	NEUROLEPTICS [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACEPROMETAZINE, MEPROBAMATE, MEPRONIZINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ALIMEMAZINE, ALIMEMAZINE TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE, SODIUM CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE, SODIUM CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE GEL, DRIED USP, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALUMINIUM HYDROXIDE GEL, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, SODIUM ALGINATE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DOMPERIDONE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OXYGEN] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[STERCULIA, STERCULIA GUM, STERCULIA URENS ROXB. GUM] (C - n/a - n/a - [n/a - n/a - n/a])|[TAMSULOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[VALPROMIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3026751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-3010727	Spontaneous	2009-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Complex regional pain syndrome (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Tendonitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=3010727&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2996211	Spontaneous	2009-08-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Allodynia (n/a - Not Specified - Disabling);Arthralgia (n/a - Not Specified - Disabling);Hyperaesthesia (n/a - Not Specified - Disabling);Radiculitis brachial (n/a - Unknown - Disabling);Tendonitis (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2996211&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-2980216	Spontaneous	2009-07-28 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2980216&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2980223	Spontaneous	2009-07-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Unknown - Other Medically Important Condition);Face oedema (n/a - Unknown - Other Medically Important Condition);Laryngeal oedema (n/a - Unknown - Other Medically Important Condition);Vaccination site reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2980223&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2981209	Spontaneous	2009-07-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactoid reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2981209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2979018	Spontaneous	2009-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Vestibular neuronitis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2979018&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2961206	Spontaneous	2009-07-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Febrile convulsion (.5min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2961206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2940237	Spontaneous	2009-07-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Pyrexia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2940237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2931511	Spontaneous	2009-07-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Haemorrhage (n/a - Unknown - );Petechiae (n/a - Unknown - );Thrombocytopenia (n/a - Unknown - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[AMLODIPINE, AMLODIPINE BESILATE] (S - n/a - n/a - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2931511&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-2905070	Spontaneous	2009-06-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pallor (0d - Not Specified - Caused/Prolonged Hospitalisation);Seizure (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2905070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2891667	Spontaneous	2009-06-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoproteinaemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Not Specified - Caused/Prolonged Hospitalisation);Physical disability (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pneumonia bacterial (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Slow response to stimuli (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Urethritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2891667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2891675	Spontaneous	2009-06-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Angioedema (13d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site reaction (13d - Not Specified - Caused/Prolonged Hospitalisation);Pain in extremity (13d - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (13d - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2891675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2868702	Spontaneous	2009-06-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Normocytic anaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Renal tubular necrosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Systemic lupus erythematosus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tubulointerstitial nephritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	MICARDISPLUS [HYDROCHLOROTHIAZIDE, TELMISARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACEBUTOLOL, ACEBUTOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOCETIRIZINE, LEVOCETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOLPIDEM TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2868702&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2869120	Spontaneous	2009-06-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vertigo positional (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2869120&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2865954	Spontaneous	2009-06-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema multiforme (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphocyte count decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	COAPROVEL [HYDROCHLOROTHIAZIDE, IRBESARTAN] (S - n/a - Drug withdrawn - [3d - n/a - Oral])|IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (S - Pyrexia - n/a - [6d - n/a - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [1d - n/a - n/a])|[FENOFIBRATE, FENOFIBRATE (NANONISED)] (S - n/a - n/a - [n/a - n/a - Oral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2865954&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2857840	Spontaneous	2009-06-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Acute lymphocytic leukaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Bronchitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2857840&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2857886	Spontaneous	2009-06-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Conjunctival hyperaemia (n/a - Not Specified - Life Threatening, Caused/Prolonged Hospitalisation);Face oedema (n/a - Not Specified - Life Threatening, Caused/Prolonged Hospitalisation);Multiple organ dysfunction syndrome (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Not Specified - Life Threatening, Caused/Prolonged Hospitalisation);Oropharyngeal discomfort (n/a - Not Specified - Life Threatening, Caused/Prolonged Hospitalisation);Pruritus (n/a - Not Specified - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Rash (n/a - Not Specified - Life Threatening, Caused/Prolonged Hospitalisation);Tonsillitis bacterial (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Urticaria (n/a - Not Specified - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Specified - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2857886&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-2843729	Spontaneous	2009-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (3d - Recovered/Resolved - );Myalgia (3d - Recovered/Resolved - );Pyrexia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2843729&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2837970	Spontaneous	2009-05-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cough (n/a - Not Specified - Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Specified - Other Medically Important Condition);Rales (n/a - Not Specified - Other Medically Important Condition);Throat irritation (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2837970&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2839127	Spontaneous	2009-05-27 00:00:00	Not Specified	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Blister (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bronchopneumopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ecchymosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Faeces discoloured (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fall (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Haemoglobin decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Head injury (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpable purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (8640min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Subcutaneous])|[ANHYDROUS PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM] (S - Hypercalcaemia - Unknown - [1d - n/a - Intravenous (not otherwise specified)])|[ANHYDROUS PAMIDRONATE DISODIUM, PAMIDRONATE DISODIUM] (S - n/a - Unknown - [1d - n/a - Intravenous (not otherwise specified)])|[NADROPARIN CALCIUM] (S - Joint prosthesis user - Unknown - [31d - n/a - Subcutaneous])|[NADROPARIN CALCIUM] (S - n/a - Unknown - [11d - n/a - Subcutaneous])|[NITROFURANTOIN] (S - n/a - Drug withdrawn - [3d - n/a - Oral])	[DRIED FERROUS SULFATE, FERROUS SULFATE, FERROUS SULFATE HYDRATE, FERROUS SULPHATE SESQUIHYDRATE] (C - n/a - Unknown - [n/a - n/a - Oral])|[ETIDRONATE DISODIUM] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[LACTULOSE] (C - n/a - Unknown - [n/a - n/a - Oral])|[MIANSERIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[OFLOXACIN, OFLOXACIN HYDROCHLORIDE] (C - n/a - Unknown - [10d - n/a - Oral])|[PARACETAMOL] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2839127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2833506	Spontaneous	2009-05-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Abdominal pain upper (n/a - Not Specified - Caused/Prolonged Hospitalisation);Anaphylactic shock (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cyanosis (n/a - Not Specified - Caused/Prolonged Hospitalisation);Hypotension (n/a - Not Specified - Caused/Prolonged Hospitalisation);Peripheral coldness (n/a - Not Specified - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Specified - Caused/Prolonged Hospitalisation);Wheezing (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Rhinitis allergic - n/a - [1mo - n/a - n/a])|[ISONIAZID] (C - Tuberculosis - n/a - [n/a - n/a - n/a])|[RIFAMPICIN] (C - Tuberculosis - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2833506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2833529	Spontaneous	2009-05-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation);Swelling face (n/a - Unknown - Caused/Prolonged Hospitalisation);Urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2833529&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2834603	Spontaneous	2009-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Giant cell arteritis (n/a - Unknown - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Unknown - Other Medically Important Condition);Rheumatic disorder (n/a - Unknown - Other Medically Important Condition);Visual impairment (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2834603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2826581	Spontaneous	2009-05-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Injected limb mobility decreased (n/a - Not Specified - Other Medically Important Condition);Injection site pain (n/a - Not Specified - Other Medically Important Condition);Injection site pruritus (n/a - Not Specified - Other Medically Important Condition);Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (n/a - Not Specified - Other Medically Important Condition);Injection site ulcer (n/a - Recovered/Resolved - Other Medically Important Condition);Lethargy (n/a - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Not Specified - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2826581&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2827101	Spontaneous	2009-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Lichen planus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	[CLONAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[PROMETHAZINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SULPIRIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2827101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2815283	Spontaneous	2009-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Borrelia test positive (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eczema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Erythema nodosum (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Livedo reticularis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lyme disease (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lymphocytic infiltration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash erythematous (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Skin plaque (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[VALSARTAN] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2815283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2804972	Spontaneous	2009-05-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Abscess (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Febrile convulsion (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperkeratosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperpyrexia (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site swelling (3mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2804972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2799357	Spontaneous	2009-05-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Seizure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[VARICELLA VIRUS OKA STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2799357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2781245	Spontaneous	2009-04-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (7h - Recovered/Resolved - Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Lip swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Vertigo (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, ACETYLSALICYLIC ACID, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - 10mg - Oral])|[NIFEDIPINE] (C - n/a - n/a - [n/a - 30mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2781245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2740226	Spontaneous	2009-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Erythema (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site oedema (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2740226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2742669	Spontaneous	2009-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2742669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2742670	Spontaneous	2009-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2742670&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2742684	Spontaneous	2009-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Drug ineffective (n/a - Unknown - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2742684&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2730942	Spontaneous	2009-04-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bronchial hyperreactivity (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (60d - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (60d - Recovered/Resolved - Other Medically Important Condition);Superinfection (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2730942&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-2728003	Spontaneous	2009-04-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Bradycardia (2h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Circulatory collapse (2h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hyperhidrosis (2h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pallor (2h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Seizure (2h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2728003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-2728004	Spontaneous	2009-04-08 00:00:00	Healthcare Professional	Non European Economic Area	Cheng S.T., Hu S.C., Ke C.L., Chen G.S.. Parallel correlation of immunofluorescence studies with clinical course in a patient with influenza vaccine induced lymphocytic vasculitis. JEADV 2009:23:441-496.	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Cutaneous vasculitis (1a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Not Specified - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Necrosis (n/a - Not Specified - Caused/Prolonged Hospitalisation);Palpable purpura (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Rash (n/a - Not Specified - Caused/Prolonged Hospitalisation);Skin mass (n/a - Not Specified - Caused/Prolonged Hospitalisation);Skin ulcer (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2728004&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2728005	Spontaneous	2009-04-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Anaphylactic shock (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2728005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2716034	Spontaneous	2009-04-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Paralysis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2716034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2708942	Spontaneous	2009-03-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Conjunctivitis (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Febrile convulsion (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2708942&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2708954	Spontaneous	2009-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bell's palsy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2708954&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2708960	Spontaneous	2009-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cat scratch disease (1mo - Recovered/Resolved - Other Medically Important Condition);Injection site nodule (n/a - Recovered/Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2708960&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2703165	Spontaneous	2009-03-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Fall (2.5wk - Recovering/Resolving - Other Medically Important Condition);Gait disturbance (2.5wk - Recovering/Resolving - Other Medically Important Condition);Urinary tract infection (n/a - Unknown - Other Medically Important Condition);Weight bearing difficulty (2.5wk - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[INDOMETACIN] (C - n/a - n/a - [n/a - n/a - n/a])|[MORNIFLUMATE, TAMSULOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2703165&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2693843	Spontaneous	2009-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Cough (19d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Epistaxis (14d - Not Specified - Caused/Prolonged Hospitalisation);Haemorrhagic disorder (14d - Not Specified - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Productive cough (19d - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenic purpura (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2693843&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2684550	Spontaneous	2009-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Hyperpyrexia (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2684550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2676909	Spontaneous	2009-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Systemic lupus erythematosus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2676909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2675096	Spontaneous	2009-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Application site oedema (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dermatitis allergic (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eyelid oedema (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site pruritus (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lip oedema (12h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Asthma - n/a - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2675096&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-2671131	Spontaneous	2009-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Injection site erythema (n/a - Recovered/Resolved - );Oedema peripheral (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - n/a - Not applicable - [n/a - .5mL - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2671131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2668090	Spontaneous	2009-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site inflammation (3d - Recovered/Resolved - Other Medically Important Condition);Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Systemic lupus erythematosus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2668090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2668292	Spontaneous	2009-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Crying (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Streptococcal sepsis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2668292&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2670353	Spontaneous	2009-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthmatic crisis (n/a - Recovering/Resolving - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Unknown])|[FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE] (S - Asthma - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (S - n/a - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2670353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-2665172	Spontaneous	2009-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Acute kidney injury (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Photophobia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	[LEVOCETIRIZINE, LEVOCETIRIZINE DIHYDROCHLORIDE] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2665172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2662757	Spontaneous	2009-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site warmth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash pruritic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash pustular (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[HEPARIN, HEPARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2662757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2663401	Spontaneous	2009-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Angioedema (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Lip swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Salivary gland adenoma (n/a - Unknown - Other Medically Important Condition);Swelling face (n/a - Unknown - Other Medically Important Condition);Swollen tongue (n/a - Unknown - Other Medically Important Condition)	TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (C - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[LOSARTAN POTASSIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE, METOPROLOL SUCCINATE (PH. EUR.)] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2663401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2654356	Spontaneous	2009-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Seizure (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Dose not changed - [n/a - 1{DF} - Subcutaneous])	[ACETYLSALICYLIC ACID] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[BISOPROLOL HEMIFUMARATE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2654356&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-2647735	Spontaneous	2009-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Blood creatine phosphokinase increased (10mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hepatitis (10mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myositis (10mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (10mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2647735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2641948	Spontaneous	2009-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dysaesthesia (12d - Recovered/Resolved - );Headache (8d - Recovered/Resolved - );Myalgia (4d - Recovered/Resolved - );Paraesthesia (12d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2641948&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2640215	Spontaneous	2009-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Gait inability (n/a - Not Recovered/Not Resolved - Disabling);Muscle spasms (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Blood pressure measurement - n/a - [n/a - n/a - n/a])|[ATENOLOL, ATENOLOL BP] (C - Blood pressure measurement - n/a - [n/a - 50mg - n/a])|[HYDROCHLOROTHIAZIDE, LISINOPRIL] (C - Blood pressure measurement - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2640215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-2632820	Spontaneous	2009-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Fatal - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2632820&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2630482	Spontaneous	2009-02-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Erythema (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2630482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2628373	Spontaneous	2009-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Coordination abnormal (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Respiratory therapy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2628373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-2622436	Spontaneous	2009-02-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Skin necrosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vascular purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2622436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2612615	Spontaneous	2009-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Eosinophilia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash maculo-papular (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	EMEND [APREPITANT, FOSAPREPITANT DIMEGLUMINE] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])|[ONDANSETRON, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE DIHYDRATE] (S - n/a - Drug withdrawn - [n/a - 8mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2612615&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2597189	Spontaneous	2009-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myalgia (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2597189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2598313	Spontaneous	2009-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cough (1mo - Recovered/Resolved - Other Medically Important Condition);Influenza (1mo - Recovered/Resolved - Other Medically Important Condition);Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (1mo - Recovered/Resolved - Other Medically Important Condition);Productive cough (1mo - Recovered/Resolved - Other Medically Important Condition);Pyrexia (1mo - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[FINASTERIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2598313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2598319	Spontaneous	2009-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2598319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2576631	Spontaneous	2009-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Male	Back pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Neuromyopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2576631&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2562866	Spontaneous	2009-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Rheumatoid arthritis (2mo - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	METHOTREXATE [METHOTREXATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2562866&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2562870	Spontaneous	2009-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	C-reactive protein increased (14d - Recovered/Resolved - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);General physical health deterioration (n/a - Unknown - Other Medically Important Condition);Giant cell arteritis (n/a - Unknown - Other Medically Important Condition);Granulocytosis (7d - Recovered/Resolved - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Unknown - Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition);Visual impairment (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[OFLOXACIN, OFLOXACIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2562870&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2562871	Spontaneous	2009-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fall (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[EZETIMIBE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[GABAPENTIN] (C - n/a - n/a - [n/a - 300mg - n/a])|[MIANSERIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - 40mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2562871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2562887	Spontaneous	2009-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Acute sinusitis (n/a - Recovered/Resolved - Other Medically Important Condition);Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (20d - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (20d - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2562887&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2559261	Spontaneous	2009-01-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Henoch-Schonlein purpura (22d - Recovered/Resolved - Other Medically Important Condition);Rash (22d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2559261&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-2559273	Spontaneous	2009-01-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Decreased appetite (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site inflammation (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lethargy (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2559273&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2559503	Spontaneous	2009-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2559503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2560517	Spontaneous	2009-01-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Influenza like illness (n/a - Recovering/Resolving - );Injection site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[BECLOMETASONE DIPROPIONATE] (C - n/a - Dose not changed - [n/a - 2{DF} - Nasal])|[CARBASALATE CALCIUM] (C - n/a - Dose not changed - [n/a - 38mg - Oral])|[POVIDONE] (C - n/a - Dose not changed - [n/a - 1{DF} - Ophthalmic])|[TESTOSTERONE UNDECANOATE] (C - n/a - Dose not changed - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2560517&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2553634	Spontaneous	2009-01-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Breath sounds abnormal (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Drug eruption (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal discomfort (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2553634&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2551963	Spontaneous	2009-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Eosinophilia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Proteinuria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash morbilliform (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[DILTIAZEM, DILTIAZEM HYDROCHLORIDE] (S - n/a - n/a - [n/a - n/a - Oral])|[GLYCERYL TRINITRATE] (S - n/a - n/a - [n/a - n/a - Oral])|[GLYCERYL TRINITRATE] (S - n/a - n/a - [n/a - n/a - Transdermal])|[MESALAZINE] (S - n/a - Unknown - [11d - n/a - Rectal])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2551963&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2543919	Spontaneous	2009-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Vaginal haemorrhage (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2543919&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2536429	Spontaneous	2009-01-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2536429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2533783	Spontaneous	2009-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2533783&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2525845	Spontaneous	2009-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Therapeutic product ineffective (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - n/a - n/a])	[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Dose not changed - [n/a - 1{DF} - Respiratory (inhalation)])|[SALBUTAMOL] (C - n/a - Dose not changed - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2525845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2519650	Spontaneous	2009-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Balance disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Confusional state (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vertigo (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2519650&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2520127	Spontaneous	2009-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pyrexia (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2520127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2503996	Spontaneous	2009-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema nodosum (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2503996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2491889	Spontaneous	2008-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Blister (n/a - Recovered/Resolved - Other Medically Important Condition);Eczema (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Not Specified - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2491889&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2492162	Spontaneous	2008-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Myocardial infarction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2492162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2472282	Spontaneous	2008-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arthralgia (7d - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (7d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (7d - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 160mg - n/a])|[AMLODIPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2472282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2470018	Spontaneous	2008-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chills (5min - Recovered/Resolved - Other Medically Important Condition);Epilepsy (5min - Recovered/Resolved - Other Medically Important Condition);Petit mal epilepsy (5min - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2470018&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2467473	Spontaneous	2008-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Body temperature increased (n/a - Not Recovered/Not Resolved - );Cough (n/a - Recovered/Resolved With Sequelae - );Malaise (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - Dose not changed - [n/a - 80mg - Oral])|[BETAHISTINE DIHYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 16mg - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - Dose not changed - [n/a - 25mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2467473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-2467474	Spontaneous	2008-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Muscle discomfort (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2467474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2467475	Spontaneous	2008-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Gastrointestinal disorder (n/a - Recovering/Resolving - );Injection site pain (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2467475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2467476	Spontaneous	2008-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diabetes mellitus inadequate control (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (I - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])|[METFORMIN HYDROCHLORIDE] (I - n/a - Dose not changed - [n/a - 500mg - Oral])	[BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - Dose not changed - [n/a - 2.5mg - Oral])|[SIMVASTATIN] (C - n/a - Dose not changed - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2467476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2467478	Spontaneous	2008-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site haematoma (n/a - Recovered/Resolved - );Monoparesis (n/a - Recovered/Resolved - );Palpitations (n/a - Recovered/Resolved - );Paraesthesia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	[ATENOLOL] (C - n/a - Dose not changed - [n/a - 25mg - Oral])|[ATORVASTATIN] (C - n/a - Dose not changed - [n/a - 40mg - Oral])|[DIAZEPAM] (C - n/a - Dose not changed - [n/a - 10mg - Oral])|[GLIMEPIRIDE] (C - n/a - Dose not changed - [n/a - 4mg - Oral])|[HYDROCHLOROTHIAZIDE, LISINOPRIL, HYDROCHLOROTHIAZIDE, LISINOPRIL ANHYDROUS, LISINOPRIL DIHYDRATE, HYDROCHLOROTHIAZIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - Dose not changed - [n/a - 12.5mg - Oral])|[LISINOPRIL ANHYDROUS] (C - n/a - Dose not changed - [n/a - 10mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 1000mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2467478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-2467489	Spontaneous	2008-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Angioedema (n/a - Recovered/Resolved - );Dyspnoea (n/a - Recovered/Resolved - );Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2467489&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-2467498	Spontaneous	2008-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Angioedema (n/a - Recovering/Resolving - );Pruritus (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[LOSARTAN, LOSARTAN POTASSIUM] (S - Hypertension - Drug withdrawn - [n/a - 50mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2467498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2467507	Spontaneous	2008-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Herpes zoster (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2467507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-2464124	Spontaneous	2008-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Quadriparesis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[MAGNESIUM CITRATE, PYRIDOXINE HYDROCHLORIDE, MAGNESIUM PIDOLATE, MAGNESIUM LACTATE, PYRIDOXINE HYDROCHLORIDE, MAGNESIUM PIDOLATE, PYRIDOXINE HYDROCHLORIDE, MAGNESIUM LACTATE DIHYDRATE, PYRIDOXINE HYDROCHLORIDE, MAGNESIUM CITRATE ANHYDROUS, PYRIDOXINE HYDROCHLORIDE, MAGNESIUM LACTATE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TETRAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2464124&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2464132	Spontaneous	2008-12-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Skin plaque (n/a - Recovered/Resolved - Other Medically Important Condition);Swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (6d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2464132&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2459070	Spontaneous	2008-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2459070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2452996	Spontaneous	2008-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angioedema (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2452996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2453003	Spontaneous	2008-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Facial paralysis (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2453003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2443191	Spontaneous	2008-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2443191&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2443994	Spontaneous	2008-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vertigo (n/a - Not Specified - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Thrombosis prophylaxis - n/a - [n/a - 100mg - Oral])|[ATORVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 10mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - 500mg - Oral])|[RAMIPRIL] (C - Hypertension - n/a - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2443994&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2436581	Spontaneous	2008-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (2d - Recovered/Resolved - Other Medically Important Condition);Erythema (2d - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (4d - Recovered/Resolved - Other Medically Important Condition);Injection site inflammation (4d - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (4d - Recovered/Resolved - Other Medically Important Condition);Joint swelling (2d - Recovered/Resolved - Other Medically Important Condition);Mobility decreased (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2436581&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2436633	Spontaneous	2008-12-04 00:00:00	Healthcare Professional	European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository DE SIMONE C, CALDAROLA GIACOMO, D&apos;AGOSTINO M, ZAMPETTI A, AMERIO P, FELICIANI C. Exacerbation of pemphigus after influenza vaccination. Clinical and Experimental Dermatology 2008:33:718-720.	18-64 Years	Adult	No	Male	Condition aggravated (n/a - Unknown - Other Medically Important Condition);Pemphigus (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[PREDNISONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2436633&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2430293	Spontaneous	2008-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Seizure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2430293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2427153	Spontaneous	2008-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])|[GABAPENTIN] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])	APROVEL [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|NOVONORM [REPAGLINIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ERGOCALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[FINASTERIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLECAINIDE ACETATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[TERAZOSIN, TERAZOSIN HYDROCHLORIDE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[URSODEOXYCHOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2427153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2420917	Spontaneous	2008-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Malaise (3d - Recovered/Resolved - );Neurological symptom (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1mL - Intraocular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2420917&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2413399	Spontaneous	2008-11-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pruritus (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2413399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2400860	Spontaneous	2008-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Nystagmus (n/a - Recovered/Resolved - Other Medically Important Condition);Vertigo (3wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2400860&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2401500	Spontaneous	2008-11-24 00:00:00	Not Specified	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hypertensive nephropathy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Inflammation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Osteoarthritis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Proteinuria (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Red blood cell sedimentation rate increased (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Renal disorder (n/a - Not Specified - Caused/Prolonged Hospitalisation);Rheumatoid arthritis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Vasculitis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [1d - n/a - Subcutaneous])|[ACEBUTOLOL, ACEBUTOLOL HYDROCHLORIDE] (S - n/a - Dose not changed - [n/a - n/a - Oral])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (S - n/a - Dose not changed - [n/a - n/a - Oral])|[ALLOPURINOL] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2401500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2402461	Spontaneous	2008-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Radiculitis brachial (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS (INACTIVATED) ADSORBED] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2402461&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2388090	Spontaneous	2008-11-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Rash (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swelling face (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2388090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2388654	Spontaneous	2008-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Dyspnoea exertional (n/a - Recovered/Resolved - Other Medically Important Condition);Left ventricular dysfunction (n/a - Recovered/Resolved - Other Medically Important Condition);Myocarditis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	APROVEL [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[GLIMEPIRIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAVASTATIN SODIUM, ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2388654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2389064	Spontaneous	2008-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Angina pectoris (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2389064&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2390652	Spontaneous	2008-11-20 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2390652&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2390653	Spontaneous	2008-11-20 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Dysgeusia (n/a - Recovered/Resolved - Other Medically Important Condition);Eyelid oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Nasal congestion (n/a - Recovered/Resolved - Other Medically Important Condition);Overdose (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2390653&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2391469	Spontaneous	2008-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Hypersensitivity (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2391469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2391528	Spontaneous	2008-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Erythema (n/a - Recovering/Resolving - );Hypersensitivity (n/a - Recovering/Resolving - );Injection site swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - n/a - Not applicable - [n/a - n/a - n/a])	[BECLOMETASONE DIPROPIONATE] (C - n/a - Dose not changed - [n/a - 4{DF} - Respiratory (inhalation)])|[FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2391528&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2391532	Spontaneous	2008-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Bronchospasm (n/a - Unknown - );Chills (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2391532&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-2391547	Spontaneous	2008-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2391547&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2368165	Spontaneous	2008-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arthralgia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cutaneous vasculitis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ecchymosis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Expired product administered (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Haemorrhage subepidermal (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Multiple organ dysfunction syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vasculitis necrotising (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	APROVEL [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ISOSORBIDE 5 MONONITRATE, ISOSORBIDE DINITRATE, ISOSORBIDE MONONITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE, METOPROLOL TARTRATE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2368165&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-2341724	Spontaneous	2008-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - n/a])|[ENALAPRIL, ENALAPRIL MALEATE] (S - n/a - n/a - [n/a - 5mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2341724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2339789	Spontaneous	2008-11-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Conjunctival hyperaemia (1d - Not Specified - Caused/Prolonged Hospitalisation);Cough (1d - Not Specified - Caused/Prolonged Hospitalisation);Dysphonia (1d - Not Specified - Caused/Prolonged Hospitalisation);Dyspnoea (1d - Not Specified - Caused/Prolonged Hospitalisation);Hypersensitivity (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (1d - Not Specified - Caused/Prolonged Hospitalisation);Wheezing (1d - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2339789&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2340116	Spontaneous	2008-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Eczema infected (72h - Recovered/Resolved - );Eyelid oedema (72h - Recovered/Resolved - );Skin burning sensation (72h - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Unknown - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2340116&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2330726	Spontaneous	2008-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Hairy cell leukaemia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2330726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2332348	Spontaneous	2008-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Melaena (n/a - Not Specified - Results in Death);Purpura (n/a - Not Specified - Results in Death);Thrombocytopenia (n/a - Not Specified - Results in Death)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2332348&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-2333476	Spontaneous	2008-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hepatomegaly (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Liver disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Splenomegaly (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2333476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2333715	Spontaneous	2008-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - );Asthenia (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2333715&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2333784	Spontaneous	2008-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2333784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2327546	Spontaneous	2008-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pulmonary embolism (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2327546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-2313265	Spontaneous	2008-10-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Pyrexia (n/a - Not Recovered/Not Resolved - );Throat irritation (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2313265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2300136	Spontaneous	2008-10-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Laryngeal discomfort (n/a - Unknown - Other Medically Important Condition);Swelling (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])|[ENALAPRIL, ENALAPRIL MALEATE] (S - Product used for unknown indication - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2300136&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2294331	Spontaneous	2008-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Laryngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oedema mucosal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oesophageal discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palatal oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2294331&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2272100	Spontaneous	2008-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Asthenia (n/a - Not Specified - Other Medically Important Condition);Chills (n/a - Not Specified - Other Medically Important Condition);Palpitations (n/a - Not Specified - Other Medically Important Condition);Peripheral swelling (n/a - Not Specified - Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	MICARDIS [TELMISARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[BIOFLAVONOIDS, DIOSMIN, HESPERIDIN, MICRONISED PURIFIED FLAVONOIC FRACTION] (C - n/a - n/a - [n/a - n/a - n/a])|[DRY EXTRACT OF GINKGO BILOBA LEAVES (35-67:1), EXTRACTION SOLVENT: ACETONE 60% ( M / M), GINKGO BILOBA EXTRACT, GINKGO BILOBA L., FOLIUM (DRY EXTRACT), GINKGO BILOBAE EXTRACTUM SICCUM NORMATUM, GINKGO LEAF DRY EXTRACT, REFINED AND QUANTIFIED, REFINED AND QUANTIFIED GINKGO DRY EXTRACT (35-67:1), CORRESPONDING TO 8.80-10.80 MG OF FLAVONOIDS EXPRESSED AS FLAVONE GLYCOSIDES, 1.12-1.36 MG OF GINKGOLIDES A, B AND C, 1.04-1.28 MG OF BILOBALIDE, EXTRACTION SOLVENT: ACETONE 60% M/M, STANDARDISED GINKGO BILOBA EXTRACT] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2272100&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2263070	Spontaneous	2008-09-30 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Coordination abnormal (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Recovered/Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Recovered/Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[PREDNISONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2263070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-2249022	Spontaneous	2008-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hospitalisation (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Seizure (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2249022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-2220680	Spontaneous	2008-09-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Inflammation (n/a - Not Specified - );Pain (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2220680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2211259	Spontaneous	2008-08-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Polymyalgia rheumatica (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])|[A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2211259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2193262	Spontaneous	2008-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Inflammation (n/a - Not Specified - );Malaise (n/a - Not Specified - );Pain (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2193262&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2191362	Spontaneous	2008-08-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Neuritis (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2191362&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2191397	Spontaneous	2008-08-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Facial paresis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2191397&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2191399	Spontaneous	2008-08-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Multiple organ dysfunction syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sepsis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	[DOMPERIDONE, DOMPERIDONE MALEATE] (C - n/a - n/a - [n/a - 10mg - Oral])|[SULFOGAIACOL, SODIUM BENZOATE, CODEINE] (C - n/a - n/a - [n/a - 500mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2191399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-2191401	Spontaneous	2008-08-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Back pain (n/a - Recovered/Resolved - Disabling);Burning sensation (n/a - Recovered/Resolved - Disabling);Chest pain (n/a - Recovered/Resolved - Disabling);Pain (n/a - Recovered/Resolved - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2191401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-2191403	Spontaneous	2008-08-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Elderly	No	Male	Arthralgia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	ALDARA 5% [IMIQUIMOD] (S - n/a - n/a - [6d - 12.5mg - n/a])|[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	MYCOPHENOLATE MOFETIL [MYCOPHENOLATE MOFETIL] (C - n/a - n/a - [n/a - 1000mg - n/a])|TACROLIMUS [TACROLIMUS, TACROLIMUS MONOHYDRATE] (C - n/a - n/a - [n/a - 5mg - n/a])|[CO-TRIMOXAZOLE, SULFAMETHOXAZOLE, TRIMETHOPRIM, TRIMETHOPRIM BP, SULFAMETHOXAZOLE BP] (C - n/a - n/a - [n/a - 480mg - n/a])|[COLECALCIFEROL, CALCIUM] (C - n/a - n/a - [n/a - 1000mg - n/a])|[INSULIN LONG-ACTING] (C - n/a - n/a - [n/a - 92[iU] - Subcutaneous])|[PREDNISONE] (C - n/a - n/a - [n/a - 5mg - n/a])|[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 300mg - n/a])|[TORASEMIDE] (C - n/a - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2191403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2183445	Spontaneous	2008-08-08 00:00:00	Healthcare Professional	European Economic Area	Van der Sande MA, van Asten L, Straus SM, Schim van der Loeff MF, Wallinga J, Conyn-van Spaendonck MA. Sudden deaths following influenza vaccination: can this be expected?. Vaccine 17-JAN-2008:26(3):379-382.	More than 85 Years	Elderly	No	Male	Sudden death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	BUMETANIDE [BUMETANIDE] (C - n/a - n/a - [n/a - 1mg - Unknown])|[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Unknown])|[CARBASALATE CALCIUM] (C - n/a - n/a - [n/a - 30mg - Unknown])|[DIGOXIN, DIGOXIN PH. EUR.] (C - n/a - n/a - [n/a - .125mg - Unknown])|[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - 10mg - Unknown])|[FINASTERIDE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2183445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-2176399	Spontaneous	2008-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Psychotic disorder (11d - Recovered/Resolved With Sequelae - Disabling)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2176399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-2176663	Spontaneous	2008-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Bronchitis (43d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Laryngitis (43d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - n/a - Drug withdrawn - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2176663&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-2176664	Spontaneous	2008-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Bronchitis (11d - Recovered/Resolved - Life Threatening)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - n/a - Drug withdrawn - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2176664&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-2176721	Spontaneous	2008-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Bronchospasm (n/a - Unknown - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza - Drug withdrawn - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2176721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2176748	Spontaneous	2008-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Condition aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza - Drug withdrawn - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2176748&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2176776	Spontaneous	2008-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Bronchospasm (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza - Drug withdrawn - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2176776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2176779	Spontaneous	2008-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bronchospasm (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza - Drug withdrawn - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2176779&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2176780	Spontaneous	2008-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Condition aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza - Drug withdrawn - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2176780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2177330	Spontaneous	2008-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Bone marrow failure (17d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza immunisation - Drug withdrawn - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2177330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-2177866	Spontaneous	2008-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Bronchospasm (20d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (20d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza - Drug withdrawn - [n/a - .5mL - Subcutaneous])	[ALOPURINOL, BENZBROMARONA] (C - Blood test abnormal - Dose not changed - [n/a - n/a - Oral])|[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE] (C - Cardiac failure congestive - Dose not changed - [n/a - n/a - Oral])|[BUDESONIDE] (C - Chronic obstructive pulmonary disease - Dose not changed - [n/a - n/a - Respiratory (inhalation)])|[DIGOXIN] (C - Cardiac failure congestive - Dose not changed - [n/a - n/a - Oral])|[FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE MONOHYDRATE] (C - Chronic obstructive pulmonary disease - Dose not changed - [n/a - n/a - Respiratory (inhalation)])|[THEOPHYLLINE] (C - Chronic obstructive pulmonary disease - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2177866&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2178497	Spontaneous	2008-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Acute kidney injury (3d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Circulatory collapse (3d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Confusional state (9d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Diarrhoea (7d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Hepatic failure (3d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (7d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Rash maculo-papular (7d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sepsis (3d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza immunisation - Drug withdrawn - [n/a - .5mL - Unknown])	[MEFENAMIC ACID] (C - Pyrexia - Unknown - [n/a - n/a - Oral])|[PARACETAMOL] (C - Pyrexia - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2178497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-2172012	Spontaneous	2008-08-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cardiac failure (7d - Fatal - Results in Death);Upper respiratory tract infection (7d - Fatal - Results in Death)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - n/a - Drug withdrawn - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2172012&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-2172854	Spontaneous	2008-08-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dyspnoea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza immunisation - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2172854&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2173516	Spontaneous	2008-08-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Neuritis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2173516&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-2174144	Spontaneous	2008-08-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (6d - Recovered/Resolved - Life Threatening);Bronchospasm (6d - Recovered/Resolved - Life Threatening);Cough (6d - Recovered/Resolved - Life Threatening);Diarrhoea (6d - Recovered/Resolved - Life Threatening);Malaise (6d - Recovered/Resolved - Life Threatening);Myalgia (6d - Recovered/Resolved - Life Threatening);Pyrexia (6d - Recovered/Resolved - Life Threatening);Vomiting (6d - Recovered/Resolved - Life Threatening)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza - Drug withdrawn - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2174144&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-2174533	Spontaneous	2008-08-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Neuritis (n/a - Not Recovered/Not Resolved - Life Threatening)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2174533&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-2166776	Spontaneous	2008-08-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypersensitivity vasculitis (19d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2166776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2167037	Spontaneous	2008-08-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Herpes zoster (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza immunisation - Drug withdrawn - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2167037&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2167590	Spontaneous	2008-08-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Erythema multiforme (22d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])|[PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2167590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2157084	Spontaneous	2008-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Bronchospasm (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2157084&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2157164	Spontaneous	2008-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Bronchospasm (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2157164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2157225	Spontaneous	2008-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Henoch-Schonlein purpura (n/a - Recovered/Resolved - Life Threatening)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza - Drug withdrawn - [n/a - 5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2157225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-2157309	Spontaneous	2008-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pneumonia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2157309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-2157444	Spontaneous	2008-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (3d - Recovered/Resolved - Other Medically Important Condition);Myalgia (3d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition);Vomiting (3d - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2157444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2157671	Spontaneous	2008-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myasthenic syndrome (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Myocarditis (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza - Drug withdrawn - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2157671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-2158169	Spontaneous	2008-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site inflammation (16d - Recovered/Resolved - Other Medically Important Condition);Injection site pain (16d - Recovered/Resolved - Other Medically Important Condition);Purpura (16d - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza immunisation - Drug withdrawn - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2158169&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2158303	Spontaneous	2008-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Deafness (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza - Drug withdrawn - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2158303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2160354	Spontaneous	2008-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Circulatory collapse (12d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (12d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2160354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-2160739	Spontaneous	2008-08-01 00:00:00	Healthcare Professional	European Economic Area	ACTA DERM VENEREOL 2001; 81 (6): 450-1	More than 85 Years	Not Specified	No	Female	Dermatitis bullous (2wk - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Pemphigoid (2wk - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Unknown])	[NIMODIPINE] (C - n/a - Drug withdrawn - [55d - n/a - Oral])|[STANDARDISED GINKGO BILOBA EXTRACT] (C - n/a - Drug withdrawn - [55d - n/a - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - Essential hypertension - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2160739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2149635	Spontaneous	2008-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoacusis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vertigo (49d - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2149635&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-2151763	Spontaneous	2008-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2151763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2153017	Spontaneous	2008-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Cow pox - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2153017&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2153310	Spontaneous	2008-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site inflammation (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2153310&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2156230	Spontaneous	2008-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Motor neurone disease (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2156230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2142777	Spontaneous	2008-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Deafness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])	KARVEZIDE 300/12.5 MG TABLETS [HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - Cardiomyopathy - Dose not changed - [n/a - n/a - Oral])|OPTRUMA 60 MG FILM-COATED TABLETS [RALOXIFENE HYDROCHLORIDE] (C - Osteoporosis - Dose not changed - [n/a - 60mg - Oral])|[ACETYLSALICYLIC ACID] (C - Cardiomyopathy - Dose not changed - [n/a - 100mg - Oral])|[BISOPROLOL FUMARATE] (C - Cardiomyopathy - Dose not changed - [n/a - n/a - Oral])|[CALCIUM CARBONATE, CALCIUM LACTATE GLUCONATE] (C - Osteoporosis - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2142777&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2142914	Spontaneous	2008-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Paresis (3mo - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Unknown])	[ALPRAZOLAM] (C - n/a - Dose not changed - [n/a - n/a - Unknown])|[PARACETAMOL] (C - n/a - Dose not changed - [n/a - n/a - Unknown])|[PERINDOPRIL TERT-BUTYLAMINE, INDAPAMIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[TOLTERODINE L-TARTRATE, TOLTERODINE TARTRATE] (C - n/a - Dose not changed - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2142914&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-2143819	Spontaneous	2008-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Henoch-Schonlein purpura (n/a - Unknown - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Cow pox - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2143819&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2145828	Spontaneous	2008-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dermatitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Oedema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Psoriasis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2145828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2147776	Spontaneous	2008-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pericardial effusion (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Cow pox - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2147776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-2147782	Spontaneous	2008-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypoacusis (66d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (0d - Recovered/Resolved - Other Medically Important Condition)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2147782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-2147848	Spontaneous	2008-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Bronchospasm (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2147848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2142180	Spontaneous	2008-07-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Rash morbilliform (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intradermal])	REPAGLINIDE [REPAGLINIDE] (C - n/a - n/a - [n/a - 2mg - Oral])|[RAMIPRIL] (C - n/a - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2142180&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2121718	Spontaneous	2008-07-21 00:00:00	Healthcare Professional	Non European Economic Area	CONFINO I., PASSWELL J.H., PADEH S.. Erythromelalgia following influenza vaccine in a child. Clinical and Experimental Rheumatology 1997:15:111-113.	3-11 Years	Child	No	Female	Burning sensation (n/a - Not Specified - Caused/Prolonged Hospitalisation);Decreased appetite (3wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Not Specified - Caused/Prolonged Hospitalisation);Erythromelalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Localised oedema (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pain (n/a - Not Specified - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Not Specified - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2121718&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2109076	Spontaneous	2008-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abortion induced (n/a - Recovered/Resolved - Congenital Anomaly);Klinefelter's syndrome (n/a - Unknown - Congenital Anomaly)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2109076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-2082968	Spontaneous	2008-06-26 00:00:00	Not Specified	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site reaction (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2082968&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-2087792	Spontaneous	2008-06-26 00:00:00	Healthcare Professional	Non European Economic Area	PICARD ANDRE. Flu shot left executive paralyzed. The Globe and Mail 18-NOV-2002:METRO:A1.	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Not Specified - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Paralysis (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2087792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2087794	Spontaneous	2008-06-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2087794&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2087824	Spontaneous	2008-06-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Face oedema (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	ACE INHIBITOR NOS [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2087824&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2087826	Spontaneous	2008-06-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Oedema mouth (n/a - Not Specified - Life Threatening, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2087826&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-2087831	Spontaneous	2008-06-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Malignant melanoma (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2087831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-2087836	Spontaneous	2008-06-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Optic neuritis (n/a - Not Specified - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2087836&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-2087840	Spontaneous	2008-06-26 00:00:00	Not Specified	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Systemic lupus erythematosus (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2087840&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2087841	Spontaneous	2008-06-26 00:00:00	Not Specified	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Haemorrhage (n/a - Recovered/Resolved - Life Threatening);Petechiae (n/a - Recovered/Resolved - Life Threatening);Pruritus (n/a - Recovered/Resolved - Life Threatening);Purpura (n/a - Recovered/Resolved - Life Threatening);Thrombocytopenic purpura (4wk - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2087841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-2087871	Spontaneous	2008-06-26 00:00:00	Not Specified	Non European Economic Area	Greenbaum E, Nir-Paz R, Linton DM, Ben-Hur T, Meirovitz A, Zakay-Rones Z. Severe influenza infection in a chronic hepatitis C carrier: failure of protective serum HI antibodies after IM vaccination. Journal of Clinical Virology 2004:29:23-26.	18-64 Years	Adult	No	Male	Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nephrotic syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nervous system disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2087871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2074298	Spontaneous	2008-06-24 00:00:00	Not Specified	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Scleroderma (n/a - Not Specified - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2074298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-2074351	Spontaneous	2008-06-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Injection site abscess (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2074351&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2074462	Spontaneous	2008-06-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest pain (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[GLIBENCLAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2074462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2074498	Spontaneous	2008-06-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chest pain (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2074498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2074992	Spontaneous	2008-06-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Polymyalgia rheumatica (n/a - Not Specified - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2074992&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2074995	Spontaneous	2008-06-24 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cerebrovascular accident (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2074995&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2075238	Spontaneous	2008-06-24 00:00:00	Not Specified	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Cellulitis (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site erythema (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	IRON [IRON] (C - n/a - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2075238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2066536	Spontaneous	2008-06-23 00:00:00	Not Specified	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Malaise (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - );Urticaria (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - .5mL - Unknown])	[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])|[GEMFIBROZIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2066536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2067355	Spontaneous	2008-06-23 00:00:00	Not Specified	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Thrombocytopenia (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2067355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2067357	Spontaneous	2008-06-23 00:00:00	Not Specified	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain (25d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (30d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gastrointestinal disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (20d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 137ug - n/a])|[LIOTHYRONINE SODIUM] (C - n/a - n/a - [n/a - 30ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2067357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2067358	Spontaneous	2008-06-23 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Thrombocytopenia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	METHOTREXATE [METHOTREXATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CHLOROQUINE] (C - n/a - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[NAPROXEN ETEMESIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2067358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-2069727	Spontaneous	2008-06-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Oedema mouth (n/a - Not Specified - Life Threatening, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2069727&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-2069741	Spontaneous	2008-06-23 00:00:00	Not Specified	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myocardial infarction (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2069741&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2069744	Spontaneous	2008-06-23 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Parkinsonism (n/a - Not Specified - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[PERGOLIDE MESILATE] (C - n/a - n/a - [n/a - 1mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2069744&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-2070336	Spontaneous	2008-06-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Chest pain (5d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Dizziness (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pericarditis (1wk - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pleuritic pain (5d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2070336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2070345	Spontaneous	2008-06-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Depressed level of consciousness (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2070345&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2045926	Spontaneous	2008-06-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	THYROID HORMONES [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2045926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2044797	Spontaneous	2008-06-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2044797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2038484	Spontaneous	2008-06-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Hypersensitivity (n/a - Not Specified - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2038484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-2038517	Spontaneous	2008-06-10 00:00:00	Not Specified	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Autoantibody positive (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hepatic enzyme increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2038517&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2038546	Spontaneous	2008-06-10 00:00:00	Not Specified	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening);Eyelid oedema (n/a - Recovered/Resolved - Life Threatening);Face oedema (n/a - Recovered/Resolved - Life Threatening);Lip swelling (n/a - Recovered/Resolved - Life Threatening);Rash (n/a - Recovered/Resolved - Life Threatening);Urticaria (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	CORTICOSTEROIDS (AEROSOL) [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|IMMUNOTHERAPY (NOT SPECIFIED) [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2038546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-2038586	Spontaneous	2008-06-10 00:00:00	Not Specified	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2038586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-2038814	Spontaneous	2008-06-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Anaphylactic reaction (n/a - Recovering/Resolving - Other Medically Important Condition);Cough (n/a - Recovering/Resolving - Other Medically Important Condition);Injection site erythema (n/a - Not Specified - Other Medically Important Condition);Injection site swelling (n/a - Not Specified - Other Medically Important Condition);Pruritus (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Other Medically Important Condition);Urticaria (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2038814&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-2036093	Spontaneous	2008-06-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2036093&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-2037426	Spontaneous	2008-06-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Wheezing (n/a - Not Specified - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2037426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-2037432	Spontaneous	2008-06-09 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Ataxia (n/a - Not Specified - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2037432&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-2037436	Spontaneous	2008-06-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - );Injection site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2037436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2037437	Spontaneous	2008-06-09 00:00:00	Not Specified	Non European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Arthralgia (n/a - Not Recovered/Not Resolved - );Decreased appetite (n/a - Unknown - );Fatigue (n/a - Unknown - );Paraesthesia (n/a - Unknown - );Weight decreased (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	ANTIHYPERTENSIVE DRUG [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[LORAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2037437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2032179	Spontaneous	2008-06-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Urticaria (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - 200ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2032179&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-2009300	Spontaneous	2008-05-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Not Specified - Other Medically Important Condition);Cardiac murmur (n/a - Not Specified - Other Medically Important Condition);Mitral valve incompetence (n/a - Not Specified - Other Medically Important Condition);Neck pain (12h - Not Specified - Other Medically Important Condition);Paraesthesia (1h - Not Specified - Other Medically Important Condition);Vomiting (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=2009300&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1997281	Spontaneous	2008-05-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Alanine aminotransferase increased (n/a - Not Specified - Life Threatening, Caused/Prolonged Hospitalisation);Aspartate aminotransferase increased (n/a - Not Specified - Life Threatening, Caused/Prolonged Hospitalisation);Conjunctival hyperaemia (n/a - Not Specified - Life Threatening, Caused/Prolonged Hospitalisation);Papule (34d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (5d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Rash papular (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Rash pruritic (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 2.5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1997281&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-1997361	Spontaneous	2008-05-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (2d - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal discomfort (2d - Recovered/Resolved - Other Medically Important Condition);Palindromic rheumatism (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition);Raynaud's phenomenon (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[FLUTAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[OXYBUTYNIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PNEUMOCOCCAL VACCINE] (C - Immunisation - n/a - [n/a - n/a - Unknown])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1997361&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1997414	Spontaneous	2008-05-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Bell's palsy (187d - Recovered/Resolved - Other Medically Important Condition);Facial paralysis (187d - Recovered/Resolved - Other Medically Important Condition);Lacrimation increased (187d - Recovered/Resolved - Other Medically Important Condition);Mastication disorder (181d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LORAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[MEDROXYPROGESTERONE ACETATE, ESTROGENS CONJUGATED] (C - n/a - n/a - [n/a - n/a - n/a])|[TRIMIPRAMINE, TRIMIPRAMINE MALEATE] (C - n/a - n/a - [n/a - 75mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1997414&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1997417	Spontaneous	2008-05-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Eye pain (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Nasal congestion (n/a - Recovered/Resolved - Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[ACRIVASTINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1997417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1997424	Spontaneous	2008-05-22 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Bell's palsy (2d - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (2d - Recovered/Resolved - Other Medically Important Condition);Facial paralysis (2d - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (2d - Recovered/Resolved - Other Medically Important Condition);Nausea (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1997424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1997429	Spontaneous	2008-05-22 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Full blood count decreased (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Leukaemia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pallor (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Viral infection (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1997429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1986172	Spontaneous	2008-05-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Elderly	No	Female	Pneumonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1986172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1956510	Spontaneous	2008-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - );Musculoskeletal stiffness (n/a - Recovering/Resolving - );Peripheral swelling (n/a - Recovering/Resolving - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1956510&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1952070	Spontaneous	2008-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Thrombocytopenic purpura (4wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	[AMLODIPINE BESILATE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1952070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1963213	Spontaneous	2008-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dermatitis bullous (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash erythematous (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])|[TENOXICAM] (S - Osteoarthritis - Not applicable - [2d - n/a - Rectal])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1963213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1942095	Spontaneous	2008-05-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1942095&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1950272	Spontaneous	2008-05-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Agranulocytosis (10d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intravenous (not otherwise specified)])|[CARBUTAMIDE] (S - Diabetes mellitus - Dose not changed - [n/a - n/a - Oral])|[CEFTRIAXONE, CEFTRIAXONE SODIUM] (S - Pyrexia - Drug withdrawn - [5d - n/a - Intravenous (not otherwise specified)])	[AMOXICILLIN, AMOXICILLIN SODIUM, AMOXICILLIN TRIHYDRATE] (C - Diarrhoea - n/a - [n/a - n/a - n/a])|[CLARITHROMYCIN] (C - Diarrhoea - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1950272&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1941277	Spontaneous	2008-05-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site pain (n/a - Not Specified - Other Medically Important Condition);Lymphadenopathy (n/a - Not Specified - Other Medically Important Condition);Pain (n/a - Not Specified - Other Medically Important Condition);Skin disorder (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	[FENOFIBRATE, FENOFIBRATE MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1941277&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1941283	Spontaneous	2008-05-13 00:00:00	Healthcare Professional	Non European Economic Area	Cunha Paulo Rowilson, Thomazescki Patricia V., Hipolito Patricia, Michalany Nilceou S., Bystryn Jean-Claude. Bullous pemphigoid in a 2-month-old infant. International Journal of Dermatology 1998:37:934-948.	2 Months - 2 Years	Not Specified	No	Male	Pemphigoid (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[DIPHTHERIA, TETANUS AND PERTUSSIS VACCINE (ADSORBED)] (C - n/a - n/a - [n/a - n/a - n/a])|[POLIOMYELITIS VACCINE (ORAL)] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1941283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1927265	Spontaneous	2008-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Retching (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1927265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1918157	Spontaneous	2008-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Hot flush (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (2d - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1918157&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1918448	Spontaneous	2008-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Conjunctivitis allergic (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Eyelid oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1918448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1908519	Spontaneous	2008-05-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Ataxia (n/a - Not Specified - Disabling);Deafness (n/a - Not Specified - Disabling);Dizziness (n/a - Not Specified - Disabling);Hypoacusis (n/a - Not Specified - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1908519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-1908521	Spontaneous	2008-05-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dyspnoea (n/a - Not Specified - Caused/Prolonged Hospitalisation);Hypersensitivity (6d - Not Specified - Caused/Prolonged Hospitalisation);Urticaria (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	[AMBAZONE] (C - n/a - n/a - [n/a - n/a - n/a])|[DIHYDRALAZINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1908521&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1908983	Spontaneous	2008-05-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cardiac arrest (n/a - Not Specified - Results in Death);Pneumonia (n/a - Not Specified - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1908983&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1910105	Spontaneous	2008-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lymphadenopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1910105&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1890172	Spontaneous	2008-04-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anxiety (n/a - Recovered/Resolved - Other Medically Important Condition);Arrhythmia (n/a - Recovered/Resolved - Other Medically Important Condition);Atrial fibrillation (n/a - Recovered/Resolved - Other Medically Important Condition);Blood creatine phosphokinase MB increased (n/a - Recovered/Resolved - Other Medically Important Condition);Blood creatine phosphokinase increased (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (3d - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, QUINAPRIL, QUINAPRIL HYDROCHLORIDE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PHENPROCOUMON] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1890172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1888508	Spontaneous	2008-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Radicular pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	[CALCIUM DOBESILATE, CALCIUM DOBESILATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[CAPTOPRIL] (C - Hypertension - n/a - [n/a - n/a - Oral])|[GLICLAZIDE] (C - Diabetes mellitus - n/a - [n/a - n/a - Oral])|[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1888508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1877629	Spontaneous	2008-04-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1877629&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1875028	Spontaneous	2008-04-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 325mg - n/a])|[ATENOLOL, ATENOLOL HYDROCHLORIDE, ATENOLOL PH. EUR.] (C - n/a - n/a - [n/a - 100mg - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - 20mg - n/a])|[FENOFIBRATE, FENOFIBRATE (NANONISED)] (C - n/a - n/a - [n/a - 200mg - n/a])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 25mg - n/a])|[IRBESARTAN] (C - n/a - n/a - [n/a - 300mg - n/a])|[NIFEDIPINE] (C - n/a - n/a - [n/a - 60mg - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 100mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1875028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1875300	Spontaneous	2008-04-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest pain (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Other Medically Important Condition);Wheezing (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1875300&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1875304	Spontaneous	2008-04-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Results in Death, Other Medically Important Condition);Anal incontinence (0d - Recovered/Resolved - Results in Death, Other Medically Important Condition);Brain neoplasm (n/a - Fatal - Results in Death, Other Medically Important Condition);Hallucination (1mo - Not Recovered/Not Resolved - Results in Death, Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Results in Death, Other Medically Important Condition);Nausea (6wk - Recovered/Resolved - Results in Death, Other Medically Important Condition);Seizure (0d - Fatal - Results in Death, Other Medically Important Condition);Tongue biting (0d - Recovered/Resolved - Results in Death, Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Results in Death, Other Medically Important Condition);Urinary incontinence (0d - Recovered/Resolved - Results in Death, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1875304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1874055	Spontaneous	2008-04-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthritis (n/a - Unknown - Other Medically Important Condition);Diarrhoea (2d - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Myalgia (2wk - Unknown - Other Medically Important Condition);Pyrexia (2d - Unknown - Other Medically Important Condition);Skin exfoliation (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1874055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1874529	Spontaneous	2008-04-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1874529&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1870238	Spontaneous	2008-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Unknown - Other Medically Important Condition);Injected limb mobility decreased (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1870238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1868234	Spontaneous	2008-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Not Specified	Cough (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1868234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1868947	Spontaneous	2008-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Asthenia (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1868947&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1863250	Spontaneous	2008-04-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Rash pustular (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1863250&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1864940	Spontaneous	2008-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Retinitis (n/a - Unknown - Other Medically Important Condition);Visual impairment (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1864940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1860025	Spontaneous	2008-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1860025&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1860248	Spontaneous	2008-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Facial paralysis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Varicella virus test positive (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Varicella zoster virus infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	ANTIHYPERTENSIVES [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|LIPID REDUCER [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[NITRIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1860248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1860313	Spontaneous	2008-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Muscular weakness (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Paresis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1860313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1860314	Spontaneous	2008-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Gastrointestinal haemorrhage (4wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (4wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OLMESARTAN, OLMESARTAN MEDOXOMIL] (C - n/a - n/a - [n/a - n/a - n/a])|[TORASEMIDE, TORASEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1860314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1840875	Spontaneous	2008-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Tenosynovitis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1840875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1823394	Spontaneous	2008-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (4d - Recovered/Resolved - Other Medically Important Condition);Fatigue (4d - Recovered/Resolved - Other Medically Important Condition);Headache (4d - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (4d - Recovered/Resolved - Other Medically Important Condition);Rhinitis (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1823394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1823659	Spontaneous	2008-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Arthralgia (1d - Recovered/Resolved - Other Medically Important Condition);Fatigue (4d - Recovered/Resolved - Other Medically Important Condition);Headache (1d - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (1d - Recovered/Resolved - Other Medically Important Condition);Rhinitis (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1823659&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1821404	Spontaneous	2008-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (4d - Recovered/Resolved - Other Medically Important Condition);Fatigue (4d - Recovered/Resolved - Other Medically Important Condition);Headache (4d - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (4d - Recovered/Resolved - Other Medically Important Condition);Rhinitis (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1821404&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1821415	Spontaneous	2008-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (4d - Recovered/Resolved - Other Medically Important Condition);Fatigue (4d - Recovered/Resolved - Other Medically Important Condition);Headache (4d - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (4d - Recovered/Resolved - Other Medically Important Condition);Rhinitis (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1821415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1822234	Spontaneous	2008-04-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1822234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1818086	Spontaneous	2008-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Pyrexia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	[FOLIC ACID] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN BENZATHINE] (C - n/a - Dose not changed - [n/a - 1500000[iU] - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1818086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1819751	Spontaneous	2008-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angioedema (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Myocardial ischaemia - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - Essential hypertension - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[NEBIVOLOL] (C - Essential hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1819751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1819936	Spontaneous	2008-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myelitis (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1819936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1805548	Spontaneous	2008-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Diarrhoea (n/a - Fatal - Results in Death);Hyperpyrexia (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[THIOCOLCHICOSIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1805548&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1801249	Spontaneous	2008-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Clonus (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1801249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1744536	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site reaction (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1744536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1746202	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1746202&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1746222	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1746222&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1747371	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Not Specified - );Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1747371&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1747894	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1747894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1748206	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Peripheral motor neuropathy (n/a - Not Specified - );Peripheral sensory neuropathy (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1748206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1749309	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema multiforme (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])|[IPRIFLAVONE] (S - n/a - n/a - [n/a - 3{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1749309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1749313	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Neuropathy peripheral (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[CAPTOPRIL, HYDROCHLOROTHIAZIDE, ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE, ENALAPRIL, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DIGOXIN, DIGOXIN PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1749313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1749342	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Not Specified - );Depression (n/a - Not Specified - );Hyperhidrosis (n/a - Not Specified - );Vertigo (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1749342&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1749349	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Not Specified - );Myalgia (n/a - Not Specified - );Rash (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1749349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1749798	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site reaction (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[AMITRIPTYLINE HYDROCHLORIDE, PERPHENAZINE, GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[GLICLAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[TIMOLOL, TIMOLOL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1749798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1751002	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - );Chills (n/a - Not Specified - );Headache (n/a - Not Specified - );Hyperpyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1751002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1751353	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1751353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1751969	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1751969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1752021	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Paresis (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1752021&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1752375	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Application site oedema (n/a - Not Specified - );Erythema multiforme (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1752375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1752794	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chills (n/a - Not Specified - );Pyrexia (n/a - Not Specified - );Tremor (n/a - Not Specified - );Vertigo (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE, FLUTICASONE, SALMETEROL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1752794&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1752810	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chest pain (n/a - Not Specified - );Dyspnoea (n/a - Not Specified - );Hyperhidrosis (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1752810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1752934	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Headache (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, ALUMINIUM HYDROXIDE GEL, MAGNESIUM HYDROXIDE, ACETYLSALICYLIC ACID, MAGNESIUM HYDROXIDE, ALGELDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, AMILORIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE DIHYDRATE, HYDROCHLOROTHIAZIDE, ANHYDROUS AMILORIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[NIFEDIPINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1752934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1752952	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hyperpyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1752952&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1753134	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site inflammation (n/a - Not Specified - );Pruritus (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Generalised vaccinia - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1753134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1753406	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[RIFAXIMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1753406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1753563	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest pain (n/a - Not Specified - );Hypertension (n/a - Not Specified - );Malaise (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1753563&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1753565	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Cystitis haemorrhagic (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1753565&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1753567	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Cystitis haemorrhagic (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[TAMOXIFEN, TAMOXIFEN CITRATE, TAMOXIFEN CITRATE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1753567&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1754422	Spontaneous	2008-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Specified - );Diarrhoea (n/a - Not Specified - );Hypotonia (n/a - Not Specified - );Pallor (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1754422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1734692	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Autoimmune haemolytic anaemia (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])|[BENZODODECINIUM BROMIDE, POLYSORBATE 80] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])|[CEFUROXIME, CEFUROXIME AXETIL, CEFUROXIME SODIUM] (S - n/a - Drug withdrawn - [n/a - 500mg - Oral])|[PREDNISOLONE METASULFOBENZOATE SODIUM] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	APROVEL 300 MG FILM-COATED TABLETS [IRBESARTAN] (C - n/a - n/a - [n/a - 300mg - Oral])|[CHONDROITIN SULFATE, CHONDROITIN SULFATE SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[DIHYDROERGOTAMINE MESILATE] (C - n/a - n/a - [n/a - 5mg - Oral])|[LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1734692&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1737895	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Syncope (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1737895&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1738541	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Nausea (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1738541&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1738654	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Bronchospasm (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE, FLUTICASONE, SALMETEROL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1738654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1738690	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hypoaesthesia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1738690&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1738830	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Agitation (n/a - Not Specified - );Erythema (n/a - Not Specified - );Paraesthesia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	[BROMAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1738830&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1738837	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Lethargy (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1738837&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1738879	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vertigo (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1738879&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739080	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739104	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Erythema (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739105	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739105&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739118	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Persistent generalised lymphadenopathy (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739172	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739219	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Joint swelling (n/a - Not Specified - Other Medically Important Condition);Pain in extremity (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[DILTIAZEM, DILTIAZEM HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[OMEPRAZOLE, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[PIRETANIDE, RAMIPRIL, RAMIPRIL] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739219&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1739247	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Specified - );Chest pain (n/a - Not Specified - );Diarrhoea (n/a - Not Specified - );Stupor (n/a - Not Specified - );Vomiting (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739283	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Asthenia (n/a - Not Specified - );Hypotonia (n/a - Not Specified - );Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .25mL - n/a])	[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - CHARGE syndrome - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739297	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (n/a - Not Specified - );Injection site pruritus (n/a - Not Specified - );Swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739442	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[AMITRIPTYLINE HYDROCHLORIDE, PERPHENAZINE, GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CARVEDILOL] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISONE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[TICLOPIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739442&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739474	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - );Chills (n/a - Not Specified - );Fatigue (n/a - Not Specified - );Headache (n/a - Not Specified - );Myalgia (n/a - Not Specified - );Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739504	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Not Specified - );Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739516	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - );Hyperaemia (n/a - Not Specified - );Localised oedema (n/a - Not Specified - );Pain (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739516&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739537	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Erythema (n/a - Not Specified - );Oedema (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739630	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Oedema peripheral (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739630&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739855	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hyperpyrexia (n/a - Not Specified - );Local reaction (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739855&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739875	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1739965	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Flushing (n/a - Not Specified - );Swelling face (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1739965&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1740403	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Neuralgic amyotrophy (n/a - Not Specified - Disabling);Paraesthesia (n/a - Not Specified - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1740403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-1741338	Spontaneous	2008-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Face oedema (n/a - Not Specified - );Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1741338&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1732090	Spontaneous	2008-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Not Specified - );Nausea (n/a - Not Specified - );Pain (n/a - Not Specified - );Vomiting (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1732090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1728916	Spontaneous	2008-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Granuloma skin (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site reaction (n/a - Not Specified - Other Medically Important Condition);Limb discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1728916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1718659	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Coma (n/a - Not Specified - Life Threatening);Confusional state (n/a - Not Specified - Life Threatening);Pyrexia (n/a - Not Specified - Life Threatening);Respiratory failure (n/a - Not Specified - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1718659&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-1719044	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Arthralgia (n/a - Not Specified - );Hyperpyrexia (n/a - Not Specified - );Injection site reaction (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1719044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1719045	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hyperpyrexia (n/a - Not Specified - );Injection site reaction (n/a - Not Specified - );Somnolence (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1719045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1719462	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hyperpyrexia (n/a - Not Specified - );Injection site abscess sterile (n/a - Not Specified - );Injection site reaction (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1719462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1720305	Spontaneous	2008-03-03 00:00:00	Not Specified	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Discomfort (1d - Recovered/Resolved - Life Threatening);Glomerulonephritis (2d - Recovering/Resolving - Life Threatening);Haematuria (3d - Recovering/Resolving - Life Threatening);Headache (1d - Recovered/Resolved - Life Threatening);Pyrexia (1d - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1720305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-1721706	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Paresis (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[AMINOPHYLLINE DIHYDRATE, AMINOPHYLLINE HYDRATE, THEOPHYLLINE] (C - Asthma - n/a - [n/a - 167mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1721706&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1722443	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthritis (n/a - Not Specified - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1722443&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-1723152	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - Life Threatening);Toxic epidermal necrolysis (n/a - Not Specified - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1723152&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-1723375	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Oedema (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1723375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1723382	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Not Specified - );Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[INSULIN HUMAN, INSULIN HUMAN, INSULIN INJECTION SOLUBLE] (C - n/a - n/a - [n/a - n/a - n/a])|[ISOSORBIDE 5 MONONITRATE, ISOSORBIDE MONONITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1723382&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1723385	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Asthenia (n/a - Not Specified - );Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1723385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1723393	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site reaction (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[TICLOPIDINE] (C - n/a - n/a - [n/a - 250mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1723393&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1723443	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - );Erythema nodosum (n/a - Not Specified - );Hyperpyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])|[DIPHTHERIA TOXOID ADSORBED, TETANUS TOXOID ADSORBED] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1723443&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1723512	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[FENOFIBRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE, GLIBENCLAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL TARTRATE, METOPROLOL TARTRATE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1723512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1723523	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cutaneous vasculitis (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza - n/a - [n/a - .5mL - Intramuscular])	[ALENDRONATE SODIUM, ALENDRONATE SODIUM TRIHYDRATE, ALENDRONIC ACID] (C - n/a - n/a - [n/a - 70mg - Oral])|[AMLODIPINE] (C - n/a - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1723523&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1723618	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[DOXAZOSIN, DOXAZOSIN MESILATE] (C - n/a - n/a - [n/a - 2mg - Oral])|[NIFEDIPINE] (C - n/a - n/a - [n/a - 30mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1723618&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1723623	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Flushing (n/a - Not Specified - );Injection site pain (n/a - Not Specified - );Oedema (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1723623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1723877	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1723877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1724000	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	[OXYMETAZOLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1724000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1724083	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Rash vesicular (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1724083&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1724308	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Vertigo (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1724308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1724637	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - );Injection site reaction (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1724637&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1725046	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Specified - );Hyperpyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1725046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1725068	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Not Specified - );Confusional state (n/a - Not Specified - );Hypotonia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	[LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1725068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1725185	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hyperpyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mg - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1725185&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1725212	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Headache (n/a - Not Specified - );Hyperpyrexia (n/a - Not Specified - )	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1725212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1725346	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactoid reaction (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1725346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1725401	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pericarditis (n/a - Not Specified - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1725401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-1725527	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hyperpyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1725527&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1725626	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[SODIUM VALPROATE, VALPROIC ACID, SODIUM VALPROATE] (C - n/a - n/a - [n/a - 2mL - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1725626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1725733	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Presyncope (n/a - Not Specified - );Vertigo (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - 1{DF} - Transdermal])|[PROPAFENONE, PROPAFENONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 2{DF} - Oral])|[RAMIPRIL] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1725733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1725796	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Epilepsy (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[DELORAZEPAM] (C - n/a - n/a - [n/a - 1mg - Oral])|[ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[LEVOSULPIRIDE] (C - n/a - n/a - [n/a - 15mg - Oral])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1725796&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1725798	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dehydration (n/a - Not Specified - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Specified - Caused/Prolonged Hospitalisation);Hyperglycaemia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[BUPROPION, BUPROPION HYDROCHLORIDE] (C - n/a - n/a - [n/a - 850mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - 850mg - Oral])|[TICLOPIDINE, TICLOPIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1725798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1725802	Spontaneous	2008-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Specified - );Asthenia (n/a - Not Specified - );Chills (n/a - Not Specified - );Nausea (n/a - Not Specified - );Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1725802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1705204	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[FELODIPINE, VASELINE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1705204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1706448	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Agitation (n/a - Not Specified - );Anxiety (n/a - Not Specified - );Hypotension (n/a - Not Specified - );Tachycardia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1706448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1708014	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vasculitis (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1708014&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1708029	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Not Specified - );Influenza like illness (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[ALPHA-TOCOPHEROL, DL-ALPHA TOCOPHEROL ACETATE] (C - Cystic fibrosis - n/a - [n/a - n/a - n/a])|[AMYLASE, LIPASE, PROTEASE] (C - Cystic fibrosis - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, CYANOCOBALAMIN, NICOTINAMIDE, RIBOFLAVIN, THIAMINE NITRATE, ZINC, CALCIUM, COPPER, IRON, MAGNESIUM, MANGANESE, PYRIDOXINE HYDROCHLORIDE, RETINOL, ALPHATOCOPHEROL ACETATE, MOLYBDENUM, ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, PHYTOMENADIONE, RIBOFLAVIN, THIAMINE, CALCIUM HYDROGEN PHOSPHATE (ANHYDROUS), COPPER SULPHATE, ANHYDROUS, MANGANESE SULPHATE MONOHYDRATE, SODIUM MOLYBDATE DIHYDRATE, VITAMIN B6, CALCIUM CARBONATE, FERROUS FUMARATE, POTASSIUM IODIDE, SODIUM FLUORIDE, RETINOL, ALPHA-TOCOPHEROL, CHROMIUM TRICHLORIDE HEXAHYDRATE, SODIUM SELENATE, ZINC CITRATE TRIHYDRATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, VITAMIN B12, ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, COPPER SULPHATE, ANHYDROUS, MAGNESIUM OXIDE, LIGHT, MANGANESE SULPHATE MONOHYDRATE, SODIUM MOLYBDATE DIHYDRATE, THIAMINE NITRATE, ZINC, VITAMIN B6, FERROUS SULFATE, PHOSPHORUS, RETINOL, ALPHATOCOPHEROL ACETATE, CALCIUM PHOSPHATE, VITAMIN B12, ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, COPPER SULPHATE, ANHYDROUS, MAGNESIUM OXIDE, LIGHT, MANGANESE SULPHATE MONOHYDRATE, SODIUM MOLYBDATE DIHYDRATE, THIAMINE NITRATE, ZINC, VITAMIN B6, FERROUS SULFATE, PHOSPHORUS, RETINOL, CALCIUM PHOSPHATE, DL-ALPHA TOCOPHEROL ACETATE, VITAMIN B12, ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, THIAMINE NITRATE, ZINC, VITAMIN B6, CALCIUM, COPPER, IRON, MAGNESIUM, MANGANESE, PHOSPHORUS, RETINOL, MOLYBDENUM, DL-ALPHA TOCOPHEROL ACETATE, VITAMIN B12, ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, THIAMINE, COPPER SULPHATE, ANHYDROUS, MAGNESIUM OXIDE, LIGHT, MANGANESE SULPHATE MONOHYDRATE, SODIUM MOLYBDATE DIHYDRATE, VITAMIN B6, FERROUS SULFATE, RETINOL, ALPHA-TOCOPHEROL, CALCIUM PHOSPHATE, ZINC SULPHATE MONOHYDRATE, VITAMIN B12, POTASSIUM ASCORBATE] (C - Cystic fibrosis - n/a - [n/a - n/a - n/a])|[BECLOMETASONE DIPROPIONATE, BECLOMETASONE DIPROPIONATE ANHYDROUS] (C - Cystic fibrosis - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Cystic fibrosis - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1708029&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1709532	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pericarditis (n/a - Not Specified - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Subcutaneous])	[LACIDIPINE] (C - Essential hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1709532&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-1709950	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dermatitis (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1709950&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1709957	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Rash erythematous (n/a - Not Specified - );Rash maculo-papular (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])|[PNEUMOCOCCAL VACCINE] (S - n/a - n/a - [n/a - 1{DF} - n/a])	[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, AMILORIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE DIHYDRATE, HYDROCHLOROTHIAZIDE, ANHYDROUS AMILORIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1709957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1710601	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Not Specified - );Influenza like illness (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1710601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1710606	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Not Specified - );Influenza like illness (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1710606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1711256	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Thrombocytopenia (n/a - Not Specified - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1711256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-1712149	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Brain injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysarthria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Speech disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vision blurred (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1712149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1714505	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hyperpyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[ACENOCOUMAROL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1714505&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1715845	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Formication (n/a - Not Specified - );Injection site reaction (n/a - Not Specified - );Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1715845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1715856	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1715856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1715966	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1715966&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1715974	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Skin reaction (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1715974&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1716067	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Diplopia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Headache (n/a - Not Specified - Caused/Prolonged Hospitalisation);IIIrd nerve paresis (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[BACLOFEN, BACLOFEN PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716067&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1716191	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Dyspnoea (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716191&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1716325	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Radiculopathy (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1716335	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716335&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1716341	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Encephalomyelitis (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza - n/a - [n/a - 1M[iU] - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716341&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1716360	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Polyneuropathy (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1716501	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Malaise (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1716506	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hyperpyrexia (n/a - Not Specified - );Rash (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[CALCITRIOL] (C - n/a - n/a - [n/a - n/a - n/a])|[CALCIUM, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM LACTATE GLUCONATE, CALCIUM GLUBIONATE, CALCIUM GLUBIONATE, CALCIUM LACTOBIONATE, CALCIUM GLUCONATE, CALCIUM GLUCONATE MONOHYDRATE, CALCIUM LACTOBIONATE DIHYDRATE, CALCIUM LACTOBIONATE, CALCIUM GLUCONATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CHORIONIC GONADOTROPIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1716593	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hypotonic-hyporesponsive episode (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intradermal])	[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - Type IIa hyperlipidaemia - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716593&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1716616	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hallucination (n/a - Not Specified - );Nausea (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, ALUMINIUM HYDROXIDE GEL, MAGNESIUM HYDROXIDE, ACETYLSALICYLIC ACID, MAGNESIUM HYDROXIDE, ALGELDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1716617	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[CALCIUM, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LISINOPRIL, LISINOPRIL ANHYDROUS, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716617&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1716764	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myocarditis (n/a - Not Specified - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[RAMIPRIL] (C - Essential hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-1716832	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1716846	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - );Chills (n/a - Not Specified - );Hyperhidrosis (n/a - Not Specified - );Myalgia (n/a - Not Specified - );Paraesthesia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1716846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1717018	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Sudden death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1717018&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1717101	Spontaneous	2008-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Platelet count decreased (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1717101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1689117	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Blister (2d - Not Recovered/Not Resolved - );Body temperature increased (2d - Recovering/Resolving - );Injection site erythema (2d - Recovering/Resolving - );Injection site scar (n/a - Not Recovered/Not Resolved - );Injection site swelling (2d - Recovering/Resolving - );Nasopharyngitis (2d - Recovering/Resolving - );Pain in extremity (2d - Recovering/Resolving - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1689117&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1691387	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	Non European Economic Area	Yanai-Berar N., Ben-Itzhak O., Green J., Nakhoul F.. Influenza vaccination induced leukocytoclastic vasculitis and pauci-immune crescentic glomerulonephritis. Clinical Nephrology 2002:220-223.	18-64 Years	Elderly	No	Male	Acute kidney injury (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Duodenitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Glomerulonephritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vasculitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1691387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1691408	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaginal haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1691408&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1692540	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Injection site reaction (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1692540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1692848	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Rhabdomyolysis (n/a - Not Specified - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[FOSINOPRIL SODIUM, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[GEMCITABINE, GEMCITABINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1692848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-1693093	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Limb discomfort (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1693093&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1693108	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Oedema (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1693108&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1693506	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1693506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1693589	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Gait disturbance (n/a - Not Specified - );Limb discomfort (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1693589&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1694063	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Not Specified - );Irritability (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[ALPRAZOLAM] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[TICLOPIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1694063&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1694161	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Gait disturbance (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1694161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1694688	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Specified - );Headache (n/a - Not Specified - );Malaise (n/a - Not Specified - );Neck pain (n/a - Not Specified - );Vertigo (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	[INDOBUFEN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1694688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1695046	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Diarrhoea (n/a - Not Specified - );Vertigo (n/a - Not Specified - );Vomiting (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1695046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1695583	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Injection site reaction (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[CLODRONATE DISODIUM, CLODRONATE DISODIUM TETRAHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[THEOPHYLLINE, THEOPHYLLINE ANHYDROUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1695583&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1695997	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lymphadenopathy (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1695997&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1696373	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pruritus (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, AMILORIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE DIHYDRATE, HYDROCHLOROTHIAZIDE, ANHYDROUS AMILORIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[BIOFLAVONOIDS, MICRONISED PURIFIED FLAVONOIC FRACTION] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPRANOLOL, PROPRANOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1696373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1696435	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Thrombocytopenia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1696435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1697340	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1697340&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1700467	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lymphadenopathy (n/a - Not Specified - );Neuritis (n/a - Not Specified - );Pain in extremity (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1700467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1700487	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vomiting (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1700487&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1700759	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myocardial infarction (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[BECLOMETASONE DIPROPIONATE, BECLOMETASONE DIPROPIONATE ANHYDROUS] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1700759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1700779	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hyperpyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Purpura (n/a - Not Specified - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[CAPTOPRIL] (C - Cardiomyopathy - n/a - [n/a - n/a - n/a])|[CARVEDILOL] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - Cardiomyopathy - n/a - [n/a - n/a - n/a])|[METILDIGOXIN] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM CANRENOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1700779&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1701038	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Fall (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1701038&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1701051	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1701051&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1701075	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Laryngospasm (n/a - Not Specified - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1701075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-1701082	Spontaneous	2008-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 5mL - n/a])...	[BROMAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[CLOMIPRAMINE, CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM PHOSPHATE, COLECALCIFEROL, CALCIUM PHOSPHATE, TRIBASIC] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PERICIAZINE] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM SULFATE ANHYDROUS, MACROGOL 4000] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1701082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1687513	Spontaneous	2008-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hyperpyrexia (n/a - Not Specified - );Injection site reaction (n/a - Not Specified - );Rash (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1687513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1682743	Spontaneous	2008-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - );Face oedema (n/a - Recovered/Resolved - );Lip swelling (n/a - Recovered/Resolved - );Rash (n/a - Recovered/Resolved - );Tongue ulceration (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1682743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1660437	Spontaneous	2008-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Encephalomyelitis (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1660437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1670149	Spontaneous	2008-02-20 00:00:00	Not Specified	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (25min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1670149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1670150	Spontaneous	2008-02-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Blindness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Encephalopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eye pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Optic neuritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1670150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1670151	Spontaneous	2008-02-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1670151&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1670152	Spontaneous	2008-02-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1670152&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-1670156	Spontaneous	2008-02-20 00:00:00	Not Specified	Non European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Glomerulonephritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1670156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1646073	Spontaneous	2008-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema peripheral (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1646073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1631823	Spontaneous	2008-02-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - n/a - n/a - [n/a - n/a - Oral])|[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1631823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1641494	Spontaneous	2008-02-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - n/a])	[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - 50mg - Oral])|[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 150mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1641494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1641495	Spontaneous	2008-02-15 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation);Atrial fibrillation (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Demyelination (n/a - Unknown - Caused/Prolonged Hospitalisation);Diplopia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Myelitis transverse (n/a - Unknown - Caused/Prolonged Hospitalisation);Neurogenic bladder (n/a - Unknown - Caused/Prolonged Hospitalisation);Nystagmus (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Urinary retention (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	[DOXAZOSIN, DOXAZOSIN MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[NIFEDIPINE] (C - n/a - n/a - [n/a - 30mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1641495&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1641496	Spontaneous	2008-02-15 00:00:00	Not Specified	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic obstructive pulmonary disease (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Condition aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (2d - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 30mg - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - 10mg - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[THEOPHYLLINE] (C - n/a - n/a - [n/a - 300mg - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1641496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1641497	Spontaneous	2008-02-15 00:00:00	Not Specified	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthritis (n/a - Not Specified - Disabling, Other Medically Important Condition);Carpal tunnel syndrome (n/a - Not Specified - Disabling, Other Medically Important Condition);Pain (n/a - Not Specified - Disabling, Other Medically Important Condition);Scleroderma (n/a - Not Specified - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1641497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-1641499	Spontaneous	2008-02-15 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Infection (n/a - Not Specified - );Neck pain (4d - Not Specified - );Oedema (n/a - Recovered/Resolved - );Oropharyngeal pain (3d - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1641499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1641500	Spontaneous	2008-02-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1641500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1641501	Spontaneous	2008-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Hemiplegia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1641501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1630947	Spontaneous	2008-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Nausea (n/a - Recovered/Resolved - );Oedema peripheral (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .3mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1630947&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1622034	Spontaneous	2008-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1622034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1622185	Spontaneous	2008-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hyperpyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[AMLODIPINE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1622185&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1622876	Spontaneous	2008-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1622876&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1617565	Spontaneous	2008-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site erythema (n/a - Not Specified - );Injection site paraesthesia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	[BROTIZOLAM] (C - n/a - n/a - [n/a - .25mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1617565&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1617566	Spontaneous	2008-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Confusional state (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1617566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1595713	Spontaneous	2008-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1595713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1596079	Spontaneous	2008-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (n/a - Not Recovered/Not Resolved - Disabling);Localised oedema (n/a - Recovered/Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Skin warm (n/a - Recovered/Resolved - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1596079&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-1599046	Spontaneous	2008-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1599046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1599172	Spontaneous	2008-02-06 00:00:00	Not Specified	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Joint swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1599172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1599186	Spontaneous	2008-02-06 00:00:00	Not Specified	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Henoch-Schonlein purpura (58d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1599186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-1599188	Spontaneous	2008-02-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Abortion spontaneous (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1599188&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1599190	Spontaneous	2008-02-06 00:00:00	Not Specified	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Upper respiratory tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1599190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1599198	Spontaneous	2008-02-06 00:00:00	Not Specified	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Abdominal pain upper (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Joint swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1599198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1599200	Spontaneous	2008-02-06 00:00:00	Not Specified	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Breath sounds abnormal (3d - Recovered/Resolved - Other Medically Important Condition);Headache (3d - Recovered/Resolved - Other Medically Important Condition);Pharyngeal erythema (3d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1599200&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1599204	Spontaneous	2008-02-06 00:00:00	Not Specified	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Dermatitis exfoliative (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .2mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1599204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1599206	Spontaneous	2008-02-06 00:00:00	Not Specified	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site haemorrhage (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1599206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1590388	Spontaneous	2008-02-05 00:00:00	Not Specified	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Chest pain (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chills (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Discomfort (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle twitching (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Throat irritation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Upper respiratory tract infection (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1590388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1590390	Spontaneous	2008-02-05 00:00:00	Not Specified	Non European Economic Area	Not available	18-64 Years	Elderly	No	Male	Acute disseminated encephalomyelitis (21d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscle twitching (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sopor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1590390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1590392	Spontaneous	2008-02-05 00:00:00	Not Specified	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Dermatitis (6d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Specified - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1590392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1590393	Spontaneous	2008-02-05 00:00:00	Not Specified	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Furuncle (n/a - Unknown - Disabling);Injection site erythema (n/a - Not Specified - Disabling);Injection site pain (n/a - Not Specified - Disabling);Mechanical urticaria (n/a - Unknown - Disabling);Porokeratosis (n/a - Unknown - Disabling);Skin lesion (n/a - Unknown - Disabling);Staphylococcal infection (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1590393&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-1590395	Spontaneous	2008-02-05 00:00:00	Not Specified	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Injection site cellulitis (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Not Specified - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Not Specified - Caused/Prolonged Hospitalisation);Injection site swelling (n/a - Not Specified - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swelling (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1590395&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1581204	Spontaneous	2008-02-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site inflammation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Serum sickness-like reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Swelling (n/a - Unknown - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation);Vasodilatation (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[ATORVASTATIN] (C - Hyperlipidaemia - n/a - [n/a - n/a - Oral])|[INDAPAMIDE, INDAPAMIDE HEMIHYDRATE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[NIFEDIPINE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[VALSARTAN] (C - Hypertension - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1581204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1581209	Spontaneous	2008-02-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Chills (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lethargy (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1581209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1588798	Spontaneous	2008-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1588798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1579490	Spontaneous	2008-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Aphasia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1579490&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1579336	Spontaneous	2008-02-01 00:00:00	Not Specified	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Blister (n/a - Unknown - Caused/Prolonged Hospitalisation);Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Irritability (n/a - Unknown - Caused/Prolonged Hospitalisation);Skin exfoliation (n/a - Unknown - Caused/Prolonged Hospitalisation);Staphylococcal scalded skin syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5{DF} - Intramuscular])	[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1579336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1579338	Spontaneous	2008-02-01 00:00:00	Not Specified	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (6d - Recovered/Resolved - Disabling);Optic neuritis (n/a - Not Recovered/Not Resolved - Disabling);Retinitis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[DROSPIRENONE, ETHINYLESTRADIOL] (C - Contraception - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1579338&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-1549271	Spontaneous	2008-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Disorientation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Electroencephalogram abnormal (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lasegue's test positive (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Meningitis aseptic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[BETAXOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1549271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1532782	Spontaneous	2008-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1532782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1528281	Spontaneous	2008-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - );Localised oedema (5d - Recovered/Resolved - );Pain (5d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1528281&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1528879	Spontaneous	2008-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1528879&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1524923	Spontaneous	2008-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Amputation (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Ear disorder (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Gangrene (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Infection (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Joint swelling (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Multiple organ dysfunction syndrome (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Necrotising fasciitis (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Sepsis (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Septic shock (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Soft tissue infection (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Streptococcal sepsis (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Swelling (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1524923&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1525019	Spontaneous	2008-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute kidney injury (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Diarrhoea (3d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Headache (8d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Nausea (3d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (8d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Renal failure (12d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1525019&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-1525973	Spontaneous	2008-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Encephalitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);VIth nerve paralysis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1525973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-1526249	Spontaneous	2008-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Alpha 2 globulin increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Red blood cell sedimentation rate increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Transaminases increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1526249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1501314	Spontaneous	2008-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dermatitis bullous (n/a - Recovering/Resolving - );Toxic skin eruption (n/a - Recovering/Resolving - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Drug withdrawn - [n/a - .5mg - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1501314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1487679	Spontaneous	2008-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1487679&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1488015	Spontaneous	2008-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Cough (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1488015&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1488074	Spontaneous	2008-01-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Intestinal perforation (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1488074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-1498485	Spontaneous	2008-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Dose not changed - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1498485&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-1499224	Spontaneous	2008-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Vasculitis (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Dose not changed - [n/a - n/a - Oral])|[CARBASALATE CALCIUM] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[DEXCHLORPHENIRAMINE MALEATE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[TERBUTALINE SULFATE] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1499224&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1500864	Spontaneous	2008-01-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dyspnoea (n/a - Recovering/Resolving - );Eye irritation (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Injection site reaction (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - );Swelling face (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Asthma - Drug withdrawn - [n/a - n/a - n/a])	[FLUTICASONE PROPIONATE] (C - n/a - Dose not changed - [n/a - n/a - Respiratory (inhalation)])|[SALMETEROL] (C - n/a - Dose not changed - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1500864&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1478379	Spontaneous	2008-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Enteritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .7mL - n/a])	[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1478379&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1478804	Spontaneous	2008-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Optic neuritis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1478804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1478807	Spontaneous	2008-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cerebrovascular accident (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - 80mg - Oral])|[BACLOFEN] (C - n/a - Unknown - [n/a - 5mg - Oral])|[CAPTOPRIL] (C - n/a - Unknown - [n/a - 25mg - Oral])|[CHLORTALIDONE] (C - n/a - Unknown - [n/a - 12.5mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 850mg - Oral])|[NAPROXEN] (C - n/a - Unknown - [n/a - 500mg - Oral])|[OMEPRAZOLE] (C - n/a - Unknown - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1478807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1480233	Spontaneous	2008-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Skin reaction (n/a - Not Specified - );Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1480233&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1470795	Spontaneous	2008-01-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Deafness unilateral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1470795&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1450750	Spontaneous	2008-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1450750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1447653	Spontaneous	2007-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Leukopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Mouth ulceration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neutropenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1447653&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1447713	Spontaneous	2007-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Specified - );Hypotension (n/a - Not Specified - );Influenza (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	[TACROLIMUS, TACROLIMUS MONOHYDRATE] (C - n/a - n/a - [n/a - 6mg - Oral])|[TICLOPIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 250mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1447713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1438538	Spontaneous	2007-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Not applicable - [n/a - 20mg - Oral])|NOT AVAILABLE (C - n/a - Not applicable - [n/a - 40mg - Oral])|[DIGOXIN] (C - n/a - Not applicable - [n/a - .625mg - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Not applicable - [n/a - 2{DF} - Intratracheal])|[OXPRENOLOL HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - 160mg - Oral])|[TIOTROPIUM BROMIDE] (C - n/a - Not applicable - [n/a - 1{DF} - Intratracheal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1438538&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1438540	Spontaneous	2007-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Not applicable - [n/a - 2mg - Oral])|NOT AVAILABLE (C - n/a - Not applicable - [n/a - 300mg - Oral])|NOT AVAILABLE (C - n/a - Not applicable - [n/a - 50mg - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Not applicable - [n/a - 50ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1438540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1440439	Spontaneous	2007-12-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Asthenia (n/a - Recovering/Resolving - Other Medically Important Condition);C-reactive protein increased (n/a - Recovering/Resolving - Other Medically Important Condition);Hyperhidrosis (n/a - Recovering/Resolving - Other Medically Important Condition);Lip swelling (n/a - Recovering/Resolving - Other Medically Important Condition);Oedema peripheral (n/a - Recovering/Resolving - Other Medically Important Condition);Palpitations (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Rash (4d - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[MINOCYCLINE] (C - n/a - n/a - [5d - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1440439&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1411209	Spontaneous	2007-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erysipelas (5d - Recovered/Resolved - Other Medically Important Condition);Injection site inflammation (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (2d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1411209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1409003	Spontaneous	2007-12-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	MIXTARD 30 [INSULIN HUMAN (RDNA), INSULIN ISOPHANE, INSULIN HUMAN REGULAR (RDNA)] (C - n/a - n/a - [n/a - 12[iU] - Subcutaneous])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - Oral])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - 2mg - Oral])|[FOLIC ACID] (C - n/a - n/a - [n/a - 5mg - Oral])|[FUROSEMIDE] (C - n/a - n/a - [n/a - 20mg - Oral])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - .02mg - Oral])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - 10mg - Oral])|[PRAVASTATIN, PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1409003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1402999	Spontaneous	2007-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Night sweats (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vertigo positional (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1402999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1391268	Spontaneous	2007-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1391268&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1387549	Spontaneous	2007-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Confusional state (n/a - Not Specified - Caused/Prolonged Hospitalisation);Hyperpyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1387549&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1380718	Spontaneous	2007-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Rash (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	[SALBUTAMOL] (C - Chronic obstructive pulmonary disease - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1380718&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1378330	Spontaneous	2007-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Haemolysis (6mo - Recovered/Resolved - Life Threatening);Pancytopenia (9mo - Recovered/Resolved - Life Threatening);Thrombocytopenia (n/a - Recovered/Resolved - Life Threatening)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1378330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-1373458	Spontaneous	2007-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Sudden death (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - 75mg - Oral])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - Oral])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - 22.3mg - Oral])|[INSULIN, INSULIN HUMAN] (C - n/a - n/a - [n/a - n/a - Subcutaneous])|[LISINOPRIL] (C - n/a - n/a - [n/a - mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - Oral])|[METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - mg - Oral])|[PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - 1000mg - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1373458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1373497	Spontaneous	2007-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Febrile convulsion (1min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Upper respiratory tract infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1373497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1369174	Spontaneous	2007-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (2d - Recovered/Resolved - Life Threatening);Chills (2d - Recovered/Resolved - Life Threatening);Malaise (2d - Recovered/Resolved - Life Threatening);Pyrexia (2d - Recovered/Resolved - Life Threatening)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1369174&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-1363426	Spontaneous	2007-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Rash (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1363426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1363748	Spontaneous	2007-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (5d - Recovered/Resolved - );Blister (4d - Recovered/Resolved - );Chills (3d - Recovered/Resolved - );Disturbance in attention (1d - Recovered/Resolved - );Fatigue (5d - Recovered/Resolved - );Hyperhidrosis (0d - Recovered/Resolved - );Malaise (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1363748&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1363752	Spontaneous	2007-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (5d - Recovered/Resolved - );Back pain (2d - Recovered/Resolved - );Blister (4d - Recovered/Resolved - );Disturbance in attention (1d - Recovered/Resolved - );Fatigue (5d - Recovered/Resolved - );Malaise (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1363752&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1360857	Spontaneous	2007-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Neuropathy peripheral (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[DIGOXIN, DIGOXIN PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1360857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1359847	Spontaneous	2007-11-14 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Blister (n/a - Unknown - Other Medically Important Condition);Injection site inflammation (n/a - Unknown - Other Medically Important Condition);Injection site rash (n/a - Unknown - Other Medically Important Condition);Rash macular (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1359847&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1348003	Spontaneous	2007-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - Prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1348003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1337920	Spontaneous	2007-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pleurisy (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1337920&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1331907	Spontaneous	2007-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Haemoptysis (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 500uL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1331907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1323996	Spontaneous	2007-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Pyrexia (n/a - Recovered/Resolved - Life Threatening);Tongue oedema (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1323996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-1282987	Spontaneous	2007-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Anaemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);C-reactive protein increased (5mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Performance status decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Red blood cell sedimentation rate increased (5mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vasculitis (5mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1282987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1264976	Spontaneous	2007-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Septic shock (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1264976&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1266398	Spontaneous	2007-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cardiovascular disorder (90min - Recovered/Resolved - );Dizziness (90min - Recovered/Resolved - );Hyperhidrosis (90min - Recovered/Resolved - );Hypersensitivity (90min - Recovered/Resolved - );Vertigo (90min - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1266398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1230186	Spontaneous	2007-09-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Bell's palsy (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1230186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1198923	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Body temperature increased (1d - Recovered/Resolved - );Chills (2d - Recovered/Resolved - );Pain in extremity (2d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - n/a - [n/a - 50mg - n/a])|[BEZAFIBRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CINEOLE, LIQUID EXTRACT FROM THYME HERB (DER 1:2-2,5), EXTRACTION SOLVENTS: AMMONIA SOLUTION 10 % (M/M), GLYCEROL 85%, ETHANOL 90%, WATER (1:20:70:109), THYMUS VULGARIS FLUID EXTRACT] (C - n/a - n/a - [n/a - n/a - n/a])|[CRATAEGI FOLIUM CUM FLORE, HAWTHORN LEAF AND FLOWER DRY EXTRACT (DER 1 : 4-7), EXTRACTION SOLVENT: METHANOL 70% (V/V), LEVOFLOXACIN] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYPERICUM PERFORATUM] (C - n/a - n/a - [n/a - n/a - n/a])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1198923&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1198955	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Injection site erythema (n/a - Not Recovered/Not Resolved - );Joint swelling (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1198955&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1198979	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Keratitis (4wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1198979&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1198993	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Local reaction (6h - Recovered/Resolved - );Pruritus (2h - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1198993&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1199045	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Diarrhoea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Extrasystoles (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Facial paresis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Quadriplegia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Not Specified - Life Threatening, Caused/Prolonged Hospitalisation);Sinus tachycardia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1199045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-1199055	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myositis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1199055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1199065	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Rhabdomyolysis (n/a - Unknown - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1199065&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1199071	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Aphasia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Confusional state (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1199071&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1199080	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Joint swelling (n/a - Recovering/Resolving - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1199080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1199208	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Contusion (n/a - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1199208&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1199218	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Fatal - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Performance status decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1199218&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1199224	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aphonia (1d - Recovered/Resolved - Life Threatening);Dyspnoea (1d - Recovered/Resolved - Life Threatening);Hypersensitivity (1d - Recovered/Resolved - Life Threatening);Laryngeal oedema (1d - Recovered/Resolved - Life Threatening);Ocular hyperaemia (3h - Recovered/Resolved - Life Threatening);Respiratory disorder (3h - Recovered/Resolved - Life Threatening);Swelling (3h - Recovered/Resolved - Life Threatening)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	DEXAMETHASONE [DEXAMETHASONE, DEXAMETHASONE SODIUM PHOSPHATE] (C - n/a - n/a - [n/a - 16mg - Intravenous (not otherwise specified)])|[ADRENALINE TARTRATE PH. EUR., EPINEPHRINE BITARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CLEMASTINE, CLEMASTINE FUMARATE] (C - n/a - n/a - [n/a - n/a - Intramuscular])|[THEOPHYLLINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1199224&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-1199429	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Alveolitis (17d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Blood culture positive (17d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (17d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (17d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Lung disorder (17d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (17d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vasculitis (17d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1199429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1199444	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Headache (1d - Unknown - )	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1199444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1202483	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Henoch-Schonlein purpura (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1202483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-1202832	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Joint swelling (6wk - Recovered/Resolved - );Urticaria (6wk - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1202832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1210453	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Partial seizures (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Status epilepticus (1h - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - n/a])|[BENFOTIAMINE, CYANOCOBALAMIN] (C - n/a - n/a - [n/a - 100mg - n/a])|[RISPERIDONE] (C - n/a - n/a - [n/a - 2mg - n/a])|[SODIUM VALPROATE, VALPROIC ACID, SODIUM VALPROATE] (C - n/a - n/a - [n/a - 500mg - n/a])|[TAMSULOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1210453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-1210559	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Injection site abscess (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1210559&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1210571	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Conjunctivitis (1d - Recovered/Resolved - );Dermatitis allergic (5h - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1210571&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1210576	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (3d - Recovered/Resolved - );Injection site erythema (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - );Lymph node pain (n/a - Not Recovered/Not Resolved - );Lymphadenopathy (n/a - Not Recovered/Not Resolved - );Pain (n/a - Not Recovered/Not Resolved - );Pain in extremity (3d - Recovered/Resolved - );Paraesthesia (3d - Recovered/Resolved - );Pyrexia (3d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1210576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1210764	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Elderly	No	Female	Conjunctivitis allergic (n/a - Not Recovered/Not Resolved - );Cough (n/a - Not Recovered/Not Resolved - );Dermatitis allergic (n/a - Not Recovered/Not Resolved - );Pyrexia (1d - Recovered/Resolved - );Rhinitis (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1210764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1211331	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Drug eruption (1wk - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1211331&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1211377	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Hypotonia (20min - Recovered/Resolved - );Syncope (20min - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1211377&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1211378	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Syncope (10min - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1211378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1211442	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Mastitis (2wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1211442&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1211512	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Sudden cardiac death (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1211512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1211693	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Myalgia (10d - Recovered/Resolved - );Myositis (10d - Recovered/Resolved - );Pyrexia (10d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1211693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1211694	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Gait disturbance (22d - Not Recovered/Not Resolved - );Myalgia (22d - Not Recovered/Not Resolved - );Myositis (22d - Not Recovered/Not Resolved - );Peripheral swelling (22d - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1211694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Duration
EU-EC-1211695	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Myalgia (4wk - Unknown - );Myositis (n/a - Unknown - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1211695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1211911	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Tendonitis (n/a - Unknown - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1211911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1212049	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Eyelid ptosis (n/a - Recovering/Resolving - Other Medically Important Condition);Hypoaesthesia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212049&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212130	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Deafness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (48d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212130&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1212145	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Bronchitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212153	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Dysaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Loss of proprioception (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Polyarteritis nodosa (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Sensorimotor disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Vasculitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])|[BETAHISTINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[BIOFLAVONOIDS, DIOSMIN, BIOFLAVONOIDS, DIOSMIN, HESPERIDIN, FLAVONOIDS EXTRACTED FROM RUTACAE (AURANTIAE), MICRONISED PURIFIED FLAVONOIC FRACTION] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[LORAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212162	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Circumoral oedema (n/a - Unknown - Other Medically Important Condition);Dyspnoea (30min - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (1h - Unknown - Other Medically Important Condition);Paraesthesia (1h - Recovered/Resolved - Other Medically Important Condition);Rhonchi (30min - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1212165	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ventricular extrasystoles (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212165&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212182	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Fatal - Results in Death);Pyrexia (n/a - Fatal - Results in Death);Upper respiratory tract congestion (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212182&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1212183	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Epilepsy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[AMLODIPINE, AMLODIPINE BESILATE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[FENOFIBRATE, FENOFIBRATE MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - Gastrooesophageal reflux disease - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212183&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212204	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Injection site abscess (8d - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (8d - Recovered/Resolved - Other Medically Important Condition);Injection site infection (8d - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (8d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212207	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Joint swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212208	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site inflammation (13d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Not Specified - Caused/Prolonged Hospitalisation);Injection site swelling (n/a - Not Specified - Caused/Prolonged Hospitalisation);Rash (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212208&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212210	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Infectious mononucleosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Meningism (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tonsillitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Transaminases increased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212210&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212211	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Hypersensitivity (8d - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])|[CHLORPHENAMINE] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212211&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212213	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212241	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Muscle spasms (3d - Not Recovered/Not Resolved - );Neuralgia (3d - Not Recovered/Not Resolved - );Paraesthesia (3d - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212241&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1212244	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain upper (2d - Recovered/Resolved - );Body temperature increased (2d - Recovered/Resolved - );Nausea (2d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212244&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1212269	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Injection site erythema (n/a - Not Specified - Other Medically Important Condition);Injection site inflammation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site swelling (n/a - Not Specified - Other Medically Important Condition);Oedema peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [5min - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212270	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Rash (3d - Recovered/Resolved - Other Medically Important Condition);Rash papular (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212270&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212271	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Abdominal pain upper (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Joint swelling (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Osteoarthritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212274	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Arthralgia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngeal erythema (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rales (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212274&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212275	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neutrophilia (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (5min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212276	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hypoacusis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (1wk - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (1wk - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212276&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212282	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Petechiae (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212333	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Injection site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Scar (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	ANTI-ANAPHYLACTICS [NOT AVAILABLE] (C - n/a - n/a - [5d - n/a - n/a])|ANTI-INFLAMMATORY DRUGS [NOT AVAILABLE] (C - n/a - n/a - [5d - .5mL - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212333&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212336	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Herpes dermatitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash pruritic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [5min - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212351	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (5d - Recovered/Resolved - Other Medically Important Condition);Asthenia (14d - Recovered/Resolved - Other Medically Important Condition);Disturbance in attention (5d - Recovered/Resolved - Other Medically Important Condition);Erythema (3d - Recovered/Resolved - Other Medically Important Condition);Fatigue (2wk - Recovered/Resolved - Other Medically Important Condition);Hypotension (14d - Recovered/Resolved - Other Medically Important Condition);Myalgia (1d - Recovered/Resolved - Other Medically Important Condition);Pain (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212351&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212352	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Paralysis (8d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212352&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1212355	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212357	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest pain (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Injection site pain (1d - Recovered/Resolved - Other Medically Important Condition);Muscle contractions involuntary (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Respiratory disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Weight decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1212358	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Vertigo (3wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE, LYSINE ASPIRIN, LYSINE, ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[CRATAEGI FOLIUM CUM FLORE, PASSIFLORA EXTRACT, VALERIANA OFFICINALIS EXTRACT, BALLOTA NIGRA, CRATAEGUS, BALLOTA NIGRA, PASSIFLORA INCARNATA L. HERBA, VALERIANA OFFICINALIS L.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212359	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cutaneous vasculitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Haematuria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	HUMALOG [INSULIN LISPRO] (C - n/a - n/a - [n/a - n/a - n/a])|[ACENOCOUMAROL] (C - n/a - n/a - [n/a - n/a - n/a])|[CARVEDILOL] (C - n/a - n/a - [n/a - n/a - n/a])|[DIGOXIN] (C - n/a - n/a - [n/a - n/a - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212362	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Ankylosing spondylitis (n/a - Recovering/Resolving - Other Medically Important Condition);Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212362&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212363	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212363&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212365	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Face oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212366	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Blindness unilateral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1212368	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Fatal - Results in Death);Pyrexia (n/a - Fatal - Results in Death);Sputum abnormal (n/a - Fatal - Results in Death);Upper respiratory tract congestion (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1212369	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Influenza (n/a - Fatal - Results in Death);Pyrexia (n/a - Fatal - Results in Death);Upper respiratory tract congestion (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212369&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1212370	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Influenza (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1212392	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Male	Discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypokinesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212438	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Body temperature increased (4d - Recovered/Resolved - );Dyspnoea (4d - Recovered/Resolved - );Feeling hot (4d - Recovered/Resolved - );Pain (4d - Recovered/Resolved - );Pain in extremity (4d - Recovered/Resolved - );Swelling (4d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212438&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-1212531	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (2d - Not Recovered/Not Resolved - );Pain in extremity (2d - Not Recovered/Not Resolved - );Productive cough (n/a - Not Recovered/Not Resolved - );Pyrexia (2d - Recovering/Resolving - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212531&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1212562	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (18d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212562&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212608	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	C-reactive protein increased (n/a - Recovered/Resolved - Other Medically Important Condition);Chills (9d - Recovered/Resolved - Other Medically Important Condition);Confusional state (3d - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (9d - Recovered/Resolved - Other Medically Important Condition);Injection site inflammation (9d - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (9d - Recovered/Resolved - Other Medically Important Condition);Leukocytosis (n/a - Recovered/Resolved - Other Medically Important Condition);Neck pain (9d - Recovered/Resolved - Other Medically Important Condition);Tachycardia (9d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	INSUMAN COMB 25 [INSULIN HUMAN, INSULIN HUMAN ISOPHANE (RDNA), INSULIN HUMAN REGULAR (RDNA)] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - n/a - [n/a - 100mg - n/a])|[ISOSORBIDE DINITRATE] (C - n/a - n/a - [n/a - 40mg - n/a])|[METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 50mg - n/a])|[MOLSIDOMINE] (C - n/a - n/a - [n/a - 8mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1212640	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site haematoma (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212640&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1212660	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hemiparesis (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212660&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1212662	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema multiforme (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1212662&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1213003	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Epilepsy (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1213003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-1213314	Spontaneous	2007-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Papule (n/a - Not Recovered/Not Resolved - );Rash maculo-papular (n/a - Not Recovered/Not Resolved - );Urticaria (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1213314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1197298	Spontaneous	2007-09-14 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Liver function test abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	NOT AVAILABLE (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1197298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1184159	Spontaneous	2007-09-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Paresis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1184159&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1174626	Spontaneous	2007-08-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[ACENOCOUMAROL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1174626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1133223	Spontaneous	2007-07-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Malaise (1d - Recovered/Resolved - Other Medically Important Condition);Nausea (1d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (1d - Recovered/Resolved - Other Medically Important Condition);Syncope (1d - Recovered/Resolved - Other Medically Important Condition);Vomiting (2h - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[HEPATITIS B SURFACE ANTIGEN, HEPATITIS A VACCINE (INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[POLIOMYELITIS VACCINE (INACTIVATED), POLIOVIRUS TYPE 1 (INACTIVATED), POLIOVIRUS TYPE 2 (INACTIVATED), POLIOVIRUS TYPE 3 (INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[INFLUENZA VIRUS] (C - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[POLIOMYELITIS VACCINE (INACTIVATED)] (C - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1133223&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-1105728	Spontaneous	2007-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (6mo - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1105728&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1105885	Spontaneous	2007-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1105885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1099600	Spontaneous	2007-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Demyelinating polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1099600&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1100050	Spontaneous	2007-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1100050&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1096400	Spontaneous	2007-07-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cerebrovascular accident (1d - Fatal - Results in Death)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1096400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-1054625	Spontaneous	2007-05-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Petit mal epilepsy (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])|[ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1054625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1049540	Spontaneous	2007-05-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Eosinophilic pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1049540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1037891	Spontaneous	2007-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Back pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Laryngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Meningism (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neck pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tinnitus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1037891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-1038636	Spontaneous	2007-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Presyncope (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	[LORAZEPAM] (C - n/a - n/a - [n/a - 1mg - Oral])|[TICLOPIDINE] (C - n/a - n/a - [n/a - 250mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1038636&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-1035870	Spontaneous	2007-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1035870&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1035900	Spontaneous	2007-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Diarrhoea (6wk - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1035900&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-1016483	Spontaneous	2007-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cardiomegaly (n/a - Not Specified - Caused/Prolonged Hospitalisation);Pneumonia viral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=1016483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-999307	Spontaneous	2007-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=999307&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-999329	Spontaneous	2007-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (10d - Recovered/Resolved - );Vaccination failure (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=999329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-999665	Spontaneous	2007-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=999665&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-999668	Spontaneous	2007-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=999668&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-998230	Spontaneous	2007-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=998230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-995666	Spontaneous	2007-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Unknown - Other Medically Important Condition);Muscle atrophy (n/a - Unknown - Other Medically Important Condition);Paresis (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=995666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-989020	Spontaneous	2007-04-12 00:00:00	Healthcare Professional	European Economic Area	Bergsaker M. Vaccination against influenza--why, for whom and with which vaccine?. Tidsskr Nor Laegeforen. 02-NOV-2006:126:2814-2817.	3-11 Years	Child	No	Male	Pyrexia (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition);Upper respiratory tract infection (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=989020&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-969271	Spontaneous	2007-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=969271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-961147	Spontaneous	2007-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Febrile infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pleuropericarditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	[DORZOLAMIDE, DORZOLAMIDE HYDROCHLORIDE] (C - Glaucoma - Dose not changed - [n/a - n/a - Ophthalmic])|[LATANOPROST] (C - Glaucoma - Dose not changed - [n/a - n/a - Ophthalmic])|[TRIMETAZIDINE DIHYDROCHLORIDE] (C - Vasodilatation - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=961147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-950681	Spontaneous	2007-03-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Injection site abscess (91d - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (91d - Recovered/Resolved - Other Medically Important Condition);Injection site induration (91d - Recovered/Resolved - Other Medically Important Condition);Injection site pruritus (91d - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (91d - Recovered/Resolved - Other Medically Important Condition);Injection site ulcer (81d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=950681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-950841	Spontaneous	2007-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Paraesthesia (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=950841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-947149	Spontaneous	2007-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Facial paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=947149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-948457	Spontaneous	2007-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute myocardial infarction (0d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=948457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-945445	Spontaneous	2007-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Depressed mood (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Subcutaneous])|[CIPROFLOXACIN, CIPROFLOXACIN HYDRATED, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, HYDROCORTISONE] (S - n/a - n/a - [2wk - 1g - Oral])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[CARVEDILOL] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=945445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-945721	Spontaneous	2007-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);C-reactive protein increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rheumatoid factor positive (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=945721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-945787	Spontaneous	2007-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Laryngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Meningism (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=945787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-939306	Spontaneous	2007-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Demyelination (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Radiculopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=939306&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-934262	Spontaneous	2007-02-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cerebellar ataxia (n/a - Not Specified - Caused/Prolonged Hospitalisation, Disabling);Facial paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Not Specified - Caused/Prolonged Hospitalisation, Disabling);Loss of consciousness (n/a - Not Specified - Caused/Prolonged Hospitalisation, Disabling);Monoparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Not Specified - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=934262&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-934294	Spontaneous	2007-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Eye swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Swelling face (12h - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=934294&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-933082	Spontaneous	2007-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=933082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-930019	Spontaneous	2007-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=930019&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-930066	Spontaneous	2007-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injected limb mobility decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tenderness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=930066&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-930067	Spontaneous	2007-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (4wk - Recovered/Resolved - Other Medically Important Condition);Urticaria (4wk - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=930067&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-928267	Spontaneous	2007-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Blood glucose abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Blood glucose increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cardiovascular disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chills (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Other Medically Important Condition);Peripheral vascular disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=928267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-927826	Spontaneous	2007-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Neuropathy peripheral (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=927826&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-928139	Spontaneous	2007-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=928139&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-915752	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Application site reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Subcutaneous])...	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[CAPTOPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[INSULIN HUMAN] (C - n/a - n/a - [n/a - n/a - n/a])|[ISOSORBIDE MONONITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=915752&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-918341	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - n/a])	[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SOTALOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - n/a])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=918341&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-919434	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - n/a])	[ATENOLOL, ATENOLOL HYDROCHLORIDE, ATENOLOL PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[CALCIUM, CHOLECALCIFEROL CONCENTRATE, COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[NORETHISTERONE ACETATE, ESTRADIOL, NORETHISTERONE ACETATE, ESTRADIOL HEMIHYDRATE, NORETHISTERONE, ESTRADIOL HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=919434&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-920498	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[QUININE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=920498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-920670	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=920670&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-920714	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myocardial infarction (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - n/a])...	HUMALOG [INSULIN LISPRO] (C - n/a - n/a - [n/a - n/a - n/a])|INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - n/a - n/a - [n/a - n/a - n/a])|PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[CALCIUM, CHOLECALCIFEROL CONCENTRATE, COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DRIED FERROUS SULFATE, FERROUS SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[ROFECOXIB] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=920714&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-920844	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myocardial infarction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Subcutaneous])	[ATENOLOL, ATENOLOL HYDROCHLORIDE, ATENOLOL PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=920844&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-920845	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myocardial infarction (n/a - Fatal - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Subcutaneous])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])|[GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=920845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-920846	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Myocardial infarction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Subcutaneous])	[DEXTROPROPOXYPHENE, PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[FELODIPINE, FELODIPINE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=920846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-920972	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Subcutaneous])	[AMILORIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ISPAGHULA HUSK] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=920972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-921566	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Coordination abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Intramuscular])	[DIGOXIN] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=921566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-922147	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Bradycardia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Subcutaneous])	[DICOUMAROL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=922147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-922199	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myocarditis (n/a - Fatal - Results in Death);Ventricular fibrillation (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=922199&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-924476	Spontaneous	2007-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Diplopia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - n/a])	TESTOSTERONE [TESTOSTERONE] (C - n/a - n/a - [n/a - n/a - n/a])|[CILAZAPRIL, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DILTIAZEM, DILTIAZEM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=924476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-911453	Spontaneous	2007-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic shock (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - n/a])	[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[GABAPENTIN] (C - n/a - n/a - [n/a - n/a - n/a])|[MAGNESIUM, MAGNESIUM HYDROXIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PYRIDOXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[RISEDRONATE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[THIAMINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=911453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-908937	Spontaneous	2007-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Aortic aneurysm (n/a - Not Specified - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cystitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Demyelinating polyneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Impaired work ability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pulmonary embolism (n/a - Not Specified - Caused/Prolonged Hospitalisation, Disabling);Sensory disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sepsis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Urinary incontinence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[AMLODIPINE, AMLODIPINE BESILATE] (C - Hypertension - n/a - [n/a - 10mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=908937&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-905506	Spontaneous	2007-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Pneumonia (n/a - Fatal - Results in Death);Pyrexia (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=905506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-905507	Spontaneous	2007-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Asthma (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=905507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-902248	Spontaneous	2007-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tinnitus (n/a - Recovering/Resolving - Other Medically Important Condition);Trigeminal neuralgia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=902248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-902413	Spontaneous	2007-02-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Myocardial infarction (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	SIFROL [PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LACTITOL, LACTITOL MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MOLSIDOMINE] (C - n/a - n/a - [n/a - n/a - Oral])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - Oral])|[TORASEMIDE, TORASEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=902413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-901540	Spontaneous	2007-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Urticaria (n/a - Not Specified - Caused/Prolonged Hospitalisation)	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=901540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-896749	Spontaneous	2007-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Limb discomfort (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Quadriparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=896749&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-898295	Spontaneous	2007-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hypoacusis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[FELODIPINE, FELODIPINE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=898295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-898820	Spontaneous	2007-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Deafness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Subcutaneous])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[DIGOXIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=898820&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-899361	Spontaneous	2007-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Encephalomyelitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - n/a])	[FELODIPINE, FELODIPINE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=899361&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-890603	Spontaneous	2007-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site reaction (6d - Recovered/Resolved - Other Medically Important Condition);Lymphadenitis (6d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	COAPROVEL [HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - Hypertension - n/a - [n/a - 300mg - Oral])|[AMLODIPINE, AMLODIPINE BESILATE] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Dyslipidaemia - n/a - [n/a - 10mg - Oral])|[CALCIUM CARBONATE, CHOLECALCIFEROL CONCENTRATE (POWDER FORM), COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - Osteoporosis - n/a - [n/a - n/a - Oral])|[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - .1mg - Oral])|[METOPROLOL TARTRATE, METOPROLOL TARTRATE BP] (C - Hypertension - n/a - [n/a - 100mg - Oral])|[RISEDRONATE MONOSODIUM, RISEDRONATE SODIUM] (C - Osteoporosis - n/a - [n/a - 35mg - Oral])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - Depression - n/a - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=890603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-891029	Spontaneous	2007-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=891029&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-888696	Spontaneous	2007-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cutaneous vasculitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=888696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-887537	Spontaneous	2007-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Rash maculo-papular (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=887537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-885885	Spontaneous	2007-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=885885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-881966	Spontaneous	2007-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - 1{DF} - Intramuscular])	APROVEL [IRBESARTAN] (C - Essential hypertension - n/a - [n/a - n/a - Oral])|[DRY EXTRACT OF GINKGO BILOBA LEAVES (35-67:1), EXTRACTION SOLVENT: ACETONE 60% ( M / M), GINKGO BILOBA EXTRACT, GINKGO BILOBA L., FOLIUM (DRY EXTRACT), GINKGO BILOBAE EXTRACTUM SICCUM NORMATUM, GINKGO LEAF DRY EXTRACT, REFINED AND QUANTIFIED, REFINED AND QUANTIFIED GINKGO DRY EXTRACT (35-67:1), CORRESPONDING TO 8.80-10.80 MG OF FLAVONOIDS EXPRESSED AS FLAVONE GLYCOSIDES, 1.12-1.36 MG OF GINKGOLIDES A, B AND C, 1.04-1.28 MG OF BILOBALIDE, EXTRACTION SOLVENT: ACETONE 60% M/M, STANDARDISED GINKGO BILOBA EXTRACT] (C - n/a - n/a - [n/a - n/a - Oral])|[LACTULOSE, PARAFFIN WHITE SOFT, LIQUID PARAFFIN, LACTULOSE, VASELINE, LIQUID PARAFFIN] (C - Constipation - n/a - [n/a - n/a - Oral])|[METOPROLOL, METOPROLOL TARTRATE] (C - Essential hypertension - n/a - [n/a - 200mg - Oral])|[PROMETHAZINE, PROMETHAZINE HYDROCHLORIDE] (C - Hypersensitivity - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=881966&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-879198	Spontaneous	2007-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Sudden death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - n/a])	[ACETYLCYSTEINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ISOSORBIDE MONONITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[OXAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPIOMAZINE, PROPIOMAZINE MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[THEOPHYLLINE, THEOPHYLLINE ANHYDROUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=879198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-879297	Spontaneous	2007-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - 1{DF} - Intramuscular])...	[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[DRIED FERROUS SULFATE, FERROUS SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPIOMAZINE, PROPIOMAZINE MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=879297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-878819	Spontaneous	2007-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pharyngitis (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=878819&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-876585	Spontaneous	2007-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Agranulocytosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza - n/a - [1d - n/a - Subcutaneous])|[LEVOFLOXACIN, LEVOFLOXACIN HEMIHYDRATE] (S - n/a - n/a - [7d - n/a - Oral])|[METAMIZOLE SODIUM] (S - n/a - n/a - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=876585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-876835	Spontaneous	2007-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=876835&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-871419	Spontaneous	2007-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=871419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-871795	Spontaneous	2007-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pharyngeal swelling (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=871795&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-871812	Spontaneous	2007-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lymphopenia (10d - Unknown - Other Medically Important Condition);Neuritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=871812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-872884	Spontaneous	2007-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site inflammation (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=872884&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-870682	Spontaneous	2007-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gastrointestinal infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injected limb mobility decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=870682&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-867897	Spontaneous	2007-01-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphangitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Movement disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash vesicular (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Varicella (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=867897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-868153	Spontaneous	2007-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Bell's palsy (14d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=868153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-868160	Spontaneous	2007-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Gait disturbance (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neuropathy peripheral (12d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vertigo (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=868160&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-866958	Spontaneous	2007-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Injection site pain (n/a - Not Specified - );Myalgia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=866958&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-866960	Spontaneous	2007-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - );Myalgia (n/a - Not Specified - );Pyrexia (n/a - Not Specified - );Swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=866960&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-863905	Spontaneous	2007-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[ATORVASTATIN] (C - n/a - n/a - [n/a - 10mg - Oral])|[BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - 2.5mg - Oral])|[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 160mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=863905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-863912	Spontaneous	2007-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hyperpyrexia (n/a - Not Specified - );Somnolence (n/a - Not Specified - );Vomiting (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[TRAZODONE, TRAZODONE HYDROCHLORIDE] (C - Depression - n/a - [n/a - 60[drp] - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=863912&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-861862	Spontaneous	2007-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Myocardial infarction (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])|[TIOTROPIUM BROMIDE] (C - n/a - Unknown - [n/a - 18ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=861862&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-861932	Spontaneous	2007-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Fatigue (n/a - Unknown - );Myalgia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=861932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-861973	Spontaneous	2007-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza like illness (n/a - Unknown - );Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intradermal])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=861973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-859599	Spontaneous	2007-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	C-reactive protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Not Specified - Caused/Prolonged Hospitalisation);Injection site inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation);Leukocytosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=859599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-857798	Spontaneous	2007-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - .5mL - Subcutaneous])	[HYDROCORTISONE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[NORETHISTERONE ACETATE, ESTRADIOL, NORETHISTERONE ACETATE, ESTRADIOL HEMIHYDRATE, NORETHISTERONE, ESTRADIOL HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM CHLORIDE, UREA] (C - n/a - n/a - [n/a - n/a - n/a])|[SOMATROPIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=857798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-858157	Spontaneous	2007-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Not Specified - );Hyperpyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=858157&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-855380	Spontaneous	2007-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Parenteral])	[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - 40mg - Oral])|[LAMOTRIGINE] (C - n/a - n/a - [n/a - 400mg - Oral])|[VITAMIN B12] (C - n/a - n/a - [n/a - n/a - Parenteral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=855380&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-852715	Spontaneous	2006-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Inflammation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=852715&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-853358	Spontaneous	2006-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Chills (n/a - Recovered/Resolved - Life Threatening);Throat tightness (n/a - Recovered/Resolved - Life Threatening)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=853358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-853365	Spontaneous	2006-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Ascites (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hepatic enzyme increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=853365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-851933	Spontaneous	2006-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=851933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-852476	Spontaneous	2006-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Peripheral motor neuropathy (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=852476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-849798	Spontaneous	2006-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Disabling);Dizziness (n/a - Unknown - Disabling);Heart rate increased (n/a - Unknown - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Peripheral sensory neuropathy (n/a - Not Recovered/Not Resolved - Disabling);Polyneuropathy (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intravenous (not otherwise specified)])	[CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 10{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=849798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-849848	Spontaneous	2006-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Eyelid sensory disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in jaw (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Skin burning sensation (n/a - Recovered/Resolved - Other Medically Important Condition);Trigeminal neuralgia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=849848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-848009	Spontaneous	2006-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=848009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-848268	Spontaneous	2006-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Encephalitis (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=848268&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-848726	Spontaneous	2006-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=848726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-846604	Spontaneous	2006-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])...	[ALFUZOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=846604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-844768	Spontaneous	2006-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[ETHINYLESTRADIOL, GESTODENE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=844768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-844770	Spontaneous	2006-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site reaction (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[ANASTROZOLE] (C - n/a - n/a - [n/a - 1mg - Oral])|[BUPROPION, BUPROPION HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1000mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - 1000mg - Oral])|[RAMIPRIL] (C - n/a - n/a - [n/a - 5mg - Oral])|[ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=844770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-844774	Spontaneous	2006-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Urticaria (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	AZOPT [BRINZOLAMIDE] (C - n/a - n/a - [n/a - n/a - Intraocular])|[ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - 10mg - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE, FLUTICASONE, SALMETEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL TARTRATE, METOPROLOL TARTRATE BP] (C - n/a - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=844774&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-844776	Spontaneous	2006-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - );Injection site reaction (n/a - Not Specified - );Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - Oral])|[ALLOPURINOL] (C - n/a - n/a - [n/a - 150mg - Oral])|[FUROSEMIDE] (C - n/a - n/a - [n/a - 25mg - Oral])|[POTASSIUM CANRENOATE] (C - n/a - n/a - [n/a - 50mg - Oral])|[RAMIPRIL] (C - n/a - n/a - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=844776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-838816	Spontaneous	2006-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);CSF protein increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait inability (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ALENDRONATE SODIUM, ALENDRONATE SODIUM TRIHYDRATE, ALENDRONIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[BENDROFLUMETHIAZIDE, POTASSIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[ISOSORBIDE 5 MONONITRATE, ISOSORBIDE MONONITRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=838816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-840059	Spontaneous	2006-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 250uL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=840059&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-836117	Spontaneous	2006-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Feeling hot (n/a - Not Specified - );Laryngospasm (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 500uL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=836117&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-834436	Spontaneous	2006-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Venous thrombosis limb (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Subcutaneous])	[PAROXETINE, PAROXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=834436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-827823	Spontaneous	2006-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	CELLCEPT 500 MG TABLETS [MYCOPHENOLATE MOFETIL] (C - n/a - Dose not changed - [n/a - 1000mg - Oral])|NOT AVAILABLE (C - n/a - Dose not changed - [n/a - 5mg - Oral])|[ATORVASTATIN] (C - n/a - Dose not changed - [n/a - 10mg - Oral])|[OMEPRAZOLE] (C - n/a - Dose not changed - [n/a - 20mg - Oral])|[POVIDONE] (C - n/a - Dose not changed - [n/a - n/a - Ophthalmic])|[SPIRONOLACTONE] (C - n/a - Dose not changed - [n/a - 25mg - Oral])|[TIMOLOL] (C - n/a - Dose not changed - [n/a - 1[drp] - Ophthalmic])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=827823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-828383	Spontaneous	2006-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Meningitis viral (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=828383&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-828720	Spontaneous	2006-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site reaction (n/a - Not Specified - );Vomiting (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=828720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-826453	Spontaneous	2006-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=826453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-827153	Spontaneous	2006-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypotonia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=827153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-824512	Spontaneous	2006-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Facial paresis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	SERETIN [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=824512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-822565	Spontaneous	2006-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Specified - );Myalgia (n/a - Not Specified - );Rash (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=822565&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-820146	Spontaneous	2006-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=820146&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-820876	Spontaneous	2006-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Altered state of consciousness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=820876&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-818785	Spontaneous	2006-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Thrombocytopenia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=818785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-818991	Spontaneous	2006-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=818991&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-818016	Spontaneous	2006-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Oedema (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=818016&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-818017	Spontaneous	2006-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site reaction (n/a - Not Specified - );Pyrexia (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[MANIDIPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAVASTATIN, PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=818017&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-814949	Spontaneous	2006-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Body temperature increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dry mouth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=814949&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-815132	Spontaneous	2006-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Erythema (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=815132&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-815681	Spontaneous	2006-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Ecchymosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Petechiae (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Skin haemorrhage (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vasculitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Parenteral])	[ACETYLSALICYLIC ACID] (C - Cardiac disorder - Drug withdrawn - [n/a - 75mg - Oral])|[FERROUS SULFATE] (C - Anaemia - n/a - [n/a - n/a - Oral])|[FUROSEMIDE] (C - Cardiac disorder - Dose not changed - [n/a - 20mg - n/a])|[ISOSORBIDE 5 MONONITRATE, ISOSORBIDE MONONITRATE] (C - Cardiac disorder - Dose not changed - [n/a - 60mg - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - .05mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=815681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-809770	Spontaneous	2006-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (5d - Recovered/Resolved - );Chills (5d - Recovered/Resolved - );Myalgia (5d - Recovered/Resolved - );Pyrexia (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=809770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-810552	Spontaneous	2006-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[GEMFIBROZIL] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM CANRENOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPAFENONE, PROPAFENONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SOTALOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=810552&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-802723	Spontaneous	2006-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])|[LAMOTRIGINE] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=802723&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-786413	Spontaneous	2006-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (n/a - Recovered/Resolved With Sequelae - Disabling);Paraesthesia (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=786413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-786978	Spontaneous	2006-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hepatitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash erythematous (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])|[GLICLAZIDE] (S - n/a - n/a - [7wk - 30mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=786978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-775286	Spontaneous	2006-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Angioedema (9d - Recovered/Resolved - Other Medically Important Condition);Urticaria (9d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=775286&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-756504	Spontaneous	2006-09-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Diarrhoea (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Infection susceptibility increased (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=756504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-755394	Spontaneous	2006-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Amnestic disorder (n/a - Not Specified - Disabling);Aphasia (n/a - Not Specified - Disabling);Asthenia (n/a - Not Specified - Disabling);Balance disorder (n/a - Not Specified - Disabling);Hallucination, visual (n/a - Not Specified - Disabling);Immunisation reaction (n/a - Not Specified - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=755394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-702392	Spontaneous	2006-08-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Haematoma (n/a - Recovered/Resolved - Other Medically Important Condition);Myosclerosis (n/a - Unknown - Other Medically Important Condition);Nerve injury (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=702392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-694918	Spontaneous	2006-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ischaemic cerebral infarction (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neurological symptom (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=694918&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-691697	Spontaneous	2006-08-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Injection site inflammation (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=691697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-692874	Spontaneous	2006-08-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Thrombocytopenic purpura (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=692874&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-686713	Spontaneous	2006-08-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Lymphadenopathy (n/a - Not Specified - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=686713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-650560	Spontaneous	2006-07-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Mixed anxiety and depressive disorder (n/a - Unknown - Other Medically Important Condition);Muscle twitching (n/a - Unknown - Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Paresis (n/a - Unknown - Other Medically Important Condition);Radiculopathy (n/a - Unknown - Other Medically Important Condition);Swelling face (n/a - Recovered/Resolved - Other Medically Important Condition);Uveitis (n/a - Unknown - Other Medically Important Condition);Vertigo (n/a - Unknown - Other Medically Important Condition);Weight decreased (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=650560&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-650258	Spontaneous	2006-07-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia (n/a - Not Specified - );Pruritus (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=650258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-630655	Spontaneous	2006-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Neuropathy peripheral (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=630655&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-474721	Spontaneous	2006-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Peripheral swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=474721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-474723	Spontaneous	2006-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Peripheral swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=474723&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-474725	Spontaneous	2006-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Peripheral swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=474725&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-474729	Spontaneous	2006-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Peripheral swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=474729&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-474731	Spontaneous	2006-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Peripheral swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=474731&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-474733	Spontaneous	2006-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Peripheral swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=474733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-474734	Spontaneous	2006-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Peripheral swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=474734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-474737	Spontaneous	2006-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Peripheral swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=474737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-474738	Spontaneous	2006-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Peripheral swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=474738&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-474739	Spontaneous	2006-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Peripheral swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=474739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-474740	Spontaneous	2006-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Peripheral swelling (n/a - Not Specified - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=474740&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-468017	Spontaneous	2006-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Groin pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Testicular pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tinea pedis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Walking disability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=468017&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-462150	Spontaneous	2006-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Epilepsy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=462150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-462445	Spontaneous	2006-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Throat irritation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Throat tightness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Trichoglossia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vertigo (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=462445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-458197	Spontaneous	2006-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Elderly	No	Female	Macular oedema (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=458197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-453239	Spontaneous	2006-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Giant cell arteritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=453239&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-449814	Spontaneous	2006-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Aphasia (n/a - Unknown - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Personality change (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=449814&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-445137	Spontaneous	2006-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Peroneal nerve palsy (n/a - Not Recovered/Not Resolved - Disabling);Sensory loss (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - Asthma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=445137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-440071	Spontaneous	2006-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (28mo - Recovered/Resolved - Other Medically Important Condition);Rotator cuff syndrome (28mo - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=440071&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-440448	Spontaneous	2006-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Haematoma (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Immune thrombocytopenia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Petechiae (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[SULTIAME] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=440448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-431629	Spontaneous	2006-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Facial paralysis (6wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoacusis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=431629&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-427029	Spontaneous	2006-03-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Balance disorder (3wk - Recovered/Resolved - Other Medically Important Condition);Fatigue (3wk - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Tinnitus (41d - Recovered/Resolved - Other Medically Important Condition);Vertigo (3wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mg - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=427029&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-389757	Spontaneous	2006-02-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pneumonia staphylococcal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper gastrointestinal haemorrhage (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ALENDRONATE SODIUM, ALENDRONATE SODIUM TRIHYDRATE, ALENDRONIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=389757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-374054	Spontaneous	2006-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pancreatitis acute (1min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza - n/a - [n/a - n/a - Intramuscular])	CELLCEPT [MYCOPHENOLATE MOFETIL] (C - Complications of transplant surgery - n/a - [n/a - 1g - Oral])|[CICLOSPORIN] (C - n/a - n/a - [n/a - 150mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=374054&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-370123	Spontaneous	2006-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=370123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-360928	Spontaneous	2006-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Phlebitis deep (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=360928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-358232	Spontaneous	2006-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Erythema multiforme (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=358232&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-358704	Spontaneous	2006-01-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Henoch-Schonlein purpura (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nephritis (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=358704&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-353584	Spontaneous	2006-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Paraesthesia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=353584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-337998	Spontaneous	2005-12-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chest pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site pain (7d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=337998&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-326815	Spontaneous	2005-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Hemiparesis (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Transient ischaemic attack (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=326815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-327666	Spontaneous	2005-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Colitis (n/a - Unknown - Other Medically Important Condition);Constipation (5d - Recovered/Resolved - Other Medically Important Condition);Diarrhoea haemorrhagic (n/a - Unknown - Other Medically Important Condition);Flatulence (n/a - Unknown - Other Medically Important Condition);Large intestinal haemorrhage (1d - Recovered/Resolved - Other Medically Important Condition);Mucous stools (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Dose not changed - [1d - 1{DF} - Intramuscular])|[NITROFURANTOIN] (S - Urinary tract infection - Drug withdrawn - [1d - n/a - n/a])|[NITROFURANTOIN] (S - Urinary tract infection - Drug withdrawn - [2d - 2{DF} - Oral])|[NITROFURANTOIN] (S - Urinary tract infection - Drug withdrawn - [3d - 1{DF} - Oral])|[NITROFURANTOIN] (S - Urinary tract infection - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=327666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-305907	Spontaneous	2005-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Demyelination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Specified - Caused/Prolonged Hospitalisation);Monoparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[HEPATITIS B VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=305907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-303714	Spontaneous	2005-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Syncope (5min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 150{DF} - Oral])|[BENDROFLUMETHIAZIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[TIMOLOL, TIMOLOL MALEATE] (C - n/a - n/a - [n/a - n/a - Subconjunctival])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=303714&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-296391	Spontaneous	2005-10-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Deafness unilateral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=296391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-215086	Spontaneous	2005-08-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cardiac tamponade (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=215086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-152733	Spontaneous	2005-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=152733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-141850	Spontaneous	2005-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Conjunctivitis (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema of eyelid (n/a - Recovered/Resolved - Other Medically Important Condition);Eyelid oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[CYANOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[FENOFIBRATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=141850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-141882	Spontaneous	2005-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Erythema of eyelid (n/a - Recovered/Resolved - Other Medically Important Condition);Eyelid oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[OMEPRAZOLE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[PERINDOPRIL] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=141882&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-125799	Spontaneous	2004-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angina pectoris (0d - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=125799&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-120292	Spontaneous	2004-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Diarrhoea (2d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - );Vomiting (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [2d - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=120292&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-118930	Spontaneous	2004-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Anaphylactic reaction (4d - Recovered/Resolved - Life Threatening, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=118930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Life Threatening	Hospitalisation
EU-EC-118937	Spontaneous	2004-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Polyneuropathy (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	[ESTRADIOL, ESTRADIOL HEMIHYDRATE] (C - n/a - n/a - [n/a - 25{DF} - Vaginal])|[TIBOLONE] (C - n/a - n/a - [n/a - {DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=118937&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-117920	Spontaneous	2004-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	C-reactive protein increased (n/a - Recovered/Resolved - Life Threatening);Pneumonia (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, MAGNESIUM OXIDE] (C - n/a - n/a - [n/a - 75{DF} - Oral])|[BENDROFLUMETHIAZIDE] (C - n/a - n/a - [n/a - 2.5{DF} - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 10{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=117920&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-116334	Spontaneous	2004-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Brain stem thrombosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	[ACETYLSALICYLIC ACID] (C - Hypertension - n/a - [n/a - 100 - n/a])|[HYDROCHLOROTHIAZIDE, LOSARTAN, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=116334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-116391	Spontaneous	2004-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Deafness unilateral (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Swelling (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	[ALENDRONATE SODIUM, ALENDRONATE SODIUM TRIHYDRATE, ALENDRONIC ACID] (C - n/a - n/a - [n/a - {DF} - Oral])|[PYRIDOSTIGMINE, PYRIDOSTIGMINE BROMIDE] (C - n/a - n/a - [n/a - {DF} - Oral])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - n/a - n/a - [n/a - {DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=116391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-116409	Spontaneous	2004-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=116409&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-112738	Spontaneous	2004-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Vertigo (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - n/a - n/a - [n/a - 2.5{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=112738&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-107652	Spontaneous	2004-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Transient ischaemic attack (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - .5mL - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=107652&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-104959	Spontaneous	2004-10-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Neuritis (n/a - Not Recovered/Not Resolved - Disabling);Rash (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, MAGNESIUM OXIDE] (C - n/a - n/a - [n/a - 75{DF} - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - 80{DF} - Oral])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 50{DF} - Oral])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - 8{DF} - Oral])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - 25{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=104959&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-79204	Spontaneous	2004-06-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Osteonecrosis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=79204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-64264	Spontaneous	2004-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angioedema (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (S - n/a - n/a - [n/a - 1.25mg - Oral])	[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - 40mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=64264&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-64271	Spontaneous	2004-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	C-reactive protein increased (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Discomfort (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=64271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-62898	Spontaneous	2004-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Facial paresis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	[DICLOFENAC POTASSIUM] (C - n/a - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=62898&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-58195	Spontaneous	2004-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=58195&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-58724	Spontaneous	2004-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Meningism (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=58724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-58737	Spontaneous	2004-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=58737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-58739	Spontaneous	2004-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pneumonitis (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=58739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-59795	Spontaneous	2004-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vertigo (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=59795&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-60010	Spontaneous	2004-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Malaise (n/a - Recovered/Resolved - Disabling);Purpura (n/a - Recovered/Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[TIZANIDINE, TIZANIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=60010&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-60291	Spontaneous	2004-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Visual impairment (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, MAGNESIUM OXIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[CAPTOPRIL] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=60291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-60303	Spontaneous	2004-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	IIIrd nerve paralysis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=60303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-60632	Spontaneous	2004-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic shock (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=60632&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-60654	Spontaneous	2004-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	[AMILORIDE HYDROCHLORIDE, FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=60654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-57079	Spontaneous	2004-02-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=57079&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-57649	Spontaneous	2004-02-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Sudden death (n/a - Fatal - Results in Death, Life Threatening, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=57649&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-52891	Spontaneous	2004-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=52891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10016895466	Spontaneous	2024-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - H1N1 influenza, Immunisation - Not applicable - [n/a - n/a - Subcutaneous use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016895466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10016838455	Spontaneous	2024-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Expired product administered (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016838455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10016795042	Spontaneous	2024-02-09 00:00:00	Healthcare Professional	European Economic Area	Mayet A, Haus-Cheymol R, Bouaiti E, Decam C, Simon F, Mérens A, et al. Adverse events following vaccination in the French armed forces: An overview of surveillance conducted from 2002 to 2010. Euro Surveillance 2012 Jun 14;17(24):.	18-64 Years	Not Specified	No	Male	Headache (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Renal failure (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016795042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10016736352	Spontaneous	2024-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016736352&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10016630100	Spontaneous	2024-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Exposure during pregnancy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Platelet count decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Thrombocytopenia (n/a - Unknown - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 7ug - n/a])|CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])|CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - 7.5ug - n/a])	[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016630100&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10016634553	Spontaneous	2024-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Arthralgia (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - );Pain in extremity (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016634553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016603151	Spontaneous	2024-01-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Blood pressure increased (n/a - Unknown - );Heart rate increased (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016603151&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10016560669	Spontaneous	2024-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adult	No	Male	Intracranial pressure increased (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016560669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10016541557	Spontaneous	2023-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic shock (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - Subcutaneous use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016541557&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10016526798	Spontaneous	2023-12-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Bursitis (n/a - Recovering/Resolving - Other Medically Important Condition);Rotator cuff syndrome (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	ABILIFY [ARIPIPRAZOLE] (C - Osteoarthritis - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016526798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10016460842	Spontaneous	2023-12-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Headache (n/a - Recovered/Resolved - );Hypertension (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - n/a])	VIDPREVTYN BETA [POLYSORBATE 80, SARS-COV-2, B.1.351 VARIANT, PREFUSION SPIKE DELTA TM PROTEIN, RECOMBINANT, SQUALENE, DL-ALPHA-TOCOPHEROL] (C - COVID-19 immunisation - Not applicable - [1d - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016460842&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016453076	Spontaneous	2023-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016453076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10016403539	Spontaneous	2023-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	ASIA syndrome (n/a - Unknown - Other Medically Important Condition);Abdominal discomfort (n/a - Unknown - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Other Medically Important Condition);Fungal infection (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Other Medically Important Condition);Vasculitis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016403539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10016382877	Spontaneous	2023-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016382877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10016387585	Spontaneous	2023-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abnormal dreams (n/a - Unknown - Caused/Prolonged Hospitalisation);Affect lability (n/a - Unknown - Caused/Prolonged Hospitalisation);Anxiety (n/a - Unknown - );Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Bruxism (n/a - Unknown - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Circadian rhythm sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - );Cystitis (n/a - Unknown - );Decreased appetite (n/a - Unknown - );Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - );Epigastric discomfort (n/a - Unknown - );Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling abnormal (n/a - Unknown - );Feeling cold (n/a - Unknown - );Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastritis (n/a - Unknown - );Hallucination (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - );Hypoaesthesia (n/a - Unknown - );Inappropriate affect (n/a - Unknown - Caused/Prolonged Hospitalisation);Middle insomnia (n/a - Unknown - );Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - );Nausea (n/a - Unknown - );Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation);Peripheral coldness (n/a - Unknown - );Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation);Rapid eye movements sleep abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Reaction to excipient (n/a - Unknown - );Rhinorrhoea (n/a - Unknown - );Sleep apnoea syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep talking (n/a - Unknown - Caused/Prolonged Hospitalisation);Sneezing (n/a - Unknown - Caused/Prolonged Hospitalisation);Snoring (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Vertigo (n/a - Unknown - );Weight decreased (n/a - Unknown - );Weight increased (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular use])|[EPHEDRINE] (S - Product used for unknown indication - Unknown - [n/a - 25mg - n/a - More in ICSR])|[METHYLPHENIDATE HYDROCHLORIDE] (S - Product used for unknown indication - Unknown - [n/a - 10mg - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016387585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10016329623	Spontaneous	2023-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Agitation (n/a - Unknown - Disabling);Anaemia (n/a - Unknown - Disabling);Anxiety (n/a - Unknown - Disabling);Aphasia (n/a - Unknown - Disabling);Asthenia (n/a - Unknown - Disabling);Back pain (n/a - Unknown - Disabling);Bedridden (7d - Recovered/Resolved - Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Disabling);Circadian rhythm sleep disorder (n/a - Unknown - Disabling);Coeliac disease (n/a - Unknown - Disabling, Other Medically Important Condition);Depression (n/a - Unknown - Disabling);Diarrhoea (n/a - Unknown - Disabling);Disorientation (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling of despair (n/a - Unknown - Disabling);Hypertension (n/a - Unknown - Disabling);Hypoaesthesia (n/a - Unknown - Disabling);Hypopnoea (n/a - Unknown - Disabling);Hypotonia (n/a - Unknown - Disabling);Influenza like illness (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Insomnia (n/a - Unknown - Disabling);Lethargy (n/a - Not Recovered/Not Resolved - Disabling);Loss of personal independence in daily activities (n/a - Unknown - Disabling);Mental disorder (n/a - Unknown - Disabling);Microsleep (n/a - Unknown - Disabling);Mood altered (n/a - Unknown - Disabling);Movement disorder (n/a - Unknown - Disabling);Muscle twitching (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nervousness (n/a - Unknown - Disabling);Nightmare (n/a - Unknown - Disabling);Obesity (n/a - Unknown - Disabling);Palpitations (n/a - Unknown - Disabling);Periodic limb movement disorder (n/a - Unknown - Disabling);Pyrexia (7d - Recovered/Resolved - Disabling);Rapid eye movement sleep behaviour disorder (n/a - Unknown - Disabling);Respiratory distress (n/a - Unknown - Disabling, Other Medically Important Condition);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rheumatic disorder (n/a - Unknown - Disabling);Sciatica (n/a - Unknown - Disabling);Sleep apnoea syndrome (n/a - Unknown - Disabling);Sleep attacks (n/a - Unknown - Disabling);Sleep disorder (n/a - Unknown - Disabling);Sleep paralysis (n/a - Unknown - Disabling);Slow response to stimuli (n/a - Unknown - Disabling);Social avoidant behaviour (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Unknown - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[METHYLPHENIDATE HYDROCHLORIDE] (S - Product used for unknown indication - Unknown - [n/a - n/a - n/a])	[MODAFINIL] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016329623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10016209690	Spontaneous	2023-11-03 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cough (n/a - Unknown - );Dyslalia (n/a - Unknown - );Dyspnoea (n/a - Unknown - );Eyelid oedema (n/a - Unknown - Other Medically Important Condition);Face oedema (n/a - Unknown - Other Medically Important Condition);Lip oedema (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - );Pain (n/a - Unknown - );Pyrexia (n/a - Unknown - );Rhinitis (n/a - Unknown - );Throat irritation (n/a - Unknown - );Vomiting (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016209690&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10016192330	Spontaneous	2023-10-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Male	Dermatitis allergic (n/a - Recovered/Resolved - );Erythema (n/a - Recovered/Resolved - );Injection site rash (n/a - Recovered/Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016192330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10016043497	Spontaneous	2023-10-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Cerebral thrombosis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10016043497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10015951493	Spontaneous	2023-09-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Condition aggravated (n/a - Not Recovered/Not Resolved - );Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015951493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10015919875	Spontaneous	2023-09-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Aggression (4560d - Recovered/Resolved With Sequelae - );Anxiety (4560d - Recovered/Resolved With Sequelae - );Disturbance in attention (4560d - Recovered/Resolved With Sequelae - );Fatigue (4560d - Recovered/Resolved With Sequelae - );Panic attack (4560d - Recovered/Resolved With Sequelae - );Paraesthesia (4560d - Recovered/Resolved With Sequelae - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015919875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10015840713	Spontaneous	2023-09-04 00:00:00	Healthcare Professional	European Economic Area	FERREIRA O, ANTUNES I, CRUZ MJ, MOTA A, BETTENCOURT H, CANELHAS Á, AZEVEDO F. ACUTE HEMORRHAGIC EDEMA OF CHILDHOOD AFTER H1N1 IMMUNIZATION. CUTANEOUS AND OCULAR TOXICOLOGY. JUN2011; 30(2): 167-169.	2 Months - 2 Years	Not Specified	No	Male	Acute haemorrhagic oedema of infancy (2wk - Recovered/Resolved - Other Medically Important Condition);Cutaneous vasculitis (2wk - Recovered/Resolved - Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Lymphocytic infiltration (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema peripheral (2wk - Recovered/Resolved - Other Medically Important Condition);Pain of skin (n/a - Recovered/Resolved - Other Medically Important Condition);Papule (n/a - Recovered/Resolved - Other Medically Important Condition);Purpura (2wk - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Skin lesion (n/a - Unknown - Other Medically Important Condition);Skin plaque (n/a - Recovered/Resolved - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015840713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10015780984	Spontaneous	2023-08-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015780984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10015678846	Spontaneous	2023-08-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bedridden (n/a - Unknown - );Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Impaired work ability (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (S - Hypothyroidism - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015678846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10015621509	Spontaneous	2023-07-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Vaccination complication (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - n/a - n/a - [n/a - n/a - n/a])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS NEUDOERFL STRAIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED PRODUCED IN CHICK EMBRYO CELLS, ALGELDRATE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[DIPHTHERIA, TETANUS AND PERTUSSIS VACCINE (ADSORBED)] (S - n/a - n/a - [n/a - n/a - n/a])|[DIPHTHERIA, TETANUS AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED, REDUCED ANTIGEN(S) CONTENT)] (S - n/a - n/a - [n/a - n/a - n/a])|[HEPATITIS B VACCINE] (S - n/a - n/a - [n/a - n/a - n/a])|[MEASLES VACCINE] (S - n/a - n/a - [n/a - n/a - n/a])|[MYCOBACTERIUM BOVIS, DANISH STRAIN 1331] (S - n/a - n/a - [n/a - n/a - n/a])|[POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - n/a - n/a - [n/a - n/a - n/a])|[TETANUS TOXOID, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED, ALGELDRATE, TETANUS TOXOID, ALUMINIUM HYDROXIDE] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015621509&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10015568330	Spontaneous	2023-07-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adult	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015568330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10015522180	Spontaneous	2023-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015522180&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10015461233	Spontaneous	2023-06-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015461233&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10015446361	Spontaneous	2023-06-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015446361&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10015371002	Spontaneous	2023-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Vaccination complication (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM PHOSPHATE, ALUMINIUM, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS (INACTIVATED) ADSORBED] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN] (S - Immunisation - n/a - [n/a - n/a - n/a])|[DIPHTHERIA AND TETANUS VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015371002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10015359981	Spontaneous	2023-06-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Respiratory tract infection (7mo - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular use])	APROVEL [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[DIOSMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL ARGININE] (C - n/a - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[TIOCONAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015359981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10015329246	Spontaneous	2023-06-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Administration site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015329246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10015301802	Spontaneous	2023-06-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Vertigo (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [1d - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015301802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10015264198	Spontaneous	2023-05-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Unknown - );Headache (n/a - Unknown - );Pain in extremity (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015264198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10015188773	Spontaneous	2023-05-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain (n/a - Recovered/Resolved - );Uterine contractions during pregnancy (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015188773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10015179086	Spontaneous	2023-05-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Unknown - Disabling);Disability (n/a - Unknown - Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015179086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10015151830	Spontaneous	2023-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015151830&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10015092610	Spontaneous	2023-04-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Injection site pain (2d - Recovered/Resolved - );Mobility decreased (2d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015092610&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10015071090	Spontaneous	2023-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination complication (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|[BACILLUS CALMETTE-GUERIN VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[DIPHTHERIA, TETANUS, PERTUSSIS AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS (DTAP) VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[HEPATITIS B VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[MEASLES VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[MUMPS VACCINE (LIVE)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[POLIOMYELITIS VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[RUBELLA VACCINE (LIVE)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015071090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10015064279	Spontaneous	2023-04-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015064279&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10015022708	Spontaneous	2023-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015022708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10014907780	Spontaneous	2023-03-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Apathy (n/a - Unknown - );Arthralgia (n/a - Unknown - );Asthenia (n/a - Unknown - );Disturbance in attention (n/a - Unknown - );Fatigue (n/a - Unknown - );Hyperacusis (n/a - Unknown - );Hyperphagia (n/a - Unknown - );Memory impairment (n/a - Unknown - );Mental fatigue (n/a - Unknown - );Myalgia (n/a - Unknown - );Nasopharyngitis (n/a - Unknown - );Photophobia (n/a - Unknown - );Pneumonia (n/a - Unknown - Other Medically Important Condition);Social problem (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014907780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10014905982	Spontaneous	2023-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Bronchospasm (1d - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA SUSPENSION FOR INJECTION IN MULTIDOSE CONTAINER [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014905982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10014892967	Spontaneous	2023-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site reaction (n/a - Unknown - )	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular use])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014892967&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014884033	Spontaneous	2023-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Immunisation reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014884033&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014724070	Spontaneous	2023-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pancytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014724070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10014648625	Spontaneous	2023-02-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash pruritic (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014648625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014550846	Spontaneous	2023-02-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Nausea (38d - Recovered/Resolved - );Syncope (38d - Recovered/Resolved - );Vaccination site pain (38d - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014550846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10014532678	Spontaneous	2023-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (10a - Recovered/Resolved - );Dizziness (n/a - Recovered/Resolved - );Joint ankylosis (10a - Recovered/Resolved - );Migraine (10a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Presyncope (10a - Recovered/Resolved - );Tinnitus (10a - Recovered/Resolved - )	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014532678&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10014506590	Spontaneous	2023-01-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Migraine (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014506590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10014494303	Spontaneous	2023-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Aggression (n/a - Unknown - Disabling);Anxiety (n/a - Unknown - Disabling);Asthenia (n/a - Recovered/Resolved - Disabling);Automatism (n/a - Not Recovered/Not Resolved - Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Depressed mood (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Educational problem (n/a - Unknown - Disabling);Eyelid ptosis (n/a - Unknown - Disabling);Facial paresis (n/a - Unknown - Disabling);Fall (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling);Grimacing (n/a - Unknown - Disabling);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Disabling);Increased appetite (n/a - Unknown - Disabling);Injection site erythema (n/a - Unknown - Disabling);Loss of personal independence in daily activities (n/a - Unknown - Disabling);Middle insomnia (n/a - Unknown - Disabling);Muscle disorder (n/a - Unknown - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nightmare (n/a - Unknown - Disabling);Oropharyngeal pain (n/a - Recovered/Resolved - Disabling);Protrusion tongue (n/a - Unknown - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling);Sleep talking (n/a - Unknown - Disabling);Snoring (n/a - Unknown - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Suicidal ideation (n/a - Unknown - Disabling, Other Medically Important Condition);Tension headache (n/a - Not Recovered/Not Resolved - Disabling);Weight increased (n/a - Unknown - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular use])	WAKIX [PITOLISANT] (C - Product used for unknown indication - Unknown - [n/a - 36mg - n/a])|[FERROUS SULFATE] (C - Iron deficiency - Unknown - [n/a - 60mg - Oral use])|[FERROUS SULPHATE SESQUIHYDRATE, IRON] (C - Iron deficiency - Unknown - [n/a - 60mg - n/a])|[LEVOTHYROXINE SODIUM] (C - Hyperthyroidism - Unknown - [n/a - 100g - Oral use])|[LIOTHYRONINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LIOTHYRONINE SODIUM, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - 110ug - Oral use])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014494303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10014477743	Spontaneous	2023-01-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Immune thrombocytopenia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Petechiae (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014477743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10014369478	Spontaneous	2023-01-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Administration site pain (3d - Recovered/Resolved - );Chills (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - 1{DF} - n/a])	[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - )|[EZETIMIBE, ROSUVASTATIN, EZETIMIBE, ROSUVASTATIN ZINC] (C - n/a - n/a - )|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014369478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014333745	Spontaneous	2022-12-29 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Female	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Movement disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Parkinson's disease (n/a - Recovered/Resolved - Other Medically Important Condition);Reflexes abnormal (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014333745&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10014328545	Spontaneous	2022-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Inappropriate schedule of product administration (n/a - Unknown - );Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014328545&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014329154	Spontaneous	2022-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Cardiac failure (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014329154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10014304483	Spontaneous	2022-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pericarditis (6wk - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014304483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10014240656	Spontaneous	2022-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pain (3d - Recovered/Resolved - );Pyrexia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014240656&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10014214131	Spontaneous	2022-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014214131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10014139320	Spontaneous	2022-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adolescent	No	Male	Lacrimation increased (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Soft tissue injury (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014139320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10014042173	Spontaneous	2022-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cerebral infarction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cerebrovascular accident (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Product complaint (n/a - Unknown - );Transient ischaemic attack (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014042173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10014034623	Spontaneous	2022-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Systemic lupus erythematosus (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10014034623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10013910441	Spontaneous	2022-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Mobility decreased (n/a - Unknown - Disabling);Neuralgia (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013910441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10013854771	Spontaneous	2022-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling);Faeces discoloured (n/a - Not Recovered/Not Resolved - Disabling);Faeces soft (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Heart rate increased (n/a - Not Recovered/Not Resolved - Disabling);Injection site pain (n/a - Not Recovered/Not Resolved - Disabling);Injection site reaction (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular use])	[PARACETAMOL] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013854771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10013837934	Spontaneous	2022-10-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Productive cough (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013837934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10013826784	Spontaneous	2022-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Crying (n/a - Unknown - );Device physical property issue (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013826784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10013796036	Spontaneous	2022-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013796036&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10013738551	Spontaneous	2022-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Amenorrhoea (n/a - Unknown - Other Medically Important Condition);Anxiety (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Emotional distress (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Migraine (n/a - Unknown - Other Medically Important Condition);Mood altered (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Polycystic ovarian syndrome (n/a - Unknown - Other Medically Important Condition);Psychiatric symptom (n/a - Unknown - Other Medically Important Condition);Quality of life decreased (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Not applicable - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013738551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10013675124	Spontaneous	2022-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Immunisation reaction (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE STRAIN (A/CALIFORNIA/7/2009, X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/TEXAS/50/2012 (H3N2)-LIKE STRAIN (A/TEXAS/50/2012, X-223A), B/MASSACHUSETTS/2/2012-LIKE STRAIN (B/MASSACHUSETTS/2/2012, BX-51B), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), INFLUENZA VIRUS A/DARWIN/9/2021 SAN-010 (H3N2), INFLUENZA VIRUS B/AUSTRIA/1359417/2021-LIKE STRAIN (B/AUSTRIA/1359417/2021, BVR-26), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), INFLUENZA VIRUS A/DARWIN/9/2021 SAN-010 (H3N2), INFLUENZA VIRUS B/AUSTRIA/1359417/2021-LIKE STRAIN (B/AUSTRIA/1359417/2021, BVR-26), INFLUENZA A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVATED] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS NEUDOERFL STRAIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED PRODUCED IN CHICK EMBRYO CELLS, ALGELDRATE] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013675124&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10013675136	Spontaneous	2022-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Immunisation reaction (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE STRAIN (A/CALIFORNIA/7/2009, X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/TEXAS/50/2012 (H3N2)-LIKE STRAIN (A/TEXAS/50/2012, X-223A), B/MASSACHUSETTS/2/2012-LIKE STRAIN (B/MASSACHUSETTS/2/2012, BX-51B), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), INFLUENZA VIRUS A/DARWIN/9/2021 SAN-010 (H3N2), INFLUENZA VIRUS B/AUSTRIA/1359417/2021-LIKE STRAIN (B/AUSTRIA/1359417/2021, BVR-26), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), INFLUENZA VIRUS A/DARWIN/9/2021 SAN-010 (H3N2), INFLUENZA VIRUS B/AUSTRIA/1359417/2021-LIKE STRAIN (B/AUSTRIA/1359417/2021, BVR-26), INFLUENZA A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVATED] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS NEUDOERFL STRAIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED PRODUCED IN CHICK EMBRYO CELLS, ALGELDRATE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[BCG (BACILLUS CALMETTE-GUÉRIN) BACTERIA] (S - Immunisation - n/a - [n/a - n/a - n/a])|[DIPHTHERIA TOXOID ADSORBED, TETANUS TOXOID ADSORBED, ALGELDRATE, DIPHTHERIA TOXOID ADSORBED, TETANUS TOXOID ADSORBED, ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID, TETANUS TOXOID, DIPHTHERIA TOXOID, TETANUS TOXOID, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM HYDROXIDE] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013675136&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10013676083	Spontaneous	2022-10-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013676083&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10013676687	Spontaneous	2022-10-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Abdominal pain (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Colitis ulcerative (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Suicidal ideation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013676687&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10013391228	Spontaneous	2022-08-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cerebrovascular accident (n/a - Unknown - Life Threatening, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013391228&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Life Threatening	Hospitalisation
EU-EC-10013178301	Spontaneous	2022-08-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013178301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10013142900	Spontaneous	2022-08-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013142900&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10013063550	Spontaneous	2022-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Elderly	No	Female	Contusion (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013063550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10013043186	Spontaneous	2022-07-20 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Unknown - );Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10013043186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10012958794	Spontaneous	2022-07-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Gastroenteritis (407d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypertension (406d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Osteopenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Respiratory distress (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sarcoidosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tachycardia (406d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012958794&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10012949326	Spontaneous	2022-07-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012949326&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10012952410	Spontaneous	2022-07-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Vestibular neuronitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - Subcutaneous use])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012952410&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10012853162	Spontaneous	2022-06-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012853162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10012631478	Spontaneous	2022-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012631478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10012575486	Spontaneous	2022-05-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (14d - Recovered/Resolved - );Pyrexia (14d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012575486&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10012460400	Spontaneous	2022-05-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Thrombocytopenia (29d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012460400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10012422102	Spontaneous	2022-05-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Bradycardia (1d - Recovered/Resolved - Other Medically Important Condition);Dizziness (1d - Recovered/Resolved - Other Medically Important Condition);Dry mouth (1d - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Hypotension (1d - Recovered/Resolved - Other Medically Important Condition);Nausea (1d - Recovered/Resolved - Other Medically Important Condition);Pallor (1d - Recovered/Resolved - Other Medically Important Condition);Syncope (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012422102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10012374499	Spontaneous	2022-05-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012374499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10012370632	Spontaneous	2022-05-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012370632&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10012331825	Spontaneous	2022-04-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - );Syncope (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012331825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10012299510	Spontaneous	2022-04-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bone pain (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Food allergy (n/a - Unknown - Disabling);Head discomfort (n/a - Unknown - Disabling);Hemihypoaesthesia (n/a - Unknown - Disabling);Hypoaesthesia (n/a - Unknown - Disabling);Immune system disorder (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Sinus disorder (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012299510&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10012308692	Spontaneous	2022-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012308692&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10012264144	Spontaneous	2022-04-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Mouth swelling (n/a - Unknown - Life Threatening);Pharyngeal swelling (n/a - Unknown - Life Threatening);Urticaria (n/a - Unknown - Life Threatening)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012264144&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10012267980	Spontaneous	2022-04-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012267980&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10012241540	Spontaneous	2022-04-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adolescent	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - );Narcolepsy (n/a - Recovered/Resolved With Sequelae - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012241540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10012190546	Spontaneous	2022-04-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Movement disorder (n/a - Not Recovered/Not Resolved - );Muscle strength abnormal (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012190546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10012046336	Spontaneous	2022-03-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Flatulence (4412d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - );Nausea (n/a - Unknown - );Urinary tract infection (n/a - Unknown - );Visual impairment (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012046336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10012034710	Spontaneous	2022-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10012034710&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10011989923	Spontaneous	2022-03-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Back pain (3835d - Recovered/Resolved With Sequelae - );Fatigue (n/a - Unknown - );Mobility decreased (3774d - Recovering/Resolving - );Narcolepsy (n/a - Unknown - );Respiratory distress (3795d - Recovered/Resolved With Sequelae - );Syncope (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011989923&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10011923422	Spontaneous	2022-03-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Psoriasis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Spondylitis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Immunisation - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011923422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10011856277	Spontaneous	2022-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011856277&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10011852339	Spontaneous	2022-03-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011852339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10011736843	Spontaneous	2022-02-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Sensory disturbance (4427d - Recovered/Resolved With Sequelae - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011736843&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10011705103	Spontaneous	2022-02-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Child	No	Female	Narcolepsy (n/a - Recovered/Resolved With Sequelae - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011705103&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10011696745	Spontaneous	2022-02-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Induced labour (n/a - Unknown - );Influenza like illness (n/a - Unknown - Disabling);Premature labour (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011696745&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10011697139	Spontaneous	2022-02-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Foetal exposure during pregnancy (n/a - Unknown - );Poor weight gain neonatal (n/a - Not Recovered/Not Resolved - );Premature baby (n/a - Unknown - );Vision abnormal neonatal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011697139&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10011664533	Spontaneous	2022-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Dose not changed - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011664533&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10011601140	Spontaneous	2022-02-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011601140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10011555451	Spontaneous	2022-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Vaccination site rash (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011555451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10011488144	Spontaneous	2022-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Unknown - );Malaise (n/a - Unknown - );Myalgia (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011488144&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10011444005	Spontaneous	2022-01-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011444005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10011416280	Spontaneous	2022-01-28 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysstasia (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Inflammation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Interchange of vaccine products (n/a - Unknown - Caused/Prolonged Hospitalisation);Limb discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nervousness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Neuropathy peripheral (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Off label use (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pericarditis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Retching (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vertigo (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - Unknown])|[COVID-19 VACCINE] (S - COVID-19 immunisation - Not applicable - [1d - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011416280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10011346599	Spontaneous	2022-01-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Decreased appetite (n/a - Recovered/Resolved - Disabling);Fatigue (n/a - Recovered/Resolved - Disabling);Maternal exposure during pregnancy (n/a - Recovered/Resolved - Disabling);Pain (n/a - Recovered/Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Sinusitis (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011346599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10011346751	Spontaneous	2022-01-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Foetal exposure during pregnancy (n/a - Recovered/Resolved - Disabling);Foetal growth restriction (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011346751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10011349770	Spontaneous	2022-01-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Psychomotor hyperactivity (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011349770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10011273405	Spontaneous	2022-01-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011273405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10011259378	Spontaneous	2022-01-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypersensitivity (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011259378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10011239699	Spontaneous	2022-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011239699&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10011216005	Spontaneous	2022-01-11 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Ageusia (n/a - Recovered/Resolved - Other Medically Important Condition);Anosmia (n/a - Recovered/Resolved - Other Medically Important Condition);Blood test abnormal (n/a - Recovered/Resolved - Other Medically Important Condition);Bronchitis (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (31d - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (4d - Recovered/Resolved - Other Medically Important Condition);Paranasal sinus discomfort (31d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Other Medically Important Condition);Upper respiratory tract infection (31d - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011216005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10011216038	Spontaneous	2022-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Parapsoriasis (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011216038&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10011185155	Spontaneous	2022-01-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Elderly	No	Male	Fatigue (n/a - Recovered/Resolved With Sequelae - );Narcolepsy (n/a - Recovered/Resolved With Sequelae - );Sick leave (n/a - Recovering/Resolving - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (C - Immunisation - n/a - [n/a - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011185155&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10011123462	Spontaneous	2021-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Face oedema (2d - Recovered/Resolved - );Influenza like illness (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011123462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10011110342	Spontaneous	2021-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site erythema (n/a - Recovered/Resolved - );Injection site induration (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011110342&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10011025405	Spontaneous	2021-12-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Psoriasis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10011025405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10010958594	Spontaneous	2021-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoacusis (n/a - Recovered/Resolved With Sequelae - Disabling);Myalgia (n/a - Recovered/Resolved With Sequelae - Disabling);Neuralgia (n/a - Recovered/Resolved With Sequelae - Disabling);Peripheral swelling (n/a - Recovered/Resolved With Sequelae - Disabling);Poor quality sleep (n/a - Recovered/Resolved With Sequelae - Disabling);Vaccination site pain (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010958594&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10010946288	Spontaneous	2021-12-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chronic fatigue syndrome (n/a - Recovered/Resolved With Sequelae - Disabling);Condition aggravated (n/a - Recovered/Resolved With Sequelae - Disabling);Impaired work ability (n/a - Recovered/Resolved With Sequelae - Disabling);Musculoskeletal disorder (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010946288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10010886070	Spontaneous	2021-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Palatal oedema (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010886070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10010760982	Spontaneous	2021-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Psychological factor affecting medical condition (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Soft tissue injury (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010760982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10010740025	Spontaneous	2021-11-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Lymphoedema (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010740025&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010724628	Spontaneous	2021-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bursitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010724628&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010727305	Spontaneous	2021-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010727305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10010727401	Spontaneous	2021-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010727401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10010729456	Spontaneous	2021-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Application site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010729456&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010714439	Spontaneous	2021-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Nightmare (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [3s - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010714439&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010660202	Spontaneous	2021-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Blister (n/a - Not Recovered/Not Resolved - );Rash erythematous (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010660202&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010541727	Spontaneous	2021-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pernicious anaemia (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - H1N1 influenza - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010541727&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10010513302	Spontaneous	2021-11-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Autism spectrum disorder (4315d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010513302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10010415049	Spontaneous	2021-10-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Multiple sclerosis (n/a - Recovered/Resolved With Sequelae - Disabling);Myelitis transverse (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010415049&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10010335978	Spontaneous	2021-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Uveitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010335978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10010316277	Spontaneous	2021-10-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Palpitations (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Syncope (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010316277&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10010240909	Spontaneous	2021-10-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dermatitis (n/a - Not Recovered/Not Resolved - );Hypersensitivity (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010240909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010159238	Spontaneous	2021-09-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010159238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010137279	Spontaneous	2021-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Insomnia (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Radiculopathy (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010137279&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10010112212	Spontaneous	2021-09-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dizziness (n/a - Recovered/Resolved - );Dyspepsia (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010112212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10010021952	Spontaneous	2021-09-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010021952&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10010010961	Spontaneous	2021-09-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010010961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10009990763	Spontaneous	2021-09-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hemiparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009990763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10009976693	Spontaneous	2021-09-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fine motor skill dysfunction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Motor dysfunction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neurological symptom (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - n/a - [1227d - n/a - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009976693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10009935379	Spontaneous	2021-09-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Adolescent	No	Female	Pyrexia (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009935379&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10009906072	Spontaneous	2021-09-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Anger (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Behaviour disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Blood iron decreased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Circadian rhythm sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Impaired quality of life (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Lethargy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Mood swings (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep terror (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009906072&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10009756663	Spontaneous	2021-08-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Depression (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009756663&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10009731184	Spontaneous	2021-08-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza like illness (n/a - Recovered/Resolved With Sequelae - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009731184&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10009651001	Spontaneous	2021-08-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Areflexia (n/a - Recovering/Resolving - );Balance disorder (n/a - Recovering/Resolving - );Confusional state (n/a - Recovering/Resolving - );Dizziness (n/a - Recovering/Resolving - );Muscular weakness (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - );Nervous system disorder (n/a - Recovering/Resolving - );Nystagmus (n/a - Recovering/Resolving - );Pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009651001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10009656696	Spontaneous	2021-08-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Paraesthesia (16d - Recovered/Resolved - );Peripheral coldness (16d - Recovered/Resolved - )	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009656696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10009628044	Spontaneous	2021-08-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Joint swelling (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009628044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10009631695	Spontaneous	2021-08-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Muscular weakness (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009631695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10009631796	Spontaneous	2021-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pernicious anaemia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Thyroiditis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intradermal])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009631796&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10009610929	Spontaneous	2021-08-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009610929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10009564104	Spontaneous	2021-08-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Subdermal])	[CANDESARTAN CILEXETIL] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009564104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10009520068	Spontaneous	2021-07-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arrhythmia (4085d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Dizziness (4085d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Dyspnoea (4085d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Palpitations (4085d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Respiration abnormal (4085d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009520068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10009439285	Spontaneous	2021-07-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Infection susceptibility increased (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Vaccination site movement impairment (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009439285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10009387914	Spontaneous	2021-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009387914&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10009242425	Spontaneous	2021-07-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Allergy to vaccine (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009242425&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10009223275	Spontaneous	2021-07-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009223275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10009210025	Spontaneous	2021-06-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (4147d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Hodgkin's disease (4147d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Influenza like illness (4147d - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009210025&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10009190371	Spontaneous	2021-06-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - );Disturbance in attention (n/a - Recovered/Resolved With Sequelae - );Fatigue (n/a - Recovered/Resolved With Sequelae - );Sleep paralysis (n/a - Recovered/Resolved With Sequelae - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009190371&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10009190497	Spontaneous	2021-06-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Coma (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Renal failure (865d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009190497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10009128611	Spontaneous	2021-06-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain (n/a - Unknown - Life Threatening);Burning sensation (n/a - Unknown - Life Threatening);Cardiovascular symptom (n/a - Unknown - Life Threatening);Chest pain (n/a - Unknown - Life Threatening);Dyspnoea (n/a - Unknown - Life Threatening);Fatigue (n/a - Unknown - Life Threatening);Muscle spasms (n/a - Unknown - Life Threatening);Pyrexia (n/a - Unknown - Life Threatening);Vomiting (n/a - Unknown - Life Threatening)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009128611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10008947420	Spontaneous	2021-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008947420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10008900871	Spontaneous	2021-06-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Dizziness (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Hypersomnia (n/a - Not Recovered/Not Resolved - );Injection site hypoaesthesia (2d - Not Recovered/Not Resolved - )	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008900871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008884907	Spontaneous	2021-06-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved With Sequelae - Disabling);Malaise (n/a - Recovered/Resolved With Sequelae - Disabling);Paralysis (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008884907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10008608817	Spontaneous	2021-05-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008608817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10008447598	Spontaneous	2021-04-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia (n/a - Not Recovered/Not Resolved - );Paraesthesia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008447598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008407259	Spontaneous	2021-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute kidney injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Glomerulonephritis membranoproliferative (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Proteinuria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	RYDAPT [MIDOSTAURIN] (S - Systemic mastocytosis - Dose not changed - [n/a - 100mg - Oral])|TAMIFLU [OSELTAMIVIR, OSELTAMIVIR PHOSPHATE] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])...	EYLEA [AFLIBERCEPT] (C - n/a - n/a - [n/a - n/a - Intraocular])|NEORECORMON [EPOETIN BETA] (C - n/a - n/a - [n/a - n/a - Subcutaneous])|PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 40mg - Oral])|[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - 1.25mg - Oral])|[CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 20mg - Oral])|[ENOXAPARIN, ENOXAPARIN SODIUM] (C - n/a - n/a - [n/a - 40mg - Subcutaneous])|[RANITIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 450mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008407259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10008404902	Spontaneous	2021-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Allergy to plants (n/a - Unknown - );Burning sensation (7d - Recovered/Resolved - );Food allergy (n/a - Unknown - );Hypersensitivity (n/a - Unknown - );Paraesthesia (n/a - Unknown - );Pruritus (7d - Recovered/Resolved - );Seasonal allergy (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[OMEPRAZOLE] (C - Product used for unknown indication - Unknown - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008404902&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008389844	Spontaneous	2021-04-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Influenza like illness (6d - Recovered/Resolved - );Vaccination error (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008389844&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008333279	Spontaneous	2021-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bursitis (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008333279&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008273773	Spontaneous	2021-04-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Alopecia totalis (n/a - Not Recovered/Not Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008273773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008208736	Spontaneous	2021-04-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Depression (n/a - Recovered/Resolved With Sequelae - Disabling);Fatigue (n/a - Recovered/Resolved With Sequelae - Disabling);Headache (n/a - Recovered/Resolved With Sequelae - Disabling);Impaired work ability (n/a - Recovered/Resolved With Sequelae - Disabling);Mental fatigue (n/a - Recovered/Resolved With Sequelae - Disabling);Urticaria chronic (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008208736&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10008146378	Spontaneous	2021-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthritis (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008146378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008152275	Spontaneous	2021-03-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Neuralgia (n/a - Recovered/Resolved With Sequelae - Disabling);Pain (n/a - Recovered/Resolved With Sequelae - Disabling);Pain in extremity (n/a - Recovered/Resolved With Sequelae - Disabling);Vaccination site pain (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008152275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10008088853	Spontaneous	2021-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Atrial fibrillation (n/a - Recovering/Resolving - Other Medically Important Condition);Balance disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Mouth ulceration (n/a - Recovering/Resolving - Other Medically Important Condition);Ophthalmic migraine (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	ELIQUIS [APIXABAN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008088853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10008039632	Spontaneous	2021-03-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Diarrhoea (2d - Recovered/Resolved - );Headache (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008039632&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10008047158	Spontaneous	2021-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[MODAFINIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008047158&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10008021973	Spontaneous	2021-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Headache (1d - Recovered/Resolved - );Pyrexia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10008021973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007990705	Spontaneous	2021-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia-bulimia syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007990705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007943395	Spontaneous	2021-03-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Not Specified	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Behaviour disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Emotional disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Rapid eye movement sleep behaviour disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007943395&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10007943397	Spontaneous	2021-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Aggression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Behaviour disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Eating disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Educational problem (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperphagia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Overweight (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007943397&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007910037	Spontaneous	2021-03-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypotonia (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling);Waxy flexibility (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007910037&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10007908973	Spontaneous	2021-03-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Behaviour disorder (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Depression (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Hot flush (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Hyperprolactinaemia (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Hyperventilation (n/a - Unknown - Other Medically Important Condition);Limb discomfort (n/a - Unknown - Other Medically Important Condition);Loss of consciousness (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007908973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10007860674	Spontaneous	2021-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Osteochondrosis (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007860674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007850190	Spontaneous	2021-03-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Quadriplegia (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007850190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007850847	Spontaneous	2021-03-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Narcolepsy (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007850847&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007805198	Spontaneous	2021-03-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Not Specified	Behaviour disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Cataplexy (n/a - Unknown - Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Educational problem (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Hallucination (n/a - Unknown - Disabling, Other Medically Important Condition);Hypotonia (n/a - Unknown - Disabling, Other Medically Important Condition);Increased appetite (n/a - Unknown - );Narcolepsy (n/a - Unknown - Disabling, Other Medically Important Condition);Oral herpes (n/a - Unknown - );Somnolence (n/a - Unknown - Disabling, Other Medically Important Condition);Weight increased (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007805198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10007805199	Spontaneous	2021-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Male	Abdominal pain (n/a - Unknown - );Agitation (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Behaviour disorder (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Cognitive disorder (n/a - Unknown - Other Medically Important Condition);Decreased appetite (n/a - Unknown - );Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Mouth breathing (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Rapid eye movement sleep behaviour disorder (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Sleep talking (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007805199&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10007787072	Spontaneous	2021-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Behaviour disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Decreased appetite (n/a - Not Recovered/Not Resolved - Disabling);Depressed mood (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Social avoidant behaviour (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Speech disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007787072&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10007778930	Spontaneous	2021-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Migraine (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007778930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10007763286	Spontaneous	2021-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Behaviour disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Educational problem (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])|[ALUMINIUM OXIDE, HYDRATED, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])|[ALUMINIUM PHOSPHATE, CORYNEBACTERIUM DIPHTHERIAE CRM197 CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE, ALUMINIUM PHOSPHATE, CORYNEBACTERIUM DIPHTHERIAE, NEISSERIA MENINGITIDIS, ALUMINIUM PHOSPHATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007763286&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10007751616	Spontaneous	2021-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Liver function test abnormal (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM, TULIP] (C - n/a - n/a - [n/a - 40mg - Oral])|[BISOPROLOL FUMARATE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[HYDROCHLOROTHIAZIDE, RAMIPRIL] (C - Hypertension - n/a - [n/a - n/a - Oral])|[LEVETIRACETAM] (C - n/a - n/a - [n/a - 500mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 40mg - Oral])|[RAMIPRIL] (C - n/a - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007751616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007753320	Spontaneous	2021-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute kidney injury (32d - Unknown - Caused/Prolonged Hospitalisation, Disabling);Musculoskeletal discomfort (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Vasculitis (32d - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007753320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007710843	Spontaneous	2021-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007710843&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007687562	Spontaneous	2021-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Bruxism (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Obstructive sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Psychomotor hyperactivity (n/a - Unknown - );Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007687562&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007671868	Spontaneous	2021-02-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Vaccination site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007671868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007674096	Spontaneous	2021-02-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Malaise (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])	NOVORAPID FLEXPEN [INSULIN ASPART] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007674096&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007641761	Spontaneous	2021-02-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Fatigue (n/a - Recovering/Resolving - Disabling);Muscle spasms (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007641761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10007614478	Spontaneous	2021-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (2d - Recovered/Resolved - );Fatigue (2d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - );Vaccination site oedema (2d - Recovered/Resolved - );Vaccination site pain (2d - Recovered/Resolved - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007614478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007618845	Spontaneous	2021-02-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007618845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10007608103	Spontaneous	2021-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Synovitis (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007608103&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007593874	Spontaneous	2021-02-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[DESOGESTREL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007593874&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10007594101	Spontaneous	2021-02-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Injected limb mobility decreased (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - );Tendonitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007594101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007578723	Spontaneous	2021-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Eczema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007578723&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007583947	Spontaneous	2021-02-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Altered state of consciousness (n/a - Unknown - );Arrhythmia (n/a - Unknown - );Circulatory collapse (n/a - Unknown - );Fatigue (n/a - Unknown - );Infection (n/a - Unknown - );Ophthalmic migraine (n/a - Not Recovered/Not Resolved - Disabling);Seizure (n/a - Not Recovered/Not Resolved - )	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007583947&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10007587453	Spontaneous	2021-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Meningitis (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007587453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10007548668	Spontaneous	2021-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 3.75ug - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007548668&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007451220	Spontaneous	2021-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007451220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007452540	Spontaneous	2021-01-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Hypotonia (11a - Recovered/Resolved With Sequelae - );Mobility decreased (11a - Recovered/Resolved With Sequelae - );Movement disorder (11a - Recovered/Resolved With Sequelae - );Muscular weakness (11a - Recovered/Resolved With Sequelae - );Pyrexia (11a - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007452540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10007423644	Spontaneous	2021-01-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Back pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007423644&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007416684	Spontaneous	2021-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Muscular weakness (1mo - Recovered/Resolved - Other Medically Important Condition);Myalgia (1mo - Recovered/Resolved - Other Medically Important Condition);Vasculitis (1mo - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007416684&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007404555	Spontaneous	2021-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Narcolepsy (6a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007404555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007381143	Spontaneous	2021-01-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - );Vaccination site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007381143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007381909	Spontaneous	2021-01-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthenia (4d - Recovered/Resolved - );Paraesthesia (4d - Recovered/Resolved - )	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007381909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007389250	Spontaneous	2021-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007389250&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007372982	Spontaneous	2021-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Apathy (n/a - Not Recovered/Not Resolved - );Chills (3d - Recovered/Resolved - );Decreased appetite (n/a - Not Recovered/Not Resolved - );Dysphonia (n/a - Not Recovered/Not Resolved - );Fatigue (3d - Recovered/Resolved - );Nasal congestion (n/a - Not Recovered/Not Resolved - );Pyrexia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	[COLECALCIFEROL] (C - n/a - Dose not changed - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007372982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007376314	Spontaneous	2021-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Muscle twitching (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007376314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10007370146	Spontaneous	2021-01-18 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007370146&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10007355666	Spontaneous	2021-01-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Facial paralysis (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007355666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10007357131	Spontaneous	2021-01-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Disturbance in attention (11a - Not Recovered/Not Resolved - );Dizziness (11a - Not Recovered/Not Resolved - );Fatigue (11a - Not Recovered/Not Resolved - );Food intolerance (n/a - Not Recovered/Not Resolved - );Influenza like illness (11a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007357131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007349271	Spontaneous	2021-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (1d - Recovered/Resolved - );Blood pressure decreased (1d - Recovered/Resolved - );Nausea (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007349271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007327082	Spontaneous	2021-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Application site erythema (5d - Recovered/Resolved - );Application site haematoma (3d - Recovered/Resolved - );Application site pain (5d - Recovered/Resolved - );Application site pruritus (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Unknown - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007327082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007330594	Spontaneous	2021-01-11 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Paraplegia (n/a - Unknown - Other Medically Important Condition);Product use in unapproved indication (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[POTASSIUM CHLORIDE] (S - Guillain-Barre syndrome, Pain - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007330594&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10007306926	Spontaneous	2021-01-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthma (n/a - Unknown - Caused/Prolonged Hospitalisation);Behaviour disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dermatitis allergic (n/a - Unknown - Caused/Prolonged Hospitalisation);Developmental delay (n/a - Unknown - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation);Enuresis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Otitis media (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Sinusitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Stomatitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Tonsillitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007306926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007299924	Spontaneous	2021-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (3d - Not Recovered/Not Resolved - );Swollen tongue (3d - Not Recovered/Not Resolved - );Urticaria (3d - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007299924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007293404	Spontaneous	2021-01-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Hypersensitivity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007293404&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007293927	Spontaneous	2021-01-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007293927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007290180	Spontaneous	2021-01-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Loss of personal independence in daily activities (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	[VITAMIN D] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007290180&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007287539	Spontaneous	2021-01-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007287539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007272656	Spontaneous	2020-12-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Paraesthesia (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[BROMAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007272656&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007275667	Spontaneous	2020-12-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - );Sleep disorder (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/BRISBANE/60/2008-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007275667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007278048	Spontaneous	2020-12-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Headache (6d - Recovered/Resolved - );Myalgia (6d - Recovered/Resolved - );Nasal congestion (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007278048&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007267200	Spontaneous	2020-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007267200&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007260280	Spontaneous	2020-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Recovered/Resolved With Sequelae - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007260280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10007253173	Spontaneous	2020-12-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Balance disorder (3d - Recovered/Resolved - );Fatigue (3d - Recovered/Resolved - );Palpitations (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - Graves' disease - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007253173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10007239657	Spontaneous	2020-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Facial paresis (n/a - Recovered/Resolved With Sequelae - Disabling);Formication (n/a - Recovered/Resolved With Sequelae - Disabling);Motor dysfunction (n/a - Recovered/Resolved With Sequelae - Disabling);Paraesthesia oral (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007239657&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10007242608	Spontaneous	2020-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rheumatoid arthritis (33d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [1d - 1{DF} - n/a])	TELMISARTAN [TELMISARTAN] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Hypertension - n/a - [28d - 1{DF} - n/a])|[BUPROPION, BUPROPION HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[CODEINE PHOSPHATE] (C - n/a - n/a - [7d - n/a - n/a])|[ECONAZOLE, ECONAZOLE NITRATE] (C - n/a - n/a - [1d - 1{DF} - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[NITROFURANTOIN] (C - n/a - n/a - [4d - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Blood cholesterol increased - n/a - [n/a - 1{DF} - n/a])|[TRIMETHOPRIM] (C - Urinary tract infection - n/a - [5d - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007242608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-10007245601	Spontaneous	2020-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Autoimmune encephalopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Back pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Electrocardiogram abnormal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Flushing (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Head discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neck pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neuropathy peripheral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Presyncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pulse pressure increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vasculitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007245601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007214657	Spontaneous	2020-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Osteoarthritis (n/a - Not Recovered/Not Resolved - Disabling);Rheumatic disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007214657&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10007203687	Spontaneous	2020-12-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling);Waxy flexibility (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007203687&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10007204528	Spontaneous	2020-12-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - );Exercise tolerance decreased (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007204528&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007208080	Spontaneous	2020-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007208080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007208933	Spontaneous	2020-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Obstructive sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - n/a - [n/a - n/a - n/a])	[ANHYDROUS LEVOTHYROXINE SODIUM, LEVOTHYROXINE] (C - n/a - n/a - [n/a - 125ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007208933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007193245	Spontaneous	2020-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular - More in ICSR])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007193245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007181258	Spontaneous	2020-12-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007181258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007177143	Spontaneous	2020-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Transfusion (n/a - Unknown - Caused/Prolonged Hospitalisation)	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007177143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007158406	Spontaneous	2020-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (n/a - Not Recovered/Not Resolved - );Limb discomfort (n/a - Not Recovered/Not Resolved - );Vaccination site movement impairment (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007158406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007141595	Spontaneous	2020-12-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dizziness (n/a - Recovering/Resolving - );Immunisation reaction (n/a - Recovering/Resolving - );Muscular weakness (n/a - Recovering/Resolving - );Paraesthesia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007141595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007125945	Spontaneous	2020-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Angioedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007125945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10007118497	Spontaneous	2020-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007118497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007118499	Spontaneous	2020-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007118499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007118500	Spontaneous	2020-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007118500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007118520	Spontaneous	2020-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007118520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007118521	Spontaneous	2020-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007118521&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007118560	Spontaneous	2020-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007118560&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007118904	Spontaneous	2020-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Rash (n/a - Unknown - );Rash macular (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Unknown - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007118904&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007118905	Spontaneous	2020-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Injection site erythema (n/a - Unknown - );Injection site inflammation (n/a - Unknown - );Injection site pain (n/a - Unknown - );Injection site warmth (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Unknown - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007118905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007111559	Spontaneous	2020-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Rash (n/a - Unknown - );Rash macular (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Unknown - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007111559&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007111560	Spontaneous	2020-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Rash (n/a - Unknown - );Rash macular (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Unknown - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007111560&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007113579	Spontaneous	2020-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007113579&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007105054	Spontaneous	2020-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Injection site erythema (n/a - Unknown - );Malaise (n/a - Unknown - );Rash (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007105054&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007078639	Spontaneous	2020-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dysaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (S - Myocardial infarction - Dose not changed - [n/a - 80mg - Oral])|[FUROSEMIDE] (S - Myocardial infarction - Dose not changed - [n/a - 40mg - Oral])|[RAMIPRIL] (S - Myocardial infarction - Dose not changed - [n/a - 10mg - Oral])	[BISOPROLOL FUMARATE] (C - Myocardial infarction - n/a - [n/a - 10mg - Oral])|[D,L-LYSINE ACETYLSALICYLATE] (C - Myocardial infarction - n/a - [n/a - 75mg - Oral])|[EPLERENONE] (C - Cardiac failure - n/a - [n/a - 50mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - 1g - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007078639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10007081768	Spontaneous	2020-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Collagen disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Impaired work ability (n/a - Recovered/Resolved With Sequelae - Disabling);Mixed connective tissue disease (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007081768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10007071929	Spontaneous	2020-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Rash macular (n/a - Unknown - );Skin warm (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007071929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10007067041	Spontaneous	2020-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007067041&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007057911	Spontaneous	2020-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Allergy to chemicals (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthma (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Auditory disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Bedridden (2wk - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dairy intolerance (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Food allergy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Food intolerance (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Gluten sensitivity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Immunodeficiency (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Impaired quality of life (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Influenza (2wk - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Lower respiratory tract infection (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Misophonia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscle fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sinusitis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Toothache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Upper respiratory tract infection (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007057911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10007058098	Spontaneous	2020-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007058098&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10007049829	Spontaneous	2020-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007049829&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10007033996	Spontaneous	2020-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007033996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10007035021	Spontaneous	2020-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007035021&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10007026584	Spontaneous	2020-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10007026584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006996984	Spontaneous	2020-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling);Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Paralysis (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006996984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10006999098	Spontaneous	2020-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Blood glucose increased (n/a - Recovering/Resolving - );Chills (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Subcutaneous])	[INSULIN, INSULIN HUMAN] (C - Diabetes mellitus - Dose not changed - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006999098&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006969649	Spontaneous	2020-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Optic neuritis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006969649&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10006943584	Spontaneous	2020-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Depressed level of consciousness (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006943584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006928020	Spontaneous	2020-10-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Pain (n/a - Unknown - );Rash macular (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006928020&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006912873	Spontaneous	2020-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Myalgia (14d - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006912873&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006913779	Spontaneous	2020-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006913779&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006898381	Spontaneous	2020-10-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [3d - n/a - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006898381&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006880841	Spontaneous	2020-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006880841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10006880865	Spontaneous	2020-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006880865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006880873	Spontaneous	2020-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Middle insomnia (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Screaming (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Weight increased (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006880873&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10006875873	Spontaneous	2020-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006875873&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006875874	Spontaneous	2020-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006875874&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006875892	Spontaneous	2020-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006875892&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10006875901	Spontaneous	2020-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006875901&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006875908	Spontaneous	2020-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006875908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006875926	Spontaneous	2020-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006875926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006875927	Spontaneous	2020-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006875927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10006876068	Spontaneous	2020-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Mood swings (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006876068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006876091	Spontaneous	2020-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006876091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10006876111	Spontaneous	2020-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006876111&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006876342	Spontaneous	2020-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	[ETHINYLESTRADIOL, NORETHISTERONE, LACTOSE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006876342&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10006876927	Spontaneous	2020-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006876927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006877409	Spontaneous	2020-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006877409&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006866073	Spontaneous	2020-10-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006866073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006866549	Spontaneous	2020-10-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006866549&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006868673	Spontaneous	2020-10-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site cellulitis (2d - Recovered/Resolved - );Vaccination site erythema (2d - Recovered/Resolved - );Vaccination site pruritus (2d - Recovered/Resolved - );Vaccination site swelling (2d - Recovered/Resolved - );Vaccination site warmth (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [0d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006868673&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006848161	Spontaneous	2020-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - n/a])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006848161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10006848657	Spontaneous	2020-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Unknown - );Pruritus (n/a - Unknown - );Rash papular (n/a - Unknown - );Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [1d - n/a - n/a])	METHOTREXATE [METHOTREXATE] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006848657&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006848832	Spontaneous	2020-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006848832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006850675	Spontaneous	2020-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Flushing (5d - Recovered/Resolved - );Hypersensitivity (5d - Recovered/Resolved - );Injection site erythema (5d - Recovered/Resolved - );Injection site pruritus (5d - Recovered/Resolved - );Respiratory distress (5d - Recovered/Resolved - );Urticaria (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006850675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10006816393	Spontaneous	2020-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Fatigue (7mo - Recovered/Resolved - );Headache (7mo - Recovered/Resolved - );Narcolepsy (7mo - Recovered/Resolved - );Nightmare (7mo - Recovered/Resolved - );Personality change (7mo - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006816393&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006807163	Spontaneous	2020-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Hypertension (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	EXFORGE 5 MG/160 MG FILM-COATED TABLETS [VALSARTAN, AMLODIPINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006807163&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006809310	Spontaneous	2020-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cognitive disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006809310&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006802199	Spontaneous	2020-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006802199&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10006793350	Spontaneous	2020-10-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Abnormal behaviour (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);COVID-19 pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Constipation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);SARS-CoV-2 test positive (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urinary tract disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006793350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006788480	Spontaneous	2020-10-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006788480&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10006730180	Spontaneous	2020-09-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006730180&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10006697791	Spontaneous	2020-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006697791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006693415	Spontaneous	2020-09-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006693415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006693725	Spontaneous	2020-09-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006693725&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006669337	Spontaneous	2020-09-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Deafness unilateral (n/a - Unknown - Disabling);Vertigo (n/a - Unknown - Disabling)	ZOSTAVAX [VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (S - Immunisation - Not applicable - [n/a - .5mL - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1mL - Intramuscular])	ELIQUIS [APIXABAN] (C - n/a - n/a - [n/a - n/a - n/a])|MICARDIS [TELMISARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[EZETIMIBE] (C - n/a - n/a - [n/a - n/a - n/a])|[PHENOXYMETHYLPENICILLIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006669337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10006638957	Spontaneous	2020-09-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (n/a - Unknown - );Hypoaesthesia (n/a - Not Recovered/Not Resolved - );Local reaction (n/a - Unknown - );Nausea (n/a - Unknown - );Neuralgia (n/a - Not Recovered/Not Resolved - );Neuritis (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006638957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10006639141	Spontaneous	2020-09-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Asthma (n/a - Not Recovered/Not Resolved - );Chills (n/a - Unknown - );Hypersensitivity (n/a - Not Recovered/Not Resolved - );Infection susceptibility increased (n/a - Not Recovered/Not Resolved - );Local reaction (n/a - Unknown - );Nausea (n/a - Unknown - );Pyrexia (n/a - Unknown - );Seasonal allergy (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, ALGELDRATE, NEISSERIA MENINGITIDIS GROUP C, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, TETANUS TOXOID, ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, ALUMINIUM, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, N. MENINGITIDIS GROUP C POLYSACCHARIDE, ALGELDRATE] (S - Immunisation - n/a - [n/a - n/a - n/a])|[VARICELLA VIRUS OKA STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006639141&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006605014	Spontaneous	2020-08-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006605014&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006566892	Spontaneous	2020-08-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Aphasia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dissociation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Eyelid disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006566892&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006342277	Spontaneous	2020-07-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Abdominal pain lower (10a - Not Recovered/Not Resolved - Other Medically Important Condition);Abnormal faeces (10a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Alopecia (10a - Recovering/Resolving - Other Medically Important Condition);Cognitive disorder (10a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (20mo - Recovered/Resolved - Other Medically Important Condition);Disturbance in attention (10a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (10a - Recovering/Resolving - Other Medically Important Condition);Memory impairment (10a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Movement disorder (10a - Recovering/Resolving - Other Medically Important Condition);Visual impairment (6a - Recovering/Resolving - Other Medically Important Condition);Vomiting (10a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006342277&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10006325372	Spontaneous	2020-07-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Apathy (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Bradyphrenia (n/a - Not Recovered/Not Resolved - Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Dysarthria (n/a - Not Recovered/Not Resolved - Disabling);Hallucination (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Migraine (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	TWINRIX ADULT SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006325372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10006319973	Spontaneous	2020-07-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Painful respiration (n/a - Recovered/Resolved - Other Medically Important Condition);Sleep apnoea syndrome (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006319973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006282793	Spontaneous	2020-07-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006282793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10006231447	Spontaneous	2020-06-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006231447&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10006209283	Spontaneous	2020-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Disabling);Subacute inflammatory demyelinating polyneuropathy (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006209283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10006218131	Spontaneous	2020-06-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006218131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10006185792	Spontaneous	2020-06-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006185792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10006129625	Spontaneous	2020-06-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pruritus (n/a - Not Recovered/Not Resolved - );Psoriasis (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006129625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006114853	Spontaneous	2020-06-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Dose not changed - [1d - 2mL - Intramuscular])	SOMAC CONTROL [PANTOPRAZOLE] (C - Product used for unknown indication - Dose not changed - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006114853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10006100280	Spontaneous	2020-06-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Rash erythematous (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006100280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006100282	Spontaneous	2020-06-02 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Pyrexia (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006100282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006100283	Spontaneous	2020-06-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Infant	No	Female	Decreased appetite (n/a - Not Recovered/Not Resolved - );Diarrhoea (n/a - Not Recovered/Not Resolved - );Listless (n/a - Not Recovered/Not Resolved - );Somnolence (n/a - Not Recovered/Not Resolved - );Tearfulness (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006100283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006100287	Spontaneous	2020-06-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Emotional distress (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Dose not changed - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006100287&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006100288	Spontaneous	2020-06-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Recovered/Resolved - );Influenza like illness (n/a - Recovered/Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006100288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006092292	Spontaneous	2020-05-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Decreased appetite (n/a - Recovered/Resolved - );Diarrhoea (n/a - Recovered/Resolved - );Injection site swelling (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006092292&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10006092312	Spontaneous	2020-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Psychomotor hyperactivity (n/a - Recovering/Resolving - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - Not applicable - [n/a - n/a - n/a])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - Not applicable - [n/a - n/a - n/a])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10006092312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005999251	Spontaneous	2020-05-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Maternal exposure before pregnancy (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005999251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005982001	Spontaneous	2020-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (1wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005982001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005982056	Spontaneous	2020-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005982056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005983112	Spontaneous	2020-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling);Sleep apnoea syndrome (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005983112&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10005983117	Spontaneous	2020-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Impaired driving ability (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])|[DIPHTHERIA TOXOID, TETANUS TOXOID, DIPHTHERIA TOXOID, TETANUS TOXOID, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005983117&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10005922609	Spontaneous	2020-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005922609&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10005890212	Spontaneous	2020-04-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (10a - Not Recovered/Not Resolved - );Influenza (4wk - Not Recovered/Not Resolved - );Monoplegia (10a - Not Recovered/Not Resolved - );Pain (10a - Not Recovered/Not Resolved - );Tendonitis (10a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005890212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10005885024	Spontaneous	2020-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Infection susceptibility increased (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Plasma cell myeloma (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005885024&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10005887594	Spontaneous	2020-04-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hepatic function abnormal (n/a - Unknown - );Sarcoidosis (n/a - Not Recovered/Not Resolved - Disabling);Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005887594&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10005875962	Spontaneous	2020-04-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Bronchospasm (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005875962&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10005869988	Spontaneous	2020-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005869988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005827640	Spontaneous	2020-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (1d - Recovered/Resolved - );Diarrhoea (1d - Recovered/Resolved - );Nausea (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005827640&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005828159	Spontaneous	2020-04-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza A virus test positive (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005828159&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10005828490	Spontaneous	2020-04-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Child	No	Male	Influenza A virus test positive (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005828490&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005806928	Spontaneous	2020-04-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Bronchitis (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005806928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10005813628	Spontaneous	2020-04-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Depressed level of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza A virus test positive (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005813628&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005732527	Spontaneous	2020-03-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abnormal faeces (n/a - Not Recovered/Not Resolved - );Disturbance in attention (10a - Not Recovered/Not Resolved - );Dizziness (10a - Not Recovered/Not Resolved - );Memory impairment (10a - Not Recovered/Not Resolved - );Somnolence (10a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005732527&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005708775	Spontaneous	2020-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005708775&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005690678	Spontaneous	2020-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Product quality issue (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - .5mL - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005690678&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005674219	Spontaneous	2020-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Formication (3d - Recovered/Resolved - );Paraesthesia (3d - Recovered/Resolved - );Vaccination complication (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005674219&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005670867	Spontaneous	2020-03-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Movement disorder (n/a - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005670867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005647829	Spontaneous	2020-03-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (3721d - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005647829&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10005633213	Spontaneous	2020-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Food intolerance (n/a - Not Recovered/Not Resolved - );Gastrocardiac syndrome (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005633213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10005620750	Spontaneous	2020-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Medication error (n/a - Unknown - );No adverse event (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005620750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005620764	Spontaneous	2020-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epistaxis (n/a - Unknown - );Loss of consciousness (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005620764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10005620767	Spontaneous	2020-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Medication error (n/a - Unknown - );No adverse event (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005620767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005606505	Spontaneous	2020-03-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arterial thrombosis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Flank pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Renal impairment (n/a - Unknown - Disabling);Renal infarct (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Hepatitis A, Hepatitis B - Drug withdrawn - [209d - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005606505&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10005597930	Spontaneous	2020-03-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthritis (n/a - Recovered/Resolved With Sequelae - Disabling);Psoriasis (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005597930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10005588897	Spontaneous	2020-03-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Vaccination site reaction (2d - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005588897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005591519	Spontaneous	2020-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drug intolerance (n/a - Unknown - );Vaccination site erythema (n/a - Recovered/Resolved - );Vaccination site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005591519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005577192	Spontaneous	2020-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hepatitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	EXFORGE 10 MG/160 MG FILM-COATED TABLETS [VALSARTAN, AMLODIPINE] (S - Hypertension - Drug withdrawn - [n/a - 1{DF} - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (S - Hypercholesterolaemia - Drug withdrawn - [n/a - 10mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005577192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005559313	Spontaneous	2020-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Eye swelling (n/a - Unknown - );Inappropriate schedule of product administration (n/a - Unknown - );Injection site oedema (n/a - Recovered/Resolved - );Injection site pruritus (n/a - Recovered/Resolved - );Injection site reaction (n/a - Recovered/Resolved - );Injection site swelling (n/a - Recovered/Resolved - );Off label use (n/a - Unknown - )	XOLAIR [OMALIZUMAB] (S - Respiratory disorder - Unknown - [n/a - 150mg - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Unknown - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005559313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005543130	Spontaneous	2020-02-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Administration site bruise (n/a - Not Recovered/Not Resolved - );Blister (n/a - Not Recovered/Not Resolved - );Decreased appetite (n/a - Not Recovered/Not Resolved - );Dry skin (n/a - Not Recovered/Not Resolved - );Feeling hot (n/a - Not Recovered/Not Resolved - );Injection site erythema (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Not Recovered/Not Resolved - );Injection site swelling (n/a - Not Recovered/Not Resolved - );Pain (n/a - Not Recovered/Not Resolved - );Peripheral swelling (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Rash macular (n/a - Not Recovered/Not Resolved - );Skin hypertrophy (n/a - Not Recovered/Not Resolved - );Somnolence (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Dose increased - [n/a - n/a - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE VACCINE] (S - Immunisation, Pneumococcal immunisation - Dose increased - [n/a - n/a - Intramuscular])	AVAMYS [FLUTICASONE FUROATE] (C - n/a - n/a - [n/a - n/a - n/a])|OPATANOL [OLOPATADINE, OLOPATADINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])|[CARBOMER 980, CARBOMERS] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DOCONEXENT, ICOSAPENT, FISH OIL, ICOSAPENT ETHYL, DOCOSAHEXAENOIC ACID ETHYL ESTER, OMEGA-3-ACID ETHYL ESTERS 90, OMEGA-3-ACID ETHYL ESTERS 90, DOCOSAHEXAENOIC ACID ETHYL ESTER] (C - n/a - n/a - )|[FEXOFENADINE, FEXOFENADINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[KETOPROFEN, KETOPROFEN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LIOTHYRONINE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL, PARACETAMOL, ASPARTAME] (C - n/a - n/a - [n/a - n/a - n/a])|[POVIDONE, POVIDONE K25] (C - n/a - n/a - [n/a - n/a - n/a])|[SELENIUM, SODIUM SELENITE] (C - n/a - n/a - )|[THIAMINE HYDROCHLORIDE, RETINOL] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005543130&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005543344	Spontaneous	2020-02-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Autoimmune thyroiditis (n/a - Recovered/Resolved With Sequelae - )	TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS (LIVE, ATTENUATED), RUBELLA VIRUS (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005543344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10005524480	Spontaneous	2020-02-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Fatigue (n/a - Recovered/Resolved - );Night sweats (n/a - Recovered/Resolved - );Vertigo (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005524480&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005532539	Spontaneous	2020-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hemiparesis (n/a - Unknown - Other Medically Important Condition);Hypogeusia (n/a - Unknown - Other Medically Important Condition);Sensitisation (n/a - Unknown - Other Medically Important Condition);Sensitive skin (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	TRUMENBA [ALUMINIUM, NEISSERIA MENINGITIDIS GROUP B FHBP PROTEIN SUBFAMILY A, NEISSERIA MENINGITIDIS GROUP B FHBP PROTEIN SUBFAMILY B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005532539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10005508193	Spontaneous	2020-02-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (5d - Recovered/Resolved - Disabling);Inflammation (5d - Recovered/Resolved - Disabling);Vertigo (5d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[HYDROCHLOROTHIAZIDE, BISOPROLOL HEMIFUMARATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[ZOLPIDEM, ZOLPIDEM HEMITARTRATE, ZOLPIDEM TARTRATE] (C - n/a - Unknown - [n/a - .5{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005508193&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10005475387	Spontaneous	2020-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Neuralgic amyotrophy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005475387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005480440	Spontaneous	2020-02-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Back pain (4h - Recovered/Resolved - );Diarrhoea (4h - Recovered/Resolved - );Headache (4h - Recovered/Resolved - );Pain in extremity (4h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - Dose not changed - [n/a - 1{DF} - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - Dose not changed - [n/a - 1{DF} - n/a])|[INDAPAMIDE, PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE, INDAPAMIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - n/a])|[VINPOCETINE] (C - n/a - Dose not changed - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005480440&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005468245	Spontaneous	2020-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccine breakthrough infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005468245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005456106	Spontaneous	2020-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Sudden death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005456106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10005456109	Spontaneous	2020-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Sudden death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005456109&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10005452315	Spontaneous	2020-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hemiparesis (30d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypogeusia (30d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensitisation (30d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensitive skin (30d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (30d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	TRUMENBA [ALUMINIUM, NEISSERIA MENINGITIDIS GROUP B FHBP PROTEIN SUBFAMILY A, NEISSERIA MENINGITIDIS GROUP B FHBP PROTEIN SUBFAMILY B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005452315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005436707	Spontaneous	2020-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Body temperature increased (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005436707&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005428845	Spontaneous	2020-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005428845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005417449	Spontaneous	2020-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Listless (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005417449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005391757	Spontaneous	2020-02-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Product complaint (n/a - Unknown - Other Medically Important Condition);Respiratory tract infection (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005391757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10005373197	Spontaneous	2020-01-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Life Threatening);Anaphylactic shock (n/a - Not Recovered/Not Resolved - Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005373197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10005295551	Spontaneous	2020-01-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Petit mal epilepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005295551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10005268956	Spontaneous	2020-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Nausea (n/a - Recovering/Resolving - );Vertigo (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005268956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005243379	Spontaneous	2020-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Erythema (1d - Recovered/Resolved - );Papule (1d - Recovered/Resolved - );Pruritus (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1[drp] - Intradermal])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005243379&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005249293	Spontaneous	2020-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Acute kidney injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dehydration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fungal infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Urinary tract infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Urosepsis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005249293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005220730	Spontaneous	2020-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	ESOMEPRAZOLE [ESOMEPRAZOLE] (C - n/a - n/a - [n/a - 40mg - Oral])|SILODYX 8 MG HARD CAPSULES [SILODOSIN] (C - n/a - n/a - [n/a - 8mg - Oral])|[AMLODIPINE BESILATE, PERINDOPRIL ARGININE, AMLODIPINE, PERINDOPRIL] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - n/a - Topical])|[MOXONIDINE] (C - n/a - n/a - [n/a - .4mg - Oral])|[SOLIFENACIN, SOLIFENACIN SUCCINATE] (C - n/a - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005220730&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005214271	Spontaneous	2020-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Mental fatigue (n/a - Not Recovered/Not Resolved - Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005214271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10005201894	Spontaneous	2020-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005201894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10005186566	Spontaneous	2020-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	PREGABALIN [PREGABALIN] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[COATED THIAMINE NITRATE (VITAMIN B1), COATED PYRIDOXINE HYDROCHLORIDE (VITAMIN B6), THIAMINE NITRATE, PYRIDOXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DISODIUM PHOSPHATE, ANHYDROUS, CALCIUM, MAGNESIUM GLYCEROPHOSPHATE, PHOSPHORIC ACID CONCENTRATED, DISODIUM PHOSPHATE, ANHYDROUS, MAGNESIUM GLYCEROPHOSPHATE, PHOSPHORIC ACID CONCENTRATED, CALCIUM BIS(DIHYDROGENPHOSPHATE) MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENOXAPARIN, ENOXAPARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[LACTULOSE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[MORPHINE SULFATE, MORPHINE SULFATE PENTAHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[NEFOPAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005186566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005186741	Spontaneous	2020-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005186741&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005186780	Spontaneous	2020-01-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Fatigue (n/a - Recovering/Resolving - );Insomnia (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Vaccination complication (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005186780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005179856	Spontaneous	2020-01-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal discomfort (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Arthralgia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Cataplexy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Contusion (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Gastric ulcer haemorrhage (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Gastrointestinal disorder (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Joint swelling (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pain (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Psychomotor hyperactivity (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Sleep apnoea syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Stress (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Swelling (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Weight increased (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005179856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10005182714	Spontaneous	2020-01-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - );Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005182714&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005147371	Spontaneous	2020-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Laryngitis (4mo - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Thyroid disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Weight increased (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005147371&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10005144656	Spontaneous	2020-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Waxy flexibility (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005144656&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005140493	Spontaneous	2020-01-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dystonia (n/a - Not Recovered/Not Resolved - Disabling);Parkinson's disease (n/a - Not Recovered/Not Resolved - Disabling);Tremor (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005140493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10005127646	Spontaneous	2020-01-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site reaction (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005127646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005128206	Spontaneous	2020-01-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Multiple sclerosis (10mo - Not Recovered/Not Resolved - Disabling)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005128206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10005117908	Spontaneous	2019-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005117908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10005100145	Spontaneous	2019-12-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Foetal hypokinesia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Maternal exposure during pregnancy (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])|[DIPHTHERIA, TETANUS AND PERTUSSIS (ACELLULAR, COMPONENT) VACCINE (ADSORBED)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005100145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10005074372	Spontaneous	2019-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Vaccination site erythema (n/a - Not Recovered/Not Resolved - );Vaccination site induration (n/a - Not Recovered/Not Resolved - );Vaccination site plaque (n/a - Not Recovered/Not Resolved - );Vaccination site warmth (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005074372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005066182	Spontaneous	2019-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute respiratory failure (10d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Asthenia (10d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (10d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Quadriparesis (10d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Respiratory distress (10d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Unknown - [n/a - .5{DF} - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - n/a - n/a])|[ANHYDROUS LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE] (C - n/a - Unknown - [n/a - .25{DF} - n/a])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - Unknown - [n/a - n/a - n/a])|[EZETIMIBE] (C - n/a - Unknown - [n/a - n/a - n/a])|[FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - Unknown - [n/a - 1{DF} - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005066182&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10005028777	Spontaneous	2019-12-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (0d - Recovered/Resolved - );Body temperature increased (3d - Recovered/Resolved - );Chills (3d - Recovered/Resolved - );Fatigue (3d - Recovered/Resolved - );Injection site erythema (6d - Recovered/Resolved - );Injection site warmth (6d - Recovered/Resolved - );Limb discomfort (3d - Recovered/Resolved - );Vaccination site pain (6d - Recovered/Resolved - );Vaccination site pruritus (3d - Recovered/Resolved - );Vaccination site swelling (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005028777&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005012875	Spontaneous	2019-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - );Influenza like illness (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005012875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005012876	Spontaneous	2019-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005012876&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10005012899	Spontaneous	2019-12-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Optic neuritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005012899&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10005003306	Spontaneous	2019-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [1d - 1{DF} - Parenteral])|[ALPRAZOLAM] (S - Anxiety - Drug withdrawn - [n/a - .5mg - Oral])|[CANDESARTAN CILEXETIL] (S - Hypertension - Drug withdrawn - [n/a - 16mg - Oral])|[HYDROCHLOROTHIAZIDE] (S - Hypertension - Drug withdrawn - [n/a - 12.5mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005003306&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10005006929	Spontaneous	2019-12-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Rash (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10005006929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004990378	Spontaneous	2019-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - );Vaccination complication (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004990378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004977601	Spontaneous	2019-12-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Maternal exposure during pregnancy (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004977601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004980294	Spontaneous	2019-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site haemorrhage (n/a - Not Recovered/Not Resolved - );Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004980294&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10004965848	Spontaneous	2019-12-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Urticaria (8d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004965848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004966430	Spontaneous	2019-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - );Vaccination site reaction (n/a - Recovered/Resolved - );Vaccination site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE, BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE] (C - Asthma - n/a - [n/a - 2{DF} - Oral])|[COLECALCIFEROL, CALCIUM CARBONATE] (C - Osteoporosis - n/a - [n/a - 1{DF} - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - n/a - [n/a - n/a - Oral])|[TAMOXIFEN, TAMOXIFEN CITRATE] (C - Breast cancer - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004966430&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004968424	Spontaneous	2019-12-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004968424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004960466	Spontaneous	2019-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diplopia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Miller Fisher syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vertigo (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004960466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004960529	Spontaneous	2019-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Agranulocytosis (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[AMOXICILLIN, AMOXICILLIN SODIUM, AMOXICILLIN TRIHYDRATE] (S - Infection - Drug withdrawn - [n/a - 3g - Oral])|[AMPHOTERICIN B] (S - Infection - Drug withdrawn - [n/a - 1{DF} - Oral])|[ZOLPIDEM, ZOLPIDEM TARTRATE] (S - Insomnia - Unknown - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004960529&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10004918635	Spontaneous	2019-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute polyneuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004918635&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004921639	Spontaneous	2019-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Disturbance in attention (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Performance status decreased (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Snoring (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004921639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004902341	Spontaneous	2019-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	C-reactive protein increased (n/a - Recovering/Resolving - Other Medically Important Condition);Cellulitis (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Tachycardia (n/a - Recovering/Resolving - Other Medically Important Condition);White blood cell count increased (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])...	[CLINDAMYCIN, BENZOYL PEROXIDE] (C - Acne - n/a - [n/a - n/a - Topical])|[DESOGESTREL, ETHINYLESTRADIOL] (C - Contraception - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004902341&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004887960	Spontaneous	2019-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drop attacks (n/a - Recovered/Resolved - );Pain in extremity (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004887960&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004890477	Spontaneous	2019-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004890477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10004890741	Spontaneous	2019-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Abnormal behaviour (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anger (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphemia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Euphoric mood (n/a - Unknown - Other Medically Important Condition);Eyelid ptosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fear (n/a - Unknown - Other Medically Important Condition);Grimacing (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination, auditory (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination, visual (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Inappropriate affect (n/a - Unknown - Other Medically Important Condition);Jaw disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Protrusion tongue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Stress (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	KIVEXA FILM-COATED TABLETS [ABACAVIR SULFATE, LAMIVUDINE, ABACAVIR, LAMIVUDINE] (C - HIV infection - Drug withdrawn - [n/a - n/a - Oral])|REZOLSTA [DARUNAVIR, COBICISTAT] (C - HIV infection - Dose not changed - [n/a - 1{DF} - Oral])|TRUVADA [EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE] (C - HIV infection - Dose not changed - [n/a - 1{DF} - Oral])|VIRAMUNE TABLETS [NEVIRAPINE] (C - HIV infection - Drug withdrawn - [n/a - 400mg - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALUMINIUM HYDROXIDE] (C - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[CLEMIZOLE PENICILLIN] (C - Prophylaxis - Drug withdrawn - [n/a - 2.4{DF} - Intramuscular])|[PNEUMOCOCCAL VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004890741&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004882454	Spontaneous	2019-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (22d - Recovered/Resolved - );Malaise (22d - Recovered/Resolved - );Nausea (22d - Recovered/Resolved - );Tinnitus (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004882454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Duration
EU-EC-10004863681	Spontaneous	2019-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - );Infection (n/a - Not Recovered/Not Resolved - );Lymphadenopathy (n/a - Not Recovered/Not Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004863681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004859030	Spontaneous	2019-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Chills (n/a - Unknown - );Fatigue (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004859030&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004848554	Spontaneous	2019-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Rash maculo-papular (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	ELIQUIS 5 MG FILM-COATED TABLETS [APIXABAN] (S - Atrial fibrillation - Drug withdrawn - [n/a - 5mg - Oral])|PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004848554&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004841269	Spontaneous	2019-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004841269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004825339	Spontaneous	2019-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004825339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004831060	Spontaneous	2019-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	Yes	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Foetal exposure during pregnancy (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - H1N1 influenza - Not applicable - [1d - n/a - Transplacental])	BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (C - Immunisation - n/a - [n/a - n/a - n/a])...	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004831060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10004837594	Spontaneous	2019-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oxygen saturation decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004837594&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004805757	Spontaneous	2019-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site vesicles (n/a - Not Recovered/Not Resolved - );Vaccination site warmth (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004805757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004803235	Spontaneous	2019-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004803235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004800056	Spontaneous	2019-11-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004800056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004800480	Spontaneous	2019-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Lipodystrophy acquired (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004800480&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004783807	Spontaneous	2019-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Chest pain (n/a - Not Recovered/Not Resolved - );Palpitations (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004783807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10004786435	Spontaneous	2019-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])|[HEPATITIS B SURFACE ANTIGEN, HEPATITIS A VACCINE (INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004786435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004788509	Spontaneous	2019-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain in extremity (n/a - Not Recovered/Not Resolved - );Vaccination site reaction (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004788509&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004789349	Spontaneous	2019-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lymphadenopathy (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004789349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004773466	Spontaneous	2019-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - );Asthenia (n/a - Recovered/Resolved - );C-reactive protein increased (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004773466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004768952	Spontaneous	2019-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Delayed sleep phase (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004768952&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10004769581	Spontaneous	2019-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Partial seizures (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004769581&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004769940	Spontaneous	2019-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004769940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004753722	Spontaneous	2019-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - );Vaccination site oedema (n/a - Recovered/Resolved - );Vaccination site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004753722&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004753729	Spontaneous	2019-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Somnolence (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004753729&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004761531	Spontaneous	2019-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Somnolence (0d - Recovered/Resolved - );Vaccination site pain (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004761531&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004750996	Spontaneous	2019-11-08 00:00:00	Healthcare Professional	European Economic Area	Sbidian E, Eftekahri P, Viguier M, Laroche L, Chosidow O, Gosselin P,  et al. National survey of psoriasis flares after 2009 monovalent H1 N1 / seasonal vaccines. Dermatology. 2014;229:130-135. doi:DOI: 10.1159/000362808	3-11 Years	Not Specified	No	Female	Guttate psoriasis (25mo - Recovered/Resolved - );Psoriasis (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004750996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004740811	Spontaneous	2019-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Eye swelling (n/a - Not Recovered/Not Resolved - );Pruritus (n/a - Not Recovered/Not Resolved - );Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Parenteral])	ALOGLIPTIN [ALOGLIPTIN] (C - n/a - n/a - [n/a - n/a - n/a])|[BUPROPION, BUPROPION HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[FERROUS SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004740811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004721060	Spontaneous	2019-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Radiculitis brachial (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004721060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004714318	Spontaneous	2019-11-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hyperthermia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004714318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004714319	Spontaneous	2019-11-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hyperthermia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004714319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004703830	Spontaneous	2019-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cardiac disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Diarrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperacusis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovering/Resolving - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mental disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Photophobia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin burning sensation (n/a - Recovering/Resolving - Other Medically Important Condition);Speech disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004703830&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004705534	Spontaneous	2019-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lethargy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004705534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004691804	Spontaneous	2019-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Atrial fibrillation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[LEVOTHYROXINE SODIUM] (S - Hypothyroidism - Dose not changed - [n/a - 1{DF} - Oral])	[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[DIGOXIN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ENOXAPARIN, ENOXAPARIN SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004691804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004694705	Spontaneous	2019-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - );Muscular weakness (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	[ASCORBIC ACID, MAGNESIUM OXIDE, HEAVY, MAGNESIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004694705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004701543	Spontaneous	2019-10-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Diarrhoea (n/a - Unknown - );Feeling cold (n/a - Unknown - );Injection site rash (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - Vitamin B complex deficiency - n/a - [n/a - n/a - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004701543&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004678085	Spontaneous	2019-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Abnormal behaviour (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Anger (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Breath holding (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cerebellar ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chills (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Disturbance in social behaviour (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyskinesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysstasia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (1min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Middle insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Psychomotor hyperactivity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Speech disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALUMINIUM HYDROXIDE, FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM HYDROXIDE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, ALUMINIUM HYDROXIDE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|PHOTOTHERAPY [NON-DRUG THERAPY] (C - n/a - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[LACTULOSE] (C - Constipation - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004678085&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004678544	Spontaneous	2019-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (1d - Recovered/Resolved - );Hypoaesthesia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004678544&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004679664	Spontaneous	2019-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypersensitivity (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [1d - .5mL - n/a])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[DICLOFENAC DIETHYLAMINE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[FLUCLOXACILLIN, FLUCLOXACILLIN SODIUM, FLUCLOXACILLIN SODIUM MONOHYDRATE] (C - n/a - n/a - [7d - 1{DF} - n/a])|[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004679664&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004667066	Spontaneous	2019-10-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza like illness (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004667066&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004663571	Spontaneous	2019-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Decreased appetite (n/a - Recovered/Resolved - Disabling);Dysstasia (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Lumbosacral plexopathy (n/a - Not Recovered/Not Resolved - Disabling);Muscle atrophy (n/a - Not Recovered/Not Resolved - Disabling);Muscle spasms (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nerve injury (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004663571&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10004655359	Spontaneous	2019-10-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depressed mood (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004655359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10004645392	Spontaneous	2019-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])|[B/BRISBANE/60/2008 (VICTORIA LINEAGE)-LIKE STRAIN (B/BRISBANE/60/2008, MEDI 228030), B/MASSACHUSETTS/2/2012 (YAMAGATA LINEAGE)-LIKE STRAIN (B/MASSACHUSETTS/2/2012, MEDI 237751), A/TEXAS/50/2012 (H3N2)-LIKE STRAIN (A/TEXAS/50/2012, X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327)] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004645392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10004633862	Spontaneous	2019-10-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Hypnagogic hallucination (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Sleep paralysis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	CERVARIX SUSPENSION FOR INJECTION [3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, ALGELDRATE, ALUMINIUM, 3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004633862&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10004635367	Spontaneous	2019-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004635367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10004624357	Spontaneous	2019-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004624357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004624358	Spontaneous	2019-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004624358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004601268	Spontaneous	2019-10-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Sleep attacks (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Sleep paralysis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004601268&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10004596888	Spontaneous	2019-10-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnopompic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004596888&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004596889	Spontaneous	2019-10-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004596889&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004597434	Spontaneous	2019-10-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Pruritus (n/a - Recovering/Resolving - );Rash erythematous (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004597434&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004572898	Spontaneous	2019-10-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Adverse drug reaction (n/a - Unknown - Other Medically Important Condition);Infection (n/a - Unknown - Other Medically Important Condition);Injury (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004572898&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004554220	Spontaneous	2019-10-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004554220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004544323	Spontaneous	2019-10-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site reaction (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004544323&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004546603	Spontaneous	2019-10-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004546603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004539201	Spontaneous	2019-10-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004539201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004539340	Spontaneous	2019-10-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Brain oedema (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly, Other Medically Important Condition);Cerebral haemorrhage neonatal (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly, Other Medically Important Condition);Congenital brain damage (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly, Other Medically Important Condition);Congenital hydrocephalus (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly, Other Medically Important Condition);Developmental coordination disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly, Other Medically Important Condition);Foetal exposure during pregnancy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly, Other Medically Important Condition);Neurodevelopmental disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) [A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - Not applicable - [n/a - n/a - Transplacental])	[IBUPROFEN, IBUPROFEN PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004539340&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10004534986	Spontaneous	2019-10-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Unknown - );Peripheral swelling (n/a - Unknown - );Vaccination site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004534986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004509874	Spontaneous	2019-10-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004509874&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10004483840	Spontaneous	2019-09-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004483840&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10004486783	Spontaneous	2019-09-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vascular purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004486783&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004417041	Spontaneous	2019-09-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Depressed mood (1wk - Recovered/Resolved - );Nasopharyngitis (1wk - Recovered/Resolved - );Rash (1wk - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004417041&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004417149	Spontaneous	2019-09-18 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Abnormal behaviour (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cognitive disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Decreased activity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depressed level of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Encephalitis post immunisation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Feeding tube user (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hospitalisation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypokinesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mood altered (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nystagmus (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004417149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004403695	Spontaneous	2019-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004403695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004404017	Spontaneous	2019-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004404017&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004378785	Spontaneous	2019-09-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Bronchitis (n/a - Unknown - Disabling);Decreased immune responsiveness (n/a - Unknown - Disabling);Diplegia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Disabling);Gait disturbance (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (n/a - Unknown - Disabling);Knee deformity (n/a - Unknown - Disabling);Learning disorder (n/a - Unknown - Disabling);Mobility decreased (n/a - Recovered/Resolved With Sequelae - Disabling);Myalgia (n/a - Recovered/Resolved With Sequelae - Disabling);Pain in extremity (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Unknown - Disabling);Renal disorder (n/a - Unknown - Disabling);Tendon disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Urinary tract infection (n/a - Unknown - Disabling)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004378785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004358976	Spontaneous	2019-09-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004358976&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004320610	Spontaneous	2019-09-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004320610&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004324585	Spontaneous	2019-09-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004324585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004324664	Spontaneous	2019-09-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004324664&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004324831	Spontaneous	2019-09-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004324831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004307088	Spontaneous	2019-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004307088&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004311321	Spontaneous	2019-09-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blood glucose abnormal (n/a - Unknown - Other Medically Important Condition);Drug ineffective (n/a - Unknown - Other Medically Important Condition);Haematocrit abnormal (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Lymphocyte count abnormal (n/a - Unknown - Other Medically Important Condition);Product complaint (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004311321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004295341	Spontaneous	2019-09-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (12d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004295341&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004298215	Spontaneous	2019-09-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Rhinitis (n/a - Unknown - Disabling, Other Medically Important Condition);Vestibular neuronitis (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Influenza immunisation - Dose not changed - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004298215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10004288256	Spontaneous	2019-09-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004288256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004247920	Spontaneous	2019-08-27 00:00:00	Healthcare Professional	European Economic Area	Gocko X, Poulteau S, Beyens M-N, Bertholon P, Pozzetto B. Case report: Recurrent peripheral facial paralysis following two influenza vaccinations in 2009 and 2016. Vaccine 2019;37(35):4864-4866.	18-64 Years	Not Specified	No	Female	Facial paralysis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004247920&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004239946	Spontaneous	2019-08-26 00:00:00	Healthcare Professional	European Economic Area	Gocko X, Poulteau S, Beyens M-N, Bertholon P, Pozzetto B. Case report: Recurrent peripheral facial paralysis following two influenza vaccinations in 2009 and 2016. Vaccine 2019;37(35):4864-4866.	65-85 Years	Not Specified	No	Female	Facial paralysis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004239946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10004217073	Spontaneous	2019-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Sarcoma (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - n/a])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - n/a - n/a - [n/a - n/a - n/a])|[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED, ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALGELDRATE, HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALUMINIUM HYDROXIDE] (S - n/a - n/a - [n/a - n/a - n/a])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004217073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004213688	Spontaneous	2019-08-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004213688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004195307	Spontaneous	2019-08-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Unknown - [n/a - n/a - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004195307&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004188331	Spontaneous	2019-08-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004188331&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10004175793	Spontaneous	2019-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004175793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10004177385	Spontaneous	2019-08-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Nerve injury (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain of skin (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Skin burning sensation (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	SHINGRIX [RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E, STIMULON, 3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	INVOKANA [CANAGLIFLOZIN] (C - n/a - n/a - [n/a - n/a - Unknown])|SEMAGLUTIDE [SEMAGLUTIDE] (C - n/a - n/a - [n/a - n/a - Subcutaneous])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - n/a - [n/a - n/a - Unknown])|[PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - Unknown])|[PHENYTOIN, PHENYTOIN SODIUM] (C - n/a - n/a - [n/a - n/a - Unknown])|[ROSUVASTATIN CALCIUM] (C - Blood pressure management - n/a - [n/a - n/a - Unknown])|[SULFAMETHOXAZOLE] (C - Diabetes mellitus - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004177385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10004171608	Spontaneous	2019-08-13 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cervicobrachial syndrome (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004171608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10004155605	Spontaneous	2019-08-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Lymphadenopathy (n/a - Recovered/Resolved - );Lymphoedema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subconjunctival])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004155605&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004140666	Spontaneous	2019-08-08 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypersomnia-bulimia syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004140666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10004124226	Spontaneous	2019-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Diplopia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Eating disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperphagia (n/a - Not Recovered/Not Resolved - Disabling);Irritability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Neutropenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Oedema (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Protrusion tongue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[STREPTOCOCCUS, HAEMOPHILUS INFLUENZAE, KLEBSIELLA PNEUMONIAE, STAPHYLOCOCCUS AUREUS, STREPTOCOCCUS PNEUMONIAE, STAPHYLOCOCCUS ALBUS, MORAXELLA CATARRHALIS] (C - Product used for unknown indication - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004124226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004084613	Spontaneous	2019-07-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 2{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004084613&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004078134	Spontaneous	2019-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Atopy (n/a - Unknown - Other Medically Important Condition);Blood immunoglobulin E increased (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Educational problem (n/a - Unknown - Other Medically Important Condition);Euphoric mood (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Gastrointestinal disorder (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Infection (n/a - Unknown - Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Respiratory disorder (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Urinary incontinence (n/a - Unknown - Other Medically Important Condition);Urinary tract disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a - More in ICSR])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004078134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004079768	Spontaneous	2019-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Axillary pain (15d - Recovered/Resolved - );Headache (8d - Recovered/Resolved - );Pain (15d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004079768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10004067142	Spontaneous	2019-07-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysuria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Micturition urgency (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myofascitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Photophobia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Small fibre neuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[ALUMINIUM, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM HYDROXIDE [PRODUCED IN S. CEREVISIAE (STRAIN 2150-2-3) BY RDNA], HEPATITIS B SURFACE ANTIGEN (RDNA), HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM HYDROXIDE [PRODUCED IN S. CEREVISIAE (STRAIN 2150-2-3) BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN, ALGELDRATE, HEPATITIS B VIRUS SURFACE ANTIGEN [PRODUCED IN S. CEREVISIAE CELLS BY RDNA] ADSORBED ON ALUMINUM HYDROXIDE, HYDRATED, ALGELDRATE] (S - Hepatitis B immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004067142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004043201	Spontaneous	2019-07-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cardiac arrest (1d - Fatal - Results in Death);Respiratory failure (1d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004043201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10004033050	Spontaneous	2019-07-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute myocardial infarction (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004033050&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10004035756	Spontaneous	2019-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004035756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10004023002	Spontaneous	2019-07-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .25mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10004023002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003995140	Spontaneous	2019-07-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003995140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003995860	Spontaneous	2019-07-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Presyncope (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003995860&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003995862	Spontaneous	2019-07-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003995862&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003986863	Spontaneous	2019-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003986863&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003943444	Spontaneous	2019-07-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tendonitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003943444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003887047	Spontaneous	2019-06-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dissociation (n/a - Recovering/Resolving - );Orthostatic hypotension (n/a - Recovering/Resolving - );Syncope (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003887047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10003863670	Spontaneous	2019-06-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Sensory disturbance (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003863670&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003848678	Spontaneous	2019-06-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Petit mal epilepsy (n/a - Unknown - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003848678&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003834357	Spontaneous	2019-06-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003834357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003837125	Spontaneous	2019-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003837125&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10003814782	Spontaneous	2019-06-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthritis reactive (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Peripheral swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003814782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003795140	Spontaneous	2019-06-13 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Elderly	No	Male	Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003795140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003755707	Spontaneous	2019-06-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (4mo - Recovered/Resolved - );Diarrhoea (4mo - Recovered/Resolved - );Faeces soft (4mo - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003755707&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003744698	Spontaneous	2019-06-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Chills (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Peripheral coldness (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003744698&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10003726654	Spontaneous	2019-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003726654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003719929	Spontaneous	2019-05-31 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Aphasia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Asthenia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Condition aggravated (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Heart rate increased (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Joint swelling (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Laryngeal oedema (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Speech sound disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Urticaria (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Wheezing (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	HYDROCORTISONE [HYDROCORTISONE, HYDROCORTISONE SODIUM SUCCINATE] (S - Hypersensitivity - Dose not changed - [n/a - n/a - Intravenous (not otherwise specified)])|HYDROCORTISONE [HYDROCORTISONE, HYDROCORTISONE SODIUM SUCCINATE] (S - Laryngeal oedema - Dose not changed - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])|[AMOXICILLIN, AMOXICILLIN TRIHYDRATE] (S - Hospitalisation - Dose not changed - [n/a - n/a - n/a])|[AMOXICILLIN, AMOXICILLIN TRIHYDRATE] (S - Hypersensitivity - Dose not changed - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003719929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10003707743	Spontaneous	2019-05-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Developmental coordination disorder (5a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Ear infection (n/a - Unknown - );Sleep apnoea syndrome (n/a - Unknown - );Syncope (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003707743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10003714633	Spontaneous	2019-05-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003714633&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003700625	Spontaneous	2019-05-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Alanine aminotransferase increased (n/a - Recovering/Resolving - Other Medically Important Condition);Aspartate aminotransferase increased (n/a - Recovering/Resolving - Other Medically Important Condition);Autoimmune hepatitis (n/a - Recovering/Resolving - Other Medically Important Condition);Blood alkaline phosphatase increased (n/a - Recovering/Resolving - Other Medically Important Condition);Gamma-glutamyltransferase increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hepatitis (n/a - Recovering/Resolving - Other Medically Important Condition)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])...	[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - Dose not changed - [n/a - 100mg - Oral])|[COLECALCIFEROL] (C - Product used for unknown indication - Not applicable - [n/a - 1000[iU] - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003700625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003701719	Spontaneous	2019-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003701719&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003692576	Spontaneous	2019-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Asthenopia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Protrusion tongue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003692576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003686794	Spontaneous	2019-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (n/a - Recovered/Resolved With Sequelae - Life Threatening);Pruritus (n/a - Recovered/Resolved With Sequelae - Life Threatening);Rash (n/a - Recovered/Resolved With Sequelae - Life Threatening);Urticaria (n/a - Recovered/Resolved With Sequelae - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003686794&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10003680210	Spontaneous	2019-05-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003680210&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003680220	Spontaneous	2019-05-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myocarditis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003680220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003681008	Spontaneous	2019-05-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myopericarditis (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [1min - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003681008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10003666254	Spontaneous	2019-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003666254&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003669473	Spontaneous	2019-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003669473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003655173	Spontaneous	2019-05-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Brain neoplasm (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003655173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003657817	Spontaneous	2019-05-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	Yes	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Pneumonia influenzal (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003657817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003644859	Spontaneous	2019-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Nasopharyngitis (n/a - Recovered/Resolved - );Purpura (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - );Skin disorder (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Unknown - [n/a - 1mL - Subcutaneous])|[HYDROCHLOROTHIAZIDE] (S - Hypertension - Drug withdrawn - [n/a - n/a - Unknown])	[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE, BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE DIHYDRATE PH.EUR., BECLOMETHASONE DIPROPIONATE PH. EUR., FORMOTEROL FUMARATE DIHYDRATE, BECLOMETASONE DIPROPIONATE ANHYDROUS] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[CANDESARTAN] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[PHLEUM PRATENSE, PHLEUM PRATENSE (225)] (C - Seasonal allergy - Unknown - [n/a - 1{DF} - Sublingual])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003644859&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003648917	Spontaneous	2019-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003648917&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003637466	Spontaneous	2019-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003637466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003626508	Spontaneous	2019-05-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003626508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003626621	Spontaneous	2019-05-17 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drug ineffective (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1mL - Intramuscular])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[MONTELUKAST] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003626621&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003626691	Spontaneous	2019-05-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Paraesthesia (n/a - Recovered/Resolved - );Vaccination site erythema (3d - Recovered/Resolved - );Vaccination site pruritus (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003626691&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003628814	Spontaneous	2019-05-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003628814&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003615705	Spontaneous	2019-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003615705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003608518	Spontaneous	2019-05-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003608518&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003608906	Spontaneous	2019-05-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003608906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003612811	Spontaneous	2019-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnambulism (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003612811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003587912	Spontaneous	2019-05-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Peroneal nerve palsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	[CYANOCOBALAMIN] (C - Vitamin B12 deficiency - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003587912&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003590225	Spontaneous	2019-05-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Generalised tonic-clonic seizure (n/a - Unknown - Caused/Prolonged Hospitalisation);Product complaint (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	[METHYLPHENIDATE HYDROCHLORIDE] (C - Attention deficit hyperactivity disorder - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003590225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003568006	Spontaneous	2019-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	No	Male	Foetal death (n/a - Fatal - Results in Death);Foetal exposure during pregnancy (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003568006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10003568167	Spontaneous	2019-05-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Abdominal distension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Amyotrophy (n/a - Unknown - Caused/Prolonged Hospitalisation);Autoimmune haemolytic anaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Autoinflammatory disease (n/a - Unknown - Caused/Prolonged Hospitalisation);Bronchial hyperreactivity (n/a - Unknown - Caused/Prolonged Hospitalisation);Cardiac murmur (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dehydration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dry mouth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Frequent bowel movements (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gastrointestinal motility disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hepatic cytolysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Infectious pleural effusion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasal congestion (n/a - Unknown - Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Psychomotor retardation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash erythematous (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Viral infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003568167&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003570652	Spontaneous	2019-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003570652&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003570959	Spontaneous	2019-05-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - );Narcolepsy (n/a - Recovered/Resolved With Sequelae - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003570959&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10003571216	Spontaneous	2019-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Adverse reaction (n/a - Unknown - );Nasopharyngitis (n/a - Recovered/Resolved - );Purpura (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - );Skin disorder (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - 1mL - Subcutaneous])|[HYDROCHLOROTHIAZIDE] (S - Hypertension - n/a - [n/a - n/a - n/a])	[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE, BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - )|[CANDESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[PHLEUM PRATENSE] (C - Seasonal allergy - n/a - [n/a - 1{DF} - Sublingual])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003571216&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003572282	Spontaneous	2019-05-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003572282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003572284	Spontaneous	2019-05-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003572284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003572737	Spontaneous	2019-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disorientation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Motor dysfunction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular - More in ICSR])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003572737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003558621	Spontaneous	2019-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Asthenopia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Protrusion tongue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003558621&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003558858	Spontaneous	2019-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003558858&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003561060	Spontaneous	2019-05-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003561060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003561444	Spontaneous	2019-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Feeling abnormal (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003561444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003562846	Spontaneous	2019-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003562846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10003563465	Spontaneous	2019-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Aggression (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Depressed mood (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Mental disorder (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003563465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003541347	Spontaneous	2019-05-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthritis reactive (n/a - Unknown - Disabling, Other Medically Important Condition);Chronic idiopathic pain syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003541347&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10003544738	Spontaneous	2019-05-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Blood pressure increased (n/a - Recovering/Resolving - Other Medically Important Condition);Chest discomfort (n/a - Recovering/Resolving - Other Medically Important Condition);Dizziness (n/a - Recovering/Resolving - Other Medically Important Condition);Vertigo (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	ELIQUIS [APIXABAN] (C - n/a - n/a - )|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003544738&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003545952	Spontaneous	2019-05-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Recovering/Resolving - Life Threatening);Dehydration (n/a - Recovering/Resolving - Life Threatening);Diarrhoea (n/a - Recovering/Resolving - Life Threatening);Hot flush (n/a - Recovering/Resolving - Life Threatening);Hypoaesthesia (n/a - Recovering/Resolving - Life Threatening);Pharyngeal oedema (n/a - Recovering/Resolving - Life Threatening);Pyrexia (n/a - Recovering/Resolving - Life Threatening);Rash (n/a - Recovering/Resolving - Life Threatening);Rhinorrhoea (n/a - Recovering/Resolving - Life Threatening);Weight decreased (n/a - Recovering/Resolving - Life Threatening);White blood cell count increased (n/a - Recovering/Resolving - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[CORTISONE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003545952&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10003532954	Spontaneous	2019-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003532954&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003537075	Spontaneous	2019-05-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Back pain (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site swelling (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])|[PNEUMOCOCCAL CONJUGATE VACCINE] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[ANHYDROUS LEVOTHYROXINE SODIUM, LEVOTHYROXINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS EP] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003537075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003524253	Spontaneous	2019-05-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003524253&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003529052	Spontaneous	2019-05-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Injection site erythema (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Injection site swelling (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003529052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10003520513	Spontaneous	2019-05-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003520513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003522387	Spontaneous	2019-05-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003522387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003511557	Spontaneous	2019-04-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003511557&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003495950	Spontaneous	2019-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Lymphangitis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	[BUPROPION, BUPROPION HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[NEBIVOLOL] (C - n/a - n/a - [n/a - .5{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003495950&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003496123	Spontaneous	2019-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disorientation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eyelid ptosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ill-defined disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Irritability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mental impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myoclonus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Screaming (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 3.75ug - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003496123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10003496413	Spontaneous	2019-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Decreased interest (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Personality change (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003496413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003483248	Spontaneous	2019-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Lip swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Oral pruritus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003483248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003485596	Spontaneous	2019-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - );Hyperhidrosis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, ACETYLSALICYLIC ACID, BISOPROLOL HEMIFUMARATE] (C - Hypertension - n/a - [n/a - 5mg - Oral])|[RAMIPRIL] (C - Hypertension - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003485596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003485602	Spontaneous	2019-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - );Hyperhidrosis (n/a - Not Recovered/Not Resolved - );Vaccination site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003485602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003476002	Spontaneous	2019-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep paralysis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnambulism (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003476002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003465487	Spontaneous	2019-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Male	Pruritus (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003465487&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003470762	Spontaneous	2019-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Rash pruritic (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003470762&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003461582	Spontaneous	2019-04-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	H1N1 influenza (n/a - Unknown - Disabling);Influenza like illness (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003461582&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10003457136	Spontaneous	2019-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site inflammation (n/a - Recovered/Resolved - );Rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003457136&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003457141	Spontaneous	2019-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003457141&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003449811	Spontaneous	2019-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003449811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003449816	Spontaneous	2019-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypoglycaemia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003449816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003449819	Spontaneous	2019-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003449819&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003449824	Spontaneous	2019-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003449824&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003446759	Spontaneous	2019-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003446759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003433519	Spontaneous	2019-04-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (6d - Recovered/Resolved - );Dizziness (0d - Recovered/Resolved - );Headache (7d - Recovered/Resolved - );Hyperhidrosis (n/a - Recovered/Resolved - );Hypersensitivity (9a - Recovering/Resolving - );Limb discomfort (7d - Recovered/Resolved - );Local reaction (n/a - Recovered/Resolved - );Muscle spasms (22d - Recovered/Resolved - );Nail bed inflammation (5a - Recovered/Resolved - );Neurodermatitis (n/a - Recovered/Resolved - );Seasonal allergy (9a - Recovering/Resolving - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	[DERMATOPHAGOIDES PTERONYSSINUS, DEPIGMENTED/POLYMERIZED EXTRACT, DERMATOPHAGOIDES FARINAE, DEPIGMENTED/POLYMERIZED EXTRACT] (C - Mite allergy - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003433519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10003436145	Spontaneous	2019-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003436145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003423901	Spontaneous	2019-04-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Diplopia (6a - Recovered/Resolved - );Dysarthria (6a - Recovered/Resolved - );Dysphagia (6a - Recovered/Resolved - );Influenza like illness (6a - Recovered/Resolved - );Muscular weakness (6a - Recovered/Resolved - );Myasthenia gravis (6a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003423901&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10003414877	Spontaneous	2019-04-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Abdominal distension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Amyotrophy (n/a - Unknown - Caused/Prolonged Hospitalisation);Autoimmune haemolytic anaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Autoinflammatory disease (n/a - Unknown - Caused/Prolonged Hospitalisation);Bronchial hyperreactivity (n/a - Unknown - Caused/Prolonged Hospitalisation);Cardiac murmur (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dehydration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dry mouth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Frequent bowel movements (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gastrointestinal motility disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hepatic cytolysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Infectious pleural effusion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasal congestion (n/a - Unknown - Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Psychomotor retardation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash erythematous (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Viral infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003414877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003415554	Spontaneous	2019-04-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Back pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Movement disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003415554&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003416121	Spontaneous	2019-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arrhythmia (n/a - Not Recovered/Not Resolved - Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - n/a - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003416121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10003403852	Spontaneous	2019-04-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Unknown - Disabling);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003403852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10003403873	Spontaneous	2019-04-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza - Not applicable - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003403873&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003396244	Spontaneous	2019-04-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003396244&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003396827	Spontaneous	2019-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003396827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003386338	Spontaneous	2019-04-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Unknown - );Pyrexia (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003386338&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003386623	Spontaneous	2019-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003386623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003366970	Spontaneous	2019-04-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hallucination (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Motor dysfunction (n/a - Not Recovered/Not Resolved - Disabling);Speech disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003366970&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10003370724	Spontaneous	2019-04-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Back pain (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myalgia (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Dose not changed - [n/a - n/a - Intramuscular])	[THIAMINE HYDROCHLORIDE, RETINOL] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003370724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10003372786	Spontaneous	2019-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Rheumatoid arthritis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003372786&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003363764	Spontaneous	2019-04-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Administration site haematoma (n/a - Recovered/Resolved - );Administration site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003363764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003358428	Spontaneous	2019-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Eyelid ptosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003358428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003358620	Spontaneous	2019-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .25mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003358620&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003349914	Spontaneous	2019-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Aggression (n/a - Unknown - Disabling, Other Medically Important Condition);Behaviour disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Breathing-related sleep disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Cataplexy (n/a - Unknown - Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Dreamy state (n/a - Unknown - Disabling, Other Medically Important Condition);Hallucination (n/a - Unknown - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Disabling, Other Medically Important Condition);Increased appetite (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Disabling, Other Medically Important Condition);Psychological trauma (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep attacks (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Disabling, Other Medically Important Condition);Weight increased (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003349914&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10003350196	Spontaneous	2019-04-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hallucination, tactile (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Neurological symptom (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003350196&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10003330695	Spontaneous	2019-04-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (n/a - Not Recovered/Not Resolved - );Vomiting (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [1d - 1{DF} - Intramuscular])	NOT AVAILABLE (C - Atrial fibrillation - n/a - [n/a - 80mg - Oral])|[PAROXETINE] (C - n/a - n/a - [n/a - 30mg - Oral])|[QUETIAPINE FUMARATE] (C - n/a - n/a - [n/a - 200mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003330695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003334957	Spontaneous	2019-04-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Malaise (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 20mg - Oral])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - Anticoagulant therapy - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003334957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10003322198	Spontaneous	2019-04-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	Yes	Male	Antiphospholipid antibodies positive (n/a - Unknown - );Immune thrombocytopenia (n/a - Not Recovered/Not Resolved - );Maternal exposure during pregnancy (n/a - Unknown - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 2{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003322198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10003323520	Spontaneous	2019-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003323520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003310436	Spontaneous	2019-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003310436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003312185	Spontaneous	2019-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003312185&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003302158	Spontaneous	2019-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003302158&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003303057	Spontaneous	2019-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003303057&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003290863	Spontaneous	2019-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Mouth haemorrhage (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003290863&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10003294788	Spontaneous	2019-03-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003294788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003294825	Spontaneous	2019-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003294825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10003294951	Spontaneous	2019-03-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Not Recovered/Not Resolved - Disabling);Limb mass (n/a - Not Recovered/Not Resolved - Disabling);Rash erythematous (n/a - Not Recovered/Not Resolved - Disabling);Sarcoidosis (n/a - Not Recovered/Not Resolved - Disabling);Secondary immunodeficiency (n/a - Not Recovered/Not Resolved - Disabling);Sjogren's syndrome (n/a - Not Recovered/Not Resolved - Disabling);Vaccination site rash (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003294951&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10003265569	Spontaneous	2019-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003265569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003266059	Spontaneous	2019-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Bursitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Synovitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003266059&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003255104	Spontaneous	2019-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cold sweat (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003255104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003255255	Spontaneous	2019-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Immune thrombocytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	NPLATE [ROMIPLOSTIM] (C - Thrombocytopenic purpura - n/a - [n/a - n/a - Subcutaneous])|PRADAXA [DABIGATRAN ETEXILATE, DABIGATRAN ETEXILATE MESILATE] (C - Thrombosis prophylaxis - n/a - [n/a - 150mg - Oral])|[ALFUZOSIN] (C - Dysuria - n/a - [n/a - 10mg - Oral])|[BUPROPION, BUPROPION HYDROCHLORIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - Oral])|[ENALAPRIL, ENALAPRIL MALEATE] (C - Hypertension - n/a - [n/a - 20mg - Oral])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 40mg - Oral])|[TRAMADOL HYDROCHLORIDE] (C - Pain - n/a - [n/a - 50mg - Oral])|[ZOPICLONE] (C - Insomnia - n/a - [n/a - 3.75mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003255255&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003236804	Spontaneous	2019-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Injection site erythema (3d - Recovered/Resolved - );Injection site pruritus (4d - Recovered/Resolved - );Vaccination complication (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003236804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003219548	Spontaneous	2019-03-15 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cardiac murmur (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Drug ineffective (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [n/a - .5mL - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003219548&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003222687	Spontaneous	2019-03-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003222687&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003213376	Spontaneous	2019-03-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Behaviour disorder (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003213376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003198677	Spontaneous	2019-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Tachycardia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003198677&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10003199081	Spontaneous	2019-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003199081&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003199086	Spontaneous	2019-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003199086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003199089	Spontaneous	2019-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003199089&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003199847	Spontaneous	2019-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003199847&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003200272	Spontaneous	2019-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Purpura (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003200272&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003200710	Spontaneous	2019-03-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003200710&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10003200771	Spontaneous	2019-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Urticaria (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003200771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003203834	Spontaneous	2019-03-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Unknown - );Chills (n/a - Recovered/Resolved - );Fatigue (n/a - Unknown - );Myalgia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [0d - 1{DF} - Intramuscular])	[ATORVASTATIN] (C - Hypercholesterolaemia - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003203834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003204903	Spontaneous	2019-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Iridocyclitis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Dose not changed - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003204903&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003205325	Spontaneous	2019-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Mouth swelling (n/a - Recovered/Resolved - );Swollen tongue (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003205325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003187096	Spontaneous	2019-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Subcutaneous])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE, LYSINE ASPIRIN, LYSINE, ACETYLSALICYLIC ACID] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[FLECAINIDE ACETATE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[FLUINDIONE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[METHYCLOTHIAZIDE, TRIAMTERENE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003187096&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003191218	Spontaneous	2019-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Behaviour disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Psychotic disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003191218&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003169415	Spontaneous	2019-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Erythema (3d - Recovered/Resolved - );Localised oedema (3d - Recovered/Resolved - );Pain (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[ENALAPRIL MALEATE, ENALAPRILAT] (C - n/a - Unknown - )|[NICERGOLINE] (C - n/a - Unknown - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003169415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003172474	Spontaneous	2019-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Subcutaneous])	[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - )|[PHENPROCOUMON] (C - n/a - n/a - )|[RAMIPRIL] (C - n/a - n/a - )|[SPIRONOLACTONE] (C - n/a - n/a - )|[TORASEMIDE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003172474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003173188	Spontaneous	2019-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Dysphagia (n/a - Not Recovered/Not Resolved - );Oedema genital (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[AMLODIPINE, AMLODIPINE BESILATE] (C - Essential hypertension - n/a - [n/a - n/a - Oral])|[HYDROCHLOROTHIAZIDE, LISINOPRIL, LISINOPRIL DIHYDRATE, HYDROCHLOROTHIAZIDE] (C - Prostatitis - n/a - [n/a - n/a - Oral])|[TAMSULOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - .4mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003173188&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003162053	Spontaneous	2019-03-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaemia (2wk - Not Recovered/Not Resolved - );Asthma (n/a - Recovered/Resolved - );Bronchial hyperreactivity (n/a - Recovered/Resolved - );Bronchitis (n/a - Recovered/Resolved - );Cough (n/a - Recovered/Resolved - );Dysphagia (2wk - Recovered/Resolved - );Fatigue (2wk - Not Recovered/Not Resolved - );Nasopharyngitis (2wk - Recovered/Resolved - );Sinusitis (2wk - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALUMINIUM HYDROXIDE] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003162053&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003091269	Spontaneous	2019-02-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Recovering/Resolving - );Diarrhoea (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003091269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003091280	Spontaneous	2019-02-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Nasal congestion (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Unknown - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003091280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003095644	Spontaneous	2019-02-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (2d - Recovered/Resolved - );Fatigue (2d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 25ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003095644&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003079596	Spontaneous	2019-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dysaesthesia (n/a - Not Recovered/Not Resolved - Life Threatening);Polyneuropathy (n/a - Not Recovered/Not Resolved - Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003079596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10003084252	Spontaneous	2019-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Deafness transitory (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003084252&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10003071274	Spontaneous	2019-02-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Aphonia (n/a - Recovered/Resolved - );Cough (n/a - Recovered/Resolved - );Drug ineffective (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Influenza A virus test positive (n/a - Recovered/Resolved - );Oropharyngeal pain (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [0d - 1{DF} - Unknown])	HUMIRA [ADALIMUMAB] (C - Uveitis - n/a - [n/a - 1{DF} - Subcutaneous])|[FOLIC ACID] (C - Prophylaxis - n/a - [n/a - 1{DF} - Oral])|[METHOTREXATE] (C - Juvenile idiopathic arthritis - n/a - [n/a - 25mg - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003071274&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003048263	Spontaneous	2019-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003048263&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003028257	Spontaneous	2019-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - Disabling);Joint stiffness (n/a - Recovering/Resolving - Disabling);Lyme disease (n/a - Recovering/Resolving - Disabling);Muscle spasms (n/a - Recovering/Resolving - Disabling);Myalgia (n/a - Recovering/Resolving - Disabling);Pain in extremity (n/a - Recovering/Resolving - Disabling);Pruritus (n/a - Recovering/Resolving - Disabling);Pyrexia (n/a - Recovering/Resolving - Disabling);Rash (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[DYDROGESTERONE, ESTRADIOL, DYDROGESTERONE, ESTRADIOL HEMIHYDRATE, ESTRADIOL, ESTRADIOL HEMIHYDRATE] (C - Menopausal symptoms - n/a - [n/a - n/a - Oral])|[MESALAZINE] (C - Colitis - n/a - [n/a - n/a - Rectal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003028257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10003020150	Spontaneous	2019-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003020150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10003022707	Spontaneous	2019-02-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Nerve injury (n/a - Unknown - Disabling, Other Medically Important Condition);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain of skin (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Rash (n/a - Unknown - Disabling, Other Medically Important Condition);Skin burning sensation (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	SHINGRIX [RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E, STIMULON, 3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	INVOKANA [CANAGLIFLOZIN] (C - n/a - n/a - [n/a - n/a - n/a])|OZEMPIC [SEMAGLUTIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PHENYTOIN, PHENYTOIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Blood pressure measurement - n/a - [n/a - n/a - n/a])|[SULFAMETHOXAZOLE] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003022707&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10003025553	Spontaneous	2019-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Neck pain (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003025553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10003003214	Spontaneous	2019-02-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Eye swelling (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Feeling cold (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neck pain (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vaccination site pain (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vaccination site swelling (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003003214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10003008362	Spontaneous	2019-02-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10003008362&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002988546	Spontaneous	2019-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002988546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002980436	Spontaneous	2019-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002980436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002983048	Spontaneous	2019-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Blood pressure decreased (n/a - Unknown - );Cough (n/a - Unknown - );Oropharyngeal pain (n/a - Unknown - );Pallor (n/a - Unknown - );Throat irritation (n/a - Unknown - );Vaccination site urticaria (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[METHYLPHENIDATE HYDROCHLORIDE] (C - Attention deficit hyperactivity disorder - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002983048&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002983492	Spontaneous	2019-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002983492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002987537	Spontaneous	2019-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002987537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002987541	Spontaneous	2019-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])|[ALUMINIUM HYDROXYPHOSPHATE SULFATE, HEPATITIS A VIRUS (STRAIN CR 326F) (INACTIVATED) PRODUCED ON HUMAN DIPLOID (MRC–5) FIBROBLAST CELLS ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, ALUMINIUM, HEPATITIS A VIRUS (STRAIN CR 326F) (INACTIVATED) PRODUCED ON HUMAN DIPLOID (MRC–5) FIBROBLAST CELLS ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HEPATITIS A VACCINE (INACTIVATED, ADSORBED), HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS ANTIGEN (INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002987541&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002987548	Spontaneous	2019-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site reaction (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002987548&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002987714	Spontaneous	2019-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002987714&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002987717	Spontaneous	2019-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002987717&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002975109	Spontaneous	2019-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Herpes zoster (13d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002975109&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002978274	Spontaneous	2019-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Localised oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002978274&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002978369	Spontaneous	2019-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002978369&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002964389	Spontaneous	2019-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnopompic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002964389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002964397	Spontaneous	2019-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral - More in ICSR])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002964397&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002964398	Spontaneous	2019-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002964398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002964401	Spontaneous	2019-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002964401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002964402	Spontaneous	2019-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002964402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002964403	Spontaneous	2019-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002964403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002964405	Spontaneous	2019-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002964405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002965225	Spontaneous	2019-02-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002965225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002967029	Spontaneous	2019-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular - More in ICSR])	[ANHYDROUS LEVOTHYROXINE SODIUM, LEVOTHYROXINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS EP] (C - Hypothyroidism - Not applicable - [n/a - 75ug - Oral])|[SODIUM VALPROATE] (C - Epilepsy - n/a - [2mo - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002967029&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002954570	Spontaneous	2019-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002954570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002937864	Spontaneous	2019-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dry eye (n/a - Not Recovered/Not Resolved - );Dysphonia (n/a - Not Recovered/Not Resolved - );Erythema (n/a - Not Recovered/Not Resolved - );Influenza like illness (n/a - Not Recovered/Not Resolved - );Paraesthesia (n/a - Not Recovered/Not Resolved - );Sneezing (n/a - Not Recovered/Not Resolved - );Throat irritation (n/a - Not Recovered/Not Resolved - );Vaccination site haematoma (n/a - Not Recovered/Not Resolved - );Visual impairment (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002937864&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002940002	Spontaneous	2019-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002940002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002941574	Spontaneous	2019-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Upper respiratory tract infection (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002941574&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002942453	Spontaneous	2019-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002942453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002932006	Spontaneous	2019-01-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abnormal dreams (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Daydreaming (n/a - Unknown - Other Medically Important Condition);Depressed mood (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysarthria (n/a - Unknown - Other Medically Important Condition);Eyelid disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination, auditory (n/a - Unknown - Other Medically Important Condition);Hallucination, tactile (n/a - Unknown - Other Medically Important Condition);Hallucination, visual (n/a - Unknown - );Jaw disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Movement disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Protrusion tongue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Suicidal ideation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Trance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002932006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002933638	Spontaneous	2019-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Vaccination failure (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002933638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002934922	Spontaneous	2019-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoaesthesia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002934922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002921815	Spontaneous	2019-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Arthropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a - More in ICSR])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002921815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002923920	Spontaneous	2019-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002923920&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002924736	Spontaneous	2019-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Vaccination failure (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002924736&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002925214	Spontaneous	2019-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002925214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002927406	Spontaneous	2019-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Seizure (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - Oral])|[CITALOPRAM HYDROBROMIDE] (C - n/a - n/a - [n/a - 40mg - Oral])|[PRAZEPAM] (C - n/a - n/a - [n/a - n/a - Oral])|[TRAMADOL HYDROCHLORIDE, PARACETAMOL] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002927406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002912719	Spontaneous	2019-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002912719&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002912842	Spontaneous	2019-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anger (n/a - Unknown - Other Medically Important Condition);Asocial behaviour (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Decreased activity (n/a - Unknown - Other Medically Important Condition);Depressed mood (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002912842&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002912886	Spontaneous	2019-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chest discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Epistaxis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperhomocysteinaemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Loss of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Photopsia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Speech disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002912886&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002913082	Spontaneous	2019-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002913082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002919288	Spontaneous	2019-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination complication (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002919288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002919451	Spontaneous	2019-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pruritus (2d - Recovered/Resolved - Other Medically Important Condition);Rash (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002919451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002903480	Spontaneous	2019-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain upper (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperventilation (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash pruritic (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Throat irritation (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002903480&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002904881	Spontaneous	2019-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lethargy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Parasomnia (n/a - Unknown - Other Medically Important Condition);Sleep attacks (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .25mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002904881&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002898956	Spontaneous	2019-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002898956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002885752	Spontaneous	2019-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (36d - Recovered/Resolved - );Pain in extremity (36d - Recovered/Resolved - );Tremor (36d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002885752&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002887263	Spontaneous	2019-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypersomnia (n/a - Unknown - );Somnolence (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002887263&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002880693	Spontaneous	2019-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved With Sequelae - );Influenza like illness (n/a - Recovered/Resolved With Sequelae - );Musculoskeletal stiffness (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002880693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10002883570	Spontaneous	2019-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Motor dysfunction (n/a - Not Recovered/Not Resolved - Disabling);Multiple sclerosis relapse (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002883570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10002872468	Spontaneous	2019-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Vaccination site pain (n/a - Not Recovered/Not Resolved - );Vaccination site swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002872468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002857029	Spontaneous	2019-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002857029&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10002866542	Spontaneous	2019-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (6d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	STELARA [USTEKINUMAB] (S - Psoriasis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002866542&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002856656	Spontaneous	2019-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002856656&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002843607	Spontaneous	2019-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pneumonia (n/a - Recovering/Resolving - );Respiratory symptom (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002843607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002845019	Spontaneous	2019-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (2d - Recovering/Resolving - );Nasopharyngitis (2d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002845019&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002845231	Spontaneous	2019-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza (3d - Recovered/Resolved - );Pyrexia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[DROSPIRENONE, ETHINYLESTRADIOL] (C - n/a - n/a - [n/a - n/a - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - 100ug - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - 75ug - Oral])|[NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE] (C - Tachycardia - n/a - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002845231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002845253	Spontaneous	2019-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [1d - n/a - Intramuscular])	ELLAONE [ULIPRISTAL ACETATE] (C - Contraception - n/a - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002845253&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002848964	Spontaneous	2019-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - );Productive cough (n/a - Not Recovered/Not Resolved - );Vaccination site pain (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002848964&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002828249	Spontaneous	2019-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Arthralgia (2d - Recovered/Resolved - );Headache (2d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - );Pyrexia (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [62d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002828249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002819305	Spontaneous	2019-01-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dysarthria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia oral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neurological symptom (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	AVAMYS [FLUTICASONE FUROATE] (C - n/a - n/a - [n/a - n/a - Nasal])|[BILASTINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ETHYL LOFLAZEPATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUVOXAMINE MALEATE] (C - n/a - n/a - [n/a - n/a - Oral])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[INDAPAMIDE, PERINDOPRIL, INDAPAMIDE, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMINE, INDAPAMIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[TERBUTALINE SULFATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002819305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002819369	Spontaneous	2019-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Aphthous ulcer (n/a - Not Recovered/Not Resolved - );General physical health deterioration (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [1d - n/a - n/a])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002819369&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002819389	Spontaneous	2019-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Arthralgia (n/a - Unknown - );Injection site pain (n/a - Unknown - );Myalgia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002819389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002819538	Spontaneous	2019-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hemiparaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002819538&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002819625	Spontaneous	2019-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site induration (n/a - Recovering/Resolving - Other Medically Important Condition);Lymphadenitis (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rash maculo-papular (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002819625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002820826	Spontaneous	2019-01-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Administration site oedema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002820826&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002821390	Spontaneous	2019-01-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Flushing (n/a - Recovered/Resolved - );Skin ulcer (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002821390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002821428	Spontaneous	2019-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pyrexia (n/a - Not Recovered/Not Resolved - );Upper respiratory tract infection (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002821428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002821448	Spontaneous	2019-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Sinusitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002821448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002821830	Spontaneous	2019-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cold sweat (n/a - Recovered/Resolved - );Somnolence (n/a - Recovered/Resolved - );Vertigo (15min - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002821830&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002821949	Spontaneous	2019-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (2d - Recovered/Resolved - );Expired product administered (1d - Recovered/Resolved - );Vomiting (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002821949&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002824541	Spontaneous	2019-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Nausea (n/a - Recovering/Resolving - );Taste disorder (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[BENDROFLUMETHIAZIDE, POTASSIUM CHLORIDE] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])|[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - n/a - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002824541&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002824545	Spontaneous	2019-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza like illness (7d - Recovered/Resolved - );Myalgia (7d - Recovered/Resolved - );Pyrexia (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	AERIUS [DESLORATADINE] (C - Hypersensitivity - n/a - [n/a - 5mg - Oral])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE] (C - Asthma - n/a - [n/a - n/a - Respiratory (inhalation)])|[FLUTICASONE PROPIONATE] (C - Hypersensitivity - n/a - [n/a - 100ug - Nasal])|[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002824545&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002815031	Spontaneous	2019-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002815031&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002801984	Spontaneous	2019-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (5d - Recovered/Resolved - );Back pain (5d - Recovered/Resolved - );Dysgeusia (n/a - Not Recovered/Not Resolved - );Eye pain (5d - Recovered/Resolved - );Malaise (5d - Recovered/Resolved - );Pain in extremity (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Haemophilus infection - Not applicable - [1d - .5mL - Intramuscular])	[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE, BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a])|[BENDROFLUMETHIAZIDE] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a])|[CALCIUM CARBONATE] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a])|[HYDROXYCHLOROQUINE SULFATE] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a])|[POTASSIUM HYDROGEN CARBONATE, SODIUM ALGINATE] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a])|[PREDNISOLONE ACETATE] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002801984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002802385	Spontaneous	2019-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (2d - Recovered/Resolved - );Listless (2d - Recovered/Resolved - );Pain (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002802385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002806102	Spontaneous	2019-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bursitis (n/a - Not Recovered/Not Resolved - );Inflammation (n/a - Not Recovered/Not Resolved - );Mobility decreased (n/a - Unknown - );Vaccination site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002806102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002806391	Spontaneous	2019-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site erythema (5d - Recovered/Resolved - );Vaccination site pain (5d - Not Recovered/Not Resolved - );Vaccination site swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002806391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002797536	Spontaneous	2019-01-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Expired product administered (n/a - Unknown - );Fatigue (8d - Recovered/Resolved - );Influenza like illness (8d - Recovered/Resolved - );Nasal obstruction (8d - Recovered/Resolved - );Rhinorrhoea (8d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002797536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002798508	Spontaneous	2019-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002798508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002784392	Spontaneous	2019-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Skin reaction (n/a - Not Recovered/Not Resolved - );Vaccination site reaction (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002784392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002773717	Spontaneous	2019-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	Yes	Female	Foetal exposure during pregnancy (n/a - Unknown - Congenital Anomaly);Urinary tract malformation (n/a - Unknown - Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002773717&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-10002776444	Spontaneous	2019-01-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Influenza immunisation - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002776444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10002777879	Spontaneous	2019-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Immune thrombocytopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Platelet count decreased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	CIALIS [TADALAFIL] (C - Erectile dysfunction - n/a - [n/a - 10mg - Oral])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Hypertension - n/a - [n/a - 5mg - Oral])|[BETAMETHASONE DIPROPIONATE, CALCIPOTRIOL, BETAMETHASONE DIPROPIONATE, CALCIPOTRIOL MONOHYDRATE, BETAMETHASONE, CALCIPOTRIOL] (C - Psoriasis - n/a - [n/a - 1{DF} - Topical])|[CARBOMER 980, CARBOMERS] (C - Dry eye - n/a - [n/a - 2{DF} - Other])|[DEXAMETHASONE] (C - Eye inflammation - n/a - [n/a - 1{DF} - Other])|[DORZOLAMIDE, TIMOLOL] (C - Glaucoma - n/a - [n/a - 1{DF} - Other])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Gastrooesophageal reflux disease - n/a - [n/a - 20mg - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 20mg - Oral])|[TRANDOLAPRIL] (C - Hypertension - n/a - [n/a - 2mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002777879&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002768237	Spontaneous	2019-01-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002768237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002759841	Spontaneous	2018-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Ventricular extrasystoles (10d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002759841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002752502	Spontaneous	2018-12-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Administration site swelling (28d - Recovering/Resolving - );Asthma (28d - Recovering/Resolving - );Dysphonia (22d - Recovering/Resolving - );Dyspnoea (28d - Recovering/Resolving - );Injection site erythema (28d - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002752502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002750313	Spontaneous	2018-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site inflammation (8d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002750313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002721916	Spontaneous	2018-12-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002721916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002722956	Spontaneous	2018-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Arthralgia (19d - Recovered/Resolved - Other Medically Important Condition);Chills (6d - Recovered/Resolved - Other Medically Important Condition);Fatigue (19d - Recovered/Resolved - Other Medically Important Condition);Lymphadenopathy (15d - Recovered/Resolved - Other Medically Important Condition);Myalgia (19d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (14d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002722956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002723999	Spontaneous	2018-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Neuralgia (n/a - Unknown - );Pain in extremity (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002723999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002702207	Spontaneous	2018-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Ageusia (n/a - Not Recovered/Not Resolved - );Anosmia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002702207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002702504	Spontaneous	2018-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cerebral infarction (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002702504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002703033	Spontaneous	2018-12-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Clumsiness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Coordination abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Economic problem (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Exercise tolerance decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eye pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Facial pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fine motor skill dysfunction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Grief reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lethargy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Limb discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mental fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mental impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neck pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in jaw (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain of skin (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sensory disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Speech disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Temperature intolerance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002703033&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002705147	Spontaneous	2018-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	General physical health deterioration (4d - Recovering/Resolving - );Pain in jaw (5d - Recovering/Resolving - );Pyrexia (4d - Recovering/Resolving - );Swelling (4d - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002705147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002705390	Spontaneous	2018-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cold sweat (3d - Recovered/Resolved - );Headache (1d - Recovered/Resolved - );Hyperhidrosis (3d - Recovered/Resolved - );Malaise (3d - Recovered/Resolved - );Visual impairment (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002705390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002705398	Spontaneous	2018-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysgeusia (1d - Recovered/Resolved - );Headache (2d - Recovered/Resolved - );Paraesthesia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002705398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002706119	Spontaneous	2018-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Humerus fracture (n/a - Unknown - Other Medically Important Condition);Lethargy (n/a - Unknown - Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nightmare (n/a - Unknown - Other Medically Important Condition);Overweight (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Sleep inertia (n/a - Unknown - Other Medically Important Condition);Somnambulism (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a - More in ICSR])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002706119&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002708664	Spontaneous	2018-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Keratouveitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Lacrimation increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Ocular hyperaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Purulence (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002708664&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002692818	Spontaneous	2018-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain (4d - Recovering/Resolving - );Pyrexia (4d - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002692818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002696544	Spontaneous	2018-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Axonal neuropathy (n/a - Unknown - Disabling, Other Medically Important Condition);Balance disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Depression (n/a - Unknown - Disabling, Other Medically Important Condition);Lacunar infarction (n/a - Unknown - Disabling, Other Medically Important Condition);Proteinuria (n/a - Unknown - Disabling, Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Vitamin D deficiency (n/a - Unknown - Disabling, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002696544&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10002696735	Spontaneous	2018-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Erythema (n/a - Not Recovered/Not Resolved - );Injection site erythema (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002696735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002699515	Spontaneous	2018-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Burning sensation (1d - Recovered/Resolved - );Butterfly rash (1d - Recovered/Resolved - );Erythema (1d - Recovered/Resolved - );Pruritus (1d - Recovered/Resolved - );Rash (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002699515&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002683216	Spontaneous	2018-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (7d - Recovered/Resolved - );Myalgia (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002683216&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002663428	Spontaneous	2018-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Lymphadenopathy (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002663428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002667602	Spontaneous	2018-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Attention deficit hyperactivity disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep talking (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002667602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002668041	Spontaneous	2018-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acne (n/a - Recovered/Resolved - );Erythema (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002668041&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002656140	Spontaneous	2018-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Dose not changed - [1d - n/a - n/a])	[LORATADINE] (C - n/a - n/a - [8d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002656140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002661269	Spontaneous	2018-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aphonia (13d - Recovered/Resolved - );Cough (17d - Recovered/Resolved - );Dysphonia (13d - Recovered/Resolved - );Headache (17d - Recovered/Resolved - );Influenza like illness (17d - Recovered/Resolved - );Peripheral swelling (18d - Recovered/Resolved - );Productive cough (17d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	[DROSPIRENONE, ETHINYLESTRADIOL] (C - Oral contraception - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002661269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002661288	Spontaneous	2018-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Musculoskeletal stiffness (n/a - Recovered/Resolved - );Vaccination site erythema (n/a - Recovered/Resolved - );Vaccination site pruritus (n/a - Recovered/Resolved - );Vaccination site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002661288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002661290	Spontaneous	2018-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Recovering/Resolving - );Pyrexia (13d - Recovered/Resolved - );Vaccination site erythema (3d - Recovered/Resolved - );Vaccination site warmth (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (C - n/a - n/a - [1d - 1{DF} - Intramuscular])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002661290&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002661553	Spontaneous	2018-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anal incontinence (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cold sweat (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002661553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002661556	Spontaneous	2018-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Nasal pruritus (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Oral pruritus (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Throat irritation (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002661556&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10002652173	Spontaneous	2018-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Urticaria (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002652173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002652177	Spontaneous	2018-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Myalgia (6d - Recovered/Resolved - );Pyrexia (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002652177&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002636435	Spontaneous	2018-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysgeusia (8d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002636435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002637827	Spontaneous	2018-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysgeusia (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002637827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002637834	Spontaneous	2018-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Feeling hot (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - );Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002637834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002639502	Spontaneous	2018-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Blindness (1d - Recovered/Resolved - );Memory impairment (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002639502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002640517	Spontaneous	2018-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - );Oedema (n/a - Recovered/Resolved - );Skin reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002640517&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002643655	Spontaneous	2018-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Malaise (17d - Recovered/Resolved - );Myalgia (13d - Recovered/Resolved - );Pyrexia (9d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002643655&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002644601	Spontaneous	2018-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Abdominal pain (60min - Recovered/Resolved - );Cold sweat (60min - Recovered/Resolved - );Feeling abnormal (60min - Recovered/Resolved - );Pallor (60min - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002644601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002644622	Spontaneous	2018-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoaesthesia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - Oral contraception - Dose not changed - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002644622&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002629173	Spontaneous	2018-12-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depression (n/a - Recovering/Resolving - Other Medically Important Condition);Feeling of despair (n/a - Unknown - Other Medically Important Condition);Tearfulness (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Parenteral])	[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002629173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002634939	Spontaneous	2018-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Facial paralysis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002634939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002634987	Spontaneous	2018-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002634987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002621165	Spontaneous	2018-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (1d - Recovered/Resolved - );Malaise (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002621165&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002622061	Spontaneous	2018-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Musculoskeletal stiffness (n/a - Unknown - );Neck pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002622061&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002625818	Spontaneous	2018-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Chest pain (n/a - Recovered/Resolved - );Hyperhidrosis (n/a - Recovered/Resolved - );Hypotension (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Presyncope (1d - Recovered/Resolved - );Vomiting (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002625818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002625889	Spontaneous	2018-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site inflammation (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002625889&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002612382	Spontaneous	2018-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypotonia (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Unknown - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002612382&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002616093	Spontaneous	2018-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pyrexia (3d - Recovered/Resolved - );Vaccination site oedema (9d - Recovered/Resolved - );Vaccination site pain (9d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002616093&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002616094	Spontaneous	2018-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Herpes zoster (8d - Recovered/Resolved - );Rash (8d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{total} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002616094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002601534	Spontaneous	2018-12-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Feeling hot (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling of body temperature change (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vertigo (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002601534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002601666	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Malaise (5d - Recovered/Resolved - );Myalgia (5d - Recovered/Resolved - );Pyrexia (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002601666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002602101	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002602101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002603570	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Immunisation reaction (n/a - Not Recovered/Not Resolved - );Superinfection (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002603570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002603711	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Pruritus (n/a - Not Recovered/Not Resolved - );Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])...	[RAMIPRIL] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002603711&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002605473	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Malaise (n/a - Unknown - );Nausea (n/a - Unknown - );Pruritus (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - );Vaccination site pain (n/a - Unknown - );Vaccination site pruritus (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - );Vaccination site vesicles (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002605473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002605967	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (3d - Recovered/Resolved - );Malaise (3d - Recovered/Resolved - );Vaccination site erythema (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002605967&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002605969	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest pain (4d - Recovered/Resolved - );Hyperhidrosis (4d - Recovered/Resolved - );Malaise (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002605969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002605973	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Headache (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Nasal congestion (n/a - Not Recovered/Not Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002605973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002605979	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Erythema (6d - Recovered/Resolved - );Pruritus (6d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{total} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002605979&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002607379	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - .5{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002607379&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002607381	Spontaneous	2018-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002607381&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002586667	Spontaneous	2018-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002586667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002586995	Spontaneous	2018-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Female	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Hypnopompic hallucination (n/a - Recovering/Resolving - Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002586995&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002587008	Spontaneous	2018-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002587008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002589623	Spontaneous	2018-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Ataxia (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Recovered/Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Tremor (n/a - Not Recovered/Not Resolved - Disabling);Weight decreased (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002589623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10002590607	Spontaneous	2018-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Humerus fracture (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lethargy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Overweight (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep inertia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnambulism (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002590607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002596158	Spontaneous	2018-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest discomfort (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - );Nasopharyngitis (n/a - Not Recovered/Not Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - );Tenderness (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002596158&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002596165	Spontaneous	2018-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza like illness (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002596165&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002597315	Spontaneous	2018-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vertigo (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002597315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002583457	Spontaneous	2018-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abortion spontaneous complete (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002583457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002583485	Spontaneous	2018-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002583485&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10002584445	Spontaneous	2018-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dizziness (n/a - Recovering/Resolving - );Dysarthria (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Pain in extremity (n/a - Recovering/Resolving - );Pharyngeal haemorrhage (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Vaccination site pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002584445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002585769	Spontaneous	2018-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Urticaria (1wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, HYDRATE] (C - Hypothyroidism - n/a - [n/a - 75ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002585769&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002570929	Spontaneous	2018-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hypersensitivity (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002570929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002572485	Spontaneous	2018-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002572485&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10002573724	Spontaneous	2018-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Urticaria (14d - Recovered/Resolved - );Vomiting (14d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002573724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002574152	Spontaneous	2018-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chills (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002574152&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002575293	Spontaneous	2018-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Contraindicated product administered (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002575293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002577246	Spontaneous	2018-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Unknown - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002577246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002578432	Spontaneous	2018-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Expired product administered (0d - Recovered/Resolved - );Nausea (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002578432&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002563805	Spontaneous	2018-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002563805&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10002565751	Spontaneous	2018-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Joint stiffness (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Joint swelling (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Polyarthritis (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Rheumatoid arthritis (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002565751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10002566566	Spontaneous	2018-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ocular ischaemic syndrome (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	PROCORALAN [IVABRADINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - Unknown])|[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[BARNIDIPINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[ESTRADIOL HEMIHYDRATE, ESTRADIOL VALERATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[FLUTICASONE PROPIONATE] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - Nasal])|[FLUTICASONE PROPIONATE] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[METOPROLOL, METOPROLOL TARTRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[RABEPRAZOLE SODIUM] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002566566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002566619	Spontaneous	2018-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza like illness (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002566619&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002568639	Spontaneous	2018-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Wheezing (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002568639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002570369	Spontaneous	2018-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Mobility decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002570369&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002555235	Spontaneous	2018-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal distension (n/a - Not Recovered/Not Resolved - );Abdominal pain (n/a - Not Recovered/Not Resolved - );Arthritis (n/a - Not Recovered/Not Resolved - );Decreased appetite (n/a - Not Recovered/Not Resolved - );Diarrhoea (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Vaccination site inflammation (n/a - Recovered/Resolved With Sequelae - );Vaccination site pain (n/a - Recovered/Resolved With Sequelae - );Vaccination site swelling (n/a - Recovered/Resolved With Sequelae - );Vaccination site vesicles (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002555235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10002556206	Spontaneous	2018-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Not Specified	Vaccination site erythema (n/a - Recovering/Resolving - );Vaccination site induration (n/a - Recovering/Resolving - );Vaccination site oedema (n/a - Recovering/Resolving - );Vaccination site pain (n/a - Recovering/Resolving - );Vaccination site warmth (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002556206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002560042	Spontaneous	2018-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dermo-hypodermitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002560042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002560485	Spontaneous	2018-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dermo-hypodermitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002560485&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002561374	Spontaneous	2018-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002561374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002546403	Spontaneous	2018-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Feeling of body temperature change (n/a - Unknown - );Night sweats (n/a - Recovered/Resolved - );Palpitations (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE, BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE] (C - Ill-defined disorder - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002546403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002549316	Spontaneous	2018-11-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Lymph node pain (n/a - Recovering/Resolving - Other Medically Important Condition);Lymphadenopathy (n/a - Recovering/Resolving - Other Medically Important Condition);Nasal obstruction (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [0d - 1{DF} - Intramuscular])	CHAMPIX [VARENICLINE, VARENICLINE TARTRATE] (C - Ex-tobacco user - n/a - [3mo - 1{DF} - Oral])|[IBUPROFEN, IBUPROFEN BP, IBUPROFEN, CODEINE PHOSPHATE HEMIHYDRATE] (C - Nasopharyngitis - n/a - [0mo - 600mg - Oral])|[PARACETAMOL] (C - Nasopharyngitis - n/a - [0mo - 1000mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002549316&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002550346	Spontaneous	2018-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Vaccination site rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002550346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002550363	Spontaneous	2018-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Rash (n/a - Not Recovered/Not Resolved - );Scratch (n/a - Not Recovered/Not Resolved - );Skin wound (n/a - Not Recovered/Not Resolved - );Vaccination site pruritus (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Dose not changed - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002550363&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002536035	Spontaneous	2018-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cardiovascular disorder (n/a - Not Recovered/Not Resolved - );Pruritus (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - );Throat tightness (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - Carotid artery stenosis - n/a - [n/a - 100mg - Oral])|[METOPROLOL, METOPROLOL TARTRATE] (C - Hypertension - n/a - [n/a - 95mg - Oral])|[VALSARTAN] (C - Hypertension - n/a - [n/a - 160mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002536035&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002542427	Spontaneous	2018-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Arthralgia (24h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002542427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002542491	Spontaneous	2018-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (5d - Recovered/Resolved - );Pruritus (5d - Recovered/Resolved - );Vaccination site pain (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002542491&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002528591	Spontaneous	2018-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Alopecia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002528591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002530547	Spontaneous	2018-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal distension (n/a - Not Recovered/Not Resolved - );Diarrhoea (n/a - Not Recovered/Not Resolved - );Flatulence (n/a - Not Recovered/Not Resolved - );Nausea (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[DESOGESTREL] (C - n/a - n/a - [n/a - n/a - n/a])|[NIFEDIPINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002530547&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002533475	Spontaneous	2018-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Diarrhoea (6d - Recovered/Resolved - );Headache (6d - Recovered/Resolved - );Pyrexia (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002533475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002533487	Spontaneous	2018-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Diarrhoea (5d - Recovered/Resolved - );Myalgia (7d - Recovered/Resolved - );Pyrexia (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002533487&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002533490	Spontaneous	2018-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pyrexia (2d - Recovered/Resolved - );Vaccination site erythema (4d - Recovered/Resolved - );Vaccination site swelling (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [1d - 1{DF} - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002533490&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002534210	Spontaneous	2018-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (2d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002534210&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002534230	Spontaneous	2018-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002534230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002534237	Spontaneous	2018-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002534237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002534251	Spontaneous	2018-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002534251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002526468	Spontaneous	2018-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002526468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002526554	Spontaneous	2018-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - );Asthenia (n/a - Recovered/Resolved - );Chills (n/a - Recovered/Resolved - );Ear pain (n/a - Recovered/Resolved - );Oropharyngeal pain (n/a - Recovered/Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Rhinitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002526554&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002510075	Spontaneous	2018-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chills (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - );Vaccination site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002510075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002510715	Spontaneous	2018-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anger (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Personality change (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Scratch (n/a - Unknown - Other Medically Important Condition);Self-injurious ideation (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Thinking abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002510715&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002517295	Spontaneous	2018-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Diarrhoea (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Vaccination complication (n/a - Recovered/Resolved - );Vertigo (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002517295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002517301	Spontaneous	2018-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (2h - Recovered/Resolved - );Vaccination complication (2h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002517301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002501688	Spontaneous	2018-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Endocrine ophthalmopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Eye disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Graves' disease (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hyperthyroidism (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002501688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002503060	Spontaneous	2018-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Vaccination site pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002503060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002503254	Spontaneous	2018-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Oedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vertigo (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002503254&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002503444	Spontaneous	2018-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Erythema multiforme (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002503444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002506583	Spontaneous	2018-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Local reaction (n/a - Unknown - );Pain (n/a - Unknown - );Paraesthesia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002506583&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002484744	Spontaneous	2018-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (3d - Recovered/Resolved - );Hyperhidrosis (3d - Recovered/Resolved - );Nausea (3d - Recovered/Resolved - );Rash (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002484744&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002487312	Spontaneous	2018-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002487312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002487337	Spontaneous	2018-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Headache (9d - Recovered/Resolved - );Hypotension (9d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [1d - 1{DF} - Unknown])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - Immunisation - Drug withdrawn - [1d - 1{DF} - Unknown])	[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED, ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALGELDRATE, HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALUMINIUM HYDROXIDE] (C - Immunisation - Drug withdrawn - [1d - 1{DF} - Unknown])|[RABIES VACCINE, RABIES VIRUS (INACTIVATED) STRAIN FLURY LEP] (C - Immunisation - Drug withdrawn - [1d - 1{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002487337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002488301	Spontaneous	2018-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002488301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002488304	Spontaneous	2018-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002488304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002464481	Spontaneous	2018-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vomiting (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVONORGESTREL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002464481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002470173	Spontaneous	2018-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002470173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002454617	Spontaneous	2018-11-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - );Pruritus (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Dose not changed - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002454617&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002460634	Spontaneous	2018-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002460634&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002460639	Spontaneous	2018-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Conjunctivitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002460639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002460651	Spontaneous	2018-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Catarrh (8d - Recovered/Resolved - );Cough (8d - Recovered/Resolved - );Myalgia (8d - Recovered/Resolved - );Pyrexia (8d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002460651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002462230	Spontaneous	2018-11-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002462230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10002438660	Spontaneous	2018-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002438660&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10002438669	Spontaneous	2018-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Basilar migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Head discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Head titubation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002438669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002439895	Spontaneous	2018-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (1d - Recovered/Resolved - );Dyspnoea (1d - Recovered/Resolved - );Tachypnoea (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002439895&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002443804	Spontaneous	2018-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Vaccination site induration (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002443804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002432983	Spontaneous	2018-11-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Herpes simplex reactivation (n/a - Not Recovered/Not Resolved - );Injection site hypoaesthesia (n/a - Recovering/Resolving - );Injection site swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [1d - n/a - n/a])	[DESOGESTREL, ETHINYLESTRADIOL, LACTOSE, LACTOSE MONOHYDRATE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002432983&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002425171	Spontaneous	2018-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Drug interaction (n/a - Unknown - Other Medically Important Condition);Epilepsy (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (I - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[PHENYTOIN] (I - Product used for unknown indication - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002425171&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002425693	Spontaneous	2018-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anxiety (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Irritability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Mood disorder due to a general medical condition (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002425693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002425695	Spontaneous	2018-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Male	Aggression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Anxiety (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Confusional state (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Irritability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Social problem (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002425695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002425696	Spontaneous	2018-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Educational problem (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hyperthermia (n/a - Unknown - Disabling);Influenza (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Social problem (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Weight decreased (n/a - Unknown - Disabling)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002425696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10002425784	Spontaneous	2018-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anxiety (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Attention deficit hyperactivity disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Diplegia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Loss of personal independence in daily activities (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Middle insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Protrusion tongue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Speech disorder developmental (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002425784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002408220	Spontaneous	2018-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Gait disturbance (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Injury (n/a - Unknown - Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Unknown - Other Medically Important Condition);Movement disorder (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pharyngitis (n/a - Unknown - Other Medically Important Condition);Pharyngitis streptococcal (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002408220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002394931	Spontaneous	2018-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin discolouration (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002394931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002397309	Spontaneous	2018-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002397309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002398318	Spontaneous	2018-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Dyspnoea (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypersensitivity (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Oedema (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Urticaria (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - n/a - [5s - 1{DF} - Intramuscular])...	[ACETYLSALICYLIC ACID] (C - n/a - n/a - )|[ATORVASTATIN] (C - n/a - n/a - )|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, HYDRATE] (C - n/a - n/a - )|[MELOXICAM] (C - n/a - n/a - )|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002398318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10002400785	Spontaneous	2018-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anaphylactic reaction (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002400785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002390496	Spontaneous	2018-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Rash papular (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	NOT AVAILABLE (C - n/a - n/a - [n/a - 100mg - n/a])|[CICLESONIDE] (C - n/a - n/a - [n/a - 160ug - n/a])|[COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESOMEPRAZOLE] (C - n/a - n/a - [n/a - 20mg - n/a])|[FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - 2{DF} - n/a])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 12mg - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 20mg - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - 5ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002390496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002378264	Spontaneous	2018-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anosmia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	CANNABIDIOL [CANNABIDIOL] (C - Pain - n/a - [n/a - n/a - n/a])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - Erysipelas - n/a - [6d - 800mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002378264&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002378267	Spontaneous	2018-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Bacterial infection (n/a - Unknown - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pulmonary embolism (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002378267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002379784	Spontaneous	2018-10-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dizziness (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[CICLESONIDE] (C - Asthma - Not applicable - [n/a - n/a - n/a])|[FORMOTEROL FUMARATE] (C - Asthma - Not applicable - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - Asthma - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002379784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002384557	Spontaneous	2018-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002384557&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002384571	Spontaneous	2018-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002384571&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10002368599	Spontaneous	2018-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition);Polydipsia (n/a - Unknown - Other Medically Important Condition);Polyuria (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002368599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002373568	Spontaneous	2018-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Medication error (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002373568&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002358213	Spontaneous	2018-10-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Diabetes insipidus (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002358213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10002363885	Spontaneous	2018-10-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dizziness (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002363885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002351475	Spontaneous	2018-10-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Facial paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Nasal])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002351475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002357162	Spontaneous	2018-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Recovered/Resolved - Disabling);Somnolence (n/a - Recovered/Resolved - Disabling);Weight increased (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002357162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10002357185	Spontaneous	2018-10-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovering/Resolving - );Cough (n/a - Recovering/Resolving - );Dyspnoea (n/a - Recovering/Resolving - );Ocular hyperaemia (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	[FLUINDIONE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[SOTALOL HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002357185&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002343834	Spontaneous	2018-10-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - );Asthenia (n/a - Recovering/Resolving - );Injection site reaction (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Oedema (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002343834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002344332	Spontaneous	2018-10-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Burning sensation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002344332&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002347015	Spontaneous	2018-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Not Recovered/Not Resolved - );Immunisation reaction (6h - Recovered/Resolved - );Nausea (6h - Recovered/Resolved - );Vertigo (6h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002347015&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002347140	Spontaneous	2018-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Immunisation reaction (n/a - Not Recovered/Not Resolved - );Nausea (n/a - Not Recovered/Not Resolved - );Vertigo (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002347140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002348757	Spontaneous	2018-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Product administration error (n/a - Recovered/Resolved - );Product dispensing error (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002348757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002335850	Spontaneous	2018-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Daydreaming (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Distractibility (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Emotional distress (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lethargy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Social avoidant behaviour (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	[METHYLPHENIDATE HYDROCHLORIDE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002335850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002327773	Spontaneous	2018-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Obstructive sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	[HUMAN PAPILLOMAVIRUS VACCINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002327773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002331304	Spontaneous	2018-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Fatigue (24h - Recovered/Resolved - );Hyperthermia (36h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002331304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002319762	Spontaneous	2018-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002319762&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002321405	Spontaneous	2018-10-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Recovering/Resolving - );Illness (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - );Pain (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - n/a - [n/a - 50mg - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002321405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002292131	Spontaneous	2018-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002292131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002296464	Spontaneous	2018-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site erythema (n/a - Not Recovered/Not Resolved - );Vaccination site pruritus (n/a - Not Recovered/Not Resolved - );Vaccination site rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	OTEZLA [APREMILAST] (C - Rheumatoid arthritis - n/a - [n/a - 30mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002296464&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002283712	Spontaneous	2018-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Neuralgic amyotrophy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002283712&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002284258	Spontaneous	2018-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Monoplegia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	LYRICA [PREGABALIN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - Hypertension - Not applicable - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002284258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002284336	Spontaneous	2018-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002284336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002273540	Spontaneous	2018-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Fall (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Intervertebral disc protrusion (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Radiculopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002273540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002278966	Spontaneous	2018-10-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Head discomfort (n/a - Recovering/Resolving - );Nasopharyngitis (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002278966&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002267467	Spontaneous	2018-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Bronchospasm (2d - Recovered/Resolved - Life Threatening);Dyspnoea (n/a - Unknown - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002267467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10002272464	Spontaneous	2018-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myopericarditis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOLMITRIPTAN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002272464&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002261255	Spontaneous	2018-10-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - );Swelling (n/a - Unknown - );Swelling face (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[AMOXICILLIN, AMOXICILLIN TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE, BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ETHINYLESTRADIOL, NORETHISTERONE, NORETHISTERONE ACETATE, ETHINYLESTRADIOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[TOPIRAMATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002261255&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002262372	Spontaneous	2018-10-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002262372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10002253683	Spontaneous	2018-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Agitation (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood calcium increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood pressure increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash maculo-papular (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [1d - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002253683&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002245256	Spontaneous	2018-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Vaccination site haemorrhage (n/a - Not Recovered/Not Resolved - );Vaccination site scab (n/a - Not Recovered/Not Resolved - );Vaccination site ulcer (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - Oral])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - Oral])|[HYDROCHLOROTHIAZIDE, LOSARTAN] (C - n/a - n/a - [n/a - n/a - Oral])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002245256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10002247198	Spontaneous	2018-10-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Chills (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (86400s - Recovered/Resolved - Other Medically Important Condition);Feeling of body temperature change (86400s - Recovered/Resolved - Other Medically Important Condition);Nervousness (86400s - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	ZOSTAVAX [VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (S - Prophylaxis - Not applicable - [n/a - .65mL - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002247198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002230609	Spontaneous	2018-10-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002230609&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002223584	Spontaneous	2018-10-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Obstructive sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Overweight (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Periodic limb movement disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Upper airway resistance syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002223584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002215446	Spontaneous	2018-10-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Immune system disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site erythema (2wk - Recovered/Resolved - );Injection site inflammation (2wk - Recovered/Resolved - );Injection site pain (2wk - Recovered/Resolved - );Injection site swelling (2wk - Recovered/Resolved - );Injection site warmth (2wk - Recovered/Resolved - );Pyrexia (3wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002215446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002215747	Spontaneous	2018-10-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002215747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10002202386	Spontaneous	2018-09-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lip swelling (n/a - Recovering/Resolving - Other Medically Important Condition);Swelling face (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002202386&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002197462	Spontaneous	2018-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002197462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002169820	Spontaneous	2018-09-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002169820&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002171276	Spontaneous	2018-09-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Immune system disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	[CLOZAPINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002171276&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002162424	Spontaneous	2018-09-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Listless (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pneumonia respiratory syncytial viral (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002162424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002164924	Spontaneous	2018-09-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002164924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10002146322	Spontaneous	2018-09-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Infection reactivation (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002146322&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10002136842	Spontaneous	2018-09-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Arrhythmia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Coma (6wk - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fall (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypertension (n/a - Unknown - );Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Polyneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Quadriparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Respiratory muscle weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002136842&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002139118	Spontaneous	2018-09-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMYLASE, LIPASE, PROTEASE, PANCREALIPASE, PANCREAS POWDER, PANCREAS POWDER FROM PORCINE, PANCREATIN, PANCREATIN BP] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[BENDROFLUAZIDE, BENDROFLUMETHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002139118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002128112	Spontaneous	2018-09-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002128112&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002122809	Spontaneous	2018-09-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chills (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hodgkin's disease (7a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002122809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002115434	Spontaneous	2018-09-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Balance disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Coordination abnormal (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dysarthria (n/a - Unknown - Disabling, Other Medically Important Condition);Eyelid ptosis (n/a - Unknown - Disabling, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Neurotransmitter level altered (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002115434&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002108352	Spontaneous	2018-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Vaccination site erythema (n/a - Not Recovered/Not Resolved - );Vaccination site pruritus (n/a - Not Recovered/Not Resolved - );Vaccination site swelling (n/a - Not Recovered/Not Resolved - );Vaccination site warmth (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002108352&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002102637	Spontaneous	2018-09-11 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acne (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthma (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Choking sensation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Drug ineffective (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eye discharge (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eye swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ocular hyperaemia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin exfoliation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002102637&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10002102646	Spontaneous	2018-09-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Myelitis (32d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002102646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002094746	Spontaneous	2018-09-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Limb discomfort (n/a - Not Recovered/Not Resolved - Disabling);Mobility decreased (n/a - Not Recovered/Not Resolved - Disabling);Vaccination site pain (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mg - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002094746&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10002096349	Spontaneous	2018-09-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Facial paralysis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[VALACICLOVIR] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002096349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10002096350	Spontaneous	2018-09-10 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002096350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002097090	Spontaneous	2018-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Abdominal distension (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Bedridden (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Blister (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Blood pressure decreased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Blood pressure increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Contusion (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Discomfort (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Epistaxis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Heart rate increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hyperacusis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperhidrosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Impaired work ability (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Menstrual disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Palpitations (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Photophobia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Postural orthostatic tachycardia syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Presyncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Sinus tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Skin disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Skin exfoliation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Urticaria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - Human papilloma virus immunisation - Dose not changed - [n/a - 1{DF} - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - Intramuscular])|[MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS (LIVE, ATTENUATED), RUBELLA VIRUS (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002097090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002084601	Spontaneous	2018-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Erythema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002084601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002085285	Spontaneous	2018-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Orthostatic hypotension (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002085285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10002076054	Spontaneous	2018-09-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002076054&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002045321	Spontaneous	2018-08-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Blepharospasm (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Corneal reflex decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Facial spasm (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Meige's syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscle spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Torticollis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - n/a - [n/a - 100mg - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - 500mg - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 2.5mg - n/a])|[RISPERIDONE] (C - n/a - n/a - [n/a - .5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002045321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002028550	Spontaneous	2018-08-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002028550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10002003288	Spontaneous	2018-08-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002003288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10002003357	Spontaneous	2018-08-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10002003357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001994965	Spontaneous	2018-08-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blood pressure increased (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Postural orthostatic tachycardia syndrome (n/a - Not Recovered/Not Resolved - Disabling);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [1d - n/a - n/a])|[A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001994965&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10001996918	Spontaneous	2018-08-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthma (n/a - Not Recovered/Not Resolved - Disabling);Conjunctivitis allergic (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001996918&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10001997142	Spontaneous	2018-08-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hallucination (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001997142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001989349	Spontaneous	2018-08-22 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Drug ineffective (4d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001989349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001990646	Spontaneous	2018-08-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pain in extremity (n/a - Recovering/Resolving - );Pruritus (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001990646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001971407	Spontaneous	2018-08-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001971407&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001941928	Spontaneous	2018-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	No adverse event (n/a - Unknown - );Vaccination error (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (C - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001941928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001924482	Spontaneous	2018-08-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - );Influenza like illness (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001924482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001912964	Spontaneous	2018-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[METHYLPHENIDATE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001912964&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001906427	Spontaneous	2018-08-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved With Sequelae - Disabling);Headache (n/a - Recovered/Resolved With Sequelae - Disabling);Muscle twitching (n/a - Recovered/Resolved With Sequelae - Disabling);Neuralgia (n/a - Recovered/Resolved With Sequelae - Disabling);Pain in extremity (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001906427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10001907195	Spontaneous	2018-08-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001907195&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001899459	Spontaneous	2018-08-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Decreased appetite (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Hepatitis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (11d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Sinusitis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	HUMIRA [ADALIMUMAB] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|LEFLUNOMIDE [LEFLUNOMIDE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001899459&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10001881223	Spontaneous	2018-08-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Diarrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001881223&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001868394	Spontaneous	2018-08-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dysphagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dysphonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Motor neurone disease (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Paraparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001868394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001869768	Spontaneous	2018-08-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Amnesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Clonus (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pre-eclampsia (n/a - Unknown - Caused/Prolonged Hospitalisation);Presyncope (n/a - Unknown - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001869768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001857744	Spontaneous	2018-08-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pain in extremity (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001857744&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001858691	Spontaneous	2018-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Immune system disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001858691&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001858699	Spontaneous	2018-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Female	Developmental delay (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001858699&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001852427	Spontaneous	2018-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Intracranial pressure increased (n/a - Recovering/Resolving - Other Medically Important Condition);Iridocyclitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Papilloedema (n/a - Recovering/Resolving - Other Medically Important Condition);Photophobia (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001852427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001854580	Spontaneous	2018-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Decreased appetite (16d - Recovered/Resolved - Other Medically Important Condition);Fatigue (16d - Recovered/Resolved - Other Medically Important Condition);Myalgia (16d - Recovered/Resolved - Other Medically Important Condition);Vertigo (16d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001854580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001841942	Spontaneous	2018-07-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Generalised tonic-clonic seizure (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001841942&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001842419	Spontaneous	2018-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [1d - 1{DF} - Parenteral])	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (C - n/a - n/a - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001842419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001831586	Spontaneous	2018-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001831586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001819853	Spontaneous	2018-07-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Rash (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (C - Immunisation - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001819853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001809939	Spontaneous	2018-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001809939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001810669	Spontaneous	2018-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Ataxia (n/a - Unknown - );Vertigo (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001810669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001816724	Spontaneous	2018-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Balance disorder (1d - Recovered/Resolved - );Vertigo (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001816724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10001802068	Spontaneous	2018-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	XELEVIA [SITAGLIPTIN] (C - Product used for unknown indication - Not applicable - [n/a - 2{DF} - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Product used for unknown indication - Not applicable - [n/a - 1000mg - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Product used for unknown indication - Not applicable - [n/a - 40mg - n/a])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001802068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001786046	Spontaneous	2018-07-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001786046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10001782497	Spontaneous	2018-07-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Not Recovered/Not Resolved - );Vaccination site cellulitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001782497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001756244	Spontaneous	2018-07-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001756244&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10001737933	Spontaneous	2018-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Erectile dysfunction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Facial paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fine motor skill dysfunction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Neuralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Peripheral sensory neuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Sensory disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001737933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001727089	Spontaneous	2018-07-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001727089&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001727174	Spontaneous	2018-07-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001727174&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001727175	Spontaneous	2018-07-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001727175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001727176	Spontaneous	2018-07-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001727176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001717817	Spontaneous	2018-07-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anger (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Personality change (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Scratch (n/a - Unknown - Other Medically Important Condition);Self-injurious ideation (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Thinking abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001717817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001722388	Spontaneous	2018-07-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Alopecia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	[COLECALCIFEROL, CALCIUM CARBONATE, VITAMIN D, CALCIUM CARBONATE] (C - Osteoporosis - n/a - [n/a - n/a - Oral])|[FENOFIBRATE, FENOFIBRATE MICRONISED] (C - Dyslipidaemia - n/a - [n/a - 145mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001722388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001705205	Spontaneous	2018-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001705205&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10001707375	Spontaneous	2018-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001707375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001709419	Spontaneous	2018-07-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Brain fog (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001709419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001709926	Spontaneous	2018-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Depressed level of consciousness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Encephalopathy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hypersomnia-bulimia syndrome (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001709926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001697332	Spontaneous	2018-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001697332&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001702422	Spontaneous	2018-07-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Optic neuritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[LEVOTHYROXINE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001702422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001703598	Spontaneous	2018-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Anxiety (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fall (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gastrointestinal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001703598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001690303	Spontaneous	2018-07-04 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Vaccination site discolouration (n/a - Not Recovered/Not Resolved - );Vaccination site induration (n/a - Not Recovered/Not Resolved - );Vaccination site pruritus (n/a - Not Recovered/Not Resolved - )	M-M-RVAXPRO [MEASLES VIRUS ENDERS' EDMONSTON STRAIN (LIVE, ATTENUATED), MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS] (S - n/a - n/a - [1d - n/a - Intramuscular])|SYNFLORIX [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001690303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001682674	Spontaneous	2018-07-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Facial paresis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Restless legs syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tension headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	[FERROUS SULFATE] (C - Iron deficiency - Unknown - [n/a - 60mg - Oral])|[LIOTHYRONINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LIOTHYRONINE SODIUM, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001682674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001623055	Spontaneous	2018-06-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001623055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001630090	Spontaneous	2018-06-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Skin discolouration (n/a - Not Recovered/Not Resolved - );Vaccination site abscess (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001630090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001630440	Spontaneous	2018-06-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hypersensitivity (n/a - Recovered/Resolved - );Rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])...	[LEVOTHYROXINE] (C - Hypothyroidism - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001630440&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001620781	Spontaneous	2018-06-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lower respiratory tract infection (n/a - Recovered/Resolved - Other Medically Important Condition);Presyncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001620781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001620783	Spontaneous	2018-06-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bronchospasm (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001620783&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001605679	Spontaneous	2018-06-27 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza (10d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001605679&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001610731	Spontaneous	2018-06-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001610731&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001610932	Spontaneous	2018-06-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001610932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001581110	Spontaneous	2018-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001581110&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10001586934	Spontaneous	2018-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Herpes zoster (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001586934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10001562405	Spontaneous	2018-06-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001562405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001562946	Spontaneous	2018-06-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Pneumonia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - 1{DF} - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001562946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001552832	Spontaneous	2018-06-21 00:00:00	Healthcare Professional	Non European Economic Area	BALBINOTTO A, OSORIO S, de Tarso Roth DALCIN P, Piva PENTEADO L. Influenza A non-H1N1 associated with respiratory failure and acute renal failure in a previously vaccinated cystic fibrosis patient. Rev. bras. ter. intensiva. 2018 MAR;VOL.30,N.1:127-130.	18-64 Years	Not Specified	No	Male	Influenza (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001552832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001532491	Spontaneous	2018-06-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pemphigus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	PRITORPLUS [HYDROCHLOROTHIAZIDE, TELMISARTAN] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - Dose not changed - [n/a - 112.5ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001532491&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001506369	Spontaneous	2018-06-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Adverse event (n/a - Unknown - Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001506369&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10001500802	Spontaneous	2018-06-13 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Apnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (24h - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001500802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001492605	Spontaneous	2018-06-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dry skin (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gingival pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lip swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain of skin (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - )|[ALENDRONATE SODIUM, ALENDRONATE SODIUM TRIHYDRATE, ALENDRONIC ACID] (C - n/a - n/a - )|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - )|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - )|[PARACETAMOL, PARACETAMOL, ASPARTAME] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001492605&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001482813	Spontaneous	2018-06-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (2d - Recovered/Resolved - );Injection site mass (n/a - Recovered/Resolved - )	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001482813&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001480423	Spontaneous	2018-06-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site urticaria (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001480423&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001455535	Spontaneous	2018-06-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Recovered/Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001455535&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10001455691	Spontaneous	2018-06-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Speech disorder (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001455691&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001459373	Spontaneous	2018-06-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001459373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001447599	Spontaneous	2018-06-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - );Hypertrichosis (n/a - Not Recovered/Not Resolved - );Sensory level abnormal (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001447599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001452534	Spontaneous	2018-06-05 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Pemphigoid (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[ECONAZOLE, ECONAZOLE NITRATE] (C - n/a - n/a - [n/a - n/a - Topical])|[METOPROLOL TARTRATE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[OXAZEPAM] (C - n/a - n/a - [n/a - 10mg - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 5mg - Oral])|[SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - Oral])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001452534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001432138	Spontaneous	2018-06-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Aggression (n/a - Unknown - Other Medically Important Condition);Anxiety (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Emotional disorder (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Muscle disorder (n/a - Unknown - Other Medically Important Condition);Muscle spasms (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Suicidal ideation (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001432138&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001423614	Spontaneous	2018-05-31 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001423614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001410538	Spontaneous	2018-05-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved With Sequelae - Disabling);Asthenia (n/a - Recovered/Resolved With Sequelae - Disabling);Autoimmune thyroiditis (n/a - Recovered/Resolved With Sequelae - Disabling);Back pain (n/a - Recovered/Resolved With Sequelae - Disabling);Balance disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Burning sensation (n/a - Recovered/Resolved With Sequelae - Disabling);Dysphagia (n/a - Recovered/Resolved With Sequelae - Disabling);Fatigue (n/a - Recovered/Resolved With Sequelae - Disabling);Gait disturbance (n/a - Recovered/Resolved With Sequelae - Disabling);Headache (n/a - Recovered/Resolved With Sequelae - Disabling);Hypoaesthesia (n/a - Recovered/Resolved With Sequelae - Disabling);Memory impairment (n/a - Recovered/Resolved With Sequelae - Disabling);Muscle rigidity (n/a - Recovered/Resolved With Sequelae - Disabling);Muscle spasms (n/a - Recovered/Resolved With Sequelae - Disabling);Muscle twitching (n/a - Recovered/Resolved With Sequelae - Disabling);Muscular weakness (n/a - Recovered/Resolved With Sequelae - Disabling);Myalgia (n/a - Recovered/Resolved With Sequelae - Disabling);Nausea (n/a - Recovered/Resolved With Sequelae - Disabling);Neuralgia (n/a - Recovered/Resolved With Sequelae - Disabling);Oropharyngeal pain (n/a - Recovered/Resolved With Sequelae - Disabling);Pain in extremity (n/a - Recovered/Resolved With Sequelae - Disabling);Pyrexia (n/a - Recovered/Resolved With Sequelae - Disabling);Sleep disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Speech disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Tremor (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001410538&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10001400906	Spontaneous	2018-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001400906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001404074	Spontaneous	2018-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Obstructive sleep apnoea syndrome (n/a - Unknown - Other Medically Important Condition);Overweight (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001404074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001394792	Spontaneous	2018-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Febrile infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - Drug withdrawn - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 50ug - n/a])|[NEBIVOLOL] (C - n/a - n/a - [n/a - 5mg - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM] (C - n/a - n/a - [n/a - 20mg - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 20mg - n/a])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - n/a])|[TORASEMIDE, TORASEMIDE SODIUM] (C - n/a - n/a - [n/a - 10mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001394792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001384700	Spontaneous	2018-05-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depressive symptom (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Emotional distress (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Facial paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Facial paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fall (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait inability (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hallucination, auditory (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Speech disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tooth fracture (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[LYMECYCLINE, TETRACYCLINE] (C - Acne - Unknown - [n/a - 300mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001384700&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001384872	Spontaneous	2018-05-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001384872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001372319	Spontaneous	2018-05-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001372319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001357740	Spontaneous	2018-05-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Male	Drug ineffective (n/a - Unknown - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001357740&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001360827	Spontaneous	2018-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Not Specified	Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Oropharyngeal pain (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001360827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001362196	Spontaneous	2018-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001362196&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10001353114	Spontaneous	2018-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Bell's palsy (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Decreased interest (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Facial paresis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mood altered (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Quality of life decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Social avoidant behaviour (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001353114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001357198	Spontaneous	2018-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pericarditis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001357198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001333981	Spontaneous	2018-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001333981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001334006	Spontaneous	2018-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001334006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001334582	Spontaneous	2018-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Dyskinesia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Middle insomnia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Restlessness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep talking (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Trance (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001334582&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001337705	Spontaneous	2018-05-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Encephalitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001337705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001321087	Spontaneous	2018-05-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001321087&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001331505	Spontaneous	2018-05-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Encephalopathy (4mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination complication (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	SITAGLIPTIN [SITAGLIPTIN] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[ACEBUTOLOL, ACEBUTOLOL HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 200mg - Oral])|[ALLOPURINOL] (C - n/a - Dose not changed - [n/a - 100mg - Oral])|[DIPYRIDAMOLE, DIPYRIDAMOLE, ACETYLSALICYLIC ACID] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[FUROSEMIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[INDAPAMIDE, INDAPAMIDE HEMIHYDRATE] (C - n/a - Dose not changed - [n/a - 1.25mg - Oral])|[LERCANIDIPINE HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 10mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 1000mg - Oral])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - Dose not changed - [n/a - 5mg - Oral])|[PRAVASTATIN SODIUM] (C - n/a - Dose not changed - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001331505&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001316780	Spontaneous	2018-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001316780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10001308190	Spontaneous	2018-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Apathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[CHOLECALCIFEROL CONCENTRATE (POWDER FORM), COLECALCIFEROL, COLECALCIFEROL CONCENTRATE (OILY FORM)] (C - Vitamin D deficiency - n/a - [n/a - n/a - n/a])|[FENOFIBRATE, FENOFIBRATE (NANONISED)] (C - Hyperlipidaemia - n/a - [n/a - 160mg - n/a])|[METFORMIN HYDROCHLORIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - 500mg - n/a])|[RAMIPRIL] (C - Hypertension - n/a - [n/a - n/a - n/a])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - Depression - n/a - [n/a - 75mg - n/a])|[VITAMINS NOS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001308190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001293984	Spontaneous	2018-05-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (n/a - Recovering/Resolving - );Feeling abnormal (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS (INACTIVATED) ADSORBED] (C - n/a - n/a - [n/a - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001293984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001295542	Spontaneous	2018-05-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001295542&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001295667	Spontaneous	2018-05-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bronchitis (n/a - Unknown - );Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001295667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001284566	Spontaneous	2018-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001284566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001263916	Spontaneous	2018-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Rash vesicular (n/a - Recovered/Resolved - );Rhinorrhoea (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - )	M-M-RVAXPRO [MEASLES VIRUS ENDERS' EDMONSTON STRAIN (LIVE, ATTENUATED), MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001263916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001254017	Spontaneous	2018-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	Yes	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001254017&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10001256648	Spontaneous	2018-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Aggression (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Decreased interest (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Feeling abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Head banging (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Irritability (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mood altered (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Psychiatric symptom (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Quality of life decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Screaming (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Self esteem decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep terror (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Social avoidant behaviour (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001256648&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001232963	Spontaneous	2018-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Feeling abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Peripheral sensory neuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001232963&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001234069	Spontaneous	2018-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hemianaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Intervertebral disc protrusion (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myelopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Osteoarthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Temperature intolerance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001234069&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001234076	Spontaneous	2018-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epiglottitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperthermia (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oral herpes (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngeal ulceration (31d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Synovial cyst (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001234076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001217700	Spontaneous	2018-05-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001217700&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001218178	Spontaneous	2018-05-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dysphonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Flushing (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngeal oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Throat irritation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001218178&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001219516	Spontaneous	2018-05-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Balance disorder (n/a - Recovered/Resolved With Sequelae - );Fatigue (n/a - Recovered/Resolved With Sequelae - );Headache (n/a - Recovered/Resolved With Sequelae - );Movement disorder (n/a - Recovered/Resolved With Sequelae - );Muscle spasms (n/a - Recovered/Resolved With Sequelae - );Muscular weakness (n/a - Recovered/Resolved With Sequelae - );Myalgia (n/a - Recovered/Resolved With Sequelae - );Narcolepsy (n/a - Recovered/Resolved With Sequelae - );Sudden onset of sleep (n/a - Recovered/Resolved With Sequelae - );Tendon sheath disorder (n/a - Recovered/Resolved With Sequelae - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001219516&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10001202372	Spontaneous	2018-04-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Unknown - );Eye allergy (n/a - Unknown - );Food allergy (n/a - Unknown - );Nasopharyngitis (n/a - Unknown - );Seborrhoeic keratosis (n/a - Unknown - );Skin exfoliation (n/a - Unknown - );Skin fissures (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - n/a])	[LEVOTHYROXINE] (C - Hypothyroidism - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001202372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001199827	Spontaneous	2018-04-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site pruritus (n/a - Recovering/Resolving - Other Medically Important Condition);Injection site rash (70d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (S - Arteriosclerosis - Unknown - [n/a - n/a - Oral])|[LEVOTHYROXINE SODIUM] (S - Hyperthyroidism - Unknown - [n/a - n/a - Oral])|[RILMENIDINE, RILMENIDINE DIHYDROGEN PHOSPHATE] (S - Hypertension - Unknown - [n/a - n/a - Oral])|[SIMVASTATIN, EZETIMIBE] (S - Hypercholesterolaemia - Drug withdrawn - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001199827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-10001179787	Spontaneous	2018-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Deafness unilateral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001179787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001185722	Spontaneous	2018-04-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Elderly	No	Male	Influenza (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Renal failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - Not applicable - [1min - 1{DF} - n/a])|[AMINOPHYLLINE, QUININE] (C - Product used for unknown indication - Not applicable - [n/a - 1{DF} - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - Product used for unknown indication - Not applicable - [n/a - 40mg - n/a])|[MAGNESIUM ASPARTATE HYDROCHLORIDE, MAGNESIUM L-ASPARTATE HYDROCHLORIDE TRIHYDRATE] (C - Product used for unknown indication - Not applicable - [n/a - 10mg - n/a])|[METAMIZOLE SODIUM, METAMIZOLE SODIUM MONOHYDRATE] (C - Product used for unknown indication - Not applicable - [n/a - 10mg - n/a])|[MIRTAZAPINE] (C - Product used for unknown indication - Not applicable - [n/a - 30mg - n/a])|[OXAZEPAM] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - Product used for unknown indication - Not applicable - [n/a - 1{DF} - n/a])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - Not applicable - [n/a - 40mg - n/a])|[TORASEMIDE] (C - Product used for unknown indication - Not applicable - [n/a - 200mg - n/a])|[TORASEMIDE] (C - n/a - Not applicable - [n/a - 30mg - n/a])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - Product used for unknown indication - Not applicable - [n/a - 1{DF} - n/a])|[TRIAZOLAM] (C - Product used for unknown indication - Not applicable - [n/a - .25mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001185722&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10001187929	Spontaneous	2018-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Blister (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Skin exfoliation (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001187929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001170784	Spontaneous	2018-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Oropharyngeal pain (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001170784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001170905	Spontaneous	2018-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001170905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001171421	Spontaneous	2018-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001171421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001159501	Spontaneous	2018-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001159501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001159636	Spontaneous	2018-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Not Specified	Asthenia (n/a - Unknown - );Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001159636&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001159737	Spontaneous	2018-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001159737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001159811	Spontaneous	2018-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001159811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001159894	Spontaneous	2018-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Not Specified	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001159894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001160775	Spontaneous	2018-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Respiratory distress (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001160775&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10001164137	Spontaneous	2018-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001164137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001164347	Spontaneous	2018-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001164347&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001164350	Spontaneous	2018-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001164350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001165675	Spontaneous	2018-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001165675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001165718	Spontaneous	2018-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Not Specified	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001165718&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001154449	Spontaneous	2018-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001154449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001154988	Spontaneous	2018-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001154988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001157231	Spontaneous	2018-04-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001157231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001138454	Spontaneous	2018-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Neurological symptom (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001138454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001138494	Spontaneous	2018-04-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Autoimmune hepatitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypothyroidism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Seronegative arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Spondyloarthropathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001138494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001138526	Spontaneous	2018-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Autoimmune disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001138526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001138854	Spontaneous	2018-04-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001138854&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10001139030	Spontaneous	2018-04-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal discomfort (n/a - Unknown - Other Medically Important Condition);Ataxia (n/a - Unknown - Other Medically Important Condition);Chest pain (n/a - Unknown - Other Medically Important Condition);Dehydration (n/a - Unknown - Other Medically Important Condition);Diarrhoea (n/a - Unknown - Other Medically Important Condition);Gastroenteritis viral (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Sneezing (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001139030&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001140767	Spontaneous	2018-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	[CARBOMER, CARBOMER 980] (C - n/a - n/a - [n/a - n/a - n/a])|[CERTOPARIN SODIUM] (C - n/a - n/a - [n/a - n/a - Subcutaneous])|[LIQUID PARAFFIN] (C - n/a - n/a - [n/a - 10mL - n/a])|[METAMIZOLE, METAMIZOLE SODIUM, METAMIZOLE SODIUM MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOCLOPRAMIDE, METOCLOPRAMIDE DIHYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE MONOHYDRATE, METOCLOPRAMIDE HYDROCHLORIDE PH. EUR.] (C - n/a - n/a - [n/a - 10mg - n/a])|[NALOXONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - n/a])|[OXYCODONE, OXYCODONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 20mg - n/a])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - 7.5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001140767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001145841	Spontaneous	2018-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Local reaction (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001145841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001133379	Spontaneous	2018-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Bronchospasm (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Drug ineffective (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001133379&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001136133	Spontaneous	2018-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chronic obstructive pulmonary disease (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001136133&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001137289	Spontaneous	2018-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Generalised tonic-clonic seizure (1d - Recovered/Resolved - Other Medically Important Condition);Vaccination complication (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	DIACOMIT [STIRIPENTOL] (C - Severe myoclonic epilepsy of infancy - Dose not changed - [n/a - 625mg - Oral])|[CLOBAZAM] (C - Severe myoclonic epilepsy of infancy - Dose not changed - [n/a - 2{DF} - Oral])|[TOPIRAMATE] (C - Severe myoclonic epilepsy of infancy - Dose not changed - [n/a - 75mg - Oral])|[VALPROIC ACID, SODIUM VALPROATE] (C - Severe myoclonic epilepsy of infancy - Dose not changed - [n/a - 2{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001137289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001137298	Spontaneous	2018-04-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Vaccination complication (n/a - Unknown - );Vaccine breakthrough infection (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001137298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001137720	Spontaneous	2018-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Thyroiditis subacute (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination complication (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001137720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001128288	Spontaneous	2018-04-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Bruxism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination, auditory (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination, visual (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Patient isolation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Seizure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Speech disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001128288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001128556	Spontaneous	2018-04-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001128556&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001089968	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Disease recurrence (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Sciatica (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001089968&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10001091237	Spontaneous	2018-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001091237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10001096393	Spontaneous	2018-04-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Nasal congestion (n/a - Unknown - );Pyrexia (n/a - Unknown - );Sneezing (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001096393&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001077245	Spontaneous	2018-04-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cellulitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001077245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001077283	Spontaneous	2018-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hemiparaesthesia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001077283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001062357	Spontaneous	2018-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Dysphonia (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - Oral])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001062357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001064608	Spontaneous	2018-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Not Specified	Product administered to patient of inappropriate age (n/a - Unknown - );Pyrexia (n/a - Unknown - );Wrong product administered (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001064608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001067973	Spontaneous	2018-04-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Lymphoma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001067973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001051610	Spontaneous	2018-04-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Back pain (n/a - Not Recovered/Not Resolved - );Body temperature increased (n/a - Not Recovered/Not Resolved - );Chills (n/a - Not Recovered/Not Resolved - );Dysphagia (n/a - Unknown - );Neck pain (n/a - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[BACTERIA NOS] (C - Abdominal pain - n/a - [3d - n/a - Oral])|[LACTOBACILLUS ACIDOPHILUS, BIFIDOBACTERIUM, LACTOBACILLUS ACIDOPHILUS, BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS] (C - Diarrhoea - n/a - [5d - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001051610&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001058116	Spontaneous	2018-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001058116&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001058318	Spontaneous	2018-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001058318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10001045833	Spontaneous	2018-04-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Bronchiolitis (n/a - Not Recovered/Not Resolved - Disabling);Dyskinesia (n/a - Not Recovered/Not Resolved - Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling);Restlessness (n/a - Not Recovered/Not Resolved - Disabling);Urticaria (n/a - Not Recovered/Not Resolved - Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - n/a - Intravenous (not otherwise specified)])|[DIPHTHERIA, TETANUS, PERTUSSIS, HEPATITIS B (RDNA) AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE (ADSORBED)] (S - n/a - Drug withdrawn - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001045833&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10001039246	Spontaneous	2018-04-06 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angina pectoris (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001039246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001039247	Spontaneous	2018-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pharyngeal swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001039247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001040142	Spontaneous	2018-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001040142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10001025986	Spontaneous	2018-04-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Blood glucose increased (n/a - Fatal - Results in Death);Blood pressure decreased (n/a - Fatal - Results in Death);Decubitus ulcer (n/a - Fatal - Results in Death);Dehydration (n/a - Fatal - Results in Death);Diarrhoea (n/a - Fatal - Results in Death);Leg amputation (n/a - Fatal - Results in Death);Neutropenic infection (n/a - Fatal - Results in Death);Pelvic fracture (n/a - Fatal - Results in Death);Peripheral circulatory failure (n/a - Fatal - Results in Death);Postoperative wound complication (n/a - Fatal - Results in Death);Pyrexia (n/a - Fatal - Results in Death);Rectal haemorrhage (n/a - Fatal - Results in Death);Respiratory syncytial virus test positive (n/a - Fatal - Results in Death);Shoulder fracture (n/a - Fatal - Results in Death);Syncope (n/a - Fatal - Results in Death);Wound necrosis (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - n/a])	LANTUS [INSULIN GLARGINE] (C - n/a - n/a - [n/a - n/a - Subcutaneous])|NOVORAPID FLEXPEN [INSULIN ASPART] (C - n/a - n/a - [n/a - n/a - Subcutaneous])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - Oral])|[CEFUROXIME, CEFUROXIME SODIUM] (C - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])|[HYDROXYCARBAMIDE] (C - Polycythaemia vera - n/a - [n/a - n/a - Oral])|[NALOXONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, NALOXONE, OXYCODONE, OXYCODONE HYDROCHLORIDE, NALOXONE, OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[OXYCODONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Intramuscular])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - Oral])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001025986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10001026590	Spontaneous	2018-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Oral pruritus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tinnitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001026590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001017096	Spontaneous	2018-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Affect lability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Akinesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Amimia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Amnestic disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Apathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Behaviour disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Confusional state (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Crying (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Depressed mood (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Derealisation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disorientation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperthermia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Irritability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Learning disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Logorrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Micturition frequency decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Motor dysfunction (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Ovarian cyst (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Photophobia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	[PARACETAMOL] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001017096&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001018789	Spontaneous	2018-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001018789&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000990003	Spontaneous	2018-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Sudden death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000990003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10000995944	Spontaneous	2018-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000995944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000995972	Spontaneous	2018-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site pain (n/a - Unknown - );Oral mucosal erythema (n/a - Unknown - );Pyrexia (n/a - Unknown - )	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000995972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000980847	Spontaneous	2018-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000980847&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000971642	Spontaneous	2018-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngeal oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000971642&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000972400	Spontaneous	2018-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Feeling cold (n/a - Recovering/Resolving - Disabling);Headache (n/a - Recovering/Resolving - Disabling);Nausea (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000972400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000960159	Spontaneous	2018-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...	[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - Oral])|[ATORVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000960159&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000961657	Spontaneous	2018-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abnormal behaviour (n/a - Unknown - Other Medically Important Condition);Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Agnosia (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Confusional state (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Emotional distress (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Fear (n/a - Unknown - Other Medically Important Condition);Frustration tolerance decreased (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Hypnopompic hallucination (n/a - Unknown - Other Medically Important Condition);Illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Irritability (n/a - Unknown - Other Medically Important Condition);Learning disability (n/a - Unknown - Other Medically Important Condition);Lethargy (n/a - Unknown - Other Medically Important Condition);Mood swings (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Prosopagnosia (n/a - Unknown - Other Medically Important Condition);Psychiatric symptom (n/a - Unknown - Other Medically Important Condition);Psychotic disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Screaming (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep terror (n/a - Unknown - Other Medically Important Condition);Social avoidant behaviour (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tinnitus (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000961657&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000961950	Spontaneous	2018-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Apathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depressed mood (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyskinesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Emotional distress (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Impaired driving ability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Irritability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep terror (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown - More in ICSR - More in ICSR])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000961950&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000967692	Spontaneous	2018-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (9d - Recovered/Resolved - );Pruritus (9d - Recovered/Resolved - );Urticaria (9d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000967692&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000955243	Spontaneous	2018-03-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - n/a])|[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000955243&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000955305	Spontaneous	2018-03-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Viral infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - n/a])	[PYRIDOXINE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000955305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000956313	Spontaneous	2018-03-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bronchospasm (n/a - Recovered/Resolved - Life Threatening);Flushing (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .25mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000956313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10000956402	Spontaneous	2018-03-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - Life Threatening);Dyspnoea (n/a - Recovered/Resolved - Life Threatening);Paraesthesia oral (n/a - Recovered/Resolved - Life Threatening);Throat tightness (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000956402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10000937607	Spontaneous	2018-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000937607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000939374	Spontaneous	2018-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination, visual (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS (INACTIVATED) ADSORBED] (S - Prophylaxis - Unknown - [1d - n/a - n/a])|[HEPATITIS A VACCINE] (S - Prophylaxis - Unknown - [1d - n/a - n/a])|[TYPHOID VACCINE] (S - Prophylaxis - Unknown - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000939374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000939384	Spontaneous	2018-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aphasia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eye movement disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Functional gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Gait inability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucinations, mixed (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hemiplegic migraine (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injury (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Loss of control of legs (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nervous system disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Seizure like phenomena (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000939384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000940126	Spontaneous	2018-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000940126&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000941316	Spontaneous	2018-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Apathy (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Food intolerance (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Lower respiratory tract infection (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Menstruation irregular (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Overweight (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Pneumonia viral (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tonsillitis (n/a - Unknown - Other Medically Important Condition);Upper respiratory tract infection (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000941316&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000945722	Spontaneous	2018-03-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000945722&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000929550	Spontaneous	2018-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000929550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000931609	Spontaneous	2018-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	[ANHYDROUS LEVOTHYROXINE SODIUM, LEVOTHYROXINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS EP] (C - Hypothyroidism - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000931609&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10000932217	Spontaneous	2018-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnambulism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular - More in ICSR - More in ICSR])	[CEFACLOR, CEFACLOR MONOHYDRATE] (C - Otitis media acute - n/a - [5d - 250mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000932217&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000932825	Spontaneous	2018-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000932825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000932826	Spontaneous	2018-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abnormal dreams (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Circulatory collapse (n/a - Recovering/Resolving - Other Medically Important Condition);Diplopia (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Dysphonia (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Irritability (n/a - Unknown - Other Medically Important Condition);Lethargy (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pharyngitis (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Quality of life decreased (n/a - Unknown - Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vision blurred (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 3.75 - n/a - More in ICSR - More in ICSR])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000932826&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000932872	Spontaneous	2018-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin plaque (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Toxic skin eruption (n/a - Recovering/Resolving - Other Medically Important Condition);Urticaria chronic (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	[CETIRIZINE DIHYDROCHLORIDE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - Autoimmune thyroiditis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000932872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000935259	Spontaneous	2018-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Overweight (n/a - Not Recovered/Not Resolved - Disabling);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000935259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000918824	Spontaneous	2018-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000918824&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000920491	Spontaneous	2018-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Emotional distress (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown - More in ICSR - More in ICSR])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000920491&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000921106	Spontaneous	2018-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown - More in ICSR - More in ICSR])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000921106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000921723	Spontaneous	2018-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000921723&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000921725	Spontaneous	2018-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Alopecia (n/a - Recovering/Resolving - Other Medically Important Condition);Amnesia (n/a - Unknown - Other Medically Important Condition);Anxiety (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Emotional distress (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injury (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mood swings (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Personality change (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - );Quality of life decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Stress (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tonsillitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000921725&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000922681	Spontaneous	2018-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Eczema (53d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000922681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Duration
EU-EC-10000922853	Spontaneous	2018-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute kidney injury (43d - Recovered/Resolved - Other Medically Important Condition);Arthralgia (43d - Recovered/Resolved - Other Medically Important Condition);Cholestasis (43d - Recovered/Resolved - Other Medically Important Condition);Hepatic cytolysis (43d - Recovered/Resolved - Other Medically Important Condition);Leukopenia (43d - Recovered/Resolved - Other Medically Important Condition);Myalgia (43d - Recovered/Resolved - Other Medically Important Condition);Vasculitis (43d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000922853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000910576	Spontaneous	2018-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Listless (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000910576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10000911009	Spontaneous	2018-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000911009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000912119	Spontaneous	2018-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Nasopharyngitis (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000912119&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000912181	Spontaneous	2018-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000912181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000900959	Spontaneous	2018-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pruritus (5d - Recovered/Resolved - );Rash erythematous (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000900959&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000902215	Spontaneous	2018-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Pharyngeal inflammation (12d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000902215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000903511	Spontaneous	2018-03-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Near death experience (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000903511&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000903947	Spontaneous	2018-03-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000903947&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000893471	Spontaneous	2018-03-17 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Illness (n/a - Unknown - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000893471&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10000883227	Spontaneous	2018-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000883227&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000885851	Spontaneous	2018-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000885851&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000886095	Spontaneous	2018-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000886095&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000886187	Spontaneous	2018-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000886187&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000886578	Spontaneous	2018-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000886578&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000888758	Spontaneous	2018-03-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000888758&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000888759	Spontaneous	2018-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000888759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000889681	Spontaneous	2018-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anorectal discomfort (n/a - Unknown - Other Medically Important Condition);Back pain (n/a - Unknown - Other Medically Important Condition);Cardiac murmur (n/a - Unknown - Other Medically Important Condition);Circadian rhythm sleep disorder (n/a - Unknown - Other Medically Important Condition);Dermatopathic lymphadenopathy (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Generalised anxiety disorder (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Hypersomnia-bulimia syndrome (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Palpitations (n/a - Unknown - Other Medically Important Condition);Panic attack (n/a - Unknown - Other Medically Important Condition);Rectal haemorrhage (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somatic symptom disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Stress (n/a - Unknown - Other Medically Important Condition);Ventricular extrasystoles (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a - More in ICSR - More in ICSR])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000889681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000890184	Spontaneous	2018-03-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000890184&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000876801	Spontaneous	2018-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Muscular weakness (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000876801&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000877512	Spontaneous	2018-03-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Unknown - );Headache (n/a - Unknown - );Malaise (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000877512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000877648	Spontaneous	2018-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Not Recovered/Not Resolved - );Dysphonia (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - );Infection (n/a - Not Recovered/Not Resolved - );Productive cough (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[LISINOPRIL ANHYDROUS, LISINOPRIL DIHYDRATE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000877648&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000868140	Spontaneous	2018-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000868140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000856713	Spontaneous	2018-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza (n/a - Not Recovered/Not Resolved - );Vaccination failure (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000856713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000858092	Spontaneous	2018-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000858092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000834551	Spontaneous	2018-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Hyperventilation (n/a - Unknown - );Pallor (n/a - Unknown - );Respiratory arrest (n/a - Unknown - );Syncope (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000834551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000827379	Spontaneous	2018-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000827379&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000831376	Spontaneous	2018-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Not Specified	Exposure via breast milk (n/a - Unknown - );Urine abnormality (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Transmammary])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000831376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000831390	Spontaneous	2018-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Injury associated with device (n/a - Not Recovered/Not Resolved - );Product quality issue (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000831390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000817310	Spontaneous	2018-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000817310&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000818597	Spontaneous	2018-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Incorrect route of product administration (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000818597&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000820317	Spontaneous	2018-03-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000820317&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000808062	Spontaneous	2018-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash maculo-papular (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000808062&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000814076	Spontaneous	2018-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Ophthalmic herpes zoster (2mo - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - n/a - Unknown])|[METHOTREXATE] (S - n/a - Dose not changed - [n/a - 15mg - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000814076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000799891	Spontaneous	2018-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Erythema (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [53d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000799891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000800941	Spontaneous	2018-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema multiforme (n/a - Recovered/Resolved - );Lip erythema (n/a - Recovered/Resolved - );Lip oedema (n/a - Recovered/Resolved - );Lip ulceration (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000800941&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000801294	Spontaneous	2018-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000801294&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000795763	Spontaneous	2018-03-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - );Lymphadenopathy (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Vaccination site swelling (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000795763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000795804	Spontaneous	2018-03-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Constipation (n/a - Recovered/Resolved - Other Medically Important Condition);Diplegia (n/a - Recovered/Resolved - Other Medically Important Condition);Ear infection (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Hypertension (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	MIRAPEXIN [PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE] (C - Pain - Not applicable - [n/a - .18mg - Oral])|PROLIA [DENOSUMAB] (C - Osteoporosis - Not applicable - [n/a - n/a - n/a])|[METHYLPREDNISOLONE] (C - Pain - Not applicable - [n/a - 4mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000795804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000787293	Spontaneous	2018-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - Oral])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - Oral])|[SUMATRIPTAN, SUMATRIPTAN SUCCINATE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000787293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000788499	Spontaneous	2018-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000788499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000788608	Spontaneous	2018-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000788608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000788793	Spontaneous	2018-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000788793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000789557	Spontaneous	2018-03-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Janus kinase 2 mutation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000789557&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000790529	Spontaneous	2018-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blister (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000790529&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000794672	Spontaneous	2018-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dysaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nervous system disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000794672&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000780735	Spontaneous	2018-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Pain in extremity (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000780735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000786126	Spontaneous	2018-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Muscle spasms (15d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000786126&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000772133	Spontaneous	2018-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Gait disturbance (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000772133&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000773078	Spontaneous	2018-02-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	No	Male	Amniotic band syndrome (n/a - Recovered/Resolved With Sequelae - Disabling);Foetal exposure during pregnancy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000773078&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10000762500	Spontaneous	2018-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Facial paralysis (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Quality of life decreased (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000762500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000763151	Spontaneous	2018-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Recovered/Resolved - );Vaccination failure (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000763151&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000764976	Spontaneous	2018-02-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000764976&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000756016	Spontaneous	2018-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000756016&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000757329	Spontaneous	2018-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination failure (7d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [0d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000757329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000758955	Spontaneous	2018-02-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Life Threatening);Subarachnoid haemorrhage (n/a - Not Recovered/Not Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Subcutaneous])	[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - Not applicable - [n/a - 100mg - Oral])|[CILAZAPRIL] (C - Hypertension - Not applicable - [n/a - 5mg - Oral])|[METOPROLOL, METOPROLOL TARTRATE] (C - Product used for unknown indication - Not applicable - [n/a - 23.75mg - Oral])|[SIMVASTATIN] (C - Hyperlipidaemia - Not applicable - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000758955&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10000759574	Spontaneous	2018-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000759574&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000759602	Spontaneous	2018-02-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	Yes	Male	Autism spectrum disorder (n/a - Not Recovered/Not Resolved - Disabling);Psychomotor retardation (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000759602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000751203	Spontaneous	2018-02-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site oedema (8d - Recovered/Resolved - Disabling);Vaccination site pain (8d - Recovered/Resolved - Disabling);Vaccination site papule (8d - Recovered/Resolved - Disabling);Vaccination site warmth (8d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000751203&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000751142	Spontaneous	2018-02-24 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000751142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000741191	Spontaneous	2018-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - );Hypersensitivity (n/a - Recovered/Resolved - );Oedema peripheral (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000741191&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000741415	Spontaneous	2018-02-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Alopecia areata (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000741415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000741599	Spontaneous	2018-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Visual impairment (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000741599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000745343	Spontaneous	2018-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000745343&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000745984	Spontaneous	2018-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Drug eruption (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000745984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000746281	Spontaneous	2018-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Atrial fibrillation (12h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	XARELTO [RIVAROXABAN] (C - n/a - n/a - [n/a - n/a - n/a])|[TAMSULOSIN HYDROCHLORIDE, DUTASTERIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000746281&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000722047	Spontaneous	2018-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Urticaria (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000722047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000722134	Spontaneous	2018-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000722134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000722487	Spontaneous	2018-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Not Recovered/Not Resolved - );Vaccination failure (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000722487&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000724092	Spontaneous	2018-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - Disabling);Dizziness (n/a - Recovering/Resolving - Disabling);Musculoskeletal stiffness (n/a - Recovering/Resolving - Disabling);Myalgia (n/a - Recovering/Resolving - Disabling);Pyrexia (n/a - Recovering/Resolving - Disabling);Rash (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000724092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000724123	Spontaneous	2018-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000724123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000727772	Spontaneous	2018-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ankylosing spondylitis (22d - Recovered/Resolved - Other Medically Important Condition);Arthralgia (22d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (22d - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (22d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000727772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-10000712172	Spontaneous	2018-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Muscular weakness (n/a - Recovering/Resolving - );Pain in extremity (n/a - Recovering/Resolving - );Paraesthesia (n/a - Recovering/Resolving - );Tremor (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])|[DIPHTHERIA AND TETANUS VACCINE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000712172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000712174	Spontaneous	2018-02-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Malaise (n/a - Unknown - );Myalgia (n/a - Unknown - );Nasal congestion (n/a - Unknown - );Sinusitis (n/a - Unknown - );Skin burning sensation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000712174&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000712262	Spontaneous	2018-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Unknown - );Feeling abnormal (n/a - Unknown - );Malaise (n/a - Unknown - );Pyrexia (n/a - Unknown - );Tremor (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000712262&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000715102	Spontaneous	2018-02-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Angina pectoris (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000715102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000717078	Spontaneous	2018-02-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bronchospasm (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site inflammation (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000717078&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000717080	Spontaneous	2018-02-20 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Nausea (n/a - Unknown - Other Medically Important Condition);Presyncope (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000717080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000719913	Spontaneous	2018-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Tendonitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000719913&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000719922	Spontaneous	2018-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000719922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000719924	Spontaneous	2018-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000719924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000702109	Spontaneous	2018-02-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000702109&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000706936	Spontaneous	2018-02-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pain of skin (n/a - Unknown - );Rash (n/a - Unknown - );Skin burning sensation (n/a - Recovering/Resolving - );Vaccination site erythema (n/a - Not Recovered/Not Resolved - );Vaccination site pain (n/a - Unknown - );Vaccination site rash (n/a - Recovered/Resolved - );Vaccination site swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000706936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000707590	Spontaneous	2018-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Burning sensation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lymphadenitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000707590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000707594	Spontaneous	2018-02-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Lichen planus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])|[HYDROCHLOROTHIAZIDE, QUINAPRIL] (S - Essential hypertension - Dose not changed - [n/a - 1{DF} - Oral])|[SIMVASTATIN] (S - Hypercholesterolaemia - Dose not changed - [n/a - 40mg - Oral])|[VARICELLA VACCINE (LIVE)] (S - Immunisation - Not applicable - [1d - .65mL - Subcutaneous])|[ZOPICLONE] (S - Insomnia - Dose not changed - [n/a - 7.5mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000707594&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000707597	Spontaneous	2018-02-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Presyncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000707597&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000707599	Spontaneous	2018-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site cellulitis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000707599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000707601	Spontaneous	2018-02-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Presyncope (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000707601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000707603	Spontaneous	2018-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chest pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tachycardia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - .5mL - n/a])|[DIPHTHERIA AND TETANUS VACCINE (ADSORBED)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000707603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000707988	Spontaneous	2018-02-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Hallucination (n/a - Recovered/Resolved - Other Medically Important Condition);Skin burning sensation (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000707988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000707989	Spontaneous	2018-02-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Chest pain (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Hypertension (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000707989&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000699710	Spontaneous	2018-02-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000699710&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000699761	Spontaneous	2018-02-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000699761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000699873	Spontaneous	2018-02-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Motor neurone disease (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000699873&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10000688752	Spontaneous	2018-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Asthenia (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000688752&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000689137	Spontaneous	2018-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Dysarthria (n/a - Recovered/Resolved - );Foaming at mouth (n/a - Recovered/Resolved - );Muscular weakness (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	LYRICA [PREGABALIN] (C - Neuralgia - n/a - [n/a - n/a - Oral])|MELATONIN [MELATONIN] (C - Insomnia - n/a - [n/a - n/a - Oral])|[AMLODIPINE, AMLODIPINE MALEATE, TEMAZEPAM] (C - Insomnia - n/a - [n/a - n/a - Oral])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - Oral])|[DICLOFENAC DIETHYLAMINE, DICLOFENAC SODIUM] (C - Arthralgia - n/a - [n/a - n/a - Topical])|[FUROSEMIDE] (C - Oedema peripheral - n/a - [n/a - n/a - Oral])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - Pruritus - n/a - [n/a - n/a - Oral])|[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - n/a - Oral])|[MICONAZOLE, MICONAZOLE NITRATE] (C - n/a - n/a - [n/a - n/a - Topical])|[NORTRIPTYLINE, NORTRIPTYLINE HYDROCHLORIDE] (C - Pain - n/a - [n/a - n/a - Oral])|[PARACETAMOL] (C - Pain - n/a - [n/a - n/a - Oral])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - Constipation - n/a - [n/a - n/a - Oral])|[RAMIPRIL] (C - Cardiac failure - n/a - [n/a - n/a - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - n/a - Oral])|[SODIUM CHLORIDE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM SULFATE ANHYDROUS, MACROGOL 4000] (C - Constipation prophylaxis - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000689137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000689446	Spontaneous	2018-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000689446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000679000	Spontaneous	2018-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000679000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000679883	Spontaneous	2018-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (3d - Recovered/Resolved - );Influenza like illness (3d - Recovered/Resolved - );Vomiting (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000679883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000680743	Spontaneous	2018-02-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000680743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000681105	Spontaneous	2018-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Epilepsy (1d - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000681105&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-10000681106	Spontaneous	2018-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - );Feeling hot (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Speech disorder (n/a - Recovered/Resolved - );Urinary incontinence (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000681106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000686235	Spontaneous	2018-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Unknown - );Vaccination site pain (n/a - Unknown - );Vaccination site rash (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - )|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - n/a - )|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000686235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000687532	Spontaneous	2018-02-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000687532&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000670799	Spontaneous	2018-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000670799&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000672173	Spontaneous	2018-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Headache (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000672173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000672209	Spontaneous	2018-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000672209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000672557	Spontaneous	2018-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000672557&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000672579	Spontaneous	2018-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000672579&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000673185	Spontaneous	2018-02-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000673185&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000673540	Spontaneous	2018-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000673540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000676894	Spontaneous	2018-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bronchitis (n/a - Recovering/Resolving - );Dyspnoea (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000676894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000663429	Spontaneous	2018-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Neck pain (n/a - Recovering/Resolving - );Neuralgia (n/a - Recovering/Resolving - );Pain in extremity (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[AMILORIDE HYDROCHLORIDE DIHYDRATE, AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000663429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000664212	Spontaneous	2018-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pain in extremity (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000664212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000652317	Spontaneous	2018-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	JANUVIA [SITAGLIPTIN, SITAGLIPTIN PHOSPHATE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (C - Diabetes mellitus - n/a - [n/a - n/a - Oral])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[MEMANTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000652317&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000652329	Spontaneous	2018-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hyperaesthesia (n/a - Recovered/Resolved - );Muscular weakness (n/a - Recovered/Resolved - );Pain in extremity (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - );Vaccination site reaction (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000652329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000652495	Spontaneous	2018-02-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Cough (n/a - Recovering/Resolving - );Feeling abnormal (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Oedema (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000652495&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000652503	Spontaneous	2018-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Dizziness (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000652503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000652673	Spontaneous	2018-02-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (n/a - Recovered/Resolved - );Chronic fatigue syndrome (n/a - Unknown - );Coordination abnormal (n/a - Unknown - );Dizziness (n/a - Unknown - );Encephalomyelitis (n/a - Unknown - );Erythema (n/a - Recovered/Resolved - );Fatigue (n/a - Unknown - );Headache (n/a - Unknown - );Hypersensitivity (n/a - Unknown - );Immunodeficiency (n/a - Unknown - );Local reaction (n/a - Recovered/Resolved - );Nasopharyngitis (n/a - Unknown - );Pyrexia (n/a - Recovered/Resolved - );Sensory disturbance (n/a - Unknown - );Swelling (n/a - Recovered/Resolved - );Tachycardia (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000652673&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000653200	Spontaneous	2018-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adolescent	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Respiratory arrest (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Snoring (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000653200&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000653235	Spontaneous	2018-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000653235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000654121	Spontaneous	2018-02-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000654121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000654591	Spontaneous	2018-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (7d - Recovered/Resolved - Disabling);Chest pain (6d - Recovered/Resolved - Disabling);Cough (6d - Recovered/Resolved - Disabling);Headache (7d - Recovered/Resolved - Disabling);Hyperthermia (7d - Recovered/Resolved - Disabling);Malaise (7d - Recovered/Resolved - Disabling);Myalgia (7d - Recovered/Resolved - Disabling);Oropharyngeal pain (6d - Recovered/Resolved - Disabling);Tonsillitis (4d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [0d - 1{DF} - Intramuscular])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000654591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000656246	Spontaneous	2018-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000656246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000642909	Spontaneous	2018-02-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	CSF protein (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hemiplegia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myelitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neurogenic bladder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Quadriplegia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000642909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000631407	Spontaneous	2018-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Recovered/Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - );Vaccination site swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000631407&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000631710	Spontaneous	2018-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Nausea (4d - Recovered/Resolved - );Pain in extremity (4d - Recovered/Resolved - );Vaccination site pain (4d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000631710&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000632026	Spontaneous	2018-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Drug eruption (3mo - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000632026&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000636136	Spontaneous	2018-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	No adverse event (n/a - Unknown - );Vaccination error (0d - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000636136&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000625642	Spontaneous	2018-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngeal erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngeal oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000625642&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000626622	Spontaneous	2018-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000626622&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000611457	Spontaneous	2018-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pruritus (6d - Recovered/Resolved - );Urticaria (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000611457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000612128	Spontaneous	2018-02-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000612128&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000615721	Spontaneous	2018-02-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Brain injury (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cardiac disorder (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Feeling abnormal (0d - Recovered/Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypertension (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypotension (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Multi-organ disorder (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Quality of life decreased (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Syncope (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000615721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10000615782	Spontaneous	2018-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000615782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000617193	Spontaneous	2018-02-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Sarcoidosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000617193&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000605807	Spontaneous	2018-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chills (2d - Recovered/Resolved - );Headache (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000605807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000606476	Spontaneous	2018-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000606476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000606929	Spontaneous	2018-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Colitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	STELARA [USTEKINUMAB] (C - Colitis - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000606929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000607990	Spontaneous	2018-02-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Injection site rash (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Unknown - [n/a - .5mL - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - )|[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, AMILORIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE DIHYDRATE, HYDROCHLOROTHIAZIDE, ANHYDROUS AMILORIDE HYDROCHLORIDE] (C - n/a - n/a - )|[BIOFLAVONOIDS, DIOSMIN, HESPERIDIN, MICRONISED PURIFIED FLAVONOIC FRACTION] (C - n/a - n/a - )|[CELIPROLOL HYDROCHLORIDE] (C - n/a - n/a - )|[CICLESONIDE] (C - n/a - n/a - )|[PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - )|[ROSUVASTATIN] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000607990&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000593188	Spontaneous	2018-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Stasis dermatitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000593188&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000597724	Spontaneous	2018-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000597724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000597725	Spontaneous	2018-02-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Muscular weakness (n/a - Unknown - );Myalgia (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000597725&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000584792	Spontaneous	2018-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000584792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000585546	Spontaneous	2018-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000585546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000585816	Spontaneous	2018-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000585816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000586400	Spontaneous	2018-02-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abortion incomplete (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Exposure during pregnancy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000586400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10000586416	Spontaneous	2018-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[BISOPROLOL, BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - Oral])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - Oral])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000586416&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000586463	Spontaneous	2018-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Migraine (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling)	HBVAXPRO [ALUMINIUM, HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - n/a - n/a - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000586463&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000586473	Spontaneous	2018-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Headache (n/a - Recovered/Resolved - Disabling);Neck pain (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - Oral])|[CICLESONIDE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[ESTRADIOL, ESTRADIOL HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - Vaginal])|[ETORICOXIB] (C - n/a - n/a - [n/a - n/a - Oral])|[HYDROCORTISONE ACETATE, POLYMYXIN B, OXYTETRACYCLINE, POLYMYXIN B SULFATE, HYDROCORTISONE, OXYTETRACYCLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000586473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000586638	Spontaneous	2018-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000586638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000587788	Spontaneous	2018-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Encephalitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Meningitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000587788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10000575212	Spontaneous	2018-01-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hypoaesthesia (n/a - Not Recovered/Not Resolved - );Pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000575212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000577293	Spontaneous	2018-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Vaccination failure (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [0d - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000577293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000578604	Spontaneous	2018-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000578604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000578753	Spontaneous	2018-01-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Back pain (n/a - Recovered/Resolved With Sequelae - Disabling);Chronic fatigue syndrome (n/a - Recovered/Resolved With Sequelae - Disabling);Fibromyalgia (n/a - Recovered/Resolved With Sequelae - Disabling);Idiopathic environmental intolerance (n/a - Recovered/Resolved With Sequelae - Disabling);Insomnia (n/a - Recovered/Resolved With Sequelae - Disabling);Neuralgia (n/a - Recovered/Resolved With Sequelae - Disabling);Sciatica (n/a - Recovered/Resolved With Sequelae - Disabling);Sick building syndrome (n/a - Recovered/Resolved With Sequelae - Disabling);Sleep apnoea syndrome (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000578753&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10000557790	Spontaneous	2018-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000557790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000561006	Spontaneous	2018-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Chest pain (8d - Recovered/Resolved - );Neuralgia (8d - Recovered/Resolved - );Paraesthesia (8d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	LANTUS [INSULIN GLARGINE] (C - n/a - Not applicable - [n/a - n/a - Subcutaneous])|TRAJENTA [LINAGLIPTIN] (C - n/a - Not applicable - [n/a - n/a - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - Not applicable - [n/a - n/a - Oral])|[CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - Not applicable - [n/a - n/a - Oral])|[INDAPAMIDE, AMLODIPINE BESILATE, PERINDOPRIL ARGININE] (C - n/a - Not applicable - [n/a - n/a - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - n/a - Oral])|[NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000561006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000564507	Spontaneous	2018-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[DIENOGEST, ESTRADIOL VALERATE, ESTRADIOL VALERATE, LACTOSE, LACTOSE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000564507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000555608	Spontaneous	2018-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Product administration error (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	XARELTO [RIVAROXABAN] (C - n/a - n/a - )|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - n/a - n/a - )|[DONEPEZIL HYDROCHLORIDE] (C - n/a - n/a - )|[FUROSEMIDE] (C - n/a - n/a - )|[LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - )|[VALSARTAN] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000555608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000555933	Spontaneous	2018-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema multiforme (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash maculo-papular (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site inflammation (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site oedema (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	DUOPLAVIN 75 MG/75 MG FILM-COATED TABLETS [ACETYLSALICYLIC ACID, CLOPIDOGREL] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - Dose not changed - [n/a - 20mg - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - Dose not changed - [n/a - 40mg - Oral])|[BROMAZEPAM] (C - n/a - Dose not changed - [n/a - 1.5mg - Oral])|[EPLERENONE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[FUROSEMIDE] (C - n/a - Dose not changed - [n/a - 20mg - Oral])|[NEBIVOLOL] (C - n/a - Dose not changed - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000555933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000550090	Spontaneous	2018-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000550090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000553110	Spontaneous	2018-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Coordination abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Speech disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000553110&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000553365	Spontaneous	2018-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Idiopathic environmental intolerance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Periarthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sick building syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000553365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000555074	Spontaneous	2018-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000555074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000541537	Spontaneous	2018-01-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000541537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000541624	Spontaneous	2018-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000541624&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000541685	Spontaneous	2018-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000541685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000541769	Spontaneous	2018-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza B virus test positive (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000541769&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000541948	Spontaneous	2018-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000541948&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000532738	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal distension (7d - Recovered/Resolved - );Malaise (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000532738&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000533114	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Angioedema (n/a - Recovering/Resolving - Other Medically Important Condition);Back pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Blister (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Burning sensation (n/a - Recovering/Resolving - Other Medically Important Condition);Chest pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[NAFTIDROFURYL, NAFTIDROFURYL OXALATE] (C - Raynaud's phenomenon - Not applicable - [n/a - 200mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000533114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000533298	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000533298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000534506	Spontaneous	2018-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000534506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000535093	Spontaneous	2018-01-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pain (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Rheumatoid arthritis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Swelling (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000535093&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000524316	Spontaneous	2018-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000524316&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000526390	Spontaneous	2018-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersomnia (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Loss of consciousness (n/a - Unknown - Other Medically Important Condition);Multiple allergies (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000526390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000528940	Spontaneous	2018-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [0d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000528940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000529326	Spontaneous	2018-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Influenza (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000529326&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000529390	Spontaneous	2018-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [0d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000529390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000530279	Spontaneous	2018-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chest discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diaphragmatic paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea exertional (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Emphysema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000530279&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000531860	Spontaneous	2018-01-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Joint stiffness (4d - Recovered/Resolved - );Odynophagia (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	[RAMIPRIL] (C - Hypertension - n/a - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000531860&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000516708	Spontaneous	2018-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dizziness (1d - Recovered/Resolved - );Muscle spasms (1d - Recovered/Resolved - );Paraesthesia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	CONTRACEPTIVES NOS [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000516708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000516794	Spontaneous	2018-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Muscle twitching (n/a - Recovering/Resolving - );Paraesthesia (n/a - Recovering/Resolving - );Skin discolouration (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Parenteral])	IRBESARTAN [IRBESARTAN] (C - Ill-defined disorder - n/a - )|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Ill-defined disorder - n/a - )|[INDAPAMIDE, INDAPAMIDE HEMIHYDRATE] (C - Ill-defined disorder - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000516794&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000512236	Spontaneous	2018-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Joint stiffness (n/a - Not Recovered/Not Resolved - );Oedema peripheral (n/a - Not Recovered/Not Resolved - );Pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	PROCORALAN 7.5 MG FILM-COATED TABLETS [IVABRADINE HYDROCHLORIDE] (C - n/a - n/a - )|[ANHYDROUS CALCIFEDIOL, CALCIFEDIOL] (C - n/a - n/a - )|[BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - )|[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - )|[GLYCERYL TRINITRATE, GLYCERYL TRINITRATE SOLUTION] (C - n/a - n/a - )|[SIMVASTATIN, EZETIMIBE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000512236&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000503205	Spontaneous	2018-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (4d - Recovered/Resolved - );Pain (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000503205&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000506409	Spontaneous	2018-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000506409&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000507803	Spontaneous	2018-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Henoch-Schonlein purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Skin discomfort (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	OPIOID [OPIOID] (C - Osteoarthritis - n/a - )|PREGABALIN [PREGABALIN] (C - n/a - n/a - [n/a - 75mg - n/a])|[COLECALCIFEROL] (C - n/a - n/a - )|[METOPROLOL SUCCINATE, METOPROLOL SUCCINATE (PH. EUR.)] (C - n/a - n/a - [n/a - 47.5mg - n/a])|[MORPHINE, MORPHINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 60mg - n/a])|[OXAZEPAM] (C - n/a - n/a - [n/a - 10mg - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM] (C - n/a - n/a - [n/a - 40mg - n/a])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - )|[PREDNISOLONE] (C - n/a - n/a - [n/a - 40mg - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 2.5mg - n/a])|[TORASEMIDE, TORASEMIDE SODIUM] (C - n/a - n/a - [n/a - 10mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000507803&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000507999	Spontaneous	2018-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Vaccination failure (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [0mo - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000507999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000510462	Spontaneous	2018-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000510462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000512096	Spontaneous	2018-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Rash (11d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])|[DILTIAZEM HYDROCHLORIDE] (S - Hypertension - Dose not changed - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000512096&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000494358	Spontaneous	2018-01-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Nausea (n/a - Not Recovered/Not Resolved - );Tremor (n/a - Not Recovered/Not Resolved - );Vertigo (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000494358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000495913	Spontaneous	2018-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[LEVOTHYROXINE] (C - n/a - n/a - [n/a - n/a - Oral])|[TAMOXIFEN, TAMOXIFEN CITRATE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000495913&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000496191	Spontaneous	2018-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia oral (n/a - Recovered/Resolved - );Paraesthesia oral (n/a - Recovered/Resolved - );Tongue pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[LEVOTHYROXINE] (C - Hypothyroidism - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000496191&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000496195	Spontaneous	2018-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Paraesthesia oral (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[AZATHIOPRINE] (C - Liver disorder - n/a - [n/a - n/a - Oral])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE] (C - Panic disorder - n/a - [n/a - n/a - Oral])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - Osteoporosis - n/a - [n/a - n/a - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - n/a - Oral])|[URSODEOXYCHOLIC ACID] (C - Psoriatic arthropathy - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000496195&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000496204	Spontaneous	2018-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - );Asthenia (n/a - Recovering/Resolving - );Hypoaesthesia (n/a - Recovering/Resolving - );Muscular weakness (n/a - Recovering/Resolving - );Pain in extremity (n/a - Recovering/Resolving - );Paraesthesia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000496204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000496891	Spontaneous	2018-01-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000496891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000498758	Spontaneous	2018-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cold sweat (1d - Recovered/Resolved - );Dizziness (1d - Recovered/Resolved - );Hyperhidrosis (1d - Recovered/Resolved - );Pallor (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000498758&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000499170	Spontaneous	2018-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Product use complaint (n/a - Recovered/Resolved - );Vaccination site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000499170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000499172	Spontaneous	2018-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Product use complaint (n/a - Recovered/Resolved - );Vaccination site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000499172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000502302	Spontaneous	2018-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pruritus (1wk - Recovered/Resolved - );Skin reaction (1wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000502302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000502339	Spontaneous	2018-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myalgia (10d - Recovered/Resolved - );Pyrexia (10d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000502339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000485536	Spontaneous	2018-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	C-reactive protein increased (n/a - Not Recovered/Not Resolved - );Mobility decreased (n/a - Recovered/Resolved - );Vaccination site inflammation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000485536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000485953	Spontaneous	2018-01-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blister (n/a - Recovering/Resolving - Other Medically Important Condition);Erythema (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000485953&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000488660	Spontaneous	2018-01-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000488660&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000488669	Spontaneous	2018-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000488669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000488693	Spontaneous	2018-01-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000488693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000490406	Spontaneous	2018-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oxygen saturation decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000490406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000475395	Spontaneous	2018-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000475395&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000475402	Spontaneous	2018-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site warmth (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Tetany (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	KEPPRA [LEVETIRACETAM] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000475402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000468674	Spontaneous	2018-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - n/a - n/a - )|[PARACETAMOL] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000468674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000469857	Spontaneous	2018-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood pressure increased (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition);Vision blurred (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000469857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000470136	Spontaneous	2018-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Impaired work ability (n/a - Unknown - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000470136&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000471474	Spontaneous	2018-01-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Recovering/Resolving - );Inflammation (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - );Vaccination site pain (n/a - Recovering/Resolving - );Vaccination site plaque (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000471474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000471502	Spontaneous	2018-01-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Recovered/Resolved - );Laryngitis (n/a - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000471502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000472677	Spontaneous	2018-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Male	Vaccination failure (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [0d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000472677&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000467050	Spontaneous	2018-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Cough (n/a - Not Recovered/Not Resolved - Disabling);Eczema (n/a - Unknown - Disabling);Eye infection (n/a - Unknown - Disabling);Hyposmia (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Unknown - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling);Taste disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[ALLOPURINOL] (C - Gout - Unknown - [n/a - 300mg - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Blood cholesterol - Unknown - [n/a - 10mg - n/a])|[ATORVASTATIN] (C - Blood pressure measurement - Unknown - [n/a - 20mg - n/a])|[CANDESARTAN] (C - n/a - Unknown - [n/a - 16mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000467050&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000465164	Spontaneous	2018-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site reaction (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000465164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000465296	Spontaneous	2018-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site induration (n/a - Not Recovered/Not Resolved - );Vaccination site inflammation (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000465296&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000465335	Spontaneous	2018-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Vertigo (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000465335&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000465591	Spontaneous	2018-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Injection site erythema (n/a - Unknown - );Injection site papule (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000465591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000465607	Spontaneous	2018-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (4d - Recovered/Resolved - );Pain in extremity (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000465607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000466602	Spontaneous	2018-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lactation insufficiency (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000466602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000466616	Spontaneous	2018-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adolescent	No	Male	Arthralgia (n/a - Unknown - );Headache (n/a - Unknown - );Hyperhidrosis (n/a - Unknown - );Injection site erythema (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - );Injection site swelling (n/a - Recovered/Resolved - );Malaise (n/a - Unknown - );Myalgia (n/a - Unknown - );Pyrexia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000466616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000457663	Spontaneous	2018-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Blood pressure increased (n/a - Recovered/Resolved - );Chills (n/a - Recovered/Resolved - );Dizziness (n/a - Recovered/Resolved - );Head discomfort (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000457663&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000457694	Spontaneous	2018-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Oropharyngeal pain (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000457694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000457712	Spontaneous	2018-01-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arrhythmia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	BRINTELLIX [VORTIOXETINE] (C - n/a - n/a - [n/a - n/a - Oral])|ESOMEPRAZOLE [ESOMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - Oral])|[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000457712&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000457782	Spontaneous	2018-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Superficial vein thrombosis (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000457782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000457800	Spontaneous	2018-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - );Burning sensation (n/a - Not Recovered/Not Resolved - );Erythema (n/a - Not Recovered/Not Resolved - );Joint swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[ATORVASTATIN] (C - n/a - n/a - )|[BETAMETHASONE, BETAMETHASONE DIPROPIONATE, SALICYLIC ACID, BETAMETHASONE DIPROPIONATE, SALSALATE, BETAMETHASONE, SALICYLIC ACID] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000457800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000457819	Spontaneous	2018-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia (n/a - Not Recovered/Not Resolved - );Neuralgia (n/a - Not Recovered/Not Resolved - );Vaccination site reaction (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[LEVOTHYROXINE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000457819&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000460362	Spontaneous	2018-01-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Hypertension (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000460362&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000460439	Spontaneous	2018-01-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Head discomfort (n/a - Unknown - );Musculoskeletal stiffness (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000460439&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000460746	Spontaneous	2018-01-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Subcutaneous])	VELMETIA [METFORMIN HYDROCHLORIDE, SITAGLIPTIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (C - Diabetes mellitus - n/a - [n/a - n/a - Oral])|[CANDESARTAN CILEXETIL] (C - Migraine - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000460746&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000461613	Spontaneous	2018-01-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vitiligo (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000461613&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000448688	Spontaneous	2018-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Back pain (n/a - Recovered/Resolved - Other Medically Important Condition);Blister (n/a - Recovered/Resolved - Other Medically Important Condition);Burning sensation (n/a - Recovered/Resolved - Other Medically Important Condition);Chest pain (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[NAFTIDROFURYL, NAFTIDROFURYL OXALATE] (C - Raynaud's phenomenon - Not applicable - [n/a - 200mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000448688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000449761	Spontaneous	2018-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Contusion (n/a - Recovering/Resolving - );Paraesthesia (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000449761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000449798	Spontaneous	2018-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000449798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000451061	Spontaneous	2018-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angioedema (24h - Recovered/Resolved - Other Medically Important Condition);Urticaria (24h - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000451061&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000454247	Spontaneous	2018-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Seizure (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000454247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000445041	Spontaneous	2018-01-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypertension (n/a - Unknown - );Hypoglycaemia (n/a - Unknown - );Nervous system disorder (n/a - Unknown - );Visual impairment (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000445041&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000445267	Spontaneous	2018-01-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovering/Resolving - Disabling);Blood pressure increased (n/a - Recovering/Resolving - Disabling);Dizziness (n/a - Recovering/Resolving - Disabling);Ear discomfort (n/a - Recovering/Resolving - Disabling);Heart rate increased (n/a - Recovering/Resolving - Disabling);Insomnia (n/a - Recovering/Resolving - Disabling);Muscular weakness (n/a - Recovering/Resolving - Disabling);Musculoskeletal stiffness (n/a - Recovering/Resolving - Disabling);Nausea (n/a - Recovering/Resolving - Disabling);Palpitations (n/a - Recovering/Resolving - Disabling);Pyrexia (n/a - Recovering/Resolving - Disabling);Raynaud's phenomenon (n/a - Recovering/Resolving - Disabling);Respiratory tract infection (n/a - Recovering/Resolving - Disabling);Tinnitus (n/a - Recovering/Resolving - Disabling);Tremor (n/a - Recovering/Resolving - Disabling);Ventricular tachycardia (n/a - Recovering/Resolving - Disabling);Vertigo (n/a - Recovering/Resolving - Disabling);Visual impairment (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000445267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10000434040	Spontaneous	2018-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aphthous ulcer (n/a - Recovered/Resolved - );Fatigue (5d - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000434040&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000436749	Spontaneous	2018-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000436749&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000438076	Spontaneous	2018-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Coma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoglycaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neurotoxicity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Reaction to excipient (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008 - DERIVED STRAIN USED NYMC BX-35, B/BRISBANE/60/2008-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/MASSACHUSETTS/2/2012-LIKE STRAIN USED B/MASSACHUSETTS/2/2012 WILD TYPE, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012-LIKE STRAIN USED B/MASSACHUSETTS/2/2012 WILD TYPE, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, ALGELDRATE, NEISSERIA MENINGITIDIS GROUP C, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, TETANUS TOXOID, ALGELDRATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, ALUMINIUM, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED), TETANUS TOXOID, N. MENINGITIDIS GROUP C POLYSACCHARIDE, ALGELDRATE] (S - Immunisation - n/a - [n/a - n/a - n/a])...	[DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALUMINIUM HYDROXIDE, FILAMENTOUS HAEMAGGLUTININ, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM HYDROXIDE, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000438076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000438487	Spontaneous	2018-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Neutropenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000438487&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000438490	Spontaneous	2018-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Herpes zoster (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Unknown - Other Medically Important Condition);Vaccination site rash (n/a - Unknown - Other Medically Important Condition);Vaccination site vesicles (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000438490&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000440181	Spontaneous	2018-01-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Angina pectoris (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pulmonary embolism (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sweating fever (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000440181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000429983	Spontaneous	2018-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000429983&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000430035	Spontaneous	2018-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Neuralgia (n/a - Recovering/Resolving - );Pain in extremity (n/a - Recovering/Resolving - );Paraesthesia (n/a - Recovering/Resolving - );Vaccination site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000430035&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000430042	Spontaneous	2018-01-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Urticaria (n/a - Recovered/Resolved - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - n/a - n/a - [1d - n/a - Intramuscular])...	[CANDESARTAN CILEXETIL] (C - Hypertension - n/a - [n/a - n/a - Oral])|[ENOXAPARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROXOCOBALAMIN, HYDROXOCOBALAMIN ACETATE] (C - n/a - n/a - )|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Hypercholesterolaemia - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000430042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000430052	Spontaneous	2018-01-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Chills (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - n/a - n/a - [1d - n/a - Intramuscular])...	[CANDESARTAN CILEXETIL] (C - Migraine prophylaxis - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000430052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000430143	Spontaneous	2018-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000430143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000430682	Spontaneous	2018-01-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Sensory disturbance (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000430682&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000433493	Spontaneous	2018-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dysaesthesia (n/a - Not Recovered/Not Resolved - );Hypoaesthesia (n/a - Not Recovered/Not Resolved - );Injection site pain (n/a - Not Recovered/Not Resolved - );Weight decreased (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000433493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000433756	Spontaneous	2018-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute kidney injury (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fall (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (26d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lung disorder (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhabdomyolysis (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	PEGASYS [PEGINTERFERON ALFA-2A] (C - n/a - n/a - )|[ALLOPURINOL] (C - n/a - n/a - )|[INDAPAMIDE, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMINE, INDAPAMIDE] (C - n/a - n/a - )|[PARACETAMOL, CODEINE PHOSPHATE, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - )|[POTASSIUM CHLORIDE] (C - n/a - n/a - )|[RABEPRAZOLE, RABEPRAZOLE SODIUM] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000433756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000417313	Spontaneous	2018-01-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Postural orthostatic tachycardia syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000417321	Spontaneous	2018-01-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthma (n/a - Recovered/Resolved With Sequelae - Disabling);Chronic fatigue syndrome (n/a - Recovered/Resolved With Sequelae - Disabling);Depression (n/a - Recovered/Resolved With Sequelae - Disabling);Hypertension (n/a - Recovered/Resolved With Sequelae - Disabling);Insomnia (n/a - Recovered/Resolved With Sequelae - Disabling);Malaise (n/a - Recovered/Resolved With Sequelae - Disabling);Myalgia (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10000417357	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema of eyelid (n/a - Not Recovered/Not Resolved - );Eyelid rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417367	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pruritus (n/a - Unknown - );Rash erythematous (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417405	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Dysphagia (n/a - Not Recovered/Not Resolved - );Lymph node pain (n/a - Not Recovered/Not Resolved - );Throat irritation (n/a - Not Recovered/Not Resolved - );Vaccination site induration (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417418	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza like illness (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417418&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417498	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hyperaesthesia (n/a - Not Recovered/Not Resolved - );Lymphadenopathy (n/a - Not Recovered/Not Resolved - );Pruritus (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417511	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Pruritus (n/a - Unknown - );Skin exfoliation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417511&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417520	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Skin exfoliation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417527	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Eyelid oedema (n/a - Not Recovered/Not Resolved - );Eyelid pain (n/a - Not Recovered/Not Resolved - );Face oedema (n/a - Not Recovered/Not Resolved - );Oral mucosal eruption (n/a - Not Recovered/Not Resolved - );Oral pain (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - );Vaccination site reaction (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417527&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417651	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Recovered/Resolved - );Feeling abnormal (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - );Paraesthesia (n/a - Recovered/Resolved - );Presyncope (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417691	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - );Vision blurred (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417691&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417727	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Infant	No	Female	Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417727&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417728	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cheilitis (n/a - Recovering/Resolving - );Lip oedema (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417728&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417751	Spontaneous	2018-01-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Blepharitis (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417789	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Recovered/Resolved - );Paraesthesia (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417789&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000417815	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site reaction (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000417815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000418366	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000418366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000419720	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000419720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000419754	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - );Neck pain (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000419754&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000419778	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Recovered/Resolved - );Paraesthesia (n/a - Recovered/Resolved - );Rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000419778&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000419787	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Insomnia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000419787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000419832	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Burning sensation (n/a - Not Recovered/Not Resolved - );Lymphadenopathy (n/a - Not Recovered/Not Resolved - );Pruritus (n/a - Not Recovered/Not Resolved - );Urticaria (n/a - Not Recovered/Not Resolved - );Vaccination site erythema (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000419832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000419865	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Paraesthesia oral (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000419865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000419910	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000419910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000419938	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Not Recovered/Not Resolved - );Pain (n/a - Not Recovered/Not Resolved - );Vaccination site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000419938&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000419959	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - );Throat irritation (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000419959&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000419963	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cough (n/a - Recovered/Resolved - );Eyelid oedema (n/a - Recovered/Resolved - );Rhinorrhoea (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000419963&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000419968	Spontaneous	2018-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000419968&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000408895	Spontaneous	2018-01-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adolescent	No	Not Specified	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000408895&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000413016	Spontaneous	2018-01-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - );Tinnitus (n/a - Not Recovered/Not Resolved - );Vertigo (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000413016&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000416091	Spontaneous	2018-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Meningitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000416091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000398480	Spontaneous	2018-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Infant	No	Male	Blood glucose decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Blood pressure increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urine output decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	HBVAXPRO [ALUMINIUM, HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - n/a - n/a - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000398480&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000366866	Spontaneous	2018-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000366866&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10000367097	Spontaneous	2018-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000367097&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000367152	Spontaneous	2018-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Alanine aminotransferase increased (n/a - Recovering/Resolving - Disabling);C-reactive protein increased (n/a - Recovering/Resolving - Disabling);Cough (n/a - Recovering/Resolving - Disabling);Erythema (n/a - Recovering/Resolving - Disabling);Pruritus (n/a - Recovering/Resolving - Disabling);Rash papular (n/a - Recovering/Resolving - Disabling);White blood cell count increased (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[IBUPROFEN, IBUPROFEN SODIUM DIHYDRATE] (C - Pain - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000367152&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000367212	Spontaneous	2018-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Feeling cold (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lip oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000367212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000381705	Spontaneous	2018-01-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000381705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000333267	Spontaneous	2017-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Erythema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000333267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000333630	Spontaneous	2017-12-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Not Recovered/Not Resolved - Disabling);Pruritus (n/a - Recovered/Resolved - Disabling);Temperature intolerance (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000333630&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000333816	Spontaneous	2017-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000333816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000336934	Spontaneous	2017-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Bursitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000336934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000337961	Spontaneous	2017-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000337961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000330674	Spontaneous	2017-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Tendonitis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000330674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000331148	Spontaneous	2017-12-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pruritus (n/a - Not Recovered/Not Resolved - );Skin reaction (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intradermal])	APROVEL 75 MG TABLETS [IRBESARTAN] (C - n/a - n/a - )|[ACETYLSALICYLIC ACID] (C - n/a - n/a - )|[CELIPROLOL HYDROCHLORIDE] (C - n/a - n/a - )|[LANSOPRAZOLE] (C - n/a - n/a - )|[SIMVASTATIN, EZETIMIBE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000331148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000307231	Spontaneous	2017-12-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Blood urine (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000307231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000312168	Spontaneous	2017-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000312168&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000317704	Spontaneous	2017-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Not Specified	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Disabling);Miller Fisher syndrome (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000317704&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10000320476	Spontaneous	2017-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000320476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000302740	Spontaneous	2017-12-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000302740&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000302750	Spontaneous	2017-12-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000302750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000302753	Spontaneous	2017-12-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000302753&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000307023	Spontaneous	2017-12-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Burning sensation (n/a - Recovered/Resolved - );Choking sensation (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - );Skin plaque (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000307023&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000307047	Spontaneous	2017-12-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000307047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000288712	Spontaneous	2017-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Face oedema (4d - Recovered/Resolved - );Pharyngeal paraesthesia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000288712&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000277371	Spontaneous	2017-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Epigastric discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Food aversion (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000277371&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000280484	Spontaneous	2017-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000280484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000281823	Spontaneous	2017-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Ageusia (2mo - Recovered/Resolved - );Anosmia (2mo - Recovered/Resolved - );Dysgeusia (2mo - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	NOT AVAILABLE (C - n/a - n/a - [n/a - 100mg - n/a])|NOT AVAILABLE (C - n/a - n/a - [n/a - 10mg - n/a])|NOT AVAILABLE (C - n/a - n/a - [n/a - 1{DF} - n/a])|NOT AVAILABLE (C - n/a - n/a - [n/a - 8mg - n/a])|TADALAFIL 5 MG - FILM-COATED TABLET  (C - n/a - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000281823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000282196	Spontaneous	2017-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000282196&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000266381	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Erythema (n/a - Recovered/Resolved - );Oedema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000266381&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000269084	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoaesthesia (30min - Recovered/Resolved - );Paraesthesia (30min - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000269084&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000269832	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Vaccination site erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site oedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site warmth (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CICLESONIDE] (C - Asthma - n/a - [n/a - 2{DF} - Respiratory (inhalation)])|[IBANDRONIC ACID] (C - Osteoporosis - n/a - [n/a - 150mg - Oral])|[RABEPRAZOLE SODIUM] (C - Gastritis - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000269832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000270934	Spontaneous	2017-12-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Blindness (n/a - Not Recovered/Not Resolved - Disabling);Brain fog (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000270934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10000274420	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Rash (5wk - Recovered/Resolved - Other Medically Important Condition);Rash pruritic (5wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	METHOTREXATE [METHOTREXATE] (C - Psoriatic arthropathy - n/a - [n/a - 5mg - Oral])|[BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, ACETYLSALICYLIC ACID, BISOPROLOL HEMIFUMARATE] (C - Cardiac failure - n/a - [n/a - 2.5mg - Oral])|[CALCIUM CARBONATE, CALCIUM LACTATE GLUCONATE] (C - Osteoporosis - n/a - [n/a - 1{DF} - Oral])|[COLECALCIFEROL] (C - Osteoporosis - n/a - [n/a - 22400[iU] - Oral])|[FOLIC ACID] (C - Prophylaxis - n/a - [n/a - 25mg - Oral])|[NALOXONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, ANHYDROUS NALOXONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE DIHYDRATE] (C - Osteoarthritis - n/a - [n/a - 1{DF} - Oral])|[OMEGA-3-ACID ETHYL ESTERS 90] (C - Dyslipidaemia - n/a - [n/a - 1{DF} - Oral])|[OMEPRAZOLE] (C - Prophylaxis against gastrointestinal ulcer - n/a - [n/a - 10mg - Oral])|[PREGABALIN] (C - Osteoarthritis - n/a - [n/a - 50mg - Oral])|[TORASEMIDE] (C - Cardiac failure - n/a - [n/a - 5mg - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000274420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000275284	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Erythema (n/a - Recovered/Resolved - );Hypersensitivity (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Product used for unknown indication - Not applicable - )|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - Product used for unknown indication - Not applicable - )|[PARACETAMOL] (C - Product used for unknown indication - Not applicable - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000275284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000277086	Spontaneous	2017-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Breast abscess (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000277086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000255795	Spontaneous	2017-12-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Myalgia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000255795&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000257666	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Muscular weakness (1d - Recovered/Resolved - );Paraesthesia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[LORATADINE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000257666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000257821	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Anti-neutrophil cytoplasmic antibody positive vasculitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Aortic aneurysm (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Cough (2wk - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Fatigue (2wk - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypophagia (2wk - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Myalgia (2wk - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Nausea (2wk - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pyrexia (2wk - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	[COD-LIVER OIL] (C - n/a - n/a - )|[GLUCOSAMINE, GLUCOSAMINE SULFATE] (C - n/a - n/a - )|[TURMERIC] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000257821&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10000258634	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000258634&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10000260590	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Local reaction (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000260590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000263754	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site pain (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000263754&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000263756	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000263756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000264809	Spontaneous	2017-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Administration site induration (n/a - Recovered/Resolved - );Asthenia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000264809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000245139	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - );Chills (n/a - Not Recovered/Not Resolved - );Cough (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Pyrexia (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000245139&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000245185	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Epilepsy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	LYRICA 150 MG HARD CAPSULES [PREGABALIN] (C - Epilepsy - n/a - [n/a - 1{DF} - Oral])|ZONEGRAN [ZONISAMIDE] (C - Epilepsy - n/a - [n/a - 175mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000245185&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000245238	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Erythema (n/a - Recovering/Resolving - );Pruritus (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000245238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000246506	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000246506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000246921	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - );Pain (n/a - Not Recovered/Not Resolved - );Vaccination site joint movement impairment (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000246921&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000247150	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000247150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000248635	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chest pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Chills (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Immunisation reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000248635&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000249964	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovering/Resolving - );Pruritus (n/a - Recovering/Resolving - );Urticaria (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000249964&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000250977	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Aspiration (n/a - Unknown - Results in Death, Life Threatening);Pneumonia (n/a - Fatal - Results in Death, Life Threatening);Pneumonitis (n/a - Fatal - Results in Death, Life Threatening);Pyrexia (1d - Recovering/Resolving - Results in Death, Life Threatening);Respiratory tract inflammation (n/a - Fatal - Results in Death, Life Threatening);Vaccination complication (n/a - Fatal - Results in Death, Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000250977&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10000252031	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation);Epilepsy (8d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Personality change (n/a - Unknown - Caused/Prolonged Hospitalisation);Status epilepticus (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000252031&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000252961	Spontaneous	2017-12-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site induration (3d - Recovered/Resolved - );Oedema (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000252961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000253431	Spontaneous	2017-12-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000253431&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000253472	Spontaneous	2017-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Laryngeal discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash pruritic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000253472&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000253896	Spontaneous	2017-12-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Balance disorder (n/a - Recovered/Resolved - );C-reactive protein increased (n/a - Recovered/Resolved - );Gait disturbance (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Influenza like illness (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000253896&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000235701	Spontaneous	2017-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Ligament laxity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000235701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000235896	Spontaneous	2017-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amnesia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Subcutaneous])	[ATORVASTATIN] (C - n/a - n/a - [n/a - 20mg - Oral])|[FENOFIBRATE, FENOFIBRATE (NANONISED)] (C - n/a - n/a - [n/a - 160mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000235896&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000236072	Spontaneous	2017-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Encephalomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000236072&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000239235	Spontaneous	2017-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Carotid artery stenosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cerebrovascular accident (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ophthalmoplegia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Organic brain syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - Not applicable - [n/a - 100mg - Oral])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - Product used for unknown indication - Not applicable - [n/a - 2.5mg - Oral])|[CYANOCOBALAMIN] (C - Anaemia megaloblastic - Not applicable - [n/a - n/a - Intramuscular])|[HALOPERIDOL] (C - Product used for unknown indication - Not applicable - [n/a - 2mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000239235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000233765	Spontaneous	2017-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (14d - Recovered/Resolved - );Lymphadenopathy (14d - Recovered/Resolved - );Vaccination site reaction (14d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	AERIUS [DESLORATADINE] (C - n/a - n/a - )|NBG 24:7 [BETA-1,3/1,6-GLUCANE, VITAMIN C] (C - n/a - n/a - )|[DROSPIRENONE, ETHINYLESTRADIOL, LACTOSE] (C - n/a - n/a - )|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000233765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000233822	Spontaneous	2017-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (14d - Recovered/Resolved - );Hypertension (14d - Recovered/Resolved - );Influenza like illness (14d - Recovered/Resolved - );Nausea (13d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000233822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000219991	Spontaneous	2017-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - );Asthenia (n/a - Recovering/Resolving - );Balance disorder (n/a - Recovering/Resolving - );Diarrhoea (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Hyperhidrosis (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000219991&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000220240	Spontaneous	2017-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute kidney injury (n/a - Recovering/Resolving - Other Medically Important Condition);Antineutrophil cytoplasmic antibody positive (n/a - Recovering/Resolving - Other Medically Important Condition);Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);C-reactive protein increased (n/a - Recovered/Resolved - Other Medically Important Condition);Hepatic cytolysis (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Neutropenia (n/a - Recovering/Resolving - Other Medically Important Condition);Proteinuria (13d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Red blood cell sedimentation rate increased (n/a - Recovering/Resolving - Other Medically Important Condition);Thrombocytopenia (13d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000220240&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000220261	Spontaneous	2017-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Administration site reaction (n/a - Recovered/Resolved - );Asthenia (n/a - Recovered/Resolved - );Chills (n/a - Recovered/Resolved - );Headache (n/a - Recovering/Resolving - );Muscular weakness (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Vertigo (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000220261&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000225740	Spontaneous	2017-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Radial nerve injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000225740&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000227720	Spontaneous	2017-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Musculoskeletal pain (n/a - Recovering/Resolving - );Torticollis (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000227720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000229240	Spontaneous	2017-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Neck pain (n/a - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Subcutaneous])	[ACECLOFENAC] (C - Product used for unknown indication - Not applicable - [6d - n/a - Oral])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (C - Product used for unknown indication - Not applicable - [11d - 3{DF} - Oral])|[NIFLUMIC ACID] (C - Product used for unknown indication - Not applicable - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000229240&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000232339	Spontaneous	2017-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Decreased appetite (n/a - Recovered/Resolved - );Feeling cold (15d - Recovered/Resolved - );Respiratory arrest (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000232339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000232427	Spontaneous	2017-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000232427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000215495	Spontaneous	2017-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Type IV hypersensitivity reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000215495&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000215733	Spontaneous	2017-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000215733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000218470	Spontaneous	2017-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Lip swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000218470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000218646	Spontaneous	2017-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anterograde amnesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000218646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000201850	Spontaneous	2017-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Headache (48h - Recovered/Resolved - );Pain in extremity (48h - Recovered/Resolved - );Pyrexia (48h - Recovered/Resolved - );Serum sickness (48h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000201850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000202414	Spontaneous	2017-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Product quality issue (n/a - Unknown - );Sensation of foreign body (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000202414&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000202557	Spontaneous	2017-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Hallucination, visual (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Product quality issue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000202557&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000202724	Spontaneous	2017-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pruritus (3d - Recovered/Resolved - Other Medically Important Condition);Injection site urticaria (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000202724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000206065	Spontaneous	2017-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Rash (1d - Recovered/Resolved - );Vaccination site erythema (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000206065&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000208052	Spontaneous	2017-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000208052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000210005	Spontaneous	2017-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000210005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000191615	Spontaneous	2017-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - );Pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000191615&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000192983	Spontaneous	2017-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000192983&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000193368	Spontaneous	2017-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000193368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000195391	Spontaneous	2017-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chest pain (n/a - Unknown - );Dyspnoea exertional (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000195391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000197754	Spontaneous	2017-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Chronic obstructive pulmonary disease (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000197754&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000197770	Spontaneous	2017-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Erythema (n/a - Not Recovered/Not Resolved - );Hypersensitivity (n/a - Not Recovered/Not Resolved - );Pruritus (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000197770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000177572	Spontaneous	2017-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Myalgia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000177572&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000179384	Spontaneous	2017-12-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Facial paralysis (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Lung disorder (n/a - Unknown - Other Medically Important Condition);Musculoskeletal disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000179384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000180496	Spontaneous	2017-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anaemia (2wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (2wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Leukopenia (2wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (2wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (2wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (2wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000180496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000181359	Spontaneous	2017-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arthritis reactive (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000181359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000182710	Spontaneous	2017-12-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000182710&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000182735	Spontaneous	2017-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000182735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000168821	Spontaneous	2017-12-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Autoimmune disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Coordination abnormal (n/a - Unknown - Disabling, Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Disabling, Other Medically Important Condition);Gait inability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Live birth (n/a - Unknown - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nerve injury (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nervous system disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Wheelchair user (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000168821&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10000168831	Spontaneous	2017-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000168831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000169749	Spontaneous	2017-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Radial nerve injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000169749&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000170784	Spontaneous	2017-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Erythema (3d - Recovered/Resolved - );Hypersensitivity (n/a - Recovered/Resolved - );Myalgia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000170784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000159711	Spontaneous	2017-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Partial seizures (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000159711&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000159889	Spontaneous	2017-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Systemic inflammatory response syndrome (n/a - Not Recovered/Not Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000159889&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10000162244	Spontaneous	2017-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000162244&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000165093	Spontaneous	2017-12-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Myalgia (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000165093&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000165122	Spontaneous	2017-12-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypersensitivity (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - );Vaccination site nodule (n/a - Unknown - );Vaccination site pain (n/a - Unknown - );Vaccination site pruritus (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - );Vaccination site warmth (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000165122&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000150278	Spontaneous	2017-12-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000150278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000154193	Spontaneous	2017-12-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Pyrexia (7d - Recovered/Resolved - Other Medically Important Condition);Rash (3d - Recovered/Resolved - Other Medically Important Condition);Vaccination error (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - .25mg - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000154193&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000143866	Spontaneous	2017-12-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - );Nausea (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000143866&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000144211	Spontaneous	2017-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Henoch-Schonlein purpura (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000144211&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000144775	Spontaneous	2017-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000144775&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10000146625	Spontaneous	2017-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dysaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Off label use (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[FLUOROURACIL] (S - Small cell carcinoma - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000146625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000135509	Spontaneous	2017-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema (n/a - Not Recovered/Not Resolved - );Pruritus (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000135509&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000136612	Spontaneous	2017-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Inappropriate schedule of product administration (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Obesity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000136612&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000139220	Spontaneous	2017-12-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypersomnia (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000139220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000139676	Spontaneous	2017-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthma (n/a - Recovering/Resolving - );Hypersensitivity (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - );Vaccination site rash (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000139676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000133241	Spontaneous	2017-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Feeling cold (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Hypoaesthesia (n/a - Not Recovered/Not Resolved - );Muscle spasms (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000133241&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000133243	Spontaneous	2017-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - );Feeling hot (n/a - Not Recovered/Not Resolved - );Hyperhidrosis (n/a - Not Recovered/Not Resolved - );Localised oedema (n/a - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Thinking abnormal (n/a - Not Recovered/Not Resolved - );Tongue oedema (n/a - Not Recovered/Not Resolved - );Vaccination site erythema (n/a - Not Recovered/Not Resolved - );Vaccination site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000133243&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000133249	Spontaneous	2017-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	HBVAXPRO [ALUMINIUM, HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], HEPATITIS B SURFACE ANTIGEN (RDNA)] (C - n/a - n/a - [1d - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000133249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000133252	Spontaneous	2017-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dysphagia (n/a - Recovered/Resolved - );Dysphonia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	AUBAGIO [TERIFLUNOMIDE] (C - Multiple sclerosis - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000133252&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000133254	Spontaneous	2017-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Vaccination site reaction (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000133254&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000133255	Spontaneous	2017-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dysgeusia (n/a - Recovered/Resolved - );Paraesthesia oral (n/a - Recovered/Resolved - );Rash (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000133255&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000133256	Spontaneous	2017-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Paraesthesia (n/a - Recovered/Resolved - );Skin burning sensation (n/a - Recovered/Resolved - );Urticaria (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000133256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000133257	Spontaneous	2017-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Hypoaesthesia (n/a - Recovered/Resolved - );Peripheral coldness (n/a - Recovered/Resolved - );Peripheral vascular disorder (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000133257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000133258	Spontaneous	2017-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000133258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000131982	Spontaneous	2017-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Thrombosis (n/a - Recovering/Resolving - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[LEVOTHYROXINE] (C - Hypothyroidism - n/a - [n/a - n/a - Oral])|[MEDROXYPROGESTERONE ACETATE, ESTRADIOL VALERATE] (C - Hormone replacement therapy - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000131982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10000131986	Spontaneous	2017-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Impetigo (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Staphylococcal scalded skin syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	TWINRIX PAEDIATRIC [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - n/a - n/a - [1d - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000131986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000131987	Spontaneous	2017-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (n/a - Recovering/Resolving - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000131987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10000124908	Spontaneous	2017-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Performance status decreased (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Sleep attacks (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000124908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10000125295	Spontaneous	2017-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Meningism (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000125295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000125470	Spontaneous	2017-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Pulse absent (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory arrest (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[AMLODIPINE] (C - n/a - n/a - [n/a - n/a - Oral])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - Oral])|[HYDROXOCOBALAMIN, HYDROXOCOBALAMIN ACETATE] (C - n/a - n/a - [n/a - n/a - Intramuscular])|[MEMANTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[RABEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000125470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000127421	Spontaneous	2017-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000127421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000116117	Spontaneous	2017-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Medication error (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])	RENVELA [SEVELAMER CARBONATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - Oral])|[ENALAPRIL MALEATE, LERCANIDIPINE, ENALAPRIL MALEATE, LERCANIDIPINE HYDROCHLORIDE] (C - Hypertension - Not applicable - [n/a - n/a - Oral])|[SODIUM HYDROGEN CARBONATE] (C - Acidosis - Not applicable - [n/a - n/a - Oral])|[TORASEMIDE] (C - Polyuria - Not applicable - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000116117&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000116596	Spontaneous	2017-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Herpes zoster (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	MICARDIS [TELMISARTAN] (C - Hypertension - n/a - [n/a - n/a - Oral])|[LEVOTHYROXINE] (C - Hypothyroidism - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000116596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000116606	Spontaneous	2017-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anaphylactic shock (n/a - Recovered/Resolved - Life Threatening);Arrhythmia (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	MELATONIN [MELATONIN] (C - n/a - n/a - [n/a - n/a - Oral])|[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[DIPYRIDAMOLE, ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[FLUVASTATIN, FLUVASTATIN SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - Oral])|[POTASSIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[TOPIRAMATE] (C - n/a - n/a - [n/a - n/a - Oral])|[VALSARTAN] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000116606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10000116610	Spontaneous	2017-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Neck mass (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - n/a - n/a - [1d - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000116610&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000116654	Spontaneous	2017-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Angioedema (n/a - Recovering/Resolving - Other Medically Important Condition);Erythema (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	EXFORGE [VALSARTAN, AMLODIPINE, VALSARTAN, AMLODIPINE BESILATE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000116654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000116656	Spontaneous	2017-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lip oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000116656&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000117697	Spontaneous	2017-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oxygen saturation decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	ANORO [UMECLIDINIUM BROMIDE, VILANTEROL] (C - n/a - n/a - )|XARELTO [RIVAROXABAN] (C - n/a - n/a - )|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - )|[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - )|[OMEPRAZOLE] (C - n/a - n/a - )|[SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000117697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000118992	Spontaneous	2017-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pruritus (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[LEVOTHYROXINE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000118992&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000119300	Spontaneous	2017-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - );Tinnitus (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[LEVOTHYROXINE] (C - n/a - n/a - [n/a - n/a - Oral])|[METHOTREXATE] (C - n/a - n/a - [n/a - n/a - Subcutaneous])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000119300&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000119608	Spontaneous	2017-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Vaccination site erythema (n/a - Recovered/Resolved - );Vaccination site warmth (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000119608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000121570	Spontaneous	2017-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - );Nausea (n/a - Unknown - );Vomiting (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000121570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000110626	Spontaneous	2017-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000110626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000111601	Spontaneous	2017-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Immune thrombocytopenia (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [3d - 1{DF} - Intramuscular])	[CALCIUM CARBONATE] (C - n/a - n/a - )|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - n/a - n/a - )|[OMEPRAZOLE] (C - n/a - n/a - )|[PREDNISOLONE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000111601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000114648	Spontaneous	2017-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Vaccination site erythema (1d - Recovered/Resolved - );Vaccination site pruritus (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000114648&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000114665	Spontaneous	2017-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (1d - Recovered/Resolved - );Chills (1d - Recovered/Resolved - );Diarrhoea (1d - Recovered/Resolved - );Headache (1d - Recovered/Resolved - );Myalgia (1d - Recovered/Resolved - );Pyrexia (1d - Recovered/Resolved - );Vomiting (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000114665&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000103201	Spontaneous	2017-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Encephalitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000103201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10000103388	Spontaneous	2017-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site erythema (n/a - Not Recovered/Not Resolved - );Vaccination site swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000103388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000104992	Spontaneous	2017-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Dysarthria (1d - Recovered/Resolved - );Erythema (1d - Recovered/Resolved - );Excessive eye blinking (0d - Recovered/Resolved - );Heart rate increased (0d - Recovered/Resolved - );Hemiplegia (1d - Recovered/Resolved - );Malaise (5d - Recovered/Resolved - );Oral herpes (n/a - Unknown - );Somnolence (5d - Recovered/Resolved - );Swelling (1d - Recovered/Resolved - );Swelling face (1d - Recovered/Resolved - );Swelling of eyelid (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	INSUMAN RAPID SOLOSTAR [INSULIN HUMAN] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - Subcutaneous])|[PREDNISOLONE] (C - Brain oedema - n/a - [n/a - 25mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000104992&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000091494	Spontaneous	2017-11-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dermatitis allergic (n/a - Unknown - );Pruritus (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000091494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000092606	Spontaneous	2017-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Male	Facial paresis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000092606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10000092700	Spontaneous	2017-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hepatic cancer (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lung neoplasm malignant (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pulmonary resection (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Renal cancer (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000092700&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000094893	Spontaneous	2017-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000094893&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000096941	Spontaneous	2017-11-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain (n/a - Recovering/Resolving - );Diarrhoea (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - );Vomiting (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000096941&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000096963	Spontaneous	2017-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Hypersensitivity (5d - Recovered/Resolved - );Vaccination site erythema (5d - Recovered/Resolved - );Vaccination site pruritus (5d - Recovered/Resolved - );Vaccination site swelling (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[AMLODIPINE BESILATE] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Hypercholesterolaemia - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000096963&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000096964	Spontaneous	2017-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Urticaria (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000096964&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000089175	Spontaneous	2017-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Injury associated with device (n/a - Unknown - );Product packaging difficult to open (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000089175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000074063	Spontaneous	2017-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pruritus (n/a - Recovering/Resolving - );Skin burning sensation (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	AERIUS [DESLORATADINE] (C - Rhinitis allergic - n/a - [n/a - n/a - Oral])|[BECLOMETASONE DIPROPIONATE] (C - Asthma - n/a - [n/a - n/a - Respiratory (inhalation)])|[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000074063&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000074080	Spontaneous	2017-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Oedema peripheral (n/a - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - );Vaccination site reaction (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000074080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000074121	Spontaneous	2017-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Burning sensation (n/a - Recovering/Resolving - );Face oedema (n/a - Recovering/Resolving - );Flushing (n/a - Recovering/Resolving - );Pruritus (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000074121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000074161	Spontaneous	2017-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000074161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000074935	Spontaneous	2017-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000074935&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10000075748	Spontaneous	2017-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Headache (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000075748&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000076083	Spontaneous	2017-11-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest discomfort (n/a - Not Recovered/Not Resolved - );Palpitations (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[MELOXICAM] (C - n/a - n/a - )|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000076083&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000076160	Spontaneous	2017-11-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site nodule (n/a - Not Recovered/Not Resolved - );Vaccination site reaction (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	DESLORATADINE ACTAVIS [DESLORATADINE] (C - Dust allergy - n/a - [n/a - n/a - Oral])|VICTOZA [LIRAGLUTIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000076160&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000076231	Spontaneous	2017-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Aphonia (n/a - Not Recovered/Not Resolved - );Axillary pain (n/a - Not Recovered/Not Resolved - );Cough (n/a - Not Recovered/Not Resolved - );Productive cough (n/a - Not Recovered/Not Resolved - );Vaccination site reaction (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[TERBUTALINE SULFATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000076231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000080403	Spontaneous	2017-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bacterial infection (n/a - Recovering/Resolving - Disabling);Muscular weakness (n/a - Recovering/Resolving - Disabling);Oedema peripheral (n/a - Recovering/Resolving - Disabling);Pain in extremity (n/a - Recovering/Resolving - Disabling);Paraesthesia (n/a - Recovering/Resolving - Disabling);Vaccination site erythema (n/a - Recovering/Resolving - Disabling);Vaccination site pain (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000080403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000056328	Spontaneous	2017-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cardiac arrest (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Chest discomfort (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Circulatory collapse (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	ADVAGRAF [TACROLIMUS] (C - n/a - n/a - [n/a - n/a - n/a])|CELLCEPT 500 MG [MYCOPHENOLATE MOFETIL] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ISPAGHULA, PLANTAGO INDICA, PSYLLIUM SEED] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000056328&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10000057209	Spontaneous	2017-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Rotator cuff syndrome (n/a - Recovering/Resolving - Disabling);Tendonitis (n/a - Recovering/Resolving - Disabling);Vaccination site pain (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[DESOGESTREL] (C - Contraception - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000057209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000069210	Spontaneous	2017-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Anaphylactic reaction (3h - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000069210&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000069870	Spontaneous	2017-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Abdominal pain upper (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	ANORO [UMECLIDINIUM BROMIDE, VILANTEROL] (C - Chronic obstructive pulmonary disease - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, MAGNESIUM OXIDE] (C - Thrombosis prophylaxis - n/a - [n/a - 75mg - Oral])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - Cardiac disorder - n/a - [n/a - 50mg - Oral])|[SIMVASTATIN] (C - Cardiac disorder - n/a - [n/a - 40mg - Oral])|[TERBUTALINE SULFATE] (C - Bronchospasm - n/a - [n/a - .5mg - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000069870&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000070255	Spontaneous	2017-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000070255&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000070258	Spontaneous	2017-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000070258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000070261	Spontaneous	2017-11-23 00:00:00	Healthcare Professional	European Economic Area	Dyer C. Irish MP calls for key documents on Pandemrix to be handed to lawyers representing children with narcolepsy.. BMJ(Clinical research ed.). 2017;357:j1959	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000070261&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000070787	Spontaneous	2017-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (1d - Recovered/Resolved - );Dizziness (0d - Recovered/Resolved - );Feeling of body temperature change (1d - Recovered/Resolved - );Headache (1d - Recovered/Resolved - );Hyperhidrosis (0d - Recovered/Resolved - );Syncope (0d - Recovered/Resolved - );Vision blurred (0d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)] (S - Influenza immunisation - Not applicable - [n/a - 15ug - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000070787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10000000796	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000000796&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000004458	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovering/Resolving - Disabling);Blood pressure increased (n/a - Recovering/Resolving - Disabling);Dizziness (n/a - Recovering/Resolving - Disabling);Dry skin (n/a - Recovering/Resolving - Disabling);Headache (n/a - Recovering/Resolving - Disabling);Muscular weakness (n/a - Recovering/Resolving - Disabling);Palpitations (n/a - Recovering/Resolving - Disabling);Pyrexia (n/a - Recovering/Resolving - Disabling);Skin exfoliation (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000004458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10000004687	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Not Specified	Altered state of consciousness (n/a - Recovered/Resolved - Life Threatening);Cold sweat (n/a - Recovered/Resolved - Life Threatening);Hypotonia (n/a - Recovered/Resolved - Life Threatening);Pain (n/a - Recovered/Resolved - Life Threatening);Pallor (n/a - Recovered/Resolved - Life Threatening);Pulse absent (n/a - Recovered/Resolved - Life Threatening);Tremor (n/a - Recovered/Resolved - Life Threatening);Vomiting (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])|[VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (S - n/a - n/a - [1d - n/a - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - n/a - )|[MONTELUKAST, MONTELUKAST SODIUM] (C - Asthma - n/a - )|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000004687&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10000004743	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000004743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000004745	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Anaphylactic shock (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000004745&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10000005274	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Eczema (n/a - Unknown - );Pruritus (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000005274&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000006275	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000006275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000008990	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Diarrhoea (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Nausea (n/a - Not Recovered/Not Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000008990&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000010550	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Aphonia (n/a - Recovered/Resolved - );Paraesthesia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000010550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000011510	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia (n/a - Not Recovered/Not Resolved - );Lip oedema (n/a - Not Recovered/Not Resolved - );Oedema peripheral (n/a - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [366d - n/a - Intramuscular])	[BUDESONIDE] (C - Asthma - n/a - [n/a - n/a - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000011510&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000011818	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Coronary artery disease (n/a - Fatal - Results in Death);Metastasis (n/a - Fatal - Results in Death);Metastatic renal cell carcinoma (n/a - Fatal - Results in Death);Renal cancer (n/a - Fatal - Results in Death);Renal failure (n/a - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000011818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10000013309	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hyperreflexia (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Vertigo (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000013309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000014174	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Confusional state (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Hip fracture (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site induration (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site swelling (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site warmth (n/a - Unknown - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - n/a - n/a - [1d - n/a - Intramuscular])...	MELATONIN [MELATONIN] (C - n/a - n/a - [n/a - n/a - Oral])|[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - Oral])|[BUPRENORPHINE] (C - n/a - n/a - [n/a - n/a - Transdermal])|[DIGOXIN] (C - n/a - n/a - [n/a - n/a - Oral])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - Oral])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[GLUCOSAMINE, GLUCOSAMINE SULFATE] (C - n/a - n/a - [n/a - n/a - Oral])|[HAEMOPHILUS INFLUENZAE, KLEBSIELLA OZAENAE, KLEBSIELLA PNEUMONIAE, NEISSERIA CATARRHALIS, STAPHYLOCOCCUS AUREUS, STREPTOCOCCUS PYOGENES, STREPTOCOCCUS VIRIDANS, DIPLOCOCCUS PNEUMONIAE, LOPERAMIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[LEVOTHYROXINE] (C - n/a - n/a - )|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - Oral])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000014174&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000016537	Spontaneous	2017-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Microsleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000016537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000016555	Spontaneous	2017-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Osteoarthritis (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000016555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10000016817	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Vaccination site erythema (n/a - Not Recovered/Not Resolved - );Vaccination site oedema (n/a - Not Recovered/Not Resolved - );Vaccination site warmth (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000016817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000018560	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Nausea (n/a - Not Recovered/Not Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Vomiting (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000018560&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000021064	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000021064&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10000025885	Spontaneous	2017-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000025885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000025900	Spontaneous	2017-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000025900&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000026194	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000026194&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000026507	Spontaneous	2017-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cognitive disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000026507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000030277	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Administration site pain (n/a - Recovered/Resolved - );Erythema (n/a - Recovered/Resolved - );Feeling hot (n/a - Recovered/Resolved - );Peripheral swelling (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[ETHYL LOFLAZEPATE] (C - Product used for unknown indication - Not applicable - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000030277&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000030713	Spontaneous	2017-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	C-reactive protein increased (n/a - Unknown - );Cough (n/a - Unknown - );Inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	[WARFARIN SODIUM] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000030713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000030824	Spontaneous	2017-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Unevaluable event (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000030824&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10000030894	Spontaneous	2017-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Clostridium difficile infection (n/a - Unknown - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])...	INSULIN ASPART [INSULIN ASPART] (C - Diabetes mellitus - n/a - [n/a - n/a - Unknown])|INSULIN GLARGINE [INSULIN GLARGINE] (C - Diabetes mellitus - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000030894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000032535	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Altered state of consciousness (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Skin exfoliation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	AERIUS [DESLORATADINE] (C - n/a - n/a - )|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (C - n/a - n/a - )|[GALANTAMINE, GALANTAMINE HYDROBROMIDE] (C - n/a - n/a - )|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - )|[PARACETAMOL, BELLADONNA DRY EXTRACT, CAFFEINE, OPIUM, PARACETAMOL, CAFFEINE, OPIUM, PARACETAMOL, CAFFEINE, OPIUM EXTRACTS, PARACETAMOL, CAFFEINE, OPIUM, PREPARED] (C - n/a - n/a - )|[PARACETAMOL] (C - n/a - n/a - )|[VALPROMIDE] (C - n/a - n/a - )|[ZOPICLONE] (C - n/a - n/a - )	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000032535&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10000033471	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000033471&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10000044562	Spontaneous	2017-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Incorrect dose administered (n/a - Recovered/Resolved - );Medication error (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10000044562&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12970006	Spontaneous	2017-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12970006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12970213	Spontaneous	2017-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12970213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12972000	Spontaneous	2017-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12972000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12972243	Spontaneous	2017-11-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Autoimmune disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyschezia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gastrooesophageal reflux disease (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza - Drug withdrawn - [1mo - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12972243&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12950266	Spontaneous	2017-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12950266&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12951791	Spontaneous	2017-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Dizziness (n/a - Unknown - Disabling);Hypoaesthesia (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Muscular weakness (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Seizure (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12951791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12951821	Spontaneous	2017-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - Disabling);Headache (n/a - Recovering/Resolving - Disabling);Rash (n/a - Recovering/Resolving - Disabling);Vaccination site erythema (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12951821&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12956032	Spontaneous	2017-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aphasia (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Dry eye (n/a - Unknown - Other Medically Important Condition);Dystonia (n/a - Unknown - Other Medically Important Condition);Eye pain (n/a - Unknown - Other Medically Important Condition);Feeling hot (n/a - Unknown - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Muscle rigidity (n/a - Unknown - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Paralysis (n/a - Unknown - Other Medically Important Condition);Peripheral coldness (n/a - Unknown - Other Medically Important Condition);Rest regimen (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sciatica (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12956032&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12943907	Spontaneous	2017-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Aggression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Agitation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Crying (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Depressed mood (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dyssomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Irritability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Mood altered (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Personality change (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep attacks (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12943907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12944585	Spontaneous	2017-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Inappropriate schedule of product administration (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12944585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12944590	Spontaneous	2017-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Chills (5d - Recovered/Resolved - );General physical health deterioration (5d - Recovered/Resolved - );Incorrect route of product administration (n/a - Unknown - );Product administration error (n/a - Unknown - );Pyrexia (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - n/a - Intravenous (not otherwise specified)])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[LANTHANUM, LANTHANUM CARBONATE, LANTHANUM CARBONATE HYDRATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[TORASEMIDE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12944590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12945183	Spontaneous	2017-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	AVAMYS [FLUTICASONE FUROATE] (C - n/a - n/a - [n/a - n/a - Nasal])|RELVAR ELLIPTA [FLUTICASONE FUROATE, VILANTEROL] (C - Asthma - n/a - [n/a - n/a - Respiratory (inhalation)])|[RABEPRAZOLE, RABEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12945183&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-12948031	Spontaneous	2017-11-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (2d - Recovered/Resolved - );Chills (2d - Recovered/Resolved - );Headache (2d - Recovered/Resolved - );Myalgia (2d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12948031&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12938780	Spontaneous	2017-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Occupational exposure to product (n/a - Unknown - );Product packaging issue (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12938780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12940179	Spontaneous	2017-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Diplopia (n/a - Recovered/Resolved - Other Medically Important Condition);Ophthalmoplegia (n/a - Recovered/Resolved - Other Medically Important Condition);Unevaluable event (n/a - Recovered/Resolved - Other Medically Important Condition);Vertigo (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12940179&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12940729	Spontaneous	2017-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12940729&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-12941321	Spontaneous	2017-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12941321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12941323	Spontaneous	2017-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12941323&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12934914	Spontaneous	2017-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12934914&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12925976	Spontaneous	2017-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovering/Resolving - Disabling);Feeling abnormal (n/a - Recovering/Resolving - Disabling);Feeling cold (n/a - Recovering/Resolving - Disabling);Headache (n/a - Recovering/Resolving - Disabling);Pain in extremity (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[LEVOTHYROXINE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12925976&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12926916	Spontaneous	2017-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Autoscopy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depressed mood (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysphemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Feeling of despair (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperacusis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Impaired work ability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (3d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Photophobia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Primary stabbing headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sinusitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Social problem (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Stress (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12926916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12918080	Spontaneous	2017-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Affective disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Anaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Autoimmune disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Erectile dysfunction (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Facial paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypogeusia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Microangiopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Night sweats (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Osteoarthritis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Osteochondroma (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Raynaud's phenomenon (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sclerodactylia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Skin ulcer (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12918080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12919883	Spontaneous	2017-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Haematoma (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Unknown - [n/a - 1{DF} - n/a])	[ALLOPURINOL] (C - n/a - Dose not changed - [n/a - n/a - n/a])|[ATENOLOL] (C - n/a - Dose not changed - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE] (C - n/a - Dose not changed - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12919883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12920075	Spontaneous	2017-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Hyposmia (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Taste disorder (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12920075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12910914	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12910914&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12911106	Spontaneous	2017-10-26 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Drug interaction (n/a - Fatal - Results in Death, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|ENBREL [ETANERCEPT] (S - Rheumatoid arthritis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12911106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12911163	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dysphonia (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Throat irritation (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12911163&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12911203	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Eye inflammation (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperpyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinitis (n/a - Recovered/Resolved - Other Medically Important Condition)	M-M-RVAXPRO [MEASLES VIRUS ENDERS' EDMONSTON STRAIN (LIVE, ATTENUATED), MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS] (S - n/a - n/a - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12911203&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12911324	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12911324&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12911359	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Epistaxis (n/a - Recovered/Resolved - Other Medically Important Condition);Fall (n/a - Recovered/Resolved - Other Medically Important Condition);Feeling cold (n/a - Recovered/Resolved - Other Medically Important Condition);Lip haemorrhage (n/a - Recovered/Resolved - Other Medically Important Condition);Photopsia (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])|[DIPHTHERIA TOXOID, TETANUS TOXOID, DIPHTHERIA TOXOID, TETANUS TOXOID, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12911359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12911445	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Body temperature increased (n/a - Recovered/Resolved - );Hypertension (n/a - Recovered/Resolved - );Rash macular (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12911445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12911446	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Face oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyponatraemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation);Sepsis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12911446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12911497	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Pneumonia aspiration (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12911497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12911540	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Blood pressure fluctuation (n/a - Recovered/Resolved - Other Medically Important Condition);Haematoma (n/a - Recovered/Resolved - Other Medically Important Condition);Hypothermia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12911540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12912672	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening)	CERVARIX [3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, ALGELDRATE, ALUMINIUM, 3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN] (S - n/a - n/a - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12912672&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-12913126	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12913126&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12914922	Spontaneous	2017-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blister (n/a - Recovering/Resolving - Other Medically Important Condition);Pruritus (n/a - Recovering/Resolving - Other Medically Important Condition);Rash papular (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12914922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12907251	Spontaneous	2017-10-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Circulatory collapse (n/a - Unknown - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12907251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12907694	Spontaneous	2017-10-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Myositis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12907694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12899724	Spontaneous	2017-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Sudden death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12899724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12899907	Spontaneous	2017-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Sudden death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12899907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12900237	Spontaneous	2017-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12900237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12900696	Spontaneous	2017-10-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (1d - Recovered/Resolved - Other Medically Important Condition);Decreased appetite (1d - Recovered/Resolved - Other Medically Important Condition);Fatigue (1d - Recovered/Resolved - Other Medically Important Condition);Headache (1d - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (1d - Recovered/Resolved - Other Medically Important Condition);Malaise (1d - Recovered/Resolved - Other Medically Important Condition);Myalgia (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12900696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12902774	Spontaneous	2017-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Sensory disturbance (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	ELIQUIS [APIXABAN] (C - Thrombosis prophylaxis - n/a - [n/a - 5mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - 1000mg - Oral])|[METOPROLOL TARTRATE] (C - Heart rate irregular - n/a - [n/a - 25mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12902774&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12894071	Spontaneous	2017-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Immunisation reaction (2d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12894071&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12888993	Spontaneous	2017-10-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Decreased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12888993&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12889244	Spontaneous	2017-10-20 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Drug interaction (n/a - Fatal - Results in Death, Other Medically Important Condition);Seizure (n/a - Unknown - Results in Death, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|ENBREL [ETANERCEPT] (S - Rheumatoid arthritis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12889244&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12881107	Spontaneous	2017-10-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12881107&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12882061	Spontaneous	2017-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Feeling hot (2d - Recovered/Resolved - Disabling);Limb discomfort (n/a - Not Recovered/Not Resolved - Disabling);Mass (2d - Recovered/Resolved - Disabling);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (3d - Recovered/Resolved - Disabling);Pruritus (2d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Subcutaneous])	CLOPIDOGREL [CLOPIDOGREL, CLOPIDOGREL BESILATE] (C - n/a - n/a - [n/a - 75mg - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - 60mg - n/a])|[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - 30mg - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12882061&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12882117	Spontaneous	2017-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Cough (n/a - Not Recovered/Not Resolved - );Nausea (n/a - Not Recovered/Not Resolved - );Throat irritation (n/a - Not Recovered/Not Resolved - );Vomiting (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12882117&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12875034	Spontaneous	2017-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Female	Hyperaemia (8d - Recovered/Resolved - Other Medically Important Condition);Type III immune complex mediated reaction (n/a - Unknown - Other Medically Important Condition);Vaccination site oedema (8d - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (8d - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Unknown - Other Medically Important Condition);Vaccination site warmth (8d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12875034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12875596	Spontaneous	2017-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Expired product administered (0d - Recovered/Resolved - );No adverse event (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12875596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12876424	Spontaneous	2017-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Feeling cold (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12876424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12870008	Spontaneous	2017-10-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (3d - Recovered/Resolved - );Hyperhidrosis (2d - Recovered/Resolved - );Nausea (2d - Recovered/Resolved - );Tremor (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12870008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-12862389	Spontaneous	2017-10-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Head discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12862389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12864094	Spontaneous	2017-10-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12864094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12857766	Spontaneous	2017-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Oedema peripheral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - n/a])	AERIUS [DESLORATADINE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[CICLOPIROX, CICLOPIROX OLAMINE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[DIGOXIN] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[FLUINDIONE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[KETOCONAZOLE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[LORAZEPAM] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12857766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12855188	Spontaneous	2017-10-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Musculoskeletal chest pain (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Parenteral])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CODEINE PHOSPHATE BP, PARACETAMOL PH. EUR., PARACETAMOL BP, CODEINE PHOSPHATE BP, PARACETAMOL, CODEINE PHOSPHATE, PARACETAMOL, CODEINE PHOSPHATE BP, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE, PARACETAMOL, PARACETAMOL DC, CODEINE PHOSPHATE PH.EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12855188&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12844853	Spontaneous	2017-10-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Multiple sclerosis relapse (n/a - Not Recovered/Not Resolved - );Sensory level abnormal (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12844853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-12848214	Spontaneous	2017-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12848214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12848504	Spontaneous	2017-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[TOPIRAMATE] (C - n/a - n/a - [n/a - 50mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12848504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12848965	Spontaneous	2017-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angioedema (n/a - Recovering/Resolving - Other Medically Important Condition);Burning sensation (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	[NAFTIDROFURYL, NAFTIDROFURYL OXALATE] (C - Raynaud's phenomenon - Dose not changed - [n/a - 200mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12848965&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12831945	Spontaneous	2017-10-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Decreased activity (n/a - Not Recovered/Not Resolved - Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Migraine (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12831945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12832248	Spontaneous	2017-10-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Therapeutic product effect decreased (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12832248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12832352	Spontaneous	2017-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12832352&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12832570	Spontaneous	2017-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12832570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12833179	Spontaneous	2017-10-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12833179&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12824907	Spontaneous	2017-10-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12824907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12824988	Spontaneous	2017-10-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Developmental delay (n/a - Unknown - Other Medically Important Condition);Drooling (n/a - Unknown - Other Medically Important Condition);Epilepsy (n/a - Unknown - Other Medically Important Condition);Epileptic encephalopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gait disturbance (n/a - Unknown - Other Medically Important Condition);Neurological symptom (n/a - Unknown - Other Medically Important Condition);Petit mal epilepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12824988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12825076	Spontaneous	2017-10-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Autonomic neuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Restlessness (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12825076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12827512	Spontaneous	2017-10-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12827512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12818082	Spontaneous	2017-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Brain injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chest pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Encephalopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypothyroidism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Migraine (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Neck pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vertigo (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12818082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12818095	Spontaneous	2017-10-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Balance disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Impaired work ability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12818095&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12818096	Spontaneous	2017-10-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Coma (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Meningitis (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Snoring (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12818096&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12818529	Spontaneous	2017-10-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lymphadenopathy (6d - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12818529&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12809540	Spontaneous	2017-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12809540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12811715	Spontaneous	2017-10-05 00:00:00	Healthcare Professional	European Economic Area	Viste R et al. Long-term improvement after combined immunomodulation in early post-H1N1 vaccination narcolepsy. Neurology Neuroimmunology and Neuroinflammation. 2017;4(5):1-3	3-11 Years	Not Specified	No	Male	Abnormal dreams (n/a - Recovering/Resolving - Other Medically Important Condition);Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Hypnagogic hallucination (n/a - Recovering/Resolving - Other Medically Important Condition);Hypotonia (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Posture abnormal (n/a - Recovering/Resolving - Other Medically Important Condition);Protrusion tongue (n/a - Recovering/Resolving - Other Medically Important Condition);Rapid eye movement sleep behaviour disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep paralysis (n/a - Recovering/Resolving - Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12811715&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12808346	Spontaneous	2017-10-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12808346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12798363	Spontaneous	2017-10-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Depression (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Fear (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Hallucination (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Headache (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Insomnia (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Nightmare (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Stress (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Weight increased (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12798363&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-12799247	Spontaneous	2017-10-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12799247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12800396	Spontaneous	2017-10-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in social behaviour (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12800396&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12802075	Spontaneous	2017-10-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12802075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12792370	Spontaneous	2017-10-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12792370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12792374	Spontaneous	2017-10-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12792374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12793327	Spontaneous	2017-10-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Adverse event (n/a - Unknown - Disabling, Other Medically Important Condition);Deafness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Deafness unilateral (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Decreased immune responsiveness (n/a - Unknown - Disabling, Other Medically Important Condition);Hypoacusis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12793327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12794316	Spontaneous	2017-10-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12794316&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12789440	Spontaneous	2017-09-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Deafness unilateral (n/a - Unknown - Other Medically Important Condition);Herpes zoster (n/a - Unknown - Other Medically Important Condition)	ZOSTAVAX [VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12789440&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12782039	Spontaneous	2017-09-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dysstasia (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPAFENONE, PROPAFENONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12782039&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12771521	Spontaneous	2017-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12771521&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12775422	Spontaneous	2017-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12775422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12766262	Spontaneous	2017-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Anxiety (n/a - Unknown - Caused/Prolonged Hospitalisation);Hallucination, auditory (n/a - Unknown - Caused/Prolonged Hospitalisation);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Neutropenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Phobia (n/a - Unknown - Caused/Prolonged Hospitalisation);White blood cell count decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	OLANZAPINE [OLANZAPINE] (S - n/a - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])|[CLOZAPINE] (S - Schizophrenia - n/a - [n/a - n/a - Oral])|[CLOZAPINE] (S - n/a - n/a - [n/a - n/a - n/a])	[METFORMIN HYDROCHLORIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12766262&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12769065	Spontaneous	2017-09-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Syncope (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Parenteral])	[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE, BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[TERAZOSIN, TERAZOSIN HYDROCHLORIDE, TERAZOSIN HYDROCHLORIDE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12769065&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12769278	Spontaneous	2017-09-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthma (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neck pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Parenteral])	[BECLOMETASONE] (C - n/a - n/a - [n/a - n/a - n/a])|[FEXOFENADINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12769278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12770651	Spontaneous	2017-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12770651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12758763	Spontaneous	2017-09-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Amnesia (n/a - Unknown - Disabling, Other Medically Important Condition);Cataplexy (n/a - Unknown - Disabling, Other Medically Important Condition);Dyskinesia (n/a - Unknown - Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12758763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12758784	Spontaneous	2017-09-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Postural orthostatic tachycardia syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12758784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12758797	Spontaneous	2017-09-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Male	Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuropsychiatric syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Postural orthostatic tachycardia syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12758797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12758807	Spontaneous	2017-09-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Male	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuropsychiatric syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Postural orthostatic tachycardia syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Seasonal allergy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12758807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12758833	Spontaneous	2017-09-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12758833&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12758852	Spontaneous	2017-09-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Impaired work ability (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12758852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12758868	Spontaneous	2017-09-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);General physical health deterioration (n/a - Unknown - Other Medically Important Condition);Impaired work ability (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12758868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12751875	Spontaneous	2017-09-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abulia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Ageusia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Aggression (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Antisocial behaviour (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Anxiety (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Apathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Behaviour disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Derealisation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Educational problem (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Feeling cold (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Food craving (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Growth hormone deficiency (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperphagia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia-bulimia syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Irritability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Mental impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain (7d - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Personality change (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Photophobia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Asthmatic crisis - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12751875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12753981	Spontaneous	2017-09-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12753981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12754022	Spontaneous	2017-09-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12754022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12755248	Spontaneous	2017-09-22 00:00:00	Healthcare Professional	Non European Economic Area	Sun D, Cao S.. Leucocytoclastic vasculitis following influenza vaccination.. BMJ Case Rep 2017; Tavadia S, Drummond A, Evans CD, Wainwright NJ.. Leucocytoclastic vasculitis and influenza vaccination.. Clinical and Experimental Dermatology. 2003; 28:154-156.	65-85 Years	Not Specified	No	Female	Cutaneous vasculitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12755248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12747734	Spontaneous	2017-09-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12747734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12747735	Spontaneous	2017-09-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12747735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12748430	Spontaneous	2017-09-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12748430&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12741597	Spontaneous	2017-09-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Vision blurred (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	[RAMIPRIL] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12741597&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12733342	Spontaneous	2017-09-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Altered state of consciousness (45min - Recovered/Resolved - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Daydreaming (n/a - Unknown - Disabling);Decreased appetite (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Unknown - Disabling);Fall (n/a - Unknown - Disabling);Hallucination, auditory (n/a - Recovering/Resolving - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypnagogic hallucination (n/a - Recovering/Resolving - Disabling);Insomnia (n/a - Unknown - Disabling);Muscle contracture (n/a - Not Recovered/Not Resolved - Disabling);Muscle tightness (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Periodic limb movement disorder (n/a - Unknown - Disabling);Poor quality sleep (n/a - Unknown - Disabling);Presyncope (n/a - Recovered/Resolved - Disabling);Sleep talking (n/a - Unknown - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Tremor (n/a - Unknown - Disabling);Visual impairment (n/a - Unknown - Disabling)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12733342&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12734128	Spontaneous	2017-09-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12734128&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12720450	Spontaneous	2017-09-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12720450&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12712366	Spontaneous	2017-09-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Product quality issue (n/a - Unknown - Results in Death, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	LANTUS [INSULIN GLARGINE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR., ASPIRIN BP] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ATENOLOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CINNARIZINE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[HYDROXYCHLOROQUINE SULFATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[LOSARTAN POTASSIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[METHOTREXATE, METHOTREXATE DISODIUM, METHOTREXATE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PRAVASTATIN, PRAVASTATIN SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12712366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12713526	Spontaneous	2017-09-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12713526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12705603	Spontaneous	2017-09-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Food allergy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12705603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12706175	Spontaneous	2017-09-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12706175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12707910	Spontaneous	2017-09-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12707910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12699387	Spontaneous	2017-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12699387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12699514	Spontaneous	2017-09-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling);General physical health deterioration (n/a - Unknown - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Illness (n/a - Unknown - Disabling);Restlessness (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12699514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12700102	Spontaneous	2017-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12700102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12701709	Spontaneous	2017-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12701709&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12693435	Spontaneous	2017-09-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Adjustment disorder with depressed mood (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hypnagogic hallucination (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hypnopompic hallucination (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep paralysis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12693435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12694308	Spontaneous	2017-09-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Demyelinating polyneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Motor dysfunction (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Simple partial seizures (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Unknown])	[ACETYLSALICYLIC ACID] (C - Acute myocardial infarction - n/a - [n/a - n/a - n/a])|[BISACODYL] (C - n/a - n/a - [n/a - n/a - n/a])|[CODEINE] (C - Osteoarthritis - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE] (C - Acute myocardial infarction - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - Osteoarthritis - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Acute myocardial infarction - n/a - [n/a - n/a - n/a])|[TRANDOLAPRIL] (C - Acute myocardial infarction - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12694308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12694921	Spontaneous	2017-09-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12694921&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12684578	Spontaneous	2017-09-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12684578&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12677690	Spontaneous	2017-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Chronic fatigue syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Eye pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12677690&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12677845	Spontaneous	2017-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Alopecia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Aphthous ulcer (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Blister (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Bone marrow oedema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cardiac septal defect (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chest discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chest pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic gastritis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cold sweat (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Diplopia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysgeusia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Electrocardiogram ST segment depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Febrile infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gastrooesophageal reflux disease (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);General physical health deterioration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperlipasaemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Immune system disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Joint effusion (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Leukopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Lymphocytosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12677845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12680016	Spontaneous	2017-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Acne (3mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Colitis ulcerative (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Local reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Obstructive sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Poor quality sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12680016&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12680056	Spontaneous	2017-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Apnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Formication (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hepatic pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Musculoskeletal chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myofascitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Neck pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[ALGELDRATE, HEPATITIS B SURFACE ANTIGENS RECOMBINANT (S, PRE-S2), HEPATITIS B SURFACE ANTIGEN (RDNA), HEPATITIS B SURFACE ANTIGENS RECOMBINANT (S, PRE-S2)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[HEPATITIS B VIRUS SURFACE ANTIGEN [PRODUCED IN S. CEREVISIAE CELLS BY RDNA] ADSORBED ON ALUMINUM HYDROXIDE, HYDRATED, ALGELDRATE] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[HEPATITIS B VIRUS SURFACE ANTIGEN [PRODUCED IN S. CEREVISIAE CELLS BY RDNA] ADSORBED ON ALUMINUM HYDROXIDE, HYDRATED, ALGELDRATE] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12680056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12671410	Spontaneous	2017-09-06 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Avian influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12671410&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12663959	Spontaneous	2017-09-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bipolar disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12663959&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12664272	Spontaneous	2017-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12664272&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12665213	Spontaneous	2017-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cardiac index decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chills (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Condition aggravated (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dacryoadenitis acquired (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dry skin (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysstasia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Exophthalmos (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Haemophagocytic lymphohistiocytosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Joint swelling (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Mobility decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Motor dysfunction (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Night sweats (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Odynophagia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Osteonecrosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pulmonary arterial hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Still's disease (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tendonitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vaccination site pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Venoocclusive disease (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Venous injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	CONTRACEPTIVE PILL [ORAL CONTRACEPTIVE] (C - n/a - Unknown - [n/a - n/a - Oral])|[AMOXICILLIN SODIUM, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (C - n/a - Unknown - [8d - n/a - Unknown])|[CALCIUM CARBONATE, CHOLECALCIFEROL CONCENTRATE (POWDER FORM), COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[DRIED FERROUS SULFATE, FERROUS SULFATE, FERROUS SULFATE HYDRATE, FERROUS SULPHATE SESQUIHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[FOLIC ACID] (C - n/a - Unknown - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12665213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12665798	Spontaneous	2017-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12665798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-12668368	Spontaneous	2017-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12668368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12659783	Spontaneous	2017-09-04 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Avian influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12659783&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12662374	Spontaneous	2017-09-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12662374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12662378	Spontaneous	2017-09-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12662378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12652629	Spontaneous	2017-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Impaired work ability (n/a - Recovered/Resolved - Other Medically Important Condition);Insomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - 75mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12652629&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12644438	Spontaneous	2017-08-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12644438&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12644636	Spontaneous	2017-08-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (48h - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle discomfort (48h - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nerve injury (n/a - Unknown - Other Medically Important Condition);Nervous system disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Performance status decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight bearing difficulty (n/a - Unknown - Other Medically Important Condition)	MENVEO [MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN, NEISSERIA MENINGITIDIS GROUP C OLIGOSACCHARIDE, N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])|TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS NEUDOERFL STRAIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED PRODUCED IN CHICK EMBRYO CELLS, ALGELDRATE] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12644636&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12639127	Spontaneous	2017-08-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Autonomic neuropathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chills (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sensation of blood flow (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12639127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12641221	Spontaneous	2017-08-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12641221&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12623989	Spontaneous	2017-08-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anaemia (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Blood disorder (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Coagulopathy (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Condition aggravated (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Disorientation (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Haematoma (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hepatitis acute (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypernatraemia (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypokalaemia (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Jaundice (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Thrombocytopenia (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Urinary retention (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[DIPHTHERIA TOXOID, TETANUS TOXOID] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	JANUMET [METFORMIN HYDROCHLORIDE, SITAGLIPTIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (C - Type 2 diabetes mellitus - n/a - [n/a - 1{DF} - Oral])|[ALPRAZOLAM] (C - Anxiety - n/a - [n/a - .5mg - Oral])|[CARVEDILOL] (C - Arrhythmia - n/a - [n/a - 6.25mg - Oral])|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - Depression - n/a - [n/a - 20mg - Oral])|[FOLIC ACID] (C - Anaemia - n/a - [n/a - 5mg - Oral])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - Cardiac failure - n/a - [n/a - 40mg - Oral])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - Hypertension - n/a - [n/a - 20mg - Oral])|[OMEPRAZOLE] (C - Gastritis - n/a - [n/a - 20mg - Oral])|[SIMVASTATIN] (C - Dyslipidaemia - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12623989&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12628854	Spontaneous	2017-08-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Dyskinesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12628854&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12608798	Spontaneous	2017-08-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Hallucination (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12608798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12610454	Spontaneous	2017-08-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Discomfort (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - 37.5mg - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12610454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12610716	Spontaneous	2017-08-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (0d - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - 37.5ug - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12610716&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12602329	Spontaneous	2017-08-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Deafness unilateral (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	LEVEMIR [INSULIN DETEMIR] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|LYRICA [PREGABALIN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ACENOCOUMAROL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[BETAHISTINE DIHYDROCHLORIDE, BETAHISTINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CALCIUM CARBONATE, CHOLECALCIFEROL CONCENTRATE (POWDER FORM), COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE MONOHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[METOPROLOL TARTRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[NALOXONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, ANHYDROUS NALOXONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE DIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[OXYCODONE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[POVIDONE, POVIDONE K25] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[TORASEMIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ZOLPIDEM, ZOLPIDEM TARTRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12602329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-12605205	Spontaneous	2017-08-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hallucination (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paralysis (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12605205&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12596580	Spontaneous	2017-08-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12596580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12599999	Spontaneous	2017-08-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Blood pressure increased (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12599999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12586945	Spontaneous	2017-08-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12586945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12578881	Spontaneous	2017-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Dizziness (n/a - Recovering/Resolving - Other Medically Important Condition);Dyssomnia (n/a - Recovering/Resolving - Other Medically Important Condition);Fall (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Gait inability (n/a - Recovering/Resolving - Other Medically Important Condition);Grimacing (n/a - Recovering/Resolving - Other Medically Important Condition);Hallucination (n/a - Recovering/Resolving - Other Medically Important Condition);Head titubation (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Ill-defined disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Illness (n/a - Recovering/Resolving - Other Medically Important Condition);Insomnia (n/a - Recovering/Resolving - Other Medically Important Condition);Muscle disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Nightmare (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Personality change (n/a - Recovering/Resolving - Other Medically Important Condition);Poor quality sleep (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep paralysis (n/a - Recovering/Resolving - Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition);Suffocation feeling (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ZOPICLONE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12578881&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12579942	Spontaneous	2017-08-21 00:00:00	Healthcare Professional	European Economic Area	Dauvilliers et al. Post H1N1 narcolepsy-cataplexy. Sleep 2010 33: (11); 1-3	12-17 Years	Not Specified	No	Female	Agitation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Alopecia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Anger (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Anxiety (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Arthropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Bulimia nervosa (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Depressed mood (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Iron deficiency (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Rapid eye movements sleep abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Restless legs syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep talking (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep terror (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tearfulness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight bearing difficulty (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - Rhinitis - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12579942&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12570806	Spontaneous	2017-08-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12570806&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12572518	Spontaneous	2017-08-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12572518&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12562011	Spontaneous	2017-08-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12562011&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12554060	Spontaneous	2017-08-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12554060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12548041	Spontaneous	2017-08-14 00:00:00	Healthcare Professional	European Economic Area	Savvidou A. et al . Hypocretin deficiency develops during onset of human narcolepsy with cataplexy. SLEEP 2013;36(1):147-148.	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Food craving (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Hypnopompic hallucination (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Unknown - Other Medically Important Condition);Mood altered (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Quality of life decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Unknown - Other Medically Important Condition);Sleep talking (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Stupor (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12548041&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12548440	Spontaneous	2017-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Subcutaneous])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .2mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12548440&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12548472	Spontaneous	2017-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anger (n/a - Unknown - Other Medically Important Condition);Anxiety (n/a - Unknown - Other Medically Important Condition);Balance disorder (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysarthria (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep talking (n/a - Unknown - Other Medically Important Condition);Snoring (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12548472&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12549454	Spontaneous	2017-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12549454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12541482	Spontaneous	2017-08-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Upper respiratory tract infection (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12541482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12535024	Spontaneous	2017-08-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Unknown])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12535024&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12535070	Spontaneous	2017-08-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 2{DF} - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12535070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12537441	Spontaneous	2017-08-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (1mo - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12537441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12528421	Spontaneous	2017-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - .05mL - Intramuscular])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .05mL - Intramuscular])	[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - Depression - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12528421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12528931	Spontaneous	2017-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lichen planus (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12528931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12529929	Spontaneous	2017-08-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Unknown - Disabling);Palpitations (n/a - Unknown - Disabling);Temperature intolerance (n/a - Unknown - Disabling);Visual impairment (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12529929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12531819	Spontaneous	2017-08-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dysgraphia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - H1N1 influenza - Drug withdrawn - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12531819&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12531897	Spontaneous	2017-08-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12531897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12523915	Spontaneous	2017-08-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[MODAFINIL] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12523915&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12523952	Spontaneous	2017-08-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abnormal dreams (n/a - Recovering/Resolving - Other Medically Important Condition);Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Foaming at mouth (n/a - Recovering/Resolving - Other Medically Important Condition);Hallucination (n/a - Recovering/Resolving - Other Medically Important Condition);Muscle spasms (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Nightmare (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Seizure (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep paralysis (n/a - Recovering/Resolving - Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition);Weight increased (n/a - Recovering/Resolving - Other Medically Important Condition);Wheezing (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	NOT AVAILABLE [DIABETES MEDICATION] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12523952&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12524139	Spontaneous	2017-08-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotension (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12524139&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12510290	Spontaneous	2017-08-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12510290&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12510406	Spontaneous	2017-08-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12510406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12511433	Spontaneous	2017-08-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12511433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12513441	Spontaneous	2017-08-04 00:00:00	Healthcare Professional	European Economic Area	Cahill A. EU to look at research options on narcolepsy. Irish Examiner. 2014 FEB 14;.	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12513441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12515732	Spontaneous	2017-08-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Disturbance in attention (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12515732&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12505321	Spontaneous	2017-08-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Aggression (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Crying (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Learning disability (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Middle insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mood altered (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep talking (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12505321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12500389	Spontaneous	2017-08-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hallucination (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - 75ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12500389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12490561	Spontaneous	2017-08-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12490561&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12480490	Spontaneous	2017-07-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12480490&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12483154	Spontaneous	2017-07-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12483154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12475384	Spontaneous	2017-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amnesia (n/a - Not Recovered/Not Resolved - Disabling);Arrhythmia (n/a - Not Recovered/Not Resolved - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Back pain (n/a - Not Recovered/Not Resolved - Disabling);Chest discomfort (15d - Recovered/Resolved - Disabling);Cognitive disorder (n/a - Unknown - Disabling);Cough (15d - Recovered/Resolved - Disabling);Depression (n/a - Unknown - Disabling);Diarrhoea (1d - Recovered/Resolved - Disabling);Disability (n/a - Unknown - Disabling);Erectile dysfunction (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling cold (n/a - Unknown - Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Disabling);Gulf war syndrome (n/a - Unknown - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Injection site pain (n/a - Unknown - Disabling);Insomnia (n/a - Unknown - Disabling);Libido disorder (n/a - Unknown - Disabling);Mental disorder (n/a - Not Recovered/Not Resolved - Disabling);Middle insomnia (n/a - Unknown - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Nervous system disorder (n/a - Unknown - Disabling);Pain in extremity (n/a - Unknown - Disabling);Paraesthesia (1a - Recovered/Resolved - Disabling);Pyrexia (3d - Recovered/Resolved - Disabling);Respiratory disorder (15d - Recovered/Resolved - Disabling);Speech disorder (n/a - Unknown - Disabling);Temperature regulation disorder (n/a - Not Recovered/Not Resolved - Disabling);Vertigo (n/a - Unknown - Disabling);Visual impairment (n/a - Unknown - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12475384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12467440	Spontaneous	2017-07-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Injected limb mobility decreased (n/a - Not Recovered/Not Resolved - Disabling);Joint noise (n/a - Not Recovered/Not Resolved - Disabling);Loss of personal independence in daily activities (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12467440&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12469033	Spontaneous	2017-07-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12469033&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12461974	Spontaneous	2017-07-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Facial paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12461974&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12450435	Spontaneous	2017-07-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12450435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12451042	Spontaneous	2017-07-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Illness (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12451042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12444260	Spontaneous	2017-07-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12444260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-12447434	Spontaneous	2017-07-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	HLA marker study positive (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep study abnormal (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - n/a - Parenteral])|[INFLUENZA VIRUS] (S - n/a - Not applicable - [n/a - n/a - n/a])	[METHYLPHENIDATE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[TRAZODONE, TRAZODONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12447434&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12439690	Spontaneous	2017-07-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved With Sequelae - Disabling);Asthma (n/a - Recovered/Resolved With Sequelae - Disabling);Autoimmune disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Cardiovascular disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Chronic fatigue syndrome (n/a - Recovered/Resolved With Sequelae - Disabling);Connective tissue disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Dyspnoea (n/a - Recovered/Resolved With Sequelae - Disabling);Emotional disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Exercise tolerance decreased (n/a - Recovered/Resolved With Sequelae - Disabling);Fatigue (n/a - Recovered/Resolved With Sequelae - Disabling);Fibromyalgia (n/a - Recovered/Resolved With Sequelae - Disabling);Hypertension (n/a - Recovered/Resolved With Sequelae - Disabling);Myalgia (n/a - Recovered/Resolved With Sequelae - Disabling);Periodic limb movement disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Postural orthostatic tachycardia syndrome (n/a - Recovered/Resolved With Sequelae - Disabling);Pyrexia (n/a - Recovered/Resolved With Sequelae - Disabling);Sleep apnoea syndrome (n/a - Recovered/Resolved With Sequelae - Disabling);Sleep disorder (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12439690&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-12439710	Spontaneous	2017-07-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Abdominal pain upper (n/a - Recovered/Resolved With Sequelae - Disabling);Anxiety (n/a - Recovered/Resolved With Sequelae - Disabling);Aphasia (n/a - Recovered/Resolved With Sequelae - Disabling);Autonomic nervous system imbalance (n/a - Recovered/Resolved With Sequelae - Disabling);Developmental delay (n/a - Recovered/Resolved With Sequelae - Disabling);Disturbance in attention (n/a - Recovered/Resolved With Sequelae - Disabling);Dysgraphia (n/a - Recovered/Resolved With Sequelae - Disabling);Dyspnoea (n/a - Recovered/Resolved With Sequelae - Disabling);Educational problem (n/a - Recovered/Resolved With Sequelae - Disabling);Emotional disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Headache (n/a - Recovered/Resolved With Sequelae - Disabling);Irritability (n/a - Recovered/Resolved With Sequelae - Disabling);Loss of personal independence in daily activities (n/a - Recovered/Resolved With Sequelae - Disabling);Motor dysfunction (n/a - Recovered/Resolved With Sequelae - Disabling);Myalgia (n/a - Recovered/Resolved With Sequelae - Disabling);Nausea (n/a - Recovered/Resolved With Sequelae - Disabling);Neuropsychiatric syndrome (n/a - Recovered/Resolved With Sequelae - Disabling);Neuropsychological symptoms (n/a - Recovered/Resolved With Sequelae - Disabling);Obsessive-compulsive disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Petit mal epilepsy (n/a - Recovered/Resolved With Sequelae - Disabling);Postural orthostatic tachycardia syndrome (n/a - Recovered/Resolved With Sequelae - Disabling);Pyrexia (n/a - Recovered/Resolved With Sequelae - Disabling);Restless legs syndrome (n/a - Recovered/Resolved With Sequelae - Disabling);Sleep disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Tachycardia (n/a - Recovered/Resolved With Sequelae - Disabling);Tic (n/a - Recovered/Resolved With Sequelae - Disabling);Tourette's disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Visual impairment (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12439710&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-12439780	Spontaneous	2017-07-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Autonomic nervous system imbalance (n/a - Unknown - Disabling);Dyskinesia (n/a - Unknown - Disabling);Dysstasia (n/a - Unknown - Disabling);Eye pain (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Hypotonia (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Postural orthostatic tachycardia syndrome (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Tremor (n/a - Unknown - Disabling);Vomiting (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12439780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12432750	Spontaneous	2017-07-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Sleep attacks (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12432750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-12426237	Spontaneous	2017-07-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Renal cancer (n/a - Fatal - Results in Death, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12426237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12428811	Spontaneous	2017-07-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Diabetes mellitus (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12428811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Life Threatening	Hospitalisation
EU-EC-12428834	Spontaneous	2017-07-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Heavy menstrual bleeding (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnopompic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Infectious mononucleosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscle spasms (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[METHYLPHENIDATE HYDROCHLORIDE] (S - n/a - Unknown - [n/a - n/a - Unknown])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - Intermenstrual bleeding - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12428834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12430458	Spontaneous	2017-07-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	[MODAFINIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12430458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12419201	Spontaneous	2017-07-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12419201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12420173	Spontaneous	2017-07-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Adverse event (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Educational problem (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12420173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12407485	Spontaneous	2017-07-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12407485&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12407601	Spontaneous	2017-07-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12407601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12401527	Spontaneous	2017-07-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Abdominal symptom (n/a - Not Recovered/Not Resolved - Disabling);Dysarthria (n/a - Not Recovered/Not Resolved - Disabling);Eye symptom (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hyperpyrexia (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia oral (n/a - Not Recovered/Not Resolved - Disabling);Migraine (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12401527&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12388975	Spontaneous	2017-07-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (7d - Recovered/Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Pain (7d - Recovered/Resolved - Disabling);Pyrexia (7d - Recovered/Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12388975&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12389784	Spontaneous	2017-07-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza like illness (n/a - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12389784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12383398	Spontaneous	2017-07-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12383398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12379248	Spontaneous	2017-07-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Normochromic normocytic anaemia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[DROSPIRENONE, ETHINYLESTRADIOL] (C - Contraception - n/a - [n/a - 1{DF} - Oral])|[LEVOTHYROXINE SODIUM] (C - Hormone replacement therapy - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12379248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12372788	Spontaneous	2017-07-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Blindness (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Syncope (n/a - Not Recovered/Not Resolved - Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12372788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12372790	Spontaneous	2017-07-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12372790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12373080	Spontaneous	2017-07-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12373080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12367340	Spontaneous	2017-07-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Encephalopathy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Illness (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12367340&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12361708	Spontaneous	2017-06-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12361708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12361726	Spontaneous	2017-06-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12361726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12361727	Spontaneous	2017-06-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12361727&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12361779	Spontaneous	2017-06-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12361779&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12361835	Spontaneous	2017-06-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12361835&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12344986	Spontaneous	2017-06-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Recovered/Resolved With Sequelae - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12344986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-12338172	Spontaneous	2017-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Unknown - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12338172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12338193	Spontaneous	2017-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12338193&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12339334	Spontaneous	2017-06-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Periarthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12339334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12339341	Spontaneous	2017-06-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Dysphemia (n/a - Recovered/Resolved With Sequelae - Disabling);Dyspraxia (n/a - Recovered/Resolved With Sequelae - Disabling);Foetal exposure during pregnancy (n/a - Recovered/Resolved With Sequelae - Disabling);Speech disorder (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12339341&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-12340249	Spontaneous	2017-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12340249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12334734	Spontaneous	2017-06-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Brain death (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Withdrawal of life support (1d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12334734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-12322946	Spontaneous	2017-06-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Capillary leak syndrome (n/a - Recovered/Resolved - Life Threatening);Myalgia (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])...	MICARDIS [TELMISARTAN] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12322946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-12319153	Spontaneous	2017-06-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[IBUPROFEN] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12319153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12299445	Spontaneous	2017-06-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Insomnia (n/a - Unknown - Other Medically Important Condition);Monoplegia (n/a - Unknown - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Palpitations (n/a - Unknown - Other Medically Important Condition);Sleep attacks (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12299445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12294267	Spontaneous	2017-06-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12294267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12274799	Spontaneous	2017-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Malaise (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pharyngeal swelling (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Swelling face (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])...	EXFORGE [VALSARTAN, AMLODIPINE, VALSARTAN, AMLODIPINE BESILATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[FORMOTEROL, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[INDAPAMIDE, INDAPAMIDE HEMIHYDRATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[NIFLUMIC ACID] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12274799&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-12272180	Spontaneous	2017-06-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12272180&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12258450	Spontaneous	2017-06-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12258450&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12255932	Spontaneous	2017-06-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12255932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12241637	Spontaneous	2017-06-02 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12241637&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12231702	Spontaneous	2017-05-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Mixed connective tissue disease (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12231702&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12232325	Spontaneous	2017-05-31 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Eye pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Photophobia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12232325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12225077	Spontaneous	2017-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12225077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12227054	Spontaneous	2017-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12227054&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12216958	Spontaneous	2017-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12216958&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12218451	Spontaneous	2017-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12218451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12211186	Spontaneous	2017-05-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Acute sinusitis (n/a - Not Recovered/Not Resolved - Disabling);Autonomic nervous system imbalance (n/a - Not Recovered/Not Resolved - Disabling);Balance disorder (n/a - Not Recovered/Not Resolved - Disabling);Diplopia (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Migraine (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Postural orthostatic tachycardia syndrome (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling);Rash (n/a - Not Recovered/Not Resolved - Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12211186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12198984	Spontaneous	2017-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Foetal exposure during pregnancy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Low birth weight baby (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mg - Intramuscular])	[MINERALS NOS, VITAMINS NOS] (C - Prophylaxis - Not applicable - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12198984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12189670	Spontaneous	2017-05-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Illusion (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12189670&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12189671	Spontaneous	2017-05-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myasthenia gravis (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12189671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12189672	Spontaneous	2017-05-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Quality of life decreased (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12189672&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12192604	Spontaneous	2017-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12192604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12182784	Spontaneous	2017-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Autism spectrum disorder (n/a - Recovered/Resolved With Sequelae - Disabling);Developmental delay (n/a - Recovered/Resolved With Sequelae - Disabling);Foetal exposure during pregnancy (n/a - Recovered/Resolved With Sequelae - Disabling);Premature baby (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12182784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-12176845	Spontaneous	2017-05-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Nasopharyngitis (n/a - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12176845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-12177590	Spontaneous	2017-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12177590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12158270	Spontaneous	2017-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Colon cancer (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Metastases to liver (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema peripheral (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])...	FOLFOX [FLUOROURACIL, FOLINIC ACID, OXALIPLATIN] (C - Chemotherapy - Not applicable - [74d - n/a - n/a])|[BETAMETHASONE, BETAMETHASONE SODIUM PHOSPHATE] (C - Arthralgia - Not applicable - [n/a - n/a - n/a])|[PREDNISONE] (C - Giant cell arteritis - Not applicable - [n/a - 40mg - n/a])|[PREDNISONE] (C - n/a - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12158270&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12146570	Spontaneous	2017-05-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Antiphospholipid syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pneumothorax (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Systemic lupus erythematosus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Thrombosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12146570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12142739	Spontaneous	2017-05-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 25mg - n/a])|[LIOTHYRONINE SODIUM] (C - n/a - n/a - [n/a - 10ug - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - 10mg - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - .2mg - n/a])|[SALMETEROL, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - 50ug - n/a])|[SODIUM CROMOGLICATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12142739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12135598	Spontaneous	2017-05-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12135598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12135976	Spontaneous	2017-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12135976&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12136334	Spontaneous	2017-05-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12136334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12136466	Spontaneous	2017-05-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Connective tissue disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tachycardia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12136466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12128557	Spontaneous	2017-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12128557&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12130230	Spontaneous	2017-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12130230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12131339	Spontaneous	2017-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Autism spectrum disorder (n/a - Unknown - Other Medically Important Condition);Encephalitis (n/a - Unknown - Other Medically Important Condition);Epilepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12131339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12122366	Spontaneous	2017-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12122366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12122372	Spontaneous	2017-05-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Impaired work ability (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12122372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12123423	Spontaneous	2017-05-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Child	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12123423&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-12123456	Spontaneous	2017-05-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthma (n/a - Recovered/Resolved With Sequelae - Disabling);Immunodeficiency (n/a - Recovered/Resolved With Sequelae - Disabling);Upper respiratory tract infection (n/a - Recovered/Resolved With Sequelae - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - n/a])	[MESALAZINE] (C - Colitis ulcerative - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12123456&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-12111233	Spontaneous	2017-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Loss of employment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Motor dysfunction (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12111233&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12111377	Spontaneous	2017-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysstasia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypnagogic hallucination (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Middle insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nightmare (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rapid eye movements sleep abnormal (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Speech disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Syncope (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12111377&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12111637	Spontaneous	2017-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12111637&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12111693	Spontaneous	2017-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12111693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12112037	Spontaneous	2017-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Circulatory collapse (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12112037&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12112076	Spontaneous	2017-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anger (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hallucination (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hunger (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mood altered (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Petit mal epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12112076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12112401	Spontaneous	2017-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Alopecia areata (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Alopecia totalis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Disabling, Other Medically Important Condition);Pyrexia (n/a - Unknown - Disabling, Other Medically Important Condition);Urticaria (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [1d - .25mL - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12112401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12112795	Spontaneous	2017-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12112795&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12114507	Spontaneous	2017-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12114507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12106532	Spontaneous	2017-05-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12106532&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12106679	Spontaneous	2017-05-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12106679&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12106789	Spontaneous	2017-05-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Unknown - Disabling);Lymphadenopathy (n/a - Unknown - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Tic (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12106789&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12100827	Spontaneous	2017-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lymphoid tissue hyperplasia (159d - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12100827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-12088985	Spontaneous	2017-04-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	LYRICA [PREGABALIN] (C - n/a - n/a - [n/a - n/a - n/a])|[LAMOTRIGINE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12088985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12090957	Spontaneous	2017-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hallucination, visual (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Ligament rupture (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nervousness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Stress (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12090957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12091027	Spontaneous	2017-04-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[DRIED FERROUS SULFATE, FERROUS SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12091027&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12092451	Spontaneous	2017-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12092451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12075889	Spontaneous	2017-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (S - Product used for unknown indication - n/a - [n/a - n/a - n/a])	CLOPIDOGREL [CLOPIDOGREL, CLOPIDOGREL BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAVASTATIN SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[VERAPAMIL HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12075889&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12075904	Spontaneous	2017-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cervicobrachial syndrome (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12075904&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12075949	Spontaneous	2017-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Juvenile idiopathic arthritis (n/a - Unknown - Caused/Prolonged Hospitalisation)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12075949&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12076747	Spontaneous	2017-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Crying (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fall (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Intentional self-injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nightmare (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Personality change (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Protrusion tongue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep talking (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Toxicity to various agents (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Unknown])	[MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS (LIVE, ATTENUATED), RUBELLA VIRUS (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12076747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12079006	Spontaneous	2017-04-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12079006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12080032	Spontaneous	2017-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12080032&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12069428	Spontaneous	2017-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12069428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12070209	Spontaneous	2017-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dry skin (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eczema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Recovered/Resolved - Other Medically Important Condition);Irritability (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12070209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12070563	Spontaneous	2017-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anger (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12070563&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12070662	Spontaneous	2017-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Irritability (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Personality change (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12070662&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12070719	Spontaneous	2017-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anger (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Food craving (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyposomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Ill-defined disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation);Photophobia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Poor quality sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12070719&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12071023	Spontaneous	2017-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[TERBUTALINE SULFATE] (C - Asthma - Unknown - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12071023&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12071163	Spontaneous	2017-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Nightmare (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12071163&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12073143	Spontaneous	2017-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Asthenia (n/a - Recovering/Resolving - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Recovering/Resolving - Other Medically Important Condition);Cough (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Nerve injury (n/a - Recovering/Resolving - Other Medically Important Condition);Neurological symptom (n/a - Recovering/Resolving - Other Medically Important Condition);Pneumonia mycoplasmal (n/a - Recovering/Resolving - Other Medically Important Condition);Pneumonia viral (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Respiratory tract infection (n/a - Recovering/Resolving - Other Medically Important Condition);Rib fracture (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12073143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12061743	Spontaneous	2017-04-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12061743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12065382	Spontaneous	2017-04-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Female	Loss of personal independence in daily activities (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12065382&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12057369	Spontaneous	2017-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12057369&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-12057801	Spontaneous	2017-04-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12057801&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12047837	Spontaneous	2017-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12047837&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12048811	Spontaneous	2017-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12048811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12049863	Spontaneous	2017-04-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Burning sensation (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Peripheral coldness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Polyneuropathy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12049863&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12045685	Spontaneous	2017-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12045685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12035056	Spontaneous	2017-04-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12035056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12035895	Spontaneous	2017-04-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12035895&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12036332	Spontaneous	2017-04-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12036332&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12028551	Spontaneous	2017-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12028551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12028842	Spontaneous	2017-04-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Food allergy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Infection (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Neurological symptom (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Perfume sensitivity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Temperature regulation disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12028842&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12023306	Spontaneous	2017-04-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Illness (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12023306&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-12027844	Spontaneous	2017-04-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Haemolytic uraemic syndrome (6wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombotic thrombocytopenic purpura (6wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - Unknown])	[FLUVOXAMINE MALEATE] (C - Depressed mood - n/a - [n/a - {DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12027844&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-12016985	Spontaneous	2017-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12016985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12011888	Spontaneous	2017-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12011888&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-12013012	Spontaneous	2017-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Angioedema (n/a - Unknown - Other Medically Important Condition);Dysphonia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Odynophagia (n/a - Unknown - Other Medically Important Condition);Oral mucosal erythema (n/a - Unknown - Other Medically Important Condition);Palatal oedema (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	EUCREAS [METFORMIN HYDROCHLORIDE, VILDAGLIPTIN] (C - Type 2 diabetes mellitus - n/a - [n/a - 1{DF} - Oral])|[ACETYLSALICYLIC ACID] (C - Cardiovascular event prophylaxis - n/a - [n/a - 150mg - Oral])|[GLICLAZIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - 30mg - Oral])|[OLMESARTAN MEDOXOMIL, AMLODIPINE] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])|[RAMIPRIL] (C - Hypertension - n/a - [n/a - 150mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12013012&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-12003916	Spontaneous	2017-04-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Accidental overdose (n/a - Unknown - Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Musculoskeletal discomfort (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Quality of life decreased (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12003916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-12004634	Spontaneous	2017-04-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amyotrophic lateral sclerosis (n/a - Recovering/Resolving - Other Medically Important Condition);Aphasia (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Motor neurone disease (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Upper motor neurone lesion (n/a - Recovering/Resolving - Other Medically Important Condition);Wheelchair user (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 2{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=12004634&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11998547	Spontaneous	2017-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Anger (n/a - Recovered/Resolved With Sequelae - Disabling);Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Irritability (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11998547&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-11999483	Spontaneous	2017-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11999483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-11993489	Spontaneous	2017-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11993489&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11987009	Spontaneous	2017-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11987009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11978532	Spontaneous	2017-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Balance disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Blindness (n/a - Unknown - Disabling, Other Medically Important Condition);Burning sensation (n/a - Unknown - Disabling, Other Medically Important Condition);Chest discomfort (n/a - Unknown - Disabling, Other Medically Important Condition);Constipation (n/a - Unknown - Disabling, Other Medically Important Condition);Crying (n/a - Unknown - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Disabling, Other Medically Important Condition);Dry skin (n/a - Unknown - Disabling, Other Medically Important Condition);Dysphonia (n/a - Unknown - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Disabling, Other Medically Important Condition);Eye pain (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Feeling abnormal (n/a - Unknown - Disabling, Other Medically Important Condition);Food allergy (n/a - Unknown - Disabling, Other Medically Important Condition);Foreign body sensation in eyes (n/a - Unknown - Disabling, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Disabling, Other Medically Important Condition);General physical health deterioration (n/a - Unknown - Disabling, Other Medically Important Condition);Glossodynia (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Hepatic enzyme increased (n/a - Unknown - Disabling, Other Medically Important Condition);Hyperaesthesia (n/a - Unknown - Disabling, Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Disabling, Other Medically Important Condition);Injection site dryness (n/a - Unknown - Disabling, Other Medically Important Condition);Injection site pain (n/a - Unknown - Disabling, Other Medically Important Condition);Insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Joint noise (n/a - Unknown - Disabling, Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Mobility decreased (n/a - Unknown - Disabling, Other Medically Important Condition);Muscle spasms (n/a - Unknown - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Disabling, Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Disabling, Other Medically Important Condition);Nausea (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Neuralgia (n/a - Unknown - Disabling, Other Medically Important Condition);Ocular hyperaemia (n/a - Unknown - Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Paralysis (n/a - Unknown - Disabling, Other Medically Important Condition);Photophobia (n/a - Unknown - Disabling, Other Medically Important Condition);Pollakiuria (n/a - Unknown - Disabling, Other Medically Important Condition);Pupillary reflex impaired (n/a - Unknown - Disabling, Other Medically Important Condition);Red blood cell sedimentation rate increased (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11978532&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-11981653	Spontaneous	2017-04-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Maternal exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash macular (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mg - Intramuscular])	[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Pruritus - Not applicable - [n/a - 10mg - Oral])|[METHYLPREDNISOLONE ACEPONATE, METHYLPREDNISOLONE ACETATE] (C - Hypersensitivity - Not applicable - [n/a - n/a - n/a])|[MINERALS NOS, VITAMINS NOS] (C - Mineral supplementation - Not applicable - [n/a - n/a - Oral])|[MINERALS NOS, VITAMINS NOS] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[PREDNISOLONE] (C - Hypersensitivity - Not applicable - [4d - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11981653&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11981704	Spontaneous	2017-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11981704&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11981845	Spontaneous	2017-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11981845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11972890	Spontaneous	2017-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11972890&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11973074	Spontaneous	2017-03-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11973074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11973076	Spontaneous	2017-03-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11973076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11973077	Spontaneous	2017-03-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Impaired work ability (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11973077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11964324	Spontaneous	2017-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Unknown - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Unknown - Disabling);Hypertensive heart disease (n/a - Unknown - Disabling);Impaired work ability (n/a - Unknown - Disabling);Intervertebral disc protrusion (n/a - Unknown - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Unknown - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Sleep apnoea syndrome (n/a - Unknown - Disabling);Supraventricular extrasystoles (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[HEPATITIS A VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[HEPATITIS B VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	APROVEL [IRBESARTAN] (C - Hypertension - Unknown - [n/a - n/a - Oral])|IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - Pain - Unknown - [n/a - 600mg - Oral])|[GLYCERYL TRINITRATE] (C - Chest pain - Unknown - [n/a - n/a - Oral])|[MELOXICAM] (C - Pain - Unknown - [n/a - 15mg - Oral])|[NIFEDIPINE] (C - Hypertension - Unknown - [n/a - 80mg - Oral])|[PARACETAMOL] (C - Pain - Unknown - [n/a - 1000mg - Oral])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - Pain - Unknown - [n/a - 50mg - Oral])|[ZOPICLONE] (C - Sleep disorder - Unknown - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11964324&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-11960482	Spontaneous	2017-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fibromyalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);General physical health deterioration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hemiplegia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Injection site discolouration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Injection site swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Listless (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Neck pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Transient ischaemic attack (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [1d - 1{DF} - Parenteral])	[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - Not applicable - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11960482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11951571	Spontaneous	2017-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Diplopia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11951571&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11951583	Spontaneous	2017-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11951583&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11951584	Spontaneous	2017-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11951584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11951645	Spontaneous	2017-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Depressed mood (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Irritability (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Unknown - Other Medically Important Condition);Mobility decreased (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neck pain (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [2mo - 500uL - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11951645&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11951906	Spontaneous	2017-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11951906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11951914	Spontaneous	2017-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11951914&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11951933	Spontaneous	2017-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11951933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11954284	Spontaneous	2017-03-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hallucination, visual (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Product use issue (n/a - Recovered/Resolved - Other Medically Important Condition)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Product used for unknown indication - Not applicable - [1d - 1{DF} - Intramuscular])...	SEBIVO [TELBIVUDINE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[HUMAN HEPATITIS B IMMUNOGLOBULIN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[QUETIAPINE, QUETIAPINE FUMARATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[TACROLIMUS, TACROLIMUS MONOHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11954284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11955537	Spontaneous	2017-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11955537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11947849	Spontaneous	2017-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11947849&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11949273	Spontaneous	2017-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11949273&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11929988	Spontaneous	2017-03-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11929988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11931066	Spontaneous	2017-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Attention deficit hyperactivity disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Protrusion tongue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Speech disorder developmental (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 2{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11931066&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11922766	Spontaneous	2017-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Bursitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11922766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11922810	Spontaneous	2017-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Neuralgic amyotrophy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11922810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11923366	Spontaneous	2017-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abnormal behaviour (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11923366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11923550	Spontaneous	2017-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11923550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11923965	Spontaneous	2017-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depressed mood (n/a - Unknown - Other Medically Important Condition);Facial paresis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gastroenteritis viral (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hunger (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypervigilance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mood swings (n/a - Unknown - Other Medically Important Condition);Muscle disorder (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11923965&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11924170	Spontaneous	2017-03-22 00:00:00	Healthcare Professional	European Economic Area	M. Vrethem et al, A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination, J. Neurol Sci (2012), doi:10.106/j.jns.2012.07.025	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyssomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Fall (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Movement disorder (30s - Recovered/Resolved - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle twitching (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rapid eye movements sleep abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Speech disorder (30s - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11924170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11924207	Spontaneous	2017-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11924207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11924299	Spontaneous	2017-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11924299&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11924449	Spontaneous	2017-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11924449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11924623	Spontaneous	2017-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Increased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11924623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11924630	Spontaneous	2017-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11924630&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11924859	Spontaneous	2017-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BUDESONIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11924859&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11916016	Spontaneous	2017-03-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11916016&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11916404	Spontaneous	2017-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dry eye (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dry mouth (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Migraine (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nasal dryness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tooth disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11916404&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11899266	Spontaneous	2017-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11899266&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-11899283	Spontaneous	2017-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Burning sensation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11899283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11899987	Spontaneous	2017-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Retinal pigment epitheliopathy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11899987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11892576	Spontaneous	2017-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (n/a - Unknown - );Muscular weakness (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11892576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11883147	Spontaneous	2017-03-14 00:00:00	Healthcare Professional	Non European Economic Area	Fernandes Pimentel M, de Camargo Ferreira E, Cerbino-Neto J. Henoch-Schonlein purpura following influenza A H1NI vaccination. Revista da Sociedade Brasileira de Medicina Tropical 2011;44(4):531-531.	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Blood blister (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Diarrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Henoch-Schonlein purpura (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Leukocytosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mobility decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Platelet count increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Proteinuria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Purpura (n/a - Recovered/Resolved - Other Medically Important Condition);Rash papular (n/a - Unknown - Other Medically Important Condition);Skin ulcer (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Staphylococcal skin infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Wound infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11883147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11885493	Spontaneous	2017-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Impaired work ability (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Neuralgic amyotrophy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Paresis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Post-traumatic neck syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rotator cuff syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Winged scapula (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[METOPROLOL SUCCINATE] (C - Ventricular extrasystoles - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11885493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11887927	Spontaneous	2017-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11887927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11878171	Spontaneous	2017-03-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Panic attack (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Stress (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11878171&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11881907	Spontaneous	2017-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Periarthritis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACRIVASTINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE] (C - Seasonal allergy - n/a - [n/a - n/a - Oral])|[ALENDRONATE SODIUM, ALENDRONATE SODIUM TRIHYDRATE, ALENDRONIC ACID] (C - Osteoporosis - n/a - [n/a - n/a - Oral])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - Hypertension - n/a - [n/a - n/a - n/a])|[POVIDONE, POVIDONE K25] (C - Dry eye - n/a - [n/a - n/a - Other])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11881907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11869970	Spontaneous	2017-03-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Facial paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gastrooesophageal reflux disease (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11869970&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11870813	Spontaneous	2017-03-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anosmia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11870813&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-11864164	Spontaneous	2017-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Food allergy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11864164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-11851907	Spontaneous	2017-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11851907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11830303	Spontaneous	2017-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11830303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11823646	Spontaneous	2017-03-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Eczema (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - );Pain (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11823646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11824869	Spontaneous	2017-03-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11824869&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11827878	Spontaneous	2017-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11827878&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11827879	Spontaneous	2017-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11827879&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11817160	Spontaneous	2017-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anger (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Aphasia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Arthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Body temperature fluctuation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Frustration tolerance decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Head discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Impaired work ability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscle tightness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Neoplasm (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Peripheral swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11817160&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11820259	Spontaneous	2017-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11820259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11810478	Spontaneous	2017-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Injection site pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rheumatic disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11810478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11812889	Spontaneous	2017-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Muscular weakness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Neuralgic amyotrophy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Winged scapula (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11812889&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11804666	Spontaneous	2017-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11804666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11806453	Spontaneous	2017-02-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ageusia (n/a - Unknown - Other Medically Important Condition);Allergy to chemicals (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anaesthesia oral (n/a - Unknown - Other Medically Important Condition);Angioedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Drug hypersensitivity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Food allergy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Lip swelling (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Multiple allergies (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Seasonal allergy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Stress (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11806453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11806454	Spontaneous	2017-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cheyne-Stokes respiration (n/a - Unknown - Disabling, Other Medically Important Condition);Delayed sleep phase (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Impaired work ability (n/a - Unknown - Disabling, Other Medically Important Condition);Insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Middle insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11806454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11806980	Spontaneous	2017-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11806980&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11807005	Spontaneous	2017-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	Yes	Male	Autism spectrum disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Foetal exposure during pregnancy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11807005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11795298	Spontaneous	2017-02-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Delirium (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11795298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11796084	Spontaneous	2017-02-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Impaired work ability (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11796084&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11796501	Spontaneous	2017-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11796501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11800546	Spontaneous	2017-02-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11800546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11790231	Spontaneous	2017-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11790231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11782322	Spontaneous	2017-02-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Aggression (n/a - Unknown - Caused/Prolonged Hospitalisation);Automatism (n/a - Unknown - Caused/Prolonged Hospitalisation);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep talking (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11782322&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11784131	Spontaneous	2017-02-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Delirium (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11784131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11771906	Spontaneous	2017-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|RASILEZ [ALISKIREN, ALISKIREN HEMIFUMARATE] (C - Hypertension - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11771906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11772866	Spontaneous	2017-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Chest discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Larynx irritation (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Sputum increased (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11772866&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11773781	Spontaneous	2017-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11773781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11775362	Spontaneous	2017-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Monoparesis (7d - Recovered/Resolved - )	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11775362&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-11766659	Spontaneous	2017-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11766659&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11769251	Spontaneous	2017-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Inflammation (n/a - Recovered/Resolved - Disabling);Pain (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11769251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11769330	Spontaneous	2017-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Accommodation disorder (n/a - Not Recovered/Not Resolved - );Gait disturbance (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Nausea (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - );Vertigo (n/a - Not Recovered/Not Resolved - );Vomiting (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - .5mg - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11769330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11759756	Spontaneous	2017-02-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthritis (n/a - Unknown - Disabling, Other Medically Important Condition);Contusion (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Fibromyalgia (n/a - Unknown - Disabling, Other Medically Important Condition);Immune thrombocytopenia (n/a - Unknown - Disabling, Other Medically Important Condition);Intervertebral disc protrusion (n/a - Unknown - Disabling, Other Medically Important Condition);Myalgia (n/a - Unknown - Disabling, Other Medically Important Condition);Non-alcoholic fatty liver (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Disabling, Other Medically Important Condition);Viral infection (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11759756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-11748051	Spontaneous	2017-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Drug ineffective (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11748051&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11752110	Spontaneous	2017-02-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Drug ineffective (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11752110&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11752973	Spontaneous	2017-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11752973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11744215	Spontaneous	2017-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11744215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11744577	Spontaneous	2017-02-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11744577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11735577	Spontaneous	2017-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Immune thrombocytopenia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11735577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11737325	Spontaneous	2017-02-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Bronchitis (8d - Recovered/Resolved - Disabling);Condition aggravated (8d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11737325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11737342	Spontaneous	2017-02-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11737342&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11737733	Spontaneous	2017-02-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11737733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11737734	Spontaneous	2017-02-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11737734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11737735	Spontaneous	2017-02-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Bronchitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11737735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11738664	Spontaneous	2017-02-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11738664&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11729862	Spontaneous	2017-02-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11729862&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11732219	Spontaneous	2017-02-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11732219&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11732220	Spontaneous	2017-02-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11732220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11732866	Spontaneous	2017-02-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Bronchitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11732866&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11715222	Spontaneous	2017-02-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11715222&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11715266	Spontaneous	2017-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (37d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Inflammation (37d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Meningism (37d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (37d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Photophobia (37d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (37d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11715266&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11716233	Spontaneous	2017-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11716233&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11717301	Spontaneous	2017-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Alanine aminotransferase increased (n/a - Not Recovered/Not Resolved - );Blood creatine phosphokinase increased (n/a - Not Recovered/Not Resolved - );Blood lactate dehydrogenase increased (n/a - Not Recovered/Not Resolved - );Body temperature increased (n/a - Not Recovered/Not Resolved - );Bronchitis (n/a - Not Recovered/Not Resolved - );Cough (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11717301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11719765	Spontaneous	2017-02-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11719765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11709312	Spontaneous	2017-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11709312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11710676	Spontaneous	2017-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11710676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-11711107	Spontaneous	2017-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11711107&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11711176	Spontaneous	2017-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11711176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-11702405	Spontaneous	2017-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Eyelid ptosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Radiculopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE, BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE DIHYDRATE PH.EUR., BECLOMETHASONE DIPROPIONATE PH. EUR., FORMOTEROL FUMARATE DIHYDRATE, BECLOMETASONE DIPROPIONATE ANHYDROUS] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[VITAMIN D] (C - n/a - n/a - [n/a - 20000[iU] - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11702405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11705492	Spontaneous	2017-02-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11705492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11705493	Spontaneous	2017-02-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11705493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11705494	Spontaneous	2017-02-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11705494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11696282	Spontaneous	2017-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Application site pain (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE] (C - Product used for unknown indication - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11696282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11697381	Spontaneous	2017-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11697381&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11698319	Spontaneous	2017-02-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11698319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11698322	Spontaneous	2017-02-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11698322&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11699461	Spontaneous	2017-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11699461&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11694269	Spontaneous	2017-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Dyskinesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11694269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11688214	Spontaneous	2017-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Febrile convulsion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	KEPPRA [LEVETIRACETAM] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[ACICLOVIR, ACICLOVIR SODIUM] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[CEFTRIAXONE, CEFTRIAXONE SODIUM] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11688214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11688959	Spontaneous	2017-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pityriasis rubra pilaris (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11688959&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11689370	Spontaneous	2017-02-03 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Balance disorder (n/a - Recovering/Resolving - Disabling);Cognitive disorder (n/a - Recovering/Resolving - Disabling);Conjunctivitis allergic (n/a - Unknown - Disabling);Detachment of macular retinal pigment epithelium (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Dry eye (n/a - Unknown - Disabling);Influenza like illness (n/a - Recovered/Resolved - Disabling);Memory impairment (n/a - Recovering/Resolving - Disabling);Muscle twitching (n/a - Unknown - Disabling);Thinking abnormal (n/a - Recovering/Resolving - Disabling);Uveitis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11689370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-11689579	Spontaneous	2017-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11689579&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11690148	Spontaneous	2017-02-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11690148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11693043	Spontaneous	2017-02-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11693043&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11682539	Spontaneous	2017-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11682539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11682566	Spontaneous	2017-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11682566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11684732	Spontaneous	2017-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11684732&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11679832	Spontaneous	2017-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myocarditis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11679832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11680165	Spontaneous	2017-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Febrile convulsion (55d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11680165&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11680425	Spontaneous	2017-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Facial paralysis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11680425&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11673530	Spontaneous	2017-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Bedridden (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Body temperature increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Burning sensation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait inability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Impaired work ability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lethargy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Photophobia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rest regimen (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tenderness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[INACTIVATED TBE VIRUS, STRAIN K23] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	UNSPECIFIED MEDICATION [MEDICATION UNKNOWN] (C - Gastrointestinal disorder - Not applicable - [n/a - n/a - n/a])|[INACTIVATED TBE VIRUS, STRAIN K23] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11673530&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11659137	Spontaneous	2017-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11659137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11653728	Spontaneous	2017-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cold sweat (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - n/a - n/a - [1d - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11653728&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11654817	Spontaneous	2017-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Spontaneous haematoma (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Thrombocytopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[PRAVASTATIN, PRAVASTATIN SODIUM] (C - Dyslipidaemia - n/a - [n/a - 1{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11654817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11654883	Spontaneous	2017-01-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11654883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11647425	Spontaneous	2017-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11647425&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11643759	Spontaneous	2017-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Haematochezia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11643759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11635506	Spontaneous	2017-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Drug eruption (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])...	PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 40mg - n/a])|[BISOPROLOL] (C - n/a - n/a - [n/a - n/a - n/a])|[CLOMIPRAMINE] (C - n/a - Dose not changed - [n/a - n/a - n/a])|[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - Dose not changed - [n/a - 75mg - Oral])|[ENOXAPARIN, ENOXAPARIN SODIUM] (C - n/a - Dose not changed - [n/a - n/a - n/a])|[IPRATROPIUM] (C - n/a - Dose not changed - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 10mg - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Dose not changed - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11635506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11635788	Spontaneous	2017-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11635788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11637724	Spontaneous	2017-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Jaundice (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])|[FLUCLOXACILLIN, FLUCLOXACILLIN SODIUM, FLUCLOXACILLIN SODIUM MONOHYDRATE] (S - n/a - Not applicable - [n/a - n/a - n/a])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])|[BENDROFLUMETHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11637724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11638022	Spontaneous	2017-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Haematochezia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11638022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11638311	Spontaneous	2017-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11638311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11628214	Spontaneous	2017-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Drug ineffective (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11628214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11628826	Spontaneous	2017-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11628826&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11628961	Spontaneous	2017-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11628961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11623676	Spontaneous	2017-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11623676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11623972	Spontaneous	2017-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pharyngeal oedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	[BETAHISTINE DIHYDROCHLORIDE, BETAHISTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11623972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11626886	Spontaneous	2017-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11626886&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-11619274	Spontaneous	2017-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11619274&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11606729	Spontaneous	2017-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Moaning (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle twitching (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep talking (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11606729&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11607973	Spontaneous	2017-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11607973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11608044	Spontaneous	2017-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11608044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11608686	Spontaneous	2017-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11608686&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11600588	Spontaneous	2017-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Erysipelas (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Other Medically Important Condition);Product administration error (n/a - Recovering/Resolving - Other Medically Important Condition);Swelling (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site warmth (n/a - Recovering/Resolving - Other Medically Important Condition)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11600588&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11594320	Spontaneous	2017-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11594320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11590451	Spontaneous	2017-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11590451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11590532	Spontaneous	2017-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11590532&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11590541	Spontaneous	2017-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11590541&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11590546	Spontaneous	2017-01-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Burnout syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11590546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-11584933	Spontaneous	2017-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Herpes zoster (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - n/a])	[ACICLOVIR, ACICLOVIR SODIUM] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - Product used for unknown indication - Not applicable - [n/a - 1{DF} - n/a])|[LEVOTHYROXINE SODIUM] (C - Product used for unknown indication - Not applicable - [n/a - 1{DF} - n/a])|[METAMIZOLE SODIUM, METAMIZOLE SODIUM MONOHYDRATE] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])|[TAMSULOSIN, TAMSULOSIN HYDROCHLORIDE] (C - Product used for unknown indication - Not applicable - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11584933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11578461	Spontaneous	2017-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11578461&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11578474	Spontaneous	2017-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 2{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11578474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11573320	Spontaneous	2017-01-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - Hypertension - Dose not changed - [n/a - 2mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11573320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11573374	Spontaneous	2017-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11573374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11573376	Spontaneous	2017-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11573376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11573377	Spontaneous	2017-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site inflammation (8d - Recovered/Resolved - Other Medically Important Condition);Injection site pain (8d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (8d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11573377&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11573507	Spontaneous	2017-01-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[ENOXAPARIN SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - Subcutaneous])|[RAMIPRIL] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11573507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11573823	Spontaneous	2017-01-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Miller Fisher syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	INSULIN GLARGINE [INSULIN GLARGINE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11573823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11568561	Spontaneous	2017-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Renal failure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	LUMIGAN [BIMATOPROST] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[INSULIN, INSULIN HUMAN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[VALSARTAN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11568561&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11571793	Spontaneous	2017-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11571793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11572414	Spontaneous	2017-01-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Diplopia (n/a - Unknown - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neuromyelitis optica spectrum disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11572414&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11562747	Spontaneous	2017-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	No	Female	Abortion induced (n/a - Fatal - Results in Death);Foetal growth restriction (n/a - Not Recovered/Not Resolved - Results in Death);Oligohydramnios (n/a - Not Recovered/Not Resolved - Results in Death);Renal dysplasia (n/a - Not Recovered/Not Resolved - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Transplacental])|[BUPRENORPHINE, BUPRENORPHINE HYDROCHLORIDE] (S - n/a - Drug withdrawn - [n/a - n/a - Transplacental])|[CANNABIS] (S - n/a - Drug withdrawn - [n/a - n/a - Transplacental])|[DIPOTASSIUM CLORAZEPATE] (S - n/a - Drug withdrawn - [n/a - n/a - Transplacental])|[ETHANOL] (S - n/a - Drug withdrawn - [n/a - n/a - Transplacental])|[OXAZEPAM] (S - n/a - Drug withdrawn - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11562747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-11563433	Spontaneous	2017-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11563433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11564730	Spontaneous	2017-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11564730&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11566098	Spontaneous	2017-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site erythema (2wk - Recovered/Resolved - Other Medically Important Condition);Injection site pruritus (2wk - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (2wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11566098&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11558284	Spontaneous	2017-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11558284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11558592	Spontaneous	2017-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Ageusia (6wk - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11558592&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11559881	Spontaneous	2017-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dizziness (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11559881&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11561118	Spontaneous	2017-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Muscle disorder (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11561118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11554103	Spontaneous	2017-01-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthma (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	ENBREL [ETANERCEPT] (S - Psoriatic arthropathy - Drug withdrawn - [n/a - 50mg - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11554103&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11554295	Spontaneous	2017-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diabetes mellitus (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11554295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11555215	Spontaneous	2017-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Eye pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in jaw (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])|[DIPHTHERIA TOXOID, TETANUS TOXOID, DIPHTHERIA TOXOID, TETANUS TOXOID, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11555215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11555229	Spontaneous	2017-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Blood pressure decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11555229&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11548920	Spontaneous	2016-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11548920&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11548944	Spontaneous	2016-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11548944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11552431	Spontaneous	2016-12-30 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Diarrhoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperkalaemia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperphosphataemia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Metabolic acidosis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pancreatitis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Petechiae (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pharyngitis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Renal failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11552431&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-11552547	Spontaneous	2016-12-30 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Aspiration (0d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[BROTIZOLAM] (C - Insomnia - n/a - [n/a - n/a - n/a])|[VALPROIC ACID] (C - Seizure - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11552547&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-11543496	Spontaneous	2016-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Epilepsy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11543496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11545627	Spontaneous	2016-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Carpal tunnel syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Immunisation - n/a - [n/a - n/a - n/a])	[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11545627&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11546926	Spontaneous	2016-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11546926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11546928	Spontaneous	2016-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11546928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11546967	Spontaneous	2016-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11546967&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11546969	Spontaneous	2016-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11546969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11546972	Spontaneous	2016-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11546972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11538080	Spontaneous	2016-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Lymphangitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11538080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11539531	Spontaneous	2016-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11539531&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11532603	Spontaneous	2016-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11532603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11528669	Spontaneous	2016-12-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11528669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11528678	Spontaneous	2016-12-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11528678&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11524032	Spontaneous	2016-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Monoplegia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	LYRICA [PREGABALIN] (C - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11524032&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11517424	Spontaneous	2016-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Abdominal pain lower (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Biliary obstruction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cholangitis acute (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cholelithiasis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Liver function test abnormal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11517424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11518325	Spontaneous	2016-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11518325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11522654	Spontaneous	2016-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Abnormal dreams (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11522654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11506229	Spontaneous	2016-12-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Impaired work ability (n/a - Not Recovered/Not Resolved - Disabling);Oxygen consumption decreased (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Stress (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11506229&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11507756	Spontaneous	2016-12-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11507756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-11502091	Spontaneous	2016-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Thrombotic thrombocytopenic purpura (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11502091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-11503132	Spontaneous	2016-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11503132&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11503133	Spontaneous	2016-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11503133&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11498573	Spontaneous	2016-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11498573&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11494975	Spontaneous	2016-12-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Male	Decreased appetite (n/a - Unknown - );Nausea (n/a - Unknown - );Vaccination site erythema (n/a - Recovered/Resolved - );Vaccination site pain (n/a - Recovered/Resolved - );Vaccination site swelling (n/a - Recovered/Resolved - );Vomiting (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11494975&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11487788	Spontaneous	2016-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Epistaxis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11487788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11491088	Spontaneous	2016-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11491088&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11483890	Spontaneous	2016-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Injection site erythema (n/a - Recovering/Resolving - Disabling);Injection site pain (n/a - Recovering/Resolving - Disabling);Injection site warmth (n/a - Recovering/Resolving - Disabling);Swelling (n/a - Recovering/Resolving - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11483890&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11484706	Spontaneous	2016-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Depression (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sleep attacks (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Speech disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11484706&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11478060	Spontaneous	2016-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11478060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11479783	Spontaneous	2016-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pericarditis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	ELIQUIS [APIXABAN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ANHYDROUS LEVOTHYROXINE SODIUM, LEVOTHYROXINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS EP] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11479783&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-11465004	Spontaneous	2016-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11465004&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11467474	Spontaneous	2016-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pneumonia (n/a - Unknown - Other Medically Important Condition);Swelling face (n/a - Recovered/Resolved - Other Medically Important Condition)	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|STELARA [USTEKINUMAB] (S - Psoriasis - Unknown - [n/a - 45mg - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11467474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11452512	Spontaneous	2016-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11452512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11452534	Spontaneous	2016-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysgeusia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11452534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11453603	Spontaneous	2016-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11453603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11455460	Spontaneous	2016-12-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Axillary pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Breast pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nerve injury (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Parenteral])	[IBUPROFEN, IBUPROFEN LYSINE, IBUPROFEN PH. EUR., IBUPROFEN SODIUM, IBUPROFEN SODIUM DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11455460&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11456150	Spontaneous	2016-12-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11456150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11447576	Spontaneous	2016-12-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11447576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11448545	Spontaneous	2016-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11448545&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11448669	Spontaneous	2016-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Decreased appetite (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Listless (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11448669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11449125	Spontaneous	2016-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Injection site erythema (6d - Recovered/Resolved - );Tenderness (6d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[NIFEDIPINE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - Hypertension - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11449125&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11449254	Spontaneous	2016-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Asthenia (n/a - Not Recovered/Not Resolved - );Chest pain (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Rash erythematous (n/a - Recovering/Resolving - );Rash pruritic (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11449254&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11449350	Spontaneous	2016-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Erythema (2d - Recovered/Resolved - );Tenderness (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[LEVOTHYROXINE SODIUM, POTASSIUM IODIDE, LEVOTHYROXINE, POTASSIUM IODIDE] (C - Goitre - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - Hypertension - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Hyperlipidaemia - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11449350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11449364	Spontaneous	2016-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11449364&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11449365	Spontaneous	2016-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (4wk - Unknown - );Influenza like illness (4wk - Unknown - );Malaise (4wk - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11449365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11441833	Spontaneous	2016-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11441833&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11441838	Spontaneous	2016-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11441838&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11441845	Spontaneous	2016-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11441845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11441846	Spontaneous	2016-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11441846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11441847	Spontaneous	2016-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11441847&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11443798	Spontaneous	2016-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angioedema (0d - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACENOCOUMAROL] (C - Anticoagulant therapy - n/a - [n/a - 4mg - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - 1g - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11443798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-11443800	Spontaneous	2016-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Burning sensation (n/a - Recovering/Resolving - Other Medically Important Condition);Neuralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Other Medically Important Condition);Rash vesicular (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	IRBESARTAN [IRBESARTAN] (C - n/a - n/a - [n/a - 300mg - n/a])|[INDAPAMIDE, INDAPAMIDE HEMIHYDRATE] (C - n/a - n/a - [n/a - 1.5mg - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - .1mg - n/a])|[PROPRANOLOL, PROPRANOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11443800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11443914	Spontaneous	2016-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11443914&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11445428	Spontaneous	2016-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Sepsis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11445428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11435646	Spontaneous	2016-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[ALUMINIUM PHOSPHATE, CORYNEBACTERIUM DIPHTHERIAE CRM197 CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE, ALUMINIUM PHOSPHATE, CORYNEBACTERIUM DIPHTHERIAE, NEISSERIA MENINGITIDIS, ALUMINIUM PHOSPHATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALUMINIUM HYDROXIDE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALUMINIUM HYDROXIDE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, ALUMINIUM HYDROXIDE] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11435646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11437446	Spontaneous	2016-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Parkinson's disease (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11437446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-11439762	Spontaneous	2016-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Infection prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11439762&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-11440286	Spontaneous	2016-12-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pleuritic pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11440286&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11431142	Spontaneous	2016-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Herpes simplex (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11431142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11424127	Spontaneous	2016-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	TELMISARTAN [TELMISARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOLPIDEM, ZOLPIDEM TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11424127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11428018	Spontaneous	2016-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oedema peripheral (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11428018&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11420224	Spontaneous	2016-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11420224&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11421688	Spontaneous	2016-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Apathy (n/a - Not Recovered/Not Resolved - );Depression (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11421688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11421998	Spontaneous	2016-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Adjustment disorder with depressed mood (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Bruxism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Periodic limb movement disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Depression - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11421998&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11414289	Spontaneous	2016-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Needle issue (n/a - Unknown - );Vaccination site pain (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11414289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11416016	Spontaneous	2016-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Haemoptysis (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11416016&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11409044	Spontaneous	2016-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11409044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11409064	Spontaneous	2016-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11409064&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11409684	Spontaneous	2016-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11409684&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11409956	Spontaneous	2016-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Influenza like illness (2d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11409956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11409957	Spontaneous	2016-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11409957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11411854	Spontaneous	2016-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Body temperature increased (n/a - Recovered/Resolved - );Fatigue (2wk - Recovered/Resolved - );Vaccination site swelling (15d - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - Dose not changed - [n/a - n/a - n/a])|[FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE MONOHYDRATE] (C - Asthma - Dose not changed - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11411854&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11403220	Spontaneous	2016-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Lung disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11403220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11407123	Spontaneous	2016-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (2d - Recovered/Resolved - Disabling);Decreased appetite (2d - Recovered/Resolved - Disabling);Headache (2d - Recovered/Resolved - Disabling);Malaise (2d - Recovered/Resolved - Disabling);Nausea (2d - Recovered/Resolved - Disabling);Oropharyngeal pain (2d - Recovered/Resolved - Disabling);Pyrexia (2d - Recovered/Resolved - Disabling);Vaccination site pain (2d - Recovered/Resolved - Disabling);Vaccination site rash (2d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	ZOELY [LACTOSE MONOHYDRATE, NOMEGESTROL ACETATE, ESTRADIOL] (C - Contraception - n/a - [n/a - 1{DF} - Oral])|[TOPIRAMATE] (C - Migraine - n/a - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11407123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11392999	Spontaneous	2016-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Rash (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[AMOXICILLIN, CLAVULANIC ACID] (C - Tooth infection - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11392999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11393002	Spontaneous	2016-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pruritus (n/a - Unknown - Other Medically Important Condition);Rash macular (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	UMECLIDINIUM BROMIDE, VILANTEROL [UMECLIDINIUM BROMIDE, VILANTEROL] (C - Chronic obstructive pulmonary disease - n/a - [n/a - n/a - Respiratory (inhalation)])|XARELTO [RIVAROXABAN] (C - Atrial fibrillation - n/a - [n/a - 20mg - Oral])|[CARBOMER, CARBOMER 980] (C - Xerophthalmia - n/a - [n/a - 1[drp] - n/a])|[DIGOXIN] (C - n/a - n/a - [n/a - .125mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - n/a - [n/a - 500mg - Oral])|[TERBINAFINE, TERBINAFINE HYDROCHLORIDE] (C - Dermatophytosis - n/a - [n/a - 250mg - Oral])|[VALSARTAN] (C - Hypertension - n/a - [n/a - 80mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11393002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11393333	Spontaneous	2016-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Impaired work ability (n/a - Unknown - Disabling);Nausea (n/a - Recovered/Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Syncope (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11393333&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-11395278	Spontaneous	2016-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11395278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11379282	Spontaneous	2016-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysgeusia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	COAPROVEL 300 MG/12.5 MG TABLETS [HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - n/a - Dose not changed - [n/a - n/a - Oral])|HUMALOG [INSULIN LISPRO] (C - n/a - Dose not changed - [n/a - n/a - Subcutaneous])|INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - n/a - Dose not changed - [n/a - n/a - Subcutaneous])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[BETAHISTINE DIHYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11379282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11380134	Spontaneous	2016-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11380134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11381909	Spontaneous	2016-11-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Deafness unilateral (n/a - Unknown - Disabling);Vertigo (n/a - Unknown - Disabling)	ZOSTAVAX [VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (S - Immunisation - Not applicable - [n/a - .5mL - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1mL - Intramuscular])	APIXABAN [APIXABAN] (C - n/a - Unknown - [n/a - n/a - n/a])|MICARDIS [TELMISARTAN] (C - n/a - Unknown - [n/a - n/a - n/a])|[ATENOLOL, ATENOLOL BP] (C - n/a - Unknown - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[EZETIMIBE] (C - n/a - Unknown - [n/a - n/a - n/a])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11381909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-11374490	Spontaneous	2016-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11374490&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11377354	Spontaneous	2016-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Screaming (n/a - Unknown - Other Medically Important Condition);Sleep talking (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11377354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11368725	Spontaneous	2016-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[METHYLPHENIDATE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11368725&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11369396	Spontaneous	2016-11-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11369396&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11371003	Spontaneous	2016-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - .25mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11371003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11365103	Spontaneous	2016-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Apathy (n/a - Unknown - );Depression (n/a - Unknown - );Fatigue (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11365103&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11358339	Spontaneous	2016-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (4wk - Unknown - );Influenza like illness (4wk - Unknown - );Malaise (4wk - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11358339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11361189	Spontaneous	2016-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza like illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11361189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11355734	Spontaneous	2016-11-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Dyspnoea (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Product quality issue (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11355734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-11349465	Spontaneous	2016-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11349465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11350389	Spontaneous	2016-11-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11350389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-11351850	Spontaneous	2016-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Cardiac failure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - n/a])	PLAVIX 75 MG FILM-COATED TABLETS [CLOPIDOGREL] (C - n/a - n/a - [n/a - n/a - n/a])|[ALTHAEA OFFICINALIS ROOT, THYMUS VULGARIS, THYMUS ZYGIS, DRY EXTRACT OF THYME (7-13:1), EXTRACTION SOLVENT: WATER, DRY EXTRACT OF THYME (7-13:1), EXTRACTION SOLVENT: WATER, LIQUID EXTRACT FROM MARSHMALLOW ROOT (DER 1:12-14), EXTRACTION SOLVENT: WATER, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CELIPROLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CRATAEGI FOLIUM CUM FLORE, PASSIFLORA EXTRACT, VALERIANA OFFICINALIS EXTRACT, BALLOTA NIGRA, CRATAEGUS, BALLOTA NIGRA, PASSIFLORA INCARNATA L. HERBA, VALERIANA OFFICINALIS L., DRY EXTRACT FROM HAWTHORN LEAF AND FLOWER (5-7:1); EXTRACTION SOLVENT: WATER, DRY EXTRACT OF VALERIAN ROOT (1-5:1), EXTRACTION SOLVENT: ETHANOL 60% V/V, DRY EXTRACT OF PASSION FLOWER  (1-4:1), EXTRACTION SOLVENT: ETHANOL 60% V/V, DRY EXTRACT OF BLACK HOREHOUND (DER 2-4:1), EXTRACTION SOLVENT: WATER] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])|[MIANSERIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SALMETEROL, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOLPIDEM TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11351850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11341081	Spontaneous	2016-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11341081&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11342110	Spontaneous	2016-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Discomfort (2d - Recovered/Resolved - Disabling);Hyperthermia (2d - Recovered/Resolved - Disabling);Undersensing (2d - Recovered/Resolved - Disabling);Vomiting (2d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11342110&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11342639	Spontaneous	2016-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	[ACETYLCYSTEINE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[TERBUTALINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11342639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11336852	Spontaneous	2016-11-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Feeling abnormal (n/a - Unknown - Disabling, Other Medically Important Condition);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11336852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11330483	Spontaneous	2016-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11330483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11330905	Spontaneous	2016-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11330905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11331377	Spontaneous	2016-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Not Specified	Apnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Skin discolouration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - n/a - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11331377&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11324070	Spontaneous	2016-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11324070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11324570	Spontaneous	2016-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11324570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11325074	Spontaneous	2016-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11325074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11326369	Spontaneous	2016-11-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Condition aggravated (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pulmonary fibrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	ESOMEPRAZOLE [ESOMEPRAZOLE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE PH. EUR., BISOPROLOL HEMIFUMARATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[CORTISONE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11326369&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11318868	Spontaneous	2016-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11318868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11319799	Spontaneous	2016-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);H1N1 influenza (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperventilation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Impaired work ability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Infectious mononucleosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Job dissatisfaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Mental disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscle tightness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Panic attack (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Parosmia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pneumonia mycoplasmal (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Presyncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11319799&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11319809	Spontaneous	2016-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11319809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11320969	Spontaneous	2016-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11320969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11321265	Spontaneous	2016-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovering/Resolving - Other Medically Important Condition);Chills (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Vomiting (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Parenteral])	[HEPATITIS A VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[JAPANESE ENCEPHALITIS VACCINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SALMONELLA TYPHI] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11321265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11312339	Spontaneous	2016-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11312339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11313793	Spontaneous	2016-11-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11313793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-11314190	Spontaneous	2016-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Blister (n/a - Unknown - Other Medically Important Condition);Rash maculo-papular (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ENALAPRIL MALEATE, ENALAPRILAT] (C - n/a - n/a - [n/a - n/a - n/a])|[NEBIVOLOL] (C - n/a - n/a - [n/a - n/a - n/a])|[NITRENDIPINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11314190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11314431	Spontaneous	2016-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11314431&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11314438	Spontaneous	2016-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11314438&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11314448	Spontaneous	2016-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11314448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11306839	Spontaneous	2016-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dyskinesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11306839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11309518	Spontaneous	2016-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Overweight (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11309518&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11301897	Spontaneous	2016-10-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cold sweat (1d - Recovered/Resolved - Life Threatening);Dizziness (1d - Recovered/Resolved - Life Threatening);Hyperhidrosis (1d - Recovered/Resolved - Life Threatening);Syncope (1d - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11301897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-11294082	Spontaneous	2016-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Multifocal motor neuropathy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11294082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11295088	Spontaneous	2016-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Flushing (n/a - Recovering/Resolving - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition);Nausea (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia oral (n/a - Recovering/Resolving - Other Medically Important Condition);Pruritus (n/a - Recovering/Resolving - Other Medically Important Condition);Throat irritation (n/a - Recovering/Resolving - Other Medically Important Condition);Tongue oedema (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11295088&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11295877	Spontaneous	2016-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Joint noise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11295877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11296370	Spontaneous	2016-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11296370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11283666	Spontaneous	2016-10-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11283666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11284373	Spontaneous	2016-10-25 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspepsia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oesophageal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11284373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11284700	Spontaneous	2016-10-25 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Illness (n/a - Unknown - Other Medically Important Condition);Loss of consciousness (n/a - Unknown - Other Medically Important Condition);Wheezing (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11284700&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11270715	Spontaneous	2016-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11270715&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11270751	Spontaneous	2016-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11270751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11270809	Spontaneous	2016-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Influenza like illness (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Periodic limb movement disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11270809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11273797	Spontaneous	2016-10-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Disabling);Neuralgic amyotrophy (12mo - Recovered/Resolved - Disabling);Physical disability (12mo - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11273797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11266831	Spontaneous	2016-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Recovered/Resolved With Sequelae - Disabling);Influenza like illness (n/a - Unknown - Disabling);Listless (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11266831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-11268295	Spontaneous	2016-10-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11268295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11262002	Spontaneous	2016-10-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Parenteral])	LEVETIRACETAM [LEVETIRACETAM] (C - n/a - n/a - [n/a - n/a - n/a])|[LAMOTRIGINE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11262002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11255304	Spontaneous	2016-10-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11255304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11255312	Spontaneous	2016-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11255312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11250452	Spontaneous	2016-10-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11250452&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11233973	Spontaneous	2016-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11233973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11229783	Spontaneous	2016-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Disabling, Other Medically Important Condition);Asthma (n/a - Unknown - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Conjunctivitis (n/a - Unknown - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Iron deficiency (n/a - Unknown - Disabling, Other Medically Important Condition);Ligament sprain (n/a - Unknown - Disabling, Other Medically Important Condition);Middle insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nausea (n/a - Unknown - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Disabling, Other Medically Important Condition);Weight increased (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11229783&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-11229784	Spontaneous	2016-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthma (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Respiratory rate increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Subglottic laryngitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Varicella (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11229784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11229785	Spontaneous	2016-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11229785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11229792	Spontaneous	2016-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Disabling);Bruxism (n/a - Not Recovered/Not Resolved - Disabling);Cough (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Unknown - Disabling);Migraine (n/a - Unknown - Disabling);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Disabling);Sensory loss (n/a - Not Recovered/Not Resolved - Disabling);Snoring (n/a - Unknown - Disabling);Tonsillitis (n/a - Recovered/Resolved - Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11229792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11229797	Spontaneous	2016-10-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11229797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11227347	Spontaneous	2016-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11227347&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11227349	Spontaneous	2016-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11227349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11213527	Spontaneous	2016-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11213527&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11213528	Spontaneous	2016-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11213528&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11213530	Spontaneous	2016-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11213530&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11213921	Spontaneous	2016-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11213921&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11214205	Spontaneous	2016-10-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Influenza (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Restless legs syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11214205&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11207827	Spontaneous	2016-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11207827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11194816	Spontaneous	2016-10-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Injection site pain (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Social problem (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11194816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11194817	Spontaneous	2016-10-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cerebral haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Illness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Mental disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pulmonary fibrosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Restlessness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Suicidal behaviour (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Transient ischaemic attack (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11194817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11194818	Spontaneous	2016-10-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11194818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11194833	Spontaneous	2016-10-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11194833&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11194852	Spontaneous	2016-10-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11194852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11182631	Spontaneous	2016-09-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Insomnia (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Sleep attacks (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11182631&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-11178415	Spontaneous	2016-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11178415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11178951	Spontaneous	2016-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cerebral palsy (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Congenital central nervous system anomaly (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Epilepsy (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Generalised tonic-clonic seizure (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Maternal exposure timing unspecified (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Motor developmental delay (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Nervous system disorder (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Periventricular leukomalacia (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Speech disorder (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11178951&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Severe reaction
EU-EC-11179363	Spontaneous	2016-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Seizure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11179363&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11172880	Spontaneous	2016-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS, ALGELDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11172880&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11167712	Spontaneous	2016-09-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11167712&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11156790	Spontaneous	2016-09-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11156790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11158259	Spontaneous	2016-09-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11158259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11159178	Spontaneous	2016-09-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Acute respiratory distress syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cough (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Haemoptysis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pulmonary haemorrhage (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11159178&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-11154971	Spontaneous	2016-09-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Agitation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Angioedema (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Angiopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cardiac disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Central nervous system lesion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chills (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Circadian rhythm sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Contusion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyskinesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspepsia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspraxia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Emotional distress (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Encephalomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eye movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Febrile convulsion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Feeling abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gastrointestinal disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gulf war syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Haematochezia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11154971&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11145883	Spontaneous	2016-09-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation);Paresis cranial nerve (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11145883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11148863	Spontaneous	2016-09-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11148863&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11148865	Spontaneous	2016-09-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11148865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11144511	Spontaneous	2016-09-16 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Eye disorder (n/a - Unknown - Disabling);Headache (n/a - Recovered/Resolved - Disabling);Influenza like illness (n/a - Unknown - Disabling);Malaise (n/a - Recovered/Resolved - Disabling);Neurological symptom (n/a - Unknown - Disabling);Somnolence (n/a - Recovered/Resolved - Disabling);Visual impairment (4mo - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	FORXIGA [DAPAGLIFLOZIN] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|JANUMET [METFORMIN HYDROCHLORIDE, SITAGLIPTIN, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (C - Diabetes mellitus - n/a - [n/a - 1{DF} - Oral])|[ATENOLOL, AMLODIPINE BESILATE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[CANDESARTAN CILEXETIL] (C - Hypertension - n/a - [n/a - n/a - Oral])|[DOCONEXENT, ICOSAPENT, FISH OIL, ICOSAPENT ETHYL, DOCOSAHEXAENOIC ACID ETHYL ESTER, OMEGA-3-ACID ETHYL ESTERS 90, OMEGA-3-ACID ETHYL ESTERS 90, DOCOSAHEXAENOIC ACID ETHYL ESTER] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[SIBUTRAMINE HYDROCHLORIDE] (C - Weight decreased - n/a - [n/a - n/a - Oral])|[THIAMINE HYDROCHLORIDE, RETINOL] (C - Supplementation therapy - n/a - [n/a - n/a - n/a])|[VITAMIN D] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11144511&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11136627	Spontaneous	2016-09-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11136627&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11136628	Spontaneous	2016-09-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11136628&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11136638	Spontaneous	2016-09-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Lacrimation increased (n/a - Unknown - Other Medically Important Condition);Nasal mucosal disorder (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11136638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11133000	Spontaneous	2016-09-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cataplexy (n/a - Unknown - Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Middle insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Disabling, Other Medically Important Condition);Nightmare (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11133000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11129270	Spontaneous	2016-09-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11129270&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11129272	Spontaneous	2016-09-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Increased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mood altered (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11129272&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11129273	Spontaneous	2016-09-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11129273&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11129279	Spontaneous	2016-09-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11129279&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11129280	Spontaneous	2016-09-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11129280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11124909	Spontaneous	2016-09-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11124909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11125606	Spontaneous	2016-09-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11125606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11120570	Spontaneous	2016-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Autonomic nervous system imbalance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11120570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11118800	Spontaneous	2016-09-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11118800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11111412	Spontaneous	2016-09-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11111412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11112849	Spontaneous	2016-09-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - Not applicable - [n/a - n/a - n/a])	CIRCADIN [MELATONIN] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[TERBUTALINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11112849&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11115500	Spontaneous	2016-09-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - );Hypersomnia (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11115500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-11106633	Spontaneous	2016-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Chorea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11106633&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11097325	Spontaneous	2016-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11097325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11091611	Spontaneous	2016-09-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Herpes zoster (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11091611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-11091751	Spontaneous	2016-09-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11091751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11086429	Spontaneous	2016-09-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Narcolepsy (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11086429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11086750	Spontaneous	2016-09-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11086750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11086902	Spontaneous	2016-09-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11086902&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11081907	Spontaneous	2016-08-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Paraesthesia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11081907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11075564	Spontaneous	2016-08-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11075564&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11061726	Spontaneous	2016-08-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Product quality issue (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11061726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11061919	Spontaneous	2016-08-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Seizure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11061919&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11061973	Spontaneous	2016-08-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11061973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11061504	Spontaneous	2016-08-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Burning sensation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11061504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11041708	Spontaneous	2016-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11041708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-11031000	Spontaneous	2016-08-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11031000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11031855	Spontaneous	2016-08-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Cerebral haemorrhage (n/a - Unknown - Disabling, Other Medically Important Condition);Hemiplegia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Disabling, Other Medically Important Condition);Thrombocytopenia (n/a - Unknown - Disabling, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11031855&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-11033263	Spontaneous	2016-08-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cutaneous vasculitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11033263&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11025948	Spontaneous	2016-08-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11025948&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-11004028	Spontaneous	2016-08-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Muscle twitching (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11004028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-11005595	Spontaneous	2016-08-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hospitalisation (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11005595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-11001352	Spontaneous	2016-08-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=11001352&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10994614	Spontaneous	2016-08-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Nervous system disorder (n/a - Unknown - );Rheumatic disorder (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10994614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10981376	Spontaneous	2016-08-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10981376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10972978	Spontaneous	2016-08-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Status epilepticus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10972978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10975706	Spontaneous	2016-08-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10975706&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10975708	Spontaneous	2016-08-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10975708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10963730	Spontaneous	2016-08-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Unknown - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Unknown - Disabling);Illness (n/a - Unknown - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Unknown - Disabling);Sensory loss (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10963730&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10963802	Spontaneous	2016-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10963802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10954755	Spontaneous	2016-07-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Product contamination (n/a - Unknown - Other Medically Important Condition);Vaccination site abscess (n/a - Unknown - Other Medically Important Condition);Vaccination site mass (n/a - Unknown - Other Medically Important Condition);Vaccination site pain (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10954755&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10949168	Spontaneous	2016-07-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Bone marrow failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10949168&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10949572	Spontaneous	2016-07-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diabetes insipidus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10949572&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10946138	Spontaneous	2016-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Amnesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Aphasia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Balance disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Blood lactic acid (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Brain fog (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Clumsiness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Confusional state (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Disabling, Other Medically Important Condition);Dysphagia (n/a - Unknown - Disabling, Other Medically Important Condition);Dysphonia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Eye pain (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Feeling of body temperature change (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Genital pain (n/a - Unknown - Disabling, Other Medically Important Condition);Genito-pelvic pain/penetration disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Heart rate irregular (n/a - Unknown - Disabling, Other Medically Important Condition);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Disabling, Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Injection site swelling (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Intermenstrual bleeding (n/a - Unknown - Disabling, Other Medically Important Condition);Learning disability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Lymph node pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Motor dysfunction (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscle twitching (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CORTISONE] (C - n/a - n/a - [n/a - n/a - n/a])|[DIAZEPAM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[IBUPROFEN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LOPERAMIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LORATADINE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - Unknown - [n/a - n/a - Unknown])|[PROPIOMAZINE, PROPIOMAZINE MALEATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[ZOPICLONE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10946138&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10949577	Spontaneous	2016-07-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Rash erythematous (n/a - Unknown - Other Medically Important Condition);Rash macular (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	CYMBALTA [DULOXETINE, DULOXETINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|PROLIA [DENOSUMAB] (C - Product used for unknown indication - n/a - [n/a - n/a - Subcutaneous])|[MORPHINE SULFATE, SIMVASTATIN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PARACETAMOL, CAFFEINE, CODEINE PHOSPHATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10949577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10949578	Spontaneous	2016-07-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Scar (n/a - Unknown - Other Medically Important Condition);Vaccination site erythema (n/a - Unknown - Other Medically Important Condition);Vaccination site swelling (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[FLUTICASONE PROPIONATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[METHADONE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10949578&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10940696	Spontaneous	2016-07-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10940696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10940914	Spontaneous	2016-07-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10940914&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10942638	Spontaneous	2016-07-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Apathy (n/a - Recovering/Resolving - Congenital Anomaly);Aphonia (n/a - Recovering/Resolving - Congenital Anomaly);Asthenia (n/a - Recovering/Resolving - Congenital Anomaly);Dysgraphia (n/a - Recovering/Resolving - Congenital Anomaly);Hemiparesis (n/a - Recovering/Resolving - Congenital Anomaly);Loss of personal independence in daily activities (n/a - Recovering/Resolving - Congenital Anomaly);Musculoskeletal disorder (n/a - Recovering/Resolving - Congenital Anomaly);Musculoskeletal stiffness (n/a - Recovering/Resolving - Congenital Anomaly);Myalgia (n/a - Recovering/Resolving - Congenital Anomaly);Myocardial infarction (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Nervous system disorder (n/a - Recovering/Resolving - Congenital Anomaly);Pain (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Paraesthesia (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Sensory loss (n/a - Recovering/Resolving - Congenital Anomaly);Tremor (n/a - Recovering/Resolving - Congenital Anomaly);Weight decreased (n/a - Recovering/Resolving - Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10942638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Severe reaction
EU-EC-10944871	Spontaneous	2016-07-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Bone pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disease recurrence (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neck pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tendonitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10944871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10939238	Spontaneous	2016-07-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Bell's palsy (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10939238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10925345	Spontaneous	2016-07-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nocturia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Snoring (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[BUDESONIDE] (C - n/a - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - 150ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10925345&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10921017	Spontaneous	2016-07-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Immune thrombocytopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	CELLCEPT [MYCOPHENOLATE MOFETIL] (C - n/a - n/a - [n/a - 500mg - n/a])|RELVAR ELLIPTA [FLUTICASONE FUROATE, VILANTEROL] (C - n/a - n/a - [n/a - ug - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - n/a - n/a - [n/a - 5mg - n/a])|[CICLOSPORIN] (C - n/a - n/a - [n/a - 50mg - n/a])|[FLUCONAZOLE] (C - n/a - n/a - [n/a - 200mg - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM] (C - n/a - n/a - [n/a - 40mg - n/a])|[PREDNISOLONE] (C - n/a - n/a - [n/a - 70mg - n/a])|[SULFAMETHOXAZOLE, TRIMETHOPRIM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10921017&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10922912	Spontaneous	2016-07-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10922912&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10917359	Spontaneous	2016-07-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Diarrhoea (1d - Recovered/Resolved - Disabling);Ear infection (n/a - Recovered/Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Pharyngeal swelling (n/a - Not Recovered/Not Resolved - Disabling);Pruritus (n/a - Not Recovered/Not Resolved - Disabling);Sensory loss (n/a - Not Recovered/Not Resolved - Disabling);Vomiting (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[ASCORBIC ACID] (C - Arthralgia - n/a - [n/a - 1{DF} - n/a])|[GARLIC POWDER] (C - Antibiotic therapy - n/a - [n/a - 1{DF} - n/a])|[ROSA CANINA] (C - Arthralgia - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10917359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10909524	Spontaneous	2016-07-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Blindness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Hallucination (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Mood swings (n/a - Recovered/Resolved - Other Medically Important Condition);Photophobia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10909524&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10900146	Spontaneous	2016-07-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10900146&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10893697	Spontaneous	2016-07-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abortion spontaneous (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[CEFUROXIME, CEFUROXIME AXETIL, CEFUROXIME SODIUM, CEFUROXIME SODIUM STERILE] (C - Amniotic cavity infection - n/a - [2d - 1.5g - Intravenous drip])|[FOLIC ACID] (C - Prophylaxis of neural tube defect - n/a - [n/a - n/a - Oral])|[NIFEDIPINE] (C - Tocolysis - n/a - [2d - n/a - Intravenous drip])|[PROGESTERONE] (C - Prophylaxis of abortion - n/a - [n/a - n/a - Vaginal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10893697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10887539	Spontaneous	2016-07-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[DESOGESTREL] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10887539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10887836	Spontaneous	2016-07-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Mobility decreased (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Soft tissue swelling (n/a - Unknown - Other Medically Important Condition);Vaccination site induration (n/a - Unknown - Other Medically Important Condition);Vaccination site pain (n/a - Unknown - Other Medically Important Condition);Vaccination site swelling (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [n/a - .5mL - Intramuscular])	ADVAGRAF [TACROLIMUS] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|ARANESP [DARBEPOETIN ALFA] (C - Product used for unknown indication - n/a - [n/a - n/a - Intravenous (not otherwise specified)])|PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CALCITRIOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CHLORHEXIDINE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[GLUCOSE MONOHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PREDNISONE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[SULFAMETHOXAZOLE, TRIMETHOPRIM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10887836&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10882403	Spontaneous	2016-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10882403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10885099	Spontaneous	2016-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10885099&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10876379	Spontaneous	2016-07-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10876379&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10877422	Spontaneous	2016-07-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Partial seizures (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10877422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10867814	Spontaneous	2016-07-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10867814&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10867818	Spontaneous	2016-07-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Autoimmune disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Discomfort (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Mobility decreased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Quality of life decreased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10867818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10864856	Spontaneous	2016-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (1mo - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23, ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23, TICK-BORNE ENCEPHALITIS VIRUS, STRAIN K23, ADSORBED ON HYDROGENATED ALUMINUM HYDROXIDE, INACTIVATED, ALGELDRATE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10864856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10864857	Spontaneous	2016-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10864857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10851213	Spontaneous	2016-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10851213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10851726	Spontaneous	2016-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10851726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10851846	Spontaneous	2016-07-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Muscular weakness (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10851846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10851860	Spontaneous	2016-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10851860&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10851913	Spontaneous	2016-07-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood glucose abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood pressure increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Dry mouth (n/a - Unknown - Caused/Prolonged Hospitalisation);Dry throat (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Ketoacidosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Lymph node pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vertigo (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10851913&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10851926	Spontaneous	2016-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10851926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10847569	Spontaneous	2016-06-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10847569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10839257	Spontaneous	2016-06-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Disabling, Other Medically Important Condition);Incorrect route of product administration (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Subcutaneous])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10839257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10836986	Spontaneous	2016-06-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Condition aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dependence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysuria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gastrointestinal motility disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Peripheral sensory neuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sensory loss (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10836986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10828038	Spontaneous	2016-06-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10828038&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10831760	Spontaneous	2016-06-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Chills (0d - Fatal - Results in Death);Circulatory collapse (0d - Fatal - Results in Death);Dyspnoea (0d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	[FUROSEMIDE, FUROSEMIDE SODIUM] (C - Cardiomyopathy - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10831760&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10821884	Spontaneous	2016-06-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Death (0d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	[AMLODIPINE BESILATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ATENOLOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ESCITALOPRAM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[NORETHISTERONE ACETATE, ANHYDROUS ESTRADIOL, NORETHISTERONE ACETATE, ESTRADIOL, NORETHISTERONE ACETATE, ESTRADIOL HEMIHYDRATE, NORETHISTERONE, ESTRADIOL HEMIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PERINDOPRIL TERT-BUTYLAMINE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10821884&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10821934	Spontaneous	2016-06-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10821934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10822002	Spontaneous	2016-06-24 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - Infection prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10822002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10811538	Spontaneous	2016-06-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10811538&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10813654	Spontaneous	2016-06-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10813654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10805956	Spontaneous	2016-06-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Oedema peripheral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Viral infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10805956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10806060	Spontaneous	2016-06-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[DIPHTHERIA AND TETANUS TOXOIDS] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10806060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10807044	Spontaneous	2016-06-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Abdominal discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Formication (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash macular (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10807044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10800489	Spontaneous	2016-06-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10800489&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10801616	Spontaneous	2016-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Loss of consciousness (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CANDESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[IBUPROFEN] (C - n/a - n/a - [n/a - n/a - n/a])|[LORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10801616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10802734	Spontaneous	2016-06-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	[BUDESONIDE] (C - Asthma - n/a - [n/a - n/a - n/a])|[FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10802734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10799613	Spontaneous	2016-06-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[FLUVOXAMINE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[VALACICLOVIR, VALACICLOVIR HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10799613&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10793705	Spontaneous	2016-06-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);IIIrd nerve paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10793705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10794526	Spontaneous	2016-06-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10794526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10796309	Spontaneous	2016-06-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amnesia (n/a - Unknown - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Unknown - Disabling);Dyspnoea (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Thirst (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10796309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10790517	Spontaneous	2016-06-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Epicondylitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Local reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Periarthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10790517&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10783976	Spontaneous	2016-06-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Decreased activity (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Social problem (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[ACETYLCYSTEINE] (C - Bronchitis - Unknown - [n/a - 200mg - n/a])|[DESMOPRESSIN, DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE TRIHYDRATE] (C - Enuresis - Unknown - [n/a - 100ug - Oral])|[FLUTICASONE PROPIONATE] (C - Bronchitis - Unknown - [n/a - 100ug - n/a])|[PHENYLPROPANOLAMINE HYDROCHLORIDE] (C - Sinusitis - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10783976&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10783979	Spontaneous	2016-06-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10783979&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10784074	Spontaneous	2016-06-15 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10784074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10778396	Spontaneous	2016-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10778396&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10778975	Spontaneous	2016-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Apathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Performance status decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	BUPRENORPHINE [BUPRENORPHINE] (C - Analgesic therapy - n/a - [n/a - n/a - n/a])|PREGABALIN [PREGABALIN] (C - n/a - n/a - [n/a - n/a - n/a])|[CANNABIS] (C - Analgesic therapy - n/a - [n/a - n/a - n/a])|[DULOXETINE, DULOXETINE HYDROCHLORIDE] (C - Analgesic therapy - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10778975&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10779159	Spontaneous	2016-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10779159&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10779177	Spontaneous	2016-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10779177&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10779368	Spontaneous	2016-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10779368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10771336	Spontaneous	2016-06-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cough (n/a - Unknown - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Meningism (n/a - Unknown - Disabling, Other Medically Important Condition);Meningitis (n/a - Unknown - Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pyrexia (n/a - Unknown - Disabling, Other Medically Important Condition);Staring (n/a - Unknown - Disabling, Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10771336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10771993	Spontaneous	2016-06-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Middle insomnia (n/a - Not Recovered/Not Resolved - Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10771993&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10772289	Spontaneous	2016-06-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10772289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10772415	Spontaneous	2016-06-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])|[INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10772415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10772443	Spontaneous	2016-06-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Aphasia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cerebellar tumour (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyslexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Head discomfort (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10772443&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10770464	Spontaneous	2016-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Dose not changed - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10770464&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10766167	Spontaneous	2016-06-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10766167&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10766628	Spontaneous	2016-06-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10766628&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10767531	Spontaneous	2016-06-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10767531&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10750715	Spontaneous	2016-06-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep attacks (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10750715&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10750717	Spontaneous	2016-06-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Weight increased (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10750717&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10750720	Spontaneous	2016-06-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10750720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10750727	Spontaneous	2016-06-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Grief reaction (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Listless (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Microsleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10750727&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10744564	Spontaneous	2016-06-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cataplexy (3a - Recovered/Resolved - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10744564&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10744817	Spontaneous	2016-06-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Abnormal dreams (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Automatism (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Diplopia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypnagogic hallucination (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep talking (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnambulism (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10744817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10743108	Spontaneous	2016-06-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Bell's palsy (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10743108&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10716012	Spontaneous	2016-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoaesthesia (7mo - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10716012&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10717413	Spontaneous	2016-05-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10717413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10704258	Spontaneous	2016-05-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sinusitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10704258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10704306	Spontaneous	2016-05-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Ophthalmoplegia (n/a - Unknown - Other Medically Important Condition);Paralysis (n/a - Recovering/Resolving - Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10704306&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10704467	Spontaneous	2016-05-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Epistaxis (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Recovering/Resolving - Other Medically Important Condition);Middle insomnia (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition);Sudden onset of sleep (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10704467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10705475	Spontaneous	2016-05-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10705475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10708192	Spontaneous	2016-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Hypotension (1d - Recovered/Resolved - Other Medically Important Condition);Malaise (1d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10708192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10708436	Spontaneous	2016-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10708436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10708549	Spontaneous	2016-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Encephalitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10708549&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10709806	Spontaneous	2016-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Acute polyneuropathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10709806&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10709983	Spontaneous	2016-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10709983&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10711290	Spontaneous	2016-05-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10711290&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10699398	Spontaneous	2016-05-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abnormal dreams (n/a - Unknown - Other Medically Important Condition);Arthralgia (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Depressed mood (n/a - Unknown - Other Medically Important Condition);Distractibility (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Eye pain (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Feeling cold (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Sleep attacks (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Speech disorder (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	AERIUS [DESLORATADINE] (C - n/a - Unknown - [n/a - 5mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10699398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10700509	Spontaneous	2016-05-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mood altered (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10700509&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10700513	Spontaneous	2016-05-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10700513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10700514	Spontaneous	2016-05-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10700514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10700516	Spontaneous	2016-05-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Impaired work ability (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10700516&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10694869	Spontaneous	2016-05-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bruxism (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Hypertension (n/a - Unknown - Other Medically Important Condition);Muscle spasms (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10694869&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10689236	Spontaneous	2016-05-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10689236&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10691641	Spontaneous	2016-05-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Decreased appetite (n/a - Unknown - Other Medically Important Condition);Depression (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Mental disorder (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Somnambulism (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Suicide attempt (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10691641&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10692244	Spontaneous	2016-05-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10692244&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10692585	Spontaneous	2016-05-24 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Multiple organ dysfunction syndrome (0d - Fatal - Results in Death);Pyrexia (3d - Fatal - Results in Death);Respiratory tract infection bacterial (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	[BUDESONIDE] (C - Respiratory disorder - n/a - [n/a - 400ug - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Respiratory disorder - n/a - [n/a - n/a - Respiratory (inhalation)])|[FORMOTEROL, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE] (C - Respiratory disorder - n/a - [n/a - 12ug - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - Respiratory disorder - n/a - [n/a - 2.5ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10692585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10683838	Spontaneous	2016-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Suicidal ideation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10683838&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10683839	Spontaneous	2016-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10683839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10683840	Spontaneous	2016-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Hypoacusis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10683840&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10683841	Spontaneous	2016-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Suicide attempt (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10683841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10683848	Spontaneous	2016-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Restlessness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10683848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10683849	Spontaneous	2016-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (20min - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10683849&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10683850	Spontaneous	2016-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10683850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10683851	Spontaneous	2016-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10683851&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10683852	Spontaneous	2016-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hunger (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10683852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10683853	Spontaneous	2016-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10683853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10685358	Spontaneous	2016-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10685358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10687461	Spontaneous	2016-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Impaired quality of life (n/a - Not Recovered/Not Resolved - Disabling);Muscle twitching (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10687461&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10679135	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10679135&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10679139	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10679139&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10679140	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10679140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10679142	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (3d - Recovered/Resolved - Other Medically Important Condition);Malaise (3d - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10679142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10679143	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Anger (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10679143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10679146	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Emotional disorder (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Migraine (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Petit mal epilepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10679146&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10679148	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10679148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10679149	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10679149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10679150	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Apathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10679150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10679151	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10679151&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10679153	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10679153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10679154	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10679154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10679999	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Bruxism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10679999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10680026	Spontaneous	2016-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10680026&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10680481	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Alopecia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10680481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10682137	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10682137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10682140	Spontaneous	2016-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10682140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674100	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674100&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10674101	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Brain hypoxia (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Decreased appetite (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Emotional poverty (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paralysis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10674103	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674103&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674105	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Decreased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hunger (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674105&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674106	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Decreased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Impulsive behaviour (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Suicidal ideation (n/a - Unknown - Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight decreased (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674107	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674107&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674108	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674108&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10674109	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674109&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674111	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674111&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674112	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674112&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10674113	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyssomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674113&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10674114	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Crohn's disease (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10674117	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674117&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674119	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Insomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674119&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10674120	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Movement disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674120&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10674121	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anger (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674122	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674122&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674123	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674124	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674124&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674126	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674126&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674127	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10674928	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Micturition disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10674928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10676980	Spontaneous	2016-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10676980&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10668998	Spontaneous	2016-05-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Fall (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Muscle disorder (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10668998&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10668999	Spontaneous	2016-05-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10668999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10669002	Spontaneous	2016-05-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depressed level of consciousness (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10669002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10669003	Spontaneous	2016-05-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10669003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10669006	Spontaneous	2016-05-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10669006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10671326	Spontaneous	2016-05-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10671326&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10671327	Spontaneous	2016-05-18 00:00:00	Healthcare Professional	Non European Economic Area	Lee ST et al. An adverse event following 2009 H1N1 influenza vaccination: a case of acute disseminated encephalomyelitis. Korean J Pediatr.. 2011;54(10):422-4	2 Months - 2 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Clonic convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10671327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10671330	Spontaneous	2016-05-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10671330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10671331	Spontaneous	2016-05-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Anger (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Irritability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10671331&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10663303	Spontaneous	2016-05-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Impaired quality of life (n/a - Unknown - Other Medically Important Condition);Mood swings (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Restlessness (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10663303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10661420	Spontaneous	2016-05-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tongue movement disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10661420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10648999	Spontaneous	2016-05-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10648999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10649000	Spontaneous	2016-05-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10649000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10649002	Spontaneous	2016-05-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10649002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10649004	Spontaneous	2016-05-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10649004&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10649807	Spontaneous	2016-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depression (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10649807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10649810	Spontaneous	2016-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep talking (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10649810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10649811	Spontaneous	2016-05-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Decreased immune responsiveness (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling);Quality of life decreased (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10649811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10644772	Spontaneous	2016-05-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10644772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10646814	Spontaneous	2016-05-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10646814&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10638566	Spontaneous	2016-05-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Demyelination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10638566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10634123	Spontaneous	2016-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Automatism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Obstructive sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10634123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10635644	Spontaneous	2016-05-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Impaired work ability (n/a - Unknown - Other Medically Important Condition);Insomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Quality of life decreased (n/a - Unknown - Other Medically Important Condition);Seasonal allergy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10635644&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10627818	Spontaneous	2016-05-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersomnia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Microsleep (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	CLOPIDOGREL [CLOPIDOGREL, CLOPIDOGREL BESILATE] (C - n/a - n/a - [n/a - 75mg - n/a])|PREGABALIN [PREGABALIN] (C - n/a - n/a - [n/a - 75mg - n/a])|[ALLOPURINOL] (C - n/a - n/a - [n/a - 300mg - n/a])|[ASCORBIC ACID, MAGNESIUM OXIDE, HEAVY, MAGNESIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - 2.5mg - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - 20mg - n/a])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - n/a - n/a - [n/a - 5mg - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 100ug - n/a])|[MOLSIDOMINE] (C - n/a - n/a - [n/a - 8mg - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 40mg - n/a])|[PRAMIPEXOLE] (C - n/a - n/a - [n/a - .35mg - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 80mg - n/a])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - 100mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10627818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10628139	Spontaneous	2016-05-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10628139&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10628149	Spontaneous	2016-05-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10628149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10629671	Spontaneous	2016-05-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10629671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10618084	Spontaneous	2016-05-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10618084&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10611280	Spontaneous	2016-05-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10611280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10608507	Spontaneous	2016-05-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Delayed sleep phase (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10608507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10608512	Spontaneous	2016-05-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling abnormal (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10608512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10601206	Spontaneous	2016-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10601206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10601212	Spontaneous	2016-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (3d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10601212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10603705	Spontaneous	2016-04-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10603705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10586321	Spontaneous	2016-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[YELLOW FEVER VACCINE (LIVE), YELLOW FEVER VIRUS STRAIN 17D-204 (LIVE, ATTENUATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10586321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10587035	Spontaneous	2016-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Myoclonus (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	LEVETIRACETAM [LEVETIRACETAM] (C - Seizure - Unknown - [n/a - 500mg - Unknown])|[GABAPENTIN] (C - Pain - Unknown - [n/a - 200mg - Unknown])|[HYDROMORPHONE HYDROCHLORIDE] (C - Back pain - Unknown - [n/a - 4mg - Unknown])|[METOPROLOL SUCCINATE, METOPROLOL SUCCINATE (PH. EUR.)] (C - Hypertension - Unknown - [n/a - n/a - Unknown])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM] (C - n/a - Unknown - [n/a - 40mg - Unknown])|[RAMIPRIL] (C - Hypertension - Unknown - [n/a - 5mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10587035&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10587794	Spontaneous	2016-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10587794&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10587932	Spontaneous	2016-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Poor quality sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10587932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10591086	Spontaneous	2016-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10591086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10574304	Spontaneous	2016-04-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10574304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10576040	Spontaneous	2016-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10576040&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10576403	Spontaneous	2016-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10576403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10576404	Spontaneous	2016-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Male	Cough (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10576404&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10576628	Spontaneous	2016-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Demyelination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10576628&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10576956	Spontaneous	2016-04-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10576956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10568024	Spontaneous	2016-04-20 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Fernandes AF, Marchiori PE. Bithalamic compromise in acute disseminated encephalomyelitis following H1N1 influenza vaccine. Arq Neuropsiquiatr. 2011;69(3):571 Van Ussel  I. et al. Encephalitis related to a H1N1 vaccination: Case report and review ofthe literature. Clin. Neurol. Neurosurg.. 2014;124:8-15	3-11 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ataxia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperreflexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);IIIrd nerve paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10568024&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10561605	Spontaneous	2016-04-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Pain in extremity (2d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10561605&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10562563	Spontaneous	2016-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Gui L., Chen K., Zhang Y. Acute transverse myelitis following vaccination against H1N1 influenza: a case report. International Journal of Clinical and Experimental Pathology. 2011;4(3):312-314	12-17 Years	Not Specified	No	Male	Anal incontinence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Motor dysfunction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myelitis transverse (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory loss (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urinary retention (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10562563&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10563796	Spontaneous	2016-04-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypersensitivity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Neuralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Seizure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Syncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10563796&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10548529	Spontaneous	2016-04-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Disabling, Other Medically Important Condition);Impaired quality of life (n/a - Unknown - Disabling, Other Medically Important Condition);Irritability (n/a - Unknown - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep-related eating disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10548529&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10550229	Spontaneous	2016-04-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Burning mouth syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);Headache (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);Rhinitis (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);Scab (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);Stomatitis (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10550229&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Life Threatening	Hospitalisation
EU-EC-10550917	Spontaneous	2016-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gastrointestinal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle tightness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasal congestion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Oral mucosal eruption (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10550917&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10551035	Spontaneous	2016-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Constipation (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10551035&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10543044	Spontaneous	2016-04-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10543044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10545285	Spontaneous	2016-04-14 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10545285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10546397	Spontaneous	2016-04-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10546397&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10537777	Spontaneous	2016-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10537777&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10532322	Spontaneous	2016-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[YELLOW FEVER VACCINE (LIVE), YELLOW FEVER VIRUS STRAIN 17D-204 (LIVE, ATTENUATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10532322&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10532379	Spontaneous	2016-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	NIMENRIX [N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE (DE-O-ACETYLATED) CONJUGATED TO TETANUS TOXOID, NEISSERIA MENINGITIDIS GROUP A POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP W-135 POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP Y POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID CARRIER PROTEIN] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10532379&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10532398	Spontaneous	2016-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[YELLOW FEVER VACCINE (LIVE), YELLOW FEVER VIRUS STRAIN 17D-204 (LIVE, ATTENUATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10532398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10532426	Spontaneous	2016-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[YELLOW FEVER VACCINE (LIVE), YELLOW FEVER VIRUS STRAIN 17D-204 (LIVE, ATTENUATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10532426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10527617	Spontaneous	2016-04-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Speech disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tonsillitis (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10527617&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10527626	Spontaneous	2016-04-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10527626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10527712	Spontaneous	2016-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10527712&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10528007	Spontaneous	2016-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10528007&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10529034	Spontaneous	2016-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Oropharyngeal pain (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10529034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10526607	Spontaneous	2016-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10526607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10522508	Spontaneous	2016-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - );Vomiting (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10522508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10522550	Spontaneous	2016-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Oropharyngeal pain (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10522550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10522672	Spontaneous	2016-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Oropharyngeal pain (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10522672&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10522724	Spontaneous	2016-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Oropharyngeal pain (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10522724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10523213	Spontaneous	2016-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Female	Cough (n/a - Unknown - );Headache (n/a - Unknown - );Influenza (n/a - Unknown - );Myalgia (n/a - Unknown - );Oropharyngeal pain (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10523213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10518342	Spontaneous	2016-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10518342&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10518343	Spontaneous	2016-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10518343&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10518367	Spontaneous	2016-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10518367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10518423	Spontaneous	2016-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10518423&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10502129	Spontaneous	2016-04-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Impaired work ability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10502129&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10503412	Spontaneous	2016-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Ageusia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anosmia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Subcutaneous])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - 10mg - n/a])|[BENDROFLUMETHIAZIDE] (C - n/a - n/a - [n/a - 2.5mg - n/a])|[DOXAZOSIN, DOXAZOSIN MESILATE] (C - n/a - n/a - [n/a - 2mg - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - 15mg - n/a])|[PARACETAMOL, CODEINE PHOSPHATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - 7.5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10503412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10500104	Spontaneous	2016-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Dose not changed - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10500104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10500332	Spontaneous	2016-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10500332&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10500360	Spontaneous	2016-04-02 00:00:00	Healthcare Professional	European Economic Area	Lundgren B. Narrating Narcolepsy - Centering a Side Effect. Medical Anthropology. 2015;34:2:150-165	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10500360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10494877	Spontaneous	2016-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Dermatitis exfoliative generalised (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Eczema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10494877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10495881	Spontaneous	2016-04-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10495881&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10496155	Spontaneous	2016-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10496155&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10492760	Spontaneous	2016-03-31 00:00:00	Healthcare Professional	Non European Economic Area	Reyes A et al. Multiple sclerosis in a postgraduate student of anaesthesia: illness in doctors and fitness to practice. BMJ Case Report. 2016	18-64 Years	Not Specified	No	Female	Demyelination (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Diplopia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);VIth nerve paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10492760&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10494539	Spontaneous	2016-03-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Muscular weakness (n/a - Recovering/Resolving - );Syncope (n/a - Unknown - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10494539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10484215	Spontaneous	2016-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Toxic skin eruption (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[AMOXICILLIN SODIUM, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (S - Bronchopneumopathy - Drug withdrawn - [n/a - 1g - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10484215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10485938	Spontaneous	2016-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10485938&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10486572	Spontaneous	2016-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Not Specified	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10486572&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10486613	Spontaneous	2016-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Not Specified	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10486613&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10486681	Spontaneous	2016-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10486681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10479709	Spontaneous	2016-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Autoimmune hepatitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dehydration (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diabetes mellitus (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspepsia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	CORTICOSTEROID NOS [CORTICOSTEROID NOS] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|CORTICOSTEROID NOS [CORTICOSTEROID NOS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10479709&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10479978	Spontaneous	2016-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Influenza (n/a - Unknown - );Pneumonia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10479978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-10480177	Spontaneous	2016-03-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Autoimmune disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10480177&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10468167	Spontaneous	2016-03-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - );Diarrhoea (n/a - Not Recovered/Not Resolved - );Disturbance in attention (n/a - Not Recovered/Not Resolved - );Dizziness (n/a - Not Recovered/Not Resolved - );Gastrointestinal pain (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Hyperacusis (n/a - Not Recovered/Not Resolved - );Insomnia (n/a - Not Recovered/Not Resolved - );Muscle tightness (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Nasal mucosal disorder (n/a - Not Recovered/Not Resolved - );Photosensitivity reaction (n/a - Not Recovered/Not Resolved - );Rash (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10468167&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10460864	Spontaneous	2016-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10460864&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10462093	Spontaneous	2016-03-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10462093&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10462095	Spontaneous	2016-03-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10462095&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10463502	Spontaneous	2016-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10463502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10455206	Spontaneous	2016-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (2a - Recovered/Resolved - Other Medically Important Condition);Hypertension (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pneumonia (2a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10455206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10451585	Spontaneous	2016-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10451585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10438336	Spontaneous	2016-03-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - .25mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10438336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10433388	Spontaneous	2016-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Aggression (n/a - Not Recovered/Not Resolved - Disabling);Anger (n/a - Not Recovered/Not Resolved - Disabling);Anxiety (n/a - Not Recovered/Not Resolved - Disabling);Attention deficit hyperactivity disorder (n/a - Not Recovered/Not Resolved - Disabling);Behaviour disorder (n/a - Not Recovered/Not Resolved - Disabling);Confusional state (n/a - Not Recovered/Not Resolved - Disabling);Daydreaming (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Learning disability (n/a - Not Recovered/Not Resolved - Disabling);Reading disorder (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10433388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10434163	Spontaneous	2016-03-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Overweight (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10434163&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10434461	Spontaneous	2016-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Pyrexia (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10434461&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10434816	Spontaneous	2016-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10434816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10434826	Spontaneous	2016-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10434826&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10428333	Spontaneous	2016-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Not Recovered/Not Resolved - Disabling);Hallucination (n/a - Not Recovered/Not Resolved - Disabling);Microsleep (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10428333&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10428874	Spontaneous	2016-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (7d - Recovered/Resolved - Other Medically Important Condition);Injection site inflammation (n/a - Recovering/Resolving - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema peripheral (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (12h - Recovered/Resolved - Other Medically Important Condition);Vaccination site pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])...	[BILASTINE] (C - n/a - Not applicable - [6d - 20mg - Oral])|[CICLESONIDE] (C - n/a - Dose not changed - [n/a - 160ug - Unknown])|[LEVOTHYROXINE SODIUM] (C - n/a - Dose not changed - [n/a - 50ug - Oral])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - Dose not changed - [n/a - 2.5ug - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10428874&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10428910	Spontaneous	2016-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10428910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10425504	Spontaneous	2016-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Vaccination site pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10425504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10416360	Spontaneous	2016-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Haematoma (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10416360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10416933	Spontaneous	2016-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10416933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10410665	Spontaneous	2016-03-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10410665&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10412230	Spontaneous	2016-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10412230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10404551	Spontaneous	2016-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10404551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10405147	Spontaneous	2016-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10405147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10408118	Spontaneous	2016-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cerebral artery embolism (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10408118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10400767	Spontaneous	2016-03-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aptyalism (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Dry eye (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersensitivity pneumonitis (n/a - Recovered/Resolved - Disabling);Influenza like illness (n/a - Unknown - Disabling);Obstructive sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Disabling);Periodic limb movement disorder (n/a - Not Recovered/Not Resolved - Disabling);Pruritus (n/a - Not Recovered/Not Resolved - Disabling);Purpura (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Rash macular (n/a - Not Recovered/Not Resolved - Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling);Tooth infection (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT) AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[HEPATITIS A VACCINE] (S - Prophylaxis - Not applicable - [368d - n/a - n/a])|[HEPATITIS B VACCINE] (S - Prophylaxis - Not applicable - [368d - n/a - n/a])	[HEPATITIS A VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[HEPATITIS B VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10400767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10400807	Spontaneous	2016-03-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disorientation (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Immune system disorder (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10400807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10401599	Spontaneous	2016-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10401599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10397603	Spontaneous	2016-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Vaccination failure (0d - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10397603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10392476	Spontaneous	2016-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10392476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10392690	Spontaneous	2016-03-05 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10392690&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10387212	Spontaneous	2016-03-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Psoriatic arthropathy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10387212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10387955	Spontaneous	2016-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10387955&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10388235	Spontaneous	2016-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10388235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10389491	Spontaneous	2016-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10389491&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10384722	Spontaneous	2016-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abnormal dreams (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Depressed mood (n/a - Unknown - Other Medically Important Condition);Educational problem (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Injury (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Obesity (n/a - Unknown - Other Medically Important Condition);Obstructive sleep apnoea syndrome (n/a - Unknown - Other Medically Important Condition);Overweight (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10384722&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10378087	Spontaneous	2016-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Chest discomfort (n/a - Recovered/Resolved - );Chest pain (n/a - Recovered/Resolved - );Chills (n/a - Recovered/Resolved - );Dizziness (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Malaise (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10378087&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10378089	Spontaneous	2016-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10378089&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10379166	Spontaneous	2016-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amnesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Apathy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depressed mood (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Mood altered (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Obstructive sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Personality change (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10379166&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10369552	Spontaneous	2016-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10369552&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10369571	Spontaneous	2016-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10369571&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10369674	Spontaneous	2016-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10369674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10371247	Spontaneous	2016-03-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Anger (n/a - Not Recovered/Not Resolved - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypothyroidism (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Irritability (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10371247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10364511	Spontaneous	2016-02-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Influenza like illness (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Suspected transmission of an infectious agent via product (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10364511&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10366682	Spontaneous	2016-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Malaise (0d - Recovered/Resolved - );Pyrexia (0d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10366682&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10363164	Spontaneous	2016-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10363164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10358061	Spontaneous	2016-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Dose not changed - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10358061&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10358671	Spontaneous	2016-02-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10358671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10361020	Spontaneous	2016-02-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10361020&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10347302	Spontaneous	2016-02-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cardio-respiratory arrest (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (4d - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myocardial infarction (2d - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (4d - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Suspected transmission of an infectious agent via product (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10347302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10343342	Spontaneous	2016-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Disabling);Aggression (n/a - Not Recovered/Not Resolved - Disabling);Coeliac disease (n/a - Not Recovered/Not Resolved - Disabling);Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia-bulimia syndrome (n/a - Not Recovered/Not Resolved - Disabling);Orthostatic intolerance (n/a - Not Recovered/Not Resolved - Disabling);Restlessness (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .25mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10343342&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10338258	Spontaneous	2016-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Angioedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10338258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10335326	Spontaneous	2016-02-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Apathy (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Mood swings (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10335326&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10323300	Spontaneous	2016-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Central nervous system vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Feeling guilty (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10323300&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10315108	Spontaneous	2016-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Drug ineffective (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Influenza (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10315108&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10318209	Spontaneous	2016-02-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10318209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10309938	Spontaneous	2016-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Feeling cold (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10309938&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10309961	Spontaneous	2016-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Allergic oedema (n/a - Recovered/Resolved - );Erythema (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10309961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10309970	Spontaneous	2016-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - );Feeling cold (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - )	PREVENAR 13 [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 ADSORBED ON ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197, ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6A CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10309970&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10310705	Spontaneous	2016-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arrhythmia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10310705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10310710	Spontaneous	2016-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10310710&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10313011	Spontaneous	2016-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10313011&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10304250	Spontaneous	2016-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10304250&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10304842	Spontaneous	2016-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Depression (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Dry mouth (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Dysgeusia (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Hypnopompic hallucination (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Periodic limb movement disorder (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Pruritus (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Temperature regulation disorder (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Vertigo (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10304842&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10304949	Spontaneous	2016-02-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Systemic lupus erythematosus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10304949&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10306427	Spontaneous	2016-02-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10306427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10298664	Spontaneous	2016-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10298664&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10292767	Spontaneous	2016-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10292767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10292772	Spontaneous	2016-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10292772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10293320	Spontaneous	2016-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10293320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10294337	Spontaneous	2016-02-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Polyuria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sudden hearing loss (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10294337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10296868	Spontaneous	2016-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Automatism (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hallucination (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Weight increased (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - 6ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10296868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10289606	Spontaneous	2016-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hallucination, tactile (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Infection (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Listless (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Disabling, Other Medically Important Condition);Social fear (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10289606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10292483	Spontaneous	2016-02-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pain (n/a - Recovered/Resolved - );Presyncope (n/a - Recovered/Resolved - );Rash pruritic (n/a - Recovered/Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10292483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10281673	Spontaneous	2016-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10281673&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10282796	Spontaneous	2016-02-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Unknown - Disabling, Other Medically Important Condition);Back pain (n/a - Unknown - Disabling, Other Medically Important Condition);Depression (n/a - Unknown - Disabling, Other Medically Important Condition);Educational problem (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Unknown - Disabling, Other Medically Important Condition);Neck pain (n/a - Unknown - Disabling, Other Medically Important Condition);Stress (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10282796&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10285939	Spontaneous	2016-02-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eosinophilia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Glomerular filtration rate decreased (53d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Monocytosis (50d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Transaminases increased (53d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	CIALIS [TADALAFIL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ETORICOXIB] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[INDAPAMIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[TAMSULOSIN, TAMSULOSIN HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[TORASEMIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[TRAZODONE, TRAZODONE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10285939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10280623	Spontaneous	2016-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Fatigue (29d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (29d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Night sweats (29d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (29d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10280623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10280768	Spontaneous	2016-02-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10280768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10276711	Spontaneous	2016-02-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10276711&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10277524	Spontaneous	2016-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10277524&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10270112	Spontaneous	2016-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cognitive disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dissociative disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fall (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperuricaemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Leukocytosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Organic brain syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Post-traumatic stress disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensory level abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensory loss (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10270112&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10271348	Spontaneous	2016-02-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Transient global amnesia (2h - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	ZOSTAVAX [VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS] (S - Immunisation - Not applicable - [1d - n/a - Parenteral])...	[ATORVASTATIN] (C - n/a - n/a - [n/a - 20mg - n/a])|[FINASTERIDE] (C - n/a - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10271348&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10272321	Spontaneous	2016-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Narcolepsy (7a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	BUPRENORPHINE [BUPRENORPHINE] (C - Spinal pain - n/a - [n/a - n/a - n/a])|PREGABALIN [PREGABALIN] (C - Spinal pain - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10272321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10264221	Spontaneous	2016-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - );Influenza like illness (n/a - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10264221&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10264915	Spontaneous	2016-02-03 00:00:00	Healthcare Professional	Non European Economic Area	Pierse N, Kelly H, Thompsonf M, et al.. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014. Vaccine. 2015;34:503-509.	Not Specified	Child	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10264915&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10259278	Spontaneous	2016-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza A virus test positive (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10259278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10252834	Spontaneous	2016-02-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Eye haemorrhage (1d - Recovered/Resolved - Other Medically Important Condition);Incorrect route of product administration (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])|[DOXEPIN HYDROCHLORIDE] (S - n/a - Unknown - [n/a - 10mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10252834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10253514	Spontaneous	2016-02-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blindness (n/a - Unknown - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Disabling, Other Medically Important Condition);Nasal congestion (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Optic neuritis (67d - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sneezing (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Parenteral])	[ACRIVASTINE] (C - n/a - n/a - [n/a - n/a - n/a])|[DESOGESTREL] (C - n/a - n/a - [n/a - n/a - n/a])|[MEDROXYPROGESTERONE ACETATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10253514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-10254093	Spontaneous	2016-02-01 00:00:00	Healthcare Professional	Non European Economic Area	Pierse N, Kelly H, Thompson M, et al.. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014. Vaccine. 2015;503-509.	Not Specified	Adult	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10254093&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10254095	Spontaneous	2016-02-01 00:00:00	Healthcare Professional	Non European Economic Area	Pierse N, Kelly H, Thompson M, et al.. Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014. Vaccine. 2015;34:503-509.	Not Specified	Elderly	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10254095&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10254302	Spontaneous	2016-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Lymphadenopathy (5d - Recovering/Resolving - );Myalgia (5d - Recovering/Resolving - );Pruritus (5d - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10254302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10254883	Spontaneous	2016-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Depression (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Impaired quality of life (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Rapid eye movements sleep abnormal (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Tinnitus (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10254883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10246021	Spontaneous	2016-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Meningoradiculitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Miller Fisher syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	TWINRIX ADULT SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Prophylaxis - Not applicable - [n/a - 1mL - Intramuscular])...	EVIPLERA [EMTRICITABINE, TENOFOVIR DISOPROXIL, RILPIVIRINE] (C - HIV infection - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10246021&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10247100	Spontaneous	2016-01-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dehydration (n/a - Unknown - Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Stress (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10247100&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10247793	Spontaneous	2016-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Lymph node pain (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tachycardia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tenderness (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	[AMOXICILLIN, AMOXICILLIN TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE, BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[LORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10247793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10247835	Spontaneous	2016-01-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Optic nerve disorder (n/a - Unknown - Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10247835&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10240598	Spontaneous	2016-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abnormal behaviour (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Food craving (n/a - Unknown - Other Medically Important Condition);Hypokinesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Incoherent (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Logorrhoea (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Microsleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10240598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10234186	Spontaneous	2016-01-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Joint swelling (n/a - Unknown - Other Medically Important Condition);Muscle contracture (n/a - Unknown - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Peripheral swelling (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10234186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10234264	Spontaneous	2016-01-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Ataxia (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Communication disorder (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Congenital brain damage (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Hyperreflexia (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Maternal exposure timing unspecified (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Movement disorder (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Muscle spasms (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Muscle tightness (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Nervous system disorder (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Petit mal epilepsy (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Speech disorder developmental (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10234264&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Severe reaction
EU-EC-10235788	Spontaneous	2016-01-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Anxiety (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Restlessness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10235788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10230405	Spontaneous	2016-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Urticaria (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10230405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10232319	Spontaneous	2016-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10232319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10226684	Spontaneous	2016-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10226684&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10226688	Spontaneous	2016-01-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10226688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10217009	Spontaneous	2016-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Renal failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10217009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10217900	Spontaneous	2016-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10217900&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10217916	Spontaneous	2016-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Foetal exposure during pregnancy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Speech disorder developmental (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10217916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10218313	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10218314	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10218315	Spontaneous	2016-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cold sweat (0d - Recovered/Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Erythema (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypothermia (0d - Recovered/Resolved - Disabling, Other Medically Important Condition);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nasal congestion (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Skin hypopigmentation (n/a - Unknown - Disabling, Other Medically Important Condition);Syncope (0d - Recovered/Resolved - Disabling, Other Medically Important Condition);Tachycardia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10218319	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthma (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Hypersensitivity (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10218320	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10218322	Spontaneous	2016-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amnesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Arthralgia (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Body temperature fluctuation (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Chills (n/a - Unknown - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dysgeusia (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);H1N1 influenza (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Influenza like illness (2d - Recovered/Resolved - Disabling, Other Medically Important Condition);Migraine with aura (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Disabling, Other Medically Important Condition);Night sweats (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Respiratory disorder (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Respiratory symptom (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Sinusitis (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Tonsillitis streptococcal (10d - Recovered/Resolved - Disabling, Other Medically Important Condition);Vaccination failure (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	ENBREL [ETANERCEPT] (C - n/a - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])|[DICLOFENAC SODIUM, MISOPROSTOL] (C - n/a - Not applicable - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218322&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10218324	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Disabling);Back pain (n/a - Unknown - Disabling);Depression (n/a - Not Recovered/Not Resolved - Disabling);Epicondylitis (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Unknown - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Night sweats (n/a - Unknown - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Respiratory disorder (n/a - Unknown - Disabling);Tachycardia (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218324&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10218325	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abscess (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Injection site abscess (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Intestinal haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Prostatitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10218330	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	Yes	Male	Autism spectrum disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Maternal exposure timing unspecified (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10218333	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218333&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10218334	Spontaneous	2016-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Listless (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10218336	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10218337	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Impaired driving ability (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10218338	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Impaired work ability (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Injection site pain (n/a - Recovered/Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218338&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10218339	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Restlessness (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10218340	Spontaneous	2016-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218340&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10218766	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoaesthesia (n/a - Unknown - Disabling, Other Medically Important Condition);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10218767	Spontaneous	2016-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Discomfort (n/a - Recovered/Resolved - Disabling);Dizziness (n/a - Recovered/Resolved - Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10218767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10206176	Spontaneous	2016-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - Human papilloma virus immunisation - Not applicable - [n/a - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10206176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10201691	Spontaneous	2016-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10201691&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10205761	Spontaneous	2016-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fatigue (n/a - Recovered/Resolved - Disabling);Migraine (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Recovered/Resolved - Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10205761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10205762	Spontaneous	2016-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[BROMOCRIPTINE, BROMOCRIPTINE MESILATE] (C - n/a - Drug withdrawn - [n/a - 1.25mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10205762&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10197791	Spontaneous	2016-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10197791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10200937	Spontaneous	2016-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10200937&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10191634	Spontaneous	2016-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10191634&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10192179	Spontaneous	2016-01-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypertension (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10192179&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10192497	Spontaneous	2016-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Extrasystoles (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10192497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10192546	Spontaneous	2016-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10192546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10187637	Spontaneous	2016-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Disabling);Amyotrophic lateral sclerosis (n/a - Unknown - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Unknown - Disabling);Dry eye (n/a - Not Recovered/Not Resolved - Disabling);Dysarthria (n/a - Not Recovered/Not Resolved - Disabling);Dysphagia (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Unknown - Disabling);Flatulence (n/a - Not Recovered/Not Resolved - Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Muscle spasms (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Oedema peripheral (n/a - Not Recovered/Not Resolved - Disabling);Paresis (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Swelling (n/a - Not Recovered/Not Resolved - Disabling);Weight decreased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])|[INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED)] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10187637&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10181368	Spontaneous	2016-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Autism spectrum disorder (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Brain injury (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Hypokinesia (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Maternal exposure timing unspecified (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Social problem (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10181368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Severe reaction
EU-EC-10185759	Spontaneous	2016-01-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Headache (n/a - Not Recovered/Not Resolved - Life Threatening);Narcolepsy (n/a - Not Recovered/Not Resolved - Life Threatening)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10185759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10180816	Spontaneous	2016-01-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Disabling);Cardiac disorder (n/a - Not Recovered/Not Resolved - Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Recovered/Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	[ACETYLSALICYLZUUR] (C - n/a - n/a - [n/a - 80mg - Oral])|[FLECAINIDE ACETATE] (C - n/a - n/a - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10180816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10172399	Spontaneous	2016-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Injection site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuritis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Peripheral nerve lesion (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Tendon disorder (n/a - Unknown - Other Medically Important Condition);Tenosynovitis (n/a - Unknown - Other Medically Important Condition);Vaccination complication (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10172399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10163905	Spontaneous	2016-01-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Bronchitis (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10163905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10166009	Spontaneous	2016-01-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Life Threatening)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10166009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10159519	Spontaneous	2016-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10159519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10148591	Spontaneous	2016-01-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Dry skin (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10148591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10151173	Spontaneous	2016-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Gait inability (22d - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (22d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (22d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10151173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-10143341	Spontaneous	2015-12-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10143341&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10143342	Spontaneous	2015-12-31 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10143342&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10143343	Spontaneous	2015-12-31 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10143343&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10143747	Spontaneous	2015-12-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood pressure increased (n/a - Unknown - Other Medically Important Condition);Diarrhoea (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition);Viral infection (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	[CELIPROLOL, CELIPROLOL HYDROCHLORIDE] (C - Cardiac disorder - n/a - [n/a - n/a - n/a])|[GLIMEPIRIDE] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10143747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10146046	Spontaneous	2015-12-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10146046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10128542	Spontaneous	2015-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sarcoidosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10128542&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10125550	Spontaneous	2015-12-25 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site swelling (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10125550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10123491	Spontaneous	2015-12-24 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site swelling (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10123491&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10124447	Spontaneous	2015-12-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10124447&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10110713	Spontaneous	2015-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Aphonia (n/a - Not Recovered/Not Resolved - );Dysphonia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10110713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10114106	Spontaneous	2015-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersensitivity (n/a - Not Recovered/Not Resolved - Disabling);Oedema peripheral (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10114106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10103486	Spontaneous	2015-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Circulatory collapse (n/a - Recovered/Resolved - );Labile blood pressure (n/a - Recovered/Resolved - );Restlessness (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10103486&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10105405	Spontaneous	2015-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Vaccination site erythema (n/a - Not Recovered/Not Resolved - );Vaccination site reaction (n/a - Not Recovered/Not Resolved - );Vaccination site swelling (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10105405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10107595	Spontaneous	2015-12-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site pain (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10107595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10096857	Spontaneous	2015-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Daydreaming (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hallucination (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hypertension (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Obesity (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10096857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10098581	Spontaneous	2015-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10098581&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10101641	Spontaneous	2015-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10101641&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10092240	Spontaneous	2015-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10092240&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10086547	Spontaneous	2015-12-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Nasopharyngitis (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10086547&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-10080124	Spontaneous	2015-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (15d - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10080124&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10080272	Spontaneous	2015-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Meningitis aseptic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10080272&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10080638	Spontaneous	2015-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10080638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10080642	Spontaneous	2015-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10080642&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10077772	Spontaneous	2015-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pityriasis rosea (n/a - Recovered/Resolved - Other Medically Important Condition);Rash macular (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Unknown - [1d - n/a - Unknown])	[FOLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10077772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10077860	Spontaneous	2015-12-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	NOVORAPID [INSULIN ASPART] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[INSULIN HUMAN, INSULIN HUMAN (RDNA)] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10077860&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10073362	Spontaneous	2015-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthritis bacterial (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])|[KETOPROFEN] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])	PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Gastrooesophageal reflux disease - n/a - [n/a - 20mg - Oral])|[FELODIPINE] (C - Hypertension - n/a - [n/a - 5mg - Oral])|[PARACETAMOL] (C - Pyrexia - n/a - [n/a - n/a - Oral])|[SIMVASTATIN] (C - Dyslipidaemia - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10073362&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10073384	Spontaneous	2015-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])|[INDAPAMIDE, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMINE, INDAPAMIDE] (S - n/a - Not applicable - [n/a - n/a - Oral])	PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - Oral])|[GLICLAZIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[TAMSULOSIN HYDROCHLORIDE, DUTASTERIDE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10073384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10073452	Spontaneous	2015-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Condition aggravated (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Status epilepticus (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	KEPPRA [LEVETIRACETAM] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVONORGESTREL, LEVONORGESTREL MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10073452&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10067923	Spontaneous	2015-12-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10067923&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10068627	Spontaneous	2015-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site erythema (n/a - Not Recovered/Not Resolved - );Vaccination site pruritus (n/a - Not Recovered/Not Resolved - );Vaccination site warmth (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10068627&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10069676	Spontaneous	2015-12-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10069676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10064417	Spontaneous	2015-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Balance disorder (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Snoring (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10064417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-10056709	Spontaneous	2015-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotension (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10056709&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10059429	Spontaneous	2015-12-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Malaise (n/a - Not Recovered/Not Resolved - );Muscular weakness (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10059429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-10052569	Spontaneous	2015-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Disturbance in attention (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Memory impairment (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Restless legs syndrome (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Sleep attacks (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Sleep disorder (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Sleep paralysis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10052569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-10047319	Spontaneous	2015-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Decreased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eye movement disorder (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Initial insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lacrimation increased (n/a - Unknown - Other Medically Important Condition);Listless (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Loss of control of legs (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10047319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-10049267	Spontaneous	2015-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Conjunctivitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eye pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Immune system disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lacrimation increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mental disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ocular hyperaemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Skin irritation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Skin lesion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])|CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10049267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10049428	Spontaneous	2015-12-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[ATENOLOL, ATENOLOL BP] (C - Essential hypertension - n/a - [n/a - 50mg - Oral])|[COLECALCIFEROL] (C - Vitamin D - n/a - [n/a - n/a - n/a])|[LORATADINE] (C - Hypersensitivity - n/a - [n/a - 10mg - Oral])|[SIMVASTATIN] (C - Product used for unknown indication - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10049428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-10045676	Spontaneous	2015-12-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Urticaria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10045676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10042221	Spontaneous	2015-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic shock (1d - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10042221&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-10038175	Spontaneous	2015-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Male	Lung disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10038175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10038176	Spontaneous	2015-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Body temperature decreased (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysstasia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vertigo (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[CANDESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[KETOROLAC TROMETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10038176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10032786	Spontaneous	2015-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Acute kidney injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sepsis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10032786&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10032788	Spontaneous	2015-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Acute kidney injury (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cardiac failure (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Septic shock (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10032788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10018772	Spontaneous	2015-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Thrombocytopenia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10018772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-10015187	Spontaneous	2015-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015187&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10015542	Spontaneous	2015-11-27 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Viral infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015542&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10015797	Spontaneous	2015-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Constipation (30d - Recovered/Resolved - Other Medically Important Condition);Meniere's disease (30d - Recovered/Resolved - Other Medically Important Condition);Mouth ulceration (30d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10015797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-10017871	Spontaneous	2015-11-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Presyncope (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	[INSULIN, INSULIN HUMAN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10017871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10018188	Spontaneous	2015-11-27 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10018188&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-10009730	Spontaneous	2015-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Optic neuritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10009730&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10010141	Spontaneous	2015-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Diarrhoea (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10010141&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-10001170	Spontaneous	2015-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Neuropathy peripheral (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	[LERCANIDIPINE HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=10001170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9998164	Spontaneous	2015-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperthermia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9998164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9998555	Spontaneous	2015-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9998555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9993207	Spontaneous	2015-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9993207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9993437	Spontaneous	2015-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Atrial fibrillation (1d - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chest pain (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Circulatory collapse (1d - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Enteritis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vertigo (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Parenteral])	[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - Oral])|[BETAXOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[BIOFLAVONOIDS, DIOSMIN, HESPERIDIN, MICRONISED PURIFIED FLAVONOIC FRACTION] (C - n/a - n/a - [n/a - n/a - Oral])|[COLECALCIFEROL, MANGANESE SULPHATE MONOHYDRATE, ZINC OXIDE, CALCIUM CARBONATE, CUPRIC OXIDE, MAGNESIUM OXIDE, BORAX, COLECALCIFEROL, SODIUM TETRABORATE CRYST., ZINC OXIDE, CALCIUM CARBONATE, CUPRIC OXIDE, MAGNESIUM OXIDE, MANGANESE SULFATE, COLECALCIFEROL, ZINC OXIDE, CALCIUM CARBONATE, CUPRIC OXIDE, MAGNESIUM OXIDE, MANGANESE SULFATE, BORAX] (C - n/a - n/a - [n/a - n/a - Oral])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - Oral])|[FUROSEMIDE] (C - n/a - n/a - [n/a - 40mg - Oral])|[HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - n/a - Oral])|[IBANDRONIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[NITRENDIPINE] (C - n/a - n/a - [n/a - n/a - Oral])|[THIAMAZOLE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9993437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-9993539	Spontaneous	2015-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Optic neuritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9993539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9991585	Spontaneous	2015-11-21 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9991585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9991598	Spontaneous	2015-11-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vaccination site swelling (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9991598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9989348	Spontaneous	2015-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination site erythema (n/a - Unknown - Other Medically Important Condition);Vaccination site induration (n/a - Unknown - Other Medically Important Condition);Vaccination site pain (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9989348&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9990707	Spontaneous	2015-11-20 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injected limb mobility decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9990707&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9983493	Spontaneous	2015-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Night sweats (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9983493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9970940	Spontaneous	2015-11-17 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Seizure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9970940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9967024	Spontaneous	2015-11-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Unknown - Other Medically Important Condition);Injection site swelling (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Recovering/Resolving - Other Medically Important Condition);Sciatica (n/a - Unknown - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Spinal fracture (n/a - Unknown - Other Medically Important Condition);Vasculitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9967024&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9967400	Spontaneous	2015-11-16 00:00:00	Healthcare Professional	Non European Economic Area	De Andrade S, Santarem Andrade M, Santos P, et al.. Acute disseminated encephalomyelitis following inactivated influenza vaccination in the Brazilian Amazon: a case report. Revista da Sociedade Brasileira de Medicina Tropical. 2015;48(4):498-500.	18-64 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9967400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9969634	Spontaneous	2015-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Learning disability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Subcutaneous])	[BUDESONIDE] (C - n/a - n/a - [n/a - n/a - Unknown])|[LEVOCETIRIZINE DIHYDROCHLORIDE, LEVOCETIRIZINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9969634&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9959455	Spontaneous	2015-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9959455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9959495	Spontaneous	2015-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9959495&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9960001	Spontaneous	2015-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Electric shock sensation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Immunisation reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle spasticity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle twitching (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Small fibre neuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9960001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9961857	Spontaneous	2015-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9961857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9955048	Spontaneous	2015-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Gait disturbance (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9955048&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-9955162	Spontaneous	2015-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Body temperature increased (n/a - Unknown - );Cough (n/a - Unknown - );Limb discomfort (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9955162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9950277	Spontaneous	2015-11-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arthralgia (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9950277&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9941812	Spontaneous	2015-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthritis (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9941812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9938115	Spontaneous	2015-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9938115&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9929614	Spontaneous	2015-11-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash erythematous (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin warm (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immune system disorder - Not applicable - [n/a - .5mL - Parenteral])	CELECOXIB [CELECOXIB] (C - n/a - n/a - [n/a - n/a - n/a])|[BENDROFLUMETHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[BETAHISTINE, BETAHISTINE DIHYDROCHLORIDE, BETAHISTINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPRANOLOL, PROPRANOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9929614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9930405	Spontaneous	2015-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9930405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9930417	Spontaneous	2015-11-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Epilepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - .25mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9930417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9930784	Spontaneous	2015-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	CERVARIX [3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, ALGELDRATE, ALUMINIUM, 3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN] (S - n/a - n/a - [n/a - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9930784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9922590	Spontaneous	2015-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amyotrophic lateral sclerosis (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9922590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-9924184	Spontaneous	2015-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9924184&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9919929	Spontaneous	2015-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sciatica (n/a - Unknown - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Spinal fracture (n/a - Unknown - Other Medically Important Condition);Swelling (n/a - Unknown - Other Medically Important Condition);Vasculitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9919929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9912414	Spontaneous	2015-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dyspnoea (n/a - Unknown - Other Medically Important Condition);Neuritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Phrenic nerve paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Total lung capacity decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9912414&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9913755	Spontaneous	2015-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Needle issue (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - );Vaccination site pain (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9913755&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9913757	Spontaneous	2015-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Needle issue (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - );Vaccination site pain (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9913757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9913761	Spontaneous	2015-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Needle issue (n/a - Unknown - );Peripheral swelling (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - );Vaccination site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9913761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9902602	Spontaneous	2015-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hepatic steatosis (n/a - Unknown - Disabling);Hyperacusis (n/a - Unknown - Disabling);Hypnagogic hallucination (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Paraesthesia (n/a - Unknown - Disabling);Photophobia (n/a - Unknown - Disabling);Polydipsia (n/a - Unknown - Disabling);Polyuria (n/a - Unknown - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Sleep disorder (n/a - Unknown - Disabling);Social avoidant behaviour (n/a - Not Recovered/Not Resolved - Disabling);Tourette's disorder (n/a - Unknown - Disabling);Weight increased (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9902602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9902603	Spontaneous	2015-10-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Fibromyalgia (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9902603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9902604	Spontaneous	2015-10-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Restlessness (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9902604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9902616	Spontaneous	2015-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9902616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9898118	Spontaneous	2015-10-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pruritus (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9898118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9893092	Spontaneous	2015-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucinations, mixed (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Motor dysfunction (n/a - Unknown - Other Medically Important Condition);Muscle spasms (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9893092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9893105	Spontaneous	2015-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9893105&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9881936	Spontaneous	2015-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9881936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9876646	Spontaneous	2015-10-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Idiopathic environmental intolerance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sick building syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - n/a - n/a - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9876646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9876667	Spontaneous	2015-10-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthma (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Idiopathic environmental intolerance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Postural orthostatic tachycardia syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sick building syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - n/a - n/a - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9876667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9869878	Spontaneous	2015-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Postural orthostatic tachycardia syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	CYMBALTA [DULOXETINE, DULOXETINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9869878&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9873130	Spontaneous	2015-10-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9873130&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9861176	Spontaneous	2015-10-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Back pain (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9861176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9851690	Spontaneous	2015-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Circulatory collapse (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9851690&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9845841	Spontaneous	2015-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9845841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9846393	Spontaneous	2015-10-14 00:00:00	Healthcare Professional	European Economic Area	Williams G, Evans S, Yeo D, Al-bermani A. Retinal artery vasculitis secondary to administration of influenza vaccine. Unusual association of diseases/symptoms-BMJ Case Report. 2015 AUG 27;1-3.	65-85 Years	Not Specified	No	Female	Retinal vasculitis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Unknown])	[CALCIUM, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DIGOXIN] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - Polymyalgia rheumatica - n/a - [n/a - 9mg - n/a])|[WARFARIN, WARFARIN SODIUM] (C - Mitral valve replacement - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9846393&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9836683	Spontaneous	2015-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Balance disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Bradyphrenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dementia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dissociation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Petit mal epilepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9836683&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9834825	Spontaneous	2015-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9834825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9834885	Spontaneous	2015-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - .5g - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9834885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9815373	Spontaneous	2015-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Food craving (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Social avoidant behaviour (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9815373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9816810	Spontaneous	2015-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Alcohol intolerance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Amnesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Body temperature fluctuation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Clumsiness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Decreased appetite (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Drug hypersensitivity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dysphagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Eye pruritus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Food allergy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Infectious mononucleosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Lymph node pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Orthostatic hypotension (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pollakiuria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sinusitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	AERIUS [DESLORATADINE] (C - n/a - Not applicable - [n/a - 5mg - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Not applicable - [n/a - n/a - Respiratory (inhalation)])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - .5{DF} - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Not applicable - [n/a - 50ug - n/a])|[LIOTHYRONINE] (C - n/a - Not applicable - [n/a - n/a - n/a])|[LORATADINE] (C - n/a - Not applicable - [n/a - 10mg - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - Not applicable - [n/a - 10mg - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Not applicable - [n/a - .2mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9816810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9816816	Spontaneous	2015-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 1{DF} - Parenteral])|[INFLUENZA VACCINE (WHOLE VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - n/a - n/a])	[AMLODIPINE, AMLODIPINE BESILATE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[CANDESARTAN CILEXETIL] (C - Hypertension - n/a - [n/a - n/a - n/a])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[MELOXICAM] (C - Pain - n/a - [n/a - n/a - n/a])|[MODAFINIL] (C - n/a - Drug withdrawn - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9816816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9807835	Spontaneous	2015-10-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chills (n/a - Unknown - Caused/Prolonged Hospitalisation);Incontinence (n/a - Unknown - Caused/Prolonged Hospitalisation);Meningism (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Radiculopathy (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9807835&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9801031	Spontaneous	2015-10-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epilepsy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - n/a])	[SODIUM VALPROATE] (C - Epilepsy - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9801031&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-9796104	Spontaneous	2015-09-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Disabling);Gastrointestinal pain (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Mental disorder (n/a - Not Recovered/Not Resolved - Disabling);Migraine (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9796104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9796135	Spontaneous	2015-09-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adolescent	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9796135&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-9793160	Spontaneous	2015-09-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9793160&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9776239	Spontaneous	2015-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Unknown - Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Food intolerance (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersensitivity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Disabling, Other Medically Important Condition);Pain (n/a - Unknown - Disabling, Other Medically Important Condition);Pruritus (n/a - Unknown - Disabling, Other Medically Important Condition);Respiratory tract infection (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9776239&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9776260	Spontaneous	2015-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Rash papular (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9776260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-9771409	Spontaneous	2015-09-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9771409&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9772115	Spontaneous	2015-09-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Dyspnoea exertional (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Palpitations (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Tonsillar disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [406d - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [344d - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [442d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9772115&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9772228	Spontaneous	2015-09-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9772228&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9772319	Spontaneous	2015-09-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (3a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9772319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9768668	Spontaneous	2015-09-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Angioedema (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9768668&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9762364	Spontaneous	2015-09-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling cold (n/a - Not Recovered/Not Resolved - Disabling);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Lymph node pain (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9762364&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9762604	Spontaneous	2015-09-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Myasthenic syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9762604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9755998	Spontaneous	2015-09-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9755998&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9752832	Spontaneous	2015-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Mastitis (n/a - Unknown - Disabling);Pneumonia (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9752832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9748916	Spontaneous	2015-09-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Angioedema (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9748916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9749166	Spontaneous	2015-09-16 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Asthma (n/a - Recovered/Resolved - Other Medically Important Condition);Bronchopulmonary disease (n/a - Recovered/Resolved - Other Medically Important Condition);Lacrimation increased (n/a - Recovered/Resolved - Other Medically Important Condition);Nasopharyngitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9749166&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9749189	Spontaneous	2015-09-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza like illness (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination failure (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	[CANDESARTAN CILEXETIL] (C - Hypertension - n/a - [n/a - n/a - Oral])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9749189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9742359	Spontaneous	2015-09-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Back pain (n/a - Not Recovered/Not Resolved - Disabling);Balance disorder (4d - Recovered/Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Decreased appetite (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling hot (4d - Recovered/Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Hyperhidrosis (4d - Recovered/Resolved - Disabling);Night sweats (n/a - Not Recovered/Not Resolved - Disabling);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Peripheral coldness (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Upper respiratory tract infection (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9742359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9743226	Spontaneous	2015-09-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Blindness (n/a - Unknown - Other Medically Important Condition);Deafness (n/a - Unknown - Other Medically Important Condition);Hormone level abnormal (n/a - Unknown - Other Medically Important Condition);Respiratory failure (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9743226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9744776	Spontaneous	2015-09-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Shock (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9744776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-9737077	Spontaneous	2015-09-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - );Burning sensation (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Not Recovered/Not Resolved - );Formication (n/a - Not Recovered/Not Resolved - );Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - );Hypoaesthesia (n/a - Not Recovered/Not Resolved - );Neuralgia (n/a - Not Recovered/Not Resolved - );Paraesthesia (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9737077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9731631	Spontaneous	2015-09-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Orgasm abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep talking (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9731631&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9731729	Spontaneous	2015-09-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9731729&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9732055	Spontaneous	2015-09-11 00:00:00	Healthcare Professional	European Economic Area	Dyer, C.. UK vaccine damage scheme must pay ?120 000 to boy who developed narcolepsy after swine flu vaccination. British Medical Journal. 2015;350:h3205 Gallagher, P.. Boy, 12, wins ?120,000 in damages after swine-flu jab left him &apos;severely disabled&apos; by narcolepsy. The Independant. 2015	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9732055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9727364	Spontaneous	2015-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Crying (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Foaming at mouth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Generalised tonic-clonic seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Heavy menstrual bleeding (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Iron deficiency (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Juvenile myoclonic epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscle twitching (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Overweight (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Postictal state (20min - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Suicidal ideation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Suicide attempt (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tongue injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Urinary incontinence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9727364&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9727365	Spontaneous	2015-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Ageusia (n/a - Not Recovered/Not Resolved - Disabling);Anosmia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9727365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9720118	Spontaneous	2015-09-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Early retirement (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9720118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9720179	Spontaneous	2015-09-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9720179&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9723232	Spontaneous	2015-09-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9723232&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9717075	Spontaneous	2015-09-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9717075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9707133	Spontaneous	2015-09-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9707133&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9696756	Spontaneous	2015-09-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Not Specified	Foetal death (n/a - Fatal - Results in Death);Foetal hypokinesia (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9696756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-9697154	Spontaneous	2015-09-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthritis reactive (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Depression - Not applicable - [n/a - 30mg - Oral])|[LAMOTRIGINE] (C - Bipolar disorder - Not applicable - [n/a - 200mg - Oral])|[REBOXETINE, REBOXETINE METHANESULFONATE] (C - Depression - Not applicable - [n/a - 4mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9697154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9694745	Spontaneous	2015-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Fall (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])...	NOT AVAILABLE (C - n/a - n/a - [n/a - n/a - Oral])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9694745&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9676787	Spontaneous	2015-08-26 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Bronchitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depression (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Insomnia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pollakiuria (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Staphylococcal infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urinary tract infection enterococcal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[PARACETAMOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[VALACICLOVIR, VALACICLOVIR HYDROCHLORIDE] (C - Condition aggravated - n/a - [5d - 500mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9676787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9665658	Spontaneous	2015-08-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Sleep apnoea syndrome (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	BOTULINUM TOXIN TYPE A [BOTULINUM TOXIN TYPE A] (C - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])|[BACLOFEN] (C - n/a - n/a - [n/a - n/a - n/a])|[LAMOTRIGINE] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9665658&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9665659	Spontaneous	2015-08-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic obstructive pulmonary disease (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypoxia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Lower respiratory tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[CODEINE PHOSPHATE SESQUIHYDRATE, PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE] (C - n/a - n/a - [n/a - n/a - Oral])|[DIAZEPAM] (C - Anxiety - n/a - [n/a - n/a - Oral])|[PREDNISOLONE] (C - n/a - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9665659&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9665679	Spontaneous	2015-08-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Autoimmune disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cholangitis sclerosing (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Colitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Enteritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hepatitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9665679&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9660295	Spontaneous	2015-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain (n/a - Unknown - Disabling);Asthenia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Diarrhoea (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Unknown - Disabling);Hypersomnia (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Sleep disorder (n/a - Unknown - Disabling);Vomiting (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|[POLIOMYELITIS VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9660295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9635047	Spontaneous	2015-08-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9635047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9635638	Spontaneous	2015-08-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9635638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9636476	Spontaneous	2015-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Decreased appetite (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Palpitations (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9636476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9636480	Spontaneous	2015-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (2wk - Recovered/Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9636480&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9631494	Spontaneous	2015-08-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal discomfort (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Abdominal pain (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Abdominal pain upper (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Acute sinusitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Alopecia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Back pain (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Bruxism (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);C-reactive protein increased (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Cough (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Diarrhoea (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dry skin (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Extensive swelling of vaccinated limb (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Faeces discoloured (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Flatulence (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Frustration tolerance decreased (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Gait inability (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Gastroenteritis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Gastrointestinal tract irritation (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Genital discomfort (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Heavy menstrual bleeding (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - Immunisation - Not applicable - [1d - .5mL - Unknown])	[ACETYLCYSTEINE] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[ANHYDROUS AZITHROMYCIN, AZITHROMYCIN] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[ANHYDROUS AZITHROMYCIN, AZITHROMYCIN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Asthma - Unknown - [n/a - n/a - Respiratory (inhalation)])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - Unknown - [n/a - n/a - Respiratory (inhalation)])|[ETHINYLESTRADIOL, ETONOGESTREL] (C - Contraception - Unknown - [n/a - n/a - Unknown])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[PHENYLPROPANOLAMINE HYDROCHLORIDE] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[TERBUTALINE SULFATE] (C - Asthma - Unknown - [n/a - .5mg - Respiratory (inhalation)])|[TERBUTALINE SULFATE] (C - n/a - Unknown - [n/a - .5mg - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9631494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-9631497	Spontaneous	2015-08-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Body temperature fluctuation (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Dizziness postural (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hyperaesthesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pyelonephritis (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Tinnitus (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9631497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9631498	Spontaneous	2015-08-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9631498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9631499	Spontaneous	2015-08-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Diarrhoea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Dysstasia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Eye movement disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperacusis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Nausea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Palpitations (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9631499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9631500	Spontaneous	2015-08-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9631500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9631501	Spontaneous	2015-08-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Vestibular neuronitis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9631501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9631502	Spontaneous	2015-08-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Epigastric discomfort (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Irritable bowel syndrome (n/a - Not Recovered/Not Resolved - Disabling);Lymph node pain (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9631502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9631503	Spontaneous	2015-08-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bone pain (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9631503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9622078	Spontaneous	2015-08-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia-bulimia syndrome (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9622078&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9622079	Spontaneous	2015-08-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Epilepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9622079&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9622152	Spontaneous	2015-08-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9622152&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9622156	Spontaneous	2015-08-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9622156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9613260	Spontaneous	2015-08-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9613260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9614355	Spontaneous	2015-08-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Multiple sclerosis (n/a - Unknown - Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9614355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9608162	Spontaneous	2015-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9608162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9595637	Spontaneous	2015-08-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[ALUMINIUM PHOSPHATE, CORYNEBACTERIUM DIPHTHERIAE CRM197 CARRIER PROTEIN, NEISSERIA MENINGITIDIS GROUP C (STRAIN C11) OLIGOSACCHARIDE, ALUMINIUM PHOSPHATE, CORYNEBACTERIUM DIPHTHERIAE, NEISSERIA MENINGITIDIS, ALUMINIUM PHOSPHATE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9595637&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9598900	Spontaneous	2015-08-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Drug ineffective (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Odynophagia (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Productive cough (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sputum purulent (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	[ETHYL LOFLAZEPATE] (C - Product used for unknown indication - n/a - [n/a - 2mg - Oral])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - Hypertension - n/a - [n/a - 5mg - Oral])|[SIMVASTATIN] (C - Dyslipidaemia - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9598900&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9591578	Spontaneous	2015-08-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation);Drop attacks (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Posture abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation)	CERVARIX [3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, ALGELDRATE, ALUMINIUM, 3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9591578&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9593175	Spontaneous	2015-08-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic shock (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9593175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9587784	Spontaneous	2015-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9587784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9577141	Spontaneous	2015-07-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Adjustment disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Early retirement (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Facial paresis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Grip strength decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnopompic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Impaired driving ability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sudden onset of sleep (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Waxy flexibility (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[BUDESONIDE] (C - n/a - n/a - [n/a - 200ug - Respiratory (inhalation)])|[DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - 75mg - Oral])|[FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - 6ug - Respiratory (inhalation)])|[ISPAGHULA, PLANTAGO INDICA, PSYLLIUM SEED] (C - n/a - n/a - [n/a - 5mg - Oral])|[PARACETAMOL, TRAMADOL, TRAMADOL HYDROCHLORIDE, PARACETAMOL] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - 100ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9577141&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9577349	Spontaneous	2015-07-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Dysarthria (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Feeling abnormal (n/a - Unknown - Other Medically Important Condition);Gait disturbance (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9577349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9571412	Spontaneous	2015-07-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Frustration tolerance decreased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9571412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9571559	Spontaneous	2015-07-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9571559&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9572574	Spontaneous	2015-07-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Unknown - Other Medically Important Condition);Anger (n/a - Unknown - Other Medically Important Condition);Burning sensation (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Muscle twitching (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Social avoidant behaviour (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9572574&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9572597	Spontaneous	2015-07-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Lethargy (n/a - Unknown - Other Medically Important Condition);Mental disorder (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Psychiatric symptom (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9572597&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9565842	Spontaneous	2015-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9565842&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9565845	Spontaneous	2015-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9565845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9566168	Spontaneous	2015-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9566168&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9566171	Spontaneous	2015-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9566171&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9566172	Spontaneous	2015-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9566172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9566173	Spontaneous	2015-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9566173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9566175	Spontaneous	2015-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cough (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9566175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9566179	Spontaneous	2015-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9566179&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9559625	Spontaneous	2015-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myocardial infarction (n/a - Fatal - Results in Death, Other Medically Important Condition)	BUPRENORPHINE [BUPRENORPHINE] (S - Product used for unknown indication - Not applicable - [n/a - 8mg - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [n/a - n/a - Unknown])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9559625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-9560831	Spontaneous	2015-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9560831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9560877	Spontaneous	2015-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9560877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9560880	Spontaneous	2015-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9560880&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9561422	Spontaneous	2015-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Completed suicide (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hallucination, auditory (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Psychotic disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Quality of life decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep terror (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	[MODAFINIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9561422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9562776	Spontaneous	2015-07-24 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Distractibility (n/a - Unknown - Other Medically Important Condition);Dizziness (0d - Recovered/Resolved - Other Medically Important Condition);Erythema (0d - Recovered/Resolved - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Feeling abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (1d - Recovered/Resolved - Other Medically Important Condition);Hypertension (0d - Recovered/Resolved - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Mydriasis (n/a - Unknown - Other Medically Important Condition);Sensory loss (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [n/a - n/a - Intramuscular])	[BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, ACETYLSALICYLIC ACID, BISOPROLOL HEMIFUMARATE] (C - Heart rate irregular - n/a - [n/a - 1{DF} - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - Glucose tolerance impaired - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9562776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9563616	Spontaneous	2015-07-24 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Vaccination site rash (n/a - Recovered/Resolved - Disabling);Vaccination site swelling (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9563616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9550548	Spontaneous	2015-07-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9550548&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9544436	Spontaneous	2015-07-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Insomnia (4wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[CAFFEINE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[METAMIZOLE, ORPHENADRINE CITRATE, CAFFEINE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9544436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9544974	Spontaneous	2015-07-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Not Specified	Foetal growth restriction (n/a - Fatal - Results in Death);Oligohydramnios (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9544974&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-9534220	Spontaneous	2015-07-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Condition aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9534220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9534708	Spontaneous	2015-07-17 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9534708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9534996	Spontaneous	2015-07-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Juvenile idiopathic arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9534996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9537327	Spontaneous	2015-07-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Ischaemia (n/a - Unknown - Other Medically Important Condition);Muscle atrophy (n/a - Unknown - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Unknown])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (S - Product used for unknown indication - Unknown - [n/a - 20mg - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9537327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9527469	Spontaneous	2015-07-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9527469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9527473	Spontaneous	2015-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Respiratory failure (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9527473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9525909	Spontaneous	2015-07-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Loss of personal independence in daily activities (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle rigidity (n/a - Unknown - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	CELVAPAN PANDEMIC INFLUENZA VACCINE (H1N1) (WHOLE VIRION, VERO CELL DERIVED, INACTIVATED) SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9525909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9518763	Spontaneous	2015-07-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - .5mL - Parenteral])	[AMOXICILLIN SODIUM, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DEXAMFETAMINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MODAFINIL] (C - n/a - n/a - [n/a - n/a - n/a])|[NITROFURANTOIN] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9518763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9507880	Spontaneous	2015-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amnesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Arrhythmia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asphyxia (n/a - Unknown - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Back pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chest discomfort (15d - Recovered/Resolved - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Cough (15d - Recovered/Resolved - Disabling, Other Medically Important Condition);Depression (n/a - Unknown - Disabling, Other Medically Important Condition);Diabetes insipidus (n/a - Unknown - Disabling, Other Medically Important Condition);Diarrhoea (1d - Recovered/Resolved - Disabling, Other Medically Important Condition);Disability (n/a - Unknown - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Erectile dysfunction (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Feeling cold (n/a - Unknown - Disabling, Other Medically Important Condition);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Gulf war syndrome (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Injection site pain (n/a - Unknown - Disabling, Other Medically Important Condition);Insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Libido disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Mental disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Middle insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myositis (n/a - Unknown - Disabling, Other Medically Important Condition);Neck pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nervous system disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Noninfective encephalitis (n/a - Unknown - Disabling, Other Medically Important Condition);Oxygen saturation decreased (n/a - Unknown - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Disabling, Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Disabling, Other Medically Important Condition);Respiratory disorder (15d - Recovered/Resolved - Disabling, Other Medically Important Condition);Speech disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Temperature regulation disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9507880&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9500359	Spontaneous	2015-07-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9500359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9504118	Spontaneous	2015-07-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9504118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9504180	Spontaneous	2015-07-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9504180&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9496131	Spontaneous	2015-07-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Foetal death (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9496131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-9497182	Spontaneous	2015-07-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Disabling);Delayed sleep phase (n/a - Not Recovered/Not Resolved - Disabling);Head banging (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Tic (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9497182&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9497183	Spontaneous	2015-07-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myocarditis (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Pericarditis (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9497183&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9492565	Spontaneous	2015-07-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9492565&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9492566	Spontaneous	2015-07-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Exposure during pregnancy (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hot flush (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Muscle tightness (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Psoriasis (n/a - Not Recovered/Not Resolved - Disabling);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Disabling);Sleep talking (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Vertigo (n/a - Not Recovered/Not Resolved - Disabling);Weight decreased (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9492566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9492567	Spontaneous	2015-07-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Confusional arousal (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia-bulimia syndrome (n/a - Unknown - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep talking (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9492567&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9493582	Spontaneous	2015-07-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Limb discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malignant neoplasm of eye (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination site induration (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9493582&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9494931	Spontaneous	2015-07-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaesthesia oral (n/a - Recovering/Resolving - );Headache (n/a - Not Recovered/Not Resolved - );Injection site haematoma (n/a - Not Recovered/Not Resolved - );Injection site inflammation (n/a - Not Recovered/Not Resolved - );Visual impairment (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9494931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9487337	Spontaneous	2015-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9487337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9475076	Spontaneous	2015-07-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling cold (n/a - Recovered/Resolved - Other Medically Important Condition);H1N1 influenza (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Productive cough (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CODEINE PHOSPHATE SESQUIHYDRATE, PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE] (C - Back pain - n/a - [n/a - n/a - Oral])|[OXAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9475076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-9475077	Spontaneous	2015-07-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9475077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9469439	Spontaneous	2015-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9469439&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9471313	Spontaneous	2015-07-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dry eye (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Immunodeficiency (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Lichen planus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Miosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Oesophagitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Parosmia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Rheumatoid factor positive (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Taste disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[ACITRETIN] (C - Lichen planus - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[BETAMETHASONE, BETAMETHASONE VALERATE] (C - Lichen planus - n/a - [n/a - n/a - Buccal])|[CARBOMER 980, CARBOMERS] (C - Dry eye - n/a - [n/a - n/a - n/a])|[CLOBETASOL PROPIONATE] (C - Lichen planus - n/a - [n/a - n/a - n/a])|[CLOBETASOL PROPIONATE] (C - Rash - n/a - [n/a - n/a - n/a])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - Pruritus - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - Migraine - n/a - [n/a - n/a - n/a])|[PILOCARPINE NITRATE] (C - Photophobia - n/a - [n/a - n/a - n/a])|[POVIDONE, POVIDONE K25] (C - Dry eye - n/a - [n/a - n/a - n/a])|[THIAMINE HYDROCHLORIDE, RETINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[THIAMINE, PYRIDOXINE HYDROCHLORIDE, VITAMIN B] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9471313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9471316	Spontaneous	2015-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ataxia (n/a - Unknown - Other Medically Important Condition);Cold sweat (n/a - Recovered/Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9471316&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9472115	Spontaneous	2015-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9472115&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9464917	Spontaneous	2015-06-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Subdural haematoma (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9464917&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9466851	Spontaneous	2015-06-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9466851&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9462382	Spontaneous	2015-06-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9462382&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9456363	Spontaneous	2015-06-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Behaviour disorder (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Social problem (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9456363&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9450889	Spontaneous	2015-06-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cold sweat (n/a - Unknown - Other Medically Important Condition);Constipation (n/a - Unknown - Other Medically Important Condition);Diplopia (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Hiccups (n/a - Unknown - Other Medically Important Condition);Intracranial pressure increased (n/a - Recovering/Resolving - Other Medically Important Condition);Nausea (n/a - Recovering/Resolving - Other Medically Important Condition);Optic disc drusen (n/a - Recovering/Resolving - Other Medically Important Condition);Papilloedema (n/a - Recovering/Resolving - Other Medically Important Condition);Photophobia (n/a - Unknown - Other Medically Important Condition);Pineal gland cyst (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9450889&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9444843	Spontaneous	2015-06-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Female	Automatism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9444843&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9446247	Spontaneous	2015-06-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Skin reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9446247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-9439541	Spontaneous	2015-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Anger (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Unknown - Disabling, Other Medically Important Condition);Depressed mood (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Irritability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Loss of consciousness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Mood altered (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Disabling, Other Medically Important Condition);Stubbornness (n/a - Unknown - Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9439541&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9440165	Spontaneous	2015-06-23 00:00:00	Healthcare Professional	European Economic Area	Crowe D. Kleine Levin syndrome presenting after H1N1 vaccine. Sleep Medicine. 2013 JAN 01;14: E167:.	12-17 Years	Not Specified	No	Female	Coordination abnormal (n/a - Unknown - Disabling, Other Medically Important Condition);Derealisation (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hallucination (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia-bulimia syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Lethargy (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9440165&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9434866	Spontaneous	2015-06-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Aggression (n/a - Not Recovered/Not Resolved - Disabling);Alopecia (n/a - Unknown - Disabling);Decreased appetite (n/a - Unknown - Disabling);Depression (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Migraine (n/a - Not Recovered/Not Resolved - Disabling);Visual impairment (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9434866&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9430410	Spontaneous	2015-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9430410&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9421194	Spontaneous	2015-06-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9421194&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9424553	Spontaneous	2015-06-18 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Acute disseminated encephalomyelitis (n/a - Recovered/Resolved With Sequelae - Disabling);Learning disability (n/a - Not Recovered/Not Resolved - Disabling);Neurogenic bladder (n/a - Not Recovered/Not Resolved - Disabling);Precocious puberty (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9424553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-9417731	Spontaneous	2015-06-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Recovering/Resolving - Disabling);Influenza like illness (n/a - Recovering/Resolving - Disabling);Myalgia (n/a - Recovering/Resolving - Disabling);Pain (n/a - Recovering/Resolving - Disabling);Pain in extremity (n/a - Unknown - Disabling);Peripheral coldness (n/a - Unknown - Disabling);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9417731&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9417732	Spontaneous	2015-06-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Alopecia (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9417732&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9417733	Spontaneous	2015-06-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chest discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Listless (1a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Miller Fisher syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscle fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Neurological infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Neuropathy peripheral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sinus tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9417733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9418318	Spontaneous	2015-06-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9418318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9418524	Spontaneous	2015-06-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Aggression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Eyelid ptosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Facial spasm (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9418524&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9419010	Spontaneous	2015-06-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Diarrhoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Endometriosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gastrooesophageal reflux disease (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Heart rate increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Immunisation reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Migraine (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Orthostatic hypotension (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Palpitations (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pelvic pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Photophobia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Postural orthostatic tachycardia syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Syncope (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[MODAFINIL] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9419010&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9419723	Spontaneous	2015-06-17 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	ANTIHYPERTENSIVES [NOT AVAILABLE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9419723&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-9413237	Spontaneous	2015-06-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 500mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9413237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9407014	Spontaneous	2015-06-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9407014&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9407404	Spontaneous	2015-06-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9407404&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9407888	Spontaneous	2015-06-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysstasia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Foot deformity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gait inability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Injection site pain (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Mobility decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscle tightness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Quality of life decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Scoliosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9407888&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9408199	Spontaneous	2015-06-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9408199&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9398577	Spontaneous	2015-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9398577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9388265	Spontaneous	2015-06-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Incorrect route of product administration (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	HUMIRA 40 MG [ADALIMUMAB] (C - n/a - n/a - [n/a - 40mg - n/a])|[DEXTROPROPOXYPHENE] (C - n/a - n/a - [n/a - n/a - n/a])|[INDOMETACIN] (C - n/a - n/a - [n/a - n/a - n/a])|[KETOPROFEN] (C - n/a - n/a - [n/a - n/a - n/a])|[MODAFINIL] (C - n/a - n/a - [n/a - n/a - n/a])|[TETRAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9388265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9392555	Spontaneous	2015-06-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination, auditory (n/a - Recovered/Resolved - Other Medically Important Condition);Increased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Irritability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9392555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9387378	Spontaneous	2015-06-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9387378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9381123	Spontaneous	2015-06-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Crying (1s - Recovered/Resolved - Caused/Prolonged Hospitalisation);Extensive swelling of vaccinated limb (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site inflammation (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Panic attack (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash (1s - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9381123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9381156	Spontaneous	2015-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bruxism (n/a - Unknown - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Middle insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Mixed anxiety and depressive disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nightmare (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Sleep talking (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Weight increased (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DROSPIRENONE, ETHINYLESTRADIOL] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9381156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9382539	Spontaneous	2015-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Confusional state (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Periodontitis (n/a - Recovered/Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Sinusitis (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	METHOTREXATE [METHOTREXATE] (C - Rheumatoid arthritis - n/a - [n/a - n/a - Oral])|[METHYLPHENIDATE HYDROCHLORIDE] (C - Hypersomnia - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9382539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9382541	Spontaneous	2015-06-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9382541&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9382543	Spontaneous	2015-06-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Alopecia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Anxiety (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Autoimmune disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Decreased immune responsiveness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Herpes zoster (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Infection (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Inflammation (n/a - Unknown - Disabling, Other Medically Important Condition);Madarosis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Melanocytic naevus (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pericarditis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pleurisy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Skin exfoliation (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9382543&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9382544	Spontaneous	2015-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9382544&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9383799	Spontaneous	2015-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Anaphylactic reaction (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chest discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Flushing (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersensitivity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Throat irritation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9383799&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9372213	Spontaneous	2015-06-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9372213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9373800	Spontaneous	2015-06-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9373800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9366594	Spontaneous	2015-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Polyneuropathy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9366594&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9349533	Spontaneous	2015-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9349533&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9340298	Spontaneous	2015-05-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9340298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9332869	Spontaneous	2015-05-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9332869&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9332899	Spontaneous	2015-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation);Disturbance in social behaviour (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial spasm (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9332899&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9323956	Spontaneous	2015-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Drug ineffective (n/a - Recovered/Resolved - );Influenza (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Immunisation - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9323956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9320061	Spontaneous	2015-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9320061&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9310436	Spontaneous	2015-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lethargy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9310436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9305370	Spontaneous	2015-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Illness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9305370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9305408	Spontaneous	2015-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysphonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia oral (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Meningioma (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neuromyopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraparesis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Radiculopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory loss (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9305408&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9305414	Spontaneous	2015-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Vaccination site erythema (n/a - Unknown - Other Medically Important Condition);Vaccination site induration (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9305414&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9298296	Spontaneous	2015-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Multiple sclerosis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9298296&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9289162	Spontaneous	2015-05-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Chorioretinitis (n/a - Recovering/Resolving - Other Medically Important Condition);Neovascularisation (n/a - Recovering/Resolving - Other Medically Important Condition);Visual acuity reduced (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9289162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9284109	Spontaneous	2015-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9284109&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9284110	Spontaneous	2015-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9284110&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9284111	Spontaneous	2015-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9284111&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9284130	Spontaneous	2015-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9284130&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9284161	Spontaneous	2015-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9284161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9284522	Spontaneous	2015-05-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9284522&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9288193	Spontaneous	2015-05-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Weight increased (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9288193&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9281853	Spontaneous	2015-05-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	DIURETICS [NOT AVAILABLE] (C - Blood pressure management - n/a - [n/a - n/a - n/a])|PROTELOS [STRONTIUM RANELATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - Product used for unknown indication - n/a - [n/a - 75mg - Oral])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 75mg - Oral])|[ATENOLOL] (C - Product used for unknown indication - n/a - [n/a - 50mg - Oral])|[ATENOLOL] (C - n/a - n/a - [n/a - 50mg - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - Product used for unknown indication - n/a - [n/a - 10mg - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 10mg - Oral])|[BIOFLAVONOIDS, DIOSMIN, BIOFLAVONOIDS, DIOSMIN, HESPERIDIN, FLAVONOIDS EXTRACTED FROM RUTACAE (AURANTIAE), MICRONISED PURIFIED FLAVONOIC FRACTION] (C - Product used for unknown indication - n/a - [n/a - 500mg - Oral])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Product used for unknown indication - n/a - [n/a - 2{DF} - n/a])|[CALCIUM CARBONATE, CHOLECALCIFEROL CONCENTRATE (POWDER FORM), COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[GABAPENTIN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[GABAPENTIN] (C - n/a - n/a - [n/a - n/a - n/a])|[INDAPAMIDE, INDAPAMIDE HEMIHYDRATE] (C - Blood pressure management - n/a - [n/a - n/a - n/a])|[INDAPAMIDE, INDAPAMIDE HEMIHYDRATE] (C - n/a - n/a - [n/a - 1.5mg - n/a])|[LACTULOSE] (C - Constipation - n/a - [n/a - n/a - n/a])|[NICARDIPINE, NICARDIPINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - 20mg - n/a])|[OMEPRAZOLE] (C - Product used for unknown indication - n/a - [n/a - 20mg - Oral])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - 20mg - Oral])|[PARACETAMOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - Product used for unknown indication - n/a - [n/a - 8mg - Oral])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - 8mg - Oral])|[POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ETHYLCELLULOSE MICROENCAPSULATED 80-90%] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - n/a])|[POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ETHYLCELLULOSE MICROENCAPSULATED 80-90%] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[PREDNISOLONE, PREDNISOLONE METASULFOBENZOATE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PREDNISOLONE, PREDNISOLONE METASULFOBENZOATE SODIUM] (C - n/a - n/a - [n/a - 60mg - n/a])|[ZOLPIDEM, ZOLPIDEM TARTRATE] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9281853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9274042	Spontaneous	2015-05-08 00:00:00	Healthcare Professional	European Economic Area	Avgeri S, Mavridis E, Chatzitolios A, et al.. Effectiveness of the influenza and antipneumococcal vaccination with regard to the prevention of morbidity in patients suffering from diabetes mellitu. Book of abstracts of 1st Panhellenic Congress on continuing education in Internal Medicine. Poster:.	Not Specified	Not Specified	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9274042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9274068	Spontaneous	2015-05-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9274068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9274445	Spontaneous	2015-05-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9274445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9268599	Spontaneous	2015-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Increased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9268599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9268600	Spontaneous	2015-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9268600&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9269335	Spontaneous	2015-05-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depressed mood (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9269335&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9269627	Spontaneous	2015-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Diarrhoea (1.5a - Recovered/Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Limbal swelling (n/a - Unknown - Disabling);Musculoskeletal stiffness (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9269627&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9258684	Spontaneous	2015-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chills (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Rest regimen (6d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Unknown])...	[ALENDRONATE SODIUM, ALENDRONIC ACID] (C - Osteoporosis - n/a - [n/a - n/a - Oral])|[COLECALCIFEROL, CALCIUM] (C - Osteoporosis - n/a - [n/a - n/a - Oral])|[DOSULEPIN, DOSULEPIN HYDROCHLORIDE] (C - Insomnia - n/a - [n/a - n/a - n/a])|[DOSULEPIN, DOSULEPIN HYDROCHLORIDE] (C - Migraine - n/a - [n/a - 75mg - n/a])|[DOSULEPIN, DOSULEPIN HYDROCHLORIDE] (C - Routine health maintenance - n/a - [n/a - n/a - n/a])|[TOPIRAMATE] (C - Migraine - n/a - [n/a - 50mg - Oral])|[ZOLMITRIPTAN] (C - Product used for unknown indication - n/a - [n/a - 2.5mg - Oral])|[ZOPICLONE] (C - Initial insomnia - n/a - [n/a - 7.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9258684&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9259556	Spontaneous	2015-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9259556&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9259731	Spontaneous	2015-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypogeusia (n/a - Not Recovered/Not Resolved - Disabling);Hyposmia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9259731&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9261568	Spontaneous	2015-05-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (S - Influenza immunisation - Unknown - [n/a - n/a - n/a])	[BUDESONIDE] (C - Asthma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9261568&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9254498	Spontaneous	2015-05-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9254498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9245784	Spontaneous	2015-04-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9245784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9240046	Spontaneous	2015-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Injury (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9240046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9240502	Spontaneous	2015-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9240502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9243549	Spontaneous	2015-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9243549&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9233953	Spontaneous	2015-04-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hunger (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mood swings (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9233953&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9216410	Spontaneous	2015-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Blood immunoglobulin M decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cystitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperparathyroidism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypothyroidism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Leukopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Monocytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9216410&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9217429	Spontaneous	2015-04-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthritis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9217429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9211800	Spontaneous	2015-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9211800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9213248	Spontaneous	2015-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9213248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9213482	Spontaneous	2015-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9213482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9214966	Spontaneous	2015-04-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9214966&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9208399	Spontaneous	2015-04-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9208399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9208451	Spontaneous	2015-04-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9208451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9209872	Spontaneous	2015-04-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Lymphocytic leukaemia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9209872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-9201976	Spontaneous	2015-04-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9201976&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9189526	Spontaneous	2015-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - .25mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9189526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9184145	Spontaneous	2015-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9184145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9185783	Spontaneous	2015-04-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abnormal dreams (n/a - Unknown - Other Medically Important Condition);Amnesia (n/a - Unknown - Other Medically Important Condition);Anger (n/a - Unknown - Other Medically Important Condition);Anxiety (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Disability (n/a - Unknown - Other Medically Important Condition);Dysstasia (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Facial paralysis (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Muscle disorder (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nervousness (n/a - Unknown - Other Medically Important Condition);Sleep terror (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9185783&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9186015	Spontaneous	2015-04-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fibromyalgia (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Disabling, Other Medically Important Condition);Migraine (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myalgia (n/a - Unknown - Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Polymyalgia rheumatica (n/a - Unknown - Disabling, Other Medically Important Condition);Sneezing (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Parenteral])	[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9186015&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9186131	Spontaneous	2015-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Muscle spasms (n/a - Not Recovered/Not Resolved - Disabling);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Disabling);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9186131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9187505	Spontaneous	2015-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - .5mL - Intramuscular])	[ETHINYLESTRADIOL, NORETHISTERONE, LACTOSE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9187505&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9187513	Spontaneous	2015-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9187513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9174791	Spontaneous	2015-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Antisocial behaviour (n/a - Unknown - Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Disabling, Other Medically Important Condition);Attention deficit hyperactivity disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Cataplexy (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Crying (n/a - Unknown - Disabling, Other Medically Important Condition);Depressed mood (n/a - Unknown - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Dyssomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Fall (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Hallucination (n/a - Unknown - Disabling, Other Medically Important Condition);Hyperphagia (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Hypotonia (n/a - Unknown - Disabling, Other Medically Important Condition);Irritability (n/a - Unknown - Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Disabling, Other Medically Important Condition);Memory impairment (n/a - Unknown - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Nightmare (n/a - Unknown - Disabling, Other Medically Important Condition);Personality change (n/a - Unknown - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Disabling, Other Medically Important Condition);Protrusion tongue (n/a - Unknown - Disabling, Other Medically Important Condition);Psychiatric symptom (n/a - Unknown - Disabling, Other Medically Important Condition);Restless legs syndrome (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Speech disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Weight increased (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9174791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9177577	Spontaneous	2015-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Alopecia universalis (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9177577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9170145	Spontaneous	2015-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Decreased activity (n/a - Unknown - Disabling, Other Medically Important Condition);Depressive symptom (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Loss of consciousness (0d - Recovered/Resolved - Disabling, Other Medically Important Condition);Nausea (n/a - Unknown - Disabling, Other Medically Important Condition);Seizure (0d - Recovered/Resolved - Disabling, Other Medically Important Condition);Weight increased (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|TWINRIX PAEDIATRIC [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	TWINRIX PAEDIATRIC [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (C - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9170145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9164107	Spontaneous	2015-04-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9164107&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9166575	Spontaneous	2015-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9166575&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9158489	Spontaneous	2015-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9158489&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9161793	Spontaneous	2015-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Acute psychosis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Asthenia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cerebral haemorrhage (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Subarachnoid haemorrhage (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1min - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Hypertension - Drug withdrawn - [n/a - 100mg - Oral])|[BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, ACETYLSALICYLIC ACID, BISOPROLOL HEMIFUMARATE] (C - Hypertension - Drug withdrawn - [n/a - 5mg - Oral])|[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - Drug withdrawn - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9161793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-9161814	Spontaneous	2015-04-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Psoriasis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	APIDRA [INSULIN GLULISINE] (C - n/a - n/a - [n/a - n/a - n/a])|LANTUS [INSULIN GLARGINE] (C - n/a - n/a - [n/a - n/a - n/a])|[LORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[VERAPAMIL HYDROCHLORIDE, TRANDOLAPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9161814&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9139742	Spontaneous	2015-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9139742&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9141831	Spontaneous	2015-04-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Conjunctivitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypophagia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Kawasaki's disease (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lip erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lymphadenopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ocular hyperaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rhinorrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9141831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9133821	Spontaneous	2015-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	PFAPA syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Relapsing fever (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tonsillitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9133821&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9133956	Spontaneous	2015-04-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Condition aggravated (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])|[ALGELDRATE, HEPATITIS B SURFACE ANTIGENS RECOMBINANT (S, PRE-S2), HEPATITIS B SURFACE ANTIGEN (RDNA), HEPATITIS B SURFACE ANTIGENS RECOMBINANT (S, PRE-S2)] (S - n/a - n/a - [n/a - n/a - n/a])|[DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9133956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9134170	Spontaneous	2015-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9134170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9136763	Spontaneous	2015-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Dysarthria (n/a - Recovering/Resolving - Other Medically Important Condition);Gait disturbance (n/a - Recovering/Resolving - Other Medically Important Condition);Hallucination (n/a - Recovering/Resolving - Other Medically Important Condition);Incontinence (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9136763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9129965	Spontaneous	2015-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9129965&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9130318	Spontaneous	2015-03-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9130318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9130319	Spontaneous	2015-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Apathy (n/a - Unknown - Disabling, Other Medically Important Condition);Blunted affect (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depressed mood (n/a - Unknown - Disabling, Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);School refusal (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9130319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9130321	Spontaneous	2015-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Balance disorder (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Unknown - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Lymphoedema (n/a - Unknown - Disabling);Muscle twitching (n/a - Unknown - Disabling);Pain (n/a - Unknown - Disabling);Pallor (n/a - Unknown - Disabling);Palpitations (n/a - Unknown - Disabling);Peripheral coldness (n/a - Unknown - Disabling);Pollakiuria (n/a - Unknown - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Temperature regulation disorder (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9130321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9130604	Spontaneous	2015-03-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fear (n/a - Not Recovered/Not Resolved - Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9130604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9124564	Spontaneous	2015-03-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Micturition disorder (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Renal colic (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9124564&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-9117970	Spontaneous	2015-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abnormal behaviour (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Amnesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Crying (n/a - Unknown - Other Medically Important Condition);Dreamy state (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Educational problem (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Emotional disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Emotional distress (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Family stress (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fear (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Intentional overdose (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mood swings (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition);Skin laceration (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Sleep terror (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Social problem (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Suicide attempt (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9117970&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9112469	Spontaneous	2015-03-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthritis reactive (n/a - Recovered/Resolved With Sequelae - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9112469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-9112474	Spontaneous	2015-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9112474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9112478	Spontaneous	2015-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9112478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9113382	Spontaneous	2015-03-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cutaneous vasculitis (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Petechiae (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition);Vaccination site inflammation (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])|[A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9113382&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9113449	Spontaneous	2015-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9113449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9113470	Spontaneous	2015-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9113470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9107636	Spontaneous	2015-03-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Blindness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Blood glucose fluctuation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cold sweat (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Facial paralysis (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Increased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9107636&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9098024	Spontaneous	2015-03-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Balance disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cervical spinal stenosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphagia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Inflammation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Polyneuropathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pulmonary embolism (n/a - Unknown - Other Medically Important Condition);Respiratory arrest (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Snoring (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Superficial vein thrombosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9098024&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9102361	Spontaneous	2015-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Leila Predroso De Paula et al. INFLUENZA VACCINATION ADVERSE EFFECT: HYPOTHALAMIC-PITUITARY DISFUNCTION ASSOCIATED WITH NARCOLEPSY-CATAPLEXY IN A LITTLE GIRL. 97th Annual Meeting of the Endocrine Society (ENDO). 2015;Presentation Data migrated from the EudraVigilance E2B(R2) Literature repository	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sleep attacks (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9102361&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9095803	Spontaneous	2015-03-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9095803&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9096243	Spontaneous	2015-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Dyspnoea (6d - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (6d - Recovered/Resolved - Other Medically Important Condition);Nausea (6d - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9096243&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9083781	Spontaneous	2015-03-20 00:00:00	Healthcare Professional	Non European Economic Area	Austin A. et al. Transverse myelitis activation post-H1N1 immunization: A case of adjuvant induction. Isr. Med. Assoc. J.. 2015;17:120-122 Data migrated from the EudraVigilance E2B(R2) Literature repository	18-64 Years	Not Specified	No	Male	Dry mouth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myelitis transverse (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory loss (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9083781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-9074259	Spontaneous	2015-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abnormal behaviour (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Increased appetite (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9074259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9062908	Spontaneous	2015-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9062908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9057400	Spontaneous	2015-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9057400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9060593	Spontaneous	2015-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9060593&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9049041	Spontaneous	2015-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cough (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9049041&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9049687	Spontaneous	2015-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Tinnitus (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])...	[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - Arthralgia - n/a - [n/a - 1{DF} - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9049687&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9050585	Spontaneous	2015-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9050585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9050829	Spontaneous	2015-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza (n/a - Recovered/Resolved With Sequelae - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9050829&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-9043649	Spontaneous	2015-03-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9043649&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9044192	Spontaneous	2015-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Influenza (2d - Recovered/Resolved - Disabling);Injection site joint erythema (n/a - Recovered/Resolved - Disabling);Joint swelling (n/a - Not Recovered/Not Resolved - Disabling);Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9044192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9033008	Spontaneous	2015-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9033008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9036167	Spontaneous	2015-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9036167&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9036170	Spontaneous	2015-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hyperphagia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9036170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9028810	Spontaneous	2015-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9028810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9029519	Spontaneous	2015-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9029519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9029675	Spontaneous	2015-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9029675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9031797	Spontaneous	2015-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9031797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9024023	Spontaneous	2015-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9024023&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9018721	Spontaneous	2015-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Automatism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9018721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9020899	Spontaneous	2015-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Hyperthermia (n/a - Recovering/Resolving - Other Medically Important Condition);Productive cough (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9020899&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9020900	Spontaneous	2015-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hyperthermia (n/a - Recovering/Resolving - Other Medically Important Condition);Respiratory tract congestion (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9020900&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9020901	Spontaneous	2015-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Bronchitis (n/a - Recovering/Resolving - Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9020901&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9020903	Spontaneous	2015-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Bronchitis (n/a - Recovering/Resolving - Other Medically Important Condition);Wheezing (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9020903&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9020904	Spontaneous	2015-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Bronchitis (n/a - Recovering/Resolving - Other Medically Important Condition);Chills (n/a - Recovering/Resolving - Other Medically Important Condition);Hyperthermia (n/a - Recovering/Resolving - Other Medically Important Condition);Productive cough (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9020904&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9012982	Spontaneous	2015-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Autoimmune disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Back pain (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Gastroenteritis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Impaired work ability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Lhermitte's sign (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscle spasms (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nasal congestion (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Neck pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Osteitis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Disabling, Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sciatica (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[ANHYDROUS LEVOTHYROXINE SODIUM] (C - n/a - Not applicable - [n/a - 110ug - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Not applicable - [n/a - 650ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9012982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-9007678	Spontaneous	2015-03-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9007678&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9007679	Spontaneous	2015-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Foaming at mouth (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Loss of consciousness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Screaming (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9007679&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-9007680	Spontaneous	2015-03-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Disabling);Streptococcal infection (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9007680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9007681	Spontaneous	2015-03-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Unknown - Disabling);Irritable bowel syndrome (n/a - Not Recovered/Not Resolved - Disabling);Mobility decreased (n/a - Unknown - Disabling);Pain in extremity (7d - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9007681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9007686	Spontaneous	2015-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Disabling);Blood pressure decreased (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Hyperacusis (n/a - Unknown - Disabling);Influenza like illness (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Memory impairment (n/a - Unknown - Disabling);Muscle twitching (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Photophobia (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9007686&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9007687	Spontaneous	2015-03-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Body temperature fluctuation (n/a - Unknown - Disabling);Condition aggravated (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Unknown - Disabling);Gastrointestinal disorder (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9007687&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9007688	Spontaneous	2015-03-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Diarrhoea (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Gastrointestinal disorder (n/a - Unknown - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9007688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9007983	Spontaneous	2015-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Recovered/Resolved - );Vaccination failure (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9007983&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-9008891	Spontaneous	2015-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Unknown - Other Medically Important Condition);Anger (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Emotional distress (n/a - Unknown - Other Medically Important Condition);Fear (n/a - Unknown - Other Medically Important Condition);Frustration tolerance decreased (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sudden onset of sleep (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9008891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9008928	Spontaneous	2015-03-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Parenteral])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9008928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-9001860	Spontaneous	2015-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rheumatoid arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9001860&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-9004775	Spontaneous	2015-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Coma (n/a - Fatal - Results in Death, Life Threatening);Meningitis staphylococcal (n/a - Fatal - Results in Death, Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=9004775&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8994928	Spontaneous	2015-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8994928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8991429	Spontaneous	2015-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8991429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8991471	Spontaneous	2015-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bone pain (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination failure (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8991471&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8992320	Spontaneous	2015-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8992320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8984421	Spontaneous	2015-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8984421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8984432	Spontaneous	2015-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8984432&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8984459	Spontaneous	2015-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8984459&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8984549	Spontaneous	2015-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8984549&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8984764	Spontaneous	2015-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8984764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8984768	Spontaneous	2015-02-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8984768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8984771	Spontaneous	2015-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8984771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8984772	Spontaneous	2015-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8984772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8980523	Spontaneous	2015-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysphonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ear pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngitis streptococcal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tympanic membrane perforation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8980523&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8980524	Spontaneous	2015-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysphonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8980524&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8980529	Spontaneous	2015-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8980529&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8980535	Spontaneous	2015-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);H1N1 influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8980535&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8980536	Spontaneous	2015-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8980536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8980537	Spontaneous	2015-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8980537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8980541	Spontaneous	2015-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8980541&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8980542	Spontaneous	2015-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8980542&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8980543	Spontaneous	2015-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8980543&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8971585	Spontaneous	2015-02-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Not Specified	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8971585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8966517	Spontaneous	2015-02-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8966517&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8967294	Spontaneous	2015-02-24 00:00:00	Healthcare Professional	European Economic Area	Winstone A, Stellitano L, Verity C, Andrews N, Miller E, Stowe J, et al. Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Developmental medicine and child neurology.	Not Specified	Child	No	Not Specified	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[INFLUENZA VIRUS] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8967294&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8960521	Spontaneous	2015-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Quality of life decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8960521&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8954176	Spontaneous	2015-02-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8954176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8954230	Spontaneous	2015-02-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8954230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8955039	Spontaneous	2015-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8955039&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8955040	Spontaneous	2015-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8955040&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8948686	Spontaneous	2015-02-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8948686&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8948984	Spontaneous	2015-02-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8948984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8951711	Spontaneous	2015-02-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8951711&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8940762	Spontaneous	2015-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Recovered/Resolved - );Vaccination failure (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8940762&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8936000	Spontaneous	2015-02-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Extensive swelling of vaccinated limb (n/a - Unknown - Disabling, Other Medically Important Condition);Nerve injury (n/a - Unknown - Disabling, Other Medically Important Condition);Pericarditis infective (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8936000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8931499	Spontaneous	2015-02-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Henoch-Schonlein purpura (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - H1N1 influenza - Not applicable - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8931499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8925061	Spontaneous	2015-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8925061&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8925540	Spontaneous	2015-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8925540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8916528	Spontaneous	2015-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (21d - Recovered/Resolved - Disabling);Muscle spasms (n/a - Not Recovered/Not Resolved - Disabling);Neurological symptom (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Tremor (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Depression - Unknown - [n/a - n/a - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Chronic obstructive pulmonary disease - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - Oral])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8916528&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8917597	Spontaneous	2015-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8917597&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8919519	Spontaneous	2015-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site inflammation (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CETIRIZINE DIHYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 10mg - Oral])|[ENALAPRIL WATERSTOFMALEAAT] (C - n/a - Dose not changed - [n/a - 5mg - Oral])|[SIMVASTATIN] (C - n/a - Dose not changed - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8919519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8912506	Spontaneous	2015-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Nystagmus (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8912506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8913877	Spontaneous	2015-02-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8913877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8914916	Spontaneous	2015-02-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Relapsing-remitting multiple sclerosis (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, SORBITAN TRIOLEATE, POLYSORBATE 80, SQUALENE, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8914916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8905500	Spontaneous	2015-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8905500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8905563	Spontaneous	2015-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8905563&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8907604	Spontaneous	2015-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8907604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8901636	Spontaneous	2015-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Allodynia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Complex regional pain syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Crohn's disease (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dyspnoea exertional (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dystonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersensitivity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Joint swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Movement disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscle atrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Peripheral coldness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Photophobia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Productive cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Retching (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Serum sickness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Skin discolouration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Small fibre neuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Unknown - [n/a - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Unknown - [n/a - n/a - n/a])	[AZATHIOPRINE] (C - Abdominal pain upper - n/a - [n/a - n/a - n/a])|[CODEINE PHOSPHATE SESQUIHYDRATE, PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE] (C - n/a - n/a - [n/a - n/a - n/a])|[GABAPENTIN] (C - n/a - n/a - [n/a - n/a - n/a])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8901636&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8901671	Spontaneous	2015-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Chills (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Coordination abnormal (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Heart rate increased (n/a - Not Recovered/Not Resolved - Disabling);Hot flush (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Muscle spasms (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Night sweats (n/a - Not Recovered/Not Resolved - Disabling);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling);Sinus tachycardia (n/a - Recovered/Resolved - Disabling);Sinusitis (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Vertigo (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	METHOTREXATE [METHOTREXATE] (C - Psoriasis - Not applicable - [n/a - 7.5mg - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (C - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[CALCIPOTRIOL, CALCIPOTRIOL MONOHYDRATE, CALCIPOTRIOL, ANHYDROUS] (C - Psoriasis - Not applicable - [n/a - n/a - n/a])|[CICLOSPORIN] (C - Psoriasis - Not applicable - [n/a - 300mg - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - Depression - Not applicable - [n/a - 50mg - n/a])|[DROSPIRENONE, ETHINYLESTRADIOL] (C - Contraception - Not applicable - [n/a - n/a - n/a])|[FOLIC ACID] (C - Nausea - Not applicable - [n/a - 5mg - n/a])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - 50g - n/a])|[METHOTREXATE] (C - Psoriasis - Not applicable - [n/a - .5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8901671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8903387	Spontaneous	2015-02-09 00:00:00	Healthcare Professional	Non European Economic Area	Mecbure Nalbantoglu et al. H1N1 (Domuz Gribi) Asisini Takiben Ortaya ?ikan Narkolepsi-Katapleksi Sendromu Olgulari - Cases of Narcolepsy-Cataplexy Syndrome Following H1N1 Vaccination. Archives of Neuropsychiatry. 2014;51:283-287 Mecbure Nalbantoglu et al. Influenza A virus vaccine-H1N1 - Narcolepsy-cataplexy syndrome: 2 case reports. Reactions. 2014;1526:82	18-64 Years	Not Specified	No	Male	Abnormal dreams (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Drop attacks (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Movement disorder (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Obstructive sleep apnoea syndrome (n/a - Unknown - Other Medically Important Condition);Paralysis (n/a - Unknown - Other Medically Important Condition);Sleep attacks (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Sleep talking (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	DRUG UNSPECIFIED [MEDICATION UNKNOWN] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|DRUG UNSPECIFIED [MEDICATION UNKNOWN] (C - Hyperlipidaemia - n/a - [n/a - n/a - n/a])|DRUG UNSPECIFIED [MEDICATION UNKNOWN] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8903387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8903388	Spontaneous	2015-02-09 00:00:00	Healthcare Professional	Non European Economic Area	Mecbure Nalbantoglu et al. H1N1 (Domuz Gribi) Asisini Takiben Ortaya ?ikan Narkolepsi-Katapleksi Sendromu Olgulari - Cases of Narcolepsy-Cataplexy Syndrome Following H1N1 Vaccination. Archives of Neuropsychiatry. 2014;51:283-287 Mecbure Nalbantoglu et al. Influenza A virus vaccine-H1N1 - Narcolepsy-cataplexy syndrome: 2 case reports. Reactions. 2014;1526:82 Data migrated from the EudraVigilance E2B(R2) Literature repository	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Decreased appetite (n/a - Unknown - Other Medically Important Condition);Decreased interest (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Hypnopompic hallucination (n/a - Unknown - Other Medically Important Condition);Muscle tone disorder (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8903388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8903399	Spontaneous	2015-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8903399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8903400	Spontaneous	2015-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8903400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8903600	Spontaneous	2015-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Optic atrophy (n/a - Unknown - Caused/Prolonged Hospitalisation);Optic neuritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Unknown - [1d - 7.5ug - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8903600&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8903856	Spontaneous	2015-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Diplopia (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8903856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8895839	Spontaneous	2015-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Epilepsy (n/a - Unknown - Other Medically Important Condition);Migraine (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8895839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8888264	Spontaneous	2015-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8888264&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8891402	Spontaneous	2015-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cutaneous vasculitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8891402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8882865	Spontaneous	2015-02-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8882865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8883286	Spontaneous	2015-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pain (n/a - Unknown - );Skin warm (n/a - Unknown - );Vaccination site erythema (n/a - Recovering/Resolving - );Vaccination site swelling (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	CARENAL [BIOTIN, FOLIC ACID, NICOTINIC ACID, PANTOTHENIC ACID, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN, SELENIUM, THIAMINE HYDROCHLORIDE, TOCOPHEROL, VITAMIN B12 NOS] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CALCIUM ACETATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CICLESONIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[DIGITOXIN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE MONOHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PHENPROCOUMON] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8883286&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8884022	Spontaneous	2015-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Breath sounds abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chest discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Diplopia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Epicondylitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Heterophoria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypothyroidism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);IIIrd nerve paresis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Impaired work ability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Injection site eczema (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Positive airway pressure therapy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sputum discoloured (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Urinary tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])...	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 8.5{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8884022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8884436	Spontaneous	2015-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Female	Autism spectrum disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8884436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8884632	Spontaneous	2015-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8884632&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8886661	Spontaneous	2015-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8886661&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8886662	Spontaneous	2015-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Narcolepsy (n/a - Recovering/Resolving - Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8886662&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8886673	Spontaneous	2015-02-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Axillary mass (9d - Recovered/Resolved - );Injection site erythema (n/a - Unknown - );Malaise (10d - Recovered/Resolved - );Nausea (10d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8886673&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8879601	Spontaneous	2015-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Alcohol use (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Amnesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Apathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cerebral ischaemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chalazion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysgeusia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eczema (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fungal infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypertrophy of tongue papillae (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypopnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lethargy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Listless (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia intercostal (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nasal septum deviation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nocturia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Peripheral coldness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Persistent depressive disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Photopsia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pollakiuria (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Prostatomegaly (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Raynaud's phenomenon (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Snoring (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tinnitus (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vocal cord disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	VIAGRA [SILDENAFIL, SILDENAFIL CITRATE] (C - Sexual dysfunction - Dose not changed - [n/a - 100mg - Unknown])|[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - Dose reduced - [n/a - 160mg - Oral])|[ACETYLSALICYLIC ACID] (C - n/a - Dose reduced - [n/a - 75mg - Oral])|[NYSTATIN, NYSTATIN, ZINC OXIDE] (C - n/a - n/a - [n/a - 100000[iU] - Oral])|[PRAVASTATIN SODIUM] (C - Product used for unknown indication - Drug withdrawn - [n/a - 20mg - Unknown])|[ZOPICLONE] (C - Insomnia - Dose not changed - [n/a - 7.5mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8879601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8879605	Spontaneous	2015-02-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Central nervous system inflammation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hypersensitivity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8879605&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8879728	Spontaneous	2015-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic sinusitis (n/a - Not Recovered/Not Resolved - Disabling);Dysgeusia (n/a - Unknown - Disabling);Facial pain (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nasal congestion (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Unknown - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Neuralgia (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Toothache (n/a - Not Recovered/Not Resolved - Disabling);Upper-airway cough syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	LYRICA [PREGABALIN] (C - n/a - n/a - [n/a - 150mg - n/a])|[ESCITALOPRAM] (C - n/a - n/a - [n/a - 10mg - n/a])|[FLUTICASONE FUROATE] (C - Nasal congestion - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - 1g - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8879728&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8879730	Spontaneous	2015-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Disabling);Abdominal pain upper (n/a - Recovered/Resolved - Disabling);Anxiety (n/a - Unknown - Disabling);Asthenia (n/a - Unknown - Disabling);Autonomic nervous system imbalance (n/a - Unknown - Disabling);Bradyphrenia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Unknown - Disabling);Diarrhoea infectious (n/a - Recovered/Resolved - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);General physical health deterioration (n/a - Unknown - Disabling);Heavy menstrual bleeding (n/a - Unknown - Disabling);Hypersomnia (n/a - Unknown - Disabling);Infectious mononucleosis (n/a - Unknown - Disabling);Oropharyngeal pain (n/a - Unknown - Disabling);Pallor (n/a - Unknown - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Temperature regulation disorder (n/a - Unknown - Disabling);Tension headache (n/a - Unknown - Disabling);Tonsillar hypertrophy (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - 5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8879730&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8880249	Spontaneous	2015-02-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8880249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8880343	Spontaneous	2015-02-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8880343&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8881158	Spontaneous	2015-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8881158&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8881187	Spontaneous	2015-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8881187&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8875684	Spontaneous	2015-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Face oedema (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Laryngeal oedema (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8875684&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8865168	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Haemophagocytic lymphohistiocytosis (15d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	APROVEL 75 MG TABLETS [IRBESARTAN] (C - n/a - n/a - [n/a - 75mg - Oral])|LANTUS [INSULIN GLARGINE] (C - n/a - n/a - [n/a - 18[iU] - Subcutaneous])|NOVONORM 1 MG TABLETS [REPAGLINIDE] (C - n/a - n/a - [n/a - 1mg - Oral])|[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 75mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - Oral])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8865168&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8866558	Spontaneous	2015-01-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	[PAROXETINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE HYDROCHLORIDE, ANHYDROUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8866558&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8868685	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myocardial infarction (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	ALL OTHER THERAPEUTIC PRODUCTS [NOT AVAILABLE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8868685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8868935	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8868935&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8868967	Spontaneous	2015-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Crohn's disease (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Osteomyelitis chronic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8868967&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8856818	Spontaneous	2015-01-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Dose not changed - [n/a - 1{DF} - n/a])	AUBAGIO [TERIFLUNOMIDE] (C - Relapsing-remitting multiple sclerosis - n/a - [n/a - n/a - n/a])|EXTAVIA [INTERFERON BETA-1B, RECOMBINANT INTERFERON BETA-1B] (C - Relapsing-remitting multiple sclerosis - n/a - [n/a - n/a - n/a])|TECFIDERA [DIMETHYL FUMARATE] (C - Relapsing-remitting multiple sclerosis - n/a - [n/a - n/a - n/a])|[GLATIRAMER, GLATIRAMER ACETATE] (C - Relapsing-remitting multiple sclerosis - n/a - [n/a - n/a - n/a])|[NALTREXONE, NALTREXONE HYDROCHLORIDE DIHYDRATE] (C - Fatigue - n/a - [n/a - 4.5mg - n/a])|[VITAMIN D] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8856818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8858126	Spontaneous	2015-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Crohn's disease (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8858126&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8858144	Spontaneous	2015-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8858144&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8858939	Spontaneous	2015-01-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Guillain-Barre syndrome (1a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8858939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8849962	Spontaneous	2015-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	B-lymphocyte count decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Blood creatine phosphokinase increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cardiolipin antibody positive (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Complement factor decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Demyelination (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Early retirement (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Face oedema (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Feeling hot (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyponatraemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Immune system disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Impaired work ability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Livedo reticularis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Lividity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscle atrophy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myoglobin blood increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Neuropathic muscular atrophy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Oedema peripheral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Osteopenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Peripheral coldness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Polydipsia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Rhabdomyolysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Underweight (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	[A/CALIFORNIA/7/2009 (H1N1)] (C - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8849962&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8849964	Spontaneous	2015-01-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Middle insomnia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Restless legs syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8849964&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8850153	Spontaneous	2015-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Body temperature increased (10h - Recovered/Resolved - );Headache (10h - Recovered/Resolved - );Limb discomfort (10h - Recovered/Resolved - );Nausea (10h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8850153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8850258	Spontaneous	2015-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Disabling);Arthralgia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Heavy menstrual bleeding (n/a - Unknown - Disabling);Muscle spasms (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8850258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8847677	Spontaneous	2015-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8847677&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8847684	Spontaneous	2015-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Dysarthria (n/a - Recovered/Resolved - Other Medically Important Condition);Facial paralysis (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Migraine (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rapid eye movements sleep abnormal (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vision blurred (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8847684&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8847685	Spontaneous	2015-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8847685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8847690	Spontaneous	2015-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8847690&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8847694	Spontaneous	2015-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8847694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8847698	Spontaneous	2015-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8847698&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8848092	Spontaneous	2015-01-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8848092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8836733	Spontaneous	2015-01-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic shock (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cardiac disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Head discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Photophobia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Urinary tract infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TERBUTALINE SULFATE, TERBUTALINE SULFATE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8836733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8833905	Spontaneous	2015-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8833905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8834315	Spontaneous	2015-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Drug ineffective (n/a - Recovering/Resolving - );Influenza (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8834315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8827168	Spontaneous	2015-01-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthenia (n/a - Recovered/Resolved - );Back pain (3a - Recovered/Resolved - );Pyrexia (3wk - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8827168&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8827313	Spontaneous	2015-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Hypersensitivity (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8827313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8827314	Spontaneous	2015-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Disabling);Influenza (n/a - Not Recovered/Not Resolved - Disabling);Mouth ulceration (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Orthostatic intolerance (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Pharyngitis streptococcal (n/a - Unknown - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling);Stress (n/a - Not Recovered/Not Resolved - Disabling);Temperature intolerance (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[DESLORATADINE] (C - Hypersensitivity - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8827314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8829329	Spontaneous	2015-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pain (n/a - Unknown - Other Medically Important Condition);Rheumatoid arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8829329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8829714	Spontaneous	2015-01-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ETHINYLESTRADIOL, ETONOGESTREL] (C - n/a - n/a - [n/a - 1{DF} - Vaginal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8829714&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8829715	Spontaneous	2015-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Diarrhoea (1d - Recovered/Resolved - );Vomiting (1a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8829715&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8820588	Spontaneous	2015-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blindness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Central nervous system vasculitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ocular vasculitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Optic neuritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Retinal haemorrhage (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Visual field defect (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - 100mg - n/a])|[TAMSULOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[TICLOPIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8820588&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8822492	Spontaneous	2015-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Decreased appetite (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness postural (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Neutropenia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - Type 1 diabetes mellitus - n/a - [n/a - n/a - n/a])|LEVEMIR [INSULIN DETEMIR] (C - Type 1 diabetes mellitus - n/a - [n/a - n/a - n/a])|NOVORAPID [INSULIN ASPART] (C - Type 1 diabetes mellitus - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8822492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8824739	Spontaneous	2015-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Rheumatoid arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8824739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8817437	Spontaneous	2015-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8817437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8818393	Spontaneous	2015-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Benign muscle neoplasm (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspepsia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Food intolerance (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypoacusis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Injection site mass (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Meniere's disease (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[TYPHOID VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8818393&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8818394	Spontaneous	2015-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Bipolar II disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Depressive symptom (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Post-traumatic stress disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Retching (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Social anxiety disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Suicidal ideation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tachycardia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[METOCLOPRAMIDE HYDROCHLORIDE] (C - Migraine - Not applicable - [n/a - n/a - n/a])|[SUMATRIPTAN] (C - Migraine - Not applicable - [n/a - 20mg - Nasal])|[SUMATRIPTAN] (C - Migraine - Not applicable - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8818394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8818396	Spontaneous	2015-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Neurological symptom (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8818396&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8818398	Spontaneous	2015-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aphasia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Back pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Condition aggravated (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Connective tissue disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Lack of spontaneous speech (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nephrolithiasis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Photophobia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Vertigo positional (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])	INTRAVENOUS FLUIDS [INTRAVENOUS] (C - Gastroenteritis - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])|INTRAVENOUS FLUIDS [INTRAVENOUS] (C - Pyrexia - Not applicable - [n/a - n/a - n/a])|[INSULIN, INSULIN HUMAN] (C - Monogenic diabetes - n/a - [n/a - n/a - Cutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8818398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8818399	Spontaneous	2015-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Aggression (n/a - Unknown - Disabling, Other Medically Important Condition);Ankle deformity (201d - Recovered/Resolved - Disabling, Other Medically Important Condition);Arthritis reactive (n/a - Unknown - Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Disabling, Other Medically Important Condition);Bronchitis (n/a - Unknown - Disabling, Other Medically Important Condition);Cerebral palsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Coordination abnormal (n/a - Unknown - Disabling, Other Medically Important Condition);Dysarthria (n/a - Unknown - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Disabling, Other Medically Important Condition);Eating disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Foetal exposure during pregnancy (n/a - Unknown - Disabling, Other Medically Important Condition);Foot deformity (n/a - Unknown - Disabling, Other Medically Important Condition);Gait disturbance (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Gastroenteritis (n/a - Unknown - Disabling, Other Medically Important Condition);Gastrooesophageal reflux disease (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Hyperreflexia (201d - Recovered/Resolved - Disabling, Other Medically Important Condition);Motor dysfunction (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Muscle spasms (n/a - Unknown - Disabling, Other Medically Important Condition);Muscle spasticity (n/a - Unknown - Disabling, Other Medically Important Condition);Nerve injury (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Disabling, Other Medically Important Condition);Paraplegia (n/a - Unknown - Disabling, Other Medically Important Condition);Psychomotor skills impaired (n/a - Unknown - Disabling, Other Medically Important Condition);Respiratory arrest (n/a - Unknown - Disabling, Other Medically Important Condition);Respiratory syncytial virus infection (n/a - Unknown - Disabling, Other Medically Important Condition);Restlessness (n/a - Unknown - Disabling, Other Medically Important Condition);Speech disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Umbilical cord around neck (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Varicella (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intra-uterine])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8818399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8818400	Spontaneous	2015-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cough (n/a - Not Recovered/Not Resolved - Disabling);Decreased interest (n/a - Not Recovered/Not Resolved - Disabling);Depressive symptom (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling);Ear infection (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling hot (n/a - Not Recovered/Not Resolved - Disabling);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Disabling);Influenza (n/a - Not Recovered/Not Resolved - Disabling);Irritability (n/a - Not Recovered/Not Resolved - Disabling);Ligament laxity (n/a - Not Recovered/Not Resolved - Disabling);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Disabling);Tension headache (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8818400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8818401	Spontaneous	2015-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Lyme disease (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pneumonia mycoplasmal (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8818401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8818403	Spontaneous	2015-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Colitis ulcerative (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Constipation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Deafness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Depressed mood (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysphagia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Ear infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Granulomatosis with polyangiitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Haematochezia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypoacusis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Mastoiditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Mucous stools (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Night sweats (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Otitis media chronic (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8818403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8818944	Spontaneous	2015-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - );Dizziness (n/a - Unknown - );Hyperhidrosis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8818944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8819399	Spontaneous	2015-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Encephalitis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8819399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8812689	Spontaneous	2015-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Chest pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Cognitive disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Ear infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Muscle injury (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Nerve injury (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Sinusitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Sjogren's syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Transient ischaemic attack (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CLONIDINE, CLONIDINE HYDROCHLORIDE] (C - Migraine - Unknown - [n/a - n/a - n/a])|[FENTANYL] (C - Pain - Unknown - [n/a - n/a - n/a])|[OXYTOCIN] (C - Pain - Unknown - [n/a - n/a - n/a])|[ZOPICLONE] (C - Insomnia - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8812689&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8814575	Spontaneous	2015-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Metastases to central nervous system (n/a - Unknown - Caused/Prolonged Hospitalisation);Metastases to liver (n/a - Unknown - Caused/Prolonged Hospitalisation);Metastases to lung (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 150ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8814575&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8814605	Spontaneous	2015-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - );Pyrexia (n/a - Unknown - );Vomiting (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	NON SPECIFIED DRUG [UNKNOWN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8814605&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8814608	Spontaneous	2015-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	Yes	Female	Blister (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CARBASALATE CALCIUM] (C - n/a - n/a - [n/a - 100mg - Oral])|[COLECALCIFEROL, CALCIUM] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[DICLOFENAC NATRIUM] (C - n/a - n/a - [n/a - 3{DF} - Oral])|[DIPYRIDAMOLE] (C - n/a - n/a - [n/a - 150mg - Oral])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - 20mg - Oral])|[OXAZEPAM] (C - n/a - n/a - [n/a - 10mg - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8814608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8807288	Spontaneous	2015-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Back pain (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8807288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8807289	Spontaneous	2015-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Decreased appetite (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Decreased immune responsiveness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dysphagia (n/a - Unknown - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Ear pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Gastrooesophageal reflux disease (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Mycoplasma infection (n/a - Unknown - Disabling, Other Medically Important Condition);Otitis media (n/a - Unknown - Disabling, Other Medically Important Condition);Respiratory tract infection (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Rhinitis allergic (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Vertigo (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8807289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8807290	Spontaneous	2015-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Colitis ulcerative (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dehydration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Photophobia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	CIRCADIN [MELATONIN] (C - n/a - n/a - [n/a - n/a - n/a])|[CETIRIZINE DIHYDROCHLORIDE] (C - n/a - Not applicable - [n/a - n/a - Oral])|[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - Not applicable - [n/a - n/a - Oral])|[HEPARIN, HEPARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE OXIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8807290&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8807291	Spontaneous	2015-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Disabling, Other Medically Important Condition);Chest pain (n/a - Unknown - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Disabling, Other Medically Important Condition);Feeling cold (n/a - Unknown - Disabling, Other Medically Important Condition);Pain (n/a - Unknown - Disabling, Other Medically Important Condition);Pneumonia (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8807291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8809451	Spontaneous	2015-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8809451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8809904	Spontaneous	2015-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Back pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sinusitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8809904&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8809984	Spontaneous	2015-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dizziness (n/a - Recovered/Resolved - Disabling);Fatigue (n/a - Recovered/Resolved - Disabling);Flatulence (n/a - Recovered/Resolved - Disabling);Insomnia (n/a - Recovered/Resolved - Disabling);Lymphadenopathy (n/a - Recovered/Resolved - Disabling);Palpitations (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8809984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8810320	Spontaneous	2015-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Injection site pain (2mo - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8810320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8804291	Spontaneous	2015-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Discomfort (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Lymphadenopathy (n/a - Recovered/Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Oropharyngeal pain (n/a - Recovered/Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	AERIUS [DESLORATADINE] (C - n/a - Not applicable - [n/a - 5mg - Oral])|AVAMYS [FLUTICASONE FUROATE] (C - n/a - n/a - [n/a - 27.5ug - n/a])|[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - 50mg - n/a])|[KETOTIFEN, KETOTIFEN HYDROGEN FUMARATE] (C - Hypersensitivity - Not applicable - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE] (C - Hypersensitivity - Not applicable - [n/a - 50mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8804291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8804293	Spontaneous	2015-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amyotrophic lateral sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Atrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic respiratory failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysphagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Eating disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperreflexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Monomelic amyotrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Motor dysfunction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscle spasticity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Salivary hypersecretion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|AVAMYS [FLUTICASONE FUROATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8804293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8798974	Spontaneous	2015-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Asthenia (126d - Unknown - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chronic tonsillitis (n/a - Unknown - Disabling, Other Medically Important Condition);Cough (n/a - Unknown - Disabling, Other Medically Important Condition);Decreased activity (n/a - Unknown - Disabling, Other Medically Important Condition);Decreased appetite (n/a - Unknown - Disabling, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Disabling, Other Medically Important Condition);Dyspepsia (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Disabling, Other Medically Important Condition);Goitre (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Hyperacusis (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Listless (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Lymphadenopathy (n/a - Unknown - Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Disabling, Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Disabling, Other Medically Important Condition);Nausea (n/a - Unknown - Disabling, Other Medically Important Condition);Neck pain (n/a - Unknown - Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Disabling, Other Medically Important Condition);Pharyngitis (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Disabling, Other Medically Important Condition);Staphylococcal infection (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Streptococcal infection (n/a - Unknown - Disabling, Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Viral sinusitis (n/a - Unknown - Disabling, Other Medically Important Condition);Weight increased (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - Not applicable - [1d - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8798974&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Duration
EU-EC-8793054	Spontaneous	2015-01-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Peripheral swelling (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8793054&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8793134	Spontaneous	2015-01-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Syringe issue (n/a - Unknown - );Vaccination site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8793134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8789113	Spontaneous	2015-01-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Autonomic nervous system imbalance (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Feeling of body temperature change (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Frustration tolerance decreased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypotension (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Irritability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Presyncope (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - n/a - n/a])|[LORATADINE] (C - Hypersensitivity - n/a - [n/a - n/a - n/a])|[LORATADINE] (C - Seasonal allergy - n/a - [n/a - n/a - n/a])|[NORETHISTERONE ACETATE, ANHYDROUS ESTRADIOL, NORETHISTERONE ACETATE, ESTRADIOL, NORETHISTERONE ACETATE, ESTRADIOL HEMIHYDRATE, NORETHISTERONE, ESTRADIOL HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM CROMOGLICATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TERBUTALINE SULFATE, TERBUTALINE SULFATE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8789113&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8789118	Spontaneous	2015-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Altered state of consciousness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Temperature regulation disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8789118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8790964	Spontaneous	2015-01-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (3d - Recovered/Resolved - );Injection site reaction (n/a - Recovering/Resolving - );Malaise (4d - Recovered/Resolved - );Myalgia (4d - Recovered/Resolved - );Pyrexia (3d - Recovered/Resolved - );Vomiting (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8790964&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8790988	Spontaneous	2015-01-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Pruritus (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	KEPPRA 250 MG FILM-COATED TABLETS [LEVETIRACETAM] (C - Epilepsy - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8790988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8784995	Spontaneous	2015-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aphasia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Clumsiness (n/a - Unknown - Disabling);Coordination abnormal (n/a - Unknown - Disabling);Depression (n/a - Unknown - Disabling);Diarrhoea (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Dyspnoea (n/a - Unknown - Disabling);Exposure during pregnancy (n/a - Unknown - Disabling);Fall (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Feeling cold (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Hot flush (n/a - Unknown - Disabling);Hyperacusis (n/a - Unknown - Disabling);Hyperhidrosis (n/a - Unknown - Disabling);Hypoaesthesia (n/a - Unknown - Disabling);Infection (n/a - Unknown - Disabling);Insomnia (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Melanocytic naevus (n/a - Unknown - Disabling);Memory impairment (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Pain (n/a - Unknown - Disabling);Palpitations (n/a - Unknown - Disabling);Parosmia (n/a - Unknown - Disabling);Pharyngitis (n/a - Unknown - Disabling);Photophobia (n/a - Unknown - Disabling);Poor quality sleep (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Sensory loss (n/a - Unknown - Disabling);Sinusitis (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling);Taste disorder (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8784995&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8785005	Spontaneous	2015-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (1a - Not Recovered/Not Resolved - Disabling);Bursitis (1a - Not Recovered/Not Resolved - Disabling);Chest pain (1a - Recovering/Resolving - Disabling);Decreased appetite (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Gait disturbance (n/a - Recovering/Resolving - Disabling);Greater trochanteric pain syndrome (n/a - Not Recovered/Not Resolved - Disabling);Groin pain (n/a - Not Recovered/Not Resolved - Disabling);Hepatitis A (n/a - Unknown - Disabling);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal pain (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Unknown - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Myocardial infarction (n/a - Recovered/Resolved - Disabling);Pain (n/a - Unknown - Disabling);Poor quality sleep (n/a - Unknown - Disabling);Tendonitis (n/a - Recovering/Resolving - Disabling);Weight decreased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 1{DF} - Parenteral])	[ACETYLSALICYLIC ACID] (C - Anticoagulant therapy - n/a - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - n/a - Unknown - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - Cardiac disorder - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Blood cholesterol - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8785005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8786079	Spontaneous	2015-01-08 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Yaimi Rosales Mesa and Miguel Gon?alves Meira e Cruz. Narcolepsy with cataplexy post A/H1N1 vaccination - the first case reported from Cuba. 22nd Biennial congress of the ESRS held jointly with 12th meeting of ESST. Poster Yaimi Rosales Mesa and Miguel Gon?alves Meira e Cruz. Narcolepsy with cataplexy post A/H1N1 vaccination - A case reported from Cuba. Sleep Science. 2014;7(1):59-61	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Depression (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Food craving (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Increased appetite (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Speech disorder (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8786079&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8786915	Spontaneous	2015-01-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dysphonia (7d - Recovered/Resolved - );Malaise (48h - Recovered/Resolved - );Middle ear effusion (7d - Recovered/Resolved - );Myalgia (48h - Recovered/Resolved - );Pyrexia (48h - Recovered/Resolved - );Vomiting (24h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8786915&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8780694	Spontaneous	2015-01-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Vitiligo (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8780694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-8782967	Spontaneous	2015-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Upper respiratory tract infection (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8782967&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8777260	Spontaneous	2015-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dysaesthesia (n/a - Unknown - );Paraesthesia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8777260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8777304	Spontaneous	2015-01-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Injection site pain (n/a - Unknown - );Tendon disorder (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8777304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8777550	Spontaneous	2015-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cardiac arrest (n/a - Fatal - Results in Death);Dyspnoea (n/a - Fatal - Results in Death);Loss of consciousness (n/a - Fatal - Results in Death);Muscle spasms (n/a - Fatal - Results in Death);Musculoskeletal stiffness (n/a - Fatal - Results in Death);Seizure (n/a - Fatal - Results in Death);Sudden death (n/a - Fatal - Results in Death);Trismus (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - n/a - n/a - [n/a - n/a - n/a])|NOVOMIX 30 FLEXPEN [INSULIN ASPART, INSULIN ASPART, INSULIN ASPART PROTAMINE] (C - Diabetes mellitus - Unknown - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, LOSARTAN, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LAMOTRIGINE] (C - n/a - n/a - [n/a - n/a - n/a])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8777550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8769207	Spontaneous	2015-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chest discomfort (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Condition aggravated (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Eye pruritus (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Lower respiratory tract infection (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Morton's neuralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Mucous stools (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nasal pruritus (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pneumonia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sinusitis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Tendon pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Throat irritation (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Urinary tract infection (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Weight decreased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8769207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8756149	Spontaneous	2014-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (3d - Recovered/Resolved - Other Medically Important Condition)	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8756149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8758628	Spontaneous	2014-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8758628&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8758923	Spontaneous	2014-12-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8758923&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8750587	Spontaneous	2014-12-29 00:00:00	Healthcare Professional	European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Junkerova J, Zapletalova O, Zivny J. Myasthenia gravis - correlation with flu vaccination. Neurology for practise. 2011;12(5):359-362.	65-85 Years	Not Specified	No	Male	Myasthenia gravis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8750587&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8751812	Spontaneous	2014-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Coma (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cough (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Decreased immune responsiveness (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Depression (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Ear infection (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Infection susceptibility increased (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Learning disorder (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Malaise (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Migraine (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nausea (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tonsillitis (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Urinary tract infection (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8751812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8751820	Spontaneous	2014-12-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Body temperature increased (n/a - Recovering/Resolving - Other Medically Important Condition);Costochondritis (n/a - Recovering/Resolving - Other Medically Important Condition);Injection site bruising (n/a - Recovering/Resolving - Other Medically Important Condition);Mouth ulceration (n/a - Recovering/Resolving - Other Medically Important Condition);Oral herpes (n/a - Recovering/Resolving - Other Medically Important Condition);Painful respiration (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - n/a])	[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8751820&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8752323	Spontaneous	2014-12-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arrhythmia (n/a - Unknown - Disabling, Other Medically Important Condition);Chills (n/a - Unknown - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Disabling, Other Medically Important Condition);Dysgeusia (n/a - Unknown - Disabling, Other Medically Important Condition);Feeling abnormal (n/a - Unknown - Disabling, Other Medically Important Condition);Freezing phenomenon (n/a - Unknown - Disabling, Other Medically Important Condition);Nausea (n/a - Unknown - Disabling, Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Disabling, Other Medically Important Condition);Pelvic pain (n/a - Unknown - Disabling, Other Medically Important Condition);Pollakiuria (n/a - Unknown - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])|[MENINGOCOCCAL VACCINE] (S - Investigation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8752323&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8754135	Spontaneous	2014-12-29 00:00:00	Healthcare Professional	European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Junkerova J, Zapletalova O, Zivny J. Myasthenia gravis - correlation with influenza vaccination. Neurology for practise. 2011;12(5):359-362.	65-85 Years	Not Specified	No	Female	Myasthenia gravis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8754135&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8728251	Spontaneous	2014-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Corneal graft rejection (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8728251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8729458	Spontaneous	2014-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Abdominal discomfort (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Bladder disorder (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Inflammation (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Lymphangitis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Myelitis transverse (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Paraplegia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Urinary tract infection (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8729458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8729965	Spontaneous	2014-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Acute disseminated encephalomyelitis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Anxiety (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Back pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Clonus (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Encephalopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Eyelid ptosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Facial paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hemiparesis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperacusis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Memory impairment (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Neck pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Photophobia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Respiratory arrest (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Self esteem decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8729965&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8730385	Spontaneous	2014-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dysaesthesia (n/a - Unknown - );Paraesthesia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8730385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8732296	Spontaneous	2014-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (3d - Recovered/Resolved - );Injection site urticaria (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8732296&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8732307	Spontaneous	2014-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Arthralgia (n/a - Recovered/Resolved - );Asthma (4wk - Recovered/Resolved - );Injection site haematoma (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CICLESONIDE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Not applicable - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8732307&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8732770	Spontaneous	2014-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Encephalitis (53d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8732770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8724735	Spontaneous	2014-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Temperature regulation disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8724735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8724752	Spontaneous	2014-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Influenza immunisation - n/a - [n/a - .5mL - n/a])	[DIHYDROERGOTAMINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8724752&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8724761	Spontaneous	2014-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling);Anxiety (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Asthma (n/a - Not Recovered/Not Resolved - Disabling);Back pain (n/a - Not Recovered/Not Resolved - Disabling);Cough (n/a - Not Recovered/Not Resolved - Disabling);Dysphagia (n/a - Not Recovered/Not Resolved - Disabling);Eye irritation (n/a - Not Recovered/Not Resolved - Disabling);Hypersensitivity (n/a - Not Recovered/Not Resolved - Disabling);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Disabling);Sensation of foreign body (n/a - Not Recovered/Not Resolved - Disabling);Upper respiratory tract inflammation (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[ANTAZOLINE HYDROCHLORIDE, TETRYZOLINE HYDROCHLORIDE] (C - Hypersensitivity - n/a - [n/a - n/a - Ophthalmic])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Pruritus - n/a - [n/a - 10mg - Oral])|[CINCHOCAINE HYDROCHLORIDE, PREDNISOLONE, CINCHOCAINE HYDROCHLORIDE, PREDNISOLONE CAPROATE] (C - Haemorrhoids - n/a - [n/a - n/a - Rectal])|[KETOPROFEN, KETOPROFEN SODIUM] (C - Pain - n/a - [n/a - 200mg - Oral])|[KETOPROFEN] (C - Pain - n/a - [n/a - n/a - Transdermal])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - Hypersensitivity - n/a - [n/a - n/a - Ophthalmic])|[LORATADINE] (C - Hypersensitivity - n/a - [n/a - 10mg - Oral])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - Hypersensitivity - n/a - [n/a - 100ug - Nasal])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 40mg - n/a])|[PARACETAMOL, PARACETAMOL, ASPARTAME] (C - Pain - n/a - [n/a - 1g - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8724761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8724865	Spontaneous	2014-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Injection site pain (n/a - Unknown - );Tendon disorder (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8724865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8725145	Spontaneous	2014-12-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Diverticulitis (n/a - Recovered/Resolved - Other Medically Important Condition);Oral herpes (6mo - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tendonitis (n/a - Recovered/Resolved - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE] (S - Diverticulitis - Dose not changed - [n/a - 1{DF} - Oral])	[ACENOCOUMAROL] (C - Hypercoagulation - Dose not changed - [n/a - 1{DF} - Oral])|[SIMETICONE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8725145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8725529	Spontaneous	2014-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Face oedema (n/a - Recovering/Resolving - Other Medically Important Condition);Photophobia (n/a - Recovering/Resolving - Other Medically Important Condition);Urticaria (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8725529&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8725530	Spontaneous	2014-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Cardiovascular disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8725530&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8725631	Spontaneous	2014-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Confusional state (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dry throat (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Emotional disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Ill-defined disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Impaired driving ability (n/a - Unknown - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Loss of employment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscle spasms (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nasopharyngitis (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Nightmare (n/a - Unknown - Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Rhinorrhoea (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Seizure (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Waxy flexibility (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8725631&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8727459	Spontaneous	2014-12-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8727459&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8718850	Spontaneous	2014-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hot flush (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypoglycaemia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypometabolism (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypothyroidism (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Irritable bowel syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Lyme disease (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscle spasticity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Photophobia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pneumonia mycoplasmal (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Rash erythematous (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Tick-borne viral encephalitis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Viral myelitis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - n/a - [n/a - n/a - Respiratory (inhalation)])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - 10mg - Oral])|[SALBUTAMOL SULFATE] (C - Asthma - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[SALBUTAMOL SULFATE] (C - Asthma - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8718850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8719072	Spontaneous	2014-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8719072&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8719158	Spontaneous	2014-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chills (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chromaturia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Diarrhoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dry eye (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dry mouth (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Feeling hot (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Feeling of body temperature change (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Impaired work ability (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Influenza like illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Micturition disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Night sweats (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nocturia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Quality of life decreased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sjogren's syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tinnitus (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8719158&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8719159	Spontaneous	2014-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anxiety (n/a - Unknown - Disabling, Other Medically Important Condition);Apnoea (n/a - Unknown - Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Disabling, Other Medically Important Condition);Decreased appetite (n/a - Unknown - Disabling, Other Medically Important Condition);Depressed mood (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Hallucination (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Disabling, Other Medically Important Condition);Snoring (n/a - Unknown - Disabling, Other Medically Important Condition);Social anxiety disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Weight decreased (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8719159&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8719160	Spontaneous	2014-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aphonia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dysphonia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fibroadenoma of breast (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypokalaemia (n/a - Unknown - Disabling, Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Nasopharyngitis (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Palpitations (n/a - Unknown - Disabling, Other Medically Important Condition);Respiratory tract infection (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sinusitis (n/a - Unknown - Disabling, Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Tinnitus (n/a - Unknown - Disabling, Other Medically Important Condition);Upper respiratory tract infection (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[BUDESONIDE] (C - Hypersensitivity - Unknown - [n/a - 32ug - Nasal])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - Respiratory tract infection - Drug withdrawn - [n/a - n/a - n/a])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - Sinusitis - Drug withdrawn - [10d - 1320mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8719160&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8719161	Spontaneous	2014-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Amnesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Personality change (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	MUSCLE RELAXANT [MUSCLE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUPRENORPHINE, BUPRENORPHINE HYDROCHLORIDE] (C - Pain - Not applicable - [n/a - n/a - n/a])|[DIAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[IBUPROFEN] (C - Post-traumatic pain - Not applicable - [n/a - n/a - n/a])|[KETOBEMIDONE HYDROCHLORIDE, DIMETHYL-AMINODIPHENYL-BUTENHYDROKLORID., KETOBEMIDONE HYDROCHLORIDE, DIMETHYLAMINODIPHENYLBUTENE HYDROCHLORIDE, KETOBEMIDONE HYDROCHLORIDE, RECIPAVRIN] (C - n/a - n/a - [n/a - n/a - n/a])|[METHADONE] (C - Arthralgia - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - Post-traumatic pain - Not applicable - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE] (C - Post-traumatic pain - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8719161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8721106	Spontaneous	2014-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8721106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8713810	Spontaneous	2014-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Apathy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Breast cancer (n/a - Unknown - Disabling, Other Medically Important Condition);Bronchitis (n/a - Unknown - Disabling, Other Medically Important Condition);Conjunctivitis bacterial (n/a - Unknown - Disabling, Other Medically Important Condition);Diverticulitis (n/a - Unknown - Disabling, Other Medically Important Condition);Dysuria (n/a - Unknown - Disabling, Other Medically Important Condition);Ear infection (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Immunodeficiency (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Inflammation (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Oral herpes (n/a - Unknown - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pollakiuria (n/a - Unknown - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Psoriasis (n/a - Unknown - Disabling, Other Medically Important Condition);Pyelitis (n/a - Unknown - Disabling, Other Medically Important Condition);Tonsillitis (n/a - Unknown - Disabling, Other Medically Important Condition);Urinary tract infection (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM] (C - Inflammation - n/a - [n/a - 50mg - Oral])|[FEXOFENADINE, FEXOFENADINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 180mg - Oral])|[HYDROCHLOROTHIAZIDE, LOSARTAN, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - Erysipelas - n/a - [n/a - 660mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8713810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8714046	Spontaneous	2014-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Seizure (1d - Recovered/Resolved - Other Medically Important Condition);Syncope (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8714046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8716093	Spontaneous	2014-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8716093&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8716106	Spontaneous	2014-12-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Petit mal epilepsy (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8716106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8716133	Spontaneous	2014-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (1wk - Recovered/Resolved - );Pain in extremity (1wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8716133&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8707445	Spontaneous	2014-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - );Lacrimation increased (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8707445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8708786	Spontaneous	2014-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Unknown - Disabling, Other Medically Important Condition);Bipolar disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Depressed mood (n/a - Unknown - Disabling, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Seasonal allergy (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[DROSPIRENONE, ETHINYLESTRADIOL] (C - Contraception - n/a - [n/a - 3mg - n/a])|[PARACETAMOL] (C - Pain - n/a - [n/a - 1g - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8708786&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8709733	Spontaneous	2014-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])|CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - Not applicable - [n/a - .5mL - n/a])	ANTIBIOTICS (GENERAL) (G) [NOT AVAILABLE] (C - Mastitis - n/a - [1wk - n/a - n/a])|ANTIBIOTICS (GENERAL) (G) [NOT AVAILABLE] (C - Wound infection - n/a - [1wk - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8709733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8711171	Spontaneous	2014-12-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Eczema (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8711171&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8703063	Spontaneous	2014-12-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Rash (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8703063&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8705161	Spontaneous	2014-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Female	Acute disseminated encephalomyelitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Anal incontinence (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Aphasia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Apraxia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Blindness cortical (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cardiovascular disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Central nervous system inflammation (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Clostridium difficile colitis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cognitive disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysarthria (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Enterocolitis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hemiparesis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site hypoaesthesia (4d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of consciousness (4d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Marburg's variant multiple sclerosis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Movement disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Organic brain syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (4d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Palpitations (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Peripheral vascular disorder (4d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Quadriplegia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory distress (4d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (4d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachycardia (4d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urinary incontinence (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	ORAL CONTRACEPTION [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8705161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8699064	Spontaneous	2014-12-15 00:00:00	Healthcare Professional	Non European Economic Area	De Bruycker JJ et al. B Cell-Targeted Therapy in Narcolepsy / Cataplexy Post H1n1 Vaccination. De Bruycker J.J, Montplaisir J.Y, Nguyen B.H, Haddad E and Decaluwe H.. B cell-targeted therapy in narcolepsy/cataplexy post H1N1 vaccination. Journal of Clinical Immunology. 2014;34 (3):355	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Recovered/Resolved - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved - Other Medically Important Condition);Sleep attacks (n/a - Recovered/Resolved - Other Medically Important Condition);Therapy non-responder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])|SODIUM OXYBATE [SODIUM OXYBATE] (S - Narcolepsy - n/a - [n/a - n/a - Unknown])|[HUMAN NORMAL IMMUNOGLOBULIN] (S - Narcolepsy - n/a - [n/a - n/a - Intravenous (not otherwise specified)])|[METHYLPHENIDATE] (S - Narcolepsy - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8699064&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8699277	Spontaneous	2014-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Head discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Herpes virus infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Mood swings (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Panic attack (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Perioral dermatitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Psychiatric symptom (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Social problem (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Syncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Temperature intolerance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - Mastitis - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8699277&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8699278	Spontaneous	2014-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Anxiety (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Apathy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Back pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chills (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Ear discomfort (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscle fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Musculoskeletal chest pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Peripheral swelling (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Photophobia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pneumonia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Swollen tongue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Tendonitis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Tension headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Vertigo (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[MIRTAZAPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - Pharyngitis streptococcal - n/a - [n/a - 4g - n/a])|[SUMATRIPTAN] (C - Migraine - n/a - [n/a - n/a - n/a])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - Depression - n/a - [n/a - 37.5mg - Oral])|[ZOLMITRIPTAN] (C - Migraine - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8699278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8699279	Spontaneous	2014-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Apnoea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspepsia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nasal congestion (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Obstructive sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Quality of life decreased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Snoring (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	DIETARY SUPPLEMENT [NUTRITIONAL SUPPLEMENT] (C - n/a - n/a - [n/a - n/a - n/a])|[TOLTERODINE L-TARTRATE, TOLTERODINE TARTRATE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8699279&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8699282	Spontaneous	2014-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anosmia (n/a - Not Recovered/Not Resolved - Disabling);Condition aggravated (n/a - Not Recovered/Not Resolved - Disabling);Dysgeusia (n/a - Not Recovered/Not Resolved - Disabling);Nasopharyngitis (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	APROVEL [IRBESARTAN] (C - Hypertension - Not applicable - [n/a - 150mg - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - Not applicable - [n/a - n/a - n/a])|[DIAZEPAM] (C - n/a - Not applicable - [n/a - 5mg - n/a])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - Back pain - Not applicable - [n/a - n/a - n/a])|[ESTRADIOL, ESTRADIOL HEMIHYDRATE] (C - Atrophic vulvovaginitis - Not applicable - [n/a - 50ug - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - Not applicable - [n/a - 500mg - n/a])|[NAPROXEN, NAPROXEN SODIUM] (C - n/a - Not applicable - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - Not applicable - [n/a - 40mg - n/a])|[TRIMIPRAMINE, TRIMIPRAMINE MALEATE, TRIMIPRAMINE MESILATE] (C - n/a - Not applicable - [n/a - n/a - n/a])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - n/a - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8699282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8699283	Spontaneous	2014-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Alopecia (n/a - Unknown - Disabling, Other Medically Important Condition);Asthenopia (n/a - Unknown - Disabling, Other Medically Important Condition);Back pain (n/a - Unknown - Disabling, Other Medically Important Condition);Body temperature fluctuation (n/a - Unknown - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Condition aggravated (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Disabling, Other Medically Important Condition);Food intolerance (n/a - Unknown - Disabling, Other Medically Important Condition);Gastric infection (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Gastroenteritis (n/a - Unknown - Disabling, Other Medically Important Condition);Hyperacusis (n/a - Unknown - Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Disabling, Other Medically Important Condition);Myalgia (n/a - Unknown - Disabling, Other Medically Important Condition);Nausea (n/a - Unknown - Disabling, Other Medically Important Condition);Photophobia (n/a - Unknown - Disabling, Other Medically Important Condition);Pyelitis (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Pyrexia (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	NOT AVAILABLE (C - Myalgia - n/a - [n/a - 350mg - Oral])|[AMOXICILLIN, AMOXICILLIN TRIHYDRATE] (C - Urinary tract infection - n/a - [n/a - 250mg - n/a])|[ATENOLOL, ATENOLOL BP] (C - Migraine - n/a - [n/a - 25mg - n/a])|[CETIRIZINE DIHYDROCHLORIDE] (C - Hypersensitivity - n/a - [n/a - n/a - Oral])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Hypersensitivity - n/a - [n/a - 10mg - n/a])|[LEVONORGESTREL] (C - Contraception - n/a - [n/a - n/a - n/a])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - Sinusitis - n/a - [n/a - 660mg - Oral])|[PIROXICAM] (C - Myalgia - n/a - [n/a - 20mg - Oral])|[RIZATRIPTAN BENZOATE] (C - Migraine - n/a - [n/a - 10mg - Oral])|[SUMATRIPTAN] (C - Migraine - n/a - [n/a - 100mg - n/a])|[SUMATRIPTAN] (C - Migraine - n/a - [n/a - 20mg - Nasal])|[TRIMETHOPRIM] (C - Urinary tract infection - n/a - [n/a - 160mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8699283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8699284	Spontaneous	2014-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Epistaxis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscle atrophy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep terror (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8699284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8700790	Spontaneous	2014-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anger (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Impatience (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8700790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8693322	Spontaneous	2014-12-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Muscle twitching (1d - Recovered/Resolved - Other Medically Important Condition);Sensory disturbance (1d - Recovered/Resolved - Other Medically Important Condition);Swelling (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8693322&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8695214	Spontaneous	2014-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8695214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8695215	Spontaneous	2014-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8695215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8695217	Spontaneous	2014-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8695217&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8695223	Spontaneous	2014-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8695223&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8688461	Spontaneous	2014-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Encephalitis (n/a - Not Recovered/Not Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[FENOFIBRATE, FENOFIBRATE MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])|[NEBIVOLOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8688461&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-8689685	Spontaneous	2014-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hepatic steatosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8689685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8692134	Spontaneous	2014-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Goitre (3wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8692134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8692238	Spontaneous	2014-12-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Generalised tonic-clonic seizure (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Petit mal epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8692238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8687356	Spontaneous	2014-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8687356&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8687796	Spontaneous	2014-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Life Threatening)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[MODAFINIL] (C - n/a - n/a - [n/a - 400mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8687796&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-8687797	Spontaneous	2014-12-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8687797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8679637	Spontaneous	2014-12-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypotension (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8679637&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8683283	Spontaneous	2014-12-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (2wk - Recovered/Resolved - );Malaise (n/a - Recovering/Resolving - );Myalgia (1wk - Recovered/Resolved - );Respiratory tract infection (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[CICLESONIDE] (C - n/a - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[MOMETASONE FUROATE] (C - n/a - n/a - [n/a - 1{DF} - Nasal])|[RUPATADINE] (C - n/a - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8683283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8683312	Spontaneous	2014-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cholelithiasis (n/a - Recovering/Resolving - Other Medically Important Condition);Hepatic cytolysis (n/a - Recovering/Resolving - Other Medically Important Condition);Hepatitis viral (n/a - Unknown - Other Medically Important Condition);Influenza like illness (1mo - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	LYRICA [PREGABALIN] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[FLECAINIDE ACETATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[LEVOTHYROXINE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[PARACETAMOL] (C - Product used for unknown indication - n/a - [n/a - 1g - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8683312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8669260	Spontaneous	2014-12-05 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Contusion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Immune thrombocytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Petechiae (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8669260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8671049	Spontaneous	2014-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Myocarditis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8671049&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8671067	Spontaneous	2014-12-05 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Syncope (0d - Recovered/Resolved - Other Medically Important Condition)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8671067&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8671068	Spontaneous	2014-12-05 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Eye pain (7d - Recovered/Resolved - Other Medically Important Condition);Lymphadenopathy (7d - Recovered/Resolved - Other Medically Important Condition);Malaise (7d - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (7d - Recovered/Resolved - Other Medically Important Condition);Rash (7d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8671068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8671069	Spontaneous	2014-12-05 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bradycardia (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Oxygen saturation decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Respiratory arrest (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8671069&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8671073	Spontaneous	2014-12-05 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Head injury (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8671073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8671075	Spontaneous	2014-12-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Burning sensation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8671075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8671292	Spontaneous	2014-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8671292&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8666580	Spontaneous	2014-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8666580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8667746	Spontaneous	2014-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8667746&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8667771	Spontaneous	2014-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Condition aggravated (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Systemic lupus erythematosus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8667771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8659410	Spontaneous	2014-12-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash papular (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - Product used for unknown indication - n/a - [n/a - 50ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8659410&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8661745	Spontaneous	2014-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	C-reactive protein increased (n/a - Unknown - Other Medically Important Condition);Chills (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Purpura (n/a - Unknown - Other Medically Important Condition);Vasculitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - Hypercholesterolaemia - n/a - [n/a - n/a - Oral])|[BISOPROLOL FUMARATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - Hypertension - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8661745&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8662755	Spontaneous	2014-12-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Cough (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	[BUDESONIDE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8662755&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8654137	Spontaneous	2014-12-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Facial pain (18d - Recovered/Resolved - Other Medically Important Condition);Feeling hot (18d - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (18d - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (18d - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Pain in extremity (18d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (18d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8654137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8655972	Spontaneous	2014-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Balance disorder (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling cold (n/a - Not Recovered/Not Resolved - Disabling);Frustration tolerance decreased (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Increased appetite (n/a - Not Recovered/Not Resolved - Disabling);Irritability (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Mood swings (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Disabling);Periodic limb movement disorder (n/a - Not Recovered/Not Resolved - Disabling);Personality change (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Quality of life decreased (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Sleep talking (n/a - Not Recovered/Not Resolved - Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8655972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8650848	Spontaneous	2014-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling);Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling);Ear pain (n/a - Not Recovered/Not Resolved - Disabling);Faeces discoloured (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersensitivity (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Pain in jaw (n/a - Not Recovered/Not Resolved - Disabling);Performance status decreased (n/a - Not Recovered/Not Resolved - Disabling);Proctalgia (n/a - Not Recovered/Not Resolved - Disabling);Prostatic pain (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Tendonitis (n/a - Not Recovered/Not Resolved - Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	CIALIS [TADALAFIL] (C - n/a - n/a - [n/a - 20mg - n/a])|LEVITRA [VARDENAFIL] (C - n/a - n/a - [n/a - n/a - Oral])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [2273d - 160mg - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 40mg - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - 10mg - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 50ug - n/a])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM OLEATE] (C - n/a - n/a - [n/a - 200mg - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - 7.5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8650848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8651310	Spontaneous	2014-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cardiovascular disorder (n/a - Recovered/Resolved - );Vaccination site erythema (n/a - Recovering/Resolving - );Vaccination site pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8651310&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8653013	Spontaneous	2014-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Face oedema (5mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nephrotic syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8653013&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8653037	Spontaneous	2014-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Rash pruritic (2wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8653037&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8653039	Spontaneous	2014-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Extensive swelling of vaccinated limb (2d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8653039&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8644412	Spontaneous	2014-11-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Hypertension (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8644412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8645699	Spontaneous	2014-11-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Auricular swelling (n/a - Recovering/Resolving - Other Medically Important Condition);Body temperature increased (n/a - Recovering/Resolving - Other Medically Important Condition);Localised oedema (n/a - Recovering/Resolving - Other Medically Important Condition);Pruritus (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8645699&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8646203	Spontaneous	2014-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pneumonia (4wk - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8646203&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8642312	Spontaneous	2014-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abnormal faeces (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Reading disorder (n/a - Not Recovered/Not Resolved - Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	TWINRIX ADULT SUSPENSION FOR INJECTION [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[CHOLERA VACCINE] (C - Prophylaxis - n/a - [n/a - n/a - n/a])|[DROSPIRENONE, ETHINYLESTRADIOL] (C - Dysmenorrhoea - n/a - [712d - n/a - n/a])|[SUMATRIPTAN, SUMATRIPTAN SUCCINATE] (C - Migraine - n/a - [n/a - 50mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8642312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8637495	Spontaneous	2014-11-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8637495&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8638880	Spontaneous	2014-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (5d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8638880&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8638910	Spontaneous	2014-11-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (7d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8638910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8633200	Spontaneous	2014-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pyrexia (4d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8633200&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8633661	Spontaneous	2014-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (12h - Recovered/Resolved - );Palpitations (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ALGELDRATE, APIS MELLIFERA VENOM, ALGELDRATE, VESPULA, ALNUS GLUTINOSA (106), ALUMINIUM HYDROXIDE, ALNUS GLUTINOSA (106), CORYLUS AVELLANA (113), BETULA VERRUCOSA (108), ALNUS GLUTINOSA (106), CORYLUS AVELLANA (113), BETULA VERRUCOSA (108), ALUMINIUM HYDROXIDE, ALUMINIUM HYDROXIDE, APIS MELLIFERA VENOM, ALUMINIUM, APIS MELLIFERA, APIS MELLIFERA (801), ALGELDRATE, APIS MELLIFERA (801), ALUMINIUM, APIS MELLIFERA (801), ALUMINIUM HYDROXIDE, APIS MELLIFERA VENOM, APIS MELLIFERA, ALGELDRATE, BETULA VERRUCOSA (108), ALGELDRATE, BETULA VERRUCOSA (108), ALUMINIUM HYDROXIDE, CANIS FAMILIARIS (553), ALGELDRATE, CANIS FAMILIARIS (553), ALUMINIUM HYDROXIDE, CORYLUS AVELLANA (113), ALUMINIUM HYDROXIDE, DERMATOPHAGOIDES FARINAE (504), ALGELDRATE, DERMATOPHAGOIDES FARINAE (504), ALUMINIUM HYDROXIDE, DERMATOPHAGOIDES FARINAE (504), DERMATOPHAGOIDES PTERONYSSINUS (503), DERMATOPHAGOIDES FARINAE (504), DERMATOPHAGOIDES PTERONYSSINUS (503), ALUMINIUM HYDROXIDE, DERMATOPHAGOIDES PTERONYSSINUS (503), ALUMINIUM HYDROXIDE, EQUUS CABALLUS (552), ALGELDRATE, EQUUS CABALLUS (552), ALUMINIUM HYDROXIDE, FELIS DOMESTICUS (555), ALGELDRATE, FELIS DOMESTICUS (555), ALUMINIUM HYDROXIDE, PHLEUM PRATENSE (225), ALOPECURUS PRATENSIS (203), DACTYLIS GLOMERATA (214), FESTUCA PRATENSIS (218), LOLIUM PERENNE (223), ALUMINIUM HYDROXIDE, PHLEUM PRATENSE (225), ALUMINIUM HYDROXIDE, PHLEUM PRATENSE (225), ARRHENATHERUM ELATIUS (205), DACTYLIS GLOMERATA (214), FESTUCA PRATENSIS (218), LOLIUM PERENNE (223), POA PRATENSIS (228), PHLEUM PRATENSE (225), ARRHENATHERUM ELATIUS (205), DACTYLIS GLOMERATA (214), FESTUCA PRATENSIS (218), LOLIUM PERENNE (223), POA PRATENSIS (228), ALGELDRATE, PHLEUM PRATENSE (225), ARRHENATHERUM ELATIUS (205), DACTYLIS GLOMERATA (214), FESTUCA PRATENSIS (218), LOLIUM PERENNE (223), POA PRATENSIS (228), ALUMINIUM HYDROXIDE, PHLEUM PRATENSE (225), ARRHENATHERUM ELATIUS (205), DACTYLIS GLOMERATA (214), FESTUCA PRATENSIS (218), LOLIUM PERENNE (223), POA PRATENSIS (228), SECALE CEREALE (231), PHLEUM PRATENSE (225), ARRHENATHERUM ELATIUS (205), DACTYLIS GLOMERATA (214), FESTUCA PRATENSIS (218), LOLIUM PERENNE (223), POA PRATENSIS (228), SECALE CEREALE (231), ALUMINIUM HYDROXIDE, SECALE CEREALE (231), ALUMINIUM HYDROXIDE, VESPULA SPP. (802), ALGELDRATE, VESPULA SPP. (802), ALUMINIUM, VESPULA SPP. (802), ALUMINIUM HYDROXIDE] (C - n/a - n/a - [n/a - .5{DF} - Parenteral])|[AMYLASE, LIPASE, PROTEASE, PANCREAS POWDER FROM PORCINE, PANCREAS POWDER FROM PORCINE, AMYLASE, LIPASE, PROTEASE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - Oral])|[ESOMEPRAZOL MAGNESIUM-2-WATER] (C - n/a - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8633661&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8633709	Spontaneous	2014-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Rash (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[METOPROLOL TARTRAAT] (C - n/a - n/a - [n/a - 25mg - Oral])|[NITROFURANTOIN] (C - n/a - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8633709&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8633715	Spontaneous	2014-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Fatigue (3d - Recovered/Resolved - );Headache (2d - Recovered/Resolved - );Influenza like illness (3d - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - );Somnolence (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8633715&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8627672	Spontaneous	2014-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	International normalised ratio increased (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site induration (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site warmth (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Cerebral thrombosis - Not applicable - [n/a - n/a - Subcutaneous])|[PHENPROCOUMON] (S - Product used for unknown indication - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8627672&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8628220	Spontaneous	2014-11-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8628220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8618092	Spontaneous	2014-11-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypoaesthesia (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8618092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8618330	Spontaneous	2014-11-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abscess (n/a - Not Recovered/Not Resolved - Disabling);Deafness unilateral (n/a - Not Recovered/Not Resolved - Disabling);Middle ear effusion (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8618330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8619344	Spontaneous	2014-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Decreased activity (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[DESOGESTREL, ETHINYLESTRADIOL, LACTOSE, LACTOSE MONOHYDRATE] (C - Contraception - n/a - [n/a - 20ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8619344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8620441	Spontaneous	2014-11-21 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dizziness (0d - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (0d - Recovered/Resolved - Other Medically Important Condition);Nausea (0d - Recovered/Resolved - Other Medically Important Condition);Vomiting (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8620441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8620444	Spontaneous	2014-11-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cold sweat (10d - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (10d - Recovered/Resolved - Other Medically Important Condition);Syncope (10d - Recovered/Resolved - Other Medically Important Condition);Vomiting (10d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8620444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8622413	Spontaneous	2014-11-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Arthralgia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8622413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8622451	Spontaneous	2014-11-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Abdominal discomfort (n/a - Not Recovered/Not Resolved - );Chest pain (2wk - Recovered/Resolved - );Dyspnoea (n/a - Recovering/Resolving - );Extensive swelling of vaccinated limb (2wk - Recovered/Resolved - );Malaise (n/a - Recovering/Resolving - );Myalgia (2wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[MOMETASONE FUROATE] (C - n/a - n/a - [n/a - 1{DF} - Nasal])|[MUPIROCIN] (C - Sinusitis - n/a - [n/a - 1{DF} - Cutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8622451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8614500	Spontaneous	2014-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Photophobia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vitamin B complex deficiency (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight decreased (31d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	AERIUS [DESLORATADINE] (C - Seasonal allergy - Unknown - [n/a - 5mg - Oral])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Asthma - Unknown - [n/a - 100ug - Respiratory (inhalation)])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Rhinitis - Unknown - [n/a - n/a - n/a])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Rhinitis allergic - Unknown - [n/a - n/a - Oral])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - Seasonal allergy - Unknown - [n/a - n/a - Intraocular])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - Seasonal allergy - Unknown - [n/a - n/a - Nasal])|[TERBUTALINE SULFATE, TERBUTALINE SULFATE PH. EUR.] (C - Asthma - Unknown - [n/a - .25mg - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8614500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8614501	Spontaneous	2014-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anisocoria (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Educational problem (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Infectious mononucleosis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Learning disability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Mycoplasma infection (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nasal congestion (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Presyncope (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Reading disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Terminal insomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Tonsillar disorder (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Tonsillitis (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Tunnel vision (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8614501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8616064	Spontaneous	2014-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Male	Vaccination site erythema (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8616064&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8616067	Spontaneous	2014-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Vaccination site erythema (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8616067&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8616243	Spontaneous	2014-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vitiligo (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8616243&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8617355	Spontaneous	2014-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (2d - Recovered/Resolved - );Migraine (1d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8617355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8617358	Spontaneous	2014-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8617358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8617372	Spontaneous	2014-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (1wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8617372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612308	Spontaneous	2014-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pain (n/a - Unknown - );Skin warm (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	CARENAL [BIOTIN, FOLIC ACID, NICOTINIC ACID, PANTOTHENIC ACID, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN, SELENIUM, THIAMINE HYDROCHLORIDE, TOCOPHEROL, VITAMIN B12 NOS] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|ESOMEPRAZOLE [ESOMEPRAZOLE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CALCIUM ACETATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PROTHIPENDYL HYDROCHLORIDE, PROTHIPENDYL HYDROCHLORIDE MONOHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612309	Spontaneous	2014-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Skin warm (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612311	Spontaneous	2014-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Vaccination site erythema (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612312	Spontaneous	2014-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Vaccination site erythema (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612677	Spontaneous	2014-11-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (3d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	COAPROVEL 150 MG/12.5 MG FILM-COATED TABLETS [HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612677&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612696	Spontaneous	2014-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Injection site inflammation (n/a - Not Recovered/Not Resolved - );Lymphadenopathy (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[CARBASALAATCALCIUM] (C - n/a - n/a - [n/a - 50mg - Oral])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - 125ug - Respiratory (inhalation)])|[OMEPRAZOL] (C - n/a - Not applicable - [n/a - 20mg - Intramuscular])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - {DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612742	Spontaneous	2014-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Skin warm (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612742&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612743	Spontaneous	2014-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Skin warm (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612744	Spontaneous	2014-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Vaccination site erythema (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612744&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612747	Spontaneous	2014-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Vaccination site erythema (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612748	Spontaneous	2014-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pain (n/a - Unknown - );Pyrexia (n/a - Unknown - );Skin warm (n/a - Unknown - );Vaccination site erythema (n/a - Unknown - );Vaccination site swelling (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612748&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8612750	Spontaneous	2014-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Vaccination site erythema (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8612750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8606465	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8606465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8606652	Spontaneous	2014-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cardiac disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8606652&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8606972	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chills (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8606972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8607936	Spontaneous	2014-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovered/Resolved - );Injection site inflammation (n/a - Recovering/Resolving - );Malaise (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8607937	Spontaneous	2014-11-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Abdominal discomfort (n/a - Recovered/Resolved - );Influenza like illness (4d - Recovered/Resolved - );Injection site pain (2d - Recovered/Resolved - );Myalgia (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8607937&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8600838	Spontaneous	2014-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8600838&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8602846	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8602852	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Extensive swelling of vaccinated limb (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	INSULIN GLARGINE 100 IU/ML - SOLUTION FOR INJECTION  (C - n/a - Not applicable - [n/a - n/a - Subcutaneous])|[INSULIN ASPART] (C - n/a - n/a - [n/a - n/a - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8602853	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Balance disorder (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-8602866	Spontaneous	2014-11-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	PANTOPRAZOLE 20 MG - GASTRO-RESISTANT TABLET  (C - n/a - n/a - [n/a - 20mg - Oral])|PROPRANOLOL HYDROCHLORIDE [PROPRANOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[CLOPIDOGREL HYDROGEN SULFATE, ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 20mg - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8602866&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8594810	Spontaneous	2014-11-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Body temperature increased (n/a - Recovering/Resolving - Other Medically Important Condition);Chills (1d - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Parenteral])	[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, AMILORIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE DIHYDRATE, HYDROCHLOROTHIAZIDE, ANHYDROUS AMILORIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[SULFASALAZINE] (C - n/a - n/a - [n/a - n/a - n/a])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8594810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8596260	Spontaneous	2014-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8596260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8596731	Spontaneous	2014-11-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site induration (n/a - Unknown - );Injection site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8596731&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8597628	Spontaneous	2014-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cardio-respiratory arrest (0d - Fatal - Results in Death);Seizure (0d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Parenteral])	DUOPLAVIN [ACETYLSALICYLIC ACID, CLOPIDOGREL] (C - n/a - n/a - [n/a - n/a - Oral])|EUCREAS 50 MG/1000 MG FILM-COATED TABLETS [METFORMIN HYDROCHLORIDE, VILDAGLIPTIN] (C - Type 2 diabetes mellitus - n/a - [n/a - 1{DF} - Oral])|GLIBENCLAMIDE [GLIBENCLAMIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - Oral])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[EZETIMIBE] (C - Hypercholesterolaemia - n/a - [n/a - 1{DF} - Oral])|[NEBIVOLOL] (C - Hypertension - n/a - [n/a - 5mg - Oral])|[RAMIPRIL] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[ROSUVASTATIN] (C - Dyslipidaemia - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8597628&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8590867	Spontaneous	2014-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8590867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8590868	Spontaneous	2014-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8590868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8591894	Spontaneous	2014-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diarrhoea (n/a - Recovered/Resolved - Life Threatening);Hypotension (n/a - Recovered/Resolved - Life Threatening);Malaise (n/a - Recovered/Resolved - Life Threatening);Urticaria (n/a - Recovered/Resolved - Life Threatening);Vomiting (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8591894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-8582987	Spontaneous	2014-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8582987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8584522	Spontaneous	2014-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8584522&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8584540	Spontaneous	2014-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cholestasis of pregnancy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8584540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8581888	Spontaneous	2014-11-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (2d - Recovered/Resolved - );Myalgia (4d - Recovered/Resolved - );Oropharyngeal pain (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8581888&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8575197	Spontaneous	2014-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anxiety (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Deafness (n/a - Unknown - Other Medically Important Condition);Decreased appetite (n/a - Unknown - Other Medically Important Condition);Depression (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Educational problem (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Feeding disorder (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Hunger (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Psychiatric symptom (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight decreased (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8575197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8576963	Spontaneous	2014-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Atrial fibrillation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8576963&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8576965	Spontaneous	2014-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (n/a - Recovering/Resolving - );Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8576965&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8576972	Spontaneous	2014-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Breast pain (4d - Recovered/Resolved - );Injection site inflammation (4d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8576972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8569116	Spontaneous	2014-11-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8569116&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8569265	Spontaneous	2014-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8569265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8564092	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Headache (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - );Pain (n/a - Recovering/Resolving - );Pain in extremity (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8564092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8565125	Spontaneous	2014-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Anal incontinence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Aphasia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Apraxia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Blindness cortical (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Enterocolitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Organic brain syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Quadriplegia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Urinary incontinence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	KONTRAZEPTION [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8565125&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8566029	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Urinary tract infection (4d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566029&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8566059	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (2d - Recovered/Resolved - );Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566059&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8566069	Spontaneous	2014-11-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (6h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8566069&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8559875	Spontaneous	2014-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8559875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8560139	Spontaneous	2014-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8560139&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8561278	Spontaneous	2014-11-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Extensive swelling of vaccinated limb (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8561278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8556460	Spontaneous	2014-11-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Ataxia (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Bladder disorder (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Constipation (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Dysarthria (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Dysphagia (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Facial paralysis (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Loss of consciousness (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Respiratory paralysis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Walking disability (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Dose increased - [1d - n/a - n/a])	[ANHYDROUS LEVOTHYROXINE SODIUM, LEVOTHYROXINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS EP] (C - Hypermetabolism - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8556460&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8556477	Spontaneous	2014-11-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nightmare (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8556477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8556494	Spontaneous	2014-11-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Dizziness (2d - Recovered/Resolved - );Headache (2d - Recovered/Resolved - );Injection site pain (2d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	INTERFERON BETA-1A - SOLUTION FOR INJECTION  (C - n/a - n/a - [n/a - 1{DF} - Subcutaneous])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - 2{DF} - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 50ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8556494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8551889	Spontaneous	2014-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8551889&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8552194	Spontaneous	2014-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Arthralgia (5d - Recovered/Resolved - );Headache (4d - Recovered/Resolved - );Injection site inflammation (4d - Recovered/Resolved - );Myalgia (5d - Recovered/Resolved - );Nasopharyngitis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8552194&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8552195	Spontaneous	2014-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Headache (n/a - Recovering/Resolving - );Malaise (n/a - Not Recovered/Not Resolved - );Myalgia (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Recovering/Resolving - );Rash (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	NON SPECIFIED DRUG [UNKNOWN] (C - n/a - n/a - [n/a - {DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8552195&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8552196	Spontaneous	2014-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Myalgia (2d - Recovered/Resolved - );Oropharyngeal pain (2d - Recovered/Resolved - );Pyrexia (2d - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - 2{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8552196&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8552197	Spontaneous	2014-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Extensive swelling of vaccinated limb (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8552197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8552198	Spontaneous	2014-11-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Headache (1d - Recovered/Resolved - );Injection site inflammation (n/a - Recovering/Resolving - );Nausea (14h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ENALAPRIL WATERSTOFMALEAAT] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[METOPROLOL TARTRAAT] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[VENLAFAXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8552198&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8544725	Spontaneous	2014-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8544725&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8545832	Spontaneous	2014-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Arthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia oral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Meningism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neck pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pharyngeal hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8545832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8546346	Spontaneous	2014-10-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chills (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8546346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8546697	Spontaneous	2014-10-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ATENOLOL] (C - n/a - n/a - [n/a - 50mg - Oral])|[LISINOPRIL, LISINOPRIL ANHYDROUS, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8546697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8546707	Spontaneous	2014-10-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Unknown - [n/a - 1{DF} - Intramuscular])	[INSULIN ASPART] (C - n/a - n/a - [n/a - 1{DF} - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8546707&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8538496	Spontaneous	2014-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8538496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8541841	Spontaneous	2014-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Fibromyalgia (n/a - Unknown - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8541841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8541858	Spontaneous	2014-10-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Body temperature decreased (6d - Recovered/Resolved - );Malaise (n/a - Not Recovered/Not Resolved - );Upper respiratory tract infection (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8541858&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8531974	Spontaneous	2014-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling);Bronchitis (n/a - Recovered/Resolved - Disabling);Chest discomfort (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Recovering/Resolving - Disabling);Food intolerance (n/a - Not Recovered/Not Resolved - Disabling);Listless (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Parosmia (n/a - Recovering/Resolving - Disabling);Pharyngitis (n/a - Recovering/Resolving - Disabling);Taste disorder (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8531974&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8531981	Spontaneous	2014-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anxiety (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Autoimmune disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Childhood depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Eye pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);General physical health deterioration (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Intracranial pressure increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Meningitis viral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Mobility decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Papilloedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paresis cranial nerve (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Photophobia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Quality of life decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sinusitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Strabismus (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tonsillitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral])	[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT) AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED)] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8531981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8532148	Spontaneous	2014-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Toxoplasmosis (83d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Prophylaxis - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8532148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-8532581	Spontaneous	2014-10-29 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8532581&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8532865	Spontaneous	2014-10-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cardiac murmur (n/a - Recovering/Resolving - Other Medically Important Condition);Chills (n/a - Recovering/Resolving - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Subcutaneous])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8532865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8534154	Spontaneous	2014-10-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8534154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8534155	Spontaneous	2014-10-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8534155&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8525978	Spontaneous	2014-10-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dry mouth (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nightmare (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral])	[ETHINYLESTRADIOL, NORETHISTERONE, LACTOSE MONOHYDRATE, NORETHISTERONE ACETATE, ETHINYLESTRADIOL] (C - Contraception - Not applicable - [n/a - n/a - n/a])|[SUMATRIPTAN] (C - Migraine - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8525978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8526292	Spontaneous	2014-10-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site erythema (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8526292&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8521136	Spontaneous	2014-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Condition aggravated (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	[PHENPROCOUMON] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8521136&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8523424	Spontaneous	2014-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[DIGOXIN] (C - n/a - n/a - [n/a - 125ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8523424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8523425	Spontaneous	2014-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site pruritus (5h - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[INDOMETACINE] (C - n/a - n/a - [n/a - 75mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8523425&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8523712	Spontaneous	2014-10-27 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Body temperature increased (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal pain (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Toxic skin eruption (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	ALL OTHER THERAPEUTIC PRODUCTS [NOT AVAILABLE] (S - Product used for unknown indication - Drug withdrawn - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - .5mL - Subcutaneous])|[CHLORPHENAMINE MALEATE, PARACETAMOL, PHENYLEPHRINE, CAFFEINE] (S - Body temperature increased - Drug withdrawn - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8523712&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8509025	Spontaneous	2014-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8509025&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8512367	Spontaneous	2014-10-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	NON SPECIFIED ANTIBIOTICA [UNKNOWN] (C - n/a - Unknown - [n/a - 1{DF} - Unknown])|[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8512367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8504241	Spontaneous	2014-10-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myofascitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[ALGELDRATE, HEPATITIS B SURFACE ANTIGENS RECOMBINANT (S, PRE-S2), HEPATITIS B SURFACE ANTIGEN (RDNA), HEPATITIS B SURFACE ANTIGENS RECOMBINANT (S, PRE-S2)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[ALUMINIUM, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM HYDROXIDE [PRODUCED IN S. CEREVISIAE (STRAIN 2150-2-3) BY RDNA], HEPATITIS B SURFACE ANTIGEN (RDNA), HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM HYDROXIDE [PRODUCED IN S. CEREVISIAE (STRAIN 2150-2-3) BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS B SURFACE ANTIGEN, ALGELDRATE, HEPATITIS B VIRUS SURFACE ANTIGEN [PRODUCED IN S. CEREVISIAE CELLS BY RDNA] ADSORBED ON ALUMINUM HYDROXIDE, HYDRATED, ALGELDRATE] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8504241&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8505132	Spontaneous	2014-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Asthma (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dysgeusia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fluid intake reduced (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hyperacusis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypophagia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Photophobia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Quality of life decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Unknown - [n/a - n/a - Intramuscular])	NOT AVAILABLE (C - Migraine prophylaxis - n/a - [n/a - 20mg - Oral])|[FLUTICASONE PROPIONATE] (C - Asthma - n/a - [n/a - 100ug - Respiratory (inhalation)])|[IBUPROFEN] (C - Headache - n/a - [n/a - 200mg - Oral])|[SALBUTAMOL SULFATE] (C - Asthma - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Asthma - n/a - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8505132&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8505445	Spontaneous	2014-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);H1N1 influenza (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nasal septum deviation (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Respiratory tract infection (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Streptococcal infection (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[EBASTINE] (C - Food allergy - Dose not changed - [n/a - 20mg - Oral])|[EBASTINE] (C - Seasonal allergy - Dose not changed - [n/a - n/a - n/a])|[FLECAINIDE, FLECAINIDE ACETATE] (C - n/a - Drug withdrawn - [n/a - n/a - n/a])|[LORATADINE] (C - n/a - Dose not changed - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8505445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8506887	Spontaneous	2014-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8506887&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8507658	Spontaneous	2014-10-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site inflammation (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8507658&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8496054	Spontaneous	2014-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Back pain (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Dyspnoea (n/a - Recovering/Resolving - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Gastroenteritis viral (n/a - Not Recovered/Not Resolved - Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Hyperaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Disabling);Limb discomfort (n/a - Not Recovered/Not Resolved - Disabling);Muscle twitching (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling);Pruritus (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Vertigo (n/a - Not Recovered/Not Resolved - Disabling);Wheezing (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Unknown - [n/a - n/a - Intramuscular])	[CETIRIZINE DIHYDROCHLORIDE] (C - n/a - Unknown - [n/a - 10mg - n/a])|[CODEINE PHOSPHATE SESQUIHYDRATE, PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE] (C - Back pain - Unknown - [n/a - 50mg - n/a])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM] (C - n/a - Unknown - [n/a - 50mg - n/a])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - .5{DF} - n/a])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 100ug - n/a])|[LORATADINE] (C - n/a - Unknown - [n/a - 10mg - Oral])|[MECILLINAM, PIVMECILLINAM, PIVMECILLINAM HYDROCHLORIDE] (C - Urinary tract infection - n/a - [n/a - 200mg - n/a])|[SALBUTAMOL SULFATE] (C - Dyspnoea - Unknown - [n/a - .2mg - Respiratory (inhalation)])|[SUMATRIPTAN] (C - Migraine - Unknown - [n/a - 100mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8496054&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8498269	Spontaneous	2014-10-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Parenteral])	[BETAMETHASONE, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[ETHINYLESTRADIOL, NORETHISTERONE, NORETHISTERONE, ETHINYLESTRADIOL PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[MESALAZINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8498269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8498909	Spontaneous	2014-10-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Influenza (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Malaise (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sepsis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8498909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8499200	Spontaneous	2014-10-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bradyphrenia (n/a - Unknown - Other Medically Important Condition);Burnout syndrome (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Decreased activity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling hot (n/a - Recovered/Resolved - Other Medically Important Condition);Head injury (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8499200&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8490712	Spontaneous	2014-10-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (1d - Recovered/Resolved - );Fatigue (1d - Recovered/Resolved - );Malaise (1d - Recovered/Resolved - );Oropharyngeal pain (n/a - Not Recovered/Not Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8490712&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8491010	Spontaneous	2014-10-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Pyrexia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8491010&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8484936	Spontaneous	2014-10-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8484936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8484960	Spontaneous	2014-10-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8484960&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8486462	Spontaneous	2014-10-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8486462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8486525	Spontaneous	2014-10-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chills (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Injection site induration (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site mass (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Mouth ulceration (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oral herpes (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Parenteral])	DENOSUMAB [DENOSUMAB] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8486525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8487880	Spontaneous	2014-10-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Injection site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8487880&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8476860	Spontaneous	2014-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8476860&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8477695	Spontaneous	2014-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Leukocytosis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8477695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8470836	Spontaneous	2014-10-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	No	Male	Erythema (4d - Recovered/Resolved - Disabling);Extensive swelling of vaccinated limb (4d - Recovered/Resolved - Disabling);Vaccination site reaction (4d - Recovered/Resolved - Disabling)	PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])...	[WARFARIN, WARFARIN SODIUM] (C - Pulmonary embolism - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8470836&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8471750	Spontaneous	2014-10-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Alopecia areata (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Alopecia totalis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8471750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8473933	Spontaneous	2014-10-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza like illness (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site rash (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Pain - Not applicable - [n/a - n/a - n/a])	ALL OTHER THERAPEUTIC PRODUCTS [NOT AVAILABLE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8473933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8462233	Spontaneous	2014-10-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8462233&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8456930	Spontaneous	2014-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Needle issue (n/a - Unknown - );Vaccination site pain (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8456930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8457225	Spontaneous	2014-10-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depression (n/a - Recovered/Resolved - Disabling);Hypoaesthesia (n/a - Recovered/Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza - n/a - [n/a - n/a - n/a])	[NITROFURANTOIN, NITROFURANTOIN PH. EUR.] (C - Urinary tract infection - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8457225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8459262	Spontaneous	2014-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8459262&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8450937	Spontaneous	2014-10-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8450937&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8452827	Spontaneous	2014-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8452827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8447629	Spontaneous	2014-10-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Condition aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dyspepsia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	CIALIS [TADALAFIL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|LEVITRA [VARDENAFIL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|NOVORAPID [INSULIN ASPART] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|VIAGRA [SILDENAFIL, SILDENAFIL CITRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ACETYLCYSTEINE] (C - Increased bronchial secretion - n/a - [n/a - 200mg - n/a])|[DIAZEPAM] (C - Stiff person syndrome - n/a - [n/a - 5mg - n/a])|[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - 500mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8447629&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8441546	Spontaneous	2014-10-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Feeding disorder (3d - Unknown - Other Medically Important Condition);Foetal death (n/a - Unknown - Other Medically Important Condition);Pain (3d - Unknown - Other Medically Important Condition);Pyrexia (3d - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[DIPHTHERIA AND TETANUS TOXOIDS] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])|[HEPATITIS B VACCINE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8441546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8437803	Spontaneous	2014-10-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Irritability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Obsessive-compulsive disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Phobia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Separation anxiety disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])|PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	[METHYLPHENIDATE HYDROCHLORIDE] (C - Attention deficit hyperactivity disorder - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8437803&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8433620	Spontaneous	2014-10-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anosmia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8433620&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8429317	Spontaneous	2014-09-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Enthesopathy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Juvenile idiopathic arthritis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Keratitis (n/a - Unknown - Disabling, Other Medically Important Condition);Keratoconus (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pelvic pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	PATCH (UNSPECIFIED) [UNKNOWN] (C - Duane's syndrome - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8429317&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8423233	Spontaneous	2014-09-29 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8423233&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8423234	Spontaneous	2014-09-29 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8423234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8422248	Spontaneous	2014-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8422248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8419606	Spontaneous	2014-09-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Bedridden (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Hypokinesia (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Dose not changed - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8419606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8420919	Spontaneous	2014-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Dermatomyositis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8420919&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8420988	Spontaneous	2014-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8420988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8413384	Spontaneous	2014-09-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling hot (n/a - Unknown - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Unknown - Disabling);Pain (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8413384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8408169	Spontaneous	2014-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amnesia (n/a - Not Recovered/Not Resolved - Disabling);Back pain (n/a - Not Recovered/Not Resolved - Disabling);Candida infection (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Coordination abnormal (n/a - Not Recovered/Not Resolved - Disabling);Dengue fever (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness postural (n/a - Not Recovered/Not Resolved - Disabling);Dry eye (n/a - Not Recovered/Not Resolved - Disabling);Dry mouth (n/a - Not Recovered/Not Resolved - Disabling);Dyspepsia (n/a - Not Recovered/Not Resolved - Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling);Exostosis (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling cold (n/a - Not Recovered/Not Resolved - Disabling);Feeling hot (n/a - Not Recovered/Not Resolved - Disabling);Food poisoning (n/a - Unknown - Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Disabling);Hypoacusis (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Mouth ulceration (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nasal congestion (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Periorbital pain (n/a - Not Recovered/Not Resolved - Disabling);Pharyngitis (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling);Slow response to stimuli (n/a - Not Recovered/Not Resolved - Disabling);Social avoidant behaviour (n/a - Not Recovered/Not Resolved - Disabling);Vision blurred (n/a - Not Recovered/Not Resolved - Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling);Vomiting (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8408169&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8408170	Spontaneous	2014-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Anxiety (n/a - Unknown - Caused/Prolonged Hospitalisation);Appendicitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Bipolar disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Generalised tonic-clonic seizure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Genital infection female (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypnopompic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypomania (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypothyroidism (n/a - Unknown - Caused/Prolonged Hospitalisation);Impaired work ability (n/a - Unknown - Caused/Prolonged Hospitalisation);Menstruation irregular (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Poisoning (n/a - Unknown - Caused/Prolonged Hospitalisation);Quality of life decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Schizophrenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Suicidal ideation (n/a - Unknown - Caused/Prolonged Hospitalisation);Syncope (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8408170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8409619	Spontaneous	2014-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8409619&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8403984	Spontaneous	2014-09-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8403984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8400087	Spontaneous	2014-09-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Burning sensation (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersensitivity (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Osteoarthritis (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Polyarthritis (n/a - Not Recovered/Not Resolved - Disabling);Pruritus (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8400087&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8400091	Spontaneous	2014-09-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Decreased appetite (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dependent personality disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Weight decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	AERIUS [DESLORATADINE] (C - Rhinitis allergic - Unknown - [n/a - 5mg - n/a])|INSULIN ASPART [INSULIN ASPART] (C - Diabetes mellitus - Unknown - [n/a - 10{DF} - n/a])|JANUVIA [SITAGLIPTIN, SITAGLIPTIN PHOSPHATE, SITAGLIPTIN PHOSPHATE MONOHYDRATE] (C - Diabetes mellitus - Unknown - [n/a - 100mg - n/a])|NOVORAPID [INSULIN ASPART] (C - Diabetes mellitus - Unknown - [n/a - 4{DF} - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Diabetes mellitus - Unknown - [n/a - 10mg - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - Unknown - [n/a - 10mg - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - Unknown - [n/a - 500mg - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - Unknown - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Blood cholesterol increased - Unknown - [31d - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8400091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8393176	Spontaneous	2014-09-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8393176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8397121	Spontaneous	2014-09-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Presyncope (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8397121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8397136	Spontaneous	2014-09-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8397136&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8389893	Spontaneous	2014-09-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyskinesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Excessive eye blinking (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Head titubation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Increased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Protrusion tongue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	[BACILLUS CALMETTE-GUERIN VACCINE] (C - n/a - n/a - [1d - n/a - n/a])|[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT) AND HEPATITIS B (RDNA) VACCINE (ADSORBED)] (C - n/a - n/a - [1d - n/a - n/a])|[HEPATITIS A VIRUS] (C - n/a - n/a - [1d - n/a - n/a])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (C - n/a - n/a - [1d - n/a - n/a])|[MENINGOCOCCAL GROUP C CONJUGATE VACCINE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197] (C - n/a - n/a - [1d - n/a - n/a])|[MENINGOCOCCAL GROUP C CONJUGATE VACCINE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197] (C - n/a - n/a - [n/a - n/a - n/a])|[SALMONELLA TYPHI] (C - n/a - n/a - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8389893&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8387004	Spontaneous	2014-09-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Eye swelling (4d - Recovered/Resolved - Other Medically Important Condition);Incomplete course of vaccination (n/a - Unknown - Other Medically Important Condition);Injected limb mobility decreased (n/a - Unknown - Other Medically Important Condition);Injection site joint swelling (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination site erythema (n/a - Unknown - Other Medically Important Condition);Vaccination site swelling (4d - Recovered/Resolved - Other Medically Important Condition);Vaccination site warmth (n/a - Unknown - Other Medically Important Condition)	BEXSERO [ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN PRODUCED IN E. COLI CELLS BY RECOMBINANT DNA TECHNOLOGY ADSORBED ON ALUMINIUM HYDROXIDE, OUTER MEMBRANE VESICLES (OMV) FROM NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 MEASURED AS AMOUNT OF TOTAL PROTEIN CONTAINING THE PORA P1.4 ADSORBED ON ALUMINIUM HYDROXIDE] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8387004&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8374434	Spontaneous	2014-09-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Carpal tunnel syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Gait inability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Gait spastic (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Joint range of motion decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Mobility decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myasthenia gravis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Performance status decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMITRIPTYLINE HYDROCHLORIDE] (C - Pain in extremity - Unknown - [n/a - n/a - n/a])|[BACLOFEN] (C - n/a - Unknown - [n/a - n/a - n/a])|[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - Pain - Unknown - [n/a - n/a - n/a])|[CARBAMAZEPINE] (C - Pain - Unknown - [n/a - n/a - n/a])|[MECILLINAM, PIVMECILLINAM, PIVMECILLINAM HYDROCHLORIDE] (C - Urinary tract infection - Unknown - [n/a - n/a - n/a])|[PARACETAMOL, PARACETAMOL, ASPARTAME] (C - Pain - Unknown - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE] (C - Muscle spasms - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8374434&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8369699	Spontaneous	2014-09-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Muscle spasms (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Neuralgia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8369699&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8372274	Spontaneous	2014-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8372274&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8367765	Spontaneous	2014-09-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8367765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8357107	Spontaneous	2014-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Affect lability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Disability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Nocturia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Obstructive sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep attacks (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep talking (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Type 2 diabetes mellitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8357107&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8359855	Spontaneous	2014-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Hyperpyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8359855&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8359886	Spontaneous	2014-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8359886&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8353201	Spontaneous	2014-09-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Snoring (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8353201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8349285	Spontaneous	2014-09-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8349285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8351108	Spontaneous	2014-09-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Coordination abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation);Depression (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle atrophy (n/a - Unknown - Caused/Prolonged Hospitalisation);Peroneal nerve palsy (n/a - Unknown - Caused/Prolonged Hospitalisation);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation);Suicidal ideation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Suicide attempt (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])|[PREDNISOLONE] (S - Lung disorder - Unknown - [n/a - n/a - n/a])	VALDOXAN [AGOMELATINE] (C - Depression - n/a - [n/a - n/a - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Lung disorder - n/a - [n/a - n/a - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Lung disorder - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8351108&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8351167	Spontaneous	2014-09-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8351167&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8351168	Spontaneous	2014-09-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8351168&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8342477	Spontaneous	2014-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8342477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8337750	Spontaneous	2014-09-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8337750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8339080	Spontaneous	2014-09-04 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Cerebral palsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eye movement disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Motor developmental delay (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Optic atrophy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])|SYNFLORIX [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - n/a - n/a - [251d - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8339080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8332593	Spontaneous	2014-09-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Autoimmune hepatitis (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8332593&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8321518	Spontaneous	2014-09-02 00:00:00	Healthcare Professional	European Economic Area	OMON, DAMASE-MICHEL, HURAULT-DELARUE, LACROIX, MONTASTRUC. Non-adjuvanted 2009 influenza A (H1N1) vaccine in pregnant women: The results of a French prospective descriptive study.. VACCINE 2011;29:9649-9654. CHAVANT F, INGRAND I, JONVILLE-BERRA A, PLAZANET C, GRAS-CHAMPEL V, LAGARCE L, et al. The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza. Drug Safety 2013;36:455-465. OMON, DAMASE-MICHEL, HURAULT-DELARUE, LACROIX, MONTASTRUC.	Not Specified	Not Specified	Yes	Male	Foetal death (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Foetal exposure timing unspecified - Not applicable - [n/a - n/a - Transplacental])|[PARACETAMOL] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8321518&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8320330	Spontaneous	2014-09-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8320330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8312685	Spontaneous	2014-08-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal distension (n/a - Not Recovered/Not Resolved - Disabling);Abdominal pain (n/a - Not Recovered/Not Resolved - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Balance disorder (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling);Cyst rupture (n/a - Recovered/Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Dyspepsia (n/a - Not Recovered/Not Resolved - Disabling);Emotional distress (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Hyperaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Disabling);Mood swings (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Ovarian cyst (n/a - Recovered/Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Parosmia (n/a - Not Recovered/Not Resolved - Disabling);Peripheral coldness (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Slow speech (n/a - Not Recovered/Not Resolved - Disabling);Temperature regulation disorder (n/a - Not Recovered/Not Resolved - Disabling);Vomiting (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	BIRTH CONTROL NAME UNKNOWN [BIRTH CONTROL] (C - Contraception - Unknown - [n/a - n/a - n/a])|[AMITRIPTYLINE HYDROCHLORIDE] (C - Migraine - Unknown - [n/a - n/a - n/a])|[CANDESARTAN CILEXETIL] (C - Migraine - Unknown - [n/a - n/a - n/a])|[CODEINE PHOSPHATE SESQUIHYDRATE, PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE] (C - Migraine - Unknown - [n/a - n/a - n/a])|[GABAPENTIN] (C - Migraine - Unknown - [n/a - n/a - n/a])|[NALTREXONE, NALTREXONE HYDROCHLORIDE] (C - Migraine - Unknown - [n/a - n/a - n/a])|[PREDNISOLONE] (C - Migraine - Unknown - [n/a - n/a - n/a])|[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[SODIUM VALPROATE] (C - Migraine - Unknown - [n/a - n/a - n/a])|[TOPIRAMATE] (C - Migraine - Unknown - [n/a - n/a - n/a])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - Migraine - Unknown - [n/a - n/a - n/a])|[ZOLMITRIPTAN] (C - Migraine - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8312685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8314493	Spontaneous	2014-08-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8314493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8314520	Spontaneous	2014-08-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Depression (n/a - Recovering/Resolving - Other Medically Important Condition);Dizziness (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8314520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8310525	Spontaneous	2014-08-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fall (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Psychogenic seizure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8310525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8302728	Spontaneous	2014-08-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Recovering/Resolving - Disabling);Diarrhoea (n/a - Unknown - Disabling);Dyspepsia (n/a - Recovering/Resolving - Disabling);Ear pain (n/a - Unknown - Disabling);Headache (n/a - Recovering/Resolving - Disabling);Irritable bowel syndrome (n/a - Unknown - Disabling);Mixed anxiety and depressive disorder (n/a - Unknown - Disabling);Myalgia (n/a - Recovering/Resolving - Disabling);Nausea (n/a - Recovering/Resolving - Disabling);Panic attack (n/a - Unknown - Disabling);Retching (n/a - Recovering/Resolving - Disabling);Sleep disorder (n/a - Recovering/Resolving - Disabling);Stress (n/a - Recovering/Resolving - Disabling);Urge incontinence (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8302728&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8302729	Spontaneous	2014-08-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angina pectoris (n/a - Unknown - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Autoimmune thyroiditis (n/a - Not Recovered/Not Resolved - Disabling);Back pain (n/a - Not Recovered/Not Resolved - Disabling);Bronchitis (n/a - Unknown - Disabling);Chest discomfort (n/a - Unknown - Disabling);Chronic obstructive pulmonary disease (n/a - Not Recovered/Not Resolved - Disabling);Constipation (n/a - Unknown - Disabling);Cough (n/a - Unknown - Disabling);Decreased appetite (n/a - Unknown - Disabling);Depression (n/a - Unknown - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Emphysema (n/a - Unknown - Disabling);Facet joint syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling hot (n/a - Unknown - Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Unknown - Disabling);Hypercalcaemia (n/a - Not Recovered/Not Resolved - Disabling);Iron deficiency anaemia (n/a - Not Recovered/Not Resolved - Disabling);Metabolic disorder (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Unknown - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Pneumonia (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Sputum purulent (n/a - Unknown - Disabling);Viral infection (n/a - Not Recovered/Not Resolved - Disabling);Visual impairment (n/a - Unknown - Disabling);Vomiting (n/a - Unknown - Disabling);Weight decreased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8302729&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8302730	Spontaneous	2014-08-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Asthma exercise induced (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Autoimmune hepatitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cushingoid (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Epistaxis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hepatomegaly (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Liver induration (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Palpitations (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Splenomegaly (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8302730&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8297334	Spontaneous	2014-08-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Injury associated with device (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8297334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8300569	Spontaneous	2014-08-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anal incontinence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Arthritis reactive (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Disability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness postural (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Encephalomyelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypertension (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Upper respiratory tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8300569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8295375	Spontaneous	2014-08-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Burning sensation (n/a - Unknown - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cognitive disorder (n/a - Unknown - Other Medically Important Condition);Coordination abnormal (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fibromyalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Genital burning sensation (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Influenza immunisation - Unknown - [n/a - n/a - Intramuscular])	[ATENOLOL] (C - Palpitations - n/a - [n/a - 50mg - Oral])|[CARBIMAZOLE] (C - Hyperthyroidism - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8295375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8295376	Spontaneous	2014-08-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Burning sensation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Groin pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain in extremity (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Dose increased - [n/a - n/a - Intramuscular])	[DESOGESTREL] (C - Oral contraception - n/a - [n/a - n/a - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Depression - n/a - [n/a - 20mg - Oral])|[ETHINYLESTRADIOL, GESTODENE] (C - Oral contraception - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8295376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8287919	Spontaneous	2014-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Live birth (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8287919&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8283656	Spontaneous	2014-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8283656&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8277169	Spontaneous	2014-08-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Unknown - Disabling);Fall (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Disabling);Weight increased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8277169&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8279093	Spontaneous	2014-08-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Hallucination (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8279093&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8280240	Spontaneous	2014-08-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8280240&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8280350	Spontaneous	2014-08-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8280350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8272026	Spontaneous	2014-08-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Neck pain (151d - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (151d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (4mo - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (151d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8272026&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-8272169	Spontaneous	2014-08-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Bronchitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait spastic (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Intervertebral disc protrusion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myositis (9d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nasopharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neurodermatitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Influenza immunisation - Not applicable - [1d - 7ug - Intramuscular])	[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[ASCORBIC ACID, MAGNESIUM OXIDE, HEAVY, MAGNESIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Premedication - n/a - [n/a - n/a - Unknown])|[ENTEROCOCCUS FAECIUM, ENTEROCOCCUS FAECIUM SF68, ENTEROCOCCUS SPP.] (C - Premedication - n/a - [n/a - n/a - Unknown])|[HEPATITIS B VACCINE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[MONTELUKAST, MONTELUKAST SODIUM] (C - Premedication - n/a - [n/a - n/a - Unknown])|[PREDNISOLONE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8272169&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8272867	Spontaneous	2014-08-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Disabling);Anxiety (n/a - Not Recovered/Not Resolved - Disabling);Balance disorder (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling);Confusional state (n/a - Not Recovered/Not Resolved - Disabling);Disorientation (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Dyspnoea exertional (n/a - Not Recovered/Not Resolved - Disabling);Eye pain (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Influenza (n/a - Not Recovered/Not Resolved - Disabling);Initial insomnia (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Learning disability (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Migraine (n/a - Not Recovered/Not Resolved - Disabling);Muscle fatigue (n/a - Not Recovered/Not Resolved - Disabling);Nervous system disorder (n/a - Not Recovered/Not Resolved - Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Performance status decreased (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Stress (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8272867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8272868	Spontaneous	2014-08-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8272868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8272869	Spontaneous	2014-08-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8272869&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8268561	Spontaneous	2014-08-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8268561&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8264677	Spontaneous	2014-08-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Alopecia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Blister (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysgeusia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Eczema (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Oedema peripheral (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - {DF} - n/a])	[EZETIMIBE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8264677&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8261680	Spontaneous	2014-08-14 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Lessa R et al. Neurological complications after H1N1 influenza vaccination: Magnetic resonance imaging findings Complicações neurológicas após vacinação para H1N1: Achados de ressonância magnética [In Process] Arq. Neuro-Psiquiatr. 2014 72:7 (496-499)	12-17 Years	Not Specified	No	Female	Brain oedema (n/a - Recovering/Resolving - Life Threatening);Cerebellar ataxia (60d - Recovered/Resolved - Life Threatening);Headache (60d - Recovered/Resolved - Life Threatening);Hydrocephalus (n/a - Recovering/Resolving - Life Threatening);Intracranial pressure increased (n/a - Recovering/Resolving - Life Threatening);Vomiting (n/a - Recovering/Resolving - Life Threatening)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8261680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-8261681	Spontaneous	2014-08-14 00:00:00	Healthcare Professional	Non European Economic Area	Lessa R et al. Neurological complications after H1N1 influenza vaccination: Magnetic resonance imaging findings Complicações neurológicas após vacinação para H1N1: Achados de ressonância magnética [In Process] Arq. Neuro-Psiquiatr. 2014 72:7 (496-499)	3-11 Years	Not Specified	No	Male	Facial paralysis (n/a - Recovering/Resolving - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8261681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8261682	Spontaneous	2014-08-14 00:00:00	Healthcare Professional	Non European Economic Area	Lessa R et al. Neurological complications after H1N1 influenza vaccination: Magnetic resonance imaging findings Complicações neurológicas após vacinação para H1N1: Achados de ressonância magnética [In Process] Arq. Neuro-Psiquiatr. 2014 72:7 (496-499)	65-85 Years	Not Specified	No	Female	Abnormal behaviour (n/a - Recovering/Resolving - Other Medically Important Condition);Mental impairment (n/a - Recovering/Resolving - Other Medically Important Condition);Neurological symptom (n/a - Recovering/Resolving - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8261682&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8250316	Spontaneous	2014-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8250316&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8250614	Spontaneous	2014-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8250614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8245248	Spontaneous	2014-08-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Seizure (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8245248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8245327	Spontaneous	2014-08-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cough (4wk - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Eating disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Erythema nodosum (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hyperaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypophagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Immunodeficiency (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Initial insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Nasopharyngitis (4wk - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Poor quality sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Viral infection (4wk - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Weight decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - Contraception - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8245327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8248451	Spontaneous	2014-08-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8248451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8241455	Spontaneous	2014-08-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Disabling);Narcolepsy (n/a - Unknown - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8241455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8236361	Spontaneous	2014-08-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (C - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8236361&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8227872	Spontaneous	2014-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Alopecia areata (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Asthma - Unknown - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8227872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8230214	Spontaneous	2014-08-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8230214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8230680	Spontaneous	2014-08-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Muscle spasms (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8230680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8232240	Spontaneous	2014-08-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8232240&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8232293	Spontaneous	2014-08-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8232293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8224678	Spontaneous	2014-08-05 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Arthritis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Gastroenteritis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Lymphopenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Neutropenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - Asthma - Unknown - [n/a - 125ug - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - Asthma - Unknown - [n/a - 5mg - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8224678&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8219499	Spontaneous	2014-08-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cough (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Joint stiffness (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Respiratory tract infection (n/a - Not Recovered/Not Resolved - Disabling);Sinusitis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	[ALPRAZOLAM] (C - Anxiety disorder - Unknown - [n/a - n/a - n/a])|[CHLORCYCLIZINE HYDROCHLORIDE, ERGOTAMINE TARTRATE, CAFFEINE, CHLORCYCLIZINE HYDROCHLORIDE, ERGOTAMINE TARTRATE, MEPROBAMATE, CAFFEINE] (C - Migraine - Unknown - [n/a - n/a - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - n/a])|[CYANOCOBALAMIN, VITAMIN B12] (C - Vitamin B12 deficiency - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - Rhinitis - Unknown - [n/a - n/a - n/a])|[NORETHISTERONE ACETATE, ESTRADIOL, NORETHISTERONE ACETATE, ESTRADIOL HEMIHYDRATE, NORETHISTERONE, ESTRADIOL HEMIHYDRATE] (C - Hormone replacement therapy - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8219499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8213660	Spontaneous	2014-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Anger (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Coordination abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypophagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Initial insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Malnutrition (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Mood altered (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pharyngitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Psychomotor hyperactivity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Restlessness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Tremor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8213660&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8207371	Spontaneous	2014-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8207371&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8209860	Spontaneous	2014-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Neuritis (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site pain (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8209860&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8211187	Spontaneous	2014-07-31 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Male	Encephalopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8211187&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8198312	Spontaneous	2014-07-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Polyarthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Subcutaneous])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (S - n/a - Dose not changed - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8198312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8198343	Spontaneous	2014-07-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (1d - Recovered/Resolved - Other Medically Important Condition);Ear pain (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (1d - Recovered/Resolved - Other Medically Important Condition);Urticaria (3d - Recovered/Resolved - Other Medically Important Condition)	LANTUS [INSULIN GLARGINE] (S - n/a - Dose not changed - [n/a - n/a - Intradermal])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - Intradermal])|[METFORMIN EMBONATE] (S - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[METOPIMAZINE] (S - n/a - Dose not changed - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8198343&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8198942	Spontaneous	2014-07-29 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Peripheral swelling (0mo - Recovered/Resolved - );Rash macular (0mo - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8198942&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8200214	Spontaneous	2014-07-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8200214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8196241	Spontaneous	2014-07-28 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Drug ineffective (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8196241&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8196242	Spontaneous	2014-07-28 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Drug ineffective (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8196242&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8196607	Spontaneous	2014-07-28 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Drug ineffective (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8196607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8196608	Spontaneous	2014-07-28 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drug ineffective (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8196608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8196609	Spontaneous	2014-07-28 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Drug ineffective (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8196609&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8183156	Spontaneous	2014-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Decreased vibratory sense (n/a - Unknown - Caused/Prolonged Hospitalisation);Demyelination (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysphonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea exertional (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Formication (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Oropharyngeal discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	HORMONAL INTRAUTERINE CONTRACEPTIVE DEVICE (UNSPECIFIED) [HORMONAL CONTRACEPTIVE (UNSPECIFIED)] (C - Contraception - Unknown - [n/a - n/a - Intra-uterine])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (C - Prophylaxis - Not applicable - [1d - .5mL - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN] (C - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8183156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8183390	Spontaneous	2014-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Infection susceptibility increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8183390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8174071	Spontaneous	2014-07-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Status epilepticus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8174071&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8174753	Spontaneous	2014-07-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Antisocial behaviour (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Back disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Decreased appetite (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dysphonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Immunodeficiency (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Iron deficiency anaemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Lung disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Malnutrition (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pneumonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pneumonia haemophilus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pneumonia moraxella (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pneumonia pseudomonal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pneumonia staphylococcal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Productive cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Quality of life decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sinusitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sputum discoloured (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Staphylococcal infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Weight decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	HUMIRA [ADALIMUMAB] (C - n/a - Unknown - [n/a - n/a - n/a])|[ALIMEMAZINE TARTRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Diarrhoea - Unknown - [n/a - n/a - n/a])|[CARISOPRODOL] (C - Urinary tract infection - Unknown - [n/a - n/a - n/a])|[CARISOPRODOL] (C - n/a - Unknown - [n/a - n/a - n/a])|[LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE OXIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[MESALAZINE] (C - Diarrhoea - Unknown - [n/a - n/a - n/a])|[PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - Pain - Unknown - [n/a - n/a - n/a])|[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - Colitis ulcerative - Unknown - [n/a - n/a - n/a])|[ZOLMITRIPTAN] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8174753&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8174768	Spontaneous	2014-07-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anosmia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dry eye (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyskinesia (n/a - Unknown - Disabling, Other Medically Important Condition);Holmes-Adie pupil (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Lichen planus (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Migraine (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Oesophagitis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Polyarthritis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8174768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8169372	Spontaneous	2014-07-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (1d - Recovered/Resolved - Other Medically Important Condition);Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Diarrhoea (1d - Recovered/Resolved - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Vomiting (1d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8169372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8169652	Spontaneous	2014-07-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling);Anxiety (n/a - Unknown - Disabling);Arthralgia (n/a - Unknown - Disabling);Asthenia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Dizziness postural (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Gastroenteritis (n/a - Unknown - Disabling);Hyperacusis (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Mood swings (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Unknown - Disabling);Pyrexia (1wk - Recovered/Resolved - Disabling);Temperature regulation disorder (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[LACTULOSE] (C - Constipation - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8169652&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8169653	Spontaneous	2014-07-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anxiety (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Cardiovascular disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Conjunctivitis allergic (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Crying (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness exertional (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dizziness postural (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dysstasia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Eye pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fear (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Hallucination (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hyperacusis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypoglycaemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Immobile (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Mood swings (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Motion sickness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Ocular hyperaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Rhinorrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Temperature regulation disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8169653&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8169654	Spontaneous	2014-07-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Disabling);Balance disorder (n/a - Unknown - Disabling);Compression fracture (n/a - Unknown - Disabling);Coordination abnormal (n/a - Unknown - Disabling);Cough (n/a - Unknown - Disabling);Deafness neurosensory (n/a - Unknown - Disabling);Diarrhoea (n/a - Unknown - Disabling);Extrapyramidal disorder (n/a - Unknown - Disabling);Fall (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Gait disturbance (n/a - Unknown - Disabling);Gastroenteritis (n/a - Unknown - Disabling);General physical health deterioration (n/a - Unknown - Disabling);Influenza (n/a - Unknown - Disabling);Lacrimation increased (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Muscular weakness (n/a - Unknown - Disabling);Neck pain (n/a - Recovering/Resolving - Disabling);Pain in extremity (n/a - Recovering/Resolving - Disabling);Progressive supranuclear palsy (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Respiratory tract infection (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CASCARA, ETHYLMORPHINE HYDROCHLORIDE, ETHYLMORPHINE HYDROCHLORIDE, FRANGULA PURSHIANA BARK] (C - Bronchitis - Unknown - [n/a - n/a - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - Ill-defined disorder - Unknown - [n/a - n/a - n/a])|[NAPROXEN] (C - Psoriatic arthropathy - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8169654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8169655	Spontaneous	2014-07-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Unknown - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral])	[DIAZEPAM] (C - Epilepsy - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8169655&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8152961	Spontaneous	2014-07-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	0-1 Month	Not Specified	No	Male	Immunodeficiency (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Macrocephaly (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Psychomotor retardation (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8152961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-8154047	Spontaneous	2014-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Anaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Colitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Crohn's disease (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Erythema infectiosum (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Haematochezia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Nasopharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Weight decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8154047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8154630	Spontaneous	2014-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperpyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinitis (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8154630&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8154710	Spontaneous	2014-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8154710&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8154834	Spontaneous	2014-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8154834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8155317	Spontaneous	2014-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8155317&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8155969	Spontaneous	2014-07-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - Disabling);Loss of personal independence in daily activities (n/a - Unknown - Disabling);Mobility decreased (n/a - Unknown - Disabling);Pain (n/a - Unknown - Disabling);Vaccination site erythema (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8155969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8149642	Spontaneous	2014-07-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Fructose intolerance (n/a - Not Recovered/Not Resolved - Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Influenza (n/a - Recovered/Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Sinusitis (n/a - Recovered/Resolved - Disabling);Syncope (n/a - Recovered/Resolved - Disabling);Tension headache (n/a - Not Recovered/Not Resolved - Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ALIMEMAZINE TARTRATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8149642&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8143863	Spontaneous	2014-07-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8143863&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8143895	Spontaneous	2014-07-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8143895&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8144595	Spontaneous	2014-07-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Apathy (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);Ill-defined disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);Nasal congestion (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8144595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Life Threatening	Hospitalisation
EU-EC-8144885	Spontaneous	2014-07-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Autism spectrum disorder (n/a - Not Recovered/Not Resolved - Disabling);Exposure during pregnancy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8144885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8145190	Spontaneous	2014-07-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Unknown - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[METHYLPHENIDATE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8145190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8138587	Spontaneous	2014-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Antisocial behaviour (n/a - Recovering/Resolving - Other Medically Important Condition);Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Coordination abnormal (n/a - Recovering/Resolving - Other Medically Important Condition);Depression (n/a - Recovering/Resolving - Other Medically Important Condition);Disturbance in attention (n/a - Recovering/Resolving - Other Medically Important Condition);Fall (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Irritability (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8138587&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8139787	Spontaneous	2014-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Affect lability (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling hot (n/a - Not Recovered/Not Resolved - Disabling);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8139787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8140791	Spontaneous	2014-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8140791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8132568	Spontaneous	2014-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Polymyalgia rheumatica (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8132568&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-8134343	Spontaneous	2014-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Erythema (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Infectious mononucleosis (n/a - Recovered/Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8134343&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8134344	Spontaneous	2014-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Ageusia (n/a - Not Recovered/Not Resolved - Disabling);Anosmia (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - n/a - n/a])|[CLOBETASOL PROPIONATE] (C - Back pain - Unknown - [n/a - n/a - n/a])|[LORATADINE] (C - Arthralgia - Unknown - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Type 2 diabetes mellitus - Unknown - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8134344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8129434	Spontaneous	2014-07-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Bedridden (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Recovered/Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|[DEXCHLORPHENIRAMINE MALEATE] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|[DIAZEPAM] (C - n/a - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|[IBUPROFEN] (C - Pain - Unknown - [n/a - n/a - n/a])|[PARACETAMOL] (C - Pain - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|[ZOPICLONE] (C - Anxiety - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8129434&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8114526	Spontaneous	2014-07-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hyperventilation (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8114526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8115213	Spontaneous	2014-07-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling cold (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tongue disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8115213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8115257	Spontaneous	2014-07-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Affect lability (n/a - Unknown - Disabling, Other Medically Important Condition);Aggression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep talking (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnambulism (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8115257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8115858	Spontaneous	2014-07-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8115858&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8116390	Spontaneous	2014-07-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8116390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8116419	Spontaneous	2014-07-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8116419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8109363	Spontaneous	2014-07-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypoglycaemia (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8109363&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8110457	Spontaneous	2014-07-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Affect lability (n/a - Not Recovered/Not Resolved - Disabling);Anxiety disorder (n/a - Unknown - Disabling);Apathy (n/a - Unknown - Disabling);Arthralgia (n/a - Unknown - Disabling);Asthenia (n/a - Unknown - Disabling);Bipolar disorder (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Decreased appetite (n/a - Unknown - Disabling);Depressed mood (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling cold (n/a - Not Recovered/Not Resolved - Disabling);Feeling hot (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Influenza (n/a - Unknown - Disabling);Insomnia (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Mood swings (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Pneumonia (n/a - Unknown - Disabling);Pollakiuria (n/a - Not Recovered/Not Resolved - Disabling);Poor quality sleep (n/a - Unknown - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Social anxiety disorder (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[BUPROPION HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - n/a])|[DESOGESTREL] (C - Contraception - Unknown - [n/a - 75ug - n/a])|[DIAZEPAM] (C - n/a - Unknown - [n/a - 5mg - n/a])|[LAMOTRIGINE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypometabolism - Unknown - [n/a - 50ug - n/a])|[METOCLOPRAMIDE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[OXAZEPAM] (C - Depression - Unknown - [n/a - 15mg - n/a])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - Borrelia infection - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - n/a])|[TRIMIPRAMINE, TRIMIPRAMINE MALEATE, TRIMIPRAMINE MESILATE] (C - Depression - Unknown - [n/a - n/a - n/a])|[ZOPICLONE] (C - Sleep disorder - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8110457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8110458	Spontaneous	2014-07-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - Unknown - [n/a - n/a - n/a])|[DIGITOXIN] (C - n/a - Unknown - [n/a - n/a - Oral])|[HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - n/a - Unknown - [n/a - n/a - Oral])|[LANSOPRAZOLE] (C - n/a - Unknown - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - Atrial flutter - Unknown - [n/a - n/a - Oral])|[ZOPICLONE] (C - Insomnia - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8110458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8113242	Spontaneous	2014-07-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8113242&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8106868	Spontaneous	2014-07-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Aptyalism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dry eye (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myositis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8106868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8099391	Spontaneous	2014-07-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Depression (n/a - Not Recovered/Not Resolved - Disabling);Hallucination (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8099391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8100585	Spontaneous	2014-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Arthritis infective (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Chorioretinopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Diabetes mellitus (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dyskinesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Immune system disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	FENTANYL [FENTANYL, FENTANYL CITRATE] (C - Pain - Unknown - [n/a - n/a - n/a])|PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - Stent placement - Unknown - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - Hypertension - Unknown - [n/a - n/a - n/a])|[ISOSORBIDE 5 MONONITRATE, ISOSORBIDE MONONITRATE] (C - Angina pectoris - Unknown - [n/a - n/a - n/a])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - Hypertension - Unknown - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - Hypertension - Unknown - [n/a - n/a - n/a])|[PARACETAMOL] (C - Pain - Unknown - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Hypercholesterolaemia - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8100585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8100586	Spontaneous	2014-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Disabling);Abdominal pain upper (n/a - Unknown - Disabling);Asthma (n/a - Unknown - Disabling);Chest pain (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Conjunctivitis allergic (n/a - Unknown - Disabling);Cough (n/a - Recovering/Resolving - Disabling);Cytomegalovirus infection (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Dyspnoea (n/a - Recovering/Resolving - Disabling);Fatigue (n/a - Unknown - Disabling);Feeling cold (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Hyperacusis (n/a - Unknown - Disabling);Hypersensitivity (n/a - Unknown - Disabling);Hypersomnia (n/a - Unknown - Disabling);Hypoaesthesia (n/a - Unknown - Disabling);Influenza (n/a - Recovering/Resolving - Disabling);Insomnia (n/a - Unknown - Disabling);Migraine (n/a - Unknown - Disabling);Musculoskeletal stiffness (n/a - Unknown - Disabling);Nausea (n/a - Recovering/Resolving - Disabling);Photophobia (n/a - Unknown - Disabling);Pyrexia (n/a - Recovering/Resolving - Disabling);Rhinorrhoea (n/a - Recovering/Resolving - Disabling);Sensory loss (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling);Speech disorder (n/a - Unknown - Disabling);Tremor (n/a - Unknown - Disabling);Upper respiratory tract infection (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - Asthma exercise induced - Unknown - [218d - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma exercise induced - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8100586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8100870	Spontaneous	2014-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Anger (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Circulatory collapse (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Crying (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Emotional distress (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Frustration tolerance decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nocturia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Personality change (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Polyuria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8100870&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8100949	Spontaneous	2014-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Amnesia (n/a - Unknown - Disabling, Other Medically Important Condition);Anger (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Circulatory collapse (n/a - Unknown - Disabling, Other Medically Important Condition);Coordination abnormal (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Emotional disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fear (n/a - Unknown - Disabling, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Disabling, Other Medically Important Condition);Muscle disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Seizure (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - .25mL - Intramuscular])	ANTIDEPRESSANTS NOS [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8100949&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8095319	Spontaneous	2014-06-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8095319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8095431	Spontaneous	2014-06-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8095431&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8096658	Spontaneous	2014-06-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blood pressure increased (n/a - Not Recovered/Not Resolved - Disabling);Epistaxis (n/a - Not Recovered/Not Resolved - Disabling);Eye discharge (n/a - Not Recovered/Not Resolved - Disabling);Feeling abnormal (n/a - Not Recovered/Not Resolved - Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Lung disorder (n/a - Not Recovered/Not Resolved - Disabling);Mucosal disorder (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Polyarthritis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	[CANDESARTAN CILEXETIL] (C - Hypertension - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8096658&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8086126	Spontaneous	2014-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8086126&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8079581	Spontaneous	2014-06-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Pyelonephritis (n/a - Not Specified - );Vasculitis (n/a - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8079581&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8080172	Spontaneous	2014-06-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Decreased activity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8080172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8082405	Spontaneous	2014-06-25 00:00:00	Healthcare Professional	European Economic Area	Froes F. et al. Final report on the mortality from flu pandemic (H1N1) 2009 in Portugal (April 2009 August 2010). Revista Portuguesa de Saude Publica 2014 32:1 (55-60)	Not Specified	Elderly	No	Male	H1N1 influenza (n/a - Fatal - Results in Death);Pneumonia viral (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8082405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8068900	Spontaneous	2014-06-23 00:00:00	Healthcare Professional	Non European Economic Area	R. Barbosa Callado et al, Rhabdomyolysis secondary to influenza A H1N1 influenza vaccine resulting in acute kidney injury, Travel MEdicine and Infectious disease (2013) 11, 130-133 Francesco Daher E, Callado R.B., Ponte Carneiro T.G., Da Cunha Parahyba C.C., DeAlcantara Lima N., Da Silva Junior G.B.,. Rhabdomyolysis secondary to influenza A H1N1 vaccine resulting in acute kidney injury.. Travel Medicine and Infectious Disease. 2013;11:130-133 Callado R,Ponte Carneiro T,da Cunha Parahyba C,de Alcantara Lima N,da Silva Junior G,de Francesco Daher E. Rhabdomyolysis secondary to influenza A H1N1 vaccine resulting in acute kidney injury. Travel Med Infect Dis 2013;11:2:130-133.	18-64 Years	Not Specified	No	Male	Acute kidney injury (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Areflexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Choluria (n/a - Unknown - Caused/Prolonged Hospitalisation);Chromaturia (49d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Decubitus ulcer (n/a - Unknown - Caused/Prolonged Hospitalisation);Dehydration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysuria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hepatomegaly (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperkalaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Localised oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscle injury (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (54d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myositis (n/a - Unknown - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Unknown - Caused/Prolonged Hospitalisation);Oliguria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Pallor (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pulmonary congestion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhabdomyolysis (54d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Scrotal oedema (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])|[SIMVASTATIN] (S - Hypercholesterolaemia - Unknown - [n/a - 40mg - Unknown])	GLIBENCLAMIDE [GLIBENCLAMIDE] (C - n/a - Unknown - [n/a - 5mg - Unknown])|[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - 200mg - Unknown])|[SPIRONOLACTONE] (C - n/a - Unknown - [n/a - 25mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8068900&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8071446	Spontaneous	2014-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypothyroidism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8071446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8064391	Spontaneous	2014-06-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vaccination site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8064391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8060482	Spontaneous	2014-06-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8060482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8054191	Spontaneous	2014-06-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8054191&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8057852	Spontaneous	2014-06-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Female	Crying (n/a - Not Recovered/Not Resolved - );Fatigue (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8057852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-8045897	Spontaneous	2014-06-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Product used for unknown indication - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8045897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8039217	Spontaneous	2014-06-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8039217&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8041228	Spontaneous	2014-06-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Cough (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling);Ear discomfort (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Groin pain (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Disabling);Hypoacusis (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Rash (n/a - Unknown - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Temperature intolerance (n/a - Unknown - Disabling);Vaccination site pain (n/a - Unknown - Disabling);Vision blurred (n/a - Not Recovered/Not Resolved - Disabling);Yawning (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009] (S - n/a - n/a - [n/a - n/a - n/a])	[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - Reflux gastritis - n/a - [n/a - n/a - n/a])|[FINASTERIDE] (C - Prostatomegaly - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8041228&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-8034191	Spontaneous	2014-06-12 00:00:00	Healthcare Professional	European Economic Area	Vries L, Hunsel F V, Maarschalkerweerd B C, Puijenbroek E, Grootheest K. Adjuvanted A/H1N1 (2009) Influenza Vaccination During Pregnancy: Description of a Prospective Cohort and Reactions in the Netherlands. Birth Defects Research Part A: Clinical and Molecular Teratology. 2014	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8034191&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8035501	Spontaneous	2014-06-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8035501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8029021	Spontaneous	2014-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Acute kidney injury (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Aphasia (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Apraxia (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Ataxia (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Balance disorder (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Brain oedema (n/a - Recovering/Resolving - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Central nervous system inflammation (109d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Central nervous system lymphoma (108d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Confusional state (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Disorientation (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Encephalitis (109d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Leukopenia (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Lung abscess (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Nervous system disorder (109d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Sepsis (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);T-cell lymphoma (109d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	METHOTREXATE [METHOTREXATE] (C - Cutaneous T-cell lymphoma - Unknown - [n/a - n/a - Unknown])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Immunisation - Not applicable - [1d - n/a - Unknown])|[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - Unknown - [n/a - 100mg - Oral])|[BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - Unknown - [n/a - 5mg - Oral])|[GLIMEPIRIDE] (C - n/a - Unknown - [n/a - 2mg - Oral])|[HYDROCHLOROTHIAZIDE, TELMISARTAN] (C - n/a - Unknown - [n/a - 92.5mg - n/a])|[INDAPAMIDE] (C - n/a - Unknown - [n/a - 2.5mg - Oral])|[LEVOTHYROXINE SODIUM, POTASSIUM IODIDE] (C - n/a - Unknown - [n/a - 250ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8029021&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-8029413	Spontaneous	2014-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8029413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8030513	Spontaneous	2014-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8030513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8024431	Spontaneous	2014-06-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);General physical health deterioration (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Listless (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Throat irritation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Vertigo (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8024431&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8024961	Spontaneous	2014-06-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Impaired work ability (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8024961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8024963	Spontaneous	2014-06-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8024963&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8017233	Spontaneous	2014-06-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site inflammation (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8017233&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8017635	Spontaneous	2014-06-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Decreased appetite (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site induration (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Lethargy (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8017635&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8018028	Spontaneous	2014-06-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - n/a])	[NAPROXEN, NAPROXEN SODIUM] (C - Rheumatoid arthritis - n/a - [n/a - 1{DF} - n/a])|[PREDNISONE] (C - Rheumatoid arthritis - n/a - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8018028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8011037	Spontaneous	2014-06-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Back pain (n/a - Unknown - Other Medically Important Condition);Immune system disorder (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Neck pain (n/a - Unknown - Other Medically Important Condition);Neuropathy peripheral (n/a - Unknown - Other Medically Important Condition);Oedema (n/a - Unknown - Other Medically Important Condition);Oedema peripheral (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Skin disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8011037&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-8008347	Spontaneous	2014-06-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8008347&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7999997	Spontaneous	2014-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cardiovascular disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysgeusia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia oral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Performance status decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory distress (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tongue coated (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Weight bearing difficulty (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7999997&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8000026	Spontaneous	2014-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cyanosis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pulmonary oedema (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Rhonchi (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Road traffic accident (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8000026&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-8000027	Spontaneous	2014-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Herpes zoster (n/a - Recovering/Resolving - Other Medically Important Condition);Neuralgia (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8000027&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8000048	Spontaneous	2014-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Diplopia (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[PIROXICAM] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8000048&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-8000182	Spontaneous	2014-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Adrenal insufficiency (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8000182&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-8000249	Spontaneous	2014-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Tinnitus (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8000249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-8000308	Spontaneous	2014-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Listless (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Unknown - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Reading disorder (n/a - Not Recovered/Not Resolved - Disabling);Vertigo (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Parenteral])	AERIUS [DESLORATADINE] (C - Hypersensitivity - Unknown - [n/a - n/a - Oral])|[FEXOFENADINE, FEXOFENADINE HYDROCHLORIDE] (C - Hypersensitivity - Unknown - [n/a - n/a - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8000308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-8000430	Spontaneous	2014-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depressed mood (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (2a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=8000430&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7994872	Spontaneous	2014-06-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7994872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7994873	Spontaneous	2014-06-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7994873&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7994875	Spontaneous	2014-06-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7994875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7998113	Spontaneous	2014-06-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	[EXEMESTANE] (C - Product used for unknown indication - n/a - [n/a - 25mg - n/a])|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - 20mg - n/a])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7998113&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7989372	Spontaneous	2014-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myalgia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7989372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7989377	Spontaneous	2014-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Acute disseminated encephalomyelitis (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7989377&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7991278	Spontaneous	2014-05-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - Drug withdrawn - [n/a - .5mL - n/a])	[CETIRIZINE DIHYDROCHLORIDE] (C - Seasonal allergy - n/a - [n/a - .5{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7991278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7985171	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anxiety (n/a - Unknown - Other Medically Important Condition);Depressed mood (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paralysis (n/a - Unknown - Other Medically Important Condition);Stress (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMFETAMINE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7985171&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7985182	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Parosmia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pelvic pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Speech disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7985182&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7985780	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Not Specified - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7985780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7987537	Spontaneous	2014-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain (n/a - Unknown - );Diarrhoea (n/a - Unknown - );Nausea (n/a - Unknown - );Vaccination site pain (n/a - Unknown - );Vomiting (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - 3.75ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7987537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7980961	Spontaneous	2014-05-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fibromyalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Dose not changed - [n/a - 1{DF} - n/a])	[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 75mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7980961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7982420	Spontaneous	2014-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7982420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7982614	Spontaneous	2014-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7982614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7982615	Spontaneous	2014-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7982615&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7983062	Spontaneous	2014-05-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7983062&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7974949	Spontaneous	2014-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bronchitis (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Cough (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea at rest (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Lung disorder (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Obstructive airways disorder (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (1d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7974949&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7974957	Spontaneous	2014-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Complication of pregnancy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7974957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7976437	Spontaneous	2014-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Back pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Immune system disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neck pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oedema (n/a - Unknown - Other Medically Important Condition);Oedema peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7976437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7976638	Spontaneous	2014-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Disabling);Abdominal tenderness (n/a - Unknown - Disabling);Antisocial behaviour (n/a - Unknown - Disabling);Apathy (n/a - Unknown - Disabling);Candida infection (n/a - Not Recovered/Not Resolved - Disabling);Cataplexy (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Fall (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Gastric infection (n/a - Unknown - Disabling);Hypersomnia (n/a - Recovering/Resolving - Disabling);Middle insomnia (n/a - Unknown - Disabling);Muscular weakness (n/a - Unknown - Disabling);Narcolepsy (n/a - Unknown - Disabling);Nausea (5wk - Recovered/Resolved - Disabling);Poor quality sleep (n/a - Unknown - Disabling);Pyrexia (7wk - Recovered/Resolved - Disabling);Somnolence (n/a - Unknown - Disabling);Vitamin D decreased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CHLORAMPHENICOL] (C - Conjunctivitis - Unknown - [n/a - n/a - n/a])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - Ear infection - Unknown - [n/a - n/a - n/a])|[PHENYLPROPANOLAMINE HYDROCHLORIDE] (C - Ear infection - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7976638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7971064	Spontaneous	2014-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Autoimmune thyroiditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myoclonus (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vaccination site swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7971064&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7971123	Spontaneous	2014-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation);Atrial fibrillation (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/BRISBANE/60/2008-LIKE VIRUS] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	[ALFUZOSIN] (C - n/a - Unknown - [n/a - 2.5mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7971123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7971845	Spontaneous	2014-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Disabling);Food craving (n/a - Unknown - Disabling);Hypersomnia (n/a - Unknown - Disabling);Hypersomnia-bulimia syndrome (n/a - Not Recovered/Not Resolved - Disabling);Personality change (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7971845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7971846	Spontaneous	2014-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Feeling hot (n/a - Recovering/Resolving - Other Medically Important Condition);General physical health deterioration (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza like illness (n/a - Recovering/Resolving - Other Medically Important Condition);Joint stiffness (n/a - Recovering/Resolving - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Night sweats (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - Osteoporosis - Unknown - [n/a - 800mg - n/a])|[CYANOCOBALAMIN, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 20mg - n/a])|[SUMATRIPTAN, SUMATRIPTAN SUCCINATE] (C - Migraine - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7971846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7964776	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Gastrointestinal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Giant cell arteritis (7d - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neck pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Immunisation - Not applicable - [1d - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7964780	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Deafness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	CELVAPAN PANDEMIC INFLUENZA VACCINE (H1N1) (WHOLE VIRION, VERO CELL DERIVED, INACTIVATED) SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7964782	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Soft tissue inflammation (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7964785	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Death (1d - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7964790	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[DROSPIRENONE, ETHINYLESTRADIOL] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7964793	Spontaneous	2014-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Cough (n/a - Not Recovered/Not Resolved - );Headache (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Oropharyngeal pain (n/a - Recovered/Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7964794	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964794&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7964801	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Adult	No	Male	Decreased appetite (48h - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (48h - Recovered/Resolved - Other Medically Important Condition);Fatigue (48h - Recovered/Resolved - Other Medically Important Condition);Headache (48h - Recovered/Resolved - Other Medically Important Condition);Pyrexia (48h - Recovered/Resolved - Other Medically Important Condition);Tremor (48h - Recovered/Resolved - Other Medically Important Condition);Vision blurred (48h - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964801&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7964802	Spontaneous	2014-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Lyme disease (n/a - Not Recovered/Not Resolved - );Paraesthesia (n/a - Not Recovered/Not Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7964803	Spontaneous	2014-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Tinnitus (n/a - Not Recovered/Not Resolved - );Vertigo (n/a - Recovering/Resolving - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964803&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7964805	Spontaneous	2014-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Flushing (n/a - Recovering/Resolving - );Headache (n/a - Recovering/Resolving - );Myalgia (n/a - Recovering/Resolving - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964805&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7964806	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Brachial plexopathy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Diaphragmatic paralysis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Disability (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Radiculitis brachial (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Radiculopathy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Respiratory disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Respiratory failure (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964806&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7964807	Spontaneous	2014-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Female	Decreased appetite (n/a - Unknown - );Pyrexia (n/a - Unknown - );Somnolence (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7964812	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);Urinary incontinence (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7964813	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Colitis ulcerative (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);International normalised ratio abnormal (n/a - Unknown - Other Medically Important Condition);Prothrombin level decreased (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	[AZATHIOPRINE] (C - n/a - Unknown - [n/a - n/a - Oral])|[CORTISONE ACETATE] (C - n/a - Unknown - [n/a - n/a - Respiratory (inhalation)])|[LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE OXIDE] (C - n/a - Unknown - [n/a - 2mg - Oral])|[MESALAZINE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[OLMESARTAN, OLMESARTAN MEDOXOMIL] (C - n/a - Unknown - [n/a - 10mg - Oral])|[PHENPROCOUMON] (C - n/a - Unknown - [n/a - 3mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964813&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7964823	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Fibromyalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7964832	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7964844	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964844&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7964848	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic shock (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Angiopathy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Chills (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dysphonia (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Livedo reticularis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Malaise (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pallor (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pulse abnormal (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Tachycardia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [n/a - 7ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7964850	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Bone pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Facial paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Formication (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypergammaglobulinaemia (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Leukocytosis (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7964862	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Body temperature increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Colour blindness (n/a - Unknown - Caused/Prolonged Hospitalisation);Ear pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Encephalomyelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Eye pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Irritability (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Optic neuritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Unknown - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LEVOTHYROXINE SODIUM] (C - Autoimmune thyroiditis - n/a - [n/a - n/a - n/a])|[LIOTHYRONINE SODIUM, LEVOTHYROXINE SODIUM] (C - Autoimmune thyroiditis - Unknown - [n/a - n/a - Unknown])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964862&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7964863	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Unknown - Other Medically Important Condition);Decreased appetite (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Unknown - Other Medically Important Condition);Weight decreased (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964863&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7964865	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	H1N1 influenza (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination failure (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7964906	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	H1N1 influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7964908	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Facial paresis (4wk - Recovered/Resolved With Sequelae - Other Medically Important Condition);Formication (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Monoplegia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Paralysis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Polyneuropathy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7964923	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (7d - Recovered/Resolved - Other Medically Important Condition);Headache (7d - Recovered/Resolved - Other Medically Important Condition);Influenza (7d - Recovered/Resolved - Other Medically Important Condition);Nasopharyngitis (7d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (7d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (7d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964923&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7964924	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Red blood cell sedimentation rate increased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Rotator cuff syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sjogren's syndrome (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[A/H1N1 INFLUENZA VACCINE] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7964925	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arrhythmia (n/a - Unknown - Caused/Prolonged Hospitalisation);Autonomic nervous system imbalance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pneumonia aspiration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Quadriplegia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Restless legs syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - .5mL - Unknown])	[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 40mg - Oral])|[DESOGESTREL, ETHINYLESTRADIOL, TEMAZEPAM] (C - n/a - Unknown - [n/a - n/a - Oral])|[DRIED YEAST FROM SACCHAROMYCES CEREVISIAE HANSEN CBS 5926, SACCHAROMYCES BOULARDII, SACCHAROMYCES CEREVISIAE] (C - n/a - Unknown - [n/a - 250mg - Oral])|[MACROGOL, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - Unknown - [n/a - n/a - Oral])|[METAMIZOLE, METAMIZOLE SODIUM, METAMIZOLE SODIUM MONOHYDRATE] (C - n/a - Unknown - [n/a - 30[drp] - Oral])|[METOCLOPRAMIDE, METOCLOPRAMIDE DIHYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE MONOHYDRATE, METOCLOPRAMIDE HYDROCHLORIDE PH. EUR.] (C - n/a - Unknown - [n/a - n/a - Oral])|[NALOXONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE DIHYDRATE] (C - n/a - Unknown - [n/a - 15mg - Oral])|[SOLIFENACIN SUCCINATE] (C - n/a - Unknown - [n/a - 10mg - Oral])|[SULFAMETHOXAZOLE, TRIMETHOPRIM] (C - Urinary tract infection - Not applicable - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964925&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7964930	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Encephalitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7964930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7965014	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Back pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Dysphagia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Facial paralysis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hypogeusia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Myelitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Neuralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Neuroborreliosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Quadriparesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Radial nerve injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965014&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7965015	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthritis (4mo - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Spondylitis (n/a - Unknown - Other Medically Important Condition);Tendon pain (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	ARAVA [LEFLUNOMIDE] (C - Polyarthritis - Unknown - [n/a - 20mg - Oral])|[PREDNISOLONE] (C - Polyarthritis - Dose increased - [17y - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965015&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7965021	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Unknown - Other Medically Important Condition);Cerebellar infarction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cerebrovascular accident (n/a - Recovering/Resolving - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Haematuria (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Loss of consciousness (n/a - Unknown - Other Medically Important Condition);Renal disorder (n/a - Unknown - Other Medically Important Condition);Vertigo (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[MIRTAZAPINE] (C - Pain - Unknown - [n/a - n/a - Unknown])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - Pain - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965021&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7965047	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cough (n/a - Unknown - );Influenza (n/a - Unknown - );Pain in extremity (n/a - Unknown - );Pyrexia (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7965122	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (3d - Unknown - );Headache (3d - Unknown - );Pain in extremity (3d - Unknown - );Pyrexia (3d - Unknown - );Vaccination failure (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965122&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7965180	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	H1N1 influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965180&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7965226	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Not Recovered/Not Resolved - );Vaccination failure (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7965232	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (7d - Recovered/Resolved - );Vaccination failure (7d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965232&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7965237	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7965395	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Aggression (n/a - Unknown - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation);Dystonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[METHYLPHENIDATE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 36mg - Unknown])|[METHYLPHENIDATE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965395&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7965407	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Facial paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia oral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensorimotor disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965407&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7965415	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site atrophy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site necrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Necrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7965433	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sudden onset of sleep (n/a - Recovered/Resolved - Other Medically Important Condition)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (C - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7965445	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Antinuclear antibody positive (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Arthritis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Body temperature increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chills (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Collagen disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Electric shock sensation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Erythema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Headache (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Injection site swelling (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Insomnia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Joint stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Joint swelling (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Motor dysfunction (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Neck pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Oedema peripheral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Peripheral swelling (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Photosensitivity reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Polyarthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Raynaud's phenomenon (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sclerodactylia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Scleroderma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Skin atrophy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Skin hyperpigmentation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Skin induration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Tenosynovitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Vascular skin disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[PAROXETINE, PAROXETINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - 10mg - Oral])|[TICK-BORNE ENCEPHALITIS VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7965447	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pericardial effusion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Nasal])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965447&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7965451	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Anal incontinence (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Aphonia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Aspiration (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Ataxia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Bronchitis bacterial (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Deafness neurosensory (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Dysphagia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Encephalitis brain stem (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Encephalopathy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Enterococcal infection (14d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Escherichia infection (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Eyelid ptosis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Facial paresis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Haemophilus infection (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Heparin-induced thrombocytopenia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Middle ear effusion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Miller Fisher syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Neck pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Otitis media (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Paresis cranial nerve (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Quadriplegia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Tracheobronchitis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Urinary incontinence (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vertigo (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])|[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7965462	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (24h - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (24h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (24h - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Shock (30min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7965465	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Photopsia (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Syncope (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7965467	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Monoparesis (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7965473	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Facial paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nasal congestion (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Nasal discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Nasal turbinate hypertrophy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Neuritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Paralytic lagophthalmos (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Rhinitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sinusitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[ENALAPRIL, ENALAPRIL MALEATE] (C - Hypertension - Unknown - [n/a - 2.5mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Type 2 diabetes mellitus - Unknown - [n/a - 1000mg - Oral])|[OXYMETAZOLINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Nasal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7965476	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Acute myocardial infarction (7d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Brain injury (7d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7965478	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Encephalitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7965478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7969004	Spontaneous	2014-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7969004&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7959773	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (2wk - Recovered/Resolved - Other Medically Important Condition);Rheumatoid arthritis (15d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7959782	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Ascites (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Atrial fibrillation (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Body temperature increased (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Bradycardia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Candida infection (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cardiac arrest (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cardiac valve disease (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cardio-respiratory arrest (n/a - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diverticulitis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Endocarditis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gastroenteritis Escherichia coli (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gastrointestinal inflammation (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Intestinal perforation (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Klebsiella infection (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Multiple organ dysfunction syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Peptostreptococcus infection (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Peritonitis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Purulence (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Small intestinal obstruction (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - n/a])	[AMILORIDE HYDROCHLORIDE, CHLORTALIDONE, CHLORTALIDONE, AMILORIDE HYDROCHLORIDE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DIPYRIDAMOLE, ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[INDAPAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[TRANDOLAPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7959787	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (0d - Recovering/Resolving - );Paraesthesia (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Ill-defined disorder - Not applicable - [0d - n/a - Intramuscular])	[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7959803	Spontaneous	2014-05-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Female	Hyperpyrexia (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959803&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7959808	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Angioedema (2h - Recovered/Resolved - Other Medically Important Condition);Chest discomfort (2h - Recovered/Resolved - Other Medically Important Condition);Cough (3h - Recovered/Resolved - Other Medically Important Condition);Dysphonia (3h - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (3h - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (2h - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (2h - Recovered/Resolved - Other Medically Important Condition);Nausea (3h - Recovered/Resolved - Other Medically Important Condition);Pallor (2h - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (2h - Recovered/Resolved - Other Medically Important Condition);Tachycardia (2h - Recovered/Resolved - Other Medically Important Condition);Tachypnoea (3h - Recovered/Resolved - Other Medically Important Condition);Tremor (2h - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959808&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7959811	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Atrial fibrillation (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Cardiac failure (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cardiomyopathy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Myocarditis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7959820	Spontaneous	2014-05-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Hyperpyrexia (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959820&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7959821	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bedridden (3wk - Recovered/Resolved - );Headache (3wk - Recovered/Resolved - );Influenza like illness (3wk - Recovered/Resolved - );Pain in extremity (3wk - Recovered/Resolved - );Pyrexia (3wk - Recovered/Resolved - );Rash (3wk - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959821&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7959841	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Asthma (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7959844	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959844&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7959845	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rash erythematous (n/a - Unknown - Other Medically Important Condition);Rash pruritic (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - n/a - Unknown - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7959851	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Confusional state (30min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959851&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7959864	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Left ventricular failure (1d - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959864&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7959865	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Acute respiratory failure (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Quadriplegia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - n/a - n/a])|[CARVEDILOL] (C - n/a - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - Unknown - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7959874	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Neuritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959874&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7959875	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Abdominal pain (1d - Recovered/Resolved - Life Threatening);Anaphylactic reaction (1d - Recovered/Resolved - Life Threatening);Cold sweat (1d - Recovered/Resolved - Life Threatening);Cyanosis (1d - Recovered/Resolved - Life Threatening);Diarrhoea (1d - Recovered/Resolved - Life Threatening);Dyspnoea (1d - Recovered/Resolved - Life Threatening);Peripheral vascular disorder (1d - Recovered/Resolved - Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-7959883	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Acute myocardial infarction (n/a - Fatal - Results in Death);Angina pectoris (n/a - Fatal - Results in Death);Circulatory collapse (n/a - Fatal - Results in Death);Headache (0wk - Recovered/Resolved - Results in Death);Injection site discomfort (0wk - Recovered/Resolved - Results in Death);Pain in extremity (n/a - Recovered/Resolved - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7959884	Spontaneous	2014-05-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (1d - Recovering/Resolving - );Headache (1d - Recovering/Resolving - );Pain in extremity (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Dose not changed - [n/a - n/a - Parenteral])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (S - Dyspnoea - Dose not changed - [n/a - n/a - Respiratory (inhalation)])|[IPRATROPIUM BROMIDE] (S - Dyspnoea - Dose not changed - [n/a - n/a - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL SULFATE] (S - Dyspnoea - Dose not changed - [n/a - n/a - Respiratory (inhalation)])	[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959884&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7959885	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Dermatitis atopic (8d - Recovering/Resolving - Other Medically Important Condition);Eczema (n/a - Recovering/Resolving - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7959901	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Dehydration (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959901&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7959906	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Bronchitis bacterial (1d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Cardiac failure (n/a - Recovering/Resolving - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (9d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia aspiration (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pulmonary oedema (n/a - Recovering/Resolving - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7959907	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Atrial fibrillation (14h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cardiac disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Cardiac failure (9d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Disability (6wk - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myocarditis (9d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tricuspid valve incompetence (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7959910	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Anaphylactoid reaction (2d - Recovered/Resolved - Other Medically Important Condition);Erythema (2d - Recovered/Resolved - Other Medically Important Condition);Pruritus (2d - Recovered/Resolved - Other Medically Important Condition);Rash (2d - Recovered/Resolved - Other Medically Important Condition);Swelling face (2d - Recovered/Resolved - Other Medically Important Condition);Urticaria (2d - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN PANDEMIC INFLUENZA VACCINE (H1N1) (WHOLE VIRION, VERO CELL DERIVED, INACTIVATED) SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 7ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7959911	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Pulmonary oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7959919	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arteriosclerosis coronary artery (n/a - Unknown - Caused/Prolonged Hospitalisation);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Bundle branch block left (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Mitral valve incompetence (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - Unknown - [n/a - 100mg - Unknown])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - Unknown - [n/a - 20mg - Unknown])|[METOPROLOL SUCCINATE, METOPROLOL SUCCINATE (PH. EUR.)] (C - n/a - Unknown - [n/a - n/a - Unknown])|[RAMIPRIL] (C - n/a - Unknown - [n/a - 2.5mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959919&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7959920	Spontaneous	2014-05-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Hyperpyrexia (n/a - Recovered/Resolved With Sequelae - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959920&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-7959921	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Coronary artery insufficiency (1d - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Immunisation - Not applicable - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (C - Prophylaxis - Not applicable - [1d - .5mL - Unknown])|[ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - 35mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959921&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7959928	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Acute myocardial infarction (1d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Angina pectoris (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Bradycardia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Coma (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Pulmonary embolism (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Resuscitation (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Ventricular fibrillation (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[INSULIN, INSULIN HUMAN] (C - n/a - Unknown - [n/a - n/a - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7959930	Spontaneous	2014-05-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Hyperpyrexia (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7959933	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Balance disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling drunk (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, INFLUENZA VIRUS (INACTIVATED, SPLIT) A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-179A), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A)] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7959935	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Aortic aneurysm rupture (1d - Fatal - Results in Death);Cardiac failure (1d - Fatal - Results in Death);Cardiac tamponade (1d - Fatal - Results in Death);Diarrhoea (n/a - Unknown - Results in Death);Dizziness (n/a - Unknown - Results in Death);Gastroenteritis (n/a - Unknown - Results in Death);Nausea (n/a - Unknown - Results in Death);Vomiting (n/a - Unknown - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959935&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7959937	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Abdominal pain (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Oropharyngeal pain (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959937&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7959939	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Autoimmune haemolytic anaemia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Autoimmune thyroiditis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Cardiovascular disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Colitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Dehydration (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Gastroenteritis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Leukopenia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Thyroid operation (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Vertigo (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Warm autoimmune haemolytic anaemia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Yellow skin (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7959940	Spontaneous	2014-05-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Hypotonia (n/a - Recovered/Resolved - );Injection site haematoma (n/a - Recovering/Resolving - );Injection site pain (n/a - Recovering/Resolving - );Malaise (n/a - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7959941	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959941&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7959949	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute respiratory distress syndrome (0mo - Fatal - Results in Death, Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Viral infection (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959949&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7959951	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depressive symptom (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959951&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7959957	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Male	Hyperpyrexia (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7959958	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Type 1 diabetes mellitus (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959958&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7959959	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Humerus fracture (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Injection site joint movement impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	[METOPROLOL SUCCINATE, METOPROLOL TARTRATE, METOPROLOL TARTRATE PH. EUR.] (C - Hypertension - Unknown - [6mo - 24mg - Unknown])|[TORASEMIDE] (C - Oedema peripheral - Unknown - [3mo - 5mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959959&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7959961	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Male	Eye swelling (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7959972	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Myofascitis (n/a - Recovered/Resolved With Sequelae - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-7959987	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Injection site erythema (n/a - Recovered/Resolved - );Injection site pain (n/a - Recovered/Resolved - );Injection site pruritus (n/a - Recovered/Resolved - );Injection site swelling (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7959992	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Abortion spontaneous (1d - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959992&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7959993	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Coordination abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling abnormal (24h - Recovered/Resolved - Other Medically Important Condition);Influenza (24h - Recovered/Resolved - Other Medically Important Condition);Motor dysfunction (n/a - Unknown - Other Medically Important Condition);Muscle discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Radiculopathy (n/a - Unknown - Other Medically Important Condition);Sensory disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vibration test abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[TAMSULOSIN, TAMSULOSIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[TROSPIUM, TROSPIUM CHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959993&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7959994	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Coronary artery disease (n/a - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[GLYCEROL] (C - n/a - Unknown - [n/a - n/a - Unknown])|[INSULIN, INSULIN HUMAN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[NIFEDIPINE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959994&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7959999	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Circulatory collapse (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscle twitching (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Petit mal epilepsy (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7959999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960001	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cerebrovascular disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7960002	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Abnormal dreams (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Automatism (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hallucination (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hypnagogic hallucination (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Middle insomnia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Nightmare (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Restlessness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960003	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Autoimmune haemolytic anaemia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Warm autoimmune haemolytic anaemia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Subcutaneous])	[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (C - Immunisation - n/a - [n/a - n/a - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960004	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Condition aggravated (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hot flush (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Panic disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960004&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960010	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Muscular weakness (1d - Recovered/Resolved - Other Medically Important Condition);Neuritis (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960010&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7960011	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (10min - Recovered/Resolved - );Dizziness (10min - Recovered/Resolved - );Hyperhidrosis (10min - Recovered/Resolved - );Muscle spasms (10min - Recovered/Resolved - );Nausea (10min - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960011&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7960022	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Psoriasis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960029	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Asthenopia (n/a - Unknown - Other Medically Important Condition);Chills (3d - Recovering/Resolving - Other Medically Important Condition);Disability (6d - Recovered/Resolved - Other Medically Important Condition);Ear pain (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Limb discomfort (3d - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Pain (3d - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (3d - Recovering/Resolving - Other Medically Important Condition);Paraesthesia (3d - Recovering/Resolving - Other Medically Important Condition);Pyrexia (3d - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960029&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7960033	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Areflexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arthralgia (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyporeflexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Long thoracic nerve palsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (2d - Recovered/Resolved - Other Medically Important Condition);Mobility decreased (n/a - Recovering/Resolving - Other Medically Important Condition);Motor dysfunction (n/a - Unknown - Other Medically Important Condition);Movement disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Neuralgia (n/a - Unknown - Other Medically Important Condition);Neuropathy peripheral (n/a - Unknown - Other Medically Important Condition);Paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Winged scapula (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960033&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7960034	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Syncope (3s - Recovered/Resolved - Other Medically Important Condition);Tonic convulsion (2s - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN PANDEMIC INFLUENZA VACCINE (H1N1) (WHOLE VIRION, VERO CELL DERIVED, INACTIVATED) SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7960062	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Atypical pneumonia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Bone marrow disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Bronchiolitis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Cold sweat (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cyanosis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Hepatic steatosis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hepatomegaly (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Night sweats (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia influenzal (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Tachycardia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Weight decreased (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	[GABAPENTIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960062&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7960064	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);CSF cell count increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myelitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960064&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960096	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960096&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7960097	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Generalised tonic-clonic seizure (n/a - Fatal - Results in Death, Life Threatening);Pneumonia (n/a - Fatal - Results in Death, Life Threatening);Pulmonary oedema (n/a - Fatal - Results in Death, Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[DIAZEPAM] (S - n/a - Unknown - [1d - 10mg - Rectal])	[CARBAMAZEPINE] (C - n/a - Unknown - [n/a - 400mg - Unknown])|[RISPERIDONE] (C - n/a - Unknown - [n/a - 2mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960097&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7960107	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Hypotonia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Sleep disorder (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960107&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7960108	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chills (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Muscular weakness (4wk - Recovered/Resolved - Other Medically Important Condition);Myelitis (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Rheumatoid factor positive (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sensory level abnormal (4wk - Recovered/Resolved - Other Medically Important Condition);Somatosensory evoked potentials abnormal (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960108&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7960126	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site joint pain (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Musculoskeletal pain (n/a - Recovering/Resolving - Other Medically Important Condition);Radiculitis brachial (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960126&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7960127	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthma (n/a - Unknown - Caused/Prolonged Hospitalisation);Chest discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation);Productive cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Wheezing (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960128	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cutaneous vasculitis (n/a - Recovering/Resolving - Other Medically Important Condition);Joint swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (7h - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960128&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7960142	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Deafness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Epistaxis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Granulomatosis with polyangiitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasal congestion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pulmonary embolism (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960214	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (4a - Unknown - Other Medically Important Condition);Dissociation (4a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Mental impairment (n/a - Unknown - Other Medically Important Condition);Pain of skin (4a - Unknown - Other Medically Important Condition);Paresis (4a - Unknown - Other Medically Important Condition);Pruritus (4a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Rash pustular (4a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7960233	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Nausea (n/a - Fatal - Results in Death);Vomiting (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[LETROZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960233&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7960250	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Angina pectoris (n/a - Unknown - Results in Death, Life Threatening);Apnoea (n/a - Unknown - Results in Death, Life Threatening);Cardiac arrest (n/a - Unknown - Results in Death, Life Threatening);Cardiac failure (n/a - Unknown - Results in Death, Life Threatening);Coma scale abnormal (n/a - Unknown - Results in Death, Life Threatening);Dyspnoea (n/a - Fatal - Results in Death, Life Threatening);Loss of consciousness (n/a - Unknown - Results in Death, Life Threatening);Mydriasis (n/a - Unknown - Results in Death, Life Threatening);Myocardial infarction (n/a - Fatal - Results in Death, Life Threatening);Nausea (n/a - Fatal - Results in Death, Life Threatening);Pulmonary embolism (n/a - Unknown - Results in Death, Life Threatening);Pulmonary oedema (n/a - Unknown - Results in Death, Life Threatening);Respiratory disorder (n/a - Unknown - Results in Death, Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960250&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7960251	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Joint effusion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Synovial cyst (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960253	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Sudden death (1d - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960253&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7960301	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Dauvilliers et al. Post H1N1 narcolepsy-cataplexy. Sleep 2010 33: (11); 1-3	12-17 Years	Not Specified	Yes	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 3.75ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7960302	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cardiogenic shock (2h - Fatal - Results in Death);Coronary artery disease (n/a - Fatal - Results in Death);Hypertonia (n/a - Unknown - Results in Death);Ventricular fibrillation (2h - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - Unknown - [n/a - n/a - Unknown])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[METOPROLOL SUCCINATE] (C - n/a - Unknown - [n/a - 95mg - Unknown])|[RAMIPRIL] (C - n/a - Unknown - [n/a - 30mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7960325	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Cardiac failure acute (1d - Fatal - Results in Death, Life Threatening);Circulatory collapse (n/a - Unknown - Results in Death, Life Threatening);Cold sweat (n/a - Unknown - Results in Death, Life Threatening);Dyspnoea (n/a - Unknown - Results in Death, Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Unknown])	KEPPRA [LEVETIRACETAM] (C - n/a - Unknown - [n/a - 500mg - Oral])|PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - Unknown - [n/a - 75mg - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - 25mg - Oral])|[NADROPARIN CALCIUM] (C - n/a - Not applicable - [n/a - .3mL - Subcutaneous])|[POTASSIUM HYDROGEN CARBONATE, CITRIC ACID ANHYDROUS, POTASSIUM CITRATE, POTASSIUM HYDROGEN CARBONATE, POTASSIUM CITRATE, CITRIC ACID] (C - n/a - Unknown - [n/a - 40mmol - Oral])|[RAMIPRIL] (C - n/a - Unknown - [n/a - 5mg - Oral])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 40mg - Oral])|[TORASEMIDE, TORASEMIDE SODIUM] (C - n/a - Not applicable - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7960326	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Antibody test positive (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Multiple organ dysfunction syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Systemic inflammatory response syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960326&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7960329	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Depression (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7960334	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	H1N1 influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960342	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Influenza (n/a - Not Recovered/Not Resolved - );Vaccination failure (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960342&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7960607	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7960665	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Bradycardia (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (2s - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960665&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960669	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Myelitis transverse (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960681	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (4d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Decreased immune responsiveness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Diarrhoea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Fungal infection (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Gastroenteritis viral (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Gingival abscess (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Gingivitis (6mo - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Headache (4d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Immune system disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Infection (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (10d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Lymphadenitis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Lymphadenopathy (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (10d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Periodontitis (6mo - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pyrexia (10d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Stomatitis (6mo - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	APIDRA [INSULIN GLULISINE] (C - Type 1 diabetes mellitus - Unknown - [n/a - n/a - Subcutaneous])|LANTUS [INSULIN GLARGINE] (C - Type 1 diabetes mellitus - Unknown - [n/a - n/a - Subcutaneous])|[CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE, CIPROFLOXACIN LACTATE] (C - Infection - Unknown - [n/a - 250mg - Oral])|[CYANOCOBALAMIN] (C - Paraesthesia - Unknown - [n/a - n/a - Intramuscular])|[DESOGESTREL] (C - Oral contraception - Unknown - [n/a - n/a - Oral])|[FLUCONAZOLE] (C - Vulvovaginal candidiasis - Unknown - [n/a - 150mg - Oral])|[NYSTATIN] (C - Oral candidiasis - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7960693	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7960695	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Autoimmune thyroiditis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Thyroid function test normal (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7960697	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Abdominal discomfort (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Axonal neuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Bulbar palsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Chromaturia (n/a - Unknown - Caused/Prolonged Hospitalisation);Decreased vibratory sense (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dry mouth (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Flushing (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hepatitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myositis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	[NIFEDIPINE] (C - n/a - n/a - [n/a - 20mg - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 10mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960699	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (0d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960699&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7960716	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Bladder dysfunction (n/a - Unknown - Caused/Prolonged Hospitalisation);Decreased vibratory sense (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Functional gastrointestinal disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960716&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960727	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Depressed mood (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hallucination (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Middle insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Moaning (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960727&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960776	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Anxiety disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chronic fatigue syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pleocytosis (24d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960871	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute psychosis (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Infection (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oral herpes (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7960898	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nausea (n/a - Unknown - Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960898&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7960943	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hyperventilation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Panic attack (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - .5mL - Unknown])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (C - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7960943&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7963124	Spontaneous	2014-05-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7963124&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7954450	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Asthma (2d - Recovered/Resolved - Other Medically Important Condition);Cough (2d - Recovered/Resolved - Other Medically Important Condition);Rhonchi (2d - Recovered/Resolved - Other Medically Important Condition);Tachycardia (2d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	[MONTELUKAST, MONTELUKAST SODIUM] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954450&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954451	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954451&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954455	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Chest pain (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954456	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Bronchitis (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (22d - Recovered/Resolved - Other Medically Important Condition);Headache (5d - Recovered/Resolved - Other Medically Important Condition);Inappropriate schedule of product administration (n/a - Unknown - Other Medically Important Condition);Increased bronchial secretion (15d - Recovered/Resolved - Other Medically Important Condition);Lymphadenopathy (48h - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Reaction to preservatives (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinitis (18d - Recovered/Resolved - Other Medically Important Condition);Sinus pain (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954456&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-7954458	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Blood pressure decreased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cold sweat (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Feeling cold (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Limb discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tachypnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954459	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Neck pain (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954459&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7954460	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954460&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954462	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cardiac disorder (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Chest pain (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Dysarthria (n/a - Recovering/Resolving - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Dysphagia (n/a - Recovering/Resolving - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovering/Resolving - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Hypotension (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Myocardial infarction (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Panic attack (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Paresis (n/a - Recovering/Resolving - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pulmonary embolism (1d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Right ventricular failure (1d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Venous thrombosis limb (1d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	ESOMEPRAZOLE [ESOMEPRAZOLE] (C - Product used for unknown indication - Unknown - [n/a - 20mg - Oral])|[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - Product used for unknown indication - Unknown - [n/a - 100mg - Oral])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - Product used for unknown indication - Unknown - [n/a - 5mg - Oral])|[CERTOPARIN SODIUM] (C - n/a - Unknown - [n/a - .5mL - Subcutaneous])|[CERTOPARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[FERROUS (II) GLYCINE SULFATE COMPLEX] (C - Product used for unknown indication - Unknown - [n/a - n/a - Oral])|[GLIMEPIRIDE] (C - Product used for unknown indication - Unknown - [n/a - 3mg - Oral])|[HYDROCHLOROTHIAZIDE] (C - Product used for unknown indication - Unknown - [n/a - 12.5mg - Oral])|[LACTULOSE] (C - Product used for unknown indication - Unknown - [n/a - 10mL - Oral])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - Product used for unknown indication - Unknown - [n/a - 20mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - Unknown - [n/a - n/a - Unknown])|[MIRTAZAPINE] (C - Product used for unknown indication - n/a - [n/a - 15mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7954464	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Cardiac death (n/a - Fatal - Results in Death, Life Threatening, Other Medically Important Condition);Cardiovascular disorder (n/a - Not Recovered/Not Resolved - Results in Death, Life Threatening, Other Medically Important Condition);Circulatory collapse (n/a - Unknown - Results in Death, Life Threatening, Other Medically Important Condition);Cyanosis (n/a - Unknown - Results in Death, Life Threatening, Other Medically Important Condition);Myocardial infarction (n/a - Fatal - Results in Death, Life Threatening, Other Medically Important Condition);Pallor (n/a - Unknown - Results in Death, Life Threatening, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954464&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7954465	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bradycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Circulatory collapse (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cold sweat (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/BRISBANE/60/2008-LIKE VIRUS] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954466	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Amaurosis fugax (n/a - Recovering/Resolving - Other Medically Important Condition);Blindness (n/a - Recovering/Resolving - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Head discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Visual impairment (n/a - Recovering/Resolving - Other Medically Important Condition)	CELVAPAN PANDEMIC INFLUENZA VACCINE (H1N1) (WHOLE VIRION, VERO CELL DERIVED, INACTIVATED) SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - 7ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954467	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Extrasystoles (n/a - Unknown - Caused/Prolonged Hospitalisation);Heart rate irregular (n/a - Unknown - Caused/Prolonged Hospitalisation);Presyncope (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954469	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	General physical health deterioration (n/a - Unknown - Results in Death, Life Threatening);Respiratory failure (n/a - Fatal - Results in Death, Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	[OXYGEN] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7954470	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypertensive crisis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[METOPROLOL TARTRATE, METOPROLOL TARTRATE PH. EUR.] (S - Product used for unknown indication - Unknown - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7954473	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Female	Injection site pain (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7954477	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Myalgia (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7954478	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Angioedema (20min - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Bronchospasm (20min - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Syncope (20min - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7954479	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Recovering/Resolving - Disabling);Guillain-Barre syndrome (n/a - Recovering/Resolving - Disabling);Headache (n/a - Recovering/Resolving - Disabling);Paraesthesia (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[AMOXICILLIN SODIUM, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - 30mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954479&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7954481	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Anaphylactic reaction (1d - Fatal - Results in Death);Dyspnoea (n/a - Unknown - Results in Death);Rash (n/a - Recovered/Resolved - Results in Death);Swollen tongue (n/a - Unknown - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])|[AMOXICILLIN, AMOXICILLIN TRIHYDRATE] (S - Dental care - n/a - [n/a - n/a - Unknown])|[AMOXICILLIN, AMOXICILLIN TRIHYDRATE] (S - Prophylaxis - Unknown - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7954483	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Unknown - Disabling);Asthma (n/a - Unknown - Disabling);Migraine (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Peripheral swelling (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])	[CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7954496	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Nau JY, Du vaccin et du syndrome de Guillain-Barre, Journal de la grippe mexicaine, Revue Medicale Suisse 25nov2009	18-64 Years	Not Specified	No	Female	Acute polyneuropathy (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954497	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Tendonitis (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Dose not changed - [n/a - n/a - Parenteral])|[INDOMETACIN] (S - Psoriatic arthropathy - Dose not changed - [n/a - n/a - Oral])|[OMEPRAZOLE] (S - Psoriatic arthropathy - Dose not changed - [n/a - n/a - Oral])|[PREDNISOLONE] (S - Psoriatic arthropathy - Dose not changed - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7954500	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cyanosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Raynaud's phenomenon (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954504	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Hyperacusis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Irritability (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Peripheral coldness (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Stress (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7954505	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Unknown - Other Medically Important Condition);Disability (9d - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Polyneuropathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Swelling (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954505&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954510	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (1wk - Recovered/Resolved - Other Medically Important Condition);Erythema (1wk - Recovered/Resolved - Other Medically Important Condition);Flushing (1wk - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (1wk - Unknown - Other Medically Important Condition);Injection site erythema (1wk - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (1wk - Recovered/Resolved - Other Medically Important Condition);Papule (1wk - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (1wk - Recovered/Resolved - Other Medically Important Condition);Pruritus (1wk - Recovered/Resolved - Other Medically Important Condition);Rash macular (1wk - Recovered/Resolved - Other Medically Important Condition);Urticaria (1wk - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 3.75ug - Intramuscular])	[CODEINE] (C - Pain - n/a - [n/a - n/a - Oral])|[HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - Intramuscular])|[MESALAZINE] (C - Colitis ulcerative - n/a - [n/a - 800mg - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Ill-defined disorder - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954510&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954512	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Sudden death (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7954518	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Male	Decreased appetite (n/a - Unknown - );Diarrhoea (n/a - Recovered/Resolved - );Dyspnoea (n/a - Unknown - );Hyperpyrexia (n/a - Recovered/Resolved - );Insomnia (n/a - Recovered/Resolved - );Listless (n/a - Unknown - );Rash (n/a - Recovering/Resolving - );Respiratory tract infection (n/a - Unknown - );Tearfulness (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954518&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7954522	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Facial paralysis (3wk - Recovered/Resolved - Other Medically Important Condition);Fatigue (3d - Recovered/Resolved - Other Medically Important Condition);Injection site reaction (2d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition);Somnolence (3d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954522&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954524	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Balance disorder (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Depressed level of consciousness (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dizziness (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dysstasia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Epilepsy (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Headache (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Nausea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Tremor (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Vomiting (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954524&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7954525	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Malaise (67d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [0d - n/a - Intramuscular])	[CARBOCISTEINE] (C - n/a - n/a - [n/a - n/a - n/a])|[CODEINE PHOSPHATE BP, PARACETAMOL PH. EUR., PARACETAMOL BP, CODEINE PHOSPHATE BP, PARACETAMOL, CODEINE PHOSPHATE, PARACETAMOL, CODEINE PHOSPHATE BP, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE, PARACETAMOL, PARACETAMOL DC, CODEINE PHOSPHATE PH.EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-7954526	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Facial paralysis (7d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (7d - Recovered/Resolved - Other Medically Important Condition);Wrong product administered (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [1d - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/FLORIDA/4/2006), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), ANTIGENS OF THE INFLUENZA VIRUS A/CALIFORNIA/7/2009 (H1N1)-LIKE VIRUS PDM09, ANTIGENS OF THE INFLUENZA VIRUS A/VICTORIA/361/2011 (H3N2)-LIKE VIRUS, ANTIGENS OF THE INFLUENZA VIRUS B/WISCONSIN/1/2010-LIKE VIRUS, B/BRISBANE/60/2008-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/WISCONSIN/67/2005 REASS. NYMCX-161-B), A/SOLOMON ISLANDS/3/2006 (H1N1) - LIKE STRAIN (A/SOLOMON ISLANDS/3/2006 REASS. IVR-145), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE STRAIN (A/CALIFORNIA/7/2009, X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), SQUALENE, SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/BRISBANE/9/2014 (WILD TYPE), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/BRISBANE/9/2014 (WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), SQUALENE, SORBITAN TRIOLEATE, POLYSORBATE 80, SODIUM CITRATE, CITRIC ACID ANHYDROUS, B/MASSACHUSETTS/2/2012-LIKE STRAIN USED B/MASSACHUSETTS/2/2012 WILD TYPE, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223), SQUALENE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)] (S - Influenza immunisation - Unknown - [1d - 1{DF} - Intramuscular])	[AMISULPRIDE] (C - Depression - Unknown - [n/a - 50mg - Oral])|[LANSOPRAZOLE] (C - Gastritis - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954532	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	Non European Economic Area	Gibbs RS, Premmereur J, Fisher BM, Lynch A.. Late pregnancy loss after A(H1N1) vaccination. American Journal of Obstetrics &amp; Gynecology. 2011;S247	18-64 Years	Adult	No	Female	Foetal death (n/a - Fatal - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Staphylococcal infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Viral infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954532&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954535	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anxiety (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Epilepsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fear (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hallucination (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersomnia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nightmare (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Personality disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination error (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight decreased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954535&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954536	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aphthous ulcer (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dermatitis bullous (n/a - Unknown - Caused/Prolonged Hospitalisation);Nasal septum perforation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Papule (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyoderma gangrenosum (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Skin ulcer (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Throat lesion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tonsillitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954544	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Abscess (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Pyoderma gangrenosum (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[AZATHIOPRINE, AZATHIOPRINE SODIUM] (S - Crohn's disease - Unknown - [n/a - 50mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954544&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7954545	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Renal colic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954545&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954552	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cardiac death (n/a - Fatal - Results in Death);Cardiac failure acute (1d - Fatal - Results in Death);Dyspnoea (n/a - Unknown - Results in Death);General physical health deterioration (n/a - Unknown - Results in Death);Nausea (n/a - Unknown - Results in Death);Silent myocardial infarction (1d - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[INSULIN, INSULIN HUMAN] (C - Type 2 diabetes mellitus - Unknown - [n/a - n/a - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954552&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7954553	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Concussion (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Contusion (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Head injury (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Retrograde amnesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	CELVAPAN PANDEMIC INFLUENZA VACCINE (H1N1) (WHOLE VIRION, VERO CELL DERIVED, INACTIVATED) SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 7ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954554	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954554&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954559	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Abdominal pain (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Altered state of consciousness (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Bradycardia (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cholinergic syndrome (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Circulatory collapse (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Heart rate decreased (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotension (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954559&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954560	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (2d - Recovered/Resolved - Other Medically Important Condition);Decreased appetite (n/a - Unknown - Other Medically Important Condition);Diarrhoea (1d - Recovered/Resolved - Other Medically Important Condition);Electric shock sensation (n/a - Recovered/Resolved - Other Medically Important Condition);Formication (46d - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (2d - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Palpitations (16d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (46d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (1d - Recovered/Resolved - Other Medically Important Condition);Sensory disturbance (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[INFLUENZA VACCINE, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954560&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954563	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Contusion (n/a - Unknown - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954563&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954564	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Chest pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Condition aggravated (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Photophobia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tension headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	M-M-RVAXPRO [MEASLES VIRUS ENDERS' EDMONSTON STRAIN (LIVE, ATTENUATED), MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954564&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954565	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (2d - Recovered/Resolved - Other Medically Important Condition);Dysaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Iron deficiency anaemia (n/a - Unknown - Other Medically Important Condition);Malaise (2d - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Other Medically Important Condition);Neuropathy peripheral (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954565&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954566	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Adjustment disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Depressed mood (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysgeusia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Electric shock sensation (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Feeling of despair (n/a - Unknown - Caused/Prolonged Hospitalisation);Food aversion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Parosmia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Periodic limb movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Snoring (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somatic symptom disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tension (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954567	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Cardiac arrest (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954567&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7954571	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anxiety (n/a - Recovered/Resolved - );Hallucination (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Nasopharyngitis (n/a - Recovered/Resolved - );Oropharyngeal pain (n/a - Recovered/Resolved - );Peripheral swelling (n/a - Recovered/Resolved - );Rhinitis (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	[DIPOTASSIUM CLORAZEPATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[DROSPIRENONE, ESTRADIOL, DROSPIRENONE, ESTRADIOL HEMIHYDRATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Oral])|[SUMATRIPTAN, SUMATRIPTAN SUCCINATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954571&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7954572	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Aphasia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Cerebrovascular accident (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954572&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7954573	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mood altered (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954573&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954574	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Epilepsy (0mo - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Malaise (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954574&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7954577	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Balance disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Body temperature increased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sensory disturbance (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7954578	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Blood pressure fluctuation (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Bundle branch block right (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Cardiogenic shock (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Drug withdrawn - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954578&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7954579	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hyperaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954579&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954586	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Iron deficiency (23d - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954588	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (3wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoacusis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Otitis media (n/a - Unknown - Caused/Prolonged Hospitalisation);Ototoxicity (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (3wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paresis (3wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rheumatoid arthritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954588&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954593	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (5d - Recovering/Resolving - Other Medically Important Condition);Erythema (5d - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (5d - Recovering/Resolving - Other Medically Important Condition);Influenza like illness (5d - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	[ESTRADIOL VALERATE, ESTRADIOL VALERATE, NORETHISTERONE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[INSULIN, INSULIN HUMAN] (C - n/a - n/a - [n/a - n/a - n/a])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954593&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954599	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal discomfort (n/a - Unknown - Other Medically Important Condition);Arthralgia (n/a - Unknown - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Other Medically Important Condition);Cognitive disorder (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Insomnia (n/a - Unknown - Other Medically Important Condition);Lymph node pain (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954601	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Feeling of body temperature change (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Hyperhidrosis (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Pain (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Rhinorrhoea (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	[CRANBERRY] (C - n/a - n/a - [n/a - n/a - n/a])|[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7954612	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Immune thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954612&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954617	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Recovering/Resolving - Disabling);Bradyphrenia (n/a - Not Recovered/Not Resolved - Disabling);Chest discomfort (n/a - Recovering/Resolving - Disabling);Chills (n/a - Unknown - Disabling);Dyspnoea exertional (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Recovering/Resolving - Disabling);Infection susceptibility increased (n/a - Unknown - Disabling);Injection site pain (n/a - Recovering/Resolving - Disabling);Injection site swelling (n/a - Recovering/Resolving - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Unknown - Disabling);Nasopharyngitis (n/a - Recovering/Resolving - Disabling);Pyrexia (n/a - Recovering/Resolving - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - 150ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954617&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7954633	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954633&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954647	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pneumonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954648	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Vaccination site reaction (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954648&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7954655	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Alopecia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - H1N1 influenza - n/a - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954655&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7954660	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Colitis ulcerative (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Proctitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954660&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954661	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastrooesophageal reflux disease (n/a - Unknown - Caused/Prolonged Hospitalisation);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Night sweats (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Polymyalgia rheumatica (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[IBUPROFEN LYSINE] (C - Headache - Unknown - [n/a - n/a - Unknown])|[OMEPRAZOLE] (C - Gastrooesophageal reflux disease - Unknown - [n/a - n/a - Unknown])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Blood cholesterol increased - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954661&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954667	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	H1N1 influenza (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (15d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954669	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cervicobrachial syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chondropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Disability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Erythema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Haematuria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (0a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Joint capsule rupture (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Limb discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Meniscal degeneration (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Micturition urgency (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscle tightness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Osteoarthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Prostatic adenoma (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pseudoradicular syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pyelocaliectasis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Rotator cuff syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Urinary retention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954685	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chills (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);H1N1 influenza (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	VACCINE (UNSPECIFIED) [VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954688	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Somnolence (n/a - Recovered/Resolved - );Syncope (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7954694	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amnesia (n/a - Unknown - Disabling, Other Medically Important Condition);Apraxia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Arthralgia (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Coordination abnormal (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dementia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depression (n/a - Unknown - Disabling, Other Medically Important Condition);Diarrhoea (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Disability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Executive dysfunction (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Initial insomnia (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Memory impairment (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Muscle spasms (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Muscle twitching (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Productive cough (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Psychiatric symptom (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Sensorimotor disorder (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Speech disorder (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-7954697	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Myocardial infarction (1d - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	AVONEX [INTERFERON BETA-1A] (C - Multiple sclerosis - Unknown - [n/a - n/a - Intramuscular])|[INSULIN, INSULIN HUMAN] (C - Type 1 diabetes mellitus - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7954725	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	H1N1 influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination failure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954725&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954741	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Herpes zoster (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954741&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954750	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Disturbance in attention (n/a - Recovering/Resolving - Disabling);Fatigue (n/a - Recovering/Resolving - Disabling);Headache (n/a - Recovering/Resolving - Disabling);Hypersomnia (n/a - Unknown - Disabling);Memory impairment (n/a - Recovering/Resolving - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7954751	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	H1N1 influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination failure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954757	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Disability (1wk - Recovered/Resolved - Other Medically Important Condition);H1N1 influenza (9d - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (2d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954772	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Areflexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Back pain (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);CSF test abnormal (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Dysarthria (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Facial paresis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Paraparesis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Peripheral sensorimotor neuropathy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7954773	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Acute myocardial infarction (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cerebral infarction (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Depressed level of consciousness (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Disorientation (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Epilepsy (0h - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Ischaemia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [1d - n/a - Unknown])	[ENALAPRIL MALEATE, ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - 10mg - Unknown])|[OMEPRAZOLE] (C - n/a - Unknown - [n/a - 20mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7954798	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain (n/a - Unknown - Disabling);Abnormal behaviour (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Infection susceptibility increased (n/a - Unknown - Disabling);Musculoskeletal stiffness (n/a - Unknown - Disabling);Narcolepsy (n/a - Unknown - Disabling);Oropharyngeal pain (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7954800	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dysarthria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypoglossal nerve paresis (n/a - Unknown - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuritis cranial (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia oral (n/a - Unknown - Caused/Prolonged Hospitalisation);Tongue paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954801	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954801&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954805	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Limb discomfort (n/a - Unknown - );Monoplegia (n/a - Unknown - );Peripheral swelling (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [0d - n/a - Intramuscular])	[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954805&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7954825	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Bronchitis (n/a - Unknown - Results in Death);Quadriplegia (n/a - Unknown - Results in Death);Sudden death (1d - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[BIPERIDEN, BIPERIDEN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 4mg - Oral])|[FLUPHENAZINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Oral])|[PERAZINE DIMALONATE] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7954827	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954901	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Constipation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dry mouth (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspepsia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysstasia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ear discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myasthenic syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sensation of foreign body (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin discolouration (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954901&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954910	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cardiac failure acute (40min - Fatal - Results in Death);Gaze palsy (n/a - Unknown - Results in Death);Loss of consciousness (n/a - Unknown - Results in Death);Malaise (n/a - Unknown - Results in Death);Myocardial infarction (1d - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - Unknown - [n/a - n/a - Oral])|[ATENOLOL, ATENOLOL HYDROCHLORIDE, ATENOLOL PH. EUR.] (C - n/a - Unknown - [n/a - n/a - Oral])|[FLUVASTATIN SODIUM] (C - n/a - Unknown - [n/a - n/a - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - n/a - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - Unknown - [n/a - n/a - Oral])|[RAMIPRIL] (C - n/a - Unknown - [n/a - n/a - Oral])|[XYLOMETAZOLINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Nasal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7954911	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abscess limb (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Blindness unilateral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Diabetes mellitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Feeling abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Foot amputation (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Localised infection (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7954930	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [4wk - 2{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7954931	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Ill-defined disorder - Not applicable - [0d - n/a - Intrathecal])	METHOTREXATE [METHOTREXATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7954957	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (0d - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Dyspnoea (0d - Recovered/Resolved - Disabling, Other Medically Important Condition);Flushing (0d - Recovered/Resolved - Disabling, Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Swelling (0d - Recovered/Resolved - Disabling, Other Medically Important Condition);Swelling face (0d - Recovered/Resolved - Disabling, Other Medically Important Condition);Throat tightness (0d - Recovered/Resolved - Disabling, Other Medically Important Condition);Wheezing (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7954957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-7955020	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955020&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7955040	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955040&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7955118	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7955148	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	AERIUS [DESLORATADINE] (C - n/a - Unknown - [n/a - 5mg - Unknown])|[BUDESONIDE] (C - n/a - Unknown - [n/a - 32ug - Unknown])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7955159	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Urticaria (23d - Recovered/Resolved - Other Medically Important Condition);Urticarial vasculitis (23d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955159&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-7955161	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Hyperpyrexia (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7955169	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Female	Hyperpyrexia (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955169&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7955174	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Arthralgia (n/a - Recovered/Resolved - );Chills (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955174&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7955176	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Apnoea (n/a - Unknown - Results in Death, Life Threatening);Arrhythmia (n/a - Fatal - Results in Death, Life Threatening);Cardiac arrest (1d - Fatal - Results in Death, Life Threatening);Cardiac failure acute (1d - Fatal - Results in Death, Life Threatening);Constipation (n/a - Unknown - Results in Death, Life Threatening);Cyanosis (n/a - Unknown - Results in Death, Life Threatening);Embolism (n/a - Fatal - Results in Death, Life Threatening);Hypotonia (n/a - Unknown - Results in Death, Life Threatening);Loss of consciousness (n/a - Unknown - Results in Death, Life Threatening);Pallor (n/a - Unknown - Results in Death, Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Unknown])	ALKALOL [ALUM, BENZOIN, CAMPHOR, CINEOLE, MENTHOL, PINUS MUGO OIL, POTASSIUM CHLORATE, SODIUM BICARBONATE, SODIUM CHLORIDE, THYMOL] (C - n/a - Unknown - [n/a - 3mg - Unknown])|[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - Unknown - [n/a - 3mg - Unknown])|[MICRONISED SPIRONOLACTONE, POTASSIUM CANRENOATE, SPIRONOLACTONE, SPIRONOLACTONE BP] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7955180	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Palpitations (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	[LEVOTHYROXINE SODIUM, POTASSIUM IODIDE, LEVOTHYROXINE, POTASSIUM IODIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955180&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7955192	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Leukocytosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Meningism (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Meningitis (54d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Overdose (n/a - Unknown - Caused/Prolonged Hospitalisation);Pleocytosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7955196	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthritis (n/a - Unknown - Other Medically Important Condition);Disability (n/a - Unknown - Other Medically Important Condition);Gait disturbance (n/a - Unknown - Other Medically Important Condition);Hyperthermia (n/a - Unknown - Other Medically Important Condition);Lymphostasis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Swelling (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955196&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7955197	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Guttate psoriasis (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7955199	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Circulatory collapse (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Overdose (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Poor peripheral circulation (30min - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Tachycardia (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 2.5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955199&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7955200	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Injection site reaction (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955200&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7955202	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Gaze palsy (3s - Unknown - Caused/Prolonged Hospitalisation);Muscle twitching (3s - Unknown - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (3s - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955202&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7955206	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Abdominal pain (n/a - Recovered/Resolved - Life Threatening);Anaphylactic reaction (12h - Recovered/Resolved - Life Threatening);Asthenia (n/a - Not Recovered/Not Resolved - Life Threatening);Cardiovascular disorder (n/a - Recovered/Resolved - Life Threatening);Circulatory collapse (12h - Recovered/Resolved - Life Threatening);Decreased appetite (n/a - Recovered/Resolved - Life Threatening);Dehydration (12h - Recovered/Resolved - Life Threatening);Diarrhoea (12h - Recovered/Resolved - Life Threatening);Fall (n/a - Recovered/Resolved - Life Threatening);Hypersensitivity (12h - Recovered/Resolved - Life Threatening);Hypotension (n/a - Recovered/Resolved - Life Threatening);Loss of consciousness (n/a - Recovered/Resolved - Life Threatening);Nausea (n/a - Recovered/Resolved - Life Threatening);Shock (n/a - Recovered/Resolved - Life Threatening);Vomiting (12h - Recovered/Resolved - Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-7955208	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Atrial fibrillation (5d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Blood pressure increased (5d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Breath sounds abnormal (5d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cardiac failure (5d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Chills (5d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Oxygen saturation decreased (5d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory distress (2d - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Rhonchi (5d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Tremor (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (5d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955208&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7955212	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Ataxia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Blood creatine phosphokinase increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);C-reactive protein increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chest pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cyanosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myositis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rhabdomyolysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])|[SIMVASTATIN] (S - Hyperlipidaemia - Drug withdrawn - [4y - 20mg - Oral])	[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - Unknown - [n/a - 100mg - Oral])|[BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - Coronary artery disease - Unknown - [4y - 2.5mg - Oral])|[GABAPENTIN] (C - Trigeminal neuralgia - Unknown - [n/a - 900mg - Oral])|[HYDROCHLOROTHIAZIDE, RAMIPRIL] (C - n/a - Unknown - [n/a - 10mg - Oral])|[RAMIPRIL] (C - Product used for unknown indication - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7955213	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Nerve injury (3mo - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - );Quadriplegia (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7955215	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Blood pressure decreased (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Sarcoidosis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7955216	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Erythema (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Injection site pruritus (n/a - Recovered/Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955216&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7955226	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dysaesthesia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Dysphagia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Facial paresis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Neuropathy peripheral (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7955232	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Disability (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Injection site erythema (7d - Recovered/Resolved - Other Medically Important Condition);Injection site inflammation (7d - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site reaction (7d - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (1wk - Recovered/Resolved - Other Medically Important Condition);Injection site warmth (1wk - Recovered/Resolved - Other Medically Important Condition);Movement disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Osteonecrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tendon disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955232&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7955238	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Arthropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysstasia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fall (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscle contractions involuntary (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7955239	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[PROPIOMAZINE, PROPIOMAZINE MALEATE] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955239&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7955241	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Dysstasia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Eczema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Gait inability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);H1N1 influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hyperaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypersensitivity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Infection susceptibility increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Neuralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain of skin (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Petit mal epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pruritus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Urticaria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955241&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7955242	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Hyperpyrexia (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955242&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7955245	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Male	Eczema (n/a - Recovering/Resolving - );Oligodipsia (n/a - Recovered/Resolved - );Pyrexia (n/a - Recovered/Resolved - );Vomiting (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7955247	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Alanine aminotransferase increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Aspartate aminotransferase increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Drug-induced liver injury (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - .5mL - Intradermal])...	[ATENOLOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE, VITAMIN D, CALCIUM CARBONATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[DRY EXTRACT OF MILK THISTLE FRUIT (35-40:1), EXTRACTION SOLVENT: METHANOL, MILK THISTLE FRUIT EXTRACT, SILYBUM MARIANUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[SPIRONOLACTONE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[URSODEOXYCHOLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7955260	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cerebral vasoconstriction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Monoclonal gammopathy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Scintillating scotoma (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Subarachnoid haemorrhage (6mo - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7955265	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aphasia (n/a - Recovering/Resolving - Other Medically Important Condition);Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Burnout syndrome (n/a - Recovering/Resolving - Other Medically Important Condition);Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Dyskinesia (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Feeling abnormal (n/a - Recovering/Resolving - Other Medically Important Condition);Hallucination (n/a - Recovering/Resolving - Other Medically Important Condition);Incorrect route of product administration (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep paralysis (n/a - Recovering/Resolving - Other Medically Important Condition);Weight increased (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Subcutaneous])	[IBUPROFEN] (C - n/a - Unknown - [n/a - 400mg - Unknown])|[PARACETAMOL] (C - n/a - Unknown - [n/a - 500mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7955267	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle contractions involuntary (6d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Retching (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (6d - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7955270	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Sudden cardiac death (1d - Fatal - Results in Death, Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955270&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7955291	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute myocardial infarction (n/a - Fatal - Results in Death);Chest pain (n/a - Unknown - Results in Death);Pain in extremity (n/a - Unknown - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7955384	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anosmia (n/a - Recovering/Resolving - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7955407	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Amnesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Recovering/Resolving - Other Medically Important Condition);Paralysis (n/a - Recovering/Resolving - Other Medically Important Condition);Poor quality sleep (n/a - Recovering/Resolving - Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[WARFARIN SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955407&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7955427	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Induration (8d - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Myositis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7955498	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Dizziness (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (10s - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (20min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7955622	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Diarrhoea (n/a - Recovering/Resolving - );Influenza like illness (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955622&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7955671	Spontaneous	2014-05-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Female	Hyperpyrexia (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7955696	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Circulatory collapse (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Muscle twitching (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7955716	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	Non European Economic Area	Gibbs RS, Premmereur J, Fisher BM, Lynch A.. Late pregnancy loss after A (H1N1) vaccination. American Journal of Obstetrics &amp; Gynecology. 2011;S247	18-64 Years	Adult	No	Female	Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Foetal death (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Placental disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - n/a])	[BUPRENORPHINE, BUPRENORPHINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955716&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7955771	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Acute kidney injury (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Acute myocardial infarction (7d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Cardiac failure (7d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Dizziness (3d - Recovered/Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Hypotension (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Hypoxia (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Nausea (3d - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Peripheral circulatory failure (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (3d - Recovered/Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7955803	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic shock (2d - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Blood pressure increased (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Circulatory collapse (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Erythema (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Heart rate increased (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hot flush (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Illusion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Somatic symptom disorder (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Sympathomimetic effect (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955803&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7955804	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7955822	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (2d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Erythema (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Heart rate increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neck pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Odynophagia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pharyngeal oedema (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Throat tightness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Type I hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vertigo (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	[ELETRIPTAN, ELETRIPTAN HYDROBROMIDE] (C - n/a - n/a - [1d - 40mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7955923	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Stillbirth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	[CLOMIPRAMINE, CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE BP] (C - Depression - Unknown - [n/a - n/a - n/a])|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - n/a])|[FOLIC ACID, DRIED FERROUS SULFATE, FOLIC ACID, FERROUS SULFATE, FOLIC ACID, IRON] (C - n/a - Unknown - [n/a - n/a - Oral])|[LIQUID EXTRACT OF VALERIAN ROOT (1:10), EXTRACTION SOLVENT: ETHANOL 33% V/V, VALERIAN EXTRACT, VALERIAN ROOT DRY EXTRACT (3-6:1), ETHANOL 70 %(V/V), VALERIAN ROOT DRY HYDROALCOHOLIC EXTRACT (3-6:1; EXTRACTION SOLVENT: ETHANOL 70% V/V), VALERIANA, VALERIANA OFFICINALIS L. ROOT DRY EXTRACT, VALERIANA OFFICINALIS L. ROOT ETHANOL DRY EXTRACT, HUMULUS LUPULUS EXTRACTUM SICCUM, VALERIANAE EXTRACTUM SICCUM (3 - 6 : 1), ETHANOL 70% (V/V)] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955923&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7955952	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cardiac failure (1d - Fatal - Results in Death);Circulatory collapse (n/a - Unknown - Results in Death);Myalgia (n/a - Unknown - Results in Death);Pyrexia (n/a - Unknown - Results in Death);Tachycardia (0d - Recovered/Resolved - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955952&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7955953	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Gingival bleeding (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Haematoma (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Immune thrombocytopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Mouth haemorrhage (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Petechiae (n/a - Unknown - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LATANOPROST] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7955953&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7956053	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arrhythmia (n/a - Recovered/Resolved - Life Threatening);Injection site pain (n/a - Not Recovered/Not Resolved - Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7956053&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-7956055	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Abdominal distension (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Arrhythmia (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Aspiration (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Cardiac arrest (1d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Cardiogenic shock (1d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Multiple organ dysfunction syndrome (1d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia aspiration (1d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Sepsis (1d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7956055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7956138	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7956138&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7956248	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Dysaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7956248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7956285	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Herpes zoster (2wk - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin disorder (3wk - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7956285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7957296	Spontaneous	2014-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Goitre (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7957296&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7950497	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dyspnoea (n/a - Unknown - Results in Death);Hyperhidrosis (n/a - Unknown - Results in Death);Myocardial infarction (n/a - Fatal - Results in Death);Pain (n/a - Unknown - Results in Death);Respiration abnormal (n/a - Unknown - Results in Death);Respiratory arrest (1d - Fatal - Results in Death);Silent myocardial infarction (1d - Fatal - Results in Death);Ventricular fibrillation (1d - Fatal - Results in Death);Vomiting (n/a - Unknown - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7950497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7950510	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Deafness (3d - Not Recovered/Not Resolved - Disabling);Deafness unilateral (5d - Recovered/Resolved - Disabling);Ear discomfort (3d - Not Recovered/Not Resolved - Disabling);Tinnitus (7d - Recovering/Resolving - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])|[ACICLOVIR, ACICLOVIR SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7950510&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7950596	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7950596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7950606	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Puijenbroek van E, Broos N and Grootheest. Monitoring Adverse Events of the Vaccination Campaign against Influenza A (H1N1) in the Netherlands. Safety Monitoring of Influenza A (H1N1) Vaccination. 2010;33 (12):1097 to 1108	More than 85 Years	Elderly	Yes	Male	Death (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7950606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7950621	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hallucination (3d - Recovered/Resolved - );Insomnia (3d - Recovered/Resolved - );Pruritus (3d - Recovered/Resolved - );Psychomotor hyperactivity (3d - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Asthma - Not applicable - [0d - n/a - Intramuscular])	[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[IBUPROFEN] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7950621&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7950628	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Acute kidney injury (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Anuria (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Blood bilirubin increased (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Blood creatinine increased (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Blood lactate dehydrogenase increased (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dehydration (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Flank pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Haemoglobin decreased (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Haemolytic uraemic syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Haptoglobin decreased (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Jaundice (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Red blood cell count decreased (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Thrombotic thrombocytopenic purpura (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [1d - 1{DF} - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (S - n/a - Drug withdrawn - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7950628&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7950705	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	van Puijenbroek E, Broos N, van Grootheest K. Monitoring Adverse Events of the Vaccination Campaign Against Influenza A (H1N1) in the Netherlands. ORIGINAL RESEARCH ARTICLE. 2010;33(12):1097-1108	12-17 Years	Adolescent	No	Female	Respiratory disorder (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	AZTREONAM [AZTREONAM] (C - n/a - Not applicable - [n/a - n/a - Respiratory (inhalation)])|[ALPHA-TOCOPHEROL] (C - n/a - Unknown - [n/a - n/a - n/a])|[AMYLASE, LIPASE, PROTEASE, PANCREALIPASE, PANCREAS POWDER, PANCREAS POWDER FROM PORCINE, PANCREATIN, PANCREATIN BP] (C - n/a - Unknown - [n/a - n/a - n/a])|[COLECALCIFEROL] (C - n/a - Unknown - [n/a - n/a - Oral])|[ITRACONAZOLE] (C - n/a - Unknown - [n/a - 100mg - n/a])|[MEROPENEM, MEROPENEM ANHYDROUS, MEROPENEM TRIHYDRATE] (C - n/a - Unknown - [n/a - 500mg - Intravenous bolus])|[PHYTOMENADIONE] (C - n/a - Unknown - [n/a - n/a - n/a])|[RETINOL ACETATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - n/a - Intravenous (not otherwise specified)])|[URSODEOXYCHOLIC ACID] (C - n/a - Unknown - [n/a - 300mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7950705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7950806	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Mouth haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation);Thrombocytopenic purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (S - Asthma - Unknown - [n/a - n/a - Respiratory (inhalation)])|[NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM ANHYDROUS] (S - Product used for unknown indication - Drug withdrawn - [n/a - n/a - Unknown])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (S - Product used for unknown indication - Drug withdrawn - [n/a - n/a - Oral])|[THIAMINE HYDROCHLORIDE, QUININE BENZOATE] (S - Muscle spasms - Drug withdrawn - [n/a - n/a - Unknown])	[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - Hypercholesterolaemia - Drug withdrawn - [n/a - n/a - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[FOSINOPRIL, FOSINOPRIL SODIUM] (C - Hypertension - Unknown - [n/a - n/a - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - Respiratory (inhalation)])|[TETRAZEPAM] (C - Product used for unknown indication - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7950806&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7950820	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Vries L, Hunsel F V, Maarschalkerweerd B C, Puijenbroek E, Grootheest K. Adjuvanted A/H1N1 (2009) Influenza Vaccination During Pregnancy: Description of a Prospective Cohort and Reactions in the Netherlands. Birth Defects Research Part A: Clinical and Molecular Teratology. 2014	18-64 Years	Adult	Yes	Female	Abortion spontaneous (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])|FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7950820&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7950829	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Burning sensation (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Decubitus ulcer (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Dermatitis exfoliative generalised (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Drug eruption (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Haemorrhage (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Psoriasis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Rash macular (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Skin exfoliation (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Wound (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Product used for unknown indication - Not applicable - [1d - n/a - Intramuscular])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Product used for unknown indication - Not applicable - [1d - n/a - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[HYDROCHLOROTHIAZIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE, METOPROLOL TARTRATE PH. EUR.] (C - Hypertension - Dose not changed - [n/a - n/a - Unknown])|[SIMVASTATIN] (C - Hypercholesterolaemia - Dose not changed - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7950829&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7950954	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7950954&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7951182	Spontaneous	2014-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthma (43d - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7951182&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7951326	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Tachycardia (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Ill-defined disorder - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7951326&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7951361	Spontaneous	2014-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Fatigue (n/a - Recovering/Resolving - );Pyrexia (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7951361&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7951734	Spontaneous	2014-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anger (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Impatience (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Personality change (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7951734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7951735	Spontaneous	2014-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition);Stress (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7951735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7951736	Spontaneous	2014-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7951736&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7951738	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7951738&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7952516	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Neonate (Preterm and Term newborns)	Yes	Male	Death neonatal (n/a - Fatal - Results in Death);Foetal exposure during pregnancy (n/a - Fatal - Results in Death);Premature baby (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7952516&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7952525	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Neonate (Preterm and Term newborns)	Yes	Female	Foetal exposure during pregnancy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoglycaemia neonatal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neonatal asphyxia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neonatal infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7952525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7952534	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	Yes	Female	Congenital pneumonia (n/a - Fatal - Results in Death);Foetal death (n/a - Fatal - Results in Death);Foetal exposure during pregnancy (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7952534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7952600	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	Yes	Female	Foetal arrhythmia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Foetal exposure during pregnancy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Supraventricular tachycardia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7952600&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7952837	Spontaneous	2014-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Female	Foetal exposure during pregnancy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperexplexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sleep apnoea syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7952837&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7952858	Spontaneous	2014-05-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition);Placental necrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Uterine contractions during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7952858&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7945953	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Encephalomyelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Myelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Vertigo (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7945953&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7945980	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Not Specified - Other Medically Important Condition);Facial paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Normal newborn (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - n/a])	[ASCORBIC ACID, BIOTIN, COLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, THIAMINE, ZINC, CALCIUM, COPPER, IODINE, IRON, MAGNESIUM, MANGANESE, PANTOTHENIC ACID, PYRIDOXINE HYDROCHLORIDE, SELENIUM, RETINOL, ALPHA-TOCOPHEROL, VITAMIN B12, ASCORBIC ACID, BIOTIN, COLECALCIFEROL, FOLIC ACID, NICOTINIC ACID, RIBOFLAVIN, THIAMINE, CALCIUM HYDROGEN PHOSPHATE (ANHYDROUS), COPPER SULPHATE, ANHYDROUS, MAGNESIUM OXIDE, LIGHT, MANGANESE SULPHATE MONOHYDRATE, FERROUS FUMARATE, PANTOTHENIC ACID, PYRIDOXINE HYDROCHLORIDE, RETINOL, ALPHA-TOCOPHEROL, ZINC SULPHATE MONOHYDRATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, VITAMIN B12, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, CYANOCOBALAMIN, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, CALCIUM HYDROGEN PHOSPHATE (ANHYDROUS), COPPER SULPHATE, ANHYDROUS, MAGNESIUM OXIDE, LIGHT, MANGANESE SULPHATE MONOHYDRATE, FERROUS FUMARATE, PYRIDOXINE HYDROCHLORIDE, RETINOL, ZINC SULPHATE MONOHYDRATE, DL-ALPHA TOCOPHEROL ACETATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, THIAMINE HYDROCHLORIDE, ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, CALCIUM HYDROGEN PHOSPHATE (ANHYDROUS), COPPER SULPHATE, ANHYDROUS, MAGNESIUM OXIDE, LIGHT, MANGANESE SULPHATE MONOHYDRATE, FERROUS FUMARATE, PYRIDOXINE HYDROCHLORIDE, RETINOL, ALPHA-TOCOPHEROL, ZINC SULPHATE MONOHYDRATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, VITAMIN B12, THIAMINE HYDROCHLORIDE, ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, CALCIUM HYDROGEN PHOSPHATE (ANHYDROUS), COPPER SULPHATE, ANHYDROUS, MAGNESIUM OXIDE, LIGHT, MANGANESE SULPHATE MONOHYDRATE, VITAMIN B6, FERROUS FUMARATE, RETINOL, ZINC SULPHATE MONOHYDRATE, DL-ALPHA TOCOPHEROL ACETATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, VITAMIN B12, THIAMINE HYDROCHLORIDE, ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, COLECALCIFEROL, FOLIC ACID, NICOTINAMIDE, RIBOFLAVIN, ZINC, CALCIUM, COPPER, IRON, MAGNESIUM, MANGANESE, PHOSPHORUS, PYRIDOXINE HYDROCHLORIDE, RETINOL, DL-ALPHA TOCOPHEROL ACETATE, VITAMIN B12] (C - n/a - Unknown - [n/a - n/a - n/a])|[FERRIC HYDROXIDE POLYMALTOSE COMPLEX, IRON] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7945980&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7945984	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthma exercise induced (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Bronchial hyperreactivity (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Gastroenteritis (4d - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypotension (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (6wk - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pyelonephritis (3wk - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (4d - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7945984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7945992	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dyspnoea (2h - Recovered/Resolved - Other Medically Important Condition);Pruritus (2h - Recovered/Resolved - Other Medically Important Condition);Rash (2h - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7945992&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7945996	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (3wk - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myalgia (3wk - Unknown - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Spinal disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7945996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946007	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Bell's palsy (n/a - Recovering/Resolving - Other Medically Important Condition);Facial paresis (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia oral (n/a - Unknown - Other Medically Important Condition);Neck pain (n/a - Unknown - Other Medically Important Condition);Tongue coated (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946007&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7946008	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946023	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946023&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946058	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Female	Headache (n/a - Recovering/Resolving - );Malaise (n/a - Recovering/Resolving - );Nausea (n/a - Recovering/Resolving - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946058&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7946062	Spontaneous	2014-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovered/Resolved With Sequelae - Disabling);Diarrhoea (1d - Recovered/Resolved - Disabling);Fatigue (2d - Recovered/Resolved - Disabling);Nausea (n/a - Recovered/Resolved With Sequelae - Disabling);Pyrexia (1d - Recovered/Resolved - Disabling);Vomiting (0d - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Parenteral])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946062&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-7946068	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (10min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Blood pressure systolic (10min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cyanosis (10min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (10min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Feeling abnormal (10min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Heart rate increased (10min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Paraesthesia oral (10min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pharyngeal erythema (10min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Shock symptom (10min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Stridor (10min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Tachypnoea (10min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7946070	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Diarrhoea (0mo - Recovered/Resolved - Other Medically Important Condition);Influenza (0mo - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (0mo - Recovered/Resolved - Other Medically Important Condition);Pyrexia (0mo - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946105	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute myocardial infarction (1d - Fatal - Results in Death);Cold sweat (n/a - Fatal - Results in Death);Fatigue (n/a - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - n/a - n/a])|[CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[CYANOCOBALAMIN, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - n/a - Unknown - [n/a - n/a - n/a])|[ECONAZOLE, ECONAZOLE NITRATE, ECONAZOLE NITRATE, ZINC OXIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[LEVOMEPROMAZINE EMBONATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[MOMETASONE FUROATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[PROPYLENE GLYCOL] (C - n/a - Unknown - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946105&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7946114	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Lung infiltration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaccination failure (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - n/a - n/a - [n/a - n/a - n/a])	MYCOPHENOLATE MOFETIL [MYCOPHENOLATE MOFETIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946116	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pain in extremity (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[HYDROCHLOROTHIAZIDE, TRIAMTERENE] (C - Hypertension - Unknown - [n/a - 75mg - Oral])|[PHENPROCOUMON] (C - Thrombosis prophylaxis - Unknown - [n/a - 1.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946116&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946129	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Acute kidney injury (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Anuria (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Blood creatinine increased (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Blood urea increased (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Chills (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Chromaturia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Device dependence (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Haematuria (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Oliguria (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Urine output decreased (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946129&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7946141	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Anaphylactic reaction (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dry mouth (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hyperhidrosis (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypersensitivity (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory distress (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Tachypnoea (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Throat tightness (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Wheezing (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946141&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7946142	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7946152	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Nau JY, Du vaccin et du syndrome de Guillain-Barre, Journal de la grippe mexicaine, Revue Medicale Suisse 25nov2009	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Face oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Heart rate increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Incorrect route of product administration (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Palatal oedema (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[DESOGESTREL, ETHINYLESTRADIOL] (C - Oral contraception - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946152&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946176	Spontaneous	2014-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Male	Pyrexia (n/a - Not Recovered/Not Resolved - );Vomiting (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946176&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7946188	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Alanine aminotransferase increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood creatine phosphokinase increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood lactate dehydrogenase increased (n/a - Unknown - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Chromaturia (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	LEVEMIR [INSULIN DETEMIR] (S - Diabetes mellitus - Dose not changed - [n/a - 9{DF} - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946188&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946212	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	Yes	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysphonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Eyelid ptosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Mobility decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myasthenia gravis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Thymoma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946231	Spontaneous	2014-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946291	Spontaneous	2014-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Rhinorrhoea (n/a - Recovering/Resolving - );Sneezing (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [0d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7946367	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Altered state of consciousness (30min - Recovered/Resolved - Other Medically Important Condition);Anaphylactic reaction (30min - Recovered/Resolved - Other Medically Important Condition);Sensation of foreign body (30min - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946374	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Sensory level abnormal (n/a - Recovered/Resolved - Other Medically Important Condition);Spinal cord disorder (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946380	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Dehydration (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Febrile infection (2d - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation);Left ventricular failure (1d - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Respiratory tract infection (3d - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])|[RED BLOOD CELLS] (S - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946380&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7946385	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Body temperature increased (n/a - Not Recovered/Not Resolved - );Chills (n/a - Not Recovered/Not Resolved - );Diarrhoea (n/a - Not Recovered/Not Resolved - );Dizziness (n/a - Not Recovered/Not Resolved - );Headache (n/a - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - );Pollakiuria (n/a - Not Recovered/Not Resolved - );Sleep disorder (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7946390	Spontaneous	2014-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Cough (n/a - Recovering/Resolving - );Oropharyngeal pain (n/a - Recovering/Resolving - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7946395	Spontaneous	2014-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Fatigue (n/a - Recovering/Resolving - );Headache (n/a - Recovered/Resolved - );Pain (n/a - Recovered/Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946395&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7946397	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Unknown - Disabling);Decreased appetite (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Lethargy (n/a - Unknown - Disabling);Oropharyngeal pain (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Rhinorrhoea (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Dose not changed - [n/a - n/a - Parenteral])|[LABETALOL HYDROCHLORIDE] (S - Product used for unknown indication - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946397&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7946404	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Antibody test positive (n/a - Not Recovered/Not Resolved - );Antinuclear antibody positive (n/a - Not Recovered/Not Resolved - );Arthralgia (n/a - Recovered/Resolved With Sequelae - );Joint swelling (n/a - Not Recovered/Not Resolved - );Malaise (n/a - Unknown - );Rheumatoid arthritis (n/a - Recovered/Resolved With Sequelae - );Rheumatoid factor positive (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946404&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-7946406	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination failure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946408	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination failure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946408&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946409	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Asthenia (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946409&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946413	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Female	Hyperpyrexia (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7946414	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arrhythmia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dyspnoea exertional (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypercalciuria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Palpitations (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pulmonary sarcoidosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sarcoidosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946414&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946415	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angiopathy (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Bradycardia (2d - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (2d - Recovered/Resolved - Other Medically Important Condition);Nausea (2d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7946416	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946416&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946420	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946421	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Crying (n/a - Recovered/Resolved - Other Medically Important Condition);Hallucination, visual (n/a - Recovered/Resolved - Other Medically Important Condition);Irritability (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7946422	Spontaneous	2014-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Male	Hyperpyrexia (n/a - Recovering/Resolving - );Injection site pain (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7946426	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Monoparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Radial nerve palsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946430	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Burning sensation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946430&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946431	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Spinal osteoarthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946431&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946524	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Brain stem infarction (64d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Bronchitis bacterial (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Clostridium difficile colitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Cognitive disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Device related sepsis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Dysarthria (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Dysphonia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Encephalopathy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Endotracheal intubation (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Haemolysis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Haemolytic anaemia (60d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Infection (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Jaundice (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Myopathy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Petechiae (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pulmonary haemorrhage (60d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Renal failure (60d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Seizure (59d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Skin haemorrhage (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Thrombocytopenia (60d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Thrombotic thrombocytopenic purpura (64d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946524&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7946569	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Formication (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Polyneuropathy (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	[MESALAZINE] (C - n/a - Unknown - [n/a - 2g - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946783	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Infant	Yes	Male	Oedema peripheral (n/a - Recovering/Resolving - );Urticaria (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946783&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7946809	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Diarrhoea (n/a - Fatal - Results in Death);Gastroenteritis (n/a - Fatal - Results in Death);Infection (n/a - Fatal - Results in Death);Vomiting (24h - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[FLUDROCORTISONE] (C - Adrenogenital syndrome - Unknown - [n/a - .05mg - Oral])|[HYDROCORTISONE] (C - Adrenogenital syndrome - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7946899	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blood uric acid increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[TUBERCULIN] (C - n/a - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946899&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7946901	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Death (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946901&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7946904	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (0d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Ill-defined disorder - Not applicable - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), INFLUENZA VIRUS SURFACE ANTIGEN OF STRAIN B/BRISBANE/60/2008, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/BRISBANE/9/2014 (WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/2/2012-LIKE STRAIN USED B/MASSACHUSETTS/2/2012 WILD TYPE, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012-LIKE STRAIN USED B/MASSACHUSETTS/2/2012 WILD TYPE, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012-LIKE STRAIN USED B/MASSACHUSETTS/2/2012 WILD TYPE, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS SURFACE ANTIGEN OF STRAIN NYMC X-181, INFLUENZA VIRUS SURFACE ANTIGEN OF STRAIN A/VICTORIA/210/2009, INFLUENZA VIRUS SURFACE ANTIGEN OF STRAIN B/BRISBANE/60/2008] (S - Ill-defined disorder - Not applicable - [n/a - n/a - Intramuscular])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CLEMIZOLE PENICILLIN] (C - n/a - n/a - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUCLOXACILLIN, FLUCLOXACILLIN SODIUM, FLUCLOXACILLIN SODIUM MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[GENTAMICIN SULFATE, HYDROCORTISONE ACETATE, GENTAMICIN, HYDROCORTISONE ACETATE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[PROCHLORPERAZINE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7946904&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-7947391	Spontaneous	2014-05-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Ill-defined disorder (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7947391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7948338	Spontaneous	2014-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7948338&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940798	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Herpes zoster (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7940820	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute vestibular syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Nausea (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Nystagmus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Vertigo (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Vomiting (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940820&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940827	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - n/a - Intramuscular])	[CINCHOCAINE HYDROCHLORIDE, PREDNISOLONE, CINCHOCAINE HYDROCHLORIDE, PREDNISOLONE CAPROATE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940828	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthritis (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7940832	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Angioedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Face oedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vasodilatation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940833	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Dermatitis allergic (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vasculitis (n/a - Unknown - Other Medically Important Condition)	CELVAPAN PANDEMIC INFLUENZA VACCINE (H1N1) (WHOLE VIRION, VERO CELL DERIVED, INACTIVATED) SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 7ug - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Influenza like illness - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940833&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940835	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940835&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940841	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Abdominal pain upper (7d - Recovered/Resolved - Other Medically Important Condition);Cough (7d - Recovered/Resolved - Other Medically Important Condition);Decreased appetite (7d - Recovered/Resolved - Other Medically Important Condition);Fatigue (7d - Recovered/Resolved - Other Medically Important Condition);Gastrointestinal pain (7d - Recovered/Resolved - Other Medically Important Condition);Headache (7d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (7d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE, BECLOMETASONE DIPROPIONATE, FORMOTEROL FUMARATE DIHYDRATE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940842	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Brain fog (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Not Recovered/Not Resolved - Disabling);Disability (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Dry eye (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Unknown - Disabling);Hypoaesthesia (n/a - Unknown - Disabling);Influenza like illness (n/a - Unknown - Disabling);Lacrimation decreased (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Unknown - Disabling);Mucosal dryness (n/a - Unknown - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Unknown - Disabling);Quality of life decreased (n/a - Not Recovered/Not Resolved - Disabling);Sciatica (n/a - Unknown - Disabling);Sjogren's syndrome (n/a - Not Recovered/Not Resolved - Disabling);Stress (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])...	[CANDESARTAN CILEXETIL] (C - Hypertension - Unknown - [n/a - n/a - Unknown])|[FELODIPINE] (C - Hypertension - Unknown - [n/a - n/a - Unknown])|[LAMOTRIGINE] (C - Attention deficit hyperactivity disorder - Drug withdrawn - [n/a - n/a - Unknown])|[REBOXETINE, REBOXETINE METHANESULFONATE] (C - Attention deficit hyperactivity disorder - Unknown - [n/a - n/a - Unknown])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - Unknown])|[SUMATRIPTAN, SUMATRIPTAN SUCCINATE] (C - Migraine - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940842&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7940845	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Neck pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Retinal vein thrombosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940854	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Drug ineffective (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940854&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940855	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angioedema (1wk - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940855&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940858	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940858&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940865	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940869	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza (7d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (7d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940869&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940872	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940877	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Male	Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940887	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (2d - Unknown - Other Medically Important Condition)	BYETTA [EXENATIDE] (S - n/a - Unknown - [n/a - n/a - Subcutaneous])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Subcutaneous])	BYETTA [EXENATIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUPROPION, BUPROPION HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940887&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940923	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Ataxia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cerebellar syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dysgraphia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940923&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940932	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hemiparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[IBUPROFEN, IBUPROFEN D,L-LYSINATE, IBUPROFEN LYSINE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LORAZEPAM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[OLMESARTAN, OLMESARTAN MEDOXOMIL] (C - n/a - Unknown - [n/a - n/a - Unknown])|[PROMETHAZINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940933	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940937	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940937&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940938	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Convulsion in childhood (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940938&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940946	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7940947	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Drug ineffective (n/a - Unknown - );Influenza (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940947&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7940952	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Circulatory collapse (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[MEDROXYPROGESTERONE ACETATE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940952&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940986	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Male	Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940993	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Bronchitis (n/a - Unknown - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation);Epistaxis (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Febrile infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation);Haematoma (n/a - Unknown - Caused/Prolonged Hospitalisation);Hepatic cyst (n/a - Unknown - Caused/Prolonged Hospitalisation);Hepatic enzyme increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Lipase increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Transaminases increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Viral infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[LEVOFLOXACIN] (S - Bronchitis - Unknown - [6d - 500mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940993&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7940996	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Pharyngitis (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7940996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941013	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Eyelid ptosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Miosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Radiculopathy (n/a - Recovering/Resolving - Other Medically Important Condition);Trigeminal neuralgia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941013&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941014	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Ill-defined disorder - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941014&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941019	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])	[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941019&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941022	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Infection (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	[BECLOMETASONE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941034	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Fatigue (n/a - Fatal - Results in Death, Life Threatening);Loss of consciousness (0d - Fatal - Results in Death, Life Threatening);Paraesthesia (n/a - Unknown - Results in Death, Life Threatening);Respiratory failure (2d - Fatal - Results in Death, Life Threatening);Vaccination site paraesthesia (n/a - Unknown - Results in Death, Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	ISCOVER [CLOPIDOGREL] (C - n/a - Unknown - [n/a - 75mg - Oral])|LYRICA [PREGABALIN] (C - n/a - Unknown - [n/a - 75mg - Oral])|[CAPTOPRIL] (C - n/a - Unknown - [n/a - 25mg - Oral])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 20mg - Oral])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - Respiratory (inhalation)])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 120mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7941044	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Facial paralysis (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7941046	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Dysphonia (n/a - Recovering/Resolving - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - 80mg - Oral])|[CHLORTALIDONE] (C - n/a - Unknown - [n/a - 12.5mg - Oral])|[ENALAPRIL MALEATE] (C - n/a - Drug withdrawn - [n/a - 20mg - Oral])|[FLUVASTATIN] (C - n/a - Unknown - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941047	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Monoplegia (1d - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	[AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7941050	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chorioretinitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941050&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941052	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Amylase increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Inflammation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Lipase increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[DOXEPIN, DOXEPIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FLUOXETINE] (C - n/a - Unknown - [n/a - 20mg - Unknown])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - 200mg - Unknown])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM] (C - n/a - Unknown - [n/a - 40mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941053	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Urticaria (4d - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941053&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941058	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthritis (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Ill-defined disorder - Unknown - [n/a - n/a - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941058&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941060	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	BRITISH JOURNAL OF OPHTHALMOLOGY Rothova A, Groot JDF, Mudrikova T.. Reactivation of acute retinal necrosis after flu H1N1 vaccination. Br J Ophthalmol. 2011;95 (2):291 Rothova A, De Groot JDF, Mudrikova T.Reactivation of acute retinal necrosis after flu H1N1 vaccination. British Journal of Ophthalmology 95: 291, No. 2, Feb 2011. Available from: URL: http://dx.doi.org/10.1136/bjo.2010.185983 - Netherlands	18-64 Years	Adult	No	Male	Condition aggravated (n/a - Recovered/Resolved - Other Medically Important Condition);Necrotising retinitis (n/a - Recovered/Resolved - Other Medically Important Condition);Ocular discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Uveitis (n/a - Recovered/Resolved - Other Medically Important Condition);Varicella zoster virus infection (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7941062	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Diarrhoea infectious (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Enteritis infectious (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[COLECALCIFEROL, SODIUM FLUORIDE] (C - n/a - Unknown - [n/a - 500[iU] - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941062&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941068	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Generalised tonic-clonic seizure (0d - Recovering/Resolving - Life Threatening)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Ill-defined disorder - Not applicable - [n/a - n/a - Intramuscular])|[INFLUENZA VIRUS] (S - Ill-defined disorder - Not applicable - [n/a - n/a - Intramuscular])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|NOT AVAILABLE [FIRST DISPENSE NASAL SPRAY] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[OXYTETRACYCLINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-7941083	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM PHOSPHATE, BORDETELLA PERTUSSIS FIMBRIAE TYPE 2 AND 3 ADSORBED ON ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS TYPE 1 (INACTIVATED), POLIOVIRUS TYPE 2 (INACTIVATED), POLIOVIRUS TYPE 3 (INACTIVATED), PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE OXIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SULFASALAZINE] (C - Crohn's disease - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941083&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941093	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Toxic skin eruption (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941093&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941102	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Male	Neuralgia (n/a - Not Recovered/Not Resolved - );Radiculitis brachial (n/a - Unknown - );Ulnar neuritis (n/a - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7941104	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Vaccination site erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site swelling (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941110	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Polyneuropathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941110&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941126	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysaesthesia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Fatigue (15d - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Sciatica (7d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941126&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7941142	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abnormal dreams (n/a - Recovering/Resolving - Disabling);Cataplexy (n/a - Recovering/Resolving - Disabling);Hallucination (n/a - Recovering/Resolving - Disabling);Narcolepsy (n/a - Recovering/Resolving - Disabling);Rapid eye movements sleep abnormal (n/a - Recovering/Resolving - Disabling);Sleep paralysis (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Parenteral])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7941183	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941183&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941184	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Akathisia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Facial paresis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypnopompic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Impaired driving ability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscle tone disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Parasomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Rapid eye movements sleep abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Restlessness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sudden onset of sleep (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941184&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941185	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941185&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941195	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Back pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Bile duct stone (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cholestasis (n/a - Unknown - Caused/Prolonged Hospitalisation);Chondrosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);General physical health deterioration (6mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941195&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941213	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Sudden death (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])	[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7941223	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bursitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Other Medically Important Condition);Myositis (n/a - Unknown - Other Medically Important Condition);Neuritis (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Peripheral swelling (n/a - Unknown - Other Medically Important Condition);Skin disorder (n/a - Unknown - Other Medically Important Condition);Swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Tenosynovitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941223&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7941232	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Feeling abnormal (2d - Recovered/Resolved - Other Medically Important Condition);Hot flush (2d - Recovered/Resolved - Other Medically Important Condition);Palpitations (2d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (2d - Recovered/Resolved - Other Medically Important Condition);Tremor (2d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [0d - n/a - Intramuscular])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CANDESARTAN] (C - n/a - n/a - [n/a - n/a - n/a])|[CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE, CIPROFLOXACIN LACTATE] (C - n/a - n/a - [n/a - n/a - n/a])|[NORETHISTERONE, NORETHISTERONE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[SIBUTRAMINE HYDROCHLORIDE, SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941232&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7941238	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Pregnancy - Unknown - [n/a - n/a - Intramuscular])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7941247	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Foetal death (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7941252	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941252&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941256	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Artur Furlaneto Fernandes, Paulo Euripides Marchiori, Bithalamic compromise in acute disseminated encephalomyelitis following H1N1 influenza vaccine, Images in neurology Arq Neuropsiquiatr 2011; 69(3): 571 MARCHIORI PE. FERNANDES AF. BITHALAMIC COMPROMISE IN ACUTE DISSEMINATED ENCEPHALOMYELITIS FOLLOWING H1N1 INFLUENZA VACCINE. ARQ NEUROPSIQUIATR. 2011; 69(3): 571	3-11 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ataxia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);CSF lymphocyte count increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nervous system disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Ophthalmoplegia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941259	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Male	Hyperpyrexia (n/a - Fatal - Results in Death);Vomiting (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7941265	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Chest pain (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (WHOLE VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7941293	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Atrial fibrillation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Circulatory collapse (n/a - Unknown - Caused/Prolonged Hospitalisation);Heart rate irregular (n/a - Unknown - Caused/Prolonged Hospitalisation);Restlessness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Supraventricular extrasystoles (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tachyarrhythmia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tachycardia paroxysmal (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Ventricular extrasystoles (n/a - Unknown - Caused/Prolonged Hospitalisation);Ventricular tachycardia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - Coronary artery bypass - Unknown - [n/a - n/a - Oral])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[GLIMEPIRIDE] (C - Diabetes mellitus - Unknown - [n/a - n/a - Oral])|[METOPROLOL SUCCINATE, METOPROLOL SUCCINATE (PH. EUR.)] (C - Myocardial infarction - Unknown - [n/a - 50mg - Oral])|[PRAVASTATIN SODIUM] (C - n/a - Unknown - [n/a - 5mg - Unknown])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941294	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Atrial fibrillation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	[BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, ACETYLSALICYLIC ACID, BISOPROLOL HEMIFUMARATE] (C - Hypertension - Unknown - [n/a - n/a - Oral])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - Hypertension - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941294&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941299	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Diplopia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysdiadochokinesis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Eye movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Eyelid ptosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Miller Fisher syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paresis cranial nerve (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pupillary reflex impaired (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Slow response to stimuli (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Strabismus (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Trigeminal nerve disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - Unknown - [n/a - 100mg - Oral])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - n/a - Unknown - [n/a - 5mg - Oral])|[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - Unknown - [n/a - 10mg - Oral])|[INSULIN, INSULIN HUMAN] (C - n/a - Unknown - [n/a - n/a - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941299&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941309	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Henoch-Schonlein purpura (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 7ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941325	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Diabetes mellitus (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Giant cell arteritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (20d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Inflammation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	NOVONORM [REPAGLINIDE] (C - Type 2 diabetes mellitus - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941329	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Periarthritis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	METHOTREXATE [METHOTREXATE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID, BETACAROTENE, BIOTIN, ERGOCALCIFEROL, CYANOCOBALAMIN, FOLIC ACID, NICOTINAMIDE, PYRIDOXINE, RIBOFLAVIN, THIAMINE, ZINC, CALCIUM, CHROMIUM, COPPER, IODINE, IRON, MAGNESIUM, MANGANESE, PANTOTHENIC ACID, PHOSPHORUS, POTASSIUM, SELENIUM, TOCOPHERYL ACETATE, MOLYBDENUM, ERGOCALCIFEROL, RETINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[BENDROFLUMETHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CEFALEXIN, CEFALEXIN MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CODEINE PHOSPHATE BP, PARACETAMOL PH. EUR., PARACETAMOL BP, CODEINE PHOSPHATE BP, PARACETAMOL, CODEINE PHOSPHATE, PARACETAMOL, CODEINE PHOSPHATE BP, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE, PARACETAMOL, PARACETAMOL DC, CODEINE PHOSPHATE PH.EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[DIETHYLAMINE SALICYLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DOXAZOSIN MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[GLICLAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROXYCHLOROQUINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[NORETHISTERONE ACETATE, ESTRADIOL, NORETHISTERONE ACETATE, ESTRADIOL HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[SULFASALAZINE, SULFASALAZINE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[TERBUTALINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7941370	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Acute kidney injury (60d - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Anaemia macrocytic (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Asphyxia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Cardiac arrest (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Diarrhoea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dry mouth (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);General physical health deterioration (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Generalised oedema (77d - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypoalbuminaemia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Immunisation reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Increased upper airway secretion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Injection site erythema (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Injection site swelling (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Local reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Muscle spasms (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pleural effusion (60d - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Quadriparesis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Resuscitation (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Rhabdomyolysis (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Thirst (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[CLARITHROMYCIN] (S - Pyrexia - Unknown - [n/a - n/a - Unknown])	[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7941581	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Erythema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Unknown - Caused/Prolonged Hospitalisation);Swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941581&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941620	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Chest pain (n/a - Recovering/Resolving - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941620&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941622	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	Yes	Female	Adjustment disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Bone development abnormal (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Brain injury (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Cervicobrachial syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Crying (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Developmental delay (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hypertrophy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Macrocephaly (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Macrosomia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Motor developmental delay (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Muscle disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Scoliosis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somatic dysfunction (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - n/a - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941622&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941625	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	H. Hidalgo, N. Dahmen, U. Kallweit. Post H1N1 vaccine narcolepsy-cataplexy: spontaneous improvement of excessive daytime sleepiness and cataplexies after 2 years. J Neurol (2013) 260 (Suppl 1):S89 Kallweit U. et al. Post H1N1 vaccination narcolepsy-cataplexy with decreased CSF beta-amyloid. Sleep Medicine 2012; 13:323.	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941626	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Death (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	[ACENOCOUMAROL] (C - n/a - n/a - [n/a - n/a - n/a])|[ALPRAZOLAM] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, ACETYLSALICYLIC ACID, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - 5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7941629	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Viral infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[BECLOMETASONE DIPROPIONATE] (C - Asthma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941629&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941633	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	[PARAFFIN, LIGHT LIQUID, PARAFFIN WHITE SOFT] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941633&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-7941642	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Unknown - Disabling);Pallor (n/a - Not Recovered/Not Resolved - Disabling)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [365d - n/a - Intramuscular])	CYMBALTA [DULOXETINE, DULOXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ADAPALENE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941642&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7941650	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Aphasia (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Presyncope (n/a - Unknown - Caused/Prolonged Hospitalisation);Sensory level abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941650&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941679	Spontaneous	2014-05-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Disabling);Memory impairment (n/a - Unknown - Disabling);Multiple sclerosis (n/a - Unknown - Disabling);Visual impairment (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941679&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7941680	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Swelling (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	CALCIUM CHANNEL BLOCKER [CALCIUM CHANNEL BLOCKER] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941683	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cerebral haemorrhage (7d - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [0d - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[CHLORAMPHENICOL] (C - n/a - n/a - [n/a - n/a - n/a])|[GLICLAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941683&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7941741	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthma (n/a - Unknown - Other Medically Important Condition);Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])	[ALENDRONATE SODIUM, ALENDRONIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DOXAZOSIN, DOXAZOSIN MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALMETEROL] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[THEOPHYLLINE, THEOPHYLLINE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941741&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941784	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Disabling, Other Medically Important Condition);Muscle atrophy (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Paresis (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[POLIOMYELITIS VACCINE (INACTIVATED), POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7941790	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Not Specified	Enamel anomaly (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - Intra-uterine])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7941791	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Erythema nodosum (14d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [0d - n/a - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE STRAIN (A/CALIFORNIA/7/2009, X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SOUTH AUSTRALIA/55/2014 STRAIN, B/PHUKET/3073/2013-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181] (S - Immunisation - Not applicable - [0d - n/a - Intramuscular])	[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941811	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])	[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941813	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Palpitations (1d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Ill-defined disorder - Not applicable - [n/a - n/a - Intramuscular])	CLOPIDOGREL HYDROGEN SULFATE [CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])|[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - n/a - n/a - [n/a - n/a - n/a])|[DIPYRIDAMOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941813&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7941853	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Encephalopathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	[GABAPENTIN] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[NEFOPAM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941885	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dermatitis allergic (8h - Recovered/Resolved - Other Medically Important Condition);Oedema (8h - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7941915	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (0d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Ill-defined disorder - Not applicable - [0d - n/a - Intramuscular])	[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BETAMETHASONE VALERATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CADE OIL, COAL TAR SOLUTION, PINE TAR, COAL TAR SOLUBILISED EXTRACT, ORANGE OIL, TAR BLEND] (C - n/a - n/a - [n/a - n/a - n/a])|[CHLOROCRESOL, CHLOROCRESOL, CETOSTEARYL ALCOHOL, LIQUID PARAFFIN, PARAFFIN, PARAFFIN WHITE SOFT] (C - n/a - n/a - [n/a - n/a - n/a])|[CHLORPHENAMINE MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CLOBETASONE BUTYRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[EPINEPHRINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESTROGENS CONJUGATED] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LIQUID PARAFFIN, PARAFFIN, LIGHT LIQUID, PARAFFIN, LIGHT LIQUID, PARAFFIN WHITE SOFT] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM CROMOGLICATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941915&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-7941918	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Unknown - Disabling);Arthralgia (n/a - Unknown - Disabling);Asthenia (n/a - Unknown - Disabling);Bronchitis (n/a - Unknown - Disabling);Chest pain (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Unknown - Disabling);Contusion (n/a - Unknown - Disabling);Cough (n/a - Unknown - Disabling);Crying (n/a - Unknown - Disabling);Decreased appetite (n/a - Unknown - Disabling);Depression (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Dyspnoea (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Feeling cold (n/a - Unknown - Disabling);Feeling hot (n/a - Unknown - Disabling);Hyperacusis (n/a - Unknown - Disabling);Hyperventilation (n/a - Unknown - Disabling);Irritability (n/a - Unknown - Disabling);Memory impairment (n/a - Unknown - Disabling);Mental impairment (n/a - Unknown - Disabling);Musculoskeletal stiffness (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Nasopharyngitis (n/a - Unknown - Disabling);Night sweats (n/a - Unknown - Disabling);Palpitations (n/a - Unknown - Disabling);Photophobia (n/a - Unknown - Disabling);Productive cough (n/a - Unknown - Disabling);Quality of life decreased (n/a - Unknown - Disabling);Restless legs syndrome (n/a - Unknown - Disabling);Restlessness (n/a - Unknown - Disabling);Sinusitis (n/a - Unknown - Disabling);Sleep disorder (n/a - Unknown - Disabling);Sleep paralysis (n/a - Unknown - Disabling);Stress (n/a - Unknown - Disabling);Swollen tongue (n/a - Unknown - Disabling);Taste disorder (n/a - Unknown - Disabling);Tension headache (n/a - Unknown - Disabling);Thirst (n/a - Unknown - Disabling);Tonsillitis (n/a - Unknown - Disabling);Tremor (n/a - Unknown - Disabling);Weight decreased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941918&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7941919	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Disabling);General physical health deterioration (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[ALLOPURINOL] (C - Gout - Unknown - [n/a - n/a - n/a])|[CODEINE PHOSPHATE SESQUIHYDRATE, PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE] (C - Pain - Unknown - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypometabolism - Unknown - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - Cardiac flutter - Unknown - [n/a - n/a - n/a])|[PREDNISOLONE] (C - Arthralgia - Unknown - [n/a - n/a - n/a])|[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - Gastritis - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941919&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7941972	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Death (366d - Fatal - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Ill-defined disorder - Unknown - [n/a - n/a - Intramuscular])	[ALENDRONATE SODIUM, ALENDRONIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[BETAHISTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CODEINE PHOSPHATE BP, PARACETAMOL PH. EUR., PARACETAMOL, CODEINE PHOSPHATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FERROUS SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVODOPA, CARBIDOPA MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[URSODEOXYCHOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[VITAMIN D, CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7941975	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	[NORETHISTERONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941975&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7941992	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Supraventricular tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941992&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7941993	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Amenorrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Metabolic disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Obstructive sleep apnoea syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Peripheral swelling (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sex hormone binding globulin decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sudden onset of sleep (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tonsillar hypertrophy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Weight increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7941993&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7942005	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cerebral infarction (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Coma (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7942005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7942006	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7942006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7942086	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blepharitis allergic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Ill-defined disorder - Not applicable - [n/a - n/a - Intramuscular])	[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7942086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7942101	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Akinesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Apathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Bradykinesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Bradyphrenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Camptocormia (n/a - Unknown - Caused/Prolonged Hospitalisation);Chills (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Communication disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Derealisation (n/a - Unknown - Caused/Prolonged Hospitalisation);Disorientation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hallucination, visual (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Incoherent (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Parkinson's disease (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (0wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Reduced facial expression (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Resting tremor (n/a - Unknown - Caused/Prolonged Hospitalisation);Salivary hypersecretion (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (0wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[ROPINIROLE, ROPINIROLE HYDROCHLORIDE] (S - Parkinson's disease - Drug withdrawn - [n/a - 8mg - Oral])	STALEVO [CARBIDOPA, ENTACAPONE, LEVODOPA] (C - n/a - Unknown - [n/a - 85mg - Oral])|[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - Unknown - [n/a - 100mg - Oral])|[BENSERAZIDE HYDROCHLORIDE, LEVODOPA, BENSERAZIDE, LEVODOPA] (C - n/a - Unknown - [n/a - n/a - Oral])|[ENALAPRIL MALEATE] (C - n/a - Unknown - [n/a - 5mg - Unknown])|[METOPROLOL SUCCINATE, METOPROLOL SUCCINATE (PH. EUR.)] (C - n/a - Unknown - [n/a - n/a - Unknown])|[QUETIAPINE, QUETIAPINE FUMARATE] (C - n/a - Unknown - [n/a - 25mg - Oral])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7942101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7942203	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7942203&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7942258	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7942258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7942272	Spontaneous	2014-05-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - .5mL - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7942272&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7943965	Spontaneous	2014-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Other Medically Important Condition);Abnormal behaviour (n/a - Recovering/Resolving - Other Medically Important Condition);Abulia (11d - Recovered/Resolved - Other Medically Important Condition);Adverse drug reaction (n/a - Unknown - Other Medically Important Condition);Agoraphobia (n/a - Unknown - Other Medically Important Condition);Alopecia (n/a - Unknown - Other Medically Important Condition);Anxiety (10d - Recovered/Resolved - Other Medically Important Condition);Back pain (n/a - Unknown - Other Medically Important Condition);Brain injury (n/a - Recovering/Resolving - Other Medically Important Condition);Decreased appetite (n/a - Unknown - Other Medically Important Condition);Depression (n/a - Recovering/Resolving - Other Medically Important Condition);Dry eye (n/a - Unknown - Other Medically Important Condition);Dry mouth (n/a - Unknown - Other Medically Important Condition);Fear (n/a - Unknown - Other Medically Important Condition);Glossodynia (n/a - Unknown - Other Medically Important Condition);Lethargy (10d - Recovered/Resolved - Other Medically Important Condition);Loss of personal independence in daily activities (6mo - Recovered/Resolved - Other Medically Important Condition);Memory impairment (n/a - Recovering/Resolving - Other Medically Important Condition);Mental impairment (n/a - Unknown - Other Medically Important Condition);Pancreatitis (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Paranoia (n/a - Unknown - Other Medically Important Condition);Personality change (n/a - Unknown - Other Medically Important Condition);Phobia (n/a - Unknown - Other Medically Important Condition);Psychotic disorder (n/a - Unknown - Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Other Medically Important Condition);Skin burning sensation (n/a - Unknown - Other Medically Important Condition);Social fear (n/a - Unknown - Other Medically Important Condition);Somatic dysfunction (n/a - Unknown - Other Medically Important Condition);Spinal osteoarthritis (n/a - Unknown - Other Medically Important Condition);Staring (n/a - Unknown - Other Medically Important Condition);Supportive care (n/a - Unknown - Other Medically Important Condition);Tongue coated (n/a - Unknown - Other Medically Important Condition)	ANTIDEPRESSANTS [ANTIDEPRESSANTS] (S - Depression - Unknown - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Ill-defined disorder - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7943965&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7937361	Spontaneous	2014-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7937361&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7928080	Spontaneous	2014-05-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7928080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7928729	Spontaneous	2014-05-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (3d - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Injection site erythema (n/a - Unknown - Other Medically Important Condition);Injection site swelling (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7928729&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7930697	Spontaneous	2014-05-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Episcleritis (n/a - Recovered/Resolved - Other Medically Important Condition);Iridocyclitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7930697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7920284	Spontaneous	2014-05-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (0d - Recovered/Resolved - Other Medically Important Condition);Blindness transient (0d - Recovered/Resolved - Other Medically Important Condition)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7920284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7924181	Spontaneous	2014-05-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7924181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7918021	Spontaneous	2014-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Unknown - Other Medically Important Condition);Anogenital warts (n/a - Unknown - Other Medically Important Condition);Anuria (n/a - Unknown - Other Medically Important Condition);Arthralgia (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Back pain (n/a - Unknown - Other Medically Important Condition);Cholelithiasis (n/a - Unknown - Other Medically Important Condition);Diarrhoea (n/a - Unknown - Other Medically Important Condition);Dysuria (n/a - Unknown - Other Medically Important Condition);Ear infection (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Gestational diabetes (n/a - Unknown - Other Medically Important Condition);Haematuria (n/a - Unknown - Other Medically Important Condition);Joint injury (n/a - Unknown - Other Medically Important Condition);Live birth (n/a - Unknown - Other Medically Important Condition);Nephrolithiasis (n/a - Unknown - Other Medically Important Condition);Oliguria (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7918021&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7918022	Spontaneous	2014-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Arthritis (n/a - Not Recovered/Not Resolved - Disabling);Body temperature fluctuation (n/a - Not Recovered/Not Resolved - Disabling);Bone pain (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Chronic obstructive pulmonary disease (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling);Coordination abnormal (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling cold (n/a - Not Recovered/Not Resolved - Disabling);Language disorder (n/a - Not Recovered/Not Resolved - Disabling);Learning disorder (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Stress (n/a - Not Recovered/Not Resolved - Disabling);Temperature regulation disorder (n/a - Not Recovered/Not Resolved - Disabling);Vision blurred (n/a - Not Recovered/Not Resolved - Disabling);Visual acuity reduced (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[MEDROXYPROGESTERONE ACETATE, ESTRADIOL VALERATE] (C - Hormone replacement therapy - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7918022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7919567	Spontaneous	2014-05-09 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Rash (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7919567&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7908813	Spontaneous	2014-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Depressed level of consciousness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gastrointestinal haemorrhage (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pseudomembranous colitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])|[ACETYLSALICYLIC ACID] (S - Cardiac failure - Unknown - [n/a - 75mg - Oral])|[MEROPENEM, MEROPENEM ANHYDROUS, MEROPENEM TRIHYDRATE] (S - Pneumonia aspiration - Not applicable - [15d - 1.5g - n/a])	[CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - n/a - n/a])|[CLOMETHIAZOLE, CLOMETHIAZOLE EDISILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ECONAZOLE, ECONAZOLE NITRATE, ECONAZOLE NITRATE, ZINC OXIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[GLIMEPIRIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ISOSORBIDE 5 MONONITRATE, ISOSORBIDE MONONITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])|[RISPERIDONE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7908813&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7904354	Spontaneous	2014-05-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - );Sleep disorder (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7904354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7904890	Spontaneous	2014-05-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Disabling);Quality of life decreased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7904890&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7899234	Spontaneous	2014-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea exertional (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eosinophilia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eosinophilic pneumonia chronic (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mantle cell lymphoma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Restrictive pulmonary disease (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sinusitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (S - Gastrooesophageal reflux disease - Dose not changed - [n/a - n/a - Oral])|[SIMVASTATIN, EZETIMIBE] (S - Hypercholesterolaemia - Dose not changed - [n/a - n/a - Oral])|[TAMSULOSIN HYDROCHLORIDE] (S - Prostatic adenoma - Dose not changed - [n/a - n/a - Oral])	NOT AVAILABLE [CORTICOSTEROIDS (UNSPECIFIED)] (C - Spinal pain - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7899234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7900696	Spontaneous	2014-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Anaphylactic shock (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Asthma (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chest discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dyspepsia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Ear infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Immunodeficiency (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Lip swelling (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Neck pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Palpitations (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Rash pruritic (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Upper respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM] (C - Back pain - Unknown - [n/a - n/a - n/a])|[IBUPROFEN] (C - Pain - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7900696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7900697	Spontaneous	2014-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Akathisia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Bedridden (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Diplopia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Facial paresis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Furuncle (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Paresis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Peroneal nerve palsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sciatica (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Speech disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	[BETAMETHASONE, BETAMETHASONE ACETATE, BETAMETHASONE, BETAMETHASONE ACETATE, BETAMETHASONE SODIUM PHOSPHATE] (C - Bursitis - Unknown - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - Bursitis - Unknown - [n/a - n/a - n/a])|[ZOPICLONE] (C - Insomnia - Unknown - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7900697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7894345	Spontaneous	2014-05-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7894345&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7894363	Spontaneous	2014-05-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (3d - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Fatigue (3d - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Hypersensitivity (3d - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Pruritus (3d - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Urticaria (3d - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Parenteral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - n/a - Parenteral])	METFORMIN HYDROCHLORIDE, ROSIGLITAZONE MALEATE [METFORMIN HYDROCHLORIDE, ROSIGLITAZONE MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATOVAQUONE, PROGUANIL, PROGUANIL HYDROCHLORIDE, ATOVAQUONE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLICLAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7894363&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-7888161	Spontaneous	2014-04-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7888161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7888164	Spontaneous	2014-04-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7888164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7885243	Spontaneous	2014-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7885243&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7873896	Spontaneous	2014-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Unknown - Disabling);Arthralgia (n/a - Unknown - Disabling);Asthenia (n/a - Unknown - Disabling);Bacterial vaginosis (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Unknown - Disabling);Fracture (n/a - Unknown - Disabling);Gingival disorder (n/a - Unknown - Disabling);Headache (n/a - Recovering/Resolving - Disabling);Hyperacusis (n/a - Unknown - Disabling);Hypersomnia (n/a - Unknown - Disabling);Infectious mononucleosis (n/a - Unknown - Disabling);Influenza (n/a - Unknown - Disabling);Lymphadenopathy (n/a - Unknown - Disabling);Musculoskeletal discomfort (n/a - Unknown - Disabling);Photophobia (n/a - Unknown - Disabling);Poor quality sleep (n/a - Unknown - Disabling);Productive cough (n/a - Unknown - Disabling);Skin injury (n/a - Unknown - Disabling);Social avoidant behaviour (n/a - Unknown - Disabling);Tooth disorder (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM] (C - Arthralgia - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7873896&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7870800	Spontaneous	2014-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthritis (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Ataxia (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Hyperaesthesia (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Muscle contractions involuntary (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Muscle spasms (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Photophobia (1d - Recovered/Resolved - Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 75mg - n/a])|[INDAPAMIDE, INDAPAMIDE HEMIHYDRATE] (C - Hypertension - n/a - [n/a - 1.5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7870800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7870837	Spontaneous	2014-04-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Amnesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Back pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Weight decreased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Parenteral])	INHALERS [NOT AVAILABLE] (C - Seasonal allergy - n/a - [n/a - n/a - n/a])|[NAPROXEN, NAPROXEN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7870837&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7863253	Spontaneous	2014-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bronchial hyperreactivity (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Bronchitis (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dyspnoea exertional (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Malaise (3d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Nocturnal dyspnoea (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Obstructive airways disorder (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Respiratory failure (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BUDESONIDE] (C - n/a - Unknown - [n/a - 200ug - Respiratory (inhalation)])|[INDACATEROL] (C - n/a - Unknown - [n/a - 150ug - Respiratory (inhalation)])|[LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - 50ug - Oral])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - Unknown - [n/a - n/a - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - Respiratory (inhalation)])|[THEOPHYLLINE] (C - n/a - Unknown - [n/a - 200mg - Oral])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - Unknown - [n/a - 18ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7863253&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7865674	Spontaneous	2014-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7865674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7857353	Spontaneous	2014-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Infection susceptibility increased (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7857353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7858535	Spontaneous	2014-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Unknown - Disabling);Anxiety (n/a - Unknown - Disabling);Aphasia (n/a - Unknown - Disabling);Arthralgia (n/a - Unknown - Disabling);Asthenia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Claustrophobia (n/a - Unknown - Disabling);Depression (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling hot (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Hemiplegia (n/a - Unknown - Disabling);Hyperacusis (n/a - Unknown - Disabling);Lymph node pain (n/a - Unknown - Disabling);Migraine with aura (n/a - Unknown - Disabling);Mood swings (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Neck pain (n/a - Unknown - Disabling);Oropharyngeal pain (n/a - Unknown - Disabling);Paraesthesia (n/a - Unknown - Disabling);Paralysis (n/a - Unknown - Disabling);Photophobia (n/a - Unknown - Disabling);Sensory disturbance (n/a - Unknown - Disabling);Sleep disorder (n/a - Unknown - Disabling);Visual impairment (n/a - Unknown - Disabling);Weight decreased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CARBIMAZOLE] (C - Thyroiditis - Unknown - [n/a - 5mg - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hyperthyroidism - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7858535&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7858536	Spontaneous	2014-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Unknown - Disabling);Apathy (n/a - Unknown - Disabling);Chills (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Unknown - Disabling);Diarrhoea (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Drug hypersensitivity (n/a - Unknown - Disabling);Dysgeusia (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Feeling hot (2wk - Recovered/Resolved - Disabling);Food allergy (n/a - Unknown - Disabling);Food intolerance (n/a - Unknown - Disabling);Hot flush (n/a - Unknown - Disabling);Hyperacusis (n/a - Unknown - Disabling);Hypoaesthesia (n/a - Unknown - Disabling);Influenza like illness (n/a - Unknown - Disabling);Lymph node pain (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Muscle twitching (n/a - Unknown - Disabling);Musculoskeletal stiffness (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Pain (n/a - Unknown - Disabling);Paraesthesia oral (n/a - Unknown - Disabling);Photophobia (n/a - Unknown - Disabling);Sinusitis (n/a - Unknown - Disabling);Sleep disorder (n/a - Unknown - Disabling);Speech disorder (n/a - Unknown - Disabling);Stress (n/a - Unknown - Disabling);Syncope (n/a - Unknown - Disabling);Tremor (n/a - Unknown - Disabling);Vertigo (n/a - Unknown - Disabling);Vision blurred (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[HYDROCHLOROTHIAZIDE, LOSARTAN, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - Hypertension - Unknown - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - Hypertension - Unknown - [n/a - n/a - n/a])|[OXAZEPAM] (C - Insomnia - Unknown - [n/a - n/a - n/a])|[ZOPICLONE] (C - Insomnia - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7858536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7858537	Spontaneous	2014-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Dermatitis infected (1mo - Recovered/Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Unknown - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Pruritus (1mo - Recovered/Resolved - Disabling);Rash (1mo - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 10mg - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Hypercholesterolaemia - Unknown - [n/a - n/a - n/a])|[DALTEPARIN SODIUM] (C - Prophylaxis - Unknown - [n/a - n/a - n/a])|[ETORICOXIB] (C - Pelvic pain - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[GOSERELIN, GOSERELIN ACETATE] (C - Pain - Unknown - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hyperthyroidism - Unknown - [n/a - 100ug - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[LORATADINE] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|[LORATADINE] (C - n/a - Unknown - [n/a - n/a - n/a])|[METOCLOPRAMIDE HYDROCHLORIDE] (C - Abdominal pain upper - Unknown - [n/a - n/a - n/a])|[OXYCODONE HYDROCHLORIDE] (C - Pain - Unknown - [n/a - n/a - n/a])|[OXYTOCIN] (C - Pain - Unknown - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[PARACETAMOL, PARACETAMOL, ASPARTAME] (C - n/a - Unknown - [n/a - n/a - n/a])|[PARACETAMOL] (C - Pelvic pain - Unknown - [n/a - n/a - n/a])|[PREDNISOLONE] (C - Pelvic pain - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7858537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7858541	Spontaneous	2014-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovering/Resolving - Disabling);Chronic fatigue syndrome (n/a - Recovering/Resolving - Disabling);Cluster headache (n/a - Recovering/Resolving - Disabling);Cough (n/a - Recovering/Resolving - Disabling);Dizziness (n/a - Recovering/Resolving - Disabling);Fatigue (n/a - Recovering/Resolving - Disabling);Headache (n/a - Recovering/Resolving - Disabling);Hypersomnia (n/a - Recovering/Resolving - Disabling);Influenza like illness (n/a - Recovering/Resolving - Disabling);Migraine (n/a - Recovering/Resolving - Disabling);Nausea (n/a - Recovering/Resolving - Disabling);Pain (n/a - Recovering/Resolving - Disabling);Poor quality sleep (n/a - Recovering/Resolving - Disabling);Syncope (n/a - Recovering/Resolving - Disabling);Throat irritation (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DIAZEPAM] (C - Depression - Unknown - [n/a - n/a - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Depression - Unknown - [n/a - n/a - n/a])|[IBUPROFEN] (C - Dysmenorrhoea - Unknown - [n/a - n/a - n/a])|[NITRAZEPAM] (C - Depression - Unknown - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - n/a])|[TRIMIPRAMINE, TRIMIPRAMINE MALEATE, TRIMIPRAMINE MESILATE] (C - Depression - Unknown - [n/a - n/a - n/a])|[ZOPICLONE] (C - Sleep disorder - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7858541&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7858542	Spontaneous	2014-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Back pain (n/a - Not Recovered/Not Resolved - Disabling);Balance disorder (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Constipation (n/a - Not Recovered/Not Resolved - Disabling);Coordination abnormal (n/a - Not Recovered/Not Resolved - Disabling);Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling);Diplopia (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Ear pain (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Lymph node pain (n/a - Not Recovered/Not Resolved - Disabling);Migraine (n/a - Not Recovered/Not Resolved - Disabling);Mouth ulceration (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Disabling);Nausea (2wk - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Night sweats (n/a - Not Recovered/Not Resolved - Disabling);Pain (2wk - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Paralysis (n/a - Not Recovered/Not Resolved - Disabling);Peripheral coldness (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Pollakiuria (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (2wk - Not Recovered/Not Resolved - Disabling);Sensory loss (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Temperature intolerance (n/a - Not Recovered/Not Resolved - Disabling);Vision blurred (n/a - Not Recovered/Not Resolved - Disabling);Wound haemorrhage (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7858542&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7853566	Spontaneous	2014-04-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Application site reaction (4d - Recovered/Resolved - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [1d - n/a - Unknown])	[BICALUTAMIDE] (C - Polymyalgia rheumatica - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7853566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7853724	Spontaneous	2014-04-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Ataxia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cerebrovascular accident (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Photophobia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])|[DIPHTHERIA AND TETANUS VACCINE] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7853724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7852237	Spontaneous	2014-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7852237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7845136	Spontaneous	2014-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7845136&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7845245	Spontaneous	2014-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intrapericardial])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7845245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7845297	Spontaneous	2014-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Myofascitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7845297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7846153	Spontaneous	2014-04-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoglycaemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])|CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - n/a - [n/a - n/a - n/a])	[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - Asthma - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - n/a - [n/a - 200ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7846153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7846613	Spontaneous	2014-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7846613&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7841596	Spontaneous	2014-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7841596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7843822	Spontaneous	2014-04-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Demyelination (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7843822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7835386	Spontaneous	2014-04-15 00:00:00	Healthcare Professional	European Economic Area	Vries L, Hunsel F V, Maarschalkerweerd B C, Puijenbroek E, Grootheest K. Adjuvanted A/H1N1 (2009) Influenza Vaccination During Pregnancy: Description of a Prospective Cohort and Reactions in the Netherlands. Birth Defects Research Part A: Clinical and Molecular Teratology. 2014	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7835386&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7836428	Spontaneous	2014-04-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cataplexy (n/a - Recovered/Resolved - Other Medically Important Condition);Hallucination (n/a - Recovered/Resolved - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved - Other Medically Important Condition);Nightmare (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7836428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7838496	Spontaneous	2014-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Dyspnoea (n/a - Recovering/Resolving - Other Medically Important Condition);Fall (n/a - Recovering/Resolving - Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovering/Resolving - Other Medically Important Condition);Loss of proprioception (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [n/a - n/a - n/a])|[DIPHTHERIA AND TETANUS VACCINE (ADSORBED)] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7838496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7831036	Spontaneous	2014-04-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Amnesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Bursitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Feeling hot (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hyperacusis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Photophobia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DESOGESTREL, ETHINYLESTRADIOL, ETHINYLESTRADIOL PH. EUR., DESOGESTREL B.P.] (C - n/a - Unknown - [n/a - n/a - n/a])|[DESOGESTREL] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7831036&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7833324	Spontaneous	2014-04-14 00:00:00	Healthcare Professional	European Economic Area	Swine flu jab turned our children into zombies: It was rushed in amid fears of a global pandemic. Now it&apos;s linked to an illness that makes victims sleep 19 hours a day - Daily Mail Online	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Listless (n/a - Unknown - Other Medically Important Condition);Loss of consciousness (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Mood altered (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Product used for unknown indication - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7833324&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7824145	Spontaneous	2014-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Balance disorder (n/a - Not Recovered/Not Resolved - );Paraesthesia (n/a - Not Recovered/Not Resolved - );Tinnitus (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [0d - n/a - Intramuscular])	ESOMEPRAZOLE [ESOMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[BISMUTH OXIDE, ZINC OXIDE PHEUR, BALSAM PERU PH.EUR., HYDROCORTISONE ACETATE, PERU BALSAM, ZINC OXIDE, BENZYL BENZOATE, BISMUTH OXIDE, BISMUTH SUBGALLATE, PERU BALSAM, ZINC OXIDE, BISMUTH IODIDE OXIDE, BISMUTH OXIDE, BISMUTH SUBGALLATE, RESORCINOL, PERU BALSAM, ZINC OXIDE, BISMUTH OXIDE, PERU BALSAM, ZINC OXIDE, BISMUTH OXIDE, BISMUTH SUBGALLATE, ZINC OXIDE, LIDOCAINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CODEINE PHOSPHATE BP, PARACETAMOL PH. EUR., PARACETAMOL BP, CODEINE PHOSPHATE BP, PARACETAMOL, CODEINE PHOSPHATE, PARACETAMOL, CODEINE PHOSPHATE BP, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE, PARACETAMOL, PARACETAMOL DC, CODEINE PHOSPHATE PH.EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7824145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7825750	Spontaneous	2014-04-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Affect lability (n/a - Unknown - Other Medically Important Condition);Affective disorder (n/a - Unknown - Other Medically Important Condition);Agitation (n/a - Unknown - Other Medically Important Condition);Depressed mood (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Insomnia (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Stupor (n/a - Unknown - Other Medically Important Condition);Suicidal ideation (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - Intramuscular])|[ITRACONAZOLE] (S - Product used for unknown indication - Drug withdrawn - [n/a - n/a - Oral])|[MINOXIDIL] (S - Product used for unknown indication - Drug withdrawn - [n/a - n/a - Topical])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7825750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7825838	Spontaneous	2014-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7825838&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7825843	Spontaneous	2014-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7825843&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7825883	Spontaneous	2014-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7825883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7827925	Spontaneous	2014-04-11 00:00:00	Healthcare Professional	European Economic Area	Loes de Vries, Florence van Hunsel, Benedikte Cuppers-Maarschalkerweerd,Euge`ne van Puijenbroek , and Kees van Grootheest. Adjuvanted A/H1N1 (2009) Influenza Vaccination During Pregnancy: Description of a Prospective Cohort and Reactions in the Netherlands. Birth Defects Research Part A: Clinical and Molecular Teratology. 2014	Not Specified	Not Specified	Yes	Not Specified	Foetal distress syndrome (n/a - Fatal - Results in Death);Foetal exposure during pregnancy (n/a - Unknown - Results in Death);Stillbirth (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7827925&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7821274	Spontaneous	2014-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7821274&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7821349	Spontaneous	2014-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cataplexy (n/a - Recovered/Resolved - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7821349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7815330	Spontaneous	2014-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Unknown - Other Medically Important Condition);Dry mouth (n/a - Unknown - Other Medically Important Condition);Heart rate increased (n/a - Unknown - Other Medically Important Condition);Hypertension (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Nervousness (n/a - Unknown - Other Medically Important Condition);Palpitations (n/a - Unknown - Other Medically Important Condition);Procedural nausea (n/a - Unknown - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [0d - n/a - Intramuscular])	NOT AVAILABLE [KALMW SLEEP ( HERBAL PREPARATION)] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7815330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7812000	Spontaneous	2014-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7812000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7806950	Spontaneous	2014-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition);Parasomnia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, INFLUENZA VIRUS SURFACE ANTIGEN OF STRAIN NYMC X-181, INFLUENZA VIRUS SURFACE ANTIGEN OF STRAIN A/VICTORIA/210/2009, INFLUENZA VIRUS SURFACE ANTIGEN OF STRAIN B/BRISBANE/60/2008] (C - Influenza - n/a - [1d - 1{DF} - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7806950&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7808349	Spontaneous	2014-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Mononeuropathy multiplex (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7808349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7809225	Spontaneous	2014-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7809225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7809232	Spontaneous	2014-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic shock (1d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7809232&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7799626	Spontaneous	2014-04-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blood pressure increased (n/a - Recovering/Resolving - Other Medically Important Condition);Dizziness (n/a - Recovering/Resolving - Other Medically Important Condition);Nausea (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7799626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7800934	Spontaneous	2014-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7800934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7800962	Spontaneous	2014-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Condition aggravated (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Depressed mood (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Ear pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Eczema (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fibromyalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tendon pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Urethral syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BENZALKONIUM CHLORIDE, TRIAMCINOLONE ACETONIDE, SALICYLIC ACID] (C - Rhinitis allergic - Unknown - [n/a - n/a - n/a])|[DIAZEPAM] (C - n/a - Unknown - [n/a - n/a - n/a])|[FEXOFENADINE, FEXOFENADINE HYDROCHLORIDE] (C - Urticaria - n/a - [n/a - n/a - n/a])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - Rhinitis allergic - Unknown - [n/a - n/a - Ophthalmic])|[LORATADINE] (C - Rhinitis allergic - Unknown - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - Rhinitis - Unknown - [n/a - n/a - n/a])|[NAPROXEN, NAPROXEN SODIUM] (C - Back pain - Unknown - [n/a - n/a - n/a])|[NEDOCROMIL SODIUM] (C - Rhinitis allergic - Unknown - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Abdominal pain - Unknown - [n/a - n/a - n/a])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - Ear infection - Unknown - [n/a - n/a - n/a])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - Sinusitis - Unknown - [n/a - n/a - n/a])|[PIROXICAM, PIROXICAM BETADEX] (C - Sinusitis - Unknown - [n/a - n/a - n/a])|[TRIAMCINOLONE ACETONIDE] (C - Rhinitis allergic - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7800962&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7801405	Spontaneous	2014-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7801405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7801813	Spontaneous	2014-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7801813&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7803056	Spontaneous	2014-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7803056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7803075	Spontaneous	2014-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7803075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7803086	Spontaneous	2014-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7803086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7803742	Spontaneous	2014-04-04 00:00:00	Healthcare Professional	European Economic Area	Dauvilliers et al. Post H1N1 narcolepsy-cataplexy. Sleep 2010 33: (11); 1-3	18-64 Years	Not Specified	No	Male	Affective disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cognitive disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Irritability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Libido decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Rapid eye movements sleep abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALUMINIUM HYDROXIDE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7803742&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7795892	Spontaneous	2014-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7795892&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7797557	Spontaneous	2014-04-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Gait inability (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Refusal of treatment by patient (n/a - Unknown - Other Medically Important Condition);Wheelchair user (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7797557&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7791705	Spontaneous	2014-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	[METHYLPHENIDATE HYDROCHLORIDE] (C - Attention deficit hyperactivity disorder - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7791705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7786082	Spontaneous	2014-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7786082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7786083	Spontaneous	2014-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7786083&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7786979	Spontaneous	2014-04-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypersensitivity (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7786979&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7769735	Spontaneous	2014-03-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Croup infectious (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7769735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7766052	Spontaneous	2014-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7766052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7766056	Spontaneous	2014-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7766056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7766062	Spontaneous	2014-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7766062&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7768099	Spontaneous	2014-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Completed suicide (n/a - Fatal - Results in Death);Narcolepsy (n/a - Fatal - Results in Death);Psychotic disorder (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7768099&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7761450	Spontaneous	2014-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Communication disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hyperacusis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypothyroidism (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Photophobia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	NOT AVAILABLE [SURGERY] (C - n/a - Unknown - [n/a - n/a - n/a])|[AZELAIC ACID] (C - Hidradenitis - Unknown - [n/a - n/a - n/a])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Seasonal allergy - Unknown - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Seasonal allergy - Unknown - [n/a - n/a - n/a])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Seasonal allergy - Unknown - [n/a - 10mg - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Seasonal allergy - Unknown - [n/a - .2mg - n/a])|[TETRACYCLINE HYDROCHLORIDE] (C - Hidradenitis - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7761450&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7761882	Spontaneous	2014-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7761882&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7749234	Spontaneous	2014-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7749234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7749645	Spontaneous	2014-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7749645&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7750563	Spontaneous	2014-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7750563&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7738017	Spontaneous	2014-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Irritable bowel syndrome (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	SPIRONOLACTONE [SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7738017&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7738793	Spontaneous	2014-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7738793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7741123	Spontaneous	2014-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Facial spasm (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypertension (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Non-24-hour sleep-wake disorder (n/a - Not Recovered/Not Resolved - Disabling);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7741123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7741321	Spontaneous	2014-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Autism spectrum disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cardiovascular disorder (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Learning disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Unknown - Other Medically Important Condition);Product administered to patient of inappropriate age (n/a - Unknown - Other Medically Important Condition);Rash erythematous (n/a - Unknown - Other Medically Important Condition);Raynaud's phenomenon (n/a - Unknown - Other Medically Important Condition);Skin discolouration (n/a - Unknown - Other Medically Important Condition);Speech disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT) AND HEPATITIS B (RDNA) VACCINE (ADSORBED)] (C - n/a - n/a - [1d - n/a - n/a])|[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT) AND HEPATITIS B (RDNA) VACCINE (ADSORBED)] (C - n/a - n/a - [n/a - n/a - n/a])|[MENINGOCOCCAL GROUP C CONJUGATE VACCINE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197] (C - n/a - n/a - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7741321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7733965	Spontaneous	2014-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Other Medically Important Condition);Abdominal pain upper (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anger (n/a - Unknown - Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Back pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Blindness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Crying (n/a - Unknown - Other Medically Important Condition);Cystitis (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Irritability (n/a - Unknown - Other Medically Important Condition);Limb discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Live birth (n/a - Unknown - Other Medically Important Condition);Maternal exposure before pregnancy (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pelvic pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition);Rhinitis allergic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tunnel vision (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Urinary tract infection (n/a - Unknown - Other Medically Important Condition);Vaginal haemorrhage (n/a - Unknown - Other Medically Important Condition);Varicose vein (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM] (C - Arthralgia - Unknown - [n/a - n/a - n/a])|[IBUPROFEN] (C - Premenstrual pain - Unknown - [n/a - n/a - n/a])|[MEDROXYPROGESTERONE ACETATE] (C - Contraception - Unknown - [n/a - n/a - n/a])|[PODOPHYLLOTOXIN] (C - Anogenital warts - Unknown - [1d - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7733965&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7728859	Spontaneous	2014-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Axillary pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bladder pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Constipation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diplopia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Facial asymmetry (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia oral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urinary incontinence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7728859&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7728944	Spontaneous	2014-03-17 00:00:00	Non Healthcare Professional	European Economic Area	Rogers,L. Victims of swine flue jab to get £60m payout. The Sunday Times. 2 March 2014 p.10	Not Specified	Adolescent	No	Male	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation);Psychotic disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7728944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7728951	Spontaneous	2014-03-17 00:00:00	Non Healthcare Professional	European Economic Area	Rogers,L. Victims of swine flue jab to get £60m payout. The Sunday Times. 2 March 2014 p.10	18-64 Years	Not Specified	No	Not Specified	Cataplexy (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7728951&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7730787	Spontaneous	2014-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Tachycardia (n/a - Not Recovered/Not Resolved - Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Subcutaneous])	[COLECALCIFEROL, CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7730787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7722734	Spontaneous	2014-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chronic fatigue syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypopituitarism (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pelvic pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Secondary adrenocortical insufficiency (n/a - Unknown - Caused/Prolonged Hospitalisation);Spinal pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS ANTIGEN, STRAIN HM175, INACTIVATED, ADSORBED ON ALUMINIUM HYDROXIDE, ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7722734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7723778	Spontaneous	2014-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7723778&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7725799	Spontaneous	2014-03-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Recovered/Resolved - Disabling);Drug ineffective (n/a - Recovered/Resolved - Disabling);Influenza (n/a - Recovered/Resolved - Disabling);Pain (4d - Recovered/Resolved - Disabling);Pyrexia (3d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[EPROSARTAN MESILATE, HYDROCHLOROTHIAZIDE, EPROSARTAN, HYDROCHLOROTHIAZIDE] (C - Hypertension - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7725799&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7717530	Spontaneous	2014-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7717530&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7718534	Spontaneous	2014-03-13 00:00:00	Healthcare Professional	European Economic Area	Kwok T. and Al-Bermani A. Two rare cases of retinal vasculitis following vaccination. Scottish Medical Journal 2013; 58 (2): 10-12	18-64 Years	Not Specified	No	Male	Retinal vasculitis (n/a - Recovered/Resolved - Other Medically Important Condition);Visual acuity reduced (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7718534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7712655	Spontaneous	2014-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arthralgia (n/a - Recovering/Resolving - Results in Death, Caused/Prolonged Hospitalisation);Autoimmune disorder (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Chills (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Chronic myelomonocytic leukaemia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dry skin (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Hyperaesthesia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Increased tendency to bruise (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Insomnia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Motor dysfunction (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Myelodysplastic syndrome (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Recovering/Resolving - Results in Death, Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Results in Death, Caused/Prolonged Hospitalisation);Rash (n/a - Recovering/Resolving - Results in Death, Caused/Prolonged Hospitalisation);Renal function test abnormal (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Skin disorder (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Vasculitis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - 50mg - Oral])|[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FENOTEROL HYDROBROMIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FINASTERIDE] (C - n/a - Unknown - [n/a - n/a - Oral])|[LEVOTHYROXINE SODIUM, POTASSIUM IODIDE, LEVOTHYROXINE, POTASSIUM IODIDE] (C - n/a - Unknown - [n/a - n/a - Oral])|[NEBIVOLOL] (C - n/a - Unknown - [n/a - 2.5mg - Oral])|[PRAVASTATIN, PRAVASTATIN SODIUM] (C - n/a - Unknown - [n/a - 40mg - Oral])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - Unknown - [n/a - 18ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7712655&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7713484	Spontaneous	2014-03-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diarrhoea (n/a - Recovering/Resolving - Other Medically Important Condition);Feeling cold (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 1{DF} - n/a])	[BUPROPION, BUPROPION HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7713484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7713513	Spontaneous	2014-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Lethargy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Mood swings (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Suspected transmission of an infectious agent via product (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - 1mg - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - 2.5mg - Respiratory (inhalation)])|[TERBUTALINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7713513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7714611	Spontaneous	2014-03-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Circulatory collapse (n/a - Unknown - Results in Death);Sudden cardiac death (1d - Fatal - Results in Death);Sudden death (n/a - Fatal - Results in Death)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7714611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7708773	Spontaneous	2014-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7708773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7711215	Spontaneous	2014-03-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amyotrophic lateral sclerosis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7711215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7704374	Spontaneous	2014-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7704374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7695759	Spontaneous	2014-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination, visual (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mood altered (n/a - Unknown - Other Medically Important Condition);Musculoskeletal disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sinusitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7695759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7695761	Spontaneous	2014-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7695761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7695762	Spontaneous	2014-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7695762&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7695763	Spontaneous	2014-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Meningitis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7695763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7699764	Spontaneous	2014-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7699764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7690354	Spontaneous	2014-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7690354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7690375	Spontaneous	2014-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Small fibre neuropathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7690375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7690384	Spontaneous	2014-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Polyneuropathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7690384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7690430	Spontaneous	2014-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7690430&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7682579	Spontaneous	2014-03-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7682579&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7683390	Spontaneous	2014-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|INSULATARD FLEXPEN 100 IE/ML INJEKTIONSVÄTSKA, SUSPENSION I FÖRFYLLD INJEKTIONSPENNA [INSULIN HUMAN ISOPHANE (RDNA)] (C - n/a - n/a - [n/a - n/a - n/a])|NOVONORM [REPAGLINIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLCYSTEINE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BETAMETHASONE, BETAMETHASONE VALERATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ECONAZOLE NITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE OXIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7683390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7684336	Spontaneous	2014-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle contractions involuntary (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7684336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7675600	Spontaneous	2014-03-03 00:00:00	Healthcare Professional	European Economic Area	Krnic D, Andric A, Macolic Sarinic V. Guillain-barre syndrome and influenza vaccines: Croatian experience. Drug safety. 2013;36:936-937	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Gait inability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sensory loss (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - 100mg - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - Unknown - [n/a - 5mg - n/a])|[ATENOLOL, ATENOLOL BP] (C - n/a - Unknown - [n/a - 25mg - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - Unknown - [n/a - 20mg - n/a])|[INDAPAMIDE] (C - n/a - Unknown - [n/a - 1{DF} - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 1000mg - n/a])|[POTASSIUM CHLORIDE] (C - n/a - Unknown - [n/a - 1g - n/a])|[TAMSULOSIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - .4mg - n/a])|[THIAMINE, PYRIDOXINE HYDROCHLORIDE, VITAMIN B] (C - n/a - Unknown - [n/a - n/a - n/a])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7675600&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7679762	Spontaneous	2014-03-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7679762&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7680414	Spontaneous	2014-03-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cerebral atrophy (n/a - Unknown - Disabling);Epilepsy (n/a - Unknown - Disabling);Hemiplegia (n/a - Unknown - Disabling);Rasmussen encephalitis (n/a - Unknown - Disabling)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7680414&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7680469	Spontaneous	2014-03-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7680469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7670877	Spontaneous	2014-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7670877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7671694	Spontaneous	2014-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anal incontinence (n/a - Unknown - Other Medically Important Condition);Arthralgia (n/a - Unknown - Other Medically Important Condition);Chest pain (n/a - Unknown - Other Medically Important Condition);Diabetes mellitus (n/a - Unknown - Other Medically Important Condition);Diarrhoea (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Glucose tolerance impaired (n/a - Unknown - Other Medically Important Condition);Limb injury (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Osteoarthritis (n/a - Unknown - Other Medically Important Condition);Pancreatitis acute (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Urinary tract disorder (n/a - Unknown - Other Medically Important Condition);Vitamin D deficiency (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Arteriosclerosis - Unknown - [n/a - n/a - n/a])|[CANDESARTAN CILEXETIL] (C - Hypertension - Unknown - [n/a - n/a - n/a])|[FLUVASTATIN, FLUVASTATIN SODIUM] (C - Blood cholesterol increased - Unknown - [n/a - n/a - n/a])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - Asthma - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7671694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7671981	Spontaneous	2014-02-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depressed level of consciousness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Judgement impaired (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Stupor (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7671981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7673180	Spontaneous	2014-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7673180&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7665617	Spontaneous	2014-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Aggression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Anxiety (n/a - Unknown - Caused/Prolonged Hospitalisation);Aphasia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Clumsiness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Drooling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Gaze palsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Head injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperventilation (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Lacrimation increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle twitching (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Oppositional defiant disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Oral mucosal blistering (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Seizure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensory loss (n/a - Unknown - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Syncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Unresponsive to stimuli (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7665617&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7665618	Spontaneous	2014-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anxiety (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Increased appetite (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7665618&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7665619	Spontaneous	2014-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Ear discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnopompic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Movement disorder (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7665619&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7668988	Spontaneous	2014-02-27 00:00:00	Healthcare Professional	European Economic Area	Krnic D, Andric A., Macolic Sarinic V. Guillain-barre syndrome and influenza vaccines: Croatian experience. Drug safety. 2013;36:936-937	18-64 Years	Not Specified	No	Female	Depressed mood (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Feeling abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Gait inability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Micturition disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Poor quality sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Unknown])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - 100ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7668988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7664121	Spontaneous	2014-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Neuritis (45d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7664121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7653012	Spontaneous	2014-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain (5wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Aggression (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Attention deficit hyperactivity disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Bone pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chronic fatigue syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Coeliac disease (n/a - Unknown - Caused/Prolonged Hospitalisation);Delayed sleep phase (n/a - Unknown - Caused/Prolonged Hospitalisation);Dermatitis herpetiformis (n/a - Unknown - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gastroenteritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperthyroidism (n/a - Unknown - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CEFATRIZINE PROPYLENE GLYCOL] (C - Hypersensitivity - Unknown - [n/a - 10mg - Oral])|[DIPHTHERIA AND TETANUS VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - Hypersensitivity - Unknown - [n/a - 1mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7653012&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7653013	Spontaneous	2014-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	Yes	Male	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Abdominal pain lower (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthropod bite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Axillary pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Bedridden (n/a - Unknown - Caused/Prolonged Hospitalisation);Borrelia infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Coeliac disease (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Eczema (n/a - Unknown - Caused/Prolonged Hospitalisation);Epistaxis (n/a - Unknown - Caused/Prolonged Hospitalisation);Erythema migrans (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eye pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Foot deformity (n/a - Unknown - Caused/Prolonged Hospitalisation);Head injury (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperacusis (n/a - Unknown - Caused/Prolonged Hospitalisation);Lactose intolerance (n/a - Unknown - Caused/Prolonged Hospitalisation);Limb injury (n/a - Unknown - Caused/Prolonged Hospitalisation);Listless (n/a - Unknown - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash pruritic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Scoliosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Sinusitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Stress (n/a - Unknown - Caused/Prolonged Hospitalisation);Testicular pain (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7653013&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7653014	Spontaneous	2014-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Confusional state (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Eyelid ptosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Generalised tonic-clonic seizure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Loss of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Partial seizures (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Quality of life decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Syncope (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tongue injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DESOGESTREL] (C - Contraception - Unknown - [n/a - n/a - n/a])|[TRANEXAMIC ACID] (C - Heavy menstrual bleeding - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7653014&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7653015	Spontaneous	2014-02-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Food allergy (n/a - Not Recovered/Not Resolved - Disabling);Restlessness (n/a - Not Recovered/Not Resolved - Disabling);Rhinitis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7653015&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7653016	Spontaneous	2014-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Unknown - Disabling, Other Medically Important Condition);Arthralgia (n/a - Unknown - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Disabling, Other Medically Important Condition);Dysgeusia (n/a - Unknown - Disabling, Other Medically Important Condition);Dyshidrotic eczema (n/a - Unknown - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Gastroenteritis (n/a - Unknown - Disabling, Other Medically Important Condition);Gastrointestinal disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Disabling, Other Medically Important Condition);Insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Irritability (n/a - Unknown - Disabling, Other Medically Important Condition);Listless (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Unknown - Disabling, Other Medically Important Condition);Monoplegia (n/a - Unknown - Disabling, Other Medically Important Condition);Mood altered (n/a - Unknown - Disabling, Other Medically Important Condition);Nail infection (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Nausea (n/a - Unknown - Disabling, Other Medically Important Condition);Neutropenia (n/a - Unknown - Disabling, Other Medically Important Condition);Pain (n/a - Unknown - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Disabling, Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Disabling, Other Medically Important Condition);Respiratory tract infection (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Disabling, Other Medically Important Condition);Visual impairment (n/a - Unknown - Disabling, Other Medically Important Condition);Vomiting (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[ANTAZOLINE HYDROCHLORIDE, TETRYZOLINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Ophthalmic])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - Hypersensitivity - Unknown - [n/a - n/a - Ophthalmic])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7653016&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7654473	Spontaneous	2014-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Not Specified	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7654473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7647315	Spontaneous	2014-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Sjogren's syndrome (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7647315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7647317	Spontaneous	2014-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Not Specified	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7647317&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7647398	Spontaneous	2014-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Ataxia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyporeflexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM] (C - Dyspepsia - Unknown - [4y - n/a - Oral])|[NITRENDIPINE] (C - Hypertension - Unknown - [4y - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7647398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7648818	Spontaneous	2014-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Aphasia (n/a - Not Recovered/Not Resolved - Disabling);Cardiac disorder (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling abnormal (n/a - Not Recovered/Not Resolved - Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling);Hallucination (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Heart rate irregular (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Pityriasis rosea (n/a - Not Recovered/Not Resolved - Disabling);Purpura (n/a - Recovered/Resolved - Disabling);Rash (n/a - Not Recovered/Not Resolved - Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling);Syncope (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7648818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7641052	Spontaneous	2014-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7641052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7642326	Spontaneous	2014-02-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Burning sensation (n/a - Unknown - Other Medically Important Condition);Feeling hot (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin warm (n/a - Unknown - Other Medically Important Condition);Visual impairment (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7642326&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7643922	Spontaneous	2014-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood glucose decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysstasia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7643922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7637675	Spontaneous	2014-02-19 00:00:00	Non Healthcare Professional	European Economic Area	Article published on 09 February 2014 in the local newspaper_Sundsvalls Tidning.	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7637675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7631809	Spontaneous	2014-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Idiopathic pulmonary fibrosis (39d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	[CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - 4mg - Oral])|[D,L-LYSINE ACETYLSALICYLATE] (C - n/a - n/a - [n/a - 75mg - Oral])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (C - n/a - n/a - [n/a - 20mg - Oral])|[EZETIMIBE] (C - n/a - n/a - [n/a - 10mg - Oral])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[LAMOTRIGINE] (C - n/a - n/a - [n/a - 100mg - Oral])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7631809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7631830	Spontaneous	2014-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7631830&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7633112	Spontaneous	2014-02-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7633112&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7628425	Spontaneous	2014-02-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Recovered/Resolved - Disabling);Decreased appetite (n/a - Recovered/Resolved - Disabling);Drug ineffective (n/a - Recovered/Resolved - Disabling);Fatigue (n/a - Recovered/Resolved - Disabling);Influenza (n/a - Recovered/Resolved - Disabling);Laryngeal discomfort (n/a - Recovered/Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	[CALCIUM CARBONATE] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - Oral])|[GINKGO BILOBA, GINKGO BILOBA EXTRACT] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7628425&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7628440	Spontaneous	2014-02-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Middle insomnia (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Social avoidant behaviour (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7628440&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7629812	Spontaneous	2014-02-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nervous system disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7629812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7622514	Spontaneous	2014-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Not Specified	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7622514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7622563	Spontaneous	2014-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal symptom (n/a - Unknown - Caused/Prolonged Hospitalisation);Alopecia (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Cardiovascular disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Chest discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Flatulence (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastroenteritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotension (n/a - Unknown - Caused/Prolonged Hospitalisation);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Palpitations (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[HYPERICUM PERFORATUM] (C - Stress - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7622563&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7622731	Spontaneous	2014-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7622731&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7618902	Spontaneous	2014-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depression (n/a - Unknown - Other Medically Important Condition);Gait disturbance (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	LYRICA [PREGABALIN] (C - Pain in extremity - Unknown - [n/a - n/a - Unknown])|[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - Pain in extremity - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7618902&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7618903	Spontaneous	2014-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7618903&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7614421	Spontaneous	2014-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7614421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7607780	Spontaneous	2014-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Acne (n/a - Unknown - Caused/Prolonged Hospitalisation);Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Limb injury (n/a - Unknown - Caused/Prolonged Hospitalisation);Migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Radius fracture (n/a - Unknown - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7607780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7607781	Spontaneous	2014-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Depression (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Emotional distress (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Unknown - Disabling);Hypoacusis (n/a - Unknown - Disabling);Insomnia (n/a - Unknown - Disabling);Petit mal epilepsy (n/a - Not Recovered/Not Resolved - Disabling);Quality of life decreased (n/a - Not Recovered/Not Resolved - Disabling);Self esteem decreased (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BECLOMETASONE DIPROPIONATE] (C - Asthma - Unknown - [n/a - 50ug - n/a])|[DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS (DTAP) VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[ERYTHROMYCIN] (C - Asthma - Unknown - [n/a - 100mg - n/a])|[LORATADINE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[POLIOVIRUS (INACTIVATED)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - .1mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7607781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7608372	Spontaneous	2014-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Disabling);Cervicobrachial syndrome (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Dizziness (n/a - Recovering/Resolving - Disabling);Facial pain (n/a - Recovered/Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling hot (n/a - Unknown - Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hyperhidrosis (n/a - Unknown - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Recovering/Resolving - Disabling);Malaise (n/a - Recovering/Resolving - Disabling);Memory impairment (n/a - Unknown - Disabling);Pain in jaw (n/a - Unknown - Disabling);Paraesthesia (n/a - Unknown - Disabling);Pulpitis dental (n/a - Unknown - Disabling);Sinusitis (n/a - Unknown - Disabling);Sleep disorder (n/a - Unknown - Disabling);Trigeminal neuralgia (n/a - Unknown - Disabling);Vertigo (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7608372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7604297	Spontaneous	2014-02-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Recovered/Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Recovered/Resolved - Disabling);Nightmare (n/a - Recovered/Resolved - Disabling);Quality of life decreased (n/a - Not Recovered/Not Resolved - Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Vomiting (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7604297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7598598	Spontaneous	2014-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Anti-glomerular basement membrane antibody (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood creatinine increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Goodpasture's syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Haemoglobin decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Haemoptysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nephritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pulmonary mass (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[IBUPROFEN] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7598598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7598600	Spontaneous	2014-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7598600&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7598611	Spontaneous	2014-02-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthenia (n/a - Recovering/Resolving - Other Medically Important Condition);Depression (n/a - Recovering/Resolving - Other Medically Important Condition);Epilepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Fall (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Swelling (n/a - Recovering/Resolving - Other Medically Important Condition);Vision blurred (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7598611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7599458	Spontaneous	2014-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7599458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7600782	Spontaneous	2014-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Parkinson's disease (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7600782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7594255	Spontaneous	2014-02-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Blindness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly);Congenital brain damage (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly);Epilepsy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly);Microcephaly (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - .5mL - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7594255&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7581959	Spontaneous	2014-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Unknown - Other Medically Important Condition);Behaviour disorder (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hyperphagia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7581959&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7583638	Spontaneous	2014-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7583638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7583639	Spontaneous	2014-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Nephritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7583639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7577519	Spontaneous	2014-02-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7577519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7578969	Spontaneous	2014-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Eyelid ptosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7578969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7575053	Spontaneous	2014-02-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Drug ineffective (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Influenza (19d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory distress (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7575053&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7573436	Spontaneous	2014-01-31 00:00:00	Healthcare Professional	European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository G. Remiche et al. Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated to hereditary neuropathy with liability to pressure palsies (HNPP) and revealed after influenza AH1N1 vaccination; Acta Neurol Belg (2013) 113:4 (519-522)sa	18-64 Years	Not Specified	No	Female	Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Recovering/Resolving - Other Medically Important Condition);Hereditary neuropathy with liability to pressure palsies (n/a - Recovering/Resolving - Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Other Medically Important Condition);Neuralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Neuropathy peripheral (n/a - Recovering/Resolving - Other Medically Important Condition);Sensory loss (n/a - Recovering/Resolving - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7573436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7563069	Spontaneous	2014-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7563069&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7563070	Spontaneous	2014-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7563070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7563091	Spontaneous	2014-01-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7563091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7556951	Spontaneous	2014-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Angioedema (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tongue oedema (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[ASCORBIC ACID, ASCORBIC ACID, NICOTINAMIDE, RIBOFLAVIN, THIAMINE NITRATE, PYRIDOXINE HYDROCHLORIDE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[DEXIBUPROFEN] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[DIGOXIN] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[FUROSEMIDE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[METOPROLOL, METOPROLOL TARTRATE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[NIFEDIPINE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[OMEPRAZOLE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[PARACETAMOL] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7556951&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7557667	Spontaneous	2014-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7557667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7553073	Spontaneous	2014-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7553073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7553074	Spontaneous	2014-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7553074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7546602	Spontaneous	2014-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7546602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7547428	Spontaneous	2014-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Unknown - Disabling);Amnesia (n/a - Unknown - Disabling);Apathy (n/a - Unknown - Disabling);Arthralgia (n/a - Unknown - Disabling);Asthenia (n/a - Unknown - Disabling);Back injury (n/a - Unknown - Disabling);Bronchitis (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Unknown - Disabling);Depressed mood (n/a - Unknown - Disabling);Depression (n/a - Unknown - Disabling);Epiploic appendagitis (n/a - Unknown - Disabling);Fall (n/a - Unknown - Disabling);Insomnia (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Rash (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	SUPPLEMENT [UNKNOWN] (C - n/a - Unknown - [n/a - n/a - n/a])|[DESONIDE] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|[SOLIFENACIN, SOLIFENACIN SUCCINATE] (C - Micturition urgency - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7547428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7549602	Spontaneous	2014-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Blister (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Skin reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7549602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7550410	Spontaneous	2014-01-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Addison's disease (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypotension (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Vomiting (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	NOVORAPID [INSULIN ASPART] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7550410&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7550454	Spontaneous	2014-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7550454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7543106	Spontaneous	2014-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Disabling);Nodule (n/a - Unknown - Disabling);Pruritus (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Unknown - Disabling);Rash erythematous (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling);Tenderness (n/a - Unknown - Disabling);Urticaria (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7543106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7544757	Spontaneous	2014-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7544757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7544776	Spontaneous	2014-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition);Vertigo (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7544776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7537021	Spontaneous	2014-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abnormal dreams (n/a - Unknown - Other Medically Important Condition);Abnormal sleep-related event (n/a - Unknown - Other Medically Important Condition);Allergy to plants (n/a - Unknown - Other Medically Important Condition);Arthralgia (n/a - Unknown - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Eyelid function disorder (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypothyroidism (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Unknown - Other Medically Important Condition);Nail psoriasis (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Skin discolouration (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Tinnitus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7537021&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7537045	Spontaneous	2014-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7537045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7537046	Spontaneous	2014-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7537046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7537047	Spontaneous	2014-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7537047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7537048	Spontaneous	2014-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7537048&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7537050	Spontaneous	2014-01-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7537050&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7537498	Spontaneous	2014-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Decreased appetite (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Menstrual disorder (n/a - Unknown - Disabling);Neck pain (n/a - Unknown - Disabling);Pain (n/a - Unknown - Disabling);Pharyngitis (n/a - Unknown - Disabling);Sinusitis (n/a - Unknown - Disabling);Vaginal infection (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[CYPROTERONE ACETATE, ETHINYLESTRADIOL] (C - Acne - n/a - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM] (C - Arthralgia - n/a - [n/a - n/a - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Depression - Unknown - [n/a - n/a - n/a])|[SUMATRIPTAN, SUMATRIPTAN SUCCINATE] (C - Migraine - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7537498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7538527	Spontaneous	2014-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7538527&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7539797	Spontaneous	2014-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Influenza like illness (n/a - Fatal - Results in Death);Pyrexia (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7539797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7531344	Spontaneous	2014-01-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7531344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7531345	Spontaneous	2014-01-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Drug ineffective (n/a - Unknown - Other Medically Important Condition);H1N1 influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7531345&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7532684	Spontaneous	2014-01-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Bronchitis (n/a - Recovered/Resolved - Other Medically Important Condition);Drug ineffective (2wk - Recovered/Resolved - Other Medically Important Condition);Influenza (2wk - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - n/a])	[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMINE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7532684&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7526352	Spontaneous	2014-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7526352&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7530555	Spontaneous	2014-01-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	H1N1 influenza (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7530555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7520388	Spontaneous	2014-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Circulatory collapse (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Infection (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Snoring (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7520388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7520390	Spontaneous	2014-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7520390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7520391	Spontaneous	2014-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7520391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7521906	Spontaneous	2014-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypersomnia (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7521906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7516895	Spontaneous	2014-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7516895&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7518694	Spontaneous	2014-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7518694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7507615	Spontaneous	2014-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination, auditory (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7507615&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7508638	Spontaneous	2014-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Anxiety disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Central nervous system lesion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Eyeglasses therapy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Formication (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Gait inability (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Groin pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Injection site pain (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Lymphadenopathy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Neuralgia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Performance status decreased (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Polyneuropathy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Sensory disturbance (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Tremor (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Visual acuity reduced (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7508638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7510137	Spontaneous	2014-01-14 00:00:00	Non Healthcare Professional	European Economic Area	Aujourd&apos;hui en France 20 Decembre 2013 Page 18	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Impaired driving ability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7510137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7502385	Spontaneous	2014-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anxiety (n/a - Unknown - Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Connective tissue disorder (n/a - Unknown - Other Medically Important Condition);Cutaneous lupus erythematosus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Emotional distress (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Erythema multiforme (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fibrous histiocytoma (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ill-defined disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site induration (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin hypertrophy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Stress (n/a - Unknown - Other Medically Important Condition);Swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Systemic lupus erythematosus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7502385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7500366	Spontaneous	2014-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Autoimmune hepatitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hepatocellular injury (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7500366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7500383	Spontaneous	2014-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Subcutaneous])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - Hypertension - Dose not changed - [n/a - n/a - Oral])|[CELIPROLOL HYDROCHLORIDE] (C - Hypertension - Dose not changed - [n/a - n/a - Oral])|[FENOFIBRATE, FENOFIBRATE (NANONISED), FENOFIBRATE MICRONISED] (C - Blood cholesterol increased - Dose not changed - [n/a - n/a - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Dose not changed - [n/a - n/a - Nasal])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - Hypertension - Dose not changed - [n/a - n/a - Oral])|[OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE] (C - Hypertension - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7500383&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7500412	Spontaneous	2014-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7500412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7494207	Spontaneous	2014-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in social behaviour (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	AERIUS [DESLORATADINE] (C - Seasonal allergy - Unknown - [n/a - n/a - n/a])|MELATONIN [MELATONIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7494207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7489999	Spontaneous	2014-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Muscle spasms (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition);Status epilepticus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7489999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7491627	Spontaneous	2014-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute kidney injury (n/a - Unknown - Caused/Prolonged Hospitalisation);Anal fissure (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Back pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Bacterial test positive (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Blood creatinine increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Dermatitis exfoliative generalised (n/a - Unknown - Caused/Prolonged Hospitalisation);Erythema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation);Herpes zoster (n/a - Unknown - Caused/Prolonged Hospitalisation);Macule (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neoplasm (n/a - Unknown - Caused/Prolonged Hospitalisation);Osteopenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Osteoporosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Prostatic specific antigen increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation);Psoriasis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Radiculopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Skin exfoliation (n/a - Unknown - Caused/Prolonged Hospitalisation);Skin fissures (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Spinal osteoarthritis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7491627&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7486597	Spontaneous	2014-01-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - Asthma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7486597&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7482771	Spontaneous	2014-01-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7482771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7478005	Spontaneous	2014-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Unknown - Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Loss of consciousness (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CYPROTERONE ACETATE, ETHINYLESTRADIOL] (C - n/a - Unknown - [n/a - n/a - Oral])|[METHYLPHENIDATE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Oral])|[PIVMECILLINAM] (C - n/a - Unknown - [n/a - 600mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7478005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7474184	Spontaneous	2014-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anxiety (n/a - Unknown - Disabling);Back pain (n/a - Unknown - Disabling);Balance disorder (n/a - Recovering/Resolving - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Recovering/Resolving - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Unknown - Disabling);Hyperhidrosis (n/a - Unknown - Disabling);Influenza like illness (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Paraesthesia (n/a - Unknown - Disabling);Sinusitis (n/a - Unknown - Disabling);Vestibular neuronitis (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	AVAMYS [FLUTICASONE FUROATE] (C - Sinusitis - Unknown - [n/a - n/a - n/a])|OLOPATADINE HYDROCHLORIDE [OLOPATADINE HYDROCHLORIDE] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|[ANHYDROUS AZITHROMYCIN, AZITHROMYCIN] (C - Infection - Unknown - [n/a - n/a - n/a])|[CEFATRIZINE PROPYLENE GLYCOL] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - Sinusitis - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7474184&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7474190	Spontaneous	2014-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Acute myocardial infarction (n/a - Recovered/Resolved With Sequelae - Disabling);Acute respiratory failure (n/a - Unknown - Disabling);Apraxia (n/a - Unknown - Disabling);Balance disorder (n/a - Unknown - Disabling);Brain injury (n/a - Unknown - Disabling);Cardiac arrest (n/a - Recovered/Resolved With Sequelae - Disabling);Confusional state (n/a - Unknown - Disabling);Disorientation (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Epilepsy (n/a - Unknown - Disabling);Frustration tolerance decreased (n/a - Unknown - Disabling);General physical health deterioration (n/a - Unknown - Disabling);Infection (n/a - Unknown - Disabling);Insomnia (n/a - Unknown - Disabling);Memory impairment (n/a - Unknown - Disabling);Stress (n/a - Unknown - Disabling);Ventricular tachycardia (n/a - Unknown - Disabling);Visual impairment (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7474190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-7474192	Spontaneous	2014-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Aphasia (n/a - Unknown - Disabling);Cyanosis (n/a - Unknown - Disabling);Fall (n/a - Unknown - Disabling);Foaming at mouth (n/a - Unknown - Disabling);Injury (n/a - Unknown - Disabling);Jaw fracture (n/a - Unknown - Disabling);Juvenile myoclonic epilepsy (n/a - Not Recovered/Not Resolved - Disabling);Loss of consciousness (30min - Recovered/Resolved - Disabling);Muscle spasms (n/a - Unknown - Disabling);Musculoskeletal stiffness (n/a - Unknown - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Tremor (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[DIPHTHERIA, TETANUS, PERTUSSIS AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7474192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7476156	Spontaneous	2014-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovering/Resolving - Other Medically Important Condition);Hypersomnia (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7476156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7470945	Spontaneous	2013-12-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	CELLCEPT [MYCOPHENOLATE MOFETIL] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7470945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7463129	Spontaneous	2013-12-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cerebellar syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nystagmus (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyramidal tract syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);VIth nerve paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	[ANHYDROUS LEVOTHYROXINE SODIUM, LEVOTHYROXINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS EP] (C - Hypothyroidism - n/a - [n/a - 100ug - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7463129&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7463356	Spontaneous	2013-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Acute disseminated encephalomyelitis (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Gait inability (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Neuralgia (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Sensory level abnormal (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Visual impairment (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7463356&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7464315	Spontaneous	2013-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Unknown - Disabling);Abnormal dreams (n/a - Unknown - Disabling);Anxiety (n/a - Unknown - Disabling);Asthenia (n/a - Unknown - Disabling);Asthma (n/a - Recovered/Resolved - Disabling);Chronic fatigue syndrome (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Dyspepsia (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Gastritis (n/a - Unknown - Disabling);Hiatus hernia (n/a - Unknown - Disabling);Influenza like illness (n/a - Unknown - Disabling);Insomnia (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Oesophagitis (n/a - Unknown - Disabling);Sleep disorder (n/a - Unknown - Disabling);Sleep paralysis (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])|[METHYLPHENIDATE HYDROCHLORIDE] (C - Attention deficit hyperactivity disorder - Unknown - [81d - n/a - n/a])|[METOCLOPRAMIDE HYDROCHLORIDE] (C - Migraine - Unknown - [n/a - n/a - n/a])|[TERBUTALINE SULFATE, TERBUTALINE SULFATE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOLMITRIPTAN] (C - Migraine - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7464315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7464316	Spontaneous	2013-12-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Asthenia (n/a - Unknown - Disabling);Narcolepsy (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7464316&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7467394	Spontaneous	2013-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling)	A/CALIFORNIA/7/2009 (H1N1) [A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7467394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7459432	Spontaneous	2013-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cold sweat (1h - Recovered/Resolved - );Pallor (1h - Recovered/Resolved - );Syncope (0d - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7459432&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-7454301	Spontaneous	2013-12-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7454301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7454303	Spontaneous	2013-12-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7454303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7454305	Spontaneous	2013-12-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7454305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7454306	Spontaneous	2013-12-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7454306&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7454307	Spontaneous	2013-12-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7454307&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7454308	Spontaneous	2013-12-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7454308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7454309	Spontaneous	2013-12-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7454309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7454310	Spontaneous	2013-12-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7454310&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7454311	Spontaneous	2013-12-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7454311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7454312	Spontaneous	2013-12-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7454312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7454313	Spontaneous	2013-12-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7454313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7454314	Spontaneous	2013-12-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7454314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7451870	Spontaneous	2013-12-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Vasculitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7451870&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7451971	Spontaneous	2013-12-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injected limb mobility decreased (2mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Movement disorder (83d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nodule (2mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (2mo - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[TAMOXIFEN, TAMOXIFEN CITRATE] (C - Breast cancer - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7451971&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7443985	Spontaneous	2013-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Conjunctivitis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7443985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7443987	Spontaneous	2013-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7443987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7444494	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444495	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444495&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444497	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444498	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444500	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444501	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444502	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444503	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444505	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444505&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444507	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444508	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444509	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444509&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444510	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444510&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444512	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444513	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444514	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444515	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444515&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444517	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444517&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444518	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444518&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444519	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444520	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444521	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444521&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444522	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444522&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444523	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444523&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444524	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444524&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444525	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444526	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7444527	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444527&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444528	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444528&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444529	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444529&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444530	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444530&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444531	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444531&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444532	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444532&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444533	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444533&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444534	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7444535	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7444535&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446765	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446766	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446768	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446769	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446769&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446770	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446771	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446772	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7446774	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446774&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446775	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446775&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446776	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446778	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446778&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446779	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446779&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446781	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446782	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446783	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446783&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446784	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446785	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446786	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446786&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446787	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446788	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446789	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446789&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446790	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446791	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446792	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446793	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446794	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446794&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446796	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446796&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446797	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7446798	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446799	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446799&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446800	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7446801	Spontaneous	2013-12-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7446801&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7442235	Spontaneous	2013-12-21 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Drug ineffective (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7442235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7442236	Spontaneous	2013-12-21 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[PSEUDOEPHEDRINE HYDROCHLORIDE, IBUPROFEN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7442236&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7435533	Spontaneous	2013-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7435533&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7435712	Spontaneous	2013-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7435712&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7428745	Spontaneous	2013-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[FLUPENTIXOL, FLUPENTIXOL DECANOATE, FLUPENTIXOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - .5mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7428745&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7428748	Spontaneous	2013-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Balance disorder (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Bradycardia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Cardiac arrest (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Erythema (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypertension (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Loss of consciousness (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Neuralgia (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Quality of life decreased (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Rash (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Swelling face (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7428748&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7423882	Spontaneous	2013-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7423882&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7424070	Spontaneous	2013-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Arthritis reactive (n/a - Not Recovered/Not Resolved - Disabling);Joint swelling (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .25mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7424070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7424073	Spontaneous	2013-12-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Fatigue (n/a - Unknown - Other Medically Important Condition);Injury (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7424073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7418991	Spontaneous	2013-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Other Medically Important Condition);Abdominal symptom (n/a - Unknown - Other Medically Important Condition);Arthralgia (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Bedridden (n/a - Unknown - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Fibromyalgia (n/a - Unknown - Other Medically Important Condition);Gastrooesophageal reflux disease (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	EVRA [ETHINYLESTRADIOL, NORELGESTROMIN] (C - Contraception - Unknown - [n/a - n/a - n/a])|[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 10mg - n/a])|[CYANOCOBALAMIN, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE] (C - Vitamin B12 deficiency - Unknown - [n/a - 3mg - Oral])|[CYANOCOBALAMIN, VITAMIN B12] (C - Vitamin B12 deficiency - Unknown - [6d - 1mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7418991&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7418994	Spontaneous	2013-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Nuchal rigidity (n/a - Unknown - Other Medically Important Condition);Orthostatic hypotension (n/a - Unknown - Other Medically Important Condition);Pharyngeal disorder (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE] (C - Helicobacter infection - Unknown - [n/a - n/a - n/a])|[CEFATRIZINE PROPYLENE GLYCOL] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|[CODEINE PHOSPHATE SESQUIHYDRATE, PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE MONOHYDRATE] (C - Borrelia infection - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[IBUPROFEN] (C - n/a - Unknown - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7418994&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7412365	Spontaneous	2013-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7412365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7413359	Spontaneous	2013-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7413359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7413371	Spontaneous	2013-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Not Specified	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7413371&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7413857	Spontaneous	2013-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Autoimmune haemolytic anaemia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cold type haemolytic anaemia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7413857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7413930	Spontaneous	2013-12-13 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Hidalgo et al. Intravenous immunoglobulin treatment in post H1N1 vaccination narcolepsy-cataplexy. J. Neurol. (2012) 259 (Suppl 1): S95; P425.	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7413930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7408996	Spontaneous	2013-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7408996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7403260	Spontaneous	2013-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7403260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7403626	Spontaneous	2013-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Clumsiness (n/a - Unknown - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Unknown - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Disabling);Oral mucosal blistering (n/a - Unknown - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Sleep paralysis (n/a - Unknown - Disabling);Temperature regulation disorder (n/a - Unknown - Disabling);Weight increased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7403626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7403748	Spontaneous	2013-12-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7403748&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7404631	Spontaneous	2013-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7404631&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7405297	Spontaneous	2013-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Acute coronary syndrome (n/a - Fatal - Results in Death);Pyrexia (n/a - Unknown - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	[FLUINDIONE] (C - Arrhythmia - n/a - [n/a - n/a - Oral])|[FUROSEMIDE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[MOXONIDINE] (C - Hypertension - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7405297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7398114	Spontaneous	2013-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Facial paresis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Middle insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Periodic limb movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep attacks (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Snoring (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7398114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7399716	Spontaneous	2013-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7399716&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7394457	Spontaneous	2013-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Disabling);Back pain (n/a - Unknown - Disabling);Chest pain (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Unknown - Disabling);Chronic obstructive pulmonary disease (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Drug intolerance (n/a - Unknown - Disabling);Ear pain (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Fibromyalgia (n/a - Unknown - Disabling);Gingival bleeding (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Hyperkeratosis (n/a - Unknown - Disabling);Hypoacusis (n/a - Unknown - Disabling);Hypoaesthesia (n/a - Unknown - Disabling);Immunodeficiency (n/a - Unknown - Disabling);Loss of control of legs (n/a - Unknown - Disabling);Mobility decreased (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Neck pain (n/a - Unknown - Disabling);Pain (n/a - Unknown - Disabling);Pain in extremity (n/a - Unknown - Disabling);Palmoplantar pustulosis (n/a - Unknown - Disabling);Periodontitis (n/a - Unknown - Disabling);Psoriasis (n/a - Unknown - Disabling);Rash pustular (n/a - Unknown - Disabling);Skin fissures (n/a - Unknown - Disabling);Toothache (n/a - Unknown - Disabling);Urinary tract infection (n/a - Unknown - Disabling);Urticaria (n/a - Unknown - Disabling);Visual impairment (n/a - Unknown - Disabling);Vitamin D decreased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	METHOTREXATE [METHOTREXATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[OXAZEPAM] (C - n/a - Unknown - [n/a - n/a - n/a])|[PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7394457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7394671	Spontaneous	2013-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chest discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fibromyalgia (n/a - Unknown - Other Medically Important Condition);Gastritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Head discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Learning disability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lymph node pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tension headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Trismus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7394671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7396395	Spontaneous	2013-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Diarrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fear (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nasal congestion (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Psychomotor hyperactivity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Respiratory tract infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7396395&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7388844	Spontaneous	2013-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Circulatory collapse (3min - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7388844&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7389128	Spontaneous	2013-12-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Aggression (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Oppositional defiant disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7389128&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7390695	Spontaneous	2013-12-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7390695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7383519	Spontaneous	2013-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7383519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7386805	Spontaneous	2013-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Arthritis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - .5{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7386805&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7380854	Spontaneous	2013-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7380854&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7381812	Spontaneous	2013-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Aggression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Bulimia nervosa (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hallucination, auditory (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Hallucination, visual (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperphagia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Injection site swelling (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Middle insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep talking (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Suicide attempt (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7381812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7382174	Spontaneous	2013-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Recovered/Resolved - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7382174&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7374960	Spontaneous	2013-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnopompic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	ABILIFY [ARIPIPRAZOLE] (C - n/a - Unknown - [n/a - 5mg - Unknown])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - Unknown - [n/a - 40mg - Oral])|[LAMOTRIGINE] (C - n/a - Unknown - [n/a - 100mg - Unknown])|[LITHIUM, LITHIUM SULPHATE, ANHYDROUS] (C - n/a - Unknown - [n/a - n/a - Unknown])|[PROPRANOLOL, PROPRANOLOL HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 10mg - Oral])|[QUETIAPINE, QUETIAPINE FUMARATE] (C - n/a - Unknown - [n/a - 100mg - Unknown])|[TRAMADOL HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 100mg - Oral])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 75mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7374960&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7369275	Spontaneous	2013-12-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Chest pain (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Feeling abnormal (n/a - Unknown - Other Medically Important Condition);Formication (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (7d - Recovered/Resolved - Other Medically Important Condition);Rash papular (7d - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7369275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7370044	Spontaneous	2013-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Performance status decreased (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[CODEINE PHOSPHATE SESQUIHYDRATE, PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE] (C - Pain - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - Hypertension - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Asthma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7370044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7371248	Spontaneous	2013-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	No	Female	Congenital megacolon (n/a - Unknown - Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7371248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-7371253	Spontaneous	2013-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7371253&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7371342	Spontaneous	2013-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	No	Male	Congenital hypothyroidism (n/a - Unknown - Congenital Anomaly);Macroglossia (n/a - Unknown - Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7371342&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-7371351	Spontaneous	2013-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	No	Male	Pulmonary valve stenosis (n/a - Unknown - Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7371351&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-7371358	Spontaneous	2013-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	No	Male	Renal dysplasia (n/a - Unknown - Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7371358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Severe reaction
EU-EC-7371366	Spontaneous	2013-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	No	Male	Cryptorchism (n/a - Unknown - Congenital Anomaly);Inguinal hernia (n/a - Unknown - Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7371366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-7368321	Spontaneous	2013-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	No	Female	Urinary tract malformation (n/a - Recovered/Resolved - Congenital Anomaly);Vesicoureteric reflux (n/a - Recovered/Resolved - Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7368321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-7368386	Spontaneous	2013-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	No	Male	Laryngomalacia (n/a - Unknown - Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7368386&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-7368416	Spontaneous	2013-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	No	Female	Cardiac murmur (n/a - Unknown - Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7368416&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-7365788	Spontaneous	2013-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Back pain (n/a - Unknown - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hyperaesthesia (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Insomnia (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Neck pain (n/a - Unknown - Other Medically Important Condition);Nocturia (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ALIMEMAZINE TARTRATE] (C - Depression - Unknown - [n/a - 10mg - n/a])|[AMITRIPTYLINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - 10mg - n/a])|[BUPROPION HYDROCHLORIDE] (C - Depression - Unknown - [n/a - 150mg - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Depression - Unknown - [n/a - 20mg - Oral])|[MIANSERIN HYDROCHLORIDE] (C - Depression - Unknown - [n/a - 30mg - n/a])|[MIRTAZAPINE] (C - Depression - Unknown - [n/a - 30mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7365788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7366782	Spontaneous	2013-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Lung disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7366782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7366948	Spontaneous	2013-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aphasia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Meningitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain of skin (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vertigo positional (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7366948&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7355956	Spontaneous	2013-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Recovering/Resolving - Other Medically Important Condition);Dizziness (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[ISPAGHULA HUSK] (C - Irritable bowel syndrome - n/a - [n/a - n/a - Oral])|[LYMECYCLINE, TETRACYCLINE] (C - Acne - n/a - [n/a - 300mg - n/a])|[MEBEVERINE HYDROCHLORIDE] (C - Irritable bowel syndrome - n/a - [n/a - n/a - Oral])|[PIZOTIFEN, PIZOTIFEN MALATE, PIZOTIFEN MALATE BP] (C - Headache - n/a - [n/a - 1.5mg - Oral])|[TERBINAFINE, TERBINAFINE HYDROCHLORIDE] (C - Fungal infection - n/a - [n/a - 250mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7355956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7357204	Spontaneous	2013-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chest discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Derealisation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7357204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7357246	Spontaneous	2013-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Disorientation (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Heart rate increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Loss of libido (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Migraine (n/a - Recovered/Resolved - Other Medically Important Condition);Muscle discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ocular hyperaemia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7357246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7357651	Spontaneous	2013-11-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Epilepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7357651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7349417	Spontaneous	2013-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Male	Hallucination (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Insomnia (n/a - Recovered/Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7349417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7349506	Spontaneous	2013-11-26 00:00:00	Healthcare Professional	European Economic Area	Acute hepatic cytolysis following H1N1 vaccination in a patient with Crohn&apos;s disease on infliximab -Inflamm Bowel Dis, Volume 17, Number 2, p679, February 2011 PILLOT et all	18-64 Years	Adult	No	Female	Abdominal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Hepatic cytolysis (n/a - Unknown - Other Medically Important Condition);Injection site erythema (n/a - Unknown - Other Medically Important Condition);Injection site induration (n/a - Unknown - Other Medically Important Condition);Injection site pain (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Transaminases increased (n/a - Recovered/Resolved - Other Medically Important Condition)	INFLIXIMAB [INFLIXIMAB] (S - Crohn's disease - Unknown - [n/a - 5mg/kg - Intravenous (not otherwise specified)])|INFLIXIMAB [INFLIXIMAB] (S - Spondyloarthropathy - Unknown - [n/a - 5mg/kg - Intravenous (not otherwise specified)])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	REMICADE [INFLIXIMAB] (C - Crohn's disease - Dose not changed - [n/a - 5mg/kg - Intravenous (not otherwise specified)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7349506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7350688	Spontaneous	2013-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Educational problem (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain (n/a - Unknown - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Suicidal ideation (n/a - Unknown - Disabling, Other Medically Important Condition);Temperature regulation disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7350688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7344573	Spontaneous	2013-11-25 00:00:00	Non Healthcare Professional	European Economic Area	Journal: Elsevier: Vaccine Author: Candela S, Pergolizzi S, Ragni P , Cavuto S, Nobilio L, Mario SD et al., Title: An early (3âEuro&quot;6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria® in a province of Emilia-Romagna region, Italy âEuro&quot; Part one Volume: 31 Year: 2013 Pages: 1431-1437	12-17 Years	Not Specified	No	Male	Nervous system disorder (n/a - Unknown - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7344573&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7345961	Spontaneous	2013-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Arrhythmia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Infection susceptibility increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Joint stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation);Menstruation irregular (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Pertussis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])...	MELATONIN [MELATONIN] (C - Insomnia - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - Asthma - Unknown - [n/a - 250ug - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - .2ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7345961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7346251	Spontaneous	2013-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7346251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7348422	Spontaneous	2013-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypertension (0d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (0d - Recovered/Resolved - Other Medically Important Condition);Seizure (0d - Recovered/Resolved - Other Medically Important Condition);Vertigo (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7348422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7348424	Spontaneous	2013-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Herpes zoster (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7348424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7340785	Spontaneous	2013-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Disorientation (2d - Recovered/Resolved - );Gait disturbance (2d - Recovered/Resolved - );General physical health deterioration (2d - Recovered/Resolved - );Hyperglycaemia (2d - Recovering/Resolving - );Sensory level abnormal (2d - Recovering/Resolving - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7340785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7340907	Spontaneous	2013-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Sudden onset of sleep (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7340907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7341073	Spontaneous	2013-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Condition aggravated (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Exposure during pregnancy (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Hyperhidrosis (n/a - Unknown - Disabling);Influenza (n/a - Unknown - Disabling);Live birth (n/a - Unknown - Disabling);Memory impairment (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Sleep disorder (n/a - Unknown - Disabling);Vomiting (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	AVAMYS [FLUTICASONE FUROATE] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Hypersensitivity - Unknown - [n/a - 10mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7341073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7341085	Spontaneous	2013-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Aneurysm (n/a - Unknown - Disabling);Asthenia (n/a - Unknown - Disabling);Benign neoplasm of thyroid gland (n/a - Unknown - Disabling);Encephalitis (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Narcolepsy (n/a - Unknown - Disabling);Neoplasm (n/a - Unknown - Disabling);Sleep disorder (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling);Tinnitus (n/a - Unknown - Disabling);Vertigo (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7341085&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7338352	Spontaneous	2013-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7338352&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7338370	Spontaneous	2013-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Coordination abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7338370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7338545	Spontaneous	2013-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7338545&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7330916	Spontaneous	2013-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Demyelination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7330916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7331380	Spontaneous	2013-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7331380&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7331806	Spontaneous	2013-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chronic sinusitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypertension (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Infection susceptibility increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7331806&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7332017	Spontaneous	2013-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Back pain (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);General physical health deterioration (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);H1N1 influenza (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hodgkin's disease (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lymphadenectomy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Night sweats (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight decreased (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])...	AERIUS [DESLORATADINE] (C - Seasonal allergy - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7332017&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7332937	Spontaneous	2013-11-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7332937&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7327259	Spontaneous	2013-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cognitive disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	CIALIS [TADALAFIL] (C - Erectile dysfunction - Unknown - [n/a - 20mg - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - n/a - Not applicable - [1d - n/a - n/a])|[ACETYLCYSTEINE] (C - Chronic obstructive pulmonary disease - Unknown - [n/a - 400mg - n/a])|[ACETYLSALICYLIC ACID] (C - Thrombosis prophylaxis - Unknown - [n/a - 75mg - n/a])|[AMITRIPTYLINE HYDROCHLORIDE] (C - Fibromyalgia - Unknown - [n/a - 20mg - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - Unknown - [n/a - n/a - Respiratory (inhalation)])|[DOXAZOSIN MESILATE] (C - Hypertension - Unknown - [n/a - 4mg - n/a])|[GLYCERYL TRINITRATE] (C - Angina pectoris - Unknown - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, LISINOPRIL] (C - Hypertension - Unknown - [n/a - 12.5mg - n/a])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - Hypertension - Unknown - [n/a - 20mg - n/a])|[PARACETAMOL] (C - Pain - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - .1mg - Respiratory (inhalation)])|[SIMVASTATIN] (C - Hyperlipidaemia - Unknown - [n/a - 20mg - n/a])|[TRAMADOL HYDROCHLORIDE] (C - Pain - Unknown - [n/a - 150mg - n/a])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - Pain - Unknown - [n/a - 150mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7327259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7322045	Spontaneous	2013-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Recovering/Resolving - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Recovering/Resolving - Disabling);Hyperacusis (n/a - Unknown - Disabling);Influenza like illness (n/a - Unknown - Disabling);Nausea (n/a - Recovering/Resolving - Disabling);Photophobia (n/a - Unknown - Disabling);Tachycardia (n/a - Unknown - Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ZOLMITRIPTAN] (C - Migraine - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7322045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7322164	Spontaneous	2013-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cronobacter infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Joint swelling (n/a - Unknown - Other Medically Important Condition);Knee arthroplasty (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7322164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7324138	Spontaneous	2013-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Infant	Yes	Not Specified	Maternal exposure timing unspecified (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7324138&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7316131	Spontaneous	2013-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Bone pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Epstein-Barr virus infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Food intolerance (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Immune system disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Otitis media (n/a - Unknown - Caused/Prolonged Hospitalisation);Sinusitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Vestibular neuronitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7316131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7316134	Spontaneous	2013-11-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pneumonia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7316134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7316740	Spontaneous	2013-11-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood pressure orthostatic decreased (n/a - Unknown - Other Medically Important Condition);Cold sweat (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Presyncope (n/a - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7316740&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7316741	Spontaneous	2013-11-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Headache (n/a - Unknown - Other Medically Important Condition);Lethargy (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Swelling face (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7316741&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7312074	Spontaneous	2013-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Extensive swelling of vaccinated limb (4d - Recovered/Resolved - );Mobility decreased (4d - Recovered/Resolved - );Muscular weakness (4d - Recovered/Resolved - );Pain in extremity (4d - Recovered/Resolved - );Peripheral swelling (4d - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7312074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7312263	Spontaneous	2013-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Osteoarthritis (3d - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7312263&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7313191	Spontaneous	2013-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Bronchitis chronic (n/a - Not Recovered/Not Resolved - Disabling);Cough (n/a - Recovering/Resolving - Disabling);Nasopharyngitis (n/a - Recovering/Resolving - Disabling);Productive cough (n/a - Not Recovered/Not Resolved - Disabling);Rhinitis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7313191&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7313192	Spontaneous	2013-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain upper (18d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Adverse event (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Auditory disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Cochlea implant (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Constipation (n/a - Unknown - Caused/Prolonged Hospitalisation);Deafness unilateral (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Drug withdrawal syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Haemorrhoids (n/a - Unknown - Caused/Prolonged Hospitalisation);Head injury (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (22d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injury (n/a - Unknown - Caused/Prolonged Hospitalisation);Medical device pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Neck pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Otosclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Phonophobia (n/a - Unknown - Caused/Prolonged Hospitalisation);Scrotal dermatitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Self-medication (n/a - Unknown - Caused/Prolonged Hospitalisation);Sudden hearing loss (n/a - Unknown - Caused/Prolonged Hospitalisation);Thrombosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Tinnitus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vertigo (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation);Withdrawal syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])...	CIALIS [TADALAFIL] (C - Erectile dysfunction - n/a - [n/a - 20mg - Oral])|FENTANYL [FENTANYL, FENTANYL CITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CINCHOCAINE HYDROCHLORIDE, PREDNISOLONE, CINCHOCAINE HYDROCHLORIDE, PREDNISOLONE CAPROATE] (C - n/a - n/a - [n/a - n/a - Rectal])|[CLONIDINE, CLONIDINE HYDROCHLORIDE] (C - Drug withdrawal syndrome - n/a - [n/a - n/a - n/a])|[FENTANYL] (C - Pain - Drug withdrawn - [n/a - n/a - Topical])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - Sleep disorder - Unknown - [n/a - 40mg - Oral])|[IBUPROFEN] (C - Pain - Unknown - [n/a - 600mg - Oral])|[LEVOMEPROMAZINE, LEVOMEPROMAZINE EMBONATE, LEVOMEPROMAZINE HYDROCHLORIDE, LEVOMEPROMAZINE MALEATE] (C - Sleep disorder - Drug withdrawn - [n/a - 25mg - n/a])|[OMEPRAZOLE] (C - Gastrointestinal pain - Drug withdrawn - [n/a - n/a - Oral])|[OXYCODONE HYDROCHLORIDE] (C - Pain - Unknown - [n/a - 90mg - n/a])|[OXYCODONE, OXYCODONE HYDROCHLORIDE] (C - Pain - n/a - [n/a - 60mg - Oral])|[PARACETAMOL] (C - Pain - n/a - [n/a - n/a - Oral])|[PREDNISOLONE] (C - Ear disorder - Drug withdrawn - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7313192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7313197	Spontaneous	2013-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypothyroidism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS (LIVE, ATTENUATED), RUBELLA VIRUS (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7313197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7313401	Spontaneous	2013-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Coordination abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Developmental delay (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Epilepsy (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Fall (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Fine motor delay (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Gaze palsy (15min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Generalised tonic-clonic seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Unresponsive to stimuli (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7313401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7313413	Spontaneous	2013-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7313413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7307025	Spontaneous	2013-11-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7307025&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7308285	Spontaneous	2013-11-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dysgeusia (n/a - Unknown - Other Medically Important Condition);Feeling abnormal (n/a - Unknown - Other Medically Important Condition);Hot flush (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7308285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7308286	Spontaneous	2013-11-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysphagia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Swollen tongue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Throat tightness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7308286&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7310163	Spontaneous	2013-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Lung disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Septic shock (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	[SODIUM VALPROATE, VALPROIC ACID] (C - Epilepsy - Dose not changed - [n/a - 250ug - Oral])|[VIGABATRIN] (C - Epilepsy - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7310163&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7302617	Spontaneous	2013-11-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Pruritus (6d - Recovered/Resolved - Other Medically Important Condition);Rash erythematous (6d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7302617&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7303406	Spontaneous	2013-11-12 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Getulio Daré Rabello, Postvaccinal neurological complications; Arq Neuropsiquiatr 2013; 71 (9-B):747-751	18-64 Years	Not Specified	No	Female	Areflexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ataxia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hiccups (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ophthalmoplegia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pancreatitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vestibular disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7303406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7303439	Spontaneous	2013-11-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Compartment syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Contusion (n/a - Unknown - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Unknown - Caused/Prolonged Hospitalisation);Tenderness (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site reaction (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Other])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7303439&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7303441	Spontaneous	2013-11-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aplastic anaemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Contusion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pancytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Petechiae (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7303441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7305550	Spontaneous	2013-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7305550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7300361	Spontaneous	2013-11-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7300361&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7294208	Spontaneous	2013-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Coeliac disease (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Cystitis (n/a - Unknown - Other Medically Important Condition);Dyspepsia (n/a - Unknown - Other Medically Important Condition);Ear infection (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (39d - Recovered/Resolved - Other Medically Important Condition);Herpes simplex (n/a - Unknown - Other Medically Important Condition);Immunodeficiency (n/a - Recovered/Resolved - Other Medically Important Condition);Live birth (n/a - Unknown - Other Medically Important Condition);Mastitis (n/a - Unknown - Other Medically Important Condition);Migraine (n/a - Unknown - Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Other Medically Important Condition);Overdose (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Seasonal allergy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Secretion discharge (n/a - Unknown - Other Medically Important Condition);Sinusitis (n/a - Unknown - Other Medically Important Condition);Tinnitus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1mL - Unknown])	[CEFATRIZINE PROPYLENE GLYCOL] (C - Hypersensitivity - Unknown - [n/a - 10mg - Unknown])|[ETHINYLESTRADIOL, LEVONORGESTREL] (C - Contraception - Unknown - [n/a - n/a - Unknown])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - Unknown - [n/a - 50ug - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7294208&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-7295237	Spontaneous	2013-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (2d - Recovered/Resolved - Other Medically Important Condition);Fatigue (2d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[CODERGOCRINE MESILATE, DIHYDROERGOTOXINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7295237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7297056	Spontaneous	2013-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Eosinophilia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash maculo-papular (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	[ACICLOVIR, ACICLOVIR SODIUM] (C - Oral herpes - Drug withdrawn - [n/a - 5{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7297056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7289296	Spontaneous	2013-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7289296&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7291856	Spontaneous	2013-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7291856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7284382	Spontaneous	2013-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7284382&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7284383	Spontaneous	2013-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7284383&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7280236	Spontaneous	2013-11-05 00:00:00	Healthcare Professional	Non European Economic Area	Rubio JH, Rossetti AO, Tafti M, Heinzer R. Narcolepsy with cataplexy associated with H1N1 vaccination. Revue Neurologique. 2011	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Recovering/Resolving - Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7280236&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7283227	Spontaneous	2013-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7283227&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7283590	Spontaneous	2013-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7283590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7262338	Spontaneous	2013-10-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7262338&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7265740	Spontaneous	2013-10-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Sjogren's syndrome (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7265740&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7265822	Spontaneous	2013-10-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Autoimmune disorder (n/a - Not Recovered/Not Resolved - Disabling);Cerebral disorder (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling);Erectile dysfunction (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Testicular pain (n/a - Not Recovered/Not Resolved - Disabling);Vaccination site pain (n/a - Not Recovered/Not Resolved - Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7265822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7253841	Spontaneous	2013-10-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Disabling);Hypersomnia (n/a - Unknown - Disabling);Narcolepsy (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7253841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7248650	Spontaneous	2013-10-25 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Drug withdrawn - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7248650&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7244602	Spontaneous	2013-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7244602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7236774	Spontaneous	2013-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	H1N1 influenza (14d - Recovered/Resolved - Other Medically Important Condition);Influenza (14d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - n/a])|[INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7236774&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7237352	Spontaneous	2013-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyporeflexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Periodic limb movement disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7237352&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7237365	Spontaneous	2013-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Unknown - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Hypertension (n/a - Unknown - Disabling);Infectious mononucleosis (n/a - Unknown - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7237365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7240336	Spontaneous	2013-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Gait inability (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7240336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7227388	Spontaneous	2013-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7227388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7227402	Spontaneous	2013-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7227402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7227462	Spontaneous	2013-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Vomiting (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7227462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7227494	Spontaneous	2013-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dizziness (n/a - Recovered/Resolved - Disabling);Fatigue (n/a - Recovered/Resolved With Sequelae - Disabling);Sensory disturbance (n/a - Recovered/Resolved With Sequelae - Disabling);Vision blurred (n/a - Recovered/Resolved - Disabling);Visual impairment (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7227494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-7227499	Spontaneous	2013-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Nephritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [3mo - .25mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7227499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7228413	Spontaneous	2013-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (3a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dysarthria (3a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7228413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7228525	Spontaneous	2013-10-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	C-reactive protein increased (n/a - Unknown - Other Medically Important Condition);Dissociation (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	[CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[DIGOXIN] (C - Atrial fibrillation - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[THIAMINE, PYRIDOXINE HYDROCHLORIDE, VITAMIN B] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7228525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7222640	Spontaneous	2013-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7222640&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7224233	Spontaneous	2013-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Unknown - Disabling);Neuropathy peripheral (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - Pain - Unknown - [n/a - n/a - n/a])|[PARACETAMOL] (C - Pain - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7224233&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7224240	Spontaneous	2013-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chronic sinusitis (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Facial pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Female reproductive tract disorder (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pulmonary arteriovenous fistula (n/a - Unknown - Other Medically Important Condition);Temporomandibular joint syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vertigo (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Asthma - Unknown - [1d - n/a - Unknown])|[DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE MONOHYDRATE] (C - Pneumonia - Unknown - [648d - n/a - Unknown])|[FEXOFENADINE, FEXOFENADINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[OXAZEPAM] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7224240&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7224252	Spontaneous	2013-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Epilepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Muscle contractions involuntary (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7224252&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7217897	Spontaneous	2013-10-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7217897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7213706	Spontaneous	2013-10-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Body temperature increased (1d - Recovered/Resolved - );Chills (1d - Recovered/Resolved - );Influenza like illness (0d - Recovered/Resolved - );Malaise (1d - Recovered/Resolved - );Nausea (1d - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [0d - 7ug - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[AMOXICILLIN, AMOXICILLIN TRIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[CALCIUM CARBONATE, CHOLECALCIFEROL CONCENTRATE (POWDER FORM), CALCIUM, CHOLECALCIFEROL CONCENTRATE, COLECALCIFEROL, CALCIUM CARBONATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[RISEDRONATE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[SIMVASTATIN] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7213706&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7210164	Spontaneous	2013-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Autoimmune disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Contusion (n/a - Unknown - Other Medically Important Condition);Epistaxis (n/a - Unknown - Other Medically Important Condition);Henoch-Schonlein purpura (n/a - Recovering/Resolving - Other Medically Important Condition);Immune thrombocytopenia (n/a - Recovering/Resolving - Other Medically Important Condition);Petechiae (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Skin haemorrhage (n/a - Unknown - Other Medically Important Condition);Vasculitis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7210164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7205260	Spontaneous	2013-10-14 00:00:00	Healthcare Professional	European Economic Area	Puijenbroek van E, Broos N and Grootheest. Monitoring Adverse Events of the Vaccination Campaign against Influenza A (H1N1) in the Netherlands. Safety Monitoring of Influenza A (H1N1) Vaccination. 2010;33 (12):1097 to 1108	18-64 Years	Adult	No	Male	Death (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	NOT AVAILABLE (C - n/a - Not applicable - [n/a - 5mg - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE] (C - n/a - Not applicable - [n/a - 1{DF} - Oral])|[LISINOPRIL] (C - n/a - Not applicable - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7205260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7205267	Spontaneous	2013-10-14 00:00:00	Healthcare Professional	European Economic Area	Puijenbroek van E, Broos N and Grootheest. Monitoring Adverse Events of the Vaccination Campaign against Influenza A (H1N1) in the Netherlands. Safety Monitoring of Influenza A (H1N1) Vaccination. 2010;33 (12):1097 to 1108	65-85 Years	Elderly	No	Male	Blood pressure increased (n/a - Fatal - Results in Death);Cyanosis (n/a - Fatal - Results in Death);Fall (n/a - Fatal - Results in Death);Foaming at mouth (n/a - Fatal - Results in Death);Malaise (n/a - Not Recovered/Not Resolved - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[ACETYLCYSTEINE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - 200mg - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - n/a - Intratracheal])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - 18ug - Intratracheal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7205267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-7205455	Spontaneous	2013-10-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7205455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7206674	Spontaneous	2013-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Disabling);Hypotension (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Muscle twitching (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Peripheral coldness (n/a - Not Recovered/Not Resolved - Disabling);Psoriasis (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Vision blurred (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7206674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7206684	Spontaneous	2013-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dyspnoea (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Inflammation (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition);Tongue discolouration (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (C - Pain - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7206684&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7206696	Spontaneous	2013-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Burning sensation (n/a - Not Recovered/Not Resolved - Disabling);Disability (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Polyneuropathy (n/a - Not Recovered/Not Resolved - Disabling);Quality of life decreased (n/a - Not Recovered/Not Resolved - Disabling);Sensory disturbance (n/a - Not Recovered/Not Resolved - Disabling);Temperature intolerance (n/a - Not Recovered/Not Resolved - Disabling);Tendonitis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7206696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7208430	Spontaneous	2013-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7208430&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7196901	Spontaneous	2013-10-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Adjustment disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Arthropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Behaviour disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Bone development abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Brain injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cervicobrachial syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Crying (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Daydreaming (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Developmental delay (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Foetal exposure during pregnancy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hyperhidrosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypertrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Macrocephaly (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Macrosomia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Motor developmental delay (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscle disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Scoliosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Somatic dysfunction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7196901&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7191167	Spontaneous	2013-10-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depressed mood (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Infection susceptibility increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - .5mL - Subcutaneous])	CYMBALTA [DULOXETINE, DULOXETINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7191167&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7191173	Spontaneous	2013-10-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7191173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7186235	Spontaneous	2013-10-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Elderly	No	Female	Muscular weakness (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, SORBITAN TRIOLEATE, POLYSORBATE 80, SQUALENE, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Unknown - [n/a - n/a - n/a])	BONVIVA [IBANDRONATE SODIUM HYDRATE, IBANDRONIC ACID] (C - n/a - Unknown - [n/a - n/a - n/a])|[BUDESONIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[CALCIUM CARBONATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7186235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7186697	Spontaneous	2013-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Listless (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Monoparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7186697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7188206	Spontaneous	2013-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Coordination abnormal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Eyelid ptosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7188206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7189452	Spontaneous	2013-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Optic neuritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7189452&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7181094	Spontaneous	2013-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Diarrhoea (n/a - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [n/a - 7ug - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Antiviral prophylaxis - n/a - [n/a - n/a - Unknown])|[ALLOPURINOL] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[ATENOLOL, ATENOLOL BP] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[FUROSEMIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[ISOSORBIDE MONONITRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[NICORANDIL] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[OMEPRAZOLE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[PRAVASTATIN SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[RAMIPRIL] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[SOLIFENACIN] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[TAMSULOSIN, TAMSULOSIN HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[WARFARIN SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7181094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7182174	Spontaneous	2013-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hallucination (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7182174&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7182179	Spontaneous	2013-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Herpes zoster (n/a - Unknown - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Mental disorder (n/a - Unknown - Disabling);Obsessive thoughts (n/a - Unknown - Disabling);Social avoidant behaviour (n/a - Unknown - Disabling);Vitamin D deficiency (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[OMEPRAZOLE] (C - Gastrooesophageal reflux disease - n/a - [n/a - n/a - n/a])|[POLIOMYELITIS VACCINE] (C - Prophylaxis - n/a - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7182179&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7184796	Spontaneous	2013-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Ataxia (n/a - Not Recovered/Not Resolved - Disabling);Central nervous system inflammation (n/a - Not Recovered/Not Resolved - Disabling);Erectile dysfunction (n/a - Not Recovered/Not Resolved - Disabling);Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Joint range of motion decreased (n/a - Not Recovered/Not Resolved - Disabling);Myelopathy (n/a - Not Recovered/Not Resolved - Disabling);Paresis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7184796&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7175805	Spontaneous	2013-10-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chills (0d - Recovered/Resolved - Other Medically Important Condition);Heart rate increased (n/a - Unknown - Other Medically Important Condition);Malaise (1d - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Peripheral coldness (n/a - Unknown - Other Medically Important Condition);Pyrexia (0d - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Influenza immunisation - Not applicable - [0d - 7ug - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Product used for unknown indication - Not applicable - [0d - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[PARACETAMOL] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7175805&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7178139	Spontaneous	2013-10-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Lethargy (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Vomiting (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7178139&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7171881	Spontaneous	2013-10-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Increased upper airway secretion (0d - Recovered/Resolved - Other Medically Important Condition);Rash erythematous (0d - Recovered/Resolved - Other Medically Important Condition);Upper respiratory tract irritation (0d - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	[HEPATITIS B SURFACE ANTIGEN, HEPATITIS A VACCINE (INACTIVATED)] (C - Immunisation - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7171881&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7173271	Spontaneous	2013-10-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 3.75ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7173271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7169098	Spontaneous	2013-10-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7169098&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7163811	Spontaneous	2013-10-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (0d - Recovered/Resolved - );Sensation of foreign body (n/a - Unknown - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [0d - 7ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7163811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7163839	Spontaneous	2013-10-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Oropharyngeal pain (n/a - Recovering/Resolving - );Rash (n/a - Recovering/Resolving - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 7ug - Intramuscular])|[MEBEVERINE] (S - Irritable bowel syndrome - Unknown - [4d - 135mg - Oral])	[ASCORBIC ACID, BETACAROTENE, BIOTIN, ERGOCALCIFEROL, CYANOCOBALAMIN, FOLIC ACID, NICOTINAMIDE, PYRIDOXINE, RIBOFLAVIN, THIAMINE, ZINC, CALCIUM, CHROMIUM, COPPER, IODINE, IRON, MAGNESIUM, MANGANESE, PANTOTHENIC ACID, PHOSPHORUS, POTASSIUM, SELENIUM, TOCOPHERYL ACETATE, MOLYBDENUM, ERGOCALCIFEROL, RETINOL] (C - Malabsorption - n/a - [n/a - n/a - n/a])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Seasonal allergy - n/a - [n/a - 10mg - n/a])|[FISH OIL] (C - Malabsorption - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Malabsorption - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7163839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7163930	Spontaneous	2013-10-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Chest discomfort (n/a - Unknown - );Wheezing (n/a - Recovering/Resolving - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Asthma - Not applicable - [2d - 7ug - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7163930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7164009	Spontaneous	2013-10-01 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7164009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7164010	Spontaneous	2013-10-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abnormal dreams (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Anxiety (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Aphasia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Autoimmune thyroiditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Brain fog (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Circulatory collapse (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysphemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysstasia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dystonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Emotional distress (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Immobile (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mental disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep attacks (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Stress (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tension (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7164010&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7164011	Spontaneous	2013-10-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Epilepsy (n/a - Unknown - Other Medically Important Condition);Injection site induration (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7164011&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7164013	Spontaneous	2013-10-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7164013&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7164641	Spontaneous	2013-10-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Peripheral swelling (24h - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [1d - 0mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7164641&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7164987	Spontaneous	2013-10-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Depression (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Recovering/Resolving - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Infectious mononucleosis (n/a - Unknown - Other Medically Important Condition);Intentional self-injury (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN [HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7164987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7164989	Spontaneous	2013-10-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Bedridden (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Quality of life decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Thirst (n/a - Unknown - Caused/Prolonged Hospitalisation);Type 2 diabetes mellitus (n/a - Unknown - Caused/Prolonged Hospitalisation);Vitamin D deficiency (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	OLANZAPINE [OLANZAPINE] (C - Mental disorder - Unknown - [n/a - 10mg - n/a])|[BIPERIDEN, BIPERIDEN HYDROCHLORIDE, BIPERIDEN LACTATE] (C - Mental disorder - Unknown - [n/a - n/a - n/a])|[CHLORPROTHIXENE HYDROCHLORIDE] (C - Mental disorder - Unknown - [n/a - 25mg - n/a])|[LEVOMEPROMAZINE, LEVOMEPROMAZINE EMBONATE, LEVOMEPROMAZINE HYDROCHLORIDE, LEVOMEPROMAZINE MALEATE] (C - Mental disorder - Unknown - [n/a - 25mg - n/a])|[LITHIUM] (C - Mental disorder - Unknown - [n/a - n/a - n/a])|[QUETIAPINE, QUETIAPINE FUMARATE] (C - Mental disorder - Unknown - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Blood cholesterol increased - Unknown - [n/a - 20mg - n/a])|[ZOPICLONE] (C - Sleep disorder - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7164989&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7164995	Spontaneous	2013-10-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain upper (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Epigastric discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gastrooesophageal reflux disease (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hiatus hernia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Osteoporosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7164995&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7167348	Spontaneous	2013-10-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7167348&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7158791	Spontaneous	2013-09-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (1d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[ERYTHROMYCIN, ERYTHROMYCIN, ZINC ACETATE, ERYTHROMYCIN, ZINC ACETATE DIHYDRATE] (S - Acne - Dose not changed - [n/a - n/a - Topical])|[LYMECYCLINE] (S - Acne - Dose not changed - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7158791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7159034	Spontaneous	2013-09-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chest pain (1d - Recovered/Resolved - );Influenza like illness (24h - Recovered/Resolved - );Pain in extremity (1d - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 7ug - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7159034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7159068	Spontaneous	2013-09-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Unknown - );Neck pain (n/a - Unknown - );Pyrexia (n/a - Unknown - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Ill-defined disorder - Not applicable - [n/a - n/a - Intramuscular])	[ETHINYLESTRADIOL, GESTODENE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7159068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7159106	Spontaneous	2013-09-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cold sweat (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Influenza like illness (n/a - Unknown - Disabling);Musculoskeletal stiffness (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling)	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Influenza immunisation - Unknown - [n/a - 7ug - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7159106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7160494	Spontaneous	2013-09-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site pain (n/a - Unknown - );Limb discomfort (n/a - Unknown - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [n/a - 7ug - Parenteral])|CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Pregnancy - Not applicable - [n/a - 7ug - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7160494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7154585	Spontaneous	2013-09-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Not Specified	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7154585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7155235	Spontaneous	2013-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Behaviour disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myoclonus (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep talking (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Snoring (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnambulism (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7155235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7155257	Spontaneous	2013-09-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Antisocial behaviour (n/a - Not Recovered/Not Resolved - Disabling);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	HUMIRA [ADALIMUMAB] (C - Ankylosing spondylitis - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7155257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7155258	Spontaneous	2013-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Ankylosing spondylitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation);Polymyalgia rheumatica (n/a - Unknown - Caused/Prolonged Hospitalisation);Psoriatic arthropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Rheumatoid arthritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Sacroiliitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BUMETANIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[CORTISONE] (C - Arthralgia - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7155258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7155259	Spontaneous	2013-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Polyarthritis (n/a - Recovering/Resolving - Other Medically Important Condition);Rheumatoid arthritis (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7155259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7149636	Spontaneous	2013-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rapid eye movements sleep abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	OXYBUTYNIN [OXYBUTYNIN, OXYBUTYNIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[DESMOPRESSIN, DESMOPRESSIN ACETATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7149636&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7149638	Spontaneous	2013-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Aphasia (n/a - Unknown - Disabling, Other Medically Important Condition);Body temperature fluctuation (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Chest discomfort (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Chills (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Constipation (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Diarrhoea (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Discomfort (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Flatulence (n/a - Unknown - Disabling, Other Medically Important Condition);Food allergy (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Gastrointestinal disorder (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Heart rate irregular (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Inflammation (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Learning disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Lung disorder (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Lymph node pain (n/a - Unknown - Disabling, Other Medically Important Condition);Lymphadenopathy (n/a - Unknown - Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Disabling, Other Medically Important Condition);Memory impairment (n/a - Unknown - Disabling, Other Medically Important Condition);Middle insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Neurological symptom (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Disabling, Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Palpitations (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pleurisy (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Respiratory disorder (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Stress (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Swelling (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Tremor (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Weight decreased (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7149638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7145439	Spontaneous	2013-09-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7145439&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7140932	Spontaneous	2013-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7140932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7140935	Spontaneous	2013-09-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7140935&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7141706	Spontaneous	2013-09-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Facial pain (n/a - Unknown - Other Medically Important Condition);Herpes zoster (n/a - Unknown - Other Medically Important Condition);Insomnia (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Tinnitus (n/a - Unknown - Other Medically Important Condition);Trigeminal neuralgia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7141706&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7130400	Spontaneous	2013-09-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Allergy to animal (n/a - Recovering/Resolving - Other Medically Important Condition);Eczema (n/a - Recovering/Resolving - Other Medically Important Condition);Eye pruritus (n/a - Recovering/Resolving - Other Medically Important Condition);Lacrimation increased (n/a - Recovering/Resolving - Other Medically Important Condition);Pruritus (n/a - Recovering/Resolving - Other Medically Important Condition);Rhinorrhoea (n/a - Recovering/Resolving - Other Medically Important Condition);Seasonal allergy (n/a - Recovering/Resolving - Other Medically Important Condition);Sneezing (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7130400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7130638	Spontaneous	2013-09-20 00:00:00	Healthcare Professional	Non European Economic Area	MYELITIS AND H1N1 VACCINATION, Ribeiro, T.A.G.J., 21st World Congress of Neurology: Neurology in the Age of Globalization (WCN 2013), Vienna, Austria, 21 September 2013, MIS (10435011)	Not Specified	Not Specified	No	Male	Myelitis transverse (n/a - Recovered/Resolved - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7130638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7130639	Spontaneous	2013-09-20 00:00:00	Healthcare Professional	Non European Economic Area	MYELITIS AND H1N1 VACCINATION, Ribeiro, T.A.G.J., 21st World Congress of Neurology: Neurology in the Age of Globalization (WCN 2013), Vienna, Austria, 21 September 2013, MIS (10435011)	Not Specified	Not Specified	No	Male	Myelitis transverse (n/a - Recovered/Resolved - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7130639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7129261	Spontaneous	2013-09-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Recovered/Resolved - Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7129261&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7120904	Spontaneous	2013-09-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Epilepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7120904&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-7122118	Spontaneous	2013-09-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7122118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7116588	Spontaneous	2013-09-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eyelid ptosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Medication error (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - H1N1 influenza - Not applicable - [n/a - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7116588&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7103823	Spontaneous	2013-09-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Pain (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Sensory loss (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Weight increased (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7103823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7105057	Spontaneous	2013-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Unknown - Other Medically Important Condition);Muscle twitching (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Speech disorder (n/a - Unknown - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7105057&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7106319	Spontaneous	2013-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Wheezing (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7106319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7100373	Spontaneous	2013-09-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dermatitis atopic (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	AVAMYS [FLUTICASONE FUROATE] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|GLUCOCORTICOIDS [GLUCOCORTICOID] (C - n/a - Unknown - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[CEFATRIZINE PROPYLENE GLYCOL] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|[CICLESONIDE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[DOXEPIN, DOXEPIN HYDROCHLORIDE] (C - Pruritus - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - Urticaria - Unknown - [n/a - n/a - n/a])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7100373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7095519	Spontaneous	2013-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Amnesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Anaemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Constipation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Decreased vibratory sense (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Disability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dyspepsia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Flatulence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hunger (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Loss of consciousness (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Reduced facial expression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Syncope (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])...	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[GLIMEPIRIDE] (C - Type 2 diabetes mellitus - Unknown - [n/a - n/a - Unknown])...	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7095519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7095520	Spontaneous	2013-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Disabling);Carpal tunnel syndrome (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Migraine (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Parapsoriasis (n/a - Unknown - Disabling);Urticaria (n/a - Unknown - Disabling);Vertigo (n/a - Not Recovered/Not Resolved - Disabling);Vertigo positional (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Ill-defined disorder - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7095520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7095826	Spontaneous	2013-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7095826&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7091318	Spontaneous	2013-09-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7091318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7091319	Spontaneous	2013-09-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7091319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7093277	Spontaneous	2013-09-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7093277&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7082137	Spontaneous	2013-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rapid eye movements sleep abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7082137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7082425	Spontaneous	2013-09-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Neurological symptom (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - H1N1 influenza - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7082425&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7083724	Spontaneous	2013-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7083724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7073932	Spontaneous	2013-09-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[IBUPROFEN] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7073932&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7076420	Spontaneous	2013-09-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	Yes	Female	Hyperpyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7076420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7076890	Spontaneous	2013-09-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Disturbance in attention (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Formication (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Memory impairment (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7076890&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-7068656	Spontaneous	2013-09-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Burning sensation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hot flush (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperplasia (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasal congestion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasal disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasal septum deviation (n/a - Unknown - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Peripheral coldness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rhinitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sneezing (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somatic symptom disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - Unknown - [n/a - 100mg - Unknown])|[ALLOPURINOL] (C - n/a - Unknown - [n/a - 300mg - Unknown])|[ASCORBIC ACID, MAGNESIUM OXIDE, HEAVY, MAGNESIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[CARVEDILOL] (C - n/a - Unknown - [n/a - 25mg - Unknown])|[HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - 25mg - Unknown])|[OMEPRAZOLE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[VALSARTAN] (C - n/a - Unknown - [n/a - 80mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7068656&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7060321	Spontaneous	2013-08-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7060321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7060336	Spontaneous	2013-08-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7060336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7060461	Spontaneous	2013-08-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7060461&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7060596	Spontaneous	2013-08-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Multiple sclerosis relapse (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7060596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7063510	Spontaneous	2013-08-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cardiac failure (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7063510&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7056155	Spontaneous	2013-08-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Colitis ulcerative (n/a - Unknown - Other Medically Important Condition);Proctitis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7056155&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7056161	Spontaneous	2013-08-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Disability (n/a - Recovered/Resolved - Other Medically Important Condition);Hypokinesia (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Periarthritis (n/a - Recovering/Resolving - Other Medically Important Condition);Tenosynovitis (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7056161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7056170	Spontaneous	2013-08-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Colitis ulcerative (n/a - Unknown - Other Medically Important Condition);Proctitis ulcerative (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7056170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7056414	Spontaneous	2013-08-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Bursitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site joint movement impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Joint effusion (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Joint range of motion decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ligament disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Periarthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rotator cuff syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tendonitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7056414&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7056583	Spontaneous	2013-08-28 00:00:00	Healthcare Professional	European Economic Area	Oppermann M, Fritzsche J, Schoendorfer C W, Stanislawski B K, Allignol A, Schaefer C, et al.. A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012;30:4445-4452	Not Specified	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7056583&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7056585	Spontaneous	2013-08-28 00:00:00	Healthcare Professional	European Economic Area	Oppermann M, Fritzsche J, Schoendorfer C W, Stanislawski B K, Allignol A, Schaefer C, et al.. A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012;30:4445-4452	Not Specified	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7056585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7056586	Spontaneous	2013-08-28 00:00:00	Healthcare Professional	European Economic Area	Oppermann M, Fritzsche J, Schoendorfer C W, Stanislawski B K, Allignol A, Schaefer C, et al.. A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012;30:4445-4452	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - );Normal newborn (n/a - Unknown - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[FOLIC ACID] (C - n/a - Unknown - [n/a - 1{DF} - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7056586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7058381	Spontaneous	2013-08-28 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7058381&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7051191	Spontaneous	2013-08-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Areflexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Asthenia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Ataxia (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Formication (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Paraparesis (16d - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Peripheral coldness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Peripheral motor neuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7051191&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7051425	Spontaneous	2013-08-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Amnesia (n/a - Recovering/Resolving - Other Medically Important Condition);Disorientation (n/a - Recovering/Resolving - Other Medically Important Condition);Epilepsy (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7051425&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7051486	Spontaneous	2013-08-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	CSF test abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gait inability (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Musculoskeletal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pleocytosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Proteinuria (n/a - Unknown - Caused/Prolonged Hospitalisation);Radicular pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Type 2 diabetes mellitus - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7051486&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7052025	Spontaneous	2013-08-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Overdose (n/a - Unknown - Other Medically Important Condition);Seizure (0h - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1mL - Intramuscular])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (S - Asthma - Unknown - [n/a - n/a - Respiratory (inhalation)])|[PREDNISOLONE] (S - Asthma - Unknown - [3d - n/a - Unknown])|[SALBUTAMOL SULFATE] (S - Asthma - Unknown - [n/a - n/a - Respiratory (inhalation)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7052025&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7052051	Spontaneous	2013-08-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7052051&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7052443	Spontaneous	2013-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Oliviera D, Lara A, Luiz A, Miyaji K, Sartori A, Lopes M. Spontaneous reporting of adverse events following pandemic influenza A (H1N1) immunization in a reference center in the State of So Paulo, Brazil.. Revista da Sociedade Brasileira de Medicina Tropical 46(3):348-351.	Not Specified	Not Specified	No	Not Specified	Hypersensitivity (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7052443&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7052444	Spontaneous	2013-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Oliviera D, Lara A, Luiz A, Miyaji K, Sartori A, Lopes M. Spontaneous reporting of adverse events following pandemic influenza A (H1N1) immunization in a reference center in the State of So Paulo, Brazil.. Revista da Sociedade Brasileira de Medicina Tropical 46(3):348-351.	18-64 Years	Not Specified	No	Not Specified	Hypersensitivity (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7052444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7052468	Spontaneous	2013-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Oliviera D, Lara A, Luiz A, Miyaji K, Sartori A, Lopes M. Spontaneous reporting of adverse events following pandemic influenza A (H1N1) immunization in a reference center in the State of So Paulo, Brazil.. Revista da Sociedade Brasileira de Medicina Tropical 46(3):348-351.	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Unknown - );Local reaction (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7052468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7046513	Spontaneous	2013-08-26 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Generalised tonic-clonic seizure (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash vesicular (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, VARICELLA VIRUS OKA/RIT STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, VARICELLA VIRUS OKA/RIT STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	INFANRIX HEXA [ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), HEPATITIS B SURFACE ANTIGEN, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALGELDRATE, DIPHTHERIA TOXOID, TETANUS TOXOID, HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE), PERTUSSIS TOXOID, HEPATITIS B SURFACE ANTIGEN (RDNA), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (C - Prophylaxis - Not applicable - [1d - .5mL - Unknown])|PREVENAR [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197, PNEUMOCOCCAL OLIGOSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197] (C - Prophylaxis - Not applicable - [1d - .5mL - Unknown])...	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7046513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7048726	Spontaneous	2013-08-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Cardiac murmur (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cerebral haemorrhage (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Maternal exposure timing unspecified (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Premature baby (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Viral infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7048726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7041644	Spontaneous	2013-08-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angina pectoris (n/a - Not Recovered/Not Resolved - Disabling);Basal cell carcinoma (n/a - Recovered/Resolved - Disabling);Dyspnoea exertional (n/a - Not Recovered/Not Resolved - Disabling);Eczema (n/a - Not Recovered/Not Resolved - Disabling);Gilbert's syndrome (n/a - Not Recovered/Not Resolved - Disabling);Neuritis (n/a - Not Recovered/Not Resolved - Disabling);Vertigo (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - n/a - Unknown])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN] (S - Prophylaxis - Not applicable - [1d - 0mL - Unknown])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7041644&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7045699	Spontaneous	2013-08-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7045699&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7045755	Spontaneous	2013-08-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7045755&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7038259	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Juvenile idiopathic arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7038259&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7038398	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Juvenile idiopathic arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7038398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7038416	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Juvenile idiopathic arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7038416&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7038427	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Juvenile idiopathic arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7038427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7038429	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Juvenile idiopathic arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7038429&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7038502	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Juvenile idiopathic arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7038502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7038551	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Juvenile idiopathic arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7038551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7038656	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Juvenile idiopathic arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7038656&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7038663	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Eye pain (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Photophobia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7038663&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7038677	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Juvenile idiopathic arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7038677&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7038682	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Juvenile idiopathic arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7038682&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7038699	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7038699&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7039539	Spontaneous	2013-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anxiety (n/a - Unknown - Disabling, Other Medically Important Condition);Arthralgia (n/a - Unknown - Disabling, Other Medically Important Condition);Asthenia (n/a - Unknown - Disabling, Other Medically Important Condition);Balance disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Bedridden (n/a - Unknown - Disabling, Other Medically Important Condition);Brain fog (n/a - Unknown - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Coordination abnormal (n/a - Unknown - Disabling, Other Medically Important Condition);Depression (n/a - Unknown - Disabling, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Hyperaesthesia (n/a - Unknown - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Disabling, Other Medically Important Condition);Initial insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Irritable bowel syndrome (n/a - Unknown - Disabling, Other Medically Important Condition);Learning disability (n/a - Unknown - Disabling, Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Lymph node pain (n/a - Unknown - Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Disabling, Other Medically Important Condition);Memory impairment (n/a - Unknown - Disabling, Other Medically Important Condition);Migraine (n/a - Unknown - Disabling, Other Medically Important Condition);Mood altered (n/a - Unknown - Disabling, Other Medically Important Condition);Muscle twitching (n/a - Unknown - Disabling, Other Medically Important Condition);Myalgia (n/a - Unknown - Disabling, Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Disabling, Other Medically Important Condition);Neuralgia (n/a - Unknown - Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Disabling, Other Medically Important Condition);Pain (n/a - Unknown - Disabling, Other Medically Important Condition);Palpitations (n/a - Unknown - Disabling, Other Medically Important Condition);Photosensitivity reaction (n/a - Unknown - Disabling, Other Medically Important Condition);Pyrexia (n/a - Unknown - Disabling, Other Medically Important Condition);Raynaud's phenomenon (n/a - Unknown - Disabling, Other Medically Important Condition);Rhinorrhoea (n/a - Unknown - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[EBASTINE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7039539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-7034134	Spontaneous	2013-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Encephalitis (n/a - Unknown - Other Medically Important Condition);Mental disorder (n/a - Unknown - Other Medically Important Condition);Type 1 diabetes mellitus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7034134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7034257	Spontaneous	2013-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7034257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7035251	Spontaneous	2013-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Adrenal adenoma (n/a - Unknown - Caused/Prolonged Hospitalisation);Anal incontinence (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Hemiplegia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hepatic cyst (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation);Monoplegia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Motor neurone disease (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (14d - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Road traffic accident (n/a - Unknown - Caused/Prolonged Hospitalisation);Urinary incontinence (n/a - Unknown - Caused/Prolonged Hospitalisation);Urinary tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Unknown - [n/a - 1mL - Intramuscular])	[DIAZEPAM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[LABETALOL HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypometabolism - n/a - [n/a - n/a - n/a])|[OXAZEPAM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[VITAMIN D] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7035251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7035571	Spontaneous	2013-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Parosmia (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7035571&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7035592	Spontaneous	2013-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Blister (3wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dermatitis allergic (3wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (3wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);General symptom (3wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (3wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	BONVIVA [IBANDRONATE SODIUM HYDRATE, IBANDRONIC ACID] (S - Osteoporosis - Drug withdrawn - [n/a - n/a - Unknown])|[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7035592&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7035770	Spontaneous	2013-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Hyperhidrosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation);Leukocytosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])|[GLIBENCLAMIDE] (S - Type 2 diabetes mellitus - Dose not changed - [n/a - 3.5mg - Oral])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - Hypertension - Dose not changed - [n/a - 10mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - Type 2 diabetes mellitus - Dose not changed - [n/a - 850mg - Oral])|[METOPROLOL SUCCINATE, METOPROLOL SUCCINATE (PH. EUR.)] (C - Hypertension - Dose not changed - [n/a - 45mg - Oral])|[RAMIPRIL] (C - Hypertension - Dose not changed - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7035770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7030344	Spontaneous	2013-08-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Syncope (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])|[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALUMINIUM HYDROXIDE] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7030344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7030674	Spontaneous	2013-08-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Balance disorder (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Cholecystitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Cholelithiasis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Head discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Intentional product misuse (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Ischaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Nasal polyps (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Peripheral sensory neuropathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Soft tissue mass (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Spinal osteoarthritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Suicide attempt (3a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Vertigo (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[BENDROFLUMETHIAZIDE] (S - Prophylaxis - Drug withdrawn - [n/a - n/a - n/a])|[ZOPICLONE] (S - Sleep disorder - Dose not changed - [n/a - 7.5mg - Oral])	[ACETYLSALICYLIC ACID] (C - n/a - Dose not changed - [n/a - 75mg - Oral])|[CYANOCOBALAMIN] (C - n/a - Unknown - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - Drug withdrawn - [n/a - 50mg - Oral])|[SIMVASTATIN] (C - Blood cholesterol increased - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7030674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7025069	Spontaneous	2013-08-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Elderly	No	Female	Blood bilirubin increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cholestasis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Jaundice (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pruritus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Transaminases increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7025069&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-7025248	Spontaneous	2013-08-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Arthralgia (13d - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (13d - Recovered/Resolved - Other Medically Important Condition);Erythema (15d - Recovered/Resolved - Other Medically Important Condition);Feeling hot (15d - Recovered/Resolved - Other Medically Important Condition);Injection site reaction (15d - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (15d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (13d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Unknown])|[A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003)] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])...	[LEVOTHYROXINE SODIUM, POTASSIUM IODIDE, LEVOTHYROXINE, POTASSIUM IODIDE] (C - Ill-defined disorder - Dose not changed - [n/a - 125mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7025248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7025275	Spontaneous	2013-08-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7025275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7025311	Spontaneous	2013-08-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Chills (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7025311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7025595	Spontaneous	2013-08-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7025595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-7020284	Spontaneous	2013-08-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic shock (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7020284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-7017696	Spontaneous	2013-08-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Amnesia (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Infection susceptibility increased (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7017696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7018987	Spontaneous	2013-08-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Foetal exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7018987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7019236	Spontaneous	2013-08-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Limb discomfort (n/a - Not Recovered/Not Resolved - Disabling);Vaccination site pain (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7019236&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7010712	Spontaneous	2013-08-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Facial paresis (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7010712&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7010726	Spontaneous	2013-08-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Confusional state (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7010726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7004887	Spontaneous	2013-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Lung disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Obstructive airways disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7004887&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7004920	Spontaneous	2013-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaemia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nephritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Systemic lupus erythematosus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7004920&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-7004922	Spontaneous	2013-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Psoriasis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7004922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-7005923	Spontaneous	2013-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	IRON [IRON] (C - Anaemia - Unknown - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[TRANEXAMIC ACID] (C - Heavy menstrual bleeding - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7005923&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-7000681	Spontaneous	2013-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Polyneuropathy (n/a - Unknown - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=7000681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6992065	Spontaneous	2013-08-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Apathy (n/a - Unknown - );Decreased appetite (n/a - Unknown - );Fatigue (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6992065&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6992555	Spontaneous	2013-08-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[CLONIDINE, CLONIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6992555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6993517	Spontaneous	2013-08-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Epilepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6993517&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6993620	Spontaneous	2013-08-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphagia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Functional gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Genital hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Perineal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Radiculopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Speech disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Urinary retention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6993620&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6981291	Spontaneous	2013-08-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dermatitis bullous (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash maculo-papular (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - 1{DF} - Parenteral])|[ALLOPURINOL] (S - Gout - Drug withdrawn - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6981291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6986319	Spontaneous	2013-08-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Psychotic disorder (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6986319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6978094	Spontaneous	2013-08-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Thrombocytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	NOVONORM [REPAGLINIDE] (S - Type 2 diabetes mellitus - Drug withdrawn - [n/a - .5mg - Oral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Drug withdrawn - [n/a - 1{DF} - Intramuscular])...	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[MOLSIDOMINE] (C - n/a - n/a - [n/a - n/a - n/a])|[NAFTIDROFURYL, NAFTIDROFURYL OXALATE] (C - n/a - n/a - [n/a - n/a - n/a])|[NICORANDIL] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6978094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6979418	Spontaneous	2013-08-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6979418&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6969249	Spontaneous	2013-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6969249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6969330	Spontaneous	2013-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6969330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6959808	Spontaneous	2013-07-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6959808&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6959809	Spontaneous	2013-07-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6959809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6959810	Spontaneous	2013-07-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6959810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6956697	Spontaneous	2013-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6956697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6952111	Spontaneous	2013-07-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Thrombocytopenic purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[AMOROLFINE, AMOROLFINE HYDROCHLORIDE] (S - Onychomycosis - Drug withdrawn - [n/a - 1{DF} - Topical])	[BETAHISTINE DIHYDROCHLORIDE, BETAHISTINE HYDROCHLORIDE] (C - Meniere's disease - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6952111&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6952761	Spontaneous	2013-07-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Oedema (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6952761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6956076	Spontaneous	2013-07-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chest discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chest pain (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypokalaemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypophosphataemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pallor (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory arrest (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachypnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6956076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6944631	Spontaneous	2013-07-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Dermatomyositis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin lesion (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6944631&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6949417	Spontaneous	2013-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Altered state of consciousness (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Anaphylactic reaction (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cardiovascular disorder (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Chest discomfort (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Circulatory collapse (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Neck pain (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory distress (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Restlessness (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Slow response to stimuli (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Swollen tongue (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Tremor (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6949417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6949419	Spontaneous	2013-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	COMBIVIR [ZIDOVUDINE, LAMIVUDINE] (S - Prophylaxis against HIV infection - Unknown - [n/a - 1{DF} - Oral])|[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[LOPINAVIR, RITONAVIR] (S - Prophylaxis against HIV infection - Unknown - [n/a - 2{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6949419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6949423	Spontaneous	2013-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pulmonary embolism (1d - Fatal - Results in Death);Right ventricular failure (1d - Fatal - Results in Death);Venous thrombosis limb (n/a - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[DIGITOXIN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[NEBIVOLOL] (C - n/a - Unknown - [n/a - n/a - Unknown])|[RAMIPRIL] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SPIRONOLACTONE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[XIPAMIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6949423&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6949444	Spontaneous	2013-07-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Sudden death (1d - Fatal - Results in Death)	ACTRAPID [INSULIN HUMAN, INSULIN HUMAN (RDNA)] (S - Type 1 diabetes mellitus - Not applicable - [n/a - n/a - Subcutaneous])|LEVEMIR [INSULIN DETEMIR] (S - Type 1 diabetes mellitus - Not applicable - [n/a - n/a - Subcutaneous])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])|[BENSERAZIDE HYDROCHLORIDE, LEVODOPA, BENSERAZIDE, LEVODOPA] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Oral])|[CAPTOPRIL, HYDROCHLOROTHIAZIDE] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Oral])|[LERCANIDIPINE HYDROCHLORIDE] (S - Product used for unknown indication - Not applicable - [n/a - 10mg - Oral])|[METFORMIN HYDROCHLORIDE] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Oral])|[PIRIBEDIL, PIRIBEDIL MESYLATE] (S - Product used for unknown indication - Not applicable - [n/a - 50mg - Oral])|[POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ETHYLCELLULOSE MICROENCAPSULATED 80-90%] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Oral])|[TRIMETAZIDINE, TRIMETAZIDINE DIHYDROCHLORIDE] (S - Product used for unknown indication - Not applicable - [n/a - 35mg - Oral])|[ZUCLOPENTHIXOL, ZUCLOPENTHIXOL ACETATE, ZUCLOPENTHIXOL DECANOATE, ZUCLOPENTHIXOL HYDROCHLORIDE] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Oral])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Influenza - n/a - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6949444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6938769	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6938769&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6938780	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Anaphylactic reaction (95min - Recovered/Resolved - Life Threatening);Circulatory collapse (95min - Recovered/Resolved - Life Threatening);Dyspnoea (95min - Recovered/Resolved - Life Threatening);Hyperhidrosis (95min - Recovered/Resolved - Life Threatening);Nausea (95min - Recovered/Resolved - Life Threatening);Pulse abnormal (95min - Recovered/Resolved - Life Threatening);Tremor (95min - Recovered/Resolved - Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6938780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6938786	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation);CSF test abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Decreased vibratory sense (n/a - Unknown - Caused/Prolonged Hospitalisation);Demyelinating polyneuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hyperpathia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Peripheral sensorimotor neuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Spinal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	METHOTREXATE [METHOTREXATE] (C - Polymyalgia rheumatica - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6938786&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6938787	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chest pain (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6938787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6938885	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovering/Resolving - Other Medically Important Condition);Hypoaesthesia (5d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6938885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6938890	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Incorrect route of product administration (n/a - Unknown - Caused/Prolonged Hospitalisation);Tongue disorder (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6938890&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6938892	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Immunisation reaction (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6938892&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6938905	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Circulatory collapse (1d - Recovered/Resolved - Other Medically Important Condition);Polyarthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (3d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6938905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6938936	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anal incontinence (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (2d - Unknown - Caused/Prolonged Hospitalisation);Vomiting (2d - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 1{DF} - Unknown])	[METOPROLOL, METOPROLOL TARTRATE] (C - Hypertension - Unknown - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6938936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6939404	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Circulatory collapse (1min - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Head injury (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Local reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Loss of consciousness (1min - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939404&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6939415	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Altered state of consciousness (30min - Recovered/Resolved - Other Medically Important Condition);Anaphylactic shock (30min - Recovered/Resolved - Other Medically Important Condition);Chest discomfort (30min - Recovered/Resolved - Other Medically Important Condition);Chills (30min - Recovered/Resolved - Other Medically Important Condition);Dizziness (30min - Recovered/Resolved - Other Medically Important Condition);Flushing (30min - Recovered/Resolved - Other Medically Important Condition);Suffocation feeling (30min - Recovered/Resolved - Other Medically Important Condition);Tremor (30min - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6939469	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cardiovascular disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Circulatory collapse (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6939470	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Angina pectoris (n/a - Recovered/Resolved - Life Threatening);Dyspnoea (30min - Recovered/Resolved - Life Threatening);Flushing (30min - Recovered/Resolved - Life Threatening);Hypersensitivity (30min - Recovered/Resolved - Life Threatening);Paresis (n/a - Recovering/Resolving - Life Threatening);Renal pain (30min - Recovered/Resolved - Life Threatening);Sensory level abnormal (30min - Recovered/Resolved - Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6939482	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Agitation (8min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Crying (10min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Opisthotonus (2min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .25mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6939484	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (3h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Circulatory collapse (3h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (3h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Flushing (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6939632	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Anaphylactic reaction (15min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Burning sensation (15min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Erythema (15min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Flushing (15min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypertension (15min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Palpitations (15min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pruritus (15min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Restlessness (15min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Tachycardia (25min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939632&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6939648	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (5min - Recovered/Resolved - Life Threatening);Dyspnoea (5min - Recovered/Resolved - Life Threatening);Erythema (5min - Recovered/Resolved - Life Threatening);Flushing (5min - Recovered/Resolved - Life Threatening);Throat tightness (5min - Recovered/Resolved - Life Threatening);Type I hypersensitivity (5min - Recovered/Resolved - Life Threatening);Urticaria (5min - Recovered/Resolved - Life Threatening);Wheezing (5min - Recovered/Resolved - Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939648&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6939663	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Blood pressure decreased (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Chills (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Circulatory collapse (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dizziness (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Heart rate increased (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypersensitivity (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Rash (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Tachycardia (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939663&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6939709	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (15min - Recovered/Resolved - Other Medically Important Condition);Circulatory collapse (15min - Recovered/Resolved - Other Medically Important Condition);Erythema (15min - Recovered/Resolved - Other Medically Important Condition);Flushing (15min - Recovered/Resolved - Other Medically Important Condition);Product administration error (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939709&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6939951	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (60min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Blood pressure decreased (60min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cardiovascular disorder (60min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Heart rate increased (60min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (60min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thirst (60min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (60min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939951&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6939971	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Dyskinesia (n/a - Not Recovered/Not Resolved - Disabling);Fall (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Rash (n/a - Unknown - Disabling);Social avoidant behaviour (n/a - Unknown - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Vomiting (n/a - Unknown - Disabling);Weight decreased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939971&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6939972	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anal incontinence (n/a - Unknown - Caused/Prolonged Hospitalisation);Borrelia infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Latent syphilis (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Syncope (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6939973	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Constipation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Disability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Haematochezia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypersensitivity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Proctitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tonsillitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Urinary tract infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Vulvitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - Unknown - [n/a - 10mg - Oral])|[DESOGESTREL, ETHINYLESTRADIOL, ETHINYLESTRADIOL PH. EUR., DESOGESTREL B.P.] (C - n/a - Drug withdrawn - [n/a - n/a - Oral])|[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - Dose not changed - [n/a - .15mg - Oral])|[FOLIC ACID] (C - n/a - Unknown - [n/a - 1mg - Oral])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - Unknown - [n/a - 200ug - Intrahepatic])|[RIZATRIPTAN, RIZATRIPTAN BENZOATE] (C - n/a - Unknown - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6939973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6941766	Spontaneous	2013-07-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Seizure (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6941766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6936215	Spontaneous	2013-07-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Affect lability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Unknown - Other Medically Important Condition);Educational problem (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6936215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6930369	Spontaneous	2013-07-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Amniotic cavity infection (n/a - Unknown - Other Medically Important Condition);H1N1 influenza (n/a - Unknown - Other Medically Important Condition);Injection site pain (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Meconium in amniotic fluid (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Uterine contractions abnormal (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PLASTER [PLASTER] (C - Sciatica - Not applicable - [n/a - n/a - Topical])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6930369&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6927502	Spontaneous	2013-07-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthritis reactive (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6927502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6922761	Spontaneous	2013-07-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Circulatory collapse (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6922761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6917424	Spontaneous	2013-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6917424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6914313	Spontaneous	2013-07-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Musculoskeletal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6914313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6915239	Spontaneous	2013-07-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Glomerulonephritis acute (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Peripheral swelling (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[BUPROPION, BUPROPION HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - n/a])|[ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - 20mg - Oral])|[FUROSEMIDE] (C - n/a - n/a - [n/a - 30mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - 500mg - n/a])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 100mg - Oral])|[NIFEDIPINE] (C - n/a - n/a - [n/a - 60mg - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6915239&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6902636	Spontaneous	2013-07-11 00:00:00	Healthcare Professional	Non European Economic Area	Reynales H, Astudillo P, Valliere S, Hatz C, Schlagenhauf P, Rath B et al.. A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura® during the A/H1N1 (2009) influenza pandemic. Vaccine. 2012;30:6436-6443	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Other Medically Important Condition);Abortion spontaneous incomplete (1d - Recovered/Resolved - Other Medically Important Condition);Maternal exposure before pregnancy (n/a - Unknown - Other Medically Important Condition);Vaginal haemorrhage (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, SORBITAN TRIOLEATE, POLYSORBATE 80, SQUALENE, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Unknown - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6902636&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6904164	Spontaneous	2013-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Irregular breathing (n/a - Recovered/Resolved - Other Medically Important Condition);Listless (n/a - Recovered/Resolved - Other Medically Important Condition);Muscle spasms (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition);Strabismus (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6904164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6906298	Spontaneous	2013-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6906298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6898593	Spontaneous	2013-07-10 00:00:00	Healthcare Professional	Non European Economic Area	Reynales H, Astudillo P, Valliere S, Hatz C, Schlagenhauf P, Rath B et al.. A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura® during the A/H1N1 (2009) influenza pandemic. Vaccine. 2012;30:6436-6443	18-64 Years	Not Specified	No	Female	Ectopic pregnancy (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Uterine haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, SORBITAN TRIOLEATE, POLYSORBATE 80, SQUALENE, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Unknown - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6898593&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6901630	Spontaneous	2013-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Bronchitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ear infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sepsis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])|[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED, ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALGELDRATE, HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALUMINIUM HYDROXIDE] (S - n/a - n/a - [1d - n/a - Intramuscular])|[PNEUMOCOCCAL VACCINE] (S - n/a - n/a - [1d - n/a - Intramuscular])	[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6901630&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6897752	Spontaneous	2013-07-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Neutropenia (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	MABTHERA [RITUXIMAB] (S - Non-Hodgkin's lymphoma - Not applicable - [1d - n/a - Intrathecal])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[ANHYDROUS CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE MONOHYDRATE] (S - Non-Hodgkin's lymphoma - Not applicable - [1d - n/a - Intrathecal])|[DOXORUBICIN HYDROCHLORIDE] (S - Non-Hodgkin's lymphoma - Not applicable - [1d - n/a - Intrathecal])|[PREDNISONE] (S - Non-Hodgkin's lymphoma - Not applicable - [1d - n/a - Oral])	[CYTARABINE] (C - Ill-defined disorder - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6897752&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6889584	Spontaneous	2013-07-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6889584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6883781	Spontaneous	2013-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Oral discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Palpitations (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6883781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6883808	Spontaneous	2013-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6883808&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6884444	Spontaneous	2013-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pneumonia mycoplasmal (n/a - Unknown - Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Sinusitis (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[DESOGESTREL, ETHINYLESTRADIOL, LACTOSE, LACTOSE MONOHYDRATE] (C - Contraception - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6884444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6880213	Spontaneous	2013-07-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6880213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6871301	Spontaneous	2013-07-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Apathy (n/a - Unknown - Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - [iU] - n/a])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Immunisation - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6871301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6867094	Spontaneous	2013-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6867094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6864601	Spontaneous	2013-06-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Haematoma (6wk - Recovered/Resolved - Disabling);Influenza like illness (4d - Recovered/Resolved With Sequelae - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6864601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-6855668	Spontaneous	2013-06-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Mood swings (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Night sweats (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Phonophobia (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Presyncope (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Temperature regulation disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6855668&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6845558	Spontaneous	2013-06-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6845558&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6846161	Spontaneous	2013-06-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Migraine (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 2{DF} - n/a])	[LAMOTRIGINE] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM VALPROATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6846161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6846162	Spontaneous	2013-06-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Depressed level of consciousness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Photophobia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6846162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6846548	Spontaneous	2013-06-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Epilepsy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6846548&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6846551	Spontaneous	2013-06-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition);Suicidal ideation (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6846551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6848483	Spontaneous	2013-06-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6848483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6841209	Spontaneous	2013-06-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Aggression (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6841209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6841453	Spontaneous	2013-06-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6841453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6842130	Spontaneous	2013-06-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Insomnia (n/a - Not Recovered/Not Resolved - )	CELVAPAN PANDEMIC INFLUENZA VACCINE (H1N1) (WHOLE VIRION, VERO CELL DERIVED, INACTIVATED) SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6842130&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6844645	Spontaneous	2013-06-24 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (10min - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Immune system disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tremor (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6844645&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6831265	Spontaneous	2013-06-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adolescent	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6831265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6831925	Spontaneous	2013-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Eosinophilia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oedema peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6831925&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6832543	Spontaneous	2013-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Myelitis transverse (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6832543&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6826269	Spontaneous	2013-06-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6826269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6826278	Spontaneous	2013-06-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6826278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6826290	Spontaneous	2013-06-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6826290&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6826377	Spontaneous	2013-06-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Eye inflammation (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Mixed connective tissue disease (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6826377&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6820184	Spontaneous	2013-06-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cognitive disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Coordination abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Reading disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6820184&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6807981	Spontaneous	2013-06-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Eczema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Wound infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6807981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6796597	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6796597&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6799818	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Auditory disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cochlea implant (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Constipation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Deafness unilateral (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Facial paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Haemorrhoids (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Head injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Medical device pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neck pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Otosclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Phonophobia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Scrotal dermatitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Self-medication (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Stapedectomy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sudden hearing loss (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Thrombosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tinnitus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vertigo (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Withdrawal syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])...	CIALIS [TADALAFIL] (C - Erectile dysfunction - Unknown - [n/a - 20mg - Oral])|FENTANYL [FENTANYL, FENTANYL CITRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[CINCHOCAINE HYDROCHLORIDE, PREDNISOLONE, CINCHOCAINE HYDROCHLORIDE, PREDNISOLONE CAPROATE] (C - Haemorrhoids - Unknown - [n/a - n/a - Rectal])|[CLONIDINE HYDROCHLORIDE] (C - Drug withdrawal syndrome - Drug withdrawn - [n/a - n/a - Oral])|[FENTANYL] (C - Pain - Drug withdrawn - [n/a - n/a - Topical])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - Sleep disorder - Unknown - [n/a - 40mg - Oral])|[IBUPROFEN] (C - Pain - Unknown - [n/a - 600mg - Oral])|[LEVOMEPROMAZINE, LEVOMEPROMAZINE EMBONATE, LEVOMEPROMAZINE HYDROCHLORIDE, LEVOMEPROMAZINE MALEATE] (C - Sleep disorder - Drug withdrawn - [n/a - 25mg - n/a])|[OMEPRAZOLE] (C - Gastrointestinal pain - Drug withdrawn - [n/a - n/a - Oral])|[OXYCODONE HYDROCHLORIDE] (C - Pain - Unknown - [n/a - 90mg - n/a])|[OXYCODONE, OXYCODONE HYDROCHLORIDE] (C - Pain - Unknown - [n/a - 60mg - Oral])|[PARACETAMOL] (C - Pain - Unknown - [n/a - n/a - Oral])|[PREDNISOLONE] (C - Ear disorder - Drug withdrawn - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6799818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6800114	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Eyelid oedema (3d - Recovered/Resolved - Other Medically Important Condition);Malaise (3d - Recovered/Resolved - Other Medically Important Condition);Rash (3d - Recovered/Resolved - Other Medically Important Condition);Somnolence (3d - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6800114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6801694	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Alopecia areata (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6801694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6801761	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Dyspnoea (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Infection susceptibility increased (n/a - Unknown - Other Medically Important Condition);Irritability (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Nocturia (n/a - Unknown - Other Medically Important Condition);Otitis media (n/a - Unknown - Other Medically Important Condition);Upper respiratory tract infection (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])|SYNFLORIX [ALUMINIUM PHOSPHATE, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, ALUMINIUM, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18CCONJUGATED TO TETANUS TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO DIPHTHERIA TOXOID CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO PROTEIN D (DERIVED FROM NON-TYPEABLE HAEMOPHILUS INFLUENZAE) CARRIER PROTEIN] (S - n/a - n/a - [239d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6801761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6801897	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6801897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6803403	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6803403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6803644	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Vaccination failure (n/a - Unknown - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6803644&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6804446	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6804446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6805289	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sputum discoloured (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6805289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6805491	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Gait disturbance (n/a - Recovering/Resolving - Other Medically Important Condition);Lymphadenopathy (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6805491&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6810039	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6810039&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6810457	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (4min - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - 1mL - Intramuscular])	[LAMOTRIGINE] (C - Epilepsy - n/a - [n/a - 200mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6810457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6811041	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Hyperhidrosis (15min - Recovered/Resolved - Other Medically Important Condition);Hypotension (15min - Recovered/Resolved - Other Medically Important Condition);Syncope (15min - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6811041&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6811743	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Back pain (n/a - Unknown - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6811743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6814036	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Death (n/a - Fatal - Results in Death)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - 1mL - Intramuscular])	LEVEMIR [INSULIN DETEMIR] (C - n/a - n/a - [n/a - n/a - n/a])|PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - 75mg - n/a])|TREDAPTIVE 1000 MG/20 MG MODIFIED-RELEASE TABLETS [NICOTINIC ACID, LAROPIPRANT] (C - n/a - n/a - [n/a - n/a - n/a])|[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - 5mg - n/a])|[BUMETANIDE] (C - n/a - n/a - [n/a - 1mg - n/a])|[GLICLAZIDE] (C - n/a - n/a - [n/a - 90mg - n/a])|[METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - n/a])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - 10mg - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 5mg - n/a])|[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 300mg - n/a])|[TRIMETAZIDINE, TRIMETAZIDINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6814036&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6814280	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Sensory loss (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	[PAROXETINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE] (C - Depression - n/a - [n/a - 5mg - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Asthma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6814280&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6814345	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Unknown - Caused/Prolonged Hospitalisation)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6814345&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6816068	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Syncope (10min - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - 1mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6816068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6818330	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Apathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Petechiae (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/BRISBANE/60/2008-LIKE VIRUS] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6818330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6818507	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	S Knuden et al. No normalization of hypocretin-1 deficiency or narcoleptic phenotype after ealry IVIG treatment in post H1N1 vaccination narcolepsy with cataplexy.European Journal of Neurology: 18; 2 (334)	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Unknown - [n/a - n/a - Intramuscular])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE] (C - Asthma - n/a - [n/a - n/a - n/a])|[FEXOFENADINE HYDROCHLORIDE] (C - Rhinitis allergic - n/a - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - Asthma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6818507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6819888	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysphagia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Facial paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Facial paresis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gait inability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hemiparesis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle spasms (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tachycardia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6819888&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6820306	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Ocular hyperaemia (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6820306&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6820992	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (7d - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (7d - Recovered/Resolved - Other Medically Important Condition);Medication error (n/a - Recovered/Resolved - Other Medically Important Condition);Wheezing (7d - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - 1mL - Subcutaneous])	[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Asthma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6820992&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6821996	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tinnitus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Unknown - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6821996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6822467	Spontaneous	2013-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Subcutaneous])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6822467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-6791144	Spontaneous	2013-06-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Waxy flexibility (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6791144&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6787324	Spontaneous	2013-06-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6787324&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6787326	Spontaneous	2013-06-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[FLUPENTIXOL, FLUPENTIXOL DECANOATE, FLUPENTIXOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6787326&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6787611	Spontaneous	2013-06-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6787611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6787618	Spontaneous	2013-06-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Disabling);Asthma (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Unknown - Disabling);Disability (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Unknown - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Nasal obstruction (n/a - Unknown - Disabling);Palpitations (n/a - Unknown - Disabling);Rhinalgia (n/a - Unknown - Disabling);Sinusitis (n/a - Unknown - Disabling);Social avoidant behaviour (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling);Temperature regulation disorder (n/a - Unknown - Disabling);Vertigo (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	CHAMPIX [VARENICLINE, VARENICLINE TARTRATE] (C - n/a - Drug withdrawn - [n/a - n/a - Oral])|METHOTREXATE [METHOTREXATE] (C - n/a - Unknown - [n/a - 12.5mg - Oral])|REMICADE [INFLIXIMAB] (C - n/a - Drug withdrawn - [n/a - n/a - Oral])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[CYANOCOBALAMIN] (C - n/a - Dose not changed - [n/a - n/a - n/a])|[DROSPIRENONE, ETHINYLESTRADIOL] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - Drug withdrawn - [n/a - n/a - Oral])|[FOLIC ACID] (C - n/a - Dose not changed - [n/a - 1mg - Oral])|[LANSOPRAZOLE] (C - n/a - Drug withdrawn - [n/a - n/a - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - Drug withdrawn - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6787618&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6783169	Spontaneous	2013-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Coma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Feeding disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait inability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypokinesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Plasmapheresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Wheelchair user (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	UNKNOWN DRUG [NOT AVAILABLE] (C - Pruritus - n/a - [n/a - n/a - n/a])|[AMILORIDE HYDROCHLORIDE PH. EUR., FUROSEMIDE PH. EUR., AMILORIDE HYDROCHLORIDE, FUROSEMIDE, FUROSEMIDE BP, AMILORIDE HYDROCHLORIDE BP, FUROSEMIDE, ANHYDROUS AMILORIDE HYDROCHLORIDE] (C - Fluid retention - n/a - [n/a - n/a - n/a])|[BENZALKONIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LYMECYCLINE, TETRACYCLINE] (C - Dermatitis - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - Discomfort - n/a - [n/a - n/a - n/a])|[ZINC OXIDE, BENZYL BENZOATE, BENZYL CINNAMATE, LANOLIN, BENZYL ALCOHOL BP] (C - Dermatitis diaper - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6783169&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6784533	Spontaneous	2013-06-11 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cellulitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site warmth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6784533&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6778524	Spontaneous	2013-06-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Depressed mood (n/a - Unknown - Other Medically Important Condition);Mood altered (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Product used for unknown indication - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6778524&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6772365	Spontaneous	2013-06-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6772365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6772367	Spontaneous	2013-06-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6772367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6763929	Spontaneous	2013-06-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6763929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6765875	Spontaneous	2013-06-05 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Facial paralysis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6765875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6759230	Spontaneous	2013-06-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6759230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6754092	Spontaneous	2013-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Chorea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 2{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6754092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6755651	Spontaneous	2013-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Eczema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Impetigo (n/a - Unknown - Caused/Prolonged Hospitalisation);Lichen planus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pemphigoid (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash pruritic (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Staphylococcal infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - Diabetes mellitus - Unknown - [n/a - n/a - Unknown])|LEVEMIR [INSULIN DETEMIR] (C - Diabetes mellitus - Unknown - [n/a - n/a - Unknown])|NOVORAPID [INSULIN ASPART] (C - Diabetes mellitus - Unknown - [n/a - n/a - Unknown])|UNSPECIFIED DRUG [UNKNOWN] (C - n/a - Unknown - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[ACETYLSALICYLIC ACID] (C - Prophylaxis - Unknown - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - Cardiac disorder - Unknown - [n/a - n/a - n/a])|[BUMETANIDE] (C - Cardiac disorder - Unknown - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - Cardiac disorder - Unknown - [n/a - n/a - n/a])|[RAMIPRIL] (C - Hypotension - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6755651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6755991	Spontaneous	2013-06-03 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Diplopia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6755991&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6748831	Spontaneous	2013-05-31 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Facial paralysis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6748831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6748832	Spontaneous	2013-05-31 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Psoriatic arthropathy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6748832&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6750067	Spontaneous	2013-05-31 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Glomerulonephritis membranoproliferative (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6750067&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6745540	Spontaneous	2013-05-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Parenteral])	VIAGRA [SILDENAFIL, SILDENAFIL CITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMILORIDE HYDROCHLORIDE PH. EUR., FUROSEMIDE PH. EUR., AMILORIDE HYDROCHLORIDE, FUROSEMIDE, FUROSEMIDE BP, AMILORIDE HYDROCHLORIDE BP, FUROSEMIDE, ANHYDROUS AMILORIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[BENZALKONIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[BETAMETHASONE VALERATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LYMECYCLINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARAFFIN WHITE SOFT, LIQUID PARAFFIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6745540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6745667	Spontaneous	2013-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myelitis transverse (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neurological symptom (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sensory loss (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6745667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6746257	Spontaneous	2013-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Facial paresis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6746257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6746258	Spontaneous	2013-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Respiratory failure (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6746258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6740526	Spontaneous	2013-05-29 00:00:00	Non Healthcare Professional	European Economic Area	Cecilia Isberg. Kristianstadsbladet, published on 10 May 2013.	3-11 Years	Not Specified	No	Male	Apathy (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dysstasia (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Gait inability (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Increased appetite (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Parosmia (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Taste disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6740526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6742682	Spontaneous	2013-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Drug ineffective (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])	[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, AMILORIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE DIHYDRATE, HYDROCHLOROTHIAZIDE, ANHYDROUS AMILORIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6742682&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6735573	Spontaneous	2013-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sudden onset of sleep (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6735573&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6735737	Spontaneous	2013-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pneumonia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6735737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6735739	Spontaneous	2013-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Other Medically Important Condition);Diarrhoea (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Gastrooesophageal reflux disease (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Throat irritation (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	[LYMECYCLINE, TETRACYCLINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6735739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6736463	Spontaneous	2013-05-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuropathy peripheral (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Photophobia (n/a - Unknown - Caused/Prolonged Hospitalisation);Radiculopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6736463&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6731888	Spontaneous	2013-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Androgen deficiency (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Autonomic nervous system imbalance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Bedridden (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Crohn's disease (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Growth retardation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperthermia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypothyroidism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Increased tendency to bruise (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Irritable bowel syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Joint instability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Mucosal dryness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscle fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Neuralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	ENBREL [ETANERCEPT] (C - n/a - Unknown - [n/a - n/a - Unknown])|METHOTREXATE [METHOTREXATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6731888&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6733245	Spontaneous	2013-05-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Depressed level of consciousness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depressed mood (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dissociation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nystagmus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	ETANERCEPT [ETANERCEPT] (C - Psoriatic arthropathy - Unknown - [n/a - 50mg - Unknown])|[CALCIPOTRIOL, CALCIPOTRIOL MONOHYDRATE, CALCIPOTRIOL, ANHYDROUS] (C - Psoriasis - Unknown - [n/a - n/a - Topical])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - Pain - Unknown - [n/a - n/a - Unknown])|[IBUPROFEN] (C - Pain - Unknown - [n/a - n/a - Unknown])|[OXAZEPAM] (C - Anxiety - Unknown - [n/a - n/a - Unknown])|[PARACETAMOL, PARACETAMOL, ASPARTAME] (C - Pain - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6733245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6726836	Spontaneous	2013-05-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6726836&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6721908	Spontaneous	2013-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Akathisia (n/a - Unknown - Other Medically Important Condition);Autonomic neuropathy (n/a - Unknown - Other Medically Important Condition);Burning sensation (n/a - Unknown - Other Medically Important Condition);Bursitis (n/a - Unknown - Other Medically Important Condition);Enthesopathy (n/a - Unknown - Other Medically Important Condition);Eye pain (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Impaired gastric emptying (n/a - Unknown - Other Medically Important Condition);Neuralgia (n/a - Unknown - Other Medically Important Condition);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Palpitations (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Psoriatic arthropathy (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Temperature intolerance (n/a - Unknown - Other Medically Important Condition);Tendonitis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PROTOPIC [TACROLIMUS, TACROLIMUS MONOHYDRATE] (C - Psoriasis - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6721908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6723692	Spontaneous	2013-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	MELATONIN [MELATONIN] (C - n/a - n/a - [n/a - n/a - n/a])|[DEXAMFETAMINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MIANSERIN, MIANSERIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6723692&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6710846	Spontaneous	2013-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Drug ineffective (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6710846&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6706095	Spontaneous	2013-05-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6706095&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6701444	Spontaneous	2013-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Apnoea (n/a - Unknown - Other Medically Important Condition);Arrhythmia (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6701444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6695938	Spontaneous	2013-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Insomnia (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6695938&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6696235	Spontaneous	2013-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6696235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6691067	Spontaneous	2013-05-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Balance disorder (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Recovering/Resolving - Disabling);Hypothyroidism (n/a - Unknown - Disabling);Inflammatory pain (n/a - Not Recovered/Not Resolved - Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Disabling);Loss of consciousness (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Recovering/Resolving - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Nightmare (n/a - Not Recovered/Not Resolved - Disabling);Paralysis (n/a - Not Recovered/Not Resolved - Disabling);Physical disability (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Recovering/Resolving - Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Temperature regulation disorder (n/a - Not Recovered/Not Resolved - Disabling);Vomiting (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6691067&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6691068	Spontaneous	2013-05-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cholelithiasis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gastritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hiatus hernia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rectal haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	CIRCADIN [MELATONIN] (C - n/a - Unknown - [n/a - n/a - n/a])|[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - Neuralgia - Unknown - [n/a - n/a - n/a])|[CODEINE PHOSPHATE SESQUIHYDRATE, PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE] (C - Pain - Unknown - [n/a - n/a - n/a])|[DIGITOXIN] (C - Cardiac failure - Unknown - [n/a - n/a - n/a])|[PARACETAMOL] (C - Pain - Unknown - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - n/a])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - Hypertension - Unknown - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6691068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6691069	Spontaneous	2013-05-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Unknown - Disabling);Disability (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BENDROFLUMETHIAZIDE] (C - n/a - Unknown - [n/a - n/a - Oral])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - Unknown - [n/a - n/a - Oral])|[VALSARTAN] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6691069&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6685060	Spontaneous	2013-05-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6685060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6686684	Spontaneous	2013-05-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Facial spasm (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6686684&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6679406	Spontaneous	2013-05-10 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Facial paralysis (n/a - Unknown - Other Medically Important Condition);Nervousness (n/a - Unknown - Other Medically Important Condition);Speech disorder (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6679406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6679985	Spontaneous	2013-05-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cerumen impaction (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Unknown - Disabling);Chronic sinusitis (n/a - Unknown - Disabling);Condition aggravated (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Recovered/Resolved - Disabling);Loss of consciousness (n/a - Recovered/Resolved - Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMITRIPTYLINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - n/a])|[CODEINE PHOSPHATE SESQUIHYDRATE, PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE] (C - Back pain - Unknown - [n/a - n/a - n/a])|[DIAZEPAM] (C - Muscle disorder - Unknown - [n/a - n/a - n/a])|[OMEGA-3-ACID ETHYL ESTERS, OMEGA-3-ACID ETHYL ESTERS 90] (C - Blood cholesterol increased - Unknown - [n/a - n/a - n/a])|[ZOPICLONE] (C - Insomnia - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6679985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6679986	Spontaneous	2013-05-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Binocular eye movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Cluster headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypermobility syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[FLUTICASONE PROPIONATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[IBUPROFEN] (C - Headache - Unknown - [n/a - n/a - n/a])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[PARACETAMOL] (C - Headache - Unknown - [n/a - n/a - n/a])|[RIZATRIPTAN, RIZATRIPTAN BENZOATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[SUMATRIPTAN, SUMATRIPTAN SUCCINATE] (C - Migraine - Unknown - [n/a - n/a - n/a])|[TOPIRAMATE] (C - Migraine - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6679986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6679988	Spontaneous	2013-05-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypertension (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[LEVONORGESTREL] (C - Heavy menstrual bleeding - Unknown - [100d - n/a - Unknown])|[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - Chest pain - Unknown - [n/a - n/a - n/a])|[TRANEXAMIC ACID] (C - Heavy menstrual bleeding - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6679988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6681023	Spontaneous	2013-05-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cold sweat (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Heart rate increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Unknown - [n/a - n/a - n/a])	[ALLOPURINOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6681023&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6683847	Spontaneous	2013-05-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Hallucination (n/a - Not Recovered/Not Resolved - Disabling);Irritability (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Weight increased (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Antiviral prophylaxis - Dose not changed - [n/a - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE] (C - Asthma - n/a - [n/a - n/a - Nasal])|[FLUTICASONE PROPIONATE] (C - Asthma - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6683847&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6672297	Spontaneous	2013-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Asthenia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Back pain (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Muscle fatigue (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Neuropathy peripheral (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Pain (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Prostatic disorder (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Spondylitis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6672297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-6672476	Spontaneous	2013-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Throat tightness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Urticaria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6672476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6674376	Spontaneous	2013-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6674376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6674385	Spontaneous	2013-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	[CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6674385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6674387	Spontaneous	2013-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6674387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6674388	Spontaneous	2013-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 2{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6674388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6674389	Spontaneous	2013-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6674389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6675708	Spontaneous	2013-05-08 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Bedridden (n/a - Recovered/Resolved - Other Medically Important Condition);Impaired work ability (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6675708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6667835	Spontaneous	2013-05-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6667835&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6668477	Spontaneous	2013-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depression (n/a - Unknown - Disabling);Dyspepsia (n/a - Recovered/Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Gastrointestinal disorder (n/a - Recovered/Resolved - Disabling);Insomnia (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling);Stress (n/a - Unknown - Disabling);Stress at work (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CETIRIZINE DIHYDROCHLORIDE] (C - Hypersensitivity - Unknown - [n/a - n/a - Unknown])|[CYANOCOBALAMIN, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[DRIED FERROUS SULFATE, FERROUS SULFATE] (C - Blood iron decreased - Unknown - [n/a - n/a - Unknown])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[MONTELUKAST, MONTELUKAST SODIUM] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6668477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6668738	Spontaneous	2013-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6668738&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6668818	Spontaneous	2013-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Viral infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6668818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6668825	Spontaneous	2013-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Application site reaction (n/a - Unknown - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6668825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6668831	Spontaneous	2013-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blood creatine phosphokinase increased (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6668831&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6664787	Spontaneous	2013-05-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Epilepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Migraine (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Petit mal epilepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Photosensitivity reaction (n/a - Unknown - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	DEXAMETHASONE [DEXAMETHASONE, DEXAMETHASONE SODIUM PHOSPHATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[ANTAZOLINE HYDROCHLORIDE, TETRYZOLINE HYDROCHLORIDE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[LORATADINE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6664787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6664788	Spontaneous	2013-05-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chest discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dental operation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diplopia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eyelid ptosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Motor neurone disease (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Prostate cancer (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Unknown - [n/a - n/a - n/a])	CHAMPIX [VARENICLINE, VARENICLINE TARTRATE] (C - Smoking cessation therapy - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ATENOLOL, ATENOLOL HYDROCHLORIDE, ATENOLOL PH. EUR.] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CETIRIZINE DIHYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CODEINE PHOSPHATE SESQUIHYDRATE, PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE] (C - Pain - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[DISULFIRAM] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[ENALAPRIL MALEATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[FELODIPINE, FELODIPINE PH. EUR.] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[IBUPROFEN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Respiratory (inhalation)])|[LAMOTRIGINE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[NITRAZEPAM] (C - Insomnia - n/a - [n/a - n/a - n/a])|[PARACETAMOL, PARACETAMOL, ASPARTAME] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - Lung disorder - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6664788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6666945	Spontaneous	2013-05-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fibromyalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6666945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6659012	Spontaneous	2013-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cardiac failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cystitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Haematuria (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Troponin increased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[DIGOXIN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[GLIMEPIRIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - 850mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6659012&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6659082	Spontaneous	2013-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6659082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6659279	Spontaneous	2013-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Influenza (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6659279&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6659481	Spontaneous	2013-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Periodic limb movement disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Quality of life decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - Prophylaxis - Unknown - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Hypercholesterolaemia - Unknown - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[CEFATRIZINE PROPYLENE GLYCOL] (C - Hypersensitivity - Unknown - [n/a - n/a - n/a])|[EZETIMIBE] (C - Hypercholesterolaemia - Unknown - [n/a - n/a - n/a])|[FUROSEMIDE] (C - Hypertension - Unknown - [n/a - n/a - n/a])|[GLYCERYL TRINITRATE] (C - Angina pectoris - Unknown - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - n/a - n/a])|[PROMETHAZINE, PROMETHAZINE HYDROCHLORIDE] (C - Sleep disorder - Unknown - [n/a - n/a - n/a])|[VALSARTAN] (C - Hypertension - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6659481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6659534	Spontaneous	2013-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6659534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6661702	Spontaneous	2013-05-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Syncope (5min - Recovered/Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6661702&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-6662172	Spontaneous	2013-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6662172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6654339	Spontaneous	2013-05-02 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dry eye (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation);Eye abscess (n/a - Unknown - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (688d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gastroenteritis viral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Lumbar vertebral fracture (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (7mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation);Neck pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (24d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Salivary hypersecretion (n/a - Unknown - Caused/Prolonged Hospitalisation);Unevaluable event (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [n/a - n/a - n/a])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - Product used for unknown indication - n/a - [n/a - 10mg - n/a])|[ANHYDROUS FUSIDIC ACID, FUSIDIC ACID, FUSIDIC ACID HEMIHYDRATE, FUSIDIC ACID PENTAHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CHLORAMPHENICOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CODEINE PHOSPHATE SESQUIHYDRATE, PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE] (C - Pain - n/a - [n/a - n/a - Oral])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[DIAZEPAM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ENOXAPARIN SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[LACTULOSE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[NYSTATIN, NYSTATIN, ZINC OXIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[POVIDONE, POVIDONE K25] (C - Product used for unknown indication - n/a - [n/a - n/a - Ophthalmic])|[ZOLPIDEM, ZOLPIDEM HEMITARTRATE, ZOLPIDEM TARTRATE] (C - Insomnia - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6654339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6646785	Spontaneous	2013-04-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (C - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6646785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6639915	Spontaneous	2013-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6639915&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6639916	Spontaneous	2013-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Pharyngeal oedema (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6639916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6639917	Spontaneous	2013-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain (n/a - Unknown - Other Medically Important Condition);Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Anxiety (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6639917&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6639918	Spontaneous	2013-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain (n/a - Unknown - Other Medically Important Condition);Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Chills (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6639918&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6639919	Spontaneous	2013-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .18mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6639919&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6640005	Spontaneous	2013-04-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6640005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6634155	Spontaneous	2013-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Agitation (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Crying (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Diffuse vasculitis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Hypertension (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Irritability (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Loss of consciousness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Muscle spasticity (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Restlessness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Screaming (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Seizure (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Visual impairment (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Vomiting (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Wheelchair user (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[HEPATITIS A VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[HEPATITIS B VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6634155&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6636895	Spontaneous	2013-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myofascitis (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6636895&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6625102	Spontaneous	2013-04-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Biliary colic (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (1d - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site mass (8d - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - n/a])	AERIUS [DESLORATADINE] (C - Hypersensitivity - n/a - [n/a - n/a - n/a])|[CASCARA, ETHYLMORPHINE HYDROCHLORIDE, ETHYLMORPHINE HYDROCHLORIDE, FRANGULA PURSHIANA BARK] (C - Cough - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - Hypersensitivity - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6625102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6625112	Spontaneous	2013-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Memory impairment (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Sleep disorder (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DESOGESTREL, ETHINYLESTRADIOL, LACTOSE, LACTOSE MONOHYDRATE] (C - Contraception - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6625112&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6625670	Spontaneous	2013-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Bursitis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Joint effusion (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Periarthritis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Rotator cuff syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Tendon disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Tendon rupture (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	APROVEL [IRBESARTAN] (C - n/a - Unknown - [n/a - 150mg - Oral])|HUMALOG [INSULIN LISPRO] (C - Diabetes mellitus - Unknown - [n/a - n/a - Subcutaneous])|LEVEMIR [INSULIN DETEMIR] (C - Diabetes mellitus - Unknown - [n/a - 11[iU] - Subcutaneous])|[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - Unknown - [n/a - 100mg - Oral])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - Unknown - [n/a - 2.5mg - Oral])|[LEVOTHYROXINE SODIUM, POTASSIUM IODIDE, LEVOTHYROXINE, POTASSIUM IODIDE] (C - n/a - Unknown - [n/a - 50ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6625670&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6620265	Spontaneous	2013-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Eye disorder (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Unknown - Disabling);Illness (n/a - Unknown - Disabling);Infection (n/a - Not Recovered/Not Resolved - Disabling);Oropharyngeal pain (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Quality of life decreased (n/a - Not Recovered/Not Resolved - Disabling);Tonsillitis (n/a - Unknown - Disabling);Vertigo (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - Headache - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6620265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6622278	Spontaneous	2013-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6622278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6622595	Spontaneous	2013-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Polyarthritis (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6622595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6623336	Spontaneous	2013-04-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gastroenteritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Transaminases increased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Unknown - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE, LYSINE ASPIRIN, LYSINE, ACETYLSALICYLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[ALFUZOSIN HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[ALFUZOSIN HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ALLOPURINOL] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[ENOXAPARIN, ENOXAPARIN SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[VALSARTAN] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[VERAPAMIL HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6623336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6614149	Spontaneous	2013-04-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6614149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6608423	Spontaneous	2013-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Urticaria (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6608423&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6599003	Spontaneous	2013-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Swelling face (0d - Recovered/Resolved - );Wheezing (0d - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - Contraception - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6599003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6599053	Spontaneous	2013-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Erythema (n/a - Recovered/Resolved - );Hypersensitivity (n/a - Recovered/Resolved - );Swelling face (n/a - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6599053&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6599346	Spontaneous	2013-04-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6599346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6600518	Spontaneous	2013-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Disturbance in attention (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mood altered (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6600518&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6594536	Spontaneous	2013-04-16 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Bedridden (4d - Recovered/Resolved - Other Medically Important Condition);Decreased appetite (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Feeling abnormal (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6594536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6594852	Spontaneous	2013-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Systemic lupus erythematosus (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6594852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6595107	Spontaneous	2013-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lip swelling (0d - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Unknown - [0d - 0mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6595107&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6595133	Spontaneous	2013-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysarthria (0d - Recovered/Resolved - );Fatigue (1d - Unknown - );Paraesthesia (0d - Unknown - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [n/a - 0mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6595133&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-6595143	Spontaneous	2013-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (0d - Recovered/Resolved - );Fatigue (1d - Recovered/Resolved - );Paraesthesia (0d - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [n/a - 7ug - Intramuscular])|[RAMIPRIL] (S - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[RAMIPRIL] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6595143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6595344	Spontaneous	2013-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (21d - Recovered/Resolved - );Myalgia (21d - Recovered/Resolved - );Pruritus (21d - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 7ug - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Immunisation - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6595344&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Duration
EU-EC-6595392	Spontaneous	2013-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Lethargy (n/a - Unknown - );Malaise (n/a - Unknown - );Pyrexia (n/a - Unknown - );Skin reaction (n/a - Unknown - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Unknown - [1d - n/a - Intramuscular])	[PARACETAMOL, PARACETAMOL PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6595392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6595900	Spontaneous	2013-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Back pain (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling);Infection (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Radiation associated pain (n/a - Unknown - Disabling);Swelling (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CETIRIZINE DIHYDROCHLORIDE] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[ETHINYLESTRADIOL, ETONOGESTREL] (C - Contraception - Unknown - [n/a - n/a - Unknown])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[METHENAMINE HIPPURATE] (C - Urinary tract infection - Unknown - [n/a - n/a - Unknown])|[TERBUTALINE SULFATE, TERBUTALINE SULFATE PH. EUR.] (C - Pneumonia - Unknown - [n/a - n/a - Unknown])|[VENLAFAXINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6595900&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6595947	Spontaneous	2013-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Not Specified	Agitation (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Migraine (0d - Recovering/Resolving - Other Medically Important Condition);Myalgia (1d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (1d - Recovered/Resolved - Other Medically Important Condition);Sleep disorder (1d - Recovered/Resolved With Sequelae - Other Medically Important Condition)	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Ill-defined disorder - Unknown - [n/a - 7ug - Cutaneous])|CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Influenza immunisation - Unknown - [n/a - 7ug - Cutaneous])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Product used for unknown indication - Not applicable - [n/a - n/a - Unknown])	[ETONOGESTREL] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[FLUCLOXACILLIN, FLUCLOXACILLIN SODIUM, FLUCLOXACILLIN SODIUM MONOHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6595947&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-6582015	Spontaneous	2013-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angina pectoris (n/a - Unknown - Disabling);Body temperature fluctuation (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Dysphagia (n/a - Not Recovered/Not Resolved - Disabling);Facial paralysis (n/a - Not Recovered/Not Resolved - Disabling);Glossopharyngeal nerve paralysis (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Inflammation (n/a - Unknown - Disabling);Loss of consciousness (n/a - Unknown - Disabling);Musculoskeletal stiffness (n/a - Unknown - Disabling);Neck pain (n/a - Unknown - Disabling);Pain (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	ANTIBIOTIC [ANTIBIOTICS] (C - n/a - Unknown - [n/a - n/a - n/a])|[IBUPROFEN] (C - Pain - Unknown - [n/a - n/a - n/a])|[ZOPICLONE] (C - Sleep disorder - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6582015&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6583553	Spontaneous	2013-04-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Facial paralysis (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6583553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6576643	Spontaneous	2013-04-10 00:00:00	Healthcare Professional	European Economic Area	Puijenbroek van E, Broos N and Grootheest. Monitoring Adverse Events of the Vaccination Campaign against Influenza A (H1N1) in the Netherlands. Safety Monitoring of Influenza A (H1N1) Vaccination. 2010;33 (12):1097 to 1108	18-64 Years	Adult	No	Female	Death (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	FENTANYL [FENTANYL, FENTANYL CITRATE] (C - Pain - Unknown - [n/a - n/a - n/a])|[FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE MONOHYDRATE] (C - Chronic obstructive pulmonary disease - Unknown - [n/a - n/a - Intratracheal])|[IPRATROPIUM] (C - Chronic obstructive pulmonary disease - Unknown - [n/a - .04mg - Intratracheal])|[LACTULOSE] (C - n/a - Unknown - [n/a - n/a - Oral])|[MORPHINE SULFATE] (C - Pain - Unknown - [n/a - 10mg - Oral])|[OXAZEPAM] (C - n/a - Unknown - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6576643&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6578143	Spontaneous	2013-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Anxiety (n/a - Unknown - Disabling);Balance disorder (n/a - Unknown - Disabling);Body temperature fluctuation (n/a - Unknown - Disabling);Chest pain (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Unknown - Disabling);Headache (n/a - Recovering/Resolving - Disabling);Hypothyroidism (n/a - Unknown - Disabling);Inflammatory pain (n/a - Unknown - Disabling);Loss of consciousness (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Nausea (n/a - Recovering/Resolving - Disabling);Neck pain (n/a - Not Recovered/Not Resolved - Disabling);Physical disability (n/a - Unknown - Disabling);Pyrexia (n/a - Recovering/Resolving - Disabling);Somnolence (n/a - Unknown - Disabling);Vomiting (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	MELATONIN [MELATONIN] (C - Sleep disorder - Drug withdrawn - [n/a - n/a - Unknown])|[DIAZEPAM] (C - Sleep disorder - Unknown - [n/a - n/a - Unknown])|[IBUPROFEN] (C - Pain - Unknown - [n/a - n/a - Unknown])|[OXAZEPAM] (C - Sleep disorder - Unknown - [n/a - n/a - Unknown])|[PROPRANOLOL HYDROCHLORIDE] (C - Migraine - Drug withdrawn - [n/a - n/a - Unknown])|[ZOPICLONE] (C - Sleep disorder - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6578143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6578370	Spontaneous	2013-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Herpes zoster (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6578370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6578371	Spontaneous	2013-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	C-reactive protein increased (n/a - Recovered/Resolved - Other Medically Important Condition);Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6578371&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6578373	Spontaneous	2013-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6578373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6579167	Spontaneous	2013-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Delirium (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6579167&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6579186	Spontaneous	2013-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6579186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6579235	Spontaneous	2013-04-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Anxiety (n/a - Recovered/Resolved With Sequelae - Disabling, Congenital Anomaly);Disturbance in attention (n/a - Recovered/Resolved With Sequelae - Disabling, Congenital Anomaly);Eye pain (n/a - Recovered/Resolved With Sequelae - Disabling, Congenital Anomaly);Fatigue (n/a - Recovered/Resolved With Sequelae - Disabling, Congenital Anomaly);Headache (n/a - Recovered/Resolved With Sequelae - Disabling, Congenital Anomaly);Hypoaesthesia (n/a - Recovered/Resolved With Sequelae - Disabling, Congenital Anomaly);Memory impairment (n/a - Recovered/Resolved With Sequelae - Disabling, Congenital Anomaly);Pain (n/a - Recovered/Resolved With Sequelae - Disabling, Congenital Anomaly);Sleep disorder (n/a - Recovered/Resolved With Sequelae - Disabling, Congenital Anomaly);Tremor (n/a - Recovered/Resolved With Sequelae - Disabling, Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6579235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-6572432	Spontaneous	2013-04-09 00:00:00	Healthcare Professional	European Economic Area	Puijenbroek van E, Broos N and Grootheest. Monitoring Adverse Events of the Vaccination Campaign against Influenza A (H1N1) in the Netherlands. Safety Monitoring of Influenza A (H1N1) Vaccination. 2010;33 (12):1097 to 1108	More than 85 Years	Elderly	Yes	Female	Ventricular fibrillation (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6572432&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6572693	Spontaneous	2013-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Brain abscess (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6572693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6572694	Spontaneous	2013-04-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Depression (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6572694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6573102	Spontaneous	2013-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6573102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6573805	Spontaneous	2013-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovering/Resolving - Disabling);Chronic fatigue syndrome (n/a - Recovering/Resolving - Disabling);Cough (n/a - Recovering/Resolving - Disabling);Educational problem (n/a - Recovering/Resolving - Disabling);Encephalitis (n/a - Recovering/Resolving - Disabling);Fatigue (n/a - Recovering/Resolving - Disabling);Feeling cold (n/a - Recovering/Resolving - Disabling);Fluid intake reduced (n/a - Recovering/Resolving - Disabling);Hyperhidrosis (n/a - Recovering/Resolving - Disabling);Hypersomnia (n/a - Recovering/Resolving - Disabling);Lymphadenopathy (n/a - Recovering/Resolving - Disabling);Muscle contractions involuntary (n/a - Recovering/Resolving - Disabling);Nausea (n/a - Recovering/Resolving - Disabling);Oropharyngeal pain (n/a - Recovering/Resolving - Disabling);Palpitations (n/a - Recovering/Resolving - Disabling);Pyrexia (n/a - Recovering/Resolving - Disabling);Respiratory tract infection viral (n/a - Recovering/Resolving - Disabling);Urticaria (n/a - Recovering/Resolving - Disabling);Vascular headache (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6573805&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6573810	Spontaneous	2013-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tension headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6573810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6573811	Spontaneous	2013-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6573811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6574829	Spontaneous	2013-04-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle twitching (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6574829&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6575231	Spontaneous	2013-04-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6575231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6567799	Spontaneous	2013-04-08 00:00:00	Healthcare Professional	European Economic Area	Puijenbroek van E, Broos N and Grootheest. Monitoring Adverse Events of the Vaccination Campaign against Influenza A (H1N1) in the Netherlands. Safety Monitoring of Influenza A (H1N1) Vaccination. 2010;33 (12):1097 to 1108	65-85 Years	Elderly	Yes	Male	Death (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6567799&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6568999	Spontaneous	2013-04-08 00:00:00	Healthcare Professional	European Economic Area	Puijenbroek van E, Broos N and Grootheest. Monitoring Adverse Events of the Vaccination Campaign against Influenza A (H1N1) in the Netherlands. Safety Monitoring of Influenza A (H1N1) Vaccination. 2010;33 (12):1097 to 1108	65-85 Years	Elderly	Yes	Male	Brain compression (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Cerebral haemorrhage (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Depressed level of consciousness (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Drug interaction (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Fatigue (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Haemorrhage (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Headache (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (I - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[ACENOCOUMAROL] (I - Prophylaxis - Not applicable - [1d - 1mg - Oral])	[GLICLAZIDE] (C - n/a - Dose not changed - [n/a - 80mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 500mg - Oral])|[NIFEDIPINE] (C - n/a - Dose not changed - [n/a - 20mg - Oral])|[PANTOPRAZOLE] (C - n/a - Dose not changed - [n/a - 40mg - Oral])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - Unknown - [n/a - n/a - n/a])|[SOTALOL HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6568999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6569097	Spontaneous	2013-04-08 00:00:00	Healthcare Professional	European Economic Area	Puijenbroek van E, Broos N and Grootheest. Monitoring Adverse Events of the Vaccination Campaign against Influenza A (H1N1) in the Netherlands. Safety Monitoring of Influenza A (H1N1) Vaccination. 2010;33 (12):1097 to 1108	18-64 Years	Adult	No	Female	Cardiac arrest (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])|VIMPAT [LACOSAMIDE] (S - Epilepsy - Unknown - [n/a - 50mg - Oral])	AERIUS [DESLORATADINE] (C - n/a - Unknown - [n/a - 5mg - Oral])|KEPPRA [LEVETIRACETAM] (C - n/a - Unknown - [n/a - 250mg - Oral])|[CLONAZEPAM] (C - n/a - Unknown - [n/a - .5mg - Oral])|[DESOGESTREL] (C - n/a - Unknown - [n/a - .075mg - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - 50mg - Oral])|[LACTULOSE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[OXAZEPAM] (C - n/a - Unknown - [n/a - 20mg - Oral])|[OXCARBAZEPINE] (C - n/a - Unknown - [n/a - 150mg - Oral])|[RISPERIDONE] (C - n/a - Unknown - [n/a - 1mg - Oral])|[TRIAMTERENE] (C - n/a - Unknown - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6569097&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6563706	Spontaneous	2013-04-05 00:00:00	Healthcare Professional	European Economic Area	Puijenbroek van E, Broos N and Grootheest. Monitoring Adverse Events of the Vaccination Campaign against Influenza A (H1N1) in the Netherlands. Safety Monitoring of Influenza A (H1N1) Vaccination. 2010;33 (12):1097 to 1108	18-64 Years	Adult	No	Male	Myocardial infarction (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ATORVASTATIN] (C - Cardiac disorder - Unknown - [n/a - 40mg - Oral])|[CARBASALATE CALCIUM] (C - Cardiac disorder - Unknown - [n/a - 100mg - Oral])|[METOPROLOL TARTRATE] (C - Cardiac disorder - Unknown - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6563706&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6557972	Spontaneous	2013-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6557972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6558025	Spontaneous	2013-04-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6558025&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6558026	Spontaneous	2013-04-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6558026&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6553172	Spontaneous	2013-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Serum sickness-like reaction (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Ill-defined disorder - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6553172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6553421	Spontaneous	2013-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6553421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6556353	Spontaneous	2013-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Blood pressure immeasurable (n/a - Recovered/Resolved - Other Medically Important Condition);Depressed level of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition);Pulse absent (n/a - Recovered/Resolved - Other Medically Important Condition);Throat irritation (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6556353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6556370	Spontaneous	2013-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tendonitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6556370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6556426	Spontaneous	2013-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6556426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6548670	Spontaneous	2013-04-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6548670&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6548875	Spontaneous	2013-04-02 00:00:00	Non Healthcare Professional	European Economic Area	Journal: Case Reports in Rheumatology Author: Ferri C, Colaci M, Manzini C, Sebatiani M, Giuggioli D and Brugioni L Title: Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines Year: 2012	18-64 Years	Not Specified	No	Female	Depression (n/a - Unknown - );Fibromyalgia (n/a - Unknown - );Pneumonitis (n/a - Unknown - );Polymyositis (n/a - Unknown - );Pyrexia (n/a - Unknown - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6548875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-6548876	Spontaneous	2013-04-02 00:00:00	Non Healthcare Professional	European Economic Area	Journal: Case Reports in Rheumatology Author: Ferri C, Colaci M, Manzini C, Sebatiani M, Giuggioli D and Brugioni L Title: Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines Year: 2012	65-85 Years	Not Specified	No	Female	Dermatomyositis (n/a - Unknown - );Epstein-Barr virus infection reactivation (n/a - Unknown - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6548876&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6548879	Spontaneous	2013-04-02 00:00:00	Non Healthcare Professional	European Economic Area	Journal: Case Reports in Rheumatology Author: Ferri C, Colaci M, Manzini C, Sebatiani M, Giuggioli D and Brugioni L Title: Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines Year: 2012	18-64 Years	Not Specified	No	Male	Fibromyalgia (n/a - Unknown - );Pneumonitis (n/a - Unknown - );Polymyositis (n/a - Unknown - );Pyrexia (n/a - Unknown - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6548879&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-6549584	Spontaneous	2013-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Skin disorder (n/a - Unknown - );Type IV hypersensitivity reaction (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6549584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6552293	Spontaneous	2013-04-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Neuralgic amyotrophy (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6552293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6538803	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Pruritus (n/a - Unknown - );Urticaria (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6538803&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6539257	Spontaneous	2013-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6539257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6527537	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6527599	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Anxiety (n/a - Not Recovered/Not Resolved - Disabling);Asocial behaviour (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Conjunctivitis (n/a - Unknown - Disabling);Depression (n/a - Not Recovered/Not Resolved - Disabling);Dysphagia (n/a - Recovered/Resolved - Disabling);Dyspnoea (n/a - Recovered/Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersensitivity (n/a - Recovered/Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Ill-defined disorder (n/a - Not Recovered/Not Resolved - Disabling);Ligament sprain (n/a - Unknown - Disabling);Pain in extremity (n/a - Unknown - Disabling);Rest regimen (n/a - Not Recovered/Not Resolved - Disabling);School refusal (n/a - Not Recovered/Not Resolved - Disabling);Upper respiratory tract infection (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CETIRIZINE DIHYDROCHLORIDE] (C - Hypersensitivity - Unknown - [n/a - 10mg - Unknown])|[EPINEPHRINE] (C - Hypersensitivity - Unknown - [n/a - n/a - Unknown])|[PREDNISOLONE] (C - Hypersensitivity - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6527600	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Optic neuritis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Renal impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Urinary retention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Urinary tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	VIAGRA [SILDENAFIL, SILDENAFIL CITRATE] (C - Erectile dysfunction - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527600&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6527601	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Ataxia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Demyelinating polyneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysstasia (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Infection (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Periarthritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Radiation associated pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Sensory loss (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Staphylococcal infection (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Urinary retention (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - n/a - Unknown])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SIMVASTATIN] (C - Hypercholesterolaemia - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6527602	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthma (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic sinusitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Coeliac disease (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);General physical health deterioration (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Vertigo (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Drug withdrawn - [n/a - n/a - Unknown])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[MONTELUKAST, MONTELUKAST SODIUM] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6527603	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Muscle fatigue (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6527604	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Unknown - Disabling);Hyperhidrosis (n/a - Unknown - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Unknown - Disabling);Memory impairment (n/a - Unknown - Disabling);Muscle twitching (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Parosmia (n/a - Unknown - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Sleep disorder (n/a - Unknown - Disabling);Temperature intolerance (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	AERIUS [DESLORATADINE] (C - Asthma - Unknown - [n/a - 5mg - n/a])|IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - Pain - Unknown - [n/a - 600mg - n/a])|[FLUTICASONE PROPIONATE] (C - Asthma - Unknown - [n/a - 250ug - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - Asthma - Unknown - [n/a - 50ug - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6527605	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Disabling);Bone pain (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disability (n/a - Unknown - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Unknown - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Recovered/Resolved - Disabling);Memory impairment (n/a - Unknown - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Neck pain (n/a - Recovering/Resolving - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Stress (n/a - Not Recovered/Not Resolved - Disabling);Vertigo (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ESTRADIOL, ESTRADIOL HEMIHYDRATE] (C - n/a - Unknown - [n/a - 25ug - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527605&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6527608	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anger (n/a - Not Recovered/Not Resolved - Disabling);Autonomic nervous system imbalance (n/a - Not Recovered/Not Resolved - Disabling);Body temperature fluctuation (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling);Hyperacusis (n/a - Unknown - Disabling);Irritability (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal pain (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	MICARDIS [TELMISARTAN] (C - Hypertension - Unknown - [n/a - 80mg - Unknown])|[ALLOPURINOL] (C - Blood uric acid increased - Unknown - [n/a - 300mg - Unknown])|[BENDROFLUMETHIAZIDE] (C - Hypertension - Unknown - [n/a - 5mg - Unknown])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - Gastrooesophageal reflux disease - Unknown - [n/a - 40mg - Unknown])|[NAPROXEN, NAPROXEN SODIUM] (C - Pain - Unknown - [n/a - 250mg - Unknown])|[PARACETAMOL] (C - Pain - Unknown - [n/a - n/a - Unknown])|[TRAMADOL HYDROCHLORIDE] (C - Pain - Unknown - [n/a - 50mg - Unknown])|[VALSARTAN] (C - Hypertension - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6527609	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Autonomic nervous system imbalance (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Unknown - Disabling);Disability (n/a - Unknown - Disabling);General physical health deterioration (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Hypersensitivity (n/a - Unknown - Disabling);Mental impairment (n/a - Unknown - Disabling);Musculoskeletal pain (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Sleep disorder (n/a - Unknown - Disabling);Vomiting (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	EXFORGE [VALSARTAN, AMLODIPINE, VALSARTAN, AMLODIPINE BESILATE] (C - n/a - Drug withdrawn - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - n/a - Drug withdrawn - [n/a - n/a - n/a])|[CARVEDILOL] (C - n/a - Dose not changed - [n/a - n/a - n/a])|[LABETALOL HYDROCHLORIDE] (C - n/a - Drug withdrawn - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - Drug withdrawn - [n/a - n/a - n/a])|[VALSARTAN] (C - n/a - Dose not changed - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527609&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6527610	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Polydipsia (n/a - Unknown - Other Medically Important Condition);Thirst (n/a - Unknown - Other Medically Important Condition);Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight decreased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527610&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6527614	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Behaviour disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Developmental delay (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tuberous sclerosis complex (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[SODIUM VALPROATE] (C - Seizure - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6527615	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cholelithiasis (n/a - Unknown - Caused/Prolonged Hospitalisation);Constipation (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Intestinal pseudo-obstruction (n/a - Unknown - Caused/Prolonged Hospitalisation);Mucosal inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle spasticity (n/a - Unknown - Caused/Prolonged Hospitalisation);Myelitis transverse (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuromyelitis optica spectrum disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paresis (n/a - Unknown - Caused/Prolonged Hospitalisation);Urinary incontinence (n/a - Unknown - Caused/Prolonged Hospitalisation);Urinary retention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[EBASTINE] (C - Hypersensitivity - Unknown - [n/a - n/a - Unknown])|[ENOXAPARIN SODIUM] (C - Thrombosis prophylaxis - Drug withdrawn - [n/a - n/a - Unknown])|[FEXOFENADINE, FEXOFENADINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LACTULOSE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527615&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6527616	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Clavicle fracture (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Presyncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vertigo (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - Pain - Drug withdrawn - [n/a - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[ALIMEMAZINE TARTRATE] (C - Sleep disorder - Unknown - [n/a - n/a - Unknown])|[AMITRIPTYLINE HYDROCHLORIDE] (C - Depression - Drug withdrawn - [n/a - n/a - Unknown])|[CETIRIZINE DIHYDROCHLORIDE] (C - Hypersensitivity - Unknown - [n/a - n/a - Unknown])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - Pain - Drug withdrawn - [n/a - n/a - Unknown])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Depression - Drug withdrawn - [n/a - n/a - Unknown])|[FLUPENTIXOL, FLUPENTIXOL DECANOATE, FLUPENTIXOL HYDROCHLORIDE] (C - Mental disorder - Unknown - [n/a - n/a - Unknown])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[LEVOMEPROMAZINE, LEVOMEPROMAZINE EMBONATE, LEVOMEPROMAZINE HYDROCHLORIDE, LEVOMEPROMAZINE MALEATE] (C - Mental disorder - Drug withdrawn - [n/a - n/a - Unknown])|[MOCLOBEMIDE] (C - Depression - Unknown - [n/a - n/a - Unknown])|[OXAZEPAM] (C - Mental disorder - Unknown - [n/a - n/a - Unknown])|[PARACETAMOL] (C - Pain - Unknown - [n/a - n/a - Unknown])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - Mental disorder - Drug withdrawn - [n/a - n/a - Unknown])|[ZOPICLONE] (C - Sleep disorder - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6527617	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Atrial fibrillation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Blood pressure increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dysaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Respiratory disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[LORATADINE] (C - Hypersensitivity - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527617&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6527618	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Fibromyalgia (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6527618&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6528453	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myelitis transverse (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urinary retention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6528453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6528626	Spontaneous	2013-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthma (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Eosinophilic granulomatosis with polyangiitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Eosinophilic pneumonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Increased bronchial secretion (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Lung infiltration (n/a - Unknown - Caused/Prolonged Hospitalisation);Nasal obstruction (n/a - Unknown - Caused/Prolonged Hospitalisation);Night sweats (n/a - Unknown - Caused/Prolonged Hospitalisation);Paranasal sinus hypersecretion (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Productive cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Secretion discharge (n/a - Unknown - Caused/Prolonged Hospitalisation);Sinusitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6528626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6523412	Spontaneous	2013-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Joint swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6523412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6523417	Spontaneous	2013-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6523417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6523418	Spontaneous	2013-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Fine motor skill dysfunction (n/a - Not Recovered/Not Resolved - Disabling);Hyperaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Neuralgia (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Peripheral coldness (n/a - Not Recovered/Not Resolved - Disabling);Sensory loss (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	STEROID CREAM [STEROID] (C - Pustule - Unknown - [n/a - n/a - n/a])|XENICAL [ORLISTAT] (C - Weight decreased - Unknown - [n/a - n/a - n/a])|[CLOBETASOL PROPIONATE] (C - Pustule - Unknown - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6523418&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6523428	Spontaneous	2013-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6523428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6523433	Spontaneous	2013-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depressed mood (n/a - Unknown - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6523433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6517114	Spontaneous	2013-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Unknown - Disabling);Agitation (n/a - Unknown - Disabling);Antisocial personality disorder (n/a - Not Recovered/Not Resolved - Disabling);Anxiety (n/a - Not Recovered/Not Resolved - Disabling);Gastrooesophageal reflux disease (n/a - Unknown - Disabling);General physical health deterioration (n/a - Unknown - Disabling);Hallucination (n/a - Not Recovered/Not Resolved - Disabling);Incontinence (n/a - Unknown - Disabling);Infection (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Obsessive-compulsive disorder (n/a - Unknown - Disabling);Panic attack (n/a - Unknown - Disabling);Personality change (n/a - Not Recovered/Not Resolved - Disabling);Slow response to stimuli (n/a - Not Recovered/Not Resolved - Disabling);Weight increased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	MELATONIN [MELATONIN] (C - n/a - Dose not changed - [n/a - 3mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6517114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6512689	Spontaneous	2013-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6512689&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6512690	Spontaneous	2013-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diabetes mellitus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6512690&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6512691	Spontaneous	2013-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depressed mood (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Lip swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Taste disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tongue oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6512691&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6506839	Spontaneous	2013-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Muscle disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6506839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6507260	Spontaneous	2013-03-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Breath sounds abnormal (n/a - Not Recovered/Not Resolved - );Cough (n/a - Not Recovered/Not Resolved - );Pyrexia (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6507260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6508860	Spontaneous	2013-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6508860&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6502413	Spontaneous	2013-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6502413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6494611	Spontaneous	2013-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6494611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6494612	Spontaneous	2013-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Clumsiness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoacusis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Motor dysfunction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6494612&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6489330	Spontaneous	2013-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6489330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6489698	Spontaneous	2013-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6489698&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6489699	Spontaneous	2013-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6489699&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6489700	Spontaneous	2013-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6489700&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6489701	Spontaneous	2013-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amnesia (n/a - Unknown - Disabling, Other Medically Important Condition);Aphasia (n/a - Unknown - Disabling, Other Medically Important Condition);Arthropathy (n/a - Unknown - Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Autonomic nervous system imbalance (n/a - Unknown - Disabling, Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Body temperature fluctuation (n/a - Unknown - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depressed level of consciousness (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Depressed mood (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disability (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Disabling, Other Medically Important Condition);Feeling hot (n/a - Unknown - Disabling, Other Medically Important Condition);Fibromyalgia (n/a - Unknown - Disabling, Other Medically Important Condition);Gastrointestinal motility disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Hyperacusis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Disabling, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Disabling, Other Medically Important Condition);Insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Irritable bowel syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Joint stiffness (n/a - Unknown - Disabling, Other Medically Important Condition);Judgement impaired (n/a - Unknown - Disabling, Other Medically Important Condition);Learning disorder (n/a - Unknown - Disabling, Other Medically Important Condition);Lymph node pain (n/a - Unknown - Disabling, Other Medically Important Condition);Lymphadenopathy (n/a - Unknown - Disabling, Other Medically Important Condition);Middle insomnia (n/a - Unknown - Disabling, Other Medically Important Condition);Muscle fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Myalgia (n/a - Unknown - Disabling, Other Medically Important Condition);Nausea (n/a - Unknown - Disabling, Other Medically Important Condition);Nocturia (n/a - Unknown - Disabling, Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain of skin (n/a - Unknown - Disabling, Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Disabling, Other Medically Important Condition);Periorbital oedema (n/a - Unknown - Disabling, Other Medically Important Condition);Photophobia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pollakiuria (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - Unknown - [n/a - 50mg - Unknown])|[ZOPICLONE] (C - Sleep disorder - Unknown - [n/a - 7.5mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6489701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6489744	Spontaneous	2013-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Ageusia (n/a - Unknown - Other Medically Important Condition);Anosmia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Influenza (6d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Nasopharyngitis (6d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6489744&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-6491190	Spontaneous	2013-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6491190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6493963	Spontaneous	2013-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Foetal death (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6493963&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6479192	Spontaneous	2013-03-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chest discomfort (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Throat tightness (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Wheezing (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [1d - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6479192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6488083	Spontaneous	2013-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6488083&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6479646	Spontaneous	2013-03-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Epilepsy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6479646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6479647	Spontaneous	2013-03-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Back pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Joint stiffness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Migraine (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Musculoskeletal stiffness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6479647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6479668	Spontaneous	2013-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6479668&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6479704	Spontaneous	2013-03-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Gastrointestinal infection (n/a - Recovering/Resolving - Other Medically Important Condition);Lymphadenopathy (n/a - Recovering/Resolving - Other Medically Important Condition);Muscle atrophy (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Weight decreased (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6479704&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6480019	Spontaneous	2013-03-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Joint dislocation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myocardial infarction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myocarditis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6480019&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6480047	Spontaneous	2013-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6480047&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6480745	Spontaneous	2013-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Epilepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6480745&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6477038	Spontaneous	2013-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Derealisation (n/a - Unknown - Other Medically Important Condition);Discomfort (1wk - Recovered/Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia-bulimia syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Increased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Magical thinking (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Social avoidant behaviour (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6477038&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6468399	Spontaneous	2013-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .2mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6468399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6473195	Spontaneous	2013-03-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diarrhoea (n/a - Not Recovered/Not Resolved - Disabling);Disorientation (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling);Eye movement disorder (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Gulf war syndrome (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Loss of consciousness (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Motor dysfunction (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Myofascitis (n/a - Not Recovered/Not Resolved - Disabling);Nervous system disorder (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Respiratory disorder (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[DIPHTHERIA, TETANUS AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED, REDUCED ANTIGEN(S) CONTENT)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6473195&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6464131	Spontaneous	2013-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dry eye (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myopia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6464131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6464175	Spontaneous	2013-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6464175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6464197	Spontaneous	2013-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Altered state of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Crying (n/a - Recovered/Resolved - Other Medically Important Condition);Delirium (n/a - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6464197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6457133	Spontaneous	2013-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Generalised tonic-clonic seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lymphoma (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6457133&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6461118	Spontaneous	2013-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6461118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6461142	Spontaneous	2013-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6461142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6461145	Spontaneous	2013-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Neuropsychological symptoms (n/a - Not Recovered/Not Resolved - Disabling);Parkinsonism (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Antiviral prophylaxis - Dose not changed - [n/a - 1{DF} - Intramuscular])	LEVETIRACETAM [LEVETIRACETAM] (C - n/a - n/a - [n/a - n/a - n/a])|TACROLIMUS [TACROLIMUS, TACROLIMUS MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CLONAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6461145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6461196	Spontaneous	2013-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6461196&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6452260	Spontaneous	2013-03-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6452260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6447926	Spontaneous	2013-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6447926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6448675	Spontaneous	2013-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Arthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Depressed mood (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tendonitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tooth disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6448675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6448698	Spontaneous	2013-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pain (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6448698&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-6438760	Spontaneous	2013-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Pain (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - n/a])	[IBUPROFEN] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6438760&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6430914	Spontaneous	2013-02-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Aphasia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Calculus urinary (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Communication disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Demyelination (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysphagia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nosocomial infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ophthalmoplegia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Psychomotor hyperactivity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Quadriparesis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Renal disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory failure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6430914&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6427290	Spontaneous	2013-02-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6427290&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6408484	Spontaneous	2013-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amyotrophic lateral sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (S - Depression - Drug withdrawn - [n/a - 15mg - Oral])	[ACETYLSALICYLIC ACID, CAFFEINE] (C - n/a - n/a - [n/a - n/a - Oral])|[ALMOTRIPTAN, ALMOTRIPTAN MALATE] (C - n/a - n/a - [n/a - 13mg - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 13ug - Oral])|[NAPROXEN] (C - n/a - n/a - [n/a - 500mg - Oral])|[PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - 500mg - Oral])|[ZOPICLONE] (C - n/a - n/a - [n/a - 8mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6408484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6414212	Spontaneous	2013-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Skin reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6414212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6414214	Spontaneous	2013-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Large intestinal ulcer (n/a - Recovered/Resolved With Sequelae - Disabling);Proctitis ulcerative (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6414214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-6405275	Spontaneous	2013-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Immune thrombocytopenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])|[ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE] (S - Essential hypertension - Drug withdrawn - [n/a - n/a - Oral])|[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (S - n/a - n/a - [n/a - 25mg - Oral])|[SIMVASTATIN] (S - Hyperlipidaemia - Drug withdrawn - [n/a - 20mg - Oral])|[SIMVASTATIN] (S - Hypertriglyceridaemia - Drug withdrawn - [n/a - 20mg - Oral])	[TERBUTALINE SULFATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6405275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6410674	Spontaneous	2013-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ageusia (n/a - Unknown - Disabling, Other Medically Important Condition);Aphasia (n/a - Unknown - Disabling, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Back pain (2d - Recovered/Resolved - Disabling, Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Blepharospasm (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Bradyphrenia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Clumsiness (n/a - Unknown - Disabling, Other Medically Important Condition);Confusional state (n/a - Unknown - Disabling, Other Medically Important Condition);Contusion (n/a - Unknown - Disabling, Other Medically Important Condition);Crying (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Decreased appetite (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disorientation (n/a - Unknown - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Disabling, Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Feeling abnormal (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Feeling cold (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Feeling hot (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Flushing (n/a - Unknown - Disabling, Other Medically Important Condition);Fumbling (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Gastritis (n/a - Unknown - Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Disabling, Other Medically Important Condition);Hyperacusis (n/a - Unknown - Disabling, Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Disabling, Other Medically Important Condition);Hypoaesthesia oral (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypokinesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Limb discomfort (n/a - Unknown - Disabling, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Unknown - Disabling, Other Medically Important Condition);Motor dysfunction (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Muscle fatigue (n/a - Unknown - Disabling, Other Medically Important Condition);Muscle spasms (n/a - Unknown - Disabling, Other Medically Important Condition);Muscle tightness (n/a - Unknown - Disabling, Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6410674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6411148	Spontaneous	2013-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion late (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6411148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6411149	Spontaneous	2013-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Stillbirth (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6411149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6411150	Spontaneous	2013-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Restlessness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6411150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6412699	Spontaneous	2013-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Educational problem (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (7mo - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep study abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (7mo - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE] (C - Asthma - n/a - [n/a - 250ug - Respiratory (inhalation)])|[FLUTICASONE PROPIONATE] (C - Rhinitis - n/a - [n/a - 50ug - Nasal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6412699&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6403694	Spontaneous	2013-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Acute kidney injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Blood creatinine increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Feeling cold (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nephritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nephrotic syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Transplant rejection (n/a - Unknown - Caused/Prolonged Hospitalisation);Type IV hypersensitivity reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	CELLCEPT [MYCOPHENOLATE MOFETIL] (C - n/a - Unknown - [n/a - 500mg - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - n/a])|[ALFACALCIDOL] (C - n/a - Unknown - [n/a - .25ug - n/a])|[CANDESARTAN CILEXETIL] (C - n/a - Unknown - [n/a - 16mg - n/a])|[CICLOSPORIN] (C - n/a - Unknown - [n/a - 10mg - n/a])|[CICLOSPORIN] (C - n/a - Unknown - [n/a - 50mg - n/a])|[CYCLOPHOSPHAMIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[FELODIPINE, FELODIPINE PH. EUR.] (C - n/a - Unknown - [n/a - 2.5mg - n/a])|[FUROSEMIDE] (C - n/a - Unknown - [n/a - 60mg - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - 50mg - n/a])|[PARACETAMOL] (C - n/a - Unknown - [n/a - 500mg - n/a])|[PREDNISOLONE] (C - n/a - Unknown - [n/a - 5mg - n/a])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 40mg - n/a])|[WARFARIN SODIUM] (C - Prophylaxis - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6403694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6405199	Spontaneous	2013-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6405199&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6405262	Spontaneous	2013-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain of skin (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tendonitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6405262&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6405678	Spontaneous	2013-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6405678&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6399064	Spontaneous	2013-02-19 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Diabetes insipidus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypophysitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6399064&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6399122	Spontaneous	2013-02-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Encephalitis (n/a - Unknown - Other Medically Important Condition);Epilepsy (n/a - Recovered/Resolved - Other Medically Important Condition);Psychotic disorder (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition);Status epilepticus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6399122&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6400531	Spontaneous	2013-02-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6400531&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6400841	Spontaneous	2013-02-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Distractibility (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [3mo - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6400841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6392976	Spontaneous	2013-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Asthmatic crisis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyskinesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Eye swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Obstructive airways disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pharyngeal swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6392976&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6393030	Spontaneous	2013-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [n/a - .5mL - Intramuscular])|[IBUPROFEN] (S - Product used for unknown indication - Drug withdrawn - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6393030&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6393052	Spontaneous	2013-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Facial paralysis (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6393052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6393389	Spontaneous	2013-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Dysuria (n/a - Unknown - Caused/Prolonged Hospitalisation);Haematuria (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Kidney transplant rejection (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	TACROLIMUS [TACROLIMUS, TACROLIMUS MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[AZATHIOPRINE] (C - n/a - Unknown - [n/a - n/a - n/a])|[CORTISONE] (C - n/a - Unknown - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, LOSARTAN, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - Unknown - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - Unknown - [n/a - n/a - n/a])|[SULFAMETHOXAZOLE, TRIMETHOPRIM] (C - n/a - Unknown - [n/a - n/a - n/a])|[TACROLIMUS, TACROLIMUS MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6393389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6396765	Spontaneous	2013-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Amnesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dementia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Encephalitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Seizure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Venous thrombosis limb (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6396765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6396894	Spontaneous	2013-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6396894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6391897	Spontaneous	2013-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Agranulocytosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Autoimmune neutropenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Ear infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMOXICILLIN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[IBUPROFEN] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6391897&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6395033	Spontaneous	2013-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	General physical health deterioration (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hepatic cytolysis (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Renal failure (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);White blood cell count increased (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	COAPROVEL [HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - Hypertension - Dose not changed - [n/a - n/a - Oral])|[AMIODARONE, AMIODARONE HYDROCHLORIDE] (C - Arrhythmia - Dose not changed - [n/a - n/a - Oral])|[BISOPROLOL HEMIFUMARATE] (C - Cardiac failure - Dose not changed - [n/a - n/a - Oral])|[FLUINDIONE] (C - Thrombosis prophylaxis - Dose not changed - [n/a - n/a - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Dyslipidaemia - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6395033&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6395287	Spontaneous	2013-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Acute febrile neutrophilic dermatosis (29d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[AMISULPRIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CLOBAZAM] (C - n/a - n/a - [n/a - n/a - n/a])|[NITRAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPRANOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM VALPROATE, VALPROIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[TRIHEXYPHENIDYL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6395287&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6388281	Spontaneous	2013-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hyperaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Injection site erythema (n/a - Recovered/Resolved - Disabling);Injection site pain (n/a - Recovered/Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6388281&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6382368	Spontaneous	2013-02-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Unknown - Congenital Anomaly);Asthenia (n/a - Unknown - Congenital Anomaly);Asthma (n/a - Unknown - Congenital Anomaly);Autoimmune thyroiditis (n/a - Unknown - Congenital Anomaly);Blood thyroid stimulating hormone increased (n/a - Unknown - Congenital Anomaly);Chest pain (n/a - Unknown - Congenital Anomaly);Depressed mood (n/a - Unknown - Congenital Anomaly);Disturbance in attention (n/a - Unknown - Congenital Anomaly);Exercise tolerance decreased (n/a - Unknown - Congenital Anomaly);Fatigue (n/a - Unknown - Congenital Anomaly);Headache (n/a - Unknown - Congenital Anomaly);Milk allergy (n/a - Unknown - Congenital Anomaly);Personality change (n/a - Unknown - Congenital Anomaly);Syncope (n/a - Unknown - Congenital Anomaly);Tremor (n/a - Unknown - Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6382368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Severe reaction
EU-EC-6382374	Spontaneous	2013-02-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6382374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6382802	Spontaneous	2013-02-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6382802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6383456	Spontaneous	2013-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chills (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Joint stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myositis (2mo - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhabdomyolysis (2mo - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6383456&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6379701	Spontaneous	2013-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6379701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6379705	Spontaneous	2013-02-12 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Abnormal behaviour (2a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (2a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6379705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6381181	Spontaneous	2013-02-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[SIBUTRAMINE HYDROCHLORIDE, SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE] (C - Weight decreased - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6381181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6374181	Spontaneous	2013-02-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Blindness transient (n/a - Recovered/Resolved - Other Medically Important Condition);Meningitis (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Visual acuity reduced (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6374181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6377269	Spontaneous	2013-02-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	NOVORAPID [INSULIN ASPART] (C - n/a - n/a - [n/a - n/a - n/a])|[CODEINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - Prophylaxis - n/a - [1d - n/a - Unknown])|[MIANSERIN, MIANSERIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6377269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6377701	Spontaneous	2013-02-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal pain (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	KALETRA [LOPINAVIR, RITONAVIR] (C - HIV infection - n/a - [n/a - 200mg - Oral])|TRUVADA [EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE] (C - HIV infection - n/a - [n/a - 245mg - Oral])|[FERRIC HYDROXIDE POLYMALTOSE COMPLEX, FERROUS FUMARATE, FERROUS GLUCONATE, FERROUS GLUCONATE PH.EUR., IRON] (C - Iron deficiency anaemia - n/a - [n/a - n/a - n/a])|[SULFAMETHOXAZOLE, TRIMETHOPRIM] (C - Product used for unknown indication - n/a - [n/a - 960mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6377701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6372781	Spontaneous	2013-02-08 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Henoch-Schonlein purpura (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6372781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6360285	Spontaneous	2013-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DOXYCYCLINE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROXYCHLOROQUINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6360285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6360287	Spontaneous	2013-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6360287&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6360570	Spontaneous	2013-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Seizure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6360570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6362110	Spontaneous	2013-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Anaphylactoid reaction (2h - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (2h - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia oral (2h - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal chest pain (2h - Recovered/Resolved - Other Medically Important Condition);Pallor (2h - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (2h - Recovered/Resolved - Other Medically Important Condition);Tachycardia (2h - Recovered/Resolved - Other Medically Important Condition);Tremor (2h - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6362110&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6362126	Spontaneous	2013-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Blood pressure fluctuation (10min - Recovered/Resolved - Other Medically Important Condition);Cardiovascular disorder (30min - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (10min - Recovered/Resolved - Other Medically Important Condition);Flushing (10min - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (30min - Recovered/Resolved - Other Medically Important Condition);Laryngeal oedema (30min - Recovered/Resolved - Other Medically Important Condition);Myalgia (30min - Recovered/Resolved - Other Medically Important Condition);Palpitations (10min - Recovered/Resolved - Other Medically Important Condition);Sensation of foreign body (10min - Recovered/Resolved - Other Medically Important Condition);Suffocation feeling (30min - Recovered/Resolved - Other Medically Important Condition);Throat tightness (30min - Recovered/Resolved - Other Medically Important Condition);Type I hypersensitivity (30min - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6362126&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6363982	Spontaneous	2013-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Focal segmental glomerulosclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6363982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6356276	Spontaneous	2013-02-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Bronchospasm (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Laryngeal oedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Type I hypersensitivity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - n/a - Unknown - [1d - 1{DF} - Parenteral])|[LORATADINE] (S - n/a - Dose not changed - [n/a - .8mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6356276&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6356509	Spontaneous	2013-02-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6356509&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6356215	Spontaneous	2013-02-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Wheezing (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6356215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6348313	Spontaneous	2013-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6348313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-6336835	Spontaneous	2013-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Hypnopompic hallucination (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6336835&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6336877	Spontaneous	2013-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	[EBASTINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6336877&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6336918	Spontaneous	2013-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Growth retardation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypothyroidism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6336918&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6333905	Spontaneous	2013-01-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ageusia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anosmia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic sinusitis (n/a - Unknown - Other Medically Important Condition);Dysgeusia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypogeusia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyposmia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sinusitis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Dose not changed - [n/a - .5mL - n/a])	IRON [IRON] (C - n/a - n/a - [n/a - n/a - n/a])|[VITAMIN B12] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6333905&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6322427	Spontaneous	2013-01-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Alopecia (n/a - Recovered/Resolved - Other Medically Important Condition);Aphasia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arrhythmia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Burning sensation (n/a - Unknown - Other Medically Important Condition);Chest pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chills (n/a - Unknown - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Other Medically Important Condition);Clumsiness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dry mouth (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysgraphia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphagia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);External ear pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eye pain (n/a - Recovered/Resolved - Other Medically Important Condition);Facial pain (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Foreign body sensation in eyes (n/a - Recovered/Resolved - Other Medically Important Condition);Formication (n/a - Recovered/Resolved - Other Medically Important Condition);Fumbling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);General physical health deterioration (n/a - Unknown - Other Medically Important Condition);Hair disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Hair texture abnormal (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Heart rate increased (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nervous system disorder (n/a - Unknown - Other Medically Important Condition);Night sweats (n/a - Unknown - Other Medically Important Condition);Nocturia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Palpitations (n/a - Recovered/Resolved - Other Medically Important Condition);Peripheral coldness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Sensation of foreign body (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Visual impairment (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6322427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6318544	Spontaneous	2013-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Peripheral swelling (n/a - Recovered/Resolved With Sequelae - Disabling);Seronegative arthritis (n/a - Recovered/Resolved With Sequelae - Disabling)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6318544&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-6311669	Spontaneous	2013-01-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Extrapyramidal disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	ENBREL [ETANERCEPT] (S - n/a - Drug withdrawn - [n/a - 50mg - Subcutaneous])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6311669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6301797	Spontaneous	2013-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6301797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6301807	Spontaneous	2013-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [2mo - 2{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6301807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6304209	Spontaneous	2013-01-21 00:00:00	Healthcare Professional	European Economic Area	Van Puijenbroek E, Broos N, van Grootheest K. Monitoring Adverse Events of the Vaccination Campaign Against Influenza A (H1N1) in the Netherlands. ORIGINAL RESEARCH ARTICLE. 2010;33(12):1097-1108	More than 85 Years	Not Specified	No	Female	Dyspnoea (n/a - Unknown - Results in Death, Other Medically Important Condition);Feeling abnormal (n/a - Unknown - Results in Death, Other Medically Important Condition);Streptococcal sepsis (n/a - Fatal - Results in Death, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - n/a])	[BECLOMETASONE DIPROPIONATE, BUDESONIDE, FORMOTEROL FUMARATE HYDRATE, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - 200ug - n/a])|[FUROSEMIDE] (C - n/a - Unknown - [n/a - 40mg - n/a])|[HYDROCHLOROTHIAZIDE, TELMISARTAN] (C - n/a - Unknown - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6304209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6304876	Spontaneous	2013-01-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6304876&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6305052	Spontaneous	2013-01-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6305223	Spontaneous	2013-01-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adolescent	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305223&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6307142	Spontaneous	2013-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Mastication disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition);Tinnitus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [1d - 1{DF} - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6307142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6301736	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic lymphocytic leukaemia (n/a - Unknown - Other Medically Important Condition);Lymphadenopathy (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6301736&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6302262	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Gianotti-Crosti syndrome (n/a - Not Recovered/Not Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302262&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6302318	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injected limb mobility decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - 1{DF} - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6302331	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site mass (6d - Recovered/Resolved - Disabling);Injection site pain (n/a - Recovered/Resolved - Disabling);Pain in extremity (n/a - Recovered/Resolved - Disabling);Skin induration (n/a - Unknown - Disabling);Skin warm (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Product used for unknown indication - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302331&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6302334	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Neuropathy peripheral (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Testicular pain (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[NAPROXEN, NAPROXEN SODIUM] (C - Product used for unknown indication - n/a - [n/a - 275mg - Oral])|[PARACETAMOL] (C - Product used for unknown indication - n/a - [n/a - 1330mg - Oral])|[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - 150mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6302336	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Conversion disorder (0d - Recovered/Resolved - Other Medically Important Condition);Dizziness (0d - Recovered/Resolved - Other Medically Important Condition);Hyperventilation (0d - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (0d - Recovered/Resolved - Other Medically Important Condition);Screaming (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302336&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6302362	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Periorbital oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302362&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6302365	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6302383	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302383&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6302660	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dizziness (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302660&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6302665	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Vomiting (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302665&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6302670	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site haematoma (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302670&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6302675	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neck pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Serum sickness (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - n/a - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6302676	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Thirst (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	[THIAMINE HYDROCHLORIDE, RETINOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6302689	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (7d - Recovered/Resolved - Other Medically Important Condition);Injected limb mobility decreased (7d - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (7d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6302689&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6303004	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Chest discomfort (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Throat tightness (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6303004&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6303066	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyponatraemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Lower respiratory tract infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - .5mL - Subcutaneous])...	CHEMOTHERAPY [CHEMOTHERAPY] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|ZOMETA [ZOLEDRONIC ACID, ZOLEDRONIC ACID MONOHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[LOPERAMIDE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[MAGNESIUM ASPARTATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6303066&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6303181	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Gastrooesophageal reflux disease (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Recovered/Resolved - Other Medically Important Condition);Lethargy (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6303181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6304705	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6304705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6305320	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6305325	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6305328	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305328&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6305330	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6305339	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6305341	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition);H1N1 influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305341&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6305346	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6305351	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305351&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6305353	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6305370	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6305397	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lung disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305397&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6305551	Spontaneous	2013-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (n/a - Unknown - Results in Death, Other Medically Important Condition);Diabetes mellitus inadequate control (n/a - Unknown - Results in Death, Other Medically Important Condition);General physical health deterioration (n/a - Unknown - Results in Death, Other Medically Important Condition);Influenza like illness (3d - Fatal - Results in Death, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Results in Death, Other Medically Important Condition);Pallor (n/a - Unknown - Results in Death, Other Medically Important Condition);Pharyngitis (n/a - Unknown - Results in Death, Other Medically Important Condition);Productive cough (n/a - Unknown - Results in Death, Other Medically Important Condition);Pyrexia (n/a - Unknown - Results in Death, Other Medically Important Condition);Rhinitis (n/a - Unknown - Results in Death, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	APPROVAL [APPROVAL] (C - Hypertension - n/a - [n/a - n/a - Oral])|LANTUS [INSULIN GLARGINE] (C - Insulin-requiring type 2 diabetes mellitus - n/a - [n/a - n/a - Subcutaneous])|[GLIMEPIRIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - Oral])|[METFORMIN HYDROCHLORIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - Oral])|[SIMVASTATIN] (C - Dyslipidaemia - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6305551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6296471	Spontaneous	2013-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6296471&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6296513	Spontaneous	2013-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6296513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6296519	Spontaneous	2013-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6296519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6296525	Spontaneous	2013-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6296525&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6296580	Spontaneous	2013-01-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Porphyria (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6296580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6296999	Spontaneous	2013-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6296999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6297553	Spontaneous	2013-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Delayed sleep phase (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Hypersensitivity (n/a - Recovered/Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Weight increased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6297553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6297577	Spontaneous	2013-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Alopecia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6297577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6291542	Spontaneous	2013-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Arrhythmia (n/a - Unknown - );Fatigue (n/a - Unknown - );Malaise (n/a - Recovered/Resolved - );Performance status decreased (n/a - Recovered/Resolved - );Sleep disorder (n/a - Not Recovered/Not Resolved - );Ventricular extrasystoles (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6291542&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-6291543	Spontaneous	2013-01-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Hot flush (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site abscess (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site erythema (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site induration (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site nodule (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site pain (n/a - Recovering/Resolving - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6291543&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6293121	Spontaneous	2013-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Blindness (n/a - Recovered/Resolved - Disabling);Bradycardia (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Cough (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hiccups (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Speech disorder (n/a - Unknown - Disabling);Tachycardia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6293121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6293127	Spontaneous	2013-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Encephalopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Epilepsy (n/a - Unknown - Other Medically Important Condition);Polyneuropathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	MELATONIN [MELATONIN] (C - Sleep disorder - Unknown - [n/a - n/a - n/a])|[AMITRIPTYLINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - Back pain - Unknown - [n/a - n/a - n/a])|[MIRTAZAPINE] (C - Depression - Unknown - [n/a - n/a - n/a])|[ZOPICLONE] (C - Sleep disorder - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6293127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6293129	Spontaneous	2013-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Disabling);Atrial fibrillation (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cough (n/a - Recovered/Resolved - Disabling);Disability (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Recovered/Resolved - Disabling);Impaired work ability (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Recovered/Resolved - Disabling);Pain (n/a - Recovered/Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Upper respiratory tract infection (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	METHOTREXATE [METHOTREXATE] (C - Arthritis - Unknown - [n/a - n/a - Oral])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Asthma - Unknown - [n/a - n/a - Respiratory (inhalation)])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Hypersensitivity - Unknown - [n/a - n/a - Oral])|[DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE MONOHYDRATE] (C - Arthropod bite - Unknown - [15d - n/a - Oral])|[HYDROXYCHLOROQUINE SULFATE] (C - Arthritis - Unknown - [n/a - n/a - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - Unknown - [n/a - n/a - Oral])|[NAPROXEN, NAPROXEN SODIUM] (C - Pain - Unknown - [n/a - n/a - Oral])|[PARACETAMOL] (C - Pain - Unknown - [n/a - n/a - Oral])|[SULFASALAZINE, SULFASALAZINE PH. EUR.] (C - Arthritis - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6293129&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6294685	Spontaneous	2013-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6294685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6287297	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Expired product administered (n/a - Unknown - );Joint swelling (n/a - Unknown - );Pruritus (n/a - Unknown - );Skin discolouration (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6287297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6287447	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6287447&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6287653	Spontaneous	2013-01-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Exposure during pregnancy (n/a - Unknown - );Live birth (n/a - Unknown - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6287653&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6288462	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6288463	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Condition aggravated (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dystonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Joint dislocation (n/a - Unknown - Caused/Prolonged Hospitalisation);Joint swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Osteomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - Osteoporosis - Unknown - [n/a - n/a - Oral])|[DIPHTHERIA AND TETANUS VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[LAMOTRIGINE] (C - Epilepsy - Unknown - [n/a - n/a - Oral])|[PAMIDRONATE DISODIUM] (C - Osteoporosis - Unknown - [n/a - n/a - Intravenous (not otherwise specified)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288463&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6288465	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Anxiety (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Feeling cold (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pancreatitis acute (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tinnitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Type 2 diabetes mellitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - Diabetes mellitus - Unknown - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Hyperlipidaemia - Unknown - [n/a - n/a - n/a])|[GLIMEPIRIDE] (C - Diabetes mellitus - Unknown - [n/a - n/a - n/a])|[MIANSERIN HYDROCHLORIDE] (C - Anxiety - Unknown - [n/a - n/a - n/a])|[PARACETAMOL] (C - Pain - Unknown - [n/a - n/a - n/a])|[PROMETHAZINE, PROMETHAZINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE] (C - Pain - Unknown - [n/a - n/a - n/a])|[VALSARTAN] (C - Hypertension - Unknown - [n/a - n/a - n/a])|[ZOPICLONE] (C - Insomnia - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6288466	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Unknown - Disabling);Migraine (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Sinus tachycardia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DESOGESTREL] (C - Contraception - Unknown - [n/a - n/a - n/a])|[NAPROXEN, NAPROXEN SODIUM] (C - Migraine - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6288468	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling);Decreased activity (n/a - Not Recovered/Not Resolved - Disabling);Depression (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Mental fatigue (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling);Urinary tract infection (n/a - Recovered/Resolved - Disabling);Vertigo (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMITRIPTYLINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - Oral])|[CYPROTERONE ACETATE, ETHINYLESTRADIOL] (C - Contraception - Unknown - [n/a - n/a - Unknown])|[MICRONISED SPIRONOLACTONE, POTASSIUM CANRENOATE, SPIRONOLACTONE, SPIRONOLACTONE BP] (C - Polycystic ovarian syndrome - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6288469	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anxiety (n/a - Recovered/Resolved - Other Medically Important Condition);Claustrophobia (n/a - Recovered/Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysgeusia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling cold (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injected limb mobility decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle spasms (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Panic attack (n/a - Recovered/Resolved - Other Medically Important Condition);Paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Parkinsonism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Peroneal nerve palsy (n/a - Unknown - Other Medically Important Condition);Restlessness (n/a - Recovered/Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vision blurred (n/a - Recovered/Resolved - Other Medically Important Condition);Visual impairment (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288469&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6288470	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Amnesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Condition aggravated (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Heart rate increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neck pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tinnitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vertigo (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	NOT AVAILABLE [ANTIBIOTICS] (C - Staphylococcal infection - Unknown - [n/a - n/a - n/a])|[IBUPROFEN] (C - Pain - Unknown - [n/a - n/a - n/a])|[PARACETAMOL] (C - Pain - Unknown - [n/a - n/a - n/a])|[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - Prophylaxis - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6288471	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Burning sensation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cerebral infarction (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Condition aggravated (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Neck pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Salivary hypersecretion (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sneezing (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ACETYLSALICYLIC ACID] (C - Prophylaxis - Unknown - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Blood cholesterol increased - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288471&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6288472	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Chest pain (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Eye pain (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Peripheral coldness (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	AERIUS [DESLORATADINE] (C - Hypersensitivity - Unknown - [n/a - n/a - Unknown])|[DIAZEPAM] (C - Anxiety - Unknown - [n/a - n/a - Unknown])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - Oesophagitis - Unknown - [n/a - n/a - Unknown])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - Unknown])|[RANITIDINE, RANITIDINE HYDROCHLORIDE] (C - Hiatus hernia - Unknown - [n/a - n/a - Unknown])|[SALMETEROL, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288472&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6288474	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaemia (n/a - Recovering/Resolving - Other Medically Important Condition);Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Cytomegalovirus mononucleosis (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovering/Resolving - Other Medically Important Condition);Eating disorder (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Fibromyalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Physical disability (n/a - Recovering/Resolving - Other Medically Important Condition);Sinusitis (n/a - Recovering/Resolving - Other Medically Important Condition);Social avoidant behaviour (n/a - Unknown - Other Medically Important Condition);Viral infection (n/a - Unknown - Other Medically Important Condition);Weight decreased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6288475	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Confusional state (n/a - Unknown - Other Medically Important Condition);Disorientation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Post-traumatic stress disorder (n/a - Unknown - Other Medically Important Condition);Road traffic accident (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	CHAMPIX [VARENICLINE, VARENICLINE TARTRATE] (C - Ex-tobacco user - Unknown - [n/a - n/a - Oral])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[MIANSERIN HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - Oral])|[ZOPICLONE] (C - Hypnotherapy - Unknown - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6288476	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anger (n/a - Unknown - Other Medically Important Condition);Anxiety (n/a - Unknown - Other Medically Important Condition);Balance disorder (n/a - Unknown - Other Medically Important Condition);Bell's palsy (n/a - Recovering/Resolving - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Eye disorder (n/a - Unknown - Other Medically Important Condition);Eye infection (n/a - Unknown - Other Medically Important Condition);Facial asymmetry (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Lacrimation increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Urinary tract infection (n/a - Unknown - Other Medically Important Condition);Vertigo (n/a - Unknown - Other Medically Important Condition);Vertigo positional (n/a - Unknown - Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CANDESARTAN CILEXETIL] (C - Hypertension - Unknown - [n/a - 16mg - Unknown])|[CHLORAMPHENICOL] (C - Eye infection - Unknown - [n/a - n/a - n/a])|[ELETRIPTAN, ELETRIPTAN HYDROBROMIDE] (C - Migraine - Unknown - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - Hypertension - Unknown - [n/a - 16mg - n/a])|[PROCHLORPERAZINE, PROCHLORPERAZINE MALEATE, PROCHLORPERAZINE MALEATE BP, PROCHLORPERAZINE MESILATE] (C - Vertigo positional - Unknown - [n/a - 15mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6288477	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Disabling);Epilepsy (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Heart rate increased (n/a - Unknown - Disabling);Hyperhidrosis (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Unknown - Disabling);Restless legs syndrome (n/a - Unknown - Disabling);Restlessness (n/a - Unknown - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[FLUTICASONE PROPIONATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6288478	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Unknown - Disabling);Asthenia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cold sweat (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Drug hypersensitivity (n/a - Recovered/Resolved - Disabling);Fatigue (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Heart rate increased (n/a - Unknown - Disabling);Hyperacusis (n/a - Unknown - Disabling);Hyperhidrosis (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Mouth swelling (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Nasal oedema (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Palpitations (n/a - Unknown - Disabling);Pharyngeal swelling (n/a - Unknown - Disabling);Photophobia (n/a - Unknown - Disabling);Tension headache (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	HORMONE TREATMENT [HORMONES] (C - Infertility - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6288479	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Constipation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - Constipation - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288479&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6288480	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Antisocial behaviour (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Autonomic neuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cognitive disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dry mouth (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Ocular hyperaemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Presyncope (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Psychotic disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Temperature regulation disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vertigo (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288480&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6288481	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abulia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling);Coordination abnormal (n/a - Not Recovered/Not Resolved - Disabling);Disability (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Disabling);Influenza (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (n/a - Recovered/Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Viral infection (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	MELATONIN [MELATONIN] (C - Sleep disorder - Unknown - [n/a - 2mg - Oral])|[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - 75mg - Oral])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Hypercholesterolaemia - Unknown - [n/a - 40mg - Oral])|[CYANOCOBALAMIN, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 1{DF} - Oral])|[DOXAZOSIN MESILATE] (C - Benign prostatic hyperplasia - Unknown - [n/a - 8mg - Oral])|[FINASTERIDE] (C - Benign prostatic hyperplasia - Unknown - [n/a - n/a - Oral])|[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - Unknown - [n/a - 500mg - Oral])|[MIRTAZAPINE] (C - Depression - Unknown - [n/a - 30mg - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - Unknown - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6288482	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Diarrhoea (4wk - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pharyngitis (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Stress (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	[LORATADINE] (C - Seasonal allergy - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6288483	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Unknown - Disabling);Aphasia (n/a - Not Recovered/Not Resolved - Disabling);Arthralgia (n/a - Unknown - Disabling);Body temperature fluctuation (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Unknown - Disabling);Condition aggravated (n/a - Unknown - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Unknown - Disabling);Dysmenorrhoea (n/a - Unknown - Disabling);Epstein-Barr virus infection (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Infectious mononucleosis (n/a - Unknown - Disabling);Influenza like illness (n/a - Not Recovered/Not Resolved - Disabling);Iron deficiency (n/a - Unknown - Disabling);Learning disability (n/a - Not Recovered/Not Resolved - Disabling);Lymphadenopathy (n/a - Unknown - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Unknown - Disabling);Oropharyngeal pain (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling);Stress (n/a - Not Recovered/Not Resolved - Disabling);Syncope (n/a - Not Recovered/Not Resolved - Disabling);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DESOGESTREL, ETHINYLESTRADIOL, ETHINYLESTRADIOL PH. EUR., DESOGESTREL B.P.] (C - Dysmenorrhoea - Unknown - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE] (C - Dysmenorrhoea - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6288484	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Disabling);Arthralgia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Unknown - Disabling);General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Unknown - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BETAMETHASONE ACETATE, BETAMETHASONE SODIUM PHOSPHATE] (C - Hypersensitivity - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6288485	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dysgeusia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Flushing (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Palpitations (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia oral (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Weight increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CASCARA, ETHYLMORPHINE HYDROCHLORIDE, ETHYLMORPHINE HYDROCHLORIDE, FRANGULA PURSHIANA BARK] (C - Cough - Unknown - [n/a - n/a - Unknown])|[ZOPICLONE] (C - Sleep disorder - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288485&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6288489	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Acute disseminated encephalomyelitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Borrelia infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Coordination abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Generalised tonic-clonic seizure (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Meningitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuroborreliosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Neurogenic bladder (n/a - Unknown - Caused/Prolonged Hospitalisation);Nuchal rigidity (n/a - Unknown - Caused/Prolonged Hospitalisation);Optic neuritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Papilloedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288489&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6288490	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Condition aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Epistaxis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Photophobia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Asthma - Drug withdrawn - [n/a - n/a - Unknown])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - Drug withdrawn - [n/a - n/a - Unknown])|[CETIRIZINE DIHYDROCHLORIDE] (C - Asthma - Drug withdrawn - [n/a - n/a - Unknown])|[FLUTICASONE PROPIONATE] (C - Asthma - Drug withdrawn - [n/a - n/a - Unknown])|[PREDNISOLONE] (C - Asthma - Drug withdrawn - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - Drug withdrawn - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288490&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6288491	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Febrile infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Optic neuritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Palpitations (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Sinus tachycardia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[IBUPROFEN] (C - Headache - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288491&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6288492	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Quality of life decreased (n/a - Unknown - Other Medically Important Condition);Restless legs syndrome (n/a - Unknown - Other Medically Important Condition);Snoring (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6288494	Spontaneous	2013-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Carpal tunnel syndrome (n/a - Unknown - Disabling);Dyspnoea (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Fibromyalgia (n/a - Unknown - Disabling);Joint swelling (n/a - Unknown - Disabling);Muscle spasms (n/a - Unknown - Disabling);Muscular weakness (n/a - Unknown - Disabling);Pain (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	AERIUS [DESLORATADINE] (C - Hypersensitivity - Unknown - [n/a - n/a - Unknown])|CHAMPIX [VARENICLINE, VARENICLINE TARTRATE] (C - Ex-tobacco user - Unknown - [n/a - n/a - Unknown])|[DIPHENHYDRAMINE HYDROCHLORIDE] (C - Hypersensitivity - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6288494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6282887	Spontaneous	2013-01-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Not Specified	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Quality of life decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6282887&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6282888	Spontaneous	2013-01-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Educational problem (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6282888&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6284016	Spontaneous	2013-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Iritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Urticaria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6284016&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6285464	Spontaneous	2013-01-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cyanosis (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6285464&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6277127	Spontaneous	2013-01-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6277127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6277322	Spontaneous	2013-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6277322&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6277358	Spontaneous	2013-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6277358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6277366	Spontaneous	2013-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6277366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6277389	Spontaneous	2013-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6277389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6277394	Spontaneous	2013-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6277394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6269444	Spontaneous	2013-01-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Other Medically Important Condition);Balance disorder (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Mood altered (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6269444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6265080	Spontaneous	2013-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hyperhidrosis (n/a - Recovering/Resolving - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Road traffic accident (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6265080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6266374	Spontaneous	2013-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Axillary pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (3a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])...	[ANTAZOLINE HYDROCHLORIDE, TETRYZOLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - 250ug - n/a])|[FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - 4.5ug - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6266374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6268004	Spontaneous	2013-01-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Balance disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cerebrovascular accident (n/a - Unknown - Caused/Prolonged Hospitalisation);Diastolic dysfunction (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, AMILORIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE DIHYDRATE, HYDROCHLOROTHIAZIDE, ANHYDROUS AMILORIDE HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6268004&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6257774	Spontaneous	2013-01-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - );Feeling hot (10min - Recovered/Resolved - );Hyperhidrosis (10min - Recovered/Resolved - );Peripheral coldness (10min - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6257774&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6253717	Spontaneous	2013-01-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Gait disturbance (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Neuralgia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6253717&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-6253718	Spontaneous	2013-01-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Type 1 diabetes mellitus (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6253718&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6255595	Spontaneous	2013-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Recovering/Resolving - Disabling);Disturbance in attention (n/a - Recovering/Resolving - Disabling);Fatigue (n/a - Recovering/Resolving - Disabling);Listless (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6255595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6255607	Spontaneous	2013-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Disabling);Cough (14d - Recovered/Resolved - Disabling);Dysstasia (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Feeling abnormal (n/a - Unknown - Disabling);Feeling cold (n/a - Unknown - Disabling);Hyperhidrosis (n/a - Unknown - Disabling);Listless (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Nasopharyngitis (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	[METHENAMINE HIPPURATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - Product used for unknown indication - n/a - [n/a - 20mg - n/a])|[TAMOXIFEN, TAMOXIFEN CITRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6255607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6248606	Spontaneous	2013-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Abdominal discomfort (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Angioedema (n/a - Unknown - Life Threatening, Other Medically Important Condition);Arthralgia (n/a - Unknown - Life Threatening, Other Medically Important Condition);Bronchospasm (n/a - Unknown - Life Threatening, Other Medically Important Condition);Chest discomfort (n/a - Unknown - Life Threatening, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Feeling hot (n/a - Unknown - Life Threatening, Other Medically Important Condition);Joint swelling (n/a - Unknown - Life Threatening, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Oedema mouth (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Respiratory distress (n/a - Unknown - Life Threatening, Other Medically Important Condition);Swollen tongue (n/a - Unknown - Life Threatening, Other Medically Important Condition);Type III immune complex mediated reaction (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [n/a - 7ug - Intramuscular])	[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - Gastritis - n/a - [n/a - 20mg - n/a])|[PRAVASTATIN SODIUM] (C - Blood cholesterol increased - n/a - [n/a - 20mg - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Asthma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6248606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6248847	Spontaneous	2013-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dizziness (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [n/a - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6248847&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6249834	Spontaneous	2013-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6249834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6249871	Spontaneous	2013-01-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chills (n/a - Recovering/Resolving - Other Medically Important Condition);Diarrhoea (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Insomnia (n/a - Recovering/Resolving - Other Medically Important Condition);Irritability (n/a - Recovering/Resolving - Other Medically Important Condition);Palpitations (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep apnoea syndrome (n/a - Recovering/Resolving - Other Medically Important Condition);Vomiting (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	MITTVAL VEGETARIAN [ASCORBIC ACID, CALCIUM CARBONATE, CALCIUM PANTOTHENATE, CALCIUM PHOSPHATE, COPPER GLUCONATE, CYANOCOBALAMIN, ERGOCALCIFEROL, FERROUS FUMARATE, FOLIC ACID (HYDRATED), IODIDES, MAGNESIUM OXIDE, NICOTINAMIDE, PYRIDOXINE HYDROCHLORIDE, RETINOL PALMITATE, RIBOFLAVIN, RRR-ALPHA-TOCOPHEROL, THIAMINE NITRATE, ZINC OXIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6249871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6249893	Spontaneous	2013-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic shock (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6249893&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6250580	Spontaneous	2013-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Listless (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6250580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6252867	Spontaneous	2013-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6252867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6246495	Spontaneous	2013-01-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Drug ineffective (n/a - Unknown - );Influenza like illness (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6246495&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6247242	Spontaneous	2013-01-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthma exercise induced (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Food allergy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Infection susceptibility increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Dose not changed - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6247242&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6247601	Spontaneous	2013-01-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6247601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6240147	Spontaneous	2012-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Other Medically Important Condition);Local reaction (n/a - Unknown - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Other Medically Important Condition);Paresis (n/a - Unknown - Other Medically Important Condition);Polyneuropathy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6240147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6240149	Spontaneous	2012-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Bone pain (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Eye pain (n/a - Unknown - Other Medically Important Condition);Generalised oedema (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Odynophagia (n/a - Unknown - Other Medically Important Condition);Rhinorrhoea (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6240149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6240153	Spontaneous	2012-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Autonomic nervous system imbalance (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6240153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6240172	Spontaneous	2012-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6240172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6238221	Spontaneous	2012-12-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6238221&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6238048	Spontaneous	2012-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6238048&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6220427	Spontaneous	2012-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Asthma (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Chest discomfort (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Chills (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Depressed level of consciousness (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Dizziness (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Dyspnoea (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Eye swelling (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Fall (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hyperhidrosis (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Loss of consciousness (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Muscle spasms (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Muscle twitching (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Night sweats (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Suffocation feeling (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Syncope (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Vision blurred (2d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Influenza immunisation - Not applicable - [n/a - 7ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6220427&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6231009	Spontaneous	2012-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6231009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6232500	Spontaneous	2012-12-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bell's palsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Facial paralysis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Local reaction (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Vaccination site inflammation (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6232500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-6232909	Spontaneous	2012-12-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Facial paralysis (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[DIPHTHERIA AND TETANUS TOXOIDS] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6232909&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6224707	Spontaneous	2012-12-24 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Balance disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cerebrovascular accident (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypothyroidism (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lethargy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Slow speech (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[AMLODIPINE, AMLODIPINE BESILATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[DISOPYRAMIDE, DISOPYRAMIDE PHOSPHATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[HYDROCHLOROTHIAZIDE, LISINOPRIL, HYDROCHLOROTHIAZIDE, LISINOPRIL ANHYDROUS, LISINOPRIL ANHYDROUS, HYDROCHLOROTHIAZIDE EP, LISINOPRIL DIHYDRATE, HYDROCHLOROTHIAZIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - n/a - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[PRAVASTATIN SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6224707&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6215080	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Local reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Migraine (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6215080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6215084	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Local reaction (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6215084&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6215085	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paresis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6215085&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6215256	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6215256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6215428	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6215428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6215567	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Sarcoidosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6215567&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6215568	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6215568&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6215701	Spontaneous	2012-12-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anxiety (n/a - Recovering/Resolving - Other Medically Important Condition);Depression (n/a - Recovering/Resolving - Other Medically Important Condition);Disorientation (n/a - Recovering/Resolving - Other Medically Important Condition);Disturbance in attention (n/a - Recovering/Resolving - Other Medically Important Condition);Dizziness (n/a - Recovering/Resolving - Other Medically Important Condition);Eye disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Fumbling (n/a - Recovering/Resolving - Other Medically Important Condition);Hypoaesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Muscle spasms (n/a - Recovering/Resolving - Other Medically Important Condition);Muscle twitching (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Nightmare (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Stress (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6215701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6215759	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Local reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation);Urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6215759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6216853	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Neurological infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6216853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6217145	Spontaneous	2012-12-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6217145&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6218164	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhinitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6218164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6218234	Spontaneous	2012-12-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Local reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Tracheitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6218234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6210366	Spontaneous	2012-12-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6210366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6211891	Spontaneous	2012-12-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6211891&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6213507	Spontaneous	2012-12-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Chest pain (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Influenza like illness (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6213507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6213508	Spontaneous	2012-12-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Red blood cell sedimentation rate increased (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Seronegative arthritis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6213508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6214530	Spontaneous	2012-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hyperthermia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6214530&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6205215	Spontaneous	2012-12-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Not Specified	Amnesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fibromyalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6205215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6205218	Spontaneous	2012-12-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Epilepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6205218&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6206549	Spontaneous	2012-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Depression (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Hypoventilation (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Neck pain (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Panic attack (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Seizure (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[BOTULINUM ANTITOXIN TYPE A PH. EUR., BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A FOR INJECTION PH. EUR., CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (900 KD)] (C - n/a - n/a - [n/a - 25[iU] - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6206549&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6206552	Spontaneous	2012-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[ALENDRONATE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6206552&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6206555	Spontaneous	2012-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (2a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6206555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6206556	Spontaneous	2012-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6206556&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6206561	Spontaneous	2012-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6206561&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6208130	Spontaneous	2012-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Discomfort (n/a - Recovered/Resolved - Life Threatening);Generalised oedema (n/a - Recovered/Resolved - Life Threatening);Pruritus (n/a - Recovered/Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Unknown - [n/a - n/a - n/a])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - Coronary artery disease - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - Coronary artery disease - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[METOPROLOL TARTRATE, METOPROLOL TARTRATE BP] (C - Coronary artery disease - n/a - [n/a - n/a - n/a])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Coronary artery disease - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6208130&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-6199658	Spontaneous	2012-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnopompic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	AERIUS [DESLORATADINE] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6199658&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6203436	Spontaneous	2012-12-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6203436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6203670	Spontaneous	2012-12-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Encephalitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Status epilepticus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6203670&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6193835	Spontaneous	2012-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Tremor (3h - Recovered/Resolved - );Vomiting (3h - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Dose not changed - [n/a - .5mL - Intramuscular])	[DOXAZOSIN, DOXAZOSIN MESILATE] (C - Hypertension - Dose not changed - [n/a - 4mg - Oral])|[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - Dose not changed - [n/a - 850mg - Oral])|[METOPROLOL, METOPROLOL TARTRATE] (C - Hypertension - Dose not changed - [n/a - 100mg - Oral])|[MOXONIDINE] (C - Hypertension - Dose not changed - [n/a - .2mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6193835&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-6193844	Spontaneous	2012-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Cough (4d - Recovered/Resolved - );Pyrexia (4d - Recovered/Resolved - );Rhinitis (4d - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6193844&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6193893	Spontaneous	2012-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Oedema mouth (0d - Recovered/Resolved - );Taste disorder (0d - Recovered/Resolved - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 7ug - Intramuscular])	[BETAMETHASONE, BETAMETHASONE DIPROPIONATE, SALICYLIC ACID, BETAMETHASONE DIPROPIONATE, SALSALATE, BETAMETHASONE, SALICYLIC ACID] (C - Psoriasis - Dose not changed - [n/a - n/a - Cutaneous])|[CLOBETASOL PROPIONATE] (C - Psoriasis - Dose not changed - [n/a - n/a - Cutaneous])|[METHYLPREDNISOLONE ACEPONATE, METHYLPREDNISOLONE ACETATE] (C - Psoriasis - Dose not changed - [n/a - n/a - Cutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6193893&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6194037	Spontaneous	2012-12-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Alopecia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Atrial fibrillation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dry skin (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Joint stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6194037&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6195927	Spontaneous	2012-12-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - .5mL - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - 1mL - n/a])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - n/a - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - Rhinitis - n/a - [n/a - n/a - n/a])|[PRAMIPEXOLE, PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE] (C - Restless legs syndrome - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - Chronic obstructive pulmonary disease - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6195927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6195929	Spontaneous	2012-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Ear discomfort (2a - Not Recovered/Not Resolved - Other Medically Important Condition);Parosmia (2a - Not Recovered/Not Resolved - Other Medically Important Condition);Polyneuropathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (2a - Not Recovered/Not Resolved - Other Medically Important Condition);Taste disorder (2a - Not Recovered/Not Resolved - Other Medically Important Condition);Tendon injury (2a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6195929&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6198197	Spontaneous	2012-12-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Balance disorder (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Diarrhoea (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Dysarthria (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Dysphemia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Dysphonia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Facial paralysis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Inflammatory bowel disease (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Mouth swelling (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Obstructive airways disorder (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Physical deconditioning (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Total lung capacity decreased (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Tremor (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Weight increased (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - n/a - n/a - [n/a - n/a - n/a])	[PROPRANOLOL, PROPRANOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6198197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-6187778	Spontaneous	2012-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Mononeuropathy (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Peripheral nerve lesion (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1mL - Intramuscular])	AERIUS [DESLORATADINE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[AMLODIPINE BESILATE, PERINDOPRIL ARGININE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6187778&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6188915	Spontaneous	2012-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6188915&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6189738	Spontaneous	2012-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6189738&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6191676	Spontaneous	2012-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Juvenile idiopathic arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6191676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6192397	Spontaneous	2012-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Face oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6192397&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6179233	Spontaneous	2012-12-13 00:00:00	Healthcare Professional	Non European Economic Area	Petrovic V, Seguljev Z, Medic S, Ristic M, Tomic S and Cvetic G. ANALYSIS OF SUSPECTED ADVERSE REACTIONS FOLLOWING IMMUNIZATION AGAINST PANDEMIC INFLUENZA A (H1N1) 2009. Default Record. 2011;5:305 to 309	18-64 Years	Not Specified	No	Male	Agitation (n/a - Recovered/Resolved - Other Medically Important Condition);Dystonia (1h - Recovered/Resolved - Other Medically Important Condition);Muscle spasms (1h - Recovered/Resolved - Other Medically Important Condition);Muscle twitching (1h - Recovered/Resolved - Other Medically Important Condition);Pain (1h - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])|[HALOPERIDOL] (S - n/a - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6179233&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6183348	Spontaneous	2012-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Apathy (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Disability (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Head injury (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6183348&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6186201	Spontaneous	2012-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6186201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6186811	Spontaneous	2012-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Narcolepsy (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6186811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6186827	Spontaneous	2012-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6186827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6188045	Spontaneous	2012-12-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anxiety disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6188045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6179258	Spontaneous	2012-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Beta haemolytic streptococcal infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6179258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6174417	Spontaneous	2012-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Disorientation (n/a - Recovered/Resolved - Other Medically Important Condition);Fall (0d - Recovered/Resolved - Other Medically Important Condition);Head injury (n/a - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (0d - Recovered/Resolved - Other Medically Important Condition);Malaise (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6174417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6175046	Spontaneous	2012-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphagia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6175046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6175055	Spontaneous	2012-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6175055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6177131	Spontaneous	2012-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Somatic symptom disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6177131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6177738	Spontaneous	2012-12-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6177738&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6178123	Spontaneous	2012-12-11 00:00:00	Non Healthcare Professional	European Economic Area	L express p114-116,118 - 28 November 2012	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Crying (n/a - Unknown - Other Medically Important Condition);Dysarthria (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Protrusion tongue (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6178123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6168715	Spontaneous	2012-12-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Injury (n/a - Unknown - Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6168715&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154348	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154348&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154350	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Attention deficit hyperactivity disorder (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Clumsiness (n/a - Unknown - Other Medically Important Condition);Initial insomnia (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Psychomotor hyperactivity (n/a - Unknown - Other Medically Important Condition);Rapid eye movements sleep abnormal (n/a - Unknown - Other Medically Important Condition);Restlessness (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Tension (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154355	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abnormal dreams (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6154357	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ear infection (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154359	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6154361	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyskinesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hallucination (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation);Juvenile myoclonic epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neuroborreliosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154361&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6154363	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation);Condition aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Middle insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Poor quality sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154363&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6154365	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abnormal dreams (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paralysis (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6154367	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154368	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Blood iron decreased (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154370	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation);Clumsiness (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Irritability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Listless (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Motor dysfunction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6154373	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALUMINIUM HYDROXIDE, FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM HYDROXIDE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, ALUMINIUM HYDROXIDE, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALUMINIUM HYDROXIDE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - 2{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6154374	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - {DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154377	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anxiety (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Automatism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyskinesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myoclonus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Restlessness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154377&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6154378	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154380	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Apathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154380&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154384	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154385	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fall (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle twitching (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Poor quality sleep (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Post lumbar puncture syndrome (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6154387	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hunger (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Unknown - Other Medically Important Condition);Muscle twitching (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Sedation (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154388	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rapid eye movements sleep abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154388&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154390	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Insomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Rapid eye movements sleep abnormal (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154396	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154396&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154398	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Feeling abnormal (n/a - Unknown - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154400	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Affect lability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyskinesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucinations, mixed (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154402	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154404	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154404&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6154406	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6154410	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Periodic limb movement disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rapid eye movements sleep abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154410&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154411	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154411&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154413	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Diplopia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6154414	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154414&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154417	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Circulatory collapse (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Gait disturbance (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Unknown - Other Medically Important Condition);Muscle twitching (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Sleep talking (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6154419	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - 2{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154419&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154420	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dreamy state (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6154424	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain upper (n/a - Unknown - Other Medically Important Condition);Aggression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anger (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depressed level of consciousness (n/a - Unknown - Other Medically Important Condition);Eye movement disorder (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hunger (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypothyroidism (n/a - Unknown - Other Medically Important Condition);Irritability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154426	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation);Eye movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Gaze palsy (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle twitching (n/a - Unknown - Caused/Prolonged Hospitalisation);Myoclonus (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6154431	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154431&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154438	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154438&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154443	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154443&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6154445	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Ill-defined disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Irritability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Serum ferritin decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154445&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6154449	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Adenoidal hypertrophy (n/a - Unknown - Caused/Prolonged Hospitalisation);Anaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Back injury (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Menstrual disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neck injury (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6154455	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154457	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Muscle twitching (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Vertigo (n/a - Recovering/Resolving - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	ASTHMA MEDICATION [ASTHMA MEDICATION] (C - n/a - Unknown - [n/a - n/a - Intrahepatic])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154458	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6154461	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154461&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154463	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154463&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6154465	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fall (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154466	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Auditory disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation);Cyanopsia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diplopia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation);Eyelid ptosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperacusis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Tongue movement disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Xanthopsia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6154468	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154473	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Back pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fumbling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Haemangioma (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Impatience (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Personality change (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6154479	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fumbling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gaze palsy (n/a - Unknown - Caused/Prolonged Hospitalisation);Middle insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Petit mal epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation);Rapid eye movements sleep abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Urinary tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154479&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6154485	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154485&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154486	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154486&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154489	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154489&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6154492	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154495	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (24h - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (24h - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 500uL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154495&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154497	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Stevens-Johnson syndrome (n/a - Unknown - Other Medically Important Condition);Toxic epidermal necrolysis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])|[LAMOTRIGINE] (S - n/a - Unknown - [9d - 100mg - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154502	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Blood thyroid stimulating hormone increased (n/a - Unknown - Other Medically Important Condition);Hypothyroidism (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Rapid eye movements sleep abnormal (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154503	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154504	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Increased appetite (n/a - Unknown - Other Medically Important Condition);Iron deficiency (3mo - Recovered/Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Salt craving (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Upper respiratory tract infection (n/a - Recovered/Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .2mL - Intramuscular])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - .2mL - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154505	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154505&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154507	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154511	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154511&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154512	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154513	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	M-M-RVAXPRO [MEASLES VIRUS ENDERS' EDMONSTON STRAIN (LIVE, ATTENUATED), MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MUMPS VIRUS JERYL LYNN (LEVEL B) STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS] (S - n/a - n/a - [1d - .5mL - n/a])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6154514	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Sandin E. Sickness after influenza vaccination.14 August 2010, Aftonbladet newspaper	12-17 Years	Not Specified	No	Female	Anger (n/a - Unknown - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Circulatory collapse (n/a - Recovered/Resolved - Other Medically Important Condition);Crying (n/a - Unknown - Other Medically Important Condition);Discomfort (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Mood swings (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Obstructive sleep apnoea syndrome (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Speech disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Thinking abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Urticaria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - Unknown - [n/a - n/a - Unknown])|[TERBUTALINE SULFATE, TERBUTALINE SULFATE PH. EUR.] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6154530	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Lymphadenopathy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nasopharyngitis (10d - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Personality change (n/a - Unknown - Other Medically Important Condition);Sever's disease (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Viral infection (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Intramuscular])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154530&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-6154534	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6154534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6157604	Spontaneous	2012-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	VIth nerve paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6157604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6151379	Spontaneous	2012-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaphylactoid reaction (15min - Recovered/Resolved - Other Medically Important Condition);Back pain (15min - Recovered/Resolved - Other Medically Important Condition);Chest pain (15min - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (15min - Recovered/Resolved - Other Medically Important Condition);Dysstasia (15min - Recovered/Resolved - Other Medically Important Condition);Malaise (15min - Recovered/Resolved - Other Medically Important Condition);Sense of oppression (15min - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[TRAZODONE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6151379&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6151910	Spontaneous	2012-12-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Sacroiliitis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6151910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6148798	Spontaneous	2012-12-03 00:00:00	Not Specified	European Economic Area	Not available	Not Specified	Child	No	Not Specified	Abortion induced (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly, Other Medically Important Condition);Exposure during pregnancy (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly, Other Medically Important Condition);Hydrocephalus (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Congenital Anomaly, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6148798&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6150109	Spontaneous	2012-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Device connection issue (n/a - Unknown - );Underdose (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6150109&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6144503	Spontaneous	2012-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Drug ineffective (1mo - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6144503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6144504	Spontaneous	2012-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Asthenia (1mo - Recovered/Resolved - Other Medically Important Condition);Cough (1mo - Recovered/Resolved - Other Medically Important Condition);Drug ineffective (1mo - Recovered/Resolved - Other Medically Important Condition);Pneumonia (1mo - Recovered/Resolved - Other Medically Important Condition);Pyrexia (1mo - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6144504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6144910	Spontaneous	2012-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Foetal death (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[FOLIC ACID] (C - Prophylaxis of neural tube defect - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6144910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6145003	Spontaneous	2012-11-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dystonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6145003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6145843	Spontaneous	2012-11-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fibromyalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site pain (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])|[ALGELDRATE, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23, ALUMINIUM, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23, TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), STRAIN K23, TICK-BORNE ENCEPHALITIS VIRUS, STRAIN K23, ADSORBED ON HYDROGENATED ALUMINUM HYDROXIDE, INACTIVATED, ALGELDRATE] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6145843&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6139981	Spontaneous	2012-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Demyelination (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Epilepsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6139981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6142209	Spontaneous	2012-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6142209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6142226	Spontaneous	2012-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6142226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6142229	Spontaneous	2012-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6142229&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6142250	Spontaneous	2012-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6142250&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6142258	Spontaneous	2012-11-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fibromyalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Suicidal ideation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6142258&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6135548	Spontaneous	2012-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abnormal dreams (n/a - Recovering/Resolving - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6135548&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6135746	Spontaneous	2012-11-28 00:00:00	Healthcare Professional	European Economic Area	Oppermann M, Fritzsche J, Schoendorfer C W, Stanislawski B K, Allignol A, Schaefer C, et al.. A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012;30:4445¿ 4452	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[FOLIC ACID] (C - n/a - Unknown - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6135746&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6135930	Spontaneous	2012-11-28 00:00:00	Healthcare Professional	European Economic Area	Oppermann M, Fritzsche J, Schoendorfer C W, Stanislawski B K, Allignol A, Schaefer C, et al.. A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012;30:4445¿ 4452	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[FOLIC ACID] (C - n/a - Unknown - [n/a - 1{DF} - n/a])|[METRONIDAZOLE] (C - n/a - Unknown - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6135930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6135934	Spontaneous	2012-11-28 00:00:00	Healthcare Professional	European Economic Area	Oppermann M, Fritzsche J, Schoendorfer C W, Stanislawski B K, Allignol A, Schaefer C, et al.. A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012;30:4445¿ 4452	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[FOLIC ACID] (C - n/a - Unknown - [n/a - 1{DF} - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6135934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6136266	Spontaneous	2012-11-28 00:00:00	Healthcare Professional	European Economic Area	Oppermann M, Fritzsche J, Schoendorfer C W, Stanislawski B K, Allignol A, Schaefer C, et al.. A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012;30:4445-4452	Not Specified	Neonate (Preterm and Term newborns)	Yes	Not Specified	Foetal exposure during pregnancy (n/a - Unknown - Congenital Anomaly);Macrocephaly (n/a - Unknown - Congenital Anomaly)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Transplacental])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - n/a - n/a - [n/a - 1{DF} - Transplacental])	[FOLIC ACID] (C - n/a - Unknown - [n/a - 1{DF} - Transplacental])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - 1{DF} - Transplacental])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6136266&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-6136821	Spontaneous	2012-11-28 00:00:00	Healthcare Professional	European Economic Area	Oppermann M, Fritzsche J, Schoendorfer C W, Stanislawski B K, Allignol A, Schaefer C, et al.. A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012;30:4445¿ 4452	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[BECLOMETASONE DIPROPIONATE] (C - n/a - Unknown - [n/a - 1{DF} - n/a])|[FOLIC ACID] (C - n/a - Unknown - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6136821&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6133962	Spontaneous	2012-11-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Alopecia areata (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6133962&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6126907	Spontaneous	2012-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6126907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6126915	Spontaneous	2012-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6126915&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6123230	Spontaneous	2012-11-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anger (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hallucination (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nightmare (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sleep paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6123230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6123604	Spontaneous	2012-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Arthritis reactive (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6123604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6123756	Spontaneous	2012-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Optic neuritis (n/a - Recovered/Resolved With Sequelae - Disabling);Vision blurred (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6123756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-6123828	Spontaneous	2012-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sensory disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6123828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6124142	Spontaneous	2012-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Pyrexia (24h - Recovered/Resolved - Other Medically Important Condition);Vomiting (24h - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6124142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6124721	Spontaneous	2012-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6124721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6125037	Spontaneous	2012-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6125037&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6118009	Spontaneous	2012-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6118009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6118791	Spontaneous	2012-11-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Disability (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Lower limb fracture (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Monoplegia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Quadriplegia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	NOT AVAILABLE [SURGERY] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6118791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6121314	Spontaneous	2012-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Gait disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injury (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Joint swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Juvenile idiopathic arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Keratitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6121314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6121974	Spontaneous	2012-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Discomfort (n/a - Unknown - Other Medically Important Condition);Gait disturbance (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site pain (8d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6121974&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6113760	Spontaneous	2012-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Chest discomfort (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (12d - Recovered/Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6113760&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6114966	Spontaneous	2012-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Injection site oedema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	[DILTIAZEM HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6114966&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6115061	Spontaneous	2012-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anxiety (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Injection site swelling (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Skin discolouration (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tic (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6115061&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6115695	Spontaneous	2012-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Breast pain (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6115695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6109814	Spontaneous	2012-11-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema multiforme (n/a - Recovering/Resolving - Other Medically Important Condition);Pruritus (n/a - Recovering/Resolving - Other Medically Important Condition);Rash maculo-papular (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6109814&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6106714	Spontaneous	2012-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (3d - Recovered/Resolved - Other Medically Important Condition);Back pain (3d - Recovered/Resolved - Other Medically Important Condition);Headache (3d - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal stiffness (3d - Recovered/Resolved - Other Medically Important Condition);Myalgia (3d - Recovered/Resolved - Other Medically Important Condition);Neuralgia (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6106714&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6107056	Spontaneous	2012-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Febrile infection (n/a - Recovered/Resolved - Other Medically Important Condition);General physical health deterioration (n/a - Recovered/Resolved - Other Medically Important Condition);General symptom (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition);Myopericarditis (n/a - Recovered/Resolved - Other Medically Important Condition);Pericardial effusion (4mo - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[COLECALCIFEROL] (C - n/a - Unknown - [5mo - 1000[iU] - Oral])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FERROUS (II) GLYCINE SULFATE COMPLEX] (C - n/a - n/a - [n/a - n/a - Oral])|[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - 100ug - Oral])|[METAMIZOLE SODIUM, METAMIZOLE SODIUM MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[OMEPRAZOLE] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6107056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6108601	Spontaneous	2012-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Ocular discomfort (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6108601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6101137	Spontaneous	2012-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6101137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6101395	Spontaneous	2012-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hyperthermia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6101395&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6104060	Spontaneous	2012-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6104060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6104070	Spontaneous	2012-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6104070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6104073	Spontaneous	2012-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lichen planus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6104073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6104922	Spontaneous	2012-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Polyarthritis (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	[ALPRAZOLAM] (C - n/a - Dose not changed - [n/a - n/a - Oral])|[MIANSERIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[VALPROMIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6104922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6097661	Spontaneous	2012-11-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anger (n/a - Recovering/Resolving - Other Medically Important Condition);Antisocial personality disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Anxiety (n/a - Recovering/Resolving - Other Medically Important Condition);Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Chest discomfort (n/a - Recovering/Resolving - Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Fear (n/a - Recovering/Resolving - Other Medically Important Condition);Feeling hot (n/a - Recovering/Resolving - Other Medically Important Condition);Muscle fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Muscle spasms (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Peripheral coldness (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Other Medically Important Condition);Stress (n/a - Recovering/Resolving - Other Medically Important Condition);Temperature intolerance (n/a - Recovering/Resolving - Other Medically Important Condition);Weight increased (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6097661&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6098385	Spontaneous	2012-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Enteritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Joint swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Petechiae (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhinitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	[METHYLPHENIDATE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6098385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6099607	Spontaneous	2012-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Parkinson's disease (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6099607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6100765	Spontaneous	2012-11-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fall (0d - Recovered/Resolved - Other Medically Important Condition);Heart rate abnormal (0d - Recovered/Resolved - Other Medically Important Condition);Syncope (0d - Recovered/Resolved - Other Medically Important Condition);Tooth fracture (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6100765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6100928	Spontaneous	2012-11-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site pain (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6100928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6093338	Spontaneous	2012-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthritis (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6093338&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6093406	Spontaneous	2012-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Leukocytosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Thrombocytopenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6093406&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6093432	Spontaneous	2012-11-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Depression (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Suicidal ideation (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A) [A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6093432&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-6093441	Spontaneous	2012-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - n/a])|[METHYLPHENIDATE HYDROCHLORIDE] (S - n/a - n/a - [7mo - 36mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6093441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6093509	Spontaneous	2012-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LACTULOSE, LACTULOSE, LIQUID] (C - n/a - n/a - [n/a - n/a - n/a])|[MIRTAZAPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TIMOLOL, TIMOLOL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6093509&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6095834	Spontaneous	2012-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hyperthermia (n/a - Unknown - Other Medically Important Condition);Injection site reaction (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6095834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6097017	Spontaneous	2012-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Demyelination (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Feeling drunk (n/a - Not Recovered/Not Resolved - Disabling);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Disabling);Posture abnormal (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6097017&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6085646	Spontaneous	2012-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6085646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6086739	Spontaneous	2012-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Autoimmune hepatitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Listless (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Spider naevus (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Splenomegaly (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6086739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6087743	Spontaneous	2012-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Multiple sclerosis (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6087743&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-6079711	Spontaneous	2012-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6079711&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6079755	Spontaneous	2012-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6079755&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6079756	Spontaneous	2012-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6079756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6079757	Spontaneous	2012-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6079757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6079767	Spontaneous	2012-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6079767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6079768	Spontaneous	2012-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6079768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6079824	Spontaneous	2012-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6079824&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6079825	Spontaneous	2012-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6079825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6079827	Spontaneous	2012-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6079827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6079828	Spontaneous	2012-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Expired product administered (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6079828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6075866	Spontaneous	2012-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Intercostal neuralgia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Subcutaneous])	[HYDROCHLOROTHIAZIDE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - n/a - [n/a - n/a - Oral])|[ZOPICLONE] (C - Sleep disorder - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6075866&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6071384	Spontaneous	2012-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6071384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6073218	Spontaneous	2012-11-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6073218&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6067048	Spontaneous	2012-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Infant	No	Female	Pyrexia (n/a - Unknown - );Underdose (n/a - Unknown - );Upper respiratory tract infection (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .25mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6067048&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-6067803	Spontaneous	2012-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6067803&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6067804	Spontaneous	2012-11-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6067804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6062673	Spontaneous	2012-11-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Cough (n/a - Recovering/Resolving - Other Medically Important Condition);Dizziness (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6062673&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6062691	Spontaneous	2012-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6062691&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6063583	Spontaneous	2012-11-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Amyotrophic lateral sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Aphasia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Diplegia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysphonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling jittery (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle contractions involuntary (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Nasal congestion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasal oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuromyopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Tongue atrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tongue movement disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[BUSPIRONE, BUSPIRONE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6063583&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6064250	Spontaneous	2012-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Allodynia (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Heart rate increased (n/a - Unknown - Disabling);Hypertension (n/a - Unknown - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Unknown - Disabling);Palpitations (n/a - Unknown - Disabling);Visual impairment (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6064250&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-6064511	Spontaneous	2012-11-05 00:00:00	Healthcare Professional	Non European Economic Area	Reynales H, Astudillo P, Vallière S, Hatz C, Schlagenhauf P, Rath B et al.. A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura® during the A/H1N1 (2009) influenza pandemic. Vaccine. 2012;30:6436-6443	Not Specified	Not Specified	No	Female	Abortion threatened (n/a - Unknown - Other Medically Important Condition);Maternal exposure before pregnancy (n/a - Unknown - Other Medically Important Condition);Retroplacental haematoma (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, SORBITAN TRIOLEATE, POLYSORBATE 80, SQUALENE, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6064511&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6064564	Spontaneous	2012-11-05 00:00:00	Healthcare Professional	Non European Economic Area	Reynales H, Astudillo P, Vallière S, Hatz C, Schlagenhauf P, Rath B et al.. A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura® during the A/H1N1 (2009) influenza pandemic. Vaccine. 2012;30:6436-6443	Not Specified	Not Specified	No	Not Specified	Bronchitis (n/a - Unknown - Other Medically Important Condition);Chills (n/a - Unknown - Other Medically Important Condition);Ear pain (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Nasal congestion (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Sinusitis (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, SORBITAN TRIOLEATE, POLYSORBATE 80, SQUALENE, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6064564&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6066261	Spontaneous	2012-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myelitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6066261&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6061117	Spontaneous	2012-11-03 00:00:00	Healthcare Professional	Non European Economic Area	Reynales H, Astudillo P, Vallière S, Hatz C, Schlagenhauf P, Rath B et al.. A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura® during the A/H1N1 (2009) influenza pandemic. Vaccine. 2012;30:6436-6443	Not Specified	Not Specified	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Maternal exposure before pregnancy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, SORBITAN TRIOLEATE, POLYSORBATE 80, SQUALENE, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6061117&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6061121	Spontaneous	2012-11-03 00:00:00	Healthcare Professional	Non European Economic Area	Reynales H, Astudillo P, Valliere S, Hatz C, Schlagenhauf P, Rath B et al.. A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura® during the A/H1N1 (2009) influenza pandemic. Vaccine. 2012;30:6436-6443	18-64 Years	Not Specified	No	Female	Abdominal pain lower (n/a - Unknown - Caused/Prolonged Hospitalisation);Anembryonic gestation (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaginal haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, SORBITAN TRIOLEATE, POLYSORBATE 80, SQUALENE, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Unknown - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6061121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6058022	Spontaneous	2012-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hyperthermia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6058022&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6052981	Spontaneous	2012-11-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Syncope (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6052981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6052982	Spontaneous	2012-11-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Disturbance in attention (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep disorder (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6052982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6052994	Spontaneous	2012-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6052994&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6052998	Spontaneous	2012-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Generalised tonic-clonic seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6052998&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6053003	Spontaneous	2012-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Body temperature increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chest discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6053003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6053045	Spontaneous	2012-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dysaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Multifocal motor neuropathy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6053045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6055091	Spontaneous	2012-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Aortic valve incompetence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Arrhythmia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Deep vein thrombosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Epistaxis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Granulomatosis with polyangiitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rheumatoid arthritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6055091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6049566	Spontaneous	2012-10-31 00:00:00	Healthcare Professional	European Economic Area	Puijenbroek van E, Broos N and Grootheest. Monitoring Adverse Events of the Vaccination Campaign against Influenza A (H1N1) in the Netherlands. Safety Monitoring of Influenza A (H1N1) Vaccination. 2010;33 (12):1097 to 1108	18-64 Years	Not Specified	No	Male	Gastric haemorrhage (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Haemoptysis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[FUROSEMIDE] (C - n/a - Unknown - [n/a - 40mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6049566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6049569	Spontaneous	2012-10-31 00:00:00	Healthcare Professional	European Economic Area	Puijenbroek van E, Broos N and Grootheest. Monitoring Adverse Events of the Vaccination Campaign against Influenza A (H1N1) in the Netherlands. Safety Monitoring of Influenza A (H1N1) Vaccination. 2010;33 (12):1097 to 1108	Not Specified	Not Specified	No	Male	Sudden cardiac death (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - Unknown - [n/a - 500mg - n/a])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 10mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6049569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6049577	Spontaneous	2012-10-31 00:00:00	Healthcare Professional	European Economic Area	Puijenbroek van E, Broos N and Grootheest. Monitoring Adverse Events of the Vaccination Campaign against Influenza A (H1N1) in the Netherlands. Safety Monitoring of Influenza A (H1N1) Vaccination. 2010;33 (12):1097 to 1108	18-64 Years	Not Specified	No	Male	Nocturnal dyspnoea (n/a - Unknown - Results in Death);Sudden death (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[GLIMEPIRIDE] (C - Type 2 diabetes mellitus - Unknown - [n/a - 3mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6049577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6049580	Spontaneous	2012-10-31 00:00:00	Healthcare Professional	European Economic Area	Puijenbroek van E, Broos N and Grootheest. Monitoring Adverse Events of the Vaccination Campaign against Influenza A (H1N1) in the Netherlands. Safety Monitoring of Influenza A (H1N1) Vaccination. 2010;33 (12):1097 to 1108	Not Specified	Not Specified	No	Female	Death (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6049580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6051396	Spontaneous	2012-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6051396&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6051521	Spontaneous	2012-10-31 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6051521&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6046387	Spontaneous	2012-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Dry skin (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Exfoliative rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Herpes virus infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash erythematous (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash pruritic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[DROSPIRENONE, ETHINYLESTRADIOL] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6046387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6046730	Spontaneous	2012-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Arthritis (n/a - Recovered/Resolved - Other Medically Important Condition);Contusion (n/a - Recovered/Resolved - Other Medically Important Condition);Dark circles under eyes (n/a - Recovered/Resolved - Other Medically Important Condition);Ear pain (n/a - Recovered/Resolved - Other Medically Important Condition);Ecchymosis (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved - Other Medically Important Condition);Haematuria (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Henoch-Schonlein purpura (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Joint swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Nodule (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Petechiae (n/a - Recovered/Resolved - Other Medically Important Condition);Proteinuria (n/a - Recovered/Resolved - Other Medically Important Condition);Purpura (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Renal disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Skin mass (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6046730&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6047681	Spontaneous	2012-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6047681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6047706	Spontaneous	2012-10-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6047706&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6035088	Spontaneous	2012-10-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Laryngeal disorder (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6035088&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-6040833	Spontaneous	2012-10-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Male	Autism spectrum disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6040833&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6040834	Spontaneous	2012-10-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	Yes	Male	Autism spectrum disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6040834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6032235	Spontaneous	2012-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Alopecia areata (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Coordination abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fibromyalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myositis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Neurological symptom (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Vertigo (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6032235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6016297	Spontaneous	2012-10-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysstasia (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6016297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6016568	Spontaneous	2012-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Eyelid oedema (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Hypersensitivity (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Paraesthesia oral (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Wheezing (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6016568&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6013423	Spontaneous	2012-10-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6013423&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6013425	Spontaneous	2012-10-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hunger (n/a - Unknown - Other Medically Important Condition);Migraine (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Poor quality sleep (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6013425&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-6013431	Spontaneous	2012-10-22 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Fall (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6013431&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6014094	Spontaneous	2012-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cardiomegaly (n/a - Fatal - Results in Death);Pulmonary haemorrhage (n/a - Fatal - Results in Death);Splenomegaly (n/a - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6014094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-6007140	Spontaneous	2012-10-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Irritability (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);School refusal (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6007140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6007300	Spontaneous	2012-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Diabetes mellitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6007300&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-6007330	Spontaneous	2012-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6007330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-6011239	Spontaneous	2012-10-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myositis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6011239&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-6003302	Spontaneous	2012-10-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Fatigue (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Hallucination (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Sleep attacks (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A) [A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6003302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-6002247	Spontaneous	2012-10-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Apathy (n/a - Recovering/Resolving - );Derealisation (n/a - Recovering/Resolving - );Disturbance in attention (n/a - Recovering/Resolving - );Emotional distress (n/a - Recovering/Resolving - );Faeces pale (n/a - Not Recovered/Not Resolved - );Memory impairment (n/a - Recovering/Resolving - );Peripheral coldness (n/a - Not Recovered/Not Resolved - );Tinnitus (n/a - Not Recovered/Not Resolved - );Visual impairment (n/a - Not Recovered/Not Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=6002247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5990711	Spontaneous	2012-10-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Facial paralysis (n/a - Not Recovered/Not Resolved - Disabling);Tooth infection (n/a - Not Recovered/Not Resolved - Disabling)	A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A) [A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5990711&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5986677	Spontaneous	2012-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5986677&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5986815	Spontaneous	2012-10-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fall (n/a - Recovered/Resolved - Other Medically Important Condition);Injury (n/a - Recovered/Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Wheelchair user (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5986815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5986853	Spontaneous	2012-10-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Automatism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Unknown])	[A/CALIFORNIA/7/2009 (H1N1)] (C - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5986853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5989441	Spontaneous	2012-10-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Shock (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Respiratory tract infection - n/a - [n/a - n/a - n/a])	ANTITUBERCULAR THERAPY [ANTITUBERCULAR THERAPY] (C - Tuberculosis - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5989441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5990218	Spontaneous	2012-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Immunisation reaction (0d - Recovered/Resolved - Other Medically Important Condition);Myalgia (0d - Recovered/Resolved - Other Medically Important Condition);Nausea (0d - Recovered/Resolved - Other Medically Important Condition);Vomiting (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5990218&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5990219	Spontaneous	2012-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (3d - Recovered/Resolved - Other Medically Important Condition);Rash (3d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - n/a - [1d - .5mL - Intramuscular])	[BUDESONIDE, FORMOTEROL, BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE, FORMOTEROL FUMARATE HYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - n/a - [4y - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5990219&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5982655	Spontaneous	2012-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5982655&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5983300	Spontaneous	2012-10-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dermatitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Psoriasis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash erythematous (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Skin fissures (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|VACCINE (UNSPECIFIED) [VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	NOT AVAILABLE [PSORIASIS OINTMENT] (C - n/a - Unknown - [n/a - n/a - Topical])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5983300&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5977634	Spontaneous	2012-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5977634&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5977660	Spontaneous	2012-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphagia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5977660&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5977907	Spontaneous	2012-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5977907&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5970033	Spontaneous	2012-10-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depressed mood (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dysphagia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Loss of personal independence in daily activities (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Mobility decreased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Walking aid user (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Wheelchair user (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])|[A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE STRAIN (A/CALIFORNIA/7/2009, X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SOUTH AUSTRALIA/55/2014 STRAIN, B/PHUKET/3073/2013-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181] (S - n/a - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5970033&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5965813	Spontaneous	2012-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Depression (n/a - Recovered/Resolved - Other Medically Important Condition);Dissociation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyperphagia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia-bulimia syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Listless (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Movement disorder (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Personality change (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5965813&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5965817	Spontaneous	2012-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5965817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5965999	Spontaneous	2012-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5965999&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5960989	Spontaneous	2012-10-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5960989&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5956649	Spontaneous	2012-10-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Oral discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5956649&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5956850	Spontaneous	2012-10-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5956850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5955720	Spontaneous	2012-10-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5955720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5955765	Spontaneous	2012-10-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest pain (1d - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (0d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (1d - Recovered/Resolved - Other Medically Important Condition);Hyperthermia (4d - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (1d - Recovered/Resolved - Other Medically Important Condition);Vomiting (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5955765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5955790	Spontaneous	2012-10-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (5d - Recovered/Resolved - Other Medically Important Condition);Injection site reaction (5d - Recovered/Resolved - Other Medically Important Condition);Irritability (5d - Recovered/Resolved - Other Medically Important Condition);Sleep disorder (5d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - 1{DF} - Intramuscular])	[RAMIPRIL] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5955790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5946958	Spontaneous	2012-09-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Febrile infection (2a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5946958&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5947587	Spontaneous	2012-09-28 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza (2d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (2d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	[BECLOMETASONE] (C - Asthma - n/a - [n/a - n/a - Respiratory (inhalation)])|[FENOTEROL] (C - Asthma - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5947587&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5940141	Spontaneous	2012-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5940141&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5942725	Spontaneous	2012-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (1d - Recovered/Resolved - Other Medically Important Condition);Syncope (0d - Recovered/Resolved - Other Medically Important Condition);Tremor (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5942725&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5942736	Spontaneous	2012-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Disorientation (0d - Recovering/Resolving - Disabling);Dysarthria (0d - Recovering/Resolving - Disabling);Irritability (0d - Recovering/Resolving - Disabling);Somnolence (0d - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5942736&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5942737	Spontaneous	2012-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (4d - Recovered/Resolved - Other Medically Important Condition);Cough (3d - Recovered/Resolved - Other Medically Important Condition);Fatigue (4d - Recovered/Resolved - Other Medically Important Condition);Influenza (2d - Recovered/Resolved - Other Medically Important Condition);Injection site pain (4d - Recovered/Resolved - Other Medically Important Condition);Myalgia (2d - Recovered/Resolved - Other Medically Important Condition);Pneumonia (2d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[BUDESONIDE] (C - Asthma - n/a - [n/a - 1{DF} - n/a])|[FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE] (C - Asthma - n/a - [n/a - 1{DF} - n/a])|[LORATADINE] (C - Asthma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5942737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5942768	Spontaneous	2012-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Headache (15h - Recovering/Resolving - Other Medically Important Condition);Hyperhidrosis (15h - Recovering/Resolving - Other Medically Important Condition);Parasomnia (15h - Recovering/Resolving - Other Medically Important Condition);Sleep terror (15h - Recovered/Resolved - Other Medically Important Condition);Somnambulism (15h - Recovering/Resolving - Other Medically Important Condition);Tachycardia (15h - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[FLUTICASONE PROPIONATE] (C - Asthma - n/a - [n/a - 1{DF} - n/a])|[IBUPROFEN, IBUPROFEN BP, IBUPROFEN, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - Asthma - n/a - [n/a - 1{DF} - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5942768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5942806	Spontaneous	2012-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Lymphadenopathy (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5942806&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5942822	Spontaneous	2012-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Chest pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5942822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5942827	Spontaneous	2012-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Vaccination failure (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5942827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5942834	Spontaneous	2012-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (0d - Recovering/Resolving - Other Medically Important Condition);Headache (0d - Recovering/Resolving - Other Medically Important Condition);Myalgia (0d - Recovering/Resolving - Other Medically Important Condition);Nausea (0d - Recovering/Resolving - Other Medically Important Condition);Odynophagia (0d - Recovering/Resolving - Other Medically Important Condition);Pyrexia (0d - Recovering/Resolving - Other Medically Important Condition);Vomiting (0d - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5942834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5942876	Spontaneous	2012-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (3d - Unknown - Disabling);Feeling hot (3d - Unknown - Disabling);Papule (3d - Unknown - Disabling);Rash vesicular (3d - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5942876&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5936446	Spontaneous	2012-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Asthma (n/a - Unknown - Caused/Prolonged Hospitalisation);Blepharospasm (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle contractions involuntary (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Performance status decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Therapy non-responder (n/a - Unknown - Caused/Prolonged Hospitalisation);Tic (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5936446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5930918	Spontaneous	2012-09-25 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaemia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tinnitus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5930918&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5926463	Spontaneous	2012-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal distension (n/a - Unknown - Caused/Prolonged Hospitalisation);Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation);Apnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthma (n/a - Unknown - Caused/Prolonged Hospitalisation);Cataract (n/a - Unknown - Caused/Prolonged Hospitalisation);Constipation (n/a - Unknown - Caused/Prolonged Hospitalisation);Coordination abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dry eye (n/a - Unknown - Caused/Prolonged Hospitalisation);Dry mouth (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyskinesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Ear infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Eye pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling cold (n/a - Unknown - Caused/Prolonged Hospitalisation);Fibromyalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Flatulence (n/a - Unknown - Caused/Prolonged Hospitalisation);Fluid retention (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait inability (n/a - Unknown - Caused/Prolonged Hospitalisation);Haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Mood swings (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation);Mycoplasma infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Sensory loss (n/a - Unknown - Caused/Prolonged Hospitalisation);Spinal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Spondylitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Streptococcal infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Swelling (n/a - Unknown - Caused/Prolonged Hospitalisation);Thyroiditis (n/a - Unknown - Caused/Prolonged Hospitalisation);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation);Uterine leiomyoma (n/a - Unknown - Caused/Prolonged Hospitalisation);Vertigo positional (n/a - Unknown - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight fluctuation (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5926463&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5926704	Spontaneous	2012-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5926704&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5926705	Spontaneous	2012-09-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5926705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5916685	Spontaneous	2012-09-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (1a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (1a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5916685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5911357	Spontaneous	2012-09-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5911357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5913186	Spontaneous	2012-09-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5913186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5908649	Spontaneous	2012-09-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Alopecia (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Anaemia (n/a - Unknown - Life Threatening, Disabling, Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Asthma (n/a - Unknown - Life Threatening, Disabling, Other Medically Important Condition);Auditory disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Autoimmune thyroiditis (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Balance disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Bedridden (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Blood thyroid stimulating hormone increased (n/a - Unknown - Life Threatening, Disabling, Other Medically Important Condition);Candida infection (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Cardiac disorder (n/a - Unknown - Life Threatening, Disabling, Other Medically Important Condition);Cardiac failure (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Diarrhoea (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Disability (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Dry skin (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Epistaxis (n/a - Unknown - Life Threatening, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Feeling abnormal (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Feeling of body temperature change (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Haemorrhage (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Hypotension (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Immunodeficiency (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Infection (n/a - Unknown - Life Threatening, Disabling, Other Medically Important Condition);Inflammation (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition);Joint swelling (n/a - Not Recovered/Not Resolved - Life Threatening, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])|[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5908649&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Life Threatening	Hospitalisation
EU-EC-5902875	Spontaneous	2012-09-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5902875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5897095	Spontaneous	2012-09-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5897095&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5885816	Spontaneous	2012-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Back pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Polyarthritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	VIDERA [VIDERA] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CHONDROITIN SULFATE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[FLUNARIZINE, FLUNARIZINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[INDAPAMIDE, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMINE, INDAPAMIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[KETOPROFEN] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[LATANOPROST] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[LIPIDOSTEROLIC EXTRACT OF SERENOA REPENS, SERENOA REPENS, SERENOA REPENS (BARTRAM) SMALL.] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[NEBIVOLOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PARACETAMOL, TRAMADOL, TRAMADOL HYDROCHLORIDE, PARACETAMOL] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5885816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5885865	Spontaneous	2012-09-12 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Central nervous system vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cerebrovascular accident (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Transient ischaemic attack (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [1d - n/a - Unknown])	[DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALUMINIUM HYDROXIDE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, ALUMINIUM HYDROXIDE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, ALUMINIUM HYDROXIDE] (C - Product used for unknown indication - Not applicable - [1d - n/a - Unknown])|[MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS (LIVE, ATTENUATED), RUBELLA VIRUS (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED)] (C - Product used for unknown indication - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5885865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5888836	Spontaneous	2012-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Headache (13d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [0d - n/a - Intramuscular])	NOT AVAILABLE [CHEMOTHERAPY TREATMENT] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5888836&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5880107	Spontaneous	2012-09-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Balance disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5880107&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5882657	Spontaneous	2012-09-11 00:00:00	Healthcare Professional	European Economic Area	C. Popa, P.C. Wever, M. Moviat. H1N1 vaccination: expect the unexpected. Netherlands Journal of Medicine. 2011;69:223	65-85 Years	Not Specified	No	Female	Abdominal pain (n/a - Fatal - Results in Death);Arthralgia (n/a - Fatal - Results in Death);Blood pressure decreased (n/a - Fatal - Results in Death);Clostridium test positive (n/a - Fatal - Results in Death);Crepitations (n/a - Fatal - Results in Death);Dysarthria (n/a - Fatal - Results in Death);Gas gangrene (n/a - Fatal - Results in Death);Heart rate increased (n/a - Fatal - Results in Death);Malaise (n/a - Fatal - Results in Death);Nausea (n/a - Fatal - Results in Death);Necrosis (n/a - Fatal - Results in Death);Pyrexia (n/a - Fatal - Results in Death);Respiratory distress (n/a - Fatal - Results in Death);Septic shock (n/a - Fatal - Results in Death);Skin discolouration (n/a - Fatal - Results in Death);Skin oedema (n/a - Fatal - Results in Death);Soft tissue infection (n/a - Fatal - Results in Death);Subcutaneous emphysema (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - n/a])	PANTOPRAZOLE [PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LITHIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5882657&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5873327	Spontaneous	2012-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Back pain (n/a - Unknown - Other Medically Important Condition);Cardiovascular disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chest discomfort (n/a - Recovering/Resolving - Other Medically Important Condition);Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Clumsiness (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Recovering/Resolving - Other Medically Important Condition);Erythema (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling hot (n/a - Recovering/Resolving - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Inflammation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site reaction (n/a - Unknown - Other Medically Important Condition);Joint swelling (n/a - Unknown - Other Medically Important Condition);Lymph node pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nerve injury (n/a - Unknown - Other Medically Important Condition);Oedema (n/a - Unknown - Other Medically Important Condition);Oedema peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Palpitations (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Poor quality sleep (n/a - Recovering/Resolving - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Other Medically Important Condition);Rash erythematous (n/a - Unknown - Other Medically Important Condition);Raynaud's phenomenon (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Restless legs syndrome (n/a - Recovering/Resolving - Other Medically Important Condition);Sensation of foreign body (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Skin disorder (n/a - Unknown - Other Medically Important Condition);Skin tightness (n/a - Unknown - Other Medically Important Condition);Swelling face (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tongue erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tongue movement disturbance (n/a - Unknown - Other Medically Important Condition);Urticaria (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - Unknown - [n/a - n/a - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[CLEMASTINE, CLEMASTINE FUMARATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[LEVOCABASTINE, LEVOCABASTINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[LORATADINE] (C - n/a - Unknown - [n/a - n/a - n/a])|[TERBUTALINE SULFATE, TERBUTALINE SULFATE PH. EUR.] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5873327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5876695	Spontaneous	2012-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Angioedema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	[INFLUENZA VIRUS] (C - Prophylaxis - n/a - [n/a - 1{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5876695&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5877785	Spontaneous	2012-09-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Epilepsy (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5877785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5862369	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion late (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5862369&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5866941	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fibromyalgia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Hyperaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Joint swelling (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscle contractions involuntary (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Periarthritis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Urinary tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5866941&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5867144	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Extrapyramidal disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Neuritis (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Reflexes abnormal (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5867144&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5867395	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Seizure (1min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5867395&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5867612	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Atrial fibrillation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myocarditis (5h - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5867612&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5867922	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dermatitis allergic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eye inflammation (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypertension (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	PROTELOS [STRONTIUM RANELATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Oral])|[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Oral])|[BETAHISTINE DIHYDROCHLORIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Oral])|[CIPROFIBRATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5867922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5867927	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vertigo (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual impairment (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5867927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5867986	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Developmental hip dysplasia (n/a - Unknown - Congenital Anomaly);Foetal exposure during pregnancy (n/a - Unknown - Congenital Anomaly);Maternal exposure timing unspecified (1d - Unknown - Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - n/a])|[POTASSIUM NITRATE, SODIUM FLUORIDE] (S - Hyperaesthesia teeth - Unknown - [154d - n/a - n/a])|[VITAMIN K] (S - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5867986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-5867995	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Erythema (11d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (11d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5867995&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5868177	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthma (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ill-defined disorder (n/a - Unknown - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Obstructive airways disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinitis allergic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rhinorrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sneezing (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Wheezing (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])|[CLARITHROMYCIN] (S - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[CORTISONE] (S - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[INFLUENZA VIRUS] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5868177&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5868284	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cardiomyopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Chest pain (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Ejection fraction decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Heart rate increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperhidrosis (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myocarditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myopericarditis (n/a - Unknown - Caused/Prolonged Hospitalisation);Painful respiration (0wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tricuspid valve incompetence (n/a - Unknown - Caused/Prolonged Hospitalisation);Troponin increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Ventricular hypokinesia (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5868284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5868788	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Female	Neuritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Ulnar neuritis (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5868788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5868969	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Male	Angioedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Arterial disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cutaneous vasculitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5868969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5869068	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Back pain (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Polyneuropathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5869068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5869289	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	VACCINE 2011; 29: 519	65-85 Years	Not Specified	No	Male	Acute pulmonary oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Acute respiratory failure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chronic obstructive pulmonary disease (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypertensive crisis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[PENTOXIFYLLINE] (C - Peripheral ischaemia - n/a - [n/a - n/a - Unknown])|[TRIFLUSAL] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5869289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5869577	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Injection site reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5869577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5869761	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Epilepsy (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5869761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5869850	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Coordination abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5869850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5869978	Spontaneous	2012-09-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Coronary artery occlusion (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Supraventricular tachycardia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5869978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5870268	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Blood sodium decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5870268&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5870486	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5870486&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5870531	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Male	Apathy (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Petechiae (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/BRISBANE/60/2008-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5870531&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5870591	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Intervertebral disc disorder (n/a - Unknown - Results in Death);Loss of consciousness (n/a - Unknown - Results in Death);Nervous system disorder (0a - Fatal - Results in Death);Peptic ulcer haemorrhage (n/a - Unknown - Results in Death);Purulent discharge (n/a - Unknown - Results in Death);Renal failure (n/a - Unknown - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5870591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5870612	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5870612&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5870850	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Arthralgia (6wk - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5870850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5870866	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Optic neuritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	NEUROLOGICAL AND CARDIOLOGICAL DRUGS (NOT SPECIFIED) [NOT AVAILABLE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5870866&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5871023	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Amnesia (n/a - Recovering/Resolving - Other Medically Important Condition);Confusional state (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5871023&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5871074	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Giant cell arteritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5871074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5871349	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blood pressure increased (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (0a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vertigo (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5871349&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5871364	Spontaneous	2012-09-07 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Myocardial infarction (n/a - Fatal - Results in Death, Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5871364&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5854592	Spontaneous	2012-09-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	0-1 Month	Not Specified	Yes	Male	Foetal exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Premature baby (274d - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - Transplacental])|[TIZANIDINE, TIZANIDINE HYDROCHLORIDE] (S - n/a - Drug withdrawn - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5854592&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5854618	Spontaneous	2012-09-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Caesarean section (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Premature labour (1d - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - n/a])|[TIZANIDINE, TIZANIDINE HYDROCHLORIDE] (S - n/a - Drug withdrawn - [5d - 4mg - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5854618&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5857616	Spontaneous	2012-09-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Malaise (1d - Recovered/Resolved - Disabling, Other Medically Important Condition);Oral herpes (0mo - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition);Productive cough (8d - Recovered/Resolved - Disabling, Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5857616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-5858345	Spontaneous	2012-09-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Coma (1d - Fatal - Results in Death);Pleural effusion (0a - Fatal - Results in Death);Subileus (0a - Fatal - Results in Death);Transaminases increased (0a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Other])	[DOXYCYCLINE, DOXYCYCLINE (ANHYDROUS)] (C - Infection - Not applicable - [0mo - n/a - Oral])|[DOXYCYCLINE, DOXYCYCLINE (ANHYDROUS)] (C - Infection - Not applicable - [11d - n/a - Oral])|[TRAMADOL HYDROCHLORIDE] (C - Pain - Drug withdrawn - [40mo - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5858345&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5858365	Spontaneous	2012-09-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Altered state of consciousness (1d - Recovered/Resolved - Disabling, Other Medically Important Condition);Dysphonia (8d - Recovered/Resolved - Disabling, Other Medically Important Condition);Malaise (1d - Recovered/Resolved - Disabling, Other Medically Important Condition);Oropharyngeal pain (8d - Recovered/Resolved - Disabling, Other Medically Important Condition);Productive cough (8d - Recovered/Resolved - Disabling, Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5858365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5859478	Spontaneous	2012-09-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Choking sensation (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Face oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5859478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5847634	Spontaneous	2012-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Blood blister (n/a - Unknown - Caused/Prolonged Hospitalisation);Haematoma (n/a - Unknown - Caused/Prolonged Hospitalisation);Immune thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Petechiae (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])|[POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ASCORBIC ACID, ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[DOXAZOSIN, DOXAZOSIN MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MOXONIDINE] (C - n/a - n/a - [n/a - n/a - n/a])|[NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PENTAERITHRITYL TETRANITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[VALSARTAN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5847634&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5847758	Spontaneous	2012-09-05 00:00:00	Healthcare Professional	European Economic Area	FRICKMANN H, SCHERPE S, SCHWEIGER B, WAHLISCH S, REUTER K, BRONNERT J. DESPITE TRIPLE VACCINATION. JOURNAL OF CLINICAL VIROLOGY. 2012 AUG 01;54(4):291-294.	18-64 Years	Adult	No	Male	H1N1 influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN PANDEMIC INFLUENZA VACCINE (H1N1) (WHOLE VIRION, VERO CELL DERIVED, INACTIVATED) SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])|CELVAPAN PANDEMIC INFLUENZA VACCINE (H1N1) (WHOLE VIRION, VERO CELL DERIVED, INACTIVATED) SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - Not applicable - [n/a - n/a - n/a])	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (C - Immunisation - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5847758&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5851413	Spontaneous	2012-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation);Cardiovascular disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastrointestinal disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	BONVIVA [IBANDRONATE SODIUM HYDRATE, IBANDRONIC ACID] (S - Osteoporosis - Unknown - [n/a - n/a - Oral])|[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Antiviral prophylaxis - Unknown - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5851413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5842207	Spontaneous	2012-09-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5842207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5842210	Spontaneous	2012-09-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Depression (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eyelid ptosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gilbert's syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Initial insomnia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Suicide attempt (10d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tension headache (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	[HEPATITIS B SURFACE ANTIGEN, HEPATITIS A VACCINE (INACTIVATED)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5842210&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5842732	Spontaneous	2012-09-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pain (1a - Recovered/Resolved With Sequelae - Disabling);Tremor (1a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	[SIMVASTATIN] (C - n/a - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5842732&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-5845448	Spontaneous	2012-09-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dysphagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Speech disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5845448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5834967	Spontaneous	2012-09-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Red blood cell sedimentation rate increased (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Ill-defined disorder - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5834967&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5835383	Spontaneous	2012-09-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Blood pressure increased (n/a - Unknown - Other Medically Important Condition);Colitis (n/a - Unknown - Other Medically Important Condition);Radiculopathy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5835383&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5835726	Spontaneous	2012-09-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5835726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5838428	Spontaneous	2012-09-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Gait disturbance (7d - Recovered/Resolved - Other Medically Important Condition);Vertigo (7d - Recovered/Resolved - Other Medically Important Condition);Vomiting (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Ill-defined disorder - Not applicable - [1d - .5mL - Subcutaneous])	[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - Hypercholesterolaemia - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5838428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5840196	Spontaneous	2012-09-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Oedema mouth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pharyngeal swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Swollen tongue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5840196&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5840400	Spontaneous	2012-09-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (8d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Ill-defined disorder - Not applicable - [1d - n/a - Intramuscular])	[BROMAZEPAM] (C - Feeling of relaxation - Drug withdrawn - [0y - 1{DF} - Oral])|[OMEPRAZOLE] (C - Dyspepsia - Drug withdrawn - [2d - 1{DF} - Oral])|[OMEPRAZOLE] (C - Gastrooesophageal reflux disease - Unknown - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5840400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5840546	Spontaneous	2012-09-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Arthralgia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Unknown - Caused/Prolonged Hospitalisation);Joint swelling (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Ill-defined disorder - Not applicable - [1d - n/a - Intramuscular])	VIGOR JUNIOR [NOT AVAILABLE] (C - Ill-defined disorder - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5840546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5840708	Spontaneous	2012-09-03 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Death (1d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[DEXTROPROPOXYPHENE, PARACETAMOL] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[DICLOFENAC SODIUM, MISOPROSTOL] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5840708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5828254	Spontaneous	2012-08-31 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Dementia Alzheimer's type (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5828254&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5818603	Spontaneous	2012-08-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Gait disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (3d - Recovered/Resolved - Other Medically Important Condition);Myalgia (14d - Recovered/Resolved - Other Medically Important Condition);Myositis (14d - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paresis (14d - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [1d - 7mg - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5818603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5818646	Spontaneous	2012-08-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chills (7d - Unknown - );Hypotonia (7d - Unknown - );Influenza like illness (7d - Unknown - );Pain in extremity (7d - Unknown - );Pyrexia (7d - Unknown - );Tachycardia (7d - Unknown - )	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 7ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5818646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-5818651	Spontaneous	2012-08-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Dermatitis exfoliative generalised (n/a - Unknown - Caused/Prolonged Hospitalisation);Hepatotoxicity (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Skin disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (S - n/a - Unknown - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5818651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5819579	Spontaneous	2012-08-30 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Disturbance in attention (4mo - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovering/Resolving - Other Medically Important Condition);Gait disturbance (n/a - Unknown - Other Medically Important Condition);Loss of consciousness (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Monoplegia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Upper respiratory tract infection bacterial (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5819579&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5820401	Spontaneous	2012-08-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5820401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5813941	Spontaneous	2012-08-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5813941&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5814098	Spontaneous	2012-08-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Lymphoedema (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5814098&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5817221	Spontaneous	2012-08-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Elderly	No	Male	H1N1 influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5817221&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5802305	Spontaneous	2012-08-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Anaphylactic reaction (1d - Recovered/Resolved - Other Medically Important Condition);Chills (1d - Recovered/Resolved - Other Medically Important Condition);Dizziness (1d - Recovered/Resolved - Other Medically Important Condition);Hot flush (1d - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (1d - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN PANDEMIC INFLUENZA VACCINE (H1N1) (WHOLE VIRION, VERO CELL DERIVED, INACTIVATED) SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - 7ug - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5802305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5802346	Spontaneous	2012-08-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Facial paresis (81d - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [1d - n/a - Intramuscular])	LANTUS [INSULIN GLARGINE] (C - Diabetes mellitus - Unknown - [n/a - n/a - Subcutaneous])|[ALLOPURINOL] (C - Gout - Unknown - [n/a - 150mg - Oral])|[FENOFIBRATE, FENOFIBRATE MICRONISED] (C - Lipid metabolism disorder - Unknown - [n/a - 200mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Diabetes mellitus - Unknown - [n/a - 425mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5802346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-5810616	Spontaneous	2012-08-28 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Keun Wook Bae and al., A novel mutation and unusual clinical features in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, Eur J Pediatr (2011), 170:1611-1615	3-11 Years	Not Specified	No	Male	Blood creatinine increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Cushingoid (n/a - Unknown - Caused/Prolonged Hospitalisation);Epiphyses delayed fusion (n/a - Unknown - Caused/Prolonged Hospitalisation);Growth retardation (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypertension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Posterior reversible encephalopathy syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Proteinuria (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	NOT AVAILABLE [ANTIBIOTICS] (C - n/a - Unknown - [n/a - n/a - n/a])|[CEFTRIAXONE, CEFTRIAXONE SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[VANCOMYCIN, VANCOMYCIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5810616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5802216	Spontaneous	2012-08-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adolescent	No	Male	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);H1N1 influenza (3d - Recovered/Resolved - Other Medically Important Condition);Nasal congestion (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Upper respiratory tract infection (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition);Viral test positive (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - Intramuscular])|FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])|[AZATHIOPRINE, AZATHIOPRINE SODIUM] (S - n/a - Unknown - [n/a - n/a - n/a])|[CICLOSPORIN] (S - n/a - Unknown - [n/a - n/a - n/a])|[PREDNISONE] (S - n/a - Unknown - [n/a - n/a - n/a])	SOMATROPIN [SOMATROPIN] (C - n/a - Unknown - [n/a - n/a - n/a])|[CALCITRIOL] (C - n/a - Unknown - [n/a - n/a - n/a])|[POTASSIUM, POTASSIUM CHLORIDE, POTASSIUM GLYCEROPHOSPHATE, POTASSIUM HYDROGEN CARBONATE, POTASSIUM HYDROGEN TARTRATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5802216&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5802811	Spontaneous	2012-08-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Illness (n/a - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5802811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5795537	Spontaneous	2012-08-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Eosinophilic granulomatosis with polyangiitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Unknown])	INHALATION DRUGS [NOT AVAILABLE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5795537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5795654	Spontaneous	2012-08-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5795654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5795655	Spontaneous	2012-08-24 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5795655&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5799156	Spontaneous	2012-08-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Angioedema (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	KARVEZIDE [HYDROCHLOROTHIAZIDE, IRBESARTAN] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[OMEPRAZOLE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5799156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5801149	Spontaneous	2012-08-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paresis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vertigo (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])...	[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Ill-defined disorder - Unknown - [n/a - 10mg - Unknown])|[DIPYRIDAMOLE, ACETYLSALICYLIC ACID] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[EZETIMIBE] (C - Ill-defined disorder - Unknown - [n/a - 10mg - Unknown])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - Ill-defined disorder - Unknown - [n/a - 5mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5801149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5801153	Spontaneous	2012-08-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Immunisation reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Meningitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Vertigo (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	[METAMIZOLE SODIUM, METAMIZOLE SODIUM MONOHYDRATE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[RAMIPRIL] (C - Ill-defined disorder - Unknown - [n/a - 5mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5801153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5790632	Spontaneous	2012-08-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Alopecia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Myocarditis (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Renal pain (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5790632&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5786716	Spontaneous	2012-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cardiac failure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Coma (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dehydration (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sopor (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5786716&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5786721	Spontaneous	2012-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - n/a - n/a])	[WARFARIN, WARFARIN SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5786721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5786724	Spontaneous	2012-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Communication disorder (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dehydration (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Immobile (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5786724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5786730	Spontaneous	2012-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Altered state of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dehydration (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5786730&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5787515	Spontaneous	2012-08-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Aggression (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Cataplexy (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (1a - Recovering/Resolving - Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	TAMIFLU [OSELTAMIVIR, OSELTAMIVIR PHOSPHATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5787515&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5784190	Spontaneous	2012-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Elderly	No	Female	General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperglycaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Superinfection bacterial (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5784190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5784441	Spontaneous	2012-08-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Leukocytosis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5784441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5778408	Spontaneous	2012-08-20 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Groin pain (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Hypokinesia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Joint stiffness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Limb discomfort (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Movement disorder (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pelvic pain (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Walking aid user (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A) [A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5778408&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5773744	Spontaneous	2012-08-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5773744&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5769105	Spontaneous	2012-08-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypothyroidism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myasthenic syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5769105&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5770778	Spontaneous	2012-08-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5770778&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5767572	Spontaneous	2012-08-15 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Intrauterine infection (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5767572&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5767623	Spontaneous	2012-08-15 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Foetal disorder (n/a - Unknown - Results in Death);Foetal exposure during pregnancy (n/a - Unknown - Results in Death);Myeloproliferative neoplasm (n/a - Unknown - Results in Death);Stillbirth (n/a - Fatal - Results in Death);Viral infection (n/a - Unknown - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Maternal exposure timing unspecified - n/a - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5767623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5761002	Spontaneous	2012-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cough (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cytomegalovirus infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5761002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5761010	Spontaneous	2012-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysphagia (6d - Recovered/Resolved - Other Medically Important Condition);Speech disorder (6d - Recovered/Resolved - Other Medically Important Condition);Swelling face (6d - Recovered/Resolved - Other Medically Important Condition);Swollen tongue (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Ill-defined disorder - Not applicable - [1d - n/a - Intramuscular])	[CHLOROQUINE PHOSPHATE] (C - Polyarthritis - Unknown - [n/a - 1{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5761010&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5761026	Spontaneous	2012-08-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Purpura (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5761026&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5761031	Spontaneous	2012-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	C-reactive protein increased (n/a - Unknown - Other Medically Important Condition);Cough (26d - Recovered/Resolved - Other Medically Important Condition);General physical health deterioration (26d - Recovered/Resolved - Other Medically Important Condition);Lymphocyte count decreased (n/a - Unknown - Other Medically Important Condition);Pneumonia (25d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (26d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Ill-defined disorder - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5761031&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5761422	Spontaneous	2012-08-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Clumsiness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Depressed level of consciousness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysstasia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Feeling cold (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperacusis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Initial insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Irritability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Loss of personal independence in daily activities (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Motor dysfunction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Respiratory arrest (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5761422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5764303	Spontaneous	2012-08-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Thrombosis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5764303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5759986	Spontaneous	2012-08-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Rash papular (n/a - Recovered/Resolved - Other Medically Important Condition);Rash pruritic (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[YELLOW FEVER VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5759986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756346	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Arthralgia (n/a - Unknown - Other Medically Important Condition);Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756399	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Eosinophilia (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756400	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	Kostianovsky A, Charles P, Alves J, Goulet M, Pagnoux C, Le Guern V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. Clinical and Experimental Rheumatology 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Polyneuropathy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756402	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Arthritis (n/a - Unknown - Other Medically Important Condition);Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Purpura (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5756420	Spontaneous	2012-08-10 00:00:00	Healthcare Professional	European Economic Area	KOSTIANOVSKY A, CHARLES P, ALVES J, GOULET M, PAGNOUX C, LE GUERN V, et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2012;30:S83-S89.	Not Specified	Not Specified	No	Not Specified	Aphthous ulcer (n/a - Unknown - Other Medically Important Condition);Autoimmune disorder (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5756420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5748115	Spontaneous	2012-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Circulatory collapse (3d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dizziness (47d - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation);Migraine (3d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Nausea (3d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Tachycardia (34d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vertigo (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (3d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5748115&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5748667	Spontaneous	2012-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5748667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5748669	Spontaneous	2012-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypoacusis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5748669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5751865	Spontaneous	2012-08-09 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Lymphadenopathy (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5751865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5751866	Spontaneous	2012-08-09 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Extensive swelling of vaccinated limb (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site inflammation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])	[INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (C - Immunisation - n/a - [n/a - n/a - n/a])|[VARICELLA VACCINE (LIVE)] (C - Immunisation - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5751866&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5743356	Spontaneous	2012-08-08 00:00:00	Non Healthcare Professional	Non European Economic Area	Bita N. 10 deaths linked to anti-flu vaccines. The Australian (newspaper) 2012 Aug 03;3-3.	18-64 Years	Not Specified	No	Male	Cardiac arrest (0d - Fatal - Results in Death);Influenza like illness (3d - Fatal - Results in Death);Motor neurone disease (n/a - Fatal - Results in Death);Myocardial infarction (n/a - Fatal - Results in Death);Respiratory arrest (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5743356&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5744615	Spontaneous	2012-08-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arrhythmia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Blood pressure fluctuation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vertigo (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	[PNEUMOCOCCAL VACCINE] (C - Product used for unknown indication - Not applicable - [1d - n/a - Unknown])|[TETANUS VACCINES] (C - Product used for unknown indication - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5744615&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5732962	Spontaneous	2012-08-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Guillain-Barre syndrome (n/a - Unknown - Results in Death, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Results in Death, Other Medically Important Condition);Neuromyopathy (n/a - Unknown - Results in Death, Other Medically Important Condition);Polyneuropathy (n/a - Unknown - Results in Death, Other Medically Important Condition);Sensory loss (n/a - Unknown - Results in Death, Other Medically Important Condition);Walking disability (n/a - Unknown - Results in Death, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5732962&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5727548	Spontaneous	2012-08-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Brain injury (n/a - Recovered/Resolved With Sequelae - Disabling);Encephalitis (n/a - Recovered/Resolved With Sequelae - Disabling);Pneumonitis (n/a - Recovered/Resolved With Sequelae - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Sepsis (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5727548&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-5722217	Spontaneous	2012-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	CSF cell count increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (0a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Ill-defined disorder - Not applicable - [0mo - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5722217&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5722475	Spontaneous	2012-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Abdominal tenderness (0a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Amnesia (0a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (0a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Food intolerance (0a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (0a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (0a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	EXELON 6 MG [RIVASTIGMINE] (C - Ill-defined disorder - Unknown - [n/a - 6mg - Oral])|[ACETYLSALICYLIC ACID] (C - Ill-defined disorder - Unknown - [n/a - 100mg - Oral])|[AMLODIPINE, AMLODIPINE MALEATE, TEMAZEPAM] (C - Ill-defined disorder - Unknown - [n/a - 10mg - Oral])|[BISOPROLOL FUMARATE] (C - Ill-defined disorder - Unknown - [n/a - 2.5mg - Oral])|[DIPYRIDAMOLE] (C - Ill-defined disorder - Unknown - [n/a - 200mg - Oral])|[GLYCERYL TRINITRATE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[ISOSORBIDE DINITRATE] (C - Ill-defined disorder - Unknown - [n/a - 20mg - Oral])|[ISOSORBIDE DINITRATE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Nasal])|[METFORMIN HYDROCHLORIDE] (C - Ill-defined disorder - Unknown - [n/a - 500mg - Oral])|[PARACETAMOL] (C - Ill-defined disorder - Unknown - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5722475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5722499	Spontaneous	2012-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Cerebrovascular accident (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Drug interaction (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (I - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])|[WARFARIN, WARFARIN SODIUM] (I - Atrial fibrillation - Unknown - [n/a - n/a - Oral])	[BENDROFLUAZIDE] (C - Hypertension - Unknown - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5722499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5723375	Spontaneous	2012-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Mixed connective tissue disease (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5723375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5723694	Spontaneous	2012-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depressed mood (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5723694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5725526	Spontaneous	2012-08-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gastritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Miller Fisher syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Muscle disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Neuritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia oral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])|[A/CHRISTCHURCH/16/2010 NIB-74XP (H1N1) (AN A/CALIFORNIA/7/2009-LIKE VIRUS), A/VICTORIA/361/2011, B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, B/MASSACHUSETTS/2/2012-LIKE STRAIN USED B/MASSACHUSETTS/2/2012 WILD TYPE, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010, INFLUENZA VIRUS VACCINE POLYVALENT] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5725526&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5719208	Spontaneous	2012-07-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Diplegia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [0mo - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5719208&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5713284	Spontaneous	2012-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Blood immunoglobulin E increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cyanosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hepatic enzyme increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperventilation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[METOPROLOL TARTRATE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[THIAMINE HYDROCHLORIDE, CALCIUM PANTOTHENATE, CYANOCOBALAMIN, NICOTINAMIDE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, SILYMARIN, THIAMINE HYDROCHLORIDE, CALCIUM PANTOTHENATE, CYANOCOBALAMIN, NICOTINAMIDE, RIBOFLAVIN, SILIBININ, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, CYANOCOBALAMIN, NICOTINAMIDE, RIBOFLAVIN, PANTOTHENIC ACID, PYRIDOXINE HYDROCHLORIDE, SILYMARIN] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[TIAPRIDE HYDROCHLORIDE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5713284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5714446	Spontaneous	2012-07-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoaesthesia oral (10min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nasal pruritus (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5714446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5714508	Spontaneous	2012-07-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation);Lip swelling (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pharyngeal swelling (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	[CLINDAMYCIN, CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN PHOSPHATE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Topical])|[VENLAFAXINE HYDROCHLORIDE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5714508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5714705	Spontaneous	2012-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Blood bilirubin increased (n/a - Unknown - Life Threatening);Haemolytic anaemia (n/a - Not Recovered/Not Resolved - Life Threatening);Hepatic enzyme abnormal (n/a - Unknown - Life Threatening);Warm autoimmune haemolytic anaemia (n/a - Not Recovered/Not Resolved - Life Threatening);White blood cell disorder (n/a - Unknown - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Subcutaneous])	[NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE] (C - Hypertension - Unknown - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5714705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-5714772	Spontaneous	2012-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Loss of consciousness (1d - Recovered/Resolved - Other Medically Important Condition);Seizure (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5714772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5714800	Spontaneous	2012-07-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Flushing (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5714800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5714974	Spontaneous	2012-07-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthenia (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5714974&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5709850	Spontaneous	2012-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5709850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5709851	Spontaneous	2012-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Oedema (n/a - Unknown - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Rash (n/a - Unknown - Disabling);Spondyloarthropathy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5709851&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5709933	Spontaneous	2012-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Decreased appetite (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Transaminases increased (22d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5709933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-5709964	Spontaneous	2012-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cluster headache (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tremor (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	[CIMICIFUGA RACEMOSA, CIMICIFUGA RACEMOSA EXTRACT, CIMICIFUGA RACEMOSA ROOT DRY EXTRACT, CIMICIFUGA RACEMOSA ROOT EXTRACT, CIMICIFUGA RHIZOME DRY EXTRACT, DRY EXTRACT FROM CIMICIFUGAE RHIZOMA (6-11 : 1), EXTRACTION SOLVENT: ISOPROPYL ALCOHOL 40 % (V/V), LIQUID EXTRACT FROM CIMICIFUGAE RHIZOMA (0.78-1.14:1), EXTRACTION SOLVENT: ISOPROPYL ALCOHOL 40 % (V/V)] (C - Menopausal symptoms - Unknown - [18mo - 1{DF} - Unknown])|[ESOMEPRAZOLE] (C - Gastrooesophageal reflux disease - Unknown - [n/a - n/a - Oral])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - Depression - Unknown - [1y - 25mg - Oral])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - Depression - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5709964&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5711201	Spontaneous	2012-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood pressure decreased (16d - Recovered/Resolved - Other Medically Important Condition);Body temperature increased (n/a - Unknown - Other Medically Important Condition);C-reactive protein increased (16d - Recovering/Resolving - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Liver disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Transaminases increased (16d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5711201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5704631	Spontaneous	2012-07-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest discomfort (1d - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (2d - Recovered/Resolved - Other Medically Important Condition);Feeling hot (1d - Recovered/Resolved - Other Medically Important Condition);Nausea (1d - Recovered/Resolved - Other Medically Important Condition);Urticaria (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5704631&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5704854	Spontaneous	2012-07-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Juvenile idiopathic arthritis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5704854&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5684931	Spontaneous	2012-07-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation);Eyelid ptosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5684931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5687342	Spontaneous	2012-07-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Hepatic failure (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	[ACENOCOUMAROL] (C - n/a - n/a - [n/a - n/a - Oral])|[ATENOLOL] (C - n/a - n/a - [n/a - 100mg - Oral])|[BEZAFIBRAAT] (C - n/a - n/a - [n/a - 400mg - Oral])|[BUMETANIDE] (C - n/a - n/a - [n/a - 1mg - Oral])|[CAPTOPRIL] (C - n/a - n/a - [n/a - 50mg - Oral])|[ISOSORBIDEMONONITRAAT] (C - n/a - n/a - [n/a - 60mg - Oral])|[METFORMINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 40mg - Oral])|[SPIRONOLACTON] (C - n/a - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5687342&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5683247	Spontaneous	2012-07-19 00:00:00	Healthcare Professional	Non European Economic Area	Petrovic V, Seguljev Z, Medic S, Ristic M, Tomic S and Cvetic G. ANALYSIS OF SUSPECTED ADVERSE REACTIONS FOLLOWING IMMUNIZATION AGAINST PANDEMIC INFLUENZA A (H1N1) 2009. Default Record. 2011;5:305 to 309	18-64 Years	Not Specified	No	Male	Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Vestibular neuronitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5683247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5683248	Spontaneous	2012-07-19 00:00:00	Healthcare Professional	Non European Economic Area	Petrovic V, Seguljev Z, Medic S, Ristic M, Tomic S and Cvetic G. ANALYSIS OF SUSPECTED ADVERSE REACTIONS FOLLOWING IMMUNIZATION AGAINST PANDEMIC INFLUENZA A (H1N1) 2009. Default Record. 2011;5:305 to 309	Not Specified	Not Specified	No	Not Specified	Herpes zoster (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5683248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5683264	Spontaneous	2012-07-19 00:00:00	Healthcare Professional	Non European Economic Area	petrovic V, Seguljev Z, Medic S, Ristic M, Tomic S and Cvetic G. ANALYSIS OF SUSPECTED ADVERSE REACTIONS FOLLOWING IMMUNIZATION AGAINST PANDEMIC INFLUENZA A (H1N1) 2009. Default Record. 2011;5:305 to 309	65-85 Years	Not Specified	No	Female	Erythema of eyelid (n/a - Unknown - Other Medically Important Condition);Swelling of eyelid (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5683264&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5675508	Spontaneous	2012-07-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Adrenocortical insufficiency acute (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vaccination site reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5675508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5675550	Spontaneous	2012-07-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Myelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5675550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5676156	Spontaneous	2012-07-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5676156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5676157	Spontaneous	2012-07-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Nervous system disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5676157&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5670896	Spontaneous	2012-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Torticollis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Tremor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5670896&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5670946	Spontaneous	2012-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Autoantibody negative (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Autoimmune disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Back pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Chills (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Deep vein thrombosis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Dysphagia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Eosinophilia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Extremity necrosis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Hypereosinophilic syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Night sweats (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Painful respiration (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pericardial effusion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pericarditis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pharyngeal inflammation (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pleurisy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pollakiuria (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Pulmonary embolism (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Raynaud's phenomenon (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Systemic inflammatory response syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Thrombophlebitis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Vasculitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Viral infection (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5670946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5669283	Spontaneous	2012-07-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Unknown - Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (1d - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[BECLOMETASONE DIPROPIONATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Respiratory (inhalation)])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Product used for unknown indication - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5669283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5667630	Spontaneous	2012-07-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - Results in Death, Other Medically Important Condition);Foetal growth restriction (n/a - Unknown - Results in Death, Other Medically Important Condition);Foetal heart rate abnormal (n/a - Unknown - Results in Death, Other Medically Important Condition);Stillbirth (n/a - Fatal - Results in Death, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5667630&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5668090	Spontaneous	2012-07-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Blood pressure decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5668090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5668536	Spontaneous	2012-07-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Live birth (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CYCLIZINE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5668536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5665402	Spontaneous	2012-07-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Epilepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5665402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-5665816	Spontaneous	2012-07-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Gastroenteritis (n/a - Fatal - Results in Death);Myocarditis (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5665816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5659911	Spontaneous	2012-07-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5659911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5659916	Spontaneous	2012-07-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5659916&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5657162	Spontaneous	2012-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Thrombocytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	LEVOFLOXACIN [LEVOFLOXACIN] (S - Bronchitis - Not applicable - [6d - 500mg - Oral])|[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5657162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653488	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Monoparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	ACTOS [PIOGLITAZONE, PIOGLITAZONE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 30mg - Unknown])|[ESTRADIOL HEMIHYDRATE, ESTRADIOL VALERATE] (C - Oestrogen therapy - Unknown - [n/a - n/a - Unknown])|[GLIMEPIRIDE] (C - n/a - Unknown - [n/a - 3mg - Unknown])|[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - Unknown - [n/a - 100mg - Unknown])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653488&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653489	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dermatitis (n/a - Unknown - Other Medically Important Condition);Diverticulitis (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Gastrointestinal disorder (n/a - Unknown - Other Medically Important Condition);Haematochezia (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Infection (n/a - Unknown - Other Medically Important Condition);Migraine (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Psoriasis (n/a - Unknown - Other Medically Important Condition);Rectal haemorrhage (n/a - Unknown - Other Medically Important Condition);Tinnitus (n/a - Unknown - Other Medically Important Condition);Tooth disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653489&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5653490	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ageusia (n/a - Unknown - Other Medically Important Condition);Anosmia (n/a - Unknown - Other Medically Important Condition);Cholelithiasis (n/a - Unknown - Other Medically Important Condition);Menopause (n/a - Unknown - Other Medically Important Condition);Mental disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[LEVONORGESTREL] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653490&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5653491	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arrhythmia (n/a - Unknown - Caused/Prolonged Hospitalisation);Auditory disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation);Mental disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle tightness (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Musculoskeletal discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Orthostatic hypotension (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Road traffic accident (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653491&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653492	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Palpitations (n/a - Unknown - Other Medically Important Condition);Paralysis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[METHADONE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5653493	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Not Specified	Yes	Female	Brain injury (n/a - Unknown - Congenital Anomaly);Congenital central nervous system anomaly (n/a - Unknown - Congenital Anomaly);Decreased eye contact (n/a - Unknown - Congenital Anomaly);Dysmyelination (n/a - Unknown - Congenital Anomaly);Encephalopathy (n/a - Unknown - Congenital Anomaly);Head deformity (n/a - Unknown - Congenital Anomaly);Kinematic imbalances due to suboccipital strain (n/a - Unknown - Congenital Anomaly);Lactation disorder (n/a - Unknown - Congenital Anomaly);Live birth (n/a - Unknown - Congenital Anomaly);Maternal exposure timing unspecified (n/a - Unknown - Congenital Anomaly);Multiple congenital abnormalities (n/a - Unknown - Congenital Anomaly);Psychomotor retardation (n/a - Unknown - Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653493&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Severe reaction
EU-EC-5653494	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Back pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hepatic steatosis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypertriglyceridaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Motor dysfunction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Musculoskeletal discomfort (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Musculoskeletal disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nephritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Oedema mouth (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash pruritic (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Renal failure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Wound (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ALLOPURINOL] (C - n/a - Unknown - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, LISINOPRIL, HYDROCHLOROTHIAZIDE, LISINOPRIL ANHYDROUS, LISINOPRIL ANHYDROUS, HYDROCHLOROTHIAZIDE EP, LISINOPRIL DIHYDRATE, HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653495	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral sensory neuropathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653495&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653496	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cough (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Polyneuropathy (n/a - Unknown - Other Medically Important Condition);Productive cough (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Respiratory tract infection (n/a - Unknown - Other Medically Important Condition);Sensory loss (n/a - Unknown - Other Medically Important Condition);Upper respiratory tract infection (n/a - Unknown - Other Medically Important Condition);Viral infection (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5653497	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Depression (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Ear swelling (n/a - Unknown - Caused/Prolonged Hospitalisation);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation);Palpitations (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation);Tinnitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - Anxiety - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653498	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (1d - Recovered/Resolved - Other Medically Important Condition);Dizziness (1d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (1d - Recovered/Resolved - Other Medically Important Condition);Feeling cold (n/a - Unknown - Other Medically Important Condition);Gastrointestinal disorder (n/a - Unknown - Other Medically Important Condition);Oral mucosa atrophy (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Peripheral coldness (n/a - Unknown - Other Medically Important Condition);Presyncope (1d - Recovered/Resolved - Other Medically Important Condition);Trismus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	OLANZAPINE [OLANZAPINE] (C - n/a - Unknown - [n/a - n/a - n/a])|[ALENDRONATE SODIUM, ALENDRONATE SODIUM TRIHYDRATE, ALENDRONIC ACID] (C - n/a - Unknown - [n/a - n/a - n/a])|[AZATHIOPRINE] (C - Crohn's disease - Unknown - [n/a - n/a - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[DIAZEPAM] (C - n/a - Unknown - [n/a - n/a - n/a])|[FLUPENTIXOL, FLUPENTIXOL DECANOATE, FLUPENTIXOL HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[OXYCODONE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[PARACETAMOL, PARACETAMOL, ASPARTAME] (C - n/a - Unknown - [n/a - n/a - n/a])|[PROMETHAZINE, PROMETHAZINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5653499	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[SIMVASTATIN] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653500	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Condition aggravated (n/a - Unknown - Other Medically Important Condition);Epidermal necrosis (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Psoriasis (n/a - Unknown - Other Medically Important Condition);Rash maculo-papular (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	HYDROCORTISONE [HYDROCORTISONE, HYDROCORTISONE SODIUM SUCCINATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|LOTION [LOTION] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5653501	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diplegia (n/a - Unknown - Disabling, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Disabling, Other Medically Important Condition);Neuralgia (n/a - Unknown - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5653502	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653503	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Tic (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653504	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Glomerulonephritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Renal failure (n/a - Unknown - Caused/Prolonged Hospitalisation);Urinary tract disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653505	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ageusia (n/a - Unknown - Other Medically Important Condition);Anosmia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653505&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5653506	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5653507	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Chills (n/a - Unknown - Caused/Prolonged Hospitalisation);Condition aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperthyroidism (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653508	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diplopia (6wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Optic neuritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paresis cranial nerve (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653509	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dizziness (n/a - Unknown - Other Medically Important Condition);Ill-defined disorder (n/a - Unknown - Other Medically Important Condition);Monoparesis (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Vestibular disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	CPAP [MECHANICAL VENTILATION] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653509&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5653510	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Blindness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cognitive disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Cystitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Motor dysfunction (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nasopharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Optic neuritis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Urinary tract infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[METHYLPREDNISOLONE, METHYLPREDNISOLONE HYDROGEN SUCCINATE, METHYLPREDNISOLONE SODIUM SUCCINATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653510&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653512	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Night sweats (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pollakiuria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5653513	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood pressure fluctuation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dry mouth (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspepsia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Feeling cold (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fibromyalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Memory impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pollakiuria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tinnitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 10mg - Oral])|[AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 25mg - Oral])|[CASCARA, ETHYLMORPHINE HYDROCHLORIDE, ETHYLMORPHINE HYDROCHLORIDE, FRANGULA PURSHIANA BARK] (C - n/a - Unknown - [n/a - 10mL - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - 100mg - Oral])|[ZOPICLONE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653514	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Decreased appetite (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Unknown - Disabling);Hyperhidrosis (n/a - Unknown - Disabling);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Vertigo (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5653515	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Cardiac failure (n/a - Unknown - Caused/Prolonged Hospitalisation);Chronic obstructive pulmonary disease (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Cystitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hydronephrosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Oedema peripheral (n/a - Unknown - Caused/Prolonged Hospitalisation);Osteomyelitis chronic (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Toe amputation (n/a - Unknown - Caused/Prolonged Hospitalisation);Urinary incontinence (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[FELODIPINE, FELODIPINE PH. EUR.] (C - Hypertension - Unknown - [n/a - n/a - n/a])|[GLIMEPIRIDE] (C - Type 2 diabetes mellitus - Unknown - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Type 2 diabetes mellitus - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Chronic obstructive pulmonary disease - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653515&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653516	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Recovering/Resolving - Disabling);Ill-defined disorder (n/a - Recovering/Resolving - Disabling);Myalgia (n/a - Recovering/Resolving - Disabling);Pyrexia (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMITRIPTYLINE HYDROCHLORIDE] (C - Pain - Unknown - [n/a - 30mg - Oral])|[OXAZEPAM] (C - n/a - Unknown - [n/a - 5mg - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Gastrooesophageal reflux disease - Unknown - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653516&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5653517	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653517&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5653518	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	XYREM [SODIUM OXYBATE] (C - n/a - Unknown - [n/a - 14mL - n/a])|[CLONAZEPAM] (C - n/a - Unknown - [n/a - .5mg - n/a])|[FLUNITRAZEPAM] (C - n/a - Unknown - [n/a - n/a - n/a])|[MIANSERIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 30mg - n/a])|[MIRTAZAPINE] (C - n/a - Unknown - [n/a - 30mg - n/a])|[MODAFINIL] (C - n/a - Unknown - [n/a - n/a - n/a])|[PYRIMETHAMINE] (C - n/a - Unknown - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 25mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653518&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653519	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation);Brain fog (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Food intolerance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation);Intervertebral disc protrusion (n/a - Unknown - Caused/Prolonged Hospitalisation);Nerve injury (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5653520	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mood altered (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .25mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5653521	Spontaneous	2012-07-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Pertussis (n/a - Unknown - Caused/Prolonged Hospitalisation);Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	ACTRAPID [INSULIN HUMAN, INSULIN HUMAN (RDNA)] (C - Type 2 diabetes mellitus - Unknown - [n/a - n/a - n/a])|INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - Type 2 diabetes mellitus - Unknown - [n/a - n/a - n/a])|MYCOMIST [BENZALKONIUM CHLORIDE, CHLOROPHYLL, FORMALDEHYDE SOLUTION] (C - Bronchiectasis - Unknown - [n/a - n/a - n/a])|NOVORAPID [INSULIN ASPART] (C - Type 2 diabetes mellitus - Unknown - [n/a - n/a - n/a])|ZOLEDRONIC ACID [ZOLEDRONIC ACID] (C - Osteoporosis - Unknown - [n/a - n/a - Intravenous (not otherwise specified)])|[ALENDRONATE SODIUM, ALENDRONIC ACID] (C - Osteoporosis - Unknown - [n/a - n/a - Oral])|[AZATHIOPRINE] (C - Rheumatoid arthritis - Unknown - [n/a - n/a - n/a])|[BETAMETHASONE, BETAMETHASONE DIPROPIONATE, SALICYLIC ACID, BETAMETHASONE DIPROPIONATE, SALSALATE, BETAMETHASONE, SALICYLIC ACID] (C - n/a - Unknown - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - Osteoporosis - Unknown - [n/a - n/a - Unknown])|[CYANOCOBALAMIN] (C - Anaemia - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - n/a])|[IBUPROFEN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - Unknown - [n/a - n/a - n/a])|[PARACETAMOL] (C - Pain - Unknown - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - Unknown - [n/a - n/a - n/a])|[PREDNISONE] (C - Rheumatoid arthritis - Unknown - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - Asthma - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5653521&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5648437	Spontaneous	2012-07-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bundle branch block (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pathological fracture (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5648437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5649260	Spontaneous	2012-07-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eye pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5649260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5644467	Spontaneous	2012-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Alopecia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Anaemia folate deficiency (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Anaemia vitamin B12 deficiency (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Blood pressure increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Haematoma (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Iritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sarcoidosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5644467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5646736	Spontaneous	2012-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5646736&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5646737	Spontaneous	2012-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5646737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5641884	Spontaneous	2012-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Amyotrophic lateral sclerosis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Aphasia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Dysphonia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Feeding disorder (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	METHOTREXATE [METHOTREXATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, IVR-186), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/SOUTH AUSTRALIA/55/2014 STRAIN, A/SWITZERLAND/9715293/2013 (H3N2) - LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, B/MASSACHUSETTS/02/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, A/WISCONSIN/67/2005 (H3N2), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/MALAYSIA/2506/2004 - LIKE STRAIN, B/BEIJING/184/93-LIKE STRAIN (B/YAMANASHI/166/98), A/SYDNEY/5/97 (H3N2)-LIKE STRAIN (A/SYDNEY/5/97 REASS. RESVIR 13), A/BEIJING/262/95 (H1N1) - LIKE STRAIN (A/BEIJING/262/95 REASS. X-127), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NIB-65), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SOUTH AUSTRALIA/55/2014, IVR-175), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[DISOPYRAMIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - n/a - n/a])...	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5641884&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-5635204	Spontaneous	2012-07-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Myalgia (n/a - Unknown - Other Medically Important Condition);Type 1 diabetes mellitus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5635204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5635847	Spontaneous	2012-07-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site erythema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sepsis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5635847&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5630447	Spontaneous	2012-07-02 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5630447&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5621025	Spontaneous	2012-06-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5621025&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5618432	Spontaneous	2012-06-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of control of legs (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5618432&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5619733	Spontaneous	2012-06-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Injection site pain (n/a - Not Recovered/Not Resolved - );Pain in extremity (n/a - Not Recovered/Not Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5619733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5620337	Spontaneous	2012-06-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Bone marrow failure (n/a - Not Recovered/Not Resolved - Disabling);Pancytopenia (n/a - Not Recovered/Not Resolved - Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - 3g - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5620337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5610640	Spontaneous	2012-06-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Encephalomyelitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	ENBREL [ETANERCEPT] (C - n/a - n/a - [n/a - n/a - n/a])|METHOTREXATE [METHOTREXATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5610640&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5610660	Spontaneous	2012-06-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Encephalomyelitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5610660&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5610665	Spontaneous	2012-06-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Facial paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	EMSELEX [DARIFENACIN, DARIFENACIN HYDROBROMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[MESALAZINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5610665&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5610742	Spontaneous	2012-06-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Aggression (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Amenorrhoea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Anaemia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Ataxia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Autoimmune disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Body temperature decreased (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);C-reactive protein increased (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Decreased interest (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Endocrine disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Epilepsy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fall (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gait inability (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Haematemesis (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Heavy menstrual bleeding (9wk - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hormone level abnormal (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypotonia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Infection susceptibility increased (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Insomnia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Lethargy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Lipase increased (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Lung infiltration (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Menstrual disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Molluscum contagiosum (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Motor dysfunction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	VIGABATRIN [VIGABATRIN] (C - Epilepsy - Unknown - [n/a - n/a - Unknown])|[DESMOPRESSIN, DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE TRIHYDRATE] (C - Diabetes insipidus - Unknown - [n/a - n/a - Subcutaneous])|[LAMOTRIGINE] (C - Epilepsy - Unknown - [n/a - n/a - Oral])|[PHENOBARBITAL, PHENOBARBITAL SODIUM] (C - Epilepsy - Unknown - [n/a - n/a - Unknown])|[TRIPTORELIN] (C - Precocious puberty - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5610742&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5607044	Spontaneous	2012-06-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Burning sensation (30d - Recovered/Resolved - Disabling, Other Medically Important Condition);Chills (1h - Recovered/Resolved - Disabling, Other Medically Important Condition);Erythema (7d - Recovered/Resolved - Disabling, Other Medically Important Condition);Eye disorder (36d - Recovered/Resolved - Disabling, Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Limb discomfort (30d - Recovered/Resolved - Disabling, Other Medically Important Condition);Ocular hyperaemia (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Pain in extremity (30d - Recovered/Resolved - Disabling, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition);Rash (7d - Recovered/Resolved - Disabling, Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Disabling, Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5607044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Duration
EU-EC-5604712	Spontaneous	2012-06-25 00:00:00	Healthcare Professional	Non European Economic Area	Choe Y.J, Cho.H, Song.K.M, Jong-Hee Kim J.H, Han. O.P, Kwon Y.H, Bae G.R, Lee H.J, and Lee J.K.. Active Surveillance of Adverse Events Following Immunization against Pandemic Influenza A (H1N1) in Korea. Default Record. 2011;64:297 to 303	Not Specified	Not Specified	No	Not Specified	Syncope (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5604712&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5597118	Spontaneous	2012-06-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Parenteral])|[FOLIC ACID] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5597118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5590789	Spontaneous	2012-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pruritus (7mo - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5590789&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5592618	Spontaneous	2012-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Encephalopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Paraparesis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5592618&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5592625	Spontaneous	2012-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Chorea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5592625&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5592637	Spontaneous	2012-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Simple partial seizures (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5592637&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5590044	Spontaneous	2012-06-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anaemia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Glomerulonephritis acute (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Glomerulonephritis proliferative (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Goodpasture's syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Leukocytosis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Renal failure (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	MICARDISPLUS [HYDROCHLOROTHIAZIDE, TELMISARTAN] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])|[BECLOMETASONE, BECLOMETASONE DIPROPIONATE] (C - Asthma - n/a - [n/a - 50ug - Respiratory (inhalation)])|[FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE] (C - Asthma - n/a - [n/a - 12ug - Respiratory (inhalation)])|[LANSOPRAZOLE, LANSOPRAZOLE, SUCROSE, ASPARTAME] (C - Prophylaxis - n/a - [n/a - 30mg - Oral])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[ROSUVASTATIN] (C - Dyslipidaemia - n/a - [n/a - 10mg - Oral])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - Depression - n/a - [n/a - 1{DF} - Oral])|[ZOLPIDEM, ZOLPIDEM TARTRATE] (C - n/a - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5590044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5582628	Spontaneous	2012-06-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5582628&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5582654	Spontaneous	2012-06-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Vasculitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5582654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5576612	Spontaneous	2012-06-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5576612&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5576952	Spontaneous	2012-06-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Male	Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypnopompic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypopnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Initial insomnia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Middle insomnia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Rapid eye movements sleep abnormal (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Road traffic accident (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep apnoea syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep attacks (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Snoring (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5576952&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5581067	Spontaneous	2012-06-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Tolosa-Hunt syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (S - Depressive symptom - Dose not changed - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5581067&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5568643	Spontaneous	2012-06-13 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Abscess (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5568643&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5570267	Spontaneous	2012-06-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Disabling);Asthenia (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Recovering/Resolving - Disabling);Headache (n/a - Unknown - Disabling);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Disabling);Listless (n/a - Not Recovered/Not Resolved - Disabling);Pallor (n/a - Unknown - Disabling);Skin striae (n/a - Not Recovered/Not Resolved - Disabling);Syncope (n/a - Unknown - Disabling);Weight increased (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5570267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5565676	Spontaneous	2012-06-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cutaneous vasculitis (28d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5565676&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5561701	Spontaneous	2012-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Blood pressure increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5561701&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5561702	Spontaneous	2012-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 500ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5561702&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5563009	Spontaneous	2012-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5563009&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5563920	Spontaneous	2012-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Carbuncle (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Furuncle (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Subcutaneous abscess (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	ANTI-PSYCHOTIC MEDICATION [NEUROLEPTIC] (C - n/a - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5563920&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5563970	Spontaneous	2012-06-11 00:00:00	Healthcare Professional	European Economic Area	Oppermann M, Fritzsche J, Schoendorfer C W, Stanislawski B K, Allignol A, Schaefer C, et al.. A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012;1-8	Not Specified	Neonate (Preterm and Term newborns)	Yes	Not Specified	Foetal exposure during pregnancy (n/a - Unknown - Congenital Anomaly);Ventricular septal defect (n/a - Unknown - Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Transplacental])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - n/a - n/a - [n/a - 1{DF} - Transplacental])	[FOLIC ACID] (C - n/a - Unknown - [n/a - 1{DF} - Transplacental])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5563970&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-5564339	Spontaneous	2012-06-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[SODIUM VALPROATE] (C - Epilepsy - n/a - [n/a - n/a - n/a])|[TOPIRAMATE] (C - Seizure - n/a - [n/a - 50mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5564339&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5564340	Spontaneous	2012-06-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5564340&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5564394	Spontaneous	2012-06-11 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Genital herpes (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - .5mL - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5564394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5555828	Spontaneous	2012-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Quadriparesis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Syncope (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - n/a - n/a - [n/a - n/a - n/a])	[CYANOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5555828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5555833	Spontaneous	2012-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myocardial infarction (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	[HYDROXYCARBAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5555833&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5557591	Spontaneous	2012-06-08 00:00:00	Healthcare Professional	Non European Economic Area	Stecher D, Godoy E, Ianantuonno V, Fridman V, Ruda V H, Lasala M B. EVALUATION OF A FLU VACCINE WITH ADJUVANT IN PREGNANCY. National Infectology congress 2012. 2012	Not Specified	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Foetal death (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5557591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5559550	Spontaneous	2012-06-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Autoimmune disorder (n/a - Not Recovered/Not Resolved - );Hypothyroidism (n/a - Not Recovered/Not Resolved - );Influenza like illness (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5559550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5553466	Spontaneous	2012-06-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Not Specified	Cytogenetic abnormality (n/a - Unknown - Other Medically Important Condition);Developmental delay (n/a - Unknown - Other Medically Important Condition);Foetal exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Hypotonia (n/a - Unknown - Other Medically Important Condition);Nervous system disorder (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5553466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5547375	Spontaneous	2012-06-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pulmonary fibrosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5547375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5547378	Spontaneous	2012-06-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5547378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5542457	Spontaneous	2012-06-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Amyotrophic lateral sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysphagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dysphonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling jittery (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle contractions involuntary (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasal congestion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nasal oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuromyopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Tongue atrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tongue movement disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[BUSPIRONE, BUSPIRONE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5542457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5542458	Spontaneous	2012-06-04 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Balance disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Borrelia test (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Brain oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Encephalomyelitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nervous system disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Speech disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5542458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5543465	Spontaneous	2012-06-04 00:00:00	Healthcare Professional	Non European Economic Area	Stecher D, Godoy E, Ianantuonno V, Fridman V, Ruda V H, Lasala M B. EVALUATION OF A FLU VACCINE WITH ADJUVANT IN PREGNANCY. National Infectology congress 2012. 2012	Not Specified	Not Specified	Yes	Not Specified	Anotia (n/a - Unknown - Congenital Anomaly);Foetal exposure during pregnancy (n/a - Unknown - Congenital Anomaly)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5543465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-5537102	Spontaneous	2012-06-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation);Anti-neutrophil cytoplasmic antibody positive vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastrointestinal disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypersensitivity vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Purpura (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash macular (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5537102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5537867	Spontaneous	2012-06-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5537867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-5538254	Spontaneous	2012-06-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Stillbirth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5538254&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5541472	Spontaneous	2012-06-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5541472&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5534845	Spontaneous	2012-05-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depression (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Fibromyalgia (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5534845&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5535311	Spontaneous	2012-05-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Radiculopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[GALANTAMINE, GALANTAMINE HYDROBROMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PRAVASTATIN, PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[RISPERIDONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5535311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5535312	Spontaneous	2012-05-31 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Facial paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5535312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5535313	Spontaneous	2012-05-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[ETHINYLESTRADIOL, LEVONORGESTREL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5535313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5528911	Spontaneous	2012-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dementia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5528911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5528917	Spontaneous	2012-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5528917&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5528922	Spontaneous	2012-05-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5528922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5526468	Spontaneous	2012-05-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	CSF test abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (0min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Neurological symptom (n/a - Unknown - Caused/Prolonged Hospitalisation);Transient ischaemic attack (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vertigo positional (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	[HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - Hypertension - Dose not changed - [n/a - 20.5mg - Oral])|[NEBIVOLOL] (C - Hypertension - Dose not changed - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5526468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5523987	Spontaneous	2012-05-28 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	Not Specified	Not Specified	No	Female	Abortion spontaneous (n/a - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5523987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5523993	Spontaneous	2012-05-28 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	Not Specified	Infant	No	Not Specified	Foetal exposure during pregnancy (n/a - Recovered/Resolved - Congenital Anomaly);Maternal exposure timing unspecified (n/a - Recovered/Resolved - Congenital Anomaly);Trisomy 21 (n/a - Unknown - Congenital Anomaly)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Foetal exposure timing unspecified - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5523993&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-5523996	Spontaneous	2012-05-28 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	Not Specified	Infant	No	Not Specified	Foetal exposure during pregnancy (n/a - Recovered/Resolved - Congenital Anomaly);Hydrocephalus (n/a - Unknown - Congenital Anomaly);Maternal exposure timing unspecified (n/a - Recovered/Resolved - Congenital Anomaly)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Foetal exposure timing unspecified - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5523996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-5523997	Spontaneous	2012-05-28 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	Not Specified	Not Specified	No	Female	Abortion spontaneous (n/a - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5523997&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5523998	Spontaneous	2012-05-28 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	Not Specified	Not Specified	No	Female	Abortion spontaneous (n/a - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5523998&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5524000	Spontaneous	2012-05-28 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	Not Specified	Infant	No	Not Specified	Foetal exposure during pregnancy (n/a - Recovered/Resolved - Congenital Anomaly);Maternal exposure timing unspecified (n/a - Recovered/Resolved - Congenital Anomaly);Umbilical hernia (n/a - Unknown - Congenital Anomaly)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Foetal exposure timing unspecified - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5524000&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-5524001	Spontaneous	2012-05-28 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	Not Specified	Infant	No	Not Specified	Cleft palate (n/a - Unknown - Congenital Anomaly);Foetal exposure during pregnancy (n/a - Recovered/Resolved - Congenital Anomaly);Maternal exposure timing unspecified (n/a - Recovered/Resolved - Congenital Anomaly)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Foetal exposure timing unspecified - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5524001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-5524002	Spontaneous	2012-05-28 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	Not Specified	Infant	No	Not Specified	Foetal exposure during pregnancy (n/a - Recovered/Resolved - Congenital Anomaly);Hypospadias (n/a - Unknown - Congenital Anomaly);Maternal exposure timing unspecified (n/a - Recovered/Resolved - Congenital Anomaly)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Foetal exposure timing unspecified - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5524002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-5519829	Spontaneous	2012-05-25 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5519829&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5520441	Spontaneous	2012-05-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5520441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5520675	Spontaneous	2012-05-25 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Brain stem infarction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Bronchitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5520675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5510090	Spontaneous	2012-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Radiculopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5510090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5510091	Spontaneous	2012-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Radiculopathy (n/a - Recovered/Resolved With Sequelae - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5510091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5499958	Spontaneous	2012-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Not Specified	Sudden infant death syndrome (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5499958&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5500055	Spontaneous	2012-05-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Arthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Arthropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Blepharitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood pressure fluctuation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Conjunctivitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dry throat (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Eczema (n/a - Unknown - Caused/Prolonged Hospitalisation);Epistaxis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Joint swelling (n/a - Unknown - Caused/Prolonged Hospitalisation);Mental disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Purulent discharge (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhinitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tenosynovitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Throat irritation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	BETA-BLOCKERS [BETA-BLOCKER] (C - n/a - Not applicable - [n/a - n/a - n/a])|[CANDESARTAN CILEXETIL] (C - n/a - Unknown - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - Unknown - [n/a - n/a - Oral])|[PROPIOMAZINE, PROPIOMAZINE MALEATE] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5500055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5500224	Spontaneous	2012-05-21 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	18-64 Years	Not Specified	No	Male	Nerve injury (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5500224&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5500225	Spontaneous	2012-05-21 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5500225&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5500226	Spontaneous	2012-05-21 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	18-64 Years	Not Specified	No	Male	Lower respiratory tract infection (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5500226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5500228	Spontaneous	2012-05-21 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	18-64 Years	Not Specified	No	Female	Local reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5500228&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5500231	Spontaneous	2012-05-21 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	65-85 Years	Not Specified	No	Female	Migraine (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5500231&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5500232	Spontaneous	2012-05-21 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	18-64 Years	Not Specified	No	Female	Bell's palsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5500232&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5500234	Spontaneous	2012-05-21 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	18-64 Years	Not Specified	No	Female	Epilepsy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5500234&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-5500235	Spontaneous	2012-05-21 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	18-64 Years	Not Specified	No	Female	Epilepsy (n/a - Recovered/Resolved - Other Medically Important Condition);Postictal paralysis (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5500235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5500238	Spontaneous	2012-05-21 00:00:00	Healthcare Professional	European Economic Area	Mackenzie I, MacDonald T, Shakir S, Dryburgh M, Mantay B, McDonnell P, Layton D. Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. British Journal of Clinical Pharmacology. 2011 JAN 01;73(5):801-811.	18-64 Years	Not Specified	No	Male	Pulmonary embolism (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5500238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5491278	Spontaneous	2012-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5491278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5484837	Spontaneous	2012-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5484837&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5484838	Spontaneous	2012-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Condition aggravated (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	[DROSPIRENONE, ETHINYLESTRADIOL] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5484838&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5484839	Spontaneous	2012-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5484839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5484840	Spontaneous	2012-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5484840&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5484913	Spontaneous	2012-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5484913&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5485918	Spontaneous	2012-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5485918&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5486458	Spontaneous	2012-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5486458&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5486604	Spontaneous	2012-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5486604&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5488150	Spontaneous	2012-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (5d - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (5d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (5d - Recovered/Resolved - Other Medically Important Condition);Tonsillar ulcer (5d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5488150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5482337	Spontaneous	2012-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Flushing (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5482337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5482365	Spontaneous	2012-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [5wk - 2{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5482365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5482385	Spontaneous	2012-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - n/a])	[METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5482385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5482386	Spontaneous	2012-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Systemic lupus erythematosus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5482386&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5482387	Spontaneous	2012-05-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Granulomatosis with polyangiitis (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5482387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-5477634	Spontaneous	2012-05-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Sarcoidosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[TERBUTALINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5477634&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5480519	Spontaneous	2012-05-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Mobility decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pericarditis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5480519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5473532	Spontaneous	2012-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Unknown - Other Medically Important Condition);Condition aggravated (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5473532&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5475066	Spontaneous	2012-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5475066&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5475075	Spontaneous	2012-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Bedridden (1wk - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5475075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5475398	Spontaneous	2012-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Aphasia (n/a - Unknown - Caused/Prolonged Hospitalisation);Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Depressed level of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation);Fall (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Radiculopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - n/a - Unknown - [n/a - 5mg - Oral])|[DOXAZOSIN, DOXAZOSIN MESILATE] (C - n/a - Unknown - [n/a - 4mg - Oral])|[FUROSEMIDE] (C - n/a - Unknown - [n/a - 40mg - Oral])|[HYDROCHLOROTHIAZIDE, RAMIPRIL] (C - n/a - Unknown - [n/a - 30mg - Oral])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - 47.5mg - Oral])|[PHENPROCOUMON] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5475398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5470519	Spontaneous	2012-05-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5470519&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5467214	Spontaneous	2012-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5467214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-5468452	Spontaneous	2012-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Stiff person syndrome (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5468452&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5463520	Spontaneous	2012-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Pharyngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Tongue oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5463520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5463547	Spontaneous	2012-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Tonic convulsion (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5463547&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5463553	Spontaneous	2012-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5463553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5464193	Spontaneous	2012-05-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dry mouth (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gastrooesophageal reflux disease (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Psychomotor skills impaired (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tension (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5464193&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5460938	Spontaneous	2012-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anal incontinence (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cognitive disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Constipation (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Demyelination (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nasopharyngitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urinary retention (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5460938&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5462534	Spontaneous	2012-05-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myelitis (3mo - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5462534&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5451708	Spontaneous	2012-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5451708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5451709	Spontaneous	2012-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5451709&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5453598	Spontaneous	2012-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Influenza (7d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5453598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5454175	Spontaneous	2012-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Headache (0mo - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza B virus test positive (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (0mo - Recovered/Resolved - Other Medically Important Condition);Pyrexia (0mo - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5454175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5455119	Spontaneous	2012-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pain in extremity (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5455119&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5448817	Spontaneous	2012-05-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Abdominal pain lower (n/a - Recovering/Resolving - Results in Death, Caused/Prolonged Hospitalisation);Actinic elastosis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Acute kidney injury (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Anal incontinence (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Ascites (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Atrial fibrillation (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Atrioventricular block first degree (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Cardiac failure (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Circulatory collapse (n/a - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation);Constipation (n/a - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Depressed mood (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovering/Resolving - Results in Death, Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Diverticulum intestinal (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Flank pain (n/a - Recovering/Resolving - Results in Death, Caused/Prolonged Hospitalisation);Gastroenteritis clostridial (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Gastrointestinal haemorrhage (n/a - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation);Generalised oedema (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Glomerulonephritis acute (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura nephritis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Hepatic cyst (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Hepatomegaly (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Hypercholesterolaemia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Hypokalaemia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Inflammatory marker increased (n/a - Recovering/Resolving - Results in Death, Caused/Prolonged Hospitalisation);Intestinal polyp (17d - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation);Intestinal polypectomy (1d - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation);Leukoencephalopathy (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Melaena (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Mitral valve sclerosis (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Petechiae (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovering/Resolving - Results in Death, Caused/Prolonged Hospitalisation);Pulmonary congestion (n/a - Recovering/Resolving - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - n/a - Unknown - [n/a - 10mg - Oral])|[BENAZEPRIL, BENAZEPRIL HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 10mg - Oral])|[BENAZEPRIL, HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - 45mg - Oral])|[CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - n/a - Oral])|[CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE, CIPROFLOXACIN LACTATE] (C - n/a - Unknown - [8d - n/a - Unknown])|[DIGITOXIN] (C - n/a - Unknown - [n/a - .07mg - Oral])|[METOPROLOL SUCCINATE, METOPROLOL SUCCINATE (PH. EUR.)] (C - n/a - Unknown - [n/a - n/a - Oral])|[PENTAERITHRITYL TETRANITRATE] (C - n/a - Unknown - [n/a - 80mg - Oral])|[PHENPROCOUMON] (C - Thrombosis prophylaxis - Unknown - [n/a - n/a - Oral])|[PROPAFENONE, PROPAFENONE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Oral])|[RISPERIDONE] (C - n/a - Drug withdrawn - [n/a - n/a - Oral])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 10mg - Oral])|[TORASEMIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Oral])|[XIPAMIDE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5448817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5438443	Spontaneous	2012-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5438443&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5434394	Spontaneous	2012-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 2{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5434394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5434397	Spontaneous	2012-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5434397&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5436969	Spontaneous	2012-04-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amyotrophic lateral sclerosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5436969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5431482	Spontaneous	2012-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5431482&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5431484	Spontaneous	2012-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5431484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5431485	Spontaneous	2012-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	[ATOMOXETINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5431485&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5431486	Spontaneous	2012-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [7wk - 2{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5431486&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5431492	Spontaneous	2012-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5431492&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5431497	Spontaneous	2012-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	[ATOMOXETINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5431497&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5431498	Spontaneous	2012-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5431498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5431500	Spontaneous	2012-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5431500&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5431501	Spontaneous	2012-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5431501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5431502	Spontaneous	2012-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .2mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5431502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5431503	Spontaneous	2012-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Thyroiditis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5431503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5431505	Spontaneous	2012-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pulmonary embolism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5431505&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5428077	Spontaneous	2012-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain lower (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Stillbirth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Uterine contractions abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaginal haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5428077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5429045	Spontaneous	2012-04-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Radiculopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5429045&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5423978	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5423978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5423987	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5423987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5423991	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - n/a])	[DESOGESTREL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5423991&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5423992	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])|[TERBUTALINE SULFATE, TERBUTALINE SULFATE PH. EUR.] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5423992&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5424001	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5424001&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5424002	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5424002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5424007	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5424007&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5424008	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5424008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5424010	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5424010&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5424011	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5424011&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5424013	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [3mo - .25mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5424013&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5424016	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5424016&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5424024	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5424024&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5424026	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5424026&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5424027	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5424027&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5424031	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5424031&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5425734	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hepatic steatosis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Hepatitis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Organising pneumonia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Rheumatoid arthritis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5425734&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5425764	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5425764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5425777	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5425777&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5425783	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Erythema multiforme (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5425783&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5425800	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5425800&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5425879	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	Non European Economic Area	Maria Florencia Arcondo, Adolfo Wachs, Marcelo Zylberman. Transverse Myelitis associated with anti-influenza A (H1N1). Medicina. 2011;71:161 to 164	18-64 Years	Not Specified	No	Female	Myelitis transverse (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sensory level abnormal (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Temperature perception test decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5425879&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5425976	Spontaneous	2012-04-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5425976&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5422949	Spontaneous	2012-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (107d - Recovered/Resolved - Disabling);Feeling hot (n/a - Unknown - Disabling);Joint range of motion decreased (107d - Recovered/Resolved - Disabling);Pyrexia (97d - Recovered/Resolved - Disabling);Viral infection (n/a - Unknown - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5422949&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Duration
EU-EC-5417934	Spontaneous	2012-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Parkinson's disease (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5417934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5419402	Spontaneous	2012-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Back pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Proctitis haemorrhagic (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [1d - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [n/a - n/a - Subcutaneous])	STOCRIN [EFAVIRENZ] (C - HIV infection - n/a - [n/a - n/a - Oral])|TRUVADA [EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE] (C - HIV infection - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5419402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412385	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412385&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5412386	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412386&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5412398	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412399	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [4wk - 2{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412403	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5412418	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .2mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412418&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5412426	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412434	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - n/a])	[METHYLPHENIDATE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412434&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412436	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412436&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412437	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412439	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412439&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412446	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412448	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412449	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412455	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [6wk - 2{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412460	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412460&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412470	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412474	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [2mo - 25mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412478	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412478&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5412479	Spontaneous	2012-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5412479&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5408815	Spontaneous	2012-04-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ageusia (8mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Anosmia (8mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Burning sensation (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Central nervous system infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Diplopia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Discomfort (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dysstasia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Eating disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Feeling abnormal (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypoaesthesia oral (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Leukocytosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Lip blister (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Neurological symptom (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Oral mucosal blistering (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia oral (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pharyngeal hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Rash (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sensory loss (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Somatic symptom disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vertigo (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5408815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5405087	Spontaneous	2012-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5405087&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5405088	Spontaneous	2012-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - 1{DF} - n/a])	[ATOVAQUONE, PROGUANIL, PROGUANIL HYDROCHLORIDE, ATOVAQUONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5405088&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5405097	Spontaneous	2012-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5405097&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5405099	Spontaneous	2012-04-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5405099&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5400453	Spontaneous	2012-04-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Child	No	Not Specified	Expired product administered (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5400453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5402218	Spontaneous	2012-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Aggression (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Amenorrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Anaemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ataxia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Body temperature decreased (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);C-reactive protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chronic fatigue syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Epilepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait inability (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Infection susceptibility increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lung infiltration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Menstrual disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pancreatic failure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pancreatitis chronic (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pleural effusion (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep disorder (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Temperature regulation disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tremor (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	VIGABATRIN [VIGABATRIN] (C - Epilepsy - Unknown - [n/a - n/a - Unknown])|[LAMOTRIGINE] (C - Epilepsy - Unknown - [n/a - n/a - Oral])|[PHENOBARBITAL, PHENOBARBITAL SODIUM] (C - Epilepsy - Unknown - [n/a - n/a - Unknown])|[PHENOBARBITAL, PHENOBARBITAL SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[TRIPTORELIN] (C - Precocious puberty - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5402218&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5402778	Spontaneous	2012-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cryoglobulinaemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Joint stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Oedema (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Swelling (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[ALENDRONATE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[SALMETEROL, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5402778&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5402876	Spontaneous	2012-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Influenza (1wk - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5402876&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5403098	Spontaneous	2012-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Myocardial infarction (1d - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5403098&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5396347	Spontaneous	2012-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling cold (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Joint swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pelvic pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sensory disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5396347&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5396632	Spontaneous	2012-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diabetes mellitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5396632&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5398699	Spontaneous	2012-04-12 00:00:00	Healthcare Professional	European Economic Area	REV CLIN ESP 2010; 210: 485-6 López Nieto M, Gómez Garrido J, Losa Palacios A, Aguila Manso G. Guillain-Barre syndrome secondary to H1N1 influenza vaccine. Revista Clínica Española 2010 Oct;210(9):485-6.	65-85 Years	Not Specified	No	Male	Acute polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Areflexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Demyelinating polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Productive cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sputum purulent (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[A/H1N1 INFLUENZA VACCINE] (S - Product used for unknown indication - Not applicable - [1d - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - n/a - Not applicable - [n/a - n/a - Unknown])	ZYPREXA 10 MG [OLANZAPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[DIPOTASSIUM CLORAZEPATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METAMIZOLE MAGNESIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[OXYGEN] (C - Chronic obstructive pulmonary disease - n/a - [n/a - n/a - Nasal])|[SALBUTAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[THEOPHYLLINE] (C - n/a - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE, PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5398699&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5399888	Spontaneous	2012-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Vascular purpura (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])|[ACENOCOUMAROL] (S - Atrial fibrillation - Dose not changed - [n/a - n/a - Oral])|[ALLOPURINOL] (S - Gout - Drug withdrawn - [n/a - 1{DF} - Oral])|[ALTIZIDE, SPIRONOLACTONE] (S - Hypertension - Dose not changed - [n/a - 1{DF} - Oral])|[DIGOXIN] (S - n/a - Dose not changed - [n/a - n/a - Oral])|[ENALAPRIL MALEATE] (S - Hypertension - Dose not changed - [n/a - 1{DF} - Oral])|[FUROSEMIDE] (S - Cardiac failure - Not applicable - [n/a - n/a - Oral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5399888&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5393559	Spontaneous	2012-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5393559&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5393560	Spontaneous	2012-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5393560&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5388314	Spontaneous	2012-04-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Body temperature increased (3d - Recovered/Resolved - Other Medically Important Condition);Cough (4d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (3d - Recovered/Resolved - Other Medically Important Condition);Headache (3d - Recovered/Resolved - Other Medically Important Condition);Hot flush (3d - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (3d - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5388314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5386583	Spontaneous	2012-04-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest X-ray abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Foetal death (n/a - Fatal - Caused/Prolonged Hospitalisation);Foetal growth restriction (n/a - Fatal - Caused/Prolonged Hospitalisation);Influenza (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Odynophagia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5386583&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5381771	Spontaneous	2012-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Autism spectrum disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [3wk - 2{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5381771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5381780	Spontaneous	2012-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5381780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5381850	Spontaneous	2012-04-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Alopecia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5381850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5374786	Spontaneous	2012-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5374786&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5375067	Spontaneous	2012-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Listless (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[VITAMIN B12] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5375067&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5371051	Spontaneous	2012-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5371051&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5372006	Spontaneous	2012-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Apathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Decreased appetite (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyelonephritis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Stomatitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	AVAMYS [FLUTICASONE FUROATE] (C - n/a - n/a - [n/a - n/a - Ophthalmic])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[CARTEOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Auricular (otic)])|[CETIRIZINE DIHYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DIPYRIDAMOLE, ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[GLICLAZIDE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[HYDROCHLOROTHIAZIDE, RAMIPRIL] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5372006&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5365680	Spontaneous	2012-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5365680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5365952	Spontaneous	2012-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Irritability (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Memory impairment (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5365952&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5368567	Spontaneous	2012-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Graves' disease (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5368567&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-5368739	Spontaneous	2012-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5368739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5368809	Spontaneous	2012-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5368809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5368838	Spontaneous	2012-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5368838&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5369266	Spontaneous	2012-04-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1000{DF} - Unknown])|FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5369266&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5360786	Spontaneous	2012-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5360786&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5361080	Spontaneous	2012-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5361080&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5362718	Spontaneous	2012-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nystagmus (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5362718&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5362719	Spontaneous	2012-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (1a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (1a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5362719&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5362720	Spontaneous	2012-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5362720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5362721	Spontaneous	2012-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cataplexy (3mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5362721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5362723	Spontaneous	2012-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (21mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5362723&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5362724	Spontaneous	2012-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5362724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5362727	Spontaneous	2012-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Tic (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5362727&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5362966	Spontaneous	2012-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5362966&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5364508	Spontaneous	2012-03-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Rheumatic disorder (n/a - Recovered/Resolved With Sequelae - Disabling, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5364508&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-5357515	Spontaneous	2012-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Body temperature increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5357515&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5358068	Spontaneous	2012-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5358068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5359919	Spontaneous	2012-03-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Immune thrombocytopenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5359919&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5353958	Spontaneous	2012-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5353958&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5349947	Spontaneous	2012-03-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Unknown - Disabling);Hypoaesthesia (n/a - Recovered/Resolved - Disabling);Listless (n/a - Not Recovered/Not Resolved - Disabling);Musculoskeletal stiffness (n/a - Unknown - Disabling);Pain (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5349947&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5345146	Spontaneous	2012-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Migraine (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Palpitations (n/a - Not Recovered/Not Resolved - Disabling);Tachycardia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5345146&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5345147	Spontaneous	2012-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Eyelid ptosis (n/a - Unknown - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[ALPROSTADIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5345147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5345148	Spontaneous	2012-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5345148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5340299	Spontaneous	2012-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Disabling);Gout (n/a - Recovering/Resolving - Disabling);Pain in extremity (n/a - Recovering/Resolving - Disabling);Plantar fasciitis (n/a - Recovering/Resolving - Disabling);Rheumatic disorder (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[DROSPIRENONE, ETHINYLESTRADIOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5340299&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5340301	Spontaneous	2012-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Discomfort (n/a - Not Recovered/Not Resolved - Disabling);Disturbance in attention (n/a - Unknown - Disabling);Dyspnoea (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Listless (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	TAMIFLU [OSELTAMIVIR, OSELTAMIVIR PHOSPHATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5340301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5342550	Spontaneous	2012-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood creatine phosphokinase increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cell death (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dermatomyositis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE MONOHYDRATE] (S - n/a - Drug withdrawn - [n/a - n/a - Oral])|[LANSOPRAZOLE] (S - n/a - Drug withdrawn - [n/a - 15mg - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5342550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5335892	Spontaneous	2012-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Other Medically Important Condition);Muscle contractions involuntary (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5335892&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5336524	Spontaneous	2012-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5336524&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5330778	Spontaneous	2012-03-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Fatigue (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5330778&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5323584	Spontaneous	2012-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5323584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5325545	Spontaneous	2012-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Skin cancer (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5325545&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5326464	Spontaneous	2012-03-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5326464&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5319102	Spontaneous	2012-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Crohn's disease (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	NOVOMIX 30 FLEXPEN [INSULIN ASPART, INSULIN ASPART, INSULIN ASPART PROTAMINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[COLECALCIFEROL, CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLIBENCLAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5319102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5319129	Spontaneous	2012-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5319129&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5320252	Spontaneous	2012-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5320252&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5322729	Spontaneous	2012-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oral discomfort (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash erythematous (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5322729&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5308593	Spontaneous	2012-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Alopecia areata (n/a - Unknown - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Encephalitis viral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperacusis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Photophobia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Shock (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5308593&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5308810	Spontaneous	2012-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Cardiac failure (n/a - Unknown - Caused/Prolonged Hospitalisation);Pharyngitis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - n/a])|[A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Subcutaneous])	[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[CARBAMAZEPINE, CARBAMAZEPINE (PH. EUR.)] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[COLESTYRAMINE] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - Oral])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - Product used for unknown indication - n/a - [n/a - .5{DF} - Oral])|[METOPROLOL, METOPROLOL TARTRATE] (C - Product used for unknown indication - n/a - [n/a - 1{DF} - Oral])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[SIMVASTATIN] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[TORASEMIDE] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5308810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5311075	Spontaneous	2012-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Abdominal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Cold sweat (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5311075&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5311086	Spontaneous	2012-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition);Presyncope (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5311086&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5311103	Spontaneous	2012-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5311103&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5311503	Spontaneous	2012-03-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cervical incompetence (87d - Recovered/Resolved - Other Medically Important Condition);Hydronephrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Premature labour (87d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (C - Immunisation - n/a - [n/a - n/a - Intramuscular])|[MAGNESIUM HYDROXIDE] (C - Prophylaxis of neural tube defect - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5311503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5302537	Spontaneous	2012-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5302537&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5302597	Spontaneous	2012-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Depressed level of consciousness (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Urinary incontinence (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5302597&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5302599	Spontaneous	2012-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Generalised tonic-clonic seizure (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [7wk - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5302599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5302637	Spontaneous	2012-03-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Facial paralysis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5302637&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5299640	Spontaneous	2012-03-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5299640&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5294591	Spontaneous	2012-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Depressed level of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition);Throat irritation (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5294591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5289114	Spontaneous	2012-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5289114&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5275191	Spontaneous	2012-03-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Polyneuropathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5275191&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5271230	Spontaneous	2012-03-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (6d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Extrasystoles (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pulmonary valve incompetence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tricuspid valve incompetence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5271230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5273521	Spontaneous	2012-03-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Sleep attacks (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5273521&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5268797	Spontaneous	2012-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5268797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5269925	Spontaneous	2012-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Night sweats (n/a - Recovered/Resolved - Disabling);Nocturia (n/a - Recovering/Resolving - Disabling);Restlessness (n/a - Unknown - Disabling)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])|[DILTIAZEM HYDROCHLORIDE] (S - Hypertension - Unknown - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5269925&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5264578	Spontaneous	2012-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Sensory disturbance (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5264578&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5264591	Spontaneous	2012-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Sudden death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5264591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5264594	Spontaneous	2012-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Sudden death (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])|[CARBOMER 980, CARBOMERS] (C - n/a - n/a - [n/a - n/a - n/a])|[CODEINE, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[HALOPERIDOL, HALOPERIDOL DECANOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MACROGOL 3350, POTASSIUM, SODIUM, CHLORIDE ION, HYDROGEN CARBONATE, POTASSIUM, SODIUM, CHLORINE, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])|[OXAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[SALMETEROL, SALMETEROL XINAFOATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM PICOFOSFATE, SODIUM PICOSULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5264594&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5264598	Spontaneous	2012-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Seizure (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5264598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5265902	Spontaneous	2012-02-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diplopia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Foot deformity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash pruritic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5265902&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5261922	Spontaneous	2012-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drug ineffective (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lacrimation increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5261922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5262002	Spontaneous	2012-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Drug ineffective (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lacrimation increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5262002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5264101	Spontaneous	2012-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5264101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5257621	Spontaneous	2012-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Scleroderma (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .25mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5257621&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5260293	Spontaneous	2012-02-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Other Medically Important Condition);Arthritis (7d - Unknown - Other Medically Important Condition);Burning sensation (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Serum sickness (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5260293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5252340	Spontaneous	2012-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5252340&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5252417	Spontaneous	2012-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Autoimmune disorder (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Deep vein thrombosis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypereosinophilic syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pulmonary embolism (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Vasculitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5252417&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5245577	Spontaneous	2012-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5245577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5245578	Spontaneous	2012-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5245578&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5247494	Spontaneous	2012-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myocarditis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5247494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5242034	Spontaneous	2012-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Febrile convulsion (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5242034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5244017	Spontaneous	2012-02-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Lymphadenitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5244017&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5239760	Spontaneous	2012-02-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Post herpetic neuralgia (n/a - Recovered/Resolved - Disabling);Rash vesicular (62d - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	[DILTIAZEM HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])|[FLUTICASONE PROPIONATE] (C - Asthma - n/a - [n/a - 1{DF} - Respiratory (inhalation)])|[SALMETEROL, SALMETEROL XINAFOATE] (C - Asthma - n/a - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5239760&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Duration
EU-EC-5233988	Spontaneous	2012-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	LEVEMIR FLEXPEN [INSULIN DETEMIR] (C - Type 1 diabetes mellitus - n/a - [n/a - n/a - Subcutaneous])|NOVORAPID FLEXPEN [INSULIN ASPART] (C - Type 1 diabetes mellitus - n/a - [n/a - n/a - Subcutaneous])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - Oral])|[CALCIUM CARBONATE, CHOLECALCIFEROL CONCENTRATE (POWDER FORM), COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - Oral])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - Depression - n/a - [n/a - n/a - Oral])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[LORAZEPAM] (C - n/a - n/a - [n/a - n/a - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5233988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5234217	Spontaneous	2012-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5234217&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5228741	Spontaneous	2012-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5228741&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5228747	Spontaneous	2012-02-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5228747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5230197	Spontaneous	2012-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Epilepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5230197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-5230218	Spontaneous	2012-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5230218&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5230424	Spontaneous	2012-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Demyelination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Quadriparesis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Radiculopathy (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5230424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5231683	Spontaneous	2012-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Paraparesis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5231683&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5227101	Spontaneous	2012-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Brachial plexus injury (n/a - Unknown - Other Medically Important Condition);Headache (0d - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (0d - Recovered/Resolved - Other Medically Important Condition);Malaise (0d - Recovered/Resolved - Other Medically Important Condition);Muscular weakness (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Seizure (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	CONTRACEPTION (NOT SPECIFIED) [CONTRACEPTION (NOT SPECIFIED)] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[PARAFFIN WHITE SOFT] (C - Product used for unknown indication - n/a - [n/a - n/a - Topical])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5227101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-5218382	Spontaneous	2012-02-13 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Myelitis transverse (2a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5218382&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5216616	Spontaneous	2012-02-10 00:00:00	Healthcare Professional	European Economic Area	DURRIEU G, CAILLET C, LACROIX I, JACQUET A, FAUCHER A, OUARET S, et al. Campagne nationale de vaccination contre la grippe A (H1N1)v: suivi national de pharmacovigilance. Thérapie 2011;66(6):527-540.	Not Specified	Adult	No	Not Specified	Hepatic cytolysis (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5216616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5210455	Spontaneous	2012-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Ageusia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anosmia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nasopharyngitis (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5210455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5210827	Spontaneous	2012-02-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Body temperature increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait inability (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Haematology test abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperglycaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5210827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5205704	Spontaneous	2012-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Ventricular tachyarrhythmia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5205704&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5207422	Spontaneous	2012-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5207422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5208718	Spontaneous	2012-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (7d - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5208718&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5203996	Spontaneous	2012-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Middle insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle twitching (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Nocturia (n/a - Unknown - Caused/Prolonged Hospitalisation);Periodic limb movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation);Posture abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Snoring (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Sudden onset of sleep (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	[MONTELUKAST] (C - Asthma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5203996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5198178	Spontaneous	2012-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Henoch-Schonlein purpura (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5198178&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5198181	Spontaneous	2012-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Facial paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5198181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5198182	Spontaneous	2012-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anosmia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	[ETHINYLESTRADIOL, LEVONORGESTREL, LACTOSE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5198182&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5198211	Spontaneous	2012-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dysphagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5198211&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5198856	Spontaneous	2012-02-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Bedridden (3wk - Recovered/Resolved - Other Medically Important Condition);Headache (3wk - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (3wk - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3wk - Recovered/Resolved - Other Medically Important Condition);Rash (3wk - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	CONTRACEPTIVE (UNSPECIFIED) [BIRTH CONTROL] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5198856&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5190739	Spontaneous	2012-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Encephalitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Generalised tonic-clonic seizure (2a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Listless (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Personality change (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5190739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5190779	Spontaneous	2012-02-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5190779&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5190781	Spontaneous	2012-02-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5190781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5192870	Spontaneous	2012-02-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Paraesthesia (n/a - Not Recovered/Not Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5192870&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5186218	Spontaneous	2012-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Facial paralysis (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5186218&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5186956	Spontaneous	2012-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5186956&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5183474	Spontaneous	2012-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Listless (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Syncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5183474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5184094	Spontaneous	2012-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal discomfort (n/a - Unknown - Results in Death);Abdominal pain (n/a - Unknown - Results in Death);Depressed level of consciousness (n/a - Fatal - Results in Death);Diarrhoea (n/a - Unknown - Results in Death);Influenza (n/a - Unknown - Results in Death);Malaise (n/a - Unknown - Results in Death);Peripheral vascular disorder (n/a - Unknown - Results in Death);Pyrexia (n/a - Unknown - Results in Death);Sepsis (n/a - Fatal - Results in Death);Toxic shock syndrome streptococcal (n/a - Fatal - Results in Death);Vomiting (n/a - Unknown - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - n/a])	NONSTEROID ANTIRHEUMATICS [ANTIRHEUMATIC MEDICATION] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5184094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5179046	Spontaneous	2012-01-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Alopecia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5179046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5179308	Spontaneous	2012-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5179308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5181189	Spontaneous	2012-01-30 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cutaneous vasculitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vascular purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5181189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5174004	Spontaneous	2012-01-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	Yes	Not Specified	Anencephaly (n/a - Fatal - Results in Death, Congenital Anomaly)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Transplacental])	[FOLIC ACID] (C - Prophylaxis of neural tube defect - n/a - [92d - n/a - Transplacental])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5174004&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5174631	Spontaneous	2012-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5174631&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5171132	Spontaneous	2012-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Bronchospasm (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urticaria (2d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5171132&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5167674	Spontaneous	2012-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Acute kidney injury (21d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - n/a])	INSUMAN BASAL [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - Type 2 diabetes mellitus - Dose not changed - [n/a - 30[iU] - Subcutaneous])|[ALLOPURINOL] (C - n/a - Dose not changed - [n/a - 20mg - Oral])|[ALLOPURINOL] (C - n/a - Drug withdrawn - [n/a - 100mg - Oral])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - n/a - Drug withdrawn - [2y - 5mg - Oral])|[FENOFIBRATE] (C - n/a - Drug withdrawn - [3y - 200mg - Oral])|[GABAPENTIN] (C - n/a - Drug withdrawn - [n/a - 300mg - Oral])|[GLIMEPIRIDE] (C - Type 2 diabetes mellitus - Drug withdrawn - [2y - 6mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Type 2 diabetes mellitus - Drug withdrawn - [n/a - 850mg - Oral])|[TIMOLOL, TIMOLOL MALEATE] (C - n/a - Dose not changed - [n/a - 2[drp] - Ophthalmic])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5167674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5169149	Spontaneous	2012-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysphonia (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gastroenteritis (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain of skin (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5169149&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5164804	Spontaneous	2012-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Male	Abdominal discomfort (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Acute kidney injury (37d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Anuria (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Blood creatinine increased (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Blood urea increased (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);General physical health deterioration (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Multiple organ dysfunction syndrome (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Renal impairment (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory failure (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Shock (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[IRON, IRON(III) ION, IRON, ION (FE3+), SODIUM FERRIC GLUCONATE COMPLEX] (S - Product used for unknown indication - Drug withdrawn - [n/a - 62.5mg - Intravenous (not otherwise specified)])	[ACETYLSALICYLIC ACID, GLYCINE, ACETYLSALICYLIC ACID] (C - Product used for unknown indication - Dose not changed - [n/a - 100mg - Oral])|[COLECALCIFEROL] (C - n/a - Drug withdrawn - [24d - 1000[iU] - Oral])|[ICELAND MOSS] (C - Dysphonia - Drug withdrawn - [n/a - 80mg - Oral])|[LACTULOSE] (C - Constipation - Drug withdrawn - [n/a - 1{DF} - Oral])|[MAGNESIUM OXIDE, LIGHT] (C - Muscle spasms - Drug withdrawn - [n/a - 240mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5164804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5160708	Spontaneous	2012-01-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Borrelia infection (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Vitamin D deficiency (n/a - Unknown - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5160708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5161156	Spontaneous	2012-01-23 00:00:00	Healthcare Professional	European Economic Area	Walmsley N &amp; Hampton P et al. Bullous pemphigoid triggered by swine flu vaccination: case report and review of vaccine triggered pemphigoid. Journal of Dermatological Case Reports 2011; 4: 74-76.	65-85 Years	Not Specified	No	Male	Blister (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain of skin (n/a - Unknown - Caused/Prolonged Hospitalisation);Pemphigoid (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash erythematous (n/a - Unknown - Caused/Prolonged Hospitalisation);Urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination site rash (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - H1N1 influenza - Not applicable - [1d - n/a - Unknown])	IRBESARTAN [IRBESARTAN] (C - n/a - n/a - [n/a - n/a - Oral])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5161156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5155614	Spontaneous	2012-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5155614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5155671	Spontaneous	2012-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5155671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5155744	Spontaneous	2012-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5155744&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5157212	Spontaneous	2012-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Facial paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5157212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5159044	Spontaneous	2012-01-20 00:00:00	Healthcare Professional	European Economic Area	OMON E, DAMASE-MICHEL C, HURAULT-DELARUE C, LACROIX I, MONTASTRUC J, OUSTRIC S, et al. Non-adjuvanted 2009 influenza A (H1N1) vaccine in pregnant women: The results of a French prospective descriptive study. Vaccine 2011;29:9649-9654.	Not Specified	Neonate (Preterm and Term newborns)	Yes	Not Specified	Foetal exposure during pregnancy (n/a - Unknown - Congenital Anomaly);Poor sucking reflex (n/a - Unknown - Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])	[BROMAZEPAM] (C - n/a - n/a - [n/a - n/a - Transplacental])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5159044&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-5159105	Spontaneous	2012-01-20 00:00:00	Healthcare Professional	European Economic Area	OMON E, DAMASE-MICHEL C, HURAULT-DELARUE C, LACROIX I, MONTASTRUC J, OUSTRIC S, et al. Non-adjuvanted 2009 influenza A (H1N1) vaccine in pregnant women: The results of a French prospective descriptive study. Vaccine 2011;29:9649-9654.	Not Specified	Neonate (Preterm and Term newborns)	Yes	Not Specified	Foetal exposure during pregnancy (n/a - Unknown - Congenital Anomaly);Quadriplegia (n/a - Unknown - Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5159105&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Severe reaction
EU-EC-5159267	Spontaneous	2012-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Vascular purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	[ALFUZOSIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[BISOPROLOL FUMARATE] (C - n/a - Dose not changed - [n/a - .5{DF} - Oral])|[BROMAZEPAM] (C - n/a - Dose not changed - [n/a - .5{DF} - Oral])|[HYDROXYZINE DIHYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - .5{DF} - Oral])|[LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, ETHYLCELLULOSE MICROENCAPSULATED 80-90%] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5159267&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5152875	Spontaneous	2012-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Ageusia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Anosmia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysgeusia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - Unknown - [n/a - 75mg - Unknown])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - 75mg - Unknown])|[EPLERENONE] (C - n/a - Unknown - [n/a - 25mg - Unknown])|[RAMIPRIL] (C - n/a - Unknown - [n/a - 5mg - Unknown])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 40mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5152875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5152879	Spontaneous	2012-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Ageusia (n/a - Unknown - Other Medically Important Condition);Anosmia (n/a - Unknown - Other Medically Important Condition);Arthralgia (n/a - Unknown - Other Medically Important Condition);Back pain (n/a - Unknown - Other Medically Important Condition);Foot deformity (n/a - Unknown - Other Medically Important Condition);Neck pain (n/a - Unknown - Other Medically Important Condition);Osteoarthritis (n/a - Unknown - Other Medically Important Condition);Paresis (n/a - Unknown - Other Medically Important Condition);Sciatica (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - Asthma - Unknown - [n/a - n/a - n/a])|[SALMETEROL, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5152879&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5149985	Spontaneous	2012-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Paraparesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5149985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5144584	Spontaneous	2012-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Productive cough (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	[DIGOXIN] (C - Ill-defined disorder - Unknown - [n/a - .25mg - Oral])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[GLUCOSAMINE, GLUCOSAMINE SULFATE] (C - Ill-defined disorder - Unknown - [n/a - 1{DF} - Oral])|[GLUCOSAMINE, GLUCOSAMINE SULFATE] (C - n/a - n/a - [n/a - 400mg - n/a])|[ISOSORBIDE 5 MONONITRATE, ISOSORBIDE MONONITRATE] (C - Ill-defined disorder - Unknown - [n/a - 30mg - Oral])|[MAGNESIUM HYDROXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, LIGHT] (C - Ill-defined disorder - Unknown - [n/a - 500mg - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - 500{DF} - Oral])|[POTASSIUM CHLORIDE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])|[SIMVASTATIN] (C - Ill-defined disorder - Unknown - [n/a - 10mg - Oral])|[TRAMADOL HYDROCHLORIDE] (C - Ill-defined disorder - Unknown - [n/a - 50mg - Oral])|[TRANDOLAPRIL] (C - Ill-defined disorder - Unknown - [n/a - 2{DF} - Oral])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - Ill-defined disorder - Unknown - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5144584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5144938	Spontaneous	2012-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataract cortical (n/a - Unknown - Caused/Prolonged Hospitalisation);Corneal endotheliitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Herpes ophthalmic (n/a - Unknown - Caused/Prolonged Hospitalisation);Iritis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - Unknown - [n/a - 5mg - Oral])|[LIOTHYRONINE SODIUM, LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - 90ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5144938&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5145660	Spontaneous	2012-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Alopecia areata (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Complex regional pain syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5145660&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5141535	Spontaneous	2012-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Obstructive airways disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Ill-defined disorder - Not applicable - [0mo - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5141535&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5141548	Spontaneous	2012-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	FOCETRIA SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5141548&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5141653	Spontaneous	2012-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chest discomfort (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Syncope (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5141653&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5141986	Spontaneous	2012-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Body temperature increased (n/a - Recovering/Resolving - Other Medically Important Condition);White blood cell disorder (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	REVLIMID [LENALIDOMIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[DEXAMETHASONE, DEXAMETHASONE DISODIUM PHOSPHATE, DEXAMETHASONE PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5141986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5143638	Spontaneous	2012-01-16 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Encephalomyelitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5143638&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5137815	Spontaneous	2012-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vertigo (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5137815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5138163	Spontaneous	2012-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Not Specified	No	Male	Seizure (1d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5138163&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5138520	Spontaneous	2012-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amnesia (2a - Recovering/Resolving - Disabling);Disturbance in attention (2a - Recovering/Resolving - Disabling);Dizziness (2a - Recovering/Resolving - Disabling);Headache (2a - Recovering/Resolving - Disabling);Sleep disorder (2a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5138520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5138733	Spontaneous	2012-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5138733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5131484	Spontaneous	2012-01-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Chronic obstructive pulmonary disease - Unknown - [n/a - 250mg - Unknown])|[IPRATROPIUM BROMIDE, SALBUTAMOL] (C - Chronic obstructive pulmonary disease - Unknown - [n/a - 2 - Unknown])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - Chronic obstructive pulmonary disease - Unknown - [n/a - 1{DF} - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5131484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5131768	Spontaneous	2012-01-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5131768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5129739	Spontaneous	2012-01-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5129739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5124875	Spontaneous	2012-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Balance disorder (n/a - Unknown - Other Medically Important Condition);Cerebrovascular accident (n/a - Unknown - Other Medically Important Condition);Colitis ulcerative (n/a - Recovered/Resolved - Other Medically Important Condition);Diarrhoea haemorrhagic (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dysphagia (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Photophobia (n/a - Recovered/Resolved - Other Medically Important Condition);Transient ischaemic attack (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[CYANOCOBALAMIN, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FOLIC ACID] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5124875&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5126524	Spontaneous	2012-01-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling);Sleep attacks (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5126524&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5122094	Spontaneous	2012-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Pulmonary fibrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5122094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5122575	Spontaneous	2012-01-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Vaccination site pain (n/a - Not Recovered/Not Resolved - );Vaccination site paraesthesia (n/a - Recovering/Resolving - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5122575&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5117683	Spontaneous	2012-01-05 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Lymphadenopathy (n/a - Recovered/Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5117683&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5115764	Spontaneous	2012-01-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5115764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5110953	Spontaneous	2012-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Optic atrophy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [3mo - 2{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5110953&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5110954	Spontaneous	2012-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5110954&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5111687	Spontaneous	2012-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Blood pressure increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Heart rate increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pallor (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - Oral])|[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - Oral])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - n/a - Oral])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[SIMVASTATIN] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5111687&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5100152	Spontaneous	2012-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Aplastic anaemia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])|[METHOTREXATE SODIUM] (S - Rheumatoid arthritis - Drug withdrawn - [n/a - 15mg - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5100152&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-5100311	Spontaneous	2012-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Generalised tonic-clonic seizure (1d - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	NOT AVAILABLE (C - n/a - n/a - [n/a - 200mg - Oral])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE] (C - n/a - n/a - [n/a - 200mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5100311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5100316	Spontaneous	2012-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Application site rash (12h - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypotension (n/a - Not Specified - Caused/Prolonged Hospitalisation);Urticaria (n/a - Not Specified - Caused/Prolonged Hospitalisation);Vertigo (12h - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (WHOLE VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5100316&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5100320	Spontaneous	2012-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Fatal - Results in Death);Cough (n/a - Fatal - Results in Death);Pyrexia (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (WHOLE VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	[ALPRAZOLAM] (C - n/a - n/a - [n/a - n/a - n/a])|[CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[EZETIMIBE] (C - n/a - n/a - [n/a - n/a - n/a])|[FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLYCERYL TRINITRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PERINDOPRIL, PERINDOPRIL TERT-BUTYLAMINE] (C - n/a - n/a - [n/a - n/a - n/a])|[POTASSIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL MICRONIZED, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5100320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5100323	Spontaneous	2012-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Choking (n/a - Fatal - Results in Death);Pyrexia (2d - Unknown - Results in Death);Vomiting (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])|[INFLUENZA VACCINE (WHOLE VIRION, INACTIVATED)] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5100323&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5109444	Spontaneous	2012-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (7d - Recovered/Resolved - Other Medically Important Condition);Arthritis (1mo - Recovered/Resolved - Other Medically Important Condition);C-reactive protein increased (n/a - Unknown - Other Medically Important Condition);Myalgia (7d - Recovered/Resolved - Other Medically Important Condition);Neutrophil count increased (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rash (1mo - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5109444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5110396	Spontaneous	2012-01-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5110396&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5108651	Spontaneous	2011-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);C-reactive protein increased (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (2wk - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5108651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5108721	Spontaneous	2011-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza - Drug withdrawn - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5108721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5103978	Spontaneous	2011-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5103978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5106483	Spontaneous	2011-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute pulmonary oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperthermia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5106483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5095893	Spontaneous	2011-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Immune thrombocytopenia (23d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Influenza immunisation - Drug withdrawn - [n/a - 45ug - Unknown])|[PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (S - Immunisation - Drug withdrawn - [n/a - 580ug - Unknown])	LANTUS SOLUTION FOR INJECTION IN A VIAL [INSULIN GLARGINE] (C - Insulin-requiring type 2 diabetes mellitus - Dose not changed - [n/a - 16[iU] - Subcutaneous])|NOVORAPID [INSULIN ASPART] (C - Insulin-requiring type 2 diabetes mellitus - Dose not changed - [n/a - 7.5[iU] - Subcutaneous])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - Hypercholesterolaemia - Dose not changed - [n/a - 10mg - Oral])|[CARVEDILOL] (C - n/a - Dose not changed - [n/a - 3125ug - Oral])|[LOSARTAN POTASSIUM] (C - Hypertension - Dose not changed - [n/a - 50mg - Oral])|[TORASEMIDE] (C - n/a - Dose not changed - [n/a - 5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5095893&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5096412	Spontaneous	2011-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Acute kidney injury (28d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Gastroenteritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastroenteritis norovirus (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypertensive crisis (n/a - Unknown - Caused/Prolonged Hospitalisation);Immunisation reaction (28d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Unknown - Caused/Prolonged Hospitalisation);Pulmonary congestion (n/a - Unknown - Caused/Prolonged Hospitalisation);Renal failure (28d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tubulointerstitial nephritis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])|[LEVOTHYROXINE SODIUM] (S - n/a - Unknown - [n/a - 100ug - Oral])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - n/a - Unknown - [n/a - 5mg - Oral])|[CANDESARTAN CILEXETIL] (C - n/a - Unknown - [n/a - 8mg - Oral])|[METOPROLOL SUCCINATE, METOPROLOL SUCCINATE (PH. EUR.)] (C - n/a - Unknown - [n/a - 47.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5096412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5101380	Spontaneous	2011-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Discomfort (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea exertional (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ejection fraction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Exercise tolerance decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myocarditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myopericarditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Oedema (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pericardial effusion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sinus tachycardia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachycardia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight bearing difficulty (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5101380&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5101488	Spontaneous	2011-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Disability (6wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Iritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Neurological symptom (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5101488&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5095693	Spontaneous	2011-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Condition aggravated (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5095693&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5087356	Spontaneous	2011-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Polyneuropathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5087356&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5087357	Spontaneous	2011-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Epilepsy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - Hypertension - Unknown - [n/a - 5mg - Unknown])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - 75ug - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5087357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5087715	Spontaneous	2011-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (4d - Recovered/Resolved - );Headache (4d - Recovered/Resolved - );Paraesthesia (4d - Recovered/Resolved - );Somnolence (4d - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5087715&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5078994	Spontaneous	2011-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5078994&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5079392	Spontaneous	2011-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Pneumonia (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5079392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-5079939	Spontaneous	2011-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5079939&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5079967	Spontaneous	2011-12-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	[MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-SCHWARZ STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS (LIVE, ATTENUATED), RUBELLA VIRUS (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS, MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED) PRODUCED IN WI-38 HUMAN DIPLOID LUNG FIBROBLASTS, MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED), RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS EDMONSTON-ENDERS STRAIN (LIVE, ATTENUATED) PRODUCED IN CHICK EMBRYO CELLS, MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN (LIVE, ATTENUATED) DERIVED FROM FROM THE JERYL LYNN PRODUCED IN CHICK EMBRYO CELLS, RUBELLA VIRUS WISTAR RA 27/3 STRAIN (LIVE, ATTENUATED), MEASLES VIRUS SCHWARZ STRAIN (LIVE, ATTENUATED), MUMPS VIRUS RIT 4385 STRAIN, DERIVED FROM JERYL LYNN STRAIN (LIVE, ATTENUATED)] (C - n/a - n/a - [n/a - n/a - n/a])|[PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALGELDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5079967&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5073818	Spontaneous	2011-12-20 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Arthritis viral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunosuppression - Drug withdrawn - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5073818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5073287	Spontaneous	2011-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	Yes	Female	Burkitt's lymphoma (n/a - Recovered/Resolved - Life Threatening)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[HEPATITIS A VIRUS RG-SB STRAIN (INACTIVATED), HEPATITIS A VIRUS RG-SB STRAIN (INACTIVATED), HEMAGGLUTININ OF THE INFLUENZA VIRUS A/SINGAPORE/6/86 (H1N1)-LIKE STRAIN, LECITHIN, HEPATITIS A VIRUS RG-SB STRAIN (INACTIVATED), PHOSPHATIDYL ETHANOLAMINE, HEMAGGLUTININ OF THE INFLUENZA VIRUS A/SINGAPORE/6/86 (H1N1)-LIKE STRAIN] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[HEPATITIS B SURFACE ANTIGEN, HEPATITIS A VACCINE (INACTIVATED)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])|[SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI, VI POLYSACCHARIDE OF SALMONELLA TYPHI (TY2 STRAIN)] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	[HEPATITIS B VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5073287&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-5073435	Spontaneous	2011-12-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5073435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5066830	Spontaneous	2011-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5066830&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5069240	Spontaneous	2011-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Nausea (2a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Presyncope (2a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5069240&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5063669	Spontaneous	2011-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abnormal dreams (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5063669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5063673	Spontaneous	2011-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (6mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (6mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5063673&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5063679	Spontaneous	2011-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Eyelid function disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5063679&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5063680	Spontaneous	2011-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Aggression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (7mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (10mo - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5063680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5065751	Spontaneous	2011-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza - Drug withdrawn - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5065751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5062702	Spontaneous	2011-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Leukopenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Transaminases decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5062702&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5056671	Spontaneous	2011-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Lymphadenopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5056671&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5056697	Spontaneous	2011-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vaccination site reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5056697&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5057007	Spontaneous	2011-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain (9d - Recovered/Resolved - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Diarrhoea (3d - Recovered/Resolved - Other Medically Important Condition);Fatigue (8d - Recovered/Resolved - Other Medically Important Condition);Haematuria (n/a - Unknown - Other Medically Important Condition);Lymphadenopathy (7d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5057007&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5057286	Spontaneous	2011-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Skin mass (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5057286&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5053620	Spontaneous	2011-12-12 00:00:00	Healthcare Professional	European Economic Area	Hugues R, Lacour J, Baldin B, Reverte M, Ortonne J, Passeron T. Urticarial vasculitis secondary to H1N1 vaccination. Acta Dermato-Venereologica 2010;90:1-2.	18-64 Years	Not Specified	Yes	Female	Post inflammatory pigmentation change (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Urticarial vasculitis (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5053620&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5054264	Spontaneous	2011-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5054264&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5055160	Spontaneous	2011-12-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cough (n/a - Unknown - );Decreased appetite (n/a - Unknown - );Fatigue (n/a - Unknown - );Hyperhidrosis (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[TRIBENOSIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5055160&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5055777	Spontaneous	2011-12-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nail disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Neuritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5055777&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5049733	Spontaneous	2011-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Dry eye (n/a - Unknown - Disabling);Dry mouth (n/a - Unknown - Disabling);Joint stiffness (n/a - Unknown - Disabling);Myalgia (n/a - Unknown - Disabling);Photophobia (n/a - Unknown - Disabling);Photosensitivity reaction (n/a - Unknown - Disabling);Renal disorder (n/a - Unknown - Disabling);Temperature intolerance (n/a - Unknown - Disabling);Vaccination complication (n/a - Unknown - Disabling);Visual impairment (n/a - Unknown - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5049733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5047133	Spontaneous	2011-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza like illness (1wk - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[BIOFLAVONOIDS, DIOSMIN, HESPERIDIN, MICRONISED PURIFIED FLAVONOIC FRACTION] (C - n/a - n/a - [n/a - n/a - n/a])|[DRY EXTRACT OF GINKGO BILOBA LEAVES (35-67:1), EXTRACTION SOLVENT: ACETONE 60% ( M / M), GINKGO BILOBA EXTRACT, GINKGO BILOBA L., FOLIUM (DRY EXTRACT), GINKGO BILOBAE EXTRACTUM SICCUM NORMATUM, GINKGO LEAF DRY EXTRACT, REFINED AND QUANTIFIED, REFINED AND QUANTIFIED GINKGO DRY EXTRACT (35-67:1), CORRESPONDING TO 8.80-10.80 MG OF FLAVONOIDS EXPRESSED AS FLAVONE GLYCOSIDES, 1.12-1.36 MG OF GINKGOLIDES A, B AND C, 1.04-1.28 MG OF BILOBALIDE, EXTRACTION SOLVENT: ACETONE 60% M/M, STANDARDISED GINKGO BILOBA EXTRACT] (C - n/a - n/a - [n/a - n/a - n/a])|[LISINOPRIL, LISINOPRIL ANHYDROUS, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[RILMENIDINE, RILMENIDINE DIHYDROGEN PHOSPHATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5047133&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-5047661	Spontaneous	2011-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Decreased activity (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Hallucination (n/a - Unknown - Other Medically Important Condition);Middle insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Social problem (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5047661&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5042398	Spontaneous	2011-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Lip pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Restlessness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - Parenteral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5042398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5042407	Spontaneous	2011-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	Yes	Female	Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lymphadenopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neoplasm malignant (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pleural calcification (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pulmonary embolism (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[BISOPROLOL, BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5042407&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5042498	Spontaneous	2011-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5042498&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5039389	Spontaneous	2011-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Atrial fibrillation (1d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypotension (1d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLYCERYL TRINITRATE] (C - Angina pectoris - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - Hypertension - n/a - [n/a - n/a - n/a])|[LATANOPROST] (C - Glaucoma - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - n/a - n/a])|[TIMOLOL, TIMOLOL MALEATE] (C - Glaucoma - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5039389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5036754	Spontaneous	2011-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Infection susceptibility increased (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5036754&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5036848	Spontaneous	2011-12-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood pressure decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Depressed level of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Epilepsy - n/a - [n/a - n/a - Intramuscular])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - Oral])|KEPPRA [LEVETIRACETAM] (C - n/a - n/a - [n/a - n/a - Oral])|[DESMOPRESSIN, DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[FERRIC HYDROXIDE POLYMALTOSE COMPLEX, IRON] (C - n/a - n/a - [n/a - n/a - Oral])|[FLUTICASONE PROPIONATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[LACTULOSE] (C - n/a - n/a - [n/a - n/a - Oral])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - Nasal])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5036848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5029301	Spontaneous	2011-12-02 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dehydration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5029301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5033321	Spontaneous	2011-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5033321&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5033389	Spontaneous	2011-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5033389&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5031512	Spontaneous	2011-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (1.5a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (1.5a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5031512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5024237	Spontaneous	2011-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Abnormal dreams (n/a - Unknown - Other Medically Important Condition);Body temperature increased (n/a - Unknown - Other Medically Important Condition);Chest pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Deafness (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Feeling cold (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling hot (n/a - Unknown - Other Medically Important Condition);Gastrointestinal disorder (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Heart rate increased (n/a - Unknown - Other Medically Important Condition);Heart rate irregular (7d - Recovered/Resolved - Other Medically Important Condition);Hyperaesthesia (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Illusion (n/a - Recovering/Resolving - Other Medically Important Condition);Lip swelling (3h - Recovered/Resolved - Other Medically Important Condition);Movement disorder (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Recovering/Resolving - Other Medically Important Condition);Neuralgia (n/a - Unknown - Other Medically Important Condition);Oral herpes (3h - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Paraesthesia oral (3h - Recovered/Resolved - Other Medically Important Condition);Peripheral coldness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Respiratory rate decreased (4d - Recovered/Resolved - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition);Vaccination site pain (n/a - Unknown - Other Medically Important Condition);Vertigo (n/a - Recovering/Resolving - Other Medically Important Condition);Vision blurred (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5024237&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-5024725	Spontaneous	2011-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Petit mal epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5024725&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5025335	Spontaneous	2011-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Fatal - Results in Death);Hyperthermia (n/a - Fatal - Results in Death);Muscular weakness (n/a - Fatal - Results in Death);Paraparesis (n/a - Fatal - Results in Death);Rhonchi (n/a - Fatal - Results in Death);Urinary incontinence (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5025335&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5018787	Spontaneous	2011-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Vision blurred (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5018787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5019137	Spontaneous	2011-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Blindness (n/a - Unknown - Caused/Prolonged Hospitalisation);Central nervous system inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation);Diplopia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nervous system disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Ocular hyperaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5019137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5019142	Spontaneous	2011-11-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypersomnia (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5019142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5019844	Spontaneous	2011-11-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5019844&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5016008	Spontaneous	2011-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5016008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5016377	Spontaneous	2011-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Life Threatening);Jaundice (n/a - Unknown - Life Threatening)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5016377&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-5017005	Spontaneous	2011-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paresis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5017005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5008256	Spontaneous	2011-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Vaccination site erythema (6d - Recovered/Resolved - Other Medically Important Condition);Vaccination site oedema (6d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - n/a - Unknown - [n/a - n/a - Intramuscular])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS (INACTIVATED) ADSORBED] (S - n/a - Unknown - [n/a - n/a - Intramuscular])|[DACTYLIS GLOMERATA L., PHLEUM PRATENSE L., ANTHOXANTHUM ODORATUM L., LOLIUM PERENNE L., POA PRATENSIS L., GRASS POLLEN ALLERGEN EXTRACT FROM COCKSFOOT , SWEET VERNAL GRASS , RYE GRASS , MEADOW GRASS AND TIMOTHY] (S - Asthma - Dose not changed - [n/a - 1{DF} - Sublingual])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5008256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5008623	Spontaneous	2011-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Snoring (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5008623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5009039	Spontaneous	2011-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5009039&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-5010643	Spontaneous	2011-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Skin cancer (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5010643&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-5010651	Spontaneous	2011-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5010651&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-5011148	Spontaneous	2011-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Cerebral palsy (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Foetal exposure during pregnancy (n/a - Recovered/Resolved - Congenital Anomaly);Intraventricular haemorrhage neonatal (n/a - Recovered/Resolved With Sequelae - Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5011148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Sequelae
EU-EC-5011203	Spontaneous	2011-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Premature baby (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 3.75ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5011203&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5004586	Spontaneous	2011-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Angina pectoris (n/a - Unknown - Disabling);Chest discomfort (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Unknown - Disabling);Disability (n/a - Unknown - Disabling);Dyspnoea (n/a - Unknown - Disabling);Left ventricular dysfunction (n/a - Unknown - Disabling);Left ventricular failure (n/a - Unknown - Disabling);Malaise (n/a - Unknown - Disabling);Myocarditis (n/a - Unknown - Disabling);Night sweats (n/a - Unknown - Disabling);Palpitations (n/a - Unknown - Disabling);Physical disability (n/a - Unknown - Disabling);Sinus tachycardia (n/a - Unknown - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5004586&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-5000781	Spontaneous	2011-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal cavity drainage (n/a - Unknown - Caused/Prolonged Hospitalisation);Abdominal distension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Abdominal pain upper (n/a - Unknown - Caused/Prolonged Hospitalisation);Ascites (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Autoimmune hepatitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Cholecystitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Decreased immune responsiveness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Flank pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hepatic enzyme increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Hepatic failure (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hepatomegaly (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Liver disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Lung disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Scar (n/a - Unknown - Caused/Prolonged Hospitalisation);Sepsis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5000781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-5001510	Spontaneous	2011-11-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Radiculitis brachial (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=5001510&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4998577	Spontaneous	2011-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal discomfort (n/a - Unknown - Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vertigo (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4998577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4998710	Spontaneous	2011-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Sleep paralysis (n/a - Unknown - Other Medically Important Condition);Vaccination site pain (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4998710&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4996923	Spontaneous	2011-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Dose reduced - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4996923&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4996971	Spontaneous	2011-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Amyotrophic lateral sclerosis (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Aphasia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Dysphagia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Nervous system disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID, D,L-LYSINE ACETYLSALICYLATE] (C - Carotid artery stenosis - Unknown - [n/a - 75mg - Unknown])|[ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE] (C - Hypertension - Unknown - [n/a - n/a - Unknown])|[FLUVASTATIN, FLUVASTATIN SODIUM] (C - Hypercholesterolaemia - Unknown - [n/a - 80mg - Unknown])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - Unknown - [n/a - 500mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4996971&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4990566	Spontaneous	2011-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Eczema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	LANTUS [INSULIN GLARGINE] (C - n/a - n/a - [n/a - n/a - n/a])|NOVORAPID [INSULIN ASPART] (C - n/a - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4990566&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4991135	Spontaneous	2011-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4991135&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4991156	Spontaneous	2011-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4991156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4991213	Spontaneous	2011-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain (n/a - Recovering/Resolving - Disabling);Fatigue (n/a - Recovering/Resolving - Disabling);Hypoaesthesia (n/a - Recovering/Resolving - Disabling);Hypotonia (n/a - Recovering/Resolving - Disabling);Malaise (n/a - Recovering/Resolving - Disabling);Muscle contractions involuntary (n/a - Recovering/Resolving - Disabling);Panic attack (n/a - Recovering/Resolving - Disabling);Vasomotor rhinitis (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4991213&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4991244	Spontaneous	2011-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4991244&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4991507	Spontaneous	2011-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Photosensitivity reaction (n/a - Recovering/Resolving - );Raynaud's phenomenon (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4991507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4991741	Spontaneous	2011-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Immune thrombocytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4991741&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4991910	Spontaneous	2011-11-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Cerebrovascular accident (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Coma (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4991910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4983590	Spontaneous	2011-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4983590&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4984139	Spontaneous	2011-11-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Death (n/a - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Ill-defined disorder - Not applicable - [1d - n/a - Intramuscular])	NOVOMIX 30 FLEXPEN [INSULIN ASPART, INSULIN ASPART, INSULIN ASPART PROTAMINE] (C - Diabetes mellitus - Unknown - [n/a - 100{DF} - Subcutaneous])|[ACETYLSALICYLIC ACID] (C - Thrombosis prophylaxis - Unknown - [n/a - 150mg - Oral])|[ALLOPURINOL, ISOSORBIDE DINITRATE] (C - Angina pectoris - Unknown - [n/a - 80mg - Oral])|[BENDROFLUMETHIAZIDE, POTASSIUM CHLORIDE] (C - Diuretic therapy - Unknown - [n/a - 1{DF} - Oral])|[ENALAPRIL MALEATE] (C - Cardiac disorder - Unknown - [n/a - 20mg - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Dyspepsia - Unknown - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4984139&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4983370	Spontaneous	2011-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Alopecia (n/a - Recovered/Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [40d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4983370&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4983372	Spontaneous	2011-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Haemorrhage in pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition);Hot flush (20d - Recovered/Resolved - Other Medically Important Condition);Uterine contractions during pregnancy (20d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - 3.75ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4983372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4983374	Spontaneous	2011-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic shock (3h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperventilation (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site erythema (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pruritus (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - n/a - Intramuscular])	ENBREL [ETANERCEPT] (C - Rheumatoid arthritis - n/a - [n/a - n/a - Subcutaneous])|[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - Myalgia - n/a - [n/a - 25mg - Oral])|[ESTRADIOL, ESTRADIOL HEMIHYDRATE] (C - Mucosal dryness - n/a - [1878d - 25ug - Vaginal])|[ETODOLAC] (C - Arthralgia - n/a - [n/a - 200mg - Oral])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - Dyspepsia - n/a - [n/a - n/a - Oral])|[PARACETAMOL] (C - Arthralgia - n/a - [n/a - 1000mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4983374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4983375	Spontaneous	2011-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - 3.75ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4983375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4983376	Spontaneous	2011-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Lymphadenitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [36d - ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4983376&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4983378	Spontaneous	2011-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Burning sensation (n/a - Recovering/Resolving - Results in Death);Lung cancer metastatic (n/a - Fatal - Results in Death);Malaise (n/a - Not Recovered/Not Resolved - Results in Death);Pain (n/a - Not Recovered/Not Resolved - Results in Death);Pruritus (n/a - Recovering/Resolving - Results in Death);Restless legs syndrome (n/a - Recovering/Resolving - Results in Death);Skin disorder (n/a - Not Recovered/Not Resolved - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - 3.75% - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4983378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4983382	Spontaneous	2011-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Anisocoria (n/a - Unknown - Other Medically Important Condition);Balance disorder (n/a - Unknown - Other Medically Important Condition);Disturbance in attention (n/a - Unknown - Other Medically Important Condition);Extrasystoles (n/a - Unknown - Other Medically Important Condition);Feeling hot (n/a - Unknown - Other Medically Important Condition);Flushing (n/a - Unknown - Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Heart rate increased (n/a - Unknown - Other Medically Important Condition);Hypertonia (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Polyneuropathy (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Taste disorder (n/a - Unknown - Other Medically Important Condition);Visual impairment (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4983382&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4983384	Spontaneous	2011-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Haemorrhage in pregnancy (0d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4983384&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4983386	Spontaneous	2011-11-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Incontinence (n/a - Fatal - Results in Death);Pneumonia (n/a - Fatal - Results in Death);Pyrexia (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DIGOXIN] (C - n/a - n/a - [n/a - n/a - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SULFASALAZINE, SULFASALAZINE PH. EUR.] (C - Rheumatoid arthritis - n/a - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4983386&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4983387	Spontaneous	2011-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - 3.75ug - Intramuscular])	[PHENOXYMETHYLPENICILLIN] (C - Infection prophylaxis - n/a - [n/a - 1M[iU] - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4983387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4983390	Spontaneous	2011-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4983390&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4983392	Spontaneous	2011-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Burning sensation (n/a - Not Recovered/Not Resolved - Disabling);Erythema (3d - Recovered/Resolved - Disabling);Pruritus (n/a - Not Recovered/Not Resolved - Disabling);Sensory disturbance (n/a - Not Recovered/Not Resolved - Disabling);Urticaria (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - 3.75ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4983392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4977291	Spontaneous	2011-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4977291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4979431	Spontaneous	2011-11-10 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	Yes	Male	Therapeutic product ineffective (n/a - Not Recovered/Not Resolved - Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4979431&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4974100	Spontaneous	2011-11-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Gingival bleeding (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[YELLOW FEVER VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4974100&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4976100	Spontaneous	2011-11-09 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Amnesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	[ATENOLOL, CHLORTALIDONE] (C - Hypertonia - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4976100&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4971335	Spontaneous	2011-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4971335&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4971412	Spontaneous	2011-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Encephalomyelitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[DIAZEPAM] (C - n/a - n/a - [n/a - n/a - n/a])|[IBUPROFEN] (C - n/a - n/a - [n/a - n/a - n/a])|[LORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[PROPIOMAZINE, PROPIOMAZINE MALEATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[SIMETICONE] (C - n/a - n/a - [n/a - n/a - n/a])|[ZOPICLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4971412&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4965539	Spontaneous	2011-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN (A/BRISBANE/59/2007 REASS. IVR-148), A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN (A/URUGUAY/716/2007 REASS. NYMC X-175C), B/FLORIDA/4/2006-LIKE STRAIN (B/BRISBANE/3/2007), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/PHUKET/3073/2013-LIKE STRAIN, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1) PDM09-LIKE STRAIN USED (NIB-74XP) DERIVED FROM A/CHRISTCHURCH/16/2010, B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, HAEMAGGLUTININ, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, INFLUENZA VACCINE] (S - n/a - n/a - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4965539&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4959421	Spontaneous	2011-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Unknown - Disabling);Narcolepsy (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4959421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4959739	Spontaneous	2011-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Thrombocytopenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4959739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4954792	Spontaneous	2011-11-01 00:00:00	Healthcare Professional	European Economic Area	Braun N, Walther R, Hakenberg O, Reisinger E. Bacterial infections following adjuvanted H1N1 vaccination in three renal transplant recipients. Nephrology Dialysis Transplantation. 2010;1-2 Braun N et al. Bacterial infections following adjuvanted H1N1 vaccination in three renal transplant recipients, NDT Plus 2010; 331-333	65-85 Years	Elderly	No	Male	Bacterial infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood creatinine increased (n/a - Unknown - Caused/Prolonged Hospitalisation);C-reactive protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Haematuria (n/a - Unknown - Caused/Prolonged Hospitalisation);Lung infiltration (n/a - Unknown - Caused/Prolonged Hospitalisation);Lymphopenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Proteinuria (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhinorrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	CICLOSPORIN [CICLOSPORIN] (C - Renal transplant - Unknown - [n/a - n/a - n/a])|MYCOPHENOLATE MOFETIL [MYCOPHENOLATE MOFETIL] (C - Renal transplant - Unknown - [n/a - n/a - n/a])|[PREDNISOLONE] (C - Renal transplant - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4954792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4951056	Spontaneous	2011-10-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Alopecia universalis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4951056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4944957	Spontaneous	2011-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Blood pressure diastolic increased (n/a - Unknown - Other Medically Important Condition);Heart rate increased (n/a - Unknown - Other Medically Important Condition);Ventricular fibrillation (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4944957&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4945081	Spontaneous	2011-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Swelling (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4945081&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4945148	Spontaneous	2011-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4945148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4941803	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Injection site atrophy (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4941803&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4941804	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Blindness (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4941804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4941810	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Unknown - Other Medically Important Condition);Decreased appetite (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dry throat (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Sinusitis (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4941810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4941850	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Burnout syndrome (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4941850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4941927	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);HELLP syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral vascular disorder (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN) PRODUCED ON VERO CELLS, POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN) PRODUCED ON VERO CELLS, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, POLIOVIRUS TYPE 1 (INACTIVATED), POLIOVIRUS TYPE 2 (INACTIVATED), POLIOVIRUS TYPE 3 (INACTIVATED), PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4941927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4942977	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Blister (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Skin exfoliation (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4942977&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4942985	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Purpura (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4942985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4942991	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (15d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4942991&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4943003	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4943003&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4943440	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4943440&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4944117	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Agranulocytosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Haemolytic anaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [6wk - .5mL - Intramuscular])	KIOVIG [HUMAN NORMAL IMMUNOGLOBULIN] (C - n/a - n/a - [n/a - n/a - n/a])|MABTHERA [RITUXIMAB] (C - n/a - n/a - [n/a - n/a - n/a])|[CICLOSPORIN] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4944117&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4944120	Spontaneous	2011-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4944120&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4939120	Spontaneous	2011-10-25 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Ageusia (n/a - Unknown - Other Medically Important Condition);Anosmia (n/a - Unknown - Other Medically Important Condition);Arthralgia (n/a - Unknown - Other Medically Important Condition);Hypogeusia (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Taste disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	CYTOTOXIC TREATMENT [CYTOTOXIC AGENT] (C - n/a - Unknown - [n/a - n/a - Unknown])|RADIOTHERAPY [RADIOTHERAPY] (C - n/a - Unknown - [n/a - n/a - Unknown])|[ANASTROZOLE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[CELECOXIB] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4939120&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4937610	Spontaneous	2011-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Anxiety (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chills (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Depression (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling of body temperature change (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperacusis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain of skin (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pelvic pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Photophobia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4937610&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4937934	Spontaneous	2011-10-24 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Disabled relative (n/a - Not Recovered/Not Resolved - Congenital Anomaly, Other Medically Important Condition);Foetal cerebrovascular disorder (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Foetal exposure during pregnancy (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4937934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-4931514	Spontaneous	2011-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Bronchospasm (n/a - Unknown - );C-reactive protein increased (n/a - Unknown - );Cough (n/a - Unknown - );Dysphonia (n/a - Unknown - );Pharyngeal erythema (n/a - Unknown - );Pyrexia (n/a - Unknown - );Throat irritation (n/a - Unknown - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - 20mg - n/a])|[INDAPAMIDE, PERINDOPRIL ARGININE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 25mg - n/a])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - 25mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4931514&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4931647	Spontaneous	2011-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	[ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE, SODIUM CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE, SODIUM CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE GEL, DRIED USP, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALUMINIUM HYDROXIDE GEL, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, SODIUM ALGINATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CEFALEXIN, CEFALEXIN MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4931647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4932219	Spontaneous	2011-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Respiratory tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM VALPROATE] (C - Epilepsy - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4932219&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4932246	Spontaneous	2011-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);Neutropenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhinitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4932246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4932269	Spontaneous	2011-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4932269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4932742	Spontaneous	2011-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Abdominal pain (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4932742&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4933506	Spontaneous	2011-10-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4933506&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4927484	Spontaneous	2011-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4927484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4927538	Spontaneous	2011-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Idiopathic intracranial hypertension (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Respiratory tract infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])|TWINRIX PAEDIATRIC [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4927538&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4927853	Spontaneous	2011-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blindness transient (30min - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Subcutaneous])	[BENDROFLUAZIDE] (C - Hypertension - n/a - [n/a - 2.5mg - Oral])|[CETIRIZINE, CETIRIZINE DIHYDROCHLORIDE] (C - Hypersensitivity - n/a - [n/a - 10mg - Oral])|[FELODIPINE] (C - Hypertension - n/a - [n/a - 2.5mg - Oral])|[TERBUTALINE SULFATE, TERBUTALINE SULFATE PH. EUR.] (C - Asthma - n/a - [n/a - 50ug - Respiratory (inhalation)])|[TRAZODONE, TRAZODONE HYDROCHLORIDE] (C - Depression - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4927853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4928238	Spontaneous	2011-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Lymphadenitis (n/a - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal discomfort (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4928238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4928977	Spontaneous	2011-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Anaphylactic shock (1d - Recovered/Resolved With Sequelae - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Brain injury (9d - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Bronchospasm (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Burning sensation (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Cardiac arrest (n/a - Recovered/Resolved With Sequelae - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Circulatory collapse (n/a - Recovered/Resolved With Sequelae - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Dizziness (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Eye pruritus (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Hypotension (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Pneumonia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Pruritus (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Disabling);Resuscitation (1d - Recovered/Resolved With Sequelae - Results in Death, Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	ANALGESIC [ANALGESIC] (C - Arthralgia - Unknown - [1d - n/a - Unknown])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - Hypertension - Unknown - [n/a - n/a - Unknown])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (C - Exostosis - Not applicable - [3d - n/a - Unknown])|[ENALAPRIL, ENALAPRIL MALEATE] (C - Hypertension - Unknown - [n/a - 2.5mg - Unknown])|[METOPROLOL TARTRATE] (C - Hypertension - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4928977&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4929745	Spontaneous	2011-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Multiple sclerosis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4929745&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4930467	Spontaneous	2011-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthropathy (n/a - Not Recovered/Not Resolved - Disabling);Local reaction (n/a - Recovered/Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [21d - 3.75ug - Intramuscular])	[GLUCOSAMINE, GLUCOSAMINE SULFATE] (C - Arthritis - n/a - [n/a - 400mg - n/a])|[METOPROLOL SUCCINATE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[NABUMETONE] (C - n/a - n/a - [n/a - 500mg - Oral])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - 20mg - n/a])|[PREDNISOLONE] (C - Sarcoidosis - n/a - [n/a - n/a - n/a])|[SULFASALAZINE] (C - n/a - n/a - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4930467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4925367	Spontaneous	2011-10-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bell's palsy (n/a - Unknown - Caused/Prolonged Hospitalisation);Ear pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Facial paralysis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4925367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4925368	Spontaneous	2011-10-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Hypotonic-hyporesponsive episode (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4925368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4925714	Spontaneous	2011-10-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Immune thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Petechiae (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4925714&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4925971	Spontaneous	2011-10-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4925971&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4927060	Spontaneous	2011-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (1d - Fatal - Results in Death, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4927060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4927133	Spontaneous	2011-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Disabling);Narcolepsy (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4927133&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4920969	Spontaneous	2011-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaemia (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Injection site pain (n/a - Unknown - Other Medically Important Condition);Live birth (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMOXICILLIN, AMOXICILLIN TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FERROUS SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MESALAZINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4920969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4922797	Spontaneous	2011-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Bronchospasm (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypertensive crisis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Suffocation feeling (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4922797&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4922807	Spontaneous	2011-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Irritability (n/a - Unknown - Other Medically Important Condition);Jaundice (n/a - Unknown - Other Medically Important Condition);Muscle disorder (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Oedema (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Paralysis (n/a - Unknown - Other Medically Important Condition);Petechiae (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4922807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4922809	Spontaneous	2011-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Epistaxis (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4922809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4922837	Spontaneous	2011-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Meningitis aseptic (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4922837&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4922838	Spontaneous	2011-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Illness (n/a - Unknown - Other Medically Important Condition);Increased upper airway secretion (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4922838&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4922868	Spontaneous	2011-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4922868&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4922870	Spontaneous	2011-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Crying (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rhinitis (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4922870&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4922885	Spontaneous	2011-10-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Hypertension (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4922885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4917952	Spontaneous	2011-10-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dry throat (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (1wk - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4917952&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4920092	Spontaneous	2011-10-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Heterotaxia (n/a - Recovered/Resolved With Sequelae - Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4920092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Sequelae
EU-EC-4920207	Spontaneous	2011-10-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Cerebral haemorrhage (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4920207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4913670	Spontaneous	2011-10-14 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository J. Haba-Rubio et al, Narcolepsy with cataplexy associated with H1N1 vaccination, doi:10.106/j. neurol.2011.04.003, 563-566	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Educational problem (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypnopompic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Poor quality sleep (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep apnoea syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4913670&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4913878	Spontaneous	2011-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4913878&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4911052	Spontaneous	2011-10-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Aggression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Middle insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4911052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4911802	Spontaneous	2011-10-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Blindness (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (0d - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4911802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4907602	Spontaneous	2011-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4907602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4900180	Spontaneous	2011-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Obliterative bronchiolitis (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 2{DF} - n/a])	CELLCEPT [MYCOPHENOLATE MOFETIL] (C - n/a - n/a - [n/a - n/a - n/a])|[CICLOSPORIN] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4900180&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4900181	Spontaneous	2011-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Amyotrophic lateral sclerosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	[AMILORIDE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, AMILORIDE HYDROCHLORIDE DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUSPIRONE, BUSPIRONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4900181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4901094	Spontaneous	2011-10-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site erythema (2d - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pseudoradicular syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tendon pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site swelling (2d - Recovered/Resolved - Other Medically Important Condition);Vaccination site warmth (2d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4901094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4892987	Spontaneous	2011-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Not Specified	No	Male	Tachypnoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4892987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4894712	Spontaneous	2011-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4894712&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4895557	Spontaneous	2011-10-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4895557&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4895802	Spontaneous	2011-10-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Colitis ulcerative (216d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Dose increased - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[AZATHIOPRINE] (C - Colitis ulcerative - n/a - [n/a - n/a - Oral])|[MESALAZINE] (C - Colitis ulcerative - n/a - [n/a - 800mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4895802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-4890115	Spontaneous	2011-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bell's palsy (n/a - Recovering/Resolving - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site pain (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4890115&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4890127	Spontaneous	2011-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthritis (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4890127&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4890146	Spontaneous	2011-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Parkinson's disease (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4890146&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-4887583	Spontaneous	2011-10-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Asthenia (n/a - Recovering/Resolving - Other Medically Important Condition);Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Posture abnormal (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Other Medically Important Condition);Weight increased (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4887583&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4886034	Spontaneous	2011-10-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4886034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4880298	Spontaneous	2011-09-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4880298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4880720	Spontaneous	2011-09-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Bradyphrenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Brain injury (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Choreoathetosis (n/a - Recovered/Resolved - Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cortisol decreased (n/a - Unknown - Other Medically Important Condition);Dysgraphia (n/a - Recovering/Resolving - Other Medically Important Condition);Dyskinesia (n/a - Recovering/Resolving - Other Medically Important Condition);Embolism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Encephalopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);General physical health deterioration (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Grimacing (n/a - Recovering/Resolving - Other Medically Important Condition);Mental impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Motor dysfunction (n/a - Recovered/Resolved - Other Medically Important Condition);Muscle twitching (n/a - Recovering/Resolving - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Pallor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Speech disorder (n/a - Recovering/Resolving - Other Medically Important Condition);Sydenham's chorea (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[PROPRANOLOL, PROPRANOLOL HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4880720&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4882931	Spontaneous	2011-09-30 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4882931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4877305	Spontaneous	2011-09-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4877305&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4877387	Spontaneous	2011-09-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4877387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4877733	Spontaneous	2011-09-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4877733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4879038	Spontaneous	2011-09-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Agitation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Blood potassium decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Blood pressure decreased (n/a - Unknown - Caused/Prolonged Hospitalisation);Burning sensation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Generalised oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hallucination (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4879038&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4879601	Spontaneous	2011-09-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Radiculopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4879601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4879611	Spontaneous	2011-09-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chest pain (n/a - Recovered/Resolved - Disabling);Dyspnoea (n/a - Recovered/Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - 3.75ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4879611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4879871	Spontaneous	2011-09-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4879871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4870095	Spontaneous	2011-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Neuropathy peripheral (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Polyarteritis nodosa (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vasculitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4870095&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4870135	Spontaneous	2011-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4870135&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4870140	Spontaneous	2011-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	H1N1 influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia influenzal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4870140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4872998	Spontaneous	2011-09-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Meniere's disease (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Viral infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Unknown - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4872998&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4865992	Spontaneous	2011-09-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Not Specified	Drug ineffective (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4865992&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4866212	Spontaneous	2011-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthritis (n/a - Not Recovered/Not Resolved - Disabling);Cough (n/a - Unknown - Disabling);Deafness (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Rotator cuff syndrome (n/a - Unknown - Disabling);Tinnitus (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4866212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4866400	Spontaneous	2011-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Accidental overdose (n/a - Unknown - Caused/Prolonged Hospitalisation);Body temperature increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cellulitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - n/a - n/a - [1d - .5mL - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4866400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4866455	Spontaneous	2011-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Blood creatinine increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myositis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4866455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4867207	Spontaneous	2011-09-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved With Sequelae - Disabling);Rheumatoid arthritis (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4867207&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-4867576	Spontaneous	2011-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Polyneuropathy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4867576&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4867609	Spontaneous	2011-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Demyelination (n/a - Not Recovered/Not Resolved - Disabling);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling);Speech disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4867609&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4869481	Spontaneous	2011-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cardiopulmonary failure (n/a - Fatal - Results in Death, Life Threatening, Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Anticoagulant therapy - n/a - [n/a - 75mg - Oral])|[AMITRIPTYLINE HYDROCHLORIDE] (C - Sleep disorder therapy - n/a - [n/a - 25{DF} - Oral])|[DIGOXIN] (C - Cardiac disorder - n/a - [n/a - 62.5ug - n/a])|[FUROSEMIDE] (C - Hypertension - n/a - [n/a - 40mg - Oral])|[METOPROLOL SUCCINATE] (C - Hypertension - n/a - [n/a - 25mg - Oral])|[NITRAZEPAM, NITRAZEPAM BP] (C - n/a - n/a - [n/a - 1mg - n/a])|[POTASSIUM CHLORIDE] (C - Mineral supplementation - n/a - [n/a - 750mg - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 40{DF} - Oral])|[SPIRONOLACTONE] (C - Diuretic therapy - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4869481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4869515	Spontaneous	2011-09-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Respiratory failure (n/a - Fatal - Results in Death, Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - n/a - Intramuscular])	[CHLORPROTHIXENE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[CITALOPRAM HYDROBROMIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[IPRATROPIUM BROMIDE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[ISOSORBIDE 5 MONONITRATE, ISOSORBIDE MONONITRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[OMEPRAZOLE] (C - Gastritis - n/a - [n/a - 20mg - n/a])|[SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4869515&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4862950	Spontaneous	2011-09-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Disability (17mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Musculoskeletal stiffness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Physical disability (5mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Vaccination site pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4862950&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4858229	Spontaneous	2011-09-22 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Automatism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (1a - Not Recovered/Not Resolved - Other Medically Important Condition);Iron deficiency (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Periodic limb movement disorder (1a - Not Recovered/Not Resolved - Other Medically Important Condition);Rapid eye movements sleep abnormal (1a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (1a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep talking (1a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (1a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4858229&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4851563	Spontaneous	2011-09-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4851563&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4853050	Spontaneous	2011-09-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Throat irritation (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Ill-defined disorder - Not applicable - [n/a - n/a - Intramuscular])	HYDROXOCOBALAMIN [HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|METHOTREXATE [METHOTREXATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CODEINE PHOSPHATE BP, PARACETAMOL PH. EUR., PARACETAMOL BP, CODEINE PHOSPHATE BP, PARACETAMOL, CODEINE PHOSPHATE, PARACETAMOL, CODEINE PHOSPHATE BP, PARACETAMOL, CODEINE PHOSPHATE HEMIHYDRATE, PARACETAMOL, PARACETAMOL DC, CODEINE PHOSPHATE PH.EUR.] (C - n/a - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROXYCHLOROQUINE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[MACROGOL, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - n/a - [n/a - n/a - n/a])|[MELOXICAM] (C - n/a - n/a - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4853050&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4848535	Spontaneous	2011-09-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Rash maculo-papular (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[CEFALEXIN, CEFALEXIN MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[CYPROTERONE ACETATE, ETHINYLESTRADIOL] (C - n/a - n/a - [n/a - n/a - n/a])|[QUETIAPINE, QUETIAPINE FUMARATE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4848535&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4848654	Spontaneous	2011-09-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Epilepsy (0d - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Epilepsy - Unknown - [n/a - n/a - Intramuscular])	ZONISAMIDE [ZONISAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[IPRATROPIUM BROMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PHENYTOIN] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4848654&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4848655	Spontaneous	2011-09-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epilepsy (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])	[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[DIHYDROCODEINE TARTRATE, PARACETAMOL, PARACETAMOL BP, DIHYDROCODEINE TARTRATE BP, PARACETAMOL, DIHYDROCODEINE TARTRATE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[PHENYTOIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4848655&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4848702	Spontaneous	2011-09-20 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Chest discomfort (n/a - Not Recovered/Not Resolved - Results in Death, Other Medically Important Condition);Diarrhoea infectious (n/a - Not Recovered/Not Resolved - Results in Death, Other Medically Important Condition);Gastroenteritis (2d - Fatal - Results in Death, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Results in Death, Other Medically Important Condition);Sepsis (n/a - Not Recovered/Not Resolved - Results in Death, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])	[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])|[BUPROPION, BUPROPION HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[CARBOMER] (C - n/a - n/a - [n/a - n/a - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[LOSARTAN, LOSARTAN POTASSIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - n/a - n/a])|[TERBUTALINE] (C - n/a - n/a - [n/a - n/a - n/a])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4848702&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4841669	Spontaneous	2011-09-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PHENPROCOUMON] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4841669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4842599	Spontaneous	2011-09-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Fibromyalgia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hypoacusis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Hypoaesthesia oral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Migraine (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sensory level abnormal (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Systemic lupus erythematosus (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling);Tinnitus (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4842599&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4838173	Spontaneous	2011-09-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4838173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4840601	Spontaneous	2011-09-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Muscle atrophy (n/a - Not Recovered/Not Resolved - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - 3.75ug - Intravenous (not otherwise specified)])	[CODEINE PHOSPHATE SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[ETODOLAC] (C - n/a - n/a - [n/a - n/a - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4840601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4836596	Spontaneous	2011-09-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Not Specified	Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4836596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4836601	Spontaneous	2011-09-14 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Not Specified	No	Male	Ear malformation (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Facial paralysis (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Psychomotor skills impaired (n/a - Not Recovered/Not Resolved - Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4836601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Severe reaction
EU-EC-4836707	Spontaneous	2011-09-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4836707&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4836708	Spontaneous	2011-09-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4836708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4836709	Spontaneous	2011-09-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4836709&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4837391	Spontaneous	2011-09-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Ataxia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyponatraemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	[OXCARBAZEPINE] (C - n/a - Dose not changed - [n/a - 300mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4837391&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4828192	Spontaneous	2011-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Generalised tonic-clonic seizure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [5mo - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4828192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4828982	Spontaneous	2011-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4828982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4830644	Spontaneous	2011-09-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Stillbirth (0d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vaginal haemorrhage (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [1d - n/a - Intramuscular])	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)] (C - Influenza immunisation - n/a - [1d - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4830644&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4825055	Spontaneous	2011-09-09 00:00:00	Healthcare Professional	Non European Economic Area	Umapathi T, International collaborative safety monitoring for Pandemic 2009 H1N1 vaccines: estimation of the risk of guillain-barré syndrome-singapore experience, Journal of the Peripheral Nervous System 16(Supplement):S1-S160, 2011, S137-138	65-85 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[MENINGOCOCCAL VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4825055&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4825056	Spontaneous	2011-09-09 00:00:00	Healthcare Professional	Non European Economic Area	Umapathi T, International collaborative safety monitoring for Pandemic 2009 H1N1 vaccines: estimation of the risk of guillain-barré syndrome-singapore experience, Journal of the Peripheral Nervous System 16(Supplement):S1-S160, 2011, S137-138	18-64 Years	Not Specified	No	Not Specified	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition);Peripheral sensory neuropathy (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[POLIOMYELITIS VACCINE (ORAL)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[TETANUS VACCINES] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[TYPHOID VACCINE] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4825056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4827196	Spontaneous	2011-09-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cardiac arrest (n/a - Recovered/Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Respiration abnormal (n/a - Recovered/Resolved - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Ventricular fibrillation (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [1d - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Prophylaxis - n/a - [n/a - 75mg - Oral])|[AMLODIPINE BESILATE] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4827196&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4823103	Spontaneous	2011-09-08 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Congenital anomaly (n/a - Not Recovered/Not Resolved - Results in Death);Developmental delay (n/a - Not Recovered/Not Resolved - Results in Death);Dyspnoea (n/a - Not Recovered/Not Resolved - Results in Death);Foetal growth restriction (n/a - Not Recovered/Not Resolved - Results in Death);Hyporeflexia (n/a - Not Recovered/Not Resolved - Results in Death);Hypotonia (n/a - Not Recovered/Not Resolved - Results in Death);Laryngomalacia (n/a - Not Recovered/Not Resolved - Results in Death);Muscle spasticity (n/a - Not Recovered/Not Resolved - Results in Death);Patent ductus arteriosus (n/a - Not Recovered/Not Resolved - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4823103&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4823104	Spontaneous	2011-09-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4823104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4820938	Spontaneous	2011-09-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal distension (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Areflexia (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Arrhythmia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Arthralgia (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Atrial fibrillation (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Bradycardia (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);CSF protein abnormal (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cardio-respiratory arrest (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chills (1d - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Coma (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (3d - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait inability (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gastrointestinal infection (n/a - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotension (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neck pain (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paralysis (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraparesis (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paresis (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumothorax (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Polyneuropathy (n/a - Not Recovered/Not Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4820938&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4812789	Spontaneous	2011-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Myoclonic epilepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4812789&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4813136	Spontaneous	2011-09-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);CSF protein increased (n/a - Unknown - Other Medically Important Condition);Chronic inflammatory demyelinating polyradiculoneuropathy (n/a - Recovering/Resolving - Other Medically Important Condition);Hyperaesthesia (n/a - Unknown - Other Medically Important Condition);Joint swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4813136&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-4811853	Spontaneous	2011-09-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site haematoma (n/a - Unknown - Disabling);Pain in extremity (n/a - Unknown - Disabling);Peripheral swelling (n/a - Unknown - Disabling)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [1d - 3.75ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4811853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4808428	Spontaneous	2011-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4808428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4808435	Spontaneous	2011-09-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4808435&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4803090	Spontaneous	2011-08-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Central serous chorioretinopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Gamma-glutamyltransferase increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Glomerulonephritis chronic (n/a - Unknown - Caused/Prolonged Hospitalisation);Hepatic cirrhosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Laryngitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Nocturia (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Solar lentigo (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sudden onset of sleep (n/a - Unknown - Caused/Prolonged Hospitalisation);Transplant rejection (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	IMMUNOSUPPRESSIVE [IMMUNOSUPPRESSIVE] (C - n/a - Unknown - [n/a - n/a - Unknown])|MULTIPLE MEDICATION [MULTIPLE MEDICATION] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4803090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4803275	Spontaneous	2011-08-31 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4803275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4803998	Spontaneous	2011-08-31 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4803998&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4804060	Spontaneous	2011-08-31 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4804060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4804264	Spontaneous	2011-08-31 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Poor quality sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4804264&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4805620	Spontaneous	2011-08-31 00:00:00	Healthcare Professional	European Economic Area	Pauwels C, Bulai Livideanu C, Maza A, Lamant L, Paul C. Cytophagic Histiocytic Panniculitis after H1N1 Vaccination: A Case Report and Review of the Cutaneous Side Effects of Influenza Vaccines. Dermatology 2011;222(3):217-220.	3-11 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Chills (n/a - Unknown - Other Medically Important Condition);Decreased appetite (n/a - Unknown - Other Medically Important Condition);Fat necrosis (3wk - Recovered/Resolved - Other Medically Important Condition);Panniculitis (3wk - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Skin lesion (3wk - Recovered/Resolved - Other Medically Important Condition);Skin mass (3wk - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4805620&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4798848	Spontaneous	2011-08-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypokinesia (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4798848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4790774	Spontaneous	2011-08-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4790774&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4778204	Spontaneous	2011-08-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Injection site erythema (31d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pain (31d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site swelling (31d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Peripheral coldness (n/a - Unknown - Caused/Prolonged Hospitalisation);Tendon disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4778204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4779186	Spontaneous	2011-08-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Gamma-glutamyltransferase increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hypersomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Transplant rejection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4779186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4779736	Spontaneous	2011-08-19 00:00:00	Healthcare Professional	Non European Economic Area	Huang WT et.al. Adverse Events Following Pandemic A (H1N1) 2009 Monovalent vaccines in Pregnant Women - Taiwan, November 2009 - August 2010. PLoS ONE. 2011;6 (8) Gibbs RS, Premmereur J, Fisher BM and Lynch A.. Late pregnancy loss after A (H1N1) vaccination. American Journal of Obstetrics &amp; Gynecology. 2011;S247	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Stillbirth (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4779736&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4775053	Spontaneous	2011-08-18 00:00:00	Healthcare Professional	Non European Economic Area	Gibbs RS, Premmereur J, Fisher BM and Lynch A.. Late pregnancy loss after A (H1N1) vaccination. American Journal of Obstetrics &amp; Gynecology. 2011;S247 Huang WT et.al. Adverse Events Following Pandemic A (H1N1) 2009 Monovalent vaccines in Pregnant Women - Taiwan, November 2009 - August 2010. PLoS ONE. 2011;6 (8)	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - Congenital Anomaly);Stillbirth (n/a - Unknown - Congenital Anomaly)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4775053&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Severe reaction
EU-EC-4775265	Spontaneous	2011-08-18 00:00:00	Healthcare Professional	Non European Economic Area	Huang WT et.al. Adverse Events Following Pandemic A (H1N1) 2009 Monovalent vaccines in Pregnant Women - Taiwan, November 2009 - August 2010. PLoS ONE. 2011;6 (8) Gibbs RS, Premmereur J, Fisher BM and  Lynch A.. Late pregnancy loss after A (H1N1) vaccination. American Journal of Obstetrics &amp; Gynecology. 2011;S247	18-64 Years	Not Specified	No	Female	Amniotic cavity infection (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Foetal death (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4775265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4775759	Spontaneous	2011-08-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Haematuria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Skin ulcer (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Synovitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4775759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4775814	Spontaneous	2011-08-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4775814&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4776354	Spontaneous	2011-08-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4776354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4772862	Spontaneous	2011-08-17 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Not Specified	Congenital diaphragmatic eventration (n/a - Unknown - Caused/Prolonged Hospitalisation, Congenital Anomaly);Foetal exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation, Congenital Anomaly);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Congenital Anomaly);Pelvic kidney (n/a - Unknown - Caused/Prolonged Hospitalisation, Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Transplacental])	[TERBUTALINE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4772862&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4773170	Spontaneous	2011-08-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anisocoria (n/a - Unknown - Disabling);Bronchiolitis (n/a - Recovered/Resolved - Disabling);Cholelithiasis (n/a - Unknown - Disabling);Deafness (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (1a - Recovering/Resolving - Disabling);Ear pain (n/a - Unknown - Disabling);Facial paresis (1wk - Recovered/Resolved - Disabling);Fatigue (n/a - Recovering/Resolving - Disabling);General physical health deterioration (n/a - Unknown - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Ischaemia (n/a - Unknown - Disabling);Laryngeal oedema (n/a - Unknown - Disabling);Nausea (1a - Recovering/Resolving - Disabling);Serum ferritin increased (n/a - Unknown - Disabling);Upper respiratory tract infection (n/a - Recovered/Resolved - Disabling);Vertigo (1a - Recovering/Resolving - Disabling);Vomiting (n/a - Unknown - Disabling);Weight decreased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4773170&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4768934	Spontaneous	2011-08-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4768934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4770405	Spontaneous	2011-08-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest pain (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Diplopia (n/a - Unknown - Disabling);Fatigue (1a - Not Recovered/Not Resolved - Disabling);Feeling hot (3wk - Recovered/Resolved - Disabling);Influenza like illness (n/a - Recovered/Resolved - Disabling);Malaise (1a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Unknown - Disabling);Pain in extremity (n/a - Unknown - Disabling);Peripheral swelling (3wk - Recovered/Resolved - Disabling);Rash (3wk - Recovered/Resolved - Disabling);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4770405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4772420	Spontaneous	2011-08-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Conjunctival haemorrhage (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Conjunctivitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Corneal oedema (n/a - Unknown - Other Medically Important Condition);Corneal opacity (n/a - Unknown - Other Medically Important Condition);Dizziness (0d - Recovered/Resolved - Other Medically Important Condition);Eye haemorrhage (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eye infection viral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eye pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eye pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ocular hyperaemia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[CHONDROITIN SULFATE] (C - Osteoarthritis - n/a - [n/a - n/a - Oral])|[DIMETHYL SULFONE] (C - Osteoarthritis - n/a - [n/a - n/a - Oral])|[ESTROGENS CONJUGATED, ESTRONE SODIUM SULFATE, EQUILIN SULFATE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - Vaginal])|[GLUCOSAMINE SULFATE] (C - Osteoarthritis - n/a - [n/a - n/a - Oral])|[MEPROBAMATE, PARACETAMOL, CODEINE PHOSPHATE, MEPROBAMATE, PARACETAMOL, CODEINE PHOSPHATE, ANHYDROUS CAFFEINE] (C - Cluster headache - n/a - [n/a - 2{DF} - n/a])|[VALSARTAN] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])|[VITAMINS NOS] (C - Osteoarthritis - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4772420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4764938	Spontaneous	2011-08-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Foetal death (0d - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Asthma - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4764938&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4764942	Spontaneous	2011-08-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Cough (n/a - Recovered/Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4764942&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4764946	Spontaneous	2011-08-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Psychotic disorder (n/a - Recovering/Resolving - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4764946&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4761934	Spontaneous	2011-08-12 00:00:00	Healthcare Professional	Non European Economic Area	Toy H et al. Lymphadenitis caused by H1N1 vaccination: Case report. Vaccine (2010), doi:10.1016/j.vaccine. 2009. 12.043. TOY H, KARASOY D, KESER M. Lymphadenitis caused by H1N1 vaccination: Case report. VACCINE 2010;2158-2160.	18-64 Years	Not Specified	Yes	Male	Lymphadenitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Not Specified - Caused/Prolonged Hospitalisation);Neck mass (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4761934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4764077	Spontaneous	2011-08-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination failure (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4764077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-4760474	Spontaneous	2011-08-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Depression - Unknown - [n/a - n/a - Unknown])|[ZOPICLONE] (C - Sleep disorder - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4760474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4761354	Spontaneous	2011-08-11 00:00:00	Healthcare Professional	Non European Economic Area	Huang WT, Chen WC, Teng HJ, Huang WI, Huang YW, et al.. Adverse Events Following Pandemic A (H1N1) 2009 Monovalent Vaccines in Pregnant Women-Taiwan, November 2009-August 2010. PLOS one. 2011;6 (8)	Not Specified	Neonate (Preterm and Term newborns)	Yes	Not Specified	Foetal exposure during pregnancy (n/a - Unknown - Results in Death);Haemangioblastoma (n/a - Fatal - Results in Death);Haemorrhage intracranial (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4761354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4754019	Spontaneous	2011-08-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4754019&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4752303	Spontaneous	2011-08-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (7d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (7d - Recovered/Resolved - Other Medically Important Condition);Nasal congestion (7d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (1d - Recovered/Resolved - Other Medically Important Condition);Vaginal haemorrhage (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	[FOLIC ACID, DRIED FERROUS SULFATE, FOLIC ACID, FERROUS SULFATE, FOLIC ACID, IRON] (C - Prophylaxis - n/a - [n/a - 91mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4752303&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4747442	Spontaneous	2011-08-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Exposure during pregnancy (n/a - Unknown - Results in Death);Gestational hypertension (n/a - Fatal - Results in Death);Heart rate irregular (n/a - Unknown - Results in Death);Thrombosis (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DICLOFENAC DIETHYLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4747442&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4746156	Spontaneous	2011-08-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Blister (n/a - Recovered/Resolved - Other Medically Important Condition);Dry skin (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Skin infection (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 150mg - Oral])|[DIAZEPAM] (C - Product used for unknown indication - n/a - [n/a - n/a - Oral])|[HYDROCHLOROTHIAZIDE, TRIAMTERENE] (C - Hypertension - n/a - [n/a - 1{DF} - Oral])|[NAPROXEN] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[NITROFURANTOIN] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[PAROXETINE MESILATE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[TOPIRAMATE] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4746156&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4737476	Spontaneous	2011-08-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angioedema (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gastrointestinal candidiasis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urticaria chronic (8mo - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])|[ETHINYLESTRADIOL, ETONOGESTREL] (S - Contraception - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4737476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4739426	Spontaneous	2011-08-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4739426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4734221	Spontaneous	2011-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Ataxia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Dyspnoea (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4734221&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4735260	Spontaneous	2011-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Paraproteinaemia (n/a - Unknown - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - n/a - [n/a - 3.75ug - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4735260&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4736368	Spontaneous	2011-08-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Glomerulonephritis minimal lesion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nephrotic syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Type 1 diabetes mellitus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4736368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4730594	Spontaneous	2011-07-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Unknown - Disabling);Weight increased (n/a - Unknown - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4730594&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4732994	Spontaneous	2011-07-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest discomfort (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash erythematous (n/a - Unknown - Caused/Prolonged Hospitalisation);Throat tightness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - Other])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4732994&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4727985	Spontaneous	2011-07-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4727985&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4722611	Spontaneous	2011-07-27 00:00:00	Healthcare Professional	Non European Economic Area	Chater L et al. Suspicion of rheumatoid purpura post influenza vaccination H1N1 complicated by acute intussusception in a child of four years, The Pan African Medical Journal, 2010; Vol 7:Number18	3-11 Years	Child	No	Female	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gastrointestinal oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Intussusception (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rectal haemorrhage (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4722611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4724869	Spontaneous	2011-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4724869&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4724931	Spontaneous	2011-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4724931&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4725941	Spontaneous	2011-07-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4725941&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4719799	Spontaneous	2011-07-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4719799&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4720137	Spontaneous	2011-07-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Sleep disorder (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	NEOCLARITYN [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4720137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4718066	Spontaneous	2011-07-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypokinesia (n/a - Unknown - Other Medically Important Condition);Incontinence (n/a - Unknown - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Other Medically Important Condition);Parkinson's disease (n/a - Recovering/Resolving - Other Medically Important Condition);Salivary hypersecretion (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - 1{DF} - n/a])	ENTACAPONE [ENTACAPONE] (C - n/a - Unknown - [n/a - n/a - n/a])|LEVODOPA [LEVODOPA] (C - n/a - Unknown - [n/a - n/a - n/a])|[PRAMIPEXOLE, PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4718066&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4713134	Spontaneous	2011-07-22 00:00:00	Healthcare Professional	European Economic Area	Gibbs RS, Premmereur J, Fisher BM and Lynch A.. Late pregnancy loss after A (H1N1) vaccination. American Journal of Obstetrics &amp; Gynecology. 2011;S247 Data migrated from the EudraVigilance E2B(R2) Literature repository	18-64 Years	Not Specified	No	Female	Foetal death (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	[ASCORBIC ACID, FOLIC ACID, IRON] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[CALCIUM, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4713134&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4710613	Spontaneous	2011-07-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Aggression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Anxiety (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Hallucination (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Memory impairment (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4710613&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4712556	Spontaneous	2011-07-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Basal cell carcinoma (1a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4712556&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4707703	Spontaneous	2011-07-20 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Injection site oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Rash pruritic (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[MICRONISED SPIRONOLACTONE, POTASSIUM CANRENOATE, SPIRONOLACTONE, SPIRONOLACTONE BP] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])|[ZOLPIDEM, ZOLPIDEM TARTRATE] (C - Product used for unknown indication - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4707703&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4702082	Spontaneous	2011-07-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Drug ineffective (n/a - Unknown - Caused/Prolonged Hospitalisation);H1N1 influenza (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza A virus test positive (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4702082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4703449	Spontaneous	2011-07-18 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaplastic large cell lymphoma T- and null-cell types (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])|[ALPRAZOLAM] (S - n/a - Drug withdrawn - [n/a - .5mg - Oral])|[RISPERIDONE] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4703449&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4700573	Spontaneous	2011-07-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Alopecia (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Infection susceptibility increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	AERIUS [DESLORATADINE] (C - n/a - n/a - [n/a - n/a - n/a])|[MOMETASONE FUROATE, MOMETASONE FUROATE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MOMETASONE FUROATE] (C - n/a - n/a - [n/a - n/a - n/a])|[NAPROXEN, NAPROXEN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[TERBUTALINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4700573&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4695825	Spontaneous	2011-07-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4695825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4697210	Spontaneous	2011-07-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4697210&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4690421	Spontaneous	2011-07-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthma (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Drug ineffective (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Wheezing (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])|[BECLOMETASONE DIPROPIONATE] (S - Product used for unknown indication - Drug withdrawn - [3wk - n/a - Respiratory (inhalation)])|[SALBUTAMOL SULFATE] (S - Product used for unknown indication - Dose not changed - [n/a - n/a - Respiratory (inhalation)])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Product used for unknown indication - n/a - [n/a - 2{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4690421&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4691928	Spontaneous	2011-07-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4691928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4691975	Spontaneous	2011-07-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4691975&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4683509	Spontaneous	2011-07-12 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Amniorrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Intrauterine infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Maternal exposure before pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Oligohydramnios (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Premature delivery (1d - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Premature rupture of membranes (63d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4683509&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4685708	Spontaneous	2011-07-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Presyncope (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - 3.75ug - Intramuscular])	[CITALOPRAM HYDROBROMIDE] (C - Depression - n/a - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4685708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4679926	Spontaneous	2011-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Epilepsy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .25mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4679926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4681164	Spontaneous	2011-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Ataxia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Cognitive disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Encephalitis viral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tremor (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4681164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4681166	Spontaneous	2011-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abnormal behaviour (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4681166&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4682650	Spontaneous	2011-07-11 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	Yes	Female	Periodic limb movement disorder (n/a - Unknown - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4682650&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4676073	Spontaneous	2011-07-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Sarcoidosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4676073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4676885	Spontaneous	2011-07-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Febrile convulsion (25min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4676885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4672924	Spontaneous	2011-07-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4672924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4673933	Spontaneous	2011-07-07 00:00:00	Healthcare Professional	Non European Economic Area	Leung J. Adverse events after flu vaccination in patients with immune disorders. Hong Kong Med J April 2010; 16:158 Leung J SM. Adverse events after flu vaccination in patients with immune disorders. Hong Kong Medical Journal. 2010;16:158	65-85 Years	Not Specified	Yes	Male	Concomitant disease aggravated (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Organising pneumonia (n/a - Unknown - Other Medically Important Condition);Pneumonitis (n/a - Unknown - Other Medically Important Condition);Pulmonary fibrosis (n/a - Unknown - Other Medically Important Condition);Rhinorrhoea (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4673933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4674153	Spontaneous	2011-07-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	Yes	Male	Anaemia neonatal (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Drug exposure before pregnancy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperbilirubinaemia neonatal (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Low birth weight baby (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neonatal infection (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Parainfluenzae virus infection (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Premature baby (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rhinovirus infection (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tachycardia foetal (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4674153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4675603	Spontaneous	2011-07-07 00:00:00	Non Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Neuralgia (n/a - Unknown - Other Medically Important Condition);Palpitations (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Tremor (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4675603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4669325	Spontaneous	2011-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Sudden hearing loss (n/a - Unknown - Other Medically Important Condition);Vaccination site reaction (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	[METHOTREXATE] (C - Rheumatoid arthritis - n/a - [n/a - n/a - Oral])|[SULFASALAZINE, SULFASALAZINE PH. EUR.] (C - Rheumatoid arthritis - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4669325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4669549	Spontaneous	2011-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Infant	No	Female	Infantile spasms (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4669549&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4669559	Spontaneous	2011-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Epilepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4669559&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4669647	Spontaneous	2011-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Optic neuritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4669647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4669677	Spontaneous	2011-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bell's palsy (n/a - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4669677&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4669703	Spontaneous	2011-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Eosinophilic pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4669703&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4670494	Spontaneous	2011-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4670494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4670569	Spontaneous	2011-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4670569&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4670639	Spontaneous	2011-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Epilepsy (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4670639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4672215	Spontaneous	2011-07-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Hypersomnia-bulimia syndrome (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4672215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4666454	Spontaneous	2011-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4666454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4667226	Spontaneous	2011-07-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Irritability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4667226&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4664615	Spontaneous	2011-07-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Catatonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Chills (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eye movement disorder (3min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypnagogic hallucination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Insomnia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscle twitching (3min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nightmare (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Panic reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Restless legs syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Screaming (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep apnoea syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Snoring (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Unresponsive to stimuli (3min - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	ASTHMA MEDICATION [NOT AVAILABLE] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4664615&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4664633	Spontaneous	2011-07-04 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Congenital eye disorder (n/a - Unknown - Other Medically Important Condition);Eye pain (n/a - Unknown - Other Medically Important Condition);Foetal exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Gene mutation (n/a - Unknown - Other Medically Important Condition);Retinal anomaly congenital (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4664633&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4665812	Spontaneous	2011-07-04 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Male	Parkinson's disease (n/a - Unknown - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4665812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4661059	Spontaneous	2011-07-01 00:00:00	Healthcare Professional	Non European Economic Area	I. Katerinis et al, De Novo Anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients, American journal of transplantation, 2011 Data migrated from the EudraVigilance E2B(R2) Literature repository	65-85 Years	Not Specified	No	Male	Blood creatinine increased (n/a - Unknown - Other Medically Important Condition);Renal impairment (n/a - Unknown - Other Medically Important Condition);Thrombotic microangiopathy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4661059&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4661060	Spontaneous	2011-07-01 00:00:00	Healthcare Professional	Non European Economic Area	I. Katerinis et al, De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients, American journal of transplantation, 2011	18-64 Years	Not Specified	No	Female	Transplant rejection (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4661060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4662978	Spontaneous	2011-07-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4662978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4653256	Spontaneous	2011-06-29 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Alopecia areata (n/a - Not Recovered/Not Resolved - Disabling);Alopecia universalis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4653256&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4649612	Spontaneous	2011-06-28 00:00:00	Healthcare Professional	Non European Economic Area	Gundogdu Z, Seyhogullari M. Lymphadenitis as a Rare Side Effect of H1N1 Vaccine in a Child. Case Reports in Medicine. 2010;2010	3-11 Years	Not Specified	No	Male	Axillary pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site mass (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site bruising (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4649612&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4651850	Spontaneous	2011-06-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4651850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4651862	Spontaneous	2011-06-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Complications of transplanted kidney (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Condition aggravated (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Hepatic function abnormal (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);IgA nephropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Nasopharyngitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Proteinuria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Rash erythematous (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [20d - n/a - Intramuscular])	ADVAGRAF [TACROLIMUS] (C - Renal transplant - n/a - [n/a - 1mg - Oral])|[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, MAGNESIUM OXIDE] (C - Cardiovascular event prophylaxis - n/a - [n/a - 75mg - Oral])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Hypertension - n/a - [n/a - 10mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4651862&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4644140	Spontaneous	2011-06-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Oral pruritus (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4644140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4644160	Spontaneous	2011-06-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cellulitis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4644160&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-4641579	Spontaneous	2011-06-24 00:00:00	Healthcare Professional	Non European Economic Area	HALI F, SBAI M, BENCHIKHI H, OUAKADI A, ZAMIATI S. Sweet&apos;s syndrome after H1N1 influenza vaccination / Syndrome de Sweet aprs vaccination antigrippale H1N1. Annales de dermatologie et venereologie 2010;740-741. Data migrated from the EudraVigilance E2B(R2) Literature repository	65-85 Years	Not Specified	No	Male	Acute febrile neutrophilic dermatosis (7d - Recovered/Resolved - Other Medically Important Condition);Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (7d - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (7d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Skin mass (7d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4641579&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4631811	Spontaneous	2011-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep apnoea syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4631811&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4632601	Spontaneous	2011-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Aggression (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4632601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4632603	Spontaneous	2011-06-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Neuralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	TAMIFLU [OSELTAMIVIR, OSELTAMIVIR PHOSPHATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4632603&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4631375	Spontaneous	2011-06-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4631375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4624265	Spontaneous	2011-06-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4624265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4624268	Spontaneous	2011-06-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4624268&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4624278	Spontaneous	2011-06-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4624278&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4624285	Spontaneous	2011-06-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4624285&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4624331	Spontaneous	2011-06-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4624331&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4624116	Spontaneous	2011-06-20 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4624116&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4613177	Spontaneous	2011-06-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4613177&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4610476	Spontaneous	2011-06-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pericarditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pleurisy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4610476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4612276	Spontaneous	2011-06-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4612276&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4606196	Spontaneous	2011-06-14 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	H1N1 influenza (3d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition);Vomiting (3d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4606196&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4604222	Spontaneous	2011-06-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4604222&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4604354	Spontaneous	2011-06-13 00:00:00	Healthcare Professional	Non European Economic Area	Lubetzki IK, Dano M, Raveh D. HIN1 Vaccine-Related Acute Transverse Myelitis. IMAJ. 2011;13:249-250	18-64 Years	Not Specified	No	Male	Extensor plantar response (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperreflexia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Micturition urgency (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myelitis transverse (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Spinal cord injury cervical (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4604354&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4600106	Spontaneous	2011-06-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Pneumothorax (n/a - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4600106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4600480	Spontaneous	2011-06-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epilepsy (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4600480&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4600578	Spontaneous	2011-06-10 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Rheumatoid arthritis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A, B/MASSACHUSETTS/02/2012, A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	LEVEMIR [INSULIN DETEMIR] (C - n/a - n/a - [n/a - n/a - n/a])|NOVORAPID [INSULIN ASPART] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4600578&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4598606	Spontaneous	2011-06-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - n/a - Not applicable - [n/a - n/a - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4598606&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4598674	Spontaneous	2011-06-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling)	A/CALIFORNIA/7/2009 (H1N1) [A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4598674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4591355	Spontaneous	2011-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4591355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4592491	Spontaneous	2011-06-08 00:00:00	Healthcare Professional	European Economic Area	Willi et al. Encephalitis after vaccination against H1N1 influenza virus. Eur J Paed Neurol 2011; 15: 276-277.	3-11 Years	Child	No	Male	Atrophy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Beta haemolytic streptococcal infection (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Encephalitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Encephalomyelitis (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Enterococcal infection (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Enterococcal sepsis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Eye movement disorder (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Febrile convulsion (25min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Generalised tonic-clonic seizure (25min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Mental status changes (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Myoclonus (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Seizure (5min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Systemic inflammatory response syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BECLOMETASONE DIPROPIONATE] (C - n/a - Unknown - [n/a - 2{DF} - Respiratory (inhalation)])|[CEFTAZIDIME, CEFTAZIDIME PENTAHYDRATE STERILE BUFFERED] (C - Bronchitis - Not applicable - [10d - n/a - Unknown])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - Unknown - [n/a - 5{DF} - Respiratory (inhalation)])|[LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - 50ug - Unknown])|[METOCLOPRAMIDE, METOCLOPRAMIDE DIHYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE HYDROCHLORIDE MONOHYDRATE, METOCLOPRAMIDE HYDROCHLORIDE PH. EUR.] (C - n/a - Unknown - [n/a - 12[drp] - Unknown])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - Unknown - [n/a - 10mg - Unknown])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - 2{DF} - Respiratory (inhalation)])|[URSODEOXYCHOLIC ACID] (C - n/a - Unknown - [n/a - 1.5mL - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4592491&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4594944	Spontaneous	2011-06-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Lung disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4594944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4589997	Spontaneous	2011-06-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Respiratory distress (0d - Recovered/Resolved - Other Medically Important Condition);Throat tightness (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4589997&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4584422	Spontaneous	2011-06-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bell's palsy (n/a - Unknown - Other Medically Important Condition);Conjunctivitis (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4584422&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4581125	Spontaneous	2011-06-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Testicular mass (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Testicular seminoma-pure stage II (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Testicular swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])|[EPLERENONE] (S - Cardiac failure congestive - Dose not changed - [n/a - 25mg - Oral])	[CANDESARTAN CILEXETIL] (C - Hypertension - Dose not changed - [n/a - 1{DF} - Oral])|[DIGOXIN] (C - Arrhythmia - Dose not changed - [n/a - .25mg - Oral])|[FLUINDIONE] (C - n/a - Dose not changed - [n/a - 20mg - Oral])|[NEBIVOLOL] (C - Hypertension - Dose not changed - [n/a - 1.5{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4581125&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4573181	Spontaneous	2011-06-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Hypersensitivity (1d - Recovered/Resolved - Other Medically Important Condition);Lip swelling (1d - Recovered/Resolved - Other Medically Important Condition);Pruritus (1d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	[BECLOMETASONE] (C - n/a - n/a - [n/a - 100ug - Respiratory (inhalation)])|[INFLUENZA VIRUS] (C - Prophylaxis - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - Asthma - n/a - [n/a - 100ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4573181&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4573737	Spontaneous	2011-06-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4573737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4575959	Spontaneous	2011-06-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - 3.75% - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4575959&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4570168	Spontaneous	2011-05-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Condition aggravated (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paralysis (2h - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sinusitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	EXTAVIA [INTERFERON BETA-1B, RECOMBINANT INTERFERON BETA-1B] (S - Multiple sclerosis - Drug withdrawn - [29d - 1mL - Subcutaneous])|EXTAVIA [INTERFERON BETA-1B, RECOMBINANT INTERFERON BETA-1B] (S - n/a - Drug withdrawn - [6d - .5mL - Subcutaneous])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4570168&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4564209	Spontaneous	2011-05-27 00:00:00	Healthcare Professional	Non European Economic Area	F. Tabache et al, acute polyarthritis after influenza A (H1N1) immunization, letters to the editor/ joint bone spine, 321-322	18-64 Years	Not Specified	No	Male	Arthritis (n/a - Recovered/Resolved - Other Medically Important Condition);Cellulitis (n/a - Recovered/Resolved - Other Medically Important Condition);Inflammation (n/a - Recovered/Resolved - Other Medically Important Condition);Leukocytosis (n/a - Recovered/Resolved - Other Medically Important Condition);Neutrophil count increased (n/a - Recovered/Resolved - Other Medically Important Condition);Polyarthritis (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Tenosynovitis (n/a - Recovered/Resolved - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4564209&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4560137	Spontaneous	2011-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Stillbirth (0d - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - n/a - Subcutaneous])	ANTIBIOTICS (GENERAL) (G) [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID, ASPIRIN BP] (C - n/a - n/a - [n/a - n/a - n/a])|[DICLOFENAC, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4560137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4560446	Spontaneous	2011-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Circulatory collapse (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Diabetes mellitus - Not applicable - [n/a - n/a - Intramuscular])	[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - n/a])|[BUPROPION, BUPROPION HYDROCHLORIDE] (C - n/a - n/a - [n/a - 500mg - n/a])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - n/a])|[DIGOXIN] (C - n/a - n/a - [n/a - n/a - n/a])|[FERROUS SULFATE] (C - n/a - n/a - [n/a - 200mg - n/a])|[FUROSEMIDE] (C - n/a - n/a - [n/a - 40mg - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - 10mg - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - n/a - [n/a - 500mg - n/a])|[MORPHINE, MORPHINE POLY(STYRENE-CO-DIVINYLBENZENE) SULFONATE, MORPHINE SULFATE, MORPHINE SULFATE PENTAHYDRATE, MORPHINE SULFATE PH. EUR.] (C - n/a - n/a - [n/a - 10mg - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - 20mg - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[WARFARIN, WARFARIN SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4560446&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4560448	Spontaneous	2011-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])	[A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE STRAIN (A/CALIFORNIA/7/2009, X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SOUTH AUSTRALIA/55/2014 STRAIN, B/PHUKET/3073/2013-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181] (C - n/a - n/a - [n/a - n/a - n/a])|[DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE MONOHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4560448&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4562212	Spontaneous	2011-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181)] (S - Influenza immunisation - Dose increased - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4562212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4562223	Spontaneous	2011-05-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthritis (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4562223&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4551687	Spontaneous	2011-05-24 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Not Specified	No	Female	Congenital eye disorder (n/a - Not Recovered/Not Resolved - Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4551687&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-4552137	Spontaneous	2011-05-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Thrombocytopenia (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Ill-defined disorder - Not applicable - [n/a - n/a - Intramuscular])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[INFLUENZA VIRUS] (C - n/a - n/a - [n/a - n/a - n/a])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MOMETASONE FUROATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MONTELUKAST, MONTELUKAST SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4552137&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4553079	Spontaneous	2011-05-24 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Contusion (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Immune thrombocytopenia (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Platelet count decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Purpura (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	[AMOXICILLIN SODIUM, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (C - Lower respiratory tract infection - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4553079&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4548296	Spontaneous	2011-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Ageusia (n/a - Unknown - Other Medically Important Condition);Anosmia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4548296&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4549901	Spontaneous	2011-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Cataract (n/a - Unknown - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4549901&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4551100	Spontaneous	2011-05-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Female	Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4551100&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4551272	Spontaneous	2011-05-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hypersomnia (9d - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4551272&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4544984	Spontaneous	2011-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Encephalocele (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4544984&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4544988	Spontaneous	2011-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Foetal death (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - 1{DF} - n/a])	[VITAMINS NOS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4544988&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4544989	Spontaneous	2011-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4544989&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4545024	Spontaneous	2011-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Radiculopathy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4545024&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4545323	Spontaneous	2011-05-20 00:00:00	Healthcare Professional	Non European Economic Area	Arica D A, Ozkasap S, Arica I E, Yayli S, Ersoz S, Dereci S, Saral Y. Henoch-Schonlein Purpura After H1N1 Vaccination. Turkderm-Archives of the Turkish Dermatology and Venerology. 2011;45:46	3-11 Years	Not Specified	No	Female	Erythema (n/a - Unknown - Other Medically Important Condition);Extravasation (n/a - Recovered/Resolved - Other Medically Important Condition);Henoch-Schonlein purpura (n/a - Recovered/Resolved - Other Medically Important Condition);Oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Rash pruritic (n/a - Recovered/Resolved - Other Medically Important Condition);Skin lesion (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4545323&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4545920	Spontaneous	2011-05-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4545920&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4542626	Spontaneous	2011-05-19 00:00:00	Healthcare Professional	European Economic Area	R. Dikow et al, Immunogenicity and efficacy in hemodialysis patients of an AS03A- aduvanted vaccine for 2009 pandemic influenza a (H1N1): a nonrandomized trial, AJKD, 2011, 716-723	18-64 Years	Adult	No	Female	Acute myocardial infarction (n/a - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	HEMODIALYSIS [HEMODIALYSIS] (C - n/a - Unknown - [n/a - n/a - Unknown])|PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[HEPATITIS B VACCINE] (C - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4542626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4542816	Spontaneous	2011-05-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Hallucination, auditory (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Hallucination, visual (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4542816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4538527	Spontaneous	2011-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Diarrhoea (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Eczema (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Immune system disorder (n/a - Unknown - Other Medically Important Condition);Insomnia (n/a - Unknown - Other Medically Important Condition);Palpitations (n/a - Unknown - Other Medically Important Condition);Prurigo (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Respiratory disorder (n/a - Unknown - Other Medically Important Condition);Transient acantholytic dermatosis (n/a - Unknown - Other Medically Important Condition);Urticarial vasculitis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[BENDROFLUAZIDE, BENDROFLUMETHIAZIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[ISOSORBIDE MONONITRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4538527&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4538699	Spontaneous	2011-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4538699&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4538746	Spontaneous	2011-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4538746&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4538769	Spontaneous	2011-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4538769&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4538910	Spontaneous	2011-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4538910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4541188	Spontaneous	2011-05-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema nodosum (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sarcoidosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4541188&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4536161	Spontaneous	2011-05-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bursitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Formication (0mo - Recovered/Resolved - Other Medically Important Condition);Hypothermia (0mo - Recovered/Resolved - Other Medically Important Condition);Intervertebral disc protrusion (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuritis (n/a - Unknown - Other Medically Important Condition);Vaccination site pain (0mo - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4536161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4531527	Spontaneous	2011-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hepatitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	CERVARIX [3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, ALGELDRATE, ALUMINIUM, 3-O-DESACYL-4'-MONOPHOSPHORYL LIPID A, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN] (S - n/a - n/a - [4wk - .5mL - n/a])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4531527&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4532903	Spontaneous	2011-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4532903&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4533426	Spontaneous	2011-05-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dehydration (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotension (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4533426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4533578	Spontaneous	2011-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Guttate psoriasis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	[THIAMINE HYDROCHLORIDE, ASCORBIC ACID, BIOTIN, FOLIC ACID, NICOTINAMIDE, PHYTOMENADIONE, RIBOFLAVIN, ZINC, CALCIUM, IODINE, PANTOTHENIC ACID, POTASSIUM, PYRIDOXINE HYDROCHLORIDE, URIDINE, CYTIDINE] (C - Vitamin supplementation - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4533578&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-4534649	Spontaneous	2011-05-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	C-reactive protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Demyelination (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea haemorrhagic (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Encephalitis viral (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait inability (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myelitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraparesis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	HUMIRA 40 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE [ADALIMUMAB] (S - Colitis ulcerative - Unknown - [n/a - 80mg - Subcutaneous])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Product used for unknown indication - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4534649&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4525585	Spontaneous	2011-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4525585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4525725	Spontaneous	2011-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4525725&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4525726	Spontaneous	2011-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypersomnia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4525726&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4526859	Spontaneous	2011-05-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Encephalomyelitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4526859&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4521887	Spontaneous	2011-05-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4521887&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4518238	Spontaneous	2011-05-10 00:00:00	Healthcare Professional	Non European Economic Area	Arica D. et al. Henoch-Schonlein purpura after H1N1 vaccination; Turkderm Deri Hastaliklari ve Frengi Arsivi 2011; 45: 46-48.	3-11 Years	Not Specified	No	Female	Henoch-Schonlein purpura (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Purpura (n/a - Recovering/Resolving - Other Medically Important Condition);Rash pruritic (n/a - Recovering/Resolving - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4518238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4518713	Spontaneous	2011-05-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Cough (n/a - Unknown - Disabling);Dyskinesia (n/a - Unknown - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Heart rate irregular (n/a - Unknown - Disabling);Hypoaesthesia (n/a - Unknown - Disabling);Malaise (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Unknown - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Sleep disorder (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	TAMIFLU [OSELTAMIVIR, OSELTAMIVIR PHOSPHATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4518713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4518986	Spontaneous	2011-05-10 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza like illness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Wheezing (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4518986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4514577	Spontaneous	2011-05-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Ataxia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4514577&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4511048	Spontaneous	2011-05-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Blood creatine phosphokinase increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myoglobin blood increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4511048&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4512029	Spontaneous	2011-05-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4512029&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4512153	Spontaneous	2011-05-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Movement disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4512153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4506973	Spontaneous	2011-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Coombs positive haemolytic anaemia (26d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	WOBENZYM N, DRG, MUCOS PHARMA GMBH [BROMELAINS, CHYMOTRYPSIN, PANCREATIN, PAPAIN, RUTOSIDE, TRYPSIN] (S - Sinusitis - Drug withdrawn - [15d - 1{DF} - Oral])|[A/CALIFORNIA/7/2009 (H1N1)] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - n/a])|[AMBROXOL HYDROCHLORIDE, DOXYCYCLINE CALCIUM, AMBROXOL HYDROCHLORIDE, DOXYCYCLINE HYCLATE] (S - Sinusitis - Drug withdrawn - [15d - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4506973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4507675	Spontaneous	2011-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Presyncope (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4507675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4507685	Spontaneous	2011-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Chronic fatigue syndrome (1a - Not Recovered/Not Resolved - Disabling);Headache (1a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4507685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4510343	Spontaneous	2011-05-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Tendonitis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[ROSUVASTATIN] (S - n/a - Dose not changed - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4510343&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4503940	Spontaneous	2011-05-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Haemolytic anaemia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Neutropenia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4503940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4503945	Spontaneous	2011-05-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Goodpasture's syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	[IBUPROFEN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4503945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4503963	Spontaneous	2011-05-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4503963&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4503986	Spontaneous	2011-05-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4503986&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4503990	Spontaneous	2011-05-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hepatitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4503990&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4504399	Spontaneous	2011-05-04 00:00:00	Healthcare Professional	European Economic Area	Dauvilliers Y, Montplaisir J, Cochen V. Post-H1N1 Narcolepsy-Cataplexy. SLEEP 2010;1428-1430.	12-17 Years	Not Specified	Yes	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4504399&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4504667	Spontaneous	2011-05-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Blood immunoglobulin G increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Encephalitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Photosensitivity reaction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pleocytosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Varicella virus test positive (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4504667&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4504759	Spontaneous	2011-05-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Insomnia (n/a - Unknown - Other Medically Important Condition);Pain (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4504759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4500928	Spontaneous	2011-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Skin hyperpigmentation (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - .5mL - Intramuscular])	[CALCIUM CARBONATE, CHOLECALCIFEROL CONCENTRATE (POWDER FORM), COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - Not applicable - [n/a - 1{DF} - Oral])|[OMEPRAZOLE] (C - n/a - Not applicable - [n/a - 1{DF} - Oral])|[SIMVASTATIN] (C - n/a - Not applicable - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4500928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4501355	Spontaneous	2011-05-03 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4501355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4501499	Spontaneous	2011-05-03 00:00:00	Healthcare Professional	Non European Economic Area	Sato N, Watanabe K, Ohta K, Tanaka H. Acute transverse myelitis and acute motor axonal neuropathy developed after vaccinations against seasonal and 2009 A/H1N1 influenza. Internal Medicine 2011;50(5):503-507.	65-85 Years	Elderly	No	Female	Axonal neuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myelitis transverse (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) [A/CALIFORNIA/7/2009 (H1N1)] (S - Antiviral prophylaxis - Unknown - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Antiviral prophylaxis - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4501499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4501580	Spontaneous	2011-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Altered state of consciousness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bronchospasm (n/a - Unknown - Caused/Prolonged Hospitalisation);Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Chronic obstructive pulmonary disease (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Delirium (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Emphysema (n/a - Unknown - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypercapnia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoxia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Thinking abnormal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation);Vascular encephalopathy (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4501580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4502678	Spontaneous	2011-05-03 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Epilepsy (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4502678&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4488290	Spontaneous	2011-04-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Abdominal pain (n/a - Fatal - Results in Death);Haemorrhoids (n/a - Fatal - Results in Death)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4488290&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4488546	Spontaneous	2011-04-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Altered state of consciousness (23d - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Confusional state (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Dysarthria (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea (23d - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Endotracheal intubation (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Epilepsy (23d - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Infective exacerbation of chronic obstructive airways disease (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Intensive care unit acquired weakness (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Meningitis viral (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Muscle twitching (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pleural effusion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Postictal state (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Sepsis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Influenza immunisation - Unknown - [1d - 1{DF} - Unknown])	[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[DIGITOXIN] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[PHENPROCOUMON] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[SPIRONOLACTONE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4488546&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4481107	Spontaneous	2011-04-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Cardiac arrest (n/a - Fatal - Results in Death, Other Medically Important Condition);Somnolence (n/a - Unknown - Results in Death, Other Medically Important Condition);Vomiting (n/a - Unknown - Results in Death, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4481107&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4481169	Spontaneous	2011-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Electrocardiogram QRS complex prolonged (6d - Recovered/Resolved - Other Medically Important Condition);Tachycardia (6d - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4481169&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4481392	Spontaneous	2011-04-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion (0d - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])	[CYANOCOBALAMIN, FOLIC ACID, POTASSIUM IODIDE, FOLIC ACID, POTASSIUM IODIDE, COBALAMIN] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4481392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4474935	Spontaneous	2011-04-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Adjustment disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation);Circulatory collapse (n/a - Unknown - Caused/Prolonged Hospitalisation);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysarthria (n/a - Unknown - Caused/Prolonged Hospitalisation);Fall (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Obesity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Post procedural inflammation (n/a - Unknown - Caused/Prolonged Hospitalisation);Psychomotor retardation (n/a - Unknown - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	ANTIBIOTIC [ANTIBIOTICS] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4474935&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4472936	Spontaneous	2011-04-20 00:00:00	Healthcare Professional	Non European Economic Area	1) JOHNSTON M. MEDSAFE SEASONAL FLU VACCINE-AN UPDATE ON SPONTANEOUS REPORTING. PRESCRIBER UPDATE2011;32(1) MARCH.ON M. VACCINE REACTIONS DETER MOTHER. 2010. 2) UNKNOWN AUTHORS. MEDSAFE SEASONAL FLU VACCINE-AN UPDATE ON SPONTANEOUS REPORTING. PRESCRIBER UPDATE2011;32(1) 2011. Data migrated from the EudraVigilance E2B(R2) Literature repository	2 Months - 2 Years	Not Specified	No	Male	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fear (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Palpitations (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4472936&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4473483	Spontaneous	2011-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4473483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4474168	Spontaneous	2011-04-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vasculitis (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4474168&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4468442	Spontaneous	2011-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (0d - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Drug withdrawn - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4468442&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4470343	Spontaneous	2011-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion (n/a - Unknown - Caused/Prolonged Hospitalisation);Chills (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Foetal death (n/a - Unknown - Caused/Prolonged Hospitalisation);Foetal hypokinesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4470343&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4470360	Spontaneous	2011-04-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Foetal death (n/a - Fatal - Results in Death);Foetal exposure during pregnancy (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4470360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4471142	Spontaneous	2011-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Drug ineffective (0d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4471142&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4471143	Spontaneous	2011-04-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Drug ineffective (0d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN, B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/MICHIGAN/45/2015, NYMC X-275), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/MASSACHUSETTS/02/2012, A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09 - DERIVED STRAIN USED NYMC X-179A] (S - Influenza immunisation - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4471143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4462533	Spontaneous	2011-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Antiacetylcholine receptor antibody positive (n/a - Unknown - Other Medically Important Condition);Myasthenia gravis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4462533&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4465014	Spontaneous	2011-04-18 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Somnolence (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	LANTUS [INSULIN GLARGINE] (C - n/a - n/a - [n/a - n/a - Subcutaneous])|LYRICA [PREGABALIN] (C - n/a - n/a - [n/a - n/a - Oral])|[BISOPROLOL, BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - Oral])|[FUROSEMIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[ISOSORBIDE MONONITRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - Oral])|[POTASSIUM CHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])|[ROSUVASTATIN, ROSUVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - Oral])|[SPIRONOLACTONE] (C - n/a - n/a - [n/a - n/a - Oral])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4465014&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4459250	Spontaneous	2011-04-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Adverse event (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4459250&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4459304	Spontaneous	2011-04-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Bronchospasm (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Gastrointestinal haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Pulmonary haemorrhage (n/a - Unknown - Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4459304&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4459635	Spontaneous	2011-04-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4459635&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4461596	Spontaneous	2011-04-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myelitis transverse (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4461596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4456037	Spontaneous	2011-04-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthma (n/a - Unknown - Caused/Prolonged Hospitalisation);Bronchospasm (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rales (n/a - Unknown - Caused/Prolonged Hospitalisation);Tachypnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Wheezing (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4456037&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4456042	Spontaneous	2011-04-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Cerebrovascular accident (5d - Fatal - Results in Death, Other Medically Important Condition);Coma (5d - Fatal - Results in Death, Other Medically Important Condition);Dysarthria (5d - Fatal - Results in Death, Other Medically Important Condition);Gait disturbance (n/a - Fatal - Results in Death, Other Medically Important Condition);Headache (5d - Fatal - Results in Death, Other Medically Important Condition);Poisoning (5d - Fatal - Results in Death, Other Medically Important Condition);Stupor (n/a - Fatal - Results in Death, Other Medically Important Condition);Vomiting (5d - Fatal - Results in Death, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4456042&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4456315	Spontaneous	2011-04-14 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Neck pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Slow response to stimuli (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4456315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4457195	Spontaneous	2011-04-14 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute kidney injury (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[ANHYDROUS LEVOTHYROXINE SODIUM, LEVOTHYROXINE] (C - Hypothyroidism - n/a - [n/a - n/a - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[BETAHISTINE DIHYDROCHLORIDE, BETAHISTINE HYDROCHLORIDE] (C - Vertigo - n/a - [n/a - n/a - n/a])|[INDAPAMIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - n/a - n/a])|[VERAPAMIL HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4457195&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4452275	Spontaneous	2011-04-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysphonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4452275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4452276	Spontaneous	2011-04-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eye irritation (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia oral (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lip swelling (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pharyngeal hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4452276&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4452282	Spontaneous	2011-04-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysphonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotension (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4452282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4452299	Spontaneous	2011-04-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Face oedema (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Periorbital oedema (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urticaria (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4452299&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4452415	Spontaneous	2011-04-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Wheezing (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4452415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4452545	Spontaneous	2011-04-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Crying (n/a - Unknown - Caused/Prolonged Hospitalisation);Product administered to patient of inappropriate age (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4452545&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4452553	Spontaneous	2011-04-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Brain neoplasm (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4452553&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4452804	Spontaneous	2011-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4452804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4452899	Spontaneous	2011-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4452899&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4452960	Spontaneous	2011-04-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4452960&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4450462	Spontaneous	2011-04-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[FOLIC ACID] (S - n/a - Unknown - [n/a - n/a - Unknown])	[COLECALCIFEROL, CYANOCOBALAMIN, ERGOCALCIFEROL, RETINOL ACETATE, ERGOCALCIFEROL, TOCOPHERYL ACETATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4450462&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4445944	Spontaneous	2011-04-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abnormal dreams (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypnagogic hallucination (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4445944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4447584	Spontaneous	2011-04-11 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Haemoptysis (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4447584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4439972	Spontaneous	2011-04-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (3d - Unknown - Caused/Prolonged Hospitalisation);Vomiting (3d - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4439972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4439973	Spontaneous	2011-04-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Foetal death (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Foetal hypokinesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4439973&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4439975	Spontaneous	2011-04-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Foetal death (0d - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Foetal exposure during pregnancy (0d - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4439975&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4440387	Spontaneous	2011-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anxiety (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depressed level of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (1a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypnagogic hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Listless (1a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4440387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4440392	Spontaneous	2011-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Behaviour disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Restlessness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4440392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4442208	Spontaneous	2011-04-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[DIPHTHERIA, TETANUS, PERTUSSIS (ACELLULAR, COMPONENT) AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[HEPATITIS B VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[POLIOMYELITIS VACCINE (ORAL)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4442208&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4444111	Spontaneous	2011-04-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Transplant rejection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4444111&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4436192	Spontaneous	2011-04-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Pre-eclampsia (n/a - Unknown - Other Medically Important Condition);Premature delivery (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4436192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4436898	Spontaneous	2011-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Headache (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Inappropriate schedule of product administration (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle twitching (20min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Restlessness (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Salivary hypersecretion (20min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Seizure (20min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Staring (20min - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4436898&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4437019	Spontaneous	2011-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Eyelid disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Facial paresis (n/a - Recovered/Resolved - Other Medically Important Condition);Herpes zoster (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperacusis (n/a - Recovered/Resolved - Other Medically Important Condition);Taste disorder (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4437019&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4437220	Spontaneous	2011-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Asthenia (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Cardiac arrest (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Cardiac failure (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Chills (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Dyspnoea at rest (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Hypoxia (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation);Resuscitation (n/a - Unknown - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4437220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4437327	Spontaneous	2011-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4437327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4437574	Spontaneous	2011-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4437574&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4438359	Spontaneous	2011-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Dose increased - [n/a - n/a - Intramuscular])	[FLUTICASONE PROPIONATE] (C - Asthma - n/a - [n/a - 500ug - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4438359&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4438367	Spontaneous	2011-04-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Seizure (1d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Unknown - [n/a - n/a - Intramuscular])	ZONEGRAN [ZONISAMIDE] (C - Epilepsy - n/a - [n/a - 200mg - Oral])|[DIAZEPAM] (C - Muscle spasms - n/a - [n/a - n/a - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - Hyperchlorhydria - n/a - [n/a - 40mg - Oral])|[LAMOTRIGINE] (C - Epilepsy - n/a - [n/a - 50mg - Oral])|[LAMOTRIGINE] (C - Epilepsy - n/a - [n/a - n/a - n/a])|[METOCLOPRAMIDE HYDROCHLORIDE] (C - Nausea - n/a - [n/a - 10mg - Oral])|[SUMATRIPTAN, SUMATRIPTAN SUCCINATE] (C - Migraine - n/a - [n/a - {DF} - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4438367&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4432175	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Eczema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Swelling face (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4432175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4433411	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, ALUMINIUM, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, ALGELDRATE, ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, ALGELDRATE, FILAMENTOUS HAEMAGGLUTININ, DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS (INACTIVATED) ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433411&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433711	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Productive cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433711&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433718	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433718&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433719	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Herpes ophthalmic (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433719&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4433777	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Pollakiuria (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433777&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4433785	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Induration (n/a - Unknown - Caused/Prolonged Hospitalisation);Local reaction (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433786	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Unknown - Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433786&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433787	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433788	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Chills (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperthermia (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433791	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotension (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433792	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433793	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Foetal death (n/a - Fatal - Results in Death, Other Medically Important Condition);Foetal exposure during pregnancy (n/a - Unknown - Results in Death, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4433794	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperthermia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433794&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433804	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433804&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433805	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433805&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433806	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433806&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433807	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433807&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433828	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433894	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pallor (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433910	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Local reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[DIPHTHERIA AND TETANUS VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433919	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pruritus (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433919&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433920	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Altered state of consciousness (n/a - Unknown - Other Medically Important Condition);Disorientation (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Leukoencephalopathy (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Seizure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433920&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4433969	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Local reaction (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433970	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433970&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4433972	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhinitis (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4433972&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4434034	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4434034&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4434061	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pharyngitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4434061&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4434076	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4434076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4434077	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotension (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4434077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4434099	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4434099&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4434100	Spontaneous	2011-04-06 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Asthmatic crisis (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Wheezing (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4434100&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4425333	Spontaneous	2011-04-04 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Unknown - Disabling)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4425333&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4425472	Spontaneous	2011-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersomnia (n/a - Unknown - );Rash (n/a - Recovering/Resolving - );Rash pruritic (n/a - Recovering/Resolving - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Unknown - [n/a - n/a - Unknown])|[A/H1N1 INFLUENZA VACCINE] (S - Antiviral prophylaxis - Unknown - [n/a - 7ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4425472&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4425520	Spontaneous	2011-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Unknown - Other Medically Important Condition);Multiple sclerosis (n/a - Unknown - Other Medically Important Condition);Vertigo (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4425520&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4426581	Spontaneous	2011-04-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Adverse reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Cellulitis (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site warmth (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4426581&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4426915	Spontaneous	2011-04-04 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Back pain (3d - Recovered/Resolved - Other Medically Important Condition);Movement disorder (3d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Urinary tract infection (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	[FOLIC ACID] (C - Product used for unknown indication - n/a - [n/a - n/a - Unknown])|[MECLOZINE HYDROCHLORIDE] (C - Product used for unknown indication - n/a - [n/a - 25mg - Unknown])|[PROGESTERONE, PROGESTERONE, MICRONISED] (C - Product used for unknown indication - n/a - [n/a - 200mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4426915&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4424357	Spontaneous	2011-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthritis (n/a - Recovering/Resolving - Other Medically Important Condition);Neuralgia (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4424357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4424358	Spontaneous	2011-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Sudden hearing loss (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4424358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-4424360	Spontaneous	2011-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Lichen planus (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4424360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4424375	Spontaneous	2011-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anaphylactoid reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4424375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4424378	Spontaneous	2011-04-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4424378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4424235	Spontaneous	2011-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved - Other Medically Important Condition);Chills (n/a - Recovered/Resolved - Other Medically Important Condition);Feeling of body temperature change (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	[CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE MONOHYDRATE] (C - Campylobacter infection - n/a - [5d - 500mg - Oral])|[LANSOPRAZOLE] (C - Gastrooesophageal reflux disease - n/a - [n/a - 30mg - Oral])|[SIMVASTATIN] (C - Hyperlipidaemia - n/a - [n/a - 40mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4424235&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4424311	Spontaneous	2011-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Myositis (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4424311&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4424312	Spontaneous	2011-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abortion missed (n/a - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4424312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4424314	Spontaneous	2011-04-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - n/a])	[ASCORBIC ACID, NITROFURANTOIN, NITROFURANTOIN] (C - n/a - n/a - [n/a - n/a - Oral])|[OXCARBAZEPINE] (C - n/a - n/a - [n/a - n/a - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[SODIUM VALPROATE] (C - n/a - n/a - [n/a - n/a - Oral])|[TIZANIDINE, TIZANIDINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4424314&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4417403	Spontaneous	2011-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4417403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4419530	Spontaneous	2011-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Epilepsy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4419530&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4419532	Spontaneous	2011-03-31 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Crying (n/a - Recovered/Resolved - Other Medically Important Condition);Decreased appetite (n/a - Recovered/Resolved - Other Medically Important Condition);Excessive eye blinking (n/a - Recovered/Resolved - Other Medically Important Condition);Gait disturbance (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotonia (n/a - Recovered/Resolved - Other Medically Important Condition);Insomnia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4419532&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4416706	Spontaneous	2011-03-30 00:00:00	Healthcare Professional	European Economic Area	Mayet A. et al. Adverse events following pandemic influenza vaccine Pandemrix reported in the French military forces -2009-2010, Vaccine 21 March 2011; Volume 29; Issue 14: 2576-2581.	18-64 Years	Not Specified	No	Male	Acute polyneuropathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Areflexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Motor dysfunction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4416706&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4410301	Spontaneous	2011-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cough (5d - Recovered/Resolved - Other Medically Important Condition);Fatigue (5d - Recovered/Resolved - Other Medically Important Condition);Headache (5d - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (5d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (5d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	HYPOSENSITISATION THERAPY [HYPOSENSITIZATION THERAPY] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4410301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4410302	Spontaneous	2011-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	CELLCEPT [MYCOPHENOLATE MOFETIL] (C - n/a - Unknown - [n/a - n/a - Unknown])|IMMUNOSUPPRESSIVE [IMMUNOSUPPRESSIVE] (C - Immunosuppression - Unknown - [n/a - n/a - Unknown])|[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - Unknown - [n/a - n/a - Unknown])|[ALUMINIUM PHOSPHATE, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 1 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 2 PRODUCED IN VERO CELLS, POLIOMYELITIS VIRUS (INACTIVATED) TYPE 3 PRODUCED IN VERO CELLS, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3, DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS PERTACTIN, BORDETELLA PERTUSSIS, POLIOVIRUS TYPE 1, POLIOVIRUS TYPE 2, POLIOVIRUS TYPE 3] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[CALCITRIOL] (C - n/a - Unknown - [n/a - n/a - Unknown])|[ENALAPRIL, ENALAPRIL MALEATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FERROUS (II) GLYCINE SULFATE COMPLEX] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SODIUM HYDROGEN CARBONATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SULFAMETHOXAZOLE, TRIMETHOPRIM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[TACROLIMUS, TACROLIMUS MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4410302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4410827	Spontaneous	2011-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Diarrhoea (n/a - Unknown - Other Medically Important Condition);Gastrointestinal disorder (n/a - Unknown - Other Medically Important Condition);Hypoacusis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Unknown - Other Medically Important Condition);Sleep disorder (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition);Tinnitus (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[ALENDRONATE SODIUM, ALENDRONATE SODIUM TRIHYDRATE, ALENDRONIC ACID] (C - n/a - Unknown - [n/a - n/a - Unknown])|[COLECALCIFEROL, CALCIUM, COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4410827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4410828	Spontaneous	2011-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Beta haemolytic streptococcal infection (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Gastrointestinal disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscle disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Necrotising fasciitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Sepsis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4410828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4412467	Spontaneous	2011-03-29 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	Yes	Male	Hypersomnia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4412467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4412673	Spontaneous	2011-03-29 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Not Specified	Yes	Male	Foetal distress syndrome (n/a - Recovered/Resolved - Other Medically Important Condition);Foetal exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Respiratory distress (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4412673&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4407066	Spontaneous	2011-03-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Myelitis (n/a - Unknown - Other Medically Important Condition);Myocarditis (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4407066&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4406503	Spontaneous	2011-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Vaccination failure (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4406503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4406504	Spontaneous	2011-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination failure (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4406504&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4406608	Spontaneous	2011-03-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Somnolence (n/a - Fatal - Results in Death, Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4406608&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4403873	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Seizure (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sudden death (0d - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	TETRAVALENT VACCINE [NOT AVAILABLE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[HEPATITIS B VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[POLIOMYELITIS VACCINE (ORAL)] (S - Immunisation - Not applicable - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4403873&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4403945	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[MENINGOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4403945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4403993	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[DIPHTHERIA AND TETANUS VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4403993&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4403996	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[DIPHTHERIA AND TETANUS TOXOIDS AND PERTUSSIS] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[TRIVALENT ORAL POLIO VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4403996&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4404032	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Muscle tightness (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404032&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4404046	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4404270	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Expired product administered (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Incontinence (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4404270&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4406369	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	European Economic Area	Javelle E, et al. Delayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine. Vaccine 1 February 2011; Volume 29; Issue 6: 1123-1125. Mayet A. et al. Adverse events following pandemic influenza vaccine Pandemrix reported in the French military forces -2009-2010, Vaccine 21 March 2011; Volume 29; Issue 14: 2576-2581.	18-64 Years	Not Specified	No	Female	Injection site atrophy (n/a - Unknown - Other Medically Important Condition);Injection site discolouration (n/a - Unknown - Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4406369&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4406499	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4406499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4406501	Spontaneous	2011-03-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Vaccination failure (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4406501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4400558	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Adverse event (n/a - Unknown - Caused/Prolonged Hospitalisation);Lung disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Productive cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rales (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400558&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4400559	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400559&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4400589	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Angioedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Face oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Lymphadenopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400589&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4400607	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4400641	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400641&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4400645	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[PNEUMOCOCCAL VACCINE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400645&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4400646	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood pressure increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400646&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4400825	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Sudden death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4400826	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Foetal hypokinesia (n/a - Unknown - Other Medically Important Condition);Neonatal anoxia (n/a - Unknown - Other Medically Important Condition);Premature delivery (n/a - Unknown - Other Medically Important Condition);Stillbirth (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400826&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4400827	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Not Specified	Congenital syphilis (n/a - Fatal - Results in Death, Congenital Anomaly);Maternal exposure timing unspecified (n/a - Unknown - Results in Death, Congenital Anomaly)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4400828	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cyanosis (n/a - Fatal - Results in Death);Hyperhidrosis (n/a - Fatal - Results in Death);Malaise (n/a - Fatal - Results in Death);Muscle rigidity (n/a - Fatal - Results in Death);Sudden death (n/a - Fatal - Results in Death)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4400839	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Back pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Constipation (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Myelitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Neck pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraparesis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Thermohypoaesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4400841	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Headache (n/a - Unknown - Life Threatening, Other Medically Important Condition);Papule (n/a - Unknown - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4400841&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4401164	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401165	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401165&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401173	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (33d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypokinesia (33d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (33d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (43d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraplegia (32d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Polyneuropathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Quadriplegia (32d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401173&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401183	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Parotitis (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401183&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4401188	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401188&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4401192	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401192&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401193	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Genital rash (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401193&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4401196	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Choking sensation (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Generalised oedema (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401196&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4401197	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysphonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Face oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401199	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401199&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4401201	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401201&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4401202	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Bronchospasm (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Lung infiltration (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rhinitis (n/a - Recovered/Resolved - Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401202&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4401204	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401204&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4401208	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Acute polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401208&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401210	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Induration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401210&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401211	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site warmth (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401211&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401212	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401214	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401214&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401215	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination site reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401228	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401228&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401239	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401239&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401565	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Local reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401565&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401572	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Induration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401572&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401607	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401607&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401614	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401616	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4401719	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Eyelid oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401719&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4401756	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abnormal dreams (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4401756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4402078	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - Cardiovascular event prophylaxis - Unknown - [n/a - n/a - Oral])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Hypertension - Unknown - [n/a - n/a - Oral])|[GLICLAZIDE] (C - Type 2 diabetes mellitus - Unknown - [n/a - n/a - Oral])|[GLUCOSAMINE, GLUCOSAMINE SULFATE POTASSIUM CHLORIDE] (C - Osteoarthritis - Unknown - [n/a - n/a - Oral])|[HALOPERIDOL, LORAZEPAM] (C - Insomnia - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4402078&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4402540	Spontaneous	2011-03-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[MENINGOCOCCAL GROUP C CONJUGATE VACCINE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4402540&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4396975	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4396975&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4397481	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Oedema (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397481&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397488	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Eye oedema (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Feeling hot (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Flushing (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397488&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4397501	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blood pressure increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Confusional state (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyslalia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hemiplegia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypoglycaemia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Ischaemic stroke (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397501&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4397505	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397505&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397509	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening);Prurigo (n/a - Recovering/Resolving - Life Threatening)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397509&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397512	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Prurigo (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397512&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4397715	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	INSULIN ASPART [INSULIN ASPART] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[ALENDRONATE SODIUM, ALENDRONIC ACID] (C - Prophylaxis - n/a - [n/a - 70mg - Oral])|[ATENOLOL, ATENOLOL BP] (C - Hypertrophic cardiomyopathy - n/a - [n/a - 75mg - n/a])|[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROCHLORIDE] (C - Depression - n/a - [n/a - 10mg - n/a])|[FERROUS FUMARATE] (C - Anaemia - n/a - [n/a - 300mg - Oral])|[FUROSEMIDE] (C - Hypertrophic cardiomyopathy - n/a - [n/a - 40mg - Oral])|[LANSOPRAZOLE] (C - Prophylaxis - n/a - [n/a - 30mg - Oral])|[RAMIPRIL] (C - Diabetes mellitus - n/a - [n/a - 2.5mg - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[SIMVASTATIN] (C - Diabetes mellitus - n/a - [n/a - 20mg - Oral])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - Pain - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4397715&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4398081	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398081&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398082	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398083	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398083&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398085	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398085&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398090	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Ocular hyperaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhinitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398090&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398091	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398093	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[PNEUMOCOCCAL VACCINE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398093&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398109	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398109&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398110	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398110&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398111	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398111&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398284	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4398453	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398453&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4398816	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Face oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypertension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398817	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398827	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398835	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398835&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4398852	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398853	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398861	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398861&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398864	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypersensitivity (8h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[PNEUMOCOCCAL VACCINE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398864&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398865	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398876	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398876&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398883	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398884	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398884&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398885	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Blister (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398885&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4398935	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398935&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398940	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398941	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398941&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398944	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398944&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4398961	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[PNEUMOCOCCAL VACCINE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4398961&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399041	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399041&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399051	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399051&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399052	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399052&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399056	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399056&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399058	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[PNEUMOCOCCAL VACCINE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399058&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399059	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399059&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399061	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399061&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399073	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399076	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	VACCINE [NOT AVAILABLE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399076&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399077	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399077&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399078	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399078&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399079	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399079&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399083	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399083&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399089	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399089&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399091	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399092	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399092&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399098	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399098&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399104	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399106	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399106&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399110	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[PNEUMOCOCCAL VACCINE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399110&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399131	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399131&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399220	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Idiopathic intracranial hypertension (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Lymphadenitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399220&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399221	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Adverse event (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399221&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4399223	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dyspnoea (n/a - Recovered/Resolved - Results in Death, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Results in Death, Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Results in Death, Other Medically Important Condition);Sudden death (n/a - Fatal - Results in Death, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399223&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4399271	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399272	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[PNEUMOCOCCAL VACCINE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399272&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399298	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Adverse event (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhinitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399299	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Rash (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399299&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399300	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399300&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399302	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399302&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399313	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399316	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399316&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399317	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Adverse event following immunisation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399317&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399318	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399318&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399320	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Adverse event (n/a - Unknown - Other Medically Important Condition);Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Rash macular (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4399324	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399324&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399325	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhinitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399326	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399326&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399327	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399328	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399328&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399329	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399329&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4399330	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399330&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399332	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399332&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399333	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash erythematous (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399333&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399334	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399334&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399372	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Erythema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399398	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399398&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399401	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Radiculopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399402	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399403	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399538	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovered/Resolved - Disabling);Axillary pain (n/a - Recovered/Resolved - Disabling);Joint range of motion decreased (n/a - Unknown - Disabling);Muscle spasms (n/a - Recovered/Resolved - Disabling);Muscular weakness (n/a - Unknown - Disabling);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Disabling);Peripheral swelling (n/a - Recovered/Resolved - Disabling);Sensory disturbance (n/a - Not Recovered/Not Resolved - Disabling);Skin exfoliation (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399538&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4399639	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Cough (n/a - Recovered/Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Dose not changed - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399639&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4399679	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399679&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399680	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399681	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399682	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Induration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399682&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399763	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Palpitations (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399765	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399766	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Feeling hot (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399766&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4399767	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Induration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399767&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399768	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399769	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399769&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399770	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399771	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399772	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Adverse event (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4399776	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399777	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399777&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399778	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399778&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399779	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399779&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399781	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399782	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399783	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399783&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399784	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399786	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399786&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399787	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399788	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[PNEUMOCOCCAL VACCINE] (C - Immunisation - Not applicable - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399789	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399789&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399790	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Adverse event (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4399802	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Adverse event following immunisation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399802&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399809	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399810	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399810&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399815	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399815&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399817	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Angioedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eyelid oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399817&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399818	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399823	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399824	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bronchospasm (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Eye irritation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Generalised oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399824&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399828	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4399852	Spontaneous	2011-03-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Gait disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4399852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393698	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Bronchial dysplasia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE, 10 VALENT ADSORBED] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[POLIOMYELITIS VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393698&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4393715	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Seizure (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393715&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393716	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site erythema (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Injection site induration (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Movement disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393716&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393721	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Areflexia (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Paraparesis (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Polyneuropathy (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393721&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393744	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	VACCINATION [VACCINE] (C - n/a - Not applicable - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393744&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393745	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Headache (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393745&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393746	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Injection site abscess (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393746&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393747	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Autonomic nervous system imbalance (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Coma (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Paralysis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory distress (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Seizure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Upper respiratory tract infection (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393747&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393748	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Hyporeflexia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Urinary retention (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393748&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393749	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Nystagmus (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393749&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393750	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Fatigue (n/a - Unknown - Life Threatening);Febrile convulsion (n/a - Unknown - Life Threatening);Pallor (n/a - Unknown - Life Threatening);Vomiting (n/a - Unknown - Life Threatening)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393750&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393751	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening);Vomiting (n/a - Unknown - Life Threatening)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393751&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393752	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393752&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393753	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393753&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393754	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pancreatitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393754&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393755	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393755&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393756	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393757	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Life Threatening);Face oedema (n/a - Recovered/Resolved - Life Threatening);Urticaria (n/a - Recovered/Resolved - Life Threatening)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[DIPHTHERIA AND TETANUS VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[YELLOW FEVER VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393757&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393758	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chest pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393758&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393759	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening);Bronchospasm (n/a - Unknown - Life Threatening);Cough (n/a - Unknown - Life Threatening);Dyspnoea (n/a - Unknown - Life Threatening);Injection site erythema (n/a - Unknown - Life Threatening);Injection site pain (n/a - Unknown - Life Threatening);Injection site warmth (n/a - Unknown - Life Threatening);Rales (n/a - Unknown - Life Threatening);Respiratory failure (n/a - Unknown - Life Threatening)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393759&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393760	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Ageusia (n/a - Unknown - Caused/Prolonged Hospitalisation);Anosmia (n/a - Unknown - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Nasal obstruction (n/a - Unknown - Caused/Prolonged Hospitalisation);Sneezing (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393760&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393761	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening);Crying (n/a - Unknown - Life Threatening);Laryngospasm (n/a - Unknown - Life Threatening);Pyrexia (n/a - Unknown - Life Threatening);Rash (n/a - Unknown - Life Threatening)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393761&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393762	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Food allergy (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia viral (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393762&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393763	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening);Rash (n/a - Unknown - Life Threatening)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393763&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393764	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393764&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393765	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393765&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393768	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393768&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393769	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Rash (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Urticaria (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393769&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393770	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Movement disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Neck pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393770&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393771	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Chills (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393772	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Sudden death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	CORTICOIDS [CORTICOSTEROID] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4393773	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393774	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Muscular weakness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Optic neuritis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Urinary retention (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Visual acuity reduced (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[MENINGOCOCCAL GROUP C CONJUGATE VACCINE, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393774&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393775	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pain in extremity (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Palpitations (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sudden death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393775&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4393776	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Back pain (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Hypertensive crisis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Motor dysfunction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393776&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393777	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393777&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393778	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Adverse event (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393778&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4393779	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Facial paralysis (n/a - Recovering/Resolving - Life Threatening)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393779&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393780	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Quadriplegia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393780&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393781	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Ataxia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Disorientation (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393781&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393782	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paralysis (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393782&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4393783	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	H1N1 influenza (n/a - Fatal - Results in Death);Pneumonia (n/a - Fatal - Results in Death);Sudden death (n/a - Fatal - Results in Death)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393783&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4393784	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Cough (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393785	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393786	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393786&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393787	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Brain neoplasm (n/a - Unknown - Life Threatening);Pneumonia (n/a - Unknown - Life Threatening);Post vaccination syndrome (n/a - Unknown - Life Threatening)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393788	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Hypertensive crisis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Motor dysfunction (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393789	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Exposure during pregnancy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pneumonia viral (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393789&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393790	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Immune thrombocytopenia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393790&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393791	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Purpura non-thrombocytopenic (n/a - Unknown - Life Threatening)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393791&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4393792	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	Yes	Female	Acute respiratory distress syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Back pain (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Results in Death, Caused/Prolonged Hospitalisation);Myalgia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Painful respiration (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Sudden death (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393792&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4393793	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393793&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4393794	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393794&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4394366	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Accidental overdose (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4394366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4394785	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (30min - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4394785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4395208	Spontaneous	2011-03-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Balance disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Increased tendency to bruise (n/a - Unknown - Caused/Prolonged Hospitalisation);Lip swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation);Skin reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Swollen tongue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tinnitus (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [1d - n/a - Unknown])	[CARBASALATE CALCIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[EZETIMIBE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - Unknown - [n/a - n/a - Unknown])|[VERAPAMIL, VERAPAMIL HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4395208&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4389567	Spontaneous	2011-03-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4389567&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4393104	Spontaneous	2011-03-21 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Testicular seminoma-pure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Testicular swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[CANDESARTAN CILEXETIL] (S - Hypertension - Dose not changed - [n/a - 1{DF} - Oral])|[DIGOXIN] (S - Arrhythmia - Dose not changed - [n/a - n/a - Oral])|[EPLERENONE] (S - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[FLUINDIONE] (S - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[NEBIVOLOL] (S - Hypertension - Dose not changed - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4393104&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4387312	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Unknown - Life Threatening, Other Medically Important Condition);Hypotonic-hyporesponsive episode (n/a - Unknown - Life Threatening, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387312&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4387313	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Body temperature increased (n/a - Unknown - Life Threatening, Other Medically Important Condition);Rash (n/a - Unknown - Life Threatening, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[MEASLES, MUMPS AND RUBELLA VACCINE (LIVE)] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4387315	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Male	Anaphylactic reaction (n/a - Unknown - Life Threatening, Other Medically Important Condition);Cough (n/a - Unknown - Life Threatening, Other Medically Important Condition);Dyspnoea (n/a - Unknown - Life Threatening, Other Medically Important Condition);Urticaria (n/a - Unknown - Life Threatening, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387315&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4387363	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dysaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4387363&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4388287	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Myelitis transverse (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4388287&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4388555	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Periarthritis (n/a - Not Recovered/Not Resolved - Disabling);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4388555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4388669	Spontaneous	2011-03-18 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4388669&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4375297	Spontaneous	2011-03-17 00:00:00	Healthcare Professional	European Economic Area	VACCINE 2011; 29: 519	65-85 Years	Not Specified	No	Female	Anaphylactic reaction (0d - Recovered/Resolved - Life Threatening)	FOCETRIA SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Unknown])	BUDESONIDE [BUDESONIDE] (C - n/a - Dose not changed - [n/a - n/a - Respiratory (inhalation)])|[EPROSARTAN] (C - n/a - Dose not changed - [n/a - 600mg - Oral])|[FORMOTEROL, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - Dose not changed - [n/a - n/a - Respiratory (inhalation)])|[IPRATROPIUM BROMIDE] (C - n/a - Dose not changed - [n/a - n/a - Respiratory (inhalation)])|[LATANOPROST] (C - n/a - Dose not changed - [n/a - n/a - Ophthalmic])|[OMEPRAZOLE] (C - n/a - Dose not changed - [n/a - 20mg - Oral])|[TERBUTALINE] (C - n/a - Dose not changed - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4375297&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4375298	Spontaneous	2011-03-17 00:00:00	Healthcare Professional	European Economic Area	VACCINE 2011; 29: 519	More than 85 Years	Not Specified	No	Male	Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4375298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4376326	Spontaneous	2011-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthritis (1mo - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pneumonia bacterial (1mo - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vasculitic rash (1mo - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Ill-defined disorder - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4376326&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4378248	Spontaneous	2011-03-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4378248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4365622	Spontaneous	2011-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Influenza (n/a - Unknown - Other Medically Important Condition);Oropharyngeal pain (n/a - Unknown - Other Medically Important Condition);Pyrexia (3d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	TWINRIX ADULT [ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA], ALGELDRATE, ALUMINIUM PHOSPHATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA) [PRODUCED IN S. CEREVISIAE CELLS BY RDNA], ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS B SURFACE ANTIGEN (RDNA)] (C - Prophylaxis - Not applicable - [1d - 1mL - Intramuscular])|[TICK-BORNE ENCEPHALITIS VIRUS (INACTIVATED), NEUDOERFL STRAIN] (C - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4365622&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4365623	Spontaneous	2011-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[DICLOFENAC COLESTYRAMINE, DICLOFENAC RESINATE, DICLOFENAC SODIUM] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4365623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4365837	Spontaneous	2011-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])...	[AMITRIPTYLINE, AMITRIPTYLINE HYDROCHLORIDE] (C - Depression - Not applicable - [n/a - n/a - Oral])|[MAGNESIUM ASPARTATE HYDROCHLORIDE, MAGNESIUM L-ASPARTATE HYDROCHLORIDE TRIHYDRATE] (C - Muscle spasms - Unknown - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4365837&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4369060	Spontaneous	2011-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	No adverse event (n/a - Unknown - Other Medically Important Condition);Product administration error (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - Intramuscular])|[A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE STRAIN (A/CALIFORNIA/7/2009, X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SOUTH AUSTRALIA/55/2014 STRAIN, B/PHUKET/3073/2013-LIKE STRAIN, A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181] (S - n/a - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4369060&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4371784	Spontaneous	2011-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysphagia (2d - Recovered/Resolved - Other Medically Important Condition);Eye pain (2d - Recovered/Resolved - Other Medically Important Condition);Oral pain (2d - Recovered/Resolved - Other Medically Important Condition);Palatal disorder (2d - Recovered/Resolved - Other Medically Important Condition);Pruritus (2d - Recovered/Resolved - Other Medically Important Condition);Rash papular (2d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4371784&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4373739	Spontaneous	2011-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4373739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4374836	Spontaneous	2011-03-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic shock (1mo - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [1d - n/a - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - 37.5ug - Oral])|[SERTRALINE, SERTRALINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 25mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4374836&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4360926	Spontaneous	2011-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (8d - Recovered/Resolved - Disabling);Limb discomfort (8d - Recovered/Resolved - Disabling);Pain in extremity (8d - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	[DICLOFENAC DIETHYLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - Back pain - Unknown - [n/a - 50mg - Oral])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - Back pain - Unknown - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4360926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4361746	Spontaneous	2011-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Accommodation disorder (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Balance disorder (13d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Coordination abnormal (13d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Loss of control of legs (12d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Romberg test positive (13d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[DONEPEZIL HYDROCHLORIDE] (C - Ill-defined disorder - Unknown - [n/a - 10mg - Oral])|[ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE, ENALAPRIL, HYDROCHLOROTHIAZIDE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4361746&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4362163	Spontaneous	2011-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Listless (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Orthostatic hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation);Parkinson's disease (11mo - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tremor (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Vertigo (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4362163&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4362581	Spontaneous	2011-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Colitis (4mo - Unknown - Caused/Prolonged Hospitalisation);Colitis ulcerative (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (4mo - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea haemorrhagic (4mo - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4362581&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4363739	Spontaneous	2011-03-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Not Recovered/Not Resolved - Life Threatening);Dysphonia (n/a - Unknown - Life Threatening);Fatigue (n/a - Unknown - Life Threatening);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Life Threatening);Motor neurone disease (n/a - Unknown - Life Threatening);Muscle twitching (n/a - Not Recovered/Not Resolved - Life Threatening);Weight decreased (n/a - Unknown - Life Threatening)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Parenteral])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 75mg - n/a])|[ATORVASTATIN] (C - n/a - n/a - [n/a - 40mg - n/a])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - 2.5mg - n/a])|[CANDESARTAN] (C - n/a - n/a - [n/a - 4mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4363739&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4358550	Spontaneous	2011-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (5d - Recovered/Resolved - Other Medically Important Condition);Influenza (5d - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (5d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (5d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4358550&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4359216	Spontaneous	2011-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Cardiac failure (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Generalised oedema (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Nephropathy (n/a - Not Recovered/Not Resolved - Life Threatening, Other Medically Important Condition);Weight increased (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[DIPYRIDAMOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4359216&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4359902	Spontaneous	2011-03-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chills (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Eye swelling (n/a - Unknown - Other Medically Important Condition);Foetal growth restriction (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Injection site rash (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Rash macular (n/a - Recovering/Resolving - Other Medically Important Condition);Vaginal haemorrhage (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4359902&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4353005	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthma (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Bronchospasm (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersensitivity (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhinitis allergic (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	[BUDESONIDE, FORMOTEROL, BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE, FORMOTEROL FUMARATE HYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - Unknown - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4353005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4353894	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	Non European Economic Area	Gibbs RS, Premmereur J, Fisher BM, Lynch A.. Late pregnancy loss after A (H1N1) vaccination. American Journal of Obstetrics &amp; Gynecology. 2011;S247	Not Specified	Not Specified	Yes	Female	Asphyxia (n/a - Fatal - Results in Death, Congenital Anomaly);Exposure during pregnancy (n/a - Unknown - Results in Death, Congenital Anomaly);Foetal death (n/a - Fatal - Results in Death, Congenital Anomaly)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4353894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4353895	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	Non European Economic Area	Gibbs RS, Premmereur J, Fisher BM, Lynch A.. Late pregnancy loss after A (H1N1) vaccination. American Journal of Obstetrics &amp; Gynecology. 2011;S247	Not Specified	Not Specified	Yes	Female	Exposure during pregnancy (n/a - Unknown - Results in Death, Other Medically Important Condition);Foetal death (n/a - Fatal - Results in Death, Other Medically Important Condition);Foetal growth restriction (n/a - Unknown - Results in Death, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Transplacental])	[HUMAN ANTI-D IMMUNOGLOBULIN] (C - n/a - Unknown - [n/a - n/a - Transplacental])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4353895&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4353940	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	Non European Economic Area	Gibbs RS, Premmereur J, Fisher BM, Lynch A.. Late pregnancy loss after A (H1N1) vaccination. American Journal of Obstetrics &amp; Gynecology. 2011;S247	Not Specified	Adult	No	Female	Angiopathy (n/a - Recovered/Resolved - Other Medically Important Condition);Asphyxia (n/a - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition);Foetal death (n/a - Recovered/Resolved - Other Medically Important Condition);Retroplacental haematoma (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4353940&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4353943	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	Non European Economic Area	Gibbs RS, Premmereur J, Fisher BM, Lynch A.. Late pregnancy loss after A (H1N1) vaccination. American Journal of Obstetrics &amp; Gynecology. 2011;S247	Not Specified	Adult	No	Female	Cytomegalovirus infection (n/a - Recovered/Resolved - Congenital Anomaly, Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Foetal death (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Placental disorder (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition);Umbilical cord abnormality (n/a - Unknown - Congenital Anomaly, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - .5mL - n/a])	[MAGNESIUM ASPARTATE HYDROCHLORIDE, MAGNESIUM L-ASPARTATE HYDROCHLORIDE TRIHYDRATE] (C - n/a - Unknown - [99d - 5mL - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4353943&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Severe reaction
EU-EC-4353945	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	Non European Economic Area	Gibbs RS, Premmereur J, Fisher BM, Lynch A.. Late pregnancy loss after A (H1N1) vaccination. American Journal of Obstetrics &amp; Gynecology. 2011;S247	Not Specified	Adult	No	Female	Exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition);Gestational hypertension (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Pre-eclampsia (n/a - Recovered/Resolved - Other Medically Important Condition);Stillbirth (n/a - Unknown - Other Medically Important Condition);Vitreous floaters (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - .5mL - n/a])	[HUMAN ANTI-D IMMUNOGLOBULIN] (C - n/a - Unknown - [1d - 1{DF} - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4353945&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4354164	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4354164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4354172	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Recovered/Resolved With Sequelae - Disabling);Narcolepsy (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	[FLUTICASONE PROPIONATE] (C - Asthma - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4354172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-4354184	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4354184&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4354203	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Laryngeal oedema (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Skin reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4354203&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4354224	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Thrombocytopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[NITROFURANTOIN] (C - Urinary tract infection - Unknown - [n/a - n/a - Unknown])|[SUMATRIPTAN, SUMATRIPTAN SUCCINATE] (C - Migraine - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4354224&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4354441	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Asthma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Laryngospasm (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rhinitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sneezing (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4354441&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4354465	Spontaneous	2011-03-11 00:00:00	Healthcare Professional	Non European Economic Area	Gibbs RS, Premmereur J, Fisher BM and Lynch A.. Late pregnancy loss after A (H1N1) vaccination. American Journal of Obstetrics &amp; Gynecology. 2011;S247	18-64 Years	Not Specified	No	Female	Abortion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Amniotic cavity infection (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Bacteriuria in pregnancy (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Chills (39d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Exposure during pregnancy (32d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Foetal death (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Funisitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Inflammation (8d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Leukocytosis (8d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Placental disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Premature labour (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Premature separation of placenta (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Pyrexia (39d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Retained placenta or membranes (8d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Stillbirth (8d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly);Vasculitis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Congenital Anomaly)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, SORBITAN TRIOLEATE, POLYSORBATE 80, SQUALENE, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Unknown - [n/a - .25mL - Intramuscular])	[MISOPROSTOL] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4354465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4350130	Spontaneous	2011-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Haematuria (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Renal cancer recurrent (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	BRINZOLAMIDE [BRINZOLAMIDE] (C - Glaucoma - n/a - [n/a - n/a - Ophthalmic])|[DIGOXIN] (C - Atrial fibrillation - n/a - [n/a - n/a - Oral])|[WARFARIN, WARFARIN SODIUM] (C - Atrial fibrillation - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4350130&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4350298	Spontaneous	2011-03-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Burning sensation (n/a - Not Recovered/Not Resolved - Disabling);Erythema (n/a - Recovered/Resolved - Disabling)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Unknown])	[DICLOFENAC SODIUM] (C - Arthralgia - n/a - [n/a - 150mg - n/a])|[NORETHISTERONE ACETATE, ESTRADIOL, NORETHISTERONE ACETATE, ESTRADIOL HEMIHYDRATE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4350298&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4347274	Spontaneous	2011-03-09 00:00:00	Healthcare Professional	European Economic Area	I. Goldschmidt et al, Acceptance and Adverse Events of the 2009 H1N1 vaccination in immunosuppressed pediatric liver transplant recipients, the journal of pediatrics, 2011;158: 329-333	Not Specified	Adolescent	No	Not Specified	Biliary obstruction (n/a - Unknown - Other Medically Important Condition);Liver function test increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4347274&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4347348	Spontaneous	2011-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cellulitis (6d - Recovered/Resolved - Other Medically Important Condition);Erythema (6d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (6d - Recovered/Resolved - Other Medically Important Condition);Swelling (6d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	[CLOBETASOL] (C - Rash - n/a - [n/a - 1{DF} - Topical])|[EMULSIFYING WAX] (C - Rash - n/a - [n/a - n/a - Topical])|[LIQUID PARAFFIN] (C - Rash - n/a - [n/a - n/a - Topical])|[PARAFFIN, YELLOW SOFT] (C - Rash - n/a - [n/a - n/a - Topical])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4347348&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4349282	Spontaneous	2011-03-09 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	LUMIGAN [BIMATOPROST] (C - Glaucoma - Unknown - [n/a - n/a - Unknown])|[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4349282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4349407	Spontaneous	2011-03-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Disturbance in attention (13d - Recovered/Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (13d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])|[CEFTRIAXONE] (S - Urinary tract infection - Drug withdrawn - [n/a - 1{DF} - Intravenous (not otherwise specified)])	PLAVIX 75 MG FILM-COATED TABLETS [CLOPIDOGREL] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[ALFUZOSIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[LOPRAZOLAM, LOPRAZOLAM MESILATE] (C - n/a - Dose not changed - [n/a - .5{DF} - Oral])|[MACROGOL 4000] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[METFORMIN HYDROCHLORIDE, GLIBENCLAMIDE] (C - n/a - Dose not changed - [n/a - .5{DF} - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[PARACETAMOL] (C - n/a - Dose not changed - [n/a - 1g - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4349407&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4342718	Spontaneous	2011-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Injection site pain (4d - Recovered/Resolved - Other Medically Important Condition);Medication error (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (4d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (34d - Recovered/Resolved - Other Medically Important Condition);Vertigo (4d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4342718&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-4342822	Spontaneous	2011-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Unknown])	HOMEOPATHY [NOT AVAILABLE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[VITAMIN D] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4342822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4343483	Spontaneous	2011-03-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4343483&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4339325	Spontaneous	2011-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cardiac failure (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4339325&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4340189	Spontaneous	2011-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4340189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4340277	Spontaneous	2011-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Death (1d - Fatal - Results in Death)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4340277&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4340708	Spontaneous	2011-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dry mouth (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[CODEINE PHOSPHATE SESQUIHYDRATE, PARACETAMOL, PARACETAMOL, CODEINE PHOSPHATE] (C - n/a - n/a - [n/a - n/a - n/a])|[GLUCOSAMINE, GLUCOSAMINE SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[HYDROCHLOROTHIAZIDE, LOSARTAN, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4340708&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4341105	Spontaneous	2011-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Brain stem infarction (n/a - Unknown - Caused/Prolonged Hospitalisation);Cerebrovascular accident (n/a - Unknown - Caused/Prolonged Hospitalisation);Chills (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Disease progression (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysphagia (49d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dysphonia (49d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vocal cord paresis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4341105&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4341150	Spontaneous	2011-03-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4341150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4336850	Spontaneous	2011-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Sudden death (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4336850&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4337927	Spontaneous	2011-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Condition aggravated (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Dehydration (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Escherichia urinary tract infection (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Gastroenteritis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Hypophagia (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Oliguria (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Organic brain syndrome (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Somnolence (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4337927&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4338023	Spontaneous	2011-03-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	H1N1 influenza (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4338023&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4333283	Spontaneous	2011-03-03 00:00:00	Healthcare Professional	European Economic Area	VACCINE 2011; 29: 519-22	3-11 Years	Not Specified	No	Female	Acute respiratory distress syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	FOCETRIA SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	TAMIFLU 45 MG HARD CAPSULE [OSELTAMIVIR] (C - n/a - Drug withdrawn - [6d - 22.5mg - Oral])|[ACETYLCYSTEINE] (C - n/a - Unknown - [n/a - 300mg - Respiratory (inhalation)])|[BUDESONIDE] (C - n/a - Unknown - [n/a - 250ug - Respiratory (inhalation)])|[PHENOXYMETHYLPENICILLIN, PHENOXYMETHYLPENICILLIN POTASSIUM] (C - n/a - Drug withdrawn - [11d - 250mg - Unknown])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - Unknown - [n/a - .4mL - Respiratory (inhalation)])|[SODIUM VALPROATE, VALPROIC ACID] (C - n/a - Unknown - [n/a - 3mL - Oral])|[VIGABATRIN] (C - n/a - Unknown - [n/a - 500mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4333283&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4333284	Spontaneous	2011-03-03 00:00:00	Healthcare Professional	European Economic Area	VACCINE 2011; 29: 519-22	More than 85 Years	Not Specified	No	Female	General physical health deterioration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoventilation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4333284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4333287	Spontaneous	2011-03-03 00:00:00	Healthcare Professional	European Economic Area	VACCINE 2011; 29: 519-22	65-85 Years	Not Specified	No	Female	Amnesia (0d - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Unknown])	FARESTON 60 MG TABLETS [TOREMIFENE, TOREMIFENE CITRATE] (C - Breast cancer - Dose not changed - [n/a - n/a - Unknown])|METHOTREXATE [METHOTREXATE] (C - Rheumatoid arthritis - Dose not changed - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4333287&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4329679	Spontaneous	2011-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Athetosis (n/a - Recovered/Resolved - Other Medically Important Condition);Chorea (n/a - Recovered/Resolved - Other Medically Important Condition);Cognitive disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4329679&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4329981	Spontaneous	2011-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4329981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4331910	Spontaneous	2011-03-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4331910&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4332269	Spontaneous	2011-03-02 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Autoimmune thyroiditis (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4332269&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4325484	Spontaneous	2011-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4325484&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4325496	Spontaneous	2011-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Unknown - Other Medically Important Condition);Influenza like illness (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4325496&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4325570	Spontaneous	2011-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (8d - Recovered/Resolved - Other Medically Important Condition);H1N1 influenza (8d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (C - Prophylaxis - Not applicable - [1d - .5mL - Unknown])...	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4325570&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4325925	Spontaneous	2011-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	H1N1 influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4325925&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4326216	Spontaneous	2011-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - Unknown - [n/a - n/a - Oral])|[HYDROCHLOROTHIAZIDE, RAMIPRIL] (C - n/a - Unknown - [n/a - n/a - Oral])|[LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - n/a - Oral])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4326216&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4328934	Spontaneous	2011-03-01 00:00:00	Healthcare Professional	European Economic Area	Dauvilliers et al. Post H1N1 narcolepsy-cataplexy. Sleep 2010 33: (11); 1-3	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Unknown - Disabling);Fall (n/a - Unknown - Disabling);Hypnagogic hallucination (n/a - Unknown - Disabling);Hypnopompic hallucination (n/a - Unknown - Disabling);Injection site inflammation (n/a - Unknown - Disabling);Middle insomnia (n/a - Unknown - Disabling);Narcolepsy (n/a - Unknown - Disabling);Pyrexia (n/a - Unknown - Disabling);Rapid eye movements sleep abnormal (n/a - Unknown - Disabling);Sleep disorder (n/a - Unknown - Disabling);Sleep paralysis (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling);Weight increased (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4328934&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4328958	Spontaneous	2011-03-01 00:00:00	Healthcare Professional	European Economic Area	Dauvilliers et al. Post H1N1 narcolepsy-cataplexy. Sleep 2010 33: (11); 1-3	18-64 Years	Not Specified	Yes	Male	Cataplexy (n/a - Recovering/Resolving - Disabling);Hypnagogic hallucination (n/a - Recovering/Resolving - Disabling);Increased appetite (n/a - Unknown - Disabling);Middle insomnia (n/a - Unknown - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Disabling);Weight increased (n/a - Unknown - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4328958&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4329028	Spontaneous	2011-03-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4329028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4322175	Spontaneous	2011-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Febrile infection (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);H1N1 influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (7d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	ACTRAPID [INSULIN HUMAN, INSULIN HUMAN (RDNA)] (C - Type 1 diabetes mellitus - Unknown - [n/a - n/a - Subcutaneous])|LANTUS [INSULIN GLARGINE] (C - Type 1 diabetes mellitus - Unknown - [n/a - n/a - Subcutaneous])|[LEVOTHYROXINE SODIUM] (C - n/a - Unknown - [n/a - 25ug - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4322175&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4323091	Spontaneous	2011-02-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Cough (n/a - Unknown - Other Medically Important Condition);Oral mucosal blistering (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition);Rhinitis (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4323091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4317011	Spontaneous	2011-02-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (1wk - Recovered/Resolved - Other Medically Important Condition);Axillary nerve injury (n/a - Unknown - Other Medically Important Condition);Injected limb mobility decreased (n/a - Unknown - Other Medically Important Condition);Neck pain (1wk - Recovered/Resolved - Other Medically Important Condition);Neuralgic amyotrophy (n/a - Unknown - Other Medically Important Condition);Pain in extremity (1wk - Recovered/Resolved - Other Medically Important Condition);Paresis (n/a - Unknown - Other Medically Important Condition);Peripheral nerve injury (n/a - Unknown - Other Medically Important Condition);Winged scapula (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4317011&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4312683	Spontaneous	2011-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[DESMOPRESSIN, DESMOPRESSIN ACETATE, DESMOPRESSIN ACETATE TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - Oral])|[SODIUM CROMOGLICATE] (C - n/a - n/a - [n/a - n/a - Ophthalmic])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4312683&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4312777	Spontaneous	2011-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4312777&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4312814	Spontaneous	2011-02-24 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4312814&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4311402	Spontaneous	2011-02-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dysphonia (n/a - Not Recovered/Not Resolved - Disabling);Vocal cord paresis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4311402&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4311460	Spontaneous	2011-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Hepatitis acute (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4311460&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4311949	Spontaneous	2011-02-23 00:00:00	Healthcare Professional	European Economic Area	Pillot C, Chevaux J, Petitpain N, Peyrin-Biroulet L. Acute hepatic cytolysis following H1N1 vaccination in a patient with Crohn&apos;s disease on Infliximab. Inflamm Bowel Dis 2011 Feb;17(2):679.	Not Specified	Not Specified	No	Female	Abdominal pain upper (n/a - Recovered/Resolved - Other Medically Important Condition);Biliary tract disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Hepatic cytolysis (n/a - Recovered/Resolved - Other Medically Important Condition);Jaundice (n/a - Recovered/Resolved - Other Medically Important Condition);Transaminases increased (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4311949&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4312007	Spontaneous	2011-02-23 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amyotrophy (n/a - Not Recovered/Not Resolved - Disabling);Influenza like illness (3d - Recovered/Resolved - Disabling);Injection site inflammation (15d - Recovered/Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling)	A/CALIFORNIA/7/2009 (H1N1) [A/CALIFORNIA/7/2009 (H1N1)] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4312007&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4312043	Spontaneous	2011-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4312043&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4312123	Spontaneous	2011-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Narcolepsy (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4312123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4312211	Spontaneous	2011-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4312211&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4328857	Spontaneous	2011-02-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Depression (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Ill-defined disorder - Not applicable - [1d - n/a - Intramuscular])	[MIRTAZAPINE] (C - Depression - Unknown - [n/a - 30g - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4328857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4305393	Spontaneous	2011-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Fear (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Neuropathy peripheral (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Skin disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Somatic symptom disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (C - Prophylaxis - Not applicable - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4305393&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4306872	Spontaneous	2011-02-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Influenza (5d - Recovered/Resolved - );Vaccination failure (5d - Recovered/Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4306872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4302360	Spontaneous	2011-02-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chills (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dizziness (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyspepsia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Erythema (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Lymphadenopathy (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Peripheral swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pulmonary embolism (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pulmonary infarction (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pulmonary oedema (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Renal pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Respiratory tract infection fungal (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tonsillar hypertrophy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	CELVAPAN SUSPENSION FOR INJECTION [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	[BIFONAZOLE, CLOTRIMAZOLE] (C - Product used for unknown indication - n/a - [n/a - n/a - Topical])|[INTRAUTERINE CONTRACEPTIVE DEVICE] (C - Contraception - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - 125mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4302360&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4298353	Spontaneous	2011-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersensitivity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4298353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4298365	Spontaneous	2011-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Encephalitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4298365&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4298673	Spontaneous	2011-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Cardiac failure chronic (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dilated cardiomyopathy (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dyspnoea exertional (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Ejection fraction decreased (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Myocarditis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Tachycardia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Ventricular tachycardia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4298673&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4298694	Spontaneous	2011-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4298694&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4299300	Spontaneous	2011-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Burning sensation (11mo - Unknown - Caused/Prolonged Hospitalisation, Disabling);Erythema (11mo - Unknown - Caused/Prolonged Hospitalisation, Disabling);Pain (11mo - Unknown - Caused/Prolonged Hospitalisation, Disabling);Polyneuropathy (11mo - Unknown - Caused/Prolonged Hospitalisation, Disabling);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4299300&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4299908	Spontaneous	2011-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4299908&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4300005	Spontaneous	2011-02-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4300005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4296215	Spontaneous	2011-02-17 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Atrial flutter (n/a - Recovered/Resolved - Other Medically Important Condition);Condition aggravated (n/a - Recovered/Resolved - Other Medically Important Condition);Rash erythematous (n/a - Recovered/Resolved - Other Medically Important Condition);Subacute cutaneous lupus erythematosus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])|[MYCOPHENOLATE SODIUM, MYCOPHENOLIC ACID] (S - n/a - n/a - [n/a - n/a - n/a])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT), PNEUMOCOCCAL VACCINE] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	[ACICLOVIR, ACICLOVIR SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4296215&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4297089	Spontaneous	2011-02-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cough (n/a - Recovered/Resolved - );Influenza (n/a - Recovered/Resolved - );Vaccination failure (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4297089&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4292418	Spontaneous	2011-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Neuritis (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4292418&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4292589	Spontaneous	2011-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adolescent	Yes	Female	Optic neuritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4292589&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4292786	Spontaneous	2011-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Abdominal pain upper (n/a - Recovered/Resolved - Other Medically Important Condition);Diarrhoea (n/a - Recovered/Resolved - Other Medically Important Condition);Hepatic enzyme increased (n/a - Recovered/Resolved - Other Medically Important Condition);Hepatomegaly (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4292786&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4292981	Spontaneous	2011-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cognitive disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea exertional (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myocarditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Peripheral vascular disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4292981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4293327	Spontaneous	2011-02-16 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Encephalitis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4293327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4289310	Spontaneous	2011-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cerebral arteriosclerosis (n/a - Unknown - Other Medically Important Condition);Encephalopathy (n/a - Unknown - Other Medically Important Condition);Memory impairment (n/a - Unknown - Other Medically Important Condition);Speech disorder (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[ALLOPURINOL] (C - n/a - n/a - [n/a - n/a - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - n/a - [n/a - n/a - n/a])|[BUPRENORPHINE] (C - n/a - n/a - [n/a - n/a - n/a])|[FENOFIBRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MELOXICAM] (C - n/a - n/a - [n/a - n/a - n/a])|[METAMIZOLE] (C - n/a - n/a - [n/a - n/a - n/a])|[PIRETANIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[RAMIPRIL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4289310&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4290491	Spontaneous	2011-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Irritability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Listless (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep attacks (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	TAMIFLU [OSELTAMIVIR, OSELTAMIVIR PHOSPHATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4290491&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4327675	Spontaneous	2011-02-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angiopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Ear pain (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuralgia (n/a - Unknown - Other Medically Important Condition);Pain of skin (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	NOT AVAILABLE (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[ACETYLSALICYLIC ACID] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[ATORVASTATIN, ATORVASTATIN CALCIUM] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[BETAHISTINE DIHYDROCHLORIDE, BETAHISTINE HYDROCHLORIDE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[BISOPROLOL, BISOPROLOL FUMARATE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[GLYCERYL TRINITRATE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[MECILLINAM, PIVMECILLINAM, PIVMECILLINAM HYDROCHLORIDE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])|[TOLTERODINE L-TARTRATE, TOLTERODINE TARTRATE] (C - Ill-defined disorder - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4327675&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4287938	Spontaneous	2011-02-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Compartment syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4287938&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4284544	Spontaneous	2011-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4284544&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4286074	Spontaneous	2011-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4286074&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4327212	Spontaneous	2011-02-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Areflexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Burning sensation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);CSF cell count increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);CSF immunoglobulin increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);CSF protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Decreased activity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Decreased vibratory sense (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Electronystagmogram abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gastroenteritis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);General physical health deterioration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Insomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pruritus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Psoriasis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash pruritic (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - 1{DF} - Parenteral])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/FLORIDA/4/2006-LIKE STRAIN, A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), B/MALAYSIA/2506/2004 - LIKE STRAIN (B/MALAYSIA/2506/2004), A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN (A/HIROSHIMA/52/2005 REASS. IVR-142), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN, B/HONG KONG/330/2001 - LIKE STRAIN (B/SHANDONG/7/97), B/MALAYSIA/2506/2004 - LIKE STRAIN, A/WISCONSIN/67/2005 (H3N2) - LIKE STRAIN, A/SOLOMON ISLANDS/3/2006 (H1N1)-LIKE STRAIN, INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])|[PNEUMOCOCCAL VACCINE] (S - Immunisation - Unknown - [n/a - 1{DF} - Parenteral])	[HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4327212&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4282476	Spontaneous	2011-02-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Bell's palsy (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4282476&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4282490	Spontaneous	2011-02-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myositis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (C - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4282490&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4283413	Spontaneous	2011-02-10 00:00:00	Healthcare Professional	European Economic Area	National survey on the association between flu vaccination and onset or worsening of psoriasis. Ann Dermatol Venereol. 2010 Dec. A116-A117	18-64 Years	Not Specified	No	Female	Guttate psoriasis (n/a - Recovered/Resolved - Other Medically Important Condition);Skin lesion (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4283413&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4277186	Spontaneous	2011-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Muscle contractions involuntary (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Parkinsonism (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4277186&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4277611	Spontaneous	2011-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Antinuclear antibody positive (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Blood cholesterol increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Carpal tunnel syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Collagen disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cystitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Cystocele (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dyspareunia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dysuria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Incontinence (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Low density lipoprotein increased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Micturition urgency (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Nocturia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Peripheral swelling (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pollakiuria (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Skin discolouration (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Urinary retention (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Urinary tract infection (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Urine flow decreased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vaccination failure (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Vaginal polyp (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - 1{DF} - n/a])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS] (S - Immunisation - Unknown - [n/a - .5mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4277611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4277628	Spontaneous	2011-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anxiety (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Chest pain (n/a - Unknown - Other Medically Important Condition);Chills (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Heart rate increased (n/a - Unknown - Other Medically Important Condition);Hypersomnia (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Myalgia (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Restlessness (n/a - Unknown - Other Medically Important Condition);Tinnitus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	[DOCONEXENT, ICOSAPENT, FISH OIL, OMEGA-3-ACID ETHYL ESTERS 90] (C - n/a - n/a - [n/a - n/a - n/a])|[ETHINYLESTRADIOL, NORETHISTERONE, LACTOSE MONOHYDRATE, NORETHISTERONE ACETATE, ETHINYLESTRADIOL] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4277628&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4277643	Spontaneous	2011-02-09 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Abdominal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Eye pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Gastritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Nausea (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Oesophagitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Oropharyngeal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Vomiting (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	TAMIFLU [OSELTAMIVIR, OSELTAMIVIR PHOSPHATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4277643&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4276243	Spontaneous	2011-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Drug ineffective (0d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4276243&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4276244	Spontaneous	2011-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Drug ineffective (0d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4276244&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4276245	Spontaneous	2011-02-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Drug ineffective (0d - Recovered/Resolved - Other Medically Important Condition);Vaccination failure (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4276245&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4272189	Spontaneous	2011-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Loss of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation);Presyncope (n/a - Unknown - Caused/Prolonged Hospitalisation);Syncope (n/a - Unknown - Caused/Prolonged Hospitalisation);Wound (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4272189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4272190	Spontaneous	2011-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Atrial fibrillation (n/a - Unknown - Caused/Prolonged Hospitalisation);Atrial flutter (n/a - Unknown - Caused/Prolonged Hospitalisation);Essential hypertension (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle spasms (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neuralgic amyotrophy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neuritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Radiculitis brachial (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sensory loss (n/a - Unknown - Caused/Prolonged Hospitalisation);Spinal osteoarthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - 50mg - Unknown])|[RAMIPRIL] (C - n/a - Unknown - [n/a - 5mg - Unknown])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4272190&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4273854	Spontaneous	2011-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4273854&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4273861	Spontaneous	2011-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4273861&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4273926	Spontaneous	2011-02-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Waxy flexibility (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4273926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4269011	Spontaneous	2011-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Aspiration (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intradermal])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4269011&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4269057	Spontaneous	2011-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4269057&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4269265	Spontaneous	2011-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Multiple sclerosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4269265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4270564	Spontaneous	2011-02-04 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Weight increased (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4270564&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4265614	Spontaneous	2011-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Polymyalgia rheumatica (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4265614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4265618	Spontaneous	2011-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Headache (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4265618&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4265629	Spontaneous	2011-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Stress cardiomyopathy (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4265629&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4265704	Spontaneous	2011-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema (n/a - Recovering/Resolving - Other Medically Important Condition);Influenza like illness (n/a - Recovering/Resolving - Other Medically Important Condition);Local reaction (n/a - Recovering/Resolving - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition);Pain (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia oral (1d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4265704&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4265737	Spontaneous	2011-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Immune thrombocytopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4265737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4265756	Spontaneous	2011-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cerebral infarction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4265756&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4266002	Spontaneous	2011-02-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Polyarthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Seronegative arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Swelling (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4266002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4267787	Spontaneous	2011-02-03 00:00:00	Non Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Erythema nodosum (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4267787&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4262358	Spontaneous	2011-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Hepatic enzyme increased (n/a - Unknown - Other Medically Important Condition);Infection (n/a - Unknown - Other Medically Important Condition);Iron deficiency (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4262358&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4262773	Spontaneous	2011-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4262773&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4263591	Spontaneous	2011-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4263591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4263631	Spontaneous	2011-02-02 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4263631&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4260067	Spontaneous	2011-02-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Osteoarthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Synovitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - n/a - Unknown - [n/a - n/a - Oral])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4260067&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4256394	Spontaneous	2011-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Influenza (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4256394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4257852	Spontaneous	2011-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Anxiety (2d - Recovered/Resolved - Other Medically Important Condition);Arthralgia (n/a - Unknown - Other Medically Important Condition);Chest discomfort (1d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (2d - Recovered/Resolved - Other Medically Important Condition);Formication (1d - Recovered/Resolved - Other Medically Important Condition);Head discomfort (1d - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Peripheral vascular disorder (1d - Recovered/Resolved - Other Medically Important Condition);Respiratory distress (1d - Recovered/Resolved - Other Medically Important Condition);Restlessness (2d - Recovered/Resolved - Other Medically Important Condition);Swelling face (2d - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Type I hypersensitivity (1d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4257852&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4257902	Spontaneous	2011-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Acute febrile neutrophilic dermatosis (14d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[GABAPENTIN] (C - n/a - Unknown - [1d - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4257902&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4259268	Spontaneous	2011-01-31 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Polyarthritis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Tendonitis (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4259268&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-4253242	Spontaneous	2011-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Not Specified	Yes	Not Specified	Developmental hip dysplasia (10wk - Recovered/Resolved - Congenital Anomaly);Maternal exposure timing unspecified (n/a - Unknown - Congenital Anomaly)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4253242&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-4253255	Spontaneous	2011-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dehydration (n/a - Unknown - Caused/Prolonged Hospitalisation);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Live birth (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4253255&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4253595	Spontaneous	2011-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4253595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4254364	Spontaneous	2011-01-28 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Decreased appetite (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Disturbance in attention (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dyskinesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperphagia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Influenza (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [1d - 1{DF} - Intramuscular])	AERIUS [DESLORATADINE] (C - Hypersensitivity - n/a - [n/a - 1{DF} - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Hypersensitivity - n/a - [n/a - 1{DF} - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4254364&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4254409	Spontaneous	2011-01-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])...	[AMOXICILLIN, AMOXICILLIN TRIHYDRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[MIRTAZAPINE] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4254409&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4249948	Spontaneous	2011-01-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])...	UNKNOWN [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4249948&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4250095	Spontaneous	2011-01-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Parosmia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Taste disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (I - Immunisation - n/a - [n/a - 1{DF} - Parenteral])|[INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4250095&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4250486	Spontaneous	2011-01-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cataplexy (n/a - Recovering/Resolving - Other Medically Important Condition);Hallucination (n/a - Recovering/Resolving - Other Medically Important Condition);Hypotonia (n/a - Recovering/Resolving - Other Medically Important Condition);Narcolepsy (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep attacks (n/a - Recovering/Resolving - Other Medically Important Condition);Sleep paralysis (n/a - Recovering/Resolving - Other Medically Important Condition);Somnolence (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4250486&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4250805	Spontaneous	2011-01-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Influenza like illness (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4250805&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4246628	Spontaneous	2011-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Radiculopathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4246628&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4246990	Spontaneous	2011-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (1wk - Recovered/Resolved - Other Medically Important Condition);Dyspepsia (1wk - Recovered/Resolved - Other Medically Important Condition);Vasculitis (1wk - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4246990&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4247032	Spontaneous	2011-01-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthritis (2d - Recovered/Resolved - Other Medically Important Condition);Joint swelling (2d - Recovered/Resolved - Other Medically Important Condition);Mobility decreased (1d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (8h - Recovered/Resolved - Other Medically Important Condition);Swelling (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4247032&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4247164	Spontaneous	2011-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Abdominal pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gastrointestinal haemorrhage (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Haematochezia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Intestine transplant rejection (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4247164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4247368	Spontaneous	2011-01-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Hypoaesthesia (n/a - Not Recovered/Not Resolved - );Insomnia (n/a - Not Recovered/Not Resolved - );Nausea (n/a - Not Recovered/Not Resolved - );Paraesthesia (n/a - Not Recovered/Not Resolved - );Pruritus (n/a - Not Recovered/Not Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4247368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4247374	Spontaneous	2011-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (6d - Recovered/Resolved - );Cardiovascular disorder (n/a - Recovered/Resolved - );Fatigue (n/a - Recovered/Resolved - );Headache (6d - Recovered/Resolved - );Injection site erythema (10d - Recovered/Resolved - );Injection site pain (6d - Recovered/Resolved - );Injection site swelling (10d - Recovered/Resolved - );Pain in extremity (6d - Recovered/Resolved - );Somnolence (n/a - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - Asthma - Unknown - [n/a - 1{DF} - Respiratory (inhalation)])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM] (C - Chronic gastritis - Unknown - [n/a - 40mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4247374&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4247377	Spontaneous	2011-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (5d - Recovered/Resolved - );Dyssomnia (5d - Recovered/Resolved - );Headache (5d - Recovered/Resolved - );Hypersensitivity (5d - Recovered/Resolved - );Induration (5d - Recovered/Resolved - );Injection site pain (5d - Recovered/Resolved - )	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[ALLOPURINOL] (C - Hyperuricaemia - Unknown - [n/a - 100mg - Oral])|[RAMIPRIL] (C - Arterial disorder - Unknown - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4247377&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4247649	Spontaneous	2011-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal discomfort (n/a - Recovered/Resolved - Disabling);Cold sweat (n/a - Recovered/Resolved - Disabling);Discomfort (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Head injury (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Unknown - Disabling);Hypoaesthesia oral (1a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Unknown - Disabling);Paraesthesia (1a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling);Syncope (n/a - Recovered/Resolved - Disabling);Visual impairment (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4247649&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4249008	Spontaneous	2011-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Areflexia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Autonomic nervous system imbalance (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Monoparesis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4249008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4249040	Spontaneous	2011-01-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Encephalitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4249040&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4244203	Spontaneous	2011-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Polymyositis (n/a - Recovering/Resolving - Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4244203&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4244551	Spontaneous	2011-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Abdominal pain (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest pain (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Confusional state (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyslalia (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (11d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - Hypertension - Unknown - [n/a - 5mg - Oral])|[VALSARTAN, HYDROCHLOROTHIAZIDE] (C - Hypertension - Unknown - [n/a - 92.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4244551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4244722	Spontaneous	2011-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition);Headache (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4244722&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4246194	Spontaneous	2011-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pericarditis (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4246194&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4246197	Spontaneous	2011-01-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myelitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4246197&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4240895	Spontaneous	2011-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Arthritis reactive (n/a - Not Recovered/Not Resolved - );Spondylitis (n/a - Not Recovered/Not Resolved - )	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4240895&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4241950	Spontaneous	2011-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysphagia (1d - Recovered/Resolved - Other Medically Important Condition);Erythema (1d - Recovered/Resolved - Other Medically Important Condition);Eye swelling (1d - Recovered/Resolved - Other Medically Important Condition);Pruritus (1d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4241950&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4242293	Spontaneous	2011-01-24 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Immune thrombocytopenia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4242293&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4237619	Spontaneous	2011-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bursitis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tremor (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4237619&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4238216	Spontaneous	2011-01-21 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bronchospasm (n/a - Recovered/Resolved - Other Medically Important Condition);Cough (n/a - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4238216&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4239470	Spontaneous	2011-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Death (1d - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4239470&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4239872	Spontaneous	2011-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Rash (n/a - Recovering/Resolving - Other Medically Important Condition);Rash pruritic (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4239872&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4239977	Spontaneous	2011-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Brachial plexopathy (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4239977&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-4240218	Spontaneous	2011-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovered/Resolved With Sequelae - Disabling);Dysphonia (n/a - Recovered/Resolved With Sequelae - Disabling);Influenza like illness (n/a - Recovered/Resolved With Sequelae - Disabling);Myalgia (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4240218&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-4240254	Spontaneous	2011-01-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Periarthritis (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4240254&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4235922	Spontaneous	2011-01-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4235922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4236257	Spontaneous	2011-01-20 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Bronchiolitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Granuloma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Inflammation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Umbilical cord abnormality (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4236257&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4232032	Spontaneous	2011-01-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Osteoarthritis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Spondyloarthropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4232032&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4233987	Spontaneous	2011-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Asthenopia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling abnormal (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling hot (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Head discomfort (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Joint stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Muscle twitching (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Palpitations (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pneumococcal infection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sensory disturbance (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);White blood cell count decreased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4233987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4234008	Spontaneous	2011-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Asthma exercise induced (n/a - Recovered/Resolved - )	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4234008&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4234233	Spontaneous	2011-01-19 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Enthesopathy (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4234233&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4228922	Spontaneous	2011-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4228922&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4229341	Spontaneous	2011-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (1wk - Recovered/Resolved - Other Medically Important Condition);Dyspepsia (1wk - Recovered/Resolved - Other Medically Important Condition);Purpura (1wk - Recovered/Resolved - Other Medically Important Condition);Vasculitis (1wk - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (C - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - n/a - Unknown])|[LISINOPRIL, LISINOPRIL DIHYDRATE] (C - Hypertension - Unknown - [n/a - n/a - Unknown])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Type 2 diabetes mellitus - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4229341&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4229342	Spontaneous	2011-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (1wk - Recovered/Resolved - Other Medically Important Condition);Dyspepsia (1wk - Recovered/Resolved - Other Medically Important Condition);Vasculitis (1wk - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (C - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4229342&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4230990	Spontaneous	2011-01-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4230990&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4226994	Spontaneous	2011-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4226994&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4228408	Spontaneous	2011-01-17 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Male	Erythema multiforme (6mo - Recovered/Resolved With Sequelae - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[IBUPROFEN] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4228408&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-4222906	Spontaneous	2011-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pruritus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4222906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4223135	Spontaneous	2011-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Rash (3d - Recovered/Resolved - Other Medically Important Condition);Swelling face (3d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [0d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4223135&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4224028	Spontaneous	2011-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Tic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4224028&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4224378	Spontaneous	2011-01-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Chills (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dyspnoea exertional (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Flank pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hyponatraemia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Skin burning sensation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4224378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4220937	Spontaneous	2011-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Fatigue (1a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4220937&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4222415	Spontaneous	2011-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Facial paralysis (n/a - Recovered/Resolved With Sequelae - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4222415&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Sequelae
EU-EC-4222554	Spontaneous	2011-01-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypertensive crisis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Malaise (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pruritus (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Skin reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4222554&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4219088	Spontaneous	2011-01-12 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (8mo - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dizziness (8mo - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (8mo - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4219088&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4212688	Spontaneous	2011-01-10 00:00:00	Healthcare Professional	European Economic Area	Dauvilliers, MD, PhD Y. Post-H1N1 Nacrolepsy-Cataplexy. Letter to the Editor-Dauvilliers et al VOL. 33:1428-1430.	3-11 Years	Not Specified	Yes	Not Specified	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Nasal])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4212688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4209068	Spontaneous	2011-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4209068&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4209087	Spontaneous	2011-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - H1N1 influenza - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4209087&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4209182	Spontaneous	2011-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Not Specified	Eye disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Maternal exposure timing unspecified (n/a - Unknown - Caused/Prolonged Hospitalisation);Renal disorder (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	[CLOTRIMAZOLE] (C - n/a - n/a - [n/a - n/a - Unknown])|[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4209182&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4209206	Spontaneous	2011-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intravenous (not otherwise specified)])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4209206&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4209271	Spontaneous	2011-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4209271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4209301	Spontaneous	2011-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4209301&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4209309	Spontaneous	2011-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4209309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4210265	Spontaneous	2011-01-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Abnormal behaviour (n/a - Unknown - Caused/Prolonged Hospitalisation);Dementia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disorientation (n/a - Unknown - Caused/Prolonged Hospitalisation);Organic brain syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[DIAZEPAM] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4210265&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4204161	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Pruritus (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Rash (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204161&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4204218	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	Yes	Female	Pyrexia (1wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Urticaria (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4204218&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4205306	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Febrile convulsion (n/a - Unknown - Life Threatening, Other Medically Important Condition);Seizure (n/a - Unknown - Life Threatening, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205306&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4205880	Spontaneous	2011-01-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Thrombocytopenic purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - 1{DF} - Subcutaneous])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4205880&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4200327	Spontaneous	2011-01-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cold sweat (0d - Recovered/Resolved - Other Medically Important Condition);Dizziness (0d - Recovered/Resolved - Other Medically Important Condition);Hypotonia (0d - Recovering/Resolving - Other Medically Important Condition);Nausea (0d - Recovered/Resolved - Other Medically Important Condition);Pallor (0d - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (0d - Recovered/Resolved - Other Medically Important Condition);Seizure (0d - Recovered/Resolved - Other Medically Important Condition);Swollen tongue (0d - Recovered/Resolved - Other Medically Important Condition);Syncope (0d - Recovered/Resolved - Other Medically Important Condition);Urinary incontinence (0d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4200327&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4197828	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Generalised tonic-clonic seizure (n/a - Recovering/Resolving - Life Threatening, Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4197828&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4198155	Spontaneous	2010-12-31 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Not Specified	Yes	Not Specified	Joint dislocation (n/a - Unknown - Congenital Anomaly);Maternal exposure timing unspecified (n/a - Unknown - Congenital Anomaly)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4198155&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-4195643	Spontaneous	2010-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4195643&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4195663	Spontaneous	2010-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4195663&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4196366	Spontaneous	2010-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4196366&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4196562	Spontaneous	2010-12-30 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4196562&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4196737	Spontaneous	2010-12-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Not Specified	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [0mo - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4196737&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4193295	Spontaneous	2010-12-29 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dermatitis allergic (14d - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4193295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4193467	Spontaneous	2010-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Areflexia (n/a - Unknown - Other Medically Important Condition);Ataxia (n/a - Recovering/Resolving - Other Medically Important Condition);Disability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Feeling hot (n/a - Recovering/Resolving - Other Medically Important Condition);Hyperreflexia (n/a - Recovering/Resolving - Other Medically Important Condition);Myelitis (n/a - Recovering/Resolving - Other Medically Important Condition);Paraparesis (n/a - Recovering/Resolving - Other Medically Important Condition);Pleocytosis (n/a - Unknown - Other Medically Important Condition);Sensory disturbance (n/a - Recovering/Resolving - Other Medically Important Condition);Somatosensory evoked potentials abnormal (n/a - Unknown - Other Medically Important Condition);Spinal cord disorder (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4193467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4193503	Spontaneous	2010-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Chills (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Cough (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Dysaesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sleep disorder (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4193503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4193647	Spontaneous	2010-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Hypersomnia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Vaccination site pain (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4193647&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4194753	Spontaneous	2010-12-29 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Abortion spontaneous (1d - Fatal - Results in Death)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4194753&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4191208	Spontaneous	2010-12-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Bladder disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dysaesthesia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Dysphagia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Facial paresis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Laryngitis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Paraesthesia (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Paralysis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Paraplegia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Peripheral sensory neuropathy (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Pneumonia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Quadriparesis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Urge incontinence (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Viral infection (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[CANDESARTAN CILEXETIL] (C - Hypertension - Unknown - [n/a - n/a - Oral])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - Asthma - Unknown - [n/a - n/a - Respiratory (inhalation)])|[HYDROCHLOROTHIAZIDE, TELMISARTAN] (C - Hypertension - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4191208&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4189864	Spontaneous	2010-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4189864&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4189965	Spontaneous	2010-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4189965&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4190091	Spontaneous	2010-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	CSF protein increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyporeflexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paresis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sensory loss (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[AZATHIOPRINE] (C - Crohn's disease - Unknown - [n/a - 150mg - Oral])|[CALCIUM CARBONATE, CHOLECALCIFEROL CONCENTRATE (POWDER FORM), COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - Unknown - [n/a - n/a - Oral])|[FERROUS (II) GLYCINE SULFATE COMPLEX] (C - Iron deficiency - Unknown - [n/a - n/a - Oral])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - Prophylaxis - Unknown - [n/a - n/a - Oral])|[PREDNISOLONE] (C - Crohn's disease - Unknown - [n/a - 30mg - Oral])|[TRAMADOL, TRAMADOL HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 100mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4190091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4190098	Spontaneous	2010-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Bone lesion (n/a - Unknown - Other Medically Important Condition);Hypokinesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pain in extremity (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Periarthritis (n/a - Unknown - Other Medically Important Condition);Rotator cuff syndrome (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Tendon calcification (n/a - Unknown - Other Medically Important Condition);Tendonitis (n/a - Unknown - Other Medically Important Condition);Tenosynovitis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4190098&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4190099	Spontaneous	2010-12-27 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Ageusia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Chills (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Craniofacial fracture (n/a - Unknown - Caused/Prolonged Hospitalisation);Demyelinating polyneuropathy (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dry mouth (n/a - Unknown - Caused/Prolonged Hospitalisation);Epistaxis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Flushing (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Herpes zoster (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hyperthyroidism (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyposmia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Post herpetic neuralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4190099&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4190289	Spontaneous	2010-12-27 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Myocardial infarction (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - n/a - Subcutaneous])	ACTOS [PIOGLITAZONE, PIOGLITAZONE HYDROCHLORIDE] (C - Diabetic eye disease - Dose not changed - [n/a - 45mg - Oral])|ESOMEPRAZOLE [ESOMEPRAZOLE] (C - Product used for unknown indication - Dose not changed - [n/a - n/a - Oral])|INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - Diabetic eye disease - Dose not changed - [n/a - n/a - Subcutaneous])|INSULIN ASPART [INSULIN ASPART] (C - Diabetic eye disease - Dose not changed - [n/a - n/a - Subcutaneous])|[ESTRADIOL, ESTRADIOL HEMIHYDRATE] (C - Product used for unknown indication - Dose not changed - [n/a - n/a - Cutaneous])|[FENOFIBRATE, FENOFIBRATE (NANONISED), FENOFIBRATE MICRONISED] (C - Hyperlipidaemia - Dose not changed - [n/a - n/a - Oral])|[PROGESTERONE, PROGESTERONE, MICRONISED] (C - Product used for unknown indication - Dose not changed - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4190289&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4183373	Spontaneous	2010-12-23 00:00:00	Healthcare Professional	European Economic Area	VACCINE 2010;	18-64 Years	Not Specified	No	Female	Bronchospasm (2d - Recovered/Resolved - Other Medically Important Condition);Hypersensitivity (2d - Recovered/Resolved - Other Medically Important Condition);Hypertension (2d - Recovered/Resolved - Other Medically Important Condition);Tachycardia (2d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4183373&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4183400	Spontaneous	2010-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bone marrow oedema (190d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Monoparesis (4d - Recovered/Resolved - Other Medically Important Condition);Myositis (190d - Recovered/Resolved With Sequelae - Other Medically Important Condition);Pain in extremity (5d - Recovered/Resolved - Other Medically Important Condition);Periarthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Radiculitis brachial (8d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[LEVOTHYROXINE SODIUM] (C - Autoimmune thyroiditis - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4183400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-4184595	Spontaneous	2010-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Myosclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Trigeminal neuralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4184595&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4184825	Spontaneous	2010-12-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovering/Resolving - Other Medically Important Condition);Arthritis (n/a - Recovering/Resolving - Other Medically Important Condition);Arthritis infective (n/a - Recovering/Resolving - Other Medically Important Condition);Arthritis reactive (n/a - Recovering/Resolving - Other Medically Important Condition);Joint swelling (n/a - Unknown - Other Medically Important Condition);Mobility decreased (n/a - Recovering/Resolving - Other Medically Important Condition);Motor dysfunction (n/a - Recovering/Resolving - Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia (n/a - Unknown - Other Medically Important Condition);Peripheral coldness (n/a - Unknown - Other Medically Important Condition);Skin discolouration (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[LEVOTHYROXINE] (C - Hypothyroidism - Unknown - [n/a - 100ng - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4184825&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4181070	Spontaneous	2010-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Adjustment disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Anxiety (n/a - Unknown - Caused/Prolonged Hospitalisation);Arrhythmia (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Atrial fibrillation (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Cardiomyopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Circulatory collapse (0wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dyspnoea (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (31d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hypertensive crisis (0wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypokalaemia (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Palpitations (2h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Panic attack (n/a - Unknown - Caused/Prolonged Hospitalisation);Pericardial effusion (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Stress (31d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tremor (62d - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - n/a - Intramuscular])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[AMOXICILLIN, AMOXICILLIN TRIHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[ASCORBIC ACID, MAGNESIUM OXIDE, HEAVY, MAGNESIUM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4181070&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4181087	Spontaneous	2010-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Brachial plexopathy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Carpal tunnel syndrome (n/a - Unknown - Other Medically Important Condition);Fall (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal discomfort (n/a - Unknown - Other Medically Important Condition);Neuralgic amyotrophy (n/a - Recovering/Resolving - Other Medically Important Condition);Paresis (n/a - Recovering/Resolving - Other Medically Important Condition);Polyneuropathy (n/a - Unknown - Other Medically Important Condition);Sensory disturbance (n/a - Unknown - Other Medically Important Condition);Spinal pain (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4181087&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4182375	Spontaneous	2010-12-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Multiple sclerosis relapse (n/a - Recovered/Resolved - )	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])|[PROPRANOLOL HYDROCHLORIDE] (S - n/a - Unknown - [n/a - 1{DF} - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4182375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4174112	Spontaneous	2010-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Not Specified	Yes	Not Specified	Eczema (n/a - Unknown - Congenital Anomaly);Food allergy (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Gastroenteritis viral (n/a - Unknown - Congenital Anomaly);Jaundice neonatal (n/a - Unknown - Congenital Anomaly);Maternal exposure timing unspecified (n/a - Unknown - Congenital Anomaly);Milk allergy (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Nasopharyngitis (n/a - Unknown - Congenital Anomaly);Talipes (n/a - Unknown - Congenital Anomaly)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	[BECLOMETASONE DIPROPIONATE] (C - n/a - n/a - [n/a - n/a - n/a])|[FOLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[LACTULOSE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[PROMETHAZINE TEOCLATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SALBUTAMOL, SALBUTAMOL SULFATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4174112&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-4174233	Spontaneous	2010-12-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cellulitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Injection site induration (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Rash (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Skin warm (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])...	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4174233&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4171381	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood brain barrier defect (n/a - Unknown - Caused/Prolonged Hospitalisation);CSF protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Demyelinating polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Groin pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Leukocytosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Monoparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Radiculitis brachial (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4171381&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4172343	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Facial paresis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4172343&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4172464	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4172464&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4172465	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nausea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Nystagmus (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);VIth nerve paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vision blurred (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vomiting (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4172465&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4172466	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4172466&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4172467	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Presyncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4172467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4172468	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Uterine contractions during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4172468&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4172472	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4172472&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4172474	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Data migrated from the EudraVigilance E2B(R2) Literature repository Beckmann Y et al. Neuropatic complications of H1N1 vacination. 29th Intenantional Congress of Clinical Neurophysiology: P30-23; S285	18-64 Years	Not Specified	No	Male	Optic neuropathy (n/a - Unknown - Other Medically Important Condition);Pupillary reflex impaired (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4172474&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4172475	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	Non European Economic Area	Beckmann Y et al. Neuropatic complications of H1N1 vacination. 29th Intenantional Congress of Clinical Neurophysiology: P30-23; S285	18-64 Years	Not Specified	No	Female	Guillain-Barre syndrome (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4172475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4172611	Spontaneous	2010-12-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (1d - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (1d - Recovered/Resolved - Other Medically Important Condition);Headache (1d - Recovered/Resolved - Other Medically Important Condition);Hot flush (1d - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (1d - Recovered/Resolved - Other Medically Important Condition);Hypertension (n/a - Recovered/Resolved - Other Medically Important Condition);Hypokalaemia (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Recovered/Resolved - Other Medically Important Condition);Ventricular extrasystoles (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[E.COLI EXTRACT, E.COLI POLYSACCHARIDE, ESCHERICHIA COLI LYOPHILISED LYSATE, ESCHERICHIA COLI, LYOPHILIZED, FREEZE-DRIED IMMUNOACTIVE FRACTIONS OF SELECTED ESCHERICHIA COLI STRAINS, IMMUNOACTIVE FRACTIONS OF 18 STRAINS OF ESCHERICHIA COLI, LYSATUM ESCHERICHIAE COLI, MANNITOL, SODIUM GLUTAMATE ANHYDROUS, ESCHERICHIA COLI LYOPHILISED LYSATE, ANHYDROUS PROPYL GALLATE (E 310)] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4172611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4167698	Spontaneous	2010-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4167698&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4168455	Spontaneous	2010-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Pericardial effusion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pericarditis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4168455&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4168513	Spontaneous	2010-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4168513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4168818	Spontaneous	2010-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4168818&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4168974	Spontaneous	2010-12-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Facial paralysis (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 500{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4168974&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4168975	Spontaneous	2010-12-16 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthma (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 500{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4168975&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4170241	Spontaneous	2010-12-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Tendonitis (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4170241&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4164719	Spontaneous	2010-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Male	Arthralgia (n/a - Unknown - Other Medically Important Condition);Cystitis (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Micturition disorder (n/a - Unknown - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Unknown - Other Medically Important Condition);Pain in extremity (n/a - Unknown - Other Medically Important Condition);Peripheral swelling (n/a - Unknown - Other Medically Important Condition);Psoriatic arthropathy (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Unknown - [n/a - n/a - n/a])	[ACETYLSALICYLIC ACID] (C - n/a - Unknown - [n/a - n/a - n/a])|[ALENDRONATE SODIUM, ALENDRONATE SODIUM TRIHYDRATE, ALENDRONIC ACID] (C - n/a - Unknown - [n/a - 70mg - n/a])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - n/a])|[METOPROLOL, METOPROLOL TARTRATE] (C - n/a - Unknown - [n/a - n/a - n/a])|[NAPROXEN, NAPROXEN SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])|[PRAVASTATIN SODIUM] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4164719&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4166331	Spontaneous	2010-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Facial paralysis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);VIIth nerve injury (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4166331&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4166616	Spontaneous	2010-12-15 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Neck pain (1mo - Recovered/Resolved - );Paraesthesia (n/a - Unknown - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4166616&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4166666	Spontaneous	2010-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Paraesthesia (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4166666&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4166692	Spontaneous	2010-12-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Hypoaesthesia (7d - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (48h - Recovered/Resolved - Other Medically Important Condition);Injection site oedema (48h - Recovered/Resolved - Other Medically Important Condition);Monoplegia (8d - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4166692&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4161809	Spontaneous	2010-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Hepatic failure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161809&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4161987	Spontaneous	2010-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161987&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4162002	Spontaneous	2010-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Adult	No	Female	Injection site pain (10mo - Recovering/Resolving - Disabling);Muscle disorder (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Sensory disturbance (n/a - Not Recovered/Not Resolved - Disabling);Skin disorder (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4162002&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4162191	Spontaneous	2010-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Drug interaction (n/a - Unknown - Other Medically Important Condition);Haematemesis (n/a - Recovered/Resolved - Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Other Medically Important Condition);Renal failure (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [1d - n/a - n/a])|RITUXIMAB [RITUXIMAB] (S - Rheumatoid arthritis - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4162191&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4162981	Spontaneous	2010-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Ophthalmoplegia (n/a - Unknown - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4162981&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4164031	Spontaneous	2010-12-14 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Encephalopathy neonatal (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Not Specified - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4164031&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4159609	Spontaneous	2010-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Mucosal haemorrhage (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Petechiae (8d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombocytopenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Thrombocytopenic purpura (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID PH. EUR.] (C - n/a - Unknown - [n/a - n/a - Oral])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE] (C - n/a - Unknown - [n/a - n/a - Oral])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - Unknown - [n/a - n/a - Oral])|[CANDESARTAN CILEXETIL] (C - n/a - Unknown - [n/a - n/a - Oral])|[HYDROCHLOROTHIAZIDE] (C - n/a - Unknown - [n/a - n/a - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - n/a - Unknown - [n/a - n/a - Oral])|[OPIPRAMOL] (C - n/a - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4159609&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4159867	Spontaneous	2010-12-13 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Optic neuritis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4159867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4160153	Spontaneous	2010-12-13 00:00:00	Healthcare Professional	European Economic Area	Hermann R et al. Very severe thrombotic thrombocytopenic Purpura after H1N1 vaccination. Med Klin 2010;105:663-668	18-64 Years	Adult	No	Male	Blastomycosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood bilirubin increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Blood lactate dehydrogenase increased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Candida infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Clostridium test positive (n/a - Unknown - Caused/Prolonged Hospitalisation);Confusional state (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Corynebacterium infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Enterococcal infection (n/a - Unknown - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Geotrichum infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Haemolytic anaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Haemorrhagic cerebral infarction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Haptoglobin decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Jaundice (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Petechiae (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Renal function test abnormal (n/a - Unknown - Caused/Prolonged Hospitalisation);Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Staphylococcal infection (n/a - Unknown - Caused/Prolonged Hospitalisation);Thrombotic cerebral infarction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Thrombotic thrombocytopenic purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4160153&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4161309	Spontaneous	2010-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Foetal death (n/a - Fatal - Congenital Anomaly)	A/CALIFORNIA/7/2009 (H1N1) [A/CALIFORNIA/7/2009 (H1N1)] (S - n/a - Not applicable - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	Severe reaction
EU-EC-4161378	Spontaneous	2010-12-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Influenza like illness (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4161378&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4157588	Spontaneous	2010-12-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Swelling face (5d - Recovered/Resolved - Other Medically Important Condition);Urticaria (5d - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4157588&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4152584	Spontaneous	2010-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Pain (n/a - Recovering/Resolving - Other Medically Important Condition);Pain in extremity (n/a - Recovering/Resolving - Other Medically Important Condition);Paraesthesia (n/a - Recovering/Resolving - Other Medically Important Condition);Radiculitis brachial (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4152584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4152745	Spontaneous	2010-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Lymphadenopathy (53d - Recovered/Resolved - Other Medically Important Condition);Vasodilatation (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - Not applicable - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4152745&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-4153454	Spontaneous	2010-12-09 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Ataxia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Diplegia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4153454&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4149857	Spontaneous	2010-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Dysaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea exertional (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Immunisation reaction (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Unknown - Caused/Prolonged Hospitalisation);Myalgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (2d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pain in jaw (n/a - Unknown - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Unknown - Caused/Prolonged Hospitalisation);Toothache (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4149857&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4152039	Spontaneous	2010-12-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hypersomnia (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4152039&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4147680	Spontaneous	2010-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Hypersensitivity (2h - Recovered/Resolved - Other Medically Important Condition);Nausea (2h - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (2h - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Swollen tongue (2h - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4147680&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4147958	Spontaneous	2010-12-07 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Abdominal pain (n/a - Recovering/Resolving - Other Medically Important Condition);Nausea (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4147958&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4148457	Spontaneous	2010-12-07 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Bell's palsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Caesarean section (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition);Infant (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paresis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - .5mL - n/a])	[ANHYDROUS METHYLDOPA, METHYLDOPA, METHYLDOPA SESQUIHYDRATE] (C - n/a - Unknown - [n/a - 250mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4148457&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4144471	Spontaneous	2010-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4144471&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4145223	Spontaneous	2010-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Atrial fibrillation (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (1d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4145223&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4145229	Spontaneous	2010-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Dizziness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Gait disturbance (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Multiple sclerosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Visual impairment (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4145229&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4145591	Spontaneous	2010-12-06 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Abdominal pain (3wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Henoch-Schonlein purpura (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Joint swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (3wk - Recovered/Resolved - Caused/Prolonged Hospitalisation);Petechiae (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4145591&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4146592	Spontaneous	2010-12-06 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved - );Loss of consciousness (n/a - Recovered/Resolved - );Paraesthesia (n/a - Recovered/Resolved - );Pruritus (n/a - Recovered/Resolved - )	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - n/a - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4146592&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Severe reaction
EU-EC-4141099	Spontaneous	2010-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Asphyxia (n/a - Not Recovered/Not Resolved - Disabling, Congenital Anomaly);Brain injury (n/a - Not Recovered/Not Resolved - Disabling, Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4141099&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4141100	Spontaneous	2010-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Complication of delivery (n/a - Unknown - Other Medically Important Condition);Complication of pregnancy (n/a - Unknown - Other Medically Important Condition);Listless (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4141100&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4142150	Spontaneous	2010-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Malaise (n/a - Unknown - Caused/Prolonged Hospitalisation);Myelitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Pleocytosis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4142150&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4143509	Spontaneous	2010-12-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Periarthritis (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4143509&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4138253	Spontaneous	2010-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Speech disorder (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Tic (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4138253&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4138355	Spontaneous	2010-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Infant	No	Female	Presyncope (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|ROTATEQ [ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE) PRODUCED ON VERO CELLS, ROTAVIRUS SEROTYPE G1 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G2 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G3 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE G4 HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE), ROTAVIRUS SEROTYPE P1[8] HUMAN-BOVINE ROTAVIRUS REASSORTANTS (LIVE)] (S - n/a - n/a - [n/a - n/a - Oral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4138355&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4139679	Spontaneous	2010-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Condition aggravated (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4139679&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4140941	Spontaneous	2010-12-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Blood creatine phosphokinase increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Monoparesis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Neuropathy peripheral (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Paraesthesia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4140941&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4136221	Spontaneous	2010-12-01 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Influenza (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Antiviral prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4136221&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4136696	Spontaneous	2010-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4136696&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4136851	Spontaneous	2010-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4136851&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4136879	Spontaneous	2010-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Irritability (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4136879&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4137684	Spontaneous	2010-12-01 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Aphthous ulcer (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hyperpyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4137684&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4137685	Spontaneous	2010-12-01 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	Yes	Female	Guillain-Barre syndrome (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4137685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4132933	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Seizure (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4132933&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4133969	Spontaneous	2010-11-30 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4133969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4130735	Spontaneous	2010-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Generalised tonic-clonic seizure (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4130735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4131291	Spontaneous	2010-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Asthma (n/a - Unknown - Other Medically Important Condition);Chest discomfort (n/a - Unknown - Other Medically Important Condition);Chills (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Dyspnoea (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Heart rate increased (n/a - Unknown - Other Medically Important Condition);Lymphadenopathy (n/a - Unknown - Other Medically Important Condition);Nasopharyngitis (n/a - Unknown - Other Medically Important Condition);Peak expiratory flow rate decreased (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Throat tightness (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	PLAVIX [CLOPIDOGREL, CLOPIDOGREL HYDROGEN SULFATE] (C - n/a - Unknown - [n/a - 75mg - Unknown])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - Unknown - [n/a - n/a - Unknown])|[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - 10mg - Unknown])|[TERBUTALINE SULFATE, TERBUTALINE SULFATE PH. EUR.] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4131291&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4132408	Spontaneous	2010-11-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Burning sensation (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Unknown - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fibromyalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Formication (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);General physical health deterioration (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperhidrosis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Musculoskeletal stiffness (n/a - Unknown - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Unknown - Caused/Prolonged Hospitalisation);Oedema (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Presyncope (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation);Sexual dysfunction (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Sleep disorder (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Tinnitus (n/a - Unknown - Caused/Prolonged Hospitalisation);Vision blurred (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|OESTROPROGESTATIVE CONTRACEPTION [ESTROGEN, PROGESTERONE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE, SODIUM CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE, SODIUM CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE GEL, DRIED, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE GEL, DRIED USP, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALUMINIUM HYDROXIDE GEL, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, SODIUM ALGINATE] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - Depression - Unknown - [n/a - n/a - Unknown])|[MACROGOL 4000] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4132408&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4128335	Spontaneous	2010-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Back pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Depression (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Joint swelling (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Polyarthritis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Spondylitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Tenosynovitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4128335&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4128611	Spontaneous	2010-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4128611&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4128684	Spontaneous	2010-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Diarrhoea (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Erythema multiforme (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - Not applicable - [1d - .5mL - Intramuscular])	[FERROUS SULFATE] (C - n/a - n/a - [n/a - 200mg - Oral])|[PARACETAMOL] (C - Dysmenorrhoea - n/a - [n/a - 1g - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4128684&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4128839	Spontaneous	2010-11-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abdominal pain (n/a - Not Recovered/Not Resolved - Disabling);Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Pyrexia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4128839&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4129394	Spontaneous	2010-11-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition);Hypertension (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Influenza (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Presyncope (n/a - Recovered/Resolved - Other Medically Important Condition);Tachycardia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [1d - n/a - Intramuscular])	[ASCORBIC ACID, CALCIUM GLUBIONATE, CALCIUM CARBONATE, CALCIUM, CALCIUM GLUBIONATE, CALCIUM CARBONATE, COLECALCIFEROL, CALCIUM] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])|[CANDESARTAN CILEXETIL] (C - Product used for unknown indication - Unknown - [n/a - 16mg - Unknown])|[HYDROCHLOROTHIAZIDE] (C - Product used for unknown indication - Unknown - [n/a - 25mg - Unknown])|[VITAMIN D] (C - Product used for unknown indication - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4129394&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4129403	Spontaneous	2010-11-26 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Bronchospasm (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (2d - Recovered/Resolved - Other Medically Important Condition);Oedema mouth (2d - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal swelling (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4129403&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4125424	Spontaneous	2010-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4125424&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4125530	Spontaneous	2010-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Paresis (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4125530&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4126614	Spontaneous	2010-11-25 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Autoimmune disorder (n/a - Not Recovered/Not Resolved - Disabling);Back pain (n/a - Not Recovered/Not Resolved - Disabling);Bronchitis (n/a - Recovered/Resolved - Disabling);Carpal tunnel syndrome (16d - Recovered/Resolved - Disabling);Cell-mediated immune deficiency (n/a - Recovered/Resolved - Disabling);Dental operation (1d - Recovered/Resolved - Disabling);Formication (n/a - Unknown - Disabling);Leukopenia (n/a - Unknown - Disabling);Lymphopenia (29d - Recovered/Resolved - Disabling);Oesophageal candidiasis (n/a - Recovered/Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling);Rheumatic disorder (n/a - Not Recovered/Not Resolved - Disabling);Streptococcal infection (n/a - Recovered/Resolved - Disabling);Tooth abscess (n/a - Recovered/Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	BETA BLOCKER [BETA-BLOCKER] (C - Sinus tachycardia - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4126614&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Duration
EU-EC-4122475	Spontaneous	2010-11-24 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Tetany (n/a - Recovered/Resolved - Other Medically Important Condition);Torticollis (n/a - Recovered/Resolved - Other Medically Important Condition);Xerophthalmia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4122475&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4123124	Spontaneous	2010-11-24 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Chronic fatigue syndrome (n/a - Not Recovered/Not Resolved - Disabling);Diarrhoea (n/a - Recovering/Resolving - Disabling);Dizziness (n/a - Recovering/Resolving - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Malaise (n/a - Recovering/Resolving - Disabling);Muscular weakness (n/a - Not Recovered/Not Resolved - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Recovering/Resolving - Disabling);Palpitations (n/a - Recovering/Resolving - Disabling);Paraesthesia (n/a - Recovering/Resolving - Disabling);Paraesthesia oral (n/a - Recovering/Resolving - Disabling);Poor quality sleep (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4123124&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4118084	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Erythema (n/a - Unknown - Other Medically Important Condition);Extensive swelling of vaccinated limb (n/a - Unknown - Other Medically Important Condition);Food allergy (n/a - Unknown - Other Medically Important Condition);Induration (n/a - Unknown - Other Medically Important Condition);Injection site erythema (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Injection site necrosis (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Skin warm (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4118084&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4118275	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (8d - Recovered/Resolved - Other Medically Important Condition);Eye pain (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (8d - Recovered/Resolved - Other Medically Important Condition);Gastrointestinal infection (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (n/a - Recovered/Resolved - Other Medically Important Condition);Photophobia (n/a - Recovered/Resolved - Other Medically Important Condition);Vertigo (8d - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - 7ug - Intramuscular])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - Hypothyroidism - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4118275&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4118685	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Papilloedema (n/a - Unknown - Other Medically Important Condition);Retinal haemorrhage (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Intramuscular])|REMICADE [INFLIXIMAB] (S - Crohn's disease - Dose not changed - [n/a - n/a - Intravenous (not otherwise specified)])	[AZATHIOPRINE] (C - Crohn's disease - n/a - [n/a - 25mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4118685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4119319	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cough (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Depressed level of consciousness (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Diarrhoea (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Gastrooesophageal reflux disease (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Psychomotor hyperactivity (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Rash (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Sleep disorder (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Tic (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4119319&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4120101	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Arthralgia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Coordination abnormal (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Myalgia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neuralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Neuropathy peripheral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4120101&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4120208	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Female	Cyanosis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Febrile convulsion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypotonia (15min - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Screaming (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4120208&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4120337	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Seizure (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4120337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4120372	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Asthenia (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition);Syncope (n/a - Unknown - Other Medically Important Condition);Vision blurred (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4120372&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4120387	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Pain in extremity (n/a - Recovered/Resolved - Other Medically Important Condition);Paresis (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4120387&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4120400	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Febrile convulsion (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4120400&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4120401	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	Yes	Female	Pneumonia (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4120401&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4120440	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4120440&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4120513	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Cough (n/a - Unknown - Other Medically Important Condition);Cyanosis (n/a - Unknown - Other Medically Important Condition);Pneumonia (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Respiratory distress (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4120513&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4121246	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Dizziness (n/a - Unknown - Other Medically Important Condition);Hypertension (n/a - Unknown - Other Medically Important Condition);Nausea (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition);Tachycardia (n/a - Unknown - Other Medically Important Condition);Vomiting (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4121246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4121341	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Female	Diarrhoea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypertension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Mobility decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Sepsis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Urinary tract infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4121341&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4121523	Spontaneous	2010-11-23 00:00:00	Non Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Male	Chest discomfort (n/a - Unknown - Life Threatening);Dizziness (n/a - Unknown - Life Threatening);Dry mouth (n/a - Unknown - Life Threatening);Epilepsy (n/a - Unknown - Life Threatening);Formication (n/a - Unknown - Life Threatening);Hypoaesthesia oral (n/a - Unknown - Life Threatening)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])|[A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), INFLUENZA VACCINE] (S - Immunisation - n/a - [n/a - n/a - n/a])	TELMISARTAN [TELMISARTAN] (C - n/a - Unknown - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4121523&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4121555	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Renal colic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 2{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4121555&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4121617	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Polyneuropathy (n/a - Recovered/Resolved With Sequelae - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4121617&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-4121641	Spontaneous	2010-11-23 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Renal colic (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 2{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4121641&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4114560	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Hypotonic-hyporesponsive episode (n/a - Recovered/Resolved - Other Medically Important Condition);Pallor (n/a - Recovered/Resolved - Other Medically Important Condition);Slow response to stimuli (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4114560&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4114827	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	Yes	Male	Encephalitis (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4114827&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4114994	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	Yes	Male	Anaphylactic reaction (n/a - Recovering/Resolving - Other Medically Important Condition);Rash erythematous (n/a - Recovering/Resolving - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4114994&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4114995	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Chronic obstructive pulmonary disease (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dysaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4114995&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4115121	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Periarthritis (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - % - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4115229	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Pain in extremity (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	ACTRAPID [INSULIN HUMAN, INSULIN HUMAN (RDNA)] (C - n/a - n/a - [n/a - n/a - Subcutaneous])|INSULATARD [INSULIN HUMAN, INSULIN HUMAN (RDNA), INSULIN HUMAN ISOPHANE (RDNA)] (C - n/a - n/a - [n/a - n/a - Subcutaneous])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115229&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4115246	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Malaise (n/a - Fatal - Results in Death, Other Medically Important Condition);Sudden death (n/a - Fatal - Results in Death, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4115549	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Radiculitis brachial (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115549&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4115705	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115705&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4115892	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115892&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4115926	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	Yes	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Recovering/Resolving - Other Medically Important Condition);Rash (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4115926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4116046	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Asthma (n/a - Unknown - Other Medically Important Condition);Bronchospasm (n/a - Unknown - Other Medically Important Condition);Cough (n/a - Unknown - Other Medically Important Condition);Crying (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Tachypnoea (n/a - Unknown - Other Medically Important Condition);Tearfulness (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4116046&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4116082	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4116082&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4116105	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	3-11 Years	Not Specified	Yes	Female	Diplegia (0d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Headache (0d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hyperhidrosis (0d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Loss of consciousness (0d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Vomiting (0d - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4116105&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4116116	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Anaphylactic reaction (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Face oedema (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Laryngospasm (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Rash macular (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[DIPHTHERIA, TETANUS, PERTUSSIS AND HAEMOPHILUS B VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[HEPATITIS B VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4116116&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4116542	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	HELLP syndrome (n/a - Recovered/Resolved - Life Threatening)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Drug withdrawn - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4116542&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4116547	Spontaneous	2010-11-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Acute kidney injury (4mo - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Coma acidotic (4mo - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hepatic cytolysis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Lactic acidosis (4mo - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	APROVEL [IRBESARTAN] (S - Hypertension - Drug withdrawn - [n/a - n/a - Oral])|COMPETACT [METFORMIN HYDROCHLORIDE, PIOGLITAZONE] (S - Type 2 diabetes mellitus - Drug withdrawn - [n/a - n/a - Oral])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	[ALFUZOSIN HYDROCHLORIDE] (C - n/a - Drug withdrawn - [n/a - n/a - Oral])|[AMISULPRIDE] (C - n/a - Drug withdrawn - [n/a - n/a - Oral])|[BIPERIDEN, BIPERIDEN HYDROCHLORIDE, BIPERIDEN LACTATE] (C - n/a - Drug withdrawn - [n/a - n/a - n/a])|[KETOPROFEN] (C - n/a - Drug withdrawn - [n/a - 1{DF} - Oral])|[PRAVASTATIN SODIUM, ACETYLSALICYLIC ACID] (C - n/a - Drug withdrawn - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4116547&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4109320	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Granulomatosis with polyangiitis (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4109320&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4110551	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4110551&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4110865	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Encephalitis (n/a - Unknown - Other Medically Important Condition);Irritability (n/a - Unknown - Other Medically Important Condition);Pyrexia (3d - Unknown - Other Medically Important Condition);Tearfulness (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4110865&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4111041	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Ear infection (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Meningitis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4111041&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4111102	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Female	Eye movement disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Hyperhidrosis (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4111102&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4111140	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paresis (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4111140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4111290	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4111290&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4112248	Spontaneous	2010-11-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Peripheral paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4112248&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4105538	Spontaneous	2010-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Anaphylactic reaction (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Blood pressure decreased (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Oxygen saturation decreased (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Paraesthesia (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Speech disorder (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Swollen tongue (1d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	INSULIN ASPART [INSULIN ASPART] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - Unknown])|[AMOXICILLIN, AMOXICILLIN TRIHYDRATE] (C - Lower respiratory tract infection - n/a - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4105538&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4106043	Spontaneous	2010-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Disturbance in attention (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Fall (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Hallucination (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Nightmare (n/a - Unknown - Caused/Prolonged Hospitalisation);Restlessness (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Sleep talking (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight increased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	CONTRACEPTIVE [BIRTH CONTROL] (C - n/a - Unknown - [n/a - n/a - Unknown])|XENICAL [ORLISTAT] (C - Weight increased - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4106043&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4106682	Spontaneous	2010-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Male	General physical health deterioration (n/a - Not Recovered/Not Resolved - Disabling);Parkinsonism (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[PHENOBARBITAL] (C - n/a - n/a - [n/a - n/a - n/a])|[PHENYTOIN] (C - n/a - n/a - [n/a - n/a - Oral])|[SELEGILINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4106682&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4106991	Spontaneous	2010-11-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Encephalitis (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition);Status epilepticus (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Other Medically Important Condition)	GARDASIL [HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED - IN THE FORM OF VIRUS-LIKE PARTICLES PRODUCED IN YEAST CELLS (SACCHAROMYCES CEREVISIAE CANADE 3C-5 (STRAIN 1895)) BY RDNA, AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE, HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN, HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18] (RECOMBINANT, ADSORBED)] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])|PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[CLEMIZOLE PENICILLIN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4106991&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4102707	Spontaneous	2010-11-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Caesarean section (n/a - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4102707&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4102709	Spontaneous	2010-11-17 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	Yes	Not Specified	Cerebral haemorrhage foetal (n/a - Unknown - Disabling, Congenital Anomaly);Congenital hydrocephalus (n/a - Unknown - Disabling, Congenital Anomaly);Foetal exposure during pregnancy (n/a - Unknown - Disabling, Congenital Anomaly);Sensorimotor disorder (n/a - Unknown - Disabling, Congenital Anomaly);Surgery (n/a - Unknown - Disabling, Congenital Anomaly);Vascular shunt (n/a - Unknown - Disabling, Congenital Anomaly)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4102709&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4103005	Spontaneous	2010-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Hemiparesis (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4103005&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4103115	Spontaneous	2010-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Areflexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);CSF protein increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Fall (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypokalaemia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Leukoencephalopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paralysis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Paraparesis (50d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Quadriparesis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Sensory disturbance (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	CYMBALTA [DULOXETINE, DULOXETINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - 60mg - Unknown])|[ACETYLCYSTEINE] (C - n/a - Unknown - [n/a - 600mg - Unknown])|[ALPRAZOLAM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[BETAHISTINE, BETAHISTINE DIHYDROCHLORIDE, BETAHISTINE MESILATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[COLCHICINE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE, FENOTEROL HYDROBROMIDE, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[FLUTICASONE PROPIONATE, SALMETEROL, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[GABAPENTIN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[IPRATROPIUM, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE ANHYDROUS, IPRATROPIUM BROMIDE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LACTULOSE, LACTULOSE, LIQUID] (C - n/a - Unknown - [n/a - n/a - Unknown])|[LORMETAZEPAM] (C - n/a - Unknown - [n/a - n/a - Unknown])|[METHYLPREDNISOLONE] (C - n/a - Unknown - [n/a - 8mg - Unknown])|[MOLSIDOMINE] (C - n/a - Unknown - [n/a - 16mg - Unknown])|[OMEPRAZOLE] (C - n/a - Unknown - [n/a - 20mg - Unknown])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (C - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])|[PROTHIPENDYL HYDROCHLORIDE, PROTHIPENDYL HYDROCHLORIDE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[SIMVASTATIN] (C - n/a - Unknown - [n/a - n/a - Unknown])|[THEOPHYLLINE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[TICLOPIDINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[TIOTROPIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4103115&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4103224	Spontaneous	2010-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthma (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Blindness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Iritis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Productive cough (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[FELODIPINE, FELODIPINE PH. EUR.] (C - Hypertension - Unknown - [n/a - 10mg - Oral])|[LOSARTAN, LOSARTAN POTASSIUM] (C - Hypertension - Unknown - [n/a - 50mg - Oral])|[METFORMIN, METFORMIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE BP] (C - Type 2 diabetes mellitus - Unknown - [n/a - 1500mg - Oral])|[SIMVASTATIN] (C - Hypercholesterolaemia - Unknown - [n/a - 20mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4103224&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4104735	Spontaneous	2010-11-17 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dysgeusia (1a - Not Recovered/Not Resolved - Other Medically Important Condition);Hypogeusia (1a - Not Recovered/Not Resolved - Other Medically Important Condition);Hyposmia (1a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4104735&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4099894	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4099894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4099960	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Amnesia (n/a - Not Recovered/Not Resolved - Disabling);Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Crepitations (n/a - Not Recovered/Not Resolved - Disabling);Headache (n/a - Not Recovered/Not Resolved - Disabling);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Disabling);Lower respiratory tract infection (n/a - Not Recovered/Not Resolved - Disabling);Wheezing (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[FLUTICASONE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])|[IPRATROPIUM BROMIDE] (C - n/a - n/a - [n/a - n/a - Unknown])|[PREDNISOLONE] (C - Asthma - n/a - [5d - 30mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4099960&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4099978	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Dizziness (1d - Recovered/Resolved - Other Medically Important Condition);Feeling cold (1d - Recovered/Resolved - Other Medically Important Condition);Malaise (1d - Recovered/Resolved - Other Medically Important Condition);Peripheral coldness (1d - Recovered/Resolved - Other Medically Important Condition);Vomiting (1d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [1d - .5mL - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4099978&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4100091	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100091&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4100189	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100189&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4100561	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Abdominal pain (n/a - Recovering/Resolving - Other Medically Important Condition);Fatigue (n/a - Recovering/Resolving - Other Medically Important Condition);Gianotti-Crosti syndrome (n/a - Recovering/Resolving - Other Medically Important Condition);Vomiting (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100561&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4100677	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100677&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4100687	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Headache (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Presyncope (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100687&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4100691	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Polymyalgia rheumatica (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100691&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4100862	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Headache (n/a - Recovering/Resolving - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition);Presyncope (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4100862&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4101147	Spontaneous	2010-11-16 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Cardiac failure acute (1d - Fatal - Results in Death, Life Threatening);Cardiac hypertrophy (n/a - Fatal - Results in Death, Life Threatening);Circulatory collapse (1d - Fatal - Results in Death, Life Threatening);Decreased appetite (n/a - Unknown - Results in Death, Life Threatening);Dizziness (n/a - Unknown - Results in Death, Life Threatening);Hyperhidrosis (n/a - Unknown - Results in Death, Life Threatening);Lung disorder (n/a - Fatal - Results in Death, Life Threatening);Muscle spasms (n/a - Unknown - Results in Death, Life Threatening);Nausea (n/a - Unknown - Results in Death, Life Threatening);Pain (n/a - Unknown - Results in Death, Life Threatening)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	FENTANYL [FENTANYL, FENTANYL CITRATE] (C - n/a - Unknown - [n/a - n/a - Transdermal])|[AZATHIOPRINE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187)] (C - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[DICLOFENAC, DICLOFENAC DIETHYLAMINE, DICLOFENAC EPOLAMINE, DICLOFENAC POTASSIUM, DICLOFENAC RESINATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM PH. EUR.] (C - n/a - Unknown - [n/a - n/a - Unknown])|[IBUPROFEN, IBUPROFEN SODIUM, IBUPROFEN SODIUM DIHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[METAMIZOLE, METAMIZOLE SODIUM, METAMIZOLE SODIUM MONOHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[MIRTAZAPINE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[OXYGEN] (C - n/a - Unknown - [n/a - n/a - Respiratory (inhalation)])|[PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM SESQUIHYDRATE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1, PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A, PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT)] (C - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])|[POTASSIUM CHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[POTASSIUM, SODIUM, MACROGOL 3350, CHLORIDE ION, HYDROGEN CARBONATE, SODIUM HYDROGEN CARBONATE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, MACROGOL 3350] (C - n/a - Unknown - [n/a - n/a - Unknown])|[PREDNISONE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[TAMSULOSIN HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[TRIAMTERENE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - n/a - Unknown - [n/a - n/a - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4101147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4102155	Spontaneous	2010-11-16 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Vasa praevia (n/a - Not Specified - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4102155&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4097494	Spontaneous	2010-11-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chest pain (12h - Recovered/Resolved - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])|[INFLUENZA VIRUS VACCINE POLYVALENT] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4097494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4097568	Spontaneous	2010-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Not Specified	Yes	Male	Coloboma (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Microphthalmos (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Optic atrophy (n/a - Not Recovered/Not Resolved - Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4097568&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-4097681	Spontaneous	2010-11-15 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Rheumatoid arthritis (n/a - Not Recovered/Not Resolved - Disabling)	[A/CALIFORNIA/7/2009 (H1N1), A/VICTORIA/361/2011 (H3N2)–DERIVED STRAIN USED (IVR-165), B/WISCONSIN/1/2010-LIKE STRAIN USED (NYMC BX-39) DERIVED FROM B/HUBEI-WUJIAGANG/158/2009, A/CALIFORNIA/7/2009 (H1N1) PDM09 – LIKE STRAIN USED (NIB-74) DERIVED FROM A/CHRISTCHURCH/16/2010] (S - Prophylaxis - Not applicable - [1d - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4097681&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4096431	Spontaneous	2010-11-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chest pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling);Polyneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4096431&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4093788	Spontaneous	2010-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Back pain (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Demyelination (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hyperaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypoaesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myalgia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myelitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Spinal cord injury (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4093788&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4093990	Spontaneous	2010-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Decreased appetite (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Sudden onset of sleep (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Weight decreased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - n/a])	CLOPIDOGREL [CLOPIDOGREL, CLOPIDOGREL BESILATE] (C - n/a - n/a - [n/a - 75mg - n/a])|STEROIDS [NOT AVAILABLE] (C - Polymyalgia rheumatica - n/a - [n/a - n/a - n/a])|[AZATHIOPRINE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL TARTRATE, METOPROLOL TARTRATE BP] (C - n/a - n/a - [16y - 50mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4093990&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4094494	Spontaneous	2010-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (n/a - Recovered/Resolved - Disabling);Fatigue (1a - Recovering/Resolving - Disabling);Injection site erythema (n/a - Recovered/Resolved - Disabling);Injection site extravasation (1wk - Recovered/Resolved - Disabling);Injection site pain (1a - Recovering/Resolving - Disabling);Injection site swelling (1wk - Recovered/Resolved - Disabling);Nausea (n/a - Recovered/Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4094494&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4095123	Spontaneous	2010-11-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Aspiration (n/a - Fatal - Results in Death);Sudden death (n/a - Fatal - Results in Death)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4095123&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4087835	Spontaneous	2010-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chills (2d - Recovered/Resolved - Other Medically Important Condition);Feeling cold (2d - Recovered/Resolved - Other Medically Important Condition);Peripheral circulatory failure (2d - Recovered/Resolved - Other Medically Important Condition);Peripheral coldness (2d - Recovered/Resolved - Other Medically Important Condition);Vomiting (2d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4087835&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4087928	Spontaneous	2010-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (4mo - Recovered/Resolved - Other Medically Important Condition);Injection site discomfort (4mo - Recovered/Resolved - Other Medically Important Condition);Injection site joint pain (4mo - Recovered/Resolved - Other Medically Important Condition);Injection site pain (4mo - Recovered/Resolved - Other Medically Important Condition);Monoplegia (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (4mo - Recovered/Resolved - Other Medically Important Condition);Tenderness (4mo - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - % - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4087928&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4087947	Spontaneous	2010-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	IBUPROFEN [IBUPROFEN, IBUPROFEN SODIUM] (C - n/a - n/a - [n/a - mg - n/a])|[CLONAZEPAM] (C - n/a - n/a - [n/a - mg - Oral])|[METHADONE] (C - n/a - n/a - [n/a - n/a - Oral])|[METOCLOPRAMIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 10mg - Oral])|[OMEPRAZOLE] (C - n/a - n/a - [n/a - 20mg - n/a])|[PROPANTHELINE BROMIDE] (C - n/a - n/a - [n/a - mg - Oral])|[ZOPICLONE] (C - n/a - n/a - [n/a - 7.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4087947&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4087969	Spontaneous	2010-11-10 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Demyelination (n/a - Not Recovered/Not Resolved - Disabling);Facial paralysis (n/a - Not Recovered/Not Resolved - Disabling);Hemiparesis (n/a - Not Recovered/Not Resolved - Disabling);Local reaction (n/a - Recovered/Resolved - Disabling);Multiple sclerosis (60d - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4087969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4088444	Spontaneous	2010-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Abdominal pain upper (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Atrial fibrillation (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);General physical health deterioration (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypotension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Left ventricular hypertrophy (n/a - Unknown - Caused/Prolonged Hospitalisation);Mitral valve incompetence (n/a - Unknown - Caused/Prolonged Hospitalisation);Palpitations (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Supraventricular tachycardia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Tricuspid valve incompetence (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[TAMSULOSIN, TAMSULOSIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4088444&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4088473	Spontaneous	2010-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Hypoaesthesia (n/a - Recovering/Resolving - Disabling);Pain in extremity (n/a - Recovering/Resolving - Disabling);Paraesthesia (n/a - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4088473&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4088491	Spontaneous	2010-11-10 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Facial paresis (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (C - Influenza - n/a - [n/a - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4088491&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4085111	Spontaneous	2010-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chest pain (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Cough (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dyspnoea (16d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Respiratory failure (16d - Recovering/Resolving - Caused/Prolonged Hospitalisation);Respiratory muscle weakness (16d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - Not applicable - [n/a - .5mL - Intramuscular])	[CHLORTALIDONE] (C - Essential hypertension - Unknown - [n/a - 100mg - Oral])|[GLICLAZIDE] (C - Type 2 diabetes mellitus - Unknown - [n/a - n/a - Oral])|[LIPOIC ACID TROMETAMOL SALT, THIOCTIC ACID] (C - n/a - Unknown - [n/a - 600mg - n/a])|[LISINOPRIL] (C - Essential hypertension - Unknown - [n/a - 10mg - Oral])|[METOPROLOL, METOPROLOL TARTRATE] (C - Essential hypertension - Unknown - [n/a - 100mg - Oral])|[PENTOXIFYLLINE] (C - n/a - Unknown - [n/a - 600mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4085111&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4086246	Spontaneous	2010-11-09 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Vasculitis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4086246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4081143	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Arthralgia (n/a - Unknown - Other Medically Important Condition);Dizziness (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia oral (n/a - Unknown - Other Medically Important Condition);Malaise (n/a - Unknown - Other Medically Important Condition);Muscular weakness (n/a - Unknown - Other Medically Important Condition);Neuropathy peripheral (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4081143&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4081589	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Injection site necrosis (1a - Recovered/Resolved With Sequelae - Other Medically Important Condition)	PANDEMRIX SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4081589&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-4081602	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Acute sinusitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Arthralgia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Asthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Blood pressure increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Central pain syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Chills (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Cough (n/a - Unknown - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Unknown - Caused/Prolonged Hospitalisation);Diplegia (n/a - Unknown - Caused/Prolonged Hospitalisation);Disability (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Dyspnoea exertional (n/a - Unknown - Caused/Prolonged Hospitalisation);Fatigue (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Ill-defined disorder (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza (n/a - Unknown - Caused/Prolonged Hospitalisation);Influenza like illness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Laryngitis (n/a - Unknown - Caused/Prolonged Hospitalisation);Oropharyngeal pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Unknown - Caused/Prolonged Hospitalisation);Paranasal sinus discomfort (n/a - Unknown - Caused/Prolonged Hospitalisation);Paranasal sinus hypersecretion (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (3d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Radiculopathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Weight decreased (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4081602&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4081906	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Cerebral infarction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	UNIKALK SENIOR/SILVER [NOT AVAILABLE] (C - n/a - n/a - [n/a - n/a - n/a])|[CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - 16mg - n/a])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - Nephrotic syndrome - n/a - [n/a - 40mg - n/a])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - n/a - n/a - [n/a - 50mg - n/a])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - 20mg - n/a])|[POTASSIUM CHLORIDE] (C - Nephrotic syndrome - n/a - [n/a - 750mg - n/a])|[PREDNISOLONE] (C - Nephrotic syndrome - n/a - [n/a - n/a - n/a])|[SIMVASTATIN] (C - n/a - n/a - [n/a - 40mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4081906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4082308	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Behaviour disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Discomfort (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Fatigue (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Infantile spasms (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4082308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4082309	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion late (n/a - Fatal - Results in Death, Other Medically Important Condition);Cold sweat (n/a - Recovered/Resolved - Results in Death, Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Results in Death, Other Medically Important Condition);Nausea (n/a - Recovered/Resolved - Results in Death, Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Results in Death, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4082309&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4082598	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Hepatic enzyme abnormal (50d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hepatitis (50d - Recovered/Resolved - Life Threatening, Other Medically Important Condition);Hepatitis acute (50d - Recovered/Resolved - Life Threatening, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4082598&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4083154	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blood pressure decreased (n/a - Recovered/Resolved - Other Medically Important Condition);Dizziness (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - 1{DF} - Subcutaneous])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4083154&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4083812	Spontaneous	2010-11-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Acute kidney injury (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Pyrexia (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/GUANGDONG-MAONAN/SWL1536/2019 (H1N1)PDM09 - LIKE VIRUS (A/GUANGDONG-MAONAN/SWL1536/2019, CNIC-1909), A/HONG KONG/2671/2019 (H3N2) - LIKE VIRUS (A/HONG KONG/2671/2019, IVR-208), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - n/a - n/a])...	[ALFUZOSIN HYDROCHLORIDE] (C - n/a - Dose not changed - [n/a - 1{DF} - Oral])|[ALPRAZOLAM] (C - n/a - n/a - [n/a - 1.5{DF} - Oral])|[ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE, SODIUM CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE, SODIUM CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE GEL, DRIED, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, ALUMINIUM HYDROXIDE GEL, DRIED USP, SODIUM HYDROGEN CARBONATE, ALGINIC ACID, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, ALUMINIUM HYDROXIDE GEL, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, SODIUM HYDROGEN CARBONATE, CALCIUM CARBONATE, SODIUM ALGINATE, ALUMINIUM HYDROXIDE, SODIUM HYDROGEN CARBONATE, SODIUM ALGINATE] (C - n/a - Drug withdrawn - [n/a - 3{DF} - Oral])|[MACROGOL 4000] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[PINAVERIUM BROMIDE] (C - n/a - Drug withdrawn - [n/a - 2{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4083812&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4078685	Spontaneous	2010-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Congenital foot malformation (n/a - Not Recovered/Not Resolved - Congenital Anomaly);Congenital hand malformation (n/a - Not Recovered/Not Resolved - Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4078685&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-4078700	Spontaneous	2010-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Not Specified	No	Female	Somnolence (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - n/a - n/a])|[BENSERAZIDE HYDROCHLORIDE, LEVODOPA, BENSERAZIDE, LEVODOPA] (C - n/a - n/a - [n/a - n/a - n/a])|[BUDESONIDE, BUDESONIDE, MICRONISED] (C - n/a - n/a - [n/a - n/a - n/a])|[ESTRIOL] (C - n/a - n/a - [n/a - n/a - n/a])|[PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4078700&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4078713	Spontaneous	2010-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dizziness (14d - Recovered/Resolved - Disabling);Eye pain (14d - Recovered/Resolved - Disabling);Sudden hearing loss (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4078713&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4079118	Spontaneous	2010-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Dizziness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (C - Influenza - n/a - [n/a - n/a - Intramuscular])|[IBUPROFEN] (C - n/a - n/a - [n/a - n/a - n/a])|[LANSOPRAZOLE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4079118&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4079431	Spontaneous	2010-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dizziness (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypotension (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual impairment (n/a - Unknown - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4079431&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4079432	Spontaneous	2010-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation);Injected limb mobility decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site pain (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Injection site reaction (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Mobility decreased (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Peripheral swelling (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4079432&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4079471	Spontaneous	2010-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Atrial fibrillation (165d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Chest pain (165d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Feeling hot (165d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Night sweats (165d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pericarditis (165h - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (165d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - Myocardial ischaemia - n/a - [n/a - 50mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4079471&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4079488	Spontaneous	2010-11-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	No	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4079488&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4079502	Spontaneous	2010-11-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Infant	No	Male	Skin exfoliation (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Staphylococcal scalded skin syndrome (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4079502&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4079503	Spontaneous	2010-11-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Infant	No	Male	Skin exfoliation (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Staphylococcal scalded skin syndrome (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation)	A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4079503&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4080724	Spontaneous	2010-11-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4080724&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4074969	Spontaneous	2010-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Chest discomfort (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Dizziness (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Erythema (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Hypersensitivity (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Nausea (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory distress (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Throat tightness (30min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4074969&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4075662	Spontaneous	2010-11-04 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4075662&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4073088	Spontaneous	2010-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Bell's palsy (38d - Recovered/Resolved - Other Medically Important Condition);Dry eye (n/a - Recovered/Resolved - Other Medically Important Condition);Musculoskeletal stiffness (n/a - Recovered/Resolved - Other Medically Important Condition);Neck pain (n/a - Recovered/Resolved - Other Medically Important Condition);Tic (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4073088&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4073177	Spontaneous	2010-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Headache (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4073177&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4073337	Spontaneous	2010-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Blood creatinine increased (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Complications of transplanted kidney (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Transplant rejection (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	ADVAGRAF [TACROLIMUS] (C - Immunosuppression - n/a - [n/a - 2mg - Oral])|CELLCEPT [MYCOPHENOLATE MOFETIL] (C - Immunosuppression - n/a - [n/a - 250mg - Oral])|[ALFACALCIDOL] (C - Hyperparathyroidism secondary - n/a - [n/a - 1ug - Oral])|[FUROSEMIDE] (C - Diuretic therapy - n/a - [n/a - 125mg - Oral])|[METOPROLOL, METOPROLOL SUCCINATE, METOPROLOL TARTRATE] (C - Hypertension - n/a - [n/a - 100mg - Oral])|[OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE SODIUM] (C - Gastric ulcer - n/a - [n/a - 20mg - Oral])|[POTASSIUM CHLORIDE] (C - Mineral supplementation - n/a - [n/a - 750mg - Oral])|[PREDNISOLONE] (C - Immunosuppression - n/a - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4073337&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4073585	Spontaneous	2010-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	Yes	Male	Application site swelling (n/a - Unknown - Other Medically Important Condition);Circulatory collapse (n/a - Unknown - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - Not applicable - [n/a - .5mg - Intramuscular])	[PERINDOPRIL, PERINDOPRIL ARGININE] (C - Hypertension - Not applicable - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4073585&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4073617	Spontaneous	2010-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Female	Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Vomiting (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[POTASSIUM CHLORIDE] (C - Renal tubular acidosis - n/a - [n/a - 2mmol - Intravenous (not otherwise specified)])|[SODIUM HYDROGEN CARBONATE] (C - Renal tubular acidosis - n/a - [n/a - 9mmol - Intravenous (not otherwise specified)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4073617&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4073677	Spontaneous	2010-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	No	Female	Hepatitis acute (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4073677&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4073951	Spontaneous	2010-11-03 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abdominal pain upper (3d - Recovered/Resolved - Other Medically Important Condition);Arthralgia (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Chills (2wk - Recovered/Resolved - Other Medically Important Condition);Fatigue (3wk - Recovered/Resolved - Other Medically Important Condition);Feeling cold (2wk - Recovered/Resolved - Other Medically Important Condition);Headache (2wk - Recovered/Resolved - Other Medically Important Condition);Influenza like illness (n/a - Recovered/Resolved With Sequelae - Other Medically Important Condition);Myalgia (4wk - Recovered/Resolved - Other Medically Important Condition);Pain in extremity (1wk - Recovered/Resolved - Other Medically Important Condition);Pyrexia (1wk - Recovered/Resolved - Other Medically Important Condition);Synovial cyst (2wk - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - 1{DF} - Intramuscular])	[BISOPROLOL FUMARATE] (C - n/a - n/a - [n/a - n/a - Oral])|[ETHINYLESTRADIOL, ETONOGESTREL] (C - n/a - n/a - [n/a - n/a - n/a])|[IBUPROFEN, IBUPROFEN BP, IBUPROFEN, CODEINE PHOSPHATE HEMIHYDRATE] (C - n/a - n/a - [n/a - 400mg - Oral])|[PARACETAMOL] (C - n/a - n/a - [n/a - 1{DF} - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4073951&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Sequelae
EU-EC-4070350	Spontaneous	2010-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Female	Circulatory collapse (n/a - Unknown - Other Medically Important Condition);Fatigue (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4070350&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4070642	Spontaneous	2010-11-02 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chronic obstructive pulmonary disease (11d - Recovering/Resolving - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	[BUDESONIDE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, BUDESONIDE] (C - n/a - n/a - [n/a - n/a - Respiratory (inhalation)])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4070642&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4068295	Spontaneous	2010-11-01 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Rash (n/a - Recovered/Resolved - Other Medically Important Condition);Vasculitis (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - 3.75ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4068295&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4065426	Spontaneous	2010-10-29 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Multiple sclerosis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	[BENDROFLUAZIDE, BENDROFLUMETHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4065426&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4065544	Spontaneous	2010-10-29 00:00:00	Healthcare Professional	Non European Economic Area	Dauvilliers et al. Post H1N1 narcolepsy-cataplexy. Sleep 2010 33: (11); 1-3	3-11 Years	Not Specified	No	Not Specified	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4065544&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4059823	Spontaneous	2010-10-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Muscular weakness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	FOCETRIA SUSPENSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4059823&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4060642	Spontaneous	2010-10-28 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Discomfort (n/a - Unknown - Disabling);Dizziness (n/a - Unknown - Disabling);Fatigue (n/a - Unknown - Disabling);Headache (n/a - Unknown - Disabling);Muscular weakness (n/a - Unknown - Disabling);Nausea (n/a - Unknown - Disabling);Somnolence (n/a - Unknown - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4060642&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4060772	Spontaneous	2010-10-28 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Chest discomfort (60min - Recovered/Resolved - Other Medically Important Condition);Cough (60min - Recovered/Resolved - Other Medically Important Condition);Dizziness (5d - Recovered/Resolved - Other Medically Important Condition);Pain (5d - Recovered/Resolved - Other Medically Important Condition);Pruritus (2d - Recovered/Resolved - Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition);Urticaria (2d - Recovered/Resolved - Other Medically Important Condition);Wheezing (60min - Recovered/Resolved - Other Medically Important Condition)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Product used for unknown indication - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4060772&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4060894	Spontaneous	2010-10-28 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Muscular weakness (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Myelitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4060894&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4062622	Spontaneous	2010-10-28 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Angina unstable (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation);Troponin increased (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4062622&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4056148	Spontaneous	2010-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Epilepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Pupil fixed (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4056148&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4056425	Spontaneous	2010-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Febrile convulsion (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .25mL - Intramuscular])|[INFLUENZA VIRUS] (S - Immunisation - Not applicable - [1d - .5mL - Intramuscular])	[ALPHA-TOCOPHEROL] (C - n/a - n/a - [n/a - .5 - Oral])|[AMOXICILLIN SODIUM, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, CLAVULANIC ACID, AMOXICILLIN TRIHYDRATE, POTASSIUM CLAVULANATE, AMOXICILLIN, CLAVULANIC ACID, AMOXICILLIN, POTASSIUM CLAVULANATE] (C - n/a - n/a - [n/a - n/a - n/a])|[AMYLASE, LIPASE, PROTEASE, PANCREALIPASE, PANCREAS POWDER, PANCREAS POWDER FROM PORCINE, PANCREATIN, PANCREATIN BP] (C - n/a - n/a - [n/a - n/a - Oral])|[CLARITHROMYCIN] (C - n/a - n/a - [n/a - n/a - n/a])|[RETINOL PALMITATE, ERGOCALCIFEROL BP, NICOTINAMIDE BP, RIBOFLAVIN BP, ASCORBIC ACID BP, THIAMINE HYDROCHLORIDE BP, PYRIDOXINE HYDROCHLORIDE BP, RETINOL PALMITATE, ERGOCALCIFEROL PH. EUR., NICOTINAMIDE BP, RIBOFLAVIN BP, ASCORBIC ACID BP, THIAMINE HYDROCHLORIDE BP, PYRIDOXINE HYDROCHLORIDE BP, RETINOL PALMITATE, THIAMINE HYDROCHLORIDE, ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[RETINOL PALMITATE, RIBOFLAVIN SODIUM PHOSPHATE, THIAMINE HYDROCHLORIDE, ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, PYRIDOXINE HYDROCHLORIDE, RETINOL PALMITATE, THIAMINE HYDROCHLORIDE, ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE, ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, RETINOL] (C - n/a - n/a - [n/a - .6 - Oral])|[SODIUM CHLORIDE] (C - n/a - n/a - [n/a - 3mL - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4056425&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4056990	Spontaneous	2010-10-27 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Chronic fatigue syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Headache (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Listless (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Malaise (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling);Throat irritation (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), POLYSORBATE 80, SQUALENE, DL-ALPHA-TOCOPHEROL] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4056990&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4057018	Spontaneous	2010-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (4d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4057018&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4057867	Spontaneous	2010-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abortion spontaneous (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site pain (n/a - Recovered/Resolved - Other Medically Important Condition);Injection site swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Peripheral swelling (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (24h - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4057867&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4058167	Spontaneous	2010-10-27 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	Yes	Male	Pneumonia bacterial (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Pneumonia viral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4058167&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4053162	Spontaneous	2010-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Psoriasis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Influenza immunisation - Not applicable - [n/a - .5mL - Intramuscular])	[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 100mg - Oral])|[FENOFIBRATE, FENOFIBRATE MICRONISED] (C - Hyperlipidaemia - n/a - [n/a - n/a - Oral])|[GLICLAZIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - Oral])|[INDAPAMIDE, PERINDOPRIL ARGININE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - n/a - [n/a - 175ug - Oral])|[METFORMIN HYDROCHLORIDE] (C - Type 2 diabetes mellitus - n/a - [n/a - n/a - n/a])|[RILMENIDINE, RILMENIDINE DIHYDROGEN PHOSPHATE] (C - Hypertension - n/a - [n/a - n/a - Oral])|[VERAPAMIL HYDROCHLORIDE] (C - Hypertension - n/a - [n/a - 240mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4053162&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4053408	Spontaneous	2010-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	More than 85 Years	Elderly	No	Female	Macular degeneration (n/a - Unknown - Other Medically Important Condition);Vision blurred (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A)] (S - Immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	[GINKGO BILOBA, GINKGO LEAF DRY EXTRACT, REFINED AND QUANTIFIED] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4053408&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4054754	Spontaneous	2010-10-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Alopecia areata (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - .25mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4054754&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4054816	Spontaneous	2010-10-26 00:00:00	Healthcare Professional	European Economic Area	Dauvilliers et al. Post H1N1 narcolepsy-cataplexy. Sleep 2010 33: (11); 1-3	3-11 Years	Not Specified	No	Not Specified	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4054816&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4054883	Spontaneous	2010-10-26 00:00:00	Healthcare Professional	European Economic Area	Dauvilliers et al. Post H1N1 narcolepsy-cataplexy. Sleep 2010 33: (11); 1-3	3-11 Years	Not Specified	No	Not Specified	Cataplexy (n/a - Unknown - Other Medically Important Condition);Narcolepsy (n/a - Unknown - Other Medically Important Condition);Somnolence (n/a - Unknown - Other Medically Important Condition);Weight increased (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4054883&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4055581	Spontaneous	2010-10-26 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Ageusia (n/a - Recovered/Resolved - );Asthenia (n/a - Recovered/Resolved - );Blood triglycerides increased (n/a - Recovered/Resolved - );C-reactive protein increased (n/a - Recovered/Resolved - );Chills (n/a - Recovered/Resolved - );Constipation (2d - Recovered/Resolved - );Decreased appetite (n/a - Recovered/Resolved - );Dizziness (8d - Recovered/Resolved - );Dry mouth (n/a - Recovered/Resolved - );Dysphagia (n/a - Recovered/Resolved - );Headache (n/a - Recovered/Resolved - );Ketonuria (n/a - Recovering/Resolving - );Lymphadenopathy (5d - Recovered/Resolved - );Myalgia (n/a - Recovered/Resolved With Sequelae - );Night sweats (n/a - Recovered/Resolved - );Paraesthesia (n/a - Recovered/Resolved With Sequelae - );Pyrexia (n/a - Recovered/Resolved - );Somnolence (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	AVANDIA 4 MG FILM-COATED TABLETS [ROSIGLITAZONE MALEATE] (C - n/a - n/a - [n/a - 4mg - n/a])|[METFORMIN, METFORMIN HYDROCHLORIDE] (C - n/a - n/a - [n/a - 850mg - n/a])|[PRAVASTATIN SODIUM] (C - n/a - n/a - [n/a - 20mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4055581&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-4055601	Spontaneous	2010-10-26 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Injection site pain (n/a - Recovering/Resolving - Disabling);Myalgia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1[iU] - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4055601&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4049109	Spontaneous	2010-10-23 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Formication (n/a - Not Specified - Other Medically Important Condition);Hyperglycaemia (n/a - Not Specified - Other Medically Important Condition);Hyperpyrexia (n/a - Not Specified - Other Medically Important Condition);Nausea (n/a - Not Specified - Other Medically Important Condition);Vomiting (n/a - Not Specified - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[INSULIN, INSULIN HUMAN] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4049109&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4046140	Spontaneous	2010-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Acute disseminated encephalomyelitis (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Headache (2mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypersomnia (1mo - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual acuity reduced (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Antiviral prophylaxis - Not applicable - [n/a - n/a - Intramuscular])|[ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALUMINIUM, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED ) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED PRODUCED ON HUMAN DIPLOID (MRC-5) CELLS, ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), HEPATITIS A VIRUS (INACTIVATED) ADSORBED ON ALUMINIUM HYDROXIDE HYDRATED, ALGELDRATE, HEPATITIS A VIRUS (INACTIVATED), ALGELDRATE, HEPATITIS A VIRUS ANTIGEN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALGELDRATE, HEPATITIS A VIRUS HM175 STRAIN (INACTIVATED), ALUMINIUM HYDROXIDE] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4046140&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4046308	Spontaneous	2010-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anosmia (n/a - Unknown - Other Medically Important Condition);Taste disorder (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4046308&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4046357	Spontaneous	2010-10-22 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Not Recovered/Not Resolved - Disabling);Arthritis (n/a - Recovered/Resolved - Disabling);Inflammation (n/a - Unknown - Disabling);Limb discomfort (n/a - Not Recovered/Not Resolved - Disabling);Pain (n/a - Not Recovered/Not Resolved - Disabling);Peripheral swelling (28d - Recovering/Resolving - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4046357&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Duration
EU-EC-4043346	Spontaneous	2010-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Myelitis (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation);Paraplegia (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4043346&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4044375	Spontaneous	2010-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Sudden hearing loss (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4044375&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4044392	Spontaneous	2010-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4044392&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4044405	Spontaneous	2010-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bell's palsy (n/a - Recovering/Resolving - Other Medically Important Condition);Malaise (n/a - Recovering/Resolving - Other Medically Important Condition);Rash (n/a - Recovering/Resolving - Other Medically Important Condition);Vaccination site reaction (n/a - Recovering/Resolving - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4044405&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4044428	Spontaneous	2010-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Interstitial lung disease (212d - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])|[SULFASALAZINE, SULFASALAZINE PH. EUR.] (S - Psoriatic arthropathy - n/a - [n/a - 500mg - Oral])	MIMPARA [CINACALCET, CINACALCET HYDROCHLORIDE] (C - Hyperparathyroidism primary - n/a - [n/a - 30mg - Oral])|[ALENDRONATE SODIUM, ALENDRONIC ACID] (C - n/a - n/a - [n/a - 70mg - Oral])|[AMLODIPINE, AMLODIPINE BESILATE, AMLODIPINE MALEATE, AMLODIPINE MESILATE] (C - Hypertension - n/a - [n/a - 10mg - Oral])|[ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE, ESOMEPRAZOLE SODIUM] (C - n/a - n/a - [n/a - 20mg - Oral])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - Hypertension - n/a - [n/a - 40mg - Oral])|[METOCLOPRAMIDE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 30mg - Oral])|[POTASSIUM CHLORIDE] (C - Mineral supplementation - n/a - [n/a - 750mg - Oral])|[WARFARIN, WARFARIN SODIUM, WARFARIN SODIUM BP] (C - Atrial fibrillation - n/a - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4044428&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4044437	Spontaneous	2010-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Skin reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4044437&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4044536	Spontaneous	2010-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Cyanosis (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Respiratory rate increased (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4044536&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4044619	Spontaneous	2010-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Malaise (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Syncope (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4044619&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4044631	Spontaneous	2010-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4044631&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4044826	Spontaneous	2010-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Unknown - Other Medically Important Condition);Hypoaesthesia (n/a - Unknown - Other Medically Important Condition);Presyncope (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4044826&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4044854	Spontaneous	2010-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Angioedema (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Paraesthesia oral (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4044854&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4044871	Spontaneous	2010-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4044871&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4044882	Spontaneous	2010-10-21 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4044882&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4041430	Spontaneous	2010-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Disabling);Eye disorder (n/a - Not Recovered/Not Resolved - Disabling);Fatigue (n/a - Not Recovered/Not Resolved - Disabling);Nausea (n/a - Not Recovered/Not Resolved - Disabling);Sjogren's syndrome (n/a - Not Recovered/Not Resolved - Disabling);Sleep talking (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	[TRIAMCINOLONE ACETONIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4041430&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4041433	Spontaneous	2010-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Not Specified	No	Female	Decreased appetite (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dry mouth (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Dysarthria (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Hypersomnia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Irritability (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Nasal congestion (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Somnolence (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4041433&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4041848	Spontaneous	2010-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Narcolepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4041848&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4042834	Spontaneous	2010-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Myalgia (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - Not applicable - [n/a - n/a - Intramuscular])	[ATENOLOL, ATENOLOL BP] (C - n/a - n/a - [n/a - n/a - n/a])|[LERCANIDIPINE, LERCANIDIPINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4042834&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4042881	Spontaneous	2010-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Female	Lymphadenopathy (n/a - Recovered/Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Drug withdrawn - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4042881&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4042926	Spontaneous	2010-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Asthenia (n/a - Not Recovered/Not Resolved - );Autoimmune thyroiditis (n/a - Not Recovered/Not Resolved - )	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - Not applicable - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4042926&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4042951	Spontaneous	2010-10-20 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthralgia (n/a - Recovered/Resolved With Sequelae - );Granulomatosis with polyangiitis (n/a - Recovered/Resolved With Sequelae - )	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - n/a - Not applicable - [n/a - 1{DF} - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4042951&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		Sequelae
EU-EC-4039135	Spontaneous	2010-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Erythema multiforme (45d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - 3.75ug - Intramuscular])	[ALLOPURINOL] (C - n/a - n/a - [n/a - 300mg - Oral])|[FUROSEMIDE, FUROSEMIDE SODIUM] (C - Diuretic therapy - n/a - [n/a - 125mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4039135&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Duration
EU-EC-4039571	Spontaneous	2010-10-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Areflexia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Exostosis (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Gait disturbance (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Guillain-Barre syndrome (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hypotonia (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Intervertebral disc disorder (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Intervertebral disc protrusion (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscular weakness (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Paraparesis (n/a - Recovering/Resolving - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - Intramuscular])	[PNEUMOCOCCAL VACCINE] (C - n/a - Unknown - [n/a - n/a - Intramuscular])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4039571&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4040216	Spontaneous	2010-10-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Female	Febrile convulsion (67d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4040216&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4040222	Spontaneous	2010-10-19 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Guillain-Barre syndrome (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4040222&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4040580	Spontaneous	2010-10-19 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Guillain-Barre syndrome (n/a - Not Specified - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - 1{DF} - Intramuscular])	INVEGA [PALIPERIDONE] (C - n/a - n/a - [n/a - n/a - n/a])|[CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE, CANDESARTAN CILEXETIL] (C - n/a - n/a - [n/a - n/a - n/a])|[ESTERS OF UNSATURATED FATTY ACIDS] (C - n/a - n/a - [n/a - n/a - n/a])|[FENOFIBRATE] (C - n/a - n/a - [n/a - n/a - n/a])|[PAROXETINE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE HYDROCHLORIDE, ANHYDROUS] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4040580&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4035617	Spontaneous	2010-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Psoriasis (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - Intramuscular])	[CARBOMER 974P, CARBOMERS] (C - n/a - n/a - [n/a - n/a - n/a])|[DICLOFENAC SODIUM] (C - n/a - n/a - [n/a - n/a - n/a])|[OMEPRAZOLE, PARACETAMOL] (C - n/a - n/a - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[TRIAMCINOLONE, TRIAMCINOLONE ACETONIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4035617&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4036420	Spontaneous	2010-10-18 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4036420&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4032755	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Abnormal dreams (n/a - Unknown - Other Medically Important Condition);Depressed mood (n/a - Unknown - Other Medically Important Condition);Feeling of despair (n/a - Unknown - Other Medically Important Condition);Hyperhidrosis (n/a - Unknown - Other Medically Important Condition);Hypothyroidism (n/a - Unknown - Other Medically Important Condition);Insomnia (n/a - Unknown - Other Medically Important Condition);Nightmare (n/a - Unknown - Other Medically Important Condition);Pyrexia (2d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	[LEVOTHYROXINE, LEVOTHYROXINE SODIUM] (C - n/a - Drug withdrawn - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4032755&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4032785	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Dizziness (n/a - Recovered/Resolved - Life Threatening);Dyspnoea (n/a - Recovered/Resolved - Life Threatening);Headache (n/a - Recovered/Resolved - Life Threatening);Pharyngeal swelling (n/a - Recovered/Resolved - Life Threatening)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4032785&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Life Threatening	Hospitalisation
EU-EC-4032898	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4032898&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4032906	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Child	No	Female	Petit mal epilepsy (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4032906&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4032911	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Male	Crying (n/a - Recovered/Resolved - Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Other Medically Important Condition);Seizure (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4032911&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4032924	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4032924&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4032930	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Febrile convulsion (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4032930&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4032941	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Convulsions local (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4032941&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4032960	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Syncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4032960&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4033078	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	CIRCADIN [MELATONIN] (C - Insomnia - n/a - [n/a - n/a - Oral])|[CISAPRIDE, CISAPRIDE MONOHYDRATE] (C - Gastrooesophageal reflux disease - n/a - [n/a - n/a - Oral])|[FLUOXETINE, FLUOXETINE HYDROCHLORIDE] (C - Behaviour disorder - n/a - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4033078&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4033098	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	0-1 Month	Child	No	Male	Loss of consciousness (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4033098&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4033121	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Male	Seizure (n/a - Unknown - Other Medically Important Condition);Vaccination site reaction (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4033121&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4033157	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Syncope (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4033157&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4033886	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	Non European Economic Area	Not available	12-17 Years	Not Specified	No	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])|[YELLOW FEVER VACCINE] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4033886&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4035299	Spontaneous	2010-10-15 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cardio-respiratory arrest (n/a - Fatal - Results in Death)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[DELAPRIL] (C - Hypertension - n/a - [n/a - 30mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4035299&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4029626	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Laryngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4029626&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4029741	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Laryngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4029741&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4030007	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Malaise (n/a - Recovered/Resolved - Other Medically Important Condition);Premature labour (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4030007&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4030166	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dysphonia (n/a - Recovered/Resolved - Other Medically Important Condition);Dyspnoea (n/a - Recovered/Resolved - Other Medically Important Condition);Erythema (n/a - Recovered/Resolved - Other Medically Important Condition);Laryngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4030166&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4030246	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Presyncope (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4030246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4030368	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Blood pressure increased (0d - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation);Chest pain (0d - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation);Endocarditis (n/a - Fatal - Results in Death, Caused/Prolonged Hospitalisation);Haemorrhagic transformation stroke (10d - Recovering/Resolving - Results in Death, Caused/Prolonged Hospitalisation);Myocardial infarction (0d - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation);Pyrexia (n/a - Recovered/Resolved - Results in Death, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	[ACENOCOUMAROL] (C - n/a - n/a - [n/a - .25{DF} - Oral])|[AMIODARONE HYDROCHLORIDE] (C - n/a - n/a - [n/a - 1{DF} - n/a])|[AMLODIPINE, AMLODIPINE BESILATE] (C - n/a - n/a - [n/a - 10mg - n/a])|[ATORVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM TRIHYDRATE] (C - Dyslipidaemia - n/a - [n/a - 40mg - n/a])|[ENALAPRIL MALEATE, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - n/a - n/a])|[METOPROLOL TARTRATE, METOPROLOL TARTRATE BP] (C - n/a - n/a - [n/a - 25mg - n/a])|[OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE] (C - n/a - n/a - [n/a - 40mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4030368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4030464	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Laryngeal oedema (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])|[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4030464&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4030623	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Child	No	Female	Seizure (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4030623&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4030688	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Pneumonia (n/a - Fatal - Results in Death)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - 3.75ug - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4030688&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4030760	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Belgian center for pharmacovigilance. Folia pharmacotherapeutica, June 2010; Volume 37(8): 72	Not Specified	Neonate (Preterm and Term newborns)	Yes	Not Specified	Hydrocephalus (n/a - Unknown - Congenital Anomaly);Maternal exposure timing unspecified (n/a - Unknown - Congenital Anomaly)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4030760&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Congenital Anomaly	
EU-EC-4030982	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cough (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Dyspnoea (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pain (n/a - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Pyrexia (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - 1{DF} - n/a])	NOVONORM [REPAGLINIDE] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|TRACLEER [BOSENTAN] (C - Pulmonary hypertension - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE SODIUM] (C - Thyroid disorder - n/a - [n/a - n/a - n/a])|[METFORMIN HYDROCHLORIDE] (C - Diabetes mellitus - n/a - [n/a - n/a - n/a])|[PREDNISOLONE] (C - Idiopathic pulmonary fibrosis - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4030982&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4031120	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Myalgia (n/a - Recovered/Resolved - Other Medically Important Condition);Premature labour (n/a - Recovered/Resolved - Other Medically Important Condition);Vaccination site reaction (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4031120&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4031251	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Back pain (n/a - Recovered/Resolved - Other Medically Important Condition);Exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition);Pelvic pain (n/a - Recovered/Resolved - Other Medically Important Condition);Uterine contractions during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4031251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4031288	Spontaneous	2010-10-14 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Bell's palsy (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4031288&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4026172	Spontaneous	2010-10-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Amaurosis (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Aphasia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Asthenia (5d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation);Hypoaesthesia oral (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4026172&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4026247	Spontaneous	2010-10-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Cutaneous vasculitis (n/a - Recovered/Resolved - Other Medically Important Condition);Skin ulcer (n/a - Recovered/Resolved - Other Medically Important Condition);Staphylococcal skin infection (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - .5mL - Intramuscular])|HUMIRA [ADALIMUMAB] (S - Psoriasis - Drug withdrawn - [n/a - n/a - Subcutaneous])|HUMIRA [ADALIMUMAB] (S - Psoriasis - n/a - [n/a - n/a - Subcutaneous])	COPALIA [VALSARTAN, AMLODIPINE, VALSARTAN, AMLODIPINE BESILATE] (C - Hypertension - Dose not changed - [n/a - n/a - n/a])|METHOTREXATE [METHOTREXATE] (C - Psoriasis - n/a - [n/a - 15mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4026247&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4026313	Spontaneous	2010-10-13 00:00:00	Healthcare Professional	European Economic Area	Lazanas M.K ,Ntoutsou  F., Peristeraki S.,Tsogkas  N.,Magkafas  N., Lioni A. et, al. Vaccination coverage against the viruses of seasonal influenza and influenza a (h1n1) and pneumococcus in patients with hiv infection: experience of an infection unit. 3d Department of Pathology-Infection unit, Athens General Hospital	Not Specified	Not Specified	No	Not Specified	H1N1 influenza (n/a - Unknown - Other Medically Important Condition);Viral test positive (n/a - Unknown - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4026313&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4026368	Spontaneous	2010-10-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Back pain (n/a - Recovered/Resolved - Disabling);Guillain-Barre syndrome (n/a - Recovering/Resolving - Disabling);Hypoaesthesia (n/a - Recovered/Resolved - Disabling);Muscular weakness (n/a - Recovering/Resolving - Disabling);Myalgia (n/a - Recovered/Resolved - Disabling)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4026368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4026674	Spontaneous	2010-10-13 00:00:00	Non Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	Yes	Not Specified	Maternal exposure timing unspecified (n/a - Unknown - Other Medically Important Condition);Premature baby (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4026674&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4026717	Spontaneous	2010-10-13 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Not Specified	Yes	Male	Congenital inguinal hernia (n/a - Unknown - Other Medically Important Condition);Foetal exposure during pregnancy (n/a - Recovered/Resolved - Other Medically Important Condition);Inguinal hernia repair (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - Transplacental])	[METHYLPREDNISOLONE] (C - n/a - Unknown - [n/a - n/a - Transplacental])|[TINZAPARIN, TINZAPARIN SODIUM] (C - n/a - Unknown - [n/a - n/a - Transplacental])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4026717&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4026719	Spontaneous	2010-10-13 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Foetal death (n/a - Not Specified - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4026719&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4024124	Spontaneous	2010-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Not Specified	Influenza A virus test positive (n/a - Unknown - );Vaccination failure (n/a - Unknown - )	[A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS] (S - Immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4024124&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10		
EU-EC-4025038	Spontaneous	2010-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Complex regional pain syndrome (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Hypoaesthesia (n/a - Recovered/Resolved - Other Medically Important Condition);Muscle twitching (n/a - Recovered/Resolved - Other Medically Important Condition);Myoclonus (n/a - Recovered/Resolved - Other Medically Important Condition);Myokymia (n/a - Recovered/Resolved - Other Medically Important Condition);Neuropathy peripheral (n/a - Recovered/Resolved - Other Medically Important Condition);Vision blurred (n/a - Recovered/Resolved - Other Medically Important Condition)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4025038&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4025094	Spontaneous	2010-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Adolescent	No	Male	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4025094&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4025499	Spontaneous	2010-10-12 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Neuralgia (2mo - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4025499&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4021147	Spontaneous	2010-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Neonate (Preterm and Term newborns)	Yes	Not Specified	Deafness congenital (n/a - Not Recovered/Not Resolved - Disabling, Congenital Anomaly)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - .5mL - Transplacental])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4021147&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	
EU-EC-4022115	Spontaneous	2010-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Confusional state (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Decreased appetite (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Depression (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Fatigue (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Headache (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Nausea (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Photophobia (n/a - Unknown - Caused/Prolonged Hospitalisation);Tremor (9d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Visual impairment (4d - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4022115&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4022477	Spontaneous	2010-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Exposure during pregnancy (n/a - Unknown - Caused/Prolonged Hospitalisation, Other Medically Important Condition);Foetal death (0d - Recovered/Resolved - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - .5mL - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4022477&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4023467	Spontaneous	2010-10-11 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Pulmonary mass (n/a - Recovered/Resolved With Sequelae - Caused/Prolonged Hospitalisation, Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	[DIOSMIN, DIOSMIN, HESPERIDIN] (C - Peripheral venous disease - Unknown - [n/a - n/a - Unknown])|[GRAPES (DRY SEED) STANDARDIZED PROCYANIDOLIC OLIGOMERS, PROCYANIDOL OLIGOMER] (C - Peripheral venous disease - Unknown - [n/a - n/a - Unknown])|[PERINDOPRIL, PERINDOPRIL ARGININE, PERINDOPRIL TERT-BUTYLAMIN MONOHYDRATE, PERINDOPRIL TERT-BUTYLAMINE] (C - Hypertension - Unknown - [n/a - 4mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4023467&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4016853	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Feeling hot (n/a - Not Recovered/Not Resolved - Disabling);Multiple sclerosis (n/a - Not Recovered/Not Resolved - Disabling);Paraesthesia (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4016853&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4016855	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Generalised tonic-clonic seizure (n/a - Unknown - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Glioblastoma multiforme (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling);Glioma (n/a - Not Recovered/Not Resolved - Life Threatening, Caused/Prolonged Hospitalisation, Disabling)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4016855&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4017353	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Not Specified	Yes	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition);Pyrexia (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4017353&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4017589	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Vaginal haemorrhage (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4017589&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4017822	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Pneumonia (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4017822&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4017826	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4017826&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4018164	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthralgia (n/a - Recovering/Resolving - Disabling);Arthritis reactive (n/a - Recovering/Resolving - Disabling);Malaise (n/a - Recovered/Resolved - Disabling);Myalgia (n/a - Recovered/Resolved - Disabling);Pleurisy (n/a - Recovered/Resolved - Disabling);Pneumonia (n/a - Recovered/Resolved - Disabling);Pyrexia (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - n/a - [n/a - 1{DF} - Parenteral])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4018164&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4018271	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	12-17 Years	Not Specified	No	Male	Crohn's disease (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4018271&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4018282	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Male	Polyneuropathy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4018282&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4018507	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Pleural effusion (n/a - Fatal - Results in Death, Other Medically Important Condition);Pneumonia (n/a - Fatal - Results in Death, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4018507&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Results in Death	
EU-EC-4018610	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Asthma (n/a - Unknown - Caused/Prolonged Hospitalisation);Pneumonia (n/a - Unknown - Caused/Prolonged Hospitalisation);Pyrexia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4018610&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4018732	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	Not Specified	Adult	No	Female	Dyspnoea exertional (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Exposure during pregnancy (n/a - Not Specified - Caused/Prolonged Hospitalisation);Tachycardia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation)	FOCETRIA [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Unknown - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4018732&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4018741	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4018741&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4019511	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Female	Bronchospasm (n/a - Recovered/Resolved - Other Medically Important Condition);Pneumonia (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4019511&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4020572	Spontaneous	2010-10-08 00:00:00	Non Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Eye pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Foreign body sensation in eyes (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hemiparesis (n/a - Unknown - Caused/Prolonged Hospitalisation);Hypoaesthesia (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Myoclonus (n/a - Unknown - Caused/Prolonged Hospitalisation);Neck pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Pain in extremity (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation);Paraesthesia (n/a - Unknown - Caused/Prolonged Hospitalisation)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	[ESCITALOPRAM, ESCITALOPRAM OXALATE] (C - n/a - n/a - [n/a - n/a - n/a])|[TRAMADOL HYDROCHLORIDE] (C - n/a - n/a - [n/a - 50mg - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4020572&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4020584	Spontaneous	2010-10-08 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Glomerulonephropathy (195d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Haematuria (208d - Recovered/Resolved - Caused/Prolonged Hospitalisation);Overdose (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Antiviral prophylaxis - n/a - [n/a - 1mL - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4020584&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4013216	Spontaneous	2010-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Arthritis (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [1d - .5mL - n/a])	[CYANOCOBALAMIN, HYDROXOCOBALAMIN] (C - n/a - n/a - [n/a - n/a - n/a])|[DEXBROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE SULPHATE] (C - n/a - n/a - [n/a - n/a - n/a])|[SACCHAROMYCES BOULARDII, SACCHAROMYCES BOULARDII LYOPHILISED, SACCHAROMYCES BOULARDII CNCM I-745 LYOPHILIZED] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4013216&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4013230	Spontaneous	2010-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Male	Fatigue (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4013230&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4013347	Spontaneous	2010-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4013347&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4013771	Spontaneous	2010-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Abortion spontaneous (n/a - Unknown - Other Medically Important Condition);Exposure during pregnancy (n/a - Unknown - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4013771&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4014012	Spontaneous	2010-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Diabetes mellitus (9d - Recovered/Resolved - Other Medically Important Condition);Headache (3d - Recovered/Resolved - Other Medically Important Condition);Oropharyngeal pain (8d - Recovered/Resolved - Other Medically Important Condition);Toothache (3d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Intramuscular])	INSULIN LISPRO [INSULIN LISPRO] (C - Type 1 diabetes mellitus - Unknown - [n/a - n/a - Unknown])|LANTUS [INSULIN GLARGINE] (C - Type 1 diabetes mellitus - Unknown - [n/a - n/a - Unknown])|[FLUVASTATIN] (C - Hypercholesterolaemia - Unknown - [n/a - n/a - Oral])|[LEVOTHYROXINE SODIUM] (C - Hypothyroidism - Unknown - [n/a - n/a - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4014012&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4014073	Spontaneous	2010-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Female	Dermatitis exfoliative generalised (n/a - Recovered/Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Epilepsy (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Formication (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hepatitis toxic (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Hepatomegaly (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Myoclonus (n/a - Unknown - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition);Transaminases increased (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation, Disabling, Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - .5mL - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4014073&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling,Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4014545	Spontaneous	2010-10-07 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Elderly	No	Male	Demyelinating polyneuropathy (n/a - Unknown - Caused/Prolonged Hospitalisation);Diplopia (n/a - Recovering/Resolving - Caused/Prolonged Hospitalisation);Eyelid pain (n/a - Unknown - Caused/Prolonged Hospitalisation);Gait disturbance (n/a - Unknown - Caused/Prolonged Hospitalisation);Glycosylated haemoglobin increased (n/a - Unknown - Caused/Prolonged Hospitalisation);Headache (n/a - Unknown - Caused/Prolonged Hospitalisation);Hyperuricaemia (n/a - Unknown - Caused/Prolonged Hospitalisation);IVth nerve paralysis (n/a - Unknown - Caused/Prolonged Hospitalisation);Mononeuritis (n/a - Unknown - Caused/Prolonged Hospitalisation);Muscle spasms (n/a - Unknown - Caused/Prolonged Hospitalisation);Ocular myasthenia (n/a - Unknown - Caused/Prolonged Hospitalisation);Ophthalmoplegia (n/a - Unknown - Caused/Prolonged Hospitalisation);Spinal pain (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX PANDEMIC INFLUENZA VACCINE (H1N1)V (SPLIT VIRION, INACTIVATED, ADJUVANTED) SUSPENSION AND EMULSION FOR EMULSION FOR INJECTION [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	[BETA-ACETYLDIGOXIN] (C - n/a - Unknown - [n/a - .2mg - Oral])|[BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - Unknown - [n/a - 5mg - Oral])|[ENALAPRIL MALEATE] (C - n/a - Unknown - [n/a - 10mg - Oral])|[FUROSEMIDE] (C - n/a - Unknown - [n/a - 40mg - Oral])|[OMEPRAZOLE] (C - n/a - Unknown - [n/a - n/a - Unknown])|[PHENPROCOUMON] (C - Atrial fibrillation - Unknown - [n/a - n/a - Unknown])|[ZOPICLONE] (C - n/a - Unknown - [n/a - 7.5mg - Unknown])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4014545&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4009251	Spontaneous	2010-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Anaphylactic shock (90min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation);Respiratory failure (90min - Recovered/Resolved - Life Threatening, Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4009251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation,Life Threatening	Life Threatening
EU-EC-4009255	Spontaneous	2010-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Chills (0d - Recovered/Resolved - Other Medically Important Condition);Malaise (0d - Recovered/Resolved - Other Medically Important Condition);Syncope (0d - Recovered/Resolved - Other Medically Important Condition);Vomiting (0d - Recovered/Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4009255&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4009284	Spontaneous	2010-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	Not Specified	Adult	No	Male	Altered state of consciousness (n/a - Unknown - Other Medically Important Condition);Loss of consciousness (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [1d - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4009284&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	Severe reaction
EU-EC-4009368	Spontaneous	2010-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	3-11 Years	Child	No	Female	Cataplexy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition);Narcolepsy (n/a - Not Recovered/Not Resolved - Other Medically Important Condition)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4009368&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4009733	Spontaneous	2010-10-06 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Adult	No	Male	Epilepsy (n/a - Unknown - Caused/Prolonged Hospitalisation);Rhabdomyolysis (n/a - Unknown - Caused/Prolonged Hospitalisation)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - n/a - n/a - [n/a - n/a - Intramuscular])	[HYDROCORTISONE] (C - n/a - n/a - [n/a - n/a - n/a])|[LEVOTHYROXINE] (C - n/a - n/a - [n/a - n/a - n/a])|[TESTOSTERONE UNDECANOATE] (C - n/a - n/a - [n/a - n/a - n/a])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4009733&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4005464	Spontaneous	2010-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dysphonia (n/a - Recovered/Resolved - Disabling);Paralysis recurrent laryngeal nerve (n/a - Recovered/Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Influenza immunisation - n/a - [n/a - n/a - Intramuscular])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4005464&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Disabling	Severe reaction
EU-EC-4006238	Spontaneous	2010-10-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Erythema (n/a - Unknown - Other Medically Important Condition);Pruritus (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4006238&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4006241	Spontaneous	2010-10-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Arthralgia (n/a - Recovered/Resolved - Other Medically Important Condition);Rash (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4006241&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4006244	Spontaneous	2010-10-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Periorbital oedema (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4006244&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4006246	Spontaneous	2010-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	65-85 Years	Not Specified	No	Female	Dizziness (n/a - Not Recovered/Not Resolved - Caused/Prolonged Hospitalisation)	[A/BRISBANE/59/2007 (H1N1)-LIKE STRAIN, A/BRISBANE/10/2007 (H3N2)-LIKE STRAIN, B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, X-263B), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/SINGAPORE/INFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016, NIB-104), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/NANCHANG 933/95 (H3N2), A/BAYERN/7/95 (H1N1) - LIKE STRAIN (A/JOHANNESBURG/82/96), B/BEIJING/184/93-LIKE STRAIN (B/HARBIN/7/94), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/CALIFORNIA/7/2004 (H3N2) - LIKE STRAIN (A/NEW YORK/55/2004 REASS. NYMC X-157), B/SHANGHAI/361/2002 - LIKE STRAIN (B/JIANGSU/10/2003), A/NEW CALEDONIA/20/99 (H1N1) - LIKE STRAIN (A/NEW CALEDONIA/20/99 REASS. IVR-116), A/MOSCOW/10/99 (H3N2) - LIKE STRAIN (A/PANAMA/2007/99 REASS. RESVIR-17), B/SICHUAN/379/99-LIKE STRAIN (B/JOHANNESBURG/5/99), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), A/CALIFORNIA/7/2009 (H1N1)-DERIVED STRAIN USED NYMC X-181, B/BRISBANE/60/2008, A/SWITZERLAND/9715293/2013 (H3N2)-LIKE STRAIN (A/SWITZERLAND/9715293/2013, NIB-88), B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/BRISBANE/60/2008-LIKE STRAIN (B/BRISBANE/60/2008, WILD TYPE), A/MICHIGAN/45/2015 (H1N1)PDM09-LIKE STRAIN (A/SINGAPORE/GP1908/2015, IVR-180), A/HONG KONG/4801/2014 (H3N2)-LIKE STRAIN (A/HONG KONG/4801/2014, NYMC X-263B), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1), A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/BRISBANE/60/2008-LIKE VIRUS, A/CALIFORNIA/7/2009 (H1N1)V-LIKE VIRUS, A/PERTH/16/2009 (H3N2) - LIKE STRAIN (A/VICTORIA/210/2009 REASS. NYMC X-187), B/COLORADO/06/2017-LIKE VIRUS (B/VICTORIA/2/87 LINEAGE) (B/MARYLAND/15/2016, NYMC BX-69A), A/BRISBANE/02/2018 (H1N1)PDM09-LIKE VIRUS (A/BRISBANE/02/2018, IVR-190), A/KANSAS/14/2017 (H3N2)-LIKE VIRUS (A/KANSAS/14/2017, NYMC X-327), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/TEXAS/50/2012 (H3N2) – DERIVED STRAIN USED (NYMC X-223A), A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), B/MASSACHUSETTS/2/2012 -DERIVED STRAIN USED (NYMC BX-51B), A/VICTORIA/361/2011 (H3N2)-LIKE STRAIN USED (NYMC X-223A) DERIVED FROM A/TEXAS/50/2012, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2), INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B] (S - Influenza immunisation - n/a - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4006246&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Caused/Prolonged Hospitalisation	Life Threatening
EU-EC-4006249	Spontaneous	2010-10-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Female	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Urticaria (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4006249&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4006251	Spontaneous	2010-10-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Female	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Papule (n/a - Unknown - Other Medically Important Condition);Pyrexia (n/a - Unknown - Other Medically Important Condition);Rash (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4006251&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4006252	Spontaneous	2010-10-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	18-64 Years	Not Specified	Yes	Male	Anaphylactic reaction (n/a - Unknown - Other Medically Important Condition);Hypersensitivity (n/a - Unknown - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4006252&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4006286	Spontaneous	2010-10-05 00:00:00	Healthcare Professional	Non European Economic Area	Not available	2 Months - 2 Years	Not Specified	Yes	Male	Anaphylactic reaction (n/a - Recovered/Resolved - Other Medically Important Condition);Pruritus (n/a - Recovered/Resolved - Other Medically Important Condition)	[A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A, A/CALIFORNIA/7/2009 (H1N1)PDM09-DERIVED STRAIN USED (NYMC X-181), A/CALIFORNIA/7/2009(H1N1)-LIKE STRAIN (NYMC X-179A), INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED)] (S - Immunisation - Not applicable - [n/a - n/a - Unknown])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4006286&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4006596	Spontaneous	2010-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	2 Months - 2 Years	Not Specified	No	Male	Cold sweat (n/a - Recovered/Resolved - Other Medically Important Condition);Eye pain (n/a - Recovered/Resolved - Other Medically Important Condition);Fatigue (n/a - Recovered/Resolved - Other Medically Important Condition);Flushing (n/a - Recovered/Resolved - Other Medically Important Condition);Headache (n/a - Recovered/Resolved - Other Medically Important Condition);Listless (n/a - Recovered/Resolved - Other Medically Important Condition);Sleep disorder (n/a - Recovered/Resolved - Other Medically Important Condition);Somnolence (n/a - Recovered/Resolved - Other Medically Important Condition);Vision blurred (n/a - Recovered/Resolved - Other Medically Important Condition)	CELVAPAN [A/CALIFORNIA/07/2009 (H1N1)V, A/CALIFORNIA/7/2009 (H1N1)] (S - Prophylaxis - Not applicable - [n/a - n/a - n/a])	Not reported	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR.xdo?_xpf=&_xt=form&SR_ID=4006596&_xpt=1&_xf=pdf>ICSR</a>	influenza	2024-03-10	Other Medically Important Condition	
EU-EC-4006766	Spontaneous	2010-10-05 00:00:00	Healthcare Professional	European Economic Area	Not available	18-64 Years	Not Specified	No	Female	Arthropathy (n/a - Not Recovered/Not Resolved - Disabling);Condition aggravated (n/a - Not Recovered/Not Resolved - Disabling);Crohn's disease (n/a - Not Recovered/Not Resolved - Disabling);Haematochezia (n/a - Not Recovered/Not Resolved - Disabling);Mucous stools (n/a - Not Recovered/Not Resolved - Disabling)	PANDEMRIX [A/CALIFORNIA/7/2009 (H1N1) V REASS. X - 179 A] (S - Immunisation - Not applicable - [1d - n/a - Intramuscular])	HUMALOG [INSULIN LISPRO] (C - n/a - n/a - [n/a - n/a - n/a])|LANTUS [INSULIN GLARGINE] (C - n/a - n/a - [n/a - n/a - n/a])|MERCAPTOPURINE [MERCAPTOPURINE] (C - n/a - n/a - [n/a - n/a - n/a])|[ACETYLSALICYLIC ACID] (C - n/a - n/a - [n/a - 75mg - Oral])|[BISOPROLOL, BISOPROLOL FUMARATE, BISOPROLOL HEMIFUMARATE] (C - n/a - n/a - [n/a - 1.25mg - Oral])|[CALCIUM CARBONATE, CHOLECALCIFEROL CONCENTRATE (POWDER FORM), COLECALCIFEROL, CALCIUM CARBONATE] (C - n/a - n/a - [n/a - 1{DF} - Oral])|[EZETIMIBE] (C - n/a - n/a - [n/a - 10mg - Oral])|[LATANOPROST] (C - n/a - n/a - [n/a - 1{DF} - Ophthalmic])|[PREDNISOLONE] (C - n/a - n/a - [n/a - 2.5mg - Oral])	<a target=_blank href=https://dap.ema.europa.eu/xmlpserver/PHV%20DAP/Reports/ICSR